{"version": "v2.0", "data": [{"title": "f059e215ee14a89be75d577ec5ad4eb2", "paragraphs": [{"qas": [{"question": "What should you do if you have a fever?", "id": "100000000000000000000003", "answers": [{"text": "Drink a lot of water", "answer_start": 375}], "is_impossible": false}, {"question": "What is the name of the washcloth that you apply to the area of the shot?", "id": "100000000000000000000005", "answers": [{"text": "clean, cool, wet", "answer_start": 281}], "is_impossible": false}, {"question": "What is the name of the person who can give you medicine?", "id": "100000000000000000000007", "answers": [{"text": "healthcare provider", "answer_start": 477}], "is_impossible": false}], "context": "cdc.gov/coronavirus\nWhat to Expect after Getting a COVID-19 Vaccine\nThe COVID-19 shot may cause side effects in some people. Side effects should go away in a few days. On the arm where you got the shot:\n\u2022 Pain\n\u2022 Redness\n\u2022 Swelling\nIf you are sore where you got the shot:\n\u2022 Apply a clean, cool, wet washcloth over the area\n\u2022 Use or move your arm gently\nIf you have a fever:\n\u2022 Drink a lot of water\n\u2022 Get plenty of rest\n\u2022 Dress lightly\nIf you have pain, headache, or fever, ask a healthcare provider (or facility\nstaff) if you can have medicine."}]}, {"title": "d7bba6b692a38859debc1bf7955686d5", "paragraphs": [{"qas": [{"question": "What should you wear when you are in a correctional facility?", "id": "100000000000000000000008", "answers": [{"text": "a well-fitting mask", "answer_start": 114}], "is_impossible": false}, {"question": "How far away from others should you stay from others?", "id": "100000000000000000000009", "answers": [{"text": "6 feet", "answer_start": 156}], "is_impossible": false}, {"question": "What should go away in a few days?", "id": "100000000000000000000011", "answers": [{"text": "Side effects", "answer_start": 228}], "is_impossible": false}, {"question": "How long does it take for your body to build protection after a vaccination?", "id": "100000000000000000000014", "answers": [{"text": "It takes time", "answer_start": 542}], "is_impossible": false}], "context": "Even after your COVID-19 vaccination, when you are in a correctional facility, it\u2019s important\nto continue wearing a well-fitting mask, try to stay at least 6 feet away from others as\nmuch as possible, and wash your hands often. Side effects may make\nyou feel a little sick or\neven make it hard to\ndo daily activities, but\nthey should go away\nin a few days. vaccination rates and\nensure that staff and\nresidents stay up to date\non their COVID-19 vaccines. COVID-19 vaccines may\nnot fully protect you\nuntil a week or two after\nyour final shot. It takes\ntime for your body to\nbuild protection after\nany vaccination."}]}, {"title": "a2ebbe91c5fbc2888446cd5e8e0e63c8", "paragraphs": [{"qas": [{"question": "How long does it take for the redness or pain to get better?", "id": "100000000000000000000016", "answers": [{"text": "24 hours", "answer_start": 132}], "is_impossible": false}], "context": "Ask the facility healthcare provider (or facility staff) for help if:\n\u2022 The redness or pain where you got the shot gets worse after 24 hours\n\u2022 Your side effects are worrying you\n\u2022 Your side effects do not seem to be going away after a few days\nIn the rest of your body:\n\u2022 Fever\n\u2022 Chills\n\u2022 Tiredness\n\u2022 Headache\n\u2022 Muscle pain\n\u2022 Nausea\nCOMMON SIDE EFFECTS\nHELPFUL TIPS\nREMEMBER"}]}, {"title": "81fd262a74141ee213c771449bcfd8a4", "paragraphs": [{"qas": [{"question": "Who recommends COVID-19 vaccines for everyone 6 months and older?", "id": "100000000000000000000020", "answers": [{"text": "CDC", "answer_start": 140}], "is_impossible": false}, {"question": "What is a quick, easy, and free way to get a vaccine?", "id": "100000000000000000000023", "answers": [{"text": "Getting a COVID-19 vaccine is fast, easy, and free. Learn how to find a COVID-19 vaccine near you, and get your vaccine today", "answer_start": 531}], "is_impossible": false}, {"question": "What is the cost of getting a COVID-19 vaccine near you?", "id": "100000000000000000000024", "answers": [{"text": "free", "answer_start": 577}], "is_impossible": false}], "context": "10/30/22, 9:34 AM About COVID-19 Vaccines | CDC\nEspa\u00f1ol | Other Languages\nAbout COVID-19 Vaccines\nCOVID-19 vaccines are safe and effective. CDC recommends COVID-19 vaccines for everyone 6 months and older and boosters\nfor everyone 5 years and older, if eligible. Learn about the different vaccines available. To find a COVID-19 vaccine near you: Search vaccines.gov, text your zip\ncode to 438829, or call 1-800-232-0233 to find COVID-19 vaccine locations near you. Benefits of Getting Vaccinated\nFrequently Asked Questions\n\u2022\n\u2022\n\u2022\n\u2022\nGetting a COVID-19 vaccine is fast, easy, and free. Learn how to find a COVID-19 vaccine near you, and get your vaccine\ntoday!"}]}, {"title": "da98716b643874423d2b1e104481ee65", "paragraphs": [{"qas": [{"question": "How do Vaccines Get to You?", "id": "100000000000000000000025", "answers": [{"text": "Reporting Vaccine Data", "answer_start": 29}], "is_impossible": false}, {"question": "When was the last update for COVID-19 vaccines?", "id": "100000000000000000000026", "answers": [{"text": "July 13, 2022", "answer_start": 239}], "is_impossible": false}], "context": "\uf294 Vaccine Data\nVaccine Data\n\u203a\nReporting Vaccine Data\n\u203a\n\uf3c2 How Vaccines Get to You\nDeveloping COVID-19 vaccines\n\u203a\n\uf2ff For Healthcare and Public Health\nUse of COVID-19 Vaccines in the United States: Interim Clinical Considerations\nLast Updated July 13, 2022"}]}, {"title": "5ae09f6b7c89da2d1b5973d4cf686c0c", "paragraphs": [{"qas": [{"question": "What is the minimum age to receive boosters?", "id": "100000000000000000000030", "answers": [{"text": "5 years and older", "answer_start": 306}], "is_impossible": false}], "context": "Espa\u00f1ol | Other Languages\nGet the facts about COVID-19 and the virus that causes it, including how it spreads and new variants. CDC is reviewing this page to align with updated guidance. Protect Your Family Members\nCDC recommends COVID-19 vaccines for everyone 6 months and older and boosters for\neveryone 5 years and older, if eligible."}]}, {"title": "948373cea621f6816d541c171e687f1b", "paragraphs": [{"qas": [{"question": "How does it spread Variants of the Virus Stress & Coping Animals?", "id": "100000000000000000000033", "answers": [{"text": "\uf1aa \uf1aa \uf1aa \uf1aa", "answer_start": 345}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000000034", "answers": [{"text": "Anyone not up to date with their COVID-19 vaccines", "answer_start": 103}], "is_impossible": false}, {"question": "What is the name of the virus that causes stress in animals?", "id": "100000000000000000000036", "answers": [{"text": "COVID-19", "answer_start": 83}], "is_impossible": false}], "context": "Some people in your family may need to take more\nsteps to be better protected from COVID-19, including\nAnyone not up to date with their COVID-19 vaccines\nPeople with weakened immune systems or underlying medical conditions\n\u2022\n\u2022\nProtect Yourself & Others\nHow It Spreads\nVariants of the Virus\nStress & Coping\nAnimals & COVID-19\nBasics of COVID-19\n\uf1aa\n\uf1aa\n\uf1aa\n\uf1aa\n\uf1aa\n\uf1aa\nLast Updated Jan. 24, 2022"}]}, {"title": "cb7973e637cb213634c54a9aa03f5427", "paragraphs": [{"qas": [{"question": "What can happen if you get a COVID-19 vaccine and you think you might be having a severe allergic reaction to a vaccine?", "id": "100000000000000000000037", "answers": [{"text": "seek immediate medical care by calling 911", "answer_start": 408}], "is_impossible": false}, {"question": "What is rare but can happen?", "id": "100000000000000000000038", "answers": [{"text": "Severe allergic reactions to vaccines", "answer_start": 209}], "is_impossible": false}, {"question": "What should you do if you think you might be allergic to the COVID-19 vaccine?", "id": "100000000000000000000039", "answers": [{"text": "seek immediate medical care by calling 911", "answer_start": 408}], "is_impossible": false}, {"question": "What is a generalized rash or hives?", "id": "100000000000000000000041", "answers": [{"text": "mucus membranes", "answer_start": 634}], "is_impossible": false}], "context": "10/30/22, 9:31 AM Allergic Reactions after COVID-19 Vaccination | CDC\nEspa\u00f1ol | Other Languages\nAllergic Reactions after COVID-19 Vaccination\nIf You Are Having a Severe Allergic Reaction to a COVID-19\nVaccine\nSevere allergic reactions to vaccines are rare but can happen. If you get a COVID-19 vaccine and you think you might be\nhaving a severe allergic reaction after leaving the vaccination provider site, seek immediate medical care by calling 911. A severe allergic reaction can cause:\ndifficulty breathing or wheezing,\na drop in blood pressure,\nswelling of the tongue or throat, or\na generalized rash or hives, which may include mucus membranes."}]}, {"title": "194fe3206a0c67ecf603064b7338c8ad", "paragraphs": [{"qas": [{"question": "What are the Pfizer-BioNTech and Moderna COVID-19 vaccines also called?", "id": "100000000000000000000043", "answers": [{"text": "mRNA vaccines", "answer_start": 150}], "is_impossible": false}, {"question": "What is the name of the vaccine that is a viral vector vaccine?", "id": "100000000000000000000044", "answers": [{"text": "Johnson & Johnson\u2019s/Janssen(J&J/Janssen) COVID-19", "answer_start": 165}], "is_impossible": false}, {"question": "Novavax is what?", "id": "100000000000000000000045", "answers": [{"text": "protein subunit vaccine", "answer_start": 280}], "is_impossible": false}, {"question": "What does CDC recommend people getting a booster get?", "id": "100000000000000000000046", "answers": [{"text": "an mRNA COVID-19 vaccine", "answer_start": 552}], "is_impossible": false}, {"question": "What is the name of the mRNA COVID-19 vaccine?", "id": "100000000000000000000047", "answers": [{"text": "Moderna", "answer_start": 84}], "is_impossible": false}], "context": "If You Had a Severe Allergic Reaction to a COVID-19 Vaccine\nThe Pfizer-BioNTech and Moderna COVID-19 vaccines are messenger RNA vaccines, also called mRNA vaccines. Johnson & Johnson\u2019s/Janssen(J&J/Janssen) COVID-19 vaccine is a viral vector vaccine. Novavax COVID-19 vaccine is a protein subunit vaccine. If you had a severe allergic reaction after receiving a particular type of COVID-19 vaccine (either mRNA, protein subunit,\nor viral vector), you should not get another dose of that type of vaccine. CDC recommends that people getting a booster get an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna)."}]}, {"title": "e34dcd35e8a2caef68ba59a67638ebb3", "paragraphs": [{"qas": [{"question": "What is another name for the J&J/Janssen COVID-19 vaccine?", "id": "100000000000000000000048", "answers": [{"text": "mRNA", "answer_start": 66}], "is_impossible": false}, {"question": "What type of vaccine can you get if you have a severe allergic reaction?", "id": "100000000000000000000049", "answers": [{"text": "J&J/Janssen COVID-19 vaccine", "answer_start": 208}], "is_impossible": false}], "context": "However, if\nyou had a severe allergic reaction after a dose of an mRNA COVID-19 vaccine or if you have had a severe allergic reaction to\nany ingredient in an mRNA COVID-19 vaccine, you may be able to get the J&J/Janssen COVID-19 vaccine. Learn about getting a different type of COVID-19 vaccine after an allergic reaction."}]}, {"title": "7ff7f8b5d8e85b1fdbe91110fda87436", "paragraphs": [{"qas": [{"question": "What is the definition of an immediate allergic reaction?", "id": "100000000000000000000051", "answers": [{"text": "a reaction that started within 4 hours", "answer_start": 128}], "is_impossible": false}, {"question": "What is another term for an allergic reaction that started within 4 hours?", "id": "100000000000000000000052", "answers": [{"text": "immediate allergic reaction", "answer_start": 99}], "is_impossible": false}, {"question": "What is the name of the vaccine that your doctor may refer you to?", "id": "100000000000000000000054", "answers": [{"text": "COVID-19", "answer_start": 196}], "is_impossible": false}], "context": "If You Have Had an Immediate Allergic Reaction to Other\nVaccines or Injectables\nIf you have had an immediate allergic reaction (a reaction that started within 4 hours) to any vaccine other than a COVID-19\nvaccine or any injectable therapy, you may still be able to get a COVID-19 vaccine. However, your doctor may refer you to an\nallergy and immunology specialist for additional care or advice."}]}, {"title": "ecaf712d2fb2b519784ccb0aca7b73d5", "paragraphs": [{"qas": [{"question": "What is a non-severe allergic reaction to a COVID-19 Vaccine?", "id": "100000000000000000000055", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022", "answer_start": 64}], "is_impossible": false}, {"question": "What is an immediate allergic reaction?", "id": "100000000000000000000056", "answers": [{"text": "a reaction that started within 4 hours of getting vaccinated", "answer_start": 193}], "is_impossible": false}, {"question": "What can you receive under certain conditions?", "id": "100000000000000000000058", "answers": [{"text": "another dose of the same vaccine", "answer_start": 371}], "is_impossible": false}], "context": "If You Had a Non-severe Allergic Reaction to a COVID-19 Vaccine\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:31 AM Allergic Reactions after COVID-19 Vaccination | CDC\nIf you had an immediate allergic reaction (a reaction that started within 4 hours of getting vaccinated) to a COVID-19 vaccine,\nbut the reaction was not considered severe by a medical professional, you likely can receive another dose of the same vaccine\nunder certain conditions. Your doctor may refer you to an allergy and immunology specialist for additional care or advice."}]}, {"title": "eaa55a44539a58015dfeabf50ee6816f", "paragraphs": [{"qas": [{"question": "What should you do if you had a red, itchy, swollen, or painful rash where you got a COVID-19 shot?", "id": "100000000000000000000060", "answers": [{"text": "you should still get another shot", "answer_start": 140}], "is_impossible": false}, {"question": "What type of rashes can start a few days to more than a week after your shot?", "id": "100000000000000000000061", "answers": [{"text": "sometimes quite large", "answer_start": 452}], "is_impossible": false}], "context": "If You Had a Rash on the Arm where You Got a COVID-19 Shot\nIf you had a red, itchy, swollen, or painful rash where you got a COVID-19 shot, you should still get another shot at the\nscheduled date and time. This applies to second, additional, or booster shots. Your vaccination provider may recommend that\nyou get your next COVID-19 vaccine in the opposite arm, if possible. These rashes can start a few days to more than a week after your shot and are sometimes quite large."}]}, {"title": "99f603a81c35490975e6c53a77505766", "paragraphs": [{"qas": [{"question": "What are these rashes also known as?", "id": "100000000000000000000063", "answers": [{"text": "COVID arm", "answer_start": 32}], "is_impossible": false}, {"question": "If the rash is itchy, you can take what?", "id": "100000000000000000000065", "answers": [{"text": "an antihistamine", "answer_start": 283}], "is_impossible": false}, {"question": "What can you take if the rash is itchy?", "id": "100000000000000000000066", "answers": [{"text": "an antihistamine", "answer_start": 283}], "is_impossible": false}, {"question": "What is an NSAID?", "id": "100000000000000000000067", "answers": [{"text": "non- steroidal anti-inflammatory drug", "answer_start": 374}], "is_impossible": false}, {"question": "How long should someone who gets a COVID-19 vaccine be monitored after vaccination?", "id": "100000000000000000000068", "answers": [{"text": "at least 15 minutes", "answer_start": 514}], "is_impossible": false}], "context": "These rashes are also\nknown as \u201cCOVID arm.\u201d Tell your vaccination provider that you experienced a rash or \u201cCOVID arm\u201d after your shot. Your\nvaccination provider may recommend that you get your next COVID-19 vaccine in the opposite arm if possible. If the rash is itchy, you can take an antihistamine. If it is painful, you can take a pain medication like acetaminophen or a non-\nsteroidal anti-inflammatory drug (NSAID). Safeguards Are in Place\nEveryone who gets a COVID-19 vaccine should be monitored on site for at least 15 minutes after vaccination."}]}, {"title": "239afa78157bc2a3e3e9faf635e5ed97", "paragraphs": [{"qas": [{"question": "How long should you be monitored if you have had a severe allergic reaction?", "id": "100000000000000000000069", "answers": [{"text": "30 minutes", "answer_start": 28}], "is_impossible": false}, {"question": "What is anaphylaxis?", "id": "100000000000000000000070", "answers": [{"text": "severe allergic reaction", "answer_start": 58}], "is_impossible": false}, {"question": "How long does it take for an allergic reaction to occur?", "id": "100000000000000000000071", "answers": [{"text": "within 4 hours", "answer_start": 156}], "is_impossible": false}, {"question": "What is one type of COVID-19 vaccine?", "id": "100000000000000000000072", "answers": [{"text": "mRNA vaccine", "answer_start": 323}], "is_impossible": false}, {"question": "What type of vaccine is a viral vector?", "id": "100000000000000000000073", "answers": [{"text": "COVID-19", "answer_start": 375}], "is_impossible": false}, {"question": "Where should a person get vaccinated?", "id": "100000000000000000000074", "answers": [{"text": "a health clinic, medical facility, or doctor\u2019s office", "answer_start": 463}], "is_impossible": false}], "context": "You should be monitored for 30 minutes if:\nYou have had a severe allergic reaction called anaphylaxis due to any cause. You have had any type of immediate (within 4 hours) allergic reaction to a non-COVID-19 vaccine or injectable\ntherapy. You had a severe allergic reaction to one type of COVID-19 vaccine (for example, an mRNA vaccine) and are now\nreceiving another type of COVID-19 vaccine (for example, a viral vector). This vaccination should only be done in a\nhealth clinic, medical facility, or doctor\u2019s office."}]}, {"title": "7f367bb0227a59b0bf5f06f13849d734", "paragraphs": [{"qas": [{"question": "Where should you get your COVID-19 vaccination?", "id": "100000000000000000000076", "answers": [{"text": "health clinic, medical facility, or doctor\u2019s office", "answer_start": 173}], "is_impossible": false}, {"question": "What is the name of the national system that collects reports from healthcare professionals, vaccine manufacturers, and the public about adverse events after vaccination?", "id": "100000000000000000000078", "answers": [{"text": "VAERS", "answer_start": 450}], "is_impossible": false}], "context": "You had an immediate (within 4 hours) allergic reaction that was not severe from a previous dose of that type of\nCOVID-19 vaccine. This vaccination should only be done in a health clinic, medical facility, or doctor\u2019s office. CDC Is Monitoring Reports of Severe Allergic Reactions\nIf someone has a severe allergic reaction after getting vaccinated, their vaccination provider will send a report to the Vaccine\nAdverse Event Reporting System (VAERS). VAERS is a national system that collects reports from healthcare professionals,\nvaccine manufacturers, and the public about adverse events that happen after vaccination."}]}, {"title": "a591319cbeea9146749734234f05d143", "paragraphs": [{"qas": [{"question": "What are reports of selected adverse events after COVID-19 vaccination?", "id": "100000000000000000000080", "answers": [{"text": "adverse events that are unexpected, appear to happen more often than expected, or have unusual patterns are followed up with specific studies. Learn more about how CDC and federal partners are monitoring the safety of COVID-19 vaccines in the United States", "answer_start": 11}], "is_impossible": false}, {"question": "What should vaccination providers have at all COVID-19 vaccination provider sites?", "id": "100000000000000000000081", "answers": [{"text": "appropriate personnel, medications, and equipment", "answer_start": 388}], "is_impossible": false}, {"question": "What should you do if you experience a severe allergic reaction after getting a COVID-19 vaccine?", "id": "100000000000000000000082", "answers": [{"text": "call for emergency medical services", "answer_start": 712}], "is_impossible": false}, {"question": "What type of reaction can occur after getting a COVID-19 vaccine?", "id": "100000000000000000000083", "answers": [{"text": "severe allergic", "answer_start": 602}], "is_impossible": false}, {"question": "What can emergency medical services do?", "id": "100000000000000000000084", "answers": [{"text": "If you experience a severe allergic reaction after getting a COVID-19 vaccine, vaccination providers can provide care rapidly", "answer_start": 582}], "is_impossible": false}], "context": "Reports of adverse events that are\nunexpected, appear to happen more often than expected, or have unusual patterns are followed up with specific studies. Learn more about how CDC and federal partners are monitoring the safety of COVID-19 vaccines in the United States,\nincluding reports of selected adverse events after COVID-19 vaccination. \u2022\n\u2022\n-\n-\n-\n-\nVaccination providers should have appropriate personnel, medications, and equipment\u2014such as epinephrine,\nantihistamines, blood pressure monitor, and timing devices to check your pulse\u2014at all COVID-19 vaccination provider\nsites. If you experience a severe allergic reaction after getting a COVID-19 vaccine, vaccination providers can provide care\nrapidly and call for emergency medical services."}]}, {"title": "8e49fd6e064ee564dea7a243c32b0b3b", "paragraphs": [{"qas": [{"question": "What are the Possible Side Effects of COVID-19 Vaccines for People with Allergies?", "id": "100000000000000000000086", "answers": [{"text": "Ensuring the Safety of COVID-19 Vaccines", "answer_start": 104}], "is_impossible": false}, {"question": "What is considered for use of mRNA COVID-19 Vaccines Currently Authorized in the United States?", "id": "100000000000000000000088", "answers": [{"text": "Interim Clinical Considerations", "answer_start": 356}], "is_impossible": false}, {"question": "What is Research Allergic Reactions Including Anaphylaxis After Receipt of the First Dose?", "id": "100000000000000000000089", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 600}], "is_impossible": false}], "context": "\uf209\nRelated Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines\n\u203a\f10/30/22, 9:31 AM Allergic Reactions after COVID-19 Vaccination | CDC\n\uf2ff For Healthcare Professionals\nInterim Considerations: Preparing for the Potential Management of Anaphylaxis at COVID-19\nVaccination Sites\nInterim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United\nStates\nCOVID-19 Clinical Resources\n\u2022\n\u2022\n\u2022\nMore Information\nResearch\nAllergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine \u2014 United\nAllergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine \u2014 United States,\nMore Information\nVaccine Adverse Event Reporting System (VAERS)\nCOVID-19 Vaccine Safety Publications\n\uf209\nLast Updated July 20, 2022"}]}, {"title": "2d2d93f3f938c4d227de4e00cd007b9d", "paragraphs": [{"qas": [{"question": "What can the virus spread from people to animals during?", "id": "100000000000000000000093", "answers": [{"text": "close contact", "answer_start": 316}], "is_impossible": false}, {"question": "When can SARS-CoV-2 spread from people to animals?", "id": "100000000000000000000094", "answers": [{"text": "during close contact", "answer_start": 309}], "is_impossible": false}, {"question": "What is needed to understand how the virus is spread between people and animals? People with suspected or confirmed COVID-19 should avoid contact with animals, including what?", "id": "100000000000000000000095", "answers": [{"text": "pets, livestock, and wildlife", "answer_start": 528}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Animals and COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nAnimals and COVID-19\nCDC is reviewing this page to align with updated guidance. What You Need to Know\nThe risk of animals spreading SARS-CoV-2, the virus that causes COVID-19, to people is low. The virus can spread from people to animals during close contact. More studies and surveillance are needed to understand how SARS-CoV-2 is spread between people and animals. People with suspected or confirmed COVID-19 should avoid contact with animals, including pets, livestock, and\nwildlife."}]}, {"title": "2ad87233769032e29ecca90d80ffa575", "paragraphs": [{"qas": [{"question": "What do some coronaviruses cause in people?", "id": "100000000000000000000097", "answers": [{"text": "cold-like illnesses", "answer_start": 322}], "is_impossible": false}, {"question": "Which type of animal do some canine and feline coronvisvirus not infect people?", "id": "100000000000000000000100", "answers": [{"text": "animals", "answer_start": 516}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\nFor Pet Owners, Veterinarians, & Public Health Officials\nPet Owners\nand Others\nHandling\nAnimals\nPets and\nAnimals\nFrequently\nAsked\nQuestions\nAnimal\nTesting\nGuidance\nOne Health\nToolkit for\nHealth\nOfficials\nManaging\nCompanion\nAnimals with\n\u2022\n\u2022\n\u2022\n\u2022\nCoronaviruses are a large family of viruses. Some coronaviruses cause cold-like illnesses in people, while others cause illness\nin certain types of animals, such as cattle, camels, and bats. Some coronaviruses, such as canine and feline coronaviruses,\ninfect only animals and do not infect people. Some coronaviruses that infect animals can be spread to people and then\nspread between people, but this is rare. This is what happened with SARS-CoV-2, which likely originated in bats."}]}, {"title": "87101b9d6ca6bf13c9d14fb3245669a0", "paragraphs": [{"qas": [{"question": "What is the risk of people spreading SARS-CoV-2 to animals?", "id": "100000000000000000000101", "answers": [{"text": "Risk of people spreading SARS-CoV-2 to animals Animals infected with SARS-CoV-2 have been documented around the world. Most of these animals became infected after contact with people with COVID-19", "answer_start": 45}], "is_impossible": false}, {"question": "What has been documented around the world?", "id": "100000000000000000000102", "answers": [{"text": "Animals infected with SARS-CoV-2", "answer_start": 92}], "is_impossible": false}, {"question": "How did most animals become infected after contact with people with COVID-19?", "id": "100000000000000000000103", "answers": [{"text": "close contact", "answer_start": 295}], "is_impossible": false}, {"question": "What are some of the animals that can get infected?", "id": "100000000000000000000104", "answers": [{"text": "pet cats, dogs, hamsters, and ferrets", "answer_start": 443}], "is_impossible": false}, {"question": "What is one type of animal that is reported to be infecting humans?", "id": "100000000000000000000105", "answers": [{"text": "pet cats, dogs, hamsters, and ferrets", "answer_start": 443}], "is_impossible": false}, {"question": "How many types of big cats are in zoos?", "id": "100000000000000000000106", "answers": [{"text": "several", "answer_start": 525}], "is_impossible": false}, {"question": "What animals do lions, tigers, snow leopards, and otters have in common?", "id": "100000000000000000000107", "answers": [{"text": "big cats", "answer_start": 542}], "is_impossible": false}, {"question": "What animal is a coatimundi?", "id": "100000000000000000000108", "answers": [{"text": "binturong", "answer_start": 619}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Animals and COVID-19 | CDC\nRisk of people spreading SARS-CoV-2 to animals\nAnimals infected with SARS-CoV-2 have been documented around the world. Most of these animals became infected after\ncontact with people with COVID-19, including owners, caretakers, or others who were in close contact. We don\u2019t yet know all\nof the animals that can get infected. Animals reported infected worldwide include\nCompanion animals, including pet cats, dogs, hamsters, and ferrets. Animals in zoos and sanctuaries, including several types of big cats (e.g., lions, tigers, snow leopards), otters, non-human\nprimates, a binturong, a coatimundi, a fishing cat, hyenas, hippopotamuses, and manatees."}]}, {"title": "8aad37bad5e1f65c77e0155868940a8b", "paragraphs": [{"qas": [{"question": "What is the name of the toolkit for health officials to reduce risk of spreading COVID-19?", "id": "100000000000000000000109", "answers": [{"text": "COVID-19", "answer_start": 270}], "is_impossible": false}, {"question": "What type of deer can be found near mink farms?", "id": "100000000000000000000110", "answers": [{"text": "mule deer", "answer_start": 59}], "is_impossible": false}, {"question": "Where can you find information on how to protect pets and animals?", "id": "100000000000000000000111", "answers": [{"text": "What You Should Know about COVID-19 and Pets Companion Animals with COVID-19: Toolkit for Health Officials", "answer_start": 201}], "is_impossible": false}, {"question": "What is the risk of animals spreading SARS-CoV-2 to people?", "id": "100000000000000000000113", "answers": [{"text": "There is no evidence", "answer_start": 420}], "is_impossible": false}, {"question": "What animal has been reported to spread the virus to people during close contact?", "id": "100000000000000000000116", "answers": [{"text": "mammalian", "answer_start": 588}], "is_impossible": false}], "context": "Mink on mink farms. Wildlife, including white-tailed deer, mule deer, a black-tailed marmoset, a giant anteater, and wild mink near mink\nfarms. For information on how to protect pets and animals, visit\nWhat You Should Know about COVID-19 and Pets\nCompanion Animals with COVID-19: Toolkit for Health Officials\nReducing Risk of Spreading COVID-19 between People and Wildlife\nRisk of animals spreading SARS-CoV-2 to people\nThere is no evidence that animals play a significant role in spreading SARS-CoV-2, the virus that causes COVID-19, to people. There have been a few reports of infected mammalian animals spreading the virus to people during close contact, but this is\nrare."}]}, {"title": "72882d2ae816b477bfdc8b82b72c3827", "paragraphs": [{"qas": [{"question": "Where are pet hamsters found in Hong Kong?", "id": "100000000000000000000118", "answers": [{"text": "Hong Kong", "answer_start": 110}], "is_impossible": false}, {"question": "What is the name of the person who first infected a cat in Thailand?", "id": "100000000000000000000119", "answers": [{"text": "COVID- 19", "answer_start": 232}], "is_impossible": false}, {"question": "What could the virus infect animals, mutate and create a new strain?", "id": "100000000000000000000122", "answers": [{"text": "spread back to people", "answer_start": 529}], "is_impossible": false}, {"question": "What could a virus infect?", "id": "100000000000000000000123", "answers": [{"text": "animals", "answer_start": 489}], "is_impossible": false}, {"question": "What is the term for a new strain that could spread back to people and then among people?", "id": "100000000000000000000124", "answers": [{"text": "spillback", "answer_start": 581}], "is_impossible": false}], "context": "These cases include farmed mink in Europe and the United States, white-tailed deer in Canada, pet hamsters in Hong\nKong, and a cat in Thailand. In most of these cases, the animals were known to be first infected by a person who had COVID-\n19. It\u2019s important to remember that people are much more likely to get COVID-19 from other people than from animals. There is\nno need to euthanize or otherwise harm animals infected with SARS-CoV-2. There is a possibility that the virus could infect animals, mutate, and a new strain could spread back to people and then\namong people (called spillback)."}]}, {"title": "2d1d238b3ff66b07dc27e6073b9e840e", "paragraphs": [{"qas": [{"question": "In the United States, respiratory disease and increases in mink deaths have been seen on most affected mink farms.", "id": "100000000000000000000126", "answers": [{"text": "More studies and surveillance are needed to track variants and mutations and to understand how SARS-CoV-2 spreads between people and animals", "answer_start": 0}], "is_impossible": false}, {"question": "Some infected mink might appear what?", "id": "100000000000000000000127", "answers": [{"text": "healthy", "answer_start": 323}], "is_impossible": false}, {"question": "What is SARS-CoV-2?", "id": "100000000000000000000128", "answers": [{"text": "variants and mutations and to understand how SARS-CoV-2 spreads between people and animals", "answer_start": 50}], "is_impossible": false}, {"question": "What did workers introduce to mink on farms?", "id": "100000000000000000000129", "answers": [{"text": "SARS-CoV-2", "answer_start": 367}], "is_impossible": false}, {"question": "How did the virus spread?", "id": "100000000000000000000130", "answers": [{"text": "among the mink", "answer_start": 435}], "is_impossible": false}, {"question": "Dogs, cats, etc., are also what kind of animal?", "id": "100000000000000000000132", "answers": [{"text": "mink to other animals on the farm", "answer_start": 538}], "is_impossible": false}], "context": "More studies and surveillance are needed to track variants and mutations and to understand\nhow SARS-CoV-2 spreads between people and animals. Mink and SARS-CoV-2\nIn the United States, respiratory disease and increases in mink deaths have been seen on most affected mink farms. However, some infected mink might also appear healthy. Infected workers likely introduced SARS-CoV-2 to mink on the farms,\nand the virus then began to spread among the mink. Once the virus is introduced on a farm, spread can occur between mink,\nas well as from mink to other animals on the farm (dogs, cats)."}]}, {"title": "b06129ce4bee31b367178f3956c53e5c", "paragraphs": [{"qas": [{"question": "Where were the mink found to have been trapped?", "id": "100000000000000000000134", "answers": [{"text": "near affected farms in Utah and Oregon", "answer_start": 62}], "is_impossible": false}, {"question": "There is no evidence that mink are playing a significant role in what?", "id": "100000000000000000000136", "answers": [{"text": "the spread of SARS-CoV-2 to people", "answer_start": 218}], "is_impossible": false}, {"question": "What is the possibility of mink spreading SARS-CoV-2 to people and other animals on mink farms?", "id": "100000000000000000000137", "answers": [{"text": "there is a", "answer_start": 254}], "is_impossible": false}, {"question": "Mink-to-human spread has been reported in the Netherlands, Denmark, and Poland, and data suggest it might have occurred in what country?", "id": "100000000000000000000138", "answers": [{"text": "United States", "answer_start": 490}], "is_impossible": false}, {"question": "How can people spread SARS-CoV-2 to animals?", "id": "100000000000000000000139", "answers": [{"text": "during close contact", "answer_start": 557}], "is_impossible": false}], "context": "One wild mink and a small number of escaped farm mink\ntrapped near affected farms in Utah and Oregon were found to be infected with SARS-CoV-2. Although there is no evidence that mink are playing a significant role in the spread of SARS-CoV-2 to people, there is a\npossibility of mink spreading SARS-CoV-2 to people and other animals on mink farms. Mink-to-human spread of SARS-CoV-2\nhas been reported in the Netherlands, Denmark, and Poland, and data suggest it might have occurred in the United States. People can spread SARS-CoV-2 to animals, especially during close contact."}]}, {"title": "b52ae7fa4556e6a248c14822ad874f72", "paragraphs": [{"qas": [{"question": "What is the risk of animals spreading COVID-19 to people considered low?", "id": "100000000000000000000140", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022", "answer_start": 0}], "is_impossible": false}, {"question": "What has been reported in farmed mink in multiple countries?", "id": "100000000000000000000141", "answers": [{"text": "SARS-CoV-2", "answer_start": 82}], "is_impossible": false}, {"question": "What animal was infected with SARS-CoV-2?", "id": "100000000000000000000142", "answers": [{"text": "mink", "answer_start": 330}], "is_impossible": false}, {"question": "What type of mutations were found in mink from a Michigan farm?", "id": "100000000000000000000143", "answers": [{"text": "mink-related mutations", "answer_start": 437}], "is_impossible": false}, {"question": "Does this suggest a human-to-human spread?", "id": "100000000000000000000144", "answers": [{"text": "might have occurred", "answer_start": 538}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nThe risk of animals spreading COVID-19 to people is considered low. SARS-CoV-2 has been reported in farmed mink in multiple countries. Currently, there is no evidence that mink are playing\na significant role in the spread of COVID-19 to people. 10/30/22, 9:37 AM Animals and COVID-19 | CDC\nInvestigations found that mink from a Michigan farm and a small number of people were infected with SARS-CoV-2 that\ncontained unique mink-related mutations (changes in the virus\u2019s genetic material). This suggests mink-to-human spread\nmight have occurred."}]}, {"title": "11df74a8cf591564413db47aae7ad791", "paragraphs": [{"qas": [{"question": "What is the name of the animal that has SARS-CoV-2 mutations?", "id": "100000000000000000000145", "answers": [{"text": "mink", "answer_start": 27}], "is_impossible": false}, {"question": "In what state is the Michigan farm located?", "id": "100000000000000000000146", "answers": [{"text": "Michigan", "answer_start": 39}], "is_impossible": false}, {"question": "Where are the mutations seen before in mink?", "id": "100000000000000000000147", "answers": [{"text": "farms in the Netherlands and Denmark", "answer_start": 119}], "is_impossible": false}, {"question": "What do these results highlight the importance of?", "id": "100000000000000000000150", "answers": [{"text": "routinely studying the genetic material of SARS-CoV-2", "answer_start": 472}], "is_impossible": false}, {"question": "What kind of animal is SARS-CoV-2 susceptible to?", "id": "100000000000000000000151", "answers": [{"text": "mink", "answer_start": 565}], "is_impossible": false}], "context": "Finding these mutations in mink on the Michigan farm is not unexpected because they have been seen before in mink\nfrom farms in the Netherlands and Denmark, and also in people linked to mink farms worldwide. To confirm the spread of SARS-CoV-2 from mink to people, public health officials would need more information on the\nepidemiology and genetics of the virus in mink, mink farm workers, and the communities around mink farms. These results highlight the importance of routinely studying the genetic material of SARS-CoV-2 in susceptible animal\npopulations like mink, as well as in people."}]}, {"title": "b90829ff3c739f76090ba19ee477ffb", "paragraphs": [{"qas": [{"question": "What is available to protect worker and animal health?", "id": "100000000000000000000152", "answers": [{"text": "Guidance", "answer_start": 8}], "is_impossible": false}, {"question": "What approach is used to prevent introduction of SARS-CoV-2 on Mink farms?", "id": "100000000000000000000153", "answers": [{"text": "One Health", "answer_start": 196}], "is_impossible": false}, {"question": "What is the acronym for SARS-CoV-2?", "id": "100000000000000000000154", "answers": [{"text": "\u2022 \u2022 Guidance is available to protect worker and animal health, developed collaboratively by the U.S. Department of Agriculture (USDA), CDC, and state animal and public health partners using a One Health approach: Prevent Introduction of SARS-CoV-2 on Mink Farms", "answer_start": 3}], "is_impossible": false}, {"question": "How can this virus affect different animals?", "id": "100000000000000000000156", "answers": [{"text": "if they can spread infection to other animals", "answer_start": 700}], "is_impossible": false}, {"question": "How can animals be affected by this virus?", "id": "100000000000000000000157", "answers": [{"text": "spread infection to other animals", "answer_start": 712}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\nGuidance is available to protect worker and animal health, developed collaboratively by the U.S. Department of\nAgriculture (USDA), CDC, and state animal and public health partners using a One Health approach:\nPrevent Introduction of SARS-CoV-2 on Mink Farms: Interim SARS-CoV-2 Guidance and Recommendations for Farmed\nMink and Other Mustelids\nResponse and Containment Guidelines: Interim Guidance for Animal Health and Public Health Officials Managing Farmed\nMink and other Farmed Mustelids with SARS-CoV-2\n\uf20c \uf209\n\uf20c \uf209\nResearch on animals and COVID-19\nMany studies have been done to learn more about how this virus can affect different animals, including if they are susceptible\nto infection and if they can spread infection to other animals."}]}, {"title": "29f05dec404999d3cd435185664abe1b", "paragraphs": [{"qas": [{"question": "Invertebrates, birds, reptiles, and amphibians are not susceptible to what?", "id": "100000000000000000000159", "answers": [{"text": "infection with SARS-CoV-2", "answer_start": 186}], "is_impossible": false}, {"question": "What has CDC been doing since the beginning of the pandemic?", "id": "100000000000000000000160", "answers": [{"text": "leading efforts to improve our understanding of how SARS-CoV-2 affects animals and how the virus might spread between people and animals", "answer_start": 281}], "is_impossible": false}, {"question": "Who has been leading efforts to improve our understanding of how SARS-CoV-2 affects animals?", "id": "100000000000000000000161", "answers": [{"text": "CDC", "answer_start": 268}], "is_impossible": false}], "context": "Studies on animals do not show whether animals can spread\ninfection to people. Based on these studies, we know that invertebrates, birds, reptiles, and amphibians are not susceptible to infection with\nSARS-CoV-2. What CDC is doing\nSince the beginning of the pandemic, CDC has been leading efforts to improve our understanding of how SARS-CoV-2 affects\nanimals and how the virus might spread between people and animals. CDC has also worked to improve coordination of\nfederal, state, and other One Health partners."}]}, {"title": "1d3b1c63a6123b0a9188b7b3d6a888ac", "paragraphs": [{"qas": [{"question": "Who leads the One Health Federal Interagency COVID-19 Coordination Group?", "id": "100000000000000000000163", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "What group researches and develops guidance on the connection between people?", "id": "100000000000000000000165", "answers": [{"text": "One Health Federal Interagency COVID-19 Coordination (OH-FICC) Group", "answer_start": 14}], "is_impossible": false}, {"question": "What group leads the regular State-Federal One Health Update Call?", "id": "100000000000000000000167", "answers": [{"text": "One Health Federal Interagency COVID-19 Coordination (OH-FICC) Group", "answer_start": 14}], "is_impossible": false}], "context": "CDC leads the One Health Federal Interagency COVID-19 Coordination (OH-FICC) Group, which brings together public\nhealth, animal health, and environmental health representatives from more than 20 federal agencies to collaborate and\nexchange information on the One Health aspects of COVID-19. For example, the group researches and develops\nguidance on the connection between people and pets, wildlife, zoo animals, and livestock; animal diagnostics and\ntesting; and environmental health issues relevant to COVID-19. CDC leads the regular State-Federal One Health Update Call to bring local, state, tribal, and territorial partners together\nwith OH-FICC members."}]}, {"title": "8f2d869d86005bae756cbe5cf44ac6e5", "paragraphs": [{"qas": [{"question": "What is active surveillance of SARS-CoV-2 called?", "id": "100000000000000000000168", "answers": [{"text": "proactive testing", "answer_start": 141}], "is_impossible": false}, {"question": "What are cats, dogs, and other small mammals that had contact with a person with COVID-19?", "id": "100000000000000000000169", "answers": [{"text": "pets", "answer_start": 177}], "is_impossible": false}, {"question": "How many states did the CDC deploy One Health teams to?", "id": "100000000000000000000171", "answers": [{"text": "multiple", "answer_start": 309}], "is_impossible": false}, {"question": "What did the One Health Teams support in conducting on-farm investigations?", "id": "100000000000000000000172", "answers": [{"text": "state and local departments of health and agriculture", "answer_start": 336}], "is_impossible": false}], "context": "CDC, USDA, state public health and animal health officials, and academic partners are working in some states to conduct\nactive surveillance (proactive testing) of SARS-CoV-2 in pets, including cats, dogs, and other small mammals, that had\ncontact with a person with COVID-19. CDC deployed One Health teams to multiple states to support state and local departments of health and agriculture,\nfederal partners, and others in conducting on-farm investigations into SARS-CoV-2 in people, mink, and other animals\n(domestic and wildlife)."}]}, {"title": "1ae78230c6cc0968e84179e2e0c08ccb", "paragraphs": [{"qas": [{"question": "Who collected samples from animals on the farms?", "id": "100000000000000000000173", "answers": [{"text": "The teams", "answer_start": 0}], "is_impossible": false}, {"question": "USDA maintains a list of all animals and mink farms with SARS-CoV-2 infections confirmed by what?", "id": "100000000000000000000174", "answers": [{"text": "National Veterinary Services Laboratories", "answer_start": 221}], "is_impossible": false}, {"question": "What is needed to understand if and how different animals could be affected by COVID-19?", "id": "100000000000000000000175", "answers": [{"text": "More studies and surveillance", "answer_start": 266}], "is_impossible": false}], "context": "The teams collected samples from animals on the farms and from people working on the farms\nd i di iti\nUSDA maintains a list of all animals and mink farms in the United States with SARS-CoV-2 infections confirmed by their\nNational Veterinary Services Laboratories. \uf209\nMore studies and surveillance are needed to understand if and how different animals could be affected by COVID-19. \u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:37 AM Animals and COVID-19 | CDC\nand in surrounding communities."}]}, {"title": "fbfc8570be618f0cf8b459c2eb2c8f7a", "paragraphs": [{"qas": [{"question": "What is the risk of SARS-CoV-2 spreading between people and wildlife?", "id": "100000000000000000000176", "answers": [{"text": "Reducing", "answer_start": 14}], "is_impossible": false}, {"question": "What should you know about COVID-19 and Pets?", "id": "100000000000000000000177", "answers": [{"text": "Reducing the Risk of SARS-CoV-2 Spreading between People and Wildlife \u203a What You Should Know about COVID-19 and Pets \u203a More Information Information on Bringing an Animal into the United States", "answer_start": 14}], "is_impossible": false}, {"question": "WHO: Coronavirus Disease 2019 in Animals in the United States", "id": "100000000000000000000178", "answers": [{"text": "USDA", "answer_start": 339}], "is_impossible": false}, {"question": "What animal was confirmed to have COVID-19 in a Pennsylvania Zoo?", "id": "100000000000000000000180", "answers": [{"text": "Canada Lynx", "answer_start": 459}], "is_impossible": false}, {"question": "In what animal was the COVID-19 confirmed?", "id": "100000000000000000000181", "answers": [{"text": "Canada Lynx", "answer_start": 459}], "is_impossible": false}, {"question": "What type of animal did Texas A&M Research discover?", "id": "100000000000000000000184", "answers": [{"text": "COVID-19 UK Variant", "answer_start": 810}], "is_impossible": false}, {"question": "Where did the USDA confirm SARS-CoV-2 in Mink in Utah?", "id": "100000000000000000000185", "answers": [{"text": "Kentucky Zoo", "answer_start": 889}], "is_impossible": false}, {"question": "In what city did USDA confirm COVID-19 in Two Pet Cats?", "id": "100000000000000000000187", "answers": [{"text": "New York", "answer_start": 1036}], "is_impossible": false}, {"question": "USDA Statement on the Confirmation of Covid-19 Infection in a Tiger in New York?", "id": "100000000000000000000188", "answers": [{"text": "\uf209", "answer_start": 1127}], "is_impossible": false}, {"question": "What date was the last update?", "id": "100000000000000000000189", "answers": [{"text": "July 5, 2022", "answer_start": 1184}], "is_impossible": false}, {"question": "What year was the Last Updated?", "id": "100000000000000000000190", "answers": [{"text": "2022", "answer_start": 1192}], "is_impossible": false}], "context": "Related Pages\nReducing the Risk of SARS-CoV-2 Spreading between People and Wildlife\n\u203a\nWhat You Should Know about COVID-19 and Pets\n\u203a\nMore Information\nInformation on Bringing an Animal into the United States\nWorld Organisation for Animal Health: COVID-19 Events in\nAnimals\nUSDA: Confirmed cases of SARS-CoV-2 in Animals in the\nUnited States\nUSDA: Coronavirus Disease 2019\nFDA: Coronavirus Disease 2019\n\uf209\n\uf209\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx at a Pennsylvania Zoo\nConfirmation of COVID-19 in Hyenas at a Colorado Zoo\nConfirmation of COVID-19 in a Coatimundi at an Illinois Zoo\nConfirmation of COVID-19 in a Binturong and a Fishing Cat at an Illinois Zoo\nConfirmation of COVID-19 in Ferret in Florida\nConfirmation of COVID-19 in Deer in Ohio\nTexas A&M Research Uncovers First Known COVID-19 UK Variant In Animals\nConfirmation of COVID-19 in a Snow Leopard at a Kentucky Zoo\u200b\nUSDA Confirms SARS-CoV-2 in Mink in Utah\nConfirmation of COVID-19 in Pet Dog in New York\nConfirmation of COVID-19 in Two Pet Cats in New York\nUSDA Statement on the Confirmation of COVID-19 Infection in a Tiger in New York\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n\u2022 \uf209\nLast Updated July 5, 2022"}]}, {"title": "9e0f7d3a3c6e6d02df95f7668928f2e7", "paragraphs": [{"qas": [{"question": "What is the name of the complex network of cells, tissues, and organs that work together to protect the body from infection?", "id": "100000000000000000000191", "answers": [{"text": "The immune system", "answer_start": 143}], "is_impossible": false}, {"question": "What are proteins that your immune system makes to help fight infection and protect you?", "id": "100000000000000000000192", "answers": [{"text": "Antibodies", "answer_start": 267}], "is_impossible": false}, {"question": "What does your immune system make to help fight infection?", "id": "100000000000000000000193", "answers": [{"text": "Antibodies", "answer_start": 267}], "is_impossible": false}, {"question": "What does the immune system do when you are infected with a virus or bacteria?", "id": "100000000000000000000194", "answers": [{"text": "makes antibodies specifically to fight it", "answer_start": 465}], "is_impossible": false}, {"question": "Once you have antibodies to a disease, they provide some protection from what?", "id": "100000000000000000000196", "answers": [{"text": "that disease", "answer_start": 673}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Antibodies and COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nAntibodies and COVID-19\nAntibodies and the immune system\nDEFINITIONS\nThe immune system is a complex network of cells, tissues, and organs that\nwork together to protect the body from infection. Antibodies are proteins that your immune system makes to help fight\ninfection and protect you from getting sick in the future. \u2022\n\u2022\nWhen you are infected with a virus or bacteria, your immune system makes antibodies specifically to fight it. Your immune\nsystem can also safely learn to make antibodies through vaccination. Once you have antibodies to a particular disease, they\nprovide some protection from that disease."}]}, {"title": "f61515ed5c4bd6ca599f43df3d23bd2b", "paragraphs": [{"qas": [{"question": "What are just one part of your immune response?", "id": "100000000000000000000199", "answers": [{"text": "Antibodies", "answer_start": 260}], "is_impossible": false}, {"question": "What is the virus that causes COVID-19?", "id": "100000000000000000000200", "answers": [{"text": "SARS-CoV-2", "answer_start": 352}], "is_impossible": false}, {"question": "Antibodies to SARS-CoV-2 can be detected in the blood of people who have recovered from what?", "id": "100000000000000000000201", "answers": [{"text": "COVID-19", "answer_start": 458}], "is_impossible": false}], "context": "Even if you do get sick, having antibodies can protect you from getting severely ill\nbecause your body has some experience in fighting that disease. How long this protection lasts can be different for each\ndisease, each person, or influenced by other factors. Antibodies are just one part of your immune response. Antibodies and COVID-19\nAntibodies to SARS-CoV-2, the virus that causes COVID-19, can be detected in the blood of people who have recovered from\nCOVID-19 or people who have been vaccinated against COVID-19."}]}, {"title": "1a7a8f69193639eb536a4da7801d6788", "paragraphs": [{"qas": [{"question": "What is recommended for everyone 5 years of age and older?", "id": "100000000000000000000203", "answers": [{"text": "vaccination against COVID-19", "answer_start": 53}], "is_impossible": false}, {"question": "What is the term for a person who has antibodies to SARS-CoV-2 who may become infected after vaccination?", "id": "100000000000000000000204", "answers": [{"text": "vaccine breakthrough infection", "answer_start": 392}], "is_impossible": false}, {"question": "What is another term for someone who has recovered from a past infection?", "id": "100000000000000000000205", "answers": [{"text": "reinfected", "answer_start": 467}], "is_impossible": false}, {"question": "How long is the risk of reinfection low?", "id": "100000000000000000000206", "answers": [{"text": "at least the first 6 months", "answer_start": 544}], "is_impossible": false}, {"question": "What is the first 6 months after an infection with COVID-19 diagnosed by a laboratory test?", "id": "100000000000000000000207", "answers": [{"text": "risk of reinfection", "answer_start": 513}], "is_impossible": false}], "context": "Getting a vaccine is safer than getting COVID-19, and\nvaccination against COVID-19 is recommended for everyone 5 years of age and older. If someone has already had COVID-19,\nvaccination against COVID-19 increases their body\u2019s antibody response, which improves their protection. It is important to remember that some people with antibodies to SARS-CoV-2 may become infected after vaccination (vaccine\nbreakthrough infection) or after recovering from a past infection (reinfected). Based on what we know right now, risk of\nreinfection is low for at least the first 6 months following an infection with the virus that causes COVID-19 diagnosed by a\nlaboratory test."}]}, {"title": "2147d681250bf28a35f5d2219155002b", "paragraphs": [{"qas": [{"question": "What is it called when someone who is fully vaccinated gets COVID-19?", "id": "100000000000000000000208", "answers": [{"text": "a vaccine breakthrough infection", "answer_start": 65}], "is_impossible": false}, {"question": "No vaccine is 100% effective, so some breakthrough infections are expected.", "id": "100000000000000000000209", "answers": [{"text": "COVID-19", "answer_start": 42}], "is_impossible": false}, {"question": "What is the risk of infection, severe illness, hospitalization, and death for vacccinated people compared to people who are not?", "id": "100000000000000000000210", "answers": [{"text": "lower", "answer_start": 254}], "is_impossible": false}, {"question": "What does having antibodies help prevent when reinfections or breakthrough infections happen?", "id": "100000000000000000000212", "answers": [{"text": "severe illness, hospitalization, and death", "answer_start": 437}], "is_impossible": false}], "context": "When someone who is fully vaccinated gets COVID-19, it is called a vaccine breakthrough infection. No vaccine\nis 100% effective, so some breakthrough infections are expected. The risk of infection, severe illness, hospitalization, and\ndeath are all much lower for vaccinated people compared to people who are unvaccinated. When reinfections or\nbreakthrough infections happen, having antibodies plays an important role in helping prevent severe illness, hospitalization,\nand death. For many diseases, including COVID-19, antibodies are expected to decrease or \u201cwane\u201d over time. After a long enough period\nof time, your level of antibodies can decrease below a level that provides effective protection."}]}, {"title": "9a06ef81d3fb0c37a081191e1fed0e47", "paragraphs": [{"qas": [{"question": "How long does it take for COVID-19 antibodies to wane?", "id": "100000000000000000000218", "answers": [{"text": "threshold of protection", "answer_start": 26}], "is_impossible": false}, {"question": "Who is researching COVID-19?", "id": "100000000000000000000220", "answers": [{"text": "CDC scientists", "answer_start": 591}], "is_impossible": false}, {"question": "What is the name of the drug that is being researched?", "id": "100000000000000000000221", "answers": [{"text": "Antibodies and COVID-19", "answer_start": 565}], "is_impossible": false}], "context": "This level is called the\n\u201cthreshold of protection.\u201d When antibodies decrease below the threshold of protection, you may become more vulnerable to\nsevere illness. We do not yet know what the threshold of protection for antibodies is for the virus that causes COVID-19 or\nhow long it takes these antibodies to wane. Even after antibodies wane, your immune system may have cells that remember\nthe virus that can act quickly to protect you from severe illness if you become infected. These topics are being researched by\nscientists all over the world\f10/30/22, 9:37 AM Antibodies and COVID-19 | CDC\nscientists all over the world."}]}, {"title": "8088dde892089a20ea5c1e85e1613273", "paragraphs": [{"qas": [{"question": "What is not used if you have symptoms of COVID-19 or for diagnosing a current case of?", "id": "100000000000000000000223", "answers": [{"text": "Antibody tests", "answer_start": 179}], "is_impossible": false}, {"question": "What test is recommended to identify a current infection with the virus that causes COVID-19?", "id": "100000000000000000000224", "answers": [{"text": "viral test", "answer_start": 413}], "is_impossible": false}, {"question": "How long does it take for most people with a healthy immune system to develop antibodies?", "id": "100000000000000000000225", "answers": [{"text": "1 to 3 weeks", "answer_start": 352}], "is_impossible": false}, {"question": "What is available about the role and uses of antibody testing?", "id": "100000000000000000000227", "answers": [{"text": "More information", "answer_start": 508}], "is_impossible": false}], "context": "I have COVID-19 antibodies. What does it mean? A positive antibody test result can help identify someone who has had COVID-19 in the past or has been vaccinated against\nCOVID-19. Antibody tests are not used if you have symptoms of COVID-19 or for diagnosing a current case of COVID-19. This is\nbecause it takes most people with a healthy immune system 1 to 3 weeks after getting COVID-19 to develop antibodies. A viral\ntest is recommended to identify a current infection with the virus that causes COVID-19. More information about the role and\nuses of antibody testing is available."}]}, {"title": "6399d19610ba6e76472909bff417e540", "paragraphs": [{"qas": [{"question": "What should people do if they have a positive antibody test result?", "id": "100000000000000000000228", "answers": [{"text": "take steps to protect themselves and others", "answer_start": 128}], "is_impossible": false}, {"question": "What should a person do to protect themselves and others?", "id": "100000000000000000000229", "answers": [{"text": "getting vaccinated", "answer_start": 183}], "is_impossible": false}, {"question": "What does not necessarily mean that you are immune to getting COVID-19?", "id": "100000000000000000000230", "answers": [{"text": "A positive antibody test result alone", "answer_start": 203}], "is_impossible": false}, {"question": "If you have had an antibody test, it is important to review your test results with what?", "id": "100000000000000000000231", "answers": [{"text": "your healthcare provider", "answer_start": 507}], "is_impossible": false}], "context": "Most people who have a positive antibody test result can continue with normal activities, including work, but they should still\ntake steps to protect themselves and others, including getting vaccinated. A positive antibody test result alone, especially one from an infection at an unknown time or that was determined by a viral\ntest more than 6 months ago, does not necessarily mean that you are immune to getting COVID-19. If you have had an\nantibody test, it is important to review your test results with your healthcare provider. How do scientists study antibodies?"}]}, {"title": "4c1e6694c39d9a0e825277bf1b32a3e5", "paragraphs": [{"qas": [{"question": "What is the science of antibodies called?", "id": "100000000000000000000232", "answers": [{"text": "serology", "answer_start": 37}], "is_impossible": false}, {"question": "What do antibodies identify in blood samples?", "id": "100000000000000000000233", "answers": [{"text": "antibodies", "answer_start": 103}], "is_impossible": false}, {"question": "As of August 2021, how many antibody tests have been granted emergency approval?", "id": "100000000000000000000234", "answers": [{"text": "more than 80", "answer_start": 259}], "is_impossible": false}, {"question": "How many antibody tests have been granted EUA?", "id": "100000000000000000000235", "answers": [{"text": "more than 80", "answer_start": 259}], "is_impossible": false}, {"question": "Scientists are using these antibody tests to learn more about what?", "id": "100000000000000000000236", "answers": [{"text": "the level of antibodies needed to protect people from COVID-19 (threshold of protection)", "answer_start": 441}], "is_impossible": false}], "context": "The science of antibodies is called \u201cserology.\u201d Antibody tests, also called \u201cserology tests,\u201d identify antibodies in blood samples. While other parts of the immune system also contribute to protection, it is easiest to test for antibodies. As of August 2021, more than 80 antibody tests have been granted FDA emergency use authorization (EUA) to detect\nantibodies to SARS-CoV-2. Scientists are using these antibody tests to learn more about the level of antibodies needed to\nprotect people from COVID-19 (threshold of protection) and how long this protection lasts."}]}, {"title": "f2c7065f4a720a22bd21460e6231c0bf", "paragraphs": [{"qas": [{"question": "What is not currently recommended by FDA for routine, widespread use in making individual medical decisions?", "id": "100000000000000000000238", "answers": [{"text": "Antibody tests", "answer_start": 0}], "is_impossible": false}, {"question": "If you have questions about whether an antibody test is right for you, talk to your healthcare provider or what?", "id": "100000000000000000000239", "answers": [{"text": "your state or local health department", "answer_start": 284}], "is_impossible": false}, {"question": "What does not all antibody tests identify the same antibodies?", "id": "100000000000000000000240", "answers": [{"text": "SARS-CoV-2", "answer_start": 605}], "is_impossible": false}, {"question": "What is more or less sensitive to specific sections of the antibody protein than others?", "id": "100000000000000000000241", "answers": [{"text": "antibody tests", "answer_start": 381}], "is_impossible": false}], "context": "Antibody tests are not currently\nrecommended by FDA for routine, widespread use in making individual medical decisions while this information is being\ngathered and evaluated. If you have questions about whether an antibody test is right for you, talk with your healthcare\nprovider or your state or local health department. Not all antibody tests identify the same antibodies. Some antibody tests are more or less sensitive to specific sections of the\nantibody protein than others. This means that different antibody tests might not have the same results, even when they are\nboth testing for antibodies to SARS-CoV-2."}]}, {"title": "2216c312ae57bfb38129e782f1e891a4", "paragraphs": [{"qas": [{"question": "What do scientists use these differences in tests to help answer?", "id": "100000000000000000000243", "answers": [{"text": "different research questions", "answer_start": 57}], "is_impossible": false}, {"question": "What do antibodies to SARS-CoV-2 tell us about how to respond to COVID-19?", "id": "100000000000000000000244", "answers": [{"text": "how to treat and control", "answer_start": 383}], "is_impossible": false}, {"question": "What will scientists learn about as they learn more about the antibodies to SARS-CoV-2?", "id": "100000000000000000000245", "answers": [{"text": "how to treat and control COVID-19", "answer_start": 383}], "is_impossible": false}, {"question": "How will scientists understand and control COVID-19?", "id": "100000000000000000000246", "answers": [{"text": "As scientists learn more about the antibodies to SARS-CoV-2", "answer_start": 286}], "is_impossible": false}], "context": "Scientists use these differences in tests to help answer different research questions\nabout how immune systems respond to the virus that causes COVID-19 and to improve our understanding of COVID-19. What information do antibodies to SARS-CoV-2 tell us about how\nto respond to COVID-19? As scientists learn more about the antibodies to SARS-CoV-2, we will understand a lot more about how to treat and control\nCOVID-19."}]}, {"title": "71036bc151fa235eee1ec42899eea3e1", "paragraphs": [{"qas": [{"question": "What provides information about how long antibody protection against COVID-19 lasts?", "id": "100000000000000000000248", "answers": [{"text": "Serological surveillance", "answer_start": 0}], "is_impossible": false}, {"question": "What are immunocompromised people compared with healthy immune systems?", "id": "100000000000000000000250", "answers": [{"text": "not produce as many antibodies", "answer_start": 371}], "is_impossible": false}], "context": "Serological surveillance (studies that investigate antibodies in the population) provides information about how long antibody\nprotection against COVID-19 lasts and if this protection is different among people who have antibodies from infection,\ncompared with people who have antibodies from vaccination, or both. We can also learn more about which groups of people might not produce as many antibodies or maintain them as long as\nothers\u2014for example, immunocompromised people compared with people who have healthy immune systems. This is\nimportant information for making decisions about whether or not additional vaccine doses or boosters are needed, when\nthey would be recommended, and who would need them first."}]}, {"title": "f747b76c19a8e3e83792ec6152cab1ff", "paragraphs": [{"qas": [{"question": "What type of antibody provides the same protection against new variants of the virus that causes COVID-19?", "id": "100000000000000000000253", "answers": [{"text": "SARS-CoV-2", "answer_start": 35}], "is_impossible": false}], "context": "We can also learn if antibodies to SARS-CoV-2 provide the same protection against new variants of the virus that causes\nCOVID-19. Studies show that people who have antibodies from an infection with the virus that causes COVID-19 can improve their\nlevel of protection by getting vaccinated. \uf209\nAntibody quiz\f10/30/22, 9:37 AM Antibodies and COVID-19 | CDC\nNow that you\u2019ve learned about antibodies and COVID-19, test your knowledge with an interactive quiz. Test Your Knowledge\nAntibodies for the virus that causes COVID-19 are expected to decrease, or wane, over time. True\nFalse\nNext \uf29e\nLast Updated Nov. 10, 2021"}]}, {"title": "af6badb1eb0643d7825458117ea376d1", "paragraphs": [{"qas": [{"question": "What is one of CDC's core activities?", "id": "100000000000000000000258", "answers": [{"text": "Sharing timely and accurate information with the public", "answer_start": 236}], "is_impossible": false}, {"question": "What does CDC report online on COVID Data Tracker?", "id": "100000000000000000000259", "answers": [{"text": "COVID-19 vaccination data", "answer_start": 152}], "is_impossible": false}, {"question": "What provides the reliable data that can be reported by CDC?", "id": "100000000000000000000260", "answers": [{"text": "Timely and accurate reporting from jurisdictions", "answer_start": 325}], "is_impossible": false}, {"question": "How does CDC communicate events that affect vaccine data?", "id": "100000000000000000000261", "answers": [{"text": "through footnotes", "answer_start": 590}], "is_impossible": false}], "context": "10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nEspa\u00f1ol | Other Languages\nArchive of COVID-19 Vaccination Data Updates\nCDC reports COVID-19 vaccination data online on COVID Data Tracker and in vaccination datasets. Sharing timely and\naccurate information with the public is one of CDC\u2019s core activities. Timely and accurate reporting from jurisdictions provides\nthe reliable data that can be reported by CDC. All reported numbers may change over time as updated data are continuously\nreported to CDC. Historical Updates\nCDC communicates events that affect vaccine data through footnotes on COVID Data Tracker (CDT)."}]}, {"title": "9cbd59f7f6ae3cd74ffbbf0d735cdabb", "paragraphs": [{"qas": [{"question": "What can occur for reported changes to the vaccine data?", "id": "100000000000000000000263", "answers": [{"text": "Updates to COVID-19 vaccine policy and guidance/recommendations", "answer_start": 172}], "is_impossible": false}, {"question": "When did Vaccination Data Updates occur?", "id": "100000000000000000000264", "answers": [{"text": "October 20, 2022", "answer_start": 406}], "is_impossible": false}, {"question": "How many doses of vaccine did Indiana administer on October 20-22?", "id": "100000000000000000000266", "answers": [{"text": "69,965", "answer_start": 487}], "is_impossible": false}, {"question": "What was not reported to CDC by Indiana?", "id": "100000000000000000000267", "answers": [{"text": "historic dose administrations", "answer_start": 553}], "is_impossible": false}], "context": "This section serves as an\narchive of footnotes for historical COVID-19 vaccine data updates. Reported changes to COVID-19 vaccine data can occur for\nthe following reasons:\nUpdates to COVID-19 vaccine policy and guidance/recommendations\nData changes outside scheduled Record Management events\nChanges in reporting methods\nAdjustments made due to errors (such as syncing errors)\nVaccination Data Updates:\nOn October 20, 2022, the daily number of vaccine doses administered for Indiana was 69,965 doses. This total includes\nrecent dose administrations and historic dose administrations from August 1 to September 30, 2022 that had not been\nreported to CDC by Indiana."}]}, {"title": "4dc8f03626a94ae92913efd47a0ec7eb", "paragraphs": [{"qas": [{"question": "When did New Hampshire review vaccine data and make adjustments to reporting?", "id": "100000000000000000000268", "answers": [{"text": "September 29, 2022", "answer_start": 0}], "is_impossible": false}, {"question": "How many vaccine doses were decreased in New Hampshire since December 14, 2020?", "id": "100000000000000000000269", "answers": [{"text": "175,025", "answer_start": 109}], "is_impossible": false}, {"question": "What state submitted vaccine data on September 29, 2022?", "id": "100000000000000000000270", "answers": [{"text": "New Hampshire", "answer_start": 20}], "is_impossible": false}, {"question": "Who is reviewing the Vaccination data submitted by Texas on August 31, 2022?", "id": "100000000000000000000271", "answers": [{"text": "CDC", "answer_start": 376}], "is_impossible": false}, {"question": "When will the COVID-19 Data Tracker be updated?", "id": "100000000000000000000272", "answers": [{"text": "when available", "answer_start": 453}], "is_impossible": false}, {"question": "On what date did CDC correct an error in the Census denominator?", "id": "100000000000000000000273", "answers": [{"text": "July 28, 2022", "answer_start": 472}], "is_impossible": false}], "context": "September 29, 2022, New Hampshire reviewed data and made adjustments to reporting, resulting in a decrease of\n175,025 for the number of vaccine doses administered since December 14, 2020. The adjustment is the result of updates\nto how pharmacies report data to CDC and/or the jurisdictions. Vaccination data submitted by Texas on August 31, 2022 are currently under review by CDC and are not reflected on\nCOVID-19 Data Tracker. The data will be updated when available. On July 28, 2022, CDC corrected an error in the Census denominator used to calculate percentage-based metrics for the\nU.S. population aged 18 years and older."}]}, {"title": "e20fbb3be1f94d8532c1273f0ffd8127", "paragraphs": [{"qas": [{"question": "How many people were in the U.S. census in 2022?", "id": "100000000000000000000275", "answers": [{"text": "258,215,633", "answer_start": 143}], "is_impossible": false}, {"question": "When did HHS discontinue showing booster dose data?", "id": "100000000000000000000276", "answers": [{"text": "July 28, 2022", "answer_start": 183}], "is_impossible": false}, {"question": "What is the dashboard on COVID?", "id": "100000000000000000000277", "answers": [{"text": "Booster Vaccination Trends by Age, Sex, and Race/Ethnicity", "answer_start": 261}], "is_impossible": false}, {"question": "What is the name of the dashboard on COVID Data Tracker's Vaccination Demographic Trends site?", "id": "100000000000000000000278", "answers": [{"text": "Booster Vaccination Trends by Age, Sex, and Race/Ethnicity", "answer_start": 261}], "is_impossible": false}, {"question": "What is working to re-include regional options after preparation of necessary data?", "id": "100000000000000000000279", "answers": [{"text": "CDC", "answer_start": 392}], "is_impossible": false}, {"question": "On what date was the weekly number of vaccine doses administered for Indiana?", "id": "100000000000000000000280", "answers": [{"text": "July 21, 2022", "answer_start": 556}], "is_impossible": false}, {"question": "What was the weekly number of vaccine doses administered for Indiana in 2022?", "id": "100000000000000000000281", "answers": [{"text": "40,998 doses", "answer_start": 635}], "is_impossible": false}, {"question": "How many doses of vaccine did Indiana receive each week?", "id": "100000000000000000000282", "answers": [{"text": "40,998", "answer_start": 635}], "is_impossible": false}, {"question": "In 2022, how many vaccines were given to Indiana?", "id": "100000000000000000000283", "answers": [{"text": "40,998", "answer_start": 635}], "is_impossible": false}], "context": "No other population groups were affected. The census count for the total U.S. population aged 18 years and older decreased from 258,259,833 to 258,215,633\npeople (-44,200). Beginning July 28, 2022, HHS regional booster dose data are no longer available in the \u201cBooster Vaccination Trends by\nAge, Sex, and Race/Ethnicity\u201d dashboard on COVID Data Tracker\u2019s Vaccination Demographic Trends site. CDC is working\nto re-include regional options following preparation of necessary data. Jurisdictional (i.e., state and territory) data continue to be available. On July 21, 2022, the weekly number of vaccine doses administered for Indiana was 40,998 doses."}]}, {"title": "a6810db92255ec1494a1f5352d947af8", "paragraphs": [{"qas": [{"question": "What state did not report dose administrations from May 1 to June 30, 2022 to CDC?", "id": "100000000000000000000284", "answers": [{"text": "Indiana", "answer_start": 148}], "is_impossible": false}, {"question": "When will New Hampshire only report year of birth instead of full birthdate for vaccine recipients?", "id": "100000000000000000000285", "answers": [{"text": "July 14, 2022", "answer_start": 167}], "is_impossible": false}, {"question": "What was the daily number of vaccine doses administered for Indiana on June 15, 2022?", "id": "100000000000000000000287", "answers": [{"text": "238,242", "answer_start": 550}], "is_impossible": false}], "context": "This total includes\nrecent dose administrations and historic dose administrations from May 1 to June 30, 2022, that had not been reported\nto CDC by Indiana. Effective July 14, 2022, New Hampshire will only report year of birth instead of full birthdate for vaccine recipients to\nCDC. This will result in numbers and rates for some age groups being under- or over-estimated. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n\u2022\n-\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nOn June 15, 2022, the daily number of vaccine doses administered for Indiana was 238,242 doses."}]}, {"title": "3dcb2d94bb72cd774d4b582ec03eb863", "paragraphs": [{"qas": [{"question": "What was the daily number of vaccine doses administered for Indiana on May 26, 2022?", "id": "100000000000000000000288", "answers": [{"text": "70,721 doses", "answer_start": 230}], "is_impossible": false}, {"question": "When were the daily doses of vaccines administered in Indiana?", "id": "100000000000000000000290", "answers": [{"text": "May 26, 2022", "answer_start": 153}], "is_impossible": false}], "context": "This total includes\nrecent and historic dose administrations from September 2021\u2014 April 2022 that had not previously been reported to\nCDC by Indiana. On May 26, 2022, the daily number of vaccine doses administered for Indiana was 70,721 doses. This total includes\nrecent dose administrations and historic dose administrations from August 1 to August 31, 2021 that had not been\nreported to CDC by Indiana."}]}, {"title": "ed155ea265a9fef431a8a197415bd6c3", "paragraphs": [{"qas": [{"question": "Why were vaccination data not updated for two dashboards on vaccination Demographic Trends?", "id": "100000000000000000000293", "answers": [{"text": "data processing issue", "answer_start": 9}], "is_impossible": false}, {"question": "How many vaccine doses were given to South Carolina on May 3, 2022?", "id": "100000000000000000000295", "answers": [{"text": "152,237", "answer_start": 508}], "is_impossible": false}, {"question": "How many doses of vaccine did South Carolina receive on May 3?", "id": "100000000000000000000296", "answers": [{"text": "152,237", "answer_start": 508}], "is_impossible": false}, {"question": "What is the name of the data that CDC is working to address?", "id": "100000000000000000000297", "answers": [{"text": "Booster Vaccination Trends by Age, Sex, and Race/Ethnicity among Fully Vaccinated People Ages 12 Years and Older\u201d", "answer_start": 137}], "is_impossible": false}], "context": "Due to a data processing issue on May 9, 2022, vaccination data were not updated for two dashboards on Vaccination\nDemographic Trends \u2013 \u201cBooster Vaccination Trends by Age, Sex, and Race/Ethnicity among Fully Vaccinated People Ages\n12 Years and Older\u201d and \u201cVaccination Trends by Age and Sex\u201d \u2013 which reflect data as of May 8, 2022. CDC is actively\nworking to address this issue and the data will be updated when available. On May 3, 2022, the daily number of vaccine doses administered for South Carolina was 152,237 doses."}]}, {"title": "8c378d30f5442b9bc3acae2e5423bd3", "paragraphs": [{"qas": [{"question": "How many doses of vaccine were administered in Pennsylvania on April 27, 2022?", "id": "100000000000000000000300", "answers": [{"text": "254,383", "answer_start": 202}], "is_impossible": false}, {"question": "What was the daily number of vaccination doses administered for Pennsylvania?", "id": "100000000000000000000301", "answers": [{"text": "254,383", "answer_start": 202}], "is_impossible": false}, {"question": "On what date were 254,383 doses given?", "id": "100000000000000000000302", "answers": [{"text": "April 27, 2022", "answer_start": 118}], "is_impossible": false}, {"question": "In what year were 235,854 new and historic second booster doses reported?", "id": "100000000000000000000303", "answers": [{"text": "2022", "answer_start": 128}], "is_impossible": false}, {"question": "What may have resulted in a higher reported count for the total number of people who were fully vaccinated in the district on May 2, 2022?", "id": "100000000000000000000305", "answers": [{"text": "the District of Columbia [DC] upgraded its data collection and reporting system", "answer_start": 332}], "is_impossible": false}], "context": "This number\nincludes 152,195 recent and historic doses covering the time period from April 2, 2022 to May 2, 2022. On April 27, 2022, the daily number of vaccine doses administered for Pennsylvania was 254,383 doses. This number\nincludes 235,854 recent and historic second booster doses that were newly reported. On April 21, 2022, the District of Columbia [DC] upgraded its data collection and reporting system. The system upgrade\nmay have resulted in a higher reported count for the total number of people who were fully vaccinated in the district on\nMay 2, 2022."}]}, {"title": "14c3deb96d3642d9a6a9908e1e553df0", "paragraphs": [{"qas": [{"question": "What will occur in a timely manner if needed?", "id": "100000000000000000000307", "answers": [{"text": "data corrections", "answer_start": 74}], "is_impossible": false}, {"question": "Vaccination data submitted by Texas on April 20, 2022 are currently under review by what?", "id": "100000000000000000000308", "answers": [{"text": "CDC and state officials", "answer_start": 206}], "is_impossible": false}, {"question": "What is not reflected on the COVID-19 Data Tracker?", "id": "100000000000000000000309", "answers": [{"text": "Vaccination data", "answer_start": 122}], "is_impossible": false}, {"question": "How many vaccine doses have been decreased since December 14, 2020?", "id": "100000000000000000000312", "answers": [{"text": "62,163", "answer_start": 507}], "is_impossible": false}], "context": "CDC and DC are actively working to validate this increase, and if needed, data corrections will occur in a\ntimely manner. Vaccination data submitted by Texas on April 20, 2022 are currently under review by CDC and state officials due to the\nuse of a new reporting process and are not reflected on COVID-19 Data Tracker. The data will be updated when\navailable. April 15, 2022: New Hampshire reviewed data and made adjustments to the vaccination records they have reported to\nCDC, resulting in a decrease of 62,163 vaccine doses administered since December 14, 2020."}]}, {"title": "91659d6abb1ff910013d4f820adce731", "paragraphs": [{"qas": [{"question": "What is the result of updates to how pharmacies report data to the CDC and/or the jurisdictions?", "id": "100000000000000000000313", "answers": [{"text": "The adjustment", "answer_start": 0}], "is_impossible": false}, {"question": "When did New Hampshire review data and make adjustments to reporting?", "id": "100000000000000000000314", "answers": [{"text": "March 22, 2022", "answer_start": 103}], "is_impossible": false}, {"question": "How many doses of vaccines were decreased in New Hampshire since December 14, 2020?", "id": "100000000000000000000315", "answers": [{"text": "246,029 for the number of vaccine doses administered since December 14, 2020. The adjustment is the result of updates to how pharmacies report data to CDC and/or the jurisdictions. March 11, 2022: New Hampshire reviewed data and made adjustments to their reporting, resulting in a decrease of 91,294", "answer_start": 209}], "is_impossible": false}, {"question": "How many vaccine doses did New Hampshire decrease since December 14, 2020?", "id": "100000000000000000000316", "answers": [{"text": "246,029 for the number of vaccine doses administered since December 14, 2020. The adjustment is the result of updates to how pharmacies report data to CDC and/or the jurisdictions. March 11, 2022: New Hampshire reviewed data and made adjustments to their reporting, resulting in a decrease of 91,294", "answer_start": 209}], "is_impossible": false}, {"question": "What is the reason for the decrease in vaccination doses?", "id": "100000000000000000000317", "answers": [{"text": "updates to how pharmacies", "answer_start": 32}], "is_impossible": false}, {"question": "How many doses of vaccine were decreased in New Hampshire in 2022?", "id": "100000000000000000000318", "answers": [{"text": "246,029 for the number of vaccine doses administered since December 14, 2020. The adjustment is the result of updates to how pharmacies report data to CDC and/or the jurisdictions. March 11, 2022: New Hampshire reviewed data and made adjustments to their reporting, resulting in a decrease of 91,294", "answer_start": 209}], "is_impossible": false}, {"question": "New Hampshire reviewed data and made what?", "id": "100000000000000000000319", "answers": [{"text": "adjustments to their reporting", "answer_start": 443}], "is_impossible": false}], "context": "The adjustment is the result\nof updates to how pharmacies report data to CDC and/or the jurisdictions. March 22, 2022: New Hampshire reviewed data and made adjustments to reporting, resulting in a decrease of 246,029\nfor the number of vaccine doses administered since December 14, 2020. The adjustment is the result of updates to how\npharmacies report data to CDC and/or the jurisdictions. March 11, 2022: New Hampshire reviewed data and made adjustments to their reporting, resulting in a decrease of\n91,294 for the number of vaccine doses administered since December 14, 2020."}]}, {"title": "58a7715990ebd8c64678f1efa8f9ff8d", "paragraphs": [{"qas": [{"question": "When did CDC remove count-based options from the map views on Vaccinations in the US?", "id": "100000000000000000000320", "answers": [{"text": "March 10, 2022", "answer_start": 103}], "is_impossible": false}, {"question": "When hovering over a specific jurisdiction, what appears on the map when the relevant rate or percentage-based metric is selected?", "id": "100000000000000000000322", "answers": [{"text": "count-based options", "answer_start": 135}], "is_impossible": false}, {"question": "When does CDC begin attributing vaccine recipients to their jurisdiction of residence for the People Receiving Dose 1 metric on Vaccination Trends?", "id": "100000000000000000000323", "answers": [{"text": "March 9, 2022", "answer_start": 401}], "is_impossible": false}, {"question": "What metric previously attributed recipients to the jurisdiction where vaccine was administered?", "id": "100000000000000000000324", "answers": [{"text": "People Receiving Dose 1\u201d metric on Vaccination Trends", "answer_start": 494}], "is_impossible": false}], "context": "The adjustment is the result of updates\nto how pharmacies report data to CDC and/or the jurisdictions. March 10, 2022: CDC has removed count-based options from the map views on Vaccinations in the US. This information\nis still available for download and continues to appear on the map when hovering over a specific jurisdiction when the\nrelevant rate or percentage-based metric is selected. Beginning March 9, 2022, CDC attributes vaccine recipients to their jurisdiction of residence for the \u201cPeople Receiving\nDose 1\u201d metric on Vaccination Trends. Previously, this metric attributed recipients to the jurisdiction where vaccine was\nadministered."}]}, {"title": "50b296455f503a6fdafd680e286e5590", "paragraphs": [{"qas": [{"question": "What is CDC working to address?", "id": "100000000000000000000326", "answers": [{"text": "data processing issue on February 27, 2022, vaccination data were not updated on CDC COVID Data Tracker and reflect data as of February 26, 2022. CDC is actively working to address this issue", "answer_start": 9}], "is_impossible": false}, {"question": "When will the data be updated?", "id": "100000000000000000000327", "answers": [{"text": "when available", "answer_start": 230}], "is_impossible": false}, {"question": "How many vaccine doses did New Hampshire decrease since December 14, 2020?", "id": "100000000000000000000328", "answers": [{"text": "209,146", "answer_start": 354}], "is_impossible": false}, {"question": "How do pharmacies report data to the CDC?", "id": "100000000000000000000330", "answers": [{"text": "updates to how pharmacies report data to CDC and/or the jurisdictions", "answer_start": 465}], "is_impossible": false}], "context": "Due to a data processing issue on February 27, 2022, vaccination data were not updated on CDC COVID Data Tracker\nand reflect data as of February 26, 2022. CDC is actively working to address this issue and the data will be updated when\navailable. February 25, 2022: New Hampshire reviewed data and made adjustments to reporting, resulting in a decrease of\n209,146 for the number of vaccine doses administered since December 14, 2020. The adjustment is the result of updates\nto how pharmacies report data to CDC and/or the jurisdictions."}]}, {"title": "df58e259be88799fdc1d34991a7ea6f8", "paragraphs": [{"qas": [{"question": "How many vaccine doses were increased in Idaho in 2022?", "id": "100000000000000000000332", "answers": [{"text": "177,996", "answer_start": 140}], "is_impossible": false}, {"question": "When did CDC change the address algorithm for the Bureau of Prisons and Department of Defense?", "id": "100000000000000000000335", "answers": [{"text": "January 19, 2022", "answer_start": 325}], "is_impossible": false}], "context": "On January 25, 2022, Idaho began providing vaccine data for recipients younger than 18 years of age to CDC. This\nresulted in an increase of 177,996 doses administered. On January 20, 2022, data review and reporting adjustments resulted in a decrease of 12,298 vaccine doses\nadministered in Hawaii since December 14, 2020. On January 19, 2022, CDC changed the address algorithm for the Bureau of Prisons (BOP) and Department of Defense\n(DOD) to better align vaccine administration counts with the residential county of the recipient instead of the county\nwhere vaccine was administered."}]}, {"title": "5f6d3976c629d511e34e8a9a557eff52", "paragraphs": [{"qas": [{"question": "What was the greatest impact on vaccination records at the national level?", "id": "100000000000000000000336", "answers": [{"text": "no net change", "answer_start": 20}], "is_impossible": false}, {"question": "What will residential counties near DOD facilities see increases in?", "id": "100000000000000000000337", "answers": [{"text": "vaccine administration counts", "answer_start": 242}], "is_impossible": false}, {"question": "Where will counties where dod facilities are located see decreases in vaccination records?", "id": "100000000000000000000338", "answers": [{"text": "counties where DOD facilities are located will see decreases in vaccine administration counts. \u2022 \u2022 \u2022 \u2022", "answer_start": 277}], "is_impossible": false}, {"question": "What counties will see decreases in vaccine administration counts?", "id": "100000000000000000000339", "answers": [{"text": "counties where DOD facilities are located", "answer_start": 277}], "is_impossible": false}, {"question": "Why is CDC not showing county-level data for residents?", "id": "100000000000000000000340", "answers": [{"text": "because of the small populations in these counties", "answer_start": 620}], "is_impossible": false}, {"question": "What is the reason for the small population in these counties?", "id": "100000000000000000000341", "answers": [{"text": "residents who received vaccines in other states or counties", "answer_start": 686}], "is_impossible": false}], "context": "The change produced no net change for vaccination records at the national level and\nminimal impact at the jurisdiction level. The greatest impact was at the county level. Residential counties located near DOD facilities will see increases in vaccine administration counts, and counties\nwhere DOD facilities are located will see decreases in vaccine administration counts. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nBeginning January 19, 2022:CDC is not displaying county-level data for residents of Barnstable, Dukes, and Nantucket\ncounties in Massachusetts because of the small populations in these counties. This includes residents who received\nvaccines in other states or counties."}]}, {"title": "e179505353f1c5ca302a473d7dc97e7f", "paragraphs": [{"qas": [{"question": "What state does not provide data directly to CDC?", "id": "100000000000000000000343", "answers": [{"text": "Massachusetts", "answer_start": 0}], "is_impossible": false}, {"question": "What does CDC COVID Data Tracker create?", "id": "100000000000000000000345", "answers": [{"text": "artificially low numbers", "answer_start": 327}], "is_impossible": false}, {"question": "When was the data processing issue?", "id": "100000000000000000000346", "answers": [{"text": "January 7, 2022", "answer_start": 457}], "is_impossible": false}, {"question": "What happened to vaccination delivery data?", "id": "100000000000000000000347", "answers": [{"text": "vaccination delivery data were not updated", "answer_start": 474}], "is_impossible": false}, {"question": "What is the date of the COVID Data Tracker update?", "id": "100000000000000000000348", "answers": [{"text": "January 6, 2022", "answer_start": 566}], "is_impossible": false}], "context": "Massachusetts does not provide data directly to CDC. From January 27, 2021 to January 18, 2022, vaccination data\nwas provided from other entities on residents of the affected counties who were vaccinated in other state/counties. This data was displayed on the CDC COVID Data Tracker, but without complete reporting, it creates artificially low\nnumbers for these counties which is why this data will no longer be displayed. Due to a data processing issue on January 7, 2022, vaccination delivery data were not updated on CDC COVID Data\nTracker and reflect data as of January 6, 2022."}]}, {"title": "af26c4dbefd895c8827afd8b35cb5f7", "paragraphs": [{"qas": [{"question": "Who is actively working to address this issue?", "id": "100000000000000000000349", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "When will the data be updated?", "id": "100000000000000000000350", "answers": [{"text": "when available", "answer_start": 75}], "is_impossible": false}, {"question": "What does this update not impact?", "id": "100000000000000000000352", "answers": [{"text": "the overall number of people who have received at least one dose of a COVID-19 vaccine or the overall number of people who are fully vaccinated", "answer_start": 209}], "is_impossible": false}, {"question": "How many counties have received at least one dose of a COVID-19 vaccine?", "id": "100000000000000000000353", "answers": [{"text": "189", "answer_start": 414}], "is_impossible": false}, {"question": "The update does impact the percentage of populations within how many counties?", "id": "100000000000000000000355", "answers": [{"text": "189", "answer_start": 414}], "is_impossible": false}], "context": "CDC is actively working to address this issue and the data will be updated\nwhen available. December 30, 2021: CDC updated 349 incorrect census county-level population denominators. This update does not\nimpact the overall number of people who have received at least one dose of a COVID-19 vaccine or the overall number of\npeople who are fully vaccinated. The update does impact the percentage of populations within 189 counties who have\nreceived at least one dose or who are fully vaccinated."}]}, {"title": "da71acf0bff66206457a063103bbaee8", "paragraphs": [{"qas": [{"question": "What resulted in an undercount of fully vaccinated people with a booster dose in North Carolina?", "id": "100000000000000000000357", "answers": [{"text": "linking data across different vaccine sites", "answer_start": 101}], "is_impossible": false}, {"question": "What is being evaluated for resolution in North Carolina?", "id": "100000000000000000000358", "answers": [{"text": "fully vaccinated people with a booster dose", "answer_start": 247}], "is_impossible": false}, {"question": "When did CDC update the demographic data to use the date of vaccine administration instead of the date when the vaccine was reported to CDC?", "id": "100000000000000000000359", "answers": [{"text": "November 18, 2021", "answer_start": 360}], "is_impossible": false}, {"question": "What state now includes vaccination demographic data?", "id": "100000000000000000000360", "answers": [{"text": "Texas", "answer_start": 585}], "is_impossible": false}], "context": "December 10, 2021: North Carolina identified an issue on December 10, 2021 at the federal level with linking data across\ndifferent vaccine sites (i.e., retail pharmacy, local health department, doctor\u2019s office). This resulted in an undercount of \u201cfully vaccinated people with a booster dose\u201d in North Carolina. This issue is being\nevaluated for resolution. On November 18, 2021, CDC updated the demographic data to use the date of vaccine administration instead of the\ndate when the vaccination was reported to CDC. Beginning November 18, 2021,vaccination demographic data now include Texas."}]}, {"title": "241bedfacc2fa5b877962b7a6a61ab22", "paragraphs": [{"qas": [{"question": "What year did West Virginia conduct an internal review of their COVID-19 vaccine administrative data?", "id": "100000000000000000000361", "answers": [{"text": "2021", "answer_start": 9}], "is_impossible": false}, {"question": "What was a lag in some of West Virginia's data uploads to CDC Data Clearing House?", "id": "100000000000000000000362", "answers": [{"text": "West Virginia recently conducted an internal review of COVID-19 vaccine administrative data", "answer_start": 15}], "is_impossible": false}, {"question": "How many administration records did West Virginia submit to DCH from July to November of this year?", "id": "100000000000000000000363", "answers": [{"text": "1.47 million", "answer_start": 424}], "is_impossible": false}, {"question": "What was the increase in administration records for West Virginia?", "id": "100000000000000000000364", "answers": [{"text": "1.47 million", "answer_start": 424}], "is_impossible": false}], "context": "November 2021: West Virginia recently conducted an internal review of COVID-19 vaccine administrative data and\ndetermined that there was a lag in some of their data uploads to CDC Data Clearing House (DCH). Beginning November 15, 2021 and continuing through December 9, West Virginia submitted multiple files to DCH\ncontaining administration records from July through November of this year, which resulted in an increase of 1.47\nmillion administration records for the state."}]}, {"title": "103cca277e47b87f0ecd8e4ec249bbcb", "paragraphs": [{"qas": [{"question": "When did a temporary network outage at CDC occur?", "id": "100000000000000000000365", "answers": [{"text": "Friday, November 12, 2021", "answer_start": 66}], "is_impossible": false}, {"question": "How many records were omitted from the vaccine administration files?", "id": "100000000000000000000366", "answers": [{"text": "281,912", "answer_start": 246}], "is_impossible": false}, {"question": "What was the reason for the omission of 281,912 records?", "id": "100000000000000000000367", "answers": [{"text": "a temporary network outage", "answer_start": 22}], "is_impossible": false}, {"question": "When was the data for Sunday, November 14, 2021 included?", "id": "100000000000000000000368", "answers": [{"text": "omitted 281,912 records", "answer_start": 238}], "is_impossible": false}, {"question": "What is the population estimate for all territories and protectorates excluding Puerto Rico?", "id": "100000000000000000000370", "answers": [{"text": "2020 US Census International Data Base", "answer_start": 450}], "is_impossible": false}, {"question": "Who recommended the use of the Pfizer-BioNTech Vaccine for children ages 5-11?", "id": "100000000000000000000371", "answers": [{"text": "CDC", "answer_start": 511}], "is_impossible": false}, {"question": "What is the name of the vaccine for children aged 5 to 11?", "id": "100000000000000000000373", "answers": [{"text": "Pfizer-BioNTech Vaccine", "answer_start": 538}], "is_impossible": false}], "context": "On November 14, 2021, a temporary network outage at CDC occurring Friday, November 12, 2021 resulted in vaccine\nadministration files from 13 partner entities not being properly processed and resulted in 281,912 records being\nomitted. The omitted 281,912 records are included in the data for Sunday, November 14, 2021. On November 5, 2021, population estimates for all territories and protectorates (excluding Puerto Rico) have been\nupdated using the 2020 US Census International Data Base. On November 2, 2021, CDC recommended use of the Pfizer-BioNTech Vaccine for children ages 5 through 11 for the\npediatric population ages 5 to 11."}]}, {"title": "dd3857878a7ba60c41eef2b82cbe361b", "paragraphs": [{"qas": [{"question": "What vaccine has not been recommended for use among children ages 5-11?", "id": "100000000000000000000374", "answers": [{"text": "COVID-19", "answer_start": 20}], "is_impossible": false}, {"question": "What year does Hawaii not provide CDC with county-of-residence information?", "id": "100000000000000000000375", "answers": [{"text": "2021", "answer_start": 155}], "is_impossible": false}, {"question": "What was displayed on COVID Data Tracker from October 22 to October 31, 2021?", "id": "100000000000000000000376", "answers": [{"text": "vaccination data", "answer_start": 402}], "is_impossible": false}, {"question": "How many people in Kentucky received a decrease in vaccines in 2021 from a data review and reporting adjustment?", "id": "100000000000000000000377", "answers": [{"text": "411,224", "answer_start": 613}], "is_impossible": false}, {"question": "What was the decrease in vaccinations in Kentucky from October 29 to October 29, 2021 compared to the previous year?", "id": "100000000000000000000378", "answers": [{"text": "411,224 doses administered", "answer_start": 613}], "is_impossible": false}], "context": "The Pfizer-BioNTech COVID-19 Vaccine recommended for adults and adolescents has\nnot been recommended for use among children ages 5 through 11. November 1, 2021: Hawaii does not provide CDC with county-of-residence information. As such, CDC is suppressing\ncounty-level data for Hawaii residents, including those who received vaccines in other states or territories. From October 22 to October 31, 2021, vaccination data on residents of Hawaii receiving vaccines in other states\nwere displayed on COVID Data Tracker. On October 29, 2021, data review and reporting adjustments for Kentucky resulted in a decrease of 411,224 doses\nadministered."}]}, {"title": "37aa05585acbf6dc29f4e1878b315712", "paragraphs": [{"qas": [{"question": "When did CDC correct an error in the census denominators used to calculate percentage-based metrics for the population  65 years of age?", "id": "100000000000000000000381", "answers": [{"text": "October 26, 2021", "answer_start": 108}], "is_impossible": false}, {"question": "What was Puerto Rico's population age?", "id": "100000000000000000000382", "answers": [{"text": "65 years", "answer_start": 240}], "is_impossible": false}, {"question": "How many people were in the Puerto Rico census?", "id": "100000000000000000000384", "answers": [{"text": "679,656", "answer_start": 416}], "is_impossible": false}, {"question": "What website will the CDC update to reflect these corrections?", "id": "100000000000000000000386", "answers": [{"text": "data.cdc.gov", "answer_start": 590}], "is_impossible": false}], "context": "The adjustments are the result of updates to how pharmacies report data to CDC and/or the jurisdictions. On October 26, 2021, CDC corrected an error in the census denominators used to calculate percentage-based metrics\nfor the population \u2265 65 years of age in Puerto Rico. No other population groups were affected. The census counts for the population aged 65 years and older in Puerto Rico increased from 542,928 to 679,656\npeople. The census counts for the population aged 65 years and older in the US increased from 54,696,581 to 54,833,309\npeople. CDC will update its historical data on data.cdc.gov to reflect these corrections."}]}, {"title": "78c61b4307736bfa928cdeaaa5b2a437", "paragraphs": [{"qas": [{"question": "When did CDC correct a processing error?", "id": "100000000000000000000387", "answers": [{"text": "October 24, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "What is the age group of 50+ for October 22 and 23, 2021?", "id": "100000000000000000000389", "answers": [{"text": "50+ years of age", "answer_start": 111}], "is_impossible": false}, {"question": "On October 22, 2021: County-level graphics include what?", "id": "100000000000000000000390", "answers": [{"text": "Texas vaccination data", "answer_start": 335}], "is_impossible": false}], "context": "On October 24, 2021, CDC identified and corrected a processing error for percent of fully vaccinated people in 50+ years\nof age with a booster dose. This error resulted in a higher percentage of people reported with a booster dose in the age\ngroup of 50+ for October 22 and 23, 2021. On October 22, 2021: County-level graphics include Texas vaccination data. Texas and CDC collaborated to update how\nTexas submits aggregate vaccination data to enhance the information provided on CDC COVID Data Tracker."}]}, {"title": "aa4a73fa8daaef07951c25aa881bbd0f", "paragraphs": [{"qas": [{"question": "When did CDC correct a processing error for Texas?", "id": "100000000000000000000392", "answers": [{"text": "September 29, 2021", "answer_start": 116}], "is_impossible": false}, {"question": "What resulted in a higher count for the total number of people who were fully vaccinated in the state?", "id": "100000000000000000000393", "answers": [{"text": "reporting adjustments were made for Texas", "answer_start": 190}], "is_impossible": false}, {"question": "Who was fully vaccinated in the state?", "id": "100000000000000000000394", "answers": [{"text": "- - - \u2022 \u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC On September 29, 2021: CDC identified and corrected a processing error after reporting adjustments were made for Texas", "answer_start": 33}], "is_impossible": false}, {"question": "What resulted in a decrease of 91,119 doses?", "id": "100000000000000000000395", "answers": [{"text": "reporting adjustments for Texas", "answer_start": 365}], "is_impossible": false}], "context": "\u2022\n-\n\u2022\n\u2022\n\u2022\n-\n\u2022\n\u2022\n\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\n-\n\u2022\n\u2022\n-\n-\n-\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nOn September 29, 2021: CDC identified and corrected a processing error after reporting adjustments were made for\nTexas. This error resulted in a higher count for the total number of people who were fully vaccinated in the state. On September 28, 2021, reporting adjustments for Texas resulted in a decrease of 91,119 doses. On September 23, 2021, data review and reporting adjustments resulted in a decrease in the number of vaccine doses\nadministered for Washington State of 473,191 doses."}]}, {"title": "a6343530c25251f1ccdc94c2998fc7dd", "paragraphs": [{"qas": [{"question": "What are the results of updates to how pharmacies report data to CDC and/or the jurisdictions?", "id": "100000000000000000000397", "answers": [{"text": "The adjustments", "answer_start": 0}], "is_impossible": false}, {"question": "What was the name of the partnership between CDC and CVS, Walgreens, and Managed Health Care Associates, Inc.?", "id": "100000000000000000000401", "answers": [{"text": "The Federal Pharmacy Partnership for Long-Term Care (LTC) Program", "answer_start": 440}], "is_impossible": false}], "context": "The adjustments are the results of updates to how pharmacies\nreport data to CDC and/or the jurisdictions. Due to a short network outage at CDC on August 14, 2021, some of the vaccine administration files were not ingested on\nAugust 15, 2021. Counts from these files are not reflected in the 6am counts for August 15, 2021 but will be in August 16,\n2021 counts. This affected 11 entities for a grand total of 66,326 vaccine administrations. The Federal Pharmacy Partnership for Long-Term Care (LTC) Program was a partnership between CDC and CVS,\nWalgreens, and Managed Health Care Associates, Inc."}]}, {"title": "671c55b03b7d3edc37b752ce78e1c18b", "paragraphs": [{"qas": [{"question": "What was the name of the program that offered on-site COVID-19 vaccination services for residents of nursing homes and assisted living facilities?", "id": "100000000000000000000402", "answers": [{"text": "Pharmacy Partnership for LTC Program", "answer_start": 133}], "is_impossible": false}, {"question": "When did the federal Pharmacy Partnership for LTC Program become in effect?", "id": "100000000000000000000403", "answers": [{"text": "April 23, 2021", "answer_start": 219}], "is_impossible": false}, {"question": "What was removed on October 7, 2021?", "id": "100000000000000000000404", "answers": [{"text": "COVID-19 Data Tracker pages", "answer_start": 247}], "is_impossible": false}, {"question": "On what website are all vaccine doses administered to residents and staff of nursing homes and assisted living facilities represented?", "id": "100000000000000000000406", "answers": [{"text": "cdc.gov", "answer_start": 455}], "is_impossible": false}], "context": "The program offered on-site COVID-19 vaccination services for\nresidents of nursing homes and assisted living facilities. The federal Pharmacy Partnership for LTC Program was in effect\nafter vaccines became available to April 23, 2021, and related COVID-19 Data Tracker pages were removed on October 7,\n2021. Historical data, previously available for download, that reflects the Pharmacy Partnership for LTC Program have\nbeen archived and are available on cdc.gov.\u200b All vaccine doses administered to residents and staff of nursing homes and\nassisted living facilities continue to be represented in their appropriate jurisdiction totals."}]}, {"title": "52f97c46db8fe1697fac7d17b2068fbc", "paragraphs": [{"qas": [{"question": "How many vaccine recipients where a valid race was reported in conjunction with \u201cother\u201d race are now categorized as \u201cNon-Hispanic Multiracial\u201d?", "id": "100000000000000000000408", "answers": [{"text": "4.5 million", "answer_start": 201}], "is_impossible": false}, {"question": "What was previously categorized as \u201cNon-Hispanic Multiracial\u201d?", "id": "100000000000000000000409", "answers": [{"text": "vaccine recipients", "answer_start": 213}], "is_impossible": false}, {"question": "When will submitting entities have the ability to update or delete previously submitted records?", "id": "100000000000000000000411", "answers": [{"text": "August 9, 2021", "answer_start": 425}], "is_impossible": false}], "context": "On August 31, 2021, CDC updated its algorithm for assigning a race/ethnicity category for vaccine recipients to align with\nU.S. Census Bureau race/ethnicity classifications. As a result, approximately 4.5 million vaccine recipients where a valid\nrace was reported in conjunction with \u201cother\u201d race who were previously categorized as \u201cNon-Hispanic Multiracial\u201d are\nnow categorized into a single race/ethnicity group. Beginning August 9, 2021, submitting entities will have the ability to update or delete previously submitted records using\nnew functionality available in CDC\u2019s Data Clearinghouse."}]}, {"title": "86965f7225f29f4fb089bb1f274576fa", "paragraphs": [{"qas": [{"question": "What may result in fluctuations across metrics on the CDC COVID Data Tracker as historical data are updated or deleted?", "id": "100000000000000000000412", "answers": [{"text": "Use of this new functionality", "answer_start": 0}], "is_impossible": false}, {"question": "When did data review and reporting adjustments result in a larger-than-usual increase in data?", "id": "100000000000000000000414", "answers": [{"text": "July 1, 2021", "answer_start": 237}], "is_impossible": false}, {"question": "How many doses of vaccine did the CDC and jurisdictions work to correct?", "id": "100000000000000000000416", "answers": [{"text": "258,590 and 465,704", "answer_start": 405}], "is_impossible": false}, {"question": "What was the result of the review and reporting adjustments?", "id": "100000000000000000000417", "answers": [{"text": "a larger-than-usual increase in the number of vaccine doses administered for Arizona and Puerto Rico of 258,590 and 465,704 doses", "answer_start": 301}], "is_impossible": false}], "context": "Use of this new functionality may result in fluctuations across\nmetrics on the CDC COVID Data Tracker as historical data are updated or deleted. The functionality will also allow for\nmore accurate reporting and improved data quality. On July 1, 2021, data review and reporting adjustments resulted in a larger-than-usual increase in the number of vaccine\ndoses administered for Arizona and Puerto Rico of 258,590 and 465,704 doses respectively. The adjustment is the result\nof CDC and the jurisdictions actively working to correct data transmission errors."}]}, {"title": "77ec1b28c1032f5cac5eb8e8e227a525", "paragraphs": [{"qas": [{"question": "When did data review and reporting adjustments result in an increase in the number of vaccine doses administered for North Carolina?", "id": "100000000000000000000418", "answers": [{"text": "June 30, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "What is the reason for the increase in vaccination doses?", "id": "100000000000000000000420", "answers": [{"text": "updates to how pharmacies report data to CDC and/or the jurisdictions", "answer_start": 213}], "is_impossible": false}, {"question": "What are the results of updates to how pharmacies report data to CDC and/or the jurisdictions?", "id": "100000000000000000000424", "answers": [{"text": "adjustments", "answer_start": 510}], "is_impossible": false}], "context": "On June 30, 2021, data review and reporting adjustments resulted in an increase in the number of vaccine doses\nadministered for North Carolina of 621,198 doses since December 2020. The adjustment is the result of updates to how\npharmacies report data to CDC and/or the jurisdictions. On June 25, 2021, data review and reporting adjustments resulted in a decrease in the number of vaccine doses\nadministered for New Jersey of 331,640 doses and a smaller-than-usual increase for New Hampshire of 6,449 doses. The\nadjustments are the result of updates to how pharmacies report data to CDC and/or the jurisdictions."}]}, {"title": "f8ecdb9a228fe7b7892748066829c6e6", "paragraphs": [{"qas": [{"question": "What did the Demographic Trends of People Receiving COVID-19 Vaccinations in the United States previously show?", "id": "100000000000000000000425", "answers": [{"text": "\u201cdate administered\u201d erroneously", "answer_start": 100}], "is_impossible": false}, {"question": "When did CDC identify vaccine administration records from files that were previously received but not fully processed?", "id": "100000000000000000000427", "answers": [{"text": "June 14, 2021", "answer_start": 208}], "is_impossible": false}, {"question": "How many vaccine administration counts have been increased since June 14, 2021?", "id": "100000000000000000000428", "answers": [{"text": "339,047", "answer_start": 435}], "is_impossible": false}, {"question": "How many GU counts will decrease in the following jurisdictions?", "id": "100000000000000000000430", "answers": [{"text": "NJ (-20,609", "answer_start": 610}], "is_impossible": false}], "context": "Demographic Trends of People Receiving COVID-19 Vaccinations in the United States previously showed \u201cdate\nadministered\u201d erroneously. This has been replaced with \u201cdate reported to CDC\u201d as of June 24, 2021. On June 14, 2021: During a system upgrade, CDC identified vaccine administration records from files that were\npreviously received but not fully processed. Completion of processing on June 14, 2021 has resulted in a net increase of\n339,047 vaccine administration counts. By jurisdiction, the net increases are: CT (+39), DC (+4,528), FL (+132,008), GU\ncounts for the following jurisdictions will decrease: NJ (-20,609)."}]}, {"title": "14977aa09fe67799cd08faab196484b5", "paragraphs": [{"qas": [{"question": "On what date did CDC correct an error in the Census denominators?", "id": "100000000000000000000431", "answers": [{"text": "June 14, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "What was the population ages 12 and older, 18 and older and 65 years and older counted for?", "id": "100000000000000000000432", "answers": [{"text": "percentage-based metrics", "answer_start": 86}], "is_impossible": false}, {"question": "What were the census counts for ages 65 and older?", "id": "100000000000000000000435", "answers": [{"text": "54,696,898 to 54,696,581", "answer_start": 568}], "is_impossible": false}], "context": "On June 14, 2021, CDC corrected an error in the Census denominators used to calculate percentage-based metrics for\nthe U.S. population ages 12 years and older, 18 years and older, and 65 years and older. No other population groups\nwere affected. The census counts for the population ages 12 years and older increased from 280,216,744 to 283,545,812 people\n(+3,329,068). The census counts for the population ages 18 years and older increased from 258,130,580 to 258,259,833 people\n(+129,253). The census counts for the population ages 65 years and older decreased from 54,696,898 to 54,696,581 people\n(-317)."}]}, {"title": "47054ab6ed4f489001007bcf3422d00d", "paragraphs": [{"qas": [{"question": "On what day were records missing the 6 AM ET cutoff for inclusion on CDT?", "id": "100000000000000000000437", "answers": [{"text": "June 10, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "What date was the data correctly synchronized as of June 17, 2021?", "id": "100000000000000000000438", "answers": [{"text": "June 10, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "How many doses of COVID-19 vaccine were incorrectly reported for New Mexico on June 6, 2021?", "id": "100000000000000000000439", "answers": [{"text": "1,903,485", "answer_start": 490}], "is_impossible": false}, {"question": "Why was the incorrect number of doses reported for the state of New Mexico incorrectly?", "id": "100000000000000000000440", "answers": [{"text": "a data processing error", "answer_start": 507}], "is_impossible": false}, {"question": "What was the correct total for NM on June 6, 2021?", "id": "100000000000000000000441", "answers": [{"text": "2,175,419", "answer_start": 602}], "is_impossible": false}, {"question": "How many doses were administered?", "id": "100000000000000000000442", "answers": [{"text": "2,175,419", "answer_start": 602}], "is_impossible": false}], "context": "On June 10, 2021, a data synchronization error resulted in a number of records missing the 6 AM ET cutoff for inclusion\nthe same day on CDT. Records were instead being included on CDT the following day. The issue has been resolved and\ndata are correctly synchronized as of June 17, 2021. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n-\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nOn June 6, 2021, the total number of administered doses for New Mexico was incorrectly reported as 1,903,485 due to a\ndata processing error, which has been amended. The correct total for NM on June 6, 2021, was 2,175,419 administered\ndoses."}]}, {"title": "a5833cbac5ccec1cbacd3a30ec48db5e", "paragraphs": [{"qas": [{"question": "What state lifted its national COVID-19 emergency response declaration in May 2021?", "id": "100000000000000000000443", "answers": [{"text": "New Hampshire", "answer_start": 10}], "is_impossible": false}, {"question": "What does New Hampshire allow vaccine recipients to opt out of?", "id": "100000000000000000000444", "answers": [{"text": "having their COVID-19 vaccinations included in the state\u2019s Immunization Information System registry", "answer_start": 143}], "is_impossible": false}, {"question": "On May 27, 2021, the total doses administered data posted to what website showed a decrease in doses?", "id": "100000000000000000000446", "answers": [{"text": "COVID Data Tracker for Vermont", "answer_start": 439}], "is_impossible": false}, {"question": "What is the result of ongoing efforts to improve the data?", "id": "100000000000000000000447", "answers": [{"text": "a decrease in doses administered", "answer_start": 477}], "is_impossible": false}], "context": "May 2021: New Hampshire lifted its national COVID-19 emergency response declaration in May 2021, which allows\nvaccine recipients to opt out of having their COVID-19 vaccinations included in the state\u2019s Immunization Information\nSystem registry. As such, data submitted by New Hampshire since May 2021 may not be representative of all COVID-19\nvaccination occurring in the state. On May 27, 2021, the total doses administered data posted to COVID Data Tracker for Vermont showed a decrease in\ndoses administered. This is an accurate reflection of the data and is the result of ongoing efforts to improve the data\nquality of records reported from Vermont."}]}, {"title": "4992ee0de077a6c984d86a31347dac8f", "paragraphs": [{"qas": [{"question": "On what date did the New Hampshire \u2018at least one dose\u2019 values appear lower than that reported the day prior?", "id": "100000000000000000000449", "answers": [{"text": "May 27, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "On May 25, 2021, how many administered doses were reported for Long-Term Care Facilities?", "id": "100000000000000000000452", "answers": [{"text": "7,836,063", "answer_start": 282}], "is_impossible": false}, {"question": "On May 26, 2021 the data accurately reflect total doses for what facility?", "id": "100000000000000000000455", "answers": [{"text": "Long-Term Care Facilities", "answer_start": 324}], "is_impossible": false}, {"question": "When did the data for May 26, 2021 accurately reflect total LTCF doses?", "id": "100000000000000000000456", "answers": [{"text": "May 27, 2021", "answer_start": 3}], "is_impossible": false}], "context": "On May 27, 2021, the New Hampshire \u2018at least one dose\u2019 values posted to Tracker appeared lower than that reported the\nday prior (May 26, 2021). This correction is accurate and is due to New Hampshire and CDC collaboratively correcting\ndata transmission errors. On May 25, 2021, the 7,836,063 administered doses reported for Long-Term Care Facilities (LTCF), were fewer by 4,105\nrecords compared to the 7,840,168 reported on May 24, 2021. This was due to an error in data processing that has now\nbeen corrected. The data for May 26, 2021 accurately reflect total LTCF doses."}]}, {"title": "78c2f6002f20eeb1e44868b0e6c66c6", "paragraphs": [{"qas": [{"question": "On what date were doses incorrectly reported for the US and New Hampshire?", "id": "100000000000000000000457", "answers": [{"text": "May 16, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "How many doses were correctly reported on May 16, 2021?", "id": "100000000000000000000459", "answers": [{"text": "272,925,411", "answer_start": 258}], "is_impossible": false}, {"question": "How many doses of the vaccine were administered in the US?", "id": "100000000000000000000460", "answers": [{"text": "272,925,411", "answer_start": 258}], "is_impossible": false}, {"question": "What was incorrectly reported on the Vaccinations Demographics page on May 13, 2021?", "id": "100000000000000000000461", "answers": [{"text": "the number of persons aged <18 years, who had received at least 1 dose of vaccine was incorrectly reported as 3,687,617", "answer_start": 332}], "is_impossible": false}, {"question": "How many people aged 18 years had received at least 1 dose of vaccine?", "id": "100000000000000000000462", "answers": [{"text": "3,687,617", "answer_start": 442}], "is_impossible": false}, {"question": "What age group was included in the 18 years group?", "id": "100000000000000000000464", "answers": [{"text": "<18 years", "answer_start": 359}], "is_impossible": false}], "context": "On May 16, 2021, the total number of administered doses for the US and New Hampshire were incorrectly reported. This\nwas due to an error in data processing. The data for May 16, 2021 have been updated and now correctly report the total\nadministered doses of 272,925,411 for the US, and 1,211,530 for New Hampshire. On May 13, 2021, the number of persons aged <18 years, who had received at least 1 dose of vaccine was incorrectly\nreported as 3,687,617 on the Vaccinations Demographics page. This was due to inclusion of those ages 18 years in the\n<18 years group."}]}, {"title": "87d5f1c5050590117a60c4156c9b5f6d", "paragraphs": [{"qas": [{"question": "What is the correct number for May 13, 2021?", "id": "100000000000000000000465", "answers": [{"text": "2,340,538", "answer_start": 70}], "is_impossible": false}, {"question": "What does CDC assume residents of Texas who receive a vaccination in a different state or territory are?", "id": "100000000000000000000467", "answers": [{"text": "are not attributed to Texas in their population-based metrics but are still included in national-level metrics", "answer_start": 319}], "is_impossible": false}, {"question": "Who receives a vaccination in a different state or territory?", "id": "100000000000000000000468", "answers": [{"text": "Residents of Texas", "answer_start": 240}], "is_impossible": false}], "context": "This error has been corrected. The correct number for May 13, 2021 is 2,340,538. On May 13, 2021, CDC updated its methodology for calculating age-based metrics for Texas. Effective May 13, 2021, to\ncalculate age-based metrics, CDC assumes: Residents of Texas who receive a vaccination in a different state or territory\nare not attributed to Texas in their population-based metrics but are still included in national-level metrics. All people\nreceiving vaccinations in Texas are considered Texas residents of Texas."}]}, {"title": "ceb412d766b4cf5c5ebbecef5ac9eac9", "paragraphs": [{"qas": [{"question": "What percentage of total doses were administered to people in each age group?", "id": "100000000000000000000470", "answers": [{"text": "the same as both the percentage of people who received at least one dose and the percentage of fully vaccinated people within each age group", "answer_start": 164}], "is_impossible": false}, {"question": "What is the percentage of people who received at least one dose?", "id": "100000000000000000000471", "answers": [{"text": "the same", "answer_start": 164}], "is_impossible": false}, {"question": "How many population groups in Texas have received at least one vaccine?", "id": "100000000000000000000473", "answers": [{"text": "three", "answer_start": 423}], "is_impossible": false}], "context": "The percentage of total doses that were\nadministered to people in each age group (ages 12 years and older, ages 18 years and older, and ages 65 years and\nolder) is the same as both the percentage of people who received at least one dose and the percentage of fully\nvaccinated people within each age group. CDC estimates the \u201cat least one dose\u201d metric for these populations of Texas by\nfirst obtaining the percentage of the three population groups who have received \u2018at least one dose\u2019 from Texas."}]}, {"title": "b6625481d6431daee7e06445ff8a19bf", "paragraphs": [{"qas": [{"question": "On what date was the COVID-19 Vaccine Tracker updated?", "id": "100000000000000000000478", "answers": [{"text": "May 7, 2021", "answer_start": 314}], "is_impossible": false}, {"question": "How many dose vials did the FDA authorize?", "id": "100000000000000000000479", "answers": [{"text": "14", "answer_start": 456}], "is_impossible": false}], "context": "CDC then\nmultiplies this percentage by the count for the total population receiving at least one dose in Texas. CDC repeats the\nsame calculations to estimate the \u201cfully vaccinated\u201d metrics for the three population groups. These values will also be\nincluded in the topline national totals for 12+, 18+, and 65+. On May 7, 2021, the COVID-19 Vaccine Tracker was updated to reflect the revised Moderna emergency use authorization\n(EUA) to account for the new 14 dose vial as authorized by the Food and Drug Administration (FDA) ."}]}, {"title": "53b0dab0eb7743e9168d7eab6aa80483", "paragraphs": [{"qas": [{"question": "How many doses will Moderna deliver to a jurisdiction on or after May 7, 2021?", "id": "100000000000000000000480", "answers": [{"text": "fourteen", "answer_start": 95}], "is_impossible": false}, {"question": "What does the change to the Moderna dosage increase the number of doses delivered relative to?", "id": "100000000000000000000481", "answers": [{"text": "the number of doses administered", "answer_start": 251}], "is_impossible": false}, {"question": "On what date was the New Hampshire \u201ctotal doses administered\u201d value posted to Tracker lower than that reported on the two prior days (May 5 and 6, 2021)?", "id": "100000000000000000000482", "answers": [{"text": "May 7, 2021", "answer_start": 288}], "is_impossible": false}, {"question": "What is the reason for the downward correction?", "id": "100000000000000000000483", "answers": [{"text": "New Hampshire and CDC collaboratively correcting data transmission errors", "answer_start": 493}], "is_impossible": false}, {"question": "Which two states are working together to correct data transmission errors?", "id": "100000000000000000000484", "answers": [{"text": "New Hampshire and CDC", "answer_start": 493}], "is_impossible": false}], "context": "Moderna\ndeliveries to a jurisdiction on or after May 7, 2021, will reflect this combination of fourteen dose and ten dose vials;\nhistorical data will not be updated. The change to the Moderna dosage increases the number of doses delivered relative\nto the number of doses administered. On May 7, 2021, the New Hampshire \u201ctotal doses administered\u201d value posted to Tracker was lower than that reported on\nthe two prior days (May 5 and 6, 2021). This downward correction is accurate and is due to New Hampshire and CDC\ncollaboratively correcting data transmission errors. Updates will be provided as available."}]}, {"title": "a77214ebf44bdd677a644070fee4c017", "paragraphs": [{"qas": [{"question": "On what date were 2,406,932 new doses administered?", "id": "100000000000000000000486", "answers": [{"text": "May 6, 2021", "answer_start": 3}], "is_impossible": false}, {"question": "How many doses were initially reported on the Vaccination Trends Daily Count metric in error?", "id": "100000000000000000000487", "answers": [{"text": "2,406,932", "answer_start": 16}], "is_impossible": false}, {"question": "What has since been updated to reflect the total doses for May 6, 2021?", "id": "100000000000000000000488", "answers": [{"text": "Daily Count metrics", "answer_start": 169}], "is_impossible": false}, {"question": "New Hampshire and CDC are actively working to reconcile counts at this time?", "id": "100000000000000000000490", "answers": [{"text": "total doses administered data posted to Tracker for New Hampshire", "answer_start": 278}], "is_impossible": false}], "context": "On May 6, 2021, 2,406,932 new doses administered were initially reported on the Vaccination Trends Daily Count metric\nin error. The site has since been updated, and the Daily Count metrics now accurately reflect the total doses\nadministered for May 6, 2021. On May 6, 2021, the total doses administered data posted to Tracker for New Hampshire was the same as those\nreported the day before (May 5, 2021). New Hampshire and CDC are actively working to reconcile counts at this time. Updates will be provided as available."}]}, {"title": "1c0190e6a5c4094bf3c1ba49416b613", "paragraphs": [{"qas": [{"question": "What was the reason for the drop in population metrics?", "id": "100000000000000000000492", "answers": [{"text": "a schedule delay in updating the calculation used to infer the 65+ population metrics", "answer_start": 135}], "is_impossible": false}, {"question": "When was the issue resolved?", "id": "100000000000000000000493", "answers": [{"text": "April 19, 2021", "answer_start": 248}], "is_impossible": false}, {"question": "When was this issue resolved?", "id": "100000000000000000000494", "answers": [{"text": "April 19, 2021", "answer_start": 248}], "is_impossible": false}, {"question": "What was the total US estimates for 65+?", "id": "100000000000000000000496", "answers": [{"text": "total doses administered. This did not affect any other states, but did affect the total US estimates for 65+. On April 13, 2021, the total doses administered data posted to Tracker inadvertently included 221,081 duplicate doses affecting Vermont (6,605), Georgia (102,711), Illinois (64,886), West Virginia (60), and Maine (46,819", "answer_start": 298}], "is_impossible": false}, {"question": "How many duplicate doses were inadvertently included in Vermont?", "id": "100000000000000000000497", "answers": [{"text": "6,605", "answer_start": 546}], "is_impossible": false}, {"question": "How many doses did Georgia have?", "id": "100000000000000000000498", "answers": [{"text": "102,711", "answer_start": 563}], "is_impossible": false}, {"question": "What was the number of doses in Georgia?", "id": "100000000000000000000499", "answers": [{"text": "102,711", "answer_start": 563}], "is_impossible": false}], "context": "On April 19, 2021, the population metrics for 65+ Texas residents dropped from the metrics reported on April 18, 2021. This was due to a schedule delay in updating the calculation used to infer the 65+ population metrics. The issue was\nresolved on April 19, 2021 and metrics accurately reflect the total doses administered. This did not affect any other\nstates, but did affect the total US estimates for 65+. On April 13, 2021, the total doses administered data posted to Tracker inadvertently included 221,081 duplicate doses\naffecting Vermont (6,605), Georgia (102,711), Illinois (64,886), West Virginia (60), and Maine (46,819)."}]}, {"title": "5e7d38de844a33ef39c0b93eb4292d6c", "paragraphs": [{"qas": [{"question": "How many doses of COVID-19 vaccine were administered in 2021?", "id": "100000000000000000000501", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \uf209 \u2022 \u2022 \u2022 \u2022", "answer_start": 113}], "is_impossible": false}, {"question": "On what date did the issue with the total doses be resolved?", "id": "100000000000000000000502", "answers": [{"text": "April 14, 2021", "answer_start": 49}], "is_impossible": false}, {"question": "How many people were vaccinated by the improvements in reporting race/ethnicity data to CDC?", "id": "100000000000000000000503", "answers": [{"text": "\u2022 \u2022", "answer_start": 136}], "is_impossible": false}, {"question": "How many people have race/ethnicity data?", "id": "100000000000000000000505", "answers": [{"text": "\u2022 \u2022", "answer_start": 136}], "is_impossible": false}], "context": "The issue has since\nbeen resolved and totals for April 14, 2021 accurately reflect the total doses administered. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nOn April 6, 2021, improvements in reporting vaccine recipient race/ethnicity data to CDC resulted in an increase in the\nnumber of people for whom race/ethnicity data are available. These improvements will continue to allow for better\nrace/ethnicity data reporting. Due to a data synchronization error between April 3 and 5, 2021, the daily count of doses reporting \u201cUnknown Age\u201d in\nthe COVID-19 Case Surveillance Public Use Data incorrectly appeared higher than expected."}]}, {"title": "ce3095518f128aede04e1987efe4ce59", "paragraphs": [{"qas": [{"question": "When was the issue resolved?", "id": "100000000000000000000509", "answers": [{"text": "April 6, 2021", "answer_start": 26}], "is_impossible": false}, {"question": "When did New York State show a higher than usual increase in doses administered?", "id": "100000000000000000000510", "answers": [{"text": "April 2, 2021", "answer_start": 143}], "is_impossible": false}, {"question": "What is the result of a delay in records reported from New York?", "id": "100000000000000000000511", "answers": [{"text": "New York State showed a higher than usual increase in doses administered", "answer_start": 158}], "is_impossible": false}, {"question": "Since March 29, 2021, the total number of doses delivered and doses administered by dialysis centers are reflected in what?", "id": "100000000000000000000512", "answers": [{"text": "national totals and in jurisdictional totals", "answer_start": 527}], "is_impossible": false}, {"question": "What is the Federal Dialysis Center Program?", "id": "100000000000000000000514", "answers": [{"text": "dialysis centers participating in the Federal Dialysis Center Program are reflected in national totals and in jurisdictional totals", "answer_start": 440}], "is_impossible": false}], "context": "The issue was resolved on\nApril 6, 2021, and the count of doses reporting \u201cUnknown Age\u201d now accurately reflects the totals reported to CDC. On April 2, 2021, New York State showed a higher than usual increase in doses administered. This is an accurate\nreflection of the data and is the result of a delay in records reported from New York. Since March 29, 2021, the total number of doses delivered, and total number of doses administered by dialysis centers\nparticipating in the Federal Dialysis Center Program are reflected in national totals and in jurisdictional totals."}]}, {"title": "17e669e5ccf6e6e99652bdbd7a701f3f", "paragraphs": [{"qas": [{"question": "On what date were 4,575,496 new doses administered?", "id": "100000000000000000000515", "answers": [{"text": "March 13, 2021", "answer_start": 34}], "is_impossible": false}, {"question": "What was the regular cutoff time for daily reporting?", "id": "100000000000000000000516", "answers": [{"text": "6:00 AM ET", "answer_start": 156}], "is_impossible": false}, {"question": "When was the site updated to reflect the totals reported?", "id": "100000000000000000000517", "answers": [{"text": "March 13", "answer_start": 283}], "is_impossible": false}, {"question": "Dose counts for the state of Connecticut were updated March 13, 2021 to correct for data transmission errors that began on what date?", "id": "100000000000000000000519", "answers": [{"text": "February 20, 2021", "answer_start": 535}], "is_impossible": false}], "context": "Due to a delay in data syncing on March 13, 2021, 4,575,496 new doses administered were initially reported, which\nincluded records that were reported after 6:00 AM ET (the regular cutoff time for daily reporting). The site has since been\nupdated to reflect the totals reported as of March 13 at 6:00 AM ET. Totals for March 14, 2021reflect the number of\ndoses reported through the regular daily reporting period. Dose counts for the state of Connecticut were updated March 13, 2021to correct for data transmission errors that began\non February 20, 2021."}]}, {"title": "d9bec67713071ab47d9678f9dc367cc1", "paragraphs": [{"qas": [{"question": "What has been slightly overcounted since March 12, 2021?", "id": "100000000000000000000520", "answers": [{"text": "first doses", "answer_start": 17}], "is_impossible": false}, {"question": "What is the US Census Bureau's annual estimate of the Resident Population for the US?", "id": "100000000000000000000522", "answers": [{"text": "2019 National Census Population Estimates", "answer_start": 226}], "is_impossible": false}, {"question": "What are the 2018 CIA World Factbook population estimates for US territories and freely associated states?", "id": "100000000000000000000523", "answers": [{"text": "National Census Population Estimates from the US Census Bureau Annual Estimates of the Resident Population for the United States (including the District of Columbia [DC]) and Puerto Rico and the 2018 CIA World Factbook population estimates for US territories and freely associated states (American Samoa, the Federated States of Micronesia, Guam, the Commonwealth of Northern Mariana Islands, Republic of Palau, the Republic of the Marshall Islands, and US Virgin Islands", "answer_start": 231}], "is_impossible": false}, {"question": "Micronesia, Guam, the Commonwealth of Northern Mariana Islands, Republic of Palau, the Republic of the Marshall Islands, and the US Virgin Islands?", "id": "100000000000000000000524", "answers": [{"text": "Federated States of Micronesia", "answer_start": 539}], "is_impossible": false}], "context": "Since that date, first doses have been slightly overcounted and second doses have been slightly\nundercounted. As of March 12, 2021, to calculate national population estimates, CDC uses, as a denominator, a combination of:\nThe 2019 National Census Population Estimates from the US Census Bureau Annual Estimates of the Resident\nPopulation for the United States (including the District of Columbia [DC]) and Puerto Rico and the 2018 CIA\nWorld Factbook population estimates for US territories and freely associated states (American Samoa, the\nFederated States of Micronesia, Guam, the Commonwealth of Northern Mariana Islands, Republic of Palau, the\nRepublic of the Marshall Islands, and US Virgin Islands)."}]}, {"title": "e405db48caa19b765c2ac483e13063ec", "paragraphs": [{"qas": [{"question": "What has been updated to address variability in how jurisdictions report age-related information?", "id": "100000000000000000000525", "answers": [{"text": "The algorithm used to calculate the age of persons who have received vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "On March 5, 2021, doses were removed from the delivered doses totals for what state?", "id": "100000000000000000000526", "answers": [{"text": "Maryland", "answer_start": 293}], "is_impossible": false}, {"question": "What was removed from the delivered doses totals for Maryland?", "id": "100000000000000000000527", "answers": [{"text": "doses", "answer_start": 238}], "is_impossible": false}, {"question": "What did CDC release on February 28, 2021?", "id": "100000000000000000000528", "answers": [{"text": "an official recommendation to use the J&J/Janssen COVID-19 vaccine", "answer_start": 572}], "is_impossible": false}], "context": "The algorithm used to calculate the age of persons who have received vaccine has been updated to address\nvariability in how jurisdictions report age-related information (e.g., report date of birth, year of birth, age). On March 5, 2021 , doses were removed from the delivered doses totals for Maryland (98,475 doses), Pennsylvania\n(239,900 doses), and Virginia (91,950 doses) because it was determined that the doses, while delivered to federal\nfacilities in those states, were not intended for vaccinating persons living in the region. On February 28, 2021, CDC released an official recommendation to use the J&J/Janssen COVID-19 vaccine for people ages\n18 and older."}]}, {"title": "6b6505386eb32f2d85744d413d25ae9d", "paragraphs": [{"qas": [{"question": "On what date did vaccines begin shipping to jurisdictions?", "id": "100000000000000000000530", "answers": [{"text": "March 2, 2021", "answer_start": 36}], "is_impossible": false}, {"question": "What was the cause of the larger-than-typical daily increases in vaccine doses on February 23, 2021?", "id": "100000000000000000000531", "answers": [{"text": "recent weather events", "answer_start": 225}], "is_impossible": false}, {"question": "Which weather event caused a backlog of vaccine delivery to many parts of the US?", "id": "100000000000000000000532", "answers": [{"text": "recent weather events", "answer_start": 225}], "is_impossible": false}, {"question": "What was the backlog of vaccine delivery to many parts of the US?", "id": "100000000000000000000533", "answers": [{"text": "recent weather events", "answer_start": 225}], "is_impossible": false}, {"question": "Why were the total numbers of vaccine doses delivered incorrect on February 19, 2021 and February 20, 2021?", "id": "100000000000000000000534", "answers": [{"text": "deliveries to federal entities were inadvertently counted twice", "answer_start": 453}], "is_impossible": false}, {"question": "How many times were vaccine deliveries to federal entities inadvertently counted?", "id": "100000000000000000000535", "answers": [{"text": "twice", "answer_start": 511}], "is_impossible": false}], "context": "Shipments to jurisdictions began on March 2, 2021. On February 23, 2021, the total numbers of national doses delivered show larger-than-typical daily increases. This is an\naccurate reflection of the data and is the result of recent weather events causing a backlog of vaccine delivery to many\nparts of the United States. On February 19, 2021, and February 20, 2021, the total numbers of national aggregate doses delivered were incorrect. That\u2019s because deliveries to federal entities were inadvertently counted twice; the totals should have been 74,108,895\nand 74,979,165, respectively."}]}, {"title": "97524fd1a08979c64e6526dd33c257f", "paragraphs": [{"qas": [{"question": "Who authorized the use of a sixth dose in a vial?", "id": "100000000000000000000537", "answers": [{"text": "Food and Drug Administration", "answer_start": 213}], "is_impossible": false}, {"question": "When will historical data not be updated?", "id": "100000000000000000000541", "answers": [{"text": "Pfizer-BioNTech deliveries to a jurisdiction on or after February 15, 2021", "answer_start": 263}], "is_impossible": false}], "context": "On February 15, 2021, the COVID-19 Vaccine Tracker was updated to reflect the revised Pfizer-BioNTech emergency use\nauthorization (EUA) to allow the use of a sixth dose, if present in a vial, as authorized by the Food and Drug\nAdministration (FDA)external icon . Pfizer-BioNTech deliveries to a jurisdiction on or after February 15, 2021, will\nreflect this increase to six doses per vial compared to five doses; historical data will not be updated. The change to the\nPfizer-BioNTech dosage increases the number of doses delivered relative to the number of doses administered."}]}, {"title": "b157037d07db84c7b8713b54c8906974", "paragraphs": [{"qas": [{"question": "How many doses does the Pfizer-BioNTech COVID-19 vaccine contain?", "id": "100000000000000000000542", "answers": [{"text": "five", "answer_start": 187}], "is_impossible": false}, {"question": "What date does the FDA allow the use of a sixth dose of the vaccine?", "id": "100000000000000000000543", "answers": [{"text": "February 15, 2021", "answer_start": 0}], "is_impossible": false}, {"question": "When can the total doses administered be greater than the doses distributed?", "id": "100000000000000000000544", "answers": [{"text": "February 15, 2021", "answer_start": 0}], "is_impossible": false}, {"question": "When was the sixth dose not reflected in the doses delivered totals?", "id": "100000000000000000000545", "answers": [{"text": "Before February 15, 2021", "answer_start": 298}], "is_impossible": false}], "context": "February 15, 2021: The total doses administered can be greater than the total doses distributed. This is because vials of\nthe Pfizer-BioNTech COVID-19 vaccine officially contain at least five doses but can contain an additional sixth dose. Use\nof this sixth dose, if present, is authorized by FDA. Before February 15, 2021, the sixth dose was not reflected in the\ndoses delivered totals; however, if administered, doses were reflected in the doses administered totals."}]}, {"title": "cc4367bed4549907f4c39294c5fe5e14", "paragraphs": [{"qas": [{"question": "How many vaccine doses did Maryland transfer to DC for administration to DC residents?", "id": "100000000000000000000547", "answers": [{"text": "16,000", "answer_start": 108}], "is_impossible": false}, {"question": "What is the name of the CDC's COVID Data Tracker?", "id": "100000000000000000000549", "answers": [{"text": "approved transfer of inventory", "answer_start": 231}], "is_impossible": false}, {"question": "What may not be reflected in totals presented within other inventory management systems?", "id": "100000000000000000000550", "answers": [{"text": "these transfers", "answer_start": 468}], "is_impossible": false}], "context": "From December 21, 2020 through January 13, 2021, Virginia transferred 17,550 doses and Maryland transferred 16,000\ndoses to the District of Columbia (DC) for administration to persons from the region who were vaccinated in DC. This\napproved transfer of inventory is reflected in the totals presented on the CDC COVID Data Tracker to accurately reflect\nthe inventory made available to each jurisdiction. Because of how and when (i.e., early in the vaccination program) these\ntransfers occurred, they may not be reflected in totals presented within other inventory management systems (e.g., the\nVaccine Tracking System [VTrckS])."}]}, {"title": "a30b45352d42e2268d0c3b7dd0c74a53", "paragraphs": [{"qas": [{"question": "Doses reported as administered before the beginning of the national vaccination program are not included in what?", "id": "100000000000000000000551", "answers": [{"text": "the figures", "answer_start": 141}], "is_impossible": false}, {"question": "What is included in the cumulative count of total doses administered?", "id": "100000000000000000000552", "answers": [{"text": "Doses", "answer_start": 19}], "is_impossible": false}, {"question": "What do Record Management Jurisdictions continuously receive?", "id": "100000000000000000000553", "answers": [{"text": "new and updated vaccination information", "answer_start": 426}], "is_impossible": false}, {"question": "What may require updating and/or deleting older records to maintain current data accuracy?", "id": "100000000000000000000554", "answers": [{"text": "Jurisdictions continuously receive new and updated vaccination information", "answer_start": 391}], "is_impossible": false}, {"question": "What is a replacement record with the correct information?", "id": "100000000000000000000556", "answers": [{"text": "an organization will delete a record with data fields that cannot be updated and upload", "answer_start": 585}], "is_impossible": false}], "context": "December 14, 2020: Doses reported as administered before the beginning of the national vaccination program on\n12/14/2020 are not included in the figures but are included in the cumulative count of total doses administered in the\nCDC COVID Tracker\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n\uf209\n-\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf209\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nCDC COVID Tracker. Record Management\nJurisdictions continuously receive new and updated vaccination information from partners that may require updating and/or\ndeleting older records to maintain current data accuracy. Occasionally, an organization will delete a record with data fields\nthat cannot be updated and upload a replacement record with the correct information."}]}, {"title": "782d3b7953c287ccb59c8979c8d9928e", "paragraphs": [{"qas": [{"question": "What does the collaborative updates help ensure CDC is providing?", "id": "100000000000000000000558", "answers": [{"text": "the best, most up-to-date data", "answer_start": 294}], "is_impossible": false}, {"question": "When did this option become available for select entities?", "id": "100000000000000000000559", "answers": [{"text": "July 14, 2021", "answer_start": 378}], "is_impossible": false}], "context": "As part of ongoing efforts to improve\ndata quality and maintain accurate COVID-19 vaccination information, CDC has been working with states to remove duplicate\nor incorrect vaccination records and to add replacement records. These collaborative updates help to ensure CDC is publicly\nproviding the best, most up-to-date data. This option became available for select entities on July 14, 2021 and was expanded\nto all entities starting August 9, 2021. Historical update and delete events for reporting entities and their impacts on vaccine\ndata are reported below."}]}, {"title": "5de73d696d642874fdaa9a911cd185b2", "paragraphs": [{"qas": [{"question": "What was the net increase in administered doses in 2022?", "id": "100000000000000000000561", "answers": [{"text": "221,933", "answer_start": 110}], "is_impossible": false}, {"question": "What did Illinois do to the data previously submitted to CDC?", "id": "100000000000000000000563", "answers": [{"text": "updates", "answer_start": 32}], "is_impossible": false}, {"question": "What was the net increase in administered doses in Illinois in October of 2022?", "id": "100000000000000000000564", "answers": [{"text": "221,933", "answer_start": 110}], "is_impossible": false}, {"question": "What state made updates to data previously submitted to CDC that resulted in a net increase of 191,076 doses?", "id": "100000000000000000000565", "answers": [{"text": "Illinois", "answer_start": 296}], "is_impossible": false}, {"question": "How many doses did New Jersey make updates to?", "id": "100000000000000000000566", "answers": [{"text": "118,479", "answer_start": 529}], "is_impossible": false}], "context": "October 26, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of\n221,933 administered doses. October 20, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of\n205,853 administered doses. October 13, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of\n191,076 administered doses. October 13, 2022: New Jersey made updates to data previously submitted to CDC that resulted in a net increase of\n118,479 administered doses."}]}, {"title": "5d8e67350c9c61e56c7564d237196d2d", "paragraphs": [{"qas": [{"question": "What was the net increase in administered doses in 2022?", "id": "100000000000000000000570", "answers": [{"text": "3,409", "answer_start": 112}], "is_impossible": false}, {"question": "How many doses were increased in Illinois in August of 2022 according to CDC data?", "id": "100000000000000000000571", "answers": [{"text": "38,447", "answer_start": 528}], "is_impossible": false}, {"question": "What did Illinois do to its administered dose data on August 31, 2022 that resulted in a net increase?", "id": "100000000000000000000572", "answers": [{"text": "updates", "answer_start": 449}], "is_impossible": false}], "context": "October 13, 2022: California made updates to data previously submitted to CDC that resulted in a net increase of\n3,409 administered doses. October 6, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of\n212,852 administered doses. September 29, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of\n234,224 administered doses. August 31, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 38,447\nadministered doses."}]}, {"title": "c3a8b438008e9089095e8d06f96609e1", "paragraphs": [{"qas": [{"question": "What was the net increase in doses that Illinois increased?", "id": "100000000000000000000574", "answers": [{"text": "37,546", "answer_start": 109}], "is_impossible": false}, {"question": "How many doses of medication did Arkansas increase?", "id": "100000000000000000000575", "answers": [{"text": "11,332", "answer_start": 382}], "is_impossible": false}, {"question": "How many administered doses did Arkansas receive in August of 2022?", "id": "100000000000000000000576", "answers": [{"text": "11,332", "answer_start": 382}], "is_impossible": false}, {"question": "How many doses of medication did Illinois receive from CDC in August, 2022??", "id": "100000000000000000000577", "answers": [{"text": "37,546", "answer_start": 109}], "is_impossible": false}], "context": "August 25, 2022: Illinois made update to data previously submitted to CDC that resulted in a new increase of 37,546\nadministered doses. August 18, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 50,115\nadministered doses. August 18, 2022: Arkansas made updates to data previously submitted to CDC that resulted in a net increase of\n11,332 administered doses. August 11, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 82,375\nadministered doses."}]}, {"title": "f5d44cecd710bdb17057ef49138daf7f", "paragraphs": [{"qas": [{"question": "How many doses did New Jersey increase in 2022?", "id": "100000000000000000000579", "answers": [{"text": "37,096", "answer_start": 111}], "is_impossible": false}, {"question": "What state made updates to its data that resulted in a net increase of 202,640 doses?", "id": "100000000000000000000580", "answers": [{"text": "California", "answer_start": 156}], "is_impossible": false}, {"question": "When did Idaho make updates to their data?", "id": "100000000000000000000581", "answers": [{"text": "August 4, 2022", "answer_start": 279}], "is_impossible": false}, {"question": "What resulted in a net decrease of 42,051 doses?", "id": "100000000000000000000583", "answers": [{"text": "Idaho", "answer_start": 295}], "is_impossible": false}], "context": "August 11, 2022: New Jersey made updates to data previously submitted to CDC that resulted in a net increase of\n37,096 administered doses. August 11, 2022: California made updates to data previously submitted to CDC that resulted in a net increase of\n202,640 administered doses. August 4, 2022: Idaho made updates to data previously submitted to CDC that resulted in a net decrease of 42,051\nadministered doses. This contributed to a decrease in overall US figures. August 4, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 77,754\nadministered doses."}]}, {"title": "933187e32706f98d04a93c3f7c62255e", "paragraphs": [{"qas": [{"question": "How many doses were decreased in Texas in 2022?", "id": "100000000000000000000587", "answers": [{"text": "1,125,795", "answer_start": 106}], "is_impossible": false}, {"question": "How much was the increase in dose in Wyoming?", "id": "100000000000000000000589", "answers": [{"text": "2,013", "answer_start": 298}], "is_impossible": false}, {"question": "What was the net increase in doses that Illinois increased?", "id": "100000000000000000000591", "answers": [{"text": "91,864", "answer_start": 432}], "is_impossible": false}], "context": "August 4, 2022: Texas made updates to data previously submitted to CDC that resulted in a net decrease of\n1,125,795 administered doses. This contributed to a decrease in overall US figures. August 4, 2022: Wyoming made updates to data previously submitted to CDC that resulted in a net increase of 2,013\nadministered doses. July 28, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 91,864\nadministered doses."}]}, {"title": "5a3f1eb475e83101d593cbca79216262", "paragraphs": [{"qas": [{"question": "How many doses of COVID-19 were increased in Illinois?", "id": "100000000000000000000593", "answers": [{"text": "97,219", "answer_start": 252}], "is_impossible": false}, {"question": "What was the net increase in doses in Illinois in July of 2022?", "id": "100000000000000000000594", "answers": [{"text": "97,219", "answer_start": 252}], "is_impossible": false}, {"question": "How many doses did New Jersey add to its data in 2022?", "id": "100000000000000000000595", "answers": [{"text": "40,945", "answer_start": 523}], "is_impossible": false}, {"question": "What state made updates to data that resulted in a net increase of 63,386 doses?", "id": "100000000000000000000596", "answers": [{"text": "Illinois", "answer_start": 294}], "is_impossible": false}, {"question": "How many doses did California increase in doses?", "id": "100000000000000000000597", "answers": [{"text": "240,980", "answer_start": 661}], "is_impossible": false}], "context": "Scheduled Vaccination Data Updates\n\uf1aa\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nJuly 21, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 97,219\nadministered doses. July 14, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 63,386\nadministered doses. July 14, 2022: New Jersey made updates to data previously submitted to CDC that resulted in a net increase of\n40,945 administered doses. July 14, 2022: California made updates to data previously submitted to CDC that resulted in a net increase of 240,980\nadministered doses."}]}, {"title": "3c601b841064012aa32d3c2020e9db65", "paragraphs": [{"qas": [{"question": "How many doses did Illinois administer in 2022?", "id": "100000000000000000000600", "answers": [{"text": "64,066", "answer_start": 107}], "is_impossible": false}, {"question": "When did a federal entity make changes to data that resulted in a net increase of 732,308 doses?", "id": "100000000000000000000601", "answers": [{"text": "June 30, 2022", "answer_start": 134}], "is_impossible": false}, {"question": "What was the result of the Illinois update to CDC?", "id": "100000000000000000000603", "answers": [{"text": "net increase of 64,066 administered doses", "answer_start": 91}], "is_impossible": false}, {"question": "How many doses of medicine did Illinois add to its database?", "id": "100000000000000000000604", "answers": [{"text": "64,066", "answer_start": 107}], "is_impossible": false}], "context": "July 7, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 64,066\nadministered doses. June 30, 2022: A federal entity made updates to data previously submitted to CDC that resulted in a net increase of\n732,308 administered doses. June 30, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 27,319\nadministered doses. June 23, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net increase of 21,371\nadministered doses."}]}, {"title": "5e536128c75fbdc0754302a03859aa9d", "paragraphs": [{"qas": [{"question": "How many doses of medication were increased by a federal entity?", "id": "100000000000000000000607", "answers": [{"text": "3,354", "answer_start": 254}], "is_impossible": false}, {"question": "What state made updates to data that resulted in a net increase of 3,354 doses?", "id": "100000000000000000000608", "answers": [{"text": "Pennsylvania", "answer_start": 15}], "is_impossible": false}, {"question": "How many administered doses did Illinois increase in 2022?", "id": "100000000000000000000609", "answers": [{"text": "3,354", "answer_start": 254}], "is_impossible": false}, {"question": "What was the net decrease in doses in the District of Columbia?", "id": "100000000000000000000610", "answers": [{"text": "59,667", "answer_start": 551}], "is_impossible": false}, {"question": "How many doses were decreased in the district of Columbia in the 2022 census?", "id": "100000000000000000000611", "answers": [{"text": "59,667", "answer_start": 551}], "is_impossible": false}], "context": "June 15, 2022: Pennsylvania made updates to data previously submitted to CDC that resulted in a net increase of\n14,201 administered doses. June 15, 2022: A federal entity made updates to data previously submitted to CDC that resulted in a net increase of\n3,354 administered doses. June 10, 2022: Illinois made updates/deletes to data previously submitted to CDC that resulted in a net decrease of\n15,884 administered doses. June 9, 2022: District of Columbia made updates/deletes to data previously submitted to CDC that resulted in a net\ndecrease of 59,667 administered doses."}]}, {"title": "843a7611bbbe88c694b39e6e566847b8", "paragraphs": [{"qas": [{"question": "What state made updates/deletes to data previously submitted to CDC that resulted in a net decrease of 70,444 administered doses?", "id": "100000000000000000000612", "answers": [{"text": "Kansas", "answer_start": 14}], "is_impossible": false}, {"question": "How many administered doses were decreased in Illinois in 2022?", "id": "100000000000000000000613", "answers": [{"text": "103,668", "answer_start": 385}], "is_impossible": false}, {"question": "How many doses of medication were increased in New Jersey in June of 2022 by New Jersey?", "id": "100000000000000000000614", "answers": [{"text": "4,665", "answer_start": 522}], "is_impossible": false}, {"question": "What was the net decrease in doses in Illinois?", "id": "100000000000000000000615", "answers": [{"text": "103,668", "answer_start": 385}], "is_impossible": false}], "context": "June 9, 2022: Kansas made updates/deletes to data previously submitted to CDC that resulted in a net decrease of\n70,444 administered doses. June 8, 2022: Ohio made updates/deletes to data previously submitted to CDC that resulted in a net decrease of\n98,512 administered doses. June 3, 2022: Illinois made updates to data previously submitted to CDC that resulted in a net decrease of 103,668\nadministered doses. June 3, 2022: New Jersey made updates to data previously submitted to CDC that resulted in a net increase of 4,665\nadministered doses."}]}, {"title": "9970b3471fdfacc93e41ed7a1cec0b9d", "paragraphs": [{"qas": [{"question": "How many doses were increased in North Dakota in 2022?", "id": "100000000000000000000616", "answers": [{"text": "64", "answer_start": 247}], "is_impossible": false}, {"question": "How much was the decrease in doses administered in Illinois?", "id": "100000000000000000000619", "answers": [{"text": "31,945", "answer_start": 504}], "is_impossible": false}, {"question": "What was the result of Illinois' updates to data?", "id": "100000000000000000000620", "answers": [{"text": "decrease of 31,945 doses administered", "answer_start": 492}], "is_impossible": false}], "context": "June 2, 2022: California made updates to data previously submitted to CDC that resulted in a net increase of 37,678\nadministration records. May 25, 2022: North Dakota made updates to data previously submitted to CDC that resulted in a increase of 64\ndoses administered. May 20, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 139,447\ndoses administered. May 13, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 31,945 doses\nadministered."}]}, {"title": "36aa1344b985eee32539045e329443b4", "paragraphs": [{"qas": [{"question": "How many doses did California increase in 2022?", "id": "100000000000000000000621", "answers": [{"text": "25,505", "answer_start": 106}], "is_impossible": false}, {"question": "How many people with at least one dose received a decrease in doses?", "id": "100000000000000000000622", "answers": [{"text": "646,951", "answer_start": 157}], "is_impossible": false}, {"question": "What was the decrease in doses administered in Wyoming in May, 2022??", "id": "100000000000000000000625", "answers": [{"text": "12,716", "answer_start": 490}], "is_impossible": false}], "context": "May 12, 2022: California made updates to data previously submitted to CDC that resulted in an increase of 25,505\ntotal doses administered, a net decrease of 646,951 people with at least one dose, and a net increase of 472,028\npeople with a first booster dose. May 11, 2022: Alaska made updates to data previously submitted to CDC that resulted in an increase of 3,118 doses\nadministered. May 10, 2022: Wyoming made updates to data previously submitted to CDC that resulted in a decrease of 12,716\ndoses administered."}]}, {"title": "72558d93d8f4bb4a66e57f4c2e5ebe50", "paragraphs": [{"qas": [{"question": "How many doses of COVID-19 were decreased in Illinois in 2022?", "id": "100000000000000000000627", "answers": [{"text": "7,617", "answer_start": 484}], "is_impossible": false}, {"question": "When did New Jersey make updates to its data?", "id": "100000000000000000000629", "answers": [{"text": "April 22, 2022", "answer_start": 510}], "is_impossible": false}, {"question": "How many doses of COVID-19 vaccine were decreased in Illinois in 2022?", "id": "100000000000000000000631", "answers": [{"text": "7,617", "answer_start": 484}], "is_impossible": false}, {"question": "What state made updates to its data that resulted in an increase in doses?", "id": "100000000000000000000632", "answers": [{"text": "New Jersey", "answer_start": 142}], "is_impossible": false}, {"question": "How many doses did the CDC increase in doses?", "id": "100000000000000000000633", "answers": [{"text": "9,143", "answer_start": 234}], "is_impossible": false}], "context": "May 6, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 25,958 doses\nadministered. May 6, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of 9,143\ndoses administered. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nApril 29, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 7,617 doses\nadministered. April 22, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of 4,711\ndoses administered."}]}, {"title": "a4c747372f002b2bd543206523b9219d", "paragraphs": [{"qas": [{"question": "How many doses were decreased in Illinois in April of 2022?", "id": "100000000000000000000634", "answers": [{"text": "13,434", "answer_start": 105}], "is_impossible": false}, {"question": "What was the result of the decrease in doses administered in Maryland?", "id": "100000000000000000000635", "answers": [{"text": "50,176", "answer_start": 237}], "is_impossible": false}, {"question": "What state reported some records as being duplicates?", "id": "100000000000000000000637", "answers": [{"text": "Maryland", "answer_start": 411}], "is_impossible": false}], "context": "April 22, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 13,434 doses\nadministered. April 15, 2022: Maryland made updates to data previously submitted to CDC that resulted in a decrease of 50,176\ndoses administered. April 15, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 18,471 doses\nadministered. April 8, 2022: Maryland reported some records that were noted to be duplicates. CDC and Maryland are working to\nremove these duplicates in a timely manner."}]}, {"title": "59ab111c26bc5b01c29bd38522edc358", "paragraphs": [{"qas": [{"question": "How many doses were decreased in Illinois in April of 2022?", "id": "100000000000000000000638", "answers": [{"text": "11,575", "answer_start": 104}], "is_impossible": false}, {"question": "What was the result of the decrease in doses administered in New Jersey?", "id": "100000000000000000000639", "answers": [{"text": "increase of 12,153", "answer_start": 226}], "is_impossible": false}, {"question": "How much doses did New Jersey increase in 2022 in addition to the decrease of 11,575?", "id": "100000000000000000000640", "answers": [{"text": "12,153", "answer_start": 238}], "is_impossible": false}, {"question": "How many doses were decreased in Puerto Rico in April of 2022?", "id": "100000000000000000000641", "answers": [{"text": "32,684", "answer_start": 372}], "is_impossible": false}, {"question": "What was the result of Puerto Rico's updates to CDC's data?", "id": "100000000000000000000642", "answers": [{"text": "decrease of 32,684 doses administered", "answer_start": 360}], "is_impossible": false}], "context": "April 8, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 11,575 doses\nadministered. April 8, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of 12,153\ndoses administered. April 6, 2022: Puerto Rico made updates to data previously submitted to CDC that resulted in a decrease of 32,684\ndoses administered. April 1, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 26,134 doses\nadministered."}]}, {"title": "95e4e8b05d82e8bc89762ed47f8c4f6e", "paragraphs": [{"qas": [{"question": "What state increased doses administered?", "id": "100000000000000000000645", "answers": [{"text": "New Jersey", "answer_start": 148}], "is_impossible": false}, {"question": "How many doses did Illinois decrease?", "id": "100000000000000000000646", "answers": [{"text": "22,574", "answer_start": 105}], "is_impossible": false}, {"question": "How many doses were decreased in Illinois in March of 2022?", "id": "100000000000000000000647", "answers": [{"text": "22,574", "answer_start": 105}], "is_impossible": false}, {"question": "What was Puerto Rico's increase in doses in 2022 in comparison to the previous year?", "id": "100000000000000000000648", "answers": [{"text": "1,173", "answer_start": 507}], "is_impossible": false}, {"question": "Which state made updates to data that resulted in a decrease of 32,506 doses?", "id": "100000000000000000000649", "answers": [{"text": "Illinois", "answer_start": 282}], "is_impossible": false}], "context": "March 25, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 22,574\ndoses administered. March 25, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of 3,715\ndoses administered. March 18, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 32,506\ndoses administered. March 16, 2022: Puerto Rico made updates to data previously submitted to CDC that resulted in an increase of 1,173\ndoses administered."}]}, {"title": "984060e0ec12c5beb4e6bb14f68f5423", "paragraphs": [{"qas": [{"question": "How many doses did Illinois decrease in 2022?", "id": "100000000000000000000650", "answers": [{"text": "40,332", "answer_start": 105}], "is_impossible": false}, {"question": "What state increased its doses by 2,928 doses?", "id": "100000000000000000000651", "answers": [{"text": "New Jersey", "answer_start": 148}], "is_impossible": false}, {"question": "Which state made updates to data previously submitted to CDC?", "id": "100000000000000000000652", "answers": [{"text": "Illinois", "answer_start": 16}], "is_impossible": false}, {"question": "How many doses were decreased in Illinois in March of 2022?", "id": "100000000000000000000653", "answers": [{"text": "40,332", "answer_start": 105}], "is_impossible": false}, {"question": "How many doses were decreased in Michigan in 2022?", "id": "100000000000000000000655", "answers": [{"text": "13,028", "answer_start": 635}], "is_impossible": false}], "context": "March 11, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 40,332\ndoses administered. March 11, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of 2,928\ndoses administered. March 04, 2022: Illinois made updates to data previously submitted to CDC that resulted a decrease\nof 18,988 doses administered. March 03, 2022: California made updates to data previously submitted to CDC that resulted in an increase\nof 16,930 doses administered. March 01, 2022: Michigan made updates to data previously submitted to CDC that resulted in a decrease of 13,028\ndoses administered."}]}, {"title": "15775fcb96e2d28e58af78fb3a77ed70", "paragraphs": [{"qas": [{"question": "What was the result of the decrease in doses administered in New Jersey?", "id": "100000000000000000000658", "answers": [{"text": "increase of 12,473 doses administered", "answer_start": 234}], "is_impossible": false}, {"question": "How many doses were increased by a federal entity in 2022?", "id": "100000000000000000000660", "answers": [{"text": "4,251", "answer_start": 389}], "is_impossible": false}, {"question": "How much doses did Illinois decrease in dosages?", "id": "100000000000000000000662", "answers": [{"text": "20,754", "answer_start": 108}], "is_impossible": false}], "context": "February 18, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 20,754\ndoses administered. February 18, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of\n12,473 doses administered. February 17, 2022: A federal entity made updates to data previously submitted to CDC that resulted in an increase of\n4,251 doses administered. February 11, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 58,355\ndoses administered."}]}, {"title": "fa156fea936f1967ac2e70a996baf69d", "paragraphs": [{"qas": [{"question": "How many doses of COVID-19 were increased in New Jersey in February of 2022?", "id": "100000000000000000000663", "answers": [{"text": "14,616", "answer_start": 110}], "is_impossible": false}, {"question": "What state added doses to data previously submitted to CDC in 2022 in order to increase the doses?", "id": "100000000000000000000664", "answers": [{"text": "New Jersey", "answer_start": 19}], "is_impossible": false}, {"question": "In 2022, how many more doses were administered in Utah?", "id": "100000000000000000000665", "answers": [{"text": "73,002", "answer_start": 241}], "is_impossible": false}, {"question": "When did New Jersey make updates to its data?", "id": "100000000000000000000666", "answers": [{"text": "February 11, 2022", "answer_start": 0}], "is_impossible": false}, {"question": "How many doses of COVID-19 were decreased in Illinois in February of 2022?", "id": "100000000000000000000667", "answers": [{"text": "75,630", "answer_start": 494}], "is_impossible": false}], "context": "February 11, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of\n14,616 doses administered\nFebruary 9, 2022: Utah made updates to data previously submitted to CDC that resulted in an increase of 73,002\ndoses administered. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nFebruary 4, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 75,630\ndoses administered. February 4, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of\n32,976 doses administered."}]}, {"title": "20e562776262c6cebe19de217cd8baa5", "paragraphs": [{"qas": [{"question": "How many doses were increased in New Jersey?", "id": "100000000000000000000673", "answers": [{"text": "26,796", "answer_start": 240}], "is_impossible": false}], "context": "February 3, 2022: Alaska made updates to data previously submitted to CDC that resulted in a decrease of 3,945\ndoses administered. January 28, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of\n26,796 doses administered. January 28, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 14,973\ndoses administered."}]}, {"title": "f898b06a6ea03989a766354bc1c7d03", "paragraphs": [{"qas": [{"question": "When did California make updates to data previously submitted to CDC?", "id": "100000000000000000000676", "answers": [{"text": "January 27, 2022", "answer_start": 0}], "is_impossible": false}, {"question": "How many doses were decreased for California in January 2022?", "id": "100000000000000000000677", "answers": [{"text": "1,593,072", "answer_start": 109}], "is_impossible": false}, {"question": "When did Illinois make updates?", "id": "100000000000000000000679", "answers": [{"text": "January 21, 2022", "answer_start": 310}], "is_impossible": false}, {"question": "How many doses were decreased in Illinois in January of 2022?", "id": "100000000000000000000680", "answers": [{"text": "29,394", "answer_start": 417}], "is_impossible": false}, {"question": "How much did New Jersey's doses increase in 2022 in comparison to the previous year?", "id": "100000000000000000000682", "answers": [{"text": "34,238", "answer_start": 553}], "is_impossible": false}], "context": "January 27, 2022: California made updates to data previously submitted to CDC that resulted in a decrease of\n1,593,072 doses administered for California and a decrease of 800,606 doses administered at the National level\n(national level decrease factors in new administrations reported by other jurisdictions). January 21, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 29,394\ndoses administered. January 21, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of\n34,238 doses administered."}]}, {"title": "4e09ec2e9071607d012b71f0c4ce5fb4", "paragraphs": [{"qas": [{"question": "What state made updates to data previously submitted to CDC that resulted in an increase of 139 doses administered?", "id": "100000000000000000000683", "answers": [{"text": "Georgia", "answer_start": 18}], "is_impossible": false}, {"question": "What state added 20,015 records for persons aged 18 years not previously submitted to CDC?", "id": "100000000000000000000685", "answers": [{"text": "Idaho", "answer_start": 422}], "is_impossible": false}, {"question": "What state made updates to data that resulted in 206,575 doses administered?", "id": "100000000000000000000686", "answers": [{"text": "Pennsylvania", "answer_start": 282}], "is_impossible": false}, {"question": "How many doses did Illinois decrease?", "id": "100000000000000000000687", "answers": [{"text": "4,868", "answer_start": 615}], "is_impossible": false}], "context": "January 20, 2022: Georgia made updates to data previously submitted to CDC that resulted in an increase of 139\ndoses administered. January 20, 2022: Wyoming made updates to data previously submitted to CDC that resulted in an increase of 2,761\ndoses administered. January 20, 2022: Pennsylvania made updates to data previously submitted to CDC that resulted in an increase of\n206,575 doses administered. January 19, 2022: Idaho added 20,015 records for persons aged 18 years not previously submitted to CDC. January 14, 2022: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 4,868\ndoses administered."}]}, {"title": "4b0fe4bd8c040c89044d4159a5f4d387", "paragraphs": [{"qas": [{"question": "How many doses did North Carolina increase?", "id": "100000000000000000000691", "answers": [{"text": "41,000", "answer_start": 248}], "is_impossible": false}, {"question": "How many doses were administered in Hawaii in January of 2022?", "id": "100000000000000000000692", "answers": [{"text": "318,481", "answer_start": 382}], "is_impossible": false}, {"question": "What state made updates to data previously submitted to CDC that resulted in an increase of 318,481 doses administered?", "id": "100000000000000000000693", "answers": [{"text": "Hawaii", "answer_start": 294}], "is_impossible": false}, {"question": "Which state updated 22,696,262 records previously?", "id": "100000000000000000000694", "answers": [{"text": "California", "answer_start": 564}], "is_impossible": false}, {"question": "When did California update 22,696,262 records previously submitted to CDC?", "id": "100000000000000000000695", "answers": [{"text": "January 6, 2022", "answer_start": 547}], "is_impossible": false}], "context": "January 13, 2022: Colorado made updates to data previously submitted to CDC that resulted in an increase of\n47,260 doses administered. January 13, 2022: North Carolina made updates to data previously submitted to CDC that resulted in an increase of\n41,000 doses administered. January 13, 2022: Hawaii made updates to data previously submitted to CDC that resulted in an increase of 318,481\ndoses administered. January 11, 2022: New Jersey made updates to data previously submitted to CDC that resulted in an increase of\n31,680 doses administered. January 6, 2022: California updated 22,696,262 records previously submitted to CDC."}]}, {"title": "c3cb4fe21de18457b5367c2e8450f474", "paragraphs": [{"qas": [{"question": "Which state made updates to data previously submitted to CDC that resulted in an increase of 58,731 doses?", "id": "100000000000000000000697", "answers": [{"text": "South Dakota", "answer_start": 223}], "is_impossible": false}, {"question": "How many doses were increased by Illinois in 2021?", "id": "100000000000000000000698", "answers": [{"text": "3,074", "answer_start": 316}], "is_impossible": false}, {"question": "What was the decrease in doses administered by Illinois?", "id": "100000000000000000000699", "answers": [{"text": "58,731", "answer_start": 177}], "is_impossible": false}, {"question": "How much doses did Illinois increase?", "id": "100000000000000000000700", "answers": [{"text": "3,074", "answer_start": 316}], "is_impossible": false}, {"question": "When did Illinois decrease doses?", "id": "100000000000000000000701", "answers": [{"text": "December 30, 2021", "answer_start": 69}], "is_impossible": false}, {"question": "Data previously submitted to CDC resulted in how many doses decreased?", "id": "100000000000000000000702", "answers": [{"text": "58,731", "answer_start": 177}], "is_impossible": false}], "context": "This did not result in a change\nto the number of doses administered. December 30, 2021: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 58,731\ndoses administered. December 29, 2021: South Dakota made updates to data previously submitted to CDC that resulted in an increase of\n3,074 doses administered. December 28, 2021: Updates were made to data previously submitted to CDC that resulted in a decrease of 9,436\ndoses administered. December 23, 2021: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 4,916\ndoses administered."}]}, {"title": "a197fbb6ada9c34f59986cb52ce6de16", "paragraphs": [{"qas": [{"question": "How many doses were decreased in West Virginia in 2021?", "id": "100000000000000000000703", "answers": [{"text": "651,436", "answer_start": 112}], "is_impossible": false}, {"question": "How much did New Jersey increase in doses in 2020?", "id": "100000000000000000000704", "answers": [{"text": "25,151", "answer_start": 251}], "is_impossible": false}, {"question": "What state made updates to data that resulted in an increase of 25,151 doses?", "id": "100000000000000000000705", "answers": [{"text": "New Jersey", "answer_start": 160}], "is_impossible": false}, {"question": "How many doses were decreased in Pennsylvania in 2021?", "id": "100000000000000000000706", "answers": [{"text": "101,475", "answer_start": 390}], "is_impossible": false}, {"question": "How many records were updated in New Mexico?", "id": "100000000000000000000707", "answers": [{"text": "2,213", "answer_start": 576}], "is_impossible": false}], "context": "December 23, 2021: West Virginia made updates to data previously submitted to CDC that resulted in a decrease of\n651,436 doses administered. December 22, 2021: New Jersey made updates to data previously submitted to CDC that resulted in an increase of\n25,151 doses administered. December 21, 2021: Pennsylvania made updates to data previously submitted to CDC that resulted in a decrease of\n101,475 doses administered. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nDecember 17, 2021: New Mexico updated 2,213 records, previously submitted to CDC. This did not result in change\nto number of doses administered."}]}, {"title": "960799369dc2077444322bca33d80dbe", "paragraphs": [{"qas": [{"question": "How many doses did Illinois decrease in 2021?", "id": "100000000000000000000710", "answers": [{"text": "22,422", "answer_start": 108}], "is_impossible": false}, {"question": "How much did Illinois add to the amount of doses administered?", "id": "100000000000000000000712", "answers": [{"text": "53,344", "answer_start": 243}], "is_impossible": false}, {"question": "How many doses were decreased in Illinois in 2021?", "id": "100000000000000000000713", "answers": [{"text": "22,422", "answer_start": 108}], "is_impossible": false}, {"question": "Which state made changes to data previously submitted to CDC?", "id": "100000000000000000000715", "answers": [{"text": "Illinois", "answer_start": 19}], "is_impossible": false}], "context": "December 16, 2021: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 22,422\ndoses administered. December 9, 2021: Illinois made updates to data previously submitted to CDC that resulted in an increase of 53,344\ndoses administered. December 2, 2021: Illinois made updates to data previously submitted to CDC that resulted in a decrease of 46,380\ndoses administered. November 23, 2021: Pennsylvania made updates to data previously submitted to CDC that resulted in a decrease of\n1,151,719 doses administered. November 18, 2021: Illinois made updates to data previously submitted to CDC that resulted in a decrease of\n214,250 doses administered."}]}, {"title": "757c2f70f0a95577a4d5d411bc758742", "paragraphs": [{"qas": [{"question": "How many doses were decreased in Ohio in November of 2021?", "id": "100000000000000000000718", "answers": [{"text": "99", "answer_start": 242}], "is_impossible": false}, {"question": "How many doses were increased in Minnesota in November of 2021?", "id": "100000000000000000000719", "answers": [{"text": "136,589", "answer_start": 373}], "is_impossible": false}, {"question": "What was the decrease in doses administered in Maryland?", "id": "100000000000000000000720", "answers": [{"text": "5,975", "answer_start": 509}], "is_impossible": false}], "context": "November 10, 2021: North Dakota made updates to data previously submitted to CDC that resulted in an increase of\n3,433 doses administered. November 9, 2021: Ohio made updates to data previously submitted to CDC that resulted in a decrease of 99 doses\nadministered. November 4, 2021: Minnesota made updates to data previously submitted to CDC that resulted in an increase of\n136,589 doses administered. November 3, 2021: Maryland made updates to data previously submitted to CDC that resulted in a decrease of 5,975\ndoses administered."}]}, {"title": "79ef5f1496c60d0ecb44469ec58b6597", "paragraphs": [{"qas": [{"question": "How many records did a federal dialysis partner make changes to?", "id": "100000000000000000000721", "answers": [{"text": "30,556", "answer_start": 61}], "is_impossible": false}, {"question": "What resulted in no net change in number of doses administered?", "id": "100000000000000000000722", "answers": [{"text": "A federal dialysis partner made updates to 30,556 records previously submitted to CDC", "answer_start": 18}], "is_impossible": false}, {"question": "Which state made updates to data previously submitted to CDC?", "id": "100000000000000000000723", "answers": [{"text": "Illinois", "answer_start": 186}], "is_impossible": false}, {"question": "How many doses were increased in North Dakota in October of 2021?", "id": "100000000000000000000724", "answers": [{"text": "8,591", "answer_start": 414}], "is_impossible": false}, {"question": "What was the decrease in doses administered by North Dakota?", "id": "100000000000000000000725", "answers": [{"text": "8,591", "answer_start": 414}], "is_impossible": false}, {"question": "How much did New Mexico's doses decrease in 2021 in addition to 316,351 doses?", "id": "100000000000000000000726", "answers": [{"text": "179,565", "answer_start": 549}], "is_impossible": false}], "context": "November 3, 2021: A federal dialysis partner made updates to 30,556 records previously submitted to CDC that\nresulted in no net change in number of doses administered. October 29, 2021: Illinois made updates to data previously submitted to CDC that resulted in an increase of 316,351\ndoses administered. October 27, 2021: North Dakota made updates to data previously submitted to CDC that resulted in a decrease of\n8,591 doses administered. October 26, 2021: New Mexico made updates to data previously submitted to CDC that resulted in a decrease of\n179,565 administered doses."}]}, {"title": "48212e82d8556c3fa5a030520754f3e6", "paragraphs": [{"qas": [{"question": "What did a federal retail pharmacy partner make that resulted in a decrease of 563 records?", "id": "100000000000000000000727", "answers": [{"text": "updates to data previously submitted to CDC", "answer_start": 57}], "is_impossible": false}, {"question": "How many records did South Dakota make changes to?", "id": "100000000000000000000729", "answers": [{"text": "11,366", "answer_start": 255}], "is_impossible": false}, {"question": "How many records were decreased in October of 2021?", "id": "100000000000000000000730", "answers": [{"text": "563", "answer_start": 132}], "is_impossible": false}, {"question": "What state made updates to 7,727,520 records previously submitted to CDC that resulted in no net change in number of records?", "id": "100000000000000000000731", "answers": [{"text": "North Carolina", "answer_start": 290}], "is_impossible": false}], "context": "October 22, 2021: A federal retail pharmacy partner made updates to data previously submitted to CDC that\nresulted in a decrease of 563 records. October 21, 2021: South Dakota made updates to data previously submitted to CDC that resulted in a decrease of\n11,366 records. October 20, 2021: North Carolina made updates to 7,727,520 records previously submitted to CDC that resulted in\nno net change in number of records. October 8, 2021: Michigan made updates to 9,632,251 records previously submitted to CDC that resulted in no net\nchange in number of doses administered."}]}, {"title": "c5e25a79d0926990ce5aef7c2a03845a", "paragraphs": [{"qas": [{"question": "How many doses were increased in North Carolina in October of 2021?", "id": "100000000000000000000732", "answers": [{"text": "16,009", "answer_start": 112}], "is_impossible": false}, {"question": "How many records were updated in Florida in September of the same year?", "id": "100000000000000000000733", "answers": [{"text": "3,001,563", "answer_start": 184}], "is_impossible": false}, {"question": "What state made updates to data previously submitted to CDC?", "id": "100000000000000000000734", "answers": [{"text": "North Carolina", "answer_start": 17}], "is_impossible": false}, {"question": "How many doses were increased in Iowa in 2021?", "id": "100000000000000000000735", "answers": [{"text": "4,928", "answer_start": 400}], "is_impossible": false}, {"question": "What resulted in no net change in number of doses administered?", "id": "100000000000000000000737", "answers": [{"text": "Florida made updates to 3,001,563 records previously submitted to CDC", "answer_start": 160}], "is_impossible": false}], "context": "October 5, 2021: North Carolina made updates to data previously submitted to CDC that resulted in an increase of\n16,009 doses administered. September 29, 2021: Florida made updates to 3,001,563 records previously submitted to CDC that resulted in no net\nchange in number of doses administered. September 25, 2021: Iowa made updated to data previously submitted to CDC that resulted in an increase of 4,928\ndoses administered. September 24, 2021: Virginia made updates to 9,172,838 records previously submitted to CDC that resulted in no\nnet change in number of doses administered."}]}, {"title": "af1098595d3cfe74426f2f7c87f347ca", "paragraphs": [{"qas": [{"question": "What state made updates to data previously submitted to CDC that resulted in a decrease of 16,888 doses administered?", "id": "100000000000000000000738", "answers": [{"text": "New Jersey", "answer_start": 20}], "is_impossible": false}, {"question": "How many doses were decreased in Ohio in September of 2021?", "id": "100000000000000000000739", "answers": [{"text": "54,677", "answer_start": 243}], "is_impossible": false}, {"question": "How many doses of COVID-19 vaccine were increased in Alabama in 2021?", "id": "100000000000000000000740", "answers": [{"text": "1,329", "answer_start": 378}], "is_impossible": false}, {"question": "What was the result of the increase in doses administered in Alabama?", "id": "100000000000000000000741", "answers": [{"text": "1,329", "answer_start": 378}], "is_impossible": false}, {"question": "Which state made updates to its data that resulted in a decrease of 4,952 doses?", "id": "100000000000000000000742", "answers": [{"text": "Virginia", "answer_start": 541}], "is_impossible": false}, {"question": "How many doses were decreased?", "id": "100000000000000000000743", "answers": [{"text": "16,888", "answer_start": 110}], "is_impossible": false}], "context": "September 22, 2021: New Jersey made updates to data previously submitted to CDC that resulted in a decrease of\n16,888 doses administered. September 16, 2021: Ohio made updates to data previously submitted to CDC that resulted in a decrease of 54,677\ndoses administered. September 13, 2021: Alabama made updates to data previously submitted to CDC that resulted in an increase of\n1,329 doses administered. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Archive of COVID-19 Vaccination Data Updates | CDC\nAugust 27, 2021: Virginia made updates to data previously submitted to CDC that resulted in a decrease of 4,952\ndoses administered."}]}, {"title": "cc8ac970c7a5dafcc42be0bccd52bf51", "paragraphs": [{"qas": [{"question": "What did a federal entity make to data previously submitted to CDC that resulted in an increase of 3,818 doses administered?", "id": "100000000000000000000744", "answers": [{"text": "updates", "answer_start": 39}], "is_impossible": false}, {"question": "What did Rhode Island make updates to?", "id": "100000000000000000000745", "answers": [{"text": "data previously submitted to CDC", "answer_start": 187}], "is_impossible": false}, {"question": "How many doses were increased in Rhode Island by the federal entity?", "id": "100000000000000000000746", "answers": [{"text": "1,386", "answer_start": 251}], "is_impossible": false}, {"question": "How many doses were administered in Vermont in 2021?", "id": "100000000000000000000747", "answers": [{"text": "23,325", "answer_start": 383}], "is_impossible": false}], "context": "August 25, 2021: A federal entity made updates to data previously submitted to CDC that resulted in an increase of\n3,818 doses administered. August 17, 2021: Rhode Island made updates to data previously submitted to CDC that resulted in an increase of\n1,386 doses administered. August 12, 2021: Vermont made updates to data previously submitted to CDC that resulted in a decrease of 23,325\ndoses administered. August 4, 2021: Colorado made updates to data previously submitted to CDC that resulted in an increase of 11,379\ndoses administered."}]}, {"title": "73d952632d927c1714c249b334b25d13", "paragraphs": [{"qas": [{"question": "What was the result of a federal entity making updates to data previously submitted to CDC that resulted in 159,648 doses decreased?", "id": "100000000000000000000751", "answers": [{"text": "decrease", "answer_start": 240}], "is_impossible": false}, {"question": "How many doses were administered in Utah in 2021?", "id": "100000000000000000000752", "answers": [{"text": "6,028", "answer_start": 381}], "is_impossible": false}, {"question": "When was Utah's last update?", "id": "100000000000000000000754", "answers": [{"text": "Oct. 28, 2022", "answer_start": 436}], "is_impossible": false}], "context": "July 23, 2021: The number of doses administered by a national pharmacy provider decreased by 14,187 for the\nFederal Long-Term Care program. July 20, 2021: A federal entity made updates to data previously submitted to CDC that resulted in a decrease of\n159,648 doses administered. July 14, 2021: Utah made updates to data previously submitted to CDC that resulted in an increase of 6,028 doses\nadministered. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nLast Updated Oct. 28, 2022"}]}, {"title": "c663406059f0fa2148679fbdc22345c7", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000000755", "answers": [{"text": "SARS-CoV-2", "answer_start": 220}], "is_impossible": false}, {"question": "What was the name given to the SARS-CoV-2 virus discovered in Wuhan?", "id": "100000000000000000000757", "answers": [{"text": "COVID-19", "answer_start": 147}], "is_impossible": false}, {"question": "What year was COVID-19 first discovered in Wuhan, China?", "id": "100000000000000000000758", "answers": [{"text": "2019", "answer_start": 262}], "is_impossible": false}, {"question": "What is the most common type of respiratory symptoms?", "id": "100000000000000000000759", "answers": [{"text": "pneumonia", "answer_start": 437}], "is_impossible": false}, {"question": "Where is Wuhan located?", "id": "100000000000000000000760", "answers": [{"text": "China", "answer_start": 277}], "is_impossible": false}, {"question": "How many parts of your body may be affected by COV-19?", "id": "100000000000000000000761", "answers": [{"text": "lungs and respiratory system", "answer_start": 483}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Basics of COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nBasics of COVID-19\nCDC is reviewing this page to align with updated guidance. COVID-19 (coronavirus disease 2019) is a disease caused by a virus named SARS-CoV-2 and was discovered in December 2019\nin Wuhan, China. It is very contagious and has quickly spread around the world. COVID-19 most often causes respiratory symptoms that can feel much like a cold, a flu, or pneumonia. COVID-19 may attack\nmore than your lungs and respiratory system. Other parts of your body may also be affected by the disease."}]}, {"title": "56c7a16bdcb3dcc8006fb432c4684c99", "paragraphs": [{"qas": [{"question": "Most people with COVID-19 have what kind of symptoms?", "id": "100000000000000000000763", "answers": [{"text": "mild", "answer_start": 31}], "is_impossible": false}, {"question": "Some people become what type of ill?", "id": "100000000000000000000764", "answers": [{"text": "severely", "answer_start": 69}], "is_impossible": false}, {"question": "Older adults and people who have certain underlying medical conditions are at increased risk of what?", "id": "100000000000000000000765", "answers": [{"text": "severe illness", "answer_start": 290}], "is_impossible": false}, {"question": "How many people have died from COVID-19 in the US?", "id": "100000000000000000000766", "answers": [{"text": "Hundreds of thousands", "answer_start": 320}], "is_impossible": false}, {"question": "What do vaccines teach our immune system to fight?", "id": "100000000000000000000767", "answers": [{"text": "the virus that causes COVID-19", "answer_start": 490}], "is_impossible": false}, {"question": "SARS-CoV-2 is caused by what virus?", "id": "100000000000000000000768", "answers": [{"text": "SARS-CoV-2", "answer_start": 618}], "is_impossible": false}, {"question": "What does SARS-CoV-2 cause?", "id": "100000000000000000000770", "answers": [{"text": "COVID-19", "answer_start": 572}], "is_impossible": false}], "context": "Most people with COVID-19 have mild symptoms, but some people become severely ill. Some people including those with minor or no symptoms may suffer from post-COVID conditions \u2014 or \u201clong COVID\u201d. Older adults and people who have certain underlying medical conditions are at increased risk of severe illness from\nCOVID-19. Hundreds of thousands of people have died from COVID-19 in the United States. Vaccines against COVID-19 are safe and effective. Vaccines teach our immune system to fight the virus that causes\nCOVID-19. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\nAbout SARS-CoV-2, the virus that causes COVID-19\nCOVID-19 is caused by a virus called SARS-CoV-2."}]}, {"title": "697d545cf4a7a01e4bb6034a7f8d3cbd", "paragraphs": [{"qas": [{"question": "What is MERS?", "id": "100000000000000000000771", "answers": [{"text": "Middle East respiratory syndrome", "answer_start": 215}], "is_impossible": false}, {"question": "What is SARS?", "id": "100000000000000000000772", "answers": [{"text": "severe acute respiratory syndrome", "answer_start": 170}], "is_impossible": false}, {"question": "What does the word Corona mean?", "id": "100000000000000000000775", "answers": [{"text": "crown", "answer_start": 447}], "is_impossible": false}, {"question": "The word coron means what?", "id": "100000000000000000000776", "answers": [{"text": "crown", "answer_start": 447}], "is_impossible": false}, {"question": "What is important to the biology of this virus?", "id": "100000000000000000000777", "answers": [{"text": "spike proteins", "answer_start": 557}], "is_impossible": false}], "context": "It is part of the coronavirus family, which include common viruses that cause\na variety of diseases from head or chest colds to more severe (but more rare) diseases like severe acute respiratory syndrome\n(SARS) and Middle East respiratory syndrome (MERS). Like many other respiratory viruses, coronaviruses spread quickly through droplets that you project out of your mouth or\nnose when you breathe, cough, sneeze, or speak. The word corona means crown and refers to the appearance that coronaviruses get from the spike proteins sticking out of\nthem. These spike proteins are important to the biology of this virus."}]}, {"title": "781f2eba0475a8f046007f0de3bba82c", "paragraphs": [{"qas": [{"question": "What does the spike protein allow the virus to do?", "id": "100000000000000000000779", "answers": [{"text": "replicate inside of the cell and spread to other cells", "answer_start": 102}], "is_impossible": false}, {"question": "What is the name of the process that scientists use to monitor mutations in the SARS-CoV-2 virus?", "id": "100000000000000000000781", "answers": [{"text": "genomic surveillance", "answer_start": 440}], "is_impossible": false}, {"question": "What happens as genetic changes to the virus happen over time?", "id": "100000000000000000000782", "answers": [{"text": "the SARS-CoV-2 virus begins to form genetic lineages", "answer_start": 513}], "is_impossible": false}, {"question": "How does genomic surveillance work?", "id": "100000000000000000000783", "answers": [{"text": "constantly monitor mutations causing changes to the spike protein through a process called genomic surveillance. As genetic changes to the virus happen over time, the SARS-CoV-2 virus begins to form genetic lineages", "answer_start": 350}], "is_impossible": false}], "context": "The spike protein is the part of the virus that attaches to\na human cell to infect it, allowing it to replicate inside of the cell and spread to other cells. Some antibodies can protect you\nfrom SARS-CoV-2 by targeting these spike proteins. Because of the importance of this specific part of the virus, scientists who\nsequence the virus for research constantly monitor mutations causing changes to the spike protein through a process called\ngenomic surveillance. As genetic changes to the virus happen over time, the SARS-CoV-2 virus begins to form genetic lineages."}]}, {"title": "10625cc12d799b1ecfa63527bf897d56", "paragraphs": [{"qas": [{"question": "How can a family tree be mapped out?", "id": "100000000000000000000784", "answers": [{"text": "SARS-CoV-2 virus", "answer_start": 40}], "is_impossible": false}, {"question": "What can different attributes of a tree do to a virus?", "id": "100000000000000000000785", "answers": [{"text": "change how fast the virus spreads, or the severity of illness it causes, or the effectiveness of treatments against it", "answer_start": 149}], "is_impossible": false}, {"question": "What are the variants of SARS-CoV-2?", "id": "100000000000000000000788", "answers": [{"text": "viruses with these changes \u201cvariants\u201d. They are still SARS-CoV-2, but may act differently", "answer_start": 289}], "is_impossible": false}], "context": "Just as a family has a\nfamily tree, the SARS-CoV-2 virus can be similarly mapped out. Sometimes branches of that tree have different attributes that\nchange how fast the virus spreads, or the severity of illness it causes, or the effectiveness of treatments against it. Scientists\ncall the viruses with these changes \u201cvariants\u201d. They are still SARS-CoV-2, but may act differently. Last Updated Nov 4 2021\f10/30/22, 9:37 AM Basics of COVID-19 | CDC\nLast Updated Nov. 4, 2021"}]}, {"title": "d8e95d787828e46fbee874e649619ccc", "paragraphs": [{"qas": [{"question": "What is one of the many benefits of getting vaccinated against COVID-19?", "id": "100000000000000000000789", "answers": [{"text": "protecting people from getting seriously ill, being hospitalized, and even dying", "answer_start": 293}], "is_impossible": false}, {"question": "What is the name of the vaccine available in the United States that protects people from getting seriously ill?", "id": "100000000000000000000790", "answers": [{"text": "COVID-19", "answer_start": 214}], "is_impossible": false}, {"question": "What are effective at protecting people from getting seriously ill, being hospitalized, and even dying?", "id": "100000000000000000000791", "answers": [{"text": "COVID-19 vaccines", "answer_start": 214}], "is_impossible": false}, {"question": "What can help keep them from getting very sick if they do get COVID-19?", "id": "100000000000000000000792", "answers": [{"text": "Getting children and teens vaccinated against COVID-19", "answer_start": 375}], "is_impossible": false}, {"question": "Vaccinating children can help relieve the strain on families by providing greater confidence in what?", "id": "100000000000000000000793", "answers": [{"text": "children participating in childcare, school, and other activities", "answer_start": 598}], "is_impossible": false}, {"question": "What is a strain on families by providing greater confidence in children participating in childcare, school, and other activities?", "id": "100000000000000000000794", "answers": [{"text": "relieve", "answer_start": 532}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Benefits of Getting A COVID-19 Vaccine | CDC\nEspa\u00f1ol | Other Languages\nBenefits of Getting A COVID-19 Vaccine\nWhat You Need to Know\nThere are many benefits of getting vaccinated against COVID-19. COVID-19 vaccines available in the United States are safe and are effective at protecting people from getting\nseriously ill, being hospitalized, and even dying. Getting children and teens vaccinated against COVID-19 can help keep them from getting very sick if they do get\nCOVID-19. Vaccinating children can also help relieve the strain on families by providing greater confidence in children\nparticipating in childcare, school, and other activities."}]}, {"title": "5b3dd12cda151519679f3931e354b48b", "paragraphs": [{"qas": [{"question": "What type of vaccine can offer added protection to people who had COVID-19?", "id": "100000000000000000000795", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "People are protected best when they stay up to date with what?", "id": "100000000000000000000797", "answers": [{"text": "the recommended number of doses and boosters", "answer_start": 280}], "is_impossible": false}, {"question": "What is a safer, more reliable way to build protection than getting sick with COVID-19?", "id": "100000000000000000000798", "answers": [{"text": "Getting a COVID-19 vaccine", "answer_start": 398}], "is_impossible": false}, {"question": "What helps protect you by creating an antibody response?", "id": "100000000000000000000799", "answers": [{"text": "COVID-19 vaccination", "answer_start": 508}], "is_impossible": false}, {"question": "What does creating an antibody response do without you having to experience severe illness or post-COVID conditions?", "id": "100000000000000000000800", "answers": [{"text": "COVID-19 vaccination", "answer_start": 508}], "is_impossible": false}], "context": "COVID-19 vaccines can offer added protection to people who had COVID-19, including protection against being\nhospitalized from a new infection, especially as variants continue to emerge. As with vaccines for other diseases, people are protected best when they stay up to date with the recommended\nnumber of doses and boosters, when eligible. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\nA Safer, More Reliable Way to Build Protection\nGetting a COVID-19 vaccine is a safer, more reliable way to build protection than getting sick with COVID-19. COVID-19\nvaccination helps protect you by creating an antibody response without you having to experience potentially severe\nillness or post-COVID conditions."}]}, {"title": "be5aac7f0f716ec0e6648066ecb13c9d", "paragraphs": [{"qas": [{"question": "What can you have long-term health issues after having?", "id": "100000000000000000000802", "answers": [{"text": "COVID-19", "answer_start": 198}], "is_impossible": false}, {"question": "What are the two other terms for COVID?", "id": "100000000000000000000804", "answers": [{"text": "post-COVID conditions", "answer_start": 342}], "is_impossible": false}], "context": "Getting sick with COVID-19 can cause severe illness or death, even in children, and we can\u2019t reliably predict who will\nhave mild or severe illness. You may have long-term health issues after having COVID-19. Even people who do not have symptoms when they\nare first infected can have these ongoing health problems, also known as long COVID or post-COVID conditions. These complications can appear after mild or severe COVID-19, or after multisystem inflammatory syndrome in\nchildren (MIS-C)."}]}, {"title": "16ace4eabe59de6188f96c4678f5c03d", "paragraphs": [{"qas": [{"question": "What is the name of the CDC's post-vaccination symptom?", "id": "100000000000000000000808", "answers": [{"text": "Cough Muscle and joint pain Headache Trouble falling or staying asleep Trouble concentrating Limitations in physical activity Feeling distressed about symptoms Mental health challenges Decreased school or daycare attendance Missed opportunities for participation in sports, playdates, or other activities \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022", "answer_start": 281}], "is_impossible": false}, {"question": "What can people get some protection from having COVID-19?", "id": "100000000000000000000809", "answers": [{"text": "Immunity", "answer_start": 765}], "is_impossible": false}, {"question": "What is the term for protection from infection?", "id": "100000000000000000000811", "answers": [{"text": "Immunity", "answer_start": 765}], "is_impossible": false}, {"question": "What can vary depending on how mild or severe someone's illness was?", "id": "100000000000000000000812", "answers": [{"text": "Immunity", "answer_start": 765}], "is_impossible": false}], "context": "Getting Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination vs infection\n\uf1aa\f10/30/22, 9:34 AM Benefits of Getting A COVID-19 Vaccine | CDC\nSymptoms Post COVID-19 Vaccination Symptoms Post COVID-19 Infection\nSymptoms Post COVID-19 Vaccination Symptoms Post COVID-19 Infection\nCough\nMuscle and joint pain\nHeadache\nTrouble falling or staying asleep\nTrouble concentrating\nLimitations in physical activity\nFeeling distressed about symptoms\nMental health challenges\nDecreased school or daycare attendance\nMissed opportunities for participation in sports,\nplaydates, or other activities\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nWhile people can get some protection from having COVID-19, the level and length of that protection varies, especially as\nCOVID-19 variants continue to emerge. Immunity (protection) from infection can vary depending on how mild or severe someone\u2019s illness was and their age."}]}, {"title": "abf8d066819a28430617180bed398dd", "paragraphs": [{"qas": [{"question": "What test is available that can reliably determine if a person is protected from further infection?", "id": "100000000000000000000814", "answers": [{"text": "no antibody test", "answer_start": 73}], "is_impossible": false}, {"question": "Who should still get vaccinated against COVID-19?", "id": "100000000000000000000815", "answers": [{"text": "Children, Teens, or Adults", "answer_start": 208}], "is_impossible": false}, {"question": "What can people get added protection by getting vaccinated after being infected with the virus that causes COVID-19?", "id": "100000000000000000000816", "answers": [{"text": "you should still get vaccinated", "answer_start": 487}], "is_impossible": false}], "context": "Immunity from infection decreases over time. Importantly, there is still no antibody test available that can reliably determine if a person is protected from further\ninfection. Protection from COVID-19\n\uf1aa\n\u2022\n\u2022\nChildren, Teens, or Adults Who Have Already Had COVID-19\nShould Still Get Vaccinated\nData from ongoing studies show evidence that people can get added protection by getting vaccinated after having been\ninfected with the virus that causes COVID-19. Even if you have had COVID-19, you should still get vaccinated."}]}, {"title": "c05a6dfc60a5a3c98c3dc1580c8a59ea", "paragraphs": [{"qas": [{"question": "How long can a person who has been infected with COVID-19's next dose be delayed?", "id": "100000000000000000000817", "answers": [{"text": "3 months", "answer_start": 79}], "is_impossible": false}, {"question": "What can happen with a primary dose or a booster dose?", "id": "100000000000000000000818", "answers": [{"text": "delayed 3 months from when symptoms started or, if they did not have symptoms, when they received a positive test. This possible delay", "answer_start": 71}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000000819", "answers": [{"text": "variants", "answer_start": 482}], "is_impossible": false}], "context": "For anyone who has been infected with COVID-19, their next dose can be delayed 3 months from when symptoms started or,\nif they did not have symptoms, when they received a positive test. This possible delay can happen with a primary dose or a\nbooster dose. Read more about immunity from COVID-19 infection and vaccination. \uf549 About Variants\nMany viruses are constantly changing, including the virus that causes COVID-19. These changes occur over\ntime and can lead to the emergence of variants that may have new characteristics, including different ways\nof spreading."}]}, {"title": "d3e1c9b1aaf5db03980d73789dadb149", "paragraphs": [{"qas": [{"question": "Who recommends everyone age 6 months and older stay up to date with their vaccines?", "id": "100000000000000000000821", "answers": [{"text": "CDC", "answer_start": 32}], "is_impossible": false}, {"question": "What prevents people from getting seriously ill, being hospitalized, and even dying?", "id": "100000000000000000000823", "answers": [{"text": "COVID 19-vaccines", "answer_start": 231}], "is_impossible": false}], "context": "COVID-19 Vaccines Are Effective\nCDC recommends everyone ages 6 months and older stay up to date with their vaccines, which includes everyone 5 years and\nolder getting boosters if eligible, for the best protection against COVID-19. COVID 19-vaccines are effective at protecting people from getting seriously ill, being hospitalized, and even dying. 10/30/22, 9:34 AM Benefits of Getting A COVID-19 Vaccine | CDC\nPeople who have certain medical conditions or who are taking medications that weaken their immune system are at\nincreased risk of severe COVID-19 illness and death."}]}, {"title": "bdcaacf8e6d26db830f4658333aab69b", "paragraphs": [{"qas": [{"question": "What may not be as strong as in people who are not immunocompromised?", "id": "100000000000000000000826", "answers": [{"text": "immune response to COVID-19 vaccination", "answer_start": 20}], "is_impossible": false}, {"question": "How much protection did the vaccines show against symptomatic infection, severe illness, and death?", "id": "100000000000000000000827", "answers": [{"text": "90%", "answer_start": 405}], "is_impossible": false}, {"question": "What did CDC put forward recommendations to continue?", "id": "100000000000000000000829", "answers": [{"text": "masking", "answer_start": 622}], "is_impossible": false}, {"question": "What was recommended to continue masking even for people who had received a primary series?", "id": "100000000000000000000830", "answers": [{"text": "CDC", "answer_start": 578}], "is_impossible": false}], "context": "Additionally, their immune response to COVID-19 vaccination may not be\nas strong as in people who are not immunocompromised. People who are moderately or severely immunocompromised have\nspecific recommendations for COVID-19 vaccines, including boosters. COVID-19 vaccines were first authorized for emergency use in the U.S. in December 2020. Studies following the use of the\nvaccines showed approximately 90% protection against symptomatic infection, severe illness, and death. By July 2021, we saw\ndecreased vaccine effectiveness against infection as new variants emerged, and CDC put forward recommendations to\ncontinue masking, even for people who had received a primary series."}]}, {"title": "be38140dfb3e540fe2447880e499535a", "paragraphs": [{"qas": [{"question": "How many ACIP meetings have publicly reviewed data on vaccine effectiveness?", "id": "100000000000000000000831", "answers": [{"text": "more than 20", "answer_start": 87}], "is_impossible": false}, {"question": "What are the rates of COVID-19-associated hospitalizations and deaths substantially higher?", "id": "100000000000000000000832", "answers": [{"text": "among unvaccinated adults", "answer_start": 403}], "is_impossible": false}], "context": "Over the ensuing months and in the context of\nupdated vaccine booster recommendations, more than 20 ACIP meetings have publicly reviewed data on vaccine\neffectiveness and have provided real-time data demonstrating COVID-19 vaccines and boosters remain highly protective\nagainst severe illness and death. Importantly, the rates of COVID-19\u2013associated hospitalizations and deaths are substantially\nhigher among unvaccinated adults than among those who have received a primary series and those who are up to date with\nrecommended COVID-19 vaccination, particularly among adults aged \u226565 years."}]}, {"title": "8e0f5baf29d8d4ff90efbd40439cc76e", "paragraphs": [{"qas": [{"question": "What type of vaccines protect against symptomatic infection and transmission?", "id": "100000000000000000000834", "answers": [{"text": "current vaccines", "answer_start": 27}], "is_impossible": false}, {"question": "What kind of vaccine protects against severe disease and diminishes over time?", "id": "100000000000000000000835", "answers": [{"text": "vaccines", "answer_start": 35}], "is_impossible": false}, {"question": "Why is it important to stay up to date as new vaccines become available?", "id": "100000000000000000000836", "answers": [{"text": "Protection provided by the current vaccines against symptomatic infection and transmission is less than that against severe disease and diminishes over time", "answer_start": 0}], "is_impossible": false}, {"question": "When do vaccines become available?", "id": "100000000000000000000837", "answers": [{"text": "new vaccines become available", "answer_start": 280}], "is_impossible": false}, {"question": "Who publishes weekly summaries of covid-19 hospitalization data?", "id": "100000000000000000000839", "answers": [{"text": "COVID-NET", "answer_start": 522}], "is_impossible": false}, {"question": "What has been taken to ensure their safety and effectiveness?", "id": "100000000000000000000840", "answers": [{"text": "all steps", "answer_start": 634}], "is_impossible": false}], "context": "Protection provided by the current vaccines\nagainst symptomatic infection and transmission is less than that against severe disease and diminishes over time, especially\nagainst the currently circulating variants. For this reason, it is important to stay up to date, especially as new vaccines become\navailable. Read more about risk factors for severe COVID-19 in children published in Pediatrics, childhood COVID-19-related\nhospitalizations published in MMWR, and weekly summaries of COVID-19 hospitalization data through COVID-NET. \uf209\nCOVID-19 Vaccines Are Safe for Children and Adults\nWhile COVID-19 vaccines were developed quickly, all steps have been taken to ensure their safety and effectiveness."}]}, {"title": "209c807964fc17d7150b0d3c00452078", "paragraphs": [{"qas": [{"question": "What was developed using science that has been around for decades?", "id": "100000000000000000000841", "answers": [{"text": "COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "Before COVID-19 vaccines were recommended, scientists conducted clinical trials with thousands of children and adults and found no serious safety concerns?", "id": "100000000000000000000842", "answers": [{"text": "COVID-19 vaccines were developed using science that has been around for decades", "answer_start": 0}], "is_impossible": false}, {"question": "What is the most intensive safety monitoring program in U.S. history?", "id": "100000000000000000000844", "answers": [{"text": "COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "Serious side effects that could cause a long-term health problem are rare following any vaccination?", "id": "100000000000000000000845", "answers": [{"text": "COVID-19 vaccines were developed using science that has been around for decades. Before COVID-19 vaccines were recommended, scientists conducted clinical trials with thousands of children and adults and found no serious safety concerns. Hundreds of millions of people in the United States have received COVID-19 vaccines under the most intensive safety monitoring program in U.S. history. Serious side effects that could cause a long-term health problem are rare following any vaccination, including COVID-19 vaccination", "answer_start": 0}], "is_impossible": false}, {"question": "Who should get vaccinated against COVID-19?", "id": "100000000000000000000847", "answers": [{"text": "children and teens", "answer_start": 623}], "is_impossible": false}], "context": "COVID-19 vaccines were developed using science that has been around for decades. Before COVID-19 vaccines were recommended, scientists conducted clinical trials with thousands of children and adults\nand found no serious safety concerns. Hundreds of millions of people in the United States have received COVID-19 vaccines under the most intensive safety\nmonitoring program in U.S. history. Serious side effects that could cause a long-term health problem are rare following any vaccination, including COVID-19\nvaccination. The benefits of COVID-19 vaccination outweigh the known and potential risks. More information on why children and teens should get vaccinated against COVID-19."}]}, {"title": "dcd4f0c2cba9b7a586d64f40e10ad59d", "paragraphs": [{"qas": [{"question": "What should you continue to follow after vaccination?", "id": "100000000000000000000848", "answers": [{"text": "all current prevention measures", "answer_start": 50}], "is_impossible": false}, {"question": "What are the current prevention measures recommended by CDC based on?", "id": "100000000000000000000849", "answers": [{"text": "COVID- 19 Community Level data", "answer_start": 121}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nAfter vaccination, continue to follow all current prevention measures recommended by CDC and based on latest COVID-\n19 Community Level data. Learn more about protecting your family from COVID-19. Related Pages\nFacts about COVID-19 Vaccines\n\u203a\nFrequently Asked Questions about COVID-19\nVaccination\n\u203a\nCOVID-19 Vaccines for People Who Would Like to Have\na Baby\n\u203a\nHow Do I Find a COVID-19 Vaccine? \u203a\nLast Updated Aug. 17, 2022"}]}, {"title": "32ec16ce3d319db5efd0e8fbbbe48d67", "paragraphs": [{"qas": [{"question": "What does the CDC Espaol do?", "id": "100000000000000000000853", "answers": [{"text": "Breastfeeding and Caring for Newborns if You Have COVID-19", "answer_start": 18}], "is_impossible": false}, {"question": "What are the absolute risks of COVID-19?", "id": "100000000000000000000854", "answers": [{"text": "low", "answer_start": 317}], "is_impossible": false}, {"question": "If you are pregnant or were recently pregnant, you are more likely to get very sick from what?", "id": "100000000000000000000855", "answers": [{"text": "COVID-19", "answer_start": 411}], "is_impossible": false}, {"question": "During pregnancy, you are at increased risk of what?", "id": "100000000000000000000856", "answers": [{"text": "complications", "answer_start": 543}], "is_impossible": false}], "context": "10/30/22, 9:41 AM Breastfeeding and Caring for Newborns if You Have COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nBreastfeeding and Caring for Newborns if You Have\nWe still have much to learn about the risks of COVID-19 for newborns of people with COVID-19, however we do know these\nfacts:\nAlthough the absolute risks are low, if you are pregnant or were recently pregnant, you are more likely to get very sick\nfrom COVID-19 compared to people who are not pregnant. Additionally, if you have COVID-19 during pregnancy, you are\nat increased risk of complications that can affect your pregnancy and developing baby."}]}, {"title": "5f07e85009b79bd5fbbf0e99992c0a66", "paragraphs": [{"qas": [{"question": "Most newborns of people who had COVID-19 during pregnancy do not have what when they are born?", "id": "100000000000000000000857", "answers": [{"text": "COVID-19", "answer_start": 70}], "is_impossible": false}, {"question": "Some newborns have tested positive for what shortly after birth?", "id": "100000000000000000000858", "answers": [{"text": "COVID-19", "answer_start": 138}], "is_impossible": false}, {"question": "We don\u2019t know if these newborns got the virus before, during, or after what?", "id": "100000000000000000000859", "answers": [{"text": "birth", "answer_start": 239}], "is_impossible": false}, {"question": "Most newborns who tested positive for COVID-19 had mild or no symptoms and recovered?", "id": "100000000000000000000860", "answers": [{"text": "We don\u2019t know if these newborns got the virus before, during, or after birth", "answer_start": 168}], "is_impossible": false}, {"question": "Reports say some newborns developed what type of illness?", "id": "100000000000000000000861", "answers": [{"text": "severe", "answer_start": 368}], "is_impossible": false}], "context": "Most newborns of people who had COVID-19 during pregnancy do not have COVID-19 when they are born. Some newborns have tested positive for COVID-19 shortly after birth. We don\u2019t know if these newborns got the virus\nbefore, during, or after birth. Most newborns who tested positive for COVID-19 had mild or no symptoms and recovered. Reports say some newborns\ndeveloped severe COVID-19 illness."}]}, {"title": "aa1ecda78ed5afefc2267e2b3683e763", "paragraphs": [{"qas": [{"question": "What is the risk of a newborn getting COVID-19 from their birth parent?", "id": "100000000000000000000862", "answers": [{"text": "low", "answer_start": 160}], "is_impossible": false}, {"question": "What is the purpose of preventing spread before and during care of a newborn?", "id": "100000000000000000000864", "answers": [{"text": "wearing a mask and washing hands", "answer_start": 213}], "is_impossible": false}, {"question": "What do you decide if your newborn is rooming in with you in the hospital?", "id": "100000000000000000000865", "answers": [{"text": "Talk to your healthcare provider", "answer_start": 367}], "is_impossible": false}, {"question": "Talk to your healthcare provider about the risks and benefits of having your newborn stay in the same room with you?", "id": "100000000000000000000866", "answers": [{"text": "birth parent", "answer_start": 144}], "is_impossible": false}], "context": "Caring for your newborn in the hospital if you have COVID-19\nCurrent evidence suggests that the chance of a newborn getting COVID-19 from their birth parent is low, especially when the\nparent takes steps (such as wearing a mask and washing hands) to prevent spread before and during care of the newborn. Decide if your newborn is rooming-in with you in the hospital. Talk to your healthcare provider about the risks and benefits of having your newborn stay in the same room with you."}]}, {"title": "2447ef0cde68d6a9519320dfd36de866", "paragraphs": [{"qas": [{"question": "What does having your newborn stay with you make breastfeeding easier?", "id": "100000000000000000000867", "answers": [{"text": "parent-newborn bonding", "answer_start": 112}], "is_impossible": false}, {"question": "What helps with parent-newborn bonding?", "id": "100000000000000000000868", "answers": [{"text": "Having your newborn stay in the room with you", "answer_start": 0}], "is_impossible": false}, {"question": "CDC is reviewing this page to align with what?", "id": "100000000000000000000869", "answers": [{"text": "updated guidance", "answer_start": 177}], "is_impossible": false}, {"question": "What is the latest data on birth and infant outcomes among pregnant women with COVID-19?", "id": "100000000000000000000870", "answers": [{"text": "Vaccine Information", "answer_start": 195}], "is_impossible": false}, {"question": "What should you do if your newborn is rooming-in with you in the hospital?", "id": "100000000000000000000871", "answers": [{"text": "Take precautions", "answer_start": 429}], "is_impossible": false}], "context": "Having\nyour newborn stay in the room with you has the benefit of making breastfeeding easier, and it helps with parent-newborn\nbonding. CDC is reviewing this page to align with updated guidance. Vaccine Information if you are pregnant or breastfeeding. \u2022\n\u2022\n\u2022\n\u2022\nSee the latest data on birth and infant outcomes among pregnant women with COVID-19. 10/30/22, 9:41 AM Breastfeeding and Caring for Newborns if You Have COVID-19 | CDC\nTake precautions if your newborn is rooming-in with you in the hospital."}]}, {"title": "3823cc900b38fbbd5c6cdb45bee8df56", "paragraphs": [{"qas": [{"question": "What should you do if you are in isolation for COVID-19 and are sharing a room with your newborn?", "id": "100000000000000000000872", "answers": [{"text": "take the following steps to reduce the chance of spreading the virus to your newborn", "answer_start": 79}], "is_impossible": false}, {"question": "How long should you wash your hands with soap and water before holding or caring for your newborn?", "id": "100000000000000000000873", "answers": [{"text": "at least 20 seconds", "answer_start": 205}], "is_impossible": false}, {"question": "What should you use if soap and water aren't available?", "id": "100000000000000000000874", "answers": [{"text": "a hand sanitizer", "answer_start": 309}], "is_impossible": false}, {"question": "When you are within 6 feet of your newborn, what should you wear?", "id": "100000000000000000000876", "answers": [{"text": "a well-fitting mask", "answer_start": 358}], "is_impossible": false}], "context": "If you are in isolation for COVID-19 and are sharing a room with your newborn, take the following steps to reduce the chance\nof spreading the virus to your newborn:\nWash your hands with soap and water for at least 20 seconds before holding or caring for your newborn. If soap and\nwater are not available, use a hand sanitizer with at least 60% alcohol. Wear a well-fitting mask whenever you are within 6 feet of your newborn. Keep your newborn more than 6 feet away from you as much as possible."}]}, {"title": "18587d30d64ede630bb981613dcf8f5a", "paragraphs": [{"qas": [{"question": "What type of barrier can you use to protect a newborn?", "id": "100000000000000000000878", "answers": [{"text": "physical", "answer_start": 89}], "is_impossible": false}, {"question": "When does your isolation period end?", "id": "100000000000000000000880", "answers": [{"text": "after 5 days have passed since you tested positive for COVID-19", "answer_start": 557}], "is_impossible": false}, {"question": "What is the duration of your isolation?", "id": "100000000000000000000882", "answers": [{"text": "5 days", "answer_start": 357}], "is_impossible": false}, {"question": "If you never had symptoms, how long does it take for symptoms to improve?", "id": "100000000000000000000883", "answers": [{"text": "5 days", "answer_start": 562}], "is_impossible": false}, {"question": "How many days have passed since you tested positive for COVID-19?", "id": "100000000000000000000884", "answers": [{"text": "5", "answer_start": 562}], "is_impossible": false}], "context": "Talk to your healthcare provider about how you can protect your newborn, such as using a physical barrier (for example,\nplacing the newborn in an incubator) while in the hospital. You most likely will not pass the virus to your newborn or any other close contacts after your isolation period has ended. If you had symptoms, your isolation period ends after:\n5 days since symptoms first appeared, and\n24 hours with no fever, without fever-reducing medicine, and\nOther symptoms of COVID-19 are improving. If you never had symptoms, your isolation period ends after\n5 days have passed since you tested positive for COVID-19."}]}, {"title": "18faa5d7c58bc73d5b05a9316da907b5", "paragraphs": [{"qas": [{"question": "After 10 days, you should still wash your hands before caring for your newborn.", "id": "100000000000000000000886", "answers": [{"text": "mask until day 10. After 10 days, you should still wash your hands before caring for your newborn, but you don\u2019t need to take the other precautions", "answer_start": 61}], "is_impossible": false}, {"question": "What does not apply if you have a severely weakened immune system?", "id": "100000000000000000000887", "answers": [{"text": "These timeframes", "answer_start": 210}], "is_impossible": false}, {"question": "If you have a severely weakened immune system, what should you do?", "id": "100000000000000000000889", "answers": [{"text": "These timeframes do not apply if you have a severely weakened immune system or were severely ill with COVID-19", "answer_start": 210}], "is_impossible": false}, {"question": "What should you consult with your health care professional about?", "id": "100000000000000000000890", "answers": [{"text": "when it is safe for you to end your isolation period", "answer_start": 418}], "is_impossible": false}], "context": "Once your isolation period has ended you should still wear a mask until day 10. After 10 days, you should still wash your\nhands before caring for your newborn, but you don\u2019t need to take the other precautions. These timeframes do not apply if\nyou have a severely weakened immune system or were severely ill with COVID-19. Please refer to \u201cQuarantine and Isolation\u201d\nand consult with your health care professional about when it is safe for you to end your isolation period."}]}, {"title": "d668a7e84581ccbc1613d6a41dcf0e3b", "paragraphs": [{"qas": [{"question": "How do you care for your newborn if you have COVID-19?", "id": "100000000000000000000891", "answers": [{"text": "at home", "answer_start": 24}], "is_impossible": false}, {"question": "What do you do to separate yourself from others outside of your home?", "id": "100000000000000000000892", "answers": [{"text": "Stay home", "answer_start": 161}], "is_impossible": false}, {"question": "Do you wear a mask?", "id": "100000000000000000000893", "answers": [{"text": "wear a mask in shared spaces", "answer_start": 298}], "is_impossible": false}, {"question": "What do household members not infected wear in shared spaces?", "id": "100000000000000000000894", "answers": [{"text": "a mask", "answer_start": 303}], "is_impossible": false}, {"question": "Have a healthy caregiver who is up to date with their COVID-19 vaccines provide care for your newborn?", "id": "100000000000000000000895", "answers": [{"text": "Caring for your newborn at home if you have COVID-19 If you are in isolation for COVID-19, take the following precautions until your isolation period has ended: Stay home to separate yourself from others outside your home. Isolate (stay away) from other household members who are not infected, and wear a mask in shared spaces. Have a healthy caregiver who is up to date with their COVID-19 vaccines and not at higher risk for severe illness", "answer_start": 0}], "is_impossible": false}], "context": "Caring for your newborn at home if you have COVID-19\nIf you are in isolation for COVID-19, take the following precautions until your isolation period has ended:\nStay home to separate yourself from others outside your home. Isolate (stay away) from other household members who are not infected, and wear a mask in shared spaces. Have a healthy caregiver who is up to date with their COVID-19 vaccines and not at higher risk for severe illness provide\ncare for your newborn (see recommendations below)."}]}, {"title": "a3210781d630a15d715277f4cb39bd0f", "paragraphs": [{"qas": [{"question": "How long should caregivers wash their hands before touching their newborn?", "id": "100000000000000000000896", "answers": [{"text": "at least 20 seconds", "answer_start": 327}], "is_impossible": false}, {"question": "What is the name of the disease that causes COVID-19?", "id": "100000000000000000000897", "answers": [{"text": "- - -", "answer_start": 9}], "is_impossible": false}, {"question": "How long should a caregiver hold their hands before touching your newborn?", "id": "100000000000000000000898", "answers": [{"text": "at least 20 seconds", "answer_start": 327}], "is_impossible": false}, {"question": "What should the caregiver use if soap and water are not available?", "id": "100000000000000000000899", "answers": [{"text": "a hand sanitizer with at least 60% alcohol", "answer_start": 430}], "is_impossible": false}, {"question": "If the caregiver is living in the same home or has been in close contact with you, what might have happened?", "id": "100000000000000000000900", "answers": [{"text": "they might have been exposed", "answer_start": 557}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n-\n\u2022\n-\n\u2022\n\u2022\n\u2022\f10/30/22, 9:41 AM Breastfeeding and Caring for Newborns if You Have COVID-19 | CDC\nFollow recommended precautions if you must care for your newborn before your isolation period has ended. Recommended precautions for healthy caregivers helping care for newborns:\nCaregivers should wash their hands for at least 20 seconds before touching your newborn. If soap and water are not\navailable, they should use a hand sanitizer with at least 60% alcohol. If the caregiver is living in the same home or has been in close contact with you, they might have been exposed."}]}, {"title": "a5c987b8ad8d6266ac3971ecc29cdd51", "paragraphs": [{"qas": [{"question": "What should people who have come into contact with someone with COVID-19 be tested for?", "id": "100000000000000000000901", "answers": [{"text": "infection", "answer_start": 97}], "is_impossible": false}, {"question": "If you develop symptoms, get tested immediately and isolate until you receive what?", "id": "100000000000000000000902", "answers": [{"text": "your test results", "answer_start": 186}], "is_impossible": false}, {"question": "Self-tests are one of several options for what?", "id": "100000000000000000000904", "answers": [{"text": "testing for the virus that causes COVID-19", "answer_start": 423}], "is_impossible": false}, {"question": "What may be more convenient than laboratory-based tests and point-of-care tests?", "id": "100000000000000000000905", "answers": [{"text": "Self-tests", "answer_start": 381}], "is_impossible": false}, {"question": "What do you need to know about your test results?", "id": "100000000000000000000906", "answers": [{"text": "Ask your healthcare provider or your local health department", "answer_start": 546}], "is_impossible": false}], "context": "People who have come into close contact with someone with COVID-19 should be tested to check for infection:\nIf you develop symptoms, get tested immediately and isolate until you receive your test results. If you test\npositive, follow isolation recommendations. If you do not develop symptoms, get tested at least 5 days after you last had close contact with someone with\nCOVID-19. Self-tests are one of several options for testing for the virus that causes COVID-19 and may be more\nconvenient than laboratory-based tests and point-of-care tests. Ask your healthcare provider or your local\nhealth department if you need help interpreting your test results."}]}, {"title": "d812752c43a43b87d13a933e67cc940a", "paragraphs": [{"qas": [{"question": "Who should wear a mask when they are within 6 feet of your newborn?", "id": "100000000000000000000908", "answers": [{"text": "Caregivers", "answer_start": 0}], "is_impossible": false}, {"question": "What should caregivers wear during their own quarantine after you complete your isolation?", "id": "100000000000000000000909", "answers": [{"text": "a mask", "answer_start": 23}], "is_impossible": false}, {"question": "How long before touching your newborn do you wash your hands with soap and water?", "id": "100000000000000000000911", "answers": [{"text": "20 seconds", "answer_start": 327}], "is_impossible": false}, {"question": "What should you wear when within 6 feet of your newborn?", "id": "100000000000000000000913", "answers": [{"text": "a mask", "answer_start": 23}], "is_impossible": false}, {"question": "What should you wear when within 6 feet of your newborn and other people during your entire isolation period?", "id": "100000000000000000000914", "answers": [{"text": "a mask when they are within 6 feet of your newborn for the entire time you are in isolation, and during their own quarantine after you complete your isolation. If a healthy caregiver is not available, you can care for your newborn if you are well enough. Wash your hands with soap and water for at least 20 seconds before touching for your newborn. If soap and water are not available, use a hand sanitizer with at least 60% alcohol. Wear a mask", "answer_start": 23}], "is_impossible": false}], "context": "Caregivers should wear a mask when they are within 6 feet of your newborn for the entire time you are in isolation, and\nduring their own quarantine after you complete your isolation. If a healthy caregiver is not available, you can care for your newborn if you are well enough. Wash your hands with soap and water for at least 20 seconds before touching for your newborn. If soap and water are\nnot available, use a hand sanitizer with at least 60% alcohol. Wear a mask when within 6 feet of your newborn and other people during your entire isolation period."}]}, {"title": "550a95abf3395f2f31e5ac04dac410bd", "paragraphs": [{"qas": [{"question": "What helps prevent you from spreading the COVID-19 virus to others?", "id": "100000000000000000000915", "answers": [{"text": "The mask", "answer_start": 0}], "is_impossible": false}, {"question": "What should caregivers do if they have to care for a newborn?", "id": "100000000000000000000917", "answers": [{"text": "follow hand washing and mask recommendations above", "answer_start": 242}], "is_impossible": false}, {"question": "What are the two things that you should do to avoid spreading the virus to your newborn?", "id": "100000000000000000000918", "answers": [{"text": "hand washing and mask", "answer_start": 249}], "is_impossible": false}, {"question": "After your isolation period has ended, who will most likely not be exposed to the virus?", "id": "100000000000000000000919", "answers": [{"text": "your newborn or any other close contacts", "answer_start": 334}], "is_impossible": false}], "context": "The mask helps\nprevent you from spreading the virus to others. Others in your household, and caregivers who have COVID-19, should isolate and avoid caring for the newborn as much\nas possible. If they have to care for the newborn, they should follow hand washing and mask recommendations above. You most likely won\u2019t pass the virus to your newborn or any other close contacts after your isolation period has ended."}]}, {"title": "f42f20f2c8b413e651d909a8a723ca2", "paragraphs": [{"qas": [{"question": "How many days have passed since you tested positive for COVID-19?", "id": "100000000000000000000920", "answers": [{"text": "5 days", "answer_start": 257}], "is_impossible": false}, {"question": "When does your isolation period end if you have symptoms?", "id": "100000000000000000000922", "answers": [{"text": "5 days", "answer_start": 54}], "is_impossible": false}, {"question": "What did you test positive for?", "id": "100000000000000000000923", "answers": [{"text": "COVID-19", "answer_start": 307}], "is_impossible": false}, {"question": "How long should you wear a mask after your isolation period has ended?", "id": "100000000000000000000924", "answers": [{"text": "day 10", "answer_start": 389}], "is_impossible": false}, {"question": "What should you wash before caring for your newborn?", "id": "100000000000000000000925", "answers": [{"text": "your hands", "answer_start": 434}], "is_impossible": false}], "context": "If you had symptoms, your isolation period ends after:\n5 days since symptoms first appeared, and\n24 hours with no fever without fever-reducing medicine, and\nOther symptoms of COVID-19 are improving\nIf you never had symptoms, your isolation period ends after\n5 days have passed since you tested positive for COVID-19. Once your isolation period has ended you should still wear a mask until day 10. After 10 days, you should still wash your\nhands before caring for your newborn, but you don\u2019t need to take the other precautions."}]}, {"title": "4b30a35cd194acd878e922aefa99c993", "paragraphs": [{"qas": [{"question": "What do you need to do if you have a severely weakened immune system or were severely ill with COVID-19?", "id": "100000000000000000000926", "answers": [{"text": "consult with your health care professional about when it\u2019s safe for you to end your isolation period", "answer_start": 159}], "is_impossible": false}, {"question": "What should you consult with your health care professional about when it's safe for you to end your isolation period?", "id": "100000000000000000000927", "answers": [{"text": "Quarantine and Isolation", "answer_start": 129}], "is_impossible": false}, {"question": "Monitor your newborn for what symptoms?", "id": "100000000000000000000928", "answers": [{"text": "COVID-19", "answer_start": 286}], "is_impossible": false}, {"question": "What should you monitor your newborn for?", "id": "100000000000000000000929", "answers": [{"text": "COVID-19 symptoms", "answer_start": 286}], "is_impossible": false}], "context": "These timeframes do not apply if\nyou have a severely weakened immune system or were severely ill with COVID-19. Please refer to \u201cQuarantine and Isolation\u201d\nand consult with your health care professional about when it\u2019s safe for you to end your isolation period. Monitor your newborn for COVID-19 symptoms. If your newborn has one or more of these signs or symptoms, they may have early symptoms of COVID-19 or another illness,\nand you should contact your healthcare professional."}]}, {"title": "9c16e8b5645eb7f0e67e9e693e1256d", "paragraphs": [{"qas": [{"question": "What is an emergency?", "id": "100000000000000000000931", "answers": [{"text": "Fever", "answer_start": 0}], "is_impossible": false}, {"question": "What is a temperature of 100.4 or higher considered?", "id": "100000000000000000000932", "answers": [{"text": "Fever", "answer_start": 0}], "is_impossible": false}, {"question": "What is recommended for people who are pregnant, breastfeeding, trying to get pregnant now or might become pregnant in the near future?", "id": "100000000000000000000933", "answers": [{"text": "COVID-19 vaccination", "answer_start": 569}], "is_impossible": false}], "context": "Fever (a temperature of 100.4 or higher is considered an emergency)\nLethargy (being overly tired or inactive)\nRunny nose\nCough\nVomiting\nDiarrhea\n-\n\u2022\n\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n-\n\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:41 AM Breastfeeding and Caring for Newborns if You Have COVID-19 | CDC\nPoor feeding\nIncreased work of breathing or shallow breathing\nSee CDC\u2019s webpage on Evaluation and Management Considerations for Neonates At Risk for COVID-19 for more information. Breastfeeding and COVID-19\nCurrent evidence suggests that breast milk is not likely to spread the virus to babies. COVID-19 vaccination is recommended for people who are pregnant, breastfeeding, trying to get pregnant now, or might\nbecome pregnant in the future."}]}, {"title": "193177fa63ffc8d878ed68e3c3cfc305", "paragraphs": [{"qas": [{"question": "How long should you wash your hands with soap and water before breastfeeding?", "id": "100000000000000000000937", "answers": [{"text": "20 seconds", "answer_start": 241}], "is_impossible": false}, {"question": "What should you use if you don't have COVID-19?", "id": "100000000000000000000938", "answers": [{"text": "a hand sanitizer with at least 60% alcohol", "answer_start": 374}], "is_impossible": false}, {"question": "How much alcohol should be in a hand sanitizer?", "id": "100000000000000000000939", "answers": [{"text": "60%", "answer_start": 405}], "is_impossible": false}, {"question": "What should you wear while breastfeeding?", "id": "100000000000000000000941", "answers": [{"text": "a mask", "answer_start": 507}], "is_impossible": false}, {"question": "How close to your baby is it to you?", "id": "100000000000000000000942", "answers": [{"text": "6 feet", "answer_start": 562}], "is_impossible": false}], "context": "In addition, everyone who is eligible, including those who are pregnant, breastfeeding, trying\nto get pregnant now, or might become pregnant in the future, should get a booster shot. You should always wash your hands\nwith soap and water for 20 seconds before breastfeeding or expressing breast milk, even if you don\u2019t have COVID-19. If soap\nand water are not available, use a hand sanitizer with at least 60% alcohol. If you have COVID-19 and choose to breastfeed:\nWash your hands before breastfeeding\nWear a mask while breastfeeding and whenever you are within 6 feet of your baby."}]}, {"title": "52f637d2efedf7eb1c6589634feac8e5", "paragraphs": [{"qas": [{"question": "What should you use if you have COVID-19?", "id": "100000000000000000000943", "answers": [{"text": "your own breast pump", "answer_start": 60}], "is_impossible": false}, {"question": "How long should you wash your hands before touching any pump or bottle parts?", "id": "100000000000000000000944", "answers": [{"text": "at least 20 seconds", "answer_start": 209}], "is_impossible": false}, {"question": "How long before touching any pump or bottle parts and before expressing breast milk?", "id": "100000000000000000000945", "answers": [{"text": "at least 20 seconds", "answer_start": 209}], "is_impossible": false}, {"question": "After each use, follow recommendations for proper pump cleaning.", "id": "100000000000000000000946", "answers": [{"text": "Wash your hands with soap and water for at least 20 seconds before touching any pump or bottle parts, and before expressing breast milk. Follow recommendations for proper pump cleaning after each use. Clean all parts of the pump that come into contact with breast milk", "answer_start": 169}], "is_impossible": false}, {"question": "What should a healthy caregiver feed the expressed breast milk to the baby?", "id": "100000000000000000000947", "answers": [{"text": "Clean all parts of the pump", "answer_start": 370}], "is_impossible": false}], "context": "If you have COVID-19 and choose to express breast milk:\nUse your own breast pump (one not shared with anyone else), if possible. Wear a mask as you express breast milk. Wash your hands with soap and water for at least 20 seconds before touching any pump or bottle parts, and before\nexpressing breast milk. Follow recommendations for proper pump cleaning after each use. Clean all parts of the pump that come into contact\nwith breast milk. Consider having a healthy caregiver feed the expressed breast milk to the baby."}]}, {"title": "75c47bdc35a0a5c94c06a849cb8003fd", "paragraphs": [{"qas": [{"question": "Who should be up to date on their COVID-19 vaccines?", "id": "100000000000000000000948", "answers": [{"text": "The caregiver", "answer_start": 0}], "is_impossible": false}, {"question": "If the caregiver is living in the same home or has been in close contact with you, they might have been exposed?", "id": "100000000000000000000949", "answers": [{"text": "COVID-19 vaccines and not be at increased risk for severe illness from COVID-19", "answer_start": 44}], "is_impossible": false}, {"question": "What should people who have come into contact with someone with COVID-19 be tested for?", "id": "100000000000000000000950", "answers": [{"text": "infection", "answer_start": 335}], "is_impossible": false}, {"question": "If you develop symptoms, get tested immediately and isolate until you receive what?", "id": "100000000000000000000951", "answers": [{"text": "your test results", "answer_start": 424}], "is_impossible": false}], "context": "The caregiver should be up to date on\ntheir COVID-19 vaccines and not be at increased risk for severe illness from COVID-19. If the caregiver is living in the\nsame home or has been in close contact with you, they might have been exposed. People who have come into close contact with someone with COVID-19 should be tested to check for infection:\nIf you develop symptoms, get tested immediately and isolate until you receive your test results. If you test\npositive, follow isolation recommendations."}]}, {"title": "8b510468e336c169680a6fd9e9891faf", "paragraphs": [{"qas": [{"question": "How long after you last had close contact with someone with COVID-19 should you get tested?", "id": "100000000000000000000952", "answers": [{"text": "5 days", "answer_start": 52}], "is_impossible": false}, {"question": "Self-tests are one of several options for testing for what?", "id": "100000000000000000000953", "answers": [{"text": "the virus that causes COVID-19", "answer_start": 174}], "is_impossible": false}, {"question": "What is more convenient than laboratory-based tests and point-of-care tests?", "id": "100000000000000000000954", "answers": [{"text": "Self-tests", "answer_start": 120}], "is_impossible": false}, {"question": "What are two types of tests?", "id": "100000000000000000000955", "answers": [{"text": "laboratory-based tests and point-of-care tests", "answer_start": 237}], "is_impossible": false}, {"question": "What should a caregiver wear when caring for a baby?", "id": "100000000000000000000956", "answers": [{"text": "a mask", "answer_start": 438}], "is_impossible": false}], "context": "If you do not develop symptoms, get tested at least 5 days after you last had close contact with someone with\nCOVID-19. Self-tests are one of several options for testing for the virus that causes COVID-19 and may be more\nconvenient than laboratory-based tests and point-of-care tests. Ask your healthcare provider or your local\nhealth department if you need help interpreting your test results. Any caregiver feeding the baby should wear a mask when caring for the baby for the entire time you are in isolation and\nduring their own quarantine period after you complete isolation."}]}, {"title": "62f316192e1156e758d3a64c299c57dc", "paragraphs": [{"qas": [{"question": "What should you do if you are sick?", "id": "100000000000000000000958", "answers": [{"text": "How to Protect Yourself & Others", "answer_start": 42}], "is_impossible": false}, {"question": "What is the toolkit for Pregnant People and New Parents?", "id": "100000000000000000000959", "answers": [{"text": "COVID-19 Vaccines While Pregnant or Breastfeeding \u203a COVID-19", "answer_start": 106}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000000960", "answers": [{"text": "Vaccines While Pregnant or Breastfeeding \u203a COVID-19 Toolkit for Pregnant People and New Parents \u203a Care for Yourself", "answer_start": 115}], "is_impossible": false}, {"question": "What is CDC Breastfeeding Infant Formula Feeding from a Bottle FAQs on Nutrition for Baby and Young Children Last updated Jan. 20, 2022?", "id": "100000000000000000000961", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 - \u2022 \u2022 \u2022 \u2022", "answer_start": 3}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\nRelated Pages\nHow to Protect Yourself & Others\n\u203a\nWhat to Do If You Are Sick\n\u203a\nCOVID-19 Vaccines While Pregnant or Breastfeeding\n\u203a\nCOVID-19 Toolkit for Pregnant People and New Parents\n\u203a\nCare for Yourself\n\u203a\nMore Information\nPregnant and Recently Pregnant People Stress and Coping\f10/30/22, 9:41 AM Breastfeeding and Caring for Newborns if You Have COVID-19 | CDC\nBreastfeeding\nInfant Formula Feeding\nFeeding from a Bottle\nFAQs on Nutrition for Baby and Young Children\nLast Updated Jan. 20, 2022"}]}, {"title": "e93de8fc05f27bac972e4a63bec12691", "paragraphs": [{"qas": [{"question": "What do you need to know when you get tested?", "id": "100000000000000000000962", "answers": [{"text": "Make sure to test at the right time", "answer_start": 151}], "is_impossible": false}, {"question": "What may be less likely to correctly indicate whether you have COVID-19 or not?", "id": "100000000000000000000965", "answers": [{"text": "your results", "answer_start": 299}], "is_impossible": false}, {"question": "Do you have symptoms after being exposed to COVID-19?", "id": "100000000000000000000967", "answers": [{"text": "do not have symptoms", "answer_start": 526}], "is_impossible": false}, {"question": "How long after your exposure do you need to wait for testing?", "id": "100000000000000000000968", "answers": [{"text": "5 full days", "answer_start": 562}], "is_impossible": false}, {"question": "What is the name of the drug you were exposed to?", "id": "100000000000000000000969", "answers": [{"text": "COVID-19", "answer_start": 513}], "is_impossible": false}], "context": "10/30/22, 9:37 AM COVID-19 Testing: What You Need to Know | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Testing: What You Need to Know\nWhen you get tested:\nMake sure to test at the right time\nChoose the right type of test for your circumstance\nFollow test directions as recommended by FDA\nIf you do not, your results may be less likely to correctly indicate whether you have COVID-19 or not. \u2022\n\u2022\n\u2022\nWhen to Get Tested for COVID-19\nKey times to get tested:\nIf you have symptoms, test immediately. If you were exposed to COVID-19 and do not have symptoms, wait at\nleast 5 full days after your exposure before testing."}]}, {"title": "aae8d731b6e4258b36cd172f41759804", "paragraphs": [{"qas": [{"question": "What should you consider testing before contact with someone at high risk for severe COVID-19?", "id": "100000000000000000000972", "answers": [{"text": "If you test too early", "answer_start": 0}], "is_impossible": false}, {"question": "What can you use to determine which mitigations are recommended as you recover?", "id": "100000000000000000000974", "answers": [{"text": "tests", "answer_start": 360}], "is_impossible": false}], "context": "If you test too\nearly, you may be more likely to get an inaccurate result. If you are in certain high-risk settings, you may need to test as part of\na screening testing program. Consider testing before contact with someone at high risk for severe\nCOVID-19, especially if you are in an area with a medium or high COVID-19 Community Level. For guidance on using tests to determine which mitigations are recommended as you recover from COVID-19, go to Isolation\nand Precautions for People with COVID-19."}]}, {"title": "b92636ec6eae37a28fb5384925320a59", "paragraphs": [{"qas": [{"question": "How many types of viral tests are there?", "id": "100000000000000000000977", "answers": [{"text": "two", "answer_start": 251}], "is_impossible": false}, {"question": "What are NAATs?", "id": "100000000000000000000979", "answers": [{"text": "nucleic acid amplification tests", "answer_start": 282}], "is_impossible": false}, {"question": "Where are most NAAT tests performed?", "id": "100000000000000000000980", "answers": [{"text": "in a laboratory", "answer_start": 534}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\uf6e0 COVID-19 Tests or Treatment\nCommunity-Based Testing Locations Treatment Locator\nTypes of Tests\nViral tests look for a current infection with SARS-CoV-2, the virus that causes COVID-19, by testing specimens from your nose\nor mouth. There are two main types of viral tests: nucleic acid amplification tests (NAATs) and antigen tests. In certain\ncircumstances, one test type may be recommended over the other. All tests should be performed following FDA\u2019s\nrequirements. NAATs, such as PCR-based tests, are most often performed in a laboratory. They are typically the most reliable tests for\npeople with or without symptoms."}]}, {"title": "553d9efdf41153049d6a697e62c0d5ca", "paragraphs": [{"qas": [{"question": "How long can viral genetic material stay in your body after you test positive?", "id": "100000000000000000000981", "answers": [{"text": "up to 90 days", "answer_start": 75}], "is_impossible": false}, {"question": "What should you not use if you have tested positive in the last 90 days?", "id": "100000000000000000000982", "answers": [{"text": "a NAAT", "answer_start": 142}], "is_impossible": false}, {"question": "How long after you test positive should you use a NAAT?", "id": "100000000000000000000983", "answers": [{"text": "days", "answer_start": 262}], "is_impossible": false}, {"question": "What are rapid tests that produce results in 15-30 minutes?", "id": "100000000000000000000984", "answers": [{"text": "Antigen tests", "answer_start": 379}], "is_impossible": false}, {"question": "What are NAATs less reliable for?", "id": "100000000000000000000986", "answers": [{"text": "people who do not have symptoms", "answer_start": 499}], "is_impossible": false}, {"question": "People who do not have symptoms are less reliable than what?", "id": "100000000000000000000987", "answers": [{"text": "NAATs", "answer_start": 478}], "is_impossible": false}], "context": "These tests detect viral genetic material, which may stay in your body for up to 90\ndays after you test positive Therefore you should not use a NAAT if you have tested positive in the last 90 days\n\u2022\f10/30/22, 9:37 AM COVID-19 Testing: What You Need to Know | CDC\ndays after you test positive. Therefore, you should not use a NAAT if you have tested positive in the last 90 days. Antigen tests* are rapid tests which produce results in 15-30 minutes. They are less reliable than NAATs, especially for\npeople who do not have symptoms."}]}, {"title": "2681fa9875a2afae6e3131dc43c85052", "paragraphs": [{"qas": [{"question": "What does not rule out infection?", "id": "100000000000000000000988", "answers": [{"text": "A single, negative antigen test result", "answer_start": 0}], "is_impossible": false}, {"question": "What is serial testing?", "id": "100000000000000000000990", "answers": [{"text": "a negative antigen test should be repeated at least 48 hours apart", "answer_start": 94}], "is_impossible": false}, {"question": "What is another name for self-tests?", "id": "100000000000000000000991", "answers": [{"text": "at-home tests", "answer_start": 285}], "is_impossible": false}, {"question": "What are at-home tests?", "id": "100000000000000000000992", "answers": [{"text": "Self-tests", "answer_start": 270}], "is_impossible": false}, {"question": "Where can you take a self test without having to go to a specific testing site?", "id": "100000000000000000000993", "answers": [{"text": "anywhere", "answer_start": 344}], "is_impossible": false}, {"question": "What does negative test results increase the confidence that you are not infected with?", "id": "100000000000000000000994", "answers": [{"text": "COVID-19", "answer_start": 610}], "is_impossible": false}], "context": "A single, negative antigen test result does not rule out infection. To best detect\ninfection, a negative antigen test should be repeated at least 48 hours apart (known as serial testing). Sometimes a\nfollow-up NAAT may be recommended to confirm an antigen test result. *Self-tests, or at-home tests, are usually antigen tests that can be taken anywhere without having to go to a specific testing\nsite. Follow FDA and manufacturer\u2019s instructions, including for the number of times you may need to test. Multiple negative\ntest results increase the confidence that you are not infected with the virus that causes COVID-19."}]}, {"title": "12a5f2b2e040abf2773730c225a657d1", "paragraphs": [{"qas": [{"question": "What is a presumptive result of negative results?", "id": "100000000000000000000997", "answers": [{"text": "preliminary results", "answer_start": 325}], "is_impossible": false}, {"question": "What should negative results be treated as?", "id": "100000000000000000000998", "answers": [{"text": "presumptive", "answer_start": 290}], "is_impossible": false}], "context": "You can order free self-test kits at COVIDtests.gov or purchase tests online, in pharmacies, and retail stores. You can also visit FDA\u2019s website to see a list of authorized tests. As noted in the labeling for authorized over-the-counter antigen tests: Negative results should be treated as presumptive\n(meaning that they are preliminary results). Negative results do not rule out SARS-CoV-2 infection and should not be\nused as the sole basis for treatment or patient management decisions, including infection control decisions. Please see\nFDA guidance on the use of at-home COVID-19 antigen tests."}]}, {"title": "deab6d44d98c53fc742a082ce034cdaa", "paragraphs": [{"qas": [{"question": "What type of test can you use if you have not had COVID-19 or a positive test within the past 90 days?", "id": "100000000000000000001001", "answers": [{"text": "NAAT or antigen tests", "answer_start": 208}], "is_impossible": false}, {"question": "What is the name of the test that you may choose?", "id": "100000000000000000001002", "answers": [{"text": "NAAT or antigen tests", "answer_start": 208}], "is_impossible": false}, {"question": "What may be necessary if you use an antigen test and your result is negative?", "id": "100000000000000000001003", "answers": [{"text": "multiple tests", "answer_start": 287}], "is_impossible": false}, {"question": "What was my first positive test result?", "id": "100000000000000000001005", "answers": [{"text": "within: 30 days or less", "answer_start": 408}], "is_impossible": false}], "context": "About Self-Tests\n\u2022\n\u2022 \uf209\n\u2022 \uf209\n\u2022\nChoosing a COVID-19 Test\nI am in a circumstance where I should get tested and:\n\uf6e2 I have not had COVID-19 or I have not had a positive test within the past 90 days. You may choose NAAT or antigen tests. If you use an antigen test and your result is negative, multiple tests may be necessary. \uf6e8 I tested positive for COVID-19 in the last 90 days. My first positive test result was within:\n30 days or less\nI have symptoms\nUse antigen tests. If negative, multiple tests may be\nnecessary."}]}, {"title": "e6c4ed7ba5dee875b7fc28efb27abc45", "paragraphs": [{"qas": [{"question": "What is not recommended to detect a new infection?", "id": "100000000000000000001006", "answers": [{"text": "Testing", "answer_start": 23}], "is_impossible": false}, {"question": "What was my first positive test result?", "id": "100000000000000000001007", "answers": [{"text": "I have symptoms Use antigen tests", "answer_start": 118}], "is_impossible": false}, {"question": "What tests may be necessary after a positive test result?", "id": "100000000000000000001008", "answers": [{"text": "Use antigen tests", "answer_start": 135}], "is_impossible": false}, {"question": "How long may you continue to test positive on antigen tests after your initial positive?", "id": "100000000000000000001009", "answers": [{"text": "a few weeks", "answer_start": 427}], "is_impossible": false}], "context": "I do not have symptoms\nTesting is not recommended to detect a new infection. My first positive test result was within:\nI have symptoms\nUse antigen tests. If negative, multiple tests may be\nnecessary. I do not have symptoms\nUse antigen tests. If negative, multiple tests may be\nnecessary\nAfter a positive test result, you may continue to test positive for some time after. You may continue to test positive on\nantigen tests for a few weeks after your initial positive. You may continue to test positive on NAATs for up to 90 days."}]}, {"title": "29913cc86bfaafa4a39069e4e6508056", "paragraphs": [{"qas": [{"question": "What can happen within 90 days?", "id": "100000000000000000001010", "answers": [{"text": "Reinfections", "answer_start": 0}], "is_impossible": false}, {"question": "What do antibodies look for in your blood that fight the virus that causes COVID-19?", "id": "100000000000000000001012", "answers": [{"text": "proteins", "answer_start": 491}], "is_impossible": false}, {"question": "What are proteins created by your immune system after you have been infected or have been vaccinated against an infection?", "id": "100000000000000000001013", "answers": [{"text": "Antibodies", "answer_start": 476}], "is_impossible": false}], "context": "Reinfections can occur within 90 days, which can make it hard to know if a positive test indicates a new infection. Consider consulting a healthcare provider if you have any questions or concerns about your individual circumstances. Interpreting Your Results\f10/30/22, 9:37 AM COVID-19 Testing: What You Need to Know | CDC\nInterpreting Your Results\nTesting for Antibodies\nAntibody or serology tests look for antibodies in your blood that fight the virus that causes COVID-19. Antibodies are proteins\ncreated by your immune system after you have been infected or have been vaccinated against an infection."}]}, {"title": "14943386829f84c40f885cb102285a0e", "paragraphs": [{"qas": [{"question": "Antibody tests should not be used to diagnose a current infection with what virus?", "id": "100000000000000000001016", "answers": [{"text": "COVID-19", "answer_start": 287}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000001017", "answers": [{"text": "Any positive COVID-19 test means the virus was detected and you have an infection", "answer_start": 483}], "is_impossible": false}, {"question": "How long can it take for your body to make antibodies after an infection?", "id": "100000000000000000001018", "answers": [{"text": "1 to 3 weeks", "answer_start": 380}], "is_impossible": false}, {"question": "What does a positive test mean?", "id": "100000000000000000001019", "answers": [{"text": "the virus was detected and you have an infection", "answer_start": 516}], "is_impossible": false}, {"question": "What does a positive COVID-19 test mean?", "id": "100000000000000000001020", "answers": [{"text": "the virus was detected and you have an infection", "answer_start": 516}], "is_impossible": false}], "context": "They can help\nprotect you from infection, or severe illness if you do get infected, for a period of time afterward. How long this protection\nlasts is different for each disease and each person. Antibody tests should not be used to diagnose a current infection with the virus that causes COVID-19. An antibody test may\nnot show if you have a current infection, because it can take 1 to 3 weeks after the infection for your body to make antibodies. \uf6ec If Your COVID-19 Test is\nPositive\nAny positive COVID-19 test means the virus was detected and you have an infection."}]}, {"title": "e3c2e69a1ef435d4d637889660c3d72c", "paragraphs": [{"qas": [{"question": "What should you wear to protect others from getting infected?", "id": "100000000000000000001021", "answers": [{"text": "high-quality mask", "answer_start": 49}], "is_impossible": false}, {"question": "If you have any emergency warning signs, seek emergency care immediately.", "id": "100000000000000000001023", "answers": [{"text": "Monitor your symptoms", "answer_start": 181}], "is_impossible": false}, {"question": "What is a good time to start getting sick?", "id": "100000000000000000001024", "answers": [{"text": "if you are an older adult", "answer_start": 555}], "is_impossible": false}, {"question": "What type of person is more likely to get sick if you are an older adult?", "id": "100000000000000000001025", "answers": [{"text": "underlying medical condition", "answer_start": 592}], "is_impossible": false}], "context": "Isolate and take precautions including wearing a high-quality mask to protect others from getting\ninfected. Tell people you had recent contact with that they may have been exposed. Monitor your symptoms. If you have any emergency warning signs, seek emergency care immediately. Consider contacting a healthcare provider, community health center , or pharmacy to learn about\ntreatment options that may be available to you. Treatment must be started within several days after you\nfirst develop symptoms to be effective. You are more likely to get very sick if you are an older adult or have an underlying medical\ncondition."}]}, {"title": "93b63faf641102c321366fa70ad04b7a", "paragraphs": [{"qas": [{"question": "What does a negative COVID-19 test mean?", "id": "100000000000000000001028", "answers": [{"text": "the test did not detect the virus", "answer_start": 124}], "is_impossible": false}, {"question": "If you used an antigen test, see FDA instructions on what?", "id": "100000000000000000001029", "answers": [{"text": "repeat testing", "answer_start": 272}], "is_impossible": false}, {"question": "What can you do to prevent spreading an illness to others?", "id": "100000000000000000001031", "answers": [{"text": "Take general public health precautions", "answer_start": 411}], "is_impossible": false}, {"question": "What does a healthcare provider do if you have questions about your test result or if your symptoms worsen?", "id": "100000000000000000001032", "answers": [{"text": "Contact", "answer_start": 493}], "is_impossible": false}], "context": "Possible treatment may be available for you. \u2022\n\u2022\n\u2022\n\u2022 \uf209\n-\n\uf6ec If Your COVID-19 Test is\nNegative\nA negative COVID-19 test means the test did not detect the virus, but this doesn\u2019t rule out that you could have\nan infection. If you used an antigen test, see FDA instructions on repeat testing . If you have symptoms:\nYou may have COVID-19, but tested before the virus was detectable, or you may have another\nillness. Take general public health precautions to prevent spreading an illness to others. Contact a healthcare provider if you have any questions about your test result or if your symptoms\nworsen."}]}, {"title": "cb4b566c79dd394d0f4fb44528a99686", "paragraphs": [{"qas": [{"question": "If you do not have symptoms, but were exposed to the virus that causes COVID-19, you should continue to take what steps after exposure?", "id": "100000000000000000001033", "answers": [{"text": "recommended steps", "answer_start": 109}], "is_impossible": false}, {"question": "If you don't have symptoms and you haven't been exposed to a virus, you may return to what?", "id": "100000000000000000001034", "answers": [{"text": "normal activities", "answer_start": 254}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000001035", "answers": [{"text": "the virus", "answer_start": 49}], "is_impossible": false}, {"question": "What should you continue to do to protect yourself and others?", "id": "100000000000000000001036", "answers": [{"text": "take steps", "answer_start": 285}], "is_impossible": false}, {"question": "Get tested again if symptoms appear?", "id": "100000000000000000001037", "answers": [{"text": "- - -", "answer_start": 403}], "is_impossible": false}], "context": "If you do not have symptoms, but were exposed to the virus that causes COVID-19, you should continue\nto take recommended steps after exposure. If you do not have symptoms and you have not been exposed to the virus that causes COVID-19, you\nmay return to normal activities. Continue to take steps to protect yourself and others, including monitoring for symptoms. Get\ntested again if symptoms appear. \uf209\n\u2022\n-\n-\n-\n\u2022\n\u2022\n-\nNeed additional help? Use the Viral Testing Tool to get personalized recommendations and resources."}]}, {"title": "5afa0d71ce8da77d3c98ff058d26a07b", "paragraphs": [{"qas": [{"question": "What are both contagious respiratory illnesses?", "id": "100000000000000000001038", "answers": [{"text": "Influenza (Flu) and COVID-19", "answer_start": 303}], "is_impossible": false}, {"question": "What is the name of the coronavirus that causes COVID-19 Influenza?", "id": "100000000000000000001040", "answers": [{"text": "SARS-CoV-2", "answer_start": 474}], "is_impossible": false}, {"question": "What is a contagious respiratory illness caused by SARS-CoV-2?", "id": "100000000000000000001041", "answers": [{"text": "COVID-19", "answer_start": 417}], "is_impossible": false}, {"question": "How can you tell the difference between influenza and flu?", "id": "100000000000000000001042", "answers": [{"text": "by symptoms alone", "answer_start": 597}], "is_impossible": false}], "context": "Science at CDC\nScientific evidence and studies behind specific COVID-19 guidance and recommendations\nMMWR: Minimizing the impact of COVID-19 on Individual persons, Communities, and Health Care Systems\f10/30/22, 9:37 AM COVID-19 Testing: What You Need to Know | CDC\n\uf277 Difference Between Flu and COVID-19\nInfluenza (Flu) and COVID-19 are both contagious respiratory illnesses, but they are caused by different\nviruses. COVID-19 is caused by infection with a coronavirus named SARS-CoV-2, and flu is caused by infection\nwith influenza viruses. You cannot tell the difference between flu and COVID-19 by symptoms alone because\nsome of the symptoms are the same."}]}, {"title": "27fff678ac42f3036da6678d8a10f7ac", "paragraphs": [{"qas": [{"question": "What tests can differentiate between flu and COVID-19 at the same time?", "id": "100000000000000000001044", "answers": [{"text": "PCR tests", "answer_start": 5}], "is_impossible": false}], "context": "Some PCR tests can differentiate between flu and COVID-19 at the\nsame time. If one of these tests is not available, many testing locations provide flu and COVID-19 tests\nseparately. Talk to a healthcare provider about getting tested for both flu and COVID-19 if you have\nsymptoms."}]}, {"title": "991932a93df1eb2ac51069607c2045e5", "paragraphs": [{"qas": [{"question": "How many pages does Don\u2019t Delay: Test Soon and Treat Early contain?", "id": "100000000000000000001046", "answers": [{"text": "1", "answer_start": 145}], "is_impossible": false}, {"question": "What is the name of the Swab Specimen used for COVID-19 Testing?", "id": "100000000000000000001048", "answers": [{"text": "Nasal Mid-Turbinate", "answer_start": 264}], "is_impossible": false}, {"question": "How many pages are in Using Your Self-Test (Customizable File)?", "id": "100000000000000000001049", "answers": [{"text": "1", "answer_start": 415}], "is_impossible": false}], "context": "Learn more\nResources\nProfessional Resources on Testing: Healthcare Workers | Health Departments | Labs\n\uf2ff\nDon\u2019t Delay: Test Soon and Treat Early [1 page, 361 KB]\nHow to Collect an Anterior Nasal Swab Specimen for COVID-19 Testing [2 pages, 372 KB]\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing [2 pages, 4 MB]\nUsing Your Self-Test [1 page, 295 KB]\nUsing Your Self-Test (Customizable File) [1 page, 279 KB]\nPrint Resources\n\uf1aa\n\u2022 \uf20c\n\u2022 \uf20c\n\u2022 \uf20c\n\u2022 \uf20c\n\u2022 \uf20c\n\u2022 \uf20c\nLast Updated Sept. 28, 2022"}]}, {"title": "71924d5575606b2d03fafb349be02b5d", "paragraphs": [{"qas": [{"question": "What is the name of the drug that can be used to treat COVID-19?", "id": "100000000000000000001052", "answers": [{"text": "chances of hospitalization and death", "answer_start": 421}], "is_impossible": false}, {"question": "If you test positive for COVID-19 and are more likely to get very sick, what are treatments available that can reduce your chances of hospitalization and death?", "id": "100000000000000000001054", "answers": [{"text": "treatments", "answer_start": 376}], "is_impossible": false}, {"question": "What must be started within days after you first develop symptoms to be effective?", "id": "100000000000000000001055", "answers": [{"text": "Treatment", "answer_start": 473}], "is_impossible": false}, {"question": "What can help reduce symptoms and help you manage your illness?", "id": "100000000000000000001056", "answers": [{"text": "Other medications", "answer_start": 561}], "is_impossible": false}], "context": "10/30/22, 9:42 AM COVID-19 Treatments and Medications | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Treatments and Medications\nThis page provides a treatment overview for the General Public. For healthcare providers: Interim Clinical Considerations for COVID-19 Treatment in Outpatients\nWhat You Need to Know\nIf you test positive for COVID-19 and are more likely to get very sick, treatments are available that can reduce your\nchances of hospitalization and death. Don\u2019t delay: Treatment must be started within days after you first develop symptoms to be effective. Other medications can help reduce symptoms and help you manage your illness."}]}, {"title": "a4f4d203ce28c6e4754994d6b851b8b1", "paragraphs": [{"qas": [{"question": "What website can help you find a location that offers testing and treatment?", "id": "100000000000000000001057", "answers": [{"text": "The Treatment Locator", "answer_start": 0}], "is_impossible": false}, {"question": "What must be prescribed by a healthcare provider and started as soon as possible after diagnosis to be effective?", "id": "100000000000000000001060", "answers": [{"text": "Medications to treat COVID-19", "answer_start": 334}], "is_impossible": false}], "context": "The Treatment Locator (hhs.gov) can help you find a location that offers testing and treatment or a pharmacy\nwhere you can fill your prescription. \u2022\n\u2022\n\u2022\n\u2022 \uf209\nIf you test positive and are more\nlikely to get very sick from COVID-\n19, treatments are available\nthat can reduce your chances of\nbeing hospitalized or dying from\nthe disease. Medications to treat\nCOVID-19 must be prescribed by a\nhealthcare provider and started as\nsoon as possible after diagnosis to\nbe effective. Contact a healthcare\nprovider right away to determine if\nyou are eligible for treatment, even\nif your symptoms are mild right\nnow."}]}, {"title": "b9d94d7d086d1261aa5ab10ad11e772e", "paragraphs": [{"qas": [{"question": "What are people who are more likely to get very sick?", "id": "100000000000000000001062", "answers": [{"text": "older adults", "answer_start": 157}], "is_impossible": false}, {"question": "How old are people that are not vaccinated?", "id": "100000000000000000001063", "answers": [{"text": "50 years or more", "answer_start": 176}], "is_impossible": false}, {"question": "What does being vaccinated make you less likely to get sick?", "id": "100000000000000000001065", "answers": [{"text": "certain medical conditions", "answer_start": 271}], "is_impossible": false}], "context": "Don\u2019t delay: Treatment must be\nstarted within days of when you\nfirst develop symptoms to be effective. \uf209\nPeople who are more likely to get very sick include older adults (ages 50 years or more, with risk increasing with age), people\nwho are unvaccinated, and people with certain medical conditions, such as chronic lung disease, heart disease, or a\nweakened immune system. Being vaccinated makes you much less likely to get very sick."}]}, {"title": "578bdb7a5dfe9b8fac854ddad2864d41", "paragraphs": [{"qas": [{"question": "What age group may benefit from treatment for COVID-19?", "id": "100000000000000000001066", "answers": [{"text": "65 years or older", "answer_start": 53}], "is_impossible": false}, {"question": "What type of treatment is right for you?", "id": "100000000000000000001068", "answers": [{"text": "COVID-19", "answer_start": 175}], "is_impossible": false}, {"question": "Who has authorized certain antiviral medications and monoclonal antibodies?", "id": "100000000000000000001070", "answers": [{"text": "The FDA", "answer_start": 494}], "is_impossible": false}, {"question": "What is used to treat mild to moderate COVID-19 in people who are more likely to get very sick?", "id": "100000000000000000001071", "answers": [{"text": "antiviral medications and monoclonal antibodies", "answer_start": 524}], "is_impossible": false}], "context": "Still, some vaccinated people,\nespecially those ages 65 years or older or who have other risk factors for severe disease, may benefit from treatment if they\f10/30/22, 9:42 AM COVID-19 Treatments and Medications | CDC\nget COVID-19. A healthcare provider will help decide which treatment, if any, is right for you. Check with your healthcare\nprovider or pharmacist if you are taking other medications to make sure the COVID-19 treatments can be safely taken at the\nsame time. Types of Treatments\nThe FDA has authorized certain\nantiviral medications and\nmonoclonal antibodies to treat\nmild to moderate COVID-19 in\npeople who are more likely to get\nvery sick."}]}, {"title": "62af6f8825a998f562c20a412e188b4d", "paragraphs": [{"qas": [{"question": "What do antiviral treatments target?", "id": "100000000000000000001072", "answers": [{"text": "specific parts of the virus", "answer_start": 28}], "is_impossible": false}, {"question": "What do monoclonal antibodies help the immune system recognize and respond more effectively to?", "id": "100000000000000000001073", "answers": [{"text": "the virus", "answer_start": 229}], "is_impossible": false}, {"question": "Who provides COVID-19 Treatment Guidelines for healthcare providers?", "id": "100000000000000000001074", "answers": [{"text": "The National Institutes of Health", "answer_start": 240}], "is_impossible": false}, {"question": "What do healthcare providers do to help them work with their patients?", "id": "100000000000000000001075", "answers": [{"text": "COVID-19 Treatment Guidelines", "answer_start": 289}], "is_impossible": false}, {"question": "How many options are available for treating COVID-19?", "id": "100000000000000000001076", "answers": [{"text": "Several", "answer_start": 433}], "is_impossible": false}], "context": "Antiviral treatments\ntarget specific parts of the\nvirus to stop it from\nmultiplying in the body,\nhelping to prevent severe\nillness and death. Monoclonal antibodies\nhelp the immune system\nrecognize and respond more\neffectively to the virus. The National Institutes of Health (NIH) provides COVID-19 Treatment Guidelines for healthcare providers to help them\nwork with their patients and determine the best treatment options for them. Several options are available for treating COVID-\n19."}]}, {"title": "b880cc5dbbef2e3972969041df285bb8", "paragraphs": [{"qas": [{"question": "What is Nirmatrelvir with Ritonavi?", "id": "100000000000000000001077", "answers": [{"text": "Paxlovid", "answer_start": 75}], "is_impossible": false}, {"question": "What must begin within 7 days of when symptoms start Single IV injection Molnupiravir (Lagevrio) Antiviral  Adults Start as soon as possible?", "id": "100000000000000000001080", "answers": [{"text": "Adults and children", "answer_start": 278}], "is_impossible": false}, {"question": "How long does it take for symptoms to start?", "id": "100000000000000000001081", "answers": [{"text": "7 days", "answer_start": 569}], "is_impossible": false}], "context": "They include:\n\u2022 \uf209\n\u2022 \uf209\n\uf209\nTreatment Who When How\nNirmatrelvir with Ritonavi\n(Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears and older\nStart as soon as possible;\nmust begin within 5 days\nof when symptoms start\nTaken at home by mouth\n(orally)\nRemdesivir (Veklury)\nAntiviral\n\uf209 Adults and children Start as soon as possible;\nmust begin within 7 days\nof when symptoms start\nIntravenous (IV) infusions\nat a healthcare facility for\n3 consecutive days\nBebtelovimab\nMonoclonal antibody\n\uf209 Adults; children ages 12\nyears and older\nStart as soon as possible;\nmust begin within 7 days\nof when symptoms start\nSingle IV injection\nMolnupiravir (Lagevrio)\nAntiviral\n\uf209 Adults Start as soon as possible;\nmust begin within 5 days\nof when symptoms start\nTaken at home by mouth\n(orally)\nSome treatments might have side effects or interact with other medications you are taking."}]}, {"title": "4ecb7a8b3bea03031e6a888d99a5f3e6", "paragraphs": [{"qas": [{"question": "What is the name of the drug that can be used to treat COVID-19?", "id": "100000000000000000001083", "answers": [{"text": "Test to Treat", "answer_start": 127}], "is_impossible": false}, {"question": "If you are hospitalized, what might your healthcare provider use?", "id": "100000000000000000001085", "answers": [{"text": "other types of treatments", "answer_start": 278}], "is_impossible": false}, {"question": "What might a provider use to treat COVID-19?", "id": "100000000000000000001086", "answers": [{"text": "medications", "answer_start": 29}], "is_impossible": false}, {"question": "How can people with a mild illness recover at home?", "id": "100000000000000000001088", "answers": [{"text": "at home", "answer_start": 608}], "is_impossible": false}], "context": "Ask a healthcare provider if\nmedications to treat COVID-19 are right for you. If you don\u2019t have a healthcare provider, visit a Test to Treat location or\ncontact your local community health center or health department. If you are hospitalized, your healthcare provider might use other types of treatments, depending on how sick you are. These\ncould include medications to treat the virus, reduce an overactive immune response, or treat COVID-19 complications. \uf209\f10/30/22, 9:42 AM COVID-19 Treatments and Medications | CDC\nManaging COVID-19 symptoms\nMost people with COVID-19 have\nmild illness and can recover at\nhome."}]}, {"title": "7eb758a025f7f5405058ca12fba684e7", "paragraphs": [{"qas": [{"question": "What is acetaminophen?", "id": "100000000000000000001089", "answers": [{"text": "Tylenol", "answer_start": 79}], "is_impossible": false}, {"question": "What is another name for Motrin?", "id": "100000000000000000001091", "answers": [{"text": "ibuprofen", "answer_start": 91}], "is_impossible": false}, {"question": "Who recommends that everyone who is eligible stay up-to-date on their vaccines?", "id": "100000000000000000001093", "answers": [{"text": "CDC", "answer_start": 448}], "is_impossible": false}], "context": "You can treat symptoms\nwith over-the-counter medicines,\nsuch as acetaminophen (Tylenol)\nor ibuprofen (Motrin, Advil), to help\nyou feel better. Learn more about what to do if\nyou are sick. COVID-19 vaccines available in the United States effectively protect people from getting seriously ill, being hospitalized, and\neven dying\u2014especially people who are boosted. As with vaccines for other diseases, you are protected best when you stay up\nto date. CDC recommends that everyone who is eligible stay up to date on their COVID-19 vaccines."}]}, {"title": "eb5a12f3a1f643d3abbe8340bada70e7", "paragraphs": [{"qas": [{"question": "What does EVUSHELD stand for?", "id": "100000000000000000001095", "answers": [{"text": "cilgavimab", "answer_start": 94}], "is_impossible": false}, {"question": "What is the name of the medicine that can help protect you from getting COVID-19?", "id": "100000000000000000001096", "answers": [{"text": "EVUSHELD", "answer_start": 106}], "is_impossible": false}, {"question": "What does EVUSHELD offer?", "id": "100000000000000000001098", "answers": [{"text": "two different antibodies", "answer_start": 197}], "is_impossible": false}, {"question": "What is the name of the vaccine that can be given to people who are immunocompromised or allergic?", "id": "100000000000000000001099", "answers": [{"text": "EVUSHELD", "answer_start": 511}], "is_impossible": false}], "context": "Preventive medications\nThe FDA has issued an emergency use authorization for tixagevimab plus cilgavimab (EVUSHELD ) , a medicine that can\nhelp protect you from getting COVID-19. EVUSHELD contains two different antibodies and is given as two separate\nconsecutive intramuscular (IM) injections at a doctor\u2019s office or healthcare facility before you are exposed or test positive for\nCOVID-19. If you are moderately or severely immunocompromised, or severely allergic to COVID-19 vaccines, you may be\neligible for EVUSHELD every 6 months. EVUSHELD may offer less protection against certain strains of the Omicron\nvariant. It is important that even if you receive EVUSHELD you take multiple prevention measures."}]}, {"title": "a3a845370e9747534f8cfe26083cfb7a", "paragraphs": [{"qas": [{"question": "What should you do if you develop symptoms of COVID-19?", "id": "100000000000000000001101", "answers": [{"text": "undergo testing and seek medical attention", "answer_start": 25}], "is_impossible": false}, {"question": "Who should you talk to to determine if EVUSHELD is right for you?", "id": "100000000000000000001102", "answers": [{"text": "your healthcare provider", "answer_start": 162}], "is_impossible": false}, {"question": "How do you find a COVID-19 vaccine location near you?", "id": "100000000000000000001103", "answers": [{"text": "Search vaccines.gov", "answer_start": 482}], "is_impossible": false}, {"question": "Who can you call to find testing and treatment locations or a pharmacy?", "id": "100000000000000000001105", "answers": [{"text": "1-800-232-0233", "answer_start": 281}], "is_impossible": false}], "context": "Additionally, you should\nundergo testing and seek medical attention if you develop symptoms of COVID-19, and start treatment for COVID-19 as\nappropriate. Talk to your healthcare provider to determine if EVUSHELD is right for you. \uf19c Treatment Locator\nClick the button below or call 1-800-232-0233 (TTY 1-888-720-7489) to find a location that offers testing and\ntreatment or a pharmacy where you can fill your prescription. View Locations\nTo find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. TM \uf209\nTM\nTM TM\nTM\nTM\nThe right medications for COVID-19 can help."}]}, {"title": "68d52f30590d5f92747cae7f724618ad", "paragraphs": [{"qas": [{"question": "Talk to a healthcare provider about taking medications to treat what?", "id": "100000000000000000001107", "answers": [{"text": "COVID-19", "answer_start": 238}], "is_impossible": false}, {"question": "What is Paxlovid for Health Care Providers?", "id": "100000000000000000001109", "answers": [{"text": "Oral Antivirals", "answer_start": 632}], "is_impossible": false}, {"question": "What does Paxlovid do for Health Care Providers?", "id": "100000000000000000001110", "answers": [{"text": "FDA Updates", "answer_start": 649}], "is_impossible": false}, {"question": "What are Monoclonal Antibodies?", "id": "100000000000000000001111", "answers": [{"text": "Anti-SARS-CoV-2 Monoclonal Antibodies", "answer_start": 809}], "is_impossible": false}], "context": "People have been seriously harmed and even died after taking products\nnot approved for use to treat or prevent COVID-19, even products approved or prescribed for other uses. Talk to a\nhealthcare provider about taking medications to treat COVID-19. For Healthcare Professionals\f10/30/22, 9:42 AM COVID-19 Treatments and Medications | CDC\n\uf2ff General Treatment Resources\nCOVID-19 Treatment Guidelines: What\u2019s New\nCoronavirus (COVID-19) Drugs\nTherapeutic Management of Nonhospitalized Adults With COVID-19\nCOVID-19 Therapeutics Locator\nOral Antiviral Treatment Resources\nPaxlovid Eligibility and Effectiveness Information Sheet\nWhat are Oral Antivirals? FDA Updates on Paxlovid for Health Care Providers\nPaxlovid Patient Eligibility Screening Checklist Tool for Prescribers\nMonoclonal Antibody Treatment Resources\nAnti-SARS-CoV-2 Monoclonal Antibodies\nWhat Are Monoclonal Antibodies?"}]}, {"title": "f4d93f7936114aac468bd5112988ea03", "paragraphs": [{"qas": [{"question": "What is the name of the drug that can be used to treat COVID-19?", "id": "100000000000000000001112", "answers": [{"text": "Monoclonal Antibody", "answer_start": 12}], "is_impossible": false}, {"question": "When was the last update for this drug?", "id": "100000000000000000001113", "answers": [{"text": "Oct. 19, 2022", "answer_start": 217}], "is_impossible": false}, {"question": "How many KB of information was last updated?", "id": "100000000000000000001114", "answers": [{"text": "361", "answer_start": 161}], "is_impossible": false}], "context": "Coverage of Monoclonal Antibody Treatment for COVID-19\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf20c \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf20c \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf20c\n\uf2b2 Other Resources\nDon\u2019t Delay: Test Soon and Treat Early [361 KB, 1 page] | Additional Languages\n\u2022 \uf20c\nLast Updated Oct. 19, 2022"}]}, {"title": "fdfac301cc6447614438074a8848ef22", "paragraphs": [{"qas": [{"question": "What's New Immunization Schedule for 6 Months of Age and Older Equity in Childhood?", "id": "100000000000000000001115", "answers": [{"text": "COVID-19 Vaccination", "answer_start": 381}], "is_impossible": false}, {"question": "What are some things to know about the COVID-19 Vaccine for Children?", "id": "100000000000000000001117", "answers": [{"text": "Resources to Promote COVID- 19 Vaccine for Children and Teens", "answer_start": 459}], "is_impossible": false}, {"question": "What is the name of the tool that helps you find answers to common vaccination questions?", "id": "100000000000000000001118", "answers": [{"text": "SmartFind", "answer_start": 736}], "is_impossible": false}], "context": "10/30/22, 9:20 AM COVID-19 Vaccination Clinical and Professional Resources | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations Home\nCOVID-19 Vaccination Clinical & Professional Resources\nClinical Resources for Each COVID-19 Vaccine\nProduct Information by U.S. Vaccine\nWhat's New\nImmunization Schedule for 6\nMonths of Age and Older\nEquity in Childhood COVID-19\nVaccination\n6 Things to Know About the\nCOVID-19 Vaccine for Children\nResources to Promote COVID-\n19 Vaccine for Children and\nTeens\n\uf20c\nInterim Clinical\nConsiderations\nProvider\nRequirements and\nSupport\nTalking with\nVaccine Recipients\nand Reporting\nSystems\n\uf32c Enroll as a COVID-19 Vaccine\nProvider\nLearn More and Enroll\n\uf12c COVID-19 VACCINE CHATBOT\nUse SmartFind chat tool to find answers to\ncommon COVID-19 vaccination questions."}]}, {"title": "dabb8248c3d5cfdb88a80bfa7298fbe9", "paragraphs": [{"qas": [{"question": "What are some of the information about COVID-19 vaccination for specific populations?", "id": "100000000000000000001120", "answers": [{"text": "guidance for healthcare professionals and information for patients", "answer_start": 445}], "is_impossible": false}], "context": "Vaccination Clinic Guidance\nOperational Guidance School-Located Vaccination\nClinics\nRetail Pharmacies\nLong-term Care Settings Private and Public Healthcare\nProvider Clinics\nMobile Vaccination\nHospitals, Emergency Curbside/Drive-Through\f10/30/22, 9:20 AM COVID-19 Vaccination Clinical and Professional Resources | CDC\nDepartments, and Urgent Clinics\nSpecific Populations\nInformation about COVID-19 vaccination for specific populations, including\nguidance for healthcare professionals and information for patients."}]}, {"title": "fd6e7d5d28762061adcdea16605292", "paragraphs": [{"qas": [{"question": "Who is Vaccinated Outside of the US?", "id": "100000000000000000001122", "answers": [{"text": "Patients", "answer_start": 256}], "is_impossible": false}, {"question": "What is CDC's program called?", "id": "100000000000000000001123", "answers": [{"text": "Partnering for Vaccine Equity", "answer_start": 490}], "is_impossible": false}, {"question": "How does Partnering for Vaccine Equity work?", "id": "100000000000000000001124", "answers": [{"text": "to increase vaccine confidence and access among racial and ethnic minority groups", "answer_start": 640}], "is_impossible": false}], "context": "Older Adults and People with\nDisabilities\nChildren and Adolescents\nHomebound Persons\nDialysis Patients\nHealthcare Personnel\nTeachers, School Staff, and Child Care\nWorkers\nPregnant or Breastfeeding Patients\nPeople with Certain Underlying\nMedical Conditions\nPatients Vaccinated Outside the US\nPatients Receiving Antiviral Therapy\nResources\nHealth\nDepartments\n\uf426\nYou and Your\nFamily\n\uf426\nCOVID-19 Vaccine Effectiveness and Safety\nMMWR COVID-19 Vaccine Reports\nEquity in Vaccination\nCDC\u2019s program, Partnering for Vaccine Equity, aims to\nreduce disparities in disproportionately affected\ncommunities by supporting a wide variety of partners\nworking to increase vaccine confidence and access\namong racial and ethnic minority groups. Equity in Vaccination\nGet Vaccinated\nFind COVID-19 vaccines and boosters near you. Message & data rates may apply."}]}, {"title": "aa268638a7b5982ca9b1a71487b78e97", "paragraphs": [{"qas": [{"question": "What does CDC do to your website?", "id": "100000000000000000001130", "answers": [{"text": "Put CDC syndicated pages on your website for free. Just add a small piece of web code to your page and the content will automatically update whenever CDC updates this page", "answer_start": 255}], "is_impossible": false}, {"question": "When was Content Syndication last reviewed?", "id": "100000000000000000001131", "answers": [{"text": "May 13, 2022", "answer_start": 463}], "is_impossible": false}, {"question": "What is a small piece of web code to your page?", "id": "100000000000000000001132", "answers": [{"text": "CDC syndicated pages", "answer_start": 259}], "is_impossible": false}], "context": "CDC Privacy Policy\n\uf374 Find a vaccine near you\n\uf33f Call 1-800-232-0233\n\uf2ba Text your zip code to 438829\nGet Email Updates\nTo receive email updates about this page, enter your\nemail address:\n\uf14a\nEmail Address\nWhat's this? Submit\n\uf1e5 Add CDC web content on your site\nPut CDC syndicated pages on your website for free. Just add a small piece of web code to your page and the\ncontent will automatically update whenever CDC updates this page. Content Syndication\nLast Reviewed: May 13, 2022"}]}, {"title": "88e67e4c6c0ad1bf0ab0c069541a90e6", "paragraphs": [{"qas": [{"question": "What is one of CDC's core activities?", "id": "100000000000000000001133", "answers": [{"text": "Sharing timely and accurate information with the public", "answer_start": 242}], "is_impossible": false}, {"question": "What provides the reliable data that can be reported by CDC?", "id": "100000000000000000001135", "answers": [{"text": "Timely and accurate reporting from jurisdictions", "answer_start": 331}], "is_impossible": false}], "context": "10/30/22, 9:35 AM COVID-19 Vaccination Data Systems and Data Sources\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccination Data Systems and Data Sources\nCDC reports COVID-19 vaccination data online on COVID Data Tracker and in vaccination datasets. Sharing timely and\naccurate information with the public is one of CDC\u2019s core activities. Timely and accurate reporting from jurisdictions provides\nthe reliable data that can be reported by CDC. All reported numbers may change over time as updated data are continuously\nreported to CDC."}]}, {"title": "4f97235cb4f7f12d2b2f6f405f48c906", "paragraphs": [{"qas": [{"question": "What do CDC and other federal agencies, vaccine providers, jurisdictions, state/local public health departments and tribal health facilities do?", "id": "100000000000000000001137", "answers": [{"text": "inform decision-making regarding COVID-19 vaccination", "answer_start": 430}], "is_impossible": false}, {"question": "What does the COVID-19 Vaccination IT Overview provide an overarching view of?", "id": "100000000000000000001139", "answers": [{"text": "vaccine IT data systems", "answer_start": 558}], "is_impossible": false}], "context": "Summary\nCDC uses multiple information technology systems\u202fto rapidly collect reliable data about how many doses of COVID-19\nvaccines have been distributed and how many people have been vaccinated with those doses (administration). CDC \u2014\ntogether with other federal agencies, vaccine providers, jurisdictions, state/local public health departments, and tribal health\nfacilities across the United States \u2014 uses these data systems to inform decision-making regarding COVID-19 vaccination. The\u202fCOVID-19 Vaccination IT Overview\u202fprovides an overarching view of the vaccine IT data systems and how they integrate to\ntrack COVID-19 vaccine distribution and administration."}]}, {"title": "351306fc709ce9643a6af254e36ed99", "paragraphs": [{"qas": [{"question": "What is VTrckS?", "id": "100000000000000000001140", "answers": [{"text": "Vaccine Tracking System", "answer_start": 34}], "is_impossible": false}, {"question": "Who reports their on-hand COVID-19 vaccine inventory each day?", "id": "100000000000000000001143", "answers": [{"text": "federal entity providers", "answer_start": 323}], "is_impossible": false}, {"question": "What is the name of the cloud-hosted data repository to receive, store, manage, and analyze deidentified COVID-19 vaccination data?", "id": "100000000000000000001144", "answers": [{"text": "Immunization Data Lake", "answer_start": 406}], "is_impossible": false}], "context": "Vaccine Distribution Data Systems\nVaccine Tracking System (VTrckS) is CDC\u2019s vaccine order management system where jurisdictions (states,\nterritories, tribes, and local entities), federal agencies, and pharmacy partners order vaccines from the federal\ngovernment. VTrckS Provider Order Portal (VPOP) is CDC\u2019s platform where federal entity providers report their on-hand\nCOVID-19 vaccine inventory each day. Immunization Data Lake (IZ Data Lake) is a cloud-hosted data repository to receive, store, manage, and analyze\ndeidentified COVID-19 vaccination data. \u2022\n\u2022 \uf209\n\u2022\nVaccine Administration Data Systems\nImmunization Information Systems (IISs)\u202fMost IISs create\u202fa centralized\u202fdata repository for storing\nvaccination\u202finformation specific to that jurisdiction."}]}, {"title": "1e1873068e5bf7c3fcd336fb8e8d7219", "paragraphs": [{"qas": [{"question": "What is the name of the web-based application that supports planning and execution for temporary, mobile, or satellite COVID-19 vaccination clinics?", "id": "100000000000000000001146", "answers": [{"text": "Vaccine Administration Management System", "answer_start": 0}], "is_impossible": false}, {"question": "What does VAMS connect with and send data to IISs through?", "id": "100000000000000000001147", "answers": [{"text": "COVID-19 Data Clearing House", "answer_start": 244}], "is_impossible": false}, {"question": "What is a cloud-hosted data repository that receives, deduplicates, and deidentifies COVID-19 vaccination data?", "id": "100000000000000000001148", "answers": [{"text": "COVID-19 Data Clearing House", "answer_start": 274}], "is_impossible": false}], "context": "Vaccine Administration Management System (VAMS) is a web-based application available to support planning and\nexecution for temporary, mobile, or satellite COVID-19 vaccination clinics. VAMS connects with IISs and sends data\nto IISs through the COVID-19 Data Clearing House. COVID-19 Data Clearing House is a cloud-hosted data repository that receives, deduplicates, and deidentifies\nCOVID-19 vaccination data, which are then used to populate the Immunization (IZ) Data Lake. Immunization Data Lake (IZ Data Lake)\u202fis a cloud-hosted data repository to receive, store, manage, and analyze\ndeidentified COVID-19 vaccination data."}]}, {"title": "280b81415d3a7d8feca9111d17710beb", "paragraphs": [{"qas": [{"question": "What is the acronym for CDC COVID Data Tracker?", "id": "100000000000000000001150", "answers": [{"text": "CDT", "answer_start": 158}], "is_impossible": false}, {"question": "What is the acronym for the Bureau of Prisons?", "id": "100000000000000000001152", "answers": [{"text": "BoP", "answer_start": 355}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\nCOVID-19 Vaccination Data Sources\f10/30/22, 9:35 AM COVID-19 Vaccination Data Systems and Data Sources\nFederal Agency Data\nOn CDC COVID Data Tracker (CDT), data are individually displayed at the national level and included as part of national\ntotals for each metric for the following agencies (except Department of State, DoS):\nBureau of Prisons (BoP)\nDepartment of Defense (DoD)\nIndian Health Services (IHS)\nVeterans Health Administration (VHA)\nFederal agency data\u202fare\u202falso included as part of jurisdiction, state, or territory aggregate metrics. To avoid duplicate\ncounts, the agency data\u202fshould not be combined with other data."}]}, {"title": "64455aaeee3b99af28151d25f2d66feb", "paragraphs": [{"qas": [{"question": "When is the denominator data available for a federal agency?", "id": "100000000000000000001155", "answers": [{"text": "When denominator data are available for a federal agency, metrics such as rate per 100,000 and percent of the population are calculated", "answer_start": 0}], "is_impossible": false}, {"question": "What are metrics such as rate per 100,000 and percent of the population calculated?", "id": "100000000000000000001156", "answers": [{"text": "denominator data", "answer_start": 5}], "is_impossible": false}], "context": "When denominator data are available for a federal agency, metrics such as rate per 100,000 and percent of the\npopulation are calculated."}]}, {"title": "951ee567eaee0b86954de4811a4548a4", "paragraphs": [{"qas": [{"question": "When the denominator data are not available for federal entities, what are the metrics displayed as?", "id": "100000000000000000001157", "answers": [{"text": "\u201cN/A\u201d", "answer_start": 97}], "is_impossible": false}, {"question": "What are the national and jurisdictional metrics reported on CDT?", "id": "100000000000000000001158", "answers": [{"text": "vaccination data distribution to and administered in the following locations", "answer_start": 225}], "is_impossible": false}, {"question": "What does LTC stand for?", "id": "100000000000000000001160", "answers": [{"text": "Pharmacy Partnership for Long-term Care", "answer_start": 439}], "is_impossible": false}, {"question": "What are the rates and percentage measures for vaccination among the entire population and among select demographic groups?", "id": "100000000000000000001161", "answers": [{"text": "Census CDC", "answer_start": 710}], "is_impossible": false}], "context": "When the denominator data are not available for federal entities, these metrics are displayed\nas \u201cN/A\u201d or entered as \u201c0.\u201d\nJurisdictions and Other Reporting Partners\nNational and jurisdictional metrics reported on CDT include vaccination data distribution to and administered in the following\nlocations:\nJurisdiction (state, territory, tribe, or local entity) partner clinics\nRetail pharmacies\nFederal partners and programs such as\nFederal Pharmacy Partnership for Long-term Care (LTC) Program\nDialysis centers participating in the Federal Dialysis Center Program\nFederal Emergency Management Agency (FEMA)\nHealth Resources and Services Administration (HRSA)\n\u2022\n-\n-\n-\n-\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n-\n-\nPopulation Data Sources\nCensus\nCDC calculates rate and percentage measures for vaccination among the entire population and among select demographic\ngroups (such as people ages 65 years or older)."}]}, {"title": "781a09b1c62743f3733b33a0fdc6583a", "paragraphs": [{"qas": [{"question": "Who uses 2020 U.S. Census International Data Base estimates for American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands and Republic of Guam?", "id": "100000000000000000001164", "answers": [{"text": "CDC", "answer_start": 186}], "is_impossible": false}, {"question": "What are the CDC/ATSDR & Surgo Ventures Social Vulnerability Index scores?", "id": "100000000000000000001165", "answers": [{"text": "0 to 1", "answer_start": 502}], "is_impossible": false}, {"question": "What is the CCVI score?", "id": "100000000000000000001166", "answers": [{"text": "COVID-19 Community Vulnerability Index (CCVI) scores, which also range from 0 to 1", "answer_start": 583}], "is_impossible": false}, {"question": "What are the scores for the COVID-19 Community Vulnerability Index?", "id": "100000000000000000001167", "answers": [{"text": "0 to 1", "answer_start": 659}], "is_impossible": false}, {"question": "What is the range of the CCVI scores?", "id": "100000000000000000001168", "answers": [{"text": "0 to 1", "answer_start": 659}], "is_impossible": false}], "context": "The data used for these calculations are from the\u202fCensus Bureau Annual Estimates of the Resident Population for the\nUnited States (50 states and Washington D.C.) and Puerto Rico, 2019 . CDC uses\u202f2020 U.S. Census International Data Base \u202festimates for American Samoa, Federated States of Micronesia,\nGuam, Republic of the Marshall Islands, Republic of Palau, Republic of the Marshall Islands, and U.S. Virgin Islands. CDC/ATSDR & Surgo Ventures\nSocial Vulnerability Index (SVI) scores, which range from 0 to 1, are from\u202fCDC/ATSDR\u2019s Geospatial Research, Analysis, and\nService Program. COVID-19 Community Vulnerability Index (CCVI) scores, which also range from 0 to 1, are from\u202fSurgo\nVentures."}]}, {"title": "7430c2f840eac5b99a27b5c14b8840d7", "paragraphs": [{"qas": [{"question": "What is not available for some of the records that are directly reported to CDC?", "id": "100000000000000000001170", "answers": [{"text": "Race/ethnicity", "answer_start": 139}], "is_impossible": false}, {"question": "What are not generalizable to the entire population of individuals with COVID-19 vaccination?", "id": "100000000000000000001171", "answers": [{"text": "race/ethnicity percentages", "answer_start": 289}], "is_impossible": false}, {"question": "What is the National Immunization Survey (NIS)?", "id": "100000000000000000001172", "answers": [{"text": "Adult COVID Module", "answer_start": 624}], "is_impossible": false}, {"question": "What is the Adult COVID Module?", "id": "100000000000000000001173", "answers": [{"text": "National Immunization Survey (NIS)", "answer_start": 589}], "is_impossible": false}, {"question": "What does NIS stand for?", "id": "100000000000000000001174", "answers": [{"text": "National Immunization Survey", "answer_start": 589}], "is_impossible": false}], "context": "COVID-19 Community Vulnerability Index (CCVI) scores, which also range from 0 to 1, are from Surgo Ventures . National Immunization Survey\nRace/ethnicity is not available for some of the records that are directly reported to CDC. Thus, data reported to CDC\nsignificantly underestimate the race/ethnicity percentages and are not generalizable to the entire population of individuals\nwith COVID-19 vaccination. CDC is providing information on self-reported COVID-19 vaccination status by race/ethnicity from\n\u2022\n\uf209\n\u2022 \uf209\n\uf209\f10/30/22, 9:35 AM COVID-19 Vaccination Data Systems and Data Sources\nthe National Immunization Survey (NIS) Adult COVID Module to supplement vaccine administration data reported directly to\nCDC by jurisdictions and federal entities."}]}, {"title": "93dfc31acd0386e5de68bf427b6b32b3", "paragraphs": [{"qas": [{"question": "What do Jurisdictions collect and report to CDC?", "id": "100000000000000000001175", "answers": [{"text": "demographic data", "answer_start": 53}], "is_impossible": false}, {"question": "Who has historically provided COVID-19 vaccination administration data?", "id": "100000000000000000001177", "answers": [{"text": "Texas", "answer_start": 315}], "is_impossible": false}, {"question": "What impacted CDC's ability to report metrics requiring information at the individual dose level?", "id": "100000000000000000001179", "answers": [{"text": "Jurisdictional Reporting Conditions Texas\u202fhas historically provided COVID-19 vaccination administration data to CDC in aggregate format", "answer_start": 279}], "is_impossible": false}], "context": "Reporting Conditions\nJurisdictions currently collect demographic data and report it to CDC. Not all states and territories report to CDC demographic\ndata on vaccine recipients; the laws in each state or territory dictate whether the state can collect or report demographic\ndata. Jurisdictional Reporting Conditions\nTexas\u202fhas historically provided COVID-19 vaccination administration data to CDC in aggregate format, which impacted CDC\u2019s\nability to report metrics requiring information at the individual dose level."}]}, {"title": "25e94f4c53144a8e6d9139368f391c1f", "paragraphs": [{"qas": [{"question": "How did CDC estimate the number of people with at least one disease in Texas before updating the data?", "id": "100000000000000000001182", "answers": [{"text": "vaccinated", "answer_start": 383}], "is_impossible": false}, {"question": "How many people in Texas have at least one dose of vaccination?", "id": "100000000000000000001183", "answers": [{"text": "vaccinated", "answer_start": 383}], "is_impossible": false}, {"question": "How old are the population of people ages 18 and older?", "id": "100000000000000000001185", "answers": [{"text": "18 years", "answer_start": 439}], "is_impossible": false}, {"question": "What is Texas included in the national level metrics on the Vaccinations in the United States site?", "id": "100000000000000000001187", "answers": [{"text": "answer undefined", "answer_start": 499}], "is_impossible": false}], "context": "Although Texas still reports vaccination data in\naggregate form, Texas and CDC recently collaborated to update the format of this record submission to improve COVID-19\nreporting of Texas\u2019 data on CDC\u2019s COVID Data Tracker at the national, state, and county levels. Previously, for Texas, CDC estimated the number of people with at least one dose and the number of people who are fully\nvaccinated for the populations ages 12 years or older, 18 years or older, and 65 years or older in the metrics for Texas alone\nand when including Texas in the national level metrics on the\u202fVaccinations in the United States\u202fsite."}]}, {"title": "cf7b69afd82d43a83e1d68526e56ff3f", "paragraphs": [{"qas": [{"question": "What was omitted from several demographic and county-level graphics pages?", "id": "100000000000000000001188", "answers": [{"text": "Texas", "answer_start": 14}], "is_impossible": false}, {"question": "Prior to October 22, 2021, all records reported by Texas were assumed to be for residents of what state?", "id": "100000000000000000001189", "answers": [{"text": "Texas", "answer_start": 192}], "is_impossible": false}, {"question": "What is the age-based metrics for Texas instead of estimated for?", "id": "100000000000000000001190", "answers": [{"text": "the populations ages 12 years or older, 18 years or older, and 65 years or older", "answer_start": 305}], "is_impossible": false}, {"question": "What state has the national counts for booster dose data?", "id": "100000000000000000001192", "answers": [{"text": "Texas", "answer_start": 559}], "is_impossible": false}, {"question": "When do county-level graphics begin?", "id": "100000000000000000001193", "answers": [{"text": "October 22, 2021", "answer_start": 576}], "is_impossible": false}, {"question": "What is the name of the United States site?", "id": "100000000000000000001194", "answers": [{"text": "Vaccinations in the United States site", "answer_start": 393}], "is_impossible": false}, {"question": "When will county-level graphics on Vaccinations by County, Vaccination Equity and Other Outcomes include Texas?", "id": "100000000000000000001195", "answers": [{"text": "October 22, 2021", "answer_start": 576}], "is_impossible": false}], "context": "Additionally, Texas was\nomitted from several demographic and county-level graphics pages. Further, prior to October 22, 2021, all records reported\nby Texas were assumed to be for residents of Texas. Beginning September 28, 2021, age-based metrics for Texas are directly reported rather than estimated for the\npopulations ages 12 years or older, 18 years or older, and 65 years or older on the\u202fVaccinations in the United States site. Beginning September 28, 2021, the national counts for booster dose data on the\u202fVaccinations in the United States site\ninclude Texas. Beginning October 22, 2021, county-level graphics on\u202fVaccinations by County,\u202fVaccination Equity, and Vaccinations and\nOther Outcomes include Texas."}]}, {"title": "1854bcac3fd8f793020b1ddbc60bee2e", "paragraphs": [{"qas": [{"question": "What is now attributed to Texas residents who received a COVID-19 vaccination?", "id": "100000000000000000001197", "answers": [{"text": "population-based metrics", "answer_start": 249}], "is_impossible": false}, {"question": "When will the Vaccination Demographics and Demographic Trends sites include vaccination demographic information?", "id": "100000000000000000001198", "answers": [{"text": "November 18", "answer_start": 285}], "is_impossible": false}, {"question": "On what date did the Vaccination Demographics and Demographic Trends sites include vaccination demographic information from Texas?", "id": "100000000000000000001199", "answers": [{"text": "November 18", "answer_start": 285}], "is_impossible": false}], "context": "Beginning October 22, 2021, CDC is able to attribute non-residents of Texas to their respective state or territory of\nresidence. Texas residents who received a COVID-19 vaccination in a different state or territory are also now attributed\nto Texas\u2019 population-based metrics. Beginning November 18, the\u202fVaccination Demographics and\u202fDemographic Trends\u202fsites include vaccination demographic\ninformation from Texas. New Hampshire\u202flifted its national COVID-19 emergency response declaration in May 2021, which allows vaccine recipients to\nopt out of having their COVID-19 vaccinations included in the state\u2019s IIS. As such, data submitted by New Hampshire since May\n2021 may not be representative of all COVID-19 vaccinations occurring in the state."}]}, {"title": "20c1c6ec014cf220c9f4ee55dc797252", "paragraphs": [{"qas": [{"question": "What state does not provide county-of-residence information when reporting COVID-19 vaccination data to CDC?", "id": "100000000000000000001202", "answers": [{"text": "Hawaii", "answer_start": 188}], "is_impossible": false}, {"question": "What is the population of Barnstable, Dukes, and Nantucket counties?", "id": "100000000000000000001203", "answers": [{"text": "small populations", "answer_start": 413}], "is_impossible": false}, {"question": "What are Barnstable, Dukes, and Nantucket counties vaccinated against?", "id": "100000000000000000001204", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022", "answer_start": 433}], "is_impossible": false}], "context": "County-level Reporting\nCalifornia\u202fdoes not report the county of residence for persons receiving a COVID-19 vaccine when the resident\u2019s county\nhas a population of fewer than 20,000 people. Hawaii\u202fdoes not provide county-of-residence information when reporting COVID-19 vaccination data to CDC. Massachusetts\u202fdoes not provide COVID-19 vaccination data for Barnstable, Dukes, and Nantucket counties because of\ntheir small populations. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nLast Updated Apr. 8, 2022"}]}, {"title": "566cb4f384f59f3027af4c4d4e136afc", "paragraphs": [{"qas": [{"question": "What does CDC report online on COVID Data Tracker and in vaccination datasets?", "id": "100000000000000000001206", "answers": [{"text": "COVID-19 vaccination data", "answer_start": 190}], "is_impossible": false}, {"question": "Reporting from which jurisdiction drives the information reported by CDC?", "id": "100000000000000000001208", "answers": [{"text": "jurisdictions", "answer_start": 309}], "is_impossible": false}, {"question": "All reported numbers may change over time as updated data are continuously reported to what organization?", "id": "100000000000000000001209", "answers": [{"text": "CDC", "answer_start": 450}], "is_impossible": false}], "context": "10/30/22, 9:34 AM COVID-19 Vaccination Data in the United States | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccination Data in the United States\nVaccinations in the United States\nCDC reports COVID-19 vaccination data online on COVID Data Tracker and in\nvaccination datasets. Timely and accurate reporting from jurisdictions drives\nthe information reported by CDC. All reported numbers may change over time\nas updated data are continuously reported to CDC."}]}, {"title": "ebc907bb449650a447717e2c44158b4b", "paragraphs": [{"qas": [{"question": "What year did CDC begin a phased rollout of updates to COVID Data Tracker vaccination sites?", "id": "100000000000000000001210", "answers": [{"text": "2022", "answer_start": 297}], "is_impossible": false}, {"question": "What do Data Tracker vaccination sites reflect?", "id": "100000000000000000001211", "answers": [{"text": "the current\u202frecommendations\u202ffor updated (bivalent) booster doses", "answer_start": 392}], "is_impossible": false}, {"question": "What does ACIP stand for?", "id": "100000000000000000001212", "answers": [{"text": "Advisory Committee on Immunization Practices", "answer_start": 511}], "is_impossible": false}, {"question": "When did CDC release new bivalent booster uptake and intent data?", "id": "100000000000000000001213", "answers": [{"text": "October 28, 2022", "answer_start": 663}], "is_impossible": false}], "context": "U.S. Vaccination Data Definitions\n\uf263 About Vaccine Data\nData Systems & Data Sources\nU.S. Vaccination Data Definitions\nVaccination Data FAQs\nArchived Updates\n\uf294 Latest Numbers\nVaccinations in the United States\nVaccinations by County\nVaccination Trends\nVaccination Trends by Demographics\nIn September 2022, CDC began a phased rollout of updates to COVID Data Tracker vaccination sites to reflect the\ncurrent\u202frecommendations\u202ffor updated (bivalent) booster doses while tracking evolving guidance from FDA and the CDC\nAdvisory Committee on Immunization Practices (ACIP). As part of this phased rollout, CDC released new bivalent booster\nuptake and intent\u202fsurvey data on October 28, 2022."}]}, {"title": "8bae3524acbbc9781cc36dc77111beed", "paragraphs": [{"qas": [{"question": "What does COVID Data Tracker add to all vaccination sites?", "id": "100000000000000000001215", "answers": [{"text": "bivalent booster data", "answer_start": 273}], "is_impossible": false}, {"question": "What will be added to all vaccination sites?", "id": "100000000000000000001216", "answers": [{"text": "bivalent booster data", "answer_start": 273}], "is_impossible": false}, {"question": "Where will the snapshot of the data go?", "id": "100000000000000000001218", "answers": [{"text": "retired", "answer_start": 485}], "is_impossible": false}], "context": "In the snapshot below, CDC provides administration data on the\npercentage and number of people with an updated (bivalent) booster dose by age, sex, and racial and ethnic groups in the\nUnited States. Following these releases, over several weeks, COVID Data Tracker will add bivalent booster data to all vaccination sites,\nincluding the addition of demographic data trends (planned for release in early November 2022). Once these data go live on\nCOVID Data Tracker, the snapshot will be retired."}]}, {"title": "cfee1cb4e63332be99688336a79654ac", "paragraphs": [{"qas": [{"question": "How many MB of data does the CDC have about the number of people receiving the updated boosters?", "id": "100000000000000000001220", "answers": [{"text": "1", "answer_start": 115}], "is_impossible": false}, {"question": "What percentage of people with a known Race/Ethnicity Percent and number of people receiving COVID-19 updated (bivalent) boosters by sex?", "id": "100000000000000000001221", "answers": [{"text": "87%", "answer_start": 555}], "is_impossible": false}, {"question": "What percentage of people with known Sex receive COVID-19 updated (bivalent) boosters?", "id": "100000000000000000001222", "answers": [{"text": "99%", "answer_start": 690}], "is_impossible": false}, {"question": "What is a CVX code for Pfizer ages 5+ on or after October 12, 2022?", "id": "100000000000000000001224", "answers": [{"text": "301", "answer_start": 966}], "is_impossible": false}], "context": "Graphic: COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1 MB, JPG\nView Image\f10/30/22, 9:34 AM COVID-19 Vaccination Data in the United States | CDC\nCOVID-19 Updated (Bivalent) Booster Administrations in the United States \u2013\nPercent and number of people receiving COVID-19 updated (bivalent) boosters by age\nPercent and number of people receiving COVID-19 updated (bivalent) boosters by race/ethnicity*\nAI/AN: American Indian/Alaska Native\nNHOPI: Native Hawaiian and Other Pacific Islanders\n*Among 87% of people with a known Race/Ethnicity\nPercent and number of people receiving COVID-19 updated (bivalent) boosters by sex**\n**Among 99% of people with known Sex\nImportant considerations\nUpdated (bivalent) booster counts include the number of people administered a vaccine dose with a Covid-19 vaccine\ncode (CVX code) 229 (Moderna ages 6+) or 300 (Pfizer ages 12+) on or after September 1, 2022 or a CVX code 301 (Pfizer\nages 5+) on or after October 12, 2022."}]}, {"title": "e0b0da61d319edf85bedaae8f258e4c", "paragraphs": [{"qas": [{"question": "How many children received the updated Moderna booster dose between September 1 and October 11, 2022?", "id": "100000000000000000001225", "answers": [{"text": "900", "answer_start": 29}], "is_impossible": false}, {"question": "What represent the total U.S. populations within each demographic group regardless of prior vaccination status?", "id": "100000000000000000001226", "answers": [{"text": "Denominators for percentage calculations", "answer_start": 149}], "is_impossible": false}, {"question": "Why do Texas and Idaho not include Pfizer booster doses?", "id": "100000000000000000001227", "answers": [{"text": "reporting limitations", "answer_start": 415}], "is_impossible": false}, {"question": "What are the data presented as?", "id": "100000000000000000001228", "answers": [{"text": "underestimates", "answer_start": 473}], "is_impossible": false}], "context": "Totals include approximately 900 children ages 6-17 years who received the\nupdated Moderna booster dose between September 1, and October 11, 2022. \u200b\nDenominators for percentage calculations represent the total U.S. populations within each demographic group\nregardless of prior vaccination status.\u200b\nData reported by Texas (all ages) and Idaho (ages <18 years) currently do not include Pfizer booster doses because of\nreporting limitations; therefore, the data presented are underestimates, especially among specific groups (e.g., the\nHispanic/Latino persons), and comparisons across groups should be interpreted with caution."}]}, {"title": "7a2905706ade3e1e10c1767b54fa2637", "paragraphs": [{"qas": [{"question": "What are the 2019 and 2020 U.S. Census Estimates used for?", "id": "100000000000000000001229", "answers": [{"text": "population counts", "answer_start": 142}], "is_impossible": false}, {"question": "What is the name of the CDC's Vaccination Data for Health Departments?", "id": "100000000000000000001232", "answers": [{"text": "COVID-19", "answer_start": 568}], "is_impossible": false}, {"question": "When was the last update for the information on vaccination in the United States?", "id": "100000000000000000001233", "answers": [{"text": "Oct. 28, 2022", "answer_start": 678}], "is_impossible": false}, {"question": "What are the names of the non- Hispanic NHOPI?", "id": "100000000000000000001234", "answers": [{"text": "Non- Hispanic White", "answer_start": 359}], "is_impossible": false}], "context": "\u200b\nSources: 2019 U.S. Census Estimates (states, D.C., Puerto Rico) and 2020 U.S. Census Estimates (territories excluding Puerto\nRico) used for population counts (ages 5 years and older), CDC Immunizations Data Lake. Data as of 6 AM ET Wednesday\nAI/AN, Non-\nHispanic\nAsian, Non-\nHispanic\nBlack, Non-\nHispanic\nHispanic /\nLatino\nMultiracial,\nNon-\nHispanic\nNHOPI,\nNon-\nHispanic\nWhite, Non-\nHispanic\nMale Female\n\u2022\n\u2022\n\u2022\n\uf2ff For Healthcare and Public Health\nCOVIDVaxView: Data about Vaccination Uptake and Confidence\nCOVID 19 Information for Health Departments\f10/30/22, 9:34 AM COVID-19 Vaccination Data in the United States | CDC\nCOVID-19 Information for Health Departments\nLast Updated Oct. 28, 2022"}]}, {"title": "79a8baeaa910357ddfd6a0d01207920b", "paragraphs": [{"qas": [{"question": "What is the acronym for the Federal Retail Pharmacy Partnership Program for COVID-19 Vaccination?", "id": "100000000000000000001235", "answers": [{"text": "FRPP", "answer_start": 419}], "is_impossible": false}, {"question": "What are the 21 National Pharmacy Partners and Independent Pharmacy Networks Nationwide?", "id": "100000000000000000001236", "answers": [{"text": "The Federal Retail Pharmacy Program", "answer_start": 170}], "is_impossible": false}, {"question": "What is the acronym for the Federal Retail Pharmacy Program for COVID-19 Vaccination?", "id": "100000000000000000001237", "answers": [{"text": "FRPP", "answer_start": 419}], "is_impossible": false}, {"question": "How many miles away from a pharmacy do most Americans live?", "id": "100000000000000000001238", "answers": [{"text": "five", "answer_start": 647}], "is_impossible": false}, {"question": "What does FRPP stand for?", "id": "100000000000000000001239", "answers": [{"text": "Federal Retail Pharmacy Program", "answer_start": 386}], "is_impossible": false}, {"question": "How many miles from a pharmacy did the federal government make pharmacies a key part of its COVID-19 vaccination strategy?", "id": "100000000000000000001240", "answers": [{"text": "five", "answer_start": 647}], "is_impossible": false}], "context": "10/30/22, 9:22 AM COVID-19 Vaccination Federal Retail Pharmacy Partnership Program | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations Home\nThe Federal Retail Pharmacy Program for COVID-19\nVaccination\nA Collaboration Between the Federal Government, States and Territories, and 21 National Pharmacy\nPartners and Independent Pharmacy Networks Nationwide\nThe Federal Retail Pharmacy Program (FRPP) for COVID-19 Vaccination is one part of the federal government\u2019s strategy to\nensure access to COVID-19 vaccines for the American public. Pharmacies are readily accessible in communities \u2013 with most\nAmericans living within five miles of a pharmacy. Recognizing this, the federal government made pharmacies a key part of its\nCOVID-19 vaccination strategy."}]}, {"title": "9884f7279643a62acd47e3dd2e972be1", "paragraphs": [{"qas": [{"question": "What will increase the number of places where people can get vaccinated?", "id": "100000000000000000001242", "answers": [{"text": "COVID-19", "answer_start": 131}], "is_impossible": false}, {"question": "How is the FRPP designed to help?", "id": "100000000000000000001243", "answers": [{"text": "rapidly and conveniently vaccinate the American public", "answer_start": 309}], "is_impossible": false}, {"question": "What do pharmacy partners do to help quickly and conveniently vaccinate the American public?", "id": "100000000000000000001244", "answers": [{"text": "The FRPP", "answer_start": 225}], "is_impossible": false}, {"question": "Through the program, certain retail pharmacies nationwide receive COVID-19 vaccine supply from which government?", "id": "100000000000000000001245", "answers": [{"text": "federal", "answer_start": 487}], "is_impossible": false}], "context": "Additionally, COVID-19 vaccine is free of charge for everyone. Increasing the number of places where people can get\nvaccinated for COVID-19 will help ensure more people are protected, ultimately helping us end this pandemic. The FRPP is designed to use the strength and expertise of pharmacy partners to help rapidly and conveniently vaccinate the\nAmerican public. Through the program, certain participating retail pharmacies nationwide receive COVID-19 vaccine supply\ndirectly from the federal government, and then provide vaccinations to eligible individuals at no cost."}]}, {"title": "179e89a37cdaeb9ebaf1616fb37a62bd", "paragraphs": [{"qas": [{"question": "What is critical to educating people about the importance of vaccination and where are vaccines available?", "id": "100000000000000000001247", "answers": [{"text": "Community outreach", "answer_start": 189}], "is_impossible": false}], "context": "The program relies on collaborations between public health agencies (CDC, state, local, and territorial health departments) to\nencourage individuals to go to pharmacies and get vaccinated. Community outreach remains critical to educating people about the importance of vaccination and where vaccines are\navailable nearby. For more information, see 12 COVID-19 Vaccination Strategies for Your Community. Federal Retail Pharmacy Program Highlights\nAs of October 18, 2022, more than 276.4 million doses of COVID-19 vaccine have been administered and reported by\nFederal Retail Pharmacy Program participants in the US."}]}, {"title": "2da61c0e1cce68543a750a5ce558e41d", "paragraphs": [{"qas": [{"question": "How many retail pharmacy partners are participating in the program with more than 41,000 locations nationwide?", "id": "100000000000000000001250", "answers": [{"text": "21", "answer_start": 146}], "is_impossible": false}, {"question": "What is the Federal Retail Pharmacy Partnership Program?", "id": "100000000000000000001252", "answers": [{"text": "CDC", "answer_start": 424}], "is_impossible": false}], "context": "This includes 8 million doses administered onsite to long-\nterm care facilities in the early days of the COVID-19 vaccination program. A total of 21 retail pharmacy partners are participating in the program, with more than 41,000 locations nationwide. This includes long-term care pharmacies. How the Federal Retail Pharmacy Program Works\f10/30/22, 9:22 AM COVID-19 Vaccination Federal Retail Pharmacy Partnership Program | CDC\nParticipating Retail Pharmacies\n\uf42d\nConnecting with Federal Pharmacy Partners\n\uf18c\nCOVID-19 Vaccine Eligibility and Availability\nEveryone 6 months of age and older is eligible to get a COVID-19 vaccination."}]}, {"title": "ba49e4e8d8df31bbfc3e30aa39629b39", "paragraphs": [{"qas": [{"question": "What is the CDC's Use of COVID-19 Vaccines in the U.S.?", "id": "100000000000000000001254", "answers": [{"text": "CDC Summary Document for Interim Clinical Considerations", "answer_start": 88}], "is_impossible": false}, {"question": "Where can you find vaccination locations?", "id": "100000000000000000001256", "answers": [{"text": "Vaccines.gov", "answer_start": 217}], "is_impossible": false}, {"question": "How do you find locations that administer vaccinations?", "id": "100000000000000000001257", "answers": [{"text": "you can visit Vaccines.gov; text your zip code to 438829 (GETVAX); call 1-800-232-0233; or check your state health department website", "answer_start": 203}], "is_impossible": false}, {"question": "Where can you get vaccinated?", "id": "100000000000000000001259", "answers": [{"text": "at their local pharmacy", "answer_start": 437}], "is_impossible": false}, {"question": "What do most pharmacies now offer?", "id": "100000000000000000001260", "answers": [{"text": "walk-in vaccination appointments", "answer_start": 584}], "is_impossible": false}], "context": "Detailed information can be found in CDC\u2019s\nUse of COVID-19 Vaccines in the U.S. and the CDC Summary Document for Interim Clinical Considerations. To find locations that administer COVID-19 vaccinations, you can visit Vaccines.gov; text your zip code to 438829\n(GETVAX); call 1-800-232-0233; or check your state health department website. Visit How Do I Find a COVID-19 Vaccine to\nlearn more. Individuals interested in getting vaccinated at their local pharmacy should check the pharmacy\u2019s website to find out if\nCOVID-19 vaccine is available. Most pharmacy locations are now offering walk-in vaccination appointments as supply\nallows."}]}, {"title": "deb190e647f9737a4a3ecc81a2cf9065", "paragraphs": [{"qas": [{"question": "Who is eligible for a COVID-19 vaccine booster shot?", "id": "100000000000000000001261", "answers": [{"text": "Children and Teens", "answer_start": 153}], "is_impossible": false}, {"question": "What is the name of the vaccine that is free to the public?", "id": "100000000000000000001262", "answers": [{"text": "COVID-19 Vaccines for Children and Teens COVID-19", "answer_start": 131}], "is_impossible": false}, {"question": "When was the Federal Retail Pharmacy Program last reviewed?", "id": "100000000000000000001263", "answers": [{"text": "October 18, 2022", "answer_start": 363}], "is_impossible": false}], "context": "\u203a Learn more about who is eligible for a COVID-19 vaccine booster shot: COVID-19 Vaccine Booster Eligibility. Additional Resources\nCOVID-19 Vaccines for Children and Teens\nCOVID-19 Vaccines Are Free to the Public\nCDC COVID Data Tracker\nConnecting Long-Term Care Settings with Federal\nPharmacy Partners\nHow the Federal Retail Pharmacy Program Works\nLast Reviewed: October 18, 2022"}]}, {"title": "1e1030957deef426a3b34953be0ac56", "paragraphs": [{"qas": [{"question": "What is the name of the page that answers frequently asked questions about the Interim Clinical Considerations for COVID-19 Vaccination?", "id": "100000000000000000001264", "answers": [{"text": "Vaccines & Immunizations Home FAQs", "answer_start": 133}], "is_impossible": false}, {"question": "What is CDC Espaol?", "id": "100000000000000000001265", "answers": [{"text": "CDC Espa\u00f1ol", "answer_start": 78}], "is_impossible": false}, {"question": "What is recommended for primary series vaccinations?", "id": "100000000000000000001266", "answers": [{"text": "Moderna, Pfizer-BioNTech, and Novavax COVID-19 vaccines", "answer_start": 546}], "is_impossible": false}], "context": "10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations Home\nFAQs for the Interim Clinical Considerations for COVID-\nThis page has answers to commonly asked questions about the Interim Clinical Considerations for COVID-19 Vaccination. For information about COVID-19 vaccine storage, preparation, and administration, visit the COVID-19 Vaccine FAQs for\nHealthcare Professionals. Vaccination Schedule and Use\nYes. For primary series vaccination, Moderna, Pfizer-BioNTech, and Novavax COVID-19 vaccines are recommended. For\nbooster vaccination, Moderna and Pfizer-BioNTech are recommended."}]}, {"title": "6a0c3d3897e37d8fd238546fd14bed90", "paragraphs": [{"qas": [{"question": "What is a preferred COVID-19 vaccine?", "id": "100000000000000000001269", "answers": [{"text": "No", "answer_start": 255}], "is_impossible": false}, {"question": "What happens if the second dose is administered after this interval?", "id": "100000000000000000001272", "answers": [{"text": "there is no need to restart the series", "answer_start": 433}], "is_impossible": false}], "context": "Novavax COVID-19 vaccine for booster vaccination and Janssen COVID-19 Vaccine for primary series and booster\nvaccination should only be used in very limited situations. For more information, see COVID-19 vaccines. Is there a preferred COVID-19 vaccine? \uf1aa\nNo. You should administer the second dose as close as possible to the recommended interval after the first dose. However, if the second dose is administered after this interval, there is no need to restart the series."}]}, {"title": "47aa4f9b358692806600a16f82759016", "paragraphs": [{"qas": [{"question": "What is an optimal interval for some people?", "id": "100000000000000000001273", "answers": [{"text": "8-week", "answer_start": 3}], "is_impossible": false}, {"question": "What is the risk of myocarditis associated with Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines?", "id": "100000000000000000001274", "answers": [{"text": "small", "answer_start": 100}], "is_impossible": false}, {"question": "What is the maximum interval between doses 1 and 2 of a COVID-19 primary vaccination series?", "id": "100000000000000000001276", "answers": [{"text": "8-week", "answer_start": 3}], "is_impossible": false}], "context": "An 8-week interval may be optimal for some people, especially males ages 12\u201339 years because of the small risk of\nmyocarditis and pericarditis associated with Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines. Vaccine\neffectiveness may also be increased with an interval longer than 3 or 4 weeks. For additional information on the vaccination schedule, see:\nPeople who are not moderately or severely immunocompromised\nPeople who are moderately or severely immunocompromised\nConsiderations for extended intervals for COVID-19 vaccine primary series\nIs there a maximum interval between doses 1 and 2 of a COVID-19 primary vaccination series? \uf1aa\nYes."}]}, {"title": "a0bf91a1f3d3ded02b840e0f7a9c41d6", "paragraphs": [{"qas": [{"question": "Doses administered up to 4 days before the minimum interval are considered valid?", "id": "100000000000000000001277", "answers": [{"text": "valid", "answer_start": 108}], "is_impossible": false}, {"question": "Do not use the grace period to schedule doses?", "id": "100000000000000000001279", "answers": [{"text": "valid", "answer_start": 108}], "is_impossible": false}, {"question": "What does the grace period apply to?", "id": "100000000000000000001280", "answers": [{"text": "primary series and booster doses of vaccine. Do not use the grace period to schedule doses. Does the 4-day grace period apply to COVID-19 vaccine", "answer_start": 132}], "is_impossible": false}, {"question": "What is a vaccine administration error?", "id": "100000000000000000001281", "answers": [{"text": "If a dose is administered earlier than the grace period", "answer_start": 363}], "is_impossible": false}, {"question": "Who is required to report COVID-19 vaccine administration errors?", "id": "100000000000000000001282", "answers": [{"text": "Vaccine Adverse Event Reporting System (VAERS)", "answer_start": 593}], "is_impossible": false}, {"question": "What is the acronym for the Vaccine Adverse Event Reporting System?", "id": "100000000000000000001283", "answers": [{"text": "VAERS", "answer_start": 633}], "is_impossible": false}], "context": "Doses administered up to 4 days before the minimum interval, known as the 4-day grace period, are considered\nvalid. This applies to primary series and booster doses of vaccine. Do not use the grace period to schedule doses. Does the 4-day grace period apply to COVID-19 vaccine? \uf1aa\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nIf a dose is administered earlier than the grace period, see Appendix D for guidance on corrective actions. It is considered\na vaccine administration error; you are required to report COVID-19 vaccine administration errors to the Vaccine Adverse\nEvent Reporting System (VAERS) ."}]}, {"title": "fa0b95297584c107fbc7b4263b6689d", "paragraphs": [{"qas": [{"question": "Doses administered at any time after the recommended interval are valid?", "id": "100000000000000000001284", "answers": [{"text": "COVID-19 vaccines", "answer_start": 160}], "is_impossible": false}, {"question": "In accordance with general best practices for immunizations, routine administration of all age-appropriate doses of vaccines simultaneously is recommended for whom?", "id": "100000000000000000001286", "answers": [{"text": "children, adolescents, and adults", "answer_start": 340}], "is_impossible": false}, {"question": "What type of vaccines are recommended for children, adolescents, and adults?", "id": "100000000000000000001287", "answers": [{"text": "all age-appropriate doses of vaccines", "answer_start": 268}], "is_impossible": false}, {"question": "What is another name for monkeypox?", "id": "100000000000000000001288", "answers": [{"text": "orthopoxvirus", "answer_start": 663}], "is_impossible": false}], "context": "Doses administered at any time after the recommended interval are valid. For more information, see timing, spacing, interchangeability, and coadministration of COVID-19 vaccines. \uf209\nIn accordance with general best practices for immunizations, routine administration of all age-appropriate doses of\nvaccines simultaneously is recommended for children, adolescents, and adults for whom no specific contraindications\nexist at the time of the healthcare visit. This includes simultaneous administration of COVID-19 vaccine and other\nvaccines. However, there are additional considerations for Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines if\nadministering an orthopoxvirus (monkeypox) vaccine. For more information, see Coadministration of COVID-19 vaccines with other vaccines."}]}, {"title": "aa96c516354b1b2938bb0bee635f0626", "paragraphs": [{"qas": [{"question": "What type of vaccines can be administered at the same time?", "id": "100000000000000000001291", "answers": [{"text": "COVID-19", "answer_start": 4}], "is_impossible": false}, {"question": "What is another name for JYNNEOS or ACAM2000?", "id": "100000000000000000001294", "answers": [{"text": "orthopoxvirus vaccination", "answer_start": 317}], "is_impossible": false}, {"question": "Why would adolescent or young adult males consider waiting 4 weeks before receiving a COVID-19 vaccine?", "id": "100000000000000000001295", "answers": [{"text": "because of the observed risk for myocarditis and pericarditis", "answer_start": 531}], "is_impossible": false}, {"question": "What is the unknown risk for myocarditis after administration of JYNNEOS?", "id": "100000000000000000001296", "answers": [{"text": "pericarditis", "answer_start": 748}], "is_impossible": false}], "context": "Can COVID-19 vaccines and other vaccines be administered at the same time? \uf1aa\nPeople who previously received COVID-19 vaccination (i.e. Moderna, Novavax, or Pfizer-BioNTech) may be given\northopoxvirus vaccine (either JYNNEOS or ACAM2000) without a minimum interval between vaccinations. People who previously received orthopoxvirus vaccination (either JYNNEOS or ACAM2000), particularly adolescent or\nyoung adult males, might consider waiting 4 weeks before receiving a COVID-19 vaccine (i.e. Moderna, Novavax, or Pfizer-\nBioNTech) because of the observed risk for myocarditis and pericarditis after receipt of ACAM2000 orthopoxvirus vaccine\nand COVID-19 vaccines (i.e. Moderna, Novavax, or Pfizer-BioNTech) and the unknown risk for myocarditis and pericarditis\nafter JYNNEOS administration."}]}, {"title": "6f97395c0287df1ed5f79eb83204ed1f", "paragraphs": [{"qas": [{"question": "What vaccines are recommended for everyone ages 6 months to 6 years?", "id": "100000000000000000001298", "answers": [{"text": "COVID-19", "answer_start": 305}], "is_impossible": false}, {"question": "What is the name of the orthopoxvirus vaccine?", "id": "100000000000000000001299", "answers": [{"text": "monkeypox", "answer_start": 278}], "is_impossible": false}, {"question": "What is recommended for everyone ages 6 months and older?", "id": "100000000000000000001300", "answers": [{"text": "COVID-19 vaccination", "answer_start": 305}], "is_impossible": false}, {"question": "What type of illness can you vaccinate patients with?", "id": "100000000000000000001302", "answers": [{"text": "mild", "answer_start": 691}], "is_impossible": false}, {"question": "What is a mild illness?", "id": "100000000000000000001303", "answers": [{"text": "Monkeypox", "answer_start": 120}], "is_impossible": false}], "context": "For more information, see Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022\nU.S. Monkeypox Outbreak and Coadministration of COVID-19 vaccines with other vaccines. Can COVID-19 vaccines be administered at the same time as an orthopoxvirus (monkeypox)\nvaccine? \uf1aa\nYes. COVID-19 vaccination is recommended for everyone ages 6 months and older, including people with underlying\nmedical conditions. COVID-19 vaccines are especially important for people with underlying medical conditions associated\nwith higher risk for severe COVID-19. Can I vaccinate patients with underlying medical conditions? \uf1aa\nAs with other vaccines, you can vaccinate patients with a mild illness."}]}, {"title": "2c996f862c332692ee438eae70af76a5", "paragraphs": [{"qas": [{"question": "What is a precaution to receiving a COVID-19 vaccine?", "id": "100000000000000000001304", "answers": [{"text": "A moderate or severe illness", "answer_start": 0}], "is_impossible": false}, {"question": "What is not considered a contraindication?", "id": "100000000000000000001305", "answers": [{"text": "A moderate or severe illness", "answer_start": 0}], "is_impossible": false}, {"question": "When should vaccination be delayed?", "id": "100000000000000000001306", "answers": [{"text": "until the acute illness has improved", "answer_start": 160}], "is_impossible": false}, {"question": "What is the name of the vaccine that may be given to a patient who is sick?", "id": "100000000000000000001307", "answers": [{"text": "COVID-19", "answer_start": 60}], "is_impossible": false}, {"question": "What are the general best practice guidelines for immunizations and contraindications?", "id": "100000000000000000001308", "answers": [{"text": "if you and your patient believe the potential benefits of vaccination outweigh the potential risks, they may receive COVID-19 vaccine", "answer_start": 207}], "is_impossible": false}], "context": "A moderate or severe illness is a precaution to\nreceiving a COVID-19 vaccine; it is not considered a contraindication. Generally, vaccination should be delayed until the\nacute illness has improved. However, if you and your patient believe the potential benefits of vaccination outweigh the\npotential risks, they may receive COVID-19 vaccine. For more information, see General Best Practice Guidelines for Immunizations and contraindications and precautions for\nCOVID-19 vaccination. My patient is sick. Can they receive a COVID-19 vaccine?"}]}, {"title": "2e4907eca6e131ac66f74408971d8e47", "paragraphs": [{"qas": [{"question": "Who recommends that people should receive the age-appropriate vaccine dosage based on their age on the day of vaccination?", "id": "100000000000000000001309", "answers": [{"text": "CDC", "answer_start": 111}], "is_impossible": false}, {"question": "What does FDA stand for?", "id": "100000000000000000001311", "answers": [{"text": "Food and Drug Administration", "answer_start": 490}], "is_impossible": false}, {"question": "What allows for different dosing for certain age transitions?", "id": "100000000000000000001312", "answers": [{"text": "Food and Drug Administration (FDA) authorization", "answer_start": 490}], "is_impossible": false}], "context": "\uf1aa\nVaccine Dosage and Formulation\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nCDC recommends that people should receive the age-appropriate vaccine dosage based on their age on the day of\nvaccination. If a person moves from a younger age group to an older age group during the primary series or between the\nprimary series and receipt of the booster dose, they should receive the vaccine dosage for the older age group for all\nsubsequent doses. However, Food and Drug Administration (FDA) authorization allows for different dosing for certain age transitions."}]}, {"title": "d1f9dacf84057a98fb3e7de29a92b0d1", "paragraphs": [{"qas": [{"question": "What is the name of the Vaccine for Children who transition from a Younger to Older Age Group?", "id": "100000000000000000001313", "answers": [{"text": "Moderna COVID-19", "answer_start": 26}], "is_impossible": false}, {"question": "What should a child do if they are moving from a younger age group to an older age group with a higher dose formulation?", "id": "100000000000000000001315", "answers": [{"text": "Do not repeat dose", "answer_start": 509}], "is_impossible": false}, {"question": "What can happen if the incorrect formulation is administered?", "id": "100000000000000000001316", "answers": [{"text": "Resulting in a higher-than-authorized dose: Do not repeat dose", "answer_start": 465}], "is_impossible": false}, {"question": "In a lower-than-authorized dose, how do you repeat the dose?", "id": "100000000000000000001317", "answers": [{"text": "Repeat the dose immediately (no minimum interval) with the age- appropriate dose and formulation", "answer_start": 572}], "is_impossible": false}], "context": "For\nmore information see:\nModerna COVID-19 Vaccine for Children who Transition from a Younger to Older Age Group\nPfizer-BioNTech for Children who Transition from a Younger to Older Age Group\nInterim COVID-19 Immunization Schedule for 6 Months of Age and Older\nWhat should I do for a child who is moving from a younger age group with a lower dose\nformulation to an older age group with a higher dose formulation? \uf1aa\n\uf20c\n\uf20c\n\uf20c\nIf the incorrect formulation is administered\nResulting in a higher-than-authorized dose: Do not repeat dose. Resulting in a lower-than-authorized dose: Repeat the dose immediately (no minimum interval) with the age-\nappropriate dose and formulation."}]}, {"title": "f40a7426bd2d9432a0a468345583c631", "paragraphs": [{"qas": [{"question": "Why do some experts suggest delaying the repeat dose for 8 weeks after the invalid dose?", "id": "100000000000000000001319", "answers": [{"text": "the potential for increased reactogenicity and the rare risk of myocarditis and pericarditis associated with Moderna, Novavax, and Pfizer-BioNTech vaccines", "answer_start": 90}], "is_impossible": false}, {"question": "What is the risk associated with Moderna, Novavax, and Pfizer-BioNTech vaccines in males ages 12-39 years?", "id": "100000000000000000001320", "answers": [{"text": "myocarditis and pericarditis", "answer_start": 154}], "is_impossible": false}], "context": "Some experts suggest delaying the repeat dose for 8 weeks after the invalid dose\nbased on the potential for increased reactogenicity and the rare risk of myocarditis and pericarditis associated with\nModerna, Novavax, and Pfizer-BioNTech vaccines, especially in males ages 12-39 years. See Considerations for\nextended intervals for COVID-19 vaccine primary series. If a person moves from a younger age group to an older age group during the primary series or between the primary\nseries and booster dose, they should receive the vaccine dosage for the older age group for all subsequent doses."}]}, {"title": "d178d13d3df6b2446ab52e3c6cd6c2ad", "paragraphs": [{"qas": [{"question": "What is Moderna COVID-19 Vaccine for Children who transition from a Younger to Older Age Group?", "id": "100000000000000000001323", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 198}], "is_impossible": false}], "context": "However, FDA allows the formulation for either age group to be administered for certain age transitions. See Moderna\nCOVID-19 Vaccine for Children who Transition from a Younger to Older Age Group , Pfizer-BioNTech for Children who\nTransition from a Younger to Older Age Group , and the product-specific EUA for more information. What should be done if the incorrect vaccine formulation is administered based on a patient\u2019s\nage? \uf1aa\n\uf20c\n\uf20c \uf209\nIn general, all doses of the primary series should be with the same product."}]}, {"title": "f23acaa394ae43607c81895df3d0a62c", "paragraphs": [{"qas": [{"question": "What is not available A person starts but is not able to complete the primary series?", "id": "100000000000000000001327", "answers": [{"text": "The same vaccine is not available A previous dose is unknown The person would otherwise not complete the primary series A person starts but is unable to complete a primary series with the same COVID-19 vaccine", "answer_start": 189}], "is_impossible": false}, {"question": "Who is unable to complete a primary series with the same COVID-19 vaccine due to a contraindication?", "id": "100000000000000000001328", "answers": [{"text": "A person", "answer_start": 309}], "is_impossible": false}, {"question": "No VAERS report is required what?", "id": "100000000000000000001329", "answers": [{"text": "A person starts but is unable to complete a primary series with the same COVID-19 vaccine due to a contraindication", "answer_start": 309}], "is_impossible": false}, {"question": "What vaccine product should be used for all doses in the primary series?", "id": "100000000000000000001331", "answers": [{"text": "COVID-19", "answer_start": 560}], "is_impossible": false}], "context": "In the following exceptional situations, a different COVID-19 vaccine may be administered to complete a primary series at\na minimum interval of 28 days from the last COVID-19 vaccine dose:\nThe same vaccine is not available\nA previous dose is unknown\nThe person would otherwise not complete the primary series\nA person starts but is unable to complete a primary series with the same COVID-19 vaccine due to a contraindication. No VAERS report is required. For more information, see:\nTiming, spacing, and interchangeability of COVID-19 vaccines. Should the same COVID-19 vaccine product be used for all doses in the primary series?"}]}, {"title": "6dad045b6b0a9a528f0825856dd22945", "paragraphs": [{"qas": [{"question": "What are the two bivalent mRNA vaccines?", "id": "100000000000000000001333", "answers": [{"text": "Moderna and Pfizer-BioNTech", "answer_start": 238}], "is_impossible": false}, {"question": "What is the primary series?", "id": "100000000000000000001334", "answers": [{"text": "bivalent mRNA vaccines (i.e., Moderna and Pfizer-BioNTech) are not currently authorized to be used for the primary series; they may only be used for the booster dose. If a bivalent Pfizer-BioNTech vaccine is administered for a primary series dose: Do not repeat the dose. The primary and booster dosages are the same; the bivalent dose", "answer_start": 208}], "is_impossible": false}, {"question": "What is used for the booster dose?", "id": "100000000000000000001335", "answers": [{"text": "bivalent mRNA vaccines", "answer_start": 208}], "is_impossible": false}, {"question": "Do not repeat the dose if a bivalent Pfizer-BioNTech vaccine is administered for a primary series dose.", "id": "100000000000000000001336", "answers": [{"text": "10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC People who are not moderately or severely immunocompromised", "answer_start": 1}], "is_impossible": false}], "context": "\uf1aa\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nPeople who are not moderately or severely immunocompromised\nPeople who are moderately or severely immunocompromised\nNo, the bivalent mRNA vaccines (i.e., Moderna and Pfizer-BioNTech) are not currently authorized to be used for the\nprimary series; they may only be used for the booster dose. If a bivalent Pfizer-BioNTech vaccine is administered for a primary series dose: Do not repeat the dose. The primary and\nbooster dosages are the same; the bivalent dose can be counted as a primary series dose."}]}, {"title": "a1a6b7c0729e08c7cded365e85f952d1", "paragraphs": [{"qas": [{"question": "What type of vaccine is used for the primary series?", "id": "100000000000000000001338", "answers": [{"text": "monovalent Pfizer-BioNTech", "answer_start": 93}], "is_impossible": false}, {"question": "What is the minimum interval for a monovalent Pfizer-BioNTech vaccine?", "id": "100000000000000000001339", "answers": [{"text": "2 months", "answer_start": 178}], "is_impossible": false}, {"question": "How long after the first series of vaccinations does a bivalent booster dose last?", "id": "100000000000000000001340", "answers": [{"text": "2 months", "answer_start": 178}], "is_impossible": false}, {"question": "Do you need to repeat the dose with a monovalent Moderna vaccine?", "id": "100000000000000000001341", "answers": [{"text": "Repeat the dose immediately (no minimum interval) with a monovalent Moderna vaccine because administration of the bivalent Moderna vaccine will result in a lower-than- authorized primary series dosage", "answer_start": 294}], "is_impossible": false}, {"question": "What will result in a lower-than- authorized primary series dosage?", "id": "100000000000000000001342", "answers": [{"text": "administration of the bivalent Moderna vaccine", "answer_start": 386}], "is_impossible": false}, {"question": "Do some experts suggest delaying the repeat dose for 8 weeks after the invalid dose?", "id": "100000000000000000001343", "answers": [{"text": "Repeat the dose immediately (no minimum interval) with a monovalent Moderna vaccine because administration of the bivalent Moderna vaccine will result in a lower-than- authorized primary series dosage", "answer_start": 294}], "is_impossible": false}], "context": "Continue with the\nrecommended vaccination schedule (i.e., complete the primary series with a monovalent Pfizer-BioNTech vaccine, then\nadminister a bivalent booster dose at least 2 months after completion of the primary series). If a bivalent Moderna vaccine is administered for a primary dose: Repeat the dose immediately (no minimum interval)\nwith a monovalent Moderna vaccine because administration of the bivalent Moderna vaccine will result in a lower-than-\nauthorized primary series dosage. Some experts suggest delaying the repeat dose for 8 weeks after the invalid dose."}]}, {"title": "15ad17a0aa8459816df323bfb1fb3d54", "paragraphs": [{"qas": [{"question": "How long after the dose has been repeated should you continue with the recommended vaccination schedule?", "id": "100000000000000000001345", "answers": [{"text": "2 months", "answer_start": 204}], "is_impossible": false}, {"question": "What is considered an administration error?", "id": "100000000000000000001346", "answers": [{"text": "vaccination schedule (i.e., complete the primary series with a monovalent Moderna vaccine, then administer a bivalent booster dose", "answer_start": 64}], "is_impossible": false}, {"question": "What should be reported to VAERS?", "id": "100000000000000000001347", "answers": [{"text": "vaccine administration errors", "answer_start": 285}], "is_impossible": false}, {"question": "What is the name of the mRNA vaccines that can be used for the primary series?", "id": "100000000000000000001348", "answers": [{"text": "Moderna and Pfizer-BioNTech", "answer_start": 615}], "is_impossible": false}], "context": "After\nthe dose has been repeated, continue with the recommended vaccination schedule (i.e., complete the primary series with\na monovalent Moderna vaccine, then administer a bivalent booster dose at least 2 months after completion of the\nprimary series). Both situations are considered vaccine administration errors and should be reported to Vaccine Adverse Event Reporting\nSystem (VAERS) . For more information, see\nPeople who are not moderately or severely immunocompromised\nPeople who are moderately or severely immunocompromised\nVaccine administration errors and deviations\nCan the bivalent mRNA vaccines (i.e., Moderna and Pfizer-BioNTech) be used for the primary\nseries?"}]}, {"title": "7a8e71a13035b3572680bf3089483644", "paragraphs": [{"qas": [{"question": "What are monovalent mRNA vaccines no longer authorized for use as?", "id": "100000000000000000001349", "answers": [{"text": "a booster dose", "answer_start": 108}], "is_impossible": false}, {"question": "What type of vaccine does not need to be repeated?", "id": "100000000000000000001351", "answers": [{"text": "monovalent mRNA", "answer_start": 266}], "is_impossible": false}, {"question": "How long after the monovalent booster dose should the repeat dose be given?", "id": "100000000000000000001352", "answers": [{"text": "2 months", "answer_start": 535}], "is_impossible": false}, {"question": "Who may administer 1 bivalent booster as a repeat dose?", "id": "100000000000000000001353", "answers": [{"text": "providers", "answer_start": 370}], "is_impossible": false}, {"question": "What should be administered at least 2 months after the monovalent booster dose?", "id": "100000000000000000001354", "answers": [{"text": "repeat dose", "answer_start": 491}], "is_impossible": false}], "context": "\uf1aa\n\uf209\nNo, the monovalent mRNA vaccines (i.e., Moderna or Pfizer-BioNTech) are no longer authorized for use as a booster dose;\nthey can only be used for the primary series. A bivalent mRNA vaccine is recommended for the booster dose. If a patient accidently received a monovalent mRNA vaccine for the booster dose, the dose generally does not need to be\nrepeated. However, providers may administer 1 bivalent booster dose as a repeat dose based on clinical judgment and\npatient preference. The repeat dose should be administered at least 2 months after the monovalent booster dose. For more information, see vaccine administration errors and deviations."}]}, {"title": "40132ec5184301fc3da2ab93ef34b949", "paragraphs": [{"qas": [{"question": "How many booster doses are recommended for everyone ages 5 years and older?", "id": "100000000000000000001357", "answers": [{"text": "1", "answer_start": 169}], "is_impossible": false}, {"question": "What age group is recommended to receive 1 bivalent booster dose for COVID-19 vaccine?", "id": "100000000000000000001358", "answers": [{"text": "Everyone ages 5 years and older", "answer_start": 111}], "is_impossible": false}, {"question": "What is the recommended dose of the COVID-19 vaccine for children?", "id": "100000000000000000001359", "answers": [{"text": "1 bivalent mRNA booster dose", "answer_start": 169}], "is_impossible": false}, {"question": "What is recommended for children age 5 years?", "id": "100000000000000000001361", "answers": [{"text": "Pfizer-BioNTech bivalent booster dose", "answer_start": 348}], "is_impossible": false}], "context": "Can a monovalent mRNA vaccine (i.e., Moderna or Pfizer-BioNTech) be used for the booster dose? \uf1aa\nBooster Doses\nEveryone ages 5 years and older is recommended to receive 1 bivalent mRNA booster dose if they have completed a\nprimary series with any FDA-approved or FDA-authorized COVID-19 vaccine:\nChildren age 5 years are recommended to receive the Pfizer-BioNTech bivalent booster dose. Who should receive a booster dose? \uf1aa\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nChildren age 5 years are recommended to receive the Pfizer BioNTech bivalent booster dose."}]}, {"title": "c6168cee6c38ff34606494bb0b4e3c67", "paragraphs": [{"qas": [{"question": "Who is recommended to receive the Moderna or Pfizer-BioNTech bivalent booster dose?", "id": "100000000000000000001362", "answers": [{"text": "People ages 6 years and older", "answer_start": 0}], "is_impossible": false}, {"question": "How long after the last primary dose is the booster dose administered?", "id": "100000000000000000001363", "answers": [{"text": "2 months", "answer_start": 164}], "is_impossible": false}, {"question": "Novavax monovalent COVID-19 Vaccine may be used as a booster dose for people ages 18 and older?", "id": "100000000000000000001365", "answers": [{"text": "limited situations", "answer_start": 449}], "is_impossible": false}], "context": "People ages 6 years and older are recommended to receive either the Moderna or the Pfizer-BioNTech bivalent\nbooster dose. The booster dose is administered at least 2 months after the last primary dose. For people who previously received 1 or\nmore monovalent booster doses, the bivalent booster dose should be administered at least 2 months after the last\nmonovalent booster dose. Novavax monovalent COVID-19 Vaccine may be used as a booster dose in limited situations for people ages 18 years and\nolder."}]}, {"title": "89ed2254a484ec05ff17d1e9a0d595ea", "paragraphs": [{"qas": [{"question": "What is the bivalent booster dose administered at least 2 times a day?", "id": "100000000000000000001366", "answers": [{"text": "primary series", "answer_start": 407}], "is_impossible": false}, {"question": "What are the booster doses for people who are not moderately or severely immunocompromised?", "id": "100000000000000000001367", "answers": [{"text": "People who are not moderately or severely immunocompromised People who are moderately or severely immunocompromised For booster dose recommendations for people vaccinated outside the United States, see people who received COVID-19 vaccine outside the United States. The bivalent booster dose is administered at least 2 months after completion of the primary series", "answer_start": 56}], "is_impossible": false}, {"question": "How long after the primary series is the bivalent booster dose administered?", "id": "100000000000000000001368", "answers": [{"text": "2 months", "answer_start": 374}], "is_impossible": false}, {"question": "What is the interval between the first series and the second series?", "id": "100000000000000000001369", "answers": [{"text": "same", "answer_start": 442}], "is_impossible": false}, {"question": "Which vaccine is administered at the same interval?", "id": "100000000000000000001370", "answers": [{"text": "bivalent booster dose", "answer_start": 327}], "is_impossible": false}, {"question": "What is the interval between the primary series and the bivalent mRNA booster dose?", "id": "100000000000000000001371", "answers": [{"text": "the same", "answer_start": 439}], "is_impossible": false}], "context": "For more information on booster doses see schedules for:\nPeople who are not moderately or severely immunocompromised\nPeople who are moderately or severely immunocompromised\nFor booster dose recommendations for people vaccinated outside the United States, see people who received COVID-19\nvaccine outside the United States. The bivalent booster dose is administered at least 2 months after completion of the primary series. The interval is the\nsame regardless of which vaccine was administered for the primary series and which bivalent booster (Moderna or Pfizer-\nBioNTech) will be administered. What is the interval between the primary series and the bivalent mRNA booster dose?"}]}, {"title": "58e1921d4acd23272655f4274e46d299", "paragraphs": [{"qas": [{"question": "How long after the last monovalent mRNA booster dose is the bivalent booster dose administered?", "id": "100000000000000000001372", "answers": [{"text": "2 months", "answer_start": 53}], "is_impossible": false}, {"question": "What is the interval between a previously received monovalent and bivalent dose?", "id": "100000000000000000001373", "answers": [{"text": "2 months", "answer_start": 53}], "is_impossible": false}, {"question": "Who is recommended to receive 1 bivalent booster dose regardless of previous booster dose history?", "id": "100000000000000000001374", "answers": [{"text": "Everyone ages 5 years and older", "answer_start": 288}], "is_impossible": false}, {"question": "What should be administered at least 2 months after the first booster dose?", "id": "100000000000000000001375", "answers": [{"text": "bivalent booster dose", "answer_start": 521}], "is_impossible": false}], "context": "\uf1aa\nThe bivalent booster dose is administered at least 2 months after the last monovalent mRNA booster dose. My patient already received a monovalent mRNA booster dose(s). What is the interval between a\npreviously received monovalent mRNA booster dose and the bivalent booster dose? \uf1aa\nYes. Everyone ages 5 years and older who completed a primary series is recommended to receive 1 bivalent booster\ndose regardless of previous booster dose history. For people who previously received 1 or more monovalent booster\ndoses, the bivalent booster dose should be administered at least 2 months after the last monovalent booster dose."}]}, {"title": "219d9a5335b93b5b700d0a0352282032", "paragraphs": [{"qas": [{"question": "What is the current recommendation for everyone who is eligible to receive 1 bivalent booster dose?", "id": "100000000000000000001377", "answers": [{"text": "people who received the primary series but did not receive the previously recommended monovalent mRNA booster dose(s) and people who received 1 or 2 monovalent mRNA booster doses", "answer_start": 215}], "is_impossible": false}, {"question": "What type of booster dose can a patient get if he or she previously received a monovalent one?", "id": "100000000000000000001379", "answers": [{"text": "bivalent", "answer_start": 81}], "is_impossible": false}, {"question": "What are people who received 1 or 2 monovalent mRNA booster doses currently recommended to receive?", "id": "100000000000000000001380", "answers": [{"text": "no additional booster doses", "answer_start": 546}], "is_impossible": false}, {"question": "Why will not everyone receive the same number of booster dose(s)?", "id": "100000000000000000001381", "answers": [{"text": "the guidance has changed", "answer_start": 403}], "is_impossible": false}], "context": "My patient previously received a monovalent mRNA booster dose(s). Can they get a bivalent\nbooster dose? \uf1aa\nThe current recommendation is for everyone who is eligible to receive 1 bivalent booster dose: this includes people who\nreceived the primary series but did not receive the previously recommended monovalent mRNA booster dose(s) and\npeople who received 1 or 2 monovalent mRNA booster doses. Because the guidance has changed, not everyone will\nreceive the same number of booster doses. However, once a person receives 1 bivalent booster dose, no additional\nbooster doses are currently recommended."}]}, {"title": "db47ba4f8911530304190516f15c7abe", "paragraphs": [{"qas": [{"question": "How many bivalent booster doses are recommended for everyone ages 5 years and older?", "id": "100000000000000000001383", "answers": [{"text": "1", "answer_start": 73}], "is_impossible": false}, {"question": "How many monovalent mRNA booster dose(s) is recommended for every ages 6 months to 4 years?", "id": "100000000000000000001384", "answers": [{"text": "1", "answer_start": 73}], "is_impossible": false}, {"question": "What is a child who completes a Pfizer-BioNTech primary series able to get?", "id": "100000000000000000001385", "answers": [{"text": "a booster dose", "answer_start": 324}], "is_impossible": false}, {"question": "When should a Pfizer-BioNTech primary series at ages 6 months-4 years get a booster dose?", "id": "100000000000000000001386", "answers": [{"text": "when they turn age 5 years", "answer_start": 339}], "is_impossible": false}], "context": "My patient never received a monovalent mRNA booster dose(s) and now only 1 bivalent booster\ndose is recommended for everyone ages 5 years and older. Can my patient still get the previously\nrecommended monovalent mRNA booster dose(s)? \uf1aa\nCan a child who completes a Pfizer-BioNTech primary series at ages 6 months\u20134 years get a\nbooster dose when they turn age 5 years? \uf1aa\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nYes. The child should receive 1 bivalent booster dose when they turn age 5 years, and it has been at least 2 months since\ncompleting their primary series."}]}, {"title": "1db23be6142ad4eb8cbc633fb16d4cc0", "paragraphs": [{"qas": [{"question": "What is authorized for a booster dose in limited situations?", "id": "100000000000000000001390", "answers": [{"text": "The monovalent Novavax COVID-19 vaccine", "answer_start": 0}], "is_impossible": false}], "context": "The monovalent Novavax COVID-19 vaccine is authorized for a booster dose in limited situations. People ages 18 years\nand older who completed primary vaccination using any COVID-19 vaccine and have not received any previous booster\ndose(s) (including any previous mRNA monovalent or bivalent booster dose[s]) may receive a monovalent Novavax\nbooster dose at least 6 months after completion of the primary series if they are unable to receive an mRNA vaccine (i.e.,\nmRNA vaccine contraindicated or not available) or unwilling to receive an mRNA vaccine and would otherwise not receive\na booster dose."}]}, {"title": "b7a76ec216b065583a7d942d2c9e8357", "paragraphs": [{"qas": [{"question": "What are people who are moderately or severely immunocompromised?", "id": "100000000000000000001395", "answers": [{"text": "Guidance for COVID-19 vaccination", "answer_start": 276}], "is_impossible": false}, {"question": "Who should be vaccinated according to the schedule for people who are moderately or severely immunocompromised?", "id": "100000000000000000001396", "answers": [{"text": "People can self-attest to their moderately or severely immunocompromised status", "answer_start": 548}], "is_impossible": false}], "context": "What is the guidance for a use of the monovalent Novavax COVID-19 vaccine for a booster dose? \uf1aa\nPeople who are Moderately or Severely Immunocompromised\nYes. For COVID-19 vaccination guidance for people who are moderately or severely immunocompromised people, please\nrefer to:\nGuidance for COVID-19 vaccination for people who are moderately or severely immunocompromised\nCOVID-19 Vaccines for Moderately or Severely Immunocompromised People\nAre there special considerations for vaccinating people who are moderately or severely\nimmunocompromised? \uf1aa\nPeople can self-attest to their moderately or severely immunocompromised status and should be vaccinated according to\nthe schedule for people who are moderately or severely immunocompromised."}]}, {"title": "2033aa338775a6f172268bc98e5f6e6e", "paragraphs": [{"qas": [{"question": "What is recommended to everyone ages 5 years and older who completed a primary series?", "id": "100000000000000000001399", "answers": [{"text": "1 bivalent mRNA booster dose", "answer_start": 292}], "is_impossible": false}, {"question": "How long after the last monovalent booster dose should the bivalent mRNA booster dose be administered?", "id": "100000000000000000001400", "answers": [{"text": "2 months", "answer_start": 500}], "is_impossible": false}, {"question": "What is the recommended number of doses for people who are moderately or severely immunocompromised?", "id": "100000000000000000001401", "answers": [{"text": "1 bivalent mRNA booster dose", "answer_start": 292}], "is_impossible": false}], "context": "Vaccinators and clinic administrators\nshould not deny COVID-19 vaccination to a person because of a lack of documentation. How do I verify if a person is moderately or severely immunocompromised? \uf1aa\nYes. Everyone ages 5 years and older who completed a primary series is recommended to receive 1 bivalent mRNA\nbooster dose regardless of previous booster dose history; this includes people who are moderately or severely\nimmunocompromised. The bivalent mRNA booster dose should be administered at least 2 months after the last\nmonovalent booster dose. My patient is moderately or severely immunocompromised and received the primary series and\nthe previously recommended monovalent mRNA booster dose(s)."}]}, {"title": "b7bdadd532d6f5ed496634ecf9ec6be6", "paragraphs": [{"qas": [{"question": "Who should receive the bivalent mRNA booster dose?", "id": "100000000000000000001403", "answers": [{"text": "Patients who undergo HCT or CAR-T-cell therapy should be revaccinated", "answer_start": 54}], "is_impossible": false}, {"question": "What should a patient undergo after receiving HCT or CAR-T cell therapy?", "id": "100000000000000000001405", "answers": [{"text": "revaccinated", "answer_start": 111}], "is_impossible": false}, {"question": "What do CDC g p y p receive 1 bivalent mRNA booster dose?", "id": "100000000000000000001407", "answers": [{"text": "Patients who undergo HCT or CAR-T-cell therapy should be revaccinated for the monovalent primary series and bivalent mRNA booster dose received before or during treatment. There is no revaccination for monovalent mRNA booster dose(s) received before or during treatment. After revaccination with the primary series, the patient should My patient who is moderately or severely immunocompromised underwent HCT or CAR-T cell therapy after receiving the primary series and 2 monovalent mRNA booster doses. Should they be revaccinated", "answer_start": 54}], "is_impossible": false}], "context": "Should they receive the bivalent\nmRNA booster dose? \uf1aa\nPatients who undergo HCT or CAR-T-cell therapy should be revaccinated for the monovalent primary series\nand bivalent mRNA booster dose received before or during treatment. There is no revaccination for monovalent mRNA\nbooster dose(s) received before or during treatment. After revaccination with the primary series, the patient should\nMy patient who is moderately or severely immunocompromised underwent HCT or CAR-T cell\ntherapy after receiving the primary series and 2 monovalent mRNA booster doses. Should they be\nrevaccinated? \uf1aa\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\ng p y p\nreceive 1 bivalent mRNA booster dose."}]}, {"title": "ccdab60c22301347a9e3b6fc924d877b", "paragraphs": [{"qas": [{"question": "What is the recommended action if your patient received the primary series before or during treatment?", "id": "100000000000000000001408", "answers": [{"text": "Revaccinate the patient with the primary series", "answer_start": 126}], "is_impossible": false}, {"question": "How many doses of mRNA booster do you need to administer at least 2 months after repeating your primary series?", "id": "100000000000000000001409", "answers": [{"text": "1", "answer_start": 189}], "is_impossible": false}, {"question": "Do not revaccinate for the monovalent mRNA booster dose(s)?", "id": "100000000000000000001411", "answers": [{"text": "If your patient received the primary series and 1 or 2 (or more) monovalent booster doses before or during treatment: Revaccinate the patient with the primary series", "answer_start": 272}], "is_impossible": false}, {"question": "How long after repeating the primary series do you need to receive 1 bivalent mRNA booster dose?", "id": "100000000000000000001413", "answers": [{"text": "2 months", "answer_start": 575}], "is_impossible": false}], "context": "Below are three scenarios and the recommended action:\nIf your patient received the primary series before or during treatment: Revaccinate the patient with the primary series\nand administer 1 bivalent mRNA booster dose at least 2 months after repeating the primary series. If your patient received the primary series and 1 or 2 (or more) monovalent booster doses before or during\ntreatment: Revaccinate the patient with the primary series. Do not revaccinate for the monovalent mRNA booster dose(s). The patient is recommended to receive 1 bivalent mRNA booster dose at least 2 months after repeating the primary\nseries."}]}, {"title": "b6432009bdf78e16485e6c7efd13ffea", "paragraphs": [{"qas": [{"question": "What should be deferred for at least two weeks after COVID-19?", "id": "100000000000000000001414", "answers": [{"text": "Administration of EVUSHELD", "answer_start": 256}], "is_impossible": false}, {"question": "What should your patient receive if they received the primary series and a bivalent booster dose?", "id": "100000000000000000001415", "answers": [{"text": "Revaccinate", "answer_start": 100}], "is_impossible": false}, {"question": "What should be deferred for at least two weeks after COVID-19 vaccination per the EVUSHELD EUA?", "id": "100000000000000000001416", "answers": [{"text": "Administration of EVUSHELD", "answer_start": 256}], "is_impossible": false}, {"question": "What is the deferral period for all other passive antibody products?", "id": "100000000000000000001417", "answers": [{"text": "no", "answer_start": 511}], "is_impossible": false}, {"question": "What happens between receipt of the product and COVID-19 vaccine administration?", "id": "100000000000000000001418", "answers": [{"text": "no deferral period", "answer_start": 511}], "is_impossible": false}, {"question": "For more information, see what?", "id": "100000000000000000001419", "answers": [{"text": "considerations for COVID-19 revaccination", "answer_start": 208}], "is_impossible": false}], "context": "If your patient received the primary series and a bivalent booster dose before or during treatment: Revaccinate the\npatient with the primary series and 1 bivalent mRNA booster dose. For more information, see considerations for COVID-19 revaccination. Yes. Administration of EVUSHELD should be deferred for at least two weeks after COVID-19 vaccination per the\nEVUSHELD EUA . You can administer COVID-19 vaccine any time after receipt of EVUSHELD . For all other passive antibody products for COVID-19, there is no deferral period between receipt of the product and\nCOVID-19 vaccine administration. For more information, see COVID-19 vaccination and EVUSHELD\u2122 and CDC\u2019s EVUSHELD\u2122 guidance."}]}, {"title": "e4617d85ad2f4394c23dd6f5869a0e5d", "paragraphs": [{"qas": [{"question": "What is EVUSHELDTM?", "id": "100000000000000000001420", "answers": [{"text": "tixagevimab/cilgavimab", "answer_start": 32}], "is_impossible": false}, {"question": "Who should get the COVID-19 vaccine primary series and 1 bivalent mRNA booster dose?", "id": "100000000000000000001421", "answers": [{"text": "Everyone ages 5 years and older", "answer_start": 185}], "is_impossible": false}, {"question": "What can be administered any time after receipt of EVUSHELDTM?", "id": "100000000000000000001422", "answers": [{"text": "COVID-19 vaccines", "answer_start": 417}], "is_impossible": false}, {"question": "What should be deferred for at least 2 weeks after COVID-19 vaccination?", "id": "100000000000000000001423", "answers": [{"text": "Administration of EVUSHELD\u2122", "answer_start": 492}], "is_impossible": false}, {"question": "What is the name of the EVUSHELD EUA TM?", "id": "100000000000000000001424", "answers": [{"text": "TM TM \uf209 TM Yes. Everyone ages 5 years and older should get the COVID-19 vaccine primary series and 1 bivalent mRNA booster dose including people who are moderately or severely immunocompromised and receiving EVUSHELD\u2122 for pre-exposure prophylaxis. COVID-19 vaccines can be administered any time after receipt of EVUSHELD\u2122. Administration of EVUSHELD\u2122 should be deferred for at least 2 weeks after COVID-19 vaccination per the EVUSHELD EUA \u2122", "answer_start": 168}], "is_impossible": false}, {"question": "For more information, see what?", "id": "100000000000000000001425", "answers": [{"text": "COVID-19 vaccination and EVUSHELD\u2122 and CDC\u2019s EVUSHELD\u2122 guidance", "answer_start": 637}], "is_impossible": false}], "context": "Do I need to wait to administer tixagevimab/cilgavimab (EVUSHELD\u2122) for pre-exposure\nprophylaxis against COVID-19 after my patient received a dose of COVID-19 vaccine? \uf1aa\nTM\nTM \uf209 TM\nYes. Everyone ages 5 years and older should get the COVID-19 vaccine primary series and 1 bivalent mRNA booster dose\nincluding people who are moderately or severely immunocompromised and receiving EVUSHELD\u2122 for pre-exposure\nprophylaxis. COVID-19 vaccines can be administered any time after receipt of EVUSHELD\u2122. Administration of EVUSHELD\u2122 should be\ndeferred for at least 2 weeks after COVID-19 vaccination per the EVUSHELD EUA \u2122. For more information, see COVID-19 vaccination and EVUSHELD\u2122 and CDC\u2019s EVUSHELD\u2122 guidance."}]}, {"title": "8ca75665a711ac362596649cd3c0d673", "paragraphs": [{"qas": [{"question": "How often should EVUSHELDTM be administered to people who are moderately or severely immunocompromised?", "id": "100000000000000000001426", "answers": [{"text": "every 6 months", "answer_start": 293}], "is_impossible": false}], "context": "My patient is moderately or severely immunocompromised and receiving EVUSHELD\u2122. Should\nthey also get COVID-19 vaccines? \uf1aa\n\uf209\nYes. In addition to following the recommended COVID-19 vaccination schedule, EVUSHELD\u2122 should be administered to\npeople who are moderately or severely immunocompromised every 6 months to supplement vaccine protection. Administration of EVUSHELD\u2122 should be deferred for at least 2 weeks after COVID-19 vaccination per the EVUSHELD EUA\n\u2122. COVID-19 vaccines can be administered any time after receipt of EVUSHELD\u2122. For more information, see COVID-19 vaccination and EVUSHELD\u2122 and CDC\u2019s EVUSHELD\u2122 guidance."}]}, {"title": "6daaab554d4e9693477bee65c15b262e", "paragraphs": [{"qas": [{"question": "What is not currently recommended to assess the need for vaccination in an unvaccinated person?", "id": "100000000000000000001430", "answers": [{"text": "Antibody testing", "answer_start": 274}], "is_impossible": false}, {"question": "What is the need for vaccination in an unvaccinated person?", "id": "100000000000000000001431", "answers": [{"text": "Antibody testing", "answer_start": 274}], "is_impossible": false}, {"question": "What look for the presence of antibodies made in response to a previous infection or vaccination?", "id": "100000000000000000001432", "answers": [{"text": "Antibody tests for SARS-CoV-2", "answer_start": 479}], "is_impossible": false}, {"question": "What is an indicator of the body's efforts to fight off the SARS-CoV-2?", "id": "100000000000000000001433", "answers": [{"text": "Antibodies", "answer_start": 602}], "is_impossible": false}], "context": "My patient is moderately or severely immunocompromised and vaccinated according to current\nACIP/CDC guidance; should they also get EVUSHELD\u2122? \uf1aa\n\uf209\nVaccination and SARS-CoV-2 Laboratory Testing\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nAntibody testing is not currently recommended to assess the need for vaccination in an unvaccinated person or to assess\nimmunity to SARS-CoV-2 following COVID-19 vaccination or after SARS-CoV-2 infection. Antibody tests for SARS-CoV-2 look\nfor the presence of antibodies made in response to a previous infection or vaccination. Antibodies are an indicator of the\nbody\u2019s efforts to fight off the SARS-CoV-2 virus."}]}, {"title": "485c260be5cd3041f22acca2c83397da", "paragraphs": [{"qas": [{"question": "What is the purpose of an antibody test for COVID-19?", "id": "100000000000000000001436", "answers": [{"text": "to decide whether to get vaccinated", "answer_start": 608}], "is_impossible": false}, {"question": "What does the FDA do?", "id": "100000000000000000001437", "answers": [{"text": "Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers", "answer_start": 386}], "is_impossible": false}], "context": "None of the currently authorized SARS-CoV-2 antibody tests have been\nvalidated to evaluate specific immunity or protection from SARS-CoV-2 infection. For assistance with patient counseling and education related to COVID-19 testing and vaccination, please see:\nCOVID-19 Testing: What you Need to Know [CDC]\nUsing Antibody Tests for COVID-19: Information for Patients and Consumers [CDC]\nAntibody (Serology) Testing for COVID-19: Information for Patients and Consumers [FDA]\nFor more detailed information, please see: Interim Guidelines for COVID-19 Antibody Testing. My patient is asking for an antibody test to decide whether to get vaccinated (or revaccinated)."}]}, {"title": "9ead4d22ff96e409aa0d43bd657adaaa", "paragraphs": [{"qas": [{"question": "What do antibody tests tell us about immunity?", "id": "100000000000000000001438", "answers": [{"text": "vaccinate or revaccinate", "answer_start": 95}], "is_impossible": false}, {"question": "What does CDC recommend for people with a history of?", "id": "100000000000000000001440", "answers": [{"text": "COVID-19 vaccination", "answer_start": 180}], "is_impossible": false}, {"question": "What is an example of a prior SARS-CoV-2 infection?", "id": "100000000000000000001441", "answers": [{"text": "symptomatic or asymptomatic", "answer_start": 365}], "is_impossible": false}, {"question": "What is a possible reason for people to delay their primary or booster COVID-19 vaccine dose by 3 months?", "id": "100000000000000000001442", "answers": [{"text": "symptom onset or positive test", "answer_start": 701}], "is_impossible": false}, {"question": "What is the primary or booster dose of the COVID-19 vaccine?", "id": "100000000000000000001443", "answers": [{"text": "3 months", "answer_start": 687}], "is_impossible": false}, {"question": "How many months from symptom onset of infection is required to get the primary and booster doses?", "id": "100000000000000000001444", "answers": [{"text": "3", "answer_start": 687}], "is_impossible": false}, {"question": "What type of test is needed to determine if the infection was asymptomatic?", "id": "100000000000000000001445", "answers": [{"text": "positive", "answer_start": 718}], "is_impossible": false}], "context": "What do antibody tests tell us about immunity, and should these tests influence the decision to\nvaccinate or revaccinate? \uf1aa\n\uf209\n\uf209\nVaccination and SARS-CoV-2 Infection\nCDC recommends COVID-19 vaccination for all people ages 6 months and older, including people with a history of SARS-\nCoV-2 infection. Prior infection: Offer vaccination regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection,\nincluding to people with prolonged post-COVID-19 symptoms and people who experienced SARS-CoV-2 infection\n(symptomatic or asymptomatic) after vaccination. People who recently had SARS-CoV-2 infection may consider delaying\ntheir primary or booster COVID-19 vaccine dose by 3 months from symptom onset or positive test (if infection was\nasymptomatic)."}]}, {"title": "653d4247556e0929fa5e6a3664f0138", "paragraphs": [{"qas": [{"question": "What is not recommended for the purpose of vaccine decision-making?", "id": "100000000000000000001446", "answers": [{"text": "Laboratory testing", "answer_start": 234}], "is_impossible": false}, {"question": "What is another name for SARS-CoV-2?", "id": "100000000000000000001447", "answers": [{"text": "COVID-19", "answer_start": 453}], "is_impossible": false}, {"question": "Who recommends COVID-19 vaccination for all people who are pregnant, breastfeeding, recently pregnant, trying to get pregnant now, or trying to be pregnant?", "id": "100000000000000000001449", "answers": [{"text": "CDC", "answer_start": 539}], "is_impossible": false}, {"question": "Are you pregnant, breastfeeding, recently pregnant, trying to get pregnant now, or who might become pregnant in the future?", "id": "100000000000000000001450", "answers": [{"text": "CDC recommends COVID-19 vaccination", "answer_start": 539}], "is_impossible": false}], "context": "Current infection: Defer vaccination of people with known current SARS-CoV-2 infection until the person has recovered\nfrom acute illness (if the person has symptoms) and until criteria have been met for them to discontinue isolation. Laboratory testing is not recommended for the purpose of vaccine decision-making. For more information, see COVID-19 vaccination and SARS-CoV-2 infection. Can people with prior or current SARS-CoV-2 infection receive a COVID-19 vaccine? \uf1aa\nConsiderations Involving Pregnancy, Lactation, and Fertility\nYes. CDC recommends COVID-19 vaccination for all people who are pregnant, breastfeeding, recently pregnant, trying to\nget pregnant now, or who might become pregnant in the future."}]}, {"title": "1cef40af9292c243b52ce8ac2c3ff80f", "paragraphs": [{"qas": [{"question": "What vaccines are recommended for the primary series of vaccines?", "id": "100000000000000000001451", "answers": [{"text": "Monovalent mRNA (Moderna or Pfizer-BioNTech) and Novavax vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "What vaccine is recommended for booster dose for all vaccine-eligible populations including people who are pregnant or lactating?", "id": "100000000000000000001452", "answers": [{"text": "bivalent mRNA vaccine", "answer_start": 111}], "is_impossible": false}, {"question": "What should you see in Appendix A: Guidance for use of Janssen COVID-19 Vaccine?", "id": "100000000000000000001454", "answers": [{"text": "Those who are considering receipt", "answer_start": 283}], "is_impossible": false}], "context": "Monovalent mRNA (Moderna or Pfizer-BioNTech) and\nNovavax vaccines are recommended for the primary series and a bivalent mRNA vaccine (Moderna or Pfizer-BioNTech) is\nrecommended for the booster dose for all vaccine-eligible populations including people who are pregnant or lactating. Those who are considering receipt of the Janssen COVID-19 Vaccine should see Appendix A: Guidance for use of Janssen\nCOVID-19 Vaccine. Can pregnant or breastfeeding people be vaccinated? \uf1aa\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nFor more information, see COVID-19 Vaccines While Pregnant or Breastfeeding."}]}, {"title": "1372983d3f48de479c9d71a70f13acf8", "paragraphs": [{"qas": [{"question": "What should preterm infants receive COVID-19 vaccination at their chronological age?", "id": "100000000000000000001456", "answers": [{"text": "according to the same schedule and guidance", "answer_start": 232}], "is_impossible": false}, {"question": "What is the guidance for vaccinating preterm babies?", "id": "100000000000000000001457", "answers": [{"text": "should receive COVID-19 vaccination at their chronological age and according to the same schedule and guidance", "answer_start": 165}], "is_impossible": false}, {"question": "How long are infants born before 37 weeks gestation?", "id": "100000000000000000001458", "answers": [{"text": "preterm infants (infants born before 37 weeks\u2019 gestation), regardless of birth weight, should receive COVID-19 vaccination at their chronological age and according to the same schedule and guidance", "answer_start": 78}], "is_impossible": false}, {"question": "What is the guidance for vaccinating preterm infants?", "id": "100000000000000000001459", "answers": [{"text": "should receive COVID-19 vaccination at their chronological age and according to the same schedule and guidance", "answer_start": 165}], "is_impossible": false}, {"question": "What should infants of mothers who received a COVID-19 vaccine and/or had a SARS-CoV-2 infection do?", "id": "100000000000000000001460", "answers": [{"text": "should be vaccinated according to the recommended schedule", "answer_start": 481}], "is_impossible": false}], "context": "Special Populations and Situations\nIn accordance with general best practices, preterm infants (infants born before 37 weeks\u2019 gestation), regardless of birth\nweight, should receive COVID-19 vaccination at their chronological age and according to the same schedule and guidance\nas for full-term infants and children. What is the guidance for vaccinating preterm infants? \uf1aa\nInfants of mothers who were vaccinated and/or had COVID-19 or SARS-CoV-2 infection before or during pregnancy\nshould be vaccinated according to the recommended schedule. What is the guidance for vaccinating infants of mothers who received COVID-19 vaccine and/or\nhad COVID-19 or SARS-CoV-2 infection before or during pregnancy?"}]}, {"title": "d638fa89f1c9805b02992dd4babed2cd", "paragraphs": [{"qas": [{"question": "Who can be vaccinated at any time after receiving monoclonal antibodies or convalescent plasma?", "id": "100000000000000000001462", "answers": [{"text": "People who previously received SARS-CoV-2 antibody products", "answer_start": 2}], "is_impossible": false}, {"question": "People who are moderately or severely immunocompromised are not required to receive what?", "id": "100000000000000000001463", "answers": [{"text": "COVID-19 vaccination", "answer_start": 242}], "is_impossible": false}, {"question": "What should people who received a COVID-19 vaccination wait at least two weeks before receiving?", "id": "100000000000000000001464", "answers": [{"text": "tixagevimab/cilgavimab", "answer_start": 507}], "is_impossible": false}, {"question": "What is EVUSHELDTM?", "id": "100000000000000000001465", "answers": [{"text": "tixagevimab/cilgavimab", "answer_start": 507}], "is_impossible": false}, {"question": "For more information, see what?", "id": "100000000000000000001466", "answers": [{"text": "COVID-19 vaccination and EVUSHELD\u2122 and CDC\u2019s EVUSHELD\u2122 guidance", "answer_start": 619}], "is_impossible": false}, {"question": "What is a SARS-CoV-2 antibody product?", "id": "100000000000000000001468", "answers": [{"text": "anti-SARS-CoV-2 monoclonal antibodies or convalescent plasma", "answer_start": 63}], "is_impossible": false}], "context": "\uf1aa\nPeople who previously received SARS-CoV-2 antibody products (anti-SARS-CoV-2 monoclonal antibodies or convalescent\nplasma) as part of COVID-19 treatment, post-exposure prophylaxis, or pre-exposure prophylaxis can be vaccinated at any\ntime; COVID-19 vaccination does not need to be delayed following receipt of monoclonal antibodies or convalescent\nplasma. However, people who are moderately or severely immunocompromised and received a COVID-19 vaccination should wait\nat least two weeks before receiving tixagevimab/cilgavimab (EVUSHELD\u2122) for pre-exposure prophylaxis per the\nproduct EUA . For more information, see COVID-19 vaccination and EVUSHELD\u2122 and CDC\u2019s EVUSHELD\u2122 guidance. If my patient received a SARS-CoV-2 antibody product (anti-SARS-CoV-2 monoclonal antibodies or\nconvalescent plasma) can they be vaccinated?"}]}, {"title": "f4b855d6ffc384e0d95870811370da78", "paragraphs": [{"qas": [{"question": "What is acute peripheral facial nerve palsy?", "id": "100000000000000000001469", "answers": [{"text": "Bell\u2019s palsy", "answer_start": 18}], "is_impossible": false}, {"question": "What was reported following vaccination of participants in mRNA COVID-19 vaccine clinical trials?", "id": "100000000000000000001470", "answers": [{"text": "Rare cases of Bell\u2019s palsy", "answer_start": 4}], "is_impossible": false}, {"question": "Who was not able to determine whether these cases were causally related to vaccination?", "id": "100000000000000000001471", "answers": [{"text": "FDA", "answer_start": 167}], "is_impossible": false}, {"question": "What is Bell's palsy allowed to receive?", "id": "100000000000000000001472", "answers": [{"text": "COVID-19 vaccine", "answer_start": 350}], "is_impossible": false}, {"question": "What is recommended for the primary series of COVID-19 vaccines?", "id": "100000000000000000001473", "answers": [{"text": "Novavax", "answer_start": 412}], "is_impossible": false}, {"question": "What is the recommended vaccination for people who are not moderately or severely immunocompromised?", "id": "100000000000000000001474", "answers": [{"text": "COVID-19", "answer_start": 605}], "is_impossible": false}], "context": "\uf1aa\n\uf209\nRare cases of Bell\u2019s palsy (acute peripheral facial nerve palsy) were reported following vaccination of participants in mRNA\nCOVID-19 vaccine clinical trials, but FDA was not able to determine whether these cases were causally related to\nvaccination. People with a history of Bell\u2019s palsy may receive any currently FDA-approved or FDA-authorized COVID-19\nvaccine: mRNA (i.e., Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines are recommended for the primary\nseries and an age-appropriate mRNA vaccine is recommend for the booster dose. For more information on the recommended vaccination, see COVID-19 vaccination schedule for people who are not\nmoderately or severely immunocompromised."}]}, {"title": "4527f2e9f7e8f19ac47f275f2741ea81", "paragraphs": [{"qas": [{"question": "What type of vaccine is recommended for people with Bell's palsy?", "id": "100000000000000000001475", "answers": [{"text": "COVID-19", "answer_start": 6}], "is_impossible": false}, {"question": "What is GBS?", "id": "100000000000000000001476", "answers": [{"text": "a neurological disorder", "answer_start": 92}], "is_impossible": false}, {"question": "The body's immune system damages nerve cells, causing muscle weakness and paralysis?", "id": "100000000000000000001477", "answers": [{"text": "Novavax", "answer_start": 330}], "is_impossible": false}, {"question": "What is the name of the disease that causes Guillain-Barre syndrome?", "id": "100000000000000000001479", "answers": [{"text": "Bell\u2019s palsy", "answer_start": 69}], "is_impossible": false}, {"question": "Who recommends the COVID-19 vaccine for the primary series?", "id": "100000000000000000001480", "answers": [{"text": "Novavax", "answer_start": 330}], "is_impossible": false}], "context": "Which COVID-19 vaccines are recommended for people with a history of Bell\u2019s palsy? \uf1aa\nGBS is a neurological disorder in which the body\u2019s immune system damages nerve cells, causing muscle weakness and\nsometimes paralysis. For people with a history of GBS, as for the general population, mRNA (i.e., Moderna or Pfizer-\nBioNTech) and Novavax COVID-19 vaccines are recommended for the primary series, and an age-appropriate mRNA\nWhich COVID-19 vaccines are recommended for people with a history of Guillain-Barre syndrome\n(GBS)? \uf1aa\f10/30/22, 9:15 AM COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC\nvaccine is recommended for the booster dose."}]}, {"title": "e8f6ab5ba884e952bb8fadc2976d565b", "paragraphs": [{"qas": [{"question": "No increased risk of GBS has been identified with receipt of what vaccines?", "id": "100000000000000000001482", "answers": [{"text": "mRNA COVID-19", "answer_start": 61}], "is_impossible": false}, {"question": "See Guidance for use of which vaccine?", "id": "100000000000000000001483", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 109}], "is_impossible": false}, {"question": "For more information on the recommended vaccination, see what?", "id": "100000000000000000001484", "answers": [{"text": "COVID-19 vaccination schedule", "answer_start": 304}], "is_impossible": false}, {"question": "What is the recommended vaccination for people who are not moderately or severely immunocompromised?", "id": "100000000000000000001485", "answers": [{"text": "COVID-19 vaccination schedule", "answer_start": 304}], "is_impossible": false}, {"question": "When was the last time the COVID-19 vaccination schedule was reviewed?", "id": "100000000000000000001486", "answers": [{"text": "October 26, 2022", "answer_start": 418}], "is_impossible": false}], "context": "No increased risk of GBS has been identified with receipt of mRNA\nCOVID-19 vaccines. See Guidance for use of Janssen COVID-19 Vaccine and Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine for\ninformation on GBS and Janssen COVID-19 Vaccine. For more information on the recommended vaccination, see COVID-19 vaccination schedule for people who are not\nmoderately or severely immunocompromised. \uf209\n\uf20c\nLast Reviewed: October 26, 2022"}]}, {"title": "d186125b152e5612f1e893b135a1c05d", "paragraphs": [{"qas": [{"question": "What is the name of the CDC COVID-19 Vaccination Program?", "id": "100000000000000000001487", "answers": [{"text": "CDC Espa\u00f1ol | Other Languages Vaccines & Immunizations Vaccines & Immunizations Vaccines & Immunizations Home CDC COVID-19 Vaccination Program Provider Requirements and Support This page provides information about the CDC COVID-19 Vaccination Program \u2500 with vaccine being provided by the federal government \u2500 to ensure all people in the United States who wish to be vaccinated can receive vaccine without barriers, to the greatest extent possible. This page also serves as repository for any updates to the CDC COVID-19 Vaccination Provider Agreement", "answer_start": 75}], "is_impossible": false}, {"question": "Who provides the vaccine to all people in need?", "id": "100000000000000000001488", "answers": [{"text": "federal government", "answer_start": 363}], "is_impossible": false}, {"question": "What does CDC espaol do?", "id": "100000000000000000001489", "answers": [{"text": "CDC Espa\u00f1ol | Other Languages Vaccines & Immunizations Vaccines & Immunizations Vaccines & Immunizations Home CDC COVID-19 Vaccination Program Provider Requirements and Support This page provides information about the CDC COVID-19 Vaccination Program \u2500 with vaccine being provided by the federal government \u2500 to ensure all people in the United States who wish to be vaccinated can receive vaccine without barriers", "answer_start": 75}], "is_impossible": false}, {"question": "What is the purpose of this page?", "id": "100000000000000000001490", "answers": [{"text": "to ensure all people in the United States who wish to be vaccinated can receive vaccine without barriers", "answer_start": 384}], "is_impossible": false}, {"question": "What does this page serve as repository for?", "id": "100000000000000000001491", "answers": [{"text": "any updates to the CDC COVID-19 Vaccination Provider Agreement", "answer_start": 563}], "is_impossible": false}, {"question": "What is included in the Vaccination Provider Agreement?", "id": "100000000000000000001492", "answers": [{"text": "recommendations, requirements, and other useful information", "answer_start": 636}], "is_impossible": false}, {"question": "What are the recommendations, requirements, and other useful information for?", "id": "100000000000000000001493", "answers": [{"text": "vaccination providers participating in the program", "answer_start": 700}], "is_impossible": false}], "context": "10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations\nVaccines & Immunizations Home\nCDC COVID-19 Vaccination Program Provider\nRequirements and Support\nThis page provides information about the CDC COVID-19 Vaccination Program \u2500 with vaccine being provided by the federal\ngovernment \u2500 to ensure all people in the United States who wish to be vaccinated can receive vaccine without barriers, to the\ngreatest extent possible. This page also serves as repository for any updates to the CDC COVID-19 Vaccination Provider Agreement including\nrecommendations, requirements, and other useful information for vaccination providers participating in the program."}]}, {"title": "acbc620ff476f6ff4a3e5b96cd0369a", "paragraphs": [{"qas": [{"question": "Who has purchased all COVID-19 vaccines in the United States?", "id": "100000000000000000001494", "answers": [{"text": "the federal government", "answer_start": 78}], "is_impossible": false}, {"question": "Who is enrolled in the CDC COIVID-19 Vaccination Program?", "id": "100000000000000000001496", "answers": [{"text": "providers", "answer_start": 144}], "is_impossible": false}, {"question": "What is required of all providers participating in the COVIDR-19 vaccination program?", "id": "100000000000000000001498", "answers": [{"text": "sign a CDC COVID-19 Vaccination Program Provider Agreement", "answer_start": 604}], "is_impossible": false}], "context": "At this time, all COVID-19 vaccine in the United States has been purchased by the federal government for administration\nexclusively by enrolled providers through the CDC COVID-19 Vaccination Program. How to Enroll as a COVID-19\nVaccination Provider\n\uf2a1\nFAQs for Private & Public Healthcare\nProviders About Implementing the\nCDC COVID-19 Vaccination Program\nin Provider Practices\n\uf2a1\nVaccines for Children Program vs.\nCDC COVID-19 Vaccination Program\n\uf2a1\nFAQs for Federal Retail Pharmacy\nProgram Participants\n\uf2a1\nCOVID-19 vaccination providers participating in the CDC COVID-19 Vaccination Program are required to sign a CDC\nCOVID-19 Vaccination Program Provider Agreement."}]}, {"title": "f26f7e62f679172b9c6d3f20cb5927fd", "paragraphs": [{"qas": [{"question": "Who is responsible for adhering to all requirements outlined in the agreement?", "id": "100000000000000000001499", "answers": [{"text": "Providers", "answer_start": 0}], "is_impossible": false}, {"question": "Who must check this site regularly?", "id": "100000000000000000001500", "answers": [{"text": "Vaccination providers and organizations", "answer_start": 221}], "is_impossible": false}], "context": "Providers are responsible for adhering to all requirements outlined in the agreement, including updated\nrecommendations, requirements, and other guidance provided in the footnoted web links incorporated in the\nagreement. Vaccination providers and organizations must check this site regularly. A sign up is available below to receive emails any\ntime this page is updated."}]}, {"title": "71072ce64fe6fe8717639fdbaddb806b", "paragraphs": [{"qas": [{"question": "Who must administer the COVID-19 vaccine in accordance with prioritization groups determined?", "id": "100000000000000000001501", "answers": [{"text": "Providers", "answer_start": 435}], "is_impossible": false}, {"question": "What is the name of the Advisory Committee on Immunization Practices?", "id": "100000000000000000001502", "answers": [{"text": "Centers for Disease Control and Prevention", "answer_start": 127}], "is_impossible": false}, {"question": "Who must administer the COVID-19 vaccine in accordance with prioritization groups determined by appropriate public health authorities?", "id": "100000000000000000001503", "answers": [{"text": "Providers", "answer_start": 435}], "is_impossible": false}], "context": "CDC COVID-19 Vaccination Program Provider Agreement\nUPDATES - CDC COVID-19 Vaccination Program Provider Agreement Requirements\nCenters for Disease Control and Prevention Requirements and Advisory Committee on\nImmunization Practices (ACIP) Recommendations (Updated 10/25/2022)\n\uf1aa\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nwww.cdc.gov/vaccines/hcp/acip-recs/index.html\nCDC Requirements\nPrioritization\nProviders must administer COVID-19 vaccine in accordance with prioritization groups determined by appropriate public\nhealth authorities (i.e., HHS/CDC/ACIP, state/territorial health department in coordination with the state/territorial\ngovernor, Indian Health Service, Tribal Health Programs, Urban Indian Organizations, the Freely Associated States)."}]}, {"title": "a69103d2a24bb8e7591be24699728d73", "paragraphs": [{"qas": [{"question": "When will the Mask Distribution Initiative take place?", "id": "100000000000000000001504", "answers": [{"text": "January 20, 2022", "answer_start": 30}], "is_impossible": false}, {"question": "What is the name of the subcomponent of the CDC COVID-19 Vaccination Program?", "id": "100000000000000000001505", "answers": [{"text": "Mask Distribution Initiative", "answer_start": 0}], "is_impossible": false}, {"question": "Who will provide shipping and other necessary information to the SNS to receive shipments of the masks?", "id": "100000000000000000001507", "answers": [{"text": "Designated providers", "answer_start": 429}], "is_impossible": false}, {"question": "What is the acronym for the National Institute for Occupational Safety and Health?", "id": "100000000000000000001508", "answers": [{"text": "NIOSH", "answer_start": 365}], "is_impossible": false}, {"question": "Name, title, and contact information for the individual who will coordinate the provider\u2019s participation in this initiative?", "id": "100000000000000000001510", "answers": [{"text": "Designated providers will provide shipping and other necessary information to the SNS to receive shipments of the masks", "answer_start": 429}], "is_impossible": false}], "context": "Mask Distribution Initiative (January 20, 2022)\nAs a subcomponent of the CDC COVID-19 Vaccination Program, designated enrolled providers are authorized to\nreceive from the Department of Health and Human Services Strategic National Stockpile (SNS) N95 masks (also\nknown as respirators) that are approved by the National Institute for Occupational Safety and Health (NIOSH) for free\ndistribution to people in the United States. 1. Designated providers will provide shipping and other necessary information to the SNS to receive shipments of\nthe masks, in addition to the name, title, and contact information for the individual who will coordinate the\nprovider\u2019s participation in this initiative."}]}, {"title": "95ef4ba0d8b4d0713af400d9005d43cc", "paragraphs": [{"qas": [{"question": "Where will masks be distributed by the provider?", "id": "100000000000000000001512", "answers": [{"text": "at locations readily accessible to the public", "answer_start": 196}], "is_impossible": false}, {"question": "Who should have supply in every year?", "id": "100000000000000000001513", "answers": [{"text": "Providers", "answer_start": 309}], "is_impossible": false}, {"question": "Who should have supply in every store that offers COVID-19 vaccine?", "id": "100000000000000000001514", "answers": [{"text": "Providers", "answer_start": 309}], "is_impossible": false}], "context": "HHS is responsible to ship, at U.S. Government (USG) expense, USG-\npurchased masks to agreed-upon distribution points designated by the provider. 2. Such masks will be distributed by the provider at locations readily accessible to the public. Subject to receiving\nadequate supply from the U.S. government:\na. Providers should have supply in every store that offers COVID-19 vaccine. b. Providers should prioritize maintaining highest inventory in stores servicing high socially vulnerable (SVI)\npopulations and stores with the highest demand. 3."}]}, {"title": "21f475eb49d34a61614b5e3b3531aad9", "paragraphs": [{"qas": [{"question": "Who will have the sole responsibility for any reporting of inventory throughput or other data?", "id": "100000000000000000001516", "answers": [{"text": "USG", "answer_start": 195}], "is_impossible": false}, {"question": "What does USG purchase N95 masks for?", "id": "100000000000000000001518", "answers": [{"text": "use by individuals", "answer_start": 418}], "is_impossible": false}, {"question": "How can receipt of masks be conditioned?", "id": "100000000000000000001520", "answers": [{"text": "Receipt of masks cannot be conditioned on purchase of other products or services", "answer_start": 438}], "is_impossible": false}], "context": "Providers may direct bulk quantities of the masks to long-term care facilities for free distribution to their residents\nand communities at no cost subject to the requirements of this section. 4. USG will have the sole responsibility for any reporting of inventory throughput or other data. 5. Providers distributing USG-purchased N95 masks provided through this initiative agree to provide the masks at\nno charge, for use by individuals. Receipt of masks cannot be conditioned on purchase of other products or\nservices."}]}, {"title": "238d416520471e246b6b964a92be9aec", "paragraphs": [{"qas": [{"question": "Who shall have no responsibility for individual usage of masks or other conduct?", "id": "100000000000000000001522", "answers": [{"text": "provider", "answer_start": 218}], "is_impossible": false}, {"question": "What are providers not responsible for monitoring or enforcing?", "id": "100000000000000000001523", "answers": [{"text": "those that choose to take masks", "answer_start": 362}], "is_impossible": false}, {"question": "Providers will post a web link to a USG and/or manufacturer URL, provided by HHS, on their websites?", "id": "100000000000000000001524", "answers": [{"text": "to instructions for proper fit and use", "answer_start": 568}], "is_impossible": false}], "context": "Provider shall not be required to engage in any fit testing, medical evaluations, or training, regardless of\nwhether individuals obtain masks for employment or other purposes. 6. Absent willful misconduct by provider, provider shall have no responsibility for individual usage of masks or other\nconduct. Providers are not responsible for monitoring or enforcing those that choose to take masks nor confirm\nthat they are for personal versus business or other usage. 7. Providers will post a web link to a USG and/or manufacturer URL, provided by HHS, on their websites to\ninstructions for proper fit and use."}]}, {"title": "e01243f4d985f82137d9c3691ed2c65b", "paragraphs": [{"qas": [{"question": "What will the uniform signage address?", "id": "100000000000000000001528", "answers": [{"text": "The masks have been provided by the U.S. Department of Health and Human Services for free distribution. b. The masks are provided for personal use only", "answer_start": 230}], "is_impossible": false}, {"question": "What is the only use of masks provided?", "id": "100000000000000000001530", "answers": [{"text": "personal", "answer_start": 364}], "is_impossible": false}, {"question": "Who can use the QR code and/or weblink to obtain user instructions?", "id": "100000000000000000001531", "answers": [{"text": "recipients of the masks", "answer_start": 467}], "is_impossible": false}], "context": "In addition, providers will post notice visible to the public at the site of any\nmask distribution under this initiative utilizing uniform signage that will be provided electronically by HHS, which,\nat a minimum, will address:\na. The masks have been provided by the U.S. Department of Health and Human Services for free distribution. b. The masks are provided for personal use only. c. And, the public notice will include a QR code and/or weblink that can be used by recipients of the masks to\nobtain user instructions."}]}, {"title": "d1b729c57b9b0c26b574ee52f3945329", "paragraphs": [{"qas": [{"question": "What are U.S. Government Property Masks?", "id": "100000000000000000001532", "answers": [{"text": "Masks", "answer_start": 25}], "is_impossible": false}, {"question": "What is prohibited from selling, diversion, or distribution of masks for payment?", "id": "100000000000000000001533", "answers": [{"text": "U.S. Government Property Masks provided through this initiative are U.S. government property and remain U.S. government property until received by the individual who intends to wear the mask. Any sale, diversion, or other distribution of these masks for payment, whether direct or indirect, is prohibited and may be subject to civil or criminal prosecution", "answer_start": 0}], "is_impossible": false}, {"question": "What is prohibited and may be subject to civil or criminal prosecution?", "id": "100000000000000000001535", "answers": [{"text": "Any sale, diversion, or other distribution of these masks for payment", "answer_start": 192}], "is_impossible": false}, {"question": "Who may terminate its participation in the Mask Distribution Initiative by notifying the SNS?", "id": "100000000000000000001536", "answers": [{"text": "Provider", "answer_start": 358}], "is_impossible": false}, {"question": "What will be distributed in conformity with Agreement?", "id": "100000000000000000001537", "answers": [{"text": "Any remaining inventory of USG-purchased N95 masks", "answer_start": 529}], "is_impossible": false}], "context": "U.S. Government Property\nMasks provided through this initiative are U.S. government property and remain U.S. government property until\nreceived by the individual who intends to wear the mask. Any sale, diversion, or other distribution of these masks for\npayment, whether direct or indirect, is prohibited and may be subject to civil or criminal prosecution. Provider may terminate its participation in the Mask Distribution Initiative by notifying the SNS without impacting\nparticipation in the CDC COVID-19 Vaccination Program. Any remaining inventory of USG-purchased N95 masks will\nbe distributed in conformance with Agreement."}]}, {"title": "a060c2d68642b754b82170367803e1e0", "paragraphs": [{"qas": [{"question": "Who is required to provide a single Novavax COVID-19 vaccine booster dose for persons ages 18 years and older?", "id": "100000000000000000001538", "answers": [{"text": "Providers", "answer_start": 169}], "is_impossible": false}, {"question": "How long after completing a COVID-19 primary series vaccination should a person receive an mRNA bivalent booster dose?", "id": "100000000000000000001539", "answers": [{"text": "six months", "answer_start": 472}], "is_impossible": false}, {"question": "For persons ages 18 years and older, without history of prior booster dose, who are unable or unwilling to receive a booster dose at least?", "id": "100000000000000000001540", "answers": [{"text": "six months after completion of a COVID-19 primary series vaccination", "answer_start": 472}], "is_impossible": false}], "context": "10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nNovavax COVID-19 Vaccine Booster Doses\nPursuant to October 19, 2022, CDC recommendations:\nProviders in the CDC COVID-19 Vaccination Program shall make available and administer, upon request, a single\nNovavax COVID-19 vaccine booster dose for persons ages 18 years and older, without history of prior booster\ndose, who are unable or unwilling to receive an mRNA bivalent booster dose, at least six months after completion\nof a COVID-19 primary series vaccination."}]}, {"title": "2d6c355e32312e855f27524594634a7a", "paragraphs": [{"qas": [{"question": "What should you do if you are unable to fulfill a request from an age-eligible person for a booster dose of Novavax COVID-19 Vaccine, Adjuvanted?", "id": "100000000000000000001541", "answers": [{"text": "notify the requesting person", "answer_start": 121}], "is_impossible": false}, {"question": "Where can providers having the vaccine be located?", "id": "100000000000000000001542", "answers": [{"text": "through the website https://www.vaccines.gov/.", "answer_start": 199}], "is_impossible": false}], "context": "When unable to fulfill a request from an age-eligible person for a booster dose of Novavax COVID-19 Vaccine,\nAdjuvanted, notify the requesting person that providers having the vaccine can be located through the website\nhttps://www.vaccines.gov/."}]}, {"title": "e510a6c97d1ebbf4dd7d11641ffba94", "paragraphs": [{"qas": [{"question": "What is the date of the 10/12/22 Update?", "id": "100000000000000000001543", "answers": [{"text": "9/1/22 update to reference younger children 5 years and older who are now eligible to receive the bivalent booster): Single Bivalent COVID-19 Vaccine Booster Doses Pursuant to September 1 and October 12, 2022", "answer_start": 29}], "is_impossible": false}, {"question": "What are the dates for the Single Bivalent COVID-19 Doses?", "id": "100000000000000000001544", "answers": [{"text": "September 1 and October 12, 2022", "answer_start": 205}], "is_impossible": false}, {"question": "When did the Secretarial Directives on Bivalent COVID-19 Vaccine Booster Doses come into effect?", "id": "100000000000000000001545", "answers": [{"text": "September 1 and October 12, 2022", "answer_start": 205}], "is_impossible": false}, {"question": "Who shall make available a single booster dose of the Pfizer-BioNTech COVID-19, Bivalent (Original and Omicron BA.4/BA.5) vaccine upon request?", "id": "100000000000000000001546", "answers": [{"text": "all providers", "answer_start": 373}], "is_impossible": false}], "context": "10/12/22 Update (Revises the 9/1/22 update to reference younger children 5 years and older who are\nnow eligible to receive the bivalent booster):\nSingle Bivalent COVID-19 Vaccine Booster Doses\nPursuant to September 1 and October 12, 2022, CDC/ACIP recommendations and the September 2 and October 13,\n2022, Secretarial Directives on Bivalent COVID-19 Vaccine Booster Doses, all providers in the CDC COVID-19\nVaccination Program shall make immediately available and administer, upon request, a single booster dose of:\nPfizer-BioNTech COVID-19, Bivalent (Original and Omicron BA.4/BA.5) vaccine to individuals ages 5 years and\nolder at least 2 months after receipt of a primary series or prior monovalent booster dose with any COVID-19\nvaccine."}]}, {"title": "f0127e718daaab1827e93e11511d0248", "paragraphs": [{"qas": [{"question": "What does Moderna COVID-19, Bivalent (Original and Omicron BA.4/BA.5) vaccine give to individuals ages 6 years and older at least 2 months after receipt of a primary series or prior monovalent booster dose?", "id": "100000000000000000001548", "answers": [{"text": "COVID-19 vaccine", "answer_start": 203}], "is_impossible": false}, {"question": "What are the recommended booster doses for the Bivalent Covid-19 vaccine without regard to?", "id": "100000000000000000001549", "answers": [{"text": "the number of previous monovalent booster doses received", "answer_start": 298}], "is_impossible": false}, {"question": "What vaccine booster doses are no longer recommended for persons ages 5 and older?", "id": "100000000000000000001550", "answers": [{"text": "Monovalent COVID-19", "answer_start": 356}], "is_impossible": false}], "context": "or\nModerna COVID-19, Bivalent (Original and Omicron BA.4/BA.5) vaccine to individuals ages 6 years and older at\nleast 2 months after receipt of a primary series or prior monovalent booster dose with any COVID-19 vaccine. Bivalent COVID-19 vaccine booster dose recommendations are without regard to the number of previous\nmonovalent booster doses received. Monovalent COVID-19 vaccine booster doses are no longer recommended for persons ages 5 years and older."}]}, {"title": "e41cb7d18014ccaa7224f6a747e87e1f", "paragraphs": [{"qas": [{"question": "What is another term for heterologous booster doses?", "id": "100000000000000000001551", "answers": [{"text": "mix and match", "answer_start": 14}], "is_impossible": false}, {"question": "Who recommends groups to receive bivalent booster vaccination after a primary series of Pfizer-BioNTech, Moderna, Novavax, or Janssen COVID-19 vaccine?", "id": "100000000000000000001552", "answers": [{"text": "CDC", "answer_start": 75}], "is_impossible": false}, {"question": "What may be provided as age-eligible?", "id": "100000000000000000001553", "answers": [{"text": "a single booster dose of the bivalent Pfizer-BioNTech or Moderna COVID-19 vaccines", "answer_start": 210}], "is_impossible": false}], "context": "Heterologous (mix and match) booster doses\nAmong the groups recommended by CDC to receive bivalent booster vaccination after a primary series of Pfizer-\nBioNTech, Moderna, Novavax, or Janssen COVID-19 vaccine, a single booster dose of the bivalent Pfizer-BioNTech\nor Moderna COVID-19 vaccines may be provided as a heterologous bivalent booster dose, as age-eligible."}]}, {"title": "d85538623e7c76567e1b8fbf26a72a28", "paragraphs": [{"qas": [{"question": "How many doses of the Novavax COVID-19 Vaccine, Adjuvanted are available?", "id": "100000000000000000001556", "answers": [{"text": "two", "answer_start": 322}], "is_impossible": false}, {"question": "What is the primary series of the vaccine for persons ages 18 and older?", "id": "100000000000000000001557", "answers": [{"text": "Adjuvanted", "answer_start": 357}], "is_impossible": false}, {"question": "Where can you find providers having the vaccine?", "id": "100000000000000000001558", "answers": [{"text": "through the website", "answer_start": 601}], "is_impossible": false}, {"question": "Where can one get the vaccine?", "id": "100000000000000000001559", "answers": [{"text": "through the website", "answer_start": 601}], "is_impossible": false}, {"question": "What is the name of the website that can be used to get the vaccination?", "id": "100000000000000000001560", "answers": [{"text": "https://www.vaccines.gov/.", "answer_start": 700}], "is_impossible": false}], "context": "Novavax COVID-19 Vaccination of Persons 18 Years of Age and Older\nPursuant to CDC/ACIP recommendations and the July 21, 2022, Secretarial Directive, as of July 25, 2022, CDC COVID-\n19 Vaccination Program enrolled providers shall:\nIf they have the vaccine in stock, make immediately available and administer upon request a two-dose Novavax\nCOVID-19 Vaccine, Adjuvanted primary series for persons ages 18 years and older. When unable to fulfill a request from an age-eligible person for Novavax COVID-19 Vaccine, Adjuvanted, notify the\nrequesting person that providers having the vaccine can be located through the website\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nhttps://www.vaccines.gov/."}]}, {"title": "96f3fc949e4dcdc61d40aea7e57328b1", "paragraphs": [{"qas": [{"question": "What is the age-appropriate Moderna COVID-19 Vaccine for?", "id": "100000000000000000001563", "answers": [{"text": "6 years through 17 years of age", "answer_start": 233}], "is_impossible": false}, {"question": "How many doses of CDC COVID-19 Vaccine are available for children ages 6 months through 17 years?", "id": "100000000000000000001564", "answers": [{"text": "two", "answer_start": 528}], "is_impossible": false}, {"question": "What is the age-appropriate moderna vaccination product for children?", "id": "100000000000000000001565", "answers": [{"text": "COVID-19", "answer_start": 578}], "is_impossible": false}, {"question": "Who is responsible for administering a three dose series of the moderna vaccine?", "id": "100000000000000000001566", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 693}], "is_impossible": false}, {"question": "How many doses of the Pfizer-BioNTech COVID-19 Vaccine product are available for children ages 6 months through 4 years?", "id": "100000000000000000001567", "answers": [{"text": "three", "answer_start": 649}], "is_impossible": false}, {"question": "How many do children take in the two-dose series?", "id": "100000000000000000001568", "answers": [{"text": "6 months", "answer_start": 621}], "is_impossible": false}, {"question": "What is the name of the vaccine that replaces the 6/18/22 Update?", "id": "100000000000000000001569", "answers": [{"text": "COVID-19", "answer_start": 125}], "is_impossible": false}, {"question": "What is the third dose for recipients of Pfizer-BioNTech or Moderna COVID-19 Vaccine who are immunocompromised pursuant to CDC/ACIP recommendations and Secretarial Directives?", "id": "100000000000000000001570", "answers": [{"text": "three-dose series", "answer_start": 649}], "is_impossible": false}, {"question": "What color cap is given to children 6 months through 5 years of age?", "id": "100000000000000000001573", "answers": [{"text": "Dark blue", "answer_start": 1733}], "is_impossible": false}, {"question": "To children 6 years through 11 years, what color border is given?", "id": "100000000000000000001574", "answers": [{"text": "Dark blue cap/purple", "answer_start": 1806}], "is_impossible": false}, {"question": "Who may administer COVID-19 vaccines under the CDC Interim Clinical Considerations and Emergency Use Instructions?", "id": "100000000000000000001575", "answers": [{"text": "Providers", "answer_start": 2031}], "is_impossible": false}, {"question": "What date was the Secretarial Directive updated to include a reference to?", "id": "100000000000000000001577", "answers": [{"text": "May 23, 2022", "answer_start": 2784}], "is_impossible": false}, {"question": "When did CDC make a revision to the Vaccination Provider Requirements and Support?", "id": "100000000000000000001580", "answers": [{"text": "9/1/22", "answer_start": 2556}], "is_impossible": false}, {"question": "What group are monovalent?", "id": "100000000000000000001581", "answers": [{"text": "Children 5 through 11 Years of Age", "answer_start": 2704}], "is_impossible": false}, {"question": "What do providers in the CDC COVID-19 Vaccination Program make immediately available and administer?", "id": "100000000000000000001582", "answers": [{"text": "a single monovalent booster dose of Pfizer-BioNTech COVID-19 vaccine", "answer_start": 2979}], "is_impossible": false}, {"question": "How long after completing a Pfizer-BioNTech COVID-19 vaccine primary series should children receive a single monovalent booster dose?", "id": "100000000000000000001583", "answers": [{"text": "5 months", "answer_start": 3218}], "is_impossible": false}], "context": "6/23/22 Update (replaces 6/18/22 update; and revised to be a consolidated update that addresses all\nprimary series pediatric COVID-19 vaccination; 6/23/22 update also adds availability of age-appropriate\nModerna COVID-19 Vaccine for 6 years through 17 years of age):\nCOVID-19 Vaccination of Children 6 Months through 17 Years of Age\nPursuant to CDC/ACIP recommendations and Secretarial Directives:\nAll authorized providers in the CDC COVID-19 Vaccination Program shall make immediately available and administer\nupon request \u2013\na two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three-dose series using the age-appropriate Pfizer-BioNTech COVID-19 Vaccine product for children ages 6\nmonths through 4 years\na two-dose series using the age-appropriate Pfizer-BioNTech COVID-19 Vaccine product for children ages 5 years\nthrough 17 years\n6/23/22 Update (replaces 6/18/22, 1/6/22, 9/14/21 and 10/7/21 updates; additional eligible group noted\nin bold italics; Updated on 10/12/22 to remove reference to the purple cap Pfizer-BioNTech vials which\nare no longer available):\nThird Dose for Recipients of Pfizer-BioNTech or Moderna COVID-19 Vaccine Who Are Immunocompromised\nPursuant to CDC/ACIP recommendations and Secretarial Directives, a third primary dose of an mRNA COVID-19\nvaccine should be administered using the same mRNA COVID-19 vaccine as was administered for the 2-dose primary\nseries to persons who are moderately to severely immunocompromised at least 28 days after completing the two-\ndose primary series:\nPfizer-BioNTech COVID-19 Vaccine \u2013\nOrange cap to children 5 through 11 years of age\nGray cap to people 12 years and older\nModerna COVID-19 Vaccine \u2013\nDark blue cap/magenta border to children 6 months through 5 years of age\nDark blue cap/purple border to children 6 years through 11 years of age\nRed cap/light blue border to people 12 years and older\nCOVID-19 Vaccination Under the CDC Interim Clinical Considerations and Emergency Use Instructions\nProviders may also administer COVID-19 vaccines as described in CDC guidance as updated from time to time:\nInterim Clinical Considerations for Use of COVID-19 Vaccines in the United States\nEmergency Use Instructions (see vaccine Fact Sheets)\n5/23/22 Update (revision of 5/19/22 update to add reference to the May 23, 2022, Secretarial Directive;\n9/1/22 revision noted in bold italics to clarify that booster doses available to this age group are\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\n9/1/22 revision noted in bold italics to clarify that booster doses available to this age group are\nmonovalent):\nCOVID-19 Vaccine Booster Doses for Children 5 through 11 Years of Age\nPursuant to CDC/ACIP recommendations and the May 23, 2022, Secretarial Directive on Pediatric and Second COVID-\n19 Vaccine Booster Doses, all providers in the CDC COVID-19 Vaccination Program shall make immediately available\nand administer a single monovalent booster dose of Pfizer-BioNTech COVID-19 vaccine to individuals seeking such a\ndose as follows:\nChildren ages 5 through 11 years should receive a single monovalent Pfizer-BioNTech COVID-19 vaccine booster\ndose at least 5 months after completion of a Pfizer-BioNTech COVID-19 vaccine primary series."}]}, {"title": "4cb0b31d4a11f63628cf7181db46cc0b", "paragraphs": [{"qas": [{"question": "What should be administered to recipients of primary Janssen COVID-19 vaccination who are immunocompromised at least 28 days after the first dose?", "id": "100000000000000000001584", "answers": [{"text": "an additional dose", "answer_start": 146}], "is_impossible": false}, {"question": "What is the name of the mRNA vaccination used in the emergency use instructions?", "id": "100000000000000000001585", "answers": [{"text": "Pfizer-BioNTech or Moderna", "answer_start": 198}], "is_impossible": false}, {"question": "How many days after receiving the Janssen dose are you immunocompromised?", "id": "100000000000000000001586", "answers": [{"text": "28", "answer_start": 362}], "is_impossible": false}], "context": "Second Dose for Recipients of Janssen COVID-19 Vaccine Who are Immunocompromised\nAs provided in the February 11, 2022 Emergency Use Instructions, an additional dose, using an mRNA COVID-19\nvaccine (Pfizer-BioNTech or Moderna), should be administered to recipients of primary Janssen COVID-19 vaccination\nwho are moderately or severely immunocompromised at least 28 days after receipt of the primary Janssen dose."}]}, {"title": "64f8d1884b8a98126f0e9215cb59d182", "paragraphs": [{"qas": [{"question": "What are the Emergency Use Instructions for COVID-19 Vaccines Currently Approved or Authorized in the United States?", "id": "100000000000000000001590", "answers": [{"text": "Interim Clinical Considerations", "answer_start": 717}], "is_impossible": false}], "context": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster doses):\nThird primary dose/booster dose COVID-19 vaccination of persons in the United States who received COVID-19\nvaccination outside of the United States or as part of a clinical trial\nAll providers are required to offer third primary doses or bivalent booster doses of the Pfizer-BioNTech or Moderna\nCOVID-19 vaccine to qualifying persons who received particular non-FDA authorized/approved COVID-19 vaccines\noutside of the United States or as part of certain COVID-19 clinical trials as described in the Emergency Use\nInstructions issued by CDC on November 17, 2021, and February 11, 2022: Pfizer EUI , Moderna EUI , and\nInterim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States\n(https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html)."}]}, {"title": "e0583a09550aab1cbeea1fb08d863496", "paragraphs": [{"qas": [{"question": "When was reference to Pfizer-BioNTech COVID-19 vaccination of children 5-11 years of age moved to consolidated 6/23/22 pediatric primary series update?", "id": "100000000000000000001592", "answers": [{"text": "6/23/22", "answer_start": 238}], "is_impossible": false}, {"question": "What age group was moved to the consolidated 6/23/22 pediatric primary series update?", "id": "100000000000000000001593", "answers": [{"text": "5-11 years of age consolidated into 6/23/22 pediatric primary series update): COVID-19 Vaccination of Children 5 through 11 Years of Age 5/12/21 Update (On 6/23/22 the 5/12/21 reference to Pfizer-BioNTech COVID-19 vaccination of adolescents 12-15 years of age", "answer_start": 82}], "is_impossible": false}, {"question": "As of April 19, 2021, all persons qualified under the terms of the applicable COVID-19 vaccine Emergency Use Authorization are eligible to be vaccinated?", "id": "100000000000000000001594", "answers": [{"text": "3/17/21 Update", "answer_start": 428}], "is_impossible": false}], "context": "\uf20c \uf20c\n11/3/21 Update (reference to Pfizer-BioNTech COVID-19 vaccination of children 5-11 years of age\nconsolidated into 6/23/22 pediatric primary series update):\nCOVID-19 Vaccination of Children 5 through 11 Years of Age\n5/12/21 Update (On 6/23/22 the 5/12/21 reference to Pfizer-BioNTech COVID-19 vaccination of\nadolescents 12-15 years of age was moved to consolidated 6/23/22 pediatric primary series update)\nWith regard to the 3/17/21 Update, as of April 19, 2021, all persons qualified under the terms of the applicable\nCOVID-19 vaccine Emergency Use Authorization are eligible to be vaccinated, as that list of qualified persons may\nchange over time."}]}, {"title": "2ed3612fffda75704d01968558f55117", "paragraphs": [{"qas": [{"question": "What is not intended to prevent prioritizing specific populations for specific vaccination clinics/events with the purpose of promoting health equity?", "id": "100000000000000000001595", "answers": [{"text": "COVID-19 Vaccine", "answer_start": 370}], "is_impossible": false}, {"question": "What must providers provide before administering COVID-19 Vaccine?", "id": "100000000000000000001596", "answers": [{"text": "an approved FDA Emergency Use Authorization (EUA) Fact Sheet, FDA Vaccine Information Fact Sheet, or CDC Vaccine Information Statement (VIS),", "answer_start": 411}], "is_impossible": false}, {"question": "Who must provide an approved EUA Fact Sheet before administering COVID-19 Vaccine?", "id": "100000000000000000001597", "answers": [{"text": "providers", "answer_start": 388}], "is_impossible": false}], "context": "This is not intended to prevent prioritizing particular populations for specific vaccination\nclinics/events with the purpose of promoting health equity. 10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nProvision of Information to Vaccine Recipients (Updated 2/9/22 to reference Moderna\u2019s COVID-19 vaccine BLA approval)\nBefore administering COVID-19 Vaccine, providers must provide an approved FDA Emergency Use Authorization (EUA)\nFact Sheet, FDA Vaccine Information Fact Sheet, or CDC Vaccine Information Statement (VIS), as applicable, to each\nvaccine recipient, the adult caregiver accompanying the recipient, or other legal representative."}]}, {"title": "9d6ab4fa4537b3a38f6f24de2f55cd7b", "paragraphs": [{"qas": [{"question": "What does VIS stand for?", "id": "100000000000000000001599", "answers": [{"text": "Vaccine Information Statement", "answer_start": 46}], "is_impossible": false}, {"question": "What is the name of the combination COVID-19 Vaccine Information Fact Sheet?", "id": "100000000000000000001600", "answers": [{"text": "FDA has issued a combination COVID-19 Vaccine Information Fact Sheet for Recipients and Caregivers", "answer_start": 128}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COMIRNATY COVID-19 Vaccine?", "id": "100000000000000000001601", "answers": [{"text": "FDA authorized", "answer_start": 247}], "is_impossible": false}, {"question": "What are the names of the two vaccines?", "id": "100000000000000000001602", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine and the FDA Biologics License Application (BLA) approved (licensed) Pfizer-BioNTech COMIRNATY COVID-19 Vaccine", "answer_start": 268}], "is_impossible": false}, {"question": "Who must give each vaccine recipient a copy of the EUA or BLA approval?", "id": "100000000000000000001603", "answers": [{"text": "providers", "answer_start": 555}], "is_impossible": false}], "context": "In lieu of CDC developing a separate COVID-19 Vaccine Information Statement (VIS) at this time for the licensed Pfizer\nvaccine, FDA has issued a combination COVID-19 Vaccine Information Fact Sheet for Recipients and Caregivers to\naddress both the FDA authorized (EUA) Pfizer-BioNTech COVID-19 Vaccine and the FDA Biologics License Application (BLA)\napproved (licensed) Pfizer-BioNTech COMIRNATY COVID-19 Vaccine. The vaccines have identical formulations. When\nadministering the Pfizer-BioNTech COVID-19 vaccine under either the EUA or under BLA approval, providers must give\neach vaccine recipient, adult caregiver accompanying the recipient, or other legal representative, a copy of the age-\nappropriate Pfizer-BioNTech COVID-19 Vaccine Information Fact Sheet."}]}, {"title": "12b09723bb79199c49df9c9abce16dfe", "paragraphs": [{"qas": [{"question": "What do the vaccines have identical formulations?", "id": "100000000000000000001606", "answers": [{"text": "Moderna SPIKEVAX COVID-19 Vaccine", "answer_start": 278}], "is_impossible": false}, {"question": "What is the name of the approved (licensed) Moderna SPIKEVAX COVID-19 Vaccine?", "id": "100000000000000000001607", "answers": [{"text": "FDA BLA", "answer_start": 250}], "is_impossible": false}, {"question": "Who must give each vaccine recipient a copy of the combined Moderna COVId-19Vaccine Information Fact Sheet?", "id": "100000000000000000001609", "answers": [{"text": "providers", "answer_start": 446}], "is_impossible": false}, {"question": "What is the combined Moderna COVID-19 Vaccine Information Fact Sheet?", "id": "100000000000000000001610", "answers": [{"text": "a copy", "answer_start": 566}], "is_impossible": false}], "context": "Similarly, in lieu of a separate COVID-19 VIS for the licensed Moderna vaccine, FDA has issued a combination Moderna\nCOVID-19 Vaccine Fact Sheet for Recipients and Caregivers to address both the FDA authorized (EUA) Moderna COVID-\n19 Vaccine and the FDA BLA approved (licensed) Moderna SPIKEVAX COVID-19 Vaccine. The vaccines have identical\nformulations. When administering the Moderna COVID-19 vaccine under either the EUA or under BLA approval,\nproviders must give each vaccine recipient, adult caregiver accompanying the recipient, or other legal representative, a\ncopy of the combined Moderna COVID-19 Vaccine Information Fact Sheet. [Additions to CDC COVID-19 Vaccination Program Provider Agreements, Paragraph 1.]"}]}, {"title": "67010c1f428ee506223ebd4d03bbd2d4", "paragraphs": [{"qas": [{"question": "What is the current status of all COVID-19 vaccines in the US?", "id": "100000000000000000001611", "answers": [{"text": "all COVID-19 vaccine in the United States has been purchased by the United States Government", "answer_start": 77}], "is_impossible": false}, {"question": "How long does it take for the vaccine to be released?", "id": "100000000000000000001613", "answers": [{"text": "until vaccine is administered to the recipient", "answer_start": 370}], "is_impossible": false}, {"question": "What remains U.S. government property until vaccine is administered to the recipient?", "id": "100000000000000000001614", "answers": [{"text": "COVID-19 Vaccination Cards", "answer_start": 309}], "is_impossible": false}, {"question": "All USG furnished ancillary materials have remained property of what?", "id": "100000000000000000001615", "answers": [{"text": "United States Government", "answer_start": 631}], "is_impossible": false}, {"question": "What is the name of the CDC COVID-19 Vaccination Program?", "id": "100000000000000000001616", "answers": [{"text": "United States Government", "answer_start": 145}], "is_impossible": false}], "context": "Diversion of COVID-19 Vaccines Prohibited (updated 06/11/2021)\nAt this time, all COVID-19 vaccine in the United States has been purchased by the United States Government for\nadministration exclusively through the CDC COVID-19 Vaccination Program. The vaccine and all related ancillary supplies,\nincluding the COVID-19 Vaccination Cards, remains U.S. government property until vaccine is administered to the\nrecipient. Inherent in the reference to COVID-19 vaccine remaining property of the United States Government, all USG-\nfurnished ancillary materials, including COVID-19 Vaccination Record Cards, have remained property of the United States\nGovernment for exclusive use in the CDC COVID-19 Vaccination Program since the program\u2019s inception."}]}, {"title": "970369a5f3946e7e5511dab979f69f2c", "paragraphs": [{"qas": [{"question": "What is the name of the program that provides the CDC's vaccination record cards?", "id": "100000000000000000001618", "answers": [{"text": "COVID-19 Vaccination Program", "answer_start": 301}], "is_impossible": false}, {"question": "Who may not reproduce the COVID-19 Vaccination Record Cards without written permission of CDC?", "id": "100000000000000000001619", "answers": [{"text": "anyone other than authorized jurisdictions", "answer_start": 394}], "is_impossible": false}], "context": "This includes\nCOVID-19 Vaccination Record Cards that have been printed by agents on behalf of CDC, including the jurisdictions. USG-provided COVID-19 Vaccination Record Cards remain property of the United States Government until provided to\nthe vaccine recipient following vaccination through the CDC COVID-19 Vaccination Program. The COVID-19 Vaccination\nRecord Cards may not be reproduced by anyone other than authorized jurisdictions or without written permission of\nCDC. Any use or unauthorized reproduction of the COVID-19 Vaccination Cards outside of the CDC COVID-19 Vaccination\nProgram, or production or use of similar facsimiles of such cards, is prohibited."}]}, {"title": "e47afe733f9bb1b997efbec1f692f586", "paragraphs": [{"qas": [{"question": "What constitutes unauthorized production or use?", "id": "100000000000000000001621", "answers": [{"text": "fraud", "answer_start": 52}], "is_impossible": false}, {"question": "What is subject to criminal or civil prosecution for violation of 18 U.S.C.  1001?", "id": "100000000000000000001622", "answers": [{"text": "unauthorized production or use", "answer_start": 9}], "is_impossible": false}], "context": "Any such unauthorized production or use\nconstitutes fraud and is subject to criminal or civil prosecution for violation of 18 U.S.C. \u00a7 1001, 42 U.S.C. \u00a7 1320b-10, or\nother relevant federal statutes."}]}, {"title": "245c7c7c1ff91bb60e7490e8eb51793d", "paragraphs": [{"qas": [{"question": "Who is prohibited from selling USG-purchased COVID-19 vaccine?", "id": "100000000000000000001623", "answers": [{"text": "COVID-19 vaccination providers", "answer_start": 0}], "is_impossible": false}, {"question": "What is an example of an inducement for vaccinating an individual?", "id": "100000000000000000001624", "answers": [{"text": "direct or indirect", "answer_start": 221}], "is_impossible": false}, {"question": "What constitutes fraud and is a violation of the CDC COVID-19 Vaccination Program?", "id": "100000000000000000001625", "answers": [{"text": "diverting COVID-19 vaccine from the CDC COVID-19 Vaccination Program. Such use", "answer_start": 568}], "is_impossible": false}, {"question": "What constitutes fraud?", "id": "100000000000000000001626", "answers": [{"text": "diverting COVID-19 vaccine from the CDC COVID-19 Vaccination Program", "answer_start": 568}], "is_impossible": false}, {"question": "What is a violation of the terms of the provider agreement?", "id": "100000000000000000001627", "answers": [{"text": "fraud", "answer_start": 659}], "is_impossible": false}], "context": "COVID-19 vaccination providers are prohibited from selling USG-purchased COVID-19 vaccine (and ancillary materials\npurchased by the USG for use in the Vaccination Program), soliciting or receiving any inducement, whether direct or\nindirect, for vaccinating (or providing COVID-19 vaccine to be used for vaccinating) any individual who is not currently\neligible to receive COVID-19 vaccine as a member of a group currently authorized under prioritization specified by\nHHS/CDC/ACIP, the state/territory\u2019s governor or other relevant public health authority, or otherwise diverting COVID-19\nvaccine from the CDC COVID-19 Vaccination Program. Such use constitutes fraud and is a violation of the terms of the\nprovider agreement."}]}, {"title": "8133b423a3b6187781d9866c2ee269d", "paragraphs": [{"qas": [{"question": "What is rapidly increasing?", "id": "100000000000000000001631", "answers": [{"text": "Supplies of COVID-19 vaccine doses", "answer_start": 346}], "is_impossible": false}, {"question": "When will all persons qualified under the terms of the applicable COVID-19 vaccine Emergency Use Authorization become eligible?", "id": "100000000000000000001632", "answers": [{"text": "May 1, 2021", "answer_start": 415}], "is_impossible": false}], "context": "It shall be cause for immediate termination from the CDC COVID-19 Vaccination Program and\ncriminal or civil prosecution for violation of 18 U.S.C. \u00a7 1001 or other relevant federal statutes. Prioritization for receipt of COVID-19 vaccine in the early months of the CDC COVID-19 Vaccination Program was\nnecessary given limited supplies of vaccine. Supplies of COVID-19 vaccine doses are rapidly increasing. Effective May\n1, 2021, in conformance with the Secretary\u2019s March 17, 2021 directive to transition beyond priority groups, all\npersons qualified under the terms of the applicable COVID-19 vaccine Emergency Use Authorization are eligible to be\nvaccinated."}]}, {"title": "4272f9f5059a95b1ccea67ceaafa7731", "paragraphs": [{"qas": [{"question": "What is not intended to prevent prioritizing particular populations for specific vaccination clinics/events?", "id": "100000000000000000001635", "answers": [{"text": "CDC COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "What is not considered a diversion of COVID-19 vaccine?", "id": "100000000000000000001636", "answers": [{"text": "transfer of COVID-19 Vaccine through the CDC authorized redistribution process", "answer_start": 385}], "is_impossible": false}, {"question": "What is the CDC authorized redistribution process?", "id": "100000000000000000001637", "answers": [{"text": "transfer of COVID-19 Vaccine through the CDC authorized redistribution process from one enrolled provider to another enrolled provider for authorized vaccination", "answer_start": 385}], "is_impossible": false}], "context": "CDC COVID-19 Vaccination Program providers are required to make available and administer COVID-19\nvaccine to all such persons. This requirement is not intended to prevent prioritizing particular populations for\nspecific vaccination clinics/events with the purpose of promoting health equity. \uf209\n\uf209\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nNote that transfer of COVID-19 Vaccine through the CDC authorized redistribution process from one enrolled provider to\nanother enrolled provider for authorized vaccination is not considered to be diversion of COVID-19 vaccine."}]}, {"title": "9fba51b617e9a9de95f71a30c9ed5c70", "paragraphs": [{"qas": [{"question": "What will not be considered a prohibited diversion if vaccine doses have been prepared for scheduled administration and would otherwise be wasted due to malintent?", "id": "100000000000000000001638", "answers": [{"text": "a good faith judgment call by an enrolled provider", "answer_start": 9}], "is_impossible": false}, {"question": "What is prepared for scheduled administration and wasted due to expiration?", "id": "100000000000000000001639", "answers": [{"text": "vaccine doses", "answer_start": 270}], "is_impossible": false}], "context": "Further, a good faith judgment call by an enrolled provider to administer excess doses to individuals outside of\nauthorized prioritization groups, without malintent and without direct/indirect receipt of inducement, will not be\nconsidered a prohibited diversion if such vaccine doses have been prepared for scheduled administration and would\notherwise be wasted due to expiration."}]}, {"title": "178f6980f87cb68ed57d5da608b2d428", "paragraphs": [{"qas": [{"question": "Who is prohibited from using Vaccine Recipient Data for Commercial Marketing Purposes?", "id": "100000000000000000001640", "answers": [{"text": "providers", "answer_start": 149}], "is_impossible": false}, {"question": "What is the name of the updated provision of the COVID-19 Vaccination Provider Agreement?", "id": "100000000000000000001641", "answers": [{"text": "CDC COVID-19 Vaccination Program", "answer_start": 258}], "is_impossible": false}], "context": "Use of Vaccine Recipient Data for Commercial Marketing Purposes Prohibited (5/18/2021)\nNotwithstanding uses or disclosures otherwise allowed by law, providers are prohibited from using or disclosing data\ncollected from vaccine recipients for and through the CDC COVID-19 Vaccination Program for commercial marketing\npurposes or for any other purpose not allowed under this updated provision of the COVID-19 Vaccination Provider\nAgreement. Such data include COVID-19 vaccination registration information and vaccine administration data."}]}, {"title": "8acb08f326a421393f920acf0e3a8803", "paragraphs": [{"qas": [{"question": "What are the purposes of the CDC COVID-19 Vaccination Program?", "id": "100000000000000000001642", "answers": [{"text": "promote public health, advance positive patient outcomes, and promote health equity", "answer_start": 309}], "is_impossible": false}, {"question": "What is the purpose of the data collected?", "id": "100000000000000000001643", "answers": [{"text": "solely for the purposes of the CDC COVID-19 Vaccination Program", "answer_start": 25}], "is_impossible": false}, {"question": "What does this prohibition not limit?", "id": "100000000000000000001645", "answers": [{"text": "communications by health care providers to vaccine recipients", "answer_start": 436}], "is_impossible": false}], "context": "These\ndata are collected solely for the purposes of the CDC COVID-19 Vaccination Program and must be maintained in a\nmanner that protects the integrity of the CDC COVID-19 Vaccination Program by only being used or disclosed for the\npurposes of the COVID-19 Vaccination Program and other limited purposes that promote public health, advance positive\npatient outcomes, and promote health equity. This prohibition is not intended to limit communications by health care providers to vaccine recipients with whom the\nprovider has an existing relationship prior to contact about COVID-19 vaccination."}]}, {"title": "bb874e01828353ba46e841acf64e4bc4", "paragraphs": [{"qas": [{"question": "What is the name of a vaccine that is available for children?", "id": "100000000000000000001649", "answers": [{"text": "routine childhood vaccines", "answer_start": 534}], "is_impossible": false}, {"question": "What type of datasets can be used by providers for public health, population health, and health equity purposes?", "id": "100000000000000000001650", "answers": [{"text": "de-identified, aggregate datasets", "answer_start": 747}], "is_impossible": false}], "context": "The following are not included in the above prohibition:\nCommunications regarding receipt of a second dose, or potential booster dose(s), of COVID-19 vaccine\nCommunications to vaccine recipient for public health purposes\nCommunications to vaccine recipients involving pharmacy or clinical services of the provider, personalized to the\nvaccine recipient\u2019s medical needs, even if those services are not directly related to COVID-19 vaccination\nAvailability of other vaccines (e.g., shingles, pneumococcal conjugate, seasonal influenza, routine childhood vaccines)\nClinical emails\nDisease screening services\nCommunications about the availability of programs to manage particular health conditions (e.g., asthma, diabetes,\nheart disease)\nIn addition, de-identified, aggregate datasets can be used by providers and shared with other partners for public health,\npopulation health, and health equity purposes."}]}, {"title": "83ae723a3d0ee160f71b5b503d4f451", "paragraphs": [{"qas": [{"question": "What are communications with COVID-19 vaccine recipients involving the store component of any pharmacy or other provider considered to be?", "id": "100000000000000000001651", "answers": [{"text": "prohibited commercial marketing", "answer_start": 181}], "is_impossible": false}, {"question": "What is prohibited in the store as commercial marketing?", "id": "100000000000000000001653", "answers": [{"text": "Communications with COVID-19 vaccine recipients", "answer_start": 0}], "is_impossible": false}], "context": "Communications with COVID-19 vaccine recipients involving the store component of any pharmacy or other provider\nparticipating in the CDC COVID-19 Vaccination Program are considered prohibited commercial marketing. For example,\ntext, e-mail, mail, or other communications to COVID-19 vaccine recipients about products on sale in the store are\nprohibited as commercial marketing. COVID-19 vaccination registration information and vaccine administration data collected in the course of participation in\nthe CDC COVID-19 Vaccination Program cannot be sold, for direct or indirect remuneration, even with permission of the\nvaccine recipient."}]}, {"title": "e4fcf225a39678c8c7ee6e23cb4deac5", "paragraphs": [{"qas": [{"question": "Who can be reached at 1- 800-HHS-TIPS or TIPS.HHS.GOV?", "id": "100000000000000000001656", "answers": [{"text": "Office of the Inspector General", "answer_start": 180}], "is_impossible": false}], "context": "Reporting Suspected Fraud or Abuse\nIndividuals becoming aware of any suspected fraud or abuse or violations of provider agreement requirements are\nencouraged to report them to the Office of the Inspector General, U.S. Department of Health and Human Services at 1-\n800-HHS-TIPS or TIPS.HHS.GOV ."}]}, {"title": "940280692f10d1951f8b172a84ec1292", "paragraphs": [{"qas": [{"question": "Who must not deny anyone vaccination based on the recipient\u2019s coverage status or network status?", "id": "100000000000000000001658", "answers": [{"text": "CDC", "answer_start": 109}], "is_impossible": false}, {"question": "What does a program or plan cover?", "id": "100000000000000000001660", "answers": [{"text": "COVID-19 Vaccine administration fees", "answer_start": 649}], "is_impossible": false}, {"question": "What is a program or plan that covers COVID-19 Vaccine administration fees for the vaccine recipient?", "id": "100000000000000000001661", "answers": [{"text": "may seek appropriate reimbursement", "answer_start": 579}], "is_impossible": false}, {"question": "What is the name of the private insurance company that reimburses the recipient of the vaccine?", "id": "100000000000000000001662", "answers": [{"text": "Medicare or Medicaid", "answer_start": 768}], "is_impossible": false}, {"question": "What is another way that HRSA may not seek reimbursement from the vaccine recipient?", "id": "100000000000000000001666", "answers": [{"text": "balance billing", "answer_start": 1161}], "is_impossible": false}, {"question": "Who stopped accepting claims for reimbursement of costs associated with administering COVID-19 vaccines to uninsured?", "id": "100000000000000000001667", "answers": [{"text": "HRSA", "answer_start": 1517}], "is_impossible": false}, {"question": "What is the date of reimbursement for administering COVID-19 vaccines to uninsured and under insured individuals?", "id": "100000000000000000001668", "answers": [{"text": "April 5, 2022", "answer_start": 1685}], "is_impossible": false}, {"question": "On what date is reimbursement of costs associated with administering the vaccines?", "id": "100000000000000000001669", "answers": [{"text": "April 5, 2022", "answer_start": 1685}], "is_impossible": false}], "context": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC COVID-19 Vaccination Program:\n\uf209\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nmust administer COVID-19 Vaccine at no out-of-pocket cost to the recipient\nmay not deny anyone vaccination based on the vaccine recipient\u2019s coverage status or network status\nmay not charge an office visit or other fee if COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees for\nthe vaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement\nHRSA COVID-19 Coverage Assistance Fund for underinsured vaccine recipients (unavailable as of 11:59 ET on\nApril 5, 2022, due to lack of supplemental funding)\nHRSA COVID-19 Uninsured Program for non-insured vaccine recipients (unavailable as of 11:59 ET on April 5,\n2022, due to lack of supplemental funding)\nmay not seek any reimbursement, including through balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement of COVID-19 vaccine administration fees, go to:\nCMS Guidance \u2013 https://www.cms.gov/covidvax-provider\nCDC Statement on Exhaustion of Funding for the Uninsured Program and Coverage Assistance Fund\nDue to the lack of supplemental funding from Congress, HRSA stopped accepting claims for reimbursement of costs\nassociated with administering COVID-19 vaccines to uninsured and underinsured individuals as of 11:59 PM ET on April 5,\n2022."}]}, {"title": "a1ad1cd718ec28aa07ff254a2fe95f28", "paragraphs": [{"qas": [{"question": "Who strongly encourages providers to stay in the CDC COVID-19 Vaccination Program?", "id": "100000000000000000001670", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "What does CDC expect participating providers to continue to administer at no cost to patients?", "id": "100000000000000000001671", "answers": [{"text": "Vaccination Program", "answer_start": 62}], "is_impossible": false}], "context": "CDC strongly encourages providers to stay in the CDC COVID-19 Vaccination Program and CDC expects participating\nproviders will continue to administer these lifesaving vaccines at no cost to patients to ensure equitable access for all\nindividuals."}]}, {"title": "616ca847de0b16bd48ecb9a34ba4323", "paragraphs": [{"qas": [{"question": "What does CDC consider when it becomes aware of a provider engaging in any of the following?", "id": "100000000000000000001672", "answers": [{"text": "taking any and all appropriate measures", "answer_start": 90}], "is_impossible": false}, {"question": "What is the only medical service provided for COVID-19 vaccination?", "id": "100000000000000000001674", "answers": [{"text": "office visit", "answer_start": 427}], "is_impossible": false}, {"question": "What is another term for differentially reducing appointment access?", "id": "100000000000000000001675", "answers": [{"text": "based on the vaccine recipient\u2019s coverage status or network status", "answer_start": 348}], "is_impossible": false}, {"question": "How much does a vaccine recipient have to pay for additional medical services to receive a vaccination? When did ACIP Recommendations come out?", "id": "100000000000000000001676", "answers": [{"text": "9/7/2021", "answer_start": 695}], "is_impossible": false}, {"question": "How many medical and public health experts make recommendations for vaccine use in the US?", "id": "100000000000000000001677", "answers": [{"text": "15", "answer_start": 771}], "is_impossible": false}], "context": "Where CDC becomes aware of a provider engaging in any of the following, CDC will consider taking any and\nall appropriate measures, including the possibility of rescinding the CDC provider agreement:\nAdministering COVID-19 Vaccine at any out-of-pocket cost to the recipient\nDenying anyone vaccination, or differentially reducing appointment access, based on the vaccine recipient\u2019s\ncoverage status or network status\nCharging an office visit or other fee if COVID-19 vaccination is the sole medical service provided\nRequiring additional medical services to receive COVID-19 vaccination\nSeeking any reimbursement, including through balance billing, from the vaccine recipient\nACIP Recommendations (9/7/2021)\nThe Advisory Committee on Immunization Practices (ACIP) comprises 15 medical and public health experts who develop\nevidence-based recommendations for use of vaccines in the United States."}]}, {"title": "84db693bf6b39244bcced3f7ccf7a528", "paragraphs": [{"qas": [{"question": "What do the recommendations stand for?", "id": "100000000000000000001679", "answers": [{"text": "public health", "answer_start": 29}], "is_impossible": false}], "context": "The recommendations stand as public health\nguidance for the safe use of vaccines and related biological products."}]}, {"title": "1507a4cad9e990ac9f961289ea224f54", "paragraphs": [{"qas": [{"question": "Who adopts the recommendations of the ACIP?", "id": "100000000000000000001682", "answers": [{"text": "the CDC Director", "answer_start": 101}], "is_impossible": false}, {"question": "What is Pfizer-BioNTech's Interim Recommendation?", "id": "100000000000000000001685", "answers": [{"text": "The Advisory Committee on Immunization Practices", "answer_start": 592}], "is_impossible": false}, {"question": "What year was the Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years issued?", "id": "100000000000000000001686", "answers": [{"text": "2021", "answer_start": 587}], "is_impossible": false}, {"question": "What year did the United States release the COVID-19 Vaccine?", "id": "100000000000000000001690", "answers": [{"text": "2021", "answer_start": 1102}], "is_impossible": false}], "context": "COVID-19 vaccination providers are required to\nimplement all recommendations of the ACIP, adopted by the CDC Director, relevant to COVID-19 vaccination including:\nUse of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson)\nand mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on\nImmunization Practices \u2014 United States, July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine in Adolescents Aged 12\u201315 Years \u2014 United States, May 2021\nUpdated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen\n(Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among\nVaccine Recipients \u2014 United States, April 2021\nInterim Recommendation for Use of Janssen COVID-19 Vaccine \u2014 United States, February 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020\nInterim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine, United States, December 2020\nInterim Recommendation for Use of Moderna COVID-19 Vaccine, United States, December 2020\n\uf209\n\uf20c\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nInterim Recommendation for Use of Moderna COVID 19 Vaccine, United States, December 2020\nUpdated Interim Recommendation for Allocation of COVID-19 Vaccine, United States, December 2020\nFind more information about vaccine administration and reporting requirements."}]}, {"title": "7508864e8f2985166accc5ac569144c9", "paragraphs": [{"qas": [{"question": "After administering a dose of COVID-19 vaccine, record to the extent not already recorded in the vaccine recipient\u2019s record what?", "id": "100000000000000000001692", "answers": [{"text": "record all information marked below by an asterisk", "answer_start": 241}], "is_impossible": false}, {"question": "Where is the vaccine administered?", "id": "100000000000000000001693", "answers": [{"text": "location/facility name/ID", "answer_start": 466}], "is_impossible": false}, {"question": "What is the name of the company that administers the vaccine?", "id": "100000000000000000001694", "answers": [{"text": "Company", "answer_start": 562}], "is_impossible": false}, {"question": "Who is the recipient of the vaccine if revised by CDC?", "id": "100000000000000000001695", "answers": [{"text": "j", "answer_start": 706}], "is_impossible": false}, {"question": "What is the name of the recipient?", "id": "100000000000000000001696", "answers": [{"text": "Recipient name and ID*", "answer_start": 575}], "is_impossible": false}, {"question": "How is the recipient identified?", "id": "100000000000000000001697", "answers": [{"text": "Recipient name and ID*", "answer_start": 575}], "is_impossible": false}], "context": "For those provider agreements not specifying vaccine administration data to be recorded or reported, the following\napplies:\nAfter administering a dose of COVID-19 vaccine, record to the extent not already recorded in the vaccine recipient\u2019s\nrecord all information marked below by an asterisk and report the following required vaccine administration data, or\nother data elements if revised by CDC, to the appropriate entity noted in the agreement:\na. Administered at location/facility name/ID\nb. Administered at location type\nc. Administration address (including Company)*\nd. Recipient name and ID*\ne. Recipient date of birth*\nf. Recipient sex*\ng. Recipient race\nh. Recipient ethnicity\ni. Recipient address*\nj."}]}, {"title": "8a8eb9cb0a13232964a2acf9daac45d", "paragraphs": [{"qas": [{"question": "What is CVX?", "id": "100000000000000000001698", "answers": [{"text": "product", "answer_start": 29}], "is_impossible": false}, {"question": "What is NDC?", "id": "100000000000000000001699", "answers": [{"text": "national drug code", "answer_start": 47}], "is_impossible": false}, {"question": "Where is MVX located?", "id": "100000000000000000001700", "answers": [{"text": "o. MVX (manufacturer)*", "answer_start": 139}], "is_impossible": false}, {"question": "What has caused healthcare providers to change how they operate to continue providing essential services to patients?", "id": "100000000000000000001701", "answers": [{"text": "The COVID-19 pandemic", "answer_start": 605}], "is_impossible": false}], "context": "Administration date*\nk. CVX (product)*\nl. NDC (national drug code)\nm. Dose number*\nn. Lot number (Unit of Use [UoU] or Unit of Sale [UoS])*\no. MVX (manufacturer)*\np. Sending organization (name of the Agency submitting the report)\nq. Vaccine administering provider\u2019s name and suffix*\nr. Administering provider\u2019s address, if different than the administration address*\ns. Vaccine administration site (on the body)*\nt. Vaccine expiration date*\nu. Vaccine route of administration*\nv. Vaccine series\nCOVID-19 Vaccine Administration and Reporting Requirements\n\uf1aa\nwww.cdc.gov/vaccines/pandemic-guidance/index.html\nThe COVID-19 pandemic has caused healthcare providers to change how they operate to continue to provide essential\nservices to patients."}]}, {"title": "be3dd29bd6314fb35db2d3b367f7ffbf", "paragraphs": [{"qas": [{"question": "What has CDC issued interim guidance for?", "id": "100000000000000000001702", "answers": [{"text": "healthcare personnel", "answer_start": 36}], "is_impossible": false}, {"question": "What is required of COVID-19 vaccination providers when providing safe vaccination practices?", "id": "100000000000000000001703", "answers": [{"text": "to implement this guidance on safe vaccination practices, including COVID-19 safety measures", "answer_start": 221}], "is_impossible": false}], "context": "CDC has issued interim guidance for healthcare personnel in a variety of clinical and alternative\nsettings for the safe administration of vaccines during the COVID-19 pandemic. COVID-19 vaccination providers are\nrequired to implement this guidance on safe vaccination practices, including COVID-19 safety measures (e.g., social\ndistancing, mask wearing, hand hygiene), when providing COVID-19 vaccine."}]}, {"title": "f8ff355156b2d835f54cdd784e7a311a", "paragraphs": [{"qas": [{"question": "What must be stored and handled properly during the COVID-19 pandemic?", "id": "100000000000000000001705", "answers": [{"text": "Vaccines", "answer_start": 286}], "is_impossible": false}, {"question": "What must protect the potency of a vaccine?", "id": "100000000000000000001706", "answers": [{"text": "stored and handled properly", "answer_start": 303}], "is_impossible": false}, {"question": "What are administered to maintain the cold chain?", "id": "100000000000000000001707", "answers": [{"text": "Vaccines", "answer_start": 286}], "is_impossible": false}, {"question": "What is the purpose of the vaccine?", "id": "100000000000000000001708", "answers": [{"text": "protecting the potency and effectiveness of the vaccine and ensuring vaccine recipients are fully and safely protected from vaccine-preventable diseases", "answer_start": 428}], "is_impossible": false}], "context": "Requirements for Safe Immunization Services Practices During the COVID-19 Pandemic\n\uf1aa\nRequirements for COVID-19 Vaccine Storage and Handling\n\uf1aa\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nhttp://www.cdc.gov/vaccines/hcp/admin/storage/toolkit/index.html\nVaccines must be stored and handled properly from the time they are manufactured until they are administered to\nmaintain the cold chain, thus protecting the potency and effectiveness of the vaccine and ensuring vaccine recipients are\nfully and safely protected from vaccine-preventable diseases."}]}, {"title": "e9d91258c30cef424d00adffc1d259d9", "paragraphs": [{"qas": [{"question": "What are providers required to maintain as part of the COVID-19 Vaccination Provider Agreement?", "id": "100000000000000000001709", "answers": [{"text": "cold chain conditions and chain of custody", "answer_start": 165}], "is_impossible": false}, {"question": "What is the name of the toolkit used by the CDC to monitor storage unit temperatures?", "id": "100000000000000000001711", "answers": [{"text": "Vaccine Storage and Handling Toolkit", "answer_start": 321}], "is_impossible": false}, {"question": "What do you need to do to comply with immunization program guidance?", "id": "100000000000000000001712", "answers": [{"text": "handling temperature excursions", "answer_start": 525}], "is_impossible": false}], "context": "As part of the COVID-19 Vaccination Provider Agreement, providers are required to:\nStore and handle COVID-19 vaccines under proper conditions, including maintaining cold chain conditions and chain\nof custody at all times in accordance with an EUA or vaccine package insert, manufacturer guidance, and CDC\nguidance in the Vaccine Storage and Handling Toolkit. Monitor storage unit temperatures at all times, using equipment and practices that comply with guidance in the\ntoolkit. Comply with immunization program guidance for handling temperature excursions. Monitor and comply with COVID-19 vaccine expiration dates."}]}, {"title": "bed9df3ea5a66bbbcf7387ded634c5b9", "paragraphs": [{"qas": [{"question": "How long is required by the agreement or law of the jurisdiction?", "id": "100000000000000000001715", "answers": [{"text": "three years, or longer", "answer_start": 77}], "is_impossible": false}, {"question": "VAERS is a national early warning system to detect what?", "id": "100000000000000000001718", "answers": [{"text": "possible safety problems", "answer_start": 539}], "is_impossible": false}], "context": "Preserve all records related to COVID-19 vaccine management for a minimum of three years, or longer as required\nby the agreement or law of the jurisdiction. Comply with CDC instructions and timelines for disposing of COVID-19 vaccine and diluent, including used doses. Find detailed information regarding COVID-19 Vaccine storage and handling requirements at CDC Vaccine Storage and\nHandling Toolkit. (https://vaers.hhs.gov/reportevent.html )\nThe Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety\nproblems in vaccines used in the United States. VAERS accepts and analyzes reports of adverse events (AEs) after a\nperson has received a vaccination."}]}, {"title": "78daac88f4ea001faefe4f77a35ac8bb", "paragraphs": [{"qas": [{"question": "Who can report an adverse event to VAERS?", "id": "100000000000000000001720", "answers": [{"text": "Anyone", "answer_start": 0}], "is_impossible": false}, {"question": "What is the EUA?", "id": "100000000000000000001723", "answers": [{"text": "emergency use", "answer_start": 303}], "is_impossible": false}, {"question": "What is a BLA?", "id": "100000000000000000001724", "answers": [{"text": "Biologics License Application", "answer_start": 343}], "is_impossible": false}, {"question": "Who is required to report vaccine administration errors to VAERS?", "id": "100000000000000000001725", "answers": [{"text": "Healthcare providers", "answer_start": 380}], "is_impossible": false}, {"question": "What is required when a COVID-19 vaccine product was inadvertently administered for a second dose in a 2-dose series?", "id": "100000000000000000001726", "answers": [{"text": "VAERS reporting", "answer_start": 681}], "is_impossible": false}], "context": "Anyone can report an adverse event to VAERS. Healthcare professionals are required\nto report certain adverse events and vaccine manufacturers are required to report all adverse events that come to their\nattention. The reporting requirements for COVID-19 vaccines are the same for those authorized under emergency use (EUA) or\napproved under a Biologics License Application (BLA). Healthcare providers who administer COVID-19 vaccines are\nrequired to report the following to VAERS:\nVaccine administration errors, whether or not associated with an adverse event (AE)\nIf the incorrect mRNA COVID-19 vaccine product was inadvertently administered for a second dose in a 2-dose\nseries, VAERS reporting is required."}]}, {"title": "69bbc26847cc5059701bc87f9afc27b8", "paragraphs": [{"qas": [{"question": "What is not required for the following situations?", "id": "100000000000000000001728", "answers": [{"text": "VAERS reporting", "answer_start": 150}], "is_impossible": false}, {"question": "Why is VAERS reporting not required?", "id": "100000000000000000001729", "answers": [{"text": "If a mixed series is given intentionally", "answer_start": 212}], "is_impossible": false}, {"question": "When is mixing and matching of booster doses intentionally allowed?", "id": "100000000000000000001730", "answers": [{"text": "October 21, 2021", "answer_start": 367}], "is_impossible": false}], "context": "If a different product from the primary series is inadvertently administered for the additional or booster (third\ndose), VAERS reporting is required. VAERS reporting is not required for the following situations:\nIf a mixed series is given intentionally (e.g., due to hypersensitivity to a vaccine ingredient)\nMixing and matching of booster doses intentionally (as of October 21, 2021, mixing and matching of\nbooster doses is allowed)\nSerious AEs regardless of causality."}]}, {"title": "ae73f672e5d5909037930d069f602967", "paragraphs": [{"qas": [{"question": "What are serious AEs per FDA defined as?", "id": "100000000000000000001732", "answers": [{"text": "Death", "answer_start": 36}], "is_impossible": false}, {"question": "What is an important medical event that may require medical or surgical intervention to prevent one of the outcomes listed above?", "id": "100000000000000000001734", "answers": [{"text": "based on appropriate medical judgement may jeopardize the individual", "answer_start": 452}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech, Moderna, or Novavax vaccine that causes pericarditis?", "id": "100000000000000000001736", "answers": [{"text": "Cases of myocarditis", "answer_start": 614}], "is_impossible": false}, {"question": "What is another name for Multisystem Inflammatory Syndrome in children and adults?", "id": "100000000000000000001737", "answers": [{"text": "Cases", "answer_start": 763}], "is_impossible": false}, {"question": "What type of AEs can occur after vaccination?", "id": "100000000000000000001739", "answers": [{"text": "clinically significant", "answer_start": 957}], "is_impossible": false}, {"question": "What is the cause of the AE?", "id": "100000000000000000001740", "answers": [{"text": "life-threatening", "answer_start": 44}], "is_impossible": false}], "context": "Serious AEs per FDA are defined as:\nDeath\nA life-threatening AE\nInpatient hospitalization or prolongation of existing hospitalization\nA persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions\nA congenital anomaly/birth defect\nRequirements for Reporting to VAERS (Updated 9/13/2022)\n\uf1aa\n\uf209\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nAn important medical event that based on appropriate medical judgement may jeopardize the individual and\nmay require medical or surgical intervention to prevent one of the outcomes listed above\nCases of myocarditis after a Pfizer-BioNTech, Moderna, or Novavax vaccine\nCases of pericarditis after a Pfizer-BioNTech, Moderna, or Novavax vaccine\nCases of Multisystem Inflammatory Syndrome in children and adults\nCases of COVID-19 that result in hospitalization or death\nHealthcare providers are encouraged to report to VAERS any additional clinically significant AEs following vaccination,\neven if unsure whether vaccination caused the event."}]}, {"title": "f09f04f77262cb7be574ce8c79a82d3f", "paragraphs": [{"qas": [{"question": "Who performs vital functions for COVID-19 vaccination providers?", "id": "100000000000000000001741", "answers": [{"text": "CDC", "answer_start": 385}], "is_impossible": false}, {"question": "What is the EUA?", "id": "100000000000000000001742", "answers": [{"text": "Emergency Use Authorization", "answer_start": 190}], "is_impossible": false}, {"question": "What do COVId-19 vaccination providers properly store, handle and administer?", "id": "100000000000000000001744", "answers": [{"text": "vaccine supply", "answer_start": 470}], "is_impossible": false}], "context": "Also report any additional select AEs and/or any revised safety reporting requirements per FDA\u2019s conditions of authorized\nuse of vaccine(s) throughout the duration of any COVID-19 vaccine\u2019s Emergency Use Authorization (EUA) or as outlined in\nthe Fact Sheet for Healthcare Providers for any approved COVID-19 Vaccine. \uf209\nCOVID-19 vaccination providers perform vital functions within the CDC COVID-19 Vaccination Program, including properly\nstoring, handling, and managing vaccine supply, as well as correctly administering vaccine to intended recipients. Thus, it\nis essential for providers to have a clear understanding of COVID-19 Vaccination Program requirements."}]}, {"title": "c6ba88325fb55c335859be6b378ec1cc", "paragraphs": [{"qas": [{"question": "What are the goals of site visits?", "id": "100000000000000000001746", "answers": [{"text": "Assess COVID-19 vaccination provider adherence to program requirements and recommendations", "answer_start": 287}], "is_impossible": false}, {"question": "What do providers need to do to meet program requirements and recommendations?", "id": "100000000000000000001747", "answers": [{"text": "Identify and address educational needs", "answer_start": 477}], "is_impossible": false}], "context": "Training, site\nvisits, and other oversight measures are important for maintaining or improving providers\u2019 adherence to these\nrequirements. Site visits are a key opportunity for quality assurance monitoring and training (as necessary) enrolled\nproviders. The goals of site visits are to:\nAssess COVID-19 vaccination provider adherence to program requirements and recommendations. Identify and address areas where providers are doing well and areas needing additional follow-up. Identify and address educational needs of COVID-19 vaccination providers to help them meet program\nrequirements. Ensure that vaccine recipients are receiving properly managed and viable vaccine."}]}, {"title": "6cfdbcc046c6a214ae7bba446c4647e9", "paragraphs": [{"qas": [{"question": "Who conducts provider oversight activities in each jurisdiction?", "id": "100000000000000000001749", "answers": [{"text": "CDC and/or state/local public health staff", "answer_start": 0}], "is_impossible": false}, {"question": "What must providers and depot locations that store or redistribute COVID-19 vaccine participate in?", "id": "100000000000000000001750", "answers": [{"text": "COVID-19 quality assurance site visits and other educational opportunities", "answer_start": 270}], "is_impossible": false}], "context": "CDC and/or state/local public health staff are required to conduct certain provider oversight activities in each jurisdiction. COVID-19 vaccination providers and depot locations that store or redistribute COVID-19 vaccine must accommodate\nthese staff and participate in COVID-19 quality assurance site visits and other educational opportunities associated with\nCOVID-19 vaccination program requirements."}]}, {"title": "fadb06da8c02e6455b201fc02331fc96", "paragraphs": [{"qas": [{"question": "What must be administered at no out-of-pocket cost to the recipient?", "id": "100000000000000000001752", "answers": [{"text": "COVID-19 Vaccine", "answer_start": 172}], "is_impossible": false}, {"question": "Who may not seek reimbursement from the vaccine recipient?", "id": "100000000000000000001755", "answers": [{"text": "Medicare or Medicaid reimbursement", "answer_start": 700}], "is_impossible": false}, {"question": "What is required for COVID-19 Vaccination Program Providers?", "id": "100000000000000000001756", "answers": [{"text": "Vaccine administration fees for the vaccine recipient, such as: vaccine recipient\u2019s private insurance company Medicare or Medicaid reimbursement may not seek any reimbursement, including through balance billing, from the vaccine recipient Requirements for COVID-19 Vaccination Program Providers COVID-19 Vaccine is Provided at 100% No Cost to Recipients\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support", "answer_start": 590}], "is_impossible": false}, {"question": "Who is encouraged to report any potential violations of the requirements?", "id": "100000000000000000001757", "answers": [{"text": "Individuals", "answer_start": 1023}], "is_impossible": false}, {"question": "Who can be reached by calling 1-800-HHS-TIPS or by visiting the website TIPS.HHS.GOV?", "id": "100000000000000000001758", "answers": [{"text": "Office of the Inspector General", "answer_start": 1128}], "is_impossible": false}, {"question": "What does the Office of the Inspector General do?", "id": "100000000000000000001759", "answers": [{"text": "report them to the Office of the Inspector General, U.S. Department of Health and Human Services", "answer_start": 1109}], "is_impossible": false}], "context": "Requirements for Quality Assurance Monitoring (Updated 10/18/2021)\n\uf1aa\nAll organizations and providers\nparticipating in the CDC COVID-19\nVaccination Program:\nmust administer COVID-19 Vaccine at\nno out-of-pocket cost to the recipient\nmay not deny anyone vaccination based on the vaccine recipient\u2019s coverage status or network status\nmay not charge an office visit or other fee if COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees for the\nvaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement\nmay not seek any reimbursement, including through balance billing, from the vaccine recipient\nRequirements for COVID-19 Vaccination Program Providers\nCOVID-19 Vaccine is Provided at 100% No Cost to Recipients\f10/30/22, 9:16 AM COVID-19 Vaccination Provider Requirements and Support | CDC\nIndividuals aware of any potential violations of these requirements are encouraged to report them to the Office of the\nInspector General, U.S. Department of Health and Human Services, by calling 1-800-HHS-TIPS or the website TIPS.HHS.GOV\n."}]}, {"title": "1e0ba315437f2c979ebfde703bf99336", "paragraphs": [{"qas": [{"question": "How long must providers document vaccine administration in their medical record systems?", "id": "100000000000000000001762", "answers": [{"text": "24 hours", "answer_start": 306}], "is_impossible": false}, {"question": "How do providers use their best efforts to report vaccine administration data?", "id": "100000000000000000001763", "answers": [{"text": "as soon as practicable and no later than 72 hours after administration", "answer_start": 481}], "is_impossible": false}, {"question": "What does IIS stand for?", "id": "100000000000000000001764", "answers": [{"text": "Immunization Information Systems", "answer_start": 441}], "is_impossible": false}, {"question": "How long after administration should IIS report administration data to the relevant system for the jurisdiction?", "id": "100000000000000000001765", "answers": [{"text": "72 hours", "answer_start": 522}], "is_impossible": false}, {"question": "When was the last time IIS reported administration data?", "id": "100000000000000000001766", "answers": [{"text": "October 26, 2022", "answer_start": 711}], "is_impossible": false}], "context": "Enrolling in your jurisdiction/state-based IIS system\nAdd the COVID-19 vaccine label to your VTrckS profile\nSee CDC\u2019s Reporting Requirements\n\uf209\nData and Reporting\nVaccine Administration Documentation\nCOVID-19 vaccination providers must document vaccine administration in their medical record systems within 24 hours\nof administration and use their best efforts to report administration data to the relevant system for the jurisdiction [i.e.,\nImmunization Information Systems (IIS)] as soon as practicable and no later than 72 hours after administration. Additional Resources\nVaccination Program Operational Guidance\nHow to Enroll as a COVID-19 Vaccine Provider\nTraining and Education\nCOVIDVaxView\nLast Reviewed: October 26, 2022"}]}, {"title": "564dbe707fb5e84b22921f240c434ea0", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine for children and teens with disabilities?", "id": "100000000000000000001767", "answers": [{"text": "COVID-19", "answer_start": 18}], "is_impossible": false}, {"question": "When was the last day of the month for COVID-19 vaccination?", "id": "100000000000000000001768", "answers": [{"text": "10/30/22", "answer_start": 0}], "is_impossible": false}, {"question": "Who should get vaccinated against COVID-19?", "id": "100000000000000000001770", "answers": [{"text": "Everyone 6 months and older", "answer_start": 378}], "is_impossible": false}, {"question": "What should everyone 5 years and older get if eligible?", "id": "100000000000000000001771", "answers": [{"text": "a booster", "answer_start": 554}], "is_impossible": false}], "context": "10/30/22, 9:29 AM COVID-19 Vaccination for Children and Teens with Disabilities | Human Development and Disability | NCBDDD | CDC\nEspa\u00f1ol | Other Languages\nHuman Development and Disability\nHuman Development and Disability Home\nCOVID-19 Vaccination for Children and Teens with\nDisabilities\nWhat You Need to Know\nCOVID-19 vaccination for children and teens is safe and effective. Everyone 6 months and older, including those with disabilities and underlying medical conditions, should get\nvaccinated against COVID-19. Everyone 5 years and older should get a booster, if eligible."}]}, {"title": "6ff542c1c046c0646187a06c68af7269", "paragraphs": [{"qas": [{"question": "What do children and youth with special healthcare needs require more of than their typically developing peers?", "id": "100000000000000000001773", "answers": [{"text": "their physical, developmental, behavioral, or emotional differences", "answer_start": 209}], "is_impossible": false}, {"question": "What can a special healthcare need include?", "id": "100000000000000000001774", "answers": [{"text": "physical, intellectual, and developmental disabilities", "answer_start": 354}], "is_impossible": false}, {"question": "What are some long-standing medical conditions?", "id": "100000000000000000001775", "answers": [{"text": "asthma, diabetes, a blood disorder, or muscular dystrophy", "answer_start": 462}], "is_impossible": false}, {"question": "How can children and youth with special healthcare needs in emergencies?", "id": "100000000000000000001776", "answers": [{"text": "Use CDC\u2019s COVID-19 booster tool to learn if and when your child or teen can get boosters to stay up to date with their COVID-19 vaccines. Children and youth with special healthcare needs require more care for their physical, developmental, behavioral, or emotional differences than their typically developing peers", "answer_start": 0}], "is_impossible": false}], "context": "Use CDC\u2019s COVID-19 booster tool to learn if and when your child or teen can get boosters to stay up to date with their\nCOVID-19 vaccines. Children and youth with special healthcare needs require more care for their\nphysical, developmental, behavioral, or emotional differences than their typically\ndeveloping peers. A special healthcare need can include physical, intellectual, and\ndevelopmental disabilities, as well as long-standing medical conditions, such as\nasthma, diabetes, a blood disorder, or muscular dystrophy. Learn more\nabout Children and Youth with Special Healthcare Needs in Emergencies."}]}, {"title": "7ef97ead6c23defcd44cdbc349c71d89", "paragraphs": [{"qas": [{"question": "Children and Teens with Disabilities Are at Increased Risk for Severe Illness from COVID-19?", "id": "100000000000000000001777", "answers": [{"text": "Children and teens with one or more underlying medical condition are more likely to get severely ill from COVID-19.", "answer_start": 340}], "is_impossible": false}, {"question": "Many children and teens with disabilities have underlying medical conditions such as what?", "id": "100000000000000000001778", "answers": [{"text": "lung, heart, or kidney disease", "answer_start": 177}], "is_impossible": false}, {"question": "What are children and teens with one or more underlying medical conditions more likely to get from COVID-19?", "id": "100000000000000000001779", "answers": [{"text": "severely ill", "answer_start": 428}], "is_impossible": false}, {"question": "What may be more likely to experience mental health conditions from social isolation?", "id": "100000000000000000001780", "answers": [{"text": "children and teens with developmental disabilities", "answer_start": 467}], "is_impossible": false}], "context": "Children and Teens with Disabilities Are at Increased Risk for\nSevere Illness from COVID-19\nMany children and teens with disabilities have underlying medical conditions such as lung, heart, or kidney disease,\na weakened immune system, cancer, obesity, diabetes, some blood diseases, or conditions of the muscular or central nervous\nsystem. Children and teens with one or more underlying medical condition are more likely to get severely ill from COVID-19. Similarly, children and teens with developmental disabilities, such as cerebral palsy, an intellectual disability, or autism, may\nbe more likely to experience mental health conditions from social isolation."}]}, {"title": "9d3671361e2579561bd32f7a27692547", "paragraphs": [{"qas": [{"question": "What are some of the characteristics that can increase their risk of COVID-19?", "id": "100000000000000000001781", "answers": [{"text": "Limited mobility", "answer_start": 167}], "is_impossible": false}, {"question": "What is one of the challenges that children and teens with disabilities can have?", "id": "100000000000000000001782", "answers": [{"text": "barriers to getting needed health care and other support", "answer_start": 25}], "is_impossible": false}], "context": "They can also experience barriers to getting\nneeded health care and other support, and can have other characteristics that increase their risk of COVID-19, including:\nLimited mobility\nNeed for important support services\nChallenges practicing preventive measures, such as wearing a mask\nChallenges communicating symptoms of Illness or being sick\nGetting Children and Teens with Disabilities Vaccinated against\n1 in 6 children ages 3 through 17 years of age has one or more developmental disabilities."}]}, {"title": "db88a990c2c65663ee4a6960dd28cb5e", "paragraphs": [{"qas": [{"question": "What vaccines have been shown to be safe and effective at protecting against COVID-19 and preventing severe illness if infected?", "id": "100000000000000000001785", "answers": [{"text": "COVID-19", "answer_start": 206}], "is_impossible": false}], "context": "10/30/22, 9:29 AM COVID-19 Vaccination for Children and Teens with Disabilities | Human Development and Disability | NCBDDD | CDC\nThe benefits of COVID-19 vaccination outweigh the known and potential risks\nCOVID-19 vaccines have been shown to be safe and effective at protecting against COVID-19 and preventing severe\nillness if infected. In clinical trials, about 20% of children and teens who participated had an underlying medical condition. Some children and teens with a weakened immune system should get an additional dose of vaccine as part of their\nprimary COVID-19 vaccination series."}]}, {"title": "11e1278f6d86b5a092cd25e7475b4e3b", "paragraphs": [{"qas": [{"question": "What should parents and caregivers continue following after vaccination?", "id": "100000000000000000001788", "answers": [{"text": "all current\u202fprevention measures", "answer_start": 209}], "is_impossible": false}, {"question": "How should parents prepare their children for the vaccination visit?", "id": "100000000000000000001790", "answers": [{"text": "use resources such as picture stories for support during and after vaccination", "answer_start": 61}], "is_impossible": false}, {"question": "Who can request accommodations at COVID-19 vaccination sites?", "id": "100000000000000000001791", "answers": [{"text": "parents and caregivers", "answer_start": 432}], "is_impossible": false}, {"question": "What can parents and caregivers do when making an appointment or arriving for vaccination?", "id": "100000000000000000001792", "answers": [{"text": "let staff and/or volunteers know their child might need some accommodations", "answer_start": 459}], "is_impossible": false}], "context": "Prepare all children and teens for the vaccination visit and use resources such as picture stories for support during and after\nvaccination. After vaccination, parents and caregivers should continue following all current\u202fprevention measures\u202frecommended by CDC. Learn more about COVID-19 Vaccines for Children and Teens. Requesting accommodations at COVID-19 vaccination sites\nWhen making an appointment or arriving for vaccination, parents and caregivers\ncan let staff and/or volunteers know their child might need some\naccommodations."}]}, {"title": "8e425430dfd61afbdec396f63aff281e", "paragraphs": [{"qas": [{"question": "What is the COVID-19 Vaccine Disability Information and Access Line?", "id": "100000000000000000001793", "answers": [{"text": "DIAL", "answer_start": 57}], "is_impossible": false}, {"question": "What is DIAL?", "id": "100000000000000000001794", "answers": [{"text": "Vaccine Disability Information and Access Line", "answer_start": 9}], "is_impossible": false}, {"question": "When is the DIAL available?", "id": "100000000000000000001795", "answers": [{"text": "Monday-Friday", "answer_start": 81}], "is_impossible": false}, {"question": "Where can you find vaccination locations?", "id": "100000000000000000001796", "answers": [{"text": "local", "answer_start": 176}], "is_impossible": false}, {"question": "Who can have service animals accompany them at COVID-19 vaccination sites?", "id": "100000000000000000001798", "answers": [{"text": "Children", "answer_start": 457}], "is_impossible": false}, {"question": "What is the name of the toolkit for people with disabilities?", "id": "100000000000000000001799", "answers": [{"text": "COVID-19", "answer_start": 611}], "is_impossible": false}, {"question": "What is COVID-19 Vaccine Recommendations for Children and Teens with Disabilities Last Reviewed: October 12, 2022?", "id": "100000000000000000001800", "answers": [{"text": "COVID-19 Parental Resources Kit", "answer_start": 579}], "is_impossible": false}], "context": "COVID-19 Vaccine Disability Information and Access Line (DIAL)\nCall 888-677-1199 Monday-Friday from 9 a.m. to 8 p.m. (EST) or email\nDIAL@usaginganddisability.org to help:\nFind local vaccination locations\nMake appointments\nConnect to local services such as accessible transportation\nHome visits: If a child under your care is unable to leave the home, contact\nyour state, territorial, local , or tribal health department to request an in-home\nvaccination. \uf209\nChildren with service animals are\nallowed by law to have them\naccompany them at COVID-19\nvaccination sites. Related Pages\nCOVID-19 Parental Resources Kit\nCOVID-19: Toolkit for People with Disabilities\nCOVID-19 Vaccine Recommendations for Children and Teens\nLast Reviewed: October 12, 2022"}]}, {"title": "459f27d4d584cc5344dd3510ed848030", "paragraphs": [{"qas": [{"question": "What does the risk for severe COVID-19 illness increase with older adults and those with underlying medical conditions?", "id": "100000000000000000001801", "answers": [{"text": "increases", "answer_start": 237}], "is_impossible": false}, {"question": "What is the federal government committed to?", "id": "100000000000000000001802", "answers": [{"text": "ensuring that residents and staff in long-term care (LTC) settings, such as nursing homes, assisted living communities, residential care communities, group homes and senior housing, have access to COVID-19 vaccines", "answer_start": 366}], "is_impossible": false}, {"question": "What vaccines are available in LTC settings?", "id": "100000000000000000001804", "answers": [{"text": "COVID-19", "answer_start": 564}], "is_impossible": false}, {"question": "How is the government committed to ensuring that residents and staff have access to COVID-19 vaccines?", "id": "100000000000000000001805", "answers": [{"text": "the federal government is committed to ensuring that residents and staff in long-term care (LTC) settings", "answer_start": 328}], "is_impossible": false}], "context": "10/30/22, 9:22 AM COVID-19 Vaccine Access in Long-term Care Settings | CDC\nVaccines & Immunizations\nVaccines & Immunizations Home\nPromoting COVID-19 Vaccine in Long-term Care\nSettings\nPrint this Page\nThe risk for severe COVID-19 illness\nincreases with older adults and\nthose with underlying medical\nconditions. Because of this, the\nfederal government is committed to\nensuring that residents and staff in long-term care (LTC) settings, such as nursing homes, assisted living communities,\nresidential care communities, group homes and senior housing, have access to COVID-19 vaccines. For additional examples of\nLTC settings, see COVID-19 Vaccine Access in Long-Term Care Settings ."}]}, {"title": "18e2afb67e896ba47e1821158a7a19a1", "paragraphs": [{"qas": [{"question": "Who is disproportionately affected by COVID-19?", "id": "100000000000000000001806", "answers": [{"text": "residents in LTC settings", "answer_start": 101}], "is_impossible": false}, {"question": "What is important to build confidence in while increasing protection for LTC residents?", "id": "100000000000000000001807", "answers": [{"text": "COVID-19 vaccines", "answer_start": 167}], "is_impossible": false}, {"question": "Many LTC providers have already identified strategies and partnerships to obtain and administer what?", "id": "100000000000000000001808", "answers": [{"text": "COVID-19 vaccines", "answer_start": 328}], "is_impossible": false}, {"question": "What are partnerships used to obtain and administer COVID-19 vaccines for residents and staff?", "id": "100000000000000000001809", "answers": [{"text": "Working with established LTC partners and retail pharmacy partners", "answer_start": 400}], "is_impossible": false}, {"question": "Who is working with established LTC partners?", "id": "100000000000000000001811", "answers": [{"text": "retail pharmacy partners", "answer_start": 442}], "is_impossible": false}, {"question": "Where is the LTC Pharmacy Partnerships section of the CDC COVID-19 Vaccination Planning and Partnerships page?", "id": "100000000000000000001812", "answers": [{"text": "Additional strategies", "answer_start": 581}], "is_impossible": false}], "context": "The goal is to continue to protect people who are disproportionately affected by COVID-19\u2014especially residents in LTC\nsettings. It is important to build confidence in COVID-19 vaccines while increasing protection for LTC residents. Many LTC providers have already identified strategies and partnerships to obtain and administer COVID-19 vaccines for\nresidents and staff. These include the following:\nWorking with established LTC partners and retail pharmacy partners\nCoordinating with state and local health departments\nEnsuring COVID-19 vaccine equity for LTC staff and residents\nAdditional strategies can be found in the LTC Pharmacy Partnerships section of the CDC COVID-19 Vaccination Planning and\nPartnerships page."}]}, {"title": "e16fee7fdf9d30a4dbf0bf30c2f47b70", "paragraphs": [{"qas": [{"question": "Who is encouraged to consider the option that works best for their residents and staff when coordinating access to COVID-19 vaccines?", "id": "100000000000000000001813", "answers": [{"text": "LTC providers", "answer_start": 0}], "is_impossible": false}, {"question": "What is available on the pages linked below?", "id": "100000000000000000001814", "answers": [{"text": "Additional details on these options", "answer_start": 187}], "is_impossible": false}, {"question": "Who is Eligible for a COVID-19 Vaccine Booster Shot?", "id": "100000000000000000001815", "answers": [{"text": "LTC providers are encouraged to consider the option that works best for their residents and staff when coordinating access to COVID-19 vaccines, either in the local community or on-site. Additional details on these options are available on the pages linked below. \uf141 Information About Who Is Eligible for a COVID-19 Vaccine Booster Shot \uf209 \uf1aa Information for Long-term Care Administrators and Managers", "answer_start": 0}], "is_impossible": false}, {"question": "What are the most effective ways to prevent serious outcomes of COVID-19?", "id": "100000000000000000001817", "answers": [{"text": "COVID-19 vaccines", "answer_start": 607}], "is_impossible": false}], "context": "LTC providers are encouraged to consider the option that works best for their residents and staff when coordinating access to\nCOVID-19 vaccines, either in the local community or on-site. Additional details on these options are available on the pages\nlinked below. \uf141 Information About Who Is Eligible for a COVID-19 Vaccine Booster Shot\n\uf209\n\uf1aa Information for Long-term Care\nAdministrators and Managers\n\uf1aa Information for Jurisdictions (State and Local\nImmunization Programs)\f10/30/22, 9:22 AM COVID-19 Vaccine Access in Long-term Care Settings | CDC\nAdditional Information: COVID-19 Vaccination Recommendations\nCOVID-19 vaccines available in the United States are highly effective at preventing serious outcomes of COVID-19 including\nsevere disease, hospitalization, and death."}]}, {"title": "84b53941a69c1f4d0660e963355ce662", "paragraphs": [{"qas": [{"question": "What is the best way to protect yourself from COVID-19?", "id": "100000000000000000001819", "answers": [{"text": "stay up to date with recommended vaccine doses", "answer_start": 85}], "is_impossible": false}, {"question": "How many people in the United States are fully vaccinated?", "id": "100000000000000000001820", "answers": [{"text": "proportion", "answer_start": 157}], "is_impossible": false}, {"question": "What does staying up to date mean?", "id": "100000000000000000001822", "answers": [{"text": "getting all recommended COVID-19 vaccine doses", "answer_start": 306}], "is_impossible": false}, {"question": "What is a recommended dose of COVID-19 vaccine?", "id": "100000000000000000001823", "answers": [{"text": "an additional third dose", "answer_start": 513}], "is_impossible": false}, {"question": "People who are immunocompromised have specific recommendations for what?", "id": "100000000000000000001824", "answers": [{"text": "COVID-19 vaccine", "answer_start": 465}], "is_impossible": false}, {"question": "Who gets a booster shot?", "id": "100000000000000000001826", "answers": [{"text": "People who are moderately or severely immunocompromised", "answer_start": 395}], "is_impossible": false}], "context": "As with other infectious diseases, people are protected best from COVID-19 when\nthey stay up to date with recommended vaccine doses. Efforts to maximize the proportion of people in the United States who\nare fully vaccinated against COVID-19 remain critical to reducing the spread. Staying up to date means getting all recommended COVID-19 vaccine doses, including a booster shot, when eligible. People who are moderately or severely immunocompromised have specific COVID-19 vaccine recommendations, which\ninclude an additional third dose to complete their primary series, as well as a booster shot for those eligible."}]}, {"title": "64bbd792d77b03512c001e8f3d8fbce", "paragraphs": [{"qas": [{"question": "Where can you administer each injection of COVID-19 Vaccines?", "id": "100000000000000000001828", "answers": [{"text": "a different injection site", "answer_start": 142}], "is_impossible": false}, {"question": "How can Jurisdictions Ensure COVID-19 Vaccine Access for Staff and Residents in Long-term Care Settings?", "id": "100000000000000000001829", "answers": [{"text": "FAQs About Medical Consent & Additional Dose of mRNA", "answer_start": 480}], "is_impossible": false}, {"question": "What does Medical Consent & Additional Dose of mRNA stand for?", "id": "100000000000000000001830", "answers": [{"text": "COVID-19 Vaccine for Long-term Care Residents", "answer_start": 533}], "is_impossible": false}, {"question": "What is mRNA Vaccines: Background Information for Healthcare Providers?", "id": "100000000000000000001831", "answers": [{"text": "COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "When was this page last reviewed?", "id": "100000000000000000001832", "answers": [{"text": "July 5, 2022", "answer_start": 715}], "is_impossible": false}], "context": "COVID-19 vaccines may be administered along with and on the same day as other vaccines, such as the flu vaccine. Administer each injection in a different injection site. For more information, see Interim Clinical Considerations for Use of\nCOVID-19 Vaccines. Additional Resources\nLong-term Care Administrators and Managers: Options for Coordinating Access to COVID-19 Vaccines\nHow Jurisdictions Can Ensure COVID-19 Vaccine Access for Staff and Residents in Long-term Care Settings\nFAQs About Medical Consent & Additional Dose of mRNA COVID-19 Vaccine for Long-term Care Residents\nCOVID-19 Vaccines for Long-term Care Residents\nAbout mRNA Vaccines: Background Information for Healthcare Providers\nPage last reviewed: July 5, 2022"}]}, {"title": "ea891ff8c77d2250ec9f6b51e6e17162", "paragraphs": [{"qas": [{"question": "What is the more controlled setting that tests a vaccine before approval?", "id": "100000000000000000001836", "answers": [{"text": "clinical trial", "answer_start": 533}], "is_impossible": false}, {"question": "What kind of evaluations does CDC conduct with partners?", "id": "100000000000000000001837", "answers": [{"text": "current and planned vaccine effectiveness evaluations", "answer_start": 622}], "is_impossible": false}], "context": "10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nVaccines & Immunizations\nVaccines & Immunizations\nCOVID-19 Vaccine Effectiveness Research\nClinical trials are conducted to determine vaccine efficacy before the U.S Food and Drug Administration (FDA) determines\nwhether to approve a vaccine. CDC and other partners assess COVID-19 vaccine effectiveness under real-world conditions\nafter the FDA approves a vaccine. This helps us understand if vaccines are performing as expected outside the more\ncontrolled setting of a clinical trial, which tests a vaccine before approval. Below you\u2019ll find descriptions of current and planned vaccine effectiveness evaluations CDC is conducting with partners."}]}, {"title": "39d8b8834d3861c389dd29e47b592e8e", "paragraphs": [{"qas": [{"question": "What is included in the descriptions of the evaluations?", "id": "100000000000000000001838", "answers": [{"text": "data collection platform, protocol (if available), outcome, population, and participating sites", "answer_start": 42}], "is_impossible": false}, {"question": "What does this page provide for public health professionals and researchers?", "id": "100000000000000000001840", "answers": [{"text": "information", "answer_start": 541}], "is_impossible": false}], "context": "The\ndescriptions include the evaluation\u2019s data collection platform, protocol (if available), outcome, population, and participating\nsites. Links to protocols that detail the evaluation designs are included when possible. The list of evaluations is organized by type of study. Choose a category below to see a description of those evaluation. Vaccine Effectiveness Evaluations by Design\nSelect a study design below to get more information about the evaluation\u2019s name, population, outcome, protocol and\nparticipating sites:\nThis page provides information for public health professionals and researchers."}]}, {"title": "ae2c2142b897744f41e1d05ad6975aac", "paragraphs": [{"qas": [{"question": "What does AZ Heroes stand for?", "id": "100000000000000000001842", "answers": [{"text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance", "answer_start": 112}], "is_impossible": false}, {"question": "What is the name of the college of public health in Tucson, AZ?", "id": "100000000000000000001843", "answers": [{"text": "University of Arizona", "answer_start": 2666}], "is_impossible": false}, {"question": "What is RECOVER Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel?", "id": "100000000000000000001845", "answers": [{"text": "SARS-CoV-2 Household Transmission Study", "answer_start": 1757}], "is_impossible": false}, {"question": "Where is Baylor Scott and White Health located?", "id": "100000000000000000001846", "answers": [{"text": "Temple, TX", "answer_start": 2074}], "is_impossible": false}, {"question": "What hospital is in Portland, OR?", "id": "100000000000000000001847", "answers": [{"text": "Kaiser Permanente Northwest", "answer_start": 1515}], "is_impossible": false}, {"question": "What is the name of the hospital in Duluth, MN?", "id": "100000000000000000001849", "answers": [{"text": "St. Luke\u2019s Hospital", "answer_start": 886}], "is_impossible": false}, {"question": "What is the primary outcome of SARS-CoV-2 infections?", "id": "100000000000000000001851", "answers": [{"text": "Household transmission", "answer_start": 2460}], "is_impossible": false}, {"question": "Where is Permanente Northwest?", "id": "100000000000000000001853", "answers": [{"text": "Portland, OR", "answer_start": 2114}], "is_impossible": false}, {"question": "Where is HEROES-RECOVER located?", "id": "100000000000000000001854", "answers": [{"text": "University of Utah", "answer_start": 1325}], "is_impossible": false}, {"question": "What is the Outcome of the SARS-CoV-2 Household Transmission Study?", "id": "100000000000000000001855", "answers": [{"text": "Transmission in households of healthcare, first responder, and essential and other frontline", "answer_start": 1806}], "is_impossible": false}, {"question": "Where is Baylor Scott and White Health?", "id": "100000000000000000001856", "answers": [{"text": "Temple, TX", "answer_start": 2074}], "is_impossible": false}, {"question": "What city is the University of Utah located?", "id": "100000000000000000001857", "answers": [{"text": "CASCADIA", "answer_start": 1363}], "is_impossible": false}, {"question": "What is the acronym for Respiratory Virus Transmission Network?", "id": "100000000000000000001858", "answers": [{"text": "RVTN", "answer_start": 2371}], "is_impossible": false}, {"question": "Where is the University of Arizona?", "id": "100000000000000000001860", "answers": [{"text": "Tucson, AZ", "answer_start": 2689}], "is_impossible": false}, {"question": "What is RVTN also known as?", "id": "100000000000000000001861", "answers": [{"text": "Respiratory Virus Transmission Network", "answer_start": 2377}], "is_impossible": false}, {"question": "Where is Stanford University located?", "id": "100000000000000000001862", "answers": [{"text": "CA", "answer_start": 2731}], "is_impossible": false}, {"question": "What is the name of the University of Arizona?", "id": "100000000000000000001863", "answers": [{"text": "Tucson", "answer_start": 2185}], "is_impossible": false}], "context": "For information for the general public,\nplease see Monitoring Vaccine Effectiveness\nProspective Cohort\n\uf1aa\nHEROES\nArizona Healthcare, Emergency Response, and Other Essential Workers Surveillance (AZ Heroes) Study\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nUniversity of Arizona, Tucson, AZ\nMel and Enid Zuckerman College of Public Health, Tucson, AZ\n\uf20c\nRECOVER\nResearch on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER)\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nBaylor Scott and White Health, Temple, TX\n\uf209\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nKaiser Permanente Northwest, Portland, OR\nSt. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\nPROTECT\nPediatric Research Observing Trends and Exposures in COVID-19 Timelines\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Children aged <18 years\nParticipating Sites\nBaylor Scott and White Health, Temple, TX\nUniversity of Arizona, Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\nCASCADIA\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Children aged <18 years and adults aged <50 years\nParticipating Sites\nKaiser Permanente Northwest, Portland, OR\nUniversity of Washington, Seattle, WA\nHousehold Transmission Studies\n\uf1aa\nHEROES-RECOVER Household Transmission Study\nResearch on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER) SARS-CoV-2 Household\nTransmission Study\nOutcome: Transmission in households of healthcare, first responder, and essential and other frontline workers with\nPopulation: Households of infected healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nBaylor Scott and White Health, Temple, TX\nKaiser Permanente Northwest, Portland, OR\nSt. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\n\uf20c\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nUniversity of Utah, Salt Lake City, UT\nRVTN (Respiratory Virus Transmission Network)\nRVTN \u2013 Sentinel\nSentinel Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from sentinel testing sites\nParticipating Sites\nUniversity of Arizona, Tucson, AZ\nStanford University, Stanford, CA\nUniversity of Colorado, Denver, CO\nColumbia University, New York City, NY\nUniversity of North Carolina, Chapel Hill, NC\nVanderbilt University Medical Center, Nashville, TN\nMarshfield Clinic Research Institute, Marshfield, WI\n\uf20c\nRVTN \u2013 National\nNational Approach (also known as \u201cTrack COVID at Home \u201d)."}]}, {"title": "9ccafbf6caf7a6b2d4df00fe320c5ab4", "paragraphs": [{"qas": [{"question": "What is the National Protocol Outcome?", "id": "100000000000000000001866", "answers": [{"text": "Household transmission among community members confirmed with SARS-CoV-2", "answer_start": 27}], "is_impossible": false}, {"question": "How many locations across the US are participating in IVY Influenza and Other Viruses in the Acutely Ill (IVY) network?", "id": "100000000000000000001867", "answers": [{"text": "8,319", "answer_start": 478}], "is_impossible": false}, {"question": "What is PReventing Emerging Infections through Vaccine EffectiveNess Testing (PREVENT)?", "id": "100000000000000000001870", "answers": [{"text": "Healthcare personnel", "answer_start": 1115}], "is_impossible": false}, {"question": "In what city is the University of Massachusetts Memorial Medical Center?", "id": "100000000000000000001874", "answers": [{"text": "Worcester", "answer_start": 1635}], "is_impossible": false}, {"question": "What is the name of the medical center located in New Orleans, LA?", "id": "100000000000000000001875", "answers": [{"text": "LCMC Health Hospitals", "answer_start": 1649}], "is_impossible": false}, {"question": "What medical center is located in Dallas, TX?", "id": "100000000000000000001877", "answers": [{"text": "University of Texas Southwestern Medical Center and Parkland Hospital", "answer_start": 1742}], "is_impossible": false}], "context": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner: Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses in the Acutely Ill (IVY) network\nOutcome: Hospitalization with SARS-CoV-2\nPopulation: Hospitalized adults\nParticipating Sites: 21 large adult hospitals in 20 cities in 18 states:\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nCalifornia\nColorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York\nNorth Carolina\nOhio\nOregon\nTennessee\nTexas\nUtah\nWashington\nPReventing Emerging Infections through Vaccine EffectiveNess Testing (PREVENT ) Sites\nOutcome: Symptomatic SARS-CoV-2 infections\nPopulation: Healthcare personnel\nParticipating Sites\nBaystate Medical Center, Springfield, MA\nJackson Memorial Hospital, Miami, FL\nOlive View-UCLA Medical Center, Los Angeles, CA\nThomas Jefferson University Hospital, Philadelphia, PA\nTruman Medical Centers, Kansas City, MO\nUniversity of Alabama Hospital, Birmingham, AL\nCommunity Regional Medical Center/ UCSF, Fresno, CA\nUniversity of Chicago Medical Center, Chicago, IL\nUniversity of Iowa Hospitals and Clinics, Iowa City, IA\nUniversity of Massachusetts Memorial Medical Center, Worcester, MA\nLCMC Health Hospitals, New Orleans, LA\nUniversity of Mississippi Medical Center, Jackson, MS\nUniversity of Texas Southwestern Medical Center and Parkland Hospital, Dallas, TX\nUniversity of Washington Hospitals, Seattle, WA\nValleywise Health Medical Center, Phoenix, AZ."}]}, {"title": "693270e90e93fc9dc70e7e2abeca1fd", "paragraphs": [{"qas": [{"question": "What is the name of the US Influenza Vaccine Effectiveness Network Protocol for Influenza and Other Respiratory Viruses?", "id": "100000000000000000001878", "answers": [{"text": "FLU-VE Network", "answer_start": 36}], "is_impossible": false}, {"question": "Infection with SARS-CoV-2 is a symptomatic outcome of what?", "id": "100000000000000000001879", "answers": [{"text": "Influenza Vaccine Effectiveness Network Protocol for Influenza and Other Respiratory Viruses", "answer_start": 55}], "is_impossible": false}, {"question": "Where is Baylor Scott and White Health located?", "id": "100000000000000000001882", "answers": [{"text": "Texas", "answer_start": 921}], "is_impossible": false}, {"question": "What is the name of the university in New York?", "id": "100000000000000000001883", "answers": [{"text": "Columbia University", "answer_start": 928}], "is_impossible": false}, {"question": "Where is Kaiser Permanente Northern California?", "id": "100000000000000000001884", "answers": [{"text": "California", "answer_start": 1071}], "is_impossible": false}, {"question": "In what state is the Regenstrief Institute?", "id": "100000000000000000001885", "answers": [{"text": "Indiana", "answer_start": 1158}], "is_impossible": false}, {"question": "Where is Regenstrief Institute located?", "id": "100000000000000000001886", "answers": [{"text": "Indiana", "answer_start": 1158}], "is_impossible": false}, {"question": "Where is the University of Colorado?", "id": "100000000000000000001887", "answers": [{"text": "Colorado", "answer_start": 1191}], "is_impossible": false}, {"question": "What is the primary outcome of hospitalization?", "id": "100000000000000000001888", "answers": [{"text": "Symptomatic and asymptomatic SARS-CoV-2 infections", "answer_start": 636}], "is_impossible": false}], "context": "Emerging Infection Program Sites\n\uf209 \uf20c\nFLU-VE Network\nUS Influenza Vaccine Effectiveness Network Protocol for Influenza and Other Respiratory Viruses (including COVID-\nOutcome: Symptomatic infection with SARS-CoV-2\nPopulation: Outpatient adults and children \u22656 months of age\nParticipating Sites\nGroup Health Cooperative, Seattle, WA\nMarshfield Clinic Research Institute, Marshfield, WI\nUniversity of Michigan, Ann Arbor, MI\nHenry Ford Health Systems, Detroit, MI\n\uf20c\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nUniversity of Pittsburgh Medical Center, Pittsburgh, PA\nScott & White Healthcare, Temple, TX\nVISION\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections, emergency department/urgent care visits with\nPopulation: Individuals of all ages who have an emergency department or urgent care visit or hospitalization within\nthe facility network\nParticipating Sites\nBaylor Scott and White Health (Texas)\nColumbia University (New York)\nHealthPartners (Minnesota and Wisconsin)\nIntermountain Healthcare (Utah)\nKaiser Permanente Northern California (California)\nKaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana)\nUniversity of Colorado (Colorado)\nOvercoming COVID-19 to track and characterize development of complications in children and young adults exposed\nOutcome: Hospitalization with SARS-CoV-2\nPopulation: Hospitalized children and adolescents aged 18 years and younger\nParticipating Sites: Sites can be found here ."}]}, {"title": "d26a4de8f94b180662e3b78b04045a05", "paragraphs": [{"qas": [{"question": "When was this page last reviewed?", "id": "100000000000000000001890", "answers": [{"text": "March 22, 2022", "answer_start": 258}], "is_impossible": false}], "context": "\uf209\nRead all MMWR COVID-19 vaccine effectiveness and safety reports. For the latest CDC data on COVID-19 vaccine effectiveness: CDC COVID Data Tracker\nFor more information on COVID-19 vaccine effectiveness: COVID-19 Vaccines are Effective. Page last reviewed: March 22, 2022"}]}, {"title": "24bbfe0c4a3366a7381a9b55625164ac", "paragraphs": [{"qas": [{"question": "Who is reviewing this page to align with updated guidance?", "id": "100000000000000000001891", "answers": [{"text": "CDC", "answer_start": 113}], "is_impossible": false}, {"question": "What vaccine helps protect adults and children from getting severely ill with COVID-19?", "id": "100000000000000000001892", "answers": [{"text": "COVID-19", "answer_start": 214}], "is_impossible": false}, {"question": "What does COVID-19 help protect?", "id": "100000000000000000001893", "answers": [{"text": "adults and children ages 6 months and older", "answer_start": 249}], "is_impossible": false}], "context": "10/30/22, 9:33 AM COVID-19 Vaccine Effectiveness | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccines are Effective\nCDC is reviewing this page to align with updated guidance. COVID-19 vaccines are safe and effective. COVID-19 vaccination helps protect adults and children ages 6 months and older\nfrom getting severely ill with COVID-19 and helps protect those around them. Some people who are vaccinated against COVID-19 will still get sick and have a\nvaccine breakthrough infection because no vaccine is 100% effective."}]}, {"title": "fde2ac9b29e8b84dd58b7c8cac083c8d", "paragraphs": [{"qas": [{"question": "What is a measure of how well vaccination protects people against outcomes such as infection, symptomatic illness, hospitalization, and death?", "id": "100000000000000000001896", "answers": [{"text": "Vaccine effectiveness", "answer_start": 98}], "is_impossible": false}, {"question": "What is typically measured through observational studies specifically designed to estimate individual protection from vaccination under \u201creal-world\u201d conditions?", "id": "100000000000000000001897", "answers": [{"text": "Vaccine effectiveness", "answer_start": 258}], "is_impossible": false}, {"question": "What are the rates of breakthrough infections?", "id": "100000000000000000001899", "answers": [{"text": "CDC is monitoring vaccine effectiveness and rates of breakthrough infections, hospitalizations, and deaths", "answer_start": 589}], "is_impossible": false}], "context": "COVID-19 Vaccines Work\nHow and Why CDC Monitors Vaccine Effectiveness\n\u2022\n\u2022\n\u2022\nVaccine Effectiveness\nVaccine effectiveness is a measure of how well vaccination protects people against outcomes such as infection, symptomatic\nillness, hospitalization, and death. Vaccine effectiveness is typically measured through observational studies specifically\ndesigned to estimate individual protection from vaccination under \u201creal-world\u201d conditions. Data on Vaccine Effectiveness and Vaccine Breakthrough\nInfections\nAs part of CDC\u2019s ongoing efforts to understand how well COVID-19 vaccines are working, CDC is monitoring vaccine\neffectiveness and rates of breakthrough infections, hospitalizations, and deaths."}]}, {"title": "4afe1d41f31fa2d3c1ac5bb4b2c889ab", "paragraphs": [{"qas": [{"question": "What are the rates of COVID-19 Cases and Deaths by Vaccination Status?", "id": "100000000000000000001900", "answers": [{"text": "\u2022", "answer_start": 221}], "is_impossible": false}, {"question": "What is the CDC's measure of the effectiveness of Vaccines?", "id": "100000000000000000001901", "answers": [{"text": "COVID-19 Vaccine Effectiveness Rates of COVID-19 Cases and Deaths by Vaccination Status Hospitalizations by Vaccination Status \u2013 COVID-NET The Possibility of Getting COVID-19 after Vaccination: Breakthrough Infections \u2022 \u2022 \u2022 \u2022 Read all MMWR COVID-19 vaccine effectiveness and safety reports. 10/30/22, 9:33 AM COVID-19 Vaccine Effectiveness", "answer_start": 0}], "is_impossible": false}, {"question": "How do COVID-19 Vaccines Work?", "id": "100000000000000000001902", "answers": [{"text": "\u2022", "answer_start": 221}], "is_impossible": false}, {"question": "What does CDC Measure?", "id": "100000000000000000001903", "answers": [{"text": "COVID-19 Vaccine Effectiveness", "answer_start": 414}], "is_impossible": false}, {"question": "When was the last update for Breakthrough Infections?", "id": "100000000000000000001904", "answers": [{"text": "June 29, 2022", "answer_start": 647}], "is_impossible": false}], "context": "COVID-19 Vaccine Effectiveness\nRates of COVID-19 Cases and Deaths by Vaccination Status\nHospitalizations by Vaccination Status \u2013 COVID-NET\nThe Possibility of Getting COVID-19 after Vaccination: Breakthrough Infections\n\u2022\n\u2022\n\u2022\n\u2022\nRead all MMWR COVID-19 vaccine effectiveness and safety reports. 10/30/22, 9:33 AM COVID-19 Vaccine Effectiveness | CDC\nAbout Vaccine Effectiveness\nCOVID-19 Vaccines Work\nHow CDC Measures COVID-19 Vaccine Effectiveness\nPossibility of COVID-19 Illness After Vaccination\n\uf1aa\n\uf1aa\n\uf1aa\n\uf2ff For Healthcare Professionals and Health Departments\nCOVID-19 Clinical and Professional Resources\nReporting Breakthrough Infections\nLast Updated June 29, 2022"}]}, {"title": "d1de91bee7bba9d72b334cde1d6bb2ed", "paragraphs": [{"qas": [{"question": "What is the name of the CDC's Vaccine Monitoring Systems for Pregnant People?", "id": "100000000000000000001905", "answers": [{"text": "COVID-19", "answer_start": 18}], "is_impossible": false}, {"question": "What are some of the considerations for people who are pregnant or breastfeeding?", "id": "100000000000000000001906", "answers": [{"text": "vaccination", "answer_start": 229}], "is_impossible": false}, {"question": "What is the name of the agency that collects information about vaccination during pregnancy?", "id": "100000000000000000001909", "answers": [{"text": "Food and Drug Administration", "answer_start": 366}], "is_impossible": false}], "context": "10/30/22, 9:32 AM COVID-19 Vaccine Monitoring Systems for Pregnant People | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccine Monitoring Systems for Pregnant\nPeople\nLearn more about COVID-19 and pregnancy. Learn more about COVID-19 vaccination considerations for people who are pregnant or breastfeeding. Monitoring COVID-19 Vaccine Safety during Pregnancy\nCDC and the Food and Drug Administration (FDA) currently have five safety monitoring systems in place to capture\ninformation about vaccination during pregnancy and closely monitors that information reported to each system."}]}, {"title": "de22455f006e5820153f2518677767a3", "paragraphs": [{"qas": [{"question": "What does VAERS stand for?", "id": "100000000000000000001910", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 13}], "is_impossible": false}, {"question": "What is the name of the national system to which healthcare professionals, vaccine manufacturers, and the public can report possible side effects or health problems?", "id": "100000000000000000001911", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 13}], "is_impossible": false}, {"question": "What does the VAERS reporting form have a question to identify?", "id": "100000000000000000001912", "answers": [{"text": "pregnant people", "answer_start": 428}], "is_impossible": false}, {"question": "What is v-safe?", "id": "100000000000000000001914", "answers": [{"text": "a smartphone-based, after-vaccination health checker for people who receive COVID-19 vaccines", "answer_start": 596}], "is_impossible": false}, {"question": "What is the name of the after-vaccination health checker for people who receive COVID-19 vaccines?", "id": "100000000000000000001915", "answers": [{"text": "V-safe", "answer_start": 586}], "is_impossible": false}], "context": "CDC and FDA: Vaccine Adverse Event Reporting System (VAERS) \u2014 VAERS is a national system to which healthcare\nprofessionals, vaccine manufacturers, and the public can report possible side effects or health problems that happen\nafter vaccination. Scientists investigate reports of events that are unexpected, appear to happen more often than\nexpected, or have unusual patterns. The VAERS reporting form has a question to identify pregnant people (question\n8). CDC clinicians review all pregnancy reports related to COVID-19 vaccinations. CDC: v-safe COVID-19 Vaccine Pregnancy Registry \u2014 V-safe is a smartphone-based, after-vaccination health checker for\npeople who receive COVID-19 vaccines."}]}, {"title": "9d9dfc083ebc17d5bc1430d1564fc1f5", "paragraphs": [{"qas": [{"question": "What is the acronym for Vaccine Safety Datalink?", "id": "100000000000000000001918", "answers": [{"text": "VSD", "answer_start": 353}], "is_impossible": false}, {"question": "How many healthcare organizations are part of the VSD?", "id": "100000000000000000001919", "answers": [{"text": "nine", "answer_start": 380}], "is_impossible": false}, {"question": "What are the possible side effects identified using VAERS related to?", "id": "100000000000000000001921", "answers": [{"text": "vaccination", "answer_start": 615}], "is_impossible": false}], "context": "The v-safe COVID-19 Vaccine Pregnancy Registry is a registry to collect additional\nhealth information from v-safe participants who report being pregnant at the time of vaccination or a positive pregnancy\ntest after vaccination. This information helps CDC monitor the safety of COVID-19 vaccines in people who are pregnant. CDC: Vaccine Safety Datalink (VSD) \u2014 VSD is a network of nine integrated healthcare organizations across the United\nStates that monitor and evaluate the safety of vaccines. The system is also used to help determine whether possible side\neffects identified using VAERS are actually related to vaccination."}]}, {"title": "51660f7be8fb838073041e22df134084", "paragraphs": [{"qas": [{"question": "What will CDC study through VSD?", "id": "100000000000000000001922", "answers": [{"text": "Weekly counts and rates of COVID-19 vaccination in pregnant people", "answer_start": 29}], "is_impossible": false}, {"question": "What is one of the adverse outcomes in pregnancy following COVID-19 vaccination?", "id": "100000000000000000001923", "answers": [{"text": "Pregnancy complications", "answer_start": 268}], "is_impossible": false}, {"question": "In addition to birth complications, what is another adverse outcome for the first year of life?", "id": "100000000000000000001924", "answers": [{"text": "infant death", "answer_start": 360}], "is_impossible": false}], "context": "Through VSD, CDC will study:\nWeekly counts and rates of COVID-19 vaccination in pregnant people\nMiscarriage and stillbirth that occurs among people who received COVID-19 vaccine during pregnancy\nAdverse outcomes in pregnancy following COVID-19 vaccination, including:\nPregnancy complications\nBirth outcomes\nInfant outcomes for the first year of life (includes infant death, birth defects, and developmental disorders)\nCDC: Clinical Immunization Safety Assessment (CISA) Project \u2014 The CISA Project is a collaboration between CDC and\nseven medical research centers to provide expert consultation on individual cases of adverse events after vaccination\nand conduct clinical research studies about vaccine safety."}]}, {"title": "cf39ae9bc32b4ce8ccdee50f1324b221", "paragraphs": [{"qas": [{"question": "How many sites will CISA conduct a clinical research study on the safety of the COVID-19 vaccine among pregnant people?", "id": "100000000000000000001927", "answers": [{"text": "three", "answer_start": 98}], "is_impossible": false}], "context": "CISA will implement a clinical research study on COVID-19\nvaccine safety among pregnant people at three sites."}]}, {"title": "13fe5b7ef8677c01cad389346393d160", "paragraphs": [{"qas": [{"question": "Who will collect baseline maternal health information?", "id": "100000000000000000001930", "answers": [{"text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines will be given as part of the study Collect baseline maternal health information, including if they previously had COVID-19 Follow people during pregnancy and for three months after delivery Follow babies through their first three months of life CDC: Birth Defects Study to Evaluate Pregnancy Exposures (BD-STEPS) \u2014 BD-STEPS is an ongoing study that collects information including COVID-19 vaccination information from people who have recently been pregnant to understand \u2022 \u2022 \u2022 \uf209 \uf209 \u2022 \u2022 - - - \u2022 \u2022 \u2022 \u2022 - - - - \u2022\f10/30/22, 9:32 AM COVID-19 Vaccine Monitoring Systems for Pregnant People | CDC information, including COVID-19 vaccination information, from people who have recently been pregnant to understand the potential causes of birth defects", "answer_start": 16}], "is_impossible": false}, {"question": "How long after delivery will people follow people during pregnancy?", "id": "100000000000000000001931", "answers": [{"text": "three months", "answer_start": 261}], "is_impossible": false}, {"question": "What is the name of the ongoing study that collects information about COVID-19 vaccination from people who have recently been pregnant?", "id": "100000000000000000001933", "answers": [{"text": "BD-STEPS", "answer_start": 414}], "is_impossible": false}, {"question": "What are people who have recently been pregnant trying to understand?", "id": "100000000000000000001935", "answers": [{"text": "the potential causes of birth defects", "answer_start": 803}], "is_impossible": false}], "context": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines will be given as part of the\nstudy\nCollect baseline maternal health information, including if they previously had COVID-19\nFollow people during pregnancy and for three months after delivery\nFollow babies through their first three months of life\nCDC: Birth Defects Study to Evaluate Pregnancy Exposures (BD-STEPS) \u2014 BD-STEPS is an ongoing study that collects\ninformation including COVID-19 vaccination information from people who have recently been pregnant to understand\n\u2022\n\u2022\n\u2022 \uf209\n\uf209\n\u2022\n\u2022\n-\n-\n-\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n-\n-\n\u2022\f10/30/22, 9:32 AM COVID-19 Vaccine Monitoring Systems for Pregnant People | CDC\ninformation, including COVID-19 vaccination information, from people who have recently been pregnant to understand\nthe potential causes of birth defects and how to prevent them."}]}, {"title": "a0e58f7a03ba4fbc5fdb3e17355148b1", "paragraphs": [{"qas": [{"question": "What year was the last update?", "id": "100000000000000000001937", "answers": [{"text": "2022", "answer_start": 22}], "is_impossible": false}], "context": "Last Updated July 15, 2022"}]}, {"title": "8961723a08e6c11d322e360d0e95e3f", "paragraphs": [{"qas": [{"question": "How many people in the U.S. have received COVID-19 vaccinations?", "id": "100000000000000000001938", "answers": [{"text": "Hundreds of millions", "answer_start": 120}], "is_impossible": false}, {"question": "What is the name of the vaccine that is safe and effective?", "id": "100000000000000000001940", "answers": [{"text": "COVID-19", "answer_start": 373}], "is_impossible": false}, {"question": "What do vaccine safety surveillance systems monitor after a vaccine is approved for use?", "id": "100000000000000000001941", "answers": [{"text": "adverse events", "answer_start": 570}], "is_impossible": false}, {"question": "What can be identified with continued monitoring?", "id": "100000000000000000001942", "answers": [{"text": "adverse events that may not have been seen in clinical trials", "answer_start": 665}], "is_impossible": false}], "context": "10/30/22, 9:32 AM COVID-19 Vaccine Reporting Systems | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccine Reporting Systems\nHundreds of millions of people in the United States have safely received COVID-19 vaccinations. These vaccines have\nundergone the most intensive safety monitoring in U.S. history that includes both established and new safety monitoring\nsystems. We know COVID-19 vaccines are safe and effective because of our monitoring systems. Vaccine Safety Monitoring\nAfter a vaccine is authorized or approved for use, vaccine safety surveillance systems monitor adverse events and watch\nfor potential safety problems. This continued monitoring can identify adverse events that may not have been seen in clinical trials."}]}, {"title": "25e906641e63e8cc0e95e199ae190c0", "paragraphs": [{"qas": [{"question": "What happens if an unexpected adverse event is seen?", "id": "100000000000000000001943", "answers": [{"text": "experts quickly study it further to assess whether it is a true safety concern", "answer_start": 40}], "is_impossible": false}, {"question": "What does the FDA's COVID-19 Vaccines website include important recommendations for?", "id": "100000000000000000001946", "answers": [{"text": "ongoing safety evaluation", "answer_start": 417}], "is_impossible": false}, {"question": "What has CDC expanded safety surveillance through?", "id": "100000000000000000001947", "answers": [{"text": "new systems and additional information sources", "answer_start": 545}], "is_impossible": false}], "context": "If an unexpected\nadverse event is seen, experts quickly study it further to assess whether it is a true safety concern. Experts then decide whether changes are needed in U.S. vaccine recommendations or clinical guidance. This monitoring is critical to help ensure that the benefits continue to outweigh the risks for people who receive\nvaccines. FDA\u2019s COVID-19 Vaccines website includes important recommendations for ongoing safety evaluation after any\nCOVID-19 vaccine is made available under EUA . CDC has expanded safety surveillance through new systems and additional information sources, as well as by scaling up\nexisting safety monitoring systems."}]}, {"title": "461c08b722df52a0db52dcaf305aa2eb", "paragraphs": [{"qas": [{"question": "What does CDC v-safe do?", "id": "100000000000000000001949", "answers": [{"text": "A smartphone-based, after-vaccination health checker for people who receive COVID-19 vaccines", "answer_start": 276}], "is_impossible": false}, {"question": "What is the name of the smartphone-based, after-vaccine health checker?", "id": "100000000000000000001950", "answers": [{"text": "CDC v-safe", "answer_start": 264}], "is_impossible": false}, {"question": "What is the name of the smartphone-based, after-vaccination health checker for people who receive the vaccines?", "id": "100000000000000000001952", "answers": [{"text": "CDC v-safe", "answer_start": 264}], "is_impossible": false}, {"question": "Who provides second vaccine dose reminders if needed?", "id": "100000000000000000001953", "answers": [{"text": "V-safe", "answer_start": 492}], "is_impossible": false}], "context": "Expanded Safety Monitoring Systems\nThe following systems and information sources add an additional layer of safety monitoring, giving CDC and FDA the ability to\nevaluate COVID-19 vaccine safety in real time and make sure COVID-19 vaccines are as safe as possible:\nCDC v-safe\u2014 A smartphone-based, after-vaccination health checker for people who receive COVID-19 vaccines. V-\nsafe uses text messaging and web surveys from CDC to check in with vaccine recipients following COVID-19\nvaccination. V-safe also provides second vaccine dose reminders if needed, and telephone follow-ups to anyone who\nreports medically-attended adverse events."}]}, {"title": "1ab1f4995281d9f5fcdc403cb6f156fd", "paragraphs": [{"qas": [{"question": "What is a registry to collect health information from people who receive COVID-19 vaccines shortly before or during pregnancy?", "id": "100000000000000000001955", "answers": [{"text": "V-safe COVID-19 Vaccine Pregnancy Registry", "answer_start": 127}], "is_impossible": false}, {"question": "What is the name of the voluntary program that helps CDC monitor the safety of COVID-19 vaccines in pregnant women?", "id": "100000000000000000001956", "answers": [{"text": "V-safe COVID-19 Vaccine Pregnancy Registry", "answer_start": 127}], "is_impossible": false}], "context": "Participants can enroll in v-safe after any dose of vaccine, and parents and\nguardians can enroll on behalf of their children. V-safe COVID-19 Vaccine Pregnancy Registry \u2014 A registry to collect health information from people enrolled in v-safe\nwho receive COVID-19 vaccines shortly before or during pregnancy. This voluntary program helps CDC monitor the\nsafety of COVID-19 vaccines in people who are pregnant."}]}, {"title": "b68a621c1ab90fbcc5e38fae1a956503", "paragraphs": [{"qas": [{"question": "What do CDC, FDA, and other federal partners use to conduct ongoing safety monitoring?", "id": "100000000000000000001957", "answers": [{"text": "Existing Safety Monitoring Systems As people get vaccinated, CDC, FDA, and other federal partners will use the following existing, robust systems and data sources", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the national system that accepts reports from healthcare professionals, vaccine manufacturers, and the public of adverse events that happen after vaccination?", "id": "100000000000000000001959", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 305}], "is_impossible": false}], "context": "Existing Safety Monitoring Systems\nAs people get vaccinated, CDC, FDA, and other federal partners will use the following existing, robust systems and data\nsources to conduct ongoing safety monitoring:\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\uf209\n\u2022\n\u2022\n\u2022\f10/30/22, 9:32 AM COVID-19 Vaccine Reporting Systems | CDC\nGeneral public\nCDC & FDA Vaccine Adverse Event Reporting System (VAERS) \u2014 The national system that accepts reports from\nhealthcare professionals, vaccine manufacturers, and the public of adverse events that happen after vaccination; reports\nof adverse events that are unexpected, appear to happen more often than expected, or have unusual patterns are\nfurther assessed."}]}, {"title": "a63b7a16431a638903688c052e9b444d", "paragraphs": [{"qas": [{"question": "What is the acronym for CDC Vaccine Safety Datalink?", "id": "100000000000000000001960", "answers": [{"text": "VSD", "answer_start": 29}], "is_impossible": false}, {"question": "How many healthcare organizations are part of the VSD network?", "id": "100000000000000000001962", "answers": [{"text": "nine", "answer_start": 48}], "is_impossible": false}, {"question": "What is the CISA Project?", "id": "100000000000000000001963", "answers": [{"text": "CDC Clinical Immunization Safety Assessment", "answer_start": 326}], "is_impossible": false}, {"question": "How many medical research centers work together to provide expert consultation on individual vaccine cases?", "id": "100000000000000000001964", "answers": [{"text": "seven", "answer_start": 418}], "is_impossible": false}, {"question": "What does the CISA Project help with?", "id": "100000000000000000001965", "answers": [{"text": "vaccine safety surveillance", "answer_start": 513}], "is_impossible": false}, {"question": "Who are the Centers for Medicare and Medicaid Services?", "id": "100000000000000000001966", "answers": [{"text": "FDA", "answer_start": 602}], "is_impossible": false}, {"question": "The Centers for Medicare and Medicaid Services is a claims-based system for what?", "id": "100000000000000000001967", "answers": [{"text": "active surveillance and research", "answer_start": 685}], "is_impossible": false}], "context": "CDC Vaccine Safety Datalink (VSD)\u2014 A network of nine integrated healthcare organizations across the United States that\nconducts active surveillance and research using electronic health records; the system is also used to help determine\nwhether possible side effects identified using VAERS are actually related to vaccination. CDC Clinical Immunization Safety Assessment (CISA) Project\u2014 A collaboration between CDC and seven medical research\ncenters to provide expert consultation on individual cases, assist with vaccine safety surveillance, and conduct clinical\nresearch studies about vaccine safety. FDA and the Centers for Medicare and Medicaid Services \u2014 A claims-based system for active surveillance and\nresearch."}]}, {"title": "7be3b7fae503f3bf992643c66b90b913", "paragraphs": [{"qas": [{"question": "What is FDA Biologics Effectiveness and Safety System?", "id": "100000000000000000001968", "answers": [{"text": "A system of electronic health record, administrative, and claims-based data for active surveillance and research", "answer_start": 55}], "is_impossible": false}, {"question": "What does BEST stand for?", "id": "100000000000000000001969", "answers": [{"text": "FDA Biologics Effectiveness and Safety System", "answer_start": 0}], "is_impossible": false}, {"question": "Who is responsible for VAERS data?", "id": "100000000000000000001970", "answers": [{"text": "Department of Defense", "answer_start": 193}], "is_impossible": false}, {"question": "What is a system for case tracking and evaluation of adverse events following immunization in DOD?", "id": "100000000000000000001972", "answers": [{"text": "DOD Vaccine Adverse Event Clinical System", "answer_start": 303}], "is_impossible": false}, {"question": "What records are used for near real-time safety monitoring and research?", "id": "100000000000000000001973", "answers": [{"text": "DOD Electronic Health Record and Defense Medical Surveillance System", "answer_start": 477}], "is_impossible": false}], "context": "FDA Biologics Effectiveness and Safety System (BEST) \u2014 A system of electronic health record, administrative, and\nclaims-based data for active surveillance and research. Members of the military\nDepartment of Defense (DOD) VAERS data \u2014 Spontaneous adverse event reporting to VAERS for the DOD population. DOD Vaccine Adverse Event Clinical System (VAECS) \u2014 A system for case tracking and evaluation of adverse events\nfollowing immunization in DOD and DOD-affiliated populations. DOD Electronic Health Record and Defense Medical Surveillance System \u2014 Large, linked electronic health records\n(AHLTA/MHS GENESIS) and administrative data systems for near real-time safety monitoring and research."}]}, {"title": "30477f27d111230a3884132e9f1ca024", "paragraphs": [{"qas": [{"question": "What is the VA's Adverse Drug Event Reporting System?", "id": "100000000000000000001974", "answers": [{"text": "A national reporting system for adverse events following receipt of drugs and immunizations", "answer_start": 94}], "is_impossible": false}, {"question": "What does VA ADERS stand for?", "id": "100000000000000000001975", "answers": [{"text": "Adverse Drug Event Reporting System", "answer_start": 45}], "is_impossible": false}, {"question": "VA Electronic Health Record and Active Surveillance System is a system of what?", "id": "100000000000000000001976", "answers": [{"text": "electronic health record and administrative data", "answer_start": 260}], "is_impossible": false}], "context": "Veterans\nDepartment of Veterans Affairs (VA) Adverse Drug Event Reporting System (VA ADERS) \u2014 A national reporting system\nfor adverse events following receipt of drugs and immunizations. VA Electronic Health Record and Active Surveillance System \u2014 A system of electronic health record and\nadministrative data for active surveillance and research."}]}, {"title": "1675c247a26bad19d57656101c545250", "paragraphs": [{"qas": [{"question": "What does VAERS permit analysis of in IHS system of care?", "id": "100000000000000000001978", "answers": [{"text": "adverse events", "answer_start": 185}], "is_impossible": false}, {"question": "CDC g Allergic Reactions after getting a COVID-19 Vaccine?", "id": "100000000000000000001980", "answers": [{"text": "\u2022 \uf209 \u2022 \uf209 \u2022 \uf209 \u2022 \uf209 \u2022 \uf209 \u2022 - \u2022 - - \u2022 - - - Related Pages\f10/30/22, 9:32 AM COVID-19 Vaccine Reporting Systems", "answer_start": 555}], "is_impossible": false}, {"question": "What is the name of the CDC\u2019s Vaccine Safety Information?", "id": "100000000000000000001981", "answers": [{"text": "Ensuring the Safety of Vaccines in the United States", "answer_start": 835}], "is_impossible": false}, {"question": "When was the last time the COVID-19 vaccine safety information was updated?", "id": "100000000000000000001982", "answers": [{"text": "July 19, 2022", "answer_start": 956}], "is_impossible": false}, {"question": "What are the names of the ACIP Work Groups?", "id": "100000000000000000001983", "answers": [{"text": "COVID-19 Vaccine Safety Publications", "answer_start": 906}], "is_impossible": false}], "context": "Tribal nations\nIndian Health Service (IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VAERS)\nVAERS functionality permits analysis of adverse events (AE) in IHS system of care\nIHS Safety Tracking & Response System\nFederal and participating tribal sites\nWorker-related AEs and vaccine administration errors\nActive Surveillance\nIHS Sentinel Survey\nBiweekly survey of AEs, including vaccine administration errors\n58 federal and tribal sites representing IHS Areas\nSupports reporting to VAERS\n\u2022 \uf209\n\u2022\n\u2022\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n-\n\u2022\n-\n-\n\u2022\n-\n-\n-\nRelated Pages\f10/30/22, 9:32 AM COVID-19 Vaccine Reporting Systems | CDC\ng\nAllergic Reactions after Getting a COVID-19 Vaccine\u200b\n\u203a\nSafety of COVID-19 Vaccines\n\u203a\nDeveloping COVID-19 Vaccines\n\u203a\nMore Information\nCDC\u2019s Vaccine Safety Information\nEnsuring the Safety of Vaccines in the United States\u200b\nACIP Work Groups\nCOVID-19 Vaccine Safety Publications\nLast Updated July 19, 2022"}]}, {"title": "39e8a31c6634444323ed3cfd53d0f2ef", "paragraphs": [{"qas": [{"question": "What did scientists do before authorizing or approving COVID-19 vaccines?", "id": "100000000000000000001984", "answers": [{"text": "conducted clinical trials", "answer_start": 313}], "is_impossible": false}, {"question": "When did scientists conduct clinical trials with thousands of children and teens?", "id": "100000000000000000001985", "answers": [{"text": "10/30/22", "answer_start": 0}], "is_impossible": false}, {"question": "Who conducted clinical trials with thousands of children and teens?", "id": "100000000000000000001986", "answers": [{"text": "scientists", "answer_start": 302}], "is_impossible": false}, {"question": "Who monitors all COVID-19 vaccines after they are approved?", "id": "100000000000000000001989", "answers": [{"text": "CDC", "answer_start": 619}], "is_impossible": false}], "context": "10/30/22, 9:31 AM COVID-19 Vaccine Safety in Children and Teens | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccine Safety in Children and Teens\nClinical Trials and Ongoing Safety Monitoring Show That COVID-\n19 Vaccination Is Safe for Children and Teens\nBefore authorizing or approving COVID-19 vaccines, scientists conducted clinical trials with thousands of children and teens to\nestablish their safety and effectiveness. Learn more about how COVID-19 vaccines were developed and approved. COVID-19 vaccines are being monitored under the most comprehensive and intense vaccine safety monitoring program in\nU.S. history. CDC monitors all COVID-19 vaccines after they are authorized or approved for use."}]}, {"title": "4b400983065ca5256176e317012f9155", "paragraphs": [{"qas": [{"question": "What do CDC and FDA continue to monitor?", "id": "100000000000000000001990", "answers": [{"text": "vaccines", "answer_start": 68}], "is_impossible": false}, {"question": "What do they use data to make to make COVID-19 vaccination recommendations?", "id": "100000000000000000001991", "answers": [{"text": "CDC and U.S. Food and Drug Administration (FDA) continue to monitor vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "How rare are serious reactions after vaccination in children and teens?", "id": "100000000000000000001992", "answers": [{"text": "rare", "answer_start": 300}], "is_impossible": false}, {"question": "What is the term for inflammation of the heart muscle?", "id": "100000000000000000001994", "answers": [{"text": "myocarditis", "answer_start": 421}], "is_impossible": false}, {"question": "What is pericarditis?", "id": "100000000000000000001995", "answers": [{"text": "inflammation of the outer lining of the heart", "answer_start": 486}], "is_impossible": false}, {"question": "When do serious reactions most often occur?", "id": "100000000000000000001996", "answers": [{"text": "within a few days after vaccination", "answer_start": 370}], "is_impossible": false}], "context": "CDC and U.S. Food and Drug\nAdministration (FDA) continue to monitor vaccines, keep people informed of findings, and use data to make COVID-19\nvaccination recommendations. Serious Health Events after COVID-19 Vaccination Are Rare\nSerious reactions after COVID-19 vaccination in children and teens are rare. When they are reported, serious reactions most\nfrequently occur within a few days after vaccination. Rare cases of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer lining of the heart)\nhave been reported after children and teens ages 5 years and older got the Pfizer-BioNTech COVID-19 vaccine."}]}, {"title": "b973f410fc1d3a85985d0574386c1e1e", "paragraphs": [{"qas": [{"question": "How many confirmed cases of myocarditis in children between 5 and 11 years?", "id": "100000000000000000001998", "answers": [{"text": "20", "answer_start": 321}], "is_impossible": false}, {"question": "What is the most common age range for mRNA COVID-19 vaccination?", "id": "100000000000000000001999", "answers": [{"text": "12 and 39 years", "answer_start": 180}], "is_impossible": false}, {"question": "What are COVID-19 boosters for?", "id": "100000000000000000002003", "answers": [{"text": "everyone ages 5 years and older", "answer_start": 599}], "is_impossible": false}, {"question": "How old is everyone if they are eligible for boosters?", "id": "100000000000000000002005", "answers": [{"text": "5 years and older", "answer_start": 613}], "is_impossible": false}], "context": "New studies\nhave shown the rare risk of myocarditis and pericarditis associated with mRNA COVID-19 vaccination (Pfizer-BioNTech and\nModerna)\u2014mostly among males between the ages of 12 and 39 years\u2014may be further reduced with a longer time between\nthe first and second dose. In children ages 5 through 11 years, there were 20 confirmed reports of myocarditis out of approximately 18.1 million\ndoses given of the Pfizer-BioNTech COVID-19 vaccine between November 2021 and April 2022\nWhat You Need to Know\nCDC recommends COVID-19 vaccines for everyone ages 6 months and older, and COVID-19 boosters for everyone\nages 5 years and older, if eligible."}]}, {"title": "5abd0f8491fa775c0de7922c9c9034c9", "paragraphs": [{"qas": [{"question": "What vaccine has been found to be safe for children and teens?", "id": "100000000000000000002006", "answers": [{"text": "COVID-19", "answer_start": 37}], "is_impossible": false}, {"question": "What outweighs the potential risks of having a rare, adverse reaction to vaccination?", "id": "100000000000000000002008", "answers": [{"text": "The known risks and possible severe complications", "answer_start": 226}], "is_impossible": false}, {"question": "Use CDC\u2019s COVID-19 booster tool to learn if and when your child can get boosters?", "id": "100000000000000000002009", "answers": [{"text": "to stay up to date with their COVID-19 vaccines", "answer_start": 457}], "is_impossible": false}], "context": "Through continued safety monitoring, COVID-19 vaccination has been found to be safe for children and teens. Millions of children and teens ages 5 through 17 years have already received at least one dose of a COVID-19\nvaccine. The known risks and possible severe complications of COVID-19 outweigh the potential risks of having a rare,\nadverse reaction to vaccination. Use CDC\u2019s COVID-19 booster tool to learn if and when your child or teen can get boosters to stay up to date with\ntheir COVID-19 vaccines."}]}, {"title": "e71006be8a1fd92adf702af0494e07b9", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine used between November 2021 and April 2022?", "id": "100000000000000000002011", "answers": [{"text": "Pfizer-BioNTech COVID-19", "answer_start": 258}], "is_impossible": false}, {"question": "How many doses were given of the Pfizer-BioNTech Covid-19 vaccine?", "id": "100000000000000000002012", "answers": [{"text": "10/30/22, 9:31 AM COVID-19 Vaccine Safety in Children and Teens | CDC doses given of the Pfizer-BioNTech COVID-19 vaccine between November 2021 and April 2022 . In reports of myocarditis following mRNA-based COVID-19 vaccination from December 2020 to August 2021 , the risk of myocarditis was highest following the second", "answer_start": 169}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nLearn more about COVID-19 vaccine safety from published research and how CDC and FDA are making sure COVID-19\nvaccines used in the United States are safe. \u2022\n\uf20c\f10/30/22, 9:31 AM COVID-19 Vaccine Safety in Children and Teens | CDC\ndoses given of the Pfizer-BioNTech COVID-19 vaccine between November 2021 and April 2022 . In reports of myocarditis following mRNA-based COVID-19 vaccination from December 2020 to August 2021 , the risk\nof myocarditis was highest following the second dose of the Pfizer-BioNTech vaccine in adolescent and young adult\nmales."}]}, {"title": "bb9ae953d98fc1d0462f2f3e6fadf051", "paragraphs": [{"qas": [{"question": "How many cases per million doses were reported in males ages 12 to 15 years?", "id": "100000000000000000002015", "answers": [{"text": "70", "answer_start": 28}], "is_impossible": false}, {"question": "How many reported cases per millions doses did males report?", "id": "100000000000000000002016", "answers": [{"text": "70", "answer_start": 28}], "is_impossible": false}, {"question": "What were rare in COVID-19 vaccine clinical trials for young children?", "id": "100000000000000000002017", "answers": [{"text": "Febrile seizures", "answer_start": 156}], "is_impossible": false}, {"question": "What is an example of a severe allergic reaction after a COVID-19 vaccination?", "id": "100000000000000000002018", "answers": [{"text": "anaphylaxis", "answer_start": 396}], "is_impossible": false}, {"question": "What can be quickly provided to your child if he or she has an allergic reaction?", "id": "100000000000000000002019", "answers": [{"text": "vaccine providers can rapidly provide care", "answer_start": 580}], "is_impossible": false}], "context": "Reporting rates were around 70 cases per million doses in males ages 12 through 15 years and 105 cases per million\ndoses in males ages 16 through 17 years. Febrile seizures were rare in COVID-19 vaccine clinical trials for young children and occurred at similar rates for both Pfizer\nand Moderna COVID-19 vaccines. Learn more about febrile seizures and vaccines. A severe allergic reaction,\u202flike anaphylaxis, may happen\u202fafter any vaccination, including COVID-19 vaccination, but this is\nrare. If your child\u202fexperiences a severe allergic reaction\u202fafter getting a COVID-19 vaccine, vaccine providers can rapidly provide\ncare and call for emergency medical services, if needed."}]}, {"title": "fb63f0563e3bddfd56374f8ac2ea621e", "paragraphs": [{"qas": [{"question": "What is myocarditis?", "id": "100000000000000000002021", "answers": [{"text": "pericarditis", "answer_start": 41}], "is_impossible": false}, {"question": "What is the association between having COVID-19 and having it?", "id": "100000000000000000002022", "answers": [{"text": "myocarditis", "answer_start": 109}], "is_impossible": false}, {"question": "Who can you call if you think your child might be having a severe allergic reaction after the vaccination provider site?", "id": "100000000000000000002023", "answers": [{"text": "911", "answer_start": 326}], "is_impossible": false}, {"question": "What does 911 do?", "id": "100000000000000000002024", "answers": [{"text": "seek immediate medical care", "answer_start": 287}], "is_impossible": false}, {"question": "What do mRNA vaccines teach the body how to fight?", "id": "100000000000000000002025", "answers": [{"text": "the virus that causes COVID-19", "answer_start": 588}], "is_impossible": false}, {"question": "Which vaccines do not use the live virus that causes COVID-19?", "id": "100000000000000000002026", "answers": [{"text": "Pfizer-BioNTech and Moderna", "answer_start": 411}], "is_impossible": false}], "context": "\uf20c\n\u2022 \uf209\n\u2022\nLearn more about myocarditis and pericarditis after COVID-19 vaccination and the association between myocarditis and\nhaving COVID-19. If your child gets a COVID-19 vaccine and you think they might be having a severe allergic reaction after leaving the\nvaccination provider site, seek immediate medical care by calling 911. People Cannot Get COVID-19 from Any COVID-19 Vaccine\nmRNA vaccines, such as the Pfizer-BioNTech and Moderna vaccines, do not use the live virus that causes COVID-19 and do not\ninteract with DNA in any way. Instead, mRNA vaccines teach the body how to fight the virus that causes COVID-19."}]}, {"title": "d99ed3a119d5c646ea1c3276465a25e8", "paragraphs": [{"qas": [{"question": "What do people who would like to have a baby someday need to know about?", "id": "100000000000000000002031", "answers": [{"text": "COVID-19 vaccines", "answer_start": 354}], "is_impossible": false}, {"question": "What are two examples of mRNA vaccines?", "id": "100000000000000000002032", "answers": [{"text": "Pfizer-BioNTech and Moderna vaccines", "answer_start": 515}], "is_impossible": false}], "context": "Then, the\nbody gets rid of the mRNA within a few days after vaccination. There Is No Evidence That COVID-19 Vaccination Causes Problems\nBecoming Pregnant\nThere is no evidence that vaccine ingredients, including mRNA, or antibodies made following COVID-19 vaccination would\ncause any problems with becoming pregnant now or in the future. Learn more about COVID-19 vaccines for people who\nwould like to have a baby someday. Research on COVID-19 Vaccine Safety in Children\nLearn more about\u202fhow mRNA vaccines, like the Pfizer-BioNTech and Moderna vaccines, work."}]}, {"title": "c93a131f0a5fab8509a6ca008ac341b3", "paragraphs": [{"qas": [{"question": "What is the name of the Vaccine Adverse Event Reporting System?", "id": "100000000000000000002034", "answers": [{"text": "VAERS", "answer_start": 829}], "is_impossible": false}, {"question": "When will the Advisory Committee on Adverse Events hold an update on adverse events among children?", "id": "100000000000000000002035", "answers": [{"text": "November 3\u2013December 19, 2021 Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age Adverse events among children ages 5\u201311 years after COVID-19 vaccination", "answer_start": 69}], "is_impossible": false}, {"question": "What is the acronym for the Vaccine Adverse Event Reporting System?", "id": "100000000000000000002036", "answers": [{"text": "VAERS", "answer_start": 829}], "is_impossible": false}, {"question": "When did the Advisory Committee on Immunization Practices make a recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in the United States?", "id": "100000000000000000002037", "answers": [{"text": "September 2021", "answer_start": 1202}], "is_impossible": false}, {"question": "What is the name of the CDC system that monitors the safety of COVID-19 vaccines in children and teens?", "id": "100000000000000000002039", "answers": [{"text": "Vaccine Adverse Event Reporting System (VAERS)", "answer_start": 789}], "is_impossible": false}, {"question": "How many myocarditis cases have been reported after mRNA-based vaccinations in the US from December 2020 to August 2021?", "id": "100000000000000000002040", "answers": [{"text": "\u2022 \u2022 \uf209", "answer_start": 534}], "is_impossible": false}, {"question": "What vaccine is used in persons aged 16 years?", "id": "100000000000000000002041", "answers": [{"text": "Pfizer-BioNTech COVID-19", "answer_start": 1057}], "is_impossible": false}, {"question": "What is the name of the Advisory Committee on Immunization Practices that recommends the use of mRNA COVID-19 vaccine?", "id": "100000000000000000002042", "answers": [{"text": "Advisory Committee", "answer_start": 1317}], "is_impossible": false}, {"question": "What vaccine was used after reports of myocarditis among vaccine recipients?", "id": "100000000000000000002043", "answers": [{"text": "mRNA COVID-19", "answer_start": 1224}], "is_impossible": false}, {"question": "What was the interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 Years?", "id": "100000000000000000002044", "answers": [{"text": "The Advisory Committee on Immunization Practices", "answer_start": 1389}], "is_impossible": false}, {"question": "What is the age range of the COVID-19 vaccine in adolescents?", "id": "100000000000000000002045", "answers": [{"text": "12\u201317 years", "answer_start": 989}], "is_impossible": false}, {"question": "What is a complete list of research?", "id": "100000000000000000002047", "answers": [{"text": "Vaccine Safety Publications", "answer_start": 1619}], "is_impossible": false}], "context": "COVID-19 vaccine safety in children aged 5\u201311 Years \u2014 United States, November 3\u2013December 19, 2021\nEvaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age\nAdverse events among children ages 5\u201311 years after COVID-19 vaccination: Updates from v-safe and the Vaccine\nAdverse Event Reporting System (VAERS)\nThe Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19\nvaccine in children aged 5\u201311 years \u2014 United States, November 2021\nChildren ages 5 through 11 years\n\uf1aa\n\u2022\n\u2022 \uf209\n\u2022\n\uf20c\n\u2022\nSafety monitoring of COVID-19 vaccine booster doses among persons aged 12\u201317 years \u2014 United States, December\nChildren ages 12 through 17 years\n\uf1aa\n\u2022\f10/30/22, 9:31 AM COVID-19 Vaccine Safety in Children and Teens | CDC\nSafety monitoring in the Vaccine Adverse Event Reporting System (VAERS)\nMyocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021\nCOVID-19 vaccine safety in adolescents aged 12\u201317 years \u2014 United States, December 14, 2020\u2013July 16, 2021\nUse of Pfizer-BioNTech COVID-19 vaccine in persons aged \u226516 years: Recommendations of the Advisory Committee\non Immunization Practices \u2014 United States, September 2021\nUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021\nThe Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19\nvaccine in adolescents aged 12\u201315 Years \u2014 United States, May 2021\n\u2022 \uf209\n\u2022\n\uf209\n\u2022\n\u2022\n\u2022\n\u2022\nFor a complete list of research, visit Vaccine Safety Publications."}]}, {"title": "4475f98d50fd82ecdd85c33ae821ff3b", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine Overview and Safety?", "id": "100000000000000000002048", "answers": [{"text": "Moderna", "answer_start": 69}], "is_impossible": false}, {"question": "When was the last update for the Moderna Covid-19 vaccine overview and safety?", "id": "100000000000000000002049", "answers": [{"text": "July 20, 2022", "answer_start": 207}], "is_impossible": false}, {"question": "What type of vaccines are available for children and teens?", "id": "100000000000000000002050", "answers": [{"text": "Safety of COVID-19 Vaccines", "answer_start": 116}], "is_impossible": false}], "context": "Related Pages\nPfizer-BioNTech COVID-19 Vaccine Overview and Safety\n\u203a\nModerna COVID-19 Vaccine Overview and Safety\n\u203a\nSafety of COVID-19 Vaccines\n\u203a\nCOVID-19 Vaccine Safety in Children and Teens\n\u203a\nLast Updated July 20, 2022"}]}, {"title": "562378080b4027a2c56aa0b5d29d6609", "paragraphs": [{"qas": [{"question": "What is recommended for all people aged 6 months and older?", "id": "100000000000000000002051", "answers": [{"text": "COVID-19 vaccination", "answer_start": 166}], "is_impossible": false}], "context": "10/30/22, 9:30 AM COVID-19 Vaccines While Pregnant or Breastfeeding\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccines While Pregnant or Breastfeeding\nWhat You Need to Know\nCOVID-19 vaccination is recommended for all people aged 6 months and older. This includes people who are\npregnant, breastfeeding, trying to get pregnant now, or those who might become pregnant in the future. This also\nincludes infants ages 6 months and older born to people who were vaccinated or had a COVID-19 infection before\nor during pregnancy. If you are pregnant or were recently pregnant, you are more likely to get very sick from COVID-19 compared\nto people who are not pregnant."}]}, {"title": "8cb1a4d63b3af999448c3b633dd5d45f", "paragraphs": [{"qas": [{"question": "What vaccine can help protect you and your baby from serious health problems from COVID-19?", "id": "100000000000000000002056", "answers": [{"text": "COVID-19", "answer_start": 158}], "is_impossible": false}, {"question": "Evidence continues to build showing that vaccination during pregnancy is safe and effective?", "id": "100000000000000000002060", "answers": [{"text": "COVID-19", "answer_start": 443}], "is_impossible": false}], "context": "Additionally, if you have COVID-19 during pregnancy, you are at increased\nrisk of complications that can affect your pregnancy and developing baby. Getting a COVID-19 vaccine can help protect you and your baby from serious health problems from COVID-\n19. People who are pregnant should stay up to date with their COVID-19 vaccines, including getting a COVID-19\nbooster shot when it\u2019s time to get one. Evidence continues to build showing that:\nCOVID-19 vaccination during pregnancy is safe and effective. COVID-19 vaccines are not associated with fertility problems in women or men."}]}, {"title": "92b480a88e47594488b3d6175d411a5f", "paragraphs": [{"qas": [{"question": "What is an ICU?", "id": "100000000000000000002063", "answers": [{"text": "intensive care unit", "answer_start": 297}], "is_impossible": false}], "context": "\u2022\n-\n-\n-\n\u2022\n-\n-\nPeople who are Pregnant\nAlthough the overall risks are low, if you are pregnant or were recently\npregnant, you are\nMore likely to get very sick from COVID-19 compared to people who\nare not pregnant. People who get very sick from COVID-19 may\nrequire hospitalization, admission to an intensive care unit (ICU), or\nuse of a ventilator or special equipment to breathe. Severe COVID-19\nillness can also lead to death. At increased risk of complications that can affect your pregnancy and\ndeveloping baby. For example, COVID-19 during pregnancy increases\nthe risk of delivering a preterm or stillborn infant."}]}, {"title": "ff528527630320e09c2fb8228acb6bae", "paragraphs": [{"qas": [{"question": "What is important for the health of your baby during pregnancy?", "id": "100000000000000000002066", "answers": [{"text": "keeping you as healthy as possible", "answer_start": 107}], "is_impossible": false}, {"question": "Who recommends COVId-19 vaccines for everyone aged 6 months and older?", "id": "100000000000000000002067", "answers": [{"text": "CDC", "answer_start": 201}], "is_impossible": false}, {"question": "Who is recommended getting boosters when it is time to get one?", "id": "100000000000000000002068", "answers": [{"text": "people who are pregnant, breastfeeding, trying to get pregnant now, or those who might become pregnant in the future", "answer_start": 282}], "is_impossible": false}], "context": "Getting a COVID-19 vaccine can protect you and others around you from getting very sick from COVID-19, and keeping you as\nhealthy as possible during pregnancy is important for the health of your baby. CDC recommends COVID-19 vaccines for everyone aged 6 months and older, including people who are pregnant,\nbreastfeeding, trying to get pregnant now, or those who might become pregnant in the future. This recommendation includes\ngetting boosters when it is time to get one."}]}, {"title": "6075c063364bccbde23fd51b92b0828d", "paragraphs": [{"qas": [{"question": "What do the CDC recommendations align with?", "id": "100000000000000000002069", "answers": [{"text": "those from professional medical organizations serving people who are pregnant", "answer_start": 103}], "is_impossible": false}, {"question": "What are some of the professional medical organizations serving people who are pregnant?", "id": "100000000000000000002070", "answers": [{"text": "American College of Obstetricians and Gynecologists , Society for Maternal Fetal Medicine , and American Society for Reproductive Medicine .", "answer_start": 197}], "is_impossible": false}, {"question": "What are the benefits of receiving a COVID-19 vaccine outweighing any potential risks of vaccination during pregnancy?", "id": "100000000000000000002071", "answers": [{"text": "safe, effective, and beneficial to both the pregnant person and the baby", "answer_start": 497}], "is_impossible": false}, {"question": "What does not cause COVID-19 in people who are pregnant or their babies?", "id": "100000000000000000002072", "answers": [{"text": "COVID-19 vaccines", "answer_start": 728}], "is_impossible": false}], "context": "\u2022\n\u2022\f10/30/22, 9:30 AM COVID-19 Vaccines While Pregnant or Breastfeeding\nCDC recommendations align with those from professional medical organizations serving people who are pregnant,\nincluding the:\nAmerican College of Obstetricians and Gynecologists ,\nSociety for Maternal Fetal Medicine , and\nAmerican Society for Reproductive Medicine . Safety and Effectiveness of COVID-19 Vaccination during\nPregnancy\nEvidence continues to build showing that\nCOVID-19 vaccination before and during\npregnancy is safe, effective, and\nbeneficial to both the pregnant person\nand the baby. The benefits of receiving a\nCOVID-19 vaccine outweigh any potential\nrisks of vaccination during pregnancy. Below is a brief summary of the growing\nevidence:\nCOVID-19 vaccines do not cause\nCOVID-19, including in people who\nare pregnant or their babies."}]}, {"title": "de533715920e6e74b860cba021dee542", "paragraphs": [{"qas": [{"question": "What are the names of the two companies that provide data on the safety of receiving an mRNA vaccination?", "id": "100000000000000000002075", "answers": [{"text": "Moderna or Pfizer-BioNTech", "answer_start": 239}], "is_impossible": false}, {"question": "How are the data from vaccine safety monitoring systems?", "id": "100000000000000000002076", "answers": [{"text": "have not found any safety concerns", "answer_start": 356}], "is_impossible": false}, {"question": "What has not found any safety concerns for people who received an mRNA COVID-19 vaccine late in pregnancy or for their babies?", "id": "100000000000000000002077", "answers": [{"text": "Data from vaccine safety monitoring systems", "answer_start": 312}], "is_impossible": false}, {"question": "Scientists have not found an increased risk for miscarriage among pregnant people?", "id": "100000000000000000002078", "answers": [{"text": "COVID-19 vaccines contain live virus. They cannot make anyone sick with COVID-19, including people who are pregnant or their babies. Learn more about how vaccines work. Data on the safety of receiving an mRNA COVID-19 vaccine (Moderna or Pfizer-BioNTech), before and during pregnancy are reassuring. Data from vaccine safety monitoring systems have not found any safety concerns for people who received an mRNA COVID-19 vaccine late in pregnancy or for their babies. Scientists have not found an increased risk for miscarriage among pregnant people who received an mRNA COVID- 19 vaccine just before or during early pregnancy", "answer_start": 12}], "is_impossible": false}], "context": "None\nof the COVID-19 vaccines contain\nlive virus. They cannot make anyone\nsick with COVID-19, including\npeople who are pregnant or their\nbabies. Learn more about how\nvaccines work. Data on the safety of receiving an mRNA COVID-19 vaccine (Moderna or Pfizer-BioNTech), before and during pregnancy\nare reassuring. Data from vaccine safety monitoring systems have not found any safety concerns for people who received an\nmRNA COVID-19 vaccine late in pregnancy or for their babies. Scientists have not found an increased risk for miscarriage among pregnant people who received an mRNA COVID-\n19 vaccine just before or during early pregnancy (before 20 weeks of pregnancy)."}]}, {"title": "5d9c41545257e1297be32ca58aae9a2b", "paragraphs": [{"qas": [{"question": "What was not associated with an increased risk for pregnancy complications?", "id": "100000000000000000002080", "answers": [{"text": "vaccination with an mRNA COVID-19 vaccine", "answer_start": 63}], "is_impossible": false}, {"question": "What was not associated with an increased risk of birth defects detectable on prenatal ultrasound?", "id": "100000000000000000002082", "answers": [{"text": "vaccination of pregnant people with a COVID-19 vaccine", "answer_start": 345}], "is_impossible": false}], "context": "Data from American, European, and Canadian studies showed that vaccination with an mRNA COVID-19 vaccine\nduring pregnancy was not associated with an increased risk for pregnancy complications, including preterm birth,\nstillbirth, bacterial infection of the placenta, and excessive maternal blood loss after birth. A Chicago study has shown that vaccination of pregnant people with a COVID-19 vaccine prior to and during the\nfirst trimester was not associated with an increased risk of birth defects detectable on prenatal ultrasound. The monitoring of the effect of COVID-19 vaccination during pregnancy is ongoing."}]}, {"title": "300734cc3e2d4a564caa82ae261c7c4c", "paragraphs": [{"qas": [{"question": "Who will continue to follow people vaccinated during all trimesters of pregnancy?", "id": "100000000000000000002084", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "What does receiving an mRNA COVID-19 vaccine during pregnancy reduce?", "id": "100000000000000000002085", "answers": [{"text": "the risk of severe illness and other health effects", "answer_start": 231}], "is_impossible": false}, {"question": "What did scientists find that the vaccination was effective at reducing the risk of getting very sick from?", "id": "100000000000000000002087", "answers": [{"text": "COVID-19", "answer_start": 551}], "is_impossible": false}, {"question": "What was the name of the study that looked at people who were hospitalized during pregnancy?", "id": "100000000000000000002088", "answers": [{"text": "One study", "answer_start": 561}], "is_impossible": false}], "context": "CDC will continue to follow\npeople vaccinated during all trimesters of pregnancy to better understand any effects of the vaccine on pregnancies\nand babies. Data show that receiving an mRNA COVID-19 vaccine during pregnancy reduces the risk of severe illness and other\nhealth effects from COVID-19 for people who are pregnant. Recent studies compared people who were pregnant and\nreceived an mRNA COVID-19 vaccine with pregnant people who did not. Scientists found that COVID-19 vaccination was\neffective at reducing the risk of getting very sick from COVID-19. One study that looked at people who were\nhospitalized during pregnancy found that most were not vaccinated."}]}, {"title": "f8a0ba3ede38c840a1f973fa80ca7f4e", "paragraphs": [{"qas": [{"question": "What does COVID-19 help prevent in pregnant people?", "id": "100000000000000000002089", "answers": [{"text": "stillbirths", "answer_start": 134}], "is_impossible": false}, {"question": "Vaccination during pregnancy builds antibodies that can help protect what?", "id": "100000000000000000002090", "answers": [{"text": "the baby", "answer_start": 216}], "is_impossible": false}, {"question": "When pregnant people receive an mRNA COVID-19 vaccine, their bodies build antibodies against what?", "id": "100000000000000000002091", "answers": [{"text": "COVID-19", "answer_start": 366}], "is_impossible": false}], "context": "Other studies have shown that by reducing the\nrisk of severe illness in pregnant people, COVID-19 vaccination might also help prevent stillbirths. Vaccination during pregnancy builds antibodies that can help protect the baby. Much like people who are not pregnant,\nwhen people who are pregnant receive an mRNA COVID-19 vaccine, their bodies build antibodies against COVID-19. Antibodies made after pregnant people received an mRNA COVID-19 vaccine have been found in their baby\u2019s umbilical\ncord blood."}]}, {"title": "d5a1019770410debdba6818758d12d91", "paragraphs": [{"qas": [{"question": "What can help protect babies against COVID-19?", "id": "100000000000000000002093", "answers": [{"text": "COVID-19 vaccination", "answer_start": 11}], "is_impossible": false}, {"question": "What can be passed from the mother to her baby?", "id": "100000000000000000002094", "answers": [{"text": "COVID-19 Vaccines While Pregnant or Breastfeeding antibodies", "answer_start": 151}], "is_impossible": false}, {"question": "At what age did the majority of infants born to pregnant people who were vaccinated during pregnancy have detectable antibodies against COVID-19?", "id": "100000000000000000002095", "answers": [{"text": "6 months old", "answer_start": 367}], "is_impossible": false}, {"question": "At 6 months old, how many infants were born to people who had COVID-19 illness during pregnancy?", "id": "100000000000000000002096", "answers": [{"text": "8%", "answer_start": 530}], "is_impossible": false}], "context": "This means COVID-19 vaccination during pregnancy can help protect babies against COVID-19 by passing\n\uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n\u2022\n-\n-\n-\n-\n-\n\u2022\n\u2022\f10/30/22, 9:30 AM COVID-19 Vaccines While Pregnant or Breastfeeding\nantibodies from the mother to her baby. More data are needed to determine how these antibodies may provide\nprotection to the baby. A recent small study found that at 6 months old, the majority (57%) of infants born to pregnant people who were\nvaccinated during pregnancy had detectable antibodies against COVID-19, compared with 8% of infants born to\npregnant people who had COVID-19 illness during pregnancy."}]}, {"title": "caee4e423e533f3aecc5087168da7ed8", "paragraphs": [{"qas": [{"question": "What can completing a two-dose primary mRNA COVID-19 vaccine series during pregnancy help protect?", "id": "100000000000000000002097", "answers": [{"text": "babies younger than age 6 months", "answer_start": 115}], "is_impossible": false}, {"question": "What was the majority of babies hospitalized with COVIV-19 born to?", "id": "100000000000000000002098", "answers": [{"text": "pregnant people who were not vaccinated during pregnancy", "answer_start": 267}], "is_impossible": false}, {"question": "What did a booster dose with an mRNA COVID-19 vaccine during pregnancy significantly increase?", "id": "100000000000000000002100", "answers": [{"text": "the levels of antibodies found in umbilical cord blood", "answer_start": 446}], "is_impossible": false}, {"question": "What was found in animal studies?", "id": "100000000000000000002102", "answers": [{"text": "No safety concerns", "answer_start": 612}], "is_impossible": false}], "context": "Recent data show that completing a two-dose primary mRNA COVID-19 vaccine series during pregnancy can help\nprotect babies younger than age 6 months from hospitalization due to COVID-19. In these reports, the majority of\nbabies hospitalized with COVID-19 were born to pregnant people who were not vaccinated during pregnancy. Another study found that receiving a booster dose with an mRNA COVID-19 vaccine during pregnancy significantly\nincreased the levels of antibodies found in umbilical cord blood. This means that getting a COVID-19 booster during\npregnancy can help further protect babies against COVID-19. No safety concerns were found in animal studies."}]}, {"title": "52e7d445effd5c9792fe1de356fd57df", "paragraphs": [{"qas": [{"question": "What did studies in animals receiving a COVID-19 vaccine before or during pregnancy find no safety concerns in pregnant animals or their babies?", "id": "100000000000000000002103", "answers": [{"text": "pregnancy found no safety concerns in pregnant animals or their babies. More clinical trials on the safety of COVID-19 vaccines and how well they work in people who are pregnant are underway or planned. Vaccine manufacturers are also collecting and reviewing data from people in the completed clinical trials who received a vaccine and became pregnant during the trial. Talk to Your Healthcare Provider If you are pregnant, talk to your healthcare provider about COVID-19 vaccination. While such a conversation might be helpful, it is not required before vaccination", "answer_start": 64}], "is_impossible": false}, {"question": "What are more clinical trials on the safety and how well they work in people who are pregnant?", "id": "100000000000000000002104", "answers": [{"text": "COVID-19 vaccines", "answer_start": 175}], "is_impossible": false}, {"question": "Who is collecting and reviewing data from people in completed clinical trials who received a vaccine and became pregnant during the trial?", "id": "100000000000000000002105", "answers": [{"text": "Vaccine manufacturers", "answer_start": 268}], "is_impossible": false}, {"question": "If you are pregnant, talk to your healthcare provider about what vaccination?", "id": "100000000000000000002106", "answers": [{"text": "COVID-19", "answer_start": 528}], "is_impossible": false}, {"question": "What type of vaccination is not required before vaccination?", "id": "100000000000000000002107", "answers": [{"text": "COVID-19", "answer_start": 528}], "is_impossible": false}], "context": "Studies in animals receiving a COVID-19 vaccine before or during\npregnancy found no safety concerns in pregnant animals or their babies. More clinical trials on the safety of COVID-19 vaccines and how well they work in people who are pregnant are underway or\nplanned. Vaccine manufacturers are also collecting and reviewing data from people in the completed clinical trials who\nreceived a vaccine and became pregnant during the trial. Talk to Your Healthcare Provider\nIf you are pregnant, talk to your healthcare provider about COVID-19 vaccination. While such a conversation might be helpful,\nit is not required before vaccination."}]}, {"title": "721eb8aed18c6bcd24279094ad70af8f", "paragraphs": [{"qas": [{"question": "How can you share with CDC how you feel after getting a COVID-19 vaccine?", "id": "100000000000000000002110", "answers": [{"text": "CDC\u2019s v-safe After Vaccination Health Checker", "answer_start": 138}], "is_impossible": false}, {"question": "Who may contact you if you enroll in v-safe and report that you are pregnant at the time of vaccination?", "id": "100000000000000000002111", "answers": [{"text": "CDC\u2019s v-safe COVID- 19 Vaccine Pregnancy Registry staff", "answer_start": 525}], "is_impossible": false}], "context": "You can receive a COVID-19 vaccine, including a booster shot, without any additional\ndocumentation from your healthcare provider. -\n-\n-\n\u2022\nCDC\u2019s v-safe After Vaccination Health Checker is a voluntary smartphone-based tool that provides quick and confidential\nhealth check-ins via text messages and web surveys so you can quickly and easily share with CDC how you or your\ndependent feel after getting a COVID-19 vaccine. If you enroll in v-safe and report that you are pregnant at the time of vaccination or after vaccination, CDC\u2019s v-safe COVID-\n19 Vaccine Pregnancy Registry staff* may contact you."}]}, {"title": "1ddf44d80ed3b78be5f182489c380fc5", "paragraphs": [{"qas": [{"question": "Who contracted Abt Associates to contact participants of the CDC's v-safe COVID-19 Vaccines Pregnancy Registry?", "id": "100000000000000000002112", "answers": [{"text": "CDC", "answer_start": 179}], "is_impossible": false}, {"question": "Scientific studies to date have shown no safety concerns what?", "id": "100000000000000000002113", "answers": [{"text": "babies born to people who were vaccinated against COVID- 19 during pregnancy", "answer_start": 376}], "is_impossible": false}, {"question": "How do vaccines work in the body?", "id": "100000000000000000002115", "answers": [{"text": "Based on how these vaccines work in the body, experts believe they are unlikely to pose a risk for long-term health effects", "answer_start": 454}], "is_impossible": false}], "context": "If you have symptoms or health problems that concern you at any\ntime following COVID-19 vaccination, please contact your healthcare provider. *Abt Associates has been contract by CDC to contact participants of CDC\u2019s v-safe COVID-19 Vaccines Pregnancy\nRegistry. \uf209\nCommon Questions about Vaccination during Pregnancy\nScientific studies to date have shown no safety concerns for babies born to people who were vaccinated against COVID-\n19 during pregnancy. Based on how these vaccines work in the body, experts believe they are unlikely to pose a\nrisk for long-term health effects."}]}, {"title": "69b7541e7152dff5e7d57fefc99034e9", "paragraphs": [{"qas": [{"question": "What does the CDC do to better understand the effects on pregnancy and babies?", "id": "100000000000000000002116", "answers": [{"text": "monitor, analyze, and disseminate information", "answer_start": 17}], "is_impossible": false}, {"question": "What are the long-term effects on the baby when a person gets a COVID-19 vaccine during pregnancy?", "id": "100000000000000000002117", "answers": [{"text": "\uf1aa CDC and professional medical organizations, including the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, recommend COVID-19 vaccination at any point in pregnancy, as well as booster doses when it is time to get one. COVID-19 vaccination can protect you from getting very sick from COVID-19", "answer_start": 274}], "is_impossible": false}, {"question": "CDC and professional medical organizations include what?", "id": "100000000000000000002118", "answers": [{"text": "American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine", "answer_start": 334}], "is_impossible": false}, {"question": "What does the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine recommend?", "id": "100000000000000000002119", "answers": [{"text": "COVID-19 vaccination at any point in pregnancy", "answer_start": 441}], "is_impossible": false}], "context": "CDC continues to monitor, analyze, and disseminate information from people vaccinated\nduring all trimesters of pregnancy to better understand effects on pregnancy and babies. What are the long-term effects on the baby when a person gets a COVID-19 vaccine during\npregnancy? \uf1aa\nCDC and professional medical organizations, including the American College of Obstetricians and Gynecologists and the\nSociety for Maternal-Fetal Medicine, recommend COVID-19 vaccination at any point in pregnancy, as well as booster\ndoses when it is time to get one. COVID-19 vaccination can protect you from getting very sick from COVID-19."}]}, {"title": "3fc3f7a4e5e3ae160dcdaa8c2548fd1a", "paragraphs": [{"qas": [{"question": "When should a person get a COVID-19 vaccine?", "id": "100000000000000000002122", "answers": [{"text": "10/30/22", "answer_start": 163}], "is_impossible": false}, {"question": "Who gets vaccinated and stays up-to-date with their COVID-19 vaccines?", "id": "100000000000000000002124", "answers": [{"text": "people who are breastfeeding", "answer_start": 280}], "is_impossible": false}, {"question": "What is the name of the booster shot when it\u2019s time to get one?", "id": "100000000000000000002125", "answers": [{"text": "COVID-19", "answer_start": 394}], "is_impossible": false}], "context": "Keeping\nyourself as healthy as possible during pregnancy is important for the health of your baby. When during pregnancy should a person get a COVID-19 vaccine? \uf1aa\f10/30/22, 9:30 AM COVID-19 Vaccines While Pregnant or Breastfeeding\nPeople who are Breastfeeding\nCDC recommends that people who are breastfeeding get vaccinated and stay up to date with their COVID-19 vaccines,\nincluding getting a COVID-19 booster shot when it\u2019s time to get one. Clinical trials for the COVID-19 vaccines currently used in the United States did not include people who were breastfeeding."}]}, {"title": "96f2ecfc85a53f7cc90722421671a588", "paragraphs": [{"qas": [{"question": "What are the effects of COVID-19 vaccination on the breastfed baby and on milk production or excretion?", "id": "100000000000000000002126", "answers": [{"text": "no severe reactions", "answer_start": 273}], "is_impossible": false}, {"question": "What do the data indicate about the safety of the vaccination while breastfeeding?", "id": "100000000000000000002127", "answers": [{"text": "no severe reactions after the first or second dose", "answer_start": 273}], "is_impossible": false}, {"question": "When is there a risk of severe reactions after the first or second dose of the vaccine?", "id": "100000000000000000002128", "answers": [{"text": "no", "answer_start": 273}], "is_impossible": false}, {"question": "What can't be caused by COVID-19 in pregnant people and their babies?", "id": "100000000000000000002131", "answers": [{"text": "COVID-19 vaccines", "answer_start": 546}], "is_impossible": false}], "context": "Therefore, limited data are available on the\nSafety of COVID-19 vaccines in people who are breastfeeding\nEffects of vaccination on the breastfed baby, and\nEffects on milk production or excretion\nAvailable data on safety of COVID-19 vaccination while breastfeeding indicate no severe reactions after the first or second\ndose, neither in the breastfeeding person not the breastfed child. There has been no evidence to suggest that COVID-19\nvaccines are harmful to either people who have received a vaccine and are breastfeeding or to their babies. COVID-19 vaccines cannot cause COVID-19 in anyone, including pregnant people and their babies. None of the COVID-19\nvaccines contain live virus."}]}, {"title": "c7d695d23319b6d082860c1917258092", "paragraphs": [{"qas": [{"question": "What does the CDC recommend for children 6 months and older?", "id": "100000000000000000002135", "answers": [{"text": "COVID-19 vaccines", "answer_start": 371}], "is_impossible": false}, {"question": "What is the level of protection these antibodies might provide to the baby?", "id": "100000000000000000002136", "answers": [{"text": "More data", "answer_start": 248}], "is_impossible": false}], "context": "Vaccines are effective at preventing COVID-19 in people who are breastfeeding. Recent reports\nhave shown that breastfeeding people who have received mRNA COVID-19 vaccines have antibodies in their breastmilk, which\ncould help protect their babies. More data are needed to determine what level of protection these antibodies might provide\nto the baby. CDC also recommends COVID-19 vaccines for children aged 6 months and older."}]}, {"title": "404f120b8aeb8d03e4bf7cb54de3c4c6", "paragraphs": [{"qas": [{"question": "Who recommends that people who are trying to get pregnant get vaccinated and stay up to date with their COVID-19 vaccines?", "id": "100000000000000000002137", "answers": [{"text": "CDC", "answer_start": 36}], "is_impossible": false}, {"question": "What does the CDC recommend people who want to have a baby get?", "id": "100000000000000000002138", "answers": [{"text": "vaccinated", "answer_start": 170}], "is_impossible": false}, {"question": "When is it time to get a booster shot?", "id": "100000000000000000002139", "answers": [{"text": "when it\u2019s time to get one", "answer_start": 273}], "is_impossible": false}, {"question": "What vaccine is authorized for use only in limited situations?", "id": "100000000000000000002143", "answers": [{"text": "COVID-19", "answer_start": 527}], "is_impossible": false}, {"question": "What is the name of the J&J/Janssen vaccine?", "id": "100000000000000000002144", "answers": [{"text": "COVID-19", "answer_start": 527}], "is_impossible": false}], "context": "People Who Would Like to Have a Baby\nCDC recommends that people who are trying to get pregnant now or might become pregnant in the future, as well as their\npartners, get vaccinated and stay up to date with their COVID-19 vaccines, including getting a COVID-19 booster shot when it\u2019s\ntime to get one. COVID-19 vaccines are not associated with fertility problems in women or men. Vaccine Side Effects\nYou can choose to get either an mRNA COVID-19 vaccine (Moderna or Pfizer-BioNTech) or Novavax COVID-19 vaccine. The\nJ&J/Janssen COVID-19 vaccine is authorized for use only in certain limited situations."}]}, {"title": "766686bf2d6f9fcd4f9b4098dbe2b7c6", "paragraphs": [{"qas": [{"question": "What vaccines may pregnant people get at the same time as other vaccines?", "id": "100000000000000000002146", "answers": [{"text": "flu vaccine", "answer_start": 172}], "is_impossible": false}, {"question": "What is the name of the service that can answer questions about COVID-19 vaccination during pregnancy?", "id": "100000000000000000002147", "answers": [{"text": "MotherToBaby", "answer_start": 445}], "is_impossible": false}], "context": "Which COVID-19 vaccine should pregnant people receive? \uf1aa\nChildren, teens, and adults, including pregnant people, may get a COVID-19 vaccine and other vaccines, including a flu\nvaccine, at the same time. Can pregnant people get a COVID-19 vaccine at the same time as other vaccines? \uf1aa\nIF YOU ARE PREGNANT AND HAVE QUESTIONS ABOUT COVID-19 VACCINE\nIf you would like to speak to someone about COVID-19 vaccination during pregnancy, you can contact MotherToBaby\nwhose experts are available to answer questions in English or Spanish by phone or chat. This service is free and\nconfidential."}]}, {"title": "49d11d9a436c3fb902d9202caa5ed293", "paragraphs": [{"qas": [{"question": "What is one way to reach MotherToBaby?", "id": "100000000000000000002149", "answers": [{"text": "Chat live or send an email", "answer_start": 22}], "is_impossible": false}, {"question": "What can happen after receiving any of the available COVID-19 vaccines while pregnant or breastfeeding?", "id": "100000000000000000002150", "answers": [{"text": "Side effects", "answer_start": 143}], "is_impossible": false}, {"question": "What has been associated with adverse pregnancy outcomes?", "id": "100000000000000000002152", "answers": [{"text": "Fever", "answer_start": 496}], "is_impossible": false}, {"question": "What can be treated with acetaminophen?", "id": "100000000000000000002153", "answers": [{"text": "Fever in pregnancy", "answer_start": 589}], "is_impossible": false}, {"question": "What may be treated with acetaminophen in pregnancy?", "id": "100000000000000000002154", "answers": [{"text": "Fever", "answer_start": 589}], "is_impossible": false}], "context": "To reach MotherToBaby:\nChat live or send an email MotherToBaby\n\u2022\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\f10/30/22, 9:30 AM COVID-19 Vaccines While Pregnant or Breastfeeding\nSide effects can occur after receiving any of the available COVID-19 vaccines, especially after the second dose for vaccines that\nrequire two doses, or after a booster. People who are pregnant have not reported different side effects from people who are not pregnant after vaccination with\nmRNA COVID-19 vaccines (Moderna and Pfizer-BioNTech vaccines). Fever during pregnancy, for any reason, has been associated with adverse pregnancy outcomes. Fever in pregnancy may be treated with acetaminophen as needed, in moderation, and in consultation with a healthcare\nprovider."}]}, {"title": "e4c0777b39840dd9e92d568c3001c040", "paragraphs": [{"qas": [{"question": "What are some of the key considerations you need to make before getting a vaccine: intramuscular, intravenous, or subcutaneous?", "id": "100000000000000000002156", "answers": [{"text": "The benefits of vaccination", "answer_start": 410}], "is_impossible": false}, {"question": "What are the benefits of vaccination?", "id": "100000000000000000002158", "answers": [{"text": "The unknown risks of developing a severe allergic reaction", "answer_start": 438}], "is_impossible": false}], "context": "Learn more at Possible Side Effects After Getting a COVID-19 Vaccine. Although rare, some people have had severe allergic reactions after receiving a COVID-19 vaccine. Talk with your healthcare\nprovider if you have a history of allergic reaction to any other vaccine or injectable therapy (intramuscular, intravenous, or\nsubcutaneous). Key considerations you can discuss with your healthcare provider include:\nThe benefits of vaccination\nThe unknown risks of developing a severe allergic reaction\nIf you have an allergic reaction after receiving a COVID-19 vaccine during pregnancy, you can receive treatment for it."}]}, {"title": "9b1135a55b6662181ba83f29f6dc04d0", "paragraphs": [{"qas": [{"question": "What website can you use to find COVID-19 locations near you?", "id": "100000000000000000002159", "answers": [{"text": "vaccines.gov", "answer_start": 64}], "is_impossible": false}, {"question": "What is the name of the website that can help you find the nearest COVID-19 location?", "id": "100000000000000000002160", "answers": [{"text": "vaccines.gov", "answer_start": 64}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nTo find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233."}]}, {"title": "19417da43e567049584539b117445a1d", "paragraphs": [{"qas": [{"question": "What is the name of the ACOG video about COVID-19 vaccines for people who are pregnant?", "id": "100000000000000000002162", "answers": [{"text": "COVID-19 Vaccination Considerations for Obstetric-Gynecologic Care", "answer_start": 354}], "is_impossible": false}, {"question": "What is the name of the information for people who are pregnant of breastfeeding?", "id": "100000000000000000002163", "answers": [{"text": "Mother to Baby", "answer_start": 706}], "is_impossible": false}, {"question": "What are the names of the references?", "id": "100000000000000000002164", "answers": [{"text": "Shimabukuro TT, Kim SY, Myers TR, et al", "answer_start": 795}], "is_impossible": false}], "context": "Related Pages\nAllergic Reactions\n\u203a\nFor Healthcare and Public Health\nConsiderations for the Use of COVID-19 Vaccines Currently Available in the U.S.\nCOVID-19 Vaccination among Pregnant People\nManagement of Anaphylaxis after COVID-19 Vaccination\nACOG Vaccine Confidence Training\nACOG Recommendations for Vaccinating Pregnant People\nACOG Practice Advisory: COVID-19 Vaccination Considerations for Obstetric-Gynecologic Care\nACOG video about COVID-19 vaccines for people who are pregnant\nCOVID-19 Clinical and Professional Resources\nClinic Poster: Protect yourself and your baby from COVID-19\nClinic Poster: Protect yourself and your baby from COVID-19 (Espa\u00f1ol)\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n- \uf209\n\u2022\n\u2022\n\u2022 \uf20c\nMore Information\nMother to Baby: Information for people who are pregnant of breastfeeding \uf209\nReferences\n1. Shimabukuro TT, Kim SY, Myers TR, et al."}]}, {"title": "bff81642b7a6bec60dbc63bfa4c353b9", "paragraphs": [{"qas": [{"question": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.", "id": "100000000000000000002165", "answers": [{"text": "N Engl J Med2021", "answer_start": 74}], "is_impossible": false}, {"question": "What is the name of the mRNA COVID-19 vaccine?", "id": "100000000000000000002167", "answers": [{"text": "N Engl J Med2021", "answer_start": 74}], "is_impossible": false}, {"question": "When did New Engl J Med publish this study?", "id": "100000000000000000002168", "answers": [{"text": "September 8, 2021", "answer_start": 377}], "is_impossible": false}], "context": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384:2273-2282. DOI: https://doi.org/10.1056/NEJMoa2104983 . \uf209\f10/30/22, 9:30 AM COVID-19 Vaccines While Pregnant or Breastfeeding\ng J ; p g J\n2. Zauche LH, Wallace B, Smoots AN, et al. Receipt of mRNA COVID-19 vaccines and risk of spontaneous abortions. New\nEngl J MedPublished online September 8, 2021; DOI: https://doi.org/10.1056/NEJMc2113891\n3. Kharbanda EO, Haapata J, DeSilva M, et al. Spontaneous Abortion Following COVID-19 Vaccination During\nPregnancy. JAMA. Published online September 8, 2021. DOI: https://doi.org/10.1001/jama.2021.15494\n4. Lipkind HS, Vazquez-Benitez G, DeSilva M, et al."}]}, {"title": "41a2662584a011de1cae019f5c654a21", "paragraphs": [{"qas": [{"question": "How many Integrated Health Care Organizations are in the United States?", "id": "100000000000000000002170", "answers": [{"text": "Eight", "answer_start": 98}], "is_impossible": false}, {"question": "What is the date range for the receipt of COVID-19 Vaccine during pregnancy and at birth?", "id": "100000000000000000002171", "answers": [{"text": "December 15, 2020\u2013July 22, 2021", "answer_start": 157}], "is_impossible": false}, {"question": "What does VAERS stand for?", "id": "100000000000000000002173", "answers": [{"text": "vaccine adverse event reporting system", "answer_start": 421}], "is_impossible": false}, {"question": "What is CANVAS?", "id": "100000000000000000002175", "answers": [{"text": "Canadian National Vaccine Safety", "answer_start": 595}], "is_impossible": false}, {"question": "When was the study published?", "id": "100000000000000000002176", "answers": [{"text": "2022 Aug 11", "answer_start": 692}], "is_impossible": false}, {"question": "What was the name of the study?", "id": "100000000000000000002177", "answers": [{"text": "Canadian National Vaccine Safety (CANVAS) network cohort study", "answer_start": 595}], "is_impossible": false}], "context": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age at Birth \u2014 Eight Integrated Health Care Organizations, United States, December 15, 2020\u2013July 22, 2021. MMWR Morb Mortal Wkly Rep 2022;71:26\u201330. DOI: https://dx.doi.org/10.15585/mmwr.mm7101e1\n5. Moro PL, Olson CK, Clark E, et al. Post-authorization surveillance of adverse events following COVID-19 vaccines in\npregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 \u2013 October 2021. Vaccine. 6. Sadarangani M, Soe P, Shulha HP, et al. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety\n(CANVAS) network cohort study [published online ahead of print, 2022 Aug 11]. Lancet Infect Dis. 2022;S1473-\n7."}]}, {"title": "dd1b96a71fab92b133f273af2f017bb2", "paragraphs": [{"qas": [{"question": "Covid-19 Vaccination during pregnancy and first-trimester miscarriage. New 8. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 vaccination in pregnancy With Adverse Peripartum Outcomes. JAMA. 2022;327(15):1478-1487. DOI: https://doi.org/10.1001/jama.2022.4255 9. Badell ML, Dude CM, Rasmussen SA, Jamieson DJ.", "id": "100000000000000000002178", "answers": [{"text": "New 8. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes. JAMA. 2022;327(15):1478-1487", "answer_start": 111}], "is_impossible": false}, {"question": "Covid-19 vaccination in pregnancy. BMJ. 2022;378:e069741. Published 10. Ruderman RS, Mormol J, Trawick E, et al. Association of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal Anomalies. What is the doi:10.1001/jamapediatrics.2022.0164?", "id": "100000000000000000002179", "answers": [{"text": "Cong", "answer_start": 545}], "is_impossible": false}, {"question": "When was this study published?", "id": "100000000000000000002181", "answers": [{"text": "July 12, 2021", "answer_start": 806}], "is_impossible": false}, {"question": "What is the DOI of this study?", "id": "100000000000000000002182", "answers": [{"text": "https://doi.org/10.1001/jama.2022.4255", "answer_start": 272}], "is_impossible": false}], "context": "Magnus MC, Gjessing HK, Eide HN, et al. Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage. New\n8. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum\nOutcomes. JAMA. 2022;327(15):1478-1487. DOI: https://doi.org/10.1001/jama.2022.4255\n9. Badell ML, Dude CM, Rasmussen SA, Jamieson DJ. Covid-19 vaccination in pregnancy. BMJ. 2022;378:e069741. Published\n10. Ruderman RS, Mormol J, Trawick E, et al. Association of COVID-19 Vaccination During Early Pregnancy With Risk of\nCongenital Fetal Anomalies. JAMAPediatr. 2022;176(7):717-719. doi:10.1001/jamapediatrics.2022.0164\n11. Goldshtein I, Nevo D, Steinberg DM, et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2\nInfection in Pregnant Women.Published online July 12, 2021. DOI: https://doi.org/10.1001/jama.2021.11035\n12."}]}, {"title": "19b63c71411e767286e267027cdbeff9", "paragraphs": [{"qas": [{"question": "What are the results of the SARS-CoV-2 vaccine?", "id": "100000000000000000002184", "answers": [{"text": "Pregnancy and birth outcomes", "answer_start": 157}], "is_impossible": false}, {"question": "Who is the author of the study?", "id": "100000000000000000002185", "answers": [{"text": "Dagan N, Barda N, Biron-Shental T, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 13. Theiler RN", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the virus that infects pregnant women?", "id": "100000000000000000002187", "answers": [{"text": "Severe Acute Respiratory Syndrome Coronavirus 2", "answer_start": 302}], "is_impossible": false}, {"question": "When was the last issue of Obstetrics & Gynecology published?", "id": "100000000000000000002188", "answers": [{"text": "January 2022", "answer_start": 459}], "is_impossible": false}, {"question": "What did Stock SJ, Carruthers J, Calvert C, et al. find in pregnant women in Scotland?", "id": "100000000000000000002189", "answers": [{"text": "SARS-CoV-2 infection and COVID-19 vaccination rates", "answer_start": 604}], "is_impossible": false}, {"question": "What was the association between SARS-CoV-2 infection and COVID-19 vaccination rates?", "id": "100000000000000000002190", "answers": [{"text": "Pregnancy and birth outcomes", "answer_start": 157}], "is_impossible": false}], "context": "Dagan N, Barda N, Biron-Shental T, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 13. Theiler RN, Wick M, Mehta R, et al. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. Am J\n14. Morgan JA, Biggio JR, Martin JK, et al. Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-\nCoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients. Obstetrics & Gynecology: January 2022 \u2013\nVolume 139 \u2013 Issue 1 \u2013 p 107-109. DOI: https://doi.org/10.1097/AOG.0000000000004621\n15. Stock SJ, Carruthers J, Calvert C, et al. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in\nScotland. Nat Med(2022)."}]}, {"title": "5503f0e8fb98abf3160eaf9e8f56ff3e", "paragraphs": [{"qas": [{"question": "What is the name of the disease that affects pregnant women in hospitals?", "id": "100000000000000000002191", "answers": [{"text": "Coronavirus Disease", "answer_start": 161}], "is_impossible": false}, {"question": "When was the online version of COVID-19 published?", "id": "100000000000000000002192", "answers": [{"text": "2022 Aug 12", "answer_start": 230}], "is_impossible": false}, {"question": "Who wrote the systematic review and meta-analysis of the effectiveness of the Coronavirus Disease?", "id": "100000000000000000002193", "answers": [{"text": "Prasad, S., Kalafat, E., Blakeway, H.", "answer_start": 273}], "is_impossible": false}, {"question": "What is the association of Gestational Age at Coronavirus Disease 2019?", "id": "100000000000000000002194", "answers": [{"text": "Vaccination", "answer_start": 499}], "is_impossible": false}, {"question": "What is SARS-CoV-2?", "id": "100000000000000000002195", "answers": [{"text": "Severe Acute Respiratory Syndrome Coronavirus 2", "answer_start": 523}], "is_impossible": false}], "context": "DOI: https://doi.org/10.1038/s41591-021-01666-2\n16. Sekkarie A, Woodruff R, Whitaker M, et al. Characteristics and treatment of hospitalized pregnant women with\nCoronavirus Disease 2019, COVID-19 [published online ahead of print, 2022 Aug 12]. Am J Obstet Gynecol MFM. 17. Prasad, S., Kalafat, E., Blakeway, H. et al. Systematic review and meta-analysis of the effectiveness and perinatal\n18. Yang YJ, Murphy EA, Singh S, et al. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination,\nHistory of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With\nMaternal and Umbilical Cord Antibody Levels at Delivery. Obstetrics & Gynecology: 2021. 19."}]}, {"title": "2da6d9e1fd0626f55ce6932753c11e8", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine used to treat SARS-CoV-2 immunoglobulin G antibodies during pregnancy?", "id": "100000000000000000002197", "answers": [{"text": "BNT162b2 messenger RNA", "answer_start": 148}], "is_impossible": false}, {"question": "What vaccine was used in parturient women treated with BNT162b2 messenger RNA vaccine?", "id": "100000000000000000002198", "answers": [{"text": "SARS-CoV-2 immunoglobulin G antibodies", "answer_start": 73}], "is_impossible": false}, {"question": "When was the 2019 vaccine response in pregnant and lactating women published?", "id": "100000000000000000002200", "answers": [{"text": "March 25, 2021", "answer_start": 391}], "is_impossible": false}, {"question": "When was this study published online?", "id": "100000000000000000002202", "answers": [{"text": "March 25, 2021", "answer_start": 391}], "is_impossible": false}, {"question": "Who published this study?", "id": "100000000000000000002203", "answers": [{"text": "JAMA", "answer_start": 602}], "is_impossible": false}, {"question": "Halasa NB, Olson SM, Staat MA, et al.", "id": "100000000000000000002205", "answers": [{"text": "22", "answer_start": 688}], "is_impossible": false}], "context": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol 2022;\n20. Gray KJ, Bordt EA, Atyeo C, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort\nstudy. Am J Obstet Gynecol. Published online March 25, 2021. DOI: https://doi.org/10.1016/j.ajog.2021.03.023\n21. Shook LL, Atyeo CG, Yonker LM, et al. Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination\nor Natural Infection. JAMA. Published online February 07, 2022. DOI: https://doi.org/10.1001/jama.2022.1206\n22. Halasa NB, Olson SM, Staat MA, et al."}]}, {"title": "21f60f2cf0f3d42134318b0da90319e7", "paragraphs": [{"qas": [{"question": "What is effective against COVID-19 Hospitalization in Infants 6 Months of Age from Maternal mRNA?", "id": "100000000000000000002206", "answers": [{"text": "Vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "When did the United States begin to vaccinate infants with COVID-19?", "id": "100000000000000000002207", "answers": [{"text": "July 2021", "answer_start": 140}], "is_impossible": false}, {"question": "What is the date of the vaccination in the US in July 2021-January 2022?", "id": "100000000000000000002208", "answers": [{"text": "10/30/22", "answer_start": 222}], "is_impossible": false}, {"question": "What is the risk of hospitalization for Covid-19 among infants?", "id": "100000000000000000002209", "answers": [{"text": "<6 Months of Age", "answer_start": 66}], "is_impossible": false}, {"question": "What does COVID-19 booster vaccination during pregnancy enhance?", "id": "100000000000000000002210", "answers": [{"text": "maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn", "answer_start": 573}], "is_impossible": false}], "context": "Vaccine Effectiveness Against COVID-19 Hospitalization in Infants <6 Months of Age\nfrom Maternal mRNA COVID-19 Vaccination \u2014 United States, July 2021\u2013 January 2022 MMWR Morb Mortal Wkly Rep\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\f10/30/22, 9:30 AM COVID-19 Vaccines While Pregnant or Breastfeeding\n23. Halasa NB, Olson SM, Staat MA, et al. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants. N\nEngl J Med. 2022;387(2):109-119. doi:10.1056/NEJMoa2204399\n24. Munoz FM, Posavad CM, Richardson BA, et al. COVID-19 booster vaccination during pregnancy enhances maternal\nbinding and neutralizing antibody responses and transplacental antibody transfer to the newborn. medRxiv. 2022 Jun 13\n(Preprint) DOI: https://doi.org/10.1101/2022.06.13.22276354\n25."}]}, {"title": "158ca84d28055631b00806887002a7e0", "paragraphs": [{"qas": [{"question": "What is the name of the database that contains information on COVID-19 Vaccinations?", "id": "100000000000000000002211", "answers": [{"text": "Drugs and Lactation Database", "answer_start": 222}], "is_impossible": false}, {"question": "What does LactMed stand for?", "id": "100000000000000000002212", "answers": [{"text": "Drugs and Lactation Database", "answer_start": 222}], "is_impossible": false}, {"question": "Where is the National Library of Medicine located?", "id": "100000000000000000002213", "answers": [{"text": "Bethesda (MD): National Library of Medicine (US", "answer_start": 273}], "is_impossible": false}, {"question": "What year did the National Library of Medicine publish COVID-19 Vaccines?", "id": "100000000000000000002215", "answers": [{"text": "2006", "answer_start": 323}], "is_impossible": false}, {"question": "What is the name of the vaccine that was vaccinated breastfeeding women?", "id": "100000000000000000002216", "answers": [{"text": "COVID-19", "answer_start": 533}], "is_impossible": false}, {"question": "What is the name of the anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination?", "id": "100000000000000000002218", "answers": [{"text": "SARS-CoV-2", "answer_start": 481}], "is_impossible": false}], "context": "Muyldermans J, De Weerdt L, De Brabandere L, Maertens K, Tommelein E. The Effects of COVID-19 Vaccination on\nLactating Women: A Systematic Review of the Literature. Front Immunol. 2022;13:852928. Published 2022 Apr 8. 26. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. COVID-19\nVaccines. [Updated 2022 Sep 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK565969/\n27. Perl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2\u2013Specific Antibodies in Breast Milk After COVID-19 Vaccination of\nBreastfeeding Women. 2021;325(19):2013\u20132014. DOI: https://doi.org/10.1001/jama.2021.5782\n28. Kelly JC, Carter EB, Raghuraman N, et al. Anti\u2013severe acute respiratory syndrome coronavirus 2 antibodies induced in\nbreast milk after Pfizer-BioNTech/BNT162b2 vaccination."}]}, {"title": "fd747c9bbbd4bbffdb723179e3e462b3", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that protects breastfeeding health workers from COVID-19?", "id": "100000000000000000002219", "answers": [{"text": "Immune Response to Vaccination", "answer_start": 100}], "is_impossible": false}, {"question": "What is another name for SARS-CoV-2 Antibodies Detected in Mother's Milk after vaccination?", "id": "100000000000000000002220", "answers": [{"text": "Journal of Human 31", "answer_start": 359}], "is_impossible": false}, {"question": "What is the name of the study conducted by Charepe N, Goncalves J, Juliano M, and Di Pietro ML?", "id": "100000000000000000002221", "answers": [{"text": "a prospective cohort study", "answer_start": 486}], "is_impossible": false}, {"question": "What does the BMC Pregnancy Childbirth 2021 cover?", "id": "100000000000000000002222", "answers": [{"text": "632", "answer_start": 550}], "is_impossible": false}, {"question": "What vaccines have been shown to have a positive effect on fertility?", "id": "100000000000000000002223", "answers": [{"text": "COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study. BMC Pregnancy Childbirth 2021;(21): 632. DOI: https://doi.org/10.1186/s12884-021-04051-6 32. Za\u00e7e D, La Gatta E, Petrella L, Di Pietro ML. The impact of COVID-19", "answer_start": 422}], "is_impossible": false}, {"question": "What is the name of the systematic review of the effects of the COVID-19 vaccines?", "id": "100000000000000000002224", "answers": [{"text": "meta-", "answer_start": 722}], "is_impossible": false}], "context": "Am J Obstet Gynecol. 2021;225(1):101-103. 29. Jakuszko K, Ko\u015bcielska-Kasprzak K, \u017babi\u0144ska M, et al. Immune Response to Vaccination against COVID-19 in\nBreastfeeding Health Workers. Vaccines. 2021; 9(6):663. DOI: https://doi.org/10.3390/vaccines9060663\n30. Baird JK, Jensen SM, Urba WJ, et al. SARS-CoV-2 Antibodies Detected in Mother\u2019s Milk Post-Vaccination. Journal of Human\n31. Charepe N, Goncalves J, Juliano M, et al. COVID-19 mRNA vaccine and antibody response in lactating women: a\nprospective cohort study. BMC Pregnancy Childbirth 2021;(21): 632. DOI: https://doi.org/10.1186/s12884-021-04051-6\n32. Za\u00e7e D, La Gatta E, Petrella L, Di Pietro ML. The impact of COVID-19 vaccines on fertility-A systematic review and meta-\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\nLast Updated Oct. 20, 2022"}]}, {"title": "1a42ed18d9ae562fed7f0e9911ceeded", "paragraphs": [{"qas": [{"question": "What do all currently approved or authorized COVID-19 vaccines reduce your risk of?", "id": "100000000000000000002225", "answers": [{"text": "severe illness", "answer_start": 257}], "is_impossible": false}, {"question": "What can reduce the spread of disease?", "id": "100000000000000000002226", "answers": [{"text": "Vaccination", "answer_start": 273}], "is_impossible": false}], "context": "10/30/22, 9:33 AM COVID-19 Vaccines Work | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccines Work\nCDC is reviewing this page to align with updated guidance. All currently approved or authorized COVID-19 vaccines are safe and effective and reduce your risk of severe illness. Vaccination can reduce the spread of disease, which helps protect those who get vaccinated and the people around them. COVID-19 Vaccines Protect Against COVID-19 Infections and Hospitalizations\nVaccines reduce the risk of COVID-19, including the risk of severe illness and death among people who are fully vaccinated."}]}, {"title": "2e56372cc3e19a77f2226e35f878902c", "paragraphs": [{"qas": [{"question": "What type of vaccines help protect against COVID-19 infections?", "id": "100000000000000000002229", "answers": [{"text": "COVID-19", "answer_start": 107}], "is_impossible": false}, {"question": "What is the term for asymptomatic infection?", "id": "100000000000000000002230", "answers": [{"text": "COVID-19", "answer_start": 146}], "is_impossible": false}, {"question": "Vaccine effectiveness against hospitalizations has remained what over time?", "id": "100000000000000000002231", "answers": [{"text": "relatively high", "answer_start": 279}], "is_impossible": false}, {"question": "What is slightly lower for older adults and people with weakened immune systems?", "id": "100000000000000000002232", "answers": [{"text": "Vaccine effectiveness", "answer_start": 219}], "is_impossible": false}, {"question": "What is working well to prevent severe illness, hospitalization, and death?", "id": "100000000000000000002233", "answers": [{"text": "COVID-19 vaccines", "answer_start": 438}], "is_impossible": false}], "context": "In\naddition to data from clinical trials, evidence from real-world vaccine effectiveness studies show that COVID-19 vaccines help\nprotect against COVID-19 infections, with or without symptoms (asymptomatic infections). Vaccine effectiveness against\nhospitalizations has remained relatively high over time, although it tends to be slightly lower for older adults and for people\nwith weakened immune systems. Most People Need Booster Shots\nCOVID-19 vaccines are working well\u202fto prevent severe illness, hospitalization, and death. However, public health experts see\nreduced protection over time against mild and moderate disease, especially among certain populations."}]}, {"title": "b80ec2cfa9198a8e73a3401c4f3c8b51", "paragraphs": [{"qas": [{"question": "What is effective at preventing severe disease, hospitalization, and death?", "id": "100000000000000000002236", "answers": [{"text": "Vaccine Breakthrough Infections", "answer_start": 162}], "is_impossible": false}], "context": "For the best\nprotection, everyone 6 months and older is recommended to stay up to date with their COVID-19 vaccines, which includes\ngetting boosters if eligible. Vaccine Breakthrough Infections\nCOVID-19 vaccines are effective at preventing severe disease, hospitalization, and death. However, since vaccines are not\n100% effective at preventing infection, some people who are up to date with the recommended vaccines\u202fwill still get COVID-\n19. This is called a\u202fbreakthrough infection. When people who are vaccinated develop symptoms of COVID-19, they tend to\nexperience less severe symptoms than people who are unvaccinated."}]}, {"title": "4eca5973ef6c90eb5544fab071e46a98", "paragraphs": [{"qas": [{"question": "Who recommends everyone age 6 months and older get a COVID-19 vaccine as soon as they can?", "id": "100000000000000000002239", "answers": [{"text": "CDC", "answer_start": 54}], "is_impossible": false}, {"question": "To get the most protection, get all recommended doses of what vaccine?", "id": "100000000000000000002240", "answers": [{"text": "COVID-19", "answer_start": 212}], "is_impossible": false}, {"question": "Who is recommended to stay up to date with their COVID-19 vaccines?", "id": "100000000000000000002241", "answers": [{"text": "everyone 6 months and older", "answer_start": 334}], "is_impossible": false}, {"question": "What are variants of the virus called?", "id": "100000000000000000002242", "answers": [{"text": "variants", "answer_start": 595}], "is_impossible": false}], "context": "COVID-19 Vaccines Are Effective Against Most Variants\nCDC Recommends\nEveryone ages 6 months and older should get a COVID-19 vaccine as soon as they can. To get the most protection, get all recommended doses of a COVID-19 vaccine. Take\u202fall\u202fprecautions\u202funtil\u202fyou are\u202fup\nto date with your COVID-19 vaccinations. For the best protection, everyone 6 months and older is recommended to stay up to date with their COVID-19\nvaccines, which includes getting boosters if eligible. \u2022\n\u2022\n\u2022\f10/30/22, 9:33 AM COVID-19 Vaccines Work | CDC\nViruses are constantly changing to create new types of the virus called\u202fvariants."}]}, {"title": "bd10a2e62695ef9f655345811602df84", "paragraphs": [{"qas": [{"question": "What vaccines are used in the United States to protect against severe disease, hospitalization, and death from known circulating variants?", "id": "100000000000000000002243", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "CDC will continue to monitor vaccine effectiveness to see what impact variants have on how well?", "id": "100000000000000000002244", "answers": [{"text": "COVID-19 vaccines work in real-world conditions", "answer_start": 327}], "is_impossible": false}, {"question": "When was the last update on the monitoring of effectiveness?", "id": "100000000000000000002247", "answers": [{"text": "June 28, 2022", "answer_start": 573}], "is_impossible": false}], "context": "COVID-19 vaccines used in the United States\ncontinue to protect against severe disease, hospitalization, and death from known circulating variants. They may not be as\neffective in preventing infection from these variants. CDC will continue to monitor vaccine effectiveness to see what impact, if\nany, variants have on how well COVID-19 vaccines work in real-world conditions. For More Information\nThe latest CDC data on COVID-19 vaccine effectiveness are summarized on the CDC COVID Data Tracker. Information on CDC\u2019s Monitoring COVID-19 Vaccine Effectiveness\nLast Updated June 28, 2022"}]}, {"title": "75d370caeac2c8392731185871922e7c", "paragraphs": [{"qas": [{"question": "What is the age range for COVID-19 vaccines?", "id": "100000000000000000002249", "answers": [{"text": "6 months and older", "answer_start": 279}], "is_impossible": false}, {"question": "Who recommends boosters for everyone 5 years and older?", "id": "100000000000000000002250", "answers": [{"text": "CDC", "answer_start": 203}], "is_impossible": false}, {"question": "What are some LTC settings?", "id": "100000000000000000002252", "answers": [{"text": "residential care, assisted living, nursing homes, and continuing care retirement communities", "answer_start": 384}], "is_impossible": false}], "context": "10/30/22, 9:29 AM COVID-19 Vaccines for Long-term Care Residents | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccines for Long-term Care Residents\nCDC is reviewing this page to align with updated guidance. CDC recommends COVID-19 vaccines for residents of long-term care (LTC)\nages 6 months and older, and boosters for everyone 5 years and older, if\neligible. Many LTC settings, such as residential care, assisted living, nursing homes,\nand continuing care retirement communities provide care to older adults\nwith underlying medical conditions, often living closely together."}]}, {"title": "3ca39cfe37550e6fe3ca8ce0f5acca71", "paragraphs": [{"qas": [{"question": "What can make residents more likely to be infected by the virus that causes COVID-19?", "id": "100000000000000000002253", "answers": [{"text": "medical conditions and living situations", "answer_start": 6}], "is_impossible": false}, {"question": "LTC residents are more likely to be infected or become seriously ill from what disease?", "id": "100000000000000000002256", "answers": [{"text": "COVID-19", "answer_start": 118}], "is_impossible": false}], "context": "These\nmedical conditions and living situations can make residents more likely to\nbe infected by the virus that causes COVID-19 and to become seriously ill\nfrom COVID-19. Children and adolescents with intellectual and developmental disabilities living in any type of shared setting, including\nintermediate care facilities and group homes, are also considered LTC residents. This means they are also more likely to be\ninfected or become seriously ill from COVID-19. If you live in a LTC setting, you can help protect yourself and the people around you by getting a COVID-19 vaccine as soon as\npossible."}]}, {"title": "398fccc6f5e48b78e26b21cd2efcc83c", "paragraphs": [{"qas": [{"question": "What vaccines are safe and effective against becoming seriously ill?", "id": "100000000000000000002258", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "Older adults and people with these conditions are more likely to get very sick from what?", "id": "100000000000000000002259", "answers": [{"text": "COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "What can't get COVID-19 from?", "id": "100000000000000000002260", "answers": [{"text": "COVID-19 vaccines", "answer_start": 242}], "is_impossible": false}, {"question": "What can help keep you from getting seriously ill even if you do get COVID-19?", "id": "100000000000000000002262", "answers": [{"text": "COVID-19 vaccines", "answer_start": 385}], "is_impossible": false}], "context": "COVID-19 vaccines are safe and effective\u2014especially against becoming seriously ill\u2014and very important for older adults. Older adults and people with these conditions are more likely to get very sick from COVID-19. You can\u2019t get COVID-19 from COVID-19 vaccines. Learn more about COVID-19 vaccine recommendations specifically for\npeople who are moderately or severely immunocompromised. COVID-19 vaccines can help keep you from getting seriously ill even if you do get COVID-19. Use\u202fCDC\u2019s COVID-19 booster tool\u202fto learn if and when you can get boosters to stay up to date with your COVID-19\nvaccines."}]}, {"title": "145cef7af50e6816086718fa5507ce31", "paragraphs": [{"qas": [{"question": "What does staying up to date mean?", "id": "100000000000000000002263", "answers": [{"text": "getting all recommended COVID-19 vaccines", "answer_start": 25}], "is_impossible": false}, {"question": "Who is required by CMS to monitor weekly data for residents and healthcare personnel?", "id": "100000000000000000002268", "answers": [{"text": "Nursing homes", "answer_start": 388}], "is_impossible": false}], "context": "Staying up to date\u202fmeans getting all recommended COVID-19 vaccines including boosters when eligible. If your loved one is not able to ask questions or otherwise communicate with the LTC staff, here\u2019s what to know about\nconsent for getting a COVID-19 vaccine:\nResidents and their families can ask a LTC provider about the current COVID-19 vaccination rate among their staff and\nresidents. Nursing homes are required by the Centers for Medicare and Medicaid Services (CMS) to monitor weekly COVID-19\nvaccination data for residents and healthcare personnel through CDC\u2019s National Healthcare Safety Network."}]}, {"title": "3b68ef9b6b635e51a07d78fcda4efac3", "paragraphs": [{"qas": [{"question": "What does CMS post about individual nursing homes?", "id": "100000000000000000002269", "answers": [{"text": "updated information about individual nursing homes, including resident and staff vaccination rates, on the CMS COVID-19 Nursing Home Data", "answer_start": 10}], "is_impossible": false}, {"question": "Who may monitor resident and staff vaccination data from assisted living?", "id": "100000000000000000002271", "answers": [{"text": "your state", "answer_start": 250}], "is_impossible": false}, {"question": "Who will give consent for a COVID-19 vaccine?", "id": "100000000000000000002272", "answers": [{"text": "LTC residents", "answer_start": 407}], "is_impossible": false}, {"question": "What are people appointed to make medical decisions on their behalf called?", "id": "100000000000000000002273", "answers": [{"text": "a medical proxy", "answer_start": 491}], "is_impossible": false}], "context": "CMS\nposts updated information about individual nursing homes, including resident and staff vaccination rates, on the\nCMS COVID-19 Nursing Home Data . Resident and staff vaccination data from assisted living and other LTC settings may be monitored by your state. \u2022\n\uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:29 AM COVID-19 Vaccines for Long-term Care Residents | CDC\nConsent or assent for a COVID-19 vaccine will be given by LTC residents (or people appointed to make medical decisions\non their behalf called a medical proxy) and documented in their charts per the provider\u2019s standard practice."}]}, {"title": "f7fd4eedab9cfef4c585fee363a97bd7", "paragraphs": [{"qas": [{"question": "What do residents who receive a COVID-19 vaccine receive before vaccination?", "id": "100000000000000000002274", "answers": [{"text": "a fact sheet", "answer_start": 84}], "is_impossible": false}, {"question": "What does the fact sheet explain?", "id": "100000000000000000002275", "answers": [{"text": "the risks and benefits of COVID-19 vaccination", "answer_start": 141}], "is_impossible": false}, {"question": "Who may require written, email or verbal consent from recipients before getting vaccinated?", "id": "100000000000000000002276", "answers": [{"text": "COVID-19 vaccination providers", "answer_start": 194}], "is_impossible": false}, {"question": "What will residents receive that tells them which vaccine they received?", "id": "100000000000000000002278", "answers": [{"text": "a\u202fvaccination card", "answer_start": 503}], "is_impossible": false}], "context": "Residents who receive a COVID-19 vaccine (or their medical proxy) will also receive a fact sheet before vaccination. The\nfact sheet explains the risks and benefits of COVID-19 vaccination. Some COVID-19 vaccination providers may require written, email, or verbal consent from recipients before getting\nvaccinated. This is at the provider\u2019s discretion; written consent is not required by federal law for COVID-19 vaccination in\nthe United States (U.S.). Residents (or their medical proxies) will receive a\u202fvaccination card\u202for printout that tells them which COVID-19 vaccine\nthey received and the date they received it. This should also be recorded in their medical chart."}]}, {"title": "c899ec3e792de94b97bcf5188260b5d7", "paragraphs": [{"qas": [{"question": "What can you do to get a COVID-19 vaccine?", "id": "100000000000000000002280", "answers": [{"text": "Talk with the LTC staff", "answer_start": 113}], "is_impossible": false}, {"question": "Who can help you schedule a vaccination appointment if you can\u2019t get vaccinated?", "id": "100000000000000000002281", "answers": [{"text": "family member or friend", "answer_start": 185}], "is_impossible": false}, {"question": "Who can help you schedule a vaccination appointment if you can't get vaccinated on site?", "id": "100000000000000000002282", "answers": [{"text": "family member or friend", "answer_start": 185}], "is_impossible": false}, {"question": "Where can you find providers near you?", "id": "100000000000000000002283", "answers": [{"text": "Visit vaccines.gov", "answer_start": 293}], "is_impossible": false}, {"question": "Who can you talk to about getting a COVID-19 vaccine?", "id": "100000000000000000002284", "answers": [{"text": "your healthcare provider", "answer_start": 420}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\nHow to Get a COVID-19 Vaccine\nTo get a COVID-19 vaccine, you or your family member can take these steps:\nTalk with the LTC staff to see if you can get vaccinated on site. Ask a family member or friend to help you schedule a vaccination appointment if you can\u2019t get vaccinated on site. Visit\nvaccines.gov to find providers near you. If you have additional questions about how to get a COVID-19 vaccine, talk with your healthcare provider."}]}, {"title": "c8e6421c22c7025eb3349167a9685c22", "paragraphs": [{"qas": [{"question": "Who is providing the COVID-19 vaccine free of charge to all people living in the U.S.?", "id": "100000000000000000002285", "answers": [{"text": "The federal government", "answer_start": 50}], "is_impossible": false}, {"question": "What do you text your ZIP code to?", "id": "100000000000000000002286", "answers": [{"text": "438829", "answer_start": 328}], "is_impossible": false}, {"question": "What is a ZIP code for the COVID-19 vaccine?", "id": "100000000000000000002288", "answers": [{"text": "438829", "answer_start": 328}], "is_impossible": false}, {"question": "Who is responsible for ensuring access to COVIDE19 vaccines in LTC settings?", "id": "100000000000000000002289", "answers": [{"text": "the federal government", "answer_start": 452}], "is_impossible": false}, {"question": "What are the possible side effects of the COVID-19 vaccine?", "id": "100000000000000000002290", "answers": [{"text": "\u2022", "answer_start": 235}], "is_impossible": false}], "context": "Safe, Easy, Free, and Nearby COVID-19 Vaccination\nThe federal government is providing the vaccine free of charge to all people living in the U.S., regardless of their\nimmigration or health insurance status. COVID-19 Vaccines Are Free\n\u2022\n\u2022\n\u2022\nTo find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. 10/30/22, 9:29 AM COVID-19 Vaccines for Long-term Care Residents | CDC\nLearn more about how the federal government, LTC providers, and jurisdictions are ensuring access to COVID-19 vaccines in\nLTC settings. Learn more about possible side effects and what to expect after getting your COVID-19 vaccine."}]}, {"title": "c3f43ed961dee05c0f7d77f4d207c2ae", "paragraphs": [{"qas": [{"question": "Who has information that LTC providers can use to evaluate and manage residents\u2019 signs and symptoms after vaccination?", "id": "100000000000000000002292", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "After vaccination, everyone should continue to follow guidance to protect themselves and others.", "id": "100000000000000000002293", "answers": [{"text": "LTC providers can use to evaluate and manage residents\u2019 signs and symptoms after vaccination. After vaccination, everyone should continue to follow guidance to protect themselves and others. For your safety and the safety of those around you, LTC providers may recommend vaccinated residents continue to take precautions such as wearing a mask or getting tested for COVID-19", "answer_start": 25}], "is_impossible": false}, {"question": "What should family members wear when required?", "id": "100000000000000000002295", "answers": [{"text": "masks", "answer_start": 468}], "is_impossible": false}, {"question": "What is the name of the vaccine that is still recommended in LTC settings?", "id": "100000000000000000002296", "answers": [{"text": "COVID-19", "answer_start": 535}], "is_impossible": false}], "context": "CDC has information that LTC providers can use to evaluate and manage residents\u2019 signs and symptoms after vaccination. After vaccination, everyone should continue to follow guidance to protect\nthemselves and others. For your safety and the safety of those around you, LTC providers may recommend vaccinated residents continue to take\nprecautions such as wearing a mask or getting tested for COVID-19. Family members should follow facility guidance for visits and wear masks indoors, when required. Learn more about being up to date on COVID-19 vaccination and what precautions might still be recommended in LTC\nsettings."}]}, {"title": "c53d7c5255790d63a7faa1dbb3c7ab56", "paragraphs": [{"qas": [{"question": "When was the last update for the post-vaccination considerations for residents?", "id": "100000000000000000002299", "answers": [{"text": "July 14, 2022", "answer_start": 276}], "is_impossible": false}], "context": "Related Pages\nMyths and Facts about COVID-19 Vaccines\n\u203a\nFrequently Asked Questions about COVID-19 Vaccination\n\u203a\nCOVID-19 Vaccine Boosters\n\u203a\nInformation about Medicare and COVID-19 Vaccine\n\u203a \uf209\n\uf2ff For Healthcare Workers\nPost-Vaccination Considerations for Residents\nLast Updated July 14, 2022"}]}, {"title": "410f58af6f4ed5a74b0380a4c8ed32a4", "paragraphs": [{"qas": [{"question": "What is an increased risk of severe COVID-19 illness for people who are moderately or severely immunocompromised?", "id": "100000000000000000002300", "answers": [{"text": "death", "answer_start": 370}], "is_impossible": false}, {"question": "What is a weakened immune system?", "id": "100000000000000000002301", "answers": [{"text": "moderately or severely immunocompromised", "answer_start": 239}], "is_impossible": false}, {"question": "What is your risk of severe COVID-19 illness and death?", "id": "100000000000000000002302", "answers": [{"text": "If you are moderately or severely immunocompromised", "answer_start": 228}], "is_impossible": false}, {"question": "What may not be as strong as in people who are not immunocompromised?", "id": "100000000000000000002303", "answers": [{"text": "your immune response to COVID-19 vaccination", "answer_start": 391}], "is_impossible": false}], "context": "10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccines for People Who Are Moderately or\nSeverely Immunocompromised\nWhat You Need to Know\nIf you are moderately or severely immunocompromised (have a weakened immune system), you are at increased\nrisk of severe COVID-19 illness and death. Additionally, your immune response to COVID-19 vaccination may not\nbe as strong as in people who are not immunocompromised. As with vaccines for other diseases, you are protected best when you stay up to date with your COVID-19 vaccines\nas described below."}]}, {"title": "7aa0d008fc8ff274d275b0002055bcf0", "paragraphs": [{"qas": [{"question": "Who recommends everyone age 5 years and older get an updated COVID-19 booster?", "id": "100000000000000000002305", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "How many updated booster doses is recommended for all people ages 5 and older?", "id": "100000000000000000002306", "answers": [{"text": "One", "answer_start": 150}], "is_impossible": false}, {"question": "What does CDC recommend people with moderate immunocompromised get?", "id": "100000000000000000002307", "answers": [{"text": "an extra primary series dose", "answer_start": 358}], "is_impossible": false}], "context": "CDC recommends everyone ages 5 years and older get an updated COVID-19 booster to help restore\nprotection that has decreased since your last vaccine. One updated booster dose is recommended for all\npeople ages 5 years and older, regardless of whether or not they are immunocompromised. CDC recommends that people with moderate or severe immunocompromise get an extra primary series dose\nif receiving the Moderna or Pfizer-BioNTech series. Use CDC\u2019s COVID-19 booster tool to learn if and when you can get boosters to stay up to date with your COVID-19\nvaccines."}]}, {"title": "e1fc221f576d976302d90862faaa821f", "paragraphs": [{"qas": [{"question": "How can you self-attest to your immunocompromised status?", "id": "100000000000000000002310", "answers": [{"text": "you do not need any documentation of your status", "answer_start": 89}], "is_impossible": false}, {"question": "How often is EVUSHELD given by your healthcare provider?", "id": "100000000000000000002311", "answers": [{"text": "every six months", "answer_start": 300}], "is_impossible": false}, {"question": "How often is COVID-19 given to you by your healthcare provider?", "id": "100000000000000000002312", "answers": [{"text": "every six months", "answer_start": 300}], "is_impossible": false}], "context": "You can self-attest to your moderately or severely immunocompromised status, which means you do not need any\ndocumentation of your status in order to receive COVID-19 vaccine doses you might be eligible to receive. You may also be eligible for EVUSHELD , a medicine given by your healthcare provider every six months to help\nprevent you from getting COVID-19."}]}, {"title": "e123a6b2eea13d846e41bd4feda36e2f", "paragraphs": [{"qas": [{"question": "How long after 1st dose is PRIMARY SERIES 3 weeks after?", "id": "100000000000000000002314", "answers": [{"text": "2 months", "answer_start": 950}], "is_impossible": false}, {"question": "What does AND OLDER UPDATED mean?", "id": "100000000000000000002315", "answers": [{"text": "BIVALENT", "answer_start": 362}], "is_impossible": false}, {"question": "What is the name of the PRIMARY SERIES?", "id": "100000000000000000002317", "answers": [{"text": "Johnson & Johnson's Janssen", "answer_start": 1457}], "is_impossible": false}, {"question": "BOOSTER At least 2 months after 3rd dose or last booster Up to Date: Immediately after the most recent booster recommended for you What is the age group 18 YEARS AND OLDER AGE GROUP Moderna  PRIMARY SERIES 4 weeks after 1st dose What is BIVALENT?", "id": "100000000000000000002318", "answers": [{"text": "Johnson & Johnson's Janssen \uf1aa PRIMARY SERIES ADDITIONAL DOSE At least 4 weeks after 1st dose and should be Pfizer-BioNTech or Moderna UPDATED (BIVALENT) BOOSTER At least 2 months after 2nd dose or last booster Up to Date: Immediately after you have received the most recent booster recommended for you [ 1 ] AGE GROUP 18 YEARS AND OLDER AGE GROUP Novav", "answer_start": 1457}], "is_impossible": false}, {"question": "How long after 3rd dose or last booster is the dose UPDATED (BIVALENT) BOOSTER?", "id": "100000000000000000002319", "answers": [{"text": "2 months", "answer_start": 389}], "is_impossible": false}, {"question": "How many weeks after 1st dose is the PRIMARY SERIES at least 4 weeks after 2nd dose?", "id": "100000000000000000002320", "answers": [{"text": "3", "answer_start": 539}], "is_impossible": false}, {"question": "What is the AGE GROUP 18 YEARS AND OLDER?", "id": "100000000000000000002324", "answers": [{"text": "Johnson & Johnson's Janssen", "answer_start": 1457}], "is_impossible": false}, {"question": "How long after your first dose of Novavax should you be given a PRIMARY SERIES ADDITIONAL DOSE?", "id": "100000000000000000002325", "answers": [{"text": "3 weeks", "answer_start": 152}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech or Moderna UPDATED (BIVALENT) BOOSTER?", "id": "100000000000000000002326", "answers": [{"text": "Johnson & Johnson's Janssen", "answer_start": 1457}], "is_impossible": false}, {"question": "When should you receive the most recent booster recommended for you?", "id": "100000000000000000002327", "answers": [{"text": "Immediately after", "answer_start": 2723}], "is_impossible": false}, {"question": "What is the name of the Novavax booster available in limited situations?", "id": "100000000000000000002328", "answers": [{"text": "monovalent", "answer_start": 1929}], "is_impossible": false}, {"question": "How long after you have received the most recent booster recommended for you?", "id": "100000000000000000002329", "answers": [{"text": "2 months", "answer_start": 389}], "is_impossible": false}, {"question": "What is the name of the PRIMARY SERIES 3 weeks after 1st dose UPDATED (BIVALENT) BOOSTER At least 2 months after 2nd dose 10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderate or Severely Immunocompromised | CDC Up to Date: Immediately after you have received the most recent booster recommended for you, what should you do?", "id": "100000000000000000002330", "answers": [{"text": "Moderna", "answer_start": 3039}], "is_impossible": false}, {"question": "How long after 1st dose is the PRIMARY SERIES UPDATED (BIVALENT) BOOSTER?", "id": "100000000000000000002332", "answers": [{"text": "3 weeks", "answer_start": 2149}], "is_impossible": false}, {"question": "How many weeks after 1st dose in PRIMARY SERIES?", "id": "100000000000000000002334", "answers": [{"text": "3", "answer_start": 152}], "is_impossible": false}, {"question": "What is the minimum amount of time after 2nd dose in primary series?", "id": "100000000000000000002335", "answers": [{"text": "8 weeks", "answer_start": 2886}], "is_impossible": false}, {"question": "What is not recommended for this age group at this time?", "id": "100000000000000000002336", "answers": [{"text": "a booster", "answer_start": 2969}], "is_impossible": false}, {"question": "Who is considered up to date on COVID-19 vaccines?", "id": "100000000000000000002338", "answers": [{"text": "People Who Are Moderately or Severely Immunocompromised", "answer_start": 2272}], "is_impossible": false}, {"question": "What are you eligible for?", "id": "100000000000000000002339", "answers": [{"text": "Children Ages 6 Months-11 Years Who Are Moderately or Severely Immunocompromised", "answer_start": 2432}], "is_impossible": false}], "context": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 8 weeks after 2nd dose\nUp to Date: 2 weeks after 3rd dose in primary series, since a booster is not recommended for this age group at this\ntime\nAGE GROUP\nModerna\n\uf1aa\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nIf you have completed your primary series\u2014but are not yet eligible for a booster\u2014you are also considered up to date."}]}, {"title": "90b3ed2d1dad82574cf3c43a526059b7", "paragraphs": [{"qas": [{"question": "What is up to date two weeks after completing the 3 dose of their primary series?", "id": "100000000000000000002345", "answers": [{"text": "Children 6 months to 4 years", "answer_start": 313}], "is_impossible": false}, {"question": "Children 5 years of age who received a Moderna primary series are up-to-date immediately after they have received the most recent booster recommended?", "id": "100000000000000000002346", "answers": [{"text": "Pfizer-BioNTech booster at least 2 months after their 3rd dose", "answer_start": 170}], "is_impossible": false}], "context": "AGE GROUP\nPRIMARY SERIES PRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nChildren 5 years of age can get a\nPfizer-BioNTech booster at least\n2 months after their 3rd dose. (Children 6 months to 4 years\nare not recommended for a\nbooster.) Up to Date: Children 6 months to 4 years are up to date two weeks after completing the 3 dose of their primary\nseries. Children 5 years of age who received a Moderna primary series are up to date immediately after they have\nreceived the most recent booster recommended for them."}]}, {"title": "b381d8f507df03a73260e47a4ef1f1bb", "paragraphs": [{"qas": [{"question": "How long after 1st dose is the PRIMARY SERIES 4 weeks after?", "id": "100000000000000000002348", "answers": [{"text": "rd PRIMARY SERIES PRIMARY SERIES 4 weeks after 1st dose PRIMARY SERIES At least 4 weeks after 2nd dose", "answer_start": 0}], "is_impossible": false}, {"question": "What is the term for the most recent booster recommended for you?", "id": "100000000000000000002349", "answers": [{"text": "Up to Date", "answer_start": 163}], "is_impossible": false}, {"question": "Where can you find COVID-19 locations?", "id": "100000000000000000002350", "answers": [{"text": "Search vaccines.gov", "answer_start": 303}], "is_impossible": false}, {"question": "Where can you find vaccines near you?", "id": "100000000000000000002351", "answers": [{"text": "Search vaccines.gov", "answer_start": 303}], "is_impossible": false}, {"question": "What is the name of the website that helps people who have a weakened immune system?", "id": "100000000000000000002352", "answers": [{"text": "vaccines.gov", "answer_start": 310}], "is_impossible": false}], "context": "rd\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nUp to Date: Immediately after you have received the most recent booster recommended for you. 1\nTo find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233.\nWho Is Moderately or Severely Immunocompromised? Some people are immunocompromised (have a weakened immune system) due to a medical condition or from receipt of\nimmunosuppressive medications or treatments."}]}, {"title": "63d380e5517d8be2b85ba4f10dd99a84", "paragraphs": [{"qas": [{"question": "What are examples of medical conditions or treatments that may result in moderate to severe immunocompromise?", "id": "100000000000000000002353", "answers": [{"text": "Active treatment for solid tumor and hematologic malignancies", "answer_start": 132}], "is_impossible": false}, {"question": "What is the name of the vaccine for people who are moderately or severely immunocompromised?", "id": "100000000000000000002357", "answers": [{"text": "COVID-19", "answer_start": 691}], "is_impossible": false}], "context": "Examples of medical conditions or treatments that may result in moderate to severe immunocompromise include but are not\nlimited to:\nActive treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines regardless of current treatment status\n(e.g., chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute leukemia)\nReceipt of solid-organ transplant or an islet transplant and taking immunosuppressive therapy\nReceipt of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of\ntransplantation or taking immunosuppressive therapy)\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nTalk to your healthcare provider about COVID-19 and your medical condition."}]}, {"title": "3c5088db0d18aa93a3aaa4ea4acda140", "paragraphs": [{"qas": [{"question": "What country does COVID-19 Interim Clinical Considerations cover?", "id": "100000000000000000002363", "answers": [{"text": "United States", "answer_start": 285}], "is_impossible": false}], "context": "People Who Were Vaccinated Outside of the United States\nPeople who are moderately or severely immunocompromised and who received COVID-19 vaccines not available in the\nUnited States should either complete or restart the recommended COVID-19 vaccine series, including a booster, in the United\nStates. For more information, talk to your healthcare provider, or see the COVID-19 Interim Clinical Considerations."}]}, {"title": "475a93627cccfe89b999e08e8581f63d", "paragraphs": [{"qas": [{"question": "What type of HIV infection is untreated?", "id": "100000000000000000002365", "answers": [{"text": "Advanced", "answer_start": 225}], "is_impossible": false}, {"question": "What type of drugs are used to treat HIV?", "id": "100000000000000000002367", "answers": [{"text": "high-dose corticosteroids", "answer_start": 454}], "is_impossible": false}, {"question": "How many mg of prednisone are used per day?", "id": "100000000000000000002368", "answers": [{"text": "20", "answer_start": 487}], "is_impossible": false}, {"question": "What is the acronym for tumor necrosis factor (TNF) blockers?", "id": "100000000000000000002370", "answers": [{"text": "\u2022", "answer_start": 842}], "is_impossible": false}, {"question": "What is EVUSHELD?", "id": "100000000000000000002371", "answers": [{"text": "pre-exposure prophylaxis", "answer_start": 966}], "is_impossible": false}], "context": "transplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease, severe combined\nimmunodeficiency, DiGeorge syndrome, Wiskott-Aldrich syndrome)\nAdvanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3, history of an AIDS-\ndefining illness without immune reconstitution, or clinical manifestations of symptomatic HIV)\nActive treatment with high-dose corticosteroids (i.e., 20 or more mg of prednisone or equivalent per day when\nadministered for 2 or more weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs,\ncancer chemotherapeutic agents classified as severely immunosuppressive, tumor necrosis factor (TNF) blockers, and\nother biologic agents that are immunosuppressive or immunomodulatory\n\u2022\n\u2022\n\u2022\nIf you are moderately or severely immunocompromised or severely allergic to COVID-19 vaccines, you may be eligible for\npre-exposure prophylaxis with EVUSHELD ."}]}, {"title": "6c79295b91cb8f6b255baac6f63ca177", "paragraphs": [{"qas": [{"question": "How often is EVUSHELD given?", "id": "100000000000000000002372", "answers": [{"text": "every six months", "answer_start": 29}], "is_impossible": false}, {"question": "What is EVUSHELD?", "id": "100000000000000000002375", "answers": [{"text": "a medicine given every six months by your healthcare provider to help prevent you from getting COVID-19", "answer_start": 12}], "is_impossible": false}], "context": "EVUSHELD is a medicine given every six months by your healthcare\nprovider to help prevent you from getting COVID-19. EVUSHELD may offer less protection against three strains (BA.4.6,\nBF.7, and BA.2.75.2) of the Omicron variant. It is important to use multiple prevention measures and talk to your\nhealthcare provider to find out if EVUSHELD is right for you. TM TM\nTM\nTM\nDownload: EVUSHELD EUA Fact Sheet for Patients, Parents and Caregivers\nTM \uf209\nFrequently Asked Questions\nNo, vaccines used for the primary vaccination series should be the same product or brand."}]}, {"title": "e92908118c947a6fd01c399398c68227", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech or Moderna COVID-19 vaccine?", "id": "100000000000000000002377", "answers": [{"text": "mRNA COVID-19 vaccines", "answer_start": 151}], "is_impossible": false}, {"question": "What can be used for the third primary dose if the mRNA vaccine product is not available or unknown?", "id": "100000000000000000002378", "answers": [{"text": "Pfizer-BioNTech or Moderna COVID-19 vaccine", "answer_start": 106}], "is_impossible": false}, {"question": "What may prevent serious and possibly life-threatening COVID-19 in people who may not have responded to their two-dose mRNA COVID-19 vaccine primary series?", "id": "100000000000000000002379", "answers": [{"text": "A third primary dose", "answer_start": 292}], "is_impossible": false}], "context": "However, if the mRNA vaccine\nproduct given for the first two doses is not available or is unknown, either Pfizer-BioNTech or Moderna COVID-19 vaccine\n(mRNA COVID-19 vaccines) may be administered for the third primary dose. Can you mix the vaccines for your mRNA primary vaccination series? \uf1aa\nA third primary dose may prevent serious and possibly life-threatening COVID-19 in people who may not have responded\nto their two-dose mRNA COVID-19 vaccine primary series."}]}, {"title": "70fe1a274d310ee30323624652ae4df", "paragraphs": [{"qas": [{"question": "What may people who have low or no protection after two doses of mRNA vaccines have an improved immune response after a third primary dose of the same vaccine?", "id": "100000000000000000002380", "answers": [{"text": "moderately or severely immunocompromised", "answer_start": 15}], "is_impossible": false}, {"question": "What are the benefits of a 3rd primary dose for people who are moderately or severely immunocompromised and received a second primary dose?", "id": "100000000000000000002381", "answers": [{"text": "improved immune response", "answer_start": 131}], "is_impossible": false}, {"question": "The safety, effectiveness, and benefit of the third primary dose continues to be evaluated in people with what condition?", "id": "100000000000000000002383", "answers": [{"text": "moderately or severely immunocompromised", "answer_start": 444}], "is_impossible": false}, {"question": "What has so far been reported after the first primary dose?", "id": "100000000000000000002384", "answers": [{"text": "similar to those of the two-dose primary series", "answer_start": 600}], "is_impossible": false}, {"question": "What is similar to the two-dose primary series?", "id": "100000000000000000002386", "answers": [{"text": "reactions reported after the third primary dose", "answer_start": 520}], "is_impossible": false}], "context": "People who are moderately or severely immunocompromised\nwho have low or no protection after two doses of mRNA vaccines may have an improved immune response after a third\nprimary dose of the same vaccine. What are the benefits of a third primary dose for people who are moderately or severely\nimmunocompromised and received two doses of mRNA COVID-19 vaccine? \uf1aa\nThe safety, effectiveness, and benefit of the third primary dose in people who are moderately or severely\nimmunocompromised continues to be evaluated. So far, reactions reported after the third primary dose of an mRNA\nCOVID-19 vaccine are similar to those of the two-dose primary series."}]}, {"title": "c926569034651308916317b92849a21f", "paragraphs": [{"qas": [{"question": "Fatigue and pain at the injection site were the most commonly reported side effects?", "id": "100000000000000000002387", "answers": [{"text": "\u2014", "answer_start": 83}], "is_impossible": false}, {"question": "What was the most common side effects reported?", "id": "100000000000000000002388", "answers": [{"text": "Fatigue and pain at the injection site", "answer_start": 0}], "is_impossible": false}], "context": "Fatigue and pain at the injection site were the most\ncommonly reported side effects\u2014and overall, most symptoms were mild and temporary. As with the two-dose primary series, serious side effects are rare, but may occur. What are the risks of vaccinating people who are moderately or severely immunocompromised\nwith a third primary dose? \uf1aa\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\np y y\nFor people who are immunocompromised, the third primary dose is the final dose of the primary series of an mRNA\nCOVID-19 vaccine."}]}, {"title": "7365a77925092d51b34ba3999b7658dc", "paragraphs": [{"qas": [{"question": "What is the difference between a third primary dose and a booster?", "id": "100000000000000000002392", "answers": [{"text": "Boosters are shots that enhance or restore protection against COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "Who recommends getting the most recent booster dose?", "id": "100000000000000000002393", "answers": [{"text": "CDC", "answer_start": 328}], "is_impossible": false}], "context": "Boosters are shots that enhance or restore protection against COVID-19, which may have decreased\nover time. What is the difference between a third primary dose and a booster? \uf1aa\nPeople can stay up to date with COVID-19 vaccination by completing a primary series and receiving the most recent\nbooster dose recommended for them by CDC. The people you live or spend time with can help protect you and\nthemselves by staying up to date on their COVID-19 vaccines too."}]}, {"title": "45667969ca8ea606094ab9f3442761b7", "paragraphs": [{"qas": [{"question": "What can people who have weakened immune systems do to stay up to date with their COVID-19 vaccination?", "id": "100000000000000000002395", "answers": [{"text": "completing a primary series and receiving the most recent booster dose recommended for them by CDC", "answer_start": 147}], "is_impossible": false}, {"question": "What is the date if you receive all the recommended doses of COVID-19 vaccine?", "id": "100000000000000000002399", "answers": [{"text": "You are up to date", "answer_start": 467}], "is_impossible": false}], "context": "When are people who have weakened immune systems considered up to date with their COVID-\n\uf1aa\nPeople can stay up to date with COVID-19 vaccination by completing a primary series and receiving the most recent\nbooster dose recommended for them by CDC. The people you live or spend time with can help protect you and\nthemselves by staying up to date on their COVID-19 vaccines too. When are people who have weakened immune systems considered up to date with their COVID-\n\uf1aa\nYou are up to date if you receive all COVID-19 vaccine doses recommended for you, even if you become ill with COVID-19."}]}, {"title": "aadaefa7707054a83b44695ec10ecbcb", "paragraphs": [{"qas": [{"question": "What does not need to be re-vaccinated or receive an additional booster?", "id": "100000000000000000002400", "answers": [{"text": "You", "answer_start": 0}], "is_impossible": false}, {"question": "What do people who are up to date and get sick with COVID-19 need to get immediately?", "id": "100000000000000000002401", "answers": [{"text": "more COVID-19 vaccines", "answer_start": 138}], "is_impossible": false}, {"question": "When was Authorized or Approved in the United States?", "id": "100000000000000000002402", "answers": [{"text": "Oct. 24, 2022", "answer_start": 305}], "is_impossible": false}, {"question": "When was the Last Updated?", "id": "100000000000000000002403", "answers": [{"text": "Oct. 24, 2022", "answer_start": 305}], "is_impossible": false}], "context": "You do not need to be re-vaccinated or receive an additional booster. Do people who are up to date and get sick with COVID-19 need to get more COVID-19 vaccines\nimmediately? \uf1aa\n\uf2ff For Healthcare and Public Health\nUse of COVID-19 Vaccines Currently Authorized or Approved in the United States\n\u2022\nLast Updated Oct. 24, 2022"}]}, {"title": "5fa9a4915ba6f6a6de9abf7ff58b50e3", "paragraphs": [{"qas": [{"question": "What is recommended for everyone ages 6 months and older?", "id": "100000000000000000002404", "answers": [{"text": "COVID-19 vaccines", "answer_start": 246}], "is_impossible": false}, {"question": "What does CDC recommend for people who would like to have a baby?", "id": "100000000000000000002405", "answers": [{"text": "COVID-19 Vaccines", "answer_start": 18}], "is_impossible": false}, {"question": "What is the age range for getting a COVID-19 vaccination?", "id": "100000000000000000002406", "answers": [{"text": "6 months and older", "answer_start": 282}], "is_impossible": false}, {"question": "What are people who are pregnant, breastfeeding, trying to get pregnant now, or might become pregnant in the future eligible for?", "id": "100000000000000000002407", "answers": [{"text": "boosters", "answer_start": 431}], "is_impossible": false}], "context": "10/30/22, 9:29 AM COVID-19 Vaccines for People Who Would Like to Have a Baby | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 Vaccines for People Who Would Like to Have\na Baby\nWhat You Need to Know About COVID-19 Vaccination and Fertility\nCDC recommends COVID-19 vaccines for everyone ages 6 months and older, including people who are pregnant,\nbreastfeeding, trying to get pregnant now, or might become pregnant in the future and getting boosters, if eligible. Learn which vaccines are available by age and how to stay up to date with your COVID-19 vaccination."}]}, {"title": "2455a89018914578e4456504e788e130", "paragraphs": [{"qas": [{"question": "What is the term for problems trying to get pregnant?", "id": "100000000000000000002408", "answers": [{"text": "fertility problems", "answer_start": 85}], "is_impossible": false}, {"question": "What can COVID-19 make you very sick during pregnancy?", "id": "100000000000000000002409", "answers": [{"text": "There is currently no evidence that any vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "What is the risk of complications that can affect your pregnancy and developing baby?", "id": "100000000000000000002410", "answers": [{"text": "increased risk", "answer_start": 269}], "is_impossible": false}, {"question": "What are some people have become pregnant after receiving a COVID-19 vaccine?", "id": "100000000000000000002411", "answers": [{"text": "some who got vaccinated during COVID-19 vaccine clinical trials", "answer_start": 466}], "is_impossible": false}], "context": "There is currently no evidence that any vaccines, including COVID-19 vaccines, cause fertility problems (problems\ntrying to get pregnant) in women or men. COVID-19 can make you very sick during pregnancy. Additionally, if you have COVID-19 during pregnancy, you are\nat increased risk of complications that can affect your pregnancy and developing baby. \u2022\n\u2022\n\u2022\nPregnancy After Vaccination\nMany people have become pregnant after receiving a COVID-19 vaccine, including some who got vaccinated during COVID-19\nvaccine clinical trials."}]}, {"title": "220b6266493a61b8d1394e8ced0062a3", "paragraphs": [{"qas": [{"question": "How many people had a positive pregnancy test after receiving the first dose of an mRNA COVID-19 vaccine?", "id": "100000000000000000002412", "answers": [{"text": "4,800", "answer_start": 115}], "is_impossible": false}, {"question": "What vaccination would cause any problems with becoming pregnant now or in the future?", "id": "100000000000000000002416", "answers": [{"text": "COVID-19", "answer_start": 602}], "is_impossible": false}], "context": "In addition, a recent report using the v-safe COVID-19 vaccine pregnancy safety monitoring\nsystem data showed that 4,800 people had a positive pregnancy test after receiving the first dose of an mRNA COVID-19\nvaccine. Another report using data from eight U.S. healthcare systems documented more than 1,000 people who\ncompleted COVID-19 vaccination (with any COVID-19 vaccine) before becoming pregnant. Learn more: COVID-19 Vaccines While Pregnant or Breastfeeding. No Evidence that COVID-19 Vaccines Affect Fertility\nThere is currently no evidence that vaccine ingredients or antibodies made following COVID-19 vaccination would cause any\nproblems with becoming pregnant now or in the future."}]}, {"title": "73fcaf51c28bb6da7465a14dac472123", "paragraphs": [{"qas": [{"question": "Recent studies have found no differences in pregnancy success rates among women who had antibodies from COVID-19 vaccines?", "id": "100000000000000000002417", "answers": [{"text": "COVID-19 infection", "answer_start": 139}], "is_impossible": false}, {"question": "What did CDC and Medical Center find no difference in?", "id": "100000000000000000002418", "answers": [{"text": "pregnancy success rates", "answer_start": 44}], "is_impossible": false}, {"question": "Who recommends COVID-19 Vaccination for people who want to have children?", "id": "100000000000000000002419", "answers": [{"text": "CDC and Medical Professionals", "answer_start": 264}], "is_impossible": false}], "context": "Recent studies have found no differences in pregnancy success rates among women who had antibodies from COVID-19\nvaccines or from a recent COVID-19 infection, and women who had no antibodies, including for patients undergoing\ni t d d ti t h l d ( i it f tili ti )\nCDC and Medical Professionals Recommend COVID-19\nVaccination for People Who Want to Have Children\nProfessional medical organizations serving people of reproductive age, including adolescents, emphasize that there is\nno evidence that COVID-19 vaccination causes problems with fertility."}]}, {"title": "97c95f755760a62f991cd8cc653483da", "paragraphs": [{"qas": [{"question": "What vaccine is safe and effective during pregnancy?", "id": "100000000000000000002421", "answers": [{"text": "COVID-19", "answer_start": 40}], "is_impossible": false}, {"question": "What type of procedure is assisted reproductive technology?", "id": "100000000000000000002423", "answers": [{"text": "in vitro fertilization", "answer_start": 240}], "is_impossible": false}, {"question": "How many females found that COVID-19 vaccination did not affect the likelihood of becoming pregnant?", "id": "100000000000000000002424", "answers": [{"text": "more than 2,000", "answer_start": 276}], "is_impossible": false}, {"question": "Scientists continue to study what vaccines carefully?", "id": "100000000000000000002425", "answers": [{"text": "COVID-19", "answer_start": 491}], "is_impossible": false}], "context": "Evidence continues to grow showing that COVID-19 vaccination is safe and effective during pregnancy\n\uf209\n\uf209\n\u2022\f10/30/22, 9:29 AM COVID-19 Vaccines for People Who Would Like to Have a Baby | CDC\nassisted reproductive technology procedures (e.g., in vitro fertilization). A study of more than 2,000 females aged 21-45 years and their partners found that COVID-19 vaccination of either\npartner did not affect the likelihood of becoming pregnant. Like with all vaccines, scientists continue to study COVID-19 vaccines carefully and will continue to report findings as they\nbecome available."}]}, {"title": "79498d603ca64875d72299084fcdb0c9", "paragraphs": [{"qas": [{"question": "What are some of the changes that people who menstruate may observe after COVIV-19 vaccination?", "id": "100000000000000000002427", "answers": [{"text": "Longer-lasting menstrual periods Shorter intervals between periods Heavier bleeding than usual", "answer_start": 228}], "is_impossible": false}, {"question": "How long are the menstrual periods?", "id": "100000000000000000002428", "answers": [{"text": "Longer-lasting", "answer_start": 228}], "is_impossible": false}, {"question": "A recent small study of how many healthy men received an mRNA vaccination looked at what characteristics of sperm?", "id": "100000000000000000002430", "answers": [{"text": "45 healthy men who received an mRNA COVID-19 vaccine looked at sperm characteristics, like quantity and movement", "answer_start": 619}], "is_impossible": false}, {"question": "What did the mRNA COVID-19 vaccine look at before and after vaccination?", "id": "100000000000000000002431", "answers": [{"text": "sperm characteristics", "answer_start": 682}], "is_impossible": false}], "context": "Limited, Temporary Impact of COVID-19 Vaccines on Menstrual\nCycles\nResults from recent research studies show that people who menstruate may observe small, temporary changes in\nmenstruation after COVID-19 vaccination, including:\nLonger-lasting menstrual periods\nShorter intervals between periods\nHeavier bleeding than usual\nDespite these temporary changes in menstruation, there is no evidence that COVID-19 vaccines cause fertility problems. Research Studies of Fertility in Healthy Men\nCurrently, no evidence shows that any vaccines, including COVID-19 vaccines, cause male fertility problems. A recent\nsmall study of 45 healthy men who received an mRNA COVID-19 vaccine looked at sperm characteristics, like\nquantity and movement, before and after vaccination."}]}, {"title": "4cf2a7e81ad18709049cfdec88c0a775", "paragraphs": [{"qas": [{"question": "Fever from any illness has been associated with what in healthy men?", "id": "100000000000000000002434", "answers": [{"text": "a short-term decrease in sperm production", "answer_start": 277}], "is_impossible": false}, {"question": "What vaccines are undergoing the most intense safety monitoring?", "id": "100000000000000000002436", "answers": [{"text": "COVID-19", "answer_start": 559}], "is_impossible": false}], "context": "Researchers found no significant changes in these sperm\ncharacteristics after vaccination. However, one study found that COVID-19 infection may be associated with a decline in fertility for men for up to\n60 days after infection. Fever from any illness has been associated with a short-term decrease in sperm production in healthy men. Although fever can be a side effect of COVID-19 vaccination, there is no current evidence that fever after COVID-\nvaccination affects sperm production. Fever is also a common symptom of COVID-19 infection. Safety Monitoring\nCOVID-19 vaccines are undergoing the most intense safety monitoring in U.S. history."}]}, {"title": "f988b8519d0d5b8d1640354202b5578f", "paragraphs": [{"qas": [{"question": "What vaccines are safe and effective for use before and during pregnancy?", "id": "100000000000000000002438", "answers": [{"text": "COVID-19", "answer_start": 42}], "is_impossible": false}, {"question": "What should you take if you have side effects after COVID-19 vaccination?", "id": "100000000000000000002439", "answers": [{"text": "over-the-counter medicine", "answer_start": 241}], "is_impossible": false}, {"question": "What are antihistamines used for?", "id": "100000000000000000002440", "answers": [{"text": "pain or discomfort", "answer_start": 329}], "is_impossible": false}, {"question": "What can you take to relieve short-term side effects after getting vaccinated?", "id": "100000000000000000002441", "answers": [{"text": "ibuprofen, acetaminophen, or antihistamines", "answer_start": 276}], "is_impossible": false}, {"question": "Fever has been associated with what?", "id": "100000000000000000002442", "answers": [{"text": "adverse pregnancy outcomes", "answer_start": 603}], "is_impossible": false}], "context": "Data continue to accumulate and show\nthat COVID-19 vaccines are safe and effective for use before and during pregnancy. Managing Side Effects\nIf you have side effects after COVID-19 vaccination, talk to your healthcare provider about taking over-the-counter medicine,\nsuch as ibuprofen, acetaminophen, or antihistamines, for any pain or discomfort you may experience, including fever. You\ncan take these medications to relieve short-term side effects after getting vaccinated if you have no medical reasons that\nprevent you from taking these medications. Fever, for any reason, has been associated with adverse pregnancy outcomes."}]}, {"title": "986b98e6cfecc927756d5f24331a8bc3", "paragraphs": [{"qas": [{"question": "What are the effects of the COVID-19 vaccine?", "id": "100000000000000000002445", "answers": [{"text": "18", "answer_start": 295}], "is_impossible": false}, {"question": "What is the name of the vaccine that you can get for your child?", "id": "100000000000000000002446", "answers": [{"text": "COVID-19", "answer_start": 328}], "is_impossible": false}], "context": "Fever in pregnancy may be treated with\nacetaminophen as needed, in moderation, and in consultation with a healthcare provider. It is not recommended you take\nthese medicines before vaccination to try to prevent side effects. Learn about other ways to relieve side effects. \u2022 \uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\uf209\n- \uf209\n\u2022 \uf209 18\nLearn more about getting your COVID-19 vaccine. References\n1."}]}, {"title": "413aa3779dc2ee4fd8eb15597e7ff42a", "paragraphs": [{"qas": [{"question": "What is the acronym for American Society of Reproductive Medicine?", "id": "100000000000000000002447", "answers": [{"text": "ASRM", "answer_start": 43}], "is_impossible": false}, {"question": "What are the acronyms for American College of Obstetricians and Gynecologists?", "id": "100000000000000000002448", "answers": [{"text": "ACOG", "answer_start": 103}], "is_impossible": false}, {"question": "What is the name of the CDC Society for Maternal-Fetal Medicine?", "id": "100000000000000000002449", "answers": [{"text": "SMFM", "answer_start": 319}], "is_impossible": false}, {"question": "When is the date of the Joint Statement: Medical Experts Continue to Assert that COVID Vaccines Do Not Impact Fertility?", "id": "100000000000000000002450", "answers": [{"text": "February 5, 2021", "answer_start": 428}], "is_impossible": false}, {"question": "When is Fertility due?", "id": "100000000000000000002451", "answers": [{"text": "February 5, 2021", "answer_start": 428}], "is_impossible": false}, {"question": "What is the name of the American Academy of Pediatrics?", "id": "100000000000000000002452", "answers": [{"text": "AAP", "answer_start": 706}], "is_impossible": false}], "context": "American Society of Reproductive Medicine (ASRM), American College of Obstetricians and Gynecologists (ACOG) and the\nS i t f M t l F t l M di i (SMFM) I J i t St t t M di l E t C ti t A t th t COVID\f10/30/22, 9:29 AM COVID-19 Vaccines for People Who Would Like to Have a Baby | CDC\nSociety for Maternal-Fetal Medicine (SMFM) Issue Joint Statement: Medical Experts Continue to Assert that COVID\nVaccines Do Not Impact Fertility. February 5, 2021. Available at: https://www.asrm.org/news-and-publications/news-and-\nresearch/press-releases-and-bulletins/asrm-smfm-acog-issue-joint-statement-medical-experts-continue-to-assert-that-\ncovid-vaccines-do-not-impact-fertility/ . 2. American Academy of Pediatrics (AAP)."}]}, {"title": "c1a4e58a597fdb7c59bd88c6a5d399c4", "paragraphs": [{"qas": [{"question": "What is the acronym for the American College of Obstetricians and Gynecologists?", "id": "100000000000000000002454", "answers": [{"text": "ACOG", "answer_start": 173}], "is_impossible": false}, {"question": "What is ACOG's acronym for COVID-19 vaccination considerations for obstetric \u2013 gynaecologic care?", "id": "100000000000000000002455", "answers": [{"text": "American College of Obstetricians and Gynecologists", "answer_start": 120}], "is_impossible": false}, {"question": "Who is the ASRM?", "id": "100000000000000000002456", "answers": [{"text": "American Society for Reproductive Medicine", "answer_start": 405}], "is_impossible": false}, {"question": "What is the name of the UPDATE regarding COVID-19 Vaccination?", "id": "100000000000000000002458", "answers": [{"text": "UPDATE No. 16", "answer_start": 547}], "is_impossible": false}, {"question": "What is SMRU and SSMR?", "id": "100000000000000000002459", "answers": [{"text": "Society for Male Reproduction and Urology (SMRU) and Society for the Study of Male Reproduction", "answer_start": 740}], "is_impossible": false}, {"question": "What is available at https://www.asrm.org/news/and-for-male-reproduction-and-urology-smru and the-society for the study of male reproduction?", "id": "100000000000000000002461", "answers": [{"text": "Society for Male Reproduction and Urology (SMRU) and Society for the Study of Male Reproduction (SSMR). January 9, 2021", "answer_start": 740}], "is_impossible": false}, {"question": "What is the name of the FDA Briefing Document?", "id": "100000000000000000002462", "answers": [{"text": "Vaccines and Related Biological Products Advisory Committee Meeting", "answer_start": 1006}], "is_impossible": false}], "context": "About the COVID-19 Vaccine: Frequently Asked Questions. Available at:\ncovid-19-vaccine-frequently-asked-questions/ . 3. American College of Obstetricians and Gynecologists (ACOG). COVID-19 Vaccination Considerations for Obstetric\u2013\nGynecologic Care. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-\nvaccination-considerations-for-obstetric-gynecologic-care . 4. American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the\nCoronavirus (COVID-19) Pandemic: UPDATE No. 16 \u2013 Reproductive Facts Regarding COVID-19 Vaccination. Available at:\nhttps://www.asrm.org/covid-update-16 . 5. Joint Statement Regarding COVID-19 Vaccine in Men Desiring Fertility. Society for Male Reproduction and Urology (SMRU)\nand Society for the Study of Male Reproduction (SSMR). January 9, 2021. Available at https://www.asrm.org/news-and-\nfor-male-reproduction-and-urology-smru-and-the-society-for-the-study-of-male-reproduction-ssmr/ . 6. Vaccines and Related Biological Products Advisory Committee Meeting. FDA Briefing Document."}]}, {"title": "3127c965605b8d1d01a02bafb2581395", "paragraphs": [{"qas": [{"question": "What is the date of the Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19?", "id": "100000000000000000002463", "answers": [{"text": "February 26, 2021", "answer_start": 60}], "is_impossible": false}, {"question": "What is available at: https://www.fda.gov/media/146217/download?", "id": "100000000000000000002464", "answers": [{"text": "Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the Advisory Committee meeting held on December 17, 2020?", "id": "100000000000000000002465", "answers": [{"text": "Vaccines and Related Biological Products Advisory Committee", "answer_start": 498}], "is_impossible": false}, {"question": "What date is Moderna COVID-19 Vaccine available for purchase?", "id": "100000000000000000002466", "answers": [{"text": "December 17, 2020", "answer_start": 465}], "is_impossible": false}, {"question": "Who is the author of Preliminary Findings of mRNA Covid-19?", "id": "100000000000000000002467", "answers": [{"text": "Shimabukuro TT, Kim SY, Myers TR", "answer_start": 613}], "is_impossible": false}, {"question": "What is mRNA Covid-19 Vaccine Safety in Pregnant Persons?", "id": "100000000000000000002468", "answers": [{"text": "Preliminary Findings", "answer_start": 654}], "is_impossible": false}], "context": "Janssen Ad26.COV2.S\nVaccine for the Prevention of COVID-19. February 26, 2021. Available at: https://www.fda.gov/media/146217/download\n. 7. Vaccines and Related Biological Products Advisory Committee Meeting. FDA Briefing Document. Pfizer-BioNTech COVID-\n19 Vaccine. December 10, 2020. Available at: https://www.fda.gov/media/144245/download . 8. Vaccines and Related Biological Products Advisory Committee Meeting. FDA Briefing Document. Moderna COVID-19\nVaccine. December 17, 2020. Available at: Vaccines and Related Biological Products Advisory Committee December 17,\n2020 Meeting Briefing Document \u2013 FDA . 9. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons\n[published correction appears in N Engl J Med. 2021 Oct 14;385(16):1536]."}]}, {"title": "578f8a37c59832d76859460f3f5a376f", "paragraphs": [{"qas": [{"question": "What is the name of the Vaccination Coverage Among Pregnant Women During Pregnancy?", "id": "100000000000000000002470", "answers": [{"text": "COVID-19", "answer_start": 83}], "is_impossible": false}, {"question": "What does SARS-CoV-2 spike protein seropositivity from vaccination or infection not cause?", "id": "100000000000000000002471", "answers": [{"text": "sterility", "answer_start": 651}], "is_impossible": false}, {"question": "What is not caused by vaccination or infection?", "id": "100000000000000000002473", "answers": [{"text": "sterility", "answer_start": 651}], "is_impossible": false}], "context": "N Engl J Med. 2021;384(24):2273-2282. 10. Razzaghi H, Meghani M, Pingali C, et al. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy \u2014\nEight Integrated Health Care Organizations, United States, December 14, 2020\u2013May 8, 2021. MMWR Morb Mortal Wkly\nRep 2021;70:895\u2013899. DOI: http://dx.doi.org/10.15585/mmwr.mm7024e2 . 11. Aharon D, Lederman M, Ghofranian A, et al. In Vitro Fertilization and Early Pregnancy Outcomes After Coronavirus\nDisease 2019 (COVID-19) Vaccination [published online ahead of print, 2022 Jan 25]. Obstet Gynecol. 12. Morris RS. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility. F S Rep.\n13."}]}, {"title": "b92ec273c6d74826b69863534d26a76c", "paragraphs": [{"qas": [{"question": "When was the Reprod Biol Endocrinol published?", "id": "100000000000000000002475", "answers": [{"text": "2021 May 13", "answer_start": 199}], "is_impossible": false}, {"question": "What is the association between Menstrual Cycle Length and Coronavirus Disease 2019?", "id": "100000000000000000002477", "answers": [{"text": "COVID-19) Vaccination: A U.S. Cohort", "answer_start": 587}], "is_impossible": false}, {"question": "What year was the U.S. Cohort published?", "id": "100000000000000000002479", "answers": [{"text": "2022", "answer_start": 658}], "is_impossible": false}], "context": "Orvieto R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients\u2019\nperformance during IVF-ET cycle?. Reprod Biol Endocrinol. 2021;19(1):69. Published 2021 May 13. doi:10.1186/s12958-\n14. Wesselink AK, Hatch EE, Rothman KJ, et al. A prospective cohort study of COVID-19 vaccination, SARS-CoV-2 infection, and\nfertility [published online ahead of print, 2022 Jan 20]. Am J Epidemiol. 2022;kwac011. doi:10.1093/aje/kwac011\n15. Edelman A, Boniface ER, Benhar E, et al. Association Between Menstrual Cycle Length and Coronavirus Disease 2019\n(COVID-19) Vaccination: A U.S. Cohort [published online ahead of print, 2022 Jan 5]. Obstet Gynecol. 16."}]}, {"title": "c91c50cabab2df78da691c3d157f1ea9", "paragraphs": [{"qas": [{"question": "What is Trogstad's title?", "id": "100000000000000000002480", "answers": [{"text": "L", "answer_start": 10}], "is_impossible": false}, {"question": "Who is the author of Sperm Parameters Before and After Covid-19 mRNA vaccination?", "id": "100000000000000000002482", "answers": [{"text": "Gonzalez DC, Nassau DE, Khodamoradi K", "answer_start": 119}], "is_impossible": false}, {"question": "What is NE's history of febrile illness?", "id": "100000000000000000002483", "answers": [{"text": "Skakkebaek", "answer_start": 274}], "is_impossible": false}, {"question": "What is variation in semen quality?", "id": "100000000000000000002484", "answers": [{"text": "febrile illness", "answer_start": 300}], "is_impossible": false}], "context": "Trogstad, L. Increased Occurrence of Menstrual Disturbances in 18- to 30-Year-Old Women after COVID-19 Vaccination\n17. Gonzalez DC, Nassau DE, Khodamoradi K, et al. Sperm Parameters Before and After COVID-19 mRNA Vaccination. JAMA. 18. Carlsen E, Andersson AM, Petersen JH, Skakkebaek NE. History of febrile illness and variation in semen quality. Hum\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\n\uf209\nLast Updated July 14, 2022"}]}, {"title": "4ba1ecd061e0129873e59cf94711a680", "paragraphs": [{"qas": [{"question": "What has greatly reduced the risk of severe illness, hospitalization, and death from COVID-19 for many people?", "id": "100000000000000000002488", "answers": [{"text": "availability of tests and treatments", "answer_start": 255}], "is_impossible": false}, {"question": "What are some people who are older, immunocompromised, have certain disabilities, or have certain underlying health conditions at risk for?", "id": "100000000000000000002489", "answers": [{"text": "serious illness", "answer_start": 587}], "is_impossible": false}], "context": "10/30/22, 9:39 AM COVID-19 by County | CDC\nEspa\u00f1ol | Other Languages\nCOVID-19 by County\nMany people in the United States have some protection, or immunity, against COVID-19 due to vaccination, previous\ninfection, or both. This immunity, combined with the availability of tests and treatments, has greatly reduced the risk of\nsevere illness, hospitalization, and death from COVID-19 for many people. At the same time, some people\u2014such as those who are older, are immunocompromised, have certain disabilities, or have\ncertain underlying health conditions\u2014continue to be at higher risk for serious illness."}]}, {"title": "e412e5346a826a59f1474ae83d07730b", "paragraphs": [{"qas": [{"question": "What helps convey how much COVID-19 is impacting your community using data on hospitalizations and cases?", "id": "100000000000000000002493", "answers": [{"text": "COVID-19 Community Levels", "answer_start": 330}], "is_impossible": false}, {"question": "Using data on hospitalizations and cases, communities are classified as what?", "id": "100000000000000000002494", "answers": [{"text": "low, medium, or high", "answer_start": 622}], "is_impossible": false}], "context": "Learn more about the factors that can\naffect your risk of getting very sick from COVID-19 to better understand how COVID-19 could affect you and others around\nyou. Know Your COVID-19 Community Level\nTake action to protect yourself and others from COVID-19 based on the COVID-19 Community Level in your area. What You Need to Know\nCOVID-19 Community Levels help individuals and communities decide which prevention actions to take based on\nthe latest information. Each level helps convey how much COVID-19 is impacting your community using data on hospitalizations and\ncases. Using these data, communities are classified as low, medium, or high."}]}, {"title": "a853d067b9f4a199698a6d8c37a439b9", "paragraphs": [{"qas": [{"question": "What does CDC recommend you do to protect yourself and others from severe impacts of COVID-19?", "id": "100000000000000000002495", "answers": [{"text": "actions you can take", "answer_start": 31}], "is_impossible": false}, {"question": "How can people choose to wear a mask at the Community level?", "id": "100000000000000000002497", "answers": [{"text": "any time", "answer_start": 350}], "is_impossible": false}, {"question": "What are people allowed to wear at any time?", "id": "100000000000000000002498", "answers": [{"text": "a mask", "answer_start": 340}], "is_impossible": false}, {"question": "Who may require masks in other places?", "id": "100000000000000000002500", "answers": [{"text": "local or state authorities", "answer_start": 462}], "is_impossible": false}], "context": "For each level, CDC recommends actions you can take to help you protect yourself and others from severe impacts\nof COVID-19. \u2022\n\u2022\n\u2022\n\u2022\nFor Healthcare Facilities: Prevention actions in healthcare facilities, such as hospitals, rehabilitation centers, and\nnursing homes, are not linked to COVID-19 Community Levels. \uf313\nPeople may choose to wear a mask at any time. Masks are recommended in indoor public transportation settings and\nmay be required in other places by local or state authorities. COVID-19 County Check\nFind community levels and prevention steps by county. Data updated weekly."}]}, {"title": "4d2da4401f080ae3b9662e1984490c75", "paragraphs": [{"qas": [{"question": "Who should not be in contact with people who have asthma?", "id": "100000000000000000002503", "answers": [{"text": "people who have suspected or confirmed COVID-19", "answer_start": 364}], "is_impossible": false}, {"question": "Follow recommendations for what?", "id": "100000000000000000002505", "answers": [{"text": "isolation", "answer_start": 440}], "is_impossible": false}, {"question": "Do you have a high risk of getting very sick?", "id": "100000000000000000002506", "answers": [{"text": "If you are at high risk of getting very sick", "answer_start": 582}], "is_impossible": false}, {"question": "What should you do if you are at high risk of getting very sick?", "id": "100000000000000000002507", "answers": [{"text": "talk with a healthcare provider", "answer_start": 628}], "is_impossible": false}], "context": "Select a Location (all fields required)\nState County Go\f10/30/22, 9:39 AM COVID-19 by County | CDC\nIndividual-Level Prevention Steps You Can Take Based on Your\nCOVID-19 Community Level\nLOW, MEDIUM, AND HIGH\nAt all COVID-19 Community Levels:\nStay up to date on vaccination, including recommended booster doses. Maintain ventilation improvements. Avoid contact with people who have suspected or confirmed COVID-19. Follow recommendations for isolation if you have suspected or confirmed COVID-19. Follow the recommendations for what to do if you are exposed to someone with COVID-19. If you are at high risk of getting very sick, talk with a healthcare provider about additional\nprevention actions."}]}, {"title": "da591b49e91d1e83b8e31a67877a6f6c", "paragraphs": [{"qas": [{"question": "What is the COVID-19 Community Level?", "id": "100000000000000000002508", "answers": [{"text": "Medium", "answer_start": 65}], "is_impossible": false}, {"question": "What should you wear if you are at high risk of getting very sick?", "id": "100000000000000000002509", "answers": [{"text": "a high-quality mask or respirator", "answer_start": 132}], "is_impossible": false}, {"question": "If you have household or social contact with someone at risk, what should you do?", "id": "100000000000000000002510", "answers": [{"text": "MEDIUM AND HIGH When the COVID-19 Community Level is Medium or High: If you are at high risk of getting very sick, wear a high-quality mask or respirator (e.g., N95) when indoors in public If you have household or social contact with someone at high risk for getting very sick, consider self-testing to detect infection before contact, and consider wearing a high-quality mask when indoors with them", "answer_start": 12}], "is_impossible": false}, {"question": "What should you do if you are at high risk of getting very sick?", "id": "100000000000000000002511", "answers": [{"text": "avoiding non-essential indoor activities", "answer_start": 559}], "is_impossible": false}, {"question": "What should be worn when indoors with them?", "id": "100000000000000000002512", "answers": [{"text": "high-quality mask", "answer_start": 371}], "is_impossible": false}, {"question": "When the COVID-19 Community Level is High, wear a high quality mask or what?", "id": "100000000000000000002513", "answers": [{"text": "respirator", "answer_start": 492}], "is_impossible": false}, {"question": "If you are very sick, consider avoiding non-essential indoor activities where you could be exposed?", "id": "100000000000000000002514", "answers": [{"text": "\u2022 HIGH", "answer_start": 413}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nMEDIUM AND HIGH\nWhen the COVID-19 Community Level is Medium or High:\nIf you are at high risk of getting very sick, wear a high-quality mask or respirator (e.g., N95)\nwhen indoors in public\nIf you have household or social contact with someone at high risk for getting very sick, consider\nself-testing to detect infection before contact, and consider wearing a high-quality mask when\nindoors with them\n\u2022\n\u2022\nHIGH\nWhen the COVID-19 Community Level is High:\nWear a high-quality mask or respirator. If you are at high risk of getting very sick, consider avoiding non-essential indoor activities in\npublic where you could be exposed."}]}, {"title": "f4b39659f7c1a6e4b8508fc46bb6cc16", "paragraphs": [{"qas": [{"question": "What are the Community Levels and Making Public Health Recommendations?", "id": "100000000000000000002515", "answers": [{"text": "Science Brief", "answer_start": 105}], "is_impossible": false}, {"question": "What is LOW, MEDIUM, AND HIGH?", "id": "100000000000000000002516", "answers": [{"text": "Community-Level Prevention Strategies", "answer_start": 178}], "is_impossible": false}, {"question": "When the COVID-19 Community Level is Medium or High?", "id": "100000000000000000002519", "answers": [{"text": "10/30/22", "answer_start": 721}], "is_impossible": false}, {"question": "What is recommended in high-risk settings where screening testing is recommended?", "id": "100000000000000000002520", "answers": [{"text": "Implement screening testing", "answer_start": 764}], "is_impossible": false}], "context": "\u2022\n\u2022\nScience at CDC\nScientific evidence and studies behind specific COVID-19 guidance and recommendations\nScience Brief: Community Levels and Making Public Health Recommendations\nCommunity-Level Prevention Strategies\nLOW, MEDIUM, AND HIGH\nAt all COVID-19 Community Levels:\nPromote equitable access to vaccination, testing, masks and respirators, treatment and\nprevention medications, community outreach, and support services. Ensure access to testing, including through point-of-care and at-home tests for all people. Maintain ventilation improvements. Provide communications and messaging to encourage isolation among people who test\npositive. \u2022\n\u2022\n\u2022\n\u2022\nMEDIUM AND HIGH\nWhen the COVID-19 Community Level is Medium or High:\f10/30/22, 9:39 AM COVID-19 by County | CDC\nImplement screening testing in high-risk settings where screening testing is recommended."}]}, {"title": "719f21defe7aa787eced7a263b7a463", "paragraphs": [{"qas": [{"question": "When the COVID-19 Community Level is High: Implement healthcare surge support as needed?", "id": "100000000000000000002521", "answers": [{"text": "HIGH", "answer_start": 1}], "is_impossible": false}, {"question": "For Public Health Professionals Scientific Brief: Indicators for Monitoring what?", "id": "100000000000000000002522", "answers": [{"text": "COVID-19 Community Levels", "answer_start": 176}], "is_impossible": false}], "context": "\u2022\nHIGH\nWhen the COVID-19 Community Level is High:\nImplement healthcare surge support as needed. \u2022\n\uf348 For Public Health Professionals\nScientific Brief:\u202fIndicators\u202ffor Monitoring COVID-19 Community Levels and Making Public Health\nRecommendations\nTechnical Presentation: Indicators for Monitoring COVID-19 Community Levels and Implementing\nPrevention Strategies [5 MB, 28 pages]\n\u2022\n\u2022\n\uf20c\nLast Updated Aug. 11, 2022"}]}, {"title": "a0b0c641489563bd49fc69402fe0c49c", "paragraphs": [{"qas": [{"question": "What is the Interim COVID-19 Immunization Schedule for Persons 6 Months of Age and Older?", "id": "100000000000000000002523", "answers": [{"text": "vaccination schedules", "answer_start": 128}], "is_impossible": false}, {"question": "The following tables provide guidance for what?", "id": "100000000000000000002524", "answers": [{"text": "COVID-19 vaccination schedules", "answer_start": 119}], "is_impossible": false}], "context": "Interim COVID-19 Immunization Schedule\nfor Persons 6 Months of Age and Older\nThe following tables provide guidance for COVID-19 vaccination schedules based on age and medical condition and vaccine composition. Table 1."}]}, {"title": "e76d82e6b55ee4ea699c7367b65770ed", "paragraphs": [{"qas": [{"question": "What is the Immunization Schedule for Children 6 Months through 17 Years of Age* Type Recipient Age Product For Most People Those Who ARE Moderate or Severely Immunocompromised Doses Interval Between Doses mRNA vaccine through MONOVALENT Moderna: Blue vial cap with magenta-bordered label Primary series: Monovalent Dose 1 to 2 At least 4\u20138 weeks", "id": "100000000000000000002525", "answers": [{"text": "Monovalent", "answer_start": 512}], "is_impossible": false}, {"question": "Dose 2 to 3 At least 4 weeks through MONOVALENT Moderna: Blue vial cap with purple-bordered label What is the primary series of monovalent dosing?", "id": "100000000000000000002526", "answers": [{"text": "Monovalent", "answer_start": 326}], "is_impossible": false}, {"question": "How long does it take to do Monovalent Dosing 1 to 2 at least 4\u20138 weeks?", "id": "100000000000000000002527", "answers": [{"text": "BIVALENT Moderna: Blue vial cap with gray-bordered label Booster dose: Bivalent", "answer_start": 612}], "is_impossible": false}, {"question": "What is the primary series of Monovalent Dose 1 to 2?", "id": "100000000000000000002528", "answers": [{"text": "MONOVALENT Novavax", "answer_start": 2127}], "is_impossible": false}, {"question": "What is a Booster dose?", "id": "100000000000000000002530", "answers": [{"text": "Bivalent", "answer_start": 2004}], "is_impossible": false}, {"question": "What is a secondary series of monovalent dosing?", "id": "100000000000000000002532", "answers": [{"text": "BIVALENT", "answer_start": 1560}], "is_impossible": false}, {"question": "What is the name of the vial cap that MONOVALENT Pfizer-BioNTech: Maroon with maroon-bordered label Primary series: Monovalent Dose 1 to 2 At least 3\u20138 weeks", "id": "100000000000000000002533", "answers": [{"text": "Blue", "answer_start": 267}], "is_impossible": false}, {"question": "What Pfizer-BioNTech: Orange vial cap with orange-bordered label Primary series: Monovalent Dose 1 to 2 At least 3\u20138 weeks", "id": "100000000000000000002534", "answers": [{"text": "BIVALENT", "answer_start": 1561}], "is_impossible": false}, {"question": "How long is the Booster dose?", "id": "100000000000000000002536", "answers": [{"text": "8 weeks", "answer_start": 2034}], "is_impossible": false}, {"question": "How long does it take to get a Bivalent Dose 2 to 3?", "id": "100000000000000000002538", "answers": [{"text": "8 weeks", "answer_start": 2034}], "is_impossible": false}, {"question": "What is another name for the Novavax Primary series?", "id": "100000000000000000002539", "answers": [{"text": "Monovalent", "answer_start": 2162}], "is_impossible": false}], "context": "Immunization Schedule for Children 6 Months through 17 Years of Age*\nType\nRecipient\nAge\nProduct\u2020\nFor Most People\nThose Who ARE Moderately or\nSeverely Immunocompromised\nDoses Interval Between Doses\u2021 Doses Interval Between Doses\nmRNA\nvaccine\nthrough\nMONOVALENT Moderna:\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks\u00b6\nDose 1 to 2 At least 4 weeks\nDose 2 to 3 At least 4 weeks\nthrough\nMONOVALENT Moderna:\nBlue vial cap with\npurple-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks\u00b6\nDose 1 to 2 At least 4 weeks\nDose 2 to 3 At least 4 weeks\nBIVALENT Moderna:\nBlue vial cap with\ngray-bordered label\nBooster dose: Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months)\nthrough\nMONOVALENT Moderna:\nRed vial cap with\nblue-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks\u00b6\nDose 1 to 2 At least 4 weeks\nDose 2 to 3 At least 4 weeks\nBIVALENT Moderna:\nBlue vial cap with\ngray-bordered label\nBooster dose: Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months)\nthrough\nMONOVALENT Pfizer-BioNTech:\nMaroon vial cap with\nmaroon-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 3\u20138 weeks\u00b6 Dose 1 to 2 At least 3 weeks\nDoses 2 and 3 At least 8 weeks (2 months) Dose 2 to 3 At least 8 weeks (2 months)\nthrough\nMONOVALENT Pfizer-BioNTech:\nOrange vial cap with\norange-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 3\u20138 weeks\u00b6\nDose 1 to 2 At least 3 weeks\nDose 2 to 3 At least 4 weeks\nBIVALENT Pfizer-BioNTech:\nOrange vial cap with\norange-bordered label\nBooster dose: Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months)\nthrough\nMONOVALENT Pfizer-BioNTech:\nGray vial cap with\ngray-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 3-8 weeks\u00b6\nDose 1 to 2 At least 3 weeks\nDose 2 to 3 At least 4 weeks\nBIVALENT Pfizer-BioNTech:\nGray vial cap with\ngray-bordered label\nBooster dose: Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months)\nProtein\nsubunit\nvaccine\nand older\nMONOVALENT Novavax\nPrimary series: Monovalent\nDose 1 to 2 At least 3\u20138 weeks\u00b6 Dose 1 to 2 At least 3 weeks\nmRNA (Moderna, Pfizer-\nBioNTech) should be used for the\nbooster dose."}]}, {"title": "c2de9c0f4668ea75ff375513ea3d24c3", "paragraphs": [{"qas": [{"question": "What is a special situation when vaccinating children?", "id": "100000000000000000002541", "answers": [{"text": "those who have a birthday before completing the primary series or booster dose", "answer_start": 179}], "is_impossible": false}, {"question": "How long does it take for a child to get a booster dose?", "id": "100000000000000000002542", "answers": [{"text": "8 weeks (2 months) Dose 2 to 3 At least 8 weeks", "answer_start": 44}], "is_impossible": false}, {"question": "What is the maximum duration of a dose of COVID-19?", "id": "100000000000000000002543", "answers": [{"text": "8 weeks", "answer_start": 44}], "is_impossible": false}, {"question": "How long after the first dose of COVID-19 vaccine can any age-appropriate monovalent vaccine be administered?", "id": "100000000000000000002544", "answers": [{"text": "28 days", "answer_start": 573}], "is_impossible": false}, {"question": "What is the primary series or booster dose?", "id": "100000000000000000002545", "answers": [{"text": "Bivalent Dose 2 to 3", "answer_start": 14}], "is_impossible": false}, {"question": "If the product previously administered cannot be determined, is no longer available, or is contraindicated, what can be done?", "id": "100000000000000000002547", "answers": [{"text": "any age-appropriate monovalent COVID-19 vaccine may be administered at least 28 days after the first dose to complete the primary series", "answer_start": 496}], "is_impossible": false}], "context": "Booster dose: Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 2 to 3 At least 8 weeks (2 months)\n* Guidance related to special situations when vaccinating children, such as those who have a birthday before completing the primary series or booster dose, see Special Situations for COVID-19\nVaccination of Children and Adolescents\n\u2020 Complete the primary series with same product. If the vaccine product previously administered cannot be determined, is no longer available or contraindicated, any age-appropriate\nmonovalent COVID-19 vaccine may be administered at least 28 days after the first dose to complete the primary series."}]}, {"title": "9d409afbe041eb5902c9d3fbf0123496", "paragraphs": [{"qas": [{"question": "What can be administered for the bivalent booster dose?", "id": "100000000000000000002549", "answers": [{"text": "Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "What is a positive test for if infection was asymptomatic?", "id": "100000000000000000002551", "answers": [{"text": "delaying a primary series or booster dose", "answer_start": 204}], "is_impossible": false}, {"question": "How many doses of Pfizer Bio-NTech bivalent booster are given to children?", "id": "100000000000000000002552", "answers": [{"text": "1", "answer_start": 340}], "is_impossible": false}, {"question": "What is the primary series of Moderna COVID-19 vaccine?", "id": "100000000000000000002553", "answers": [{"text": "bivalent booster dose", "answer_start": 81}], "is_impossible": false}], "context": "Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine can be\nadministered for the bivalent booster dose, regardless of the primary series product. \u2021 Persons with a recent SARS-CoV-2 infection may consider delaying a primary series or booster dose by 3 months from symptom onset or positive test (if infection was asymptomatic). \u00a7 Administer 1 Pfizer Bio-NTech bivalent booster dose to children age 5 years who have completed a primary series of Moderna COVID-19 vaccine."}]}, {"title": "142914859998ebcc4fa65fcc60d4e39a", "paragraphs": [{"qas": [{"question": "How long is the interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines?", "id": "100000000000000000002554", "answers": [{"text": "8-week", "answer_start": 5}], "is_impossible": false}, {"question": "What may be optimal for some people ages 6 months to 64 years?", "id": "100000000000000000002555", "answers": [{"text": "An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines", "answer_start": 2}], "is_impossible": false}, {"question": "In situations where there is increased concern about COVID-19 community levels or an individual\u2019s higher risk of severe disease?", "id": "100000000000000000002559", "answers": [{"text": "8-week interval between the first and second primary series doses", "answer_start": 5}], "is_impossible": false}], "context": "\u00b6 An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines may be optimal for some people ages 6 months\u201364\nyears, especially for males ages 12\u201339 years, as it may reduce the small risk of myocarditis and pericarditis associated with these vaccines. A shorter interval (4 weeks for Moderna) between the\nfirst and second doses remains the recommended interval for people who are moderately or severely immunocompromised; adults ages 65 years and older; and in situations in which there is\nincreased concern about COVID-19 community levels or an individual\u2019s higher risk of severe disease."}]}, {"title": "a3e732581c46078608c4fe7ee9e18a99", "paragraphs": [{"qas": [{"question": "How long does it take to get the mRNA vaccine?", "id": "100000000000000000002561", "answers": [{"text": "8 weeks", "answer_start": 479}], "is_impossible": false}, {"question": "What is the primary series of doses?", "id": "100000000000000000002562", "answers": [{"text": "Monovalent", "answer_start": 306}], "is_impossible": false}, {"question": "How long is the Booster dose?", "id": "100000000000000000002563", "answers": [{"text": "8 weeks", "answer_start": 479}], "is_impossible": false}, {"question": "Which vaccine has a blue border on it?", "id": "100000000000000000002564", "answers": [{"text": "Moderna", "answer_start": 404}], "is_impossible": false}, {"question": "How long is the BIVALENT Moderna Blue cap with gray-bordered label Booster dose?", "id": "100000000000000000002565", "answers": [{"text": "8 weeks", "answer_start": 479}], "is_impossible": false}, {"question": "What type of vaccine should be used for the booster dose?", "id": "100000000000000000002567", "answers": [{"text": "COVID-19", "answer_start": 973}], "is_impossible": false}, {"question": "How long does it take to get a bivalent COVID-19 vaccine?", "id": "100000000000000000002568", "answers": [{"text": "BIVALENT Pfizer-BioNTech: Gray vial cap with gray-bordered label Booster dose\u00a7: Bivalent At least 8 weeks At least 8 weeks Protein subunit vaccine and older MONOVALENT Novavax Primary series: Monovalent At least 3\u20138 weeks\u2021 Dose 1 to 2 At least 3 weeks Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine should be used for the booster dose", "answer_start": 684}], "is_impossible": false}], "context": "Immunization Schedule for Persons 18 Years of Age\nType\nRecipient\nAge\nProduct*\nFor Most People\nThose Who ARE Moderately or\nSeverely Immunocompromised\nDoses\nInterval Between\nDoses\u2020\nDoses\nInterval Between\nDoses\nmRNA\nvaccine\nand older\nMONOVALENT Moderna\nRed vial cap with a\nblue-bordered label\nPrimary series: Monovalent\nAt least 4\u20138\nweeks\u2021\nDose 1 to 2 At least 4 weeks\nDose 2 to 3 At least 4 weeks\nBIVALENT Moderna\nBlue cap with\ngray-bordered label\nBooster dose\u00a7: Bivalent\nAt least 8 weeks\nAt least 8 weeks\nand older\nMONOVALENT Pfizer-BioNTech\nGray vial cap with\ngray-bordered label\nPrimary series: Monovalent\nAt least 3-8\nweeks\u2021\nDose 1 to 2 At least 3 weeks\nDose 2 to 3 At least 4 weeks\nBIVALENT Pfizer-BioNTech:\nGray vial cap with\ngray-bordered label\nBooster dose\u00a7: Bivalent\nAt least 8 weeks\nAt least 8 weeks\nProtein\nsubunit\nvaccine\nand older\nMONOVALENT Novavax\nPrimary series: Monovalent\nAt least 3\u20138\nweeks\u2021\nDose 1 to 2 At least 3 weeks\nModerna or Pfizer-BioNTech\nbivalent COVID-19 vaccine should\nbe used for the booster dose."}]}, {"title": "d14fe26eef0f104f67c2bb69b2837ba1", "paragraphs": [{"qas": [{"question": "What should be used for the booster dose?", "id": "100000000000000000002570", "answers": [{"text": "Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine", "answer_start": 220}], "is_impossible": false}, {"question": "What is authorized for use in limited situations?", "id": "100000000000000000002572", "answers": [{"text": "MONOVALENT Janssen Janssen COVID-19 vaccine", "answer_start": 93}], "is_impossible": false}, {"question": "How long after the previous dose is the COVID-19 vaccine given?", "id": "100000000000000000002573", "answers": [{"text": "8 weeks", "answer_start": 376}], "is_impossible": false}, {"question": "What is the minimum amount of time needed to complete the primary series?", "id": "100000000000000000002574", "answers": [{"text": "8 weeks At least 8 weeks Adenovius vector vaccine and older MONOVALENT Janssen Janssen COVID-19 vaccine is authorized for use in certain limited situations due to safety considerations.\u00b6 Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine should be used for the booster dose. Booster dose\u00a7: Bivalent Administer a single booster dose at least 8 weeks (2 months", "answer_start": 33}], "is_impossible": false}, {"question": "How many days after the first dose can any age-appropriate monovalent vaccine be administered?", "id": "100000000000000000002575", "answers": [{"text": "28", "answer_start": 658}], "is_impossible": false}, {"question": "How long after the first dose does it take to complete the primary series?", "id": "100000000000000000002577", "answers": [{"text": "28 days", "answer_start": 658}], "is_impossible": false}], "context": "Booster dose\u00a7: Bivalent\nAt least 8 weeks\nAt least 8 weeks\nAdenovius\nvector\nvaccine\nand older\nMONOVALENT Janssen\nJanssen COVID-19 vaccine is authorized for use in certain limited situations\ndue to safety considerations.\u00b6\nModerna or Pfizer-BioNTech\nbivalent COVID-19 vaccine should\nbe used for the booster dose. Booster dose\u00a7: Bivalent\nAdminister a single booster dose at least 8 weeks (2 months) after the\nprevious dose. * Complete the primary series with same product. If the vaccine product previously administered cannot be determined, is no longer available or contraindicated, any age-appropriate monovalent\nCOVID-19 vaccine may be administered at least 28 days after the first dose to complete the primary series."}]}, {"title": "94af9ac02153b74e432d2f07ba66bf", "paragraphs": [{"qas": [{"question": "Who can administer the COVID-19 vaccine for the booster dose?", "id": "100000000000000000002578", "answers": [{"text": "Moderna or Pfizer-BioNTech", "answer_start": 0}], "is_impossible": false}, {"question": "How long can people with a recent SARS-CoV-2 infection consider delaying a primary series or booster dose by?", "id": "100000000000000000002579", "answers": [{"text": "3 months", "answer_start": 240}], "is_impossible": false}, {"question": "What is the term for an 8-week delay from symptom onset?", "id": "100000000000000000002580", "answers": [{"text": "primary series doses", "answer_start": 368}], "is_impossible": false}, {"question": "What is the interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines optimal for?", "id": "100000000000000000002581", "answers": [{"text": "8-week", "answer_start": 323}], "is_impossible": false}, {"question": "What may reduce the small risk of myocarditis in males ages 12 to 39 years?", "id": "100000000000000000002582", "answers": [{"text": "An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines", "answer_start": 320}], "is_impossible": false}, {"question": "What may reduce the small risk of myocarditis?", "id": "100000000000000000002583", "answers": [{"text": "An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines", "answer_start": 320}], "is_impossible": false}, {"question": "What may be associated with the vaccines?", "id": "100000000000000000002584", "answers": [{"text": "myocarditis and pericarditis", "answer_start": 577}], "is_impossible": false}], "context": "Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine can be administered for the booster\ndose, regardless of the primary series product. \u2020 Persons with a recent SARS-CoV-2 infection may consider delaying a primary series or booster dose by 3 months from symptom onset or positive test (if infection was asymptomatic). \u2021 An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines may be optimal for some people ages 6 months\u201364\nyears, especially for males ages 12\u201339 years, as it may reduce the small risk of myocarditis and pericarditis associated with these vaccines."}]}, {"title": "f2c2f50b0984960ad89f56b4a072ace9", "paragraphs": [{"qas": [{"question": "What age group is recommended for people who are moderately or severely immunocompromised?", "id": "100000000000000000002586", "answers": [{"text": "65 years and older", "answer_start": 182}], "is_impossible": false}, {"question": "What does Novavax do instead of a bivalent mRNA booster dose?", "id": "100000000000000000002587", "answers": [{"text": "A single Novavax booster dose", "answer_start": 340}], "is_impossible": false}, {"question": "What may be given to persons 18 years of age or older who have not received a booster dose in limited situations?", "id": "100000000000000000002588", "answers": [{"text": "A single Novavax booster dose", "answer_start": 340}], "is_impossible": false}], "context": "A shorter interval (4 weeks for Moderna) between the\nfirst and second doses remains the recommended interval for people who are moderately or severely immunocompromised; adults ages 65 years and older; and in situations in which there is\nincreased concern about COVID-19 community levels or an individual\u2019s higher risk of severe disease. \u00a7 A single Novavax booster dose (instead of a bivalent mRNA booster dose) may be given to persons 18 years of age or older who have not received a previous booster dose in limited\nsituations."}]}, {"title": "9104f42d534f2ba8c85f80c2fecc19bc", "paragraphs": [{"qas": [{"question": "Is an mRNA vaccine contraindicated or not available?", "id": "100000000000000000002589", "answers": [{"text": "1. an mRNA vaccine is contraindicated, or not available", "answer_start": 21}], "is_impossible": false}, {"question": "Is the recipient unwilling or unwilling to receive a booster dose?", "id": "100000000000000000002590", "answers": [{"text": "unwilling", "answer_start": 100}], "is_impossible": false}], "context": "These situations are 1. an mRNA vaccine is contraindicated, or not available or 2. the recipient is unwilling to receive an mRNA vaccine and would otherwise not receive a booster\ndose. Administer the booster dose at least 6 months after the last primary series dose."}]}, {"title": "bd96be1302ca7f960fc7c2e35e9e5a66", "paragraphs": [{"qas": [{"question": "What is the name of the CDC resource for the use of COVID-19 vaccines?", "id": "100000000000000000002592", "answers": [{"text": "Interim Clinical Considerations", "answer_start": 252}], "is_impossible": false}, {"question": "What is CDC's guidance on use of Janssen vaccine?", "id": "100000000000000000002593", "answers": [{"text": "retrospective record review, scheduling and administration", "answer_start": 45}], "is_impossible": false}, {"question": "What is the current approval status of COVID-19 vaccines in the United States?", "id": "100000000000000000002594", "answers": [{"text": "Currently Approved or Authorized", "answer_start": 317}], "is_impossible": false}, {"question": "What does the CDC Vaccine Storage and Handling Toolkit contain?", "id": "100000000000000000002595", "answers": [{"text": "Interim COVID-19 Immunization Schedule", "answer_start": 458}], "is_impossible": false}, {"question": "Whose age is required to receive the correct vaccine?", "id": "100000000000000000002596", "answers": [{"text": "6 Months of Age and Older", "answer_start": 509}], "is_impossible": false}, {"question": "How long can a person be given the same vaccine as a child?", "id": "100000000000000000002597", "answers": [{"text": "on the same day", "answer_start": 670}], "is_impossible": false}], "context": "\u00b6 For guidance on use of Janssen vaccine and retrospective record review, scheduling and administration see Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendix A\nCDC Resources\nCDC COVID-19 vaccine clinical training and materials\nCDC Interim Clinical Considerations for the Use of COVID-19 Vaccines Currently Approved or Authorized in the United States\nCDC Vaccine administration clinical materials\nCDC Vaccine Storage and Handling Toolkit\fInterim COVID-19 Immunization Schedule\nfor Persons 6 Months of Age and Older\n\u0083 Administer the correct vaccine product based on the recipient\u2019s\nage and vaccine composition. \u0083 COVID-19 vaccines may be administered on the same day as\nother routinely recommended vaccines, including influenza\nvaccine. Table 3."}]}, {"title": "80a0878776484c77cbd84019d2db05d5", "paragraphs": [{"qas": [{"question": "What is the primary dose of MONOVALENT?", "id": "100000000000000000002599", "answers": [{"text": "100 \u00b5g/ 0.5 mL", "answer_start": 571}], "is_impossible": false}, {"question": "How many doses of BIVALENT are in the primary series?", "id": "100000000000000000002600", "answers": [{"text": "3", "answer_start": 862}], "is_impossible": false}, {"question": "What is a Booster dose?", "id": "100000000000000000002601", "answers": [{"text": "10 \u00b5g/0.2 mL", "answer_start": 1186}], "is_impossible": false}, {"question": "How much sodium chloride does MONOVALENT contain?", "id": "100000000000000000002602", "answers": [{"text": "years", "answer_start": 1115}], "is_impossible": false}, {"question": "What is the primary series dose of BIVALENT?", "id": "100000000000000000002603", "answers": [{"text": "30 \u00b5g", "answer_start": 1324}], "is_impossible": false}, {"question": "How long is the cap with gray-bordered label?", "id": "100000000000000000002604", "answers": [{"text": "years", "answer_start": 418}], "is_impossible": false}, {"question": "Which brand has a maroon vial cap?", "id": "100000000000000000002605", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 704}], "is_impossible": false}, {"question": "What color label does MONOVALENT Pfizer-BioNTech: Orange vial cap with a maroon-bordered label years sodium chloride (normal saline, preservative-free)?", "id": "100000000000000000002606", "answers": [{"text": "Gray", "answer_start": 1227}], "is_impossible": false}, {"question": "What is the name of the cap with a gray-bordered label 12 years and older NONE Any dose in the primary series or as a single booster dose, in limited situations, for persons 18 years of age or older?", "id": "100000000000000000002607", "answers": [{"text": "Novavax", "answer_start": 1488}], "is_impossible": false}, {"question": "What is authorized for use in limited situations?", "id": "100000000000000000002608", "answers": [{"text": "COVID-19 vaccine", "answer_start": 1769}], "is_impossible": false}, {"question": "What is the dose for persons 18 years of age or older?", "id": "100000000000000000002609", "answers": [{"text": "5 \u00b5g rS and 50 \u00b5g of Matrix-M\u2122", "answer_start": 1656}], "is_impossible": false}, {"question": "How much of the Matrix-MTM Viral vector vaccine is required?", "id": "100000000000000000002610", "answers": [{"text": "50 \u00b5g", "answer_start": 1668}], "is_impossible": false}], "context": "COVID-19 Vaccine Products Summary\nType Product*\nAge\nIndications\u2020\nDiluent Use For:\nDose/Injection\nAmount\nmRNA\nvaccine\nMONOVALENT Moderna:\nBlue vial cap with\nmagenta-bordered label\nthrough 5 years\nNONE Any dose in the primary series 25 \u00b5g/ 0.25 mL\nMONOVALENT Moderna:\nBlue vial cap with\npurple-bordered label\nyears\nNONE Any dose in the primary series 50 \u00b5g/0.5 mL\nBIVALENT Moderna:\nBlue vial cap with\ngray-bordered label\nyears\nNONE Booster dose 25 \u00b5g/0.25 mL\nMONOVALENT Moderna:\nRed vial cap with\nblue- bordered label\n12 years and\nolder\nNONE Any dose in the primary series 100 \u00b5g/ 0.5 mL\nBIVALENT Moderna:\nBlue vial cap with\ngray-bordered label\n12 years and\nolder\nNONE Booster dose 50 \u00b5g/0.5 mL\nMONOVALENT\nPfizer-BioNTech:\nMaroon vial cap with\nmaroon-bordered label\nthrough 4 years\nsodium chloride\n(normal saline,\npreservative-free)\nAny dose in the primary series 3 \u00b5g/0.2 mL\nMONOVALENT\nPfizer-BioNTech:\nOrange vial cap with\norange-bordered label\nyears\nsodium chloride\n(normal saline,\npreservative-free)\nAny dose in the primary series 10 \u00b5g/0.2 mL\nBIVALENT\nPFIZER-BIONTECH\nOrange vial cap with a\norange-bordered label\nyears\nsodium chloride\n(normal saline,\npreservative-free)\nBooster dose 10 \u00b5g/0.2 mL\nMONOVALENT\nPfizer-BioNTech:\nGray vial cap with a\ngray- bordered label\n12 years and\nolder\nNONE Any dose in the primary series 30 \u00b5g/0.3 mL\nBIVALENT\nPfizer-BioNTech:\nGray vial cap with\ngray-bordered label\n12 years and\nolder\nNONE Booster dose 30 \u00b5g/0.3 mL\nProtein\nsub\nunit\nvaccine\nMONOVALENT\nNovavax:\nRoyal blue cap\n12 years and\nolder\nNONE\nAny dose in the primary series or as a single\nbooster dose, in limited situations, for\npersons 18 years of age or older\n5 \u00b5g rS and 50\n\u00b5g of Matrix-M\u2122\nViral\nvector\nvaccine\nMONOVALENT Janssen:\nBlue Cap\n18 years and\nolder\nNONE\nJanssen COVID-19 vaccine is authorized\nfor use in certain limited situations due to\nsafety considerations.\u2021\n* Complete the primary series with same product."}]}, {"title": "4af61ae4a908862a300d9c214573a2fc", "paragraphs": [{"qas": [{"question": "How long after the first dose can any age-appropriate monovalent COVID-19 vaccine be administered?", "id": "100000000000000000002611", "answers": [{"text": "28 days", "answer_start": 189}], "is_impossible": false}, {"question": "What type of vaccine can be administered for the booster dose?", "id": "100000000000000000002612", "answers": [{"text": "Age-appropriate Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine", "answer_start": 250}], "is_impossible": false}, {"question": "What type of vaccine can be given for the booster dose?", "id": "100000000000000000002613", "answers": [{"text": "Age-appropriate Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine", "answer_start": 250}], "is_impossible": false}, {"question": "How can COVID-19 vaccine be administered?", "id": "100000000000000000002614", "answers": [{"text": "at least 28 days after the first dose to complete the primary series. Age-appropriate Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine can be administered for the booster dose", "answer_start": 180}], "is_impossible": false}, {"question": "What should be used to determine the appropriate vaccine?", "id": "100000000000000000002615", "answers": [{"text": "based on the recipient\u2019s age and the vaccine product's age indications", "answer_start": 448}], "is_impossible": false}, {"question": "What is the name of the appendix to the Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendix A?", "id": "100000000000000000002616", "answers": [{"text": "Janssen vaccine", "answer_start": 545}], "is_impossible": false}], "context": "If the vaccine product previously administered cannot be determined, is no longer available or contraindicated, any age-appropriate monovalent\nCOVID-19 vaccine may be administered at least 28 days after the first dose to complete the primary series. Age-appropriate Moderna or Pfizer-BioNTech bivalent COVID-19 vaccine can be administered\nfor the booster dose, regardless of the primary series product. \u2020 Administer the appropriate vaccine product based on the recipient\u2019s age and the vaccine product's age indications. \u2021 For guidance on use of Janssen vaccine and retrospective record review, scheduling and administration see Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendix A"}]}, {"title": "a168bdcf83c1130b7e121f7c303d253", "paragraphs": [{"qas": [{"question": "What happens after the mRNA delivers the instructions to your cells?", "id": "100000000000000000002619", "answers": [{"text": "your cells break it down and get rid of it", "answer_start": 366}], "is_impossible": false}, {"question": "What can happen when your body responds to the vaccine?", "id": "100000000000000000002620", "answers": [{"text": "sometimes cause a mild fever, headache, or chills", "answer_start": 466}], "is_impossible": false}, {"question": "If you have a mild fever, headache, or chills, what is it?", "id": "100000000000000000002621", "answers": [{"text": "Antibody When your body responds to the vaccine", "answer_start": 410}], "is_impossible": false}, {"question": "What is a sign that the vaccine is working?", "id": "100000000000000000002623", "answers": [{"text": "Antibody", "answer_start": 410}], "is_impossible": false}], "context": "The vaccine is made of mRNA\nwrapped in a coating that makes\ndelivery easy and keeps the body\nfrom damaging it. How does the\nvaccine work? The mRNA in the vaccine teaches\nyour cells how to make copies\nof the spike protein. If you are\nexposed to the real virus later,\nyour body will recognize it and\nknow how to fight it off. After the mRNA delivers the\ninstructions, your cells break\nit down and get rid of it. Antibody\nWhen your body\nresponds to the\nvaccine, it can\nsometimes cause a\nmild fever, headache,\nor chills. This is\ncompletely normal\nand a sign that the\nvaccine is working. GETTING VACCINATED?"}]}, {"title": "58308821c41d3b051ea70ee4a1101a31", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that causes COVID-19?", "id": "100000000000000000002624", "answers": [{"text": "Coronaviruses", "answer_start": 264}], "is_impossible": false}, {"question": "What do Coronaviruses have on their surface called?", "id": "100000000000000000002625", "answers": [{"text": "spike proteins", "answer_start": 375}], "is_impossible": false}, {"question": "What are spike proteins on their surface called?", "id": "100000000000000000002626", "answers": [{"text": "Coronaviruses", "answer_start": 264}], "is_impossible": false}, {"question": "Are spike proteins ideal targets for vaccines?", "id": "100000000000000000002627", "answers": [{"text": "Coronaviruses, like the one that causes COVID-19, are named for the crown-like spikes on their surface, called spike proteins. These spike proteins are ideal targets", "answer_start": 264}], "is_impossible": false}, {"question": "What is messenger RNA?", "id": "100000000000000000002628", "answers": [{"text": "genetic material that tells your body how to make proteins", "answer_start": 485}], "is_impossible": false}], "context": "For information about COVID-19 vaccine,\nvisit: cdc.gov/coronavirus/vaccines\nThe vaccine DOES\nNOT contain ANY\nvirus, so it cannot\ngive you COVID-19. It cannot change\nyour DNA in any way. How mRNA COVID-19\nVaccines Work\nUnderstanding\nthe virus that\ncauses COVID-19. Coronaviruses, like the one that\ncauses COVID-19, are named for\nthe crown-like spikes on their\nsurface, called spike proteins. These spike proteins are ideal\ntargets for vaccines. What is mRNA? Messenger RNA, or mRNA, is\ngenetic material that tells your\nbody how to make proteins. What is in the vaccine?"}]}, {"title": "432050677905f863f55e7be9625c290d", "paragraphs": [{"qas": [{"question": "What is the name of the disease that affects a person in a non-health care setting?", "id": "100000000000000000002629", "answers": [{"text": "COVID-19", "answer_start": 203}], "is_impossible": false}, {"question": "How do you care for someone with COVID-19 at home?", "id": "100000000000000000002630", "answers": [{"text": "to protect yourself and others", "answer_start": 271}], "is_impossible": false}, {"question": "What should you do when someone has symptoms of COVID-19?", "id": "100000000000000000002631", "answers": [{"text": "follow this advice to protect yourself and others", "answer_start": 252}], "is_impossible": false}], "context": "10/30/22, 9:41 AM COVID19 - Caring for someone at home | CDC\nEspa\u00f1ol | Other Languages\nCaring for Someone Sick at Home\nAdvice for caregivers in non-healthcare settings\nIf you are caring for someone with COVID-19 at home or in a non-healthcare setting, follow this advice to protect yourself and\nothers. Learn what to do when someone has symptoms of COVID-19 or when someone has been diagnosed with the virus. This information also should be followed when caring for people who have tested positive but are not showing symptoms."}]}, {"title": "54efdd623dec2ee2825f83cc047c3e5e", "paragraphs": [{"qas": [{"question": "What are older adults and people of any age with serious underlying medical conditions at higher risk for developing more severe illness from COVID-19?", "id": "100000000000000000002633", "answers": [{"text": "*Note: Older adults and people of any age with serious underlying medical conditions are at higher risk for developing more severe illness from COVID-19. People at higher risk of severe illness should call their doctor", "answer_start": 0}], "is_impossible": false}, {"question": "Who should call their doctor as soon as symptoms start?", "id": "100000000000000000002634", "answers": [{"text": "People at higher risk of severe illness", "answer_start": 154}], "is_impossible": false}, {"question": "What is CDC reviewing this page to align with?", "id": "100000000000000000002635", "answers": [{"text": "updated guidance", "answer_start": 287}], "is_impossible": false}, {"question": "Do over-the-counter medicines help the person feel better?", "id": "100000000000000000002638", "answers": [{"text": "See if over-the-counter medicines for fever help the person feel better", "answer_start": 518}], "is_impossible": false}, {"question": "What do over-the-counter medicines for fever help the person feel?", "id": "100000000000000000002639", "answers": [{"text": "better", "answer_start": 583}], "is_impossible": false}, {"question": "What should the person who is sick drink a lot of?", "id": "100000000000000000002640", "answers": [{"text": "fluids and rests", "answer_start": 640}], "is_impossible": false}], "context": "*Note: Older adults and people of any age with serious underlying medical conditions are at higher risk for developing more\nsevere illness from COVID-19. People at higher risk of severe illness should call their doctor as soon as symptoms start. CDC is reviewing this page to align with updated guidance. Provide support\nHelp cover basic needs\nHelp the person who is sick\nfollow their doctor\u2019s instructions\nfor care and medicine. For most people, symptoms\nlast a few days, and people\nusually feel better after a\nweek. See if over-the-counter\nmedicines for fever help the\nperson feel better. Make sure the person who is\nsick drinks a lot of fluids and\nrests."}]}, {"title": "90375bf8850dfc1a5c6dedea82f0033e", "paragraphs": [{"qas": [{"question": "What do people who are sick drink a lot of?", "id": "100000000000000000002641", "answers": [{"text": "fluids", "answer_start": 329}], "is_impossible": false}, {"question": "What is a good way to help a sick person with their grocery shopping?", "id": "100000000000000000002642", "answers": [{"text": "filling prescriptions, and getting other items they may need. Consider having the items delivered through a delivery service", "answer_start": 33}], "is_impossible": false}, {"question": "What does CDC's self-checker tool help you do?", "id": "100000000000000000002643", "answers": [{"text": "make decisions about seeking appropriate medical care", "answer_start": 464}], "is_impossible": false}, {"question": "What is the name of the tool that helps you make decisions about medical care?", "id": "100000000000000000002644", "answers": [{"text": "self-checker tool", "answer_start": 434}], "is_impossible": false}], "context": "Help them with grocery\nshopping, filling prescriptions,\nand getting other items they\nmay need. Consider having the\nitems delivered through a\ndelivery service, if possible. Take care of their pet(s), and limit contact between the person who is sick and their pet(s) when possible. Make sure the person who is sick drinks a lot of fluids and rests\n\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\nWatch for warning signs\nHave their doctor\u2019s phone number on hand. Use CDC\u2019s self-checker tool to help you make decisions about seeking appropriate medical care. \u2022\n\u2022\f10/30/22, 9:41 AM COVID19 - Caring for someone at home | CDC\nCall their doctor if the person keeps getting sicker."}]}, {"title": "6612c759e513806aa5131c5846298b16", "paragraphs": [{"qas": [{"question": "What do you look for when seeking emergency medical attention?", "id": "100000000000000000002647", "answers": [{"text": "emergency warning signs", "answer_start": 154}], "is_impossible": false}, {"question": "If someone is showing any of these signs, seek emergency medical care immediately.", "id": "100000000000000000002648", "answers": [{"text": "Trouble breathing", "answer_start": 276}], "is_impossible": false}, {"question": "What type of pain or pressure in the chest can cause confusion?", "id": "100000000000000000002649", "answers": [{"text": "Persistent", "answer_start": 294}], "is_impossible": false}, {"question": "What color is the skin, lips, or nail beds?", "id": "100000000000000000002650", "answers": [{"text": "Pale, gray, or blue", "answer_start": 381}], "is_impossible": false}, {"question": "Who can help you with any other symptoms?", "id": "100000000000000000002651", "answers": [{"text": "your medical provider", "answer_start": 511}], "is_impossible": false}], "context": "For medical emergencies, call 911 and tell the dispatcher that the\nperson has or might have COVID-19. \u2022\nWhen to seek emergency medical attention\nLook for emergency warning signs* for COVID-19. If someone is showing any of these signs, seek emergency medical\ncare immediately:\nTrouble breathing\nPersistent pain or pressure in the chest\nNew confusion\nInability to wake or stay awake\nPale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone\n*This list is not all possible symptoms. Please call your medical provider for any other symptoms that are severe or\nconcerning to you."}]}, {"title": "50c8fe6bac93768aae158339735bd7a0", "paragraphs": [{"qas": [{"question": "What does COVID-19 spread between people in close contact?", "id": "100000000000000000002652", "answers": [{"text": "respiratory droplets", "answer_start": 273}], "is_impossible": false}, {"question": "What is created when someone talks, coughs or sneezes?", "id": "100000000000000000002653", "answers": [{"text": "respiratory droplets", "answer_start": 273}], "is_impossible": false}, {"question": "What helps stop the spread of COVID-19?", "id": "100000000000000000002654", "answers": [{"text": "Staying away from others", "answer_start": 342}], "is_impossible": false}, {"question": "Who should separate themselves from others in the home?", "id": "100000000000000000002656", "answers": [{"text": "The sick person", "answer_start": 548}], "is_impossible": false}], "context": "Call 911 or call ahead to your local emergency facility: Notify the operator that you are seeking care for someone who\nhas or may have COVID-19. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\nProtect yourself\nLimit contact\nCOVID-19 spreads between people who\nare in close contact (within about 6 feet)\nthrough respiratory droplets, created\nwhen someone talks, coughs or sneezes. Staying away from others helps stop the\nspread of COVID-19. The caregiver, when possible, should not\nbe someone who is at higher risk for\nsevere illness from COVID-19. The person who is sick should isolate\nThe sick person should separate\nthemselves from others in the home. Learn when and how to isolate."}]}, {"title": "58b0553f74e8870a00e502b3b2d0edb7", "paragraphs": [{"qas": [{"question": "What should a person who is sick use if possible?", "id": "100000000000000000002658", "answers": [{"text": "a separate bedroom and bathroom", "answer_start": 45}], "is_impossible": false}, {"question": "What is a shared space?", "id": "100000000000000000002660", "answers": [{"text": "make sure the room has good air flow", "answer_start": 276}], "is_impossible": false}, {"question": "What should you do if you have to share space?", "id": "100000000000000000002662", "answers": [{"text": "make sure the room has good air flow", "answer_start": 276}], "is_impossible": false}, {"question": "What are people who are at higher risk for severe illness called?", "id": "100000000000000000002663", "answers": [{"text": "sick room", "answer_start": 138}], "is_impossible": false}], "context": "If possible, have the person who is\nsick use a separate bedroom and\nbathroom. If possible, have the\nperson who is sick stay in their own \u201csick room\u201d or area and away from others. Try to stay at least 6 feet away from\nthe sick person. Shared space: If you have to share space, make sure the room has good air flow. Open the window to increase air circulation. Improving ventilation helps remove respiratory droplets from the air. Avoid having visitors. Avoid having any unnecessary visitors, especially visits by people who are at higher risk for\nsevere illness."}]}, {"title": "37e5df81ddb6c6e247616d3aa0ed76de", "paragraphs": [{"qas": [{"question": "What is the best place to end home isolation?", "id": "100000000000000000002667", "answers": [{"text": "stay home", "answer_start": 251}], "is_impossible": false}], "context": "Caregivers should quarantine\nKeep a separate bedroom and bathroom for a person who is sick\n\u2022\n\u2022\n-\n-\n\u2022\f10/30/22, 9:41 AM COVID19 - Caring for someone at home | CDC\nCaregivers and anyone who has been in close contact with someone who has COVID-19 should stay home, except in\nlimited circumstances. Learn when and how to quarantine. When it's safe for a person who has been sick to be around others\nDeciding when it is safe to be around others is different for different situations. Find out when someone who is sick can\nsafely end home isolation."}]}, {"title": "6956c75fa0485b3c1a6f7b2b7057d71", "paragraphs": [{"qas": [{"question": "What should the person who is sick eat in if possible?", "id": "100000000000000000002668", "answers": [{"text": "their room", "answer_start": 96}], "is_impossible": false}, {"question": "What should be used to wash dishes and utensils?", "id": "100000000000000000002669", "answers": [{"text": "gloves and hot water", "answer_start": 152}], "is_impossible": false}, {"question": "Who is sick with gloves?", "id": "100000000000000000002671", "answers": [{"text": "the person", "answer_start": 229}], "is_impossible": false}, {"question": "Wash hands after taking off gloves or handling used items?", "id": "100000000000000000002672", "answers": [{"text": "Clean hands", "answer_start": 319}], "is_impossible": false}, {"question": "What is an example of an electronic device that can be used with a sick person?", "id": "100000000000000000002674", "answers": [{"text": "cell phone", "answer_start": 515}], "is_impossible": false}], "context": "Eat in separate rooms or areas\nStay separated: The person who is sick should eat (or be fed) in their room, if possible. Wash dishes and utensils using gloves and hot water: Handle any dishes, cups/glasses, or silverware used by the\nperson who is sick with gloves. Wash them with soap and hot water or in a dishwasher. Clean hands after taking off gloves or handling used items. \u2022\n\u2022\n\u2022\nAvoid sharing personal items\nDo not share: Do not share dishes, cups/glasses, silverware, towels, bedding, or electronics (like a cell phone) with\nthe person who is sick."}]}, {"title": "22f3238a9c9e3f96ef75f17263dfa9ff", "paragraphs": [{"qas": [{"question": "If you are sick and need to be around others, wear what?", "id": "100000000000000000002676", "answers": [{"text": "a mask", "answer_start": 187}], "is_impossible": false}, {"question": "What is the COVID-19 Community Level where you live?", "id": "100000000000000000002677", "answers": [{"text": "Low", "answer_start": 245}], "is_impossible": false}, {"question": "Medium If you are at risk for severe illness, talk to your healthcare provider about wearing what indoors in public?", "id": "100000000000000000002679", "answers": [{"text": "masks", "answer_start": 430}], "is_impossible": false}], "context": "\u2022\nWhen to wear a mask or gloves\nIn general, people do not need to wear masks when outdoors. If you are sick and need to be around others, or are caring for someone who has COVID-19, wear a mask. If the COVID-19 Community Level where you live is\nLow\nWear a mask based on your personal preference, informed by your personal level of risk. Medium\nIf you are at risk for severe illness, talk to your healthcare provider about wearing masks indoors in public."}]}, {"title": "524b6fe94371e23a2902929b02f02fcf", "paragraphs": [{"qas": [{"question": "What should you wear if you live with or will gather with someone at risk for severe illness?", "id": "100000000000000000002680", "answers": [{"text": "a mask", "answer_start": 78}], "is_impossible": false}, {"question": "If you are 2 or older, wear a well-fitting mask indoors in public, regardless of vaccination status or individual risk?", "id": "100000000000000000002681", "answers": [{"text": "High", "answer_start": 109}], "is_impossible": false}, {"question": "What does wearing a mask or respirator provide you with greater protection?", "id": "100000000000000000002682", "answers": [{"text": "If you are at risk for severe illness", "answer_start": 291}], "is_impossible": false}, {"question": "What should you wear if you are at risk for severe illness?", "id": "100000000000000000002683", "answers": [{"text": "a mask or respirator", "answer_start": 335}], "is_impossible": false}], "context": "If you live with or will gather with someone at risk for severe illness, wear a mask when indoors with them. High\nIf you are 2 or older, wear a well-fitting mask indoors in public, regardless of vaccination status or individual\nrisk (including in K-12 schools and other community settings). If you are at risk for severe illness, wear a mask or respirator that provides you with greater protection. If you are going to an indoor event or a gathering, test yourself immediately before or as close to the time of the event as\npossible."}]}, {"title": "823fdbb5e8eda7a99e25534d5d8caff1", "paragraphs": [{"qas": [{"question": "What should a person who is sick wear when they are sick?", "id": "100000000000000000002685", "answers": [{"text": "a mask", "answer_start": 332}], "is_impossible": false}, {"question": "What should a person wear when they are around other people at home and out before they enter a doctor's office?", "id": "100000000000000000002686", "answers": [{"text": "a mask", "answer_start": 332}], "is_impossible": false}, {"question": "What does the mask help prevent?", "id": "100000000000000000002687", "answers": [{"text": "spreading the virus to others", "answer_start": 487}], "is_impossible": false}], "context": "This is especially important before gathering with individuals at risk of severe disease, older adults, those who are\nimmunocompromised, or people who are not up to date on their COVID-19 vaccines, including children who cannot\nget vaccinated yet. \u2022\n\u2022\n\u2022\n-\n\u2022\n-\n\u2022\n\u2022\n-\n\u2022\n\u2022\n\u2022\n-\nThe person who is sick\nThe person who is sick should wear a mask when they are around other people at home and out (including before\nthey enter a doctor\u2019s office). The mask helps prevent a person who is sick from spreading the virus to others. It keeps respiratory droplets\ncontained and from reaching other people."}]}, {"title": "890064a99bec799d4416e942eda0b77c", "paragraphs": [{"qas": [{"question": "What should not be placed on young children under the age of 2?", "id": "100000000000000000002688", "answers": [{"text": "Masks", "answer_start": 0}], "is_impossible": false}, {"question": "What kind of can you put gloves in?", "id": "100000000000000000002692", "answers": [{"text": "lined trash can", "answer_start": 471}], "is_impossible": false}, {"question": "How do you wash your hands?", "id": "100000000000000000002693", "answers": [{"text": "Throw out gloves into a lined trash can", "answer_start": 447}], "is_impossible": false}], "context": "Masks should not be placed on young children under age 2, anyone who has trouble breathing, or is not able to\nremove the covering without help. Caregiver\nPut on a mask and ask the sick person to put on a mask before entering the room. \u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:41 AM COVID19 - Caring for someone at home | CDC\np p g\nWear gloves when you touch or have contact with the sick person\u2019s blood, stool, or body fluids, such as saliva,\nmucus, vomit, and urine. Throw out gloves into a lined trash can and wash your hands right away."}]}, {"title": "49bc31ce7b2a56cb109cf6fa293c669c", "paragraphs": [{"qas": [{"question": "What do you do to keep from getting sick?", "id": "100000000000000000002694", "answers": [{"text": "wash your hands often", "answer_start": 64}], "is_impossible": false}, {"question": "Wash your hands often with what?", "id": "100000000000000000002697", "answers": [{"text": "soap and water", "answer_start": 241}], "is_impossible": false}, {"question": "What is the minimum amount of alcohol in a hand sanitizer?", "id": "100000000000000000002698", "answers": [{"text": "60%", "answer_start": 480}], "is_impossible": false}, {"question": "How long does it take to wash your hands?", "id": "100000000000000000002699", "answers": [{"text": "20 seconds", "answer_start": 269}], "is_impossible": false}, {"question": "What should everyone do after being near a sick person?", "id": "100000000000000000002700", "answers": [{"text": "Wash hands: Wash your hands often with soap and water for at least 20 seconds. Tell everyone in the home to do the same", "answer_start": 202}], "is_impossible": false}, {"question": "How long do you rub your hands together until they feel dry?", "id": "100000000000000000002701", "answers": [{"text": "at least 20 seconds", "answer_start": 260}], "is_impossible": false}], "context": "Practice everyday preventive actions to keep from getting sick: wash your hands often; avoid touching your\neyes, nose, and mouth; and frequently clean and disinfect surfaces. \u2022\n-\nClean your hands often\nWash hands: Wash your hands often with soap and water for at least 20 seconds. Tell everyone in the home to do\nthe same, especially after being near the person who is sick. Hand sanitizer: If soap and water are not readily available, use a hand sanitizer that contains at least 60% alcohol. Cover all surfaces of your hands and rub them together until they feel dry."}]}, {"title": "bc35e9843de745faf285cbcb9cc295be", "paragraphs": [{"qas": [{"question": "How do you avoid touching your eyes, nose, and mouth with unwashed hands?", "id": "100000000000000000002702", "answers": [{"text": "Hands off", "answer_start": 0}], "is_impossible": false}, {"question": "What is one of several options for testing for the virus that causes COVID-19?", "id": "100000000000000000002703", "answers": [{"text": "Self-tests", "answer_start": 145}], "is_impossible": false}, {"question": "What are two types of tests?", "id": "100000000000000000002705", "answers": [{"text": "laboratory-based tests and point-of-care tests", "answer_start": 261}], "is_impossible": false}, {"question": "Who can help if you need help interpreting your test results?", "id": "100000000000000000002706", "answers": [{"text": "your healthcare provider or your local health department", "answer_start": 314}], "is_impossible": false}, {"question": "How often do you clean high-touch surfaces in your home?", "id": "100000000000000000002707", "answers": [{"text": "regularly", "answer_start": 580}], "is_impossible": false}], "context": "Hands off: Avoid touching your eyes, nose, and mouth with unwashed hands. Learn more about handwashing. \u2022\n\u2022\n\u2022\n\u2022\nTest to prevent spread to others\nSelf-tests are one of several options for testing for the virus that causes COVID-19 and may be more convenient than\nlaboratory-based tests and point-of-care tests. Ask your healthcare provider or your local health department if you need\nhelp interpreting your test results. Clean surfaces in your home regularly\nClean high-touch surfaces (such as, doorknobs, tables, handles, light switches, remote controls, phones, and\ncountertops) regularly and after you have visitors in your home."}]}, {"title": "d10af9756bd29658195c1bab0de0b868", "paragraphs": [{"qas": [{"question": "How often do people in your household get very sick from COVID-19?", "id": "100000000000000000002709", "answers": [{"text": "more likely", "answer_start": 135}], "is_impossible": false}, {"question": "What should you do if someone in your home is sick or has COVID-19?", "id": "100000000000000000002711", "answers": [{"text": "clean and disinfect your home", "answer_start": 446}], "is_impossible": false}, {"question": "What does disinfecting remove?", "id": "100000000000000000002712", "answers": [{"text": "germs", "answer_start": 498}], "is_impossible": false}, {"question": "What removes germs and reduces their spread?", "id": "100000000000000000002713", "answers": [{"text": "Disinfecting", "answer_start": 477}], "is_impossible": false}, {"question": "How long after disinfecting do you wash your hands with soap and water?", "id": "100000000000000000002714", "answers": [{"text": "20 seconds", "answer_start": 602}], "is_impossible": false}], "context": "Clean other surfaces in your home when they are visibly dirty or as needed. Clean them more frequently if people\nin your household are more likely to get very sick from COVID-19. Disinfect if certain conditions apply. Clean surfaces using a product suitable for each surface, following instructions on the product label. When Someone Is Sick\nIf someone in your home is sick or someone who has COVID-19 has been in your home in the last 24 hours, clean and\ndisinfect your home. Disinfecting removes germs and reduces their spread. Immediately after disinfecting, wash your\nhands with soap and water for 20 seconds."}]}, {"title": "4df9a7eed61e35bf908eadaa7854a9cf", "paragraphs": [{"qas": [{"question": "Trouble breathing is a warning sign that you need what kind of attention?", "id": "100000000000000000002717", "answers": [{"text": "medical", "answer_start": 305}], "is_impossible": false}, {"question": "What is a more serious warning sign that you need medical attention?", "id": "100000000000000000002718", "answers": [{"text": "Trouble breathing", "answer_start": 242}], "is_impossible": false}, {"question": "Caregivers should continue to stay home after care is complete?", "id": "100000000000000000002719", "answers": [{"text": "\u2022", "answer_start": 1}], "is_impossible": false}, {"question": "How long can caregivers leave their home after their last close contact with the person who is sick?", "id": "100000000000000000002720", "answers": [{"text": "5 days", "answer_start": 420}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\nTrack your own health\nCaregivers should stay home and monitor their health for COVID-19 symptoms while caring for the person who is\nsick. Symptoms include fever, cough, and shortness of breath but other symptoms may be present as well. Trouble\nbreathing is a more serious warning sign that you need medical attention. Caregivers should continue to stay home after care is complete. Caregivers can leave their home 5 days after their\nlast close contact with the person who is sick (based on the time it takes to develop illness), or 5 days after the\nperson who is sick meets the criteria to end home isolation."}]}, {"title": "8faafeaf799817ca8c97f1a06fdf0440", "paragraphs": [{"qas": [{"question": "What is the best way to protect yourself and others?", "id": "100000000000000000002723", "answers": [{"text": "to stay home for 5 days", "answer_start": 47}], "is_impossible": false}, {"question": "How long should you stay home if you think you've been exposed to someone who has COVID-19?", "id": "100000000000000000002724", "answers": [{"text": "5 days", "answer_start": 64}], "is_impossible": false}, {"question": "What tool can help you make decisions about seeking appropriate medical care?", "id": "100000000000000000002725", "answers": [{"text": "self-checker tool", "answer_start": 143}], "is_impossible": false}, {"question": "If you are having trouble breathing, call what?", "id": "100000000000000000002726", "answers": [{"text": "911", "answer_start": 270}], "is_impossible": false}, {"question": "What should you do if you are having trouble breathing?", "id": "100000000000000000002727", "answers": [{"text": "call 911", "answer_start": 265}], "is_impossible": false}, {"question": "What should your doctor or emergency room tell you?", "id": "100000000000000000002728", "answers": [{"text": "what to do", "answer_start": 374}], "is_impossible": false}], "context": "The best way to protect yourself and others is to stay home for 5 days if you think you\u2019ve been exposed to someone\nwho has COVID-19. Use CDC\u2019s self-checker tool to help you make decisions about seeking appropriate medical care. If you are having trouble breathing, call 911. Call your doctor or emergency room and tell them your symptoms before going in. They will tell you what to do."}]}, {"title": "15474f9533dbe55ac732a5118deb844c", "paragraphs": [{"qas": [{"question": "What is the name of the testing that was last updated Jan. 19, 2022?", "id": "100000000000000000002730", "answers": [{"text": "COVID-19", "answer_start": 250}], "is_impossible": false}], "context": "\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\n-\nMore Information\nUnderstanding Risk\f10/30/22, 9:41 AM COVID19 - Caring for someone at home | CDC\nHealthcare Professionals: Information on When to End Home Isolation\nTreatments Your Healthcare Provider Might Recommend for Severe Illness\nCOVID-19 Testing Overview\nLast Updated Jan. 19, 2022"}]}, {"title": "f4c04c19c27ccc97e1f957acf17dbb8f", "paragraphs": [{"qas": [{"question": "What is CDC Espaol?", "id": "100000000000000000002732", "answers": [{"text": "Caring for People with Post-COVID Conditions", "answer_start": 18}], "is_impossible": false}, {"question": "What should you do if you care for someone?", "id": "100000000000000000002734", "answers": [{"text": "remember to take steps to protect yourself and others from COVID-19", "answer_start": 532}], "is_impossible": false}, {"question": "What should you do to protect yourself and others from COVID-19?", "id": "100000000000000000002735", "answers": [{"text": "take steps", "answer_start": 544}], "is_impossible": false}], "context": "10/30/22, 9:42 AM Caring for People with Post-COVID Conditions | CDC\nEspa\u00f1ol | Other Languages\nCaring for People with Post-COVID Conditions\nHaving a post-COVID condition or supporting someone with a post-COVID condition can be challenging. It can be difficult to\ncare for yourself or loved ones, especially when there are few or no immediate answers or solutions. However, there are ways\nto help relieve some of the additional burdens of experiencing or caring for someone with a new and unknown condition. If you care for someone, remember to take steps to protect yourself and others from COVID-19. This information is intended for a general audience."}]}, {"title": "1285adf4899d02faa6f01fc35b49d7ee", "paragraphs": [{"qas": [{"question": "Who should see the post-COVID conditions for healthcare providers page for more details on management?", "id": "100000000000000000002737", "answers": [{"text": "Healthcare professionals", "answer_start": 0}], "is_impossible": false}, {"question": "Children and adolescents may have trouble describing the problems after COVID-19.", "id": "100000000000000000002738", "answers": [{"text": "Young children", "answer_start": 331}], "is_impossible": false}, {"question": "What type of children may have trouble describing the problems they are experiencing?", "id": "100000000000000000002739", "answers": [{"text": "Young", "answer_start": 331}], "is_impossible": false}], "context": "Healthcare professionals should see the post-COVID conditions for\nhealthcare providers page for more detail information on management. Children and Adolescents\nAlthough post-COVID conditions appear to be less common in children and adolescents than in adults, long-term effects after\nCOVID-19 do occur in children and adolescents. Young children may have trouble describing the problems they are\nexperiencing."}]}, {"title": "1fafeb043737d92826d1635b5d7eb3c7", "paragraphs": [{"qas": [{"question": "What type of condition affects your child's ability to attend school?", "id": "100000000000000000002740", "answers": [{"text": "post-COVID", "answer_start": 20}], "is_impossible": false}, {"question": "What can you do if your child has a post COVID condition?", "id": "100000000000000000002741", "answers": [{"text": "it may be helpful to discuss with your child\u2019s healthcare professional and school possible accommodations", "answer_start": 142}], "is_impossible": false}, {"question": "What can school administrators, school counselors, and school nurses work with to provide for children with post-COVID conditions?", "id": "100000000000000000002742", "answers": [{"text": "families and healthcare professionals", "answer_start": 426}], "is_impossible": false}, {"question": "What can you request accommodations for?", "id": "100000000000000000002743", "answers": [{"text": "activities outside of school", "answer_start": 671}], "is_impossible": false}], "context": "If your child has a post-COVID condition that impacts their ability to attend school, complete schoolwork, or perform their\nusual activities, it may be helpful to discuss with your child\u2019s healthcare professional and school possible accommodations\nsuch as extra time on tests, scheduled rest periods throughout the day, a modified class schedule, etc. School administrators,\nschool counselors, and school nurses can work with families and healthcare professionals to provide learning\naccommodations for children with post-COVID conditions, particularly those experiencing thinking, concentrating, or physical\ndifficulties. You may also request similar accommodations for activities outside of school, such as day care, tutoring, sports,\nscouting, etc."}]}, {"title": "1b2e2fca462c2448fe8cc6f0ce00c77b", "paragraphs": [{"qas": [{"question": "What is the OCR?", "id": "100000000000000000002745", "answers": [{"text": "Office for Civil Rights", "answer_start": 63}], "is_impossible": false}, {"question": "What is OSERS?", "id": "100000000000000000002746", "answers": [{"text": "Resource to Support Children, Students, Educators, Schools, Service Providers, and Families", "answer_start": 167}], "is_impossible": false}, {"question": "How does each person cope with a long-term illness?", "id": "100000000000000000002747", "answers": [{"text": "differently", "answer_start": 310}], "is_impossible": false}, {"question": "What do some people find taking an active role in understanding their condition is a comfort for managing?", "id": "100000000000000000002749", "answers": [{"text": "their ongoing illness", "answer_start": 540}], "is_impossible": false}, {"question": "Read about the experiences of other people with a post-COVID condition?", "id": "100000000000000000002750", "answers": [{"text": "Some people find taking an active role in understanding their condition", "answer_start": 442}], "is_impossible": false}], "context": "For more information, visit the U.S. Department of Education\u2019s Office for Civil Rights (OCR) and the Office of Special Education\nand Rehabilitative Services (OSERS)\u2019s Resource to Support Children, Students, Educators, Schools, Service Providers, and\nFamilies . \uf20c \uf209\nUnderstand Your Experience\nEach person copes differently with a long-term illness, and there are different ways to manage the stress, anxiety, and\nuncertainty of a new illness. Some people find taking an active role in understanding their condition is a comfort for managing\ntheir ongoing illness:\nRead about the experiences of other people with a post-COVID condition."}]}, {"title": "20d97cb7127f75f3b1626f98b88b1ae", "paragraphs": [{"qas": [{"question": "What can help confirm you are not alone?", "id": "100000000000000000002751", "answers": [{"text": "Understanding other people\u2019s experiences with post-COVID conditions", "answer_start": 0}], "is_impossible": false}, {"question": "What can contribute to building a larger understanding of new and unknown illnesses?", "id": "100000000000000000002752", "answers": [{"text": "Participating in research studies", "answer_start": 229}], "is_impossible": false}, {"question": "What are people with and without COVID-19 able to enroll in?", "id": "100000000000000000002754", "answers": [{"text": "clinical trials", "answer_start": 357}], "is_impossible": false}], "context": "Understanding other people\u2019s experiences with post-COVID conditions and reflecting on how these experiences\nmay be similar or different than your own can help confirm you are not alone. Contribute to ongoing scientific research. Participating in research studies can build a larger understanding of new and unknown illnesses. Information\nabout enrolling in clinical trials related to COVID-19 can be found at CombatCovid.hhs.gov , and includes\nopportunities for persons with and without COVID-19. \u2022\n\u2022\n\uf209\f10/30/22, 9:42 AM Caring for People with Post-COVID Conditions | CDC\nPeople experiencing post-COVID conditions may find different strategies to be helpful."}]}, {"title": "7b014282343681490b237fe462bf7d6e", "paragraphs": [{"qas": [{"question": "What is the goal of the RECOVER Initiative?", "id": "100000000000000000002758", "answers": [{"text": "to understand how people recover from a COVID-19 infection", "answer_start": 292}], "is_impossible": false}, {"question": "What type of medications or treatments can help to relieve the effects of post-COVID conditions?", "id": "100000000000000000002760", "answers": [{"text": "Experts are still determining which types of medications", "answer_start": 527}], "is_impossible": false}], "context": "If you are experiencing a post-COVID\ncondition, you should engage in whatever coping strategies are best for your mental and physical health. Participate in specific long COVID research. The National Institutes of Health (NIH) is conducting a research project, called the RECOVER Initiative, to\nunderstand how people recover from a COVID-19 infection and why some people do not fully recover and develop\nlong COVID or post-COVID conditions. Learn more about Researching COVID to Enhance Recovery . \u2022\n\uf209\nWays to Cope with Stress\nExperts are still determining which types of medications or treatments can help to relieve the effects of post-COVID\nconditions."}]}, {"title": "792695072b0e3689f8b692f13f8c98bc", "paragraphs": [{"qas": [{"question": "What can people do to help manage the stress associated with a post-COVID condition?", "id": "100000000000000000002761", "answers": [{"text": "established ways", "answer_start": 19}], "is_impossible": false}, {"question": "Listen to what?", "id": "100000000000000000002766", "answers": [{"text": "signs from your body", "answer_start": 490}], "is_impossible": false}, {"question": "Get plenty of sleep.", "id": "100000000000000000002767", "answers": [{"text": "Listen to signs from your body", "answer_start": 480}], "is_impossible": false}, {"question": "Do you drink alcohol or drugs?", "id": "100000000000000000002769", "answers": [{"text": "Avoid", "answer_start": 533}], "is_impossible": false}, {"question": "Do you get enough sleep?", "id": "100000000000000000002770", "answers": [{"text": "Get plenty of sleep", "answer_start": 512}], "is_impossible": false}], "context": "However, there are established ways people can manage the stress associated with a post-COVID condition. Here are some steps you can do to help manage and cope with stress:\nTake breaks from watching, reading, or listening to news stories, including social media. Hearing about the COVID-19\npandemic repeatedly can be upsetting. Take care of your body. Take deep breaths, stretch, meditate , or practice mindfulness . Try to eat healthy, well-balanced meals. Exercise, if you can. Listen to signs from your body. Get plenty of sleep. Avoid alcohol and drugs. Make time to unwind."}]}, {"title": "d6f9c6ef2b1090992ea5471b4eecacb5", "paragraphs": [{"qas": [{"question": "What do you try to do if you feel able to?", "id": "100000000000000000002771", "answers": [{"text": "some activities you enjoy", "answer_start": 31}], "is_impossible": false}, {"question": "Talk to people you trust about your concerns and how you are feeling?", "id": "100000000000000000002772", "answers": [{"text": "\u2022 - \uf209 \uf209 - - - -", "answer_start": 376}], "is_impossible": false}, {"question": "What is the CDC's recommendation on how to cope with a disaster or traumatic event?", "id": "100000000000000000002773", "answers": [{"text": "\u2022 - \uf209 \uf209 - - - -", "answer_start": 376}], "is_impossible": false}], "context": "If you feel able to, try to do some activities you enjoy. Connect with others. Talk with people you trust about your concerns and how you are feeling. For information, explore CDC\u2019s recommendations on how to cope with a disaster or traumatic event. If any of these steps require changes to your routine, diet, activity level, or medication, talk to your healthcare provider. \u2022\n\u2022\n- \uf209 \uf209\n-\n-\n-\n-\n\u2022\n\u2022\nSupport People with Post-COVID Conditions\nExperiencing post-COVID conditions can be confusing and frustrating, and a person who feels sick long-term may feel\nisolated."}]}, {"title": "99a74749c39768971d100807361de47c", "paragraphs": [{"qas": [{"question": "What does CDC's How Right Now campaign provide?", "id": "100000000000000000002776", "answers": [{"text": "helpful tools", "answer_start": 285}], "is_impossible": false}, {"question": "What does each person experience differently?", "id": "100000000000000000002777", "answers": [{"text": "these conditions", "answer_start": 21}], "is_impossible": false}, {"question": "What campaign provides helpful tools for navigating conversations about the type of support someone with COVID conditions may need?", "id": "100000000000000000002778", "answers": [{"text": "CDC\u2019s How Right Now", "answer_start": 247}], "is_impossible": false}, {"question": "What is the Disaster Distress Helpline?", "id": "100000000000000000002781", "answers": [{"text": "Call 911 if you feel like you want to harm yourself or others. Visit the Disaster Distress Helpline , call or text 1-800-985-5990", "answer_start": 522}], "is_impossible": false}], "context": "Everyone experiences these conditions differently and may want different types of support or even no support at all. To determine the most helpful steps you can take for others, first listen with compassion and ask questions about what they\nneed. CDC\u2019s How Right Now campaign provides helpful tools for navigating conversations about the type of support someone with\npost-COVID conditions may need. If you are feeling overwhelmed with emotions like sadness, depression, anxiety, or thoughts of hurting yourself or others:\nCall 911 if you feel like you want to harm yourself or others. Visit the Disaster Distress Helpline , call or text 1-800-985-5990."}]}, {"title": "e50d3b5e5bb57f0a47c8683044c89261", "paragraphs": [{"qas": [{"question": "What does the National Domestic Violence Hotline do?", "id": "100000000000000000002782", "answers": [{"text": "give feedback", "answer_start": 535}], "is_impossible": false}, {"question": "What is the TTY number for the National Suicide Prevention Lifeline?", "id": "100000000000000000002783", "answers": [{"text": "1-800-787-3224", "answer_start": 76}], "is_impossible": false}, {"question": "How long is the post-COVID condition?", "id": "100000000000000000002784", "answers": [{"text": "long-term", "answer_start": 217}], "is_impossible": false}, {"question": "What should you do when listening?", "id": "100000000000000000002786", "answers": [{"text": "give feedback that acknowledges and validates what they are going through", "answer_start": 535}], "is_impossible": false}], "context": "Visit the National Domestic Violence Hotline or call 1-800-799-7233 and TTY 1-800-787-3224. Visit the National Suicide Prevention Lifeline or call 1-800-273-8255\n\u2022\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\uf1ae Listen with compassion\nThe unknown and long-term nature of a post-COVID condition can create stress. Taking steps to\nunderstand the person\u2019s experiences might make them feel less isolated\f10/30/22, 9:42 AM Caring for People with Post-COVID Conditions | CDC\nunderstand the person s experiences might make them feel less isolated. What to do:\nWhen listening, give feedback that acknowledges and validates what they are going through."}]}, {"title": "35964dc75bbbe6c3b96cef942e33dbab", "paragraphs": [{"qas": [{"question": "Where can you find tips on how to communicate compassionately while listening to their experiences?", "id": "100000000000000000002787", "answers": [{"text": "the CDC\u2019s suggestions for listening with compassion", "answer_start": 91}], "is_impossible": false}, {"question": "Start a conversation to gain understanding What can look different to different people?", "id": "100000000000000000002788", "answers": [{"text": "Support", "answer_start": 193}], "is_impossible": false}, {"question": "What do you start by asking a person to talk and ask questions about their experiences?", "id": "100000000000000000002789", "answers": [{"text": "To best understand what type of support a person needs", "answer_start": 241}], "is_impossible": false}, {"question": "What should you start with an open-ended question?", "id": "100000000000000000002790", "answers": [{"text": "\u201cHow\u2019s it going for you these days?\u201d Then, work to narrow down what you can do to help", "answer_start": 454}], "is_impossible": false}], "context": "For tips on how to communicate compassionately while listening to their experiences, visit the CDC\u2019s\nsuggestions for listening with compassion. \u2022\n\u2022\n\uf1af Start a conversation to gain understanding\nSupport can look different to different people. To best understand what type of support a person needs,\nstart by asking them to talk and ask questions about their experiences. What to do:\nWhen having these conversations, start with an open-ended question, like \u201cHow\u2019s it going for you\nthese days?\u201d Then, work to narrow down what you can do to help."}]}, {"title": "61cad46c46e2d9f9b43ffc8249be8da0", "paragraphs": [{"qas": [{"question": "What can you do after listening to their responses?", "id": "100000000000000000002791", "answers": [{"text": "directly ask what they need or what you can do to help", "answer_start": 64}], "is_impossible": false}, {"question": "What might some people need more physical support?", "id": "100000000000000000002794", "answers": [{"text": "help with household chores, running errands", "answer_start": 502}], "is_impossible": false}], "context": "After taking time to compassionately listen to their responses, directly ask what they need or what\nyou can do to help. Learn more about CDC\u2019s tips on how to start these types of meaningful conversations. \u2022\n\u2022\n\u2022\n\uf1b0 Determine how you can help with what they need\nAfter you have listened and worked to understand what support looks like for the person, determine your\nrole in that support. Some people may want someone to listen to their experiences more frequently. Others may need more physical support (help with household chores, running errands)."}]}, {"title": "342476e9629b2a7bc5a7fd9f2182999f", "paragraphs": [{"qas": [{"question": "What is it ok to acknowledge that you may not be able to support a person exactly as they need?", "id": "100000000000000000002795", "answers": [{"text": "Just be direct in saying what you can and can\u2019t do", "answer_start": 121}], "is_impossible": false}, {"question": "Be direct in saying what you can and can't do?", "id": "100000000000000000002796", "answers": [{"text": "ok", "answer_start": 96}], "is_impossible": false}, {"question": "What can employers offer to help employees experiencing post-COVID conditions?", "id": "100000000000000000002797", "answers": [{"text": "flexible leave and work schedule policies", "answer_start": 443}], "is_impossible": false}], "context": "There will be times where you may not be able to support a person exactly as they need, and it\u2019s\nok to acknowledge that. Just be direct in saying what you can and can\u2019t do. For example:\n\u201cI understand that you need help getting groceries because you are not feeling up to grocery\nshopping. I don\u2019t have a car, but I can recommend the delivery service I use.\u201d\n\u2022\n\u2022\n\u2022\nEmployers can support employees experiencing post-COVID conditions by offering flexible leave and work schedule policies,\nand by providing access to employee assistance programs."}]}, {"title": "37ed07fcde9df8114ab4e9ecccfd68e5", "paragraphs": [{"qas": [{"question": "What is an important part of being a caregiver?", "id": "100000000000000000002799", "answers": [{"text": "maintaining healthy behaviors and seeking additional support", "answer_start": 38}], "is_impossible": false}, {"question": "What is a key part of helping other people?", "id": "100000000000000000002800", "answers": [{"text": "maintaining healthy behaviors and seeking additional support", "answer_start": 38}], "is_impossible": false}, {"question": "What does SCCM RECOVER stand for?", "id": "100000000000000000002801", "answers": [{"text": "RECOVER (recovercovid.org", "answer_start": 669}], "is_impossible": false}, {"question": "What is the name of the website that helps patients and families cope with COVID-19?", "id": "100000000000000000002802", "answers": [{"text": "SCCM RECOVER", "answer_start": 665}], "is_impossible": false}, {"question": "When was the last update for the information about clinical trials?", "id": "100000000000000000002804", "answers": [{"text": "Sept. 1, 2022", "answer_start": 764}], "is_impossible": false}], "context": "If you are a caregiver, remember that maintaining healthy behaviors and seeking additional support is an important part of\nhelping other people. Support Groups\nBody Politic\nSurvivor Corps\n\uf209\n\uf209\f10/30/22, 9:42 AM Caring for People with Post-COVID Conditions | CDC\nLong COVID Alliance\nLong COVID Kids\n\uf209\n\uf209\nAdditional Resources\nPost-COVID Conditions\nPatient Tips: Healthcare Provider Appointments for Post-COVID Conditions\nMental Health and Coping During COVID-19\nCoping with a Disaster or Traumatic Event\nHow Right Now | Finding What Helps\nGuidance for Direct Service Providers | COVID-19\nCaring for Yourself When Caring for Another\nConnect With Patients and Families | SCCM\nRECOVER (recovercovid.org)\nCombat COVID: Information about Clinical Trials\n\uf209\n\uf209\n\uf209\nLast Updated Sept. 1, 2022"}]}, {"title": "ab1c3c7dba83f166ec707309bf2bc873", "paragraphs": [{"qas": [{"question": "What is inflammation of the heart muscle?", "id": "100000000000000000002805", "answers": [{"text": "Myocarditis", "answer_start": 311}], "is_impossible": false}, {"question": "What is pericarditis inflammation of?", "id": "100000000000000000002806", "answers": [{"text": "the lining outside the heart", "answer_start": 396}], "is_impossible": false}, {"question": "What is inflammation of the lining outside the heart called?", "id": "100000000000000000002807", "answers": [{"text": "pericarditis", "answer_start": 364}], "is_impossible": false}, {"question": "The body's immune system is causing inflammation in response to what?", "id": "100000000000000000002808", "answers": [{"text": "an infection or some other trigger", "answer_start": 505}], "is_impossible": false}], "context": "10/30/22, 9:16 AM Clinical Considerations: Myocarditis after mRNA COVID-19 Vaccines | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations Home\nClinical Considerations: Myocarditis and Pericarditis\nafter Receipt of mRNA COVID-19 Vaccines Among\nAdolescents and Young Adults\nBackground\nMyocarditis is inflammation of the heart muscle, and pericarditis is inflammation of the lining outside the heart. In both cases,\nthe body\u2019s immune system is causing inflammation in response to an infection or some other trigger. CDC has published case\ndefinitions for myocarditis and pericarditis. The severity of cases of myocarditis and pericarditis can vary."}]}, {"title": "e72567d72c6c2fce9edb628dcff29d93", "paragraphs": [{"qas": [{"question": "What is CDC assessing for myocarditis after mRNA COVID-19 vaccination?", "id": "100000000000000000002809", "answers": [{"text": "long term outcomes", "answer_start": 241}], "is_impossible": false}, {"question": "How have patients responded to medications and rest and had prompt improvement of symptoms?", "id": "100000000000000000002810", "answers": [{"text": "well", "answer_start": 155}], "is_impossible": false}, {"question": "What is the name of the mRNA COVID-19 vaccination?", "id": "100000000000000000002811", "answers": [{"text": "myocarditis and pericarditis", "answer_start": 18}], "is_impossible": false}, {"question": "How long after the diagnosis of myocarditis did preliminary data show most patients were fully recovered?", "id": "100000000000000000002812", "answers": [{"text": "90 days", "answer_start": 357}], "is_impossible": false}, {"question": "What is VAERS' recommendation to report all cases of post COVId-19 vaccination to?", "id": "100000000000000000002813", "answers": [{"text": "Clinicians", "answer_start": 483}], "is_impossible": false}, {"question": "What type of pericarditis is most common in adolescents and young adults?", "id": "100000000000000000002814", "answers": [{"text": "acute chest pain, shortness of breath, or palpitations", "answer_start": 634}], "is_impossible": false}, {"question": "What is the most common cause of chest pain?", "id": "100000000000000000002815", "answers": [{"text": "acute chest pain, shortness of breath, or palpitations", "answer_start": 634}], "is_impossible": false}], "context": "For most cases of myocarditis and pericarditis following\nvaccination with an mRNA COVID-19 vaccine, patients who presented for medical care have responded well to medications\nand rest and had prompt improvement of symptoms. CDC is assessing long term outcomes of myocarditis after mRNA\nCOVID-19 vaccination. Preliminary data from surveys conducted at least 90 days after the myocarditis diagnosis showed most\npatients were fully recovered from their myocarditis. Recommendations for Clinicians\nReport all cases of myocarditis and pericarditis post COVID-19 vaccination to VAERS . Consider myocarditis and pericarditis in persons with acute chest pain, shortness of breath, or palpitations, particularly\nin adolescents and young adults."}]}, {"title": "834636093c0f9fb2bc13b05cf8f3d300", "paragraphs": [{"qas": [{"question": "What is an example of irritability, vomiting, poor feeding, tachypnea, or lethargy?", "id": "100000000000000000002817", "answers": [{"text": "myocarditis or pericarditis", "answer_start": 26}], "is_impossible": false}, {"question": "For initial evaluation, consider what?", "id": "100000000000000000002819", "answers": [{"text": "an ECG, troponin level, and inflammatory markers", "answer_start": 320}], "is_impossible": false}, {"question": "What is a possible cause of myocarditis?", "id": "100000000000000000002820", "answers": [{"text": "non-specific symptoms such as irritability, vomiting, poor feeding, tachypnea, or lethargy", "answer_start": 63}], "is_impossible": false}, {"question": "Who can help with cardiac evaluation and management?", "id": "100000000000000000002822", "answers": [{"text": "cardiology", "answer_start": 588}], "is_impossible": false}], "context": "Younger children who have myocarditis or pericarditis may have non-specific\nsymptoms such as irritability, vomiting, poor feeding, tachypnea, or lethargy. Ask about prior COVID-19 vaccination if you identify these symptoms, as well as relevant other medical, travel, and social\nhistory. For initial evaluation, consider an ECG, troponin level, and inflammatory markers such as C-reactive protein and\nerythrocyte sedimentation rate. In the setting of normal ECG, troponin, and inflammatory markers, myocarditis or\npericarditis are unlikely. For suspected cases, consider consultation with cardiology for assistance with cardiac evaluation and management."}]}, {"title": "6fb483d107214f20297e1eb4ea4a5cd7", "paragraphs": [{"qas": [{"question": "What may vary depending on the patient age, clinical presentation, potential causes, or practice preference of the provider?", "id": "100000000000000000002823", "answers": [{"text": "Evaluation and management", "answer_start": 0}], "is_impossible": false}, {"question": "In April 2021, increased cases of myocarditis were reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna).", "id": "100000000000000000002824", "answers": [{"text": "pericarditis following receipt of mRNA COVID-19 vaccines", "answer_start": 381}], "is_impossible": false}, {"question": "Data from multiple studies show a rare risk for myocarditis and/or what other condition?", "id": "100000000000000000002825", "answers": [{"text": "pericarditis", "answer_start": 381}], "is_impossible": false}, {"question": "How long after receiving the second dose of an mRNA COVID-19 vaccine do these rare cases occur?", "id": "100000000000000000002826", "answers": [{"text": "7 days", "answer_start": 587}], "is_impossible": false}], "context": "Evaluation and management may vary depending on the patient age, clinical presentation, potential causes, or practice\npreference of the provider. Summary\nIn April 2021, increased cases of myocarditis and pericarditis were reported in the United States after mRNA COVID-19\nvaccination (Pfizer-BioNTech and Moderna). Data from multiple studies show a rare risk for myocarditis and/or\npericarditis following receipt of mRNA COVID-19 vaccines. These rare cases of myocarditis or pericarditis have occurred\nmost frequently in adolescent and young adult males, ages 16 years and older, within 7 days after receiving the second\ndose of an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna)."}]}, {"title": "5c82b52e3e78b456f798f56305dd518e", "paragraphs": [{"qas": [{"question": "What is the name of the Janssen COVID-19 Vaccine?", "id": "100000000000000000002828", "answers": [{"text": "Johnson & Johnson", "answer_start": 103}], "is_impossible": false}, {"question": "What does CDC recommend for everyone 6 months of age and older?", "id": "100000000000000000002829", "answers": [{"text": "COVID-19 vaccination", "answer_start": 150}], "is_impossible": false}, {"question": "Who has determined that the benefits of vaccination are worth it?", "id": "100000000000000000002830", "answers": [{"text": "The Advisory Committee on Immunization Practices", "answer_start": 211}], "is_impossible": false}, {"question": "Who advises follow-up of patients with myocarditis?", "id": "100000000000000000002833", "answers": [{"text": "American Heart Association and American College of Cardiology", "answer_start": 630}], "is_impossible": false}], "context": "There has not been a similar reporting pattern\nobserved after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson). CDC continues to recommend COVID-19 vaccination for everyone 6 months of age and older. The Advisory Committee on\nImmunization Practices (ACIP) and CDC have determined that the benefits (such as prevention of COVID-19 cases and its\nsevere outcomes) outweigh the risks of myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines. \uf209\f10/30/22, 9:16 AM Clinical Considerations: Myocarditis after mRNA COVID-19 Vaccines | CDC\nFor follow-up of patients with myocarditis, consult the guidance from the American Heart Association and American\nCollege of Cardiology ."}]}, {"title": "f72da330adf52e902421b7d16ca68b26", "paragraphs": [{"qas": [{"question": "Who can assist in this evaluation?", "id": "100000000000000000002836", "answers": [{"text": "infectious disease and/or rheumatology", "answer_start": 111}], "is_impossible": false}, {"question": "What is an example of a previous SARS-CoV-2 infection?", "id": "100000000000000000002838", "answers": [{"text": "detection of SARS-CoV-2 antibodies", "answer_start": 369}], "is_impossible": false}, {"question": "What are two examples of viral causes?", "id": "100000000000000000002839", "answers": [{"text": "enterovirus PCR and comprehensive respiratory viral pathogen testing", "answer_start": 439}], "is_impossible": false}, {"question": "Enterovirus PCR and comprehensive respiratory viral pathogen testing are examples of what?", "id": "100000000000000000002840", "answers": [{"text": "viral causes", "answer_start": 415}], "is_impossible": false}], "context": "It is important to rule out other potential causes of myocarditis and pericarditis. Consider consultation with infectious\ndisease and/or rheumatology to assist in this evaluation. Where available, evaluate for potential causes of myocarditis and pericarditis, particularly acute COVID-19 infection\n(such as PCR testing), current or prior SARS-CoV-2 infection (such as, detection of SARS-CoV-2 antibodies), and other\nviral causes (such as, enterovirus PCR and comprehensive respiratory viral pathogen testing)."}]}, {"title": "cc45a1e896975f9df6de4da1ace1bd72", "paragraphs": [{"qas": [{"question": "What did ACIP and CDC determine outweigh the risks of COVID-19?", "id": "100000000000000000002841", "answers": [{"text": "the benefits", "answer_start": 87}], "is_impossible": false}, {"question": "What does CDC continue to recommend for everyone 6 months of age and older?", "id": "100000000000000000002842", "answers": [{"text": "COVID-19 vaccination", "answer_start": 263}], "is_impossible": false}, {"question": "Who should be vaccinated for pericarditis?", "id": "100000000000000000002843", "answers": [{"text": "everyone 6 months of age and older", "answer_start": 288}], "is_impossible": false}, {"question": "What is the name of the section of the CDC's Interim Clinical Considerations for Use of COVID-19 Vaccines?", "id": "100000000000000000002844", "answers": [{"text": "Myocarditis and Pericarditis", "answer_start": 482}], "is_impossible": false}], "context": "After reviewing available data on the risks and benefits, ACIP and CDC determined that the benefits (such as prevention\nof COVID-19 cases and its severe outcomes) outweigh the risks of myocarditis and pericarditis after receipt of mRNA\nCDC continues to recommend COVID-19 vaccination for everyone 6 months of age and older\nIf myocarditis or pericarditis is diagnosed after a dose of mRNA COVID vaccine, before giving additional doses, please\nrefer to the latest guidance under the \u2018Myocarditis and Pericarditis\u2019 section of the CDC Interim Clinical Considerations for\nUse of COVID-19 Vaccines."}]}, {"title": "4f737f6f9f17606d739424bf6494c651", "paragraphs": [{"qas": [{"question": "What is the name of the website that provides information on myocarditis?", "id": "100000000000000000002845", "answers": [{"text": "NIH materials on myocarditis and pericarditis Frequently asked questions about VAERS reporting for COVID-19 vaccines VAERS \u2013 FAQs (hhs.gov", "answer_start": 24}], "is_impossible": false}, {"question": "What is another name for COVID-19 vaccines?", "id": "100000000000000000002846", "answers": [{"text": "VAERS", "answer_start": 142}], "is_impossible": false}, {"question": "When was this page last reviewed?", "id": "100000000000000000002847", "answers": [{"text": "September 29, 2022", "answer_start": 214}], "is_impossible": false}], "context": "\uf209\n\uf209\nFor more information\nNIH materials on myocarditis and pericarditis\nFrequently asked questions about VAERS reporting for COVID-19 vaccines VAERS \u2013 FAQs (hhs.gov)\nHow to report to VAERS\n\uf209\n\uf209\n\uf209\nPage last reviewed: September 29, 2022"}]}, {"title": "e01ee4520ef6a027c60302b57acb61c1", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine currently approved or authorized in the United States?", "id": "100000000000000000002848", "answers": [{"text": "COVID-19", "answer_start": 216}], "is_impossible": false}, {"question": "When was the last update of the guidelines for use of a Novavax COVID-19 booster dose?", "id": "100000000000000000002849", "answers": [{"text": "October 19, 2022", "answer_start": 328}], "is_impossible": false}, {"question": "What is a monovalent Novavax COVID-19 booster dose for people ages 18 and older in limited situations?", "id": "100000000000000000002850", "answers": [{"text": "Guidance", "answer_start": 347}], "is_impossible": false}, {"question": "What is the Interim COVIID-19 Immunization Schedule updated to?", "id": "100000000000000000002851", "answers": [{"text": "Infographic", "answer_start": 650}], "is_impossible": false}, {"question": "What is the acronym for COVID-19 Vaccination of Children and Adolescents?", "id": "100000000000000000002852", "answers": [{"text": "Special Situations", "answer_start": 724}], "is_impossible": false}, {"question": "What are the Interim Clinical Considerations?", "id": "100000000000000000002853", "answers": [{"text": "Clinical Guidance for COVID-19 Vaccination | CDC Espa\u00f1ol | Other Languages Vaccines & Immunizations Vaccines & Immunizations Vaccines & Immunizations Home Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States", "answer_start": 18}], "is_impossible": false}, {"question": "Who receives email updates about this page?", "id": "100000000000000000002854", "answers": [{"text": "Clinical Guidance for COVID-19 Vaccination | CDC Espa\u00f1ol | Other Languages Vaccines & Immunizations Vaccines & Immunizations Vaccines & Immunizations Home Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States Summary of recent changes (last updated October 19, 2022): Guidance for use of a monovalent Novavax COVID-19 booster dose in people ages 18 years and older in limited situations Reference Materials Summary Document for Interim Clinical Considerations (Updated 10/26/2022) Interim COVID-19 Immunization Schedule (Updated 10/21/2022) COVID-19 Vaccination Schedule Infographic COVID-19 Vaccination Schedule Infographic (Immunocompromised) Special Situations for COVID-19 Vaccination of Children and Adolescents", "answer_start": 18}], "is_impossible": false}], "context": "10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations\nVaccines & Immunizations Home\nInterim Clinical Considerations for Use of COVID-19\nVaccines Currently Approved or Authorized in the\nUnited States\nSummary of recent changes (last updated October 19, 2022):\nGuidance for use of a monovalent Novavax COVID-19 booster dose in people ages 18 years and older in limited\nsituations\nReference Materials\nSummary Document for Interim Clinical Considerations (Updated 10/26/2022)\nInterim COVID-19 Immunization Schedule (Updated 10/21/2022)\nCOVID-19 Vaccination Schedule Infographic\nCOVID-19 Vaccination Schedule Infographic (Immunocompromised)\nSpecial Situations for COVID-19 Vaccination of Children and Adolescents\nFAQs for the Interim Clinical Considerations\nGet Email Updates\nReceive email updates about this\npage. What\u2019s this?"}]}, {"title": "ec8ad215ff6856d4cb1077fc52a349d4", "paragraphs": [{"qas": [{"question": "What is the acronym for the Advisory Committee on Immunization Practices?", "id": "100000000000000000002855", "answers": [{"text": "ACIP", "answer_start": 206}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000002856", "answers": [{"text": "Emergency Use Authorization", "answer_start": 346}], "is_impossible": false}, {"question": "Who approved COVID-19 vaccines?", "id": "100000000000000000002857", "answers": [{"text": "U.S. Food and Drug Administration", "answer_start": 292}], "is_impossible": false}, {"question": "Who's general best practice guidelines for immunization?", "id": "100000000000000000002859", "answers": [{"text": "ACIP", "answer_start": 533}], "is_impossible": false}], "context": "These clinical considerations provide information to healthcare professionals and public health officials on use of COVID-19\nvaccines. They are informed by the Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control\nand Prevention\u2019s (CDC) recommendations, the U.S. Food and Drug Administration\u2019s (FDA) approval or Emergency Use\nAuthorization (EUA) of COVID-19 vaccines, CDC\u2019s Emergency Use Instructions (EUI) for FDA-approved vaccines, the World\nHealth Organization (WHO) emergency use listing (EUL), ACIP\u2019s general best practice guidelines for immunization, and\nexpert opinion."}]}, {"title": "bba430f21e38599a5b9efbcd0d45c187", "paragraphs": [{"qas": [{"question": "How many vaccine types are approved under a Biologics License Application (BLA) or authorized under an EUA by FDA?", "id": "100000000000000000002861", "answers": [{"text": "three", "answer_start": 50}], "is_impossible": false}, {"question": "What is the name of the mRNA vaccines?", "id": "100000000000000000002862", "answers": [{"text": "Moderna COVID-19 Vaccine/SPIKEVAX", "answer_start": 197}], "is_impossible": false}, {"question": "Why is vaccination allowed for adults ages 18 and older?", "id": "100000000000000000002866", "answers": [{"text": "safety considerations", "answer_start": 813}], "is_impossible": false}], "context": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License\nApplication (BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna COVID-19 Vaccine/SPIKEVAX (1) and Moderna COVID-19 Vaccine, Bivalent\nPfizer-BioNTech COVID-19 Vaccine/COMIRNATY (2) and Pfizer-BioNTech COVID-19 Vaccine, Bivalent\nProtein subunit vaccine\nNovavax COVID-19 Vaccine, Adjuvanted\nAdenovirus vector vaccine\nJanssen (Johnson & Johnson) COVID-19 Vaccine\nNone of the currently FDA-approved or FDA-authorized COVID-19 vaccines are live-virus vaccines. Overview of COVID-19 vaccination\n\uf209\n\uf209\n\uf209\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nJanssen COVID-19 Vaccine is authorized for adults ages 18 years and older in certain limited situations due to safety\nconsiderations (see Appendix A)."}]}, {"title": "435eb39b61807c86f224c33c8601ad32", "paragraphs": [{"qas": [{"question": "What can be consulted for a full list of ingredients and additional information on the conditions of use, storage and handling, preparation and administration procedures for each of the FDA-approved and FDA-authorized COVID-19 vaccine products?", "id": "100000000000000000002867", "answers": [{"text": "COVID-19 vaccine-specific FDA fact sheets and U.S. COVID-19 Vaccine Product Information", "answer_start": 0}], "is_impossible": false}], "context": "COVID-19 vaccine-specific FDA fact sheets and U.S. COVID-19 Vaccine Product Information can be consulted for a full list of\ningredients and additional information on the conditions of use, storage and handling, preparation, and administration\nprocedures for each of the FDA-approved and FDA-authorized COVID-19 vaccine products. Table 1."}]}, {"title": "5f9c31794b32739d9f9b52e9c531a1e9", "paragraphs": [{"qas": [{"question": "What type of vaccine is currently approved or authorized in the United States?", "id": "100000000000000000002868", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "Moderna Age indication Vaccine composition Label border color Dilution required Dose Injection volume Primary series vaccination 6 months\u20135 years Monovalent Dark blue Magenta No 25 g 0.25 mL 6\u201311 years", "id": "100000000000000000002869", "answers": [{"text": "Moderna Age indication Vaccine composition Vaccine vial cap color Label border color Dilution required Dose Injection volume Primary series vaccination 6 months\u20135 years Monovalent Dark blue Magenta No 25 \u00b5g 0.25 mL 6\u201311 years\u2020 Monovalent Dark blue Purple No 50 \u00b5g 0.5 mL 12 years and older Monovalent Red Light blue No 100 \u00b5g 0.5 mL Booster vaccination 6\u201311 years Bivalent Dark blue Gray No 25 \u00b5g 0.25 mL 12 years and older Bivalent Dark blue Gray No 50 \u00b5g 0.5 mL Novavax", "answer_start": 81}], "is_impossible": false}, {"question": "What color is no 50 mL?", "id": "100000000000000000002870", "answers": [{"text": "Dark blue Gray", "answer_start": 514}], "is_impossible": false}, {"question": "What is no 100 ml?", "id": "100000000000000000002871", "answers": [{"text": "Monovalent Red Light blue No 100 \u00b5g 0.5 mL", "answer_start": 371}], "is_impossible": false}, {"question": "Booster vaccination 6-11 years Bivalent Dark blue Gray No 25 g what?", "id": "100000000000000000002872", "answers": [{"text": "0.25 mL", "answer_start": 478}], "is_impossible": false}, {"question": "Novavax Age indication Vaccine vial cap What is the name of the vaccine?", "id": "100000000000000000002873", "answers": [{"text": "Primary series vaccination 18 years and older", "answer_start": 1481}], "is_impossible": false}, {"question": "How many doses of Novavax are needed for Primary series vaccination?", "id": "100000000000000000002874", "answers": [{"text": "6 months\u20134 years", "answer_start": 1063}], "is_impossible": false}, {"question": "What is the name of the adjuvant that is used to Booster vaccination for 18 years and older?", "id": "100000000000000000002875", "answers": [{"text": "Matrix-M\u2122", "answer_start": 771}], "is_impossible": false}, {"question": "What is the name of the adjuvant Pfizer-BioNTech?", "id": "100000000000000000002877", "answers": [{"text": "COVID-19", "answer_start": 1847}], "is_impossible": false}, {"question": "How many mL of Monovalent Maroon Orange Yes 10 g?", "id": "100000000000000000002878", "answers": [{"text": "3 \u00b5g 0.2 mL 5\u201311 years", "answer_start": 1110}], "is_impossible": false}, {"question": "What is the abbreviation for rS?", "id": "100000000000000000002881", "answers": [{"text": "recombinant spike protein", "answer_start": 1702}], "is_impossible": false}, {"question": "How many viral particles are in 0.5 mL?", "id": "100000000000000000002882", "answers": [{"text": "5\u00d71010", "answer_start": 1555}], "is_impossible": false}], "context": "COVID-19 vaccine products currently approved or authorized in the United States*\nModerna\nAge indication Vaccine composition Vaccine vial cap color Label border color Dilution required Dose Injection volume\nPrimary series vaccination\n6 months\u20135 years Monovalent Dark blue Magenta No 25 \u00b5g 0.25 mL\n6\u201311 years\u2020 Monovalent Dark blue Purple No 50 \u00b5g 0.5 mL\n12 years and older Monovalent Red Light blue No 100 \u00b5g 0.5 mL\nBooster vaccination\n6\u201311 years Bivalent Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue Gray No 50 \u00b5g 0.5 mL\nNovavax\nAge indication Vaccine composition Vaccine vial cap color Label border color Dilution required Dose Injection volume\nPrimary series vaccination\n12 years and older Monovalent Royal blue No color No 5 \u00b5g rS and\n50 \u00b5g of Matrix-M\u2122 adjuvant\nBooster vaccination\n18 years and older Monovalent Royal blue No color No 5 \u00b5g rS and\n50 \u00b5g of Matrix-M\u2122 adjuvant\nPfizer-BioNTech\nAge indication Vaccine composition Vaccine vial cap color Label border color Dilution required Dose Injection volume\nPrimary series vaccination\n6 months\u20134 years\u2021 Monovalent Maroon Maroon Yes 3 \u00b5g 0.2 mL\n5\u201311 years Monovalent Orange Orange Yes 10 \u00b5g 0.2 mL\n12 years and older Monovalent Gray Gray No 30 \u00b5g 0.3 mL\nBooster vaccination\n5\u201311 years Bivalent Orange Orange Yes 10 \u00b5g 0.2 mL\n12 years and older Bivalent Gray Gray No 30 \u00b5g 0.3 mL\nJanssen\nAge indication Vaccine composition Vaccine vial cap color Label border color Dilution required Dose Injection volume\nPrimary series vaccination\n18 years and older Monovalent Blue No color No 5\u00d71010 viral particles 0.5 mL\nBooster vaccination\n18 years and older Monovalent Blue No color No 5\u00d71010 viral particles 0.5 mL\nAbbreviations: rS = recombinant spike protein\n*Illustrations of the different vaccine vial cap and label border colors are available for Moderna and Pfizer-BioNTech COVID-19 vaccines."}]}, {"title": "b72ff91dc1f1f6a6c3154dc9af183ab9", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that is FDA-authorized for use in children ages 6-11 years?", "id": "100000000000000000002883", "answers": [{"text": "Moderna COVID-19", "answer_start": 108}], "is_impossible": false}, {"question": "How manyml is the Booster dose?", "id": "100000000000000000002885", "answers": [{"text": "0.5", "answer_start": 248}], "is_impossible": false}, {"question": "What is FDA-authorized for use in children ages 6-11 years?", "id": "100000000000000000002886", "answers": [{"text": "Moderna COVID-19 Vaccine", "answer_start": 108}], "is_impossible": false}, {"question": "What is not authorized for use as a booster dose?", "id": "100000000000000000002887", "answers": [{"text": "Moderna COVID-19 Vaccine", "answer_start": 108}], "is_impossible": false}], "context": "Additional product-specific information is available from CDC for all FDA-authorized or -approved vaccines. Moderna COVID-19 Vaccine supplied in a vial with a dark blue cap and a label with a purple border stating \u201cBOOSTER DOSES ONLY Booster dose: 0.5mL \u201d\nis FDA-authorized for use in children ages 6\u201311 years as a primary series dose. It is not authorized for the booster dose."}]}, {"title": "a1abb9b4250ca7f04cb73f7586ad970a", "paragraphs": [{"qas": [{"question": "What may a maroon vial cap and label border say about COVID-19 Vaccines?", "id": "100000000000000000002888", "answers": [{"text": "\u201cAge 2y to < 5y \u201d or \u201cAge 6m to <5 yr.", "answer_start": 184}], "is_impossible": false}, {"question": "What may be on a carton label that states \u201cFor age 2 years to 5yr\u201d?", "id": "100000000000000000002889", "answers": [{"text": "Vials of the Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 81}], "is_impossible": false}, {"question": "What can be used for children ages 6 months-4 years?", "id": "100000000000000000002890", "answers": [{"text": "Vials", "answer_start": 313}], "is_impossible": false}, {"question": "What is recommended for everyone in the United States who is 6 months and older?", "id": "100000000000000000002891", "answers": [{"text": "COVID-19 vaccination", "answer_start": 432}], "is_impossible": false}, {"question": "What is COVID-19 for everyone in the United States?", "id": "100000000000000000002892", "answers": [{"text": "vaccination is recommended for everyone ages 6 months and older", "answer_start": 441}], "is_impossible": false}], "context": "\uf209\n\uf209\n\uf20c \uf209 \uf209\n\u2020 \uf20c\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nVials of the Pfizer-BioNTech COVID-19 Vaccine with a maroon vial cap and maroon label border may state \u201cAge 2y to < 5y \u201d or \u201cAge 6m to <5 yr.\u201d Carton\nlabels may state \u201cFor age 2 years to <5 years\u201d or \u201cFor age 6 months to <5 years.\u201d Vials with either printed age range can be used for children ages 6 months\u20134\nyears. Groups recommended for vaccination\nCOVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of\nCOVID-19."}]}, {"title": "3f3d0b7f84f8285035a9846cdd9b5c9b", "paragraphs": [{"qas": [{"question": "How can people stay up-to-date with the latest vaccination?", "id": "100000000000000000002894", "answers": [{"text": "by completing a primary series and receiving the most recent booster dose recommended for them by CDC", "answer_start": 163}], "is_impossible": false}, {"question": "Who recommends the most recent booster dose for people who are younger than 6 months?", "id": "100000000000000000002895", "answers": [{"text": "CDC", "answer_start": 261}], "is_impossible": false}, {"question": "What is the name of the appendices for people who received the COVID-19 vaccine outside of the US?", "id": "100000000000000000002897", "answers": [{"text": "B", "answer_start": 312}], "is_impossible": false}, {"question": "Who recommends the use of the C and B Appendixes?", "id": "100000000000000000002898", "answers": [{"text": "People who received COVID-19 vaccine outside the United States) and C (People who received COVID-19 vaccine as part of a clinical trial", "answer_start": 315}], "is_impossible": false}, {"question": "How many vaccines can be used for the primary series vaccine?", "id": "100000000000000000002899", "answers": [{"text": "three", "answer_start": 554}], "is_impossible": false}, {"question": "How many monovalent COVID-19 vaccines are recommended?", "id": "100000000000000000002900", "answers": [{"text": "three", "answer_start": 554}], "is_impossible": false}], "context": "There is currently no FDA-approved or FDA-authorized COVID-19 vaccine for children younger than age 6 months. People can stay up to date with COVID-19 vaccination by completing a primary series and receiving the most recent booster\ndose recommended for them by CDC (see Box, Table 2 and Table 3). See Appendices B (People who received COVID-19 vaccine outside the United States) and C (People who received COVID-19\nvaccine as part of a clinical trial) for recommendations for these populations. Primary series vaccination\nFor primary series vaccination, three monovalent COVID-19 vaccines (listed in alphabetical order by manufacturer), are\nrecommended: Moderna, Novavax, and Pfizer-BioNTech."}]}, {"title": "9b81e17a5cdf07e2fb6d6aaacbd2fb92", "paragraphs": [{"qas": [{"question": "What is not authorized or approved at this time for primary series doses?", "id": "100000000000000000002901", "answers": [{"text": "Bivalent mRNA vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "Who is recommended to receive 1 bivalent mRNA booster dose after completion of any FDA-approved or FDA-authorized monovalent primary series or previously received monovalent booster dose(s)?", "id": "100000000000000000002903", "answers": [{"text": "People ages 5 years and older", "answer_start": 398}], "is_impossible": false}, {"question": "What does the new booster recommendation replace all prior booster recommendations?", "id": "100000000000000000002904", "answers": [{"text": "People ages 5 years and older", "answer_start": 398}], "is_impossible": false}, {"question": "What is the new booster recommendation for this age group?", "id": "100000000000000000002905", "answers": [{"text": "1 bivalent mRNA booster dose", "answer_start": 455}], "is_impossible": false}], "context": "Bivalent mRNA vaccines are not authorized or approved at this time\nfor primary series doses. The same vaccine product should be used for all doses of the primary series (see Interchangeability\nof COVID-19 vaccine products). Booster vaccination\nFor booster vaccination, an mRNA vaccine (i.e., Moderna or Pfizer-BioNTech) is recommended. Recommendations vary based\non age and primary series product. People ages 5 years and older are recommended to receive 1 bivalent mRNA booster dose\nafter completion of any FDA-approved or FDA-authorized monovalent primary series or previously received monovalent\nbooster dose(s). This new booster recommendation replaces all prior booster recommendations for this age\ngroup."}]}, {"title": "576469dc68e25cbe8fbd764da041388b", "paragraphs": [{"qas": [{"question": "What is a monovalent Novavax booster dose instead of a bivalent mRNA booster dose?", "id": "100000000000000000002907", "answers": [{"text": "people ages 18 years and older", "answer_start": 216}], "is_impossible": false}, {"question": "What is the reason for not receiving a booster dose?", "id": "100000000000000000002909", "answers": [{"text": "unwilling to receive an mRNA vaccine", "answer_start": 470}], "is_impossible": false}], "context": "Monovalent mRNA vaccines are no longer authorized as a booster dose for people ages 5 years and older. A monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people\nages 18 years and older who completed any FDA-approved or FDA-authorized monovalent primary series, have not received\nany previous booster dose(s), and are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available)\nor unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose."}]}, {"title": "ed1b6b4853a1b19a390d5ff8e33d32f6", "paragraphs": [{"qas": [{"question": "Who should ensure the correct age-appropriate product is administered based on the recipient\u2019s age on the day of vaccination?", "id": "100000000000000000002910", "answers": [{"text": "Vaccination providers", "answer_start": 23}], "is_impossible": false}, {"question": "What should be administered by the intramuscular route and in accordance with the recommended intervals?", "id": "100000000000000000002911", "answers": [{"text": "Vaccine doses", "answer_start": 177}], "is_impossible": false}, {"question": "What is the age group for which the COVID-19 vaccine is administered?", "id": "100000000000000000002912", "answers": [{"text": "younger to older", "answer_start": 401}], "is_impossible": false}, {"question": "What is another name for the SARS-CoV-2- infection?", "id": "100000000000000000002913", "answers": [{"text": "COVID-19 vaccination", "answer_start": 514}], "is_impossible": false}], "context": "Vaccine administration\nVaccination providers should ensure the correct age-appropriate product is administered based on the recipient\u2019s age on the\nday of vaccination (Table 1). Vaccine doses should be administered by the intramuscular route and in accordance with the\nrecommended intervals for that age group (3). For guidance on timing of vaccination in specific situations, see Transitioning from a younger to older age group,\nConsiderations for extended intervals for COVID-19 vaccine primary series doses, and COVID-19 vaccination and SARS-CoV-2-\ninfection. \u2021 \uf20c\nRecommendations for COVID-19 vaccine use\nBox."}]}, {"title": "4a6bb562c723333d087b4be3e47edf49", "paragraphs": [{"qas": [{"question": "What is the term used for COVID-19 vaccine use?", "id": "100000000000000000002914", "answers": [{"text": "Primary series", "answer_start": 37}], "is_impossible": false}, {"question": "What can range from a single dose to a 3-dose series?", "id": "100000000000000000002915", "answers": [{"text": "Initial vaccination", "answer_start": 53}], "is_impossible": false}, {"question": "The same vaccine product should be used for all doses of the primary series.", "id": "100000000000000000002916", "answers": [{"text": "Primary series", "answer_start": 37}], "is_impossible": false}, {"question": "What is an additional dose?", "id": "100000000000000000002917", "answers": [{"text": "A dose of vaccine administered after the primary series to people who may be less likely to mount a protective immune response after initial vaccination", "answer_start": 292}], "is_impossible": false}, {"question": "Vaccine for their primary series are recommended to receive an additional dose using what?", "id": "100000000000000000002920", "answers": [{"text": "an mRNA vaccine", "answer_start": 621}], "is_impossible": false}], "context": "Terminology for COVID-19 vaccine use\nPrimary series: Initial vaccination which can range from a single dose to a 3-dose series depending on the vaccine\nproduct and a person\u2019s age and immune status. The same vaccine product should be used for all doses of the\nprimary series. Additional dose: A dose of vaccine administered after the primary series to people who may be less likely to mount a\nprotective immune response after initial vaccination. People who are moderately or severely immunocompromised\nand who received Janssen COVID-19 Vaccine for their primary series are recommended to receive an additional dose\nusing an mRNA vaccine."}]}, {"title": "b16dd77757518f733b1e1da29dff754c", "paragraphs": [{"qas": [{"question": "What is a booster dose used to enhance or restore protection after primary series vaccination?", "id": "100000000000000000002921", "answers": [{"text": "Booster dose", "answer_start": 67}], "is_impossible": false}, {"question": "What is the name of the same vaccine manufacturer used for the booster dose and the primary series?", "id": "100000000000000000002922", "answers": [{"text": "Homologous booster dose", "answer_start": 223}], "is_impossible": false}, {"question": "What is the term for a different vaccine manufacturer used for the booster dose and the primary series?", "id": "100000000000000000002923", "answers": [{"text": "Heterologous booster dose", "answer_start": 328}], "is_impossible": false}, {"question": "Which vaccine product is based on the original (ancestral) strain of SARS-CoV-2?", "id": "100000000000000000002924", "answers": [{"text": "Monovalent vaccine", "answer_start": 462}], "is_impossible": false}], "context": "10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nBooster dose: A subsequent dose of vaccine administered to enhance or restore protection which might have waned\nover time after primary series vaccination. Homologous booster dose: The same vaccine manufacturer used for the booster dose and the primary series. Heterologous booster dose (mix-and-match booster): A different vaccine manufacturer used for the booster dose\nand the primary series. Monovalent vaccine: The vaccine product is based on the original (ancestral) strain of SARS-CoV-2."}]}, {"title": "273d531a54061274aba4050007d9d420", "paragraphs": [{"qas": [{"question": "What are the Omicron BA.4 and BA.5 variants?", "id": "100000000000000000002926", "answers": [{"text": "BA.4/BA.5) variants of SARS-CoV-2", "answer_start": 147}], "is_impossible": false}, {"question": "How is COVID-19 vaccinated?", "id": "100000000000000000002927", "answers": [{"text": "The COVID-19 vaccination schedule", "answer_start": 363}], "is_impossible": false}, {"question": "What is recommended for children ages 6 months-4 years?", "id": "100000000000000000002928", "answers": [{"text": "A 2-dose primary series", "answer_start": 563}], "is_impossible": false}, {"question": "What is a booster dose using any COVID-19 vaccine?", "id": "100000000000000000002929", "answers": [{"text": "Currently, a booster dose using any COVID-19 vaccine is not authorized for children in this age group", "answer_start": 626}], "is_impossible": false}, {"question": "How long is recommended for a booster dose?", "id": "100000000000000000002930", "answers": [{"text": "4\u20138 weeks", "answer_start": 600}], "is_impossible": false}, {"question": "What is not authorized for children in this age group?", "id": "100000000000000000002931", "answers": [{"text": "a booster dose", "answer_start": 637}], "is_impossible": false}], "context": "Bivalent vaccine (\u201cupdated vaccine\u201d): The vaccine product is based on the original (ancestral) strain of SARS-CoV-2\nand the Omicron BA.4 and BA.5 (BA.4/BA.5) variants of SARS-CoV-2. Table of Contents \uf426\nCOVID-19 vaccination guidance for people who are not\nmoderately or severely immunocompromised\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nThe COVID-19 vaccination schedule for people who are not moderately or severely immunocompromised is detailed below\nand summarized in Table 2. Moderna COVID-19 Vaccine\nChildren ages 6 months\u20134 years: A 2-dose primary series separated by 4\u20138 weeks is recommended. Currently, a booster\ndose using any COVID-19 vaccine is not authorized for children in this age group."}]}, {"title": "b66530d82297a3c8c065e6759c028c5f", "paragraphs": [{"qas": [{"question": "How many doses of Pfizer-BioNTech are recommended for children under 5 years old?", "id": "100000000000000000002932", "answers": [{"text": "1 bivalent", "answer_start": 50}], "is_impossible": false}, {"question": "How long are the primary series doses separated from the bivalent booster dose?", "id": "100000000000000000002933", "answers": [{"text": "4\u20138 weeks", "answer_start": 148}], "is_impossible": false}, {"question": "Who is authorized to administer a booster dose to children under the age of 5?", "id": "100000000000000000002935", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 291}], "is_impossible": false}, {"question": "What is authorized for children 5 years who receive a Moderna primary series?", "id": "100000000000000000002936", "answers": [{"text": "Pfizer-BioNTech booster dose", "answer_start": 291}], "is_impossible": false}, {"question": "What is recommended for children 6-11 years?", "id": "100000000000000000002937", "answers": [{"text": "A 2-dose primary series and 1 bivalent mRNA booster dose", "answer_start": 423}], "is_impossible": false}, {"question": "How many doses of Pfizer-BioNTech or Moderna are recommended?", "id": "100000000000000000002938", "answers": [{"text": "1", "answer_start": 451}], "is_impossible": false}], "context": "Children age 5 years: A 2-dose primary series and 1 bivalent Pfizer-BioNTech booster dose is recommended. The primary\nseries doses are separated by 4\u20138 weeks and the bivalent booster dose is administered at least 2 months after\ncompletion of the primary series. Currently, only the bivalent Pfizer-BioNTech booster dose is authorized for children age\n5 years who receive a Moderna primary series. Children ages 6\u201311 years: A 2-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-BioNTech) is\nrecommended."}]}, {"title": "2671f59ba5df00f836adcb782960e3c6", "paragraphs": [{"qas": [{"question": "How long are the primary series doses separated?", "id": "100000000000000000002939", "answers": [{"text": "4\u20138 weeks", "answer_start": 42}], "is_impossible": false}, {"question": "What is recommended for children ages 6 months through 11 years?", "id": "100000000000000000002942", "answers": [{"text": "COVID-19 Vaccination Schedule for People who are NOT Moderately or Severely Immunocompromised \uf20a Schedule: ages 6 months through 11 years\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC administered at least 2 months after completion of the primary series. Pfizer-BioNTech COVID-19 Vaccine Children ages 6 months\u20134 years: A 3-dose primary series", "answer_start": 169}], "is_impossible": false}, {"question": "How long is the first dose of COVID-19 separated from the second?", "id": "100000000000000000002943", "answers": [{"text": "8 weeks", "answer_start": 660}], "is_impossible": false}, {"question": "What is the recommended duration of the first and second doses?", "id": "100000000000000000002944", "answers": [{"text": "3\u20138 weeks", "answer_start": 592}], "is_impossible": false}, {"question": "Who recommends a 3-dose primary series?", "id": "100000000000000000002945", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine Children ages 6 months\u20134 years", "answer_start": 444}], "is_impossible": false}, {"question": "How long are the first and second doses separated?", "id": "100000000000000000002946", "answers": [{"text": "3\u20138 weeks", "answer_start": 592}], "is_impossible": false}, {"question": "How long do the second and third doses separate?", "id": "100000000000000000002947", "answers": [{"text": "8 weeks", "answer_start": 660}], "is_impossible": false}], "context": "The primary series doses are separated by 4\u20138 weeks and the bivalent mRNA booster dose is\nadministered at least 2 months after completion of the primary series\nView the COVID-19 Vaccination Schedule for People who are NOT Moderately or Severely Immunocompromised \uf20a\nSchedule: ages 6 months through 11 years\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nadministered at least 2 months after completion of the primary series. Pfizer-BioNTech COVID-19 Vaccine\nChildren ages 6 months\u20134 years: A 3-dose primary series is recommended. The first and second doses are separated by\n3\u20138 weeks and the second and third doses are separated by at least 8 weeks."}]}, {"title": "8e0a15b90d56499afa3a2839d0a2d9b5", "paragraphs": [{"qas": [{"question": "What is not authorized for children in this age group?", "id": "100000000000000000002948", "answers": [{"text": "a booster dose using any COVID- 19 vaccine", "answer_start": 11}], "is_impossible": false}, {"question": "How long are the primary series doses separated?", "id": "100000000000000000002950", "answers": [{"text": "3\u20138 weeks", "answer_start": 252}], "is_impossible": false}, {"question": "How old is the child who receives a Pfizer-BioNTech booster dose?", "id": "100000000000000000002954", "answers": [{"text": "5 years: A 2-dose primary series and 1 bivalent Pfizer-BioNTech booster dose is recommended. The primary series doses are separated by 3\u20138 weeks and the bivalent booster dose is administered at least 2 months after completion of the primary series (for people who have not received any booster doses), or at least 2 months after the last monovalent booster dose. Currently, only the bivalent Pfizer-BioNTech booster dose is authorized for children age 5 years", "answer_start": 117}], "is_impossible": false}], "context": "Currently, a booster dose using any COVID-\n19 vaccine is not authorized for children in this age group. Children age 5 years: A 2-dose primary series and 1 bivalent Pfizer-BioNTech booster dose is recommended. The primary\nseries doses are separated by 3\u20138 weeks and the bivalent booster dose is administered at least 2 months after\ncompletion of the primary series (for people who have not received any booster doses), or at least 2 months after the\nlast monovalent booster dose. Currently, only the bivalent Pfizer-BioNTech booster dose is authorized for children age 5\nyears who receive a Pfizer-BioNTech primary series."}]}, {"title": "a63b99acd8abbaf5c2dccb4e996ad5bf", "paragraphs": [{"qas": [{"question": "What is recommended for children ages 6-11 years?", "id": "100000000000000000002955", "answers": [{"text": "A 2-dose primary series and 1 bivalent mRNA booster dose", "answer_start": 26}], "is_impossible": false}, {"question": "How long are the primary series doses separated?", "id": "100000000000000000002956", "answers": [{"text": "3-8 weeks", "answer_start": 170}], "is_impossible": false}, {"question": "What is the bivalent mRNA booster dose administered at least 2 months after?", "id": "100000000000000000002957", "answers": [{"text": "completion of the primary series", "answer_start": 255}], "is_impossible": false}, {"question": "What is recommended for people who have not received any booster doses?", "id": "100000000000000000002958", "answers": [{"text": "A 2-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-BioNTech) is recommended. The primary series doses are separated by 3-8 weeks and the bivalent mRNA booster dose is administered at least 2 months after completion of the primary series", "answer_start": 26}], "is_impossible": false}, {"question": "How long after the last monovalent booster dose is recommended?", "id": "100000000000000000002959", "answers": [{"text": "2 months", "answer_start": 354}], "is_impossible": false}, {"question": "Who recommends a 2-dose primary series and 1 bivalent mRNA booster dose?", "id": "100000000000000000002960", "answers": [{"text": "Children ages 6\u201311 years", "answer_start": 0}], "is_impossible": false}], "context": "Children ages 6\u201311 years: A 2-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-BioNTech) is\nrecommended. The primary series doses are separated by 3-8 weeks and the bivalent mRNA booster dose is\nadministered at least 2 months after completion of the primary series (for people who have not received any booster\ndoses), or at least 2 months after the last monovalent booster dose. Moderna COVID-19 Vaccine\nPeople ages 12 years and older: A 2-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-\nBioNTech) is recommended."}]}, {"title": "c67382a84a98b8cc02f8caeb9964135f", "paragraphs": [{"qas": [{"question": "How long are the primary series doses separated?", "id": "100000000000000000002961", "answers": [{"text": "4\u20138 weeks", "answer_start": 42}], "is_impossible": false}, {"question": "What is the age range of people who receive the Novavax COVID-19 Vaccine?", "id": "100000000000000000002963", "answers": [{"text": "12 years and older", "answer_start": 312}], "is_impossible": false}, {"question": "How many doses of Novavax COVID-19 Vaccine are recommended for people ages 12 years and older?", "id": "100000000000000000002964", "answers": [{"text": "2", "answer_start": 334}], "is_impossible": false}, {"question": "When is the bivalent mRNA booster dose administered?", "id": "100000000000000000002965", "answers": [{"text": "2 months", "answer_start": 112}], "is_impossible": false}, {"question": "How long after completing the primary series is the mRNA booster dose administered?", "id": "100000000000000000002966", "answers": [{"text": "2 months", "answer_start": 112}], "is_impossible": false}], "context": "The primary series doses are separated by 4\u20138 weeks and the bivalent mRNA booster dose\nis administered at least 2 months after completion of the primary series (for people who have not received any booster\ndoses), or at least 2 months after the last monovalent booster dose. Novavax COVID-19 Vaccine\nPeople ages 12 years and older: A 2-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-\nBioNTech) is recommended. The primary series doses are separated by 3\u20138 weeks and the bivalent mRNA booster dose\nis administered at least 2 months after completion of the primary series."}]}, {"title": "dd70acb7f440c478b24ee4a7078bedc5", "paragraphs": [{"qas": [{"question": "Who recommends a 2-dose primary series and 1 bivalent mRNA booster dose?", "id": "100000000000000000002967", "answers": [{"text": "People ages 12 years and older", "answer_start": 33}], "is_impossible": false}, {"question": "What is the recommended duration of a primary series?", "id": "100000000000000000002969", "answers": [{"text": "3\u20138 weeks", "answer_start": 210}], "is_impossible": false}, {"question": "When is the bivalent booster dose administered?", "id": "100000000000000000002970", "answers": [{"text": "at least 2 months", "answer_start": 271}], "is_impossible": false}, {"question": "How long after completion of the primary series?", "id": "100000000000000000002971", "answers": [{"text": "2 months", "answer_start": 280}], "is_impossible": false}, {"question": "For people who have not received any booster doses, how long after the last monovalent booster dose?", "id": "100000000000000000002972", "answers": [{"text": "2 months", "answer_start": 394}], "is_impossible": false}], "context": "Pfizer-BioNTech COVID-19 Vaccine\nPeople ages 12 years and older: A 2-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-\nBioNTech) is recommended. The primary series doses are separated by 3\u20138 weeks and the bivalent mRNA booster dose\nis administered at least 2 months after completion of the primary series (for people who have not received any booster\ndoses), or at least 2 months after the last monovalent booster dose."}]}, {"title": "513f07a1f0eca6cbe69568d3d0a1d02e", "paragraphs": [{"qas": [{"question": "What is another term for a person who is unable or unwilling to receive a booster dose?", "id": "100000000000000000002975", "answers": [{"text": "mRNA vaccine", "answer_start": 344}], "is_impossible": false}], "context": "Use of the monovalent Novavax booster dose in limited situations\nPeople ages 18 years and older who completed primary vaccination using any COVID-19 vaccine and have not received\nany previous booster dose(s) may receive a monovalent Novavax booster dose at least 6 months after completion of the\nprimary series if they are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) or\nunwilling to receive an mRNA vaccine and would otherwise not receive a booster dose. Table 2."}]}, {"title": "e276514097e15900055acc5d50f52b96", "paragraphs": [{"qas": [{"question": "What is the recommended bivalent booster dose?", "id": "100000000000000000002977", "answers": [{"text": "mRNA", "answer_start": 1188}], "is_impossible": false}, {"question": "How long is the duration of the COVID-19 vaccination?", "id": "100000000000000000002978", "answers": [{"text": "2 months", "answer_start": 823}], "is_impossible": false}, {"question": "How many weeks NA At least 2 months Novavax primary series and booster dose and older?", "id": "100000000000000000002979", "answers": [{"text": "4\u20138 weeks", "answer_start": 366}], "is_impossible": false}, {"question": "What is recommended bivalent booster dose?", "id": "100000000000000000002980", "answers": [{"text": "mRNA", "answer_start": 1188}], "is_impossible": false}, {"question": "What is the abbreviation for not authorized A monovalent Novavax booster dose (instead of a monovalent dose)?", "id": "100000000000000000002981", "answers": [{"text": "NA", "answer_start": 1111}], "is_impossible": false}, {"question": "What is a dose and older Pfizer-BioNTech?", "id": "100000000000000000002982", "answers": [{"text": "2 months", "answer_start": 1031}], "is_impossible": false}, {"question": "What is the abbreviation for the term \"not authorized\"?", "id": "100000000000000000002983", "answers": [{"text": "NA", "answer_start": 1111}], "is_impossible": false}, {"question": "What is a monovalent Novavax booster dose instead of a bivalent mRNA booster dose?", "id": "100000000000000000002984", "answers": [{"text": "3\u20138 weeks At least 8 weeks NA years Pfizer-BioNTech 3\u20138 weeks NA At least 2 months and older Pfizer-BioNTech 3\u20138 weeks NA At least 2 months Abbreviation: NA = not authorized A monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people ages 18 years and older", "answer_start": 957}], "is_impossible": false}, {"question": "In limited situations, what may be used in people who completed a primary series using any COVID-19 vaccine?", "id": "100000000000000000002985", "answers": [{"text": "monovalent Novavax booster dose", "answer_start": 1133}], "is_impossible": false}, {"question": "What type of vaccine is not available or contraindicated?", "id": "100000000000000000002986", "answers": [{"text": "mRNA", "answer_start": 1430}], "is_impossible": false}, {"question": "What is another term for someone who is unable to receive an mRNA vaccine?", "id": "100000000000000000002987", "answers": [{"text": "3\u20138 weeks At least 8 weeks NA years Pfizer-BioNTech 3\u20138 weeks NA At least 2 months and older Pfizer-BioNTech 3\u20138 weeks NA At least 2 months Abbreviation: NA = not authorized A monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people ages 18 years and older", "answer_start": 957}], "is_impossible": false}], "context": "COVID-19 vaccination schedule for people who are not moderately or severely immunocompromised\nAge\ngroup\nNumber of\nprimary doses\nNumber of\nbivalent booster\ndoses\nRecommended\nbivalent booster\ndose*\nInterval between 1st and\n2nd primary dose\nInterval between 2nd\nand 3rd primary dose\nInterval between primary\nseries and booster dose\nModerna primary series\nyears\n2 NA NA 4\u20138 weeks NA NA\nyears\nPfizer-BioNTech\n4\u20138 weeks NA At least 2 months\nSchedule: ages 12 years and older\n\u2020 \u2021\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nAge\ngroup\nNumber of\nprimary doses\nNumber of\nbivalent booster\ndoses\nRecommended\nbivalent booster\ndose*\nInterval between 1st and\n2nd primary dose\nInterval between 2nd\nand 3rd primary dose\nInterval between primary\nseries and booster dose\nand older\nPfizer-BioNTech\n4\u20138 weeks NA At least 2 months\nNovavax primary series\nand older\nPfizer-BioNTech\n3\u20138 weeks NA At least 2 months\nPfizer-BioNTech primary series\nyears\n3 NA NA 3\u20138 weeks At least 8 weeks NA\nyears\nPfizer-BioNTech\n3\u20138 weeks NA At least 2 months\nand older\nPfizer-BioNTech\n3\u20138 weeks NA At least 2 months\nAbbreviation: NA = not authorized\nA monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people ages 18 years and older who\ncompleted a primary series using any COVID-19 vaccine, have not received any previous booster dose(s), and are unable to receive an mRNA vaccine (i.e.,\nmRNA vaccine contraindicated or not available) or unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose."}]}, {"title": "18e6c4185e5bcbd9d7a52cf90b40f4d2", "paragraphs": [{"qas": [{"question": "When is the monovalent Novavax booster dose administered?", "id": "100000000000000000002988", "answers": [{"text": "at least 6 months after completion of any primary series", "answer_start": 52}], "is_impossible": false}, {"question": "How long is the interval between the first and second doses of Moderna, NovavaX, and Pfizer-BioNTech COVID-19 vaccines?", "id": "100000000000000000002989", "answers": [{"text": "8-week", "answer_start": 113}], "is_impossible": false}, {"question": "What is the optimal interval for some people ages 6 months-64 years?", "id": "100000000000000000002990", "answers": [{"text": "8-week", "answer_start": 113}], "is_impossible": false}, {"question": "How long does it take to get a vaccine for myocarditis?", "id": "100000000000000000002991", "answers": [{"text": "8-week", "answer_start": 113}], "is_impossible": false}, {"question": "Why is it important to get vaccines for males?", "id": "100000000000000000002993", "answers": [{"text": "it may reduce the small risk of myocarditis and pericarditis", "answer_start": 335}], "is_impossible": false}], "context": "The monovalent\nNovavax booster dose is administered at least 6 months after completion of any primary series. An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines may be optimal for\nsome people ages 6 months\u201364 years, especially for males ages 12\u201339 years, as it may reduce the small risk of myocarditis and pericarditis associated with\nthese vaccines."}]}, {"title": "e195d2c1de553f791c3581c3075c606c", "paragraphs": [{"qas": [{"question": "What is the recommended interval between the first and second dose of Novavax?", "id": "100000000000000000002994", "answers": [{"text": "3 weeks", "answer_start": 20}], "is_impossible": false}, {"question": "What are adults ages 65 years and older recommended intervals for?", "id": "100000000000000000002996", "answers": [{"text": "people who are moderately or severely immunocompromised", "answer_start": 154}], "is_impossible": false}, {"question": "What is an increased concern about COVID-19 community levels?", "id": "100000000000000000002997", "answers": [{"text": "higher risk of severe disease", "answer_start": 348}], "is_impossible": false}, {"question": "What is administered at least 2 months after the last monovalent booster dose?", "id": "100000000000000000002998", "answers": [{"text": "bivalent booster dose", "answer_start": 448}], "is_impossible": false}], "context": "A shorter interval (3 weeks for Novavax and Pfizer-BioNTech; 4 weeks for Moderna) between the first and second doses remains the\nrecommended interval for people who are moderately or severely immunocompromised; adults ages 65 years and older; and in situations in which there is\nincreased concern about COVID-19 community levels or an individual\u2019s higher risk of severe disease. For people who previously received a monovalent booster dose(s), the bivalent booster dose is administered at least 2 months after the last monovalent\nbooster dose."}]}, {"title": "ba220eeb6826ab5196a0b8d77503b8ce", "paragraphs": [{"qas": [{"question": "What age group is recommended to receive the Janssen COVID-19 Vaccine primary series dose?", "id": "100000000000000000003001", "answers": [{"text": "18 years and older", "answer_start": 195}], "is_impossible": false}, {"question": "How long after completion of the primary series dose are people who have not received any booster doses recommended to receive 1 bivalent mRNA booster dose?", "id": "100000000000000000003002", "answers": [{"text": "2 months", "answer_start": 376}], "is_impossible": false}, {"question": "What is another name for Pfizer-BioNTech?", "id": "100000000000000000003003", "answers": [{"text": "Moderna", "answer_start": 339}], "is_impossible": false}, {"question": "How many months after the last monovalent booster dose is recommended?", "id": "100000000000000000003004", "answers": [{"text": "2 months", "answer_start": 495}], "is_impossible": false}, {"question": "What was the last monovalent booster dose?", "id": "100000000000000000003005", "answers": [{"text": "2 months", "answer_start": 495}], "is_impossible": false}, {"question": "What is the name of the Janssen Vaccine?", "id": "100000000000000000003006", "answers": [{"text": "COVID-19", "answer_start": 239}], "is_impossible": false}], "context": "The monovalent Novavax booster dose is administered at least 6 months after completion of any primary series and cannot be used in people\nwho previously received any booster dose(s). People ages 18 years and older who received the Janssen COVID-19 Vaccine primary series dose are recommended to receive\n1 bivalent mRNA booster dose (i.e., Moderna or Pfizer-BioNTech) at least 2 months after completion of the primary series\ndose (for people who have not received any booster doses), or at least 2 months after the last monovalent booster dose. See Appendix A for additional information on Janssen COVID-19 Vaccine."}]}, {"title": "634c8d0bc8deb68fd44240d5bbb0b1c1", "paragraphs": [{"qas": [{"question": "What may be optimal for some people because it may reduce the small risk of myocarditis?", "id": "100000000000000000003008", "answers": [{"text": "An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "The absolute risk remains small, but an elevated risk for what?", "id": "100000000000000000003009", "answers": [{"text": "myocarditis and pericarditis", "answer_start": 320}], "is_impossible": false}, {"question": "What has been observed among mRNA COVID- 19 vaccine recipients?", "id": "100000000000000000003010", "answers": [{"text": "an elevated risk for myocarditis and pericarditis", "answer_start": 299}], "is_impossible": false}, {"question": "What was identified in clinical trials of Novavax?", "id": "100000000000000000003011", "answers": [{"text": "Cases of myocarditis and pericarditis", "answer_start": 508}], "is_impossible": false}, {"question": "How were cases of myocarditis identified?", "id": "100000000000000000003012", "answers": [{"text": "in clinical trials of Novavax COVID-19 Vaccine and through passive surveillance during post-authorization use outside the United States", "answer_start": 562}], "is_impossible": false}, {"question": "Novavax COVID-19 Vaccine and through what type of surveillance during post-authorization use outside of the US?", "id": "100000000000000000003013", "answers": [{"text": "passive surveillance", "answer_start": 621}], "is_impossible": false}], "context": "An 8-week interval between the first and second primary series doses of Moderna, Novavax, and Pfizer-BioNTech COVID-19\nvaccines may be optimal for some people as it may reduce the small risk of myocarditis and pericarditis associated with these\nCOVID-19 vaccines. While absolute risk remains small, an elevated risk for myocarditis and pericarditis has been observed among mRNA COVID-\n19 vaccine recipients, particularly in males ages 12\u201339 years (see COVID-19 vaccination and myocarditis and pericarditis). Cases of myocarditis and pericarditis were identified in clinical trials of Novavax COVID-19 Vaccine and through passive\nsurveillance during post-authorization use outside the United States."}]}, {"title": "9f94955a0bbc73f4fb907fe50d4de5e4", "paragraphs": [{"qas": [{"question": "What is the age range of adolescent and adult vaccine recipients?", "id": "100000000000000000003014", "answers": [{"text": "12\u201317 years", "answer_start": 34}], "is_impossible": false}, {"question": "How long is the interval between vaccinations for COVID-19?", "id": "100000000000000000003015", "answers": [{"text": "4 weeks", "answer_start": 272}], "is_impossible": false}, {"question": "What has not been shown to increase vaccine effectiveness?", "id": "100000000000000000003016", "answers": [{"text": "Extending the interval beyond 8 weeks", "answer_start": 281}], "is_impossible": false}, {"question": "What has not been shown to provide additional benefit?", "id": "100000000000000000003017", "answers": [{"text": "Extending the interval beyond 8 weeks", "answer_start": 281}], "is_impossible": false}, {"question": "How many weeks is the interval extended beyond?", "id": "100000000000000000003018", "answers": [{"text": "8", "answer_start": 311}], "is_impossible": false}], "context": "Some studies in adolescents (ages 12\u201317 years) and adults have shown the small risk of myocarditis and pericarditis\nassociated with mRNA COVID-19 vaccines might be reduced and peak antibody responses and vaccine effectiveness may be\nincreased with an interval longer than 4 weeks. Extending the interval beyond 8 weeks has not been shown to provide\nadditional benefit."}]}, {"title": "964aa9365ed7a09e670b213600fe405c", "paragraphs": [{"qas": [{"question": "Novavax and Pfizer-BioNTech are examples of what?", "id": "100000000000000000003020", "answers": [{"text": "FDA-approved or FDA-authorized for a 3-week", "answer_start": 232}], "is_impossible": false}, {"question": "What are people who are moderately or severely immunocompromised, adults ages 65 years and older, and in situations when the fullest possible protection needs to be achieved sooner?", "id": "100000000000000000003022", "answers": [{"text": "* \u2020", "answer_start": 3}], "is_impossible": false}, {"question": "What is increased concern about?", "id": "100000000000000000003023", "answers": [{"text": "COVID-19 community levels", "answer_start": 649}], "is_impossible": false}, {"question": "What is an individual\u2019s higher risk for?", "id": "100000000000000000003024", "answers": [{"text": "severe disease", "answer_start": 710}], "is_impossible": false}], "context": "\u2020 \u2021\n*\n\u2020\n\u2021\nPrevious vaccination with Janssen COVID-19 Vaccine\nConsiderations for extended intervals for COVID-19 vaccine primary series\ndoses\n\uf20c\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nCOVID-19 vaccines are FDA-approved or FDA-authorized for a 3-week (i.e., Novavax and Pfizer-BioNTech) and 4-week (i.e.,\nModerna) interval between the first and second primary series doses. These intervals continue to be recommended for\npeople who are moderately or severely immunocompromised, adults ages 65 years and older, and in situations when the\nfullest possible protection needs to be achieved sooner (e.g., increased concern about COVID-19 community levels or an\nindividual\u2019s higher risk for severe disease)."}]}, {"title": "80154fde26256a1dec1f6ebbd6380516", "paragraphs": [{"qas": [{"question": "What is summarized in Table 3?", "id": "100000000000000000003026", "answers": [{"text": "The COVID-19 vaccination schedule", "answer_start": 0}], "is_impossible": false}, {"question": "How is the COVID-19 vaccination schedule for people who are moderately or severely immunocompromised summarized?", "id": "100000000000000000003027", "answers": [{"text": "Table 3", "answer_start": 130}], "is_impossible": false}, {"question": "What should people who become moderately or severely immunocompromised follow?", "id": "100000000000000000003029", "answers": [{"text": "COVID-19 vaccination schedule", "answer_start": 550}], "is_impossible": false}], "context": "The COVID-19 vaccination schedule for people who are moderately or severely immunocompromised is detailed below and\nsummarized in Table 3; see also COVID-19 vaccination and EVUSHELD\u2122. Table of Contents \uf426\nCOVID-19 vaccination guidance for people who are moderately\nor severely immunocompromised\nView the COVID-19 Vaccination Schedule for People who are Moderately or Severely Immunocompromised \uf20a\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nPeople who are or who become moderately or severely immunocompromised should follow the COVID-19 vaccination\nschedule according to their age and immune status at the time of eligibility for that dose."}]}, {"title": "d32a8ee62fbd31bb5fbad61ca344cac3", "paragraphs": [{"qas": [{"question": "What do people who become immunocompromised after completing a 2-dose mRNA primary series do not need?", "id": "100000000000000000003030", "answers": [{"text": "additional primary doses", "answer_start": 130}], "is_impossible": false}, {"question": "How long are the first and second doses separated?", "id": "100000000000000000003033", "answers": [{"text": "4 weeks", "answer_start": 419}], "is_impossible": false}, {"question": "What is not authorized for children in this age group?", "id": "100000000000000000003034", "answers": [{"text": "a booster dose", "answer_start": 505}], "is_impossible": false}], "context": "For example, people who become\nmoderately or severely immunocompromised after completing a 2-dose mRNA primary series do not need additional primary\ndoses; however, they should follow the schedule for people who are moderately or severely immunocompromised for the\nbooster dose. Moderna COVID-19 Vaccine\nChildren ages 6 months\u20134 years: A 3-dose primary series is recommended. The first and second doses are separated by\n4 weeks and the second and third doses are separated by at least 4 weeks. Currently, a booster dose using any COVID-19\nvaccine is not authorized for children in this age group."}]}, {"title": "c230ec199d51a003b09fe8f1ea91bce8", "paragraphs": [{"qas": [{"question": "How long are the first and second doses separated?", "id": "100000000000000000003035", "answers": [{"text": "4 weeks", "answer_start": 150}], "is_impossible": false}, {"question": "How long is the second and third dose separated by?", "id": "100000000000000000003036", "answers": [{"text": "4 weeks", "answer_start": 215}], "is_impossible": false}, {"question": "When is the bivalent booster dose administered?", "id": "100000000000000000003037", "answers": [{"text": "2 months after completion of the primary series", "answer_start": 275}], "is_impossible": false}, {"question": "What is authorized for children age 5 years who receive a Moderna primary series?", "id": "100000000000000000003039", "answers": [{"text": "Pfizer-BioNTech booster dose", "answer_start": 352}], "is_impossible": false}], "context": "Children age 5 years: A 3-dose primary series and 1 bivalent Pfizer-BioNTech booster dose is recommended. The first\nand second doses are separated by 4 weeks and the second and third doses are separated by at least 4 weeks. The\nbivalent booster dose is administered at least 2 months after completion of the primary series.Currently, only the\nbivalent Pfizer-BioNTech booster dose is authorized for children age 5 years who receive a Moderna primary series. Children ages 6\u201311 years: A 3-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-BioNTech) is\nrecommended."}]}, {"title": "89a642e47561b477b5112d5a011d6ef3", "paragraphs": [{"qas": [{"question": "How long is the second and third dose separated?", "id": "100000000000000000003042", "answers": [{"text": "4 weeks", "answer_start": 109}], "is_impossible": false}, {"question": "When is the bivalent mRNA booster dose administered?", "id": "100000000000000000003043", "answers": [{"text": "2 months after completion of the primary series", "answer_start": 174}], "is_impossible": false}, {"question": "What is the age range of the COVID-19 Vaccine?", "id": "100000000000000000003044", "answers": [{"text": "6 months\u20134 years", "answer_start": 270}], "is_impossible": false}, {"question": "What is recommended for COVID-19 Vaccine Children ages 6 months-4 years?", "id": "100000000000000000003045", "answers": [{"text": "A 3-dose primary series", "answer_start": 288}], "is_impossible": false}, {"question": "What is not authorized for children in this age group?", "id": "100000000000000000003047", "answers": [{"text": "a booster dose", "answer_start": 457}], "is_impossible": false}], "context": "The first and second doses are separated by 4 weeks and the second and third doses are separated by at\nleast 4 weeks. The bivalent mRNA booster dose is administered at least 2 months after completion of the primary series. Pfizer-BioNTech COVID-19 Vaccine\nChildren ages 6 months\u20134 years: A 3-dose primary series is recommended. The first and second doses are separated by\n3 weeks and the second and third doses are separated by at least 8 weeks. Currently, a booster dose using any COVID-19\nvaccine is not authorized for children in this age group."}]}, {"title": "fd478c290f101c698b79e12bf7a23dab", "paragraphs": [{"qas": [{"question": "How many doses of Pfizer-BioNTech are recommended for children under 5 years old?", "id": "100000000000000000003048", "answers": [{"text": "1 bivalent", "answer_start": 50}], "is_impossible": false}, {"question": "How long are the first and second doses separated for the primary series?", "id": "100000000000000000003049", "answers": [{"text": "3 weeks", "answer_start": 174}], "is_impossible": false}, {"question": "What is the duration of the second and third doses?", "id": "100000000000000000003050", "answers": [{"text": "4 weeks", "answer_start": 239}], "is_impossible": false}, {"question": "How long after the primary series is the bivalent booster dose administered?", "id": "100000000000000000003052", "answers": [{"text": "2 months", "answer_start": 299}], "is_impossible": false}, {"question": "How many months after the last monovalent dose of the booster dose is given?", "id": "100000000000000000003053", "answers": [{"text": "2", "answer_start": 413}], "is_impossible": false}], "context": "Children age 5 years: A 3-dose primary series and 1 bivalent Pfizer-BioNTech booster dose is recommended. For the\nprimary series, the first and second doses are separated by 3 weeks and the second and third doses are separated by at\nleast 4 weeks. The bivalent booster dose is administered at least 2 months after completion of the primary series (for\npeople who have not received any booster doses), or at least 2 months after the last monovalent booster dose. Currently, only the bivalent Pfizer-BioNTech booster dose is authorized for children age 5 years who receive a Pfizer-\nBioNTech primary series."}]}, {"title": "ac13d270f2e84b48684256303433187b", "paragraphs": [{"qas": [{"question": "How many doses of mRNA booster are recommended for children ages 6-11 years?", "id": "100000000000000000003056", "answers": [{"text": "1", "answer_start": 54}], "is_impossible": false}, {"question": "How long are the first and second doses separated for the primary series?", "id": "100000000000000000003057", "answers": [{"text": "3 weeks", "answer_start": 196}], "is_impossible": false}, {"question": "What is the duration of the second and third doses?", "id": "100000000000000000003058", "answers": [{"text": "4 weeks", "answer_start": 261}], "is_impossible": false}, {"question": "How long does it take for a bivalent booster to be administered?", "id": "100000000000000000003059", "answers": [{"text": "2 months", "answer_start": 321}], "is_impossible": false}, {"question": "How long is it necessary for people who have not received a booster dose to receive the bivalent dose?", "id": "100000000000000000003060", "answers": [{"text": "2 months", "answer_start": 321}], "is_impossible": false}, {"question": "What is the minimum amount of time that a monovalent booster dose is given?", "id": "100000000000000000003061", "answers": [{"text": "2 months", "answer_start": 435}], "is_impossible": false}], "context": "Children ages 6\u201311 years: A 3-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-BioNTech) is\nrecommended. For the primary series, the first and second doses are separated by 3 weeks and the second and third\ndoses are separated by at least 4 weeks. The bivalent booster dose is administered at least 2 months after completion of\nthe primary series (for people who have not received any booster doses), or at least 2 months after the last monovalent\nbooster dose."}]}, {"title": "f0a9606eb350229f55a59a8e6480a399", "paragraphs": [{"qas": [{"question": "How many doses of COVID-19 Vaccine are recommended for people 12 years and older?", "id": "100000000000000000003062", "answers": [{"text": "3", "answer_start": 59}], "is_impossible": false}, {"question": "How long are the first and second doses separated from the second and third doses?", "id": "100000000000000000003063", "answers": [{"text": "4 weeks", "answer_start": 293}], "is_impossible": false}, {"question": "How long are the third doses separated?", "id": "100000000000000000003064", "answers": [{"text": "4 weeks", "answer_start": 293}], "is_impossible": false}], "context": "Moderna COVID-19 Vaccine\nPeople ages 12 years and older: A 3-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-\nBioNTech) is recommended. For the primary series, the first and second doses are separated by 4 weeks and the second\nand third doses are separated by at least 4 weeks. The bivalent mRNA booster dose is administered at least 2 months\nafter completion of the primary series (for people who have not received any booster doses), or at least 2 months after\nthe last monovalent booster dose."}]}, {"title": "6c1d92c660212f12a6dd2ce3d612bcf4", "paragraphs": [{"qas": [{"question": "Who recommends a 2-dose primary series and 1 bivalent mRNA booster dose?", "id": "100000000000000000003066", "answers": [{"text": "People ages 12 years and older", "answer_start": 25}], "is_impossible": false}, {"question": "How long are the primary series doses separated by?", "id": "100000000000000000003067", "answers": [{"text": "3 weeks", "answer_start": 202}], "is_impossible": false}, {"question": "What is the bivalent dose administered at least 2 months after completion of a primary series?", "id": "100000000000000000003068", "answers": [{"text": "mRNA booster dose", "answer_start": 227}], "is_impossible": false}, {"question": "How many doses of COVID-19 Vaccine do people ages 12 years and older need?", "id": "100000000000000000003070", "answers": [{"text": "2", "answer_start": 59}], "is_impossible": false}, {"question": "What is a bivalent mRNA booster dose?", "id": "100000000000000000003071", "answers": [{"text": "1", "answer_start": 85}], "is_impossible": false}, {"question": "How many doses of mRNA booster are recommended?", "id": "100000000000000000003072", "answers": [{"text": "1", "answer_start": 85}], "is_impossible": false}], "context": "Novavax COVID-19 Vaccine\nPeople ages 12 years and older: A 2-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-\nBioNTech) is recommended. The primary series doses are separated by 3 weeks and the bivalent mRNA booster dose is\nadministered at least 2 months after completion of the primary series. Pfizer-BioNTech COVID-19 Vaccine\nSchedule: ages 6 months through 11 years\nSchedule: ages 12 years and older\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nPeople ages 12 years and older: A 3-dose primary series and 1 bivalent mRNA booster dose (Moderna or Pfizer-\nBioNTech) is recommended."}]}, {"title": "f9c0b0f6a353a112868ab0fb673139fc", "paragraphs": [{"qas": [{"question": "How long are the first and second doses separated for the primary series?", "id": "100000000000000000003073", "answers": [{"text": "3 weeks", "answer_start": 68}], "is_impossible": false}, {"question": "How long is the second and third dose separated?", "id": "100000000000000000003074", "answers": [{"text": "4 weeks", "answer_start": 133}], "is_impossible": false}, {"question": "When is the bivalent mRNA booster dose administered?", "id": "100000000000000000003075", "answers": [{"text": "2 months", "answer_start": 198}], "is_impossible": false}, {"question": "What is the term for people who haven't received any booster doses?", "id": "100000000000000000003076", "answers": [{"text": "primary series", "answer_start": 231}], "is_impossible": false}, {"question": "How long after the last monovalent booster dose is the primary series?", "id": "100000000000000000003077", "answers": [{"text": "2 months", "answer_start": 312}], "is_impossible": false}], "context": "For the primary series, the first and second doses are separated by 3 weeks and the second\nand third doses are separated by at least 4 weeks. The bivalent mRNA booster dose is administered at least 2 months\nafter completion of the primary series (for people who have not received any booster doses), or at least 2 months after\nthe last monovalent booster dose."}]}, {"title": "d086419a3f83bd6e1363868e7988893c", "paragraphs": [{"qas": [{"question": "Who may receive a monovalent Novavax booster dose at least 6 months after completion of the primary series?", "id": "100000000000000000003078", "answers": [{"text": "People ages 18 years and older", "answer_start": 65}], "is_impossible": false}, {"question": "How long after completing the primary series is a child unable to receive an mRNA vaccine?", "id": "100000000000000000003079", "answers": [{"text": "6 months", "answer_start": 263}], "is_impossible": false}], "context": "Use of the monovalent Novavax booster dose in limited situations\nPeople ages 18 years and older who completed primary vaccination using any COVID-19 vaccine and have not received\nany previous booster dose(s) may receive a monovalent Novavax booster dose at least 6 months after completion of the\nprimary series if they are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) or\nunwilling to receive an mRNA vaccine and would otherwise not receive a booster dose. Table 3."}]}, {"title": "e550d869eb5d62fb5e6210987927e45f", "paragraphs": [{"qas": [{"question": "What is the recommended bivalent booster dose?", "id": "100000000000000000003082", "answers": [{"text": "mRNA", "answer_start": 1043}], "is_impossible": false}, {"question": "How long does it take to get the COVID-19 vaccination?", "id": "100000000000000000003083", "answers": [{"text": "Moderna primary series years 3 NA NA 4 weeks", "answer_start": 325}], "is_impossible": false}, {"question": "At least 2 months Pfizer-BioNTech primary series years 3 NA NA 3 weeks At least 8 weeks NA 5 years 3 1 What is the abbreviation of the acronym NA?", "id": "100000000000000000003085", "answers": [{"text": "not authorized", "answer_start": 970}], "is_impossible": false}, {"question": "What is the abbreviation for not authorized?", "id": "100000000000000000003086", "answers": [{"text": "NA", "answer_start": 965}], "is_impossible": false}, {"question": "What is a monovalent Novavax booster dose instead of a bivalent mRNA booster dose?", "id": "100000000000000000003087", "answers": [{"text": "*", "answer_start": 985}], "is_impossible": false}, {"question": "What type of vaccine is not available or contraindicated?", "id": "100000000000000000003088", "answers": [{"text": "mRNA vaccine (i.e., mRNA", "answer_start": 1266}], "is_impossible": false}, {"question": "What is a condition of not receiving an mRNA vaccine?", "id": "100000000000000000003089", "answers": [{"text": "unwilling", "answer_start": 1336}], "is_impossible": false}], "context": "COVID-19 vaccination schedule for people who are moderately or severely immunocompromised\nAge\ngroup\nNumber of\nprimary doses\nNumber of\nbivalent booster\ndoses\nRecommended\nbivalent booster\ndose*\nInterval between 1st\nand 2nd primary dose\nInterval between 2nd\nand 3rd primary dose\nInterval between primary\nseries and booster dose\nModerna primary series\nyears\n3 NA NA 4 weeks At least 4 weeks NA\n5 years 3 1 Pfizer-BioNTech 4 weeks At least 4 weeks At least 2 months\nyears\nPfizer-BioNTech\n4 weeks At least 4 weeks At least 2 months\nand older\nPfizer-BioNTech\n4 weeks At least 4 weeks At least 2 months\nNovavax primary series\nand older\nPfizer-BioNTech\n3 weeks NA At least 2 months\nPfizer-BioNTech primary series\nyears\n3 NA NA 3 weeks At least 8 weeks NA\n5 years 3 1 Pfizer-BioNTech 3 weeks At least 4 weeks At least 2 months\nyears\nPfizer-BioNTech\n3 weeks At least 4 weeks At least 2 months\nand older\nPfizer-BioNTech\n3 weeks At least 4 weeks At least 2 months\nAbbreviation: NA = not authorized\n*A monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people ages 18 years and older who\ncompleted a primary series using any COVID-19 vaccine, have not received any previous booster dose(s), and are unable to receive an mRNA vaccine (i.e.,\nmRNA vaccine contraindicated or not available) or unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose."}]}, {"title": "1863b4efd76afa3aec6e161e88aa28b0", "paragraphs": [{"qas": [{"question": "When is the monovalent Novavax booster dose administered?", "id": "100000000000000000003090", "answers": [{"text": "6 months after completion of any primary series", "answer_start": 61}], "is_impossible": false}, {"question": "How long after completion of any primary series is the dose given?", "id": "100000000000000000003093", "answers": [{"text": "6 months", "answer_start": 61}], "is_impossible": false}], "context": "The monovalent\nNovavax booster dose is administered at least 6 months after completion of any primary series. For people who previously received a monovalent booster dose(s), the bivalent booster dose is administered at least 2 months after the last monovalent\nbooster dose. The monovalent Novavax booster dose is administered at least 6 months after completion of any primary series and cannot be used in people\nwho previously received any booster dose(s)."}]}, {"title": "ac9b669f06258c03006d4558eb2381f9", "paragraphs": [{"qas": [{"question": "Who recommends people who are moderate or severely immunocompromised to receive an additional dose?", "id": "100000000000000000003095", "answers": [{"text": "Janssen COVID-19 Vaccine primary series dose are recommended to receive a second (additional) dose using a monovalent mRNA vaccine and 1 bivalent mRNA booster dose", "answer_start": 97}], "is_impossible": false}, {"question": "How long are the primary series dose and the additional dose separated?", "id": "100000000000000000003097", "answers": [{"text": "4 weeks", "answer_start": 371}], "is_impossible": false}, {"question": "How long after the last monovalent booster dose are people who have not received any booster doses given?", "id": "100000000000000000003099", "answers": [{"text": "2 months", "answer_start": 537}], "is_impossible": false}, {"question": "How long after the last monovalent booster dose does the Janssen COVID-19 vaccine last?", "id": "100000000000000000003100", "answers": [{"text": "2 months", "answer_start": 537}], "is_impossible": false}], "context": "People who are moderately or severely immunocompromised ages 18 years and older who received the Janssen COVID-19\nVaccine primary series dose are recommended to receive a second (additional) dose using a monovalent mRNA vaccine and 1\nbivalent mRNA booster dose (i.e., Moderna or Pfizer-BioNTech). The primary series dose and the additional dose are\nseparated by at least 4 weeks. The bivalent mRNA booster dose is administered at least 2 months after the additional dose\n(for people who have not received any booster doses), or at least 2 months after the last monovalent booster dose. See Appendix A for additional information on Janssen COVID-19 Vaccine."}]}, {"title": "8544a81b94c530487e9aaf6515143264", "paragraphs": [{"qas": [{"question": "How often is EVUSHELD given after COVID-19 vaccine?", "id": "100000000000000000003104", "answers": [{"text": "2 weeks", "answer_start": 483}], "is_impossible": false}, {"question": "How long after the first dose of EVusHELD is given?", "id": "100000000000000000003105", "answers": [{"text": "2 weeks", "answer_start": 483}], "is_impossible": false}, {"question": "What is the name of the vaccine that is given at least 2 weeks after the second dose?", "id": "100000000000000000003106", "answers": [{"text": "EVUSHELD", "answer_start": 456}], "is_impossible": false}, {"question": "Who can initiate EVOSHELD at any time after this interval?", "id": "100000000000000000003107", "answers": [{"text": "People", "answer_start": 515}], "is_impossible": false}], "context": "\u2020\n\u2020\nPrevious vaccination with Janssen COVID-19 Vaccine\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nIn addition to following the recommended COVID-19 vaccination schedule, tixagevimab/cilgavimab (EVUSHELD ), a\ncombination of two monoclonal antibodies, should be administered to people who are moderately or severely\nimmunocompromised every 6 months for pre-exposure prophylaxis to supplement vaccine protection. Per the product\nEUA , EVUSHELD is given at least 2 weeks after COVID-19 vaccine. People may initiate EVUSHELD at any time after this\ninterval, including between doses in the primary series and primary and booster doses."}]}, {"title": "d16190037de6d089ecddfbdfc273b0dc", "paragraphs": [{"qas": [{"question": "What is active treatment for for solid tumor and hematologic malignancies?", "id": "100000000000000000003110", "answers": [{"text": "high-dose corticosteroids", "answer_start": 1045}], "is_impossible": false}, {"question": "What is CAR-T-cell therapy?", "id": "100000000000000000003112", "answers": [{"text": "chimeric antigen receptor", "answer_start": 473}], "is_impossible": false}, {"question": "What is HCT?", "id": "100000000000000000003113", "answers": [{"text": "hematopoietic cell transplant", "answer_start": 523}], "is_impossible": false}, {"question": "What is the name of the disease that causes Wiskott-Aldrich syndrome?", "id": "100000000000000000003115", "answers": [{"text": "Moderate or severe primary immunodeficiency", "answer_start": 631}], "is_impossible": false}, {"question": "People with HIV and CD4 cell counts less than 200/mm3 have what type of infection?", "id": "100000000000000000003116", "answers": [{"text": "Advanced HIV", "answer_start": 803}], "is_impossible": false}, {"question": "What type of HIV infection is active treatment with high-dose corticosteroids?", "id": "100000000000000000003117", "answers": [{"text": "untreated", "answer_start": 999}], "is_impossible": false}, {"question": "How many mg or more of prednisone or equivalent per day is recommended?", "id": "100000000000000000003118", "answers": [{"text": "20", "answer_start": 1078}], "is_impossible": false}, {"question": "How many mg or more of prednisone or equivalent per day when given for 2 or more weeks?", "id": "100000000000000000003119", "answers": [{"text": "20", "answer_start": 1078}], "is_impossible": false}, {"question": "What are some factors to consider in assessing the general level of immune competence in a patient?", "id": "100000000000000000003121", "answers": [{"text": "disease severity, duration, clinical stability, complications, comorbidities, and any potentially immune-suppressing treatment", "answer_start": 1557}], "is_impossible": false}], "context": "Moderate and severe immunocompromising conditions and treatments include but are not limited to:\nActive treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines regardless of current treatment status\n(e.g., chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute leukemia)\nReceipt of solid-organ transplant or an islet transplant and taking immunosuppressive therapy\nReceipt of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant (HCT) (within 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease, severe combined\nimmunodeficiency, DiGeorge syndrome, Wiskott-Aldrich syndrome)\nAdvanced HIV infection (people with HIV and CD4 cell counts less than 200/mm3, history of an AIDS-defining illness\nwithout immune reconstitution, or clinical manifestations of symptomatic HIV) or untreated HIV infection\nActive treatment with high-dose corticosteroids (i.e., 20 mg or more of prednisone or equivalent per day when\nadministered for 2 or more weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs,\ncancer chemotherapeutic agents classified as severely immunosuppressive, tumor necrosis factor (TNF) blockers, and\nother biologic agents that are immunosuppressive or immunomodulatory (e.g., B-cell-depleting agents)\nFactors to consider in assessing the general level of immune competence in a patient include disease severity, duration,\nclinical stability, complications, comorbidities, and any potentially immune-suppressing treatment."}]}, {"title": "e7ccd11ed243fe0dfbf35474a426ca84", "paragraphs": [{"qas": [{"question": "What should not be used to determine the level of immune competence?", "id": "100000000000000000003122", "answers": [{"text": "Age or place of residence", "answer_start": 0}], "is_impossible": false}, {"question": "What can providers consult for additional information about the degree of immune suppression associated with different medical conditions and treatments?", "id": "100000000000000000003123", "answers": [{"text": "ACIP\u2019s general best practices", "answer_start": 339}], "is_impossible": false}, {"question": "What is ACIP's general best practices for vaccination of people with altered immunocompetence?", "id": "100000000000000000003124", "answers": [{"text": "the CDC Yellow Book", "answer_start": 426}], "is_impossible": false}, {"question": "What is the 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host?", "id": "100000000000000000003125", "answers": [{"text": "the CDC Yellow Book, and the Infectious Diseases Society of America policy statement", "answer_start": 426}], "is_impossible": false}, {"question": "Who can self-attest to their moderate or severe immunocompromised status?", "id": "100000000000000000003126", "answers": [{"text": "People", "answer_start": 598}], "is_impossible": false}], "context": "Age or place of residence\nalone (e.g., residence in a long-term care setting ), independent of a patient\u2019s medical condition, should not be used to\ndetermine the level of immune competence. For additional information about the degree of immune suppression associated with different medical conditions and\ntreatments, providers can consult ACIP\u2019s general best practices for vaccination of people with altered immunocompetence,\nthe CDC Yellow Book, and the Infectious Diseases Society of America policy statement, 2013 IDSA Clinical Practice Guideline\nfor Vaccination of the Immunocompromised Host . People can self-attest to their moderately or severely immunocompromised status and receive COVID-19 vaccine doses\nwherever vaccines are offered."}]}, {"title": "d6acc662d339716a255b7bd93e15aca", "paragraphs": [{"qas": [{"question": "Who should not deny COVID-19 vaccination to a person due to lack of documentation?", "id": "100000000000000000003128", "answers": [{"text": "Vaccinators", "answer_start": 0}], "is_impossible": false}, {"question": "What is defined as repeating 1 or more dose(s) of vaccine?", "id": "100000000000000000003129", "answers": [{"text": "Revaccination", "answer_start": 91}], "is_impossible": false}, {"question": "Which vaccine should be used for revaccination?", "id": "100000000000000000003130", "answers": [{"text": "Moderna, Novavax, or Pfizer-BioNTech COVID-19", "answer_start": 197}], "is_impossible": false}, {"question": "What should the patient receive after revaccination with the primary series?", "id": "100000000000000000003133", "answers": [{"text": "1 bivalent booster dose", "answer_start": 656}], "is_impossible": false}], "context": "Vaccinators should not deny COVID-19 vaccination to a person due to lack of documentation. Revaccination is defined as repeating 1 or more dose(s) of vaccine. COVID-19 revaccination should be with Moderna, Novavax,\nor Pfizer-BioNTech COVID-19 vaccine (Table 3) regardless of vaccine administered for initial vaccination. Recipients of HCT or\nCAR-T-cell therapy should undergo revaccination for the monovalent primary series and bivalent booster doses received prior\nto or during treatment. There is no revaccination for monovalent booster doses received prior to or during treatment. After\nrevaccination with the primary series, the patient should receive 1 bivalent booster dose."}]}, {"title": "e39974d47e60cb4a34bb94cb6d86e979", "paragraphs": [{"qas": [{"question": "How many doses of CAR-T-cell therapy can a patient receive?", "id": "100000000000000000003134", "answers": [{"text": "3 months (12 weeks", "answer_start": 147}], "is_impossible": false}, {"question": "What is the maximum number of primary series and booster doses?", "id": "100000000000000000003135", "answers": [{"text": "Revaccination cannot exceed the number of primary series and booster doses currently authorized", "answer_start": 0}], "is_impossible": false}, {"question": "How long should a person have to wait for a transplant to begin revascularization?", "id": "100000000000000000003136", "answers": [{"text": "3 months", "answer_start": 147}], "is_impossible": false}], "context": "Revaccination cannot exceed the\nnumber of primary series and booster doses currently authorized (see Table 3). Revaccination should start at least 3 months\n(12 weeks) after transplant or CAR-T-cell therapy."}]}, {"title": "7c2e364455d05d5a137b80b054eba317", "paragraphs": [{"qas": [{"question": "What can be considered for patients who received 1 or more doses of COVID-19 vaccine?", "id": "100000000000000000003137", "answers": [{"text": "Revaccination", "answer_start": 290}], "is_impossible": false}, {"question": "How many doses of COVID-19 vaccine were given during treatment with B-cell-depleting therapies?", "id": "100000000000000000003138", "answers": [{"text": "1 or more doses", "answer_start": 353}], "is_impossible": false}], "context": "COVID-19 vaccination and EVUSHELD\u2122\n\u2122\n\uf20a\n\uf209 \u2122 \u2122\n\u2122 \uf20c \uf209 \u2122\nDescription of moderate and severe immunocompromising conditions\nand treatment\n\uf209\n\uf209\nSelf-attestation of immunocompromised status\nConsiderations for COVID-19 revaccination\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nRevaccination may also be considered for patients who received 1 or more doses of COVID-19 vaccine (primary series and\nbivalent booster doses) during treatment with B-cell-depleting therapies (e.g., rituximab, ocrelizumab) that were administered\nover a limited period (e.g., as part of a treatment regimen for certain malignancies). There is no revaccination for monovalent\nbooster doses received prior to or during treatment."}]}, {"title": "75aa0c8b6f5886b00f56b7cfa194d523", "paragraphs": [{"qas": [{"question": "What should the patient receive after revaccination with the primary series?", "id": "100000000000000000003140", "answers": [{"text": "1 bivalent booster dose", "answer_start": 72}], "is_impossible": false}, {"question": "What can not exceed the number of primary series and booster doses currently authorized?", "id": "100000000000000000003141", "answers": [{"text": "Revaccination", "answer_start": 97}], "is_impossible": false}, {"question": "How long after completion of the B-cell-depleting therapy is the suggested interval to start revaccinate?", "id": "100000000000000000003142", "answers": [{"text": "6 months", "answer_start": 249}], "is_impossible": false}, {"question": "What does B-cell-depleting therapy treat?", "id": "100000000000000000003143", "answers": [{"text": "rheumatoid arthritis or multiple sclerosis", "answer_start": 466}], "is_impossible": false}, {"question": "What is addressed in Considerations for timing of COVID- 19 vaccination in relation to immunosuppressive therapies?", "id": "100000000000000000003144", "answers": [{"text": "Timing of vaccination", "answer_start": 308}], "is_impossible": false}], "context": "After revaccination with the primary series, the patient should receive 1\nbivalent booster dose. Revaccination cannot exceed the number of primary series and booster doses currently authorized. The suggested interval to start revaccination is about 6 months after completion of the B-cell-depleting therapy. Timing of\nvaccination for patients who receive B-cell-depleting therapies on a continuing basis (e.g., for treatment of certain\nautoimmune conditions such as rheumatoid arthritis or multiple sclerosis) is addressed in Considerations for timing of COVID-\n19 vaccination in relation to immunosuppressive therapies."}]}, {"title": "5ef4110517113a10d8b4cca23cd71d7e", "paragraphs": [{"qas": [{"question": "What is best positioned to determine the degree of immune compromise?", "id": "100000000000000000003145", "answers": [{"text": "A patient\u2019s clinical team", "answer_start": 0}], "is_impossible": false}, {"question": "What should not be delayed in patients taking immunosuppressive therapies?", "id": "100000000000000000003146", "answers": [{"text": "Administration of COVID-19 vaccines", "answer_start": 156}], "is_impossible": false}, {"question": "When should COVID-19 vaccines be administered?", "id": "100000000000000000003147", "answers": [{"text": "at least 2 weeks before initiation or resumption of immunosuppressive therapies", "answer_start": 322}], "is_impossible": false}, {"question": "How long should COVID-19 vaccines be given for patients who receive B-cell-depleting therapies on a continuing basis?", "id": "100000000000000000003149", "answers": [{"text": "4 weeks", "answer_start": 533}], "is_impossible": false}, {"question": "What type of therapy is used to treat a patient's medical condition?", "id": "100000000000000000003150", "answers": [{"text": "immunosuppressive therapies", "answer_start": 233}], "is_impossible": false}, {"question": "What are the benefits and risks of a vaccine?", "id": "100000000000000000003151", "answers": [{"text": "individual benefits and risks", "answer_start": 784}], "is_impossible": false}], "context": "A patient\u2019s clinical team is best positioned to determine the degree of immune compromise, need for revaccination, and\nappropriate timing of revaccination. Administration of COVID-19 vaccines should not be delayed in patients taking immunosuppressive therapies. Whenever\npossible, COVID-19 vaccines should be administered at least 2 weeks before initiation or resumption of immunosuppressive\ntherapies. For patients who receive B-cell-depleting therapies on a continuing basis, COVID-19 vaccines should be\nadministered approximately 4 weeks before the next scheduled therapy. Timing of COVID-19 vaccination should take into consideration current or planned immunosuppressive therapies,\noptimization of both the patient\u2019s medical condition and anticipated response to vaccination, and individual benefits and\nrisks."}]}, {"title": "8284cfa6dcb3c9c3e97223b50bb2a84b", "paragraphs": [{"qas": [{"question": "What is the utility of serologic testing, cellular immune testing, or B-cell quantification?", "id": "100000000000000000003154", "answers": [{"text": "assess immune response to vaccination and guide clinical care has not been established", "answer_start": 561}], "is_impossible": false}], "context": "On a case-by-case basis, providers caring for moderately or severely immunocompromised patients may administer\nModerna, Novavax, and Pfizer-BioNTech COVID-19 vaccines outside of the FDA and CDC dosing intervals when, based on their\nclinical judgment, the benefits of vaccination are deemed to outweigh the potential and unknown risks for the recipient. However, providers should not routinely administer doses of COVID-19 vaccine beyond those recommended in this guidance. The utility of serologic testing , cellular immune testing, or B-cell quantification to assess immune response to vaccination\nand guide clinical care has not been established."}]}, {"title": "b73c2345b4c044d7a886ea6a41a9abe3", "paragraphs": [{"qas": [{"question": "Doses administered up to 4 days before the minimum interval are considered to be what?", "id": "100000000000000000003156", "answers": [{"text": "valid", "answer_start": 198}], "is_impossible": false}, {"question": "What does the 4-day grace period apply to?", "id": "100000000000000000003157", "answers": [{"text": "primary series and booster doses", "answer_start": 221}], "is_impossible": false}, {"question": "How long is the grace period for a dose to be given?", "id": "100000000000000000003159", "answers": [{"text": "4-day", "answer_start": 163}], "is_impossible": false}, {"question": "What is a valid dose given after the recommended interval?", "id": "100000000000000000003160", "answers": [{"text": "Doses administered at any time", "answer_start": 330}], "is_impossible": false}], "context": "Such testing outside of the context of research studies is not recommended\nat this time. Doses administered up to 4 days before the minimum interval, known as the 4-day grace period, are considered valid. This\napplies to primary series and booster doses. If a dose is administered prior to the 4-day grace period, see Appendix D. Doses\nadministered at any time after the recommended interval are valid. People should receive the recommended age-appropriate vaccine product and dosage based on their age on the day of\nvaccination."}]}, {"title": "7033ec552ac292ead56ba35fc9f64c67", "paragraphs": [{"qas": [{"question": "What should a person receive if they move from a younger age group to an older age group during the primary series?", "id": "100000000000000000003161", "answers": [{"text": "vaccine product and dosage", "answer_start": 167}], "is_impossible": false}], "context": "If a person moves from a younger age group to an older age group during the primary series or between the\nprimary series and the booster dose, they should receive the vaccine product and dosage for the older age group for all\nsubsequent doses."}]}, {"title": "ef43b9036c93d1b50e168edf91a22d0a", "paragraphs": [{"qas": [{"question": "What is a consideration for timing of COVID-19 vaccination in relation to immunosuppressive therapies?", "id": "100000000000000000003163", "answers": [{"text": "Timing, spacing, interchangeability, and coadministration of 4-Day grace period", "answer_start": 115}], "is_impossible": false}, {"question": "What does FDA authorization allow for for certain situations where a child ages from birth to what age?", "id": "100000000000000000003164", "answers": [{"text": "dosing options", "answer_start": 348}], "is_impossible": false}, {"question": "What is the name of the vaccine for children ages from a younger to older age group?", "id": "100000000000000000003166", "answers": [{"text": "Moderna COVID-19 Vaccine", "answer_start": 443}], "is_impossible": false}, {"question": "What is the name of the first series and booster doses of COVID-19 vaccination after SARS-CoV-2 infection?", "id": "100000000000000000003168", "answers": [{"text": "primary", "answer_start": 644}], "is_impossible": false}], "context": "Considerations for timing of COVID-19 vaccination in relation to\nimmunosuppressive therapies\n\uf209\nTable of Contents \uf426\nTiming, spacing, interchangeability, and coadministration of\n4-Day grace period\nTransitioning from a younger to older age group\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nHowever, FDA authorization allows for dosing options for certain situations where a child ages from a younger to older age\ngroup for Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine . Refer to Table 1 for information about\nage-specific vaccine products and dosages. For information on the timing of COVID-19 vaccination (primary series and booster doses) after SARS-CoV-2 infection, see\nCOVID-19 vaccination and SARS-CoV-2 infection."}]}, {"title": "9b03c83edba2689f2328b2b4e29a7fa0", "paragraphs": [{"qas": [{"question": "What should be used for all doses in the primary series?", "id": "100000000000000000003169", "answers": [{"text": "the same monovalent vaccine product", "answer_start": 27}], "is_impossible": false}, {"question": "When a different COVID-19 vaccine is administered to complete a primary series at a minimum interval of how many days from the last dose?", "id": "100000000000000000003171", "answers": [{"text": "28", "answer_start": 506}], "is_impossible": false}], "context": "Primary series\nIn general, the same monovalent vaccine product should be used for all doses in the primary series. A mixed primary series composed of any combination of Moderna, Novavax, and Pfizer-BioNTechCOVID-19 vaccines is not\nauthorized. If a mixed primary series is inadvertently administered, the series is complete, and doses do not need to be\nrepeated. In the following exceptional situations, a different COVID-19 vaccine may be administered to complete a primary series at a\nminimum interval of 28 days from the last COVID-19 vaccine dose. No VAERS report is required."}]}, {"title": "41324445a37d8cfdb180ea37a88ae58", "paragraphs": [{"qas": [{"question": "What is the reason a person is unable to complete a primary series with the same COVID-19 vaccine?", "id": "100000000000000000003173", "answers": [{"text": "contraindication", "answer_start": 219}], "is_impossible": false}, {"question": "How many doses of the mRNA COVID-19 vaccine should be given?", "id": "100000000000000000003175", "answers": [{"text": "3", "answer_start": 377}], "is_impossible": false}, {"question": "How long should a third dose be given after the second dose?", "id": "100000000000000000003176", "answers": [{"text": "8 weeks", "answer_start": 463}], "is_impossible": false}, {"question": "What is the duration of a 3-dose primary series?", "id": "100000000000000000003177", "answers": [{"text": "8 weeks", "answer_start": 463}], "is_impossible": false}], "context": "The same vaccine is not available\nA previous dose is unknown\nThe person would otherwise not complete the primary series\nA person starts but is unable to complete a primary series with the same COVID-19 vaccine due to a contraindication. Children ages 6 months\u20134 years who receive different mRNA products for the first 2 doses of an mRNA COVID-19 vaccine\nseries should follow a 3-dose schedule . A third dose of either mRNA vaccine should be administered at least 8 weeks after\nthe second dose to complete the 3-dose primary series."}]}, {"title": "d694856682b3acd9415cafb1ff2a009d", "paragraphs": [{"qas": [{"question": "What can be used if a booster dose is FDA-authorized for use in that age group?", "id": "100000000000000000003181", "answers": [{"text": "Any homologous or heterologous bivalent mRNA vaccine", "answer_start": 254}], "is_impossible": false}, {"question": "COVID-19 vaccines may be administered without regard to what?", "id": "100000000000000000003182", "answers": [{"text": "timing of other vaccines", "answer_start": 438}], "is_impossible": false}, {"question": "What are additional considerations if administering an orthopoxvirus vaccine?", "id": "100000000000000000003183", "answers": [{"text": "simultaneous administration of COVID-19 vaccine and other vaccines on the same day", "answer_start": 478}], "is_impossible": false}], "context": "People who received Janssen COVID-19 Vaccine after a dose of another COVID-19 vaccine should be considered to have\nreceived a valid, single-dose Janssen primary series. Booster vaccination\nFor booster vaccination, bivalent mRNA vaccines are recommended. Any homologous or heterologous bivalent mRNA vaccine\ncan be used if a booster dose is FDA-authorized for use in that age group. COVID-19 vaccines may be administered without regard to timing of other vaccines. This includes simultaneous\nadministration of COVID-19 vaccine and other vaccines on the same day. However, there are additional considerations if\nadministering an orthopoxvirus vaccine (see below)."}]}, {"title": "c11ae325f1d3554f145f036017e0efd8", "paragraphs": [{"qas": [{"question": "What has demonstrated that immunogenicity and adverse event profiles are generally similar when vaccines are administered simultaneously as when they are administered alone?", "id": "100000000000000000003184", "answers": [{"text": "Extensive experience with non-COVID 19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "Studies that compared coadministration of COVID-19 vaccines and seasonal influenza vaccines with separate administration of these vaccines found similar levels of what?", "id": "100000000000000000003185", "answers": [{"text": "immunogenicity", "answer_start": 380}], "is_impossible": false}, {"question": "What vaccines showed similar levels of immunogenicity and reactogenicity?", "id": "100000000000000000003186", "answers": [{"text": "COVID-19 vaccines and seasonal influenza vaccines", "answer_start": 259}], "is_impossible": false}, {"question": "What is recommended for children, adolescents, and adults for whom no specific contraindications exist?", "id": "100000000000000000003187", "answers": [{"text": "routine administration of all age-appropriate doses of vaccines simultaneously", "answer_start": 530}], "is_impossible": false}], "context": "Extensive experience with non-COVID 19 vaccines has demonstrated that immunogenicity and adverse event profiles are\ngenerally similar when vaccines are administered simultaneously as when they are administered alone. Studies that\ncompared coadministration of COVID-19 vaccines and seasonal influenza vaccines with separate administration of these\nvaccines found similar levels of immunogenicity and similar or slightly higher reactogenicity; no specific safety concerns were\nidentified. In accordance with general best practices, routine administration of all age-appropriate doses of vaccines simultaneously is\nrecommended for children, adolescents, and adults for whom no specific contraindications exist at the time of the healthcare\nvisit."}]}, {"title": "c97ed82fcfa05e25f0bc6ef90b1a1be3", "paragraphs": [{"qas": [{"question": "What is the name of the orthopoxvirus vaccine?", "id": "100000000000000000003190", "answers": [{"text": "JYNNEOS or ACAM2000", "answer_start": 386}], "is_impossible": false}, {"question": "What is the minimum interval between vaccinations for JYNNEOS or ACAM2000?", "id": "100000000000000000003192", "answers": [{"text": "4 weeks", "answer_start": 612}], "is_impossible": false}, {"question": "Why would people who previously received orthopoxvirus vaccinations consider waiting 4 weeks before receiving a COVID-19 vaccine?", "id": "100000000000000000003193", "answers": [{"text": "because of the observed risk for myocarditis and pericarditis", "answer_start": 700}], "is_impossible": false}, {"question": "What is a risk for myocarditis after receipt of a vaccine? What is another name for Moderna, Novavax or Pfizer-BioNTech?", "id": "100000000000000000003194", "answers": [{"text": "COVID-19", "answer_start": 639}], "is_impossible": false}, {"question": "What was the observed risk for myocarditis and pericardiitis after receipt of the ACAM2000 orthopoxvirus vaccine and COVID-19 vaccine?", "id": "100000000000000000003195", "answers": [{"text": "4 weeks", "answer_start": 612}], "is_impossible": false}], "context": "Orthopoxvirus vaccination:\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products\n\uf20c\nCoadministration of COVID-19 vaccines with other vaccines\n\uf20c\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nPeople who previously received COVID-19 vaccination (i.e. Moderna, Novavax, or Pfizer-BioNTech) may be given\northopoxvirus vaccine (either JYNNEOS or ACAM2000) without a minimum interval between vaccinations. People who previously received orthopoxvirus vaccination (either JYNNEOS or ACAM2000), particularly adolescent or\nyoung adult males, might consider waiting 4 weeks before receiving a COVID-19 vaccine (i.e. Moderna, Novavax, or\nPfizer-BioNTech) because of the observed risk for myocarditis and pericarditis after receipt of ACAM2000 orthopoxvirus\nvaccine and COVID-19 vaccines (i.e."}]}, {"title": "17a45a981ec6909d52fe1bb798e778ce", "paragraphs": [{"qas": [{"question": "What is the unknown risk for myocarditis after JYNNEOS administration?", "id": "100000000000000000003196", "answers": [{"text": "pericarditis", "answer_start": 78}], "is_impossible": false}, {"question": "What should be provided to all vaccine recipients and caregivers?", "id": "100000000000000000003197", "answers": [{"text": "The vaccine-specific EUA or EUI Fact Sheet for Recipients and Caregivers", "answer_start": 291}], "is_impossible": false}, {"question": "What should be provided to all vaccine recipients before vaccination with any currently FDA-approved or FDA-authorized COVID- 19 vaccine?", "id": "100000000000000000003198", "answers": [{"text": "The vaccine-specific EUA or EUI Fact Sheet for Recipients and Caregivers", "answer_start": 291}], "is_impossible": false}, {"question": "Providers should counsel what about common local (e.g., pain/tenderness, swelling, erythema at the injection site) and systemic?", "id": "100000000000000000003199", "answers": [{"text": "COVID-19 vaccine recipients, parents, or guardians", "answer_start": 576}], "is_impossible": false}, {"question": "What are some symptoms of post-vaccination reactions?", "id": "100000000000000000003200", "answers": [{"text": "fever, fatigue/malaise, headache, chills, myalgia, arthralgia", "answer_start": 732}], "is_impossible": false}], "context": "Moderna, Novavax, or Pfizer-BioNTech) and the unknown risk for myocarditis and\npericarditis after JYNNEOS administration. For best practices for administering multiple injections, see ACIP\u2019s general best practices and Epidemiology and Prevention of\nVaccine-Preventable Diseases (Pink Book). The vaccine-specific EUA or EUI Fact Sheet for Recipients and Caregivers should be provided to all vaccine recipients, parents\nor guardians, and caregivers (when relevant) before vaccination with any currently FDA-approved or FDA-authorized COVID-\n19 vaccine. Providers should counsel COVID-19 vaccine recipients, parents, or guardians about common local (e.g.,\npain/tenderness, swelling, erythema at the injection site) and systemic (e.g., fever, fatigue/malaise, headache, chills, myalgia,\narthralgia) post-vaccination reactions."}]}, {"title": "be22c05dd597d0a5186ddb62b990f4f8", "paragraphs": [{"qas": [{"question": "What type of lymphadenopathy is seen on the same side as the vaccinated arm or groin?", "id": "100000000000000000003202", "answers": [{"text": "Localized axillary", "answer_start": 0}], "is_impossible": false}, {"question": "What vaccines have been used?", "id": "100000000000000000003203", "answers": [{"text": "Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines", "answer_start": 162}], "is_impossible": false}, {"question": "What is swelling at or near the site of a filler injection?", "id": "100000000000000000003205", "answers": [{"text": "temporary swelling", "answer_start": 294}], "is_impossible": false}, {"question": "What can systemic reactions include in younger children?", "id": "100000000000000000003206", "answers": [{"text": "irritability/crying, sleepiness, and loss of appetite", "answer_start": 528}], "is_impossible": false}], "context": "Localized axillary lymphadenopathy on the same side as the vaccinated arm or groin, if\nvaccination was in the thigh, has been observed following vaccination with Moderna, Novavax, and Pfizer-BioNTech COVID-19\nvaccines (4). Infrequently, people who have received dermal fillers might experience temporary swelling at or near the site of\nfiller injection (usually face or lips) following a dose of an mRNA COVID-19 vaccine. Among younger children, particularly those\nyounger than ages 3 years, systemic reactions also can include irritability/crying, sleepiness, and loss of appetite."}]}, {"title": "b624859d3eff932d038b6b02855d5ccd", "paragraphs": [{"qas": [{"question": "What should people be encouraged to do unless they have a contraindication to vaccination?", "id": "100000000000000000003207", "answers": [{"text": "complete the series", "answer_start": 83}], "is_impossible": false}, {"question": "Who should be made aware of the rare COVID-19 vaccine?", "id": "100000000000000000003208", "answers": [{"text": "males ages 12\u201339 years", "answer_start": 305}], "is_impossible": false}, {"question": "What age group should be made aware of the rare risk of myocarditis and pericardiitis following receipt of COVID-19 vaccines?", "id": "100000000000000000003209", "answers": [{"text": "males ages 12\u201339 years", "answer_start": 305}], "is_impossible": false}, {"question": "How long after vaccination does COVID-19 vaccine last?", "id": "100000000000000000003211", "answers": [{"text": "week", "answer_start": 583}], "is_impossible": false}], "context": "Unless people have a contraindication to vaccination, they should be encouraged to complete the series to optimize\nprotection against COVID-19 even if they experience local or systemic symptoms following the first dose. People receiving Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines, especially males ages 12\u201339 years, should be\nmade aware of the rare risk of myocarditis and pericarditis following receipt of these COVID-19 vaccines. Counseling should\ninclude the need to seek care if symptoms of myocarditis or pericarditis develop after vaccination, particularly in the week\nafter vaccination. See COVID-19 vaccination and myocarditis and pericarditis for additional information."}]}, {"title": "efabe80ebaa08cb5fa6df141473a6d4d", "paragraphs": [{"qas": [{"question": "What has been rare following receipt of COVID-19 vaccines?", "id": "100000000000000000003213", "answers": [{"text": "Anaphylactic reactions", "answer_start": 0}], "is_impossible": false}, {"question": "What may occur in association with COVID-19 Vaccination?", "id": "100000000000000000003216", "answers": [{"text": "Syncope", "answer_start": 666}], "is_impossible": false}, {"question": "What is the name of the type of allergic reaction in patients who are at higher risk for allergic reactions?", "id": "100000000000000000003217", "answers": [{"text": "milder allergic reactions", "answer_start": 333}], "is_impossible": false}], "context": "Anaphylactic reactions have been rarely reported following receipt of COVID-19 vaccines. Administration of antihistamines\nbefore COVID-19 vaccination to prevent allergic reactions is not generally recommended. However, while antihistamines will\nnot prevent anaphylaxis, some experts advise antihistamine use as a means of preventing milder allergic reactions in patients\nwho might be at higher risk for allergic reactions. For more information on the assessment and potential management of\nanaphylaxis, see Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination. For more information on patient counseling, see Vaccine Recipient Education. Syncope (fainting) may occur in association with any injectable vaccine, especially in adolescents."}]}, {"title": "4380a7aed0645df263f3132cc82d384d", "paragraphs": [{"qas": [{"question": "Vaccination providers, especially when vaccinating adolescents, should consider observing vaccine recipients for what amount of time?", "id": "100000000000000000003222", "answers": [{"text": "15 minutes", "answer_start": 264}], "is_impossible": false}], "context": "Procedures should be in\nplace to prevent falling injuries and manage syncopal reactions. Patients should be seated or lying down during vaccination. Vaccination providers, particularly when vaccinating adolescents, should consider observing vaccine recipients for 15 minutes\nafter vaccination. If syncope develops, patients should be observed until symptoms resolve."}]}, {"title": "556c32b0037839628a0c633026400f91", "paragraphs": [{"qas": [{"question": "What is a contraindication to a different type of vaccine?", "id": "100000000000000000003225", "answers": [{"text": "Allergy-related", "answer_start": 171}], "is_impossible": false}], "context": "Additionally, providers should consider observing people with the following medical histories for 30 minutes after COVID-19\nvaccination to monitor for allergic reactions:\nAllergy-related contraindication to a different type of COVID-19 vaccine\nTable of Contents \uf426\nPatient counseling\nPre-vaccination counseling\nPost-vaccination observation period\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nAllergy-related contraindication to a different type of COVID-19 vaccine\nNon-severe, immediate (onset within 4 hours) allergic reaction after a previous dose of COVID-19 vaccine\nAnaphylaxis after non-COVID-19 vaccines or injectable therapies\nSee also Contraindications and precautions."}]}, {"title": "a588f2daca10338fa8b5ce3a49f0dd68", "paragraphs": [{"qas": [{"question": "Antipyretic or analgesic medications can be taken for the treatment of what?", "id": "100000000000000000003229", "answers": [{"text": "post-vaccination local or systemic symptoms", "answer_start": 71}], "is_impossible": false}, {"question": "What is not recommended for use in children and adolescents ages 17 and younger?", "id": "100000000000000000003230", "answers": [{"text": "aspirin", "answer_start": 279}], "is_impossible": false}], "context": "Antipyretic or analgesic medications can be taken for the treatment of post-vaccination local or systemic symptoms, if\nmedically appropriate; these medications should not be used prophylactically for the purposes of prevention of post-\nvaccination symptoms. However, in general, aspirin is not recommended for use in children and adolescents ages 17 years\nand younger as an antipyretic or analgesic due to the risk of Reye\u2019s syndrome. Pre-vaccination testing\nAntibody testing is not currently recommended to assess the need for vaccination in an unvaccinated person or to assess\nimmunity to SARS-CoV-2 following COVID-19 vaccination."}]}, {"title": "bee45fbbdb5ba2906d392cf8ff3f38f6", "paragraphs": [{"qas": [{"question": "What are the performance characteristics of SARS-CoV-2 antibody tests?", "id": "100000000000000000003234", "answers": [{"text": "variable", "answer_start": 224}], "is_impossible": false}, {"question": "What does not evaluate the cellular immune response?", "id": "100000000000000000003235", "answers": [{"text": "antibody testing", "answer_start": 356}], "is_impossible": false}, {"question": "Prior receipt of a COVID-19 vaccine will not affect the results of what tests?", "id": "100000000000000000003236", "answers": [{"text": "SARS-CoV-2 viral tests", "answer_start": 551}], "is_impossible": false}], "context": "If antibody testing was done, vaccination with the primary series or a\nbooster dose should be completed as recommended regardless of the antibody test result. SARS-CoV-2 antibody tests\ncurrently authorized under an EUA have variable performance characteristics and limitations. Furthermore, serologic\ncorrelates of protection have not been established and antibody testing does not evaluate the cellular immune response. Interpretation of SARS-CoV-2 test results in vaccinated people\nPrior receipt of a COVID-19 vaccine will not affect the results of SARS-CoV-2 viral tests (nucleic acid amplification or antigen\ntests)."}]}, {"title": "a65a7c9d0034d0d55bfbea46199840f0", "paragraphs": [{"qas": [{"question": "What is a test that specifically detects IgM/IgG to the nucleocapsid protein?", "id": "100000000000000000003237", "answers": [{"text": "To evaluate for antibody evidence of prior infection in vaccinated people", "answer_start": 0}], "is_impossible": false}, {"question": "Who considers COVID-19 vaccination to be contraindicated?", "id": "100000000000000000003238", "answers": [{"text": "CDC", "answer_start": 282}], "is_impossible": false}, {"question": "Who considers COVID-19 vaccination to be contraindicated or a precaution?", "id": "100000000000000000003239", "answers": [{"text": "CDC", "answer_start": 282}], "is_impossible": false}, {"question": "What is a severe allergic reaction after a previous dose or to a component of the vaccine?", "id": "100000000000000000003240", "answers": [{"text": "anaphylaxis", "answer_start": 556}], "is_impossible": false}, {"question": "Do not vaccinate with the same type of what vaccine?", "id": "100000000000000000003241", "answers": [{"text": "COVID-19", "answer_start": 672}], "is_impossible": false}], "context": "To evaluate for antibody evidence of prior infection in vaccinated people (e.g., for public health surveillance), a test that\nspecifically detects IgM/IgG to the nucleocapsid protein should be used. For more information, see the CDC and FDA SARS-CoV-2 laboratory testing Web pages. CDC considers COVID-19 vaccination to be contraindicated or a precaution in the following situations:\nTable 4. Contraindications and precautions to COVID-19 vaccination\nMedical condition or history Guidance Recommended action(s)\nHistory of a severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the\nContraindication Do not vaccinate with the\nsame type of COVID-19\nvaccine."}]}, {"title": "320c2db2f396dbef7a414f6f8422f450", "paragraphs": [{"qas": [{"question": "Do not vaccinate with a COVID-19 vaccine that contains a component of what vaccine?", "id": "100000000000000000003242", "answers": [{"text": "Contraindication", "answer_start": 76}], "is_impossible": false}, {"question": "History of history of anaphylaxis after any vaccine other than what vaccine or after any injectable therapy?", "id": "100000000000000000003243", "answers": [{"text": "COVID-19 vaccine", "answer_start": 216}], "is_impossible": false}, {"question": "What does the benefit of vaccination outweigh the risks for most people?", "id": "100000000000000000003245", "answers": [{"text": "Precaution", "answer_start": 415}], "is_impossible": false}, {"question": "People with a history of a non-severe, immediate allergic reaction after a dose of one type of COVID-19 vaccine have a precaution to what type of vaccine?", "id": "100000000000000000003246", "answers": [{"text": "the same type of COVID-19 vaccine", "answer_start": 649}], "is_impossible": false}, {"question": "What type of vaccine have a precaution to the same type of COVID-19 vaccine?", "id": "100000000000000000003247", "answers": [{"text": "one", "answer_start": 599}], "is_impossible": false}], "context": "History of a known diagnosed allergy to a component of the COVID-19 vaccine Contraindication Do not vaccinate with a\nCOVID-19 vaccine that\ncontains that component. History of anaphylaxis after any vaccine other than COVID-19 vaccine or after any injectable therapy (i.e.,\nintramuscular, intravenous, or subcutaneous vaccines or therapies [excluding subcutaneous\nimmunotherapy for allergies, i.e., \u201callergy shots\u201d])\nPrecaution The benefit of vaccination\noutweighs the risks for\nmost people. People with a history of a non-severe, immediate (onset less than 4 hours) allergic reaction after a dose of\none type of COVID-19 vaccine have a precaution to the same type of COVID-19 vaccine."}]}, {"title": "f1cb78d586fc0be0faace5287a1236c8", "paragraphs": [{"qas": [{"question": "Vaccination and SARS-CoV-2 laboratory testing?", "id": "100000000000000000003249", "answers": [{"text": "Precaution Management of post-COVID-19-vaccination symptoms", "answer_start": 0}], "is_impossible": false}, {"question": "What do people with allergy-related contraindications have a precaution to?", "id": "100000000000000000003250", "answers": [{"text": "the other types of COVID-19 vaccines", "answer_start": 426}], "is_impossible": false}, {"question": "People with a known allergy to polysorbate have a contraindication to both Novavax and what other vaccine?", "id": "100000000000000000003252", "answers": [{"text": "Janssen", "answer_start": 569}], "is_impossible": false}, {"question": "What does COVID-19 vaccine do?", "id": "100000000000000000003254", "answers": [{"text": "Defer vaccination until the illness has improved", "answer_start": 675}], "is_impossible": false}, {"question": "What does MIS-C and -A prevent?", "id": "100000000000000000003255", "answers": [{"text": "vaccination", "answer_start": 681}], "is_impossible": false}], "context": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory testing\n\uf209\n\uf209\nTable of Contents \uf426\nContraindications and precautions\n*\n*\n\u2020\n*\n* *\n*\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nMedical condition or history Guidance Recommended action(s)\nPeople with an allergy-related contraindication to one type of COVID-19 vaccine have a precaution to\nthe other types of COVID-19 vaccines. Special situation: People with a known allergy to polysorbate have a contraindication to both Novavax and\nJanssen COVID-19 vaccines. Precaution\nModerate or severe acute illness, with or without fever Precaution Defer vaccination until the\nillness has improved. History of MIS-C or MIS-A Precaution See COVID-19 vaccination\nand MIS-C and MIS-A."}]}, {"title": "a7ab7ef3da57925e47eba587f471b6cd", "paragraphs": [{"qas": [{"question": "What does MIS-A stand for?", "id": "100000000000000000003257", "answers": [{"text": "multisystem inflammatory syndrome in adults", "answer_start": 340}], "is_impossible": false}, {"question": "What does MIS-A mean in adults?", "id": "100000000000000000003258", "answers": [{"text": "multisystem inflammatory syndrome", "answer_start": 340}], "is_impossible": false}, {"question": "What is an appendix for definitions of allergic reactions and risk assessment and triage of people with a history of allergies or allergic reactions?", "id": "100000000000000000003259", "answers": [{"text": "Appendix E", "answer_start": 388}], "is_impossible": false}, {"question": "For full list of vaccine ingredients, see what?", "id": "100000000000000000003260", "answers": [{"text": "FDA EUA fact sheets and U.S. COVID-19 Vaccine Product Information", "answer_start": 534}], "is_impossible": false}], "context": "History of myocarditis or pericarditis after a dose of an mRNA or Novavax COVID-19 vaccine Precaution A subsequent dose of any\nCOVID-19 vaccine should\ngenerally be avoided. See COVID-19 vaccination\nand myocarditis and\npericarditis for additional\nconsiderations. Abbreviations: MIS-C = multisystem inflammatory syndrome in children; MIS-A = multisystem inflammatory syndrome in adults\nSee Appendix E for definitions of allergic reactions, and risk assessment and triage of people with a history of allergies or allergic reactions. See FDA EUA fact sheets and U.S. COVID-19 Vaccine Product Information for full list of vaccine ingredients."}]}, {"title": "36e92a17c0dc78ca50f225718d439cf0", "paragraphs": [{"qas": [{"question": "What is an example of a contraindication and precaution to Janssen COVID-19 vaccination?", "id": "100000000000000000003261", "answers": [{"text": "Appendix A", "answer_start": 90}], "is_impossible": false}, {"question": "Who can consult with healthcare professionals and health departments for a complex COVIV-19 vaccine safety question?", "id": "100000000000000000003262", "answers": [{"text": "Clinical Immunization Safety Assessment COVIDvax project", "answer_start": 186}], "is_impossible": false}], "context": "For information on contraindications and precautions to Janssen COVID-19 vaccination, see Appendix A.\nHealthcare professionals and health departments may request a consultation from the Clinical Immunization Safety\nAssessment COVIDvax project for a complex COVID-19 vaccine safety question not readily addressed by CDC guidance. Adverse events that occur in a recipient following COVID-19 vaccination should be reported to VAERS."}]}, {"title": "a247ed645f1f888ab70fe4b6a4262543", "paragraphs": [{"qas": [{"question": "Vaccination administration errors are not associated with what?", "id": "100000000000000000003266", "answers": [{"text": "an adverse event", "answer_start": 251}], "is_impossible": false}, {"question": "What type of myocarditis after a Pfizer-BioNTech, Moderna, or Novavax vaccine?", "id": "100000000000000000003268", "answers": [{"text": "pericarditis", "answer_start": 491}], "is_impossible": false}, {"question": "What is encouraged for any other clinically significant adverse event?", "id": "100000000000000000003270", "answers": [{"text": "Reporting", "answer_start": 615}], "is_impossible": false}], "context": "Vaccination providers\nare required by FDA and the provider agreement for the CDC COVID-19 Vaccination Program to report the following that\noccur after COVID-19 vaccination under BLA or EUA:\nVaccine administration errors whether or not associated with an adverse event\nSerious adverse events , irrespective of attribution to vaccination\nCases of Multisystem Inflammatory Syndrome (MIS) in adults and children\nCases of myocarditis after a Pfizer-BioNTech, Moderna, or Novavax vaccine\nCases of pericarditis after a Pfizer-BioNTech, Moderna, or Novavax vaccine\nCases of COVID-19 that result in hospitalization or death\nReporting is encouraged for any other clinically significant adverse event, even if it is uncertain whether the vaccine caused\nthe event."}]}, {"title": "71a64c3588a6bd6496707fd8653e10b5", "paragraphs": [{"qas": [{"question": "Where can you submit a report to VAERS?", "id": "100000000000000000003271", "answers": [{"text": "https://vaers.hhs.gov or by calling 1-800-822- 7967", "answer_start": 63}], "is_impossible": false}, {"question": "What is the name of the voluntary, smartphone-based tool developed by CDC?", "id": "100000000000000000003272", "answers": [{"text": "v-safe", "answer_start": 187}], "is_impossible": false}, {"question": "v-safe uses what to provide near real-time health check-ins after patients receive COVID-19 vaccination?", "id": "100000000000000000003273", "answers": [{"text": "text messaging and web surveys", "answer_start": 210}], "is_impossible": false}, {"question": "Reports to v-safe indicating a medically significant health impact are followed up by what?", "id": "100000000000000000003275", "answers": [{"text": "the CDC/v-safe call center", "answer_start": 437}], "is_impossible": false}], "context": "Information on how to submit a report to VAERS is available at https://vaers.hhs.gov or by calling 1-800-822-\n7967. In addition, CDC has developed a new voluntary, smartphone-based tool, v-safe. This tool uses text messaging and web\nsurveys to provide near real-time health check-ins after patients receive COVID-19 vaccination. Reports to v-safe indicating a\nmedically significant health impact, including pregnancy, are followed up by the CDC/v-safe call center to collect additional\ninformation to complete a VAERS report, if appropriate."}]}, {"title": "25188a0c067fa176f630e0fbd212c39a", "paragraphs": [{"qas": [{"question": "What is the name of the mRNA COVID-19 vaccine?", "id": "100000000000000000003276", "answers": [{"text": "Moderna", "answer_start": 139}], "is_impossible": false}, {"question": "Fatigue, headache, and myalgia were the most common what?", "id": "100000000000000000003279", "answers": [{"text": "systemic symptoms", "answer_start": 479}], "is_impossible": false}, {"question": "Most systemic symptoms were mild to moderate in severity, occurred within how many days of vaccination?", "id": "100000000000000000003280", "answers": [{"text": "1\u20132", "answer_start": 572}], "is_impossible": false}], "context": "*\u2020\n*\n\u2020 \uf209\nTable of Contents \uf426\nReporting of vaccine adverse events\n\uf209\n\uf209\nTable of Contents \uf426\nSafety considerations for mRNA COVID-19 vaccines: Moderna\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nIn clinical trials of Moderna and Pfizer-BioNTech COVID-19 vaccines, types of post-vaccination reactions were generally similar. Pain at the injection site, sometimes severe, was the most frequent local reaction. Fatigue, headache, and myalgia were the\nmost common systemic symptoms. Most systemic symptoms were mild to moderate in severity, occurred within 1\u20132 days of\nvaccination, and resolved within 1\u20132 days of onset."}]}, {"title": "270be6d71ee255910c71fdb8e1b5e71c", "paragraphs": [{"qas": [{"question": "What was the most frequent local reaction among children ages 6 months-4 years?", "id": "100000000000000000003281", "answers": [{"text": "pain/tenderness at the injection site", "answer_start": 260}], "is_impossible": false}, {"question": "What is the name of the company that is 6 months-5 years old?", "id": "100000000000000000003282", "answers": [{"text": "Moderna", "answer_start": 250}], "is_impossible": false}, {"question": "Where was the most frequent local reaction?", "id": "100000000000000000003283", "answers": [{"text": "pain/tenderness at the injection site", "answer_start": 260}], "is_impossible": false}, {"question": "What is the most common systemic symptom in older children?", "id": "100000000000000000003284", "answers": [{"text": "fatigue", "answer_start": 391}], "is_impossible": false}], "context": "Overall, symptoms tended to be more frequent and severe following the\nsecond dose of vaccine and among adolescents and younger adults compared with older adults. Among children ages 6 months\u20134 years (i.e., Pfizer-BioNTech) or 6 months\u20135 years (i.e., Moderna), pain/tenderness at the\ninjection site was the most frequent local reaction. The most common systemic symptom in older children was fatigue; in\nyounger children (ages 6\u201323 months), irritability/crying and drowsiness/sleepiness were most common. Most systemic\nsymptoms were mild to moderate in severity, typically began 1\u20132 days after vaccination, and resolved after 1\u20132 days."}]}, {"title": "e5a8331bf393564ddd71f2b59680a314", "paragraphs": [{"qas": [{"question": "What can occur in infants and young children ages 6 months-5 years with any condition that causes a fever?", "id": "100000000000000000003286", "answers": [{"text": "Febrile seizures", "answer_start": 0}], "is_impossible": false}, {"question": "Febrile seizures are uncommon after vaccination and were rare in what clinical trials?", "id": "100000000000000000003288", "answers": [{"text": "mRNA COVID-19", "answer_start": 236}], "is_impossible": false}, {"question": "What has been associated with an increased risk of febrile seizures in infants and young children?", "id": "100000000000000000003289", "answers": [{"text": "administration of certain combination vaccines or more than one vaccine at the same clinic visit", "answer_start": 325}], "is_impossible": false}], "context": "Febrile seizures can occur in infants and young children ages 6 months\u20135 years with any condition that causes a fever (most\ncommon with high fevers), including COVID-19 . Febrile seizures are uncommon after vaccination and were rare in mRNA\nCOVID-19 vaccine clinical trials for infants and young children. In rare instances, administration of certain combination\nvaccines or more than one vaccine at the same clinic visit has been associated with an increased risk of febrile seizures in\ninfants and young children. The impact of coadministration of COVID-19 and routine vaccines on the risk of febrile seizures\nhas not been specifically studied."}]}, {"title": "50f45b65df287820607429410e5f5181", "paragraphs": [{"qas": [{"question": "Who is monitoring for febrile seizures following COVID-19 vaccination in infants and young children?", "id": "100000000000000000003292", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "What was the most frequently reported local reaction among vaccine recipients?", "id": "100000000000000000003293", "answers": [{"text": "pain/tenderness at the injection site", "answer_start": 213}], "is_impossible": false}, {"question": "What were the most commonly reported systemic reactions?", "id": "100000000000000000003294", "answers": [{"text": "Fatigue/malaise, headache, and muscle pain", "answer_start": 400}], "is_impossible": false}, {"question": "What was the most common systemic reaction?", "id": "100000000000000000003295", "answers": [{"text": "Fatigue/malaise, headache, and muscle pain", "answer_start": 400}], "is_impossible": false}, {"question": "How long did most symptoms resolve?", "id": "100000000000000000003296", "answers": [{"text": "1\u20133 days", "answer_start": 563}], "is_impossible": false}], "context": "CDC is monitoring for febrile seizures following COVID-19 vaccination in infants and young\nchildren. See also COVID-19 vaccination and myocarditis and pericarditis. In clinical trials of Novavax COVID-19 Vaccine, pain/tenderness at the injection site was the most frequently reported local\nreaction among vaccine recipients, including adolescents; redness and swelling were reported less frequently. Fatigue/malaise, headache, and muscle pain were the most commonly reported systemic reactions. Most symptoms were\nmild to moderate in severity and resolved within 1\u20133 days."}]}, {"title": "9b29e3696dee354a2d3fab4672868436", "paragraphs": [{"qas": [{"question": "What were symptoms more frequent in people ages 12 to 64 years compared to people 65 years and older?", "id": "100000000000000000003297", "answers": [{"text": "after dose 2 than dose 1 of the primary series", "answer_start": 125}], "is_impossible": false}, {"question": "What was more frequent after dose 2 than dose 1 of the primary series?", "id": "100000000000000000003298", "answers": [{"text": "symptoms", "answer_start": 9}], "is_impossible": false}, {"question": "What was more frequently reported after the booster dose than dose 2 of the primary series?", "id": "100000000000000000003299", "answers": [{"text": "symptoms", "answer_start": 249}], "is_impossible": false}], "context": "Overall, symptoms were more frequent in people ages 12\u201364 years\ncompared to people ages 65 years and older and more frequent after dose 2 than dose 1 of the primary series. Among adults\nages 18 years and older who received the Novavax booster dose, symptoms were more frequently reported after the booster\ndose than dose 2 of the primary series. See also COVID-19 vaccination and myocarditis and pericarditis. A rare risk for myocarditis and pericarditis has been observed following receipt of mRNA COVID-19 vaccines (i.e., Moderna or\nPfizer-BioNTech) and Novavax COVID-19 Vaccine."}]}, {"title": "d601ea4a9efa4be4213b435ea48eda88", "paragraphs": [{"qas": [{"question": "What is the most common type of myocarditis?", "id": "100000000000000000003301", "answers": [{"text": "Rare cases of myocarditis and pericarditis", "answer_start": 0}], "is_impossible": false}, {"question": "How long after receiving the second or booster dose of an mRNA COVID-19 vaccine have the reporting rates for myocarditis increased?", "id": "100000000000000000003303", "answers": [{"text": "first week", "answer_start": 147}], "is_impossible": false}, {"question": "What is myocarditis after mRNA COVID-19 primary series vaccination or booster vaccination?", "id": "100000000000000000003304", "answers": [{"text": "The reporting rates", "answer_start": 237}], "is_impossible": false}, {"question": "What are the highest rates observed in males ages 12 to 39 years?", "id": "100000000000000000003305", "answers": [{"text": "background rates", "answer_start": 353}], "is_impossible": false}], "context": "Rare cases of myocarditis and pericarditis have occurred most frequently, although not exclusively, in adolescent and young\nadult males within the first week after receiving the second dose or a booster dose of an mRNA COVID-19 vaccine. The reporting rates for myocarditis after mRNA COVID-19 primary series vaccination or booster vaccination exceed the\nbackground rates in several age groups in males and females with the highest rates observed in males ages 12\u201339 years; see\nthe June 23, 2022 and September 1, 2022 ACIP meetings for more information."}]}, {"title": "32e2dc25729187a73092ccb821cc3237", "paragraphs": [{"qas": [{"question": "Moderna and Pfizer-BioNTech have what type of vaccines?", "id": "100000000000000000003306", "answers": [{"text": "mRNA COVID 19 vaccines", "answer_start": 26}], "is_impossible": false}, {"question": "What is the risk for myocarditis after COVID-19 vaccination?", "id": "100000000000000000003307", "answers": [{"text": "similar to or lower than the risk after a second mRNA COVID-19 vaccine primary series dose", "answer_start": 484}], "is_impossible": false}, {"question": "What is the risk for myocarditis and pericarditus after an mRNA COVID-19 booster dose in adolescents and young adults?", "id": "100000000000000000003308", "answers": [{"text": "similar to or lower than the risk after a second mRNA COVID-19 vaccine primary series dose", "answer_start": 484}], "is_impossible": false}], "context": "Safety considerations for mRNA COVID 19 vaccines: Moderna\nand Pfizer-BioNTech\n\uf209\n\uf209\nTable of Contents \uf426\nSafety considerations for Novavax COVID-19 Vaccine\nTable of Contents \uf426\nCOVID-19 vaccination and myocarditis and pericarditis\nmRNA COVID-19 vaccines\n\uf20c \uf20c\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nBased on the overall data to date, the risk for myocarditis and pericarditis after an mRNA COVID-19 booster dose in\nadolescents and young adults appears generally similar to or lower than the risk after a second mRNA COVID-19 vaccine\nprimary series dose."}]}, {"title": "d9444afd3dd2c9b4656598a159c102ff", "paragraphs": [{"qas": [{"question": "In post-authorization surveillance, what are cases of?", "id": "100000000000000000003311", "answers": [{"text": "myocarditis and pericarditis", "answer_start": 369}], "is_impossible": false}, {"question": "What are the most common types of myocarditis in children after vaccination?", "id": "100000000000000000003312", "answers": [{"text": "males and after dose 2", "answer_start": 513}], "is_impossible": false}], "context": "In age groups where product comparisons can be made (i.e., 18\u201339 years), some evidence suggests that the risk of\nmyocarditis and pericarditis may be higher following vaccination with Moderna COVID-19 Vaccine relative to Pfizer-BioNTech\nCOVID-19 Vaccine; however, findings are not consistent in all U.S. monitoring systems. In post-authorization surveillance , cases of myocarditis and pericarditis among children ages 5\u201311 years after Pfizer-\nBioNTech COVID-19 vaccination have been rarely reported, primarily in males and after dose 2; the reporting rate of\nmyocarditis in VAERS following dose 2 of Pfizer-BioNTech marginally exceeded the background incidence rate for male\nchildren in this age group."}]}, {"title": "8412d609fbb2be18f4b7242a7e5ab58", "paragraphs": [{"qas": [{"question": "What was not reported in children in pre-authorization clinical trials of Pfizer-BioNTech or Moderna vaccines?", "id": "100000000000000000003316", "answers": [{"text": "cases of myocarditis or pericarditis", "answer_start": 3}], "is_impossible": false}, {"question": "What vaccines did not detect an increased risk for myocarditis and pericardiitis following mRNA COVID-19 vaccination?", "id": "100000000000000000003317", "answers": [{"text": "Pfizer-BioNTech (ages 6 months\u20134 years) or Moderna", "answer_start": 110}], "is_impossible": false}, {"question": "What is the name of the company that vaccinates children with mRNA COVID-19?", "id": "100000000000000000003318", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 110}], "is_impossible": false}, {"question": "What vaccine does Novavax provide?", "id": "100000000000000000003322", "answers": [{"text": "COVID-19", "answer_start": 525}], "is_impossible": false}], "context": "No cases of myocarditis or pericarditis were reported in children in the pre-authorization clinical\ntrials of Pfizer-BioNTech (ages 6 months\u20134 years) or Moderna (ages 6 months\u20135 years) vaccines. To date, post-authorization\nsurveillance has not detected an increased risk for myocarditis and pericarditis following mRNA COVID-19 vaccination in\nchildren ages 6 months\u20134 years (i.e., Pfizer-BioNTech) and ages 6 months\u20135 years (i.e., Moderna). Cases of myocarditis and pericarditis were identified in clinical trials of Novavax COVID-19 Vaccine and have also been\nreported during post-authorization use outside the United States. These findings suggest that an increased risk for these\nconditions may be present after receiving Novavax COVID-19 vaccine."}]}, {"title": "51582a144c732c62096c7bad0a9a3027", "paragraphs": [{"qas": [{"question": "What did ACIP and CDC determine outweigh the risks of COVID-19 and its severe outcomes?", "id": "100000000000000000003323", "answers": [{"text": "the benefits", "answer_start": 87}], "is_impossible": false}, {"question": "What is the rare risk of myocarditis after receipt of moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines?", "id": "100000000000000000003324", "answers": [{"text": "Extending the interval to 8 weeks", "answer_start": 346}], "is_impossible": false}, {"question": "How long is the interval between the first and second primary series doses of Moderna, Novavax, or Pfizer-BioNTech COVID-19 vaccines for some people?", "id": "100000000000000000003325", "answers": [{"text": "8 weeks", "answer_start": 372}], "is_impossible": false}, {"question": "What may reduce the rare risk of vaccine-associated myocarditis?", "id": "100000000000000000003326", "answers": [{"text": "Extending the interval to 8 weeks between the first and second primary series doses of Moderna, Novavax, or Pfizer-BioNTech COVID-19 vaccines", "answer_start": 346}], "is_impossible": false}], "context": "After reviewing available data on the risks and benefits, ACIP and CDC determined that the benefits (e.g., prevention of\nCOVID-19 and its severe outcomes) outweigh the rare risk of myocarditis and pericarditis after receipt of Moderna, Novavax,\nand Pfizer-BioNTech COVID-19 vaccines in all populations for which vaccination has been recommended. Extending the\ninterval to 8 weeks between the first and second primary series doses of Moderna, Novavax, or Pfizer-BioNTech COVID-19\nvaccines for some people may reduce the rare risk of vaccine-associated myocarditis and pericarditis (see Considerations for\nextended intervals for COVID-19 vaccine primary series doses)."}]}, {"title": "fb9a18fb0d1c31432c28a82fd32b8646", "paragraphs": [{"qas": [{"question": "What should people receiving moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines be made aware of?", "id": "100000000000000000003327", "answers": [{"text": "the rare risk of myocarditis and pericarditis", "answer_start": 133}], "is_impossible": false}, {"question": "What is the rare risk of myocarditis and pericardiitis following receipt of moderna vaccines?", "id": "100000000000000000003328", "answers": [{"text": "answer undefined", "answer_start": 133}], "is_impossible": false}, {"question": "Who should be counseled about the risk of severe outcomes from moderna vaccination?", "id": "100000000000000000003329", "answers": [{"text": "males ages 12\u201339 years", "answer_start": 85}], "is_impossible": false}, {"question": "Which vaccines are recommended for males ages 12 to 39 years?", "id": "100000000000000000003330", "answers": [{"text": "Moderna, Novavax, and Pfizer-BioNTech COVID-19", "answer_start": 17}], "is_impossible": false}, {"question": "What should be included in counseling if symptoms of myocarditis develop after vaccination?", "id": "100000000000000000003332", "answers": [{"text": "the need to seek care", "answer_start": 383}], "is_impossible": false}, {"question": "In younger children, what may also include non-specific symptoms?", "id": "100000000000000000003333", "answers": [{"text": "myocarditis", "answer_start": 609}], "is_impossible": false}, {"question": "What are some non-specific symptoms of myocarditis?", "id": "100000000000000000003334", "answers": [{"text": "irritability, vomiting, poor feeding, tachypnea, or lethargy", "answer_start": 668}], "is_impossible": false}], "context": "People receiving Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines, especially males ages 12\u201339 years, should be\nmade aware of the rare risk of myocarditis and pericarditis following receipt of these vaccines and the benefit of COVID-19\nvaccination in reducing the risk of severe outcomes from COVID-19, including the possibility of cardiac sequelae. Counseling\nshould include the need to seek care if symptoms of myocarditis or pericarditis, such as chest pain, shortness of breath, or\ntachycardia develop after vaccination, particularly in the week after vaccination. In younger children, symptoms of myocarditis\nmay also include non-specific symptoms such as irritability, vomiting, poor feeding, tachypnea, or lethargy."}]}, {"title": "f437c339e693d551bd17e881f2ac9bde", "paragraphs": [{"qas": [{"question": "What is ongoing to further assess the known and potential risks for myocarditis?", "id": "100000000000000000003335", "answers": [{"text": "Safety monitoring", "answer_start": 0}], "is_impossible": false}, {"question": "What is CDC assessing the long-term effects of after COVID-19 vaccination?", "id": "100000000000000000003336", "answers": [{"text": "myocarditis", "answer_start": 203}], "is_impossible": false}, {"question": "What is a precaution to a subsequent dose of any COVID-19 vaccine?", "id": "100000000000000000003337", "answers": [{"text": "Development of myocarditis or pericarditis after a dose of an mRNA COVID-19 vaccine (i.e., Moderna or Pfizer-BioNTech) or Novavax COVID-19 Vaccine", "answer_start": 331}], "is_impossible": false}, {"question": "What should generally be avoided?", "id": "100000000000000000003338", "answers": [{"text": "subsequent doses", "answer_start": 543}], "is_impossible": false}], "context": "Safety monitoring is ongoing to further assess the known and potential risks for myocarditis and pericarditis after COVID-19\nvaccination in all age groups. CDC is also assessing the long-term effects of myocarditis in people with myocarditis after\nCOVID-19 vaccination. Myocarditis or pericarditis after a dose of COVID-19 vaccine\nDevelopment of myocarditis or pericarditis after a dose of an mRNA COVID-19 vaccine (i.e., Moderna or Pfizer-BioNTech) or\nNovavax COVID-19 Vaccine is a precaution to a subsequent dose of any COVID-19 vaccine and subsequent doses should\ngenerally be avoided."}]}, {"title": "3c42d11c599a2bdeeb7777b39fa067fe", "paragraphs": [{"qas": [{"question": "What do experts advise people who develop myocarditis after a dose of Moderna, Novavax, or Pfizer-BioNTech COVID-19 vaccine not receive?", "id": "100000000000000000003339", "answers": [{"text": "a subsequent dose of any COVID-19 vaccine", "answer_start": 210}], "is_impossible": false}, {"question": "What should a person wait until after their pericarditis has resolved?", "id": "100000000000000000003340", "answers": [{"text": "COVID-19 vaccine dose", "answer_start": 330}], "is_impossible": false}], "context": "Until additional safety data are available, experts advise that people who develop myocarditis or pericarditis after a dose of\nModerna, Novavax, or Pfizer-BioNTech COVID-19 vaccine generally should not receive a subsequent dose of any COVID-19\nvaccine. If, after a risk assessment, the decision is made to administer a subsequent COVID-19 vaccine dose, the person\nshould wait until at least after their episode of myocarditis or pericarditis has resolved (i.e., resolution of symptoms, no\nevidence of ongoing heart inflammation or sequelae as determined by patient\u2019s clinical team). For information on potential use of Janssen COVID-19 Vaccine, see Appendix A."}]}, {"title": "de11829465633ae1d77f45ab7b182907", "paragraphs": [{"qas": [{"question": "Whose general best practice guidelines for immunization can be consulted for more information?", "id": "100000000000000000003348", "answers": [{"text": "ACIP", "answer_start": 606}], "is_impossible": false}, {"question": "What is myocarditis associated with?", "id": "100000000000000000003349", "answers": [{"text": "MIS-C or MIS-A", "answer_start": 733}], "is_impossible": false}], "context": "Considerations for subsequent COVID-19 vaccination may include:\n\uf20c\n\uf20c\n\uf20c\nNovavax COVID-19 Vaccine\nConsiderations for COVID-19 vaccination\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nThe myocarditis or pericarditis was considered unrelated to vaccination with Moderna, Novavax, or Pfizer-BioNTech (e.g.,\ndue to SARS-CoV-2 or other viruses), especially if the myocarditis or pericarditis diagnosis occurred more than 3 weeks\nafter the most recent dose of COVID-19 vaccine\nPersonal risk of severe acute COVID-19 (e.g., age, underlying conditions)\nTiming of any immunomodulatory therapies; ACIP\u2019s general best practice guidelines for immunization can be consulted\nfor more information\nFor myocarditis associated with MIS-C or MIS-A, see COVID-19 vaccination and MIS-C and MIS-A."}]}, {"title": "ce7c9b37a5e6ca37235467215291c64e", "paragraphs": [{"qas": [{"question": "Who can receive any currently FDA-approved or FDA-authorized COVID-19 vaccine?", "id": "100000000000000000003353", "answers": [{"text": "People who have a history of myocarditis or pericarditis", "answer_start": 69}], "is_impossible": false}, {"question": "After the episode of myocarditis has completely resolved, what does this include?", "id": "100000000000000000003354", "answers": [{"text": "resolution of symptoms attributed to myocarditis or pericarditis", "answer_start": 398}], "is_impossible": false}, {"question": "What type of myocarditis is associated with MIS-C?", "id": "100000000000000000003356", "answers": [{"text": "MIS-A", "answer_start": 644}], "is_impossible": false}, {"question": "What is the name of the vaccination that has been shown to be associated with COVID-19?", "id": "100000000000000000003357", "answers": [{"text": "MIS-C or MIS-A", "answer_start": 635}], "is_impossible": false}], "context": "History of myocarditis or pericarditis prior to COVID-19 vaccination\nPeople who have a history of myocarditis or pericarditis unrelated to vaccination with Moderna, Novavax, or Pfizer-BioNTech\n(e.g., due to SARS-CoV-2 or other viruses) may receive any currently FDA-approved or FDA-authorized COVID-19 vaccine after\nthe episode of myocarditis or pericarditis has completely resolved. This includes resolution of symptoms attributed to\nmyocarditis or pericarditis, as well as no evidence of ongoing heart inflammation or sequelae as determined by the person\u2019s\nclinical team. For people who have a history of myocarditis associated with MIS-C or MIS-A, see COVID-19 vaccination and MIS-\nC and MIS-A."}]}, {"title": "c1aa7b6c1999c77a97d3a1cb9bcedeaa", "paragraphs": [{"qas": [{"question": "What is not a contraindication or precaution to COVID-19 vaccination?", "id": "100000000000000000003358", "answers": [{"text": "Recent exposure to SARS-CoV-2", "answer_start": 213}], "is_impossible": false}, {"question": "What is not recommended for post-exposure prophylaxis?", "id": "100000000000000000003360", "answers": [{"text": "COVID-19 vaccines", "answer_start": 508}], "is_impossible": false}], "context": "History of other heart disease\nPeople who have a history of other heart disease, including congenital heart disease and Kawasaki disease, may receive any\ncurrently FDA-approved or FDA-authorized COVID-19 vaccine. Recent exposure to SARS-CoV-2 is not a contraindication or precaution to COVID-19 vaccination. People with a known or\npotential SARS-CoV-2 exposure can receive vaccine if they do not have symptoms consistent with SARS-CoV-2 infection;\nhowever, people should follow CDC\u2019s post-exposure guidance. COVID-19 vaccines are not recommended for post-exposure prophylaxis. People should be informed that vaccination is to\nhelp prevent severe COVID-19 following future exposures."}]}, {"title": "2e0daa3b56cbbdaee1671e1b68decea", "paragraphs": [{"qas": [{"question": "What may be necessary to differentiate between common post-vaccination symptoms and symptoms of SARS-CoV-2 infection?", "id": "100000000000000000003362", "answers": [{"text": "SARS-CoV-2 viral testing", "answer_start": 0}], "is_impossible": false}, {"question": "What should people who develop signs and symptoms associated with COVID-19 be evaluated for as soon as possible?", "id": "100000000000000000003363", "answers": [{"text": "SARS-CoV-2 infection", "answer_start": 321}], "is_impossible": false}, {"question": "If symptoms do not improve by two days post-vaccination, be evaluated for?", "id": "100000000000000000003368", "answers": [{"text": "SARS-CoV-2 infection", "answer_start": 686}], "is_impossible": false}], "context": "SARS-CoV-2 viral testing may be necessary to differentiate between\ncommon post-vaccination symptoms and symptoms of SARS-CoV-2 infection:\nPeople who develop signs and symptoms associated with COVID-19 (e.g., cough, shortness of breath, runny nose, sore\nthroat, loss of taste or smell) should isolate and be evaluated for SARS-CoV-2 infection as soon as possible. People who develop signs and symptoms that could be from either COVID-19 vaccination or SARS-CoV-2 infection (e.g.,\nfever, fatigue, headache, myalgia) without typical COVID-19 symptoms described above, and are clinically stable, should\nisolate and, if symptoms do not improve by two days post-vaccination, be evaluated for SARS-CoV-2 infection."}]}, {"title": "bf714e56934cd4033816c9b40d7c346b", "paragraphs": [{"qas": [{"question": "What is recommended for everyone ages 6 months and older?", "id": "100000000000000000003369", "answers": [{"text": "COVID-19 vaccination", "answer_start": 0}], "is_impossible": false}, {"question": "What is the recommendation for people who experience SARS-CoV-2 infection after receiving any COVID-19 vaccine dose?", "id": "100000000000000000003370", "answers": [{"text": "COVID-19 vaccination", "answer_start": 0}], "is_impossible": false}, {"question": "Who experiences SARS-CoV-2 infection after receiving any COVID-19 vaccine dose?", "id": "100000000000000000003371", "answers": [{"text": "people", "answer_start": 295}], "is_impossible": false}], "context": "COVID-19 vaccination is recommended for everyone ages 6 months and older, regardless of a history of symptomatic or\nasymptomatic SARS-CoV-2 infection. This includes people with prolonged post-COVID-19 symptoms and applies to primary\nseries and booster doses. This recommendation also applies to people who experience SARS-CoV-2 infection after receiving\nany COVID-19 vaccine dose. Growing epidemiologic evidence indicates that vaccination following SARS-CoV-2 infection further increases protection from\nsubsequent infection and hospitalization, including in the setting of increased circulation of more infectious SARS-CoV-2\nstrains."}]}, {"title": "b4dfa89ad2ebc4de1c7aa43666c1fbd9", "paragraphs": [{"qas": [{"question": "What should people with known current SARS-CoV-2 infection do?", "id": "100000000000000000003374", "answers": [{"text": "defer any COVID-19 vaccination", "answer_start": 266}], "is_impossible": false}, {"question": "How long after a symptom onset do people who recently had SARS-CoV-2 consider delaying a primary series dose or booster dose?", "id": "100000000000000000003375", "answers": [{"text": "3 months", "answer_start": 577}], "is_impossible": false}, {"question": "What criteria to discontinue isolation have been met?", "id": "100000000000000000003376", "answers": [{"text": "People with known current SARS-CoV-2 infection should defer any COVID-19 vaccination, including booster vaccination, at least until recovery from the acute illness", "answer_start": 212}], "is_impossible": false}], "context": "Table of Contents \uf426\nCOVID-19 vaccination and SARS-CoV-2 infection\nPeople exposed to SARS-CoV-2\nPeople with prior or current SARS-CoV-2 infection\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nPeople with known current SARS-CoV-2 infection should defer any COVID-19 vaccination, including booster vaccination, at\nleast until recovery from the acute illness (if symptoms were present) and criteria to discontinue isolation have been met. In addition, people who recently had SARS-CoV-2 infection may consider delaying a primary series dose or booster dose by 3\nmonths from symptom onset or positive test (if infection was asymptomatic)."}]}, {"title": "b8baf89e74e40f7a8e1dd51f485b2f87", "paragraphs": [{"qas": [{"question": "Studies have shown that increased time between infection and vaccination may result in what?", "id": "100000000000000000003377", "answers": [{"text": "an improved immune response to vaccination", "answer_start": 87}], "is_impossible": false}], "context": "Studies have shown that increased time\nbetween infection and vaccination may result in an improved immune response to vaccination. Also, a low risk of reinfection\nhas been observed in the weeks to months following infection. Individual factors such as risk of COVID-19 severe disease,\nCOVID-19 community level, or characteristics of the predominant SARS-CoV-2 strain should be taken into account when\ndetermining whether to delay getting a COVID-19 vaccination after infection. Viral testing to assess for acute SARS-CoV-2 infection or serologic testing to assess for prior infection is not recommended for\nthe purpose of vaccine decision-making."}]}, {"title": "700aeffc378c8f544f54747fd6bf90df", "paragraphs": [{"qas": [{"question": "Who can be vaccinated at any time after receiving monoclonal antibodies or convalescent plasma?", "id": "100000000000000000003381", "answers": [{"text": "People who previously received antibody products", "answer_start": 0}], "is_impossible": false}, {"question": "What was observed in people who previously received antibody products?", "id": "100000000000000000003383", "answers": [{"text": "some reduction in vaccine-induced antibody titers", "answer_start": 354}], "is_impossible": false}, {"question": "What was the clinical significance of the reduction in vaccine-induced antibody titers?", "id": "100000000000000000003384", "answers": [{"text": "unknown", "answer_start": 517}], "is_impossible": false}, {"question": "The balance of benefits vs. risks favors proceeding with what?", "id": "100000000000000000003385", "answers": [{"text": "vaccination", "answer_start": 587}], "is_impossible": false}], "context": "People who previously received antibody products (anti-SARS-CoV-2 monoclonal antibodies or convalescent plasma) as part\nof COVID-19 treatment, post-exposure prophylaxis, or pre-exposure prophylaxis can be vaccinated at any time; COVID-19\nvaccination does not need to be delayed following receipt of monoclonal antibodies or convalescent plasma. Although some\nreduction in vaccine-induced antibody titers was observed in people who previously received antibody products, the\nclinical significance of this reduction is unknown, and the balance of benefits vs. risks favors proceeding with vaccination even\nconsidering the possibility of diminished vaccine effectiveness in this situation."}]}, {"title": "b502bc91a5202f76216b495629607802", "paragraphs": [{"qas": [{"question": "What should those who received antibody products due to a recent SARS-CoV-2 infection do?", "id": "100000000000000000003386", "answers": [{"text": "follow the guidance in the section above", "answer_start": 81}], "is_impossible": false}, {"question": "What should be deferred for at least two weeks after receipt of a dose of COVID-19 vaccine?", "id": "100000000000000000003387", "answers": [{"text": "administration of tixagevimab/cilgavimab (EVUSHELD\u2122) for pre-exposure prophylaxis", "answer_start": 142}], "is_impossible": false}, {"question": "What is a rare but severe condition in children and adolescents infected with SARS-CoV-2?", "id": "100000000000000000003388", "answers": [{"text": "MIS-C", "answer_start": 436}], "is_impossible": false}, {"question": "What is another rare but less well characterized condition in adults?", "id": "100000000000000000003389", "answers": [{"text": "MIS-A", "answer_start": 527}], "is_impossible": false}], "context": "Those who received antibody products due to\na recent SARS-CoV-2 infection should follow the guidance in the section above. Special situation: administration of tixagevimab/cilgavimab (EVUSHELD\u2122) for pre-exposure prophylaxis should be deferred for\nat least two weeks after receipt of a dose of COVID-19 vaccine, per the product EUA . See COVID-19 vaccination and\nEVUSHELD\u2122 for more information on the timing of EVUSHELD\u2122 administration. MIS-C is a rare but severe condition in children and adolescents infected with SARS-CoV-2. MIS-A, a similar condition in adults,\nis even rarer and less well characterized. Both include a dysregulated immune response to SARS-CoV-2 infection."}]}, {"title": "a8af940f6c956b4916ad7e701629d5c9", "paragraphs": [{"qas": [{"question": "What is the risk of recurrence of a dysregulated immune response following a reinfection with SARS-CoV-2 or an MIS-like illness following COVID-19 vaccination?", "id": "100000000000000000003391", "answers": [{"text": "unknown", "answer_start": 259}], "is_impossible": false}, {"question": "What is the risk of myocarditis after COVID-19 vaccination for those who meet the following two criteria?", "id": "100000000000000000003393", "answers": [{"text": "1", "answer_start": 656}], "is_impossible": false}], "context": "There are\nlimited data on the safety of COVID-19 vaccines in people who have had MIS-C or MIS-A (MIS C/A). The risk of recurrence of a\ndysregulated immune response following reinfection with SARS-CoV-2 or an MIS-like illness following COVID-19 vaccination is\nunknown. People with a history of MIS-C or MIS-A\nExperts consider the benefits of COVID-19 vaccination for people with a history of MIS-C/A (i.e., a reduced risk of severe\ndisease including potential recurrence of MIS-C after reinfection) to outweigh a theoretical risk of an MIS-like illness or the risk\nof myocarditis following COVID-19 vaccination for those who meet the following two criteria:\n1."}]}, {"title": "406504dd868a47b735e5350991a12041", "paragraphs": [{"qas": [{"question": "What has been achieved, including return to baseline cardiac function?", "id": "100000000000000000003394", "answers": [{"text": "Clinical recovery", "answer_start": 0}], "is_impossible": false}, {"question": "How long has it been after the diagnosis of MIS-C/A?", "id": "100000000000000000003395", "answers": [{"text": "at least 90 days", "answer_start": 103}], "is_impossible": false}], "context": "Clinical recovery has been achieved, including return to baseline cardiac function; and\n2. It has been at least 90 days after the diagnosis of MIS-C/A\nCOVID-19 vaccination may also be considered for people who had MIS-C/A and do not meet both criteria, at the discretion of\ntheir clinical care team (see Consultation for decisions about COVID-19 vaccination). Experts view clinical recovery, including\nreturn to baseline cardiac function, as an important factor when considering COVID-19 vaccination. Additional factors, such as\nthe risk of severe COVID-19 due to age or certain medical conditions, may also be considered."}]}, {"title": "d3088c3db35287701a1ee2729be1e130", "paragraphs": [{"qas": [{"question": "Who received SARS-CoV-2 antibody-based products?", "id": "100000000000000000003399", "answers": [{"text": "People", "answer_start": 2}], "is_impossible": false}, {"question": "When should people with a history of MIS-C/A start the COVID-19 vaccination?", "id": "100000000000000000003400", "answers": [{"text": "10/30/22", "answer_start": 216}], "is_impossible": false}, {"question": "What should people with a history of MIS-C/A consider when considering vaccination?", "id": "100000000000000000003401", "answers": [{"text": "current or planned immunomodulatory therapies", "answer_start": 416}], "is_impossible": false}, {"question": "What is the name of the vaccine that should be considered when considering immunomodulatory therapies for treatment?", "id": "100000000000000000003402", "answers": [{"text": "COVID-19", "answer_start": 328}], "is_impossible": false}, {"question": "When considering COVID-19 vaccination in relation to immunosuppressive therapies?", "id": "100000000000000000003403", "answers": [{"text": "timing", "answer_start": 511}], "is_impossible": false}], "context": "\uf209\nPeople who received SARS-CoV-2 antibody-based products\n\uf209\n\uf209\nTable of Contents \uf426\nCOVID-19 vaccination and MIS-C and MIS-A\nConsiderations for initiating COVID-19 vaccination in people with a history\nof MIS-C or MIS-A\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nTiming of COVID-19 vaccination\nInitiation of COVID-19 vaccination in people with a history of MIS-C/A should take into consideration current or planned\nimmunomodulatory therapies for treatment of MIS-C/A (see Considerations for timing of COVID-19 vaccination in relation to\nimmunosuppressive therapies)."}]}, {"title": "315b87d2b426712222f7a8e250844cc6", "paragraphs": [{"qas": [{"question": "What should a person receive after receiving a COVID-19 vaccine?", "id": "100000000000000000003404", "answers": [{"text": "referral to a specialist in infectious diseases, rheumatology, and/or cardiology", "answer_start": 193}], "is_impossible": false}, {"question": "What should be included in the assessment of people who develop a MIS-C or a similar clinical illness?", "id": "100000000000000000003405", "answers": [{"text": "testing for current or prior SARS-CoV-2 infection", "answer_start": 322}], "is_impossible": false}, {"question": "Who should be referred to a specialist in infectious diseases?", "id": "100000000000000000003406", "answers": [{"text": "a person develops MIS-C, MIS-A, or a similar clinical illness after receipt of COVID-19 vaccine", "answer_start": 96}], "is_impossible": false}], "context": "Evaluation of people who develop MIS-C or MIS-A after COVID-19 vaccination\nIn the rare instance a person develops MIS-C, MIS-A, or a similar clinical illness after receipt of COVID-19 vaccine, referral to a\nspecialist in infectious diseases, rheumatology, and/or cardiology should be considered. Assessment should include testing for current or prior SARS-CoV-2 infection, in addition to other potential etiologies as\nclinically indicated. Obtaining a serum sample before any intravenous immune globulin (IVIG) is administered is highly\nrecommended so that the sample can be tested for SARS-CoV-2 anti-nucleocapsid antibody, which may require a reference\nlaboratory. Treatment should not be delayed until test results are available."}]}, {"title": "977eaa47c8a374cad76d20562c18a602", "paragraphs": [{"qas": [{"question": "What does a positive anti-nucleocapsid antibody test result indicate?", "id": "100000000000000000003410", "answers": [{"text": "prior SARS-CoV-2 infection", "answer_start": 60}], "is_impossible": false}, {"question": "What should be used to test for current SARS-CoV-2 infection?", "id": "100000000000000000003411", "answers": [{"text": "a molecular diagnostic or antigen test", "answer_start": 131}], "is_impossible": false}, {"question": "Anti-spike protein antibody testing cannot be used in a vaccinated person because of what?", "id": "100000000000000000003412", "answers": [{"text": "a positive test result can be induced by either COVID-19 vaccination or SARS-CoV-2 infection", "answer_start": 310}], "is_impossible": false}, {"question": "What depends on timing of MIS in relation to vaccination, clinical recovery and epidemiologic considerations?", "id": "100000000000000000003414", "answers": [{"text": "Decisions about administration of subsequent COVID-19 vaccine doses", "answer_start": 404}], "is_impossible": false}], "context": "A positive anti-nucleocapsid antibody test result\nindicates prior SARS-CoV-2 infection. (To test for current SARS-CoV-2 infection, a molecular diagnostic or antigen test should\nbe used). Anti-spike protein antibody testing cannot be used to determine SARS-CoV-2 infection status in a vaccinated person\nbecause a positive test result can be induced by either COVID-19 vaccination or SARS-CoV-2 infection. Decisions about administration of subsequent COVID-19 vaccine doses in people who develop MIS-C or MIS-A after COVID-19\nvaccination depend on timing of MIS in relation to vaccination, clinical recovery, and epidemiologic considerations."}]}, {"title": "804987ebe8e692785962d111f9bfe16e", "paragraphs": [{"qas": [{"question": "What does Consultation for decisions about COVID-19 do?", "id": "100000000000000000003418", "answers": [{"text": "For people who had MIS-C/A but do not meet both criteria above", "answer_start": 401}], "is_impossible": false}], "context": "Administration of subsequent COVID-19 vaccine doses: Onset of MIS 90 days or more after most recent\nCOVID-19 vaccine dose\nAdministration of subsequent COVID-19 vaccine dose(s) should be considered for those who meet the two criteria listed\nbelow:\n1. Clinical recovery has been achieved, including return to baseline cardiac function; and\n2. It has been at least 90 days after the diagnosis of MIS-C/A\nFor people who had MIS-C/A but do not meet both criteria above, see Consultation for decisions about COVID-19 vaccination."}]}, {"title": "1c5b7bc8f5aa109d9240b7f00b8d831e", "paragraphs": [{"qas": [{"question": "What should be deferred at this time until additional data are available?", "id": "100000000000000000003419", "answers": [{"text": "Subsequent COVID-19 vaccine dose(s)", "answer_start": 125}], "is_impossible": false}, {"question": "What was a complication of a recent SARS-CoV-2 infection?", "id": "100000000000000000003421", "answers": [{"text": "the MIS-C/A", "answer_start": 373}], "is_impossible": false}], "context": "Administration of subsequent COVID-19 vaccine doses: Onset of MIS fewer than 90 days after most recent\nCOVID-19 vaccine dose\nSubsequent COVID-19 vaccine dose(s) should be deferred at this time until additional data are available. However, on a case-\nby-case basis, a provider may offer subsequent dose(s) if the two criteria above are met and there is strong evidence that the\nMIS-C/A was a complication of a recent SARS-CoV-2 infection."}]}, {"title": "3e6e38e3a8296e45311e21cecd316e4d", "paragraphs": [{"qas": [{"question": "What type of situations are not addressed by a doctor?", "id": "100000000000000000003423", "answers": [{"text": "complicated situations", "answer_start": 336}], "is_impossible": false}, {"question": "What should be reported to VAERS after receiving the COVID-19 vaccine?", "id": "100000000000000000003424", "answers": [{"text": "An illness", "answer_start": 546}], "is_impossible": false}, {"question": "What should healthcare and public health professionals request a consultation from?", "id": "100000000000000000003425", "answers": [{"text": "Clinical Immunization Safety Assessment COVIDvax project", "answer_start": 488}], "is_impossible": false}], "context": "Consultation for decisions about COVID-19 vaccination\nA conversation between the patient and/or their guardian(s) and their clinical team or a specialist (e.g., infectious diseases,\nrheumatology, and/or cardiology) is strongly encouraged to assist with decisions about the use of COVID-19 vaccines in the\nsetting of MIS-C or MIS-A. For complicated situations, not addressed by the guidance above, healthcare and public health professionals may consider\nrequesting a consultation from the Clinical Immunization Safety Assessment COVIDvax project. An illness consistent with MIS-\nC or MIS-A after receiving COVID-19 vaccine should be reported to VAERS ."}]}, {"title": "68088100f6f27c5619d5db405a89d4ff", "paragraphs": [{"qas": [{"question": "What is the name of the CDC's clinical guidance for COVID-19 vaccination?", "id": "100000000000000000003427", "answers": [{"text": "10/30/22, 9:14 AM", "answer_start": 166}], "is_impossible": false}, {"question": "What is the name of a growing body of evidence on the safety and effectiveness of COVID-19 vaccination?", "id": "100000000000000000003428", "answers": [{"text": "people who are pregnant, trying to get pregnant now, or who might become pregnant in the future, and people who are breastfeeding. A growing body of evidence on the safety and effectiveness of COVID-19 vaccination indicates that the benefits of vaccination outweigh any potential risks of COVID-19 vaccination during pregnancy", "answer_start": 298}], "is_impossible": false}, {"question": "What does the benefits of vaccination outweigh any potential risks of during pregnancy?", "id": "100000000000000000003429", "answers": [{"text": "COVID-19 vaccination", "answer_start": 587}], "is_impossible": false}, {"question": "What can occur after COVID-19 vaccination in pregnant people?", "id": "100000000000000000003430", "answers": [{"text": "Side effects", "answer_start": 626}], "is_impossible": false}], "context": "Considerations for people diagnosed with MIS-C or MIS-A after COVID-19\nvaccination\n\uf209\nTable of Contents \uf426\nConsiderations involving pregnancy, lactation, and fertility\f10/30/22, 9:14 AM Clinical Guidance for COVID-19 Vaccination | CDC\nStaying up to date with COVID-19 vaccinations is recommended for people who are pregnant, trying to get pregnant now, or\nwho might become pregnant in the future, and people who are breastfeeding. A growing body of evidence on the safety and\neffectiveness of COVID-19 vaccination indicates that the benefits of vaccination outweigh any potential risks of COVID-19\nvaccination during pregnancy. Side effects can occur after COVID-19 vaccination in pregnant people, similar to those among non-pregnant people."}]}, {"title": "348bc082790b41a77d7be82bcf27790b", "paragraphs": [{"qas": [{"question": "When is the Moderna COVID-19 Vaccine available?", "id": "100000000000000000003432", "answers": [{"text": "December 18, 2020", "answer_start": 307}], "is_impossible": false}, {"question": "What has been associated with adverse pregnancy outcomes?", "id": "100000000000000000003433", "answers": [{"text": "fever", "answer_start": 82}], "is_impossible": false}, {"question": "Since when has Moderna COVID-19 Vaccine been available?", "id": "100000000000000000003434", "answers": [{"text": "December 18, 2020", "answer_start": 307}], "is_impossible": false}, {"question": "What is the name of the vaccine that is authorized for use in individuals 12 years of age and older?", "id": "100000000000000000003435", "answers": [{"text": "Moderna COVID-19", "answer_start": 343}], "is_impossible": false}], "context": "Acetaminophen can be offered as an option for pregnant people experiencing fever (fever has been associated with adverse\npregnancy outcomes) or other post-vaccination symptoms. 1. SPIKEVAX is the proprietary name for the product licensed under the BLA. The Moderna COVID-19 Vaccine has been\navailable since December 18, 2020 under an EUA. The Moderna COVID-19 Vaccine authorized for use in individuals 12\nyears of age and older (supplied in multiple-dose vials with red caps and labels with light blue borders) has the same\nformulation as SPIKEVAX."}]}, {"title": "725e247cff44b08186fcb304b0261765", "paragraphs": [{"qas": [{"question": "What is SPIKEVAX?", "id": "100000000000000000003436", "answers": [{"text": "FDA-approved", "answer_start": 4}], "is_impossible": false}, {"question": "What is the proprietary name for the product licensed under the BLA?", "id": "100000000000000000003438", "answers": [{"text": "COMIRNATY", "answer_start": 418}], "is_impossible": false}, {"question": "When is the Pfizer-BioNTech COVID-19 Vaccine available?", "id": "100000000000000000003439", "answers": [{"text": "December 10, 2020", "answer_start": 554}], "is_impossible": false}], "context": "The FDA-approved SPIKEVAX (COVID-19 Vaccine, mRNA) and the emergency use authorized\nModerna COVID-19 Vaccine for people ages 12 years and older (supplied in multiple-dose vials with red caps and labels\nwith light blue borders) have the same formulation and can be used interchangeably to provide primary series doses\nto individuals 12 years of age and older without presenting any safety or effectiveness concerns. 2. COMIRNATY is the proprietary name for the product licensed under the BLA. The Pfizer-BioNTech COVID-19 Vaccine has\nbeen available since December 10, 2020 under an EUA."}]}, {"title": "7b3c1971c8d114650be25acc24b3a9a1", "paragraphs": [{"qas": [{"question": "What are the two approved formulations of COMIRNATY?", "id": "100000000000000000003440", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 91}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine for people ages 12 years and older?", "id": "100000000000000000003441", "answers": [{"text": "COMIRNATY", "answer_start": 33}], "is_impossible": false}, {"question": "What is the name of the emergency use authorized formulations of Pfizer-BioNTech COVID-19 Vaccine for people ages 12 years and older?", "id": "100000000000000000003444", "answers": [{"text": "COMIRNATY", "answer_start": 297}], "is_impossible": false}], "context": "The two approved formulations of COMIRNATY and the two FDA-\nauthorized formulations of the Pfizer-BioNTech COVID-19 Vaccine for people ages 12 years and older are the same\nformulations, and vials of the BLA-compliant vaccine may bear the name \u201cPfizer-BioNTech COVID-19 Vaccine.\u201d The FDA-\napproved COMIRNATY (COVID-19 Vaccine, mRNA) and the emergency use authorized formulations of Pfizer-BioNTech\nCOVID-19 Vaccine for people ages 12 years and older (gray cap/label vials ), when prepared according to their\nrespective instructions for use, can be used interchangeably without presenting any safety or effectiveness concerns. 3."}]}, {"title": "8d15cebdf0278b4493f09808de983eb5", "paragraphs": [{"qas": [{"question": "For intervals of 3 months or less, how many days is a \"month\"?", "id": "100000000000000000003445", "answers": [{"text": "28", "answer_start": 35}], "is_impossible": false}, {"question": "What should be read as \u201cthrough\u201d?", "id": "100000000000000000003447", "answers": [{"text": "a dash", "answer_start": 194}], "is_impossible": false}, {"question": "What includes that year through the last day before the birth date?", "id": "100000000000000000003448", "answers": [{"text": "the upper range", "answer_start": 237}], "is_impossible": false}, {"question": "What are considerations for patients and healthcare professionals in scheduling screening exams in relation to the administration of a COVID-19 vaccine?", "id": "100000000000000000003450", "answers": [{"text": "Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination", "answer_start": 363}], "is_impossible": false}], "context": "For intervals of 3 months or less, 28 days (4 weeks) is a \u201cmonth.\u201d For intervals of 4 months or longer, a month is a\n\u201ccalendar month.\u201d For age group ranges (e.g., 6 months\u20134 years, 5\u201311 years), a dash (\u2013) should be read as \u201cthrough\u201d and\nthe upper range includes that year through the last day before the birth date. 4. The Society of Breast Imaging has developed Recommendations for the Management of Axillary Adenopathy in Patients\nwith Recent COVID-19 Vaccination which includes considerations for patients and healthcare professionals in\nscheduling screening exams in relation to the administration of a COVID-19 vaccine."}]}, {"title": "7048834e2c2589b10a577dcacfdbab27", "paragraphs": [{"qas": [{"question": "What do you need to know before traveling on a cruise ship?", "id": "100000000000000000003452", "answers": [{"text": "Check if you are up to date with your COVID-19 vaccines", "answer_start": 142}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000003454", "answers": [{"text": "The virus that causes COVID-19 spreads easily between people in close quarters on board ships", "answer_start": 537}], "is_impossible": false}, {"question": "Talk to your healthcare provider about your risk before travel.", "id": "100000000000000000003456", "answers": [{"text": "Check if you are up to date with your COVID-19 vaccines before cruise ship travel. If you have a medical condition or are taking medication that weakens your immune system, you might NOT be fully protected even if you are up to date with your COVID-19 vaccines. Talk to your healthcare provider about your risk before travel. Even after vaccination, you may need to continue taking precautions", "answer_start": 142}], "is_impossible": false}, {"question": "Where does the virus spread easily?", "id": "100000000000000000003457", "answers": [{"text": "between people in close quarters on board ships", "answer_start": 583}], "is_impossible": false}], "context": "10/30/22, 9:43 AM Cruise Ship Travel During COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nCruise Ship Travel During COVID-19\nWhat You Need to Know\nCheck if you are up to date with your COVID-19 vaccines before cruise ship travel. If you have a medical condition or are taking medication that weakens your immune system, you might NOT be fully\nprotected even if you are up to date with your COVID-19 vaccines. Talk to your healthcare provider about your risk\nbefore travel. Even after vaccination, you may need to continue taking precautions. The virus that causes COVID-19 spreads easily between people in close quarters on board ships."}]}, {"title": "18627117982c4acda224842012110fb7", "paragraphs": [{"qas": [{"question": "What are passengers and crew at risk for if the virus is spreading on a cruise ship?", "id": "100000000000000000003458", "answers": [{"text": "infection", "answer_start": 86}], "is_impossible": false}, {"question": "What should you do if your cruise line does not have a testing requirement?", "id": "100000000000000000003459", "answers": [{"text": "get tested for current infection with a COVID-19 viral test", "answer_start": 251}], "is_impossible": false}, {"question": "What is the requirement to get tested for current infection as close to time of cruise departure as possible?", "id": "100000000000000000003460", "answers": [{"text": "COVID-19 viral test", "answer_start": 291}], "is_impossible": false}, {"question": "CDC is reviewing this page to align with what?", "id": "100000000000000000003462", "answers": [{"text": "updated guidance", "answer_start": 514}], "is_impossible": false}], "context": "If the virus is spreading\non board a cruise ship, passengers and crew are at risk for infection. Check directly with your cruise line about their testing or vaccination protocols before travel. If your cruise line does not have a testing requirement, get tested for current infection with a COVID-19 viral test as close\nto time of cruise departure as possible (no more than 3 days before you travel). Get tested again with a COVID-19 viral test 3-5 days after your cruise. CDC is reviewing this page to align with updated guidance."}]}, {"title": "5307ccbba5b4f803949c33edbbde930b", "paragraphs": [{"qas": [{"question": "When is the COVID-19 Program for Cruise Ships no longer in effect?", "id": "100000000000000000003463", "answers": [{"text": "July 18, 2022", "answer_start": 8}], "is_impossible": false}, {"question": "What will CDC continue to publish to help cruise ships provide a safer and healthier environment for passengers, crew and communities?", "id": "100000000000000000003464", "answers": [{"text": "guidance", "answer_start": 116}], "is_impossible": false}, {"question": "What is the day your symptoms started?", "id": "100000000000000000003467", "answers": [{"text": "day 0", "answer_start": 470}], "is_impossible": false}, {"question": "When did your symptoms start?", "id": "100000000000000000003468", "answers": [{"text": "day 0", "answer_start": 470}], "is_impossible": false}, {"question": "What did you have no symptoms?", "id": "100000000000000000003469", "answers": [{"text": "COVID-19", "answer_start": 438}], "is_impossible": false}], "context": "\uf106 As of July 18, 2022, CDC\u2019s COVID-19 Program for Cruise Ships is no longer in effect. CDC will continue to\npublish guidance to help cruise ships continue to provide a safer and healthier environment for passengers,\ncrew and communities going forward. For more information, please see the Frequently Asked Questions\n(FAQs). Before Cruise Travel\nDo not travel or board a cruise ship if\u2026\nYou are sick with COVID-19. You tested positive for COVID-19 less than 10 days ago (day 0 is the day your symptoms started or the day your\npositive test sample was taken if you had no symptoms)."}]}, {"title": "6eb5e22681e02d63e6bad8e72cc3f51e", "paragraphs": [{"qas": [{"question": "How many days have you had close contact with a person with COVID-19?", "id": "100000000000000000003470", "answers": [{"text": "5", "answer_start": 62}], "is_impossible": false}, {"question": "How long after your last close contact should you get tested?", "id": "100000000000000000003471", "answers": [{"text": "5 days", "answer_start": 124}], "is_impossible": false}, {"question": "What should you wear when traveling?", "id": "100000000000000000003472", "answers": [{"text": "a well-fitting mask", "answer_start": 265}], "is_impossible": false}, {"question": "What should you wear when you are around others through day 10?", "id": "100000000000000000003473", "answers": [{"text": "a well-fitting mask", "answer_start": 265}], "is_impossible": false}, {"question": "If you are unable to wear a mask, you should not travel during what time?", "id": "100000000000000000003474", "answers": [{"text": "day 10", "answer_start": 320}], "is_impossible": false}, {"question": "What is CDC During Cruise Travel After COVID-19?", "id": "100000000000000000003475", "answers": [{"text": "Self-monitor for COVID-19 symptoms", "answer_start": 556}], "is_impossible": false}, {"question": "What are the symptoms of COVID-19?", "id": "100000000000000000003476", "answers": [{"text": "without symptoms", "answer_start": 215}], "is_impossible": false}], "context": "You had close contact with a person with COVID-19 in the past 5 days and are recommended to quarantine. Get tested at least 5 days after your last close contact. Make sure your test result is negative and you remain\nwithout symptoms before traveling. Properly wear a well-fitting mask when you are around others through day 10. If you are unable to wear a\nmask, you should not travel during this time. Check with your cruise line regarding their policies. 10/30/22, 9:43 AM Cruise Ship Travel During COVID-19 | CDC\nDuring Cruise Travel\nAfter Cruise Travel\nSelf-monitor for COVID-19 symptoms."}]}, {"title": "1226ba725c533d00892382e491118a1c", "paragraphs": [{"qas": [{"question": "What should you do if you know you were exposed to a person with COVID-19?", "id": "100000000000000000003478", "answers": [{"text": "Follow additional guidance", "answer_start": 0}], "is_impossible": false}, {"question": "Check if your cruise line requires proof of vaccination or what else to board?", "id": "100000000000000000003480", "answers": [{"text": "pre-embarkation testing", "answer_start": 212}], "is_impossible": false}, {"question": "What type of insurance should you buy if you are traveling by air before or after a cruise?", "id": "100000000000000000003481", "answers": [{"text": "travel insurance", "answer_start": 469}], "is_impossible": false}, {"question": "What is the U.S. requirement for flying before and after cruise travel?", "id": "100000000000000000003482", "answers": [{"text": "testing, vaccination, or other documents", "answer_start": 410}], "is_impossible": false}], "context": "Follow additional guidance if you know you were exposed to a person with COVID-19. \uf2a5 Plan ahead\nBe up to date with your COVID-19 vaccines before travel. Check if your cruise line requires proof of vaccination or pre-embarkation testing, or has any other\nrequirements to board. If traveling by air before or after cruise travel, check if your airline or destination (see here for U.S.\nrequirement) requires any testing, vaccination, or other documents. Consider getting travel insurance. Consider buying additional insurance that covers health care and\nemergency evacuation, especially if you will be traveling to remote areas."}]}, {"title": "29baeea6fa26d15c6544a530ca87ab8b", "paragraphs": [{"qas": [{"question": "What should you do if you need care overseas?", "id": "100000000000000000003484", "answers": [{"text": "a plan", "answer_start": 19}], "is_impossible": false}, {"question": "What is not recommended unless you have symptoms?", "id": "100000000000000000003487", "answers": [{"text": "testing", "answer_start": 399}], "is_impossible": false}, {"question": "How long can people continue to test positive for COVID-19?", "id": "100000000000000000003488", "answers": [{"text": "up to 90 days", "answer_start": 503}], "is_impossible": false}, {"question": "How long can it take for a person to be positive?", "id": "100000000000000000003489", "answers": [{"text": "up to 90 days", "answer_start": 503}], "is_impossible": false}], "context": "Make sure you have a plan to get\ncare overseas, in case you need it. \uf3c0 Pre-embarkation Testing\nIf your cruise line does not have a testing requirement, get tested for current infection with a viral\ntest (no more than 3 days) before boarding a cruise ship, regardless of your vaccination status. Get your test\nresults before you board your cruise. If you recovered from COVID-19 in the past 90 days, testing is not generally recommended unless you\nhave symptoms. People can continue to test positive for up to 90 days after diagnosis and not be\ninfectious to others."}]}, {"title": "d95df9f3a69cb49a15a454ea4b4712c6", "paragraphs": [{"qas": [{"question": "What do you need to provide if you have COVID-19 symptoms or test positive at embarkation?", "id": "100000000000000000003490", "answers": [{"text": "a copy of your positive test result and a letter from your healthcare provider", "answer_start": 96}], "is_impossible": false}, {"question": "If you have COVID-19 symptoms or test positive at embarkation, the cruise ship may deny you from what?", "id": "100000000000000000003491", "answers": [{"text": "boarding", "answer_start": 344}], "is_impossible": false}, {"question": "If you are allowed to board, you may be required to isolate or quarantine depending on your symptoms and test results.", "id": "100000000000000000003492", "answers": [{"text": "If you or your travel companions have COVID-19 symptoms or test positive at embarkation, the cruise ship may deny you from boarding", "answer_start": 221}], "is_impossible": false}, {"question": "What do you wash your hands often with?", "id": "100000000000000000003493", "answers": [{"text": "soap and water", "answer_start": 533}], "is_impossible": false}, {"question": "Hands often with soap and water or use hand sanitizer with at least what?", "id": "100000000000000000003494", "answers": [{"text": "60% alcohol", "answer_start": 584}], "is_impossible": false}], "context": "Check with your cruise line regarding their specific policies, including if you need to\nprovide a copy of your positive test result and a letter from your healthcare provider documenting that\nyou recovered from COVID-19. If you or your travel companions have COVID-19 symptoms or test positive at embarkation, the cruise ship\nmay deny you from boarding. If you are allowed to board, you may be required to isolate or quarantine,\ndepending on your symptoms and test results. \uf209\n\uf304 Protect Yourself and Others\nWash your hands often with soap and water or use hand sanitizer with at least 60% alcohol."}]}, {"title": "e9ee89a5a589875acaf25578aece19a7", "paragraphs": [{"qas": [{"question": "What should you do if you have symptoms of COVID-19?", "id": "100000000000000000003495", "answers": [{"text": "stay in your cabin", "answer_start": 93}], "is_impossible": false}, {"question": "If You Develop Symptoms or Use a Self-Test on Board with a Positive Result Isolate yourself in your cabin immediately.", "id": "100000000000000000003499", "answers": [{"text": "Call your ship\u2019s medical center", "answer_start": 582}], "is_impossible": false}, {"question": "Isolate yourself in your cabin immediately.", "id": "100000000000000000003500", "answers": [{"text": "If You Develop Symptoms or Use a Self-Test on Board with a Positive Result Isolate yourself in your cabin immediately. Call your ship\u2019s medical center", "answer_start": 463}], "is_impossible": false}, {"question": "Call your ship\u2019s medical center.", "id": "100000000000000000003501", "answers": [{"text": "Isolate yourself in your cabin immediately", "answer_start": 538}], "is_impossible": false}], "context": "Follow recommendations for protecting yourself and others. If you have symptoms of COVID-19, stay in your cabin and notify the onboard medical center immediately. It\u2019s important to report your symptoms, even if they are mild, to protect others on board including\npassengers at increased risk for severe illness and crew. \uf309 Masks\nFollow any ship-specific mask protocols. Follow CDC\u2019s recommendations for wearing masks in travel and public transportation settings. If You Develop Symptoms or Use a Self-Test on Board with a Positive Result\nIsolate yourself in your cabin immediately. Call your ship\u2019s medical center."}]}, {"title": "61c3bb909004056a9b0ff01d2f759dcf", "paragraphs": [{"qas": [{"question": "What should you follow if you disembark the ship before completing your isolation or quarantine period?", "id": "100000000000000000003503", "answers": [{"text": "CDC\u2019s guidance", "answer_start": 348}], "is_impossible": false}, {"question": "What should you follow if you disembark in another country?", "id": "100000000000000000003504", "answers": [{"text": "CDC\u2019s guidance, or local guidance", "answer_start": 348}], "is_impossible": false}, {"question": "How long after your trip should you get tested for COVID-19?", "id": "100000000000000000003505", "answers": [{"text": "3\u20135 days", "answer_start": 538}], "is_impossible": false}, {"question": "What do you do if you develop symptoms after your trip?", "id": "100000000000000000003506", "answers": [{"text": "Isolate", "answer_start": 591}], "is_impossible": false}], "context": "Cruise ships may have their own requirements for testing, isolation, quarantine, mask wearing, and dining for people\nwith COVID-19 or their close contacts. If you have questions about a cruise ship\u2019s specific policies, please contact them\ndirectly. If you disembark the ship before completing your isolation or quarantine period, you should follow CDC\u2019s guidance, or\nlocal guidance if you disembark in another country. 10/30/22, 9:43 AM Cruise Ship Travel During COVID-19 | CDC\nGet tested for current infection with a COVID-19 viral test 3\u20135 days after your trip or if you develop symptoms. Isolate if you develop symptoms or your test result is positive."}]}, {"title": "a71c6961ade2f39a227ee7bd300606ba", "paragraphs": [{"qas": [{"question": "If your test result is positive, tell your state, territorial, local or tribal health department to tell them you have what?", "id": "100000000000000000003509", "answers": [{"text": "COVID-19", "answer_start": 121}], "is_impossible": false}, {"question": "What do you follow after you have traveled on a cruise ship?", "id": "100000000000000000003510", "answers": [{"text": "all state, territorial, local or tribal recommendations or requirements", "answer_start": 178}], "is_impossible": false}, {"question": "Who has worked closely with the cruise industry?", "id": "100000000000000000003511", "answers": [{"text": "CDC", "answer_start": 292}], "is_impossible": false}, {"question": "What has CDC worked closely with the cruise industry, state, territorial, and local health authorities?", "id": "100000000000000000003512", "answers": [{"text": "to provide a safer and healthier environment for cruise passengers and crew", "answer_start": 425}], "is_impossible": false}, {"question": "What does CDC do to provide a safer and healthier environment for cruise passengers and crew?", "id": "100000000000000000003513", "answers": [{"text": "worked closely with the cruise industry", "answer_start": 301}], "is_impossible": false}], "context": "If your test result is positive, contact your state, territorial, local or tribal health department to tell them you have\nCOVID-19 and recently traveled on a cruise ship. Follow all state, territorial, local or tribal recommendations or requirements after travel. Frequently Asked Questions\n\uf209\nCDC has worked closely with the cruise industry, state, territorial, and local health authorities, and federal and seaport\npartners to provide a safer and healthier environment for cruise passengers and crew. Cruise ships have access to\nguidance and tools to manage their own COVID-19 mitigation programs."}]}, {"title": "8ab43cd5fc3114211a75f84a5357e303", "paragraphs": [{"qas": [{"question": "What do cruise travelers have access to that allow them to make informed decisions about cruise ship travel?", "id": "100000000000000000003514", "answers": [{"text": "recommendations", "answer_start": 46}], "is_impossible": false}, {"question": "Who will continue to publish guidance to help cruise ships provide a safer and healthier environment for crew, passengers, and communities?", "id": "100000000000000000003516", "answers": [{"text": "CDC", "answer_start": 188}], "is_impossible": false}, {"question": "What was the previous color-coding system under CDC's COVID-19 Program for Cruise Ships dependent on?", "id": "100000000000000000003517", "answers": [{"text": "each cruise line", "answer_start": 507}], "is_impossible": false}, {"question": "What may now vary among cruise lines?", "id": "100000000000000000003518", "answers": [{"text": "COVID-19 screening testing standards", "answer_start": 540}], "is_impossible": false}, {"question": "What has the cruise ship color status webpage been retired from?", "id": "100000000000000000003519", "answers": [{"text": "The previous color-coding system under CDC\u2019s COVID-19 Program for Cruise Ships depended upon each cruise line having the same COVID-19 screening testing standards", "answer_start": 414}], "is_impossible": false}], "context": "Additionally, cruise travelers have access to\nrecommendations that allow them to make informed decisions about cruise ship travel. While cruising poses some risk of\nCOVID-19 transmission, CDC will continue to publish guidance to help cruise ships continue to provide a safer and\nhealthier environment for crew, passengers, and communities going forward. What happened to CDC\u2019s COVID-19 Program for Cruise Ships? \uf1aa\nThe previous color-coding system under CDC\u2019s COVID-19 Program for Cruise Ships depended upon each cruise line\nhaving the same COVID-19 screening testing standards, which may now vary among cruise lines. Therefore, the cruise\nship color status webpage has been retired."}]}, {"title": "2ace86789e1a69b3c817391fb83726e5", "paragraphs": [{"qas": [{"question": "What does cruise travelers have the option of doing?", "id": "100000000000000000003523", "answers": [{"text": "contacting their cruise line directly", "answer_start": 244}], "is_impossible": false}, {"question": "How can travelers find out about COVID-19 outbreaks on cruise ships?", "id": "100000000000000000003524", "answers": [{"text": "contacting their cruise line", "answer_start": 244}], "is_impossible": false}, {"question": "What was the name of the pandemic that affected travel during the COVID-19 Pandemic?", "id": "100000000000000000003526", "answers": [{"text": "International Travel", "answer_start": 622}], "is_impossible": false}, {"question": "When was the last time the Frequently Asked Questions and Answers for Travelers were updated?", "id": "100000000000000000003527", "answers": [{"text": "July 18, 2022", "answer_start": 709}], "is_impossible": false}], "context": "CDC will continue to provide testing recommendations for cruise ship\noperators to follow and cruise ships will continue to report COVID-19 cases to CDC. Why was the cruise ship color-coding system removed? \uf1aa\nCruise travelers have the option of contacting their cruise line directly regarding outbreaks occurring on board their ship. How can travelers find out about COVID-19 outbreaks on cruise ships? \uf1aa\nMore Information\nIf you need to contact your health department: State & Territorial Health Department Websites\nGuidance for Cruise Ships on the Mitigation and Management of COVID-19\nTravel during the COVID-19 Pandemic\nInternational Travel\nFrequently Asked Questions and Answers for Travelers\nLast Updated July 18, 2022"}]}, {"title": "8942d9bac954bc7ae0ea988fc65c429", "paragraphs": [{"qas": [{"question": "What is the total amount of people who are fully vaccinated?", "id": "100000000000000000003529", "answers": [{"text": "number", "answer_start": 279}], "is_impossible": false}, {"question": "What is CDC estimates based on?", "id": "100000000000000000003531", "answers": [{"text": "data that include a dose number (first, second, boosters, or additional dose).", "answer_start": 394}], "is_impossible": false}], "context": "10/30/22, 9:35 AM Data Definitions for COVID-19 Vaccinations in the United States\nEspa\u00f1ol | Other Languages\nData Definitions for COVID-19 Vaccinations in the\nUnited States\nHow CDC Estimates Vaccination Coverage\nCDC estimates the number of people receiving at least one dose, the number of people who are fully vaccinated, and the\nnumber of people with booster doses. CDC estimates are based on data that include a dose number (first, second, boosters,\nor additional dose). To protect the privacy of vaccine recipients, CDC receives data without any personally identifiable\ninformation (deidentified data). Each jurisdiction or provider uses a unique person identifier to link records within their own\nsystems."}]}, {"title": "50142f1cc3cb7b7586a68b36766b0c85", "paragraphs": [{"qas": [{"question": "There are challenges in linking records when someone receives vaccine doses in different jurisdictions or from what provider?", "id": "100000000000000000003536", "answers": [{"text": "different providers", "answer_start": 203}], "is_impossible": false}, {"question": "CDC may not be able to link multiple what?", "id": "100000000000000000003537", "answers": [{"text": "unique person identifiers", "answer_start": 344}], "is_impossible": false}, {"question": "What may CDC not be able to link multiple unique person identifiers for different jurisdictions or providers to a single person?", "id": "100000000000000000003538", "answers": [{"text": "subsequent doses", "answer_start": 435}], "is_impossible": false}, {"question": "What may appear to be a first dose when reported?", "id": "100000000000000000003539", "answers": [{"text": "subsequent doses", "answer_start": 435}], "is_impossible": false}, {"question": "CDC\u2019s data may over-estimate first doses and what else?", "id": "100000000000000000003540", "answers": [{"text": "under-estimate subsequent doses", "answer_start": 548}], "is_impossible": false}, {"question": "Different jurisdictions and providers use different reporting practices what?", "id": "100000000000000000003542", "answers": [{"text": "estimating doses administered", "answer_start": 620}], "is_impossible": false}], "context": "However, CDC cannot use the unique person identifier to identify individual people by name. There are challenges in linking records when someone receives vaccine doses in different jurisdictions or from different\nproviders. That person could receive different unique person identifiers for different doses. CDC may not be able to link\nmultiple unique person identifiers for different jurisdictions or providers to a single person, and subsequent doses may\nappear to be a first dose when reported. Thus, CDC\u2019s data may over-estimate first doses and under-estimate subsequent\ndoses. Another issue that poses challenges to estimating doses administered is that different jurisdictions and providers use\ndifferent reporting practices."}]}, {"title": "52f4c6ca200909d97efb4e5c700cd9aa", "paragraphs": [{"qas": [{"question": "What can happen to people receiving doses if they move?", "id": "100000000000000000003544", "answers": [{"text": "the reporting method might change between doses if they move to a different jurisdiction", "answer_start": 83}], "is_impossible": false}, {"question": "What percentage of vaccination coverage has the CDC capped on COVID Data Tracker?", "id": "100000000000000000003545", "answers": [{"text": "95%.", "answer_start": 432}], "is_impossible": false}, {"question": "What is the reason for the overestimation of vaccine coverage?", "id": "100000000000000000003546", "answers": [{"text": "first, second, and booster doses that were not linked", "answer_start": 516}], "is_impossible": false}, {"question": "What is another reason for overestimation?", "id": "100000000000000000003548", "answers": [{"text": "census denominator data not including part-time residents or potential data reporting errors", "answer_start": 611}], "is_impossible": false}], "context": "As people receiving doses are attributed to the jurisdiction in which they reside, the reporting\nmethod might change between doses if they move to a different jurisdiction. Also, CDC may lack information about a person\u2019s\nresidence. These issues can cause CDC\u2019s dose number estimates to differ from those reported by jurisdictions and federal\nentities. CDC has capped estimates of vaccination coverage shown on COVID Data Tracker at 95%. This cap helps address potential\nover-estimates of vaccination coverage due to first, second, and booster doses that were not linked. Other reasons for\noverestimates include census denominator data not including part-time residents or potential data reporting errors."}]}, {"title": "2387eece719d57a1a8759d5796d310d4", "paragraphs": [{"qas": [{"question": "When did CDC change the vaccination coverage cap to 95%?", "id": "100000000000000000003550", "answers": [{"text": "December 9, 2021", "answer_start": 101}], "is_impossible": false}, {"question": "What does having a COVID-19 Vaccination record card help ensure?", "id": "100000000000000000003553", "answers": [{"text": "the doses are linked", "answer_start": 409}], "is_impossible": false}], "context": "Previously, CDC had capped estimates of vaccination coverage at 99.9%. CDC changed the cap to 95% on December 9, 2021,\nto account for differences in the accuracy of vaccination coverage estimates between different jurisdictions. CDC encourages people to bring their CDC COVID-19 Vaccination record card with them to their appointment for another\nCOVID-19 vaccine dose because having the card will help ensure the doses are linked."}]}, {"title": "6a0489fccff01a9ed04985d49014ed76", "paragraphs": [{"qas": [{"question": "How does CDC determine the number of people receiving at least one dose?", "id": "100000000000000000003554", "answers": [{"text": "based on information reported to CDC on dose number, dose manufacturer, administration date recipient ID and date of submission", "answer_start": 181}], "is_impossible": false}, {"question": "What is the name of the information reported to CDC on dose number, dose manufacturer, administration date and date of submission?", "id": "100000000000000000003555", "answers": [{"text": "recipient ID", "answer_start": 273}], "is_impossible": false}, {"question": "What is one of CDC's core activities?", "id": "100000000000000000003556", "answers": [{"text": "Sharing timely and accurate information with the public", "answer_start": 467}], "is_impossible": false}], "context": "How CDC Attributes Doses\nCDC determines the number of people receiving at least one dose, the number of people who are fully vaccinated, and the\nnumber of people with booster doses based on information reported to CDC on dose number, dose manufacturer,\nadministration date recipient ID and date of submission Because the method used to determine dose numbers needs to be\nCDC reports COVID-19 vaccination data online on COVID Data Tracker and in vaccination datasets. Sharing timely and\naccurate information with the public is one of CDC\u2019s core activities. Timely and accurate reporting from jurisdictions\nprovides the reliable data that can be reported by CDC."}]}, {"title": "ea70835f719f3608f5693167f57e3a3e", "paragraphs": [{"qas": [{"question": "What may change over time as updated data are continuously reported to CDC?", "id": "100000000000000000003559", "answers": [{"text": "All reported numbers", "answer_start": 0}], "is_impossible": false}, {"question": "Dose numbers need to be applied across multiple jurisdictions with different reporting practices?", "id": "100000000000000000003561", "answers": [{"text": "method", "answer_start": 245}], "is_impossible": false}, {"question": "Who administers doses administered by FEMA partner sites?", "id": "100000000000000000003563", "answers": [{"text": "Federal Emergency Management Agency", "answer_start": 585}], "is_impossible": false}, {"question": "What is the acronym for the Federal Emergency Management Agency?", "id": "100000000000000000003564", "answers": [{"text": "FEMA", "answer_start": 622}], "is_impossible": false}, {"question": "What is HRSA?", "id": "100000000000000000003565", "answers": [{"text": "Health Resources and Services Administration", "answer_start": 643}], "is_impossible": false}], "context": "All reported numbers may change over time as updated data are\ncontinuously reported to CDC. 10/30/22, 9:35 AM Data Definitions for COVID-19 Vaccinations in the United States\nadministration date, recipient ID, and date of submission. Because the method used to determine dose numbers needs to be\napplied across multiple jurisdictions with different reporting practices, CDC\u2019s dose number estimates might differ from those\nreported by jurisdictions and federal entities. People receiving doses are attributed to the jurisdiction in which they\nreside. This includes doses administered by Federal Emergency Management Agency (FEMA) partner sites, Health Resources\nand Services Administration (HRSA) partner sites, and federal entity facilities."}]}, {"title": "58115c8479e907e0f6b9b608a08fd24e", "paragraphs": [{"qas": [{"question": "Who is considered fully vaccinated with two doses when the vaccine manufacturer is not reported?", "id": "100000000000000000003566", "answers": [{"text": "the recipient", "answer_start": 197}], "is_impossible": false}, {"question": "What is the total number of vaccine doses that have been distributed?", "id": "100000000000000000003567", "answers": [{"text": "COVID-19 Vaccinations Data Definitions Total Doses Distributed", "answer_start": 258}], "is_impossible": false}, {"question": "What are the states, Washington DC, the U.S. Virgin Islands, and Puerto Rico?", "id": "100000000000000000003569", "answers": [{"text": "total counts of COVID-19 vaccine doses include doses distributed since December 14, 2020", "answer_start": 482}], "is_impossible": false}], "context": "In some limited circumstances, people might\nreceive vaccinations outside the jurisdiction (state, territory, tribe, or local entity) where they live. When the vaccine\nmanufacturer is not reported, the recipient is considered fully vaccinated with two doses. COVID-19 Vaccinations Data Definitions\nTotal Doses Distributed\nThe total number of vaccine doses that have been distributed to vaccine provider locations. For states, Washington DC, the U.S. Virgin Islands, and Puerto Rico, total counts of COVID-19 vaccine doses include doses\ndistributed since December 14, 2020."}]}, {"title": "fdbbaeea4dd21c50eb73a2c2a0d2edc2", "paragraphs": [{"qas": [{"question": "What are the total counts of COVID-19 vaccine doses?", "id": "100000000000000000003570", "answers": [{"text": "doses marked as shipped since December 13, 2020", "answer_start": 225}], "is_impossible": false}, {"question": "When were the doses marked as shipped?", "id": "100000000000000000003572", "answers": [{"text": "December 13, 2020", "answer_start": 255}], "is_impossible": false}, {"question": "How many vaccine doses have been given to people in the U.S. since December 14, 2020?", "id": "100000000000000000003573", "answers": [{"text": "COVID-19", "answer_start": 194}], "is_impossible": false}], "context": "For the Republic of Palau, the Federated States of Micronesia, the Republic of the Marshall Islands, Guam, American\nSamoa, and the Commonwealth of the Northern Marianas Islands, total counts of COVID-19 vaccine doses include doses\nmarked as shipped since December 13, 2020. Total Doses Administered\nThe total number of vaccine doses that have been given to people in the United States since December 14, 2020. This is\nthe date when the first dose was administered to a person in the United States under the Emergency Use Authorization\nnot within a clinical trial."}]}, {"title": "696e5e62ca2c4c9343dafda10e829cfc", "paragraphs": [{"qas": [{"question": "Who is fully vaccinated?", "id": "100000000000000000003577", "answers": [{"text": "People Who Are Fully Vaccinated Represents the total number of people who have received the second dose in a two-dose COVID-19 vaccine primary series or one dose of a single-dose COVID-19 vaccine primary series approved or authorized for use in the United States", "answer_start": 281}], "is_impossible": false}, {"question": "Who received more than one dose?", "id": "100000000000000000003578", "answers": [{"text": "those", "answer_start": 242}], "is_impossible": false}, {"question": "Who represents the total number of people who have received the second dose in a two-dose COVID-19 vaccine primary series?", "id": "100000000000000000003579", "answers": [{"text": "People Who Are Fully Vaccinated", "answer_start": 281}], "is_impossible": false}, {"question": "What does People Who Are Fully Vaccinated represent?", "id": "100000000000000000003580", "answers": [{"text": "the total number of people who have received the second dose in a two-dose COVID-19 vaccine primary series or one dose of a single-dose COVID-19 vaccine primary series approved or authorized for use in the United States", "answer_start": 324}], "is_impossible": false}], "context": "People Receiving at Least One Dose\nRepresents the total number of people who received at least one dose of COVID-19 vaccine approved or authorized for\nuse in the United States. This metric includes everyone who has received only one dose and those who received more\nthan one dose. People Who Are Fully Vaccinated\nRepresents the total number of people who have received the second dose in a two-dose COVID-19 vaccine primary\nseries or one dose of a single-dose COVID-19 vaccine primary series approved or authorized for use in the United States."}]}, {"title": "7e3100824a573bc7c9ae262ca0147154", "paragraphs": [{"qas": [{"question": "What was reported to have received one or more mRNA vaccines prior to receiving the single-dose J&J/ Janssen vaccination?", "id": "100000000000000000003582", "answers": [{"text": "Pfizer-BioNTech, Moderna", "answer_start": 251}], "is_impossible": false}, {"question": "Who counts people as being \u201cfully vaccinated\u201d if they received one dose of a single-dose vaccine or two doses on different days?", "id": "100000000000000000003583", "answers": [{"text": "CDC", "answer_start": 375}], "is_impossible": false}, {"question": "How many doses of an mRNA or a protein-based series did people receive?", "id": "100000000000000000003584", "answers": [{"text": "two", "answer_start": 475}], "is_impossible": false}], "context": "The number of people fully vaccinated with Johnson & Johnson\u2019s Janssen (J&J/Janssen) vaccine does not equal the\ntotal number of J&J/Janssen vaccine doses administered because some people were reported to have received one\nor more mRNA vaccines (i.e., Pfizer-BioNTech, Moderna) prior to receiving the single-dose J&J/ Janssen vaccine. For reporting on CDC COVID Data Tracker, CDC counts people as being \u201cfully vaccinated\u201d if they received one dose\nof a single-dose vaccine or two doses on different days (regardless of time interval) of either an mRNA or a protein-\nbased series."}]}, {"title": "3ced07d7865f1800d2b689c8717b05a1", "paragraphs": [{"qas": [{"question": "How long has it been at least 5 months since their completed Pfizer-BioNTech or Moderna primary series?", "id": "100000000000000000003586", "answers": [{"text": "2 months", "answer_start": 297}], "is_impossible": false}, {"question": "What does not distinguish if a recipient is immunocompromised and received an additional dose?", "id": "100000000000000000003587", "answers": [{"text": "Completion of a primary series", "answer_start": 361}], "is_impossible": false}, {"question": "What excludes recipients who received an \u201cOther\u201d primary series vaccine type?", "id": "100000000000000000003588", "answers": [{"text": "Completion of a primary series", "answer_start": 361}], "is_impossible": false}], "context": "People Who Are Eligible to Receive a First Booster Dose\nRepresents the total number of fully vaccinated people who are eligible to receive a first booster dose of an mRNA\nCOVID-19 vaccine if it has been at least 5 months since their completed Pfizer-BioNTech or Moderna primary series or at\nleast 2 months since their completed J&J/Janssen single-dose vaccine. Completion of a primary series does not distinguish\nif the recipient is immunocompromised and received an additional dose. This measure excludes recipients who received\nan \u201cOther\u201d primary series vaccine type."}]}, {"title": "57ac9adaf23b72c4f5d2442ce522b0bc", "paragraphs": [{"qas": [{"question": "What is the total number of fully vaccinated people who later received another dose of any COVID-19 vaccine on or after August 13, 2021?", "id": "100000000000000000003589", "answers": [{"text": "People Who Received a First Booster Dose", "answer_start": 0}], "is_impossible": false}, {"question": "What does this measure not consider?", "id": "100000000000000000003590", "answers": [{"text": "how much time has passed since the recipient was vaccinated", "answer_start": 212}], "is_impossible": false}, {"question": "Who is at high risk from occupational and institutional exposure to COVID-19?", "id": "100000000000000000003591", "answers": [{"text": "the vaccine recipient", "answer_start": 283}], "is_impossible": false}, {"question": "What are people who are fully vaccinated?", "id": "100000000000000000003592", "answers": [{"text": "those who\u202freceived the second dose in a two-dose COVID-19 vaccine primary series or one dose of a single-dose COVID-19 vaccine primary series", "answer_start": 477}], "is_impossible": false}, {"question": "Who receives the second dose in a two-dose series?", "id": "100000000000000000003593", "answers": [{"text": "People who are fully vaccinated", "answer_start": 441}], "is_impossible": false}], "context": "People Who Received a First Booster Dose\nRepresents the total number of fully vaccinated people who later received another dose of any COVID-19 vaccine on\nor after\u202fAugust 13, 2021. This measure does not consider how much time has passed since the recipient was vaccinated\nor whether the vaccine recipient is immunocompromised, has an underlying medical condition, or is at high-risk from\noccupational and institutional exposure to COVID-19. People who are fully vaccinated\u202fare those who\u202freceived the second\ndose in a two-dose COVID-19 vaccine primary series or one dose of a single-dose COVID-19 vaccine primary series."}]}, {"title": "d721de93217d02bff085d3ef26153336", "paragraphs": [{"qas": [{"question": "When was the language for a COVID-19 vaccine booster dose changed?", "id": "100000000000000000003594", "answers": [{"text": "September 30, 2021", "answer_start": 165}], "is_impossible": false}, {"question": "When did the language change to reflect a booster dose?", "id": "100000000000000000003595", "answers": [{"text": "September 30, 2021", "answer_start": 165}], "is_impossible": false}, {"question": "Who is included in the list of people who received an additional dose since August 13, 2021?", "id": "100000000000000000003596", "answers": [{"text": "People who received an additional dose since August 13, 2021, are included in this count. People Who Received a Second Booster Dose Represents the total number of fully vaccinated people who received two subsequent doses of COVID-19 vaccine beginning August 13, 2021, which includes people who received two booster doses", "answer_start": 261}], "is_impossible": false}, {"question": "What is the total number of fully vaccinated people who received two subsequent doses of COVID-19 vaccine beginning August 13, 2021?", "id": "100000000000000000003597", "answers": [{"text": "People Who Received a Second Booster Dose", "answer_start": 351}], "is_impossible": false}], "context": "\u2022\n\u2022\f10/30/22, 9:35 AM Data Definitions for COVID-19 Vaccinations in the United States\nLearn more about CDC\u2019s recommendations for a COVID-19 vaccine booster dose. On September 30, 2021, this language was changed to reflect the recommendation for a booster dose. People who\nreceived an additional dose since August 13, 2021, are included in this count. People Who Received a Second Booster Dose\nRepresents the total number of fully vaccinated people who received two subsequent doses of COVID-19 vaccine\nbeginning August 13, 2021, which includes people who received two booster doses and moderately or severely\nimmunocompromised people who received one additional dose and one booster dose."}]}, {"title": "ab3c09ccbc1ba25001b195a46c05c054", "paragraphs": [{"qas": [{"question": "What does not consider eligibility based on?", "id": "100000000000000000003600", "answers": [{"text": "age", "answer_start": 52}], "is_impossible": false}, {"question": "What are people who are fully vaccinated?", "id": "100000000000000000003601", "answers": [{"text": "those who received the second dose in a two-dose COVID-19 vaccine primary series or one dose of a single-dose COVID-19 vaccine primary series", "answer_start": 199}], "is_impossible": false}, {"question": "How much time has passed since first booster dose?", "id": "100000000000000000003603", "answers": [{"text": "eligibility based on age", "answer_start": 30}], "is_impossible": false}, {"question": "How many doses of a single-dose COVID-19 vaccine primary series?", "id": "100000000000000000003604", "answers": [{"text": "one", "answer_start": 283}], "is_impossible": false}, {"question": "What is the CDC's recommendation for a booster dose?", "id": "100000000000000000003605", "answers": [{"text": "COVID-19", "answer_start": 387}], "is_impossible": false}], "context": "This measure does not consider\neligibility based on age, whether the vaccine recipient is immunocompromised, or how much time has passed since first\nbooster dose. People who are fully vaccinated are those who received the second dose in a two-dose COVID-19 vaccine\nprimary series or one dose of a single-dose COVID-19 vaccine primary series. Learn more about CDC\u2019s recommendations for a COVID-19 vaccine booster dose."}]}, {"title": "2625c93da21257212c14e6e21d0afb63", "paragraphs": [{"qas": [{"question": "What represents the rate of total doses distributed?", "id": "100000000000000000003606", "answers": [{"text": "Rates per 100,000", "answer_start": 0}], "is_impossible": false}], "context": "Rates per 100,000\nRepresent the rate of total doses distributed, the rate of total doses administered, the rate of people receiving at least\none dose, the rate of people who are fully vaccinated, and the rate of people receiving a booster dose per 100,000. The\nrate per 100,000 people is calculated for the total population and select demographic groups (such as people ages 65\nyears or older) using population data. This allows comparison between areas with different population sizes."}]}, {"title": "8da1e96146d75f1f81919cfeb09bf49f", "paragraphs": [{"qas": [{"question": "What percentage of the population represents the percent of people receiving at least one dose?", "id": "100000000000000000003609", "answers": [{"text": "Percent of the Population Represents the percent of people receiving at least one dose, the percent of people who are fully vaccinated", "answer_start": 0}], "is_impossible": false}, {"question": "The percent of fully vaccinated people who have received a first booster dose represents what percentage of people?", "id": "100000000000000000003610", "answers": [{"text": "percent", "answer_start": 143}], "is_impossible": false}, {"question": "How many doses have people received?", "id": "100000000000000000003611", "answers": [{"text": "at least one dose", "answer_start": 69}], "is_impossible": false}, {"question": "How is the percentage of people who are fully vaccinated calculated?", "id": "100000000000000000003612", "answers": [{"text": "using population data", "answer_start": 438}], "is_impossible": false}, {"question": "What is the 7-Day Moving Average calculated by summing a vaccination metric?", "id": "100000000000000000003613", "answers": [{"text": "people receiving dose one) for the most recent 7 days and dividing by 7", "answer_start": 549}], "is_impossible": false}, {"question": "What is an example of a vaccination metric?", "id": "100000000000000000003614", "answers": [{"text": "people receiving dose one", "answer_start": 549}], "is_impossible": false}, {"question": "How many days have people received the most recent vaccination?", "id": "100000000000000000003615", "answers": [{"text": "7", "answer_start": 596}], "is_impossible": false}, {"question": "What is a vaccine metric that people received dose one?", "id": "100000000000000000003616", "answers": [{"text": "7-Day Moving Average", "answer_start": 461}], "is_impossible": false}], "context": "Percent of the Population\nRepresents the percent of people receiving at least one dose, the percent of people who are fully vaccinated, and the\npercent of fully vaccinated people who have received a first booster dose. The percent of people who have received at\nleast one dose and the percent of people who are fully vaccinated are calculated for the total population and select\ndemographic groups (such as people ages 65 years or older) using population data. 7-Day Moving Average\nThis metric is calculated by summing a vaccination metric (such as people receiving dose one) for the most recent 7 days\nand dividing by 7."}]}, {"title": "e52c23f934e697fea670dd918e317394", "paragraphs": [{"qas": [{"question": "What does FIPS stand for?", "id": "100000000000000000003618", "answers": [{"text": "Federal Information Processing Standard State", "answer_start": 78}], "is_impossible": false}], "context": "County of Residence\nCDC determines county of residence by matching the county Federal Information Processing Standard State (FIPS) code\nto the state as submitted in the raw data provided to CDC. Last Updated Aug. 17, 2022"}]}, {"title": "9f09ca29a2171f252451a2b54b3e7b00", "paragraphs": [{"qas": [{"question": "What do you need to know about your COVID-19 vaccines before you travel?", "id": "100000000000000000003620", "answers": [{"text": "when you can get your booster and where to get a vaccine or booster", "answer_start": 323}], "is_impossible": false}, {"question": "What is CDC Espaol?", "id": "100000000000000000003621", "answers": [{"text": "CDC Espa\u00f1ol", "answer_start": 52}], "is_impossible": false}, {"question": "What is effective at protecting people from getting seriously ill, being hospitalized, and even dying?", "id": "100000000000000000003623", "answers": [{"text": "COVID-19 vaccines", "answer_start": 392}], "is_impossible": false}, {"question": "Check the current COVID-19 Community Level at your destination.", "id": "100000000000000000003624", "answers": [{"text": "COVID-19 vaccines", "answer_start": 392}], "is_impossible": false}], "context": "10/30/22, 9:42 AM Domestic Travel During COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nDomestic Travel During COVID-19\nInformation for People Traveling by Air and Land within the United States and U.S. Territories\nBefore You Travel\nMake sure to plan ahead:\nGet up to date with your COVID-19 vaccines before you travel. Find out when you can get your booster and where to get a vaccine or booster. COVID-19 vaccines are effective at protecting people\u2014especially those who are boosted\u2014 from getting seriously ill,\nbeing hospitalized, and even dying. Check the current COVID-19 Community Level at your destination."}]}, {"title": "909615b5c435e4438eea4eb7cc5bb6af", "paragraphs": [{"qas": [{"question": "What should you do if you are traveling to an area with high or medium COVID-19 Community Levels?", "id": "100000000000000000003625", "answers": [{"text": "learn how to protect yourself and them", "answer_start": 163}], "is_impossible": false}, {"question": "If you are, live with, or are visiting someone who is at higher risk of getting very sick, learn how to protect yourself and them?", "id": "100000000000000000003626", "answers": [{"text": "traveling to an area with high or medium COVID-19 Community Levels", "answer_start": 3}], "is_impossible": false}, {"question": "Do you understand and follow all state, tribal, local, and territorial travel restrictions?", "id": "100000000000000000003627", "answers": [{"text": "Make sure you understand and follow all state, tribal, local, and territorial travel restrictions", "answer_start": 203}], "is_impossible": false}, {"question": "What must you wear when traveling by air?", "id": "100000000000000000003628", "answers": [{"text": "mask", "answer_start": 319}], "is_impossible": false}, {"question": "What should you do if you are traveling by air?", "id": "100000000000000000003630", "answers": [{"text": "check if your airline requires any testing, vaccination, or other documents", "answer_start": 582}], "is_impossible": false}], "context": "If traveling to an area with high or medium COVID-19 Community Levels, and you are, live with, or are visiting\nsomeone who is at higher risk of getting very sick, learn how to protect yourself and them. Make sure you understand and follow all state, tribal, local, and territorial travel restrictions, including proper mask\nwearing, proof of vaccination, or testing requirements. For up-to-date information and travel guidance, check the state, tribal, local and territorial health\ndepartment\u2019s website where you are, along your route, and where you are going. If traveling by air, check if your airline requires any testing, vaccination, or other documents."}]}, {"title": "f8fc31a2829b5c8c45d339043d79a0ea", "paragraphs": [{"qas": [{"question": "What can you do to provide additional layers of protection from COVID-19?", "id": "100000000000000000003633", "answers": [{"text": "take multiple prevention steps", "answer_start": 182}], "is_impossible": false}, {"question": "What should you know about COVID-19 even if you are up to date with your vaccines?", "id": "100000000000000000003634", "answers": [{"text": "what precautions to take", "answer_start": 508}], "is_impossible": false}, {"question": "Talk to your healthcare provider about your risk before travel and consider delaying travel to areas with high levels of what?", "id": "100000000000000000003635", "answers": [{"text": "COVID-19 Community", "answer_start": 437}], "is_impossible": false}], "context": "Prepare to be flexible during your trip as restrictions and policies may change during your travel. If you have a weakened immune system or are at increased risk for severe disease, take multiple prevention steps to\nprovide additional layers of protection from COVID-19 even if you are up to date with your COVID-19 vaccines. Talk to your healthcare provider about your risk before travel and consider delaying travel to areas with high\nCOVID-19 Community levels. Even if you are up to date, you should know what precautions to take."}]}, {"title": "6528177b35222104af1b3203b67cc9e7", "paragraphs": [{"qas": [{"question": "What do you need to know to protect yourself and others from COVID-19?", "id": "100000000000000000003636", "answers": [{"text": "Get up to date with your COVID-19 vaccines", "answer_start": 65}], "is_impossible": false}, {"question": "Get up-to-date with your vaccines before you travel.", "id": "100000000000000000003637", "answers": [{"text": "COVID-19", "answer_start": 55}], "is_impossible": false}, {"question": "What should you wear in travel and public transportation settings?", "id": "100000000000000000003638", "answers": [{"text": "masks", "answer_start": 207}], "is_impossible": false}, {"question": "What is the COVID-19 Community Level?", "id": "100000000000000000003639", "answers": [{"text": "Check your destination", "answer_start": 433}], "is_impossible": false}, {"question": "What may have restrictions in place?", "id": "100000000000000000003640", "answers": [{"text": "State, tribal, local, and territorial governments", "answer_start": 501}], "is_impossible": false}], "context": "What You Need to Know\nProtect yourself and others from COVID-19:\nGet up to date with your COVID-19 vaccines before you travel. Consider getting tested before travel. Follow CDC\u2019s recommendations for wearing masks in travel and public transportation settings. Get tested after travel if your travel involved situations with greater risk of exposure such as being in crowded\nplaces while not wearing a high-quality mask or respirator. Check your destination\u2019s COVID-19 Community Level before traveling. State, tribal, local, and territorial governments\nmay have travel restrictions in place."}]}, {"title": "81bbefaef018606f5ea8233aaeb67751", "paragraphs": [{"qas": [{"question": "What type of travel during COVID-19 is recommended?", "id": "100000000000000000003641", "answers": [{"text": "Domestic", "answer_start": 18}], "is_impossible": false}, {"question": "How often is the data updated for COVId-19 County Check?", "id": "100000000000000000003643", "answers": [{"text": "weekly", "answer_start": 145}], "is_impossible": false}, {"question": "What is a good time to get tested?", "id": "100000000000000000003644", "answers": [{"text": "as close to the time of departure", "answer_start": 354}], "is_impossible": false}, {"question": "How long before travel is it recommended to get a viral test?", "id": "100000000000000000003645", "answers": [{"text": "no more than 3 days", "answer_start": 401}], "is_impossible": false}, {"question": "What should you do if your test results are positive?", "id": "100000000000000000003646", "answers": [{"text": "Don\u2019t travel", "answer_start": 489}], "is_impossible": false}], "context": "10/30/22, 9:42 AM Domestic Travel During COVID-19 | CDC\nCOVID-19 County Check\nFind community levels and prevention steps by county. Data updated weekly. Select a Location (all fields required)\nState County Go\nView CDC\u2019s full list of individual and community recommendations for each level. \uf3c0 Testing\nRECOMMENDED\nConsider getting tested with a viral test as close to the time of departure as possible (no more than 3\ndays) before travel. Make sure you know your test results before travel. Don\u2019t travel if your test result is positive. Find a COVID-19 testing location near you or use a self-test."}]}, {"title": "5057be08371c424cc130dc750040cfb6", "paragraphs": [{"qas": [{"question": "What is recommended if I am sick with or tested positive?", "id": "100000000000000000003649", "answers": [{"text": "isolate", "answer_start": 183}], "is_impossible": false}, {"question": "Do NOT travel. Follow recommendations for isolation.", "id": "100000000000000000003650", "answers": [{"text": "I am sick with or tested positive for COVID-19 and am recommended to isolate", "answer_start": 114}], "is_impossible": false}, {"question": "What is the CDC\u2019s guidance?", "id": "100000000000000000003653", "answers": [{"text": "wearing my mask", "answer_start": 295}], "is_impossible": false}, {"question": "Do not travel on public transportation if you will not be able to wear a high-quality mask or respirator when around others?", "id": "100000000000000000003654", "answers": [{"text": "indoors", "answer_start": 492}], "is_impossible": false}, {"question": "What should you wear the entire time you are around others indoors?", "id": "100000000000000000003655", "answers": [{"text": "high-quality mask or respirator", "answer_start": 558}], "is_impossible": false}], "context": "If you already had COVID-19 within the past 90 days, see specific testing recommendations. \uf209\nCan I travel if ...? I am sick with or tested positive for COVID-19 and\nam recommended to isolate. Do NOT travel. Follow recommendations for isolation. I have ended isolation but still need to continue\nwearing my mask per CDC\u2019s guidance. Do not travel on public transportation such as\nairplanes, buses, and trains if you will not be able\nto wear a high-quality mask or respirator when\naround others indoors for the full duration of your\ntrip. If you travel, wear a high-quality mask or\nrespirator the entire time you are around others\nindoors."}]}, {"title": "57d7fd12a20ad9c2fc04f2a437e5aa79", "paragraphs": [{"qas": [{"question": "What can lower the chances of spreading COVID-19 to others?", "id": "100000000000000000003656", "answers": [{"text": "Traveling by private vehicle", "answer_start": 0}], "is_impossible": false}, {"question": "What should you get tested for at least 5 full days after your last exposure?", "id": "100000000000000000003658", "answers": [{"text": "CDC guidance, including getting tested at least 5 full days after your last exposure. Do not travel on public transportation", "answer_start": 166}], "is_impossible": false}, {"question": "Do not travel on public transportation if you won't be able to wear a high-quality mask or respirator when around others indoors for the full duration of your trip?", "id": "100000000000000000003660", "answers": [{"text": "airplanes, buses, and trains", "answer_start": 298}], "is_impossible": false}, {"question": "If you travel, wear what the entire time you are around others inside?", "id": "100000000000000000003661", "answers": [{"text": "high-quality mask or respirator", "answer_start": 479}], "is_impossible": false}], "context": "Traveling by private vehicle (if possible) can lower\nthe chances of spreading COVID-19 to others. I was exposed to a person with COVID-19 in the\npast 10 days. Follow CDC guidance, including getting tested at\nleast 5 full days after your last exposure. Do not travel on public transportation such as\nairplanes, buses, and trains if you will not be able\nto wear a high-quality mask or respirator when\naround others indoors for the full duration of your\ntrip. If you travel, wear a high-quality mask or\nrespirator the entire time you are around others\nindoors."}]}, {"title": "d331dd013a02f976f8089274c2f3d08f", "paragraphs": [{"qas": [{"question": "What can lower the chances of spreading COVID-19 to others?", "id": "100000000000000000003662", "answers": [{"text": "Traveling by private vehicle", "answer_start": 0}], "is_impossible": false}, {"question": "What can be worn in travel and public transportation settings?", "id": "100000000000000000003663", "answers": [{"text": "masks", "answer_start": 264}], "is_impossible": false}, {"question": "Who recommends wearing masks in travel?", "id": "100000000000000000003664", "answers": [{"text": "CDC", "answer_start": 230}], "is_impossible": false}, {"question": "What are all health recommendations and requirements at your destination?", "id": "100000000000000000003666", "answers": [{"text": "state, tribal, local, and territorial", "answer_start": 387}], "is_impossible": false}, {"question": "Get tested with a viral test if your travel involved situations with greater risk of exposure?", "id": "100000000000000000003667", "answers": [{"text": "ALL Travelers", "answer_start": 488}], "is_impossible": false}, {"question": "What type of mask or respirator are not worn in crowded places?", "id": "100000000000000000003668", "answers": [{"text": "high-quality", "answer_start": 660}], "is_impossible": false}], "context": "Traveling by private vehicle (if possible) can lower\nthe chances of spreading COVID-19 to others. 10/30/22, 9:42 AM Domestic Travel During COVID-19 | CDC\nDuring Travel\nProtect Yourself and Others\nAfter Travel\n\uf48e RECOMMENDED\nFollow CDC\u2019s recommendations for wearing masks in travel and public transportation settings. Follow recommendations for protecting yourself and others. Follow all \u202fstate, tribal, local, and territorial health recommendations and requirements at your\ndestination. \uf3c0 ALL Travelers\nRECOMMENDED\nGet tested with a viral test if your travel involved situations with greater risk of exposure such as being in\ncrowded places while not wearing a high-quality mask or respirator."}]}, {"title": "b78ee0a41d216dfe0e98ec3b6016eff9", "paragraphs": [{"qas": [{"question": "Where can you find a COVID-19 testing location near you?", "id": "100000000000000000003669", "answers": [{"text": "use a self-test", "answer_start": 45}], "is_impossible": false}, {"question": "What should you do if you have already had COVID-19 within the past 90 days?", "id": "100000000000000000003670", "answers": [{"text": "see specific testing recommendations", "answer_start": 115}], "is_impossible": false}, {"question": "How long has it been since you've been exposed to a person with COVD-19?", "id": "100000000000000000003671", "answers": [{"text": "90 days", "answer_start": 106}], "is_impossible": false}], "context": "Find a COVID-19 testing location near you or use a self-test. If you already had COVID-19 within the past 90 days, see specific testing recommendations. Monitor yourself for COVID-19 symptoms. Follow additional guidance if you know you were exposed to a person with COVID-19. Follow all state, tribal, local, and territorial recommendations or requirements after travel. If you are going to be around someone who is at higher risk of getting very sick with COVID-19, consider\nadditional precautions. \uf209\nIf Your Test is Positive or You Develop COVID-19 Symptoms\nIsolate yourself to protect others from getting infected."}]}, {"title": "225fc0772f843c8e8e1627b4a7fe18d0", "paragraphs": [{"qas": [{"question": "What is no longer in effect on public transportation conveyances and at transportation hubs?", "id": "100000000000000000003677", "answers": [{"text": "masks", "answer_start": 231}], "is_impossible": false}, {"question": "What does CDC continue to recommend that people wear in indoor public transportation settings at this time?", "id": "100000000000000000003678", "answers": [{"text": "high-quality masks", "answer_start": 412}], "is_impossible": false}], "context": "Learn what to do and when it is safe to be around others. Summary of Recent Changes\nUpdates as of April 18, 2022\nAs a result of a court order, effective immediately and as of April 18, 2022, CDC\u2019s January 29, 2021, Order requiring masks\non public transportation conveyances and at transportation hubs is no longer in effect. Therefore, CDC will not enforce\nthe Order. CDC continues to recommend that people wear high-quality masks in indoor public transportation settings at\nthis time. More Information\nFrequently Asked Questions about Travel and COVID-19\nInternational Travel\nLast Updated Aug. 24, 2022"}]}, {"title": "e2640cc4f11f0f97eae5ab116039a8b4", "paragraphs": [{"qas": [{"question": "What is the EUI Webpage Update 09/02/2022 Page 1 of 3?", "id": "100000000000000000003679", "answers": [{"text": "Emergency Use Instructions", "answer_start": 360}], "is_impossible": false}, {"question": "What is the acronym for Emergency Use Instructions?", "id": "100000000000000000003681", "answers": [{"text": "Emergency Use Instructions", "answer_start": 360}], "is_impossible": false}, {"question": "Who can use EUI to inform healthcare providers?", "id": "100000000000000000003683", "answers": [{"text": "CDC", "answer_start": 399}], "is_impossible": false}], "context": "EUI Webpage Update 09/02/2022 Page 1 of 3\nQuestions and Answers about Emergency Use Instructions (EUI)\nBelow are answers to frequently asked questions about Emergency Use Instructions (EUI). Refer to EUI for\nPfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine for primary, additional, and/or\nbooster doses. What are Emergency Use Instructions (EUI)? Emergency Use Instructions (EUI) allow CDC to inform healthcare providers and recipients about certain\nuses of medical products approved (licensed) by the U.S. Food and Drug Administration (FDA) that are\nneeded during public health emergencies without the FDA needing to issue an Emergency Use\nAuthorization (EUA)."}]}, {"title": "1710c000895b8f80f24a76061b33cb5", "paragraphs": [{"qas": [{"question": "Who has legal authority to create, issue, and disseminate EUI before or during an emergency for FDA-approved medical products?", "id": "100000000000000000003684", "answers": [{"text": "The CDC Director", "answer_start": 0}], "is_impossible": false}, {"question": "What is the scope of the approved labeling?", "id": "100000000000000000003686", "answers": [{"text": "beyond", "answer_start": 285}], "is_impossible": false}, {"question": "What did CDC issue for use of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000003687", "answers": [{"text": "EUI", "answer_start": 388}], "is_impossible": false}], "context": "The CDC Director has legal authority to create, issue, and disseminate EUI before or\nduring an emergency for FDA-approved medical products. EUI inform healthcare providers and recipients\nabout such products\u2019 approved, licensed, or cleared conditions of use under circumstances that go\nbeyond the scope of the approved labeling (package insert). What EUI did CDC issue and why? CDC issued EUI for use of the COVID-19 vaccine by Pfizer-BioNTech and COVID-19 vaccine by Moderna\nfor primary, additional, and/or booster doses in certain individuals. The EUI are necessary because\nthese uses extend beyond their FDA-approved labeling."}]}, {"title": "9784a1bcd13e039220162a82791371f4", "paragraphs": [{"qas": [{"question": "What do the EUI and CDC\u2019s clinical guidance help to ensure?", "id": "100000000000000000003688", "answers": [{"text": "these individuals can get primary, additional, and/or booster doses of the COVID-19 vaccine by Pfizer-BioNTech or Moderna so they can be better protected against COVID-19", "answer_start": 51}], "is_impossible": false}, {"question": "What are currently issued only for Pfizer-BioNTech and Moderna COVID-19 vaccines?", "id": "100000000000000000003689", "answers": [{"text": "EUI", "answer_start": 227}], "is_impossible": false}, {"question": "What can EUI only apply to?", "id": "100000000000000000003690", "answers": [{"text": "FDA-approved medical products", "answer_start": 335}], "is_impossible": false}, {"question": "What does CDC issue EUI for the Pfizer-BioNTech and Moderna COVID-19 vaccines?", "id": "100000000000000000003691", "answers": [{"text": "The EUI are currently issued only for Pfizer-BioNTech and Moderna COVID-19 vaccines since EUI can only apply to FDA-approved medical products", "answer_start": 223}], "is_impossible": false}], "context": "The EUI and CDC\u2019s clinical guidance help to\nensure these individuals can get primary, additional, and/or booster doses of the COVID-19 vaccine by\nPfizer-BioNTech or Moderna so they can be better protected against COVID-19. The EUI are currently issued only for Pfizer-BioNTech and Moderna COVID-19 vaccines since EUI can\nonly apply to FDA-approved medical products. The following describes why CDC issued EUI for the\nPfizer-BioNTech and Moderna COVID-19 vaccines."}]}, {"title": "665e545efca8192211489ed075c225a9", "paragraphs": [{"qas": [{"question": "When was the initial EUI issued for the COVID-19 vaccine by Pfizer-BioNTech1?", "id": "100000000000000000003692", "answers": [{"text": "November 17, 2021", "answer_start": 77}], "is_impossible": false}, {"question": "When did CDC update its Interim Clinical Considerations?", "id": "100000000000000000003693", "answers": [{"text": "November 17, 2021", "answer_start": 214}], "is_impossible": false}], "context": "\u2022 CDC issuance of initial EUI for the COVID-19 vaccine by Pfizer-BioNTech on November 17, 2021\nCDC issued initial EUI for the COVID-19 vaccine by Pfizer-BioNTech1 and updated its Interim Clinical\nConsiderations on November 17, 2021, to ensure that certain people who were vaccinated outside of\nthe United States, or who received certain non-FDA authorized or approved COVID-19 vaccines\nthrough participation in a clinical trial, can get an additional primary dose or booster dose of the\nCOVID-19 vaccine by Pfizer-BioNTech."}]}, {"title": "fa6a1842c96aad1fce5796c26b448d32", "paragraphs": [{"qas": [{"question": "Who issued EUI to allow additional primary doses of the COVID- 19 vaccine?", "id": "100000000000000000003695", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the vaccine by Pfizer-BioNTech?", "id": "100000000000000000003696", "answers": [{"text": "COVID- 19", "answer_start": 56}], "is_impossible": false}, {"question": "How long after completion of primary series vaccination with certain vaccines is the heterologous booster dose allowed?", "id": "100000000000000000003697", "answers": [{"text": "6 months", "answer_start": 225}], "is_impossible": false}], "context": "CDC issued EUI to allow additional primary doses of the COVID-\n19 vaccine by Pfizer-BioNTech in certain immunocompromised individuals ages 12 years and older and\na heterologous booster dose in persons ages 18 years and older 6 months after completion of primary\nseries vaccination with certain vaccines not FDA-authorized or approved."}]}, {"title": "abca474fb83fa861ab2ae8ce8fd625a9", "paragraphs": [{"qas": [{"question": "When was the initial EUI for the COVID-19 vaccine issued?", "id": "100000000000000000003698", "answers": [{"text": "February 11, 2022", "answer_start": 69}], "is_impossible": false}, {"question": "On what date was the vaccine approved by the FDA?", "id": "100000000000000000003700", "answers": [{"text": "January 31, 2022", "answer_start": 162}], "is_impossible": false}, {"question": "Who issued EUI for the Moderna COVID-19 vaccine?", "id": "100000000000000000003702", "answers": [{"text": "CDC", "answer_start": 290}], "is_impossible": false}, {"question": "What did CDC do to allow primary, additional, and/or booster doses in persons ages 18 and older?", "id": "100000000000000000003703", "answers": [{"text": "issued EUI", "answer_start": 307}], "is_impossible": false}, {"question": "What does the EUI describe for the Pfizer-BioNTech COVID-19 vaccine?", "id": "100000000000000000003704", "answers": [{"text": "uses that go beyond or differ from the FDA-approved labeling", "answer_start": 603}], "is_impossible": false}], "context": "\u2022 CDC issuance of initial EUI for the COVID-19 vaccine by Moderna on February 11, 2022\nThe FDA approvedl the COVID-19 vaccine by Moderna (brand name Spikevax) on January 31, 2022, as a\ntwo-dose primary series for active immunization to prevent COVID-19 in persons ages 18 years and\nolder., CDC subsequently issued EUI for the Moderna COVID-19 vaccine to allow primary, additional,\nand/or booster doses in persons ages 18 years and older, including those vaccinated with certain non-\nFDA authorized or approved COVID-19 vaccines and certain individuals with immunocompromising\nconditions, similar to the uses that go beyond or differ from the FDA-approved labeling as described in\nthe EUI for the Pfizer-BioNTech COVID-19 vaccine."}]}, {"title": "e2b1523b26cb6fc8183778d32bcdd6b6", "paragraphs": [{"qas": [{"question": "When did the FDA first approve the Comirnaty vaccine?", "id": "100000000000000000003707", "answers": [{"text": "August 2021", "answer_start": 88}], "is_impossible": false}, {"question": "Who approved the CoVID19 vaccine in August 2021?", "id": "100000000000000000003709", "answers": [{"text": "FDA", "answer_start": 81}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech or a different FDA-authorized COVID-19 vaccine?", "id": "100000000000000000003711", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 469}], "is_impossible": false}], "context": "1 The COVID-19 vaccine by Pfizer-BioNTech (brand name Comirnaty) was approved by FDA in August 2021 as a 2-dose\nprimary series for active immunization to prevent COVID-19 in persons aged \u2265 16 years. FDA also amended the EUA for the\nPfizer-BioNTech COVID-19 vaccine to authorize an additional primary dose in certain immunocompromised persons aged \u2265\n12 years and a homologous or heterologous booster dose in persons aged \u2265 18 years following primary vaccination with the\nPfizer-BioNTech or a different FDA-authorized COVID-19 vaccine."}]}, {"title": "e24df54c387121f5b600dafa5b1cbb40", "paragraphs": [{"qas": [{"question": "How old was the age of heterologous booster use of COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000003712", "answers": [{"text": "16 years and older", "answer_start": 282}], "is_impossible": false}, {"question": "What year did certain vaccines not FDA-authorized or approved in the United States2 expire?", "id": "100000000000000000003713", "answers": [{"text": "2021", "answer_start": 457}], "is_impossible": false}, {"question": "How long prior to December 9, 2021 were vaccines vaccinated?", "id": "100000000000000000003714", "answers": [{"text": "6 months", "answer_start": 347}], "is_impossible": false}], "context": "EUI Webpage Update 09/02/2022 Page 2 of 3\nEUI amendments, in concert with CDC Interim Clinical Considerations, subsequent to initial issuance for\nthe respective mRNA COVID-19 vaccines include:\n\u25aa Expanded the age of heterologous booster use of COVID-19 vaccine by Pfizer-BioNTech to 16\nyears and older following primary series vaccination at least 6 months previously with certain\nvaccines not FDA-authorized or approved in the United States2 on December 9, 2021."}]}, {"title": "855020fd421a34b81e0edb2c86f292e9", "paragraphs": [{"qas": [{"question": "Who updated the age of booster use of COVID-19 vaccine to 12 years and older?", "id": "100000000000000000003715", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 65}], "is_impossible": false}, {"question": "What is the new FDA-approved formulation of the vaccine for persons ages 12-12?", "id": "100000000000000000003717", "answers": [{"text": "gray-capped multi- dose vials", "answer_start": 349}], "is_impossible": false}, {"question": "When is the new vaccine approved?", "id": "100000000000000000003718", "answers": [{"text": "January 7, 2022", "answer_start": 383}], "is_impossible": false}, {"question": "What is the name of the new formulation of the vaccine?", "id": "100000000000000000003719", "answers": [{"text": "FDA- approved formulation of the vaccine for persons ages 12 years and older", "answer_start": 271}], "is_impossible": false}], "context": "\u25aa Updated the eligible age of booster use of COVID-19 vaccine by Pfizer-BioNTech to 12 years and\nolder, booster dose interval to 5 months, vaccine use for those with incomplete primary dose\nseries of non-FDA-authorized or approved COVID-19 vaccines, and included the new FDA-\napproved formulation of the vaccine for persons ages 12 years and older (gray-capped multi-\ndose vials) on January 7, 2022."}]}, {"title": "2b4351bbf231e76c58cfb1b019a0740b", "paragraphs": [{"qas": [{"question": "On what date was the Pfizer-BioNTech COVID-19 vaccine updated?", "id": "100000000000000000003721", "answers": [{"text": "February 11, 2022", "answer_start": 13}], "is_impossible": false}, {"question": "What type of immunocompromised persons received certain therapies?", "id": "100000000000000000003723", "answers": [{"text": "moderately or severely", "answer_start": 264}], "is_impossible": false}, {"question": "Who can administer the Pfizer-BioNTech COVID-19 vaccine outside of the FDA-authorized or FDA-approved labeling?", "id": "100000000000000000003726", "answers": [{"text": "healthcare providers", "answer_start": 541}], "is_impossible": false}, {"question": "What is deemed to outweigh the potential and unknown risks of vaccination?", "id": "100000000000000000003728", "answers": [{"text": "the benefits", "answer_start": 738}], "is_impossible": false}], "context": "\u25aa Updated on February 11, 2022, to allow an additional Pfizer-BioNTech COVID-19 vaccine dose in\npersons ages 18 years and older with certain immunocompromising conditions who received\nprimary vaccination with the Janssen COVID-19 vaccine; revaccination of certain moderately or\nseverely immunocompromised persons ages 12 years and older who received certain therapies\n(i.e., hematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)-T-cell therapy) and\nreceived COVID-19 vaccine prior to or during treatment; and the ability of healthcare providers\nto administer the Pfizer-BioNTech COVID-19 vaccine outside of the FDA-authorized or FDA-\napproved labeling and CDC recommended dosing intervals based on clinical judgment when the\nbenefits of vaccination are deemed to outweigh the potential and unknown risks."}]}, {"title": "321e70faa395f24ca3a2cce04b015dd1", "paragraphs": [{"qas": [{"question": "When was the dosing interval extended to 8 weeks3 between the first and second primary doses of mRNA COVID-19 vaccines?", "id": "100000000000000000003729", "answers": [{"text": "February 22, 2022", "answer_start": 169}], "is_impossible": false}, {"question": "What is the name of the vaccines that were updated on March 29, 2022 to allow a second booster dose?", "id": "100000000000000000003730", "answers": [{"text": "Pfizer-BioNTech and Moderna COVID-19 vaccines", "answer_start": 119}], "is_impossible": false}, {"question": "What are the names of the mRNA COVID-19 vaccines?", "id": "100000000000000000003731", "answers": [{"text": "Pfizer-BioNTech and Moderna COVID-19 vaccines", "answer_start": 119}], "is_impossible": false}, {"question": "What is the age range of the Pfizer-BioNTech and Moderna COVIID-19 vaccine?", "id": "100000000000000000003732", "answers": [{"text": "18\u201349 years", "answer_start": 346}], "is_impossible": false}, {"question": "Who gave the first booster dose of the Janssen Covid-19 vaccine to people ages 18-49?", "id": "100000000000000000003733", "answers": [{"text": "Pfizer-BioNTech and Moderna COVID-19 vaccines) on February 22, 2022. \u25aa Updated on March 29, 2022, to allow a second booster dose with mRNA COVID-19 vaccines (i.e., Pfizer-BioNTech and Moderna COVID-19 vaccines) in persons ages 18\u201349 years who are not moderately or severely immunocompromised", "answer_start": 119}], "is_impossible": false}], "context": "\u25aa Extended the dosing interval to 8 weeks3 between the first and second primary doses of mRNA\nCOVID-19 vaccines (i.e., Pfizer-BioNTech and Moderna COVID-19 vaccines) on February 22,\n2022. \u25aa Updated on March 29, 2022, to allow a second booster dose with mRNA COVID-19 vaccines\n(i.e., Pfizer-BioNTech and Moderna COVID-19 vaccines) in persons ages 18\u201349 years who are\nnot moderately or severely immunocompromised and received both a primary dose and first\nbooster dose with the Janssen COVID-19 vaccine."}]}, {"title": "28e9147cd7d7680127f8f0e767ba85d", "paragraphs": [{"qas": [{"question": "What was added to the EUI for Moderna COVID-19 vaccine?", "id": "100000000000000000003734", "answers": [{"text": "clarification", "answer_start": 14}], "is_impossible": false}, {"question": "How many doses of the moderna vaccine can be used to administer booster dose(s) as recommended by CDC?", "id": "100000000000000000003736", "answers": [{"text": "multi-dose", "answer_start": 201}], "is_impossible": false}, {"question": "What may be used to administer booster dose(s) as recommended in CDC\u2019s Interim Clinical Considerations?", "id": "100000000000000000003737", "answers": [{"text": "a new booster-only formulation of the Moderna COVID- 19 vaccine", "answer_start": 83}], "is_impossible": false}], "context": "Additionally, clarification was added to the\nEUI for Moderna COVID-19 vaccine that a new booster-only formulation of the Moderna COVID-\n19 vaccine for persons ages 18 years and older (dark blue-capped multi-dose vials [50 \u03bcg in 0.5\nmL] EUA-authorized on March 29, 2022) may be used to administer booster dose(s) as\nrecommended in CDC\u2019s Interim Clinical Considerations."}]}, {"title": "ef6fc2ac6bfa4dcb408ccb8389a0ca0e", "paragraphs": [{"qas": [{"question": "On what date was the update made to the Pfizer-BioNTech and Moderna COVID-19 vaccines?", "id": "100000000000000000003738", "answers": [{"text": "May 20, 2022", "answer_start": 13}], "is_impossible": false}, {"question": "In people who recently had SARS-CoV-2 infection, what is the second primary dose in an mRNA series?", "id": "100000000000000000003740", "answers": [{"text": "deferral", "answer_start": 232}], "is_impossible": false}, {"question": "How long after symptom onset did people who recently had SARS-CoV-2 infection have the mRNA COVID-19 vaccine series?", "id": "100000000000000000003741", "answers": [{"text": "3 months", "answer_start": 354}], "is_impossible": false}], "context": "\u25aa Updated on May 20, 2022, to allow the following for Pfizer-BioNTech and Moderna COVID-19\nvaccines: revaccination for any COVID-19 vaccine dose(s) received during treatment with B-cell\ndepleting therapies over a limited period and deferral of the second primary dose in an mRNA\nCOVID-19 vaccine series in people who recently had SARS-CoV-2 infection by 3 months from\nsymptom onset or positive test (if infection was asymptomatic)."}]}, {"title": "733268130beb3d542c4b79ddd879932", "paragraphs": [{"qas": [{"question": "How long is the interval between the first and second primary dose of moderna COviD-19?", "id": "100000000000000000003743", "answers": [{"text": "4\u20138 weeks", "answer_start": 127}], "is_impossible": false}, {"question": "On what date did the FDA amend the EUA for the Pfizer-BioNTech COVID-19 vaccine?", "id": "100000000000000000003744", "answers": [{"text": "December 9, 20201", "answer_start": 349}], "is_impossible": false}, {"question": "Who was eligible for homologous booster doses?", "id": "100000000000000000003745", "answers": [{"text": "persons aged \u2265 16 years", "answer_start": 433}], "is_impossible": false}], "context": "\u25aa Updated on June 24, 2022, to allow the use of Moderna COVID-19 vaccine for ages 12 years and\nolder for: a longer interval of 4\u20138 weeks between the first and second primary dose of Moderna\nCOVID-19; primary dose(s), including for those with certain immunocompromising conditions or\n2 FDA amended the EUA for the Pfizer-BioNTech COVID-19 vaccine on December 9, 20201 to expand the eligible population\nfor homologous booster doses to persons aged \u2265 16 years."}]}, {"title": "300abf2c6bd1b36245d3c1f0d4aee16c", "paragraphs": [{"qas": [{"question": "What is the recommended interval between the first and second doses for people who are moderate to severely immunocompromised?", "id": "100000000000000000003746", "answers": [{"text": "3 weeks", "answer_start": 37}], "is_impossible": false}, {"question": "What age group are people who need early protection due to increased concern about community transmission or risk of community transmission?", "id": "100000000000000000003747", "answers": [{"text": "adults ages 65 years and older", "answer_start": 225}], "is_impossible": false}], "context": "3 The original recommended interval (3 weeks for Pfizer-BioNTech; 4 weeks for Moderna) between the first and\nsecond primary doses remains the recommended interval for: people who are moderately to severely\nimmunocompromised; adults ages 65 years and older; and others who need early protection due to increased\nconcern about community transmission or risk of severe disease."}]}, {"title": "6ee051f33c4346ef10b39ffa0b28d013", "paragraphs": [{"qas": [{"question": "When was the EUI Webpage Update 09/02/2022 Page 3 of 3?", "id": "100000000000000000003750", "answers": [{"text": "09/02/2022 Page 3 of 3 those with incomplete primary series", "answer_start": 19}], "is_impossible": false}, {"question": "What is the name of the non-FDA authorized or approved COVID-19 vaccine?", "id": "100000000000000000003751", "answers": [{"text": "incomplete primary series", "answer_start": 53}], "is_impossible": false}, {"question": "How long did it take for the second primary dose to be delayed?", "id": "100000000000000000003752", "answers": [{"text": "3 months", "answer_start": 442}], "is_impossible": false}, {"question": "What is the duration of deferral of the second primary dose in an mRNA COVID-19 vaccine series in people who recently had SARS-CoV-2 infection?", "id": "100000000000000000003753", "answers": [{"text": "3 months", "answer_start": 442}], "is_impossible": false}], "context": "EUI Webpage Update 09/02/2022 Page 3 of 3\nthose with incomplete primary series, for persons who received primary vaccination with\ncertain non-FDA authorized or approved COVID-19 vaccines; revaccination for any COVID-19\nvaccine dose(s) received during treatment with B-cell depleting therapies over a limited period;\nand deferral of the second primary dose in an mRNA COVID-19 vaccine series in people who\nrecently had SARS-CoV-2 infection by 3 months from symptom onset or positive test (if\ninfection was asymptomatic)."}]}, {"title": "db346246d1e80df991de1460ddcb9997", "paragraphs": [{"qas": [{"question": "What vaccine allows similar uses as an alternative mRNA COVID-19 vaccine to Pfizer-BioNTech?", "id": "100000000000000000003754", "answers": [{"text": "Moderna", "answer_start": 49}], "is_impossible": false}], "context": "Also updated to indicate the COVID-19 vaccine by Moderna under\nEUI allows similar uses as an alternative mRNA COVID-19 vaccine to Pfizer-BioNTech, removing\nthe restriction of ages 18 years and older on those similar uses."}]}, {"title": "615f8260fcd85c870f6b23b25a52c53d", "paragraphs": [{"qas": [{"question": "On what date was the update made to the COVID-19 vaccine?", "id": "100000000000000000003756", "answers": [{"text": "September 2, 2022", "answer_start": 13}], "is_impossible": false}, {"question": "What did the update remove from the vaccines?", "id": "100000000000000000003757", "answers": [{"text": "Booster doses for those with certain immunocompromising conditions", "answer_start": 103}], "is_impossible": false}, {"question": "How many months was the interval for a first booster dose?", "id": "100000000000000000003758", "answers": [{"text": "3", "answer_start": 320}], "is_impossible": false}, {"question": "What is the 3-month interval for a first booster dose after an mRNA vaccine primary series for persons who are moderately or severely immunocompromised?", "id": "100000000000000000003759", "answers": [{"text": "FDA authorized or approved COVID-19 vaccines, a 3-month interval for a first booster dose after an mRNA vaccine primary series for persons who are moderately or severely immunocompromised, and a second booster dose in persons ages 18\u201349 years without certain immunocompromising conditions who received both a primary dose and first booster dose with the Janssen COVID-19 Vaccine", "answer_start": 271}], "is_impossible": false}, {"question": "What is a second booster dose in persons ages 18-49 years without certain immunocompromising conditions?", "id": "100000000000000000003760", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 626}], "is_impossible": false}, {"question": "Who approved COVID-19 vaccines?", "id": "100000000000000000003761", "answers": [{"text": "Janssen", "answer_start": 626}], "is_impossible": false}], "context": "\u25aa Updated on September 2, 2022 to remove the use of Pfizer-BioNTech and Moderna COVID-19\nvaccines for: Booster doses for those with certain immunocompromising conditions or those\nwith incomplete primary series who received primary or booster vaccination with certain non-\nFDA authorized or approved COVID-19 vaccines, a 3-month interval for a first booster dose\nafter an mRNA vaccine primary series for persons who are moderately or severely\nimmunocompromised, and a second booster dose in persons ages 18\u201349 years without\ncertain immunocompromising conditions who received both a primary dose and first booster\ndose with the Janssen COVID-19 Vaccine."}]}, {"title": "786c210ee97bdbf69a42fe4313424fdd", "paragraphs": [{"qas": [{"question": "What are the risks and benefits of receiving COVID-19 vaccines by Pfizer-BioNTech and Moderna as primary, additional, and/or booster vaccinations?", "id": "100000000000000000003762", "answers": [{"text": "The duration of vaccine-induced protection from primary vaccination with COVID-19 vaccines is unknown", "answer_start": 146}], "is_impossible": false}, {"question": "Clinical studies of 2-dose primary series supported benefit of the vaccine by what company?", "id": "100000000000000000003764", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 66}], "is_impossible": false}, {"question": "What are Pfizer-BioNTech and Moderna's COVID-19 vaccines?", "id": "100000000000000000003765", "answers": [{"text": "FDA-approved", "answer_start": 521}], "is_impossible": false}, {"question": "What is the FDA's opinion on the safety of additional primary or booster doses of a non-FDA approved or approved vaccine?", "id": "100000000000000000003766", "answers": [{"text": "limited", "answer_start": 653}], "is_impossible": false}, {"question": "Which company's vaccines have been approved by the FDA?", "id": "100000000000000000003767", "answers": [{"text": "Pfizer-BioNTech and Moderna", "answer_start": 66}], "is_impossible": false}], "context": "What are the risks and benefits of receiving COVID-19 vaccines by Pfizer-BioNTech and Moderna as\nprimary, additional, and/or booster vaccination? The duration of vaccine-induced protection from primary vaccination with COVID-19 vaccines is\nunknown. Efficacy data from clinical studies of 2-dose primary series supported benefit of the COVID-19\nvaccines by Pfizer-BioNTech and Moderna in preventing severe COVID-19 and supported their FDA\napproval. Data on the safety or efficacy of additional primary or booster doses of FDA-approved COVID-\n19 vaccines (Pfizer-BioNTech or Moderna) after receipt of a non-FDA authorized or approved COVID-19\nvaccine are limited."}]}, {"title": "e258c105a58b82fe0a39c5c6069c9426", "paragraphs": [{"qas": [{"question": "What might have waned over time?", "id": "100000000000000000003769", "answers": [{"text": "primary vaccination", "answer_start": 255}], "is_impossible": false}, {"question": "What is the EUI Fact Sheet for Healthcare Providers for?", "id": "100000000000000000003771", "answers": [{"text": "Pfizer-BioNTech and Moderna and Interim Clinical Considerations for Use of COVID-19 Vaccines", "answer_start": 368}], "is_impossible": false}], "context": "However, based on available information, the known and potential risks of primary,\nadditional, and/or booster doses of the COVID-19 vaccines by Pfizer-BioNTech or Moderna might be\noutweighed by their likely benefit to enhance or restore protection by the primary vaccination, which\nmight have waned over time. Refer to the EUI Fact Sheets for Healthcare Providers for Pfizer-BioNTech\nand Moderna and Interim Clinical Considerations for Use of COVID-19 Vaccines for additional\ninformation."}]}, {"title": "e561fb0af1b63c72c6efe40a9d684811", "paragraphs": [{"qas": [{"question": "What should providers give vaccine recipients before administering a dose of mRNA?", "id": "100000000000000000003772", "answers": [{"text": "BOTH the Emergency Use Authorization (EUA) and Emergency Use Instructions (EUI) Fact Sheet", "answer_start": 41}], "is_impossible": false}, {"question": "What is NOT necessary to provide both EUA and EUI Fact Sheets?", "id": "100000000000000000003773", "answers": [{"text": "Should providers give vaccine recipients BOTH the Emergency Use Authorization", "answer_start": 0}], "is_impossible": false}, {"question": "What should the EUA or EUI Recipient and Caregiver Fact Sheet correspond to?", "id": "100000000000000000003774", "answers": [{"text": "the vaccine use being administered to the individual", "answer_start": 433}], "is_impossible": false}, {"question": "How should the Emergency Use Instructions (EUI) Fact Sheet for COVID-19 be provided?", "id": "100000000000000000003775", "answers": [{"text": "Depending on the authorized or allowed vaccine use that is being administered, provide either the EUA or EUI Recipient and Caregiver Fact Sheet that corresponds to the vaccine use being administered to the individual", "answer_start": 269}], "is_impossible": false}, {"question": "How should the Emergency Use Instructions Fact Sheet for Recipients and Caregivers be provided?", "id": "100000000000000000003776", "answers": [{"text": "Should providers give vaccine recipients BOTH the Emergency Use Authorization (EUA) and Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers before administering a dose of mRNA", "answer_start": 0}], "is_impossible": false}], "context": "Should providers give vaccine recipients BOTH the Emergency Use Authorization (EUA) and Emergency\nUse Instructions (EUI) Fact Sheet for Recipients and Caregivers before administering a dose of mRNA\nIt is NOT necessary to provide both EUA and EUI Recipient Fact Sheets. Depending on the authorized or\nallowed vaccine use that is being administered, provide either the EUA or EUI Recipient and Caregiver Fact\nSheet that corresponds to the vaccine use being administered to the individual (i.e., based on which\nCOVID-19 vaccine and dose being given). How should the Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers be provided?"}]}, {"title": "33e9d00c0c90dd4a5551a25e0b52f98f", "paragraphs": [{"qas": [{"question": "What type of dissemination is used to provide the EUI Recipient and Caregiver Fact Sheet?", "id": "100000000000000000003777", "answers": [{"text": "electronic", "answer_start": 103}], "is_impossible": false}, {"question": "What is another name for Emergency Use Authorization?", "id": "100000000000000000003778", "answers": [{"text": "EUA", "answer_start": 209}], "is_impossible": false}], "context": "The EUI Recipient and Caregiver Fact Sheet may be provided through appropriate means (e.g., hard copy,\nelectronic dissemination like QR code, url) similar to the ways in which the Emergency Use Authorization\n(EUA) Recipient Fact Sheet is provided."}]}, {"title": "9bc4f17ab7ff2785a613ebf2fb7d14f8", "paragraphs": [{"qas": [{"question": "What are the FDA's rigorous scientific standards for?", "id": "100000000000000000003780", "answers": [{"text": "safety, effectiveness, and manufacturing quality", "answer_start": 361}], "is_impossible": false}, {"question": "Which vaccines are safe?", "id": "100000000000000000003781", "answers": [{"text": "COVID-19", "answer_start": 247}], "is_impossible": false}, {"question": "What is effective at preventing severe illness from COVID-19 and limiting the spread of the virus that causes it?", "id": "100000000000000000003783", "answers": [{"text": "COVID 19-vaccines", "answer_start": 411}], "is_impossible": false}, {"question": "What vaccines have been given to states?", "id": "100000000000000000003785", "answers": [{"text": "COVID 19-vaccines", "answer_start": 411}], "is_impossible": false}, {"question": "What are the most intense safety monitoring efforts in U.S. history?", "id": "100000000000000000003786", "answers": [{"text": "COVID-19 vaccines", "answer_start": 612}], "is_impossible": false}], "context": "10/30/22, 9:31 AM Ensuring COVID-19 Vaccine Safety in the US | CDC\nEspa\u00f1ol | Other Languages\nEnsuring COVID-19 Vaccine Safety in the US\nVaccine Safety and Monitoring\nCOVID-19 vaccines were developed using science that has been around for decades. COVID-19 vaccines are safe, and meet the Food and Drug Administration\u2019s (FDA\u2019s)\nrigorous scientific standards for safety, effectiveness, and manufacturing quality. COVID 19-vaccines are effective at preventing severe illness from COVID-19 and\nlimiting the spread of the virus that causes it. Millions of people in the United States have received COVID-19 vaccines. COVID-19 vaccines are monitored by the most intense safety monitoring efforts in\nU.S. history."}]}, {"title": "9f8373eee7efca7afbb37acb7f2dc76b", "paragraphs": [{"qas": [{"question": "Who recommends COVID-19 vaccines for everyone ages 6 months and older?", "id": "100000000000000000003787", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "What does CDC recommend for everyone 5 years and older if eligible?", "id": "100000000000000000003788", "answers": [{"text": "boosters", "answer_start": 75}], "is_impossible": false}, {"question": "Why did CDC expand and strengthen the country's ability to monitor vaccine safety?", "id": "100000000000000000003789", "answers": [{"text": "To make sure that COVID-19 vaccines are safe", "answer_start": 204}], "is_impossible": false}, {"question": "What do these platforms give CDC scientists information about in real time?", "id": "100000000000000000003791", "answers": [{"text": "the safety of COVID-19 vaccines", "answer_start": 485}], "is_impossible": false}, {"question": "Who can monitor and detect issues that may not have been seen during COVID-19 vaccine clinical trials?", "id": "100000000000000000003792", "answers": [{"text": "vaccine safety experts", "answer_start": 544}], "is_impossible": false}], "context": "CDC recommends COVID-19 vaccines for everyone ages 6 months and older, and boosters\nfor everyone 5 years and older, if eligible. Are the vaccines safe? Have vaccines caused any health problems? \u2022\n\u2022\n\u2022\n\u2022\n\u2022\nTo make sure that COVID-19 vaccines are safe, CDC expanded and strengthened the country\u2019s ability to monitor vaccine\nsafety. CDC created new web-based platforms to gather more information about the safety of COVID-19 vaccines. These\nplatforms give CDC scientists information about the safety of COVID-19 vaccines in real time. As a result, vaccine safety experts can monitor and detect issues that may not have been seen during the COVID-19\nvaccine clinical trials."}]}, {"title": "5692dc75f47ba602d1b66a8540d1b474", "paragraphs": [{"qas": [{"question": "What is v-safe V-safe?", "id": "100000000000000000003794", "answers": [{"text": "provides quick and confidential health check-ins via text messages and web surveys", "answer_start": 289}], "is_impossible": false}, {"question": "What is the name of the national system that collects reports on adverse events?", "id": "100000000000000000003795", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 482}], "is_impossible": false}, {"question": "What does v-safe do?", "id": "100000000000000000003796", "answers": [{"text": "provides quick and confidential health check-ins via text messages and web surveys", "answer_start": 289}], "is_impossible": false}, {"question": "What is the name of the national system that collects reports of adverse events that happen after vaccination?", "id": "100000000000000000003797", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 482}], "is_impossible": false}], "context": "If any vaccine safety issues\u2014also called adverse events\u2014 are reported, CDC scientists can quickly\nstudy them and determine if there is a safety concern with a particular vaccine. Here are some of the tools that CDC uses to keep close tabs on the safety of COVID-19 vaccines:\nv-safe\nV-safe provides quick and confidential health check-ins via text messages and web surveys so you can quickly\nand easily share with CDC how you or your dependent feel after getting a COVID-19 vaccine. Vaccine Adverse Event Reporting System (VAERS)\nVAERS is the national system that collects reports of adverse events that happen after vaccination."}]}, {"title": "24ed6ba11bc9018e184b7aade252f303", "paragraphs": [{"qas": [{"question": "What is CDC monitoring in people who are pregnant?", "id": "100000000000000000003799", "answers": [{"text": "the safety of COVID-19 vaccination", "answer_start": 147}], "is_impossible": false}, {"question": "CDC Pfizer-BioNTech Novavax Moderna Johnson & Johnson\u2019s Janssen Different Vaccines Information about Specific Vaccinations Read the latest safety-related research on what vaccines?", "id": "100000000000000000003800", "answers": [{"text": "COVID-19 vaccines", "answer_start": 494}], "is_impossible": false}], "context": "10 Things\nHealthcare Providers Need to Know about VAERS\nCOVID-19 Vaccine Safety Monitoring Systems for Pregnant People\nLearn how CDC is monitoring the safety of COVID-19 vaccination in people who are pregnant. \u2022\n\u2022\n\u2022\f10/30/22, 9:31 AM Ensuring COVID-19 Vaccine Safety in the US | CDC\nPfizer-BioNTech\nNovavax\nModerna\nJohnson & Johnson\u2019s Janssen\nDifferent Vaccines\nInformation about Specific\nVaccines\n\uf1aa\n\uf1aa\n\uf1aa\n\uf1aa\n\uf1aa\n\uf270 COVID-19 Vaccine Safety\nPublications\nRead the latest safety-related research on\nthe COVID-19 vaccines. \uf18b Safety Monitoring Systems\nInformation Sheet\nLearn more about the systems that monitor\nthe safety of COVID-19 vaccines."}]}, {"title": "ed596a3f5963d816e6eb7c33dae4f483", "paragraphs": [{"qas": [{"question": "What is the name of the Safety Technical Sub-Group for COVID-19 Vaccines?", "id": "100000000000000000003801", "answers": [{"text": "VaST", "answer_start": 274}], "is_impossible": false}, {"question": "When was the last update for the VaST?", "id": "100000000000000000003802", "answers": [{"text": "July 19, 2022", "answer_start": 295}], "is_impossible": false}], "context": "[PDF - 84 KB, 1 page]\n\uf20c\nRelated Pages\nMyths and Facts about COVID-19 Vaccines\n\u203a\nWhat to Expect after Your Vaccination\n\u203a\nVaccine Fact Sheets for People Getting the Vaccine\n\u203a\nInformation for Specific Groups\n\u203a\nAllergic Reactions\n\u203a\nCOVID-19 Vaccines Safety Technical Sub-Group (VaST)\n\u203a\nLast Updated July 19, 2022"}]}, {"title": "e5b2b50dc5523d54e2084eeaa09d1fc8", "paragraphs": [{"qas": [{"question": "What is a critical role of a healthcare provider in helping to end the COVID-19 pandemic?", "id": "100000000000000000003803", "answers": [{"text": "you", "answer_start": 302}], "is_impossible": false}, {"question": "What is one of the most trusted sources of information when it comes to vaccines?", "id": "100000000000000000003804", "answers": [{"text": "patients", "answer_start": 372}], "is_impossible": false}, {"question": "Patients may have questions and concerns about what?", "id": "100000000000000000003805", "answers": [{"text": "COVID-19 vaccines", "answer_start": 510}], "is_impossible": false}], "context": "10/30/22, 9:17 AM FAQs About Implementing COVID-19 Vaccination Program in Provider Practices | CDC\nVaccines & Immunizations\nVaccines & Immunizations\nFAQs for Private and Public Healthcare Providers About\nImplementing the CDC COVID-19 Vaccination Program\nin Provider Practices\nAs a healthcare provider, you play a critical role in helping to end the COVID-19 pandemic. For patients, you are one of\nthe most trusted sources of information when it comes to vaccines. Patients may have questions and concerns about\nCOVID-19 vaccines. You can help them understand the importance of vaccination, provide your strong recommendation,\nand build confidence in vaccines."}]}, {"title": "68a2faf066498a9282be7b44cd71634f", "paragraphs": [{"qas": [{"question": "What leads to more people getting vaccinated?", "id": "100000000000000000003806", "answers": [{"text": "Strong vaccine confidence", "answer_start": 0}], "is_impossible": false}, {"question": "Who must be licensed to administer vaccines in the jurisdiction where you will be practicing?", "id": "100000000000000000003808", "answers": [{"text": "COVID-19 vaccination provider", "answer_start": 369}], "is_impossible": false}, {"question": "Who must sign and abide by the terms of the CDC COVID-19 Vaccination Program Provider Agreement?", "id": "100000000000000000003809", "answers": [{"text": "Your health system or you, as an independent provider", "answer_start": 494}], "is_impossible": false}], "context": "Strong vaccine confidence leads to more people getting vaccinated, which leads to\nfewer COVID-19 illnesses, hospitalizations, and deaths. Learn more about:\nVaccinate with Confidence\nVaccine Recipient Education\nWhat is the advantage of signing up to participate as a COVID-19 vaccination provider in my\nhealthcare organization or individual practice site? \uf1aa\nTo become a COVID-19 vaccination provider, you must be licensed to administer vaccines in the jurisdiction where you\nwill be practicing. Your health system or you, as an independent provider, are required to sign and abide by the terms of\nthe CDC COVID-19 Vaccination Program Provider Agreement."}]}, {"title": "855c0126de4ec2ef64dbf76256e0d995", "paragraphs": [{"qas": [{"question": "What does the agreement require that you follow for storing, handling, and administering vaccine?", "id": "100000000000000000003810", "answers": [{"text": "best practices", "answer_start": 39}], "is_impossible": false}, {"question": "What is required of you to collect and report certain vaccination-related information?", "id": "100000000000000000003811", "answers": [{"text": "follow best practices", "answer_start": 32}], "is_impossible": false}, {"question": "How do you enroll in the CDC COVID-19 Vaccination Program?", "id": "100000000000000000003812", "answers": [{"text": "How to Enroll as a COVID-19 Vaccination Provider", "answer_start": 279}], "is_impossible": false}, {"question": "What are the requirements for becoming a COVID-19 vaccination provider?", "id": "100000000000000000003813", "answers": [{"text": "No. COVID-19 vaccines are provided at 100% no cost to the vaccine recipient", "answer_start": 455}], "is_impossible": false}, {"question": "What is provided at 100% no cost to the vaccine recipient?", "id": "100000000000000000003814", "answers": [{"text": "COVID-19 vaccines", "answer_start": 459}], "is_impossible": false}], "context": "The agreement requires that you follow best practices for\nstoring, handling, and administering vaccine and that you collect and report certain vaccination-related information. For\nmore information about the requirements for enrolling in the CDC COVID-19 Vaccination Program, see How to Enroll as a\nCOVID-19 Vaccination Provider or contact your state or local immunization program. What are the requirements for becoming a COVID-19 vaccination provider? \uf1aa\nNo. COVID-19 vaccines are provided at 100% no cost to the vaccine recipient."}]}, {"title": "a63baad0045e5705db50a86755caaef1", "paragraphs": [{"qas": [{"question": "Who can't charge vaccine recipients for the vaccine?", "id": "100000000000000000003815", "answers": [{"text": "COVID-19 vaccination providers", "answer_start": 0}], "is_impossible": false}, {"question": "Who cannot deny vaccination to?", "id": "100000000000000000003817", "answers": [{"text": "anyone who does not have health coverage, is underinsured, or is out of network", "answer_start": 264}], "is_impossible": false}, {"question": "Who can not charge for an office visit or any other fee if the only service provided is a COVID-19 vaccination?", "id": "100000000000000000003818", "answers": [{"text": "COVID-19 vaccination providers", "answer_start": 345}], "is_impossible": false}, {"question": "What can be provided at the same time and billed as appropriate?", "id": "100000000000000000003819", "answers": [{"text": "Additional healthcare services", "answer_start": 494}], "is_impossible": false}, {"question": "What is billed as appropriate?", "id": "100000000000000000003820", "answers": [{"text": "Additional healthcare services", "answer_start": 494}], "is_impossible": false}], "context": "COVID-19 vaccination providers cannot\ncharge vaccine recipients for the vaccine (which is provided free to enrolled providers by the U.S. government) or for any\nadministration fees, copays, or coinsurance. COVID-19 vaccination providers cannot deny vaccination to anyone who\ndoes not have health coverage, is underinsured, or is out of network. COVID-19 vaccination providers cannot charge recipients for an office visit or any other fee if the only service provided is\na COVID-19 vaccination. Additional healthcare services can be provided at the same time and billed as appropriate. However, providers cannot require additional services for a person to receive a COVID-19 vaccine."}]}, {"title": "1ea8d79c2dcb44bbf7483fd5545bc6ac", "paragraphs": [{"qas": [{"question": "What may providers seek reimbursement from a recipient's plan or program?", "id": "100000000000000000003822", "answers": [{"text": "vaccine administration fee", "answer_start": 186}], "is_impossible": false}, {"question": "What can providers not bill the recipient for?", "id": "100000000000000000003823", "answers": [{"text": "the balance not covered by the recipient\u2019s plan or program", "answer_start": 263}], "is_impossible": false}], "context": "If a vaccine recipient has health coverage, providers may seek appropriate reimbursement from the recipient\u2019s plan or\nprogram (e.g., private health insurance, Medicare, Medicaid ) for a vaccine administration fee. However, providers\ncannot bill the recipient for the balance not covered by the recipient\u2019s plan or program. For further information on\nreimbursement requirements, please see the CDC COVID-19 Vaccination Program Provider Requirements and Support\nwebpage. Can I charge patients a fee for administering COVID-19 vaccines?"}]}, {"title": "4a5d6e20d40504faa9b984bb185dd736", "paragraphs": [{"qas": [{"question": "What does CDC strongly encourage when possible?", "id": "100000000000000000003827", "answers": [{"text": "that providers make vaccine available to others in their local communities", "answer_start": 269}], "is_impossible": false}, {"question": "What do providers make available to others in their local communities?", "id": "100000000000000000003828", "answers": [{"text": "vaccine", "answer_start": 289}], "is_impossible": false}, {"question": "Pharmacies, public health clinics and any clinics held in communities are required to offer vaccination to anyone who is eligible?", "id": "100000000000000000003829", "answers": [{"text": "Does the program require that I provide vaccine to anyone", "answer_start": 512}], "is_impossible": false}], "context": "\uf1aa\n\uf209\f10/30/22, 9:17 AM FAQs About Implementing COVID-19 Vaccination Program in Provider Practices | CDC\nIf you are a private provider, you are not required to provide vaccination to anyone who is not currently a patient. However, CDC strongly encourages, when possible, that providers make vaccine available to others in their local\ncommunities, including patients\u2019 family members. Pharmacies, public health clinics and any clinics held in communities\nare required to offer vaccination to anyone who is eligible. Does the program require that I provide vaccine to anyone, even if they are not currently a\npatient?"}]}, {"title": "bed63159a7f270dc58a6a9c5d6467d5e", "paragraphs": [{"qas": [{"question": "As a VFC provider, you will have implemented or been familiar with many of the requirements of what program?", "id": "100000000000000000003831", "answers": [{"text": "COVID-19 Vaccination Provider Agreement. As a VFC provider, you will have already implemented or be familiar with many of the requirements of the program, including ordering vaccine and reporting to your jurisdiction\u2019s immunization information system (IIS). You may also have already completed some of the training recommended to become a COVID-19 vaccination provider. I am already a Vaccines for Children", "answer_start": 73}], "is_impossible": false}, {"question": "What is the acronym for immunization information system?", "id": "100000000000000000003832", "answers": [{"text": "IIS", "answer_start": 325}], "is_impossible": false}, {"question": "What is another name for Vaccines for Children?", "id": "100000000000000000003833", "answers": [{"text": "VFC", "answer_start": 481}], "is_impossible": false}, {"question": "What does CDC offer for preparing and administering COVID-19 vaccines?", "id": "100000000000000000003834", "answers": [{"text": "a variety of training resources", "answer_start": 575}], "is_impossible": false}], "context": "\uf1aa\nYes, all providers participating in the program are required to sign a COVID-19 Vaccination Provider Agreement. As a VFC\nprovider, you will have already implemented or be familiar with many of the requirements of the program, including\nordering vaccine and reporting to your jurisdiction\u2019s immunization information system (IIS). You may also have already\ncompleted some of the training recommended to become a COVID-19 vaccination provider. I am already a Vaccines for Children (VFC) provider; do I also have to sign a COVID-19 Vaccination\nProvider Agreement? \uf1aa\nCDC offers a variety of training resources for preparing and administering COVID-19 vaccines."}]}, {"title": "2a61be567266b273a6a838dd5bf386", "paragraphs": [{"qas": [{"question": "Where can the training modules be found?", "id": "100000000000000000003836", "answers": [{"text": "COVID-19 Vaccine Training Modules", "answer_start": 287}], "is_impossible": false}, {"question": "Where can you find additional vaccine preparation and administration resources?", "id": "100000000000000000003837", "answers": [{"text": "U.S. COVID-19 Vaccine Product Information", "answer_start": 442}], "is_impossible": false}, {"question": "What may your state, local, or jurisdictional immunization program have?", "id": "100000000000000000003838", "answers": [{"text": "training requirements", "answer_start": 557}], "is_impossible": false}], "context": "Visit Training and\nEducation for COVID-19 Vaccination for training information and core competencies for healthcare professionals. At a\nminimum, CDC recommends all providers complete the training module for the vaccine(s) they will be administering. The\ntraining modules can be found at COVID-19 Vaccine Training Modules. Additional vaccine preparation and administration\nresources can be found on CDC\u2019s web pages for each vaccine product at U.S. COVID-19 Vaccine Product Information. Your\nstate, local, or jurisdictional immunization program may also have training requirements. Providers who are enrolled in the VFC program may already have completed some of the training recommended to\nbecome a COVID-19 vaccination provider."}]}, {"title": "94c42634acfcd42aeeda8cd4ec490512", "paragraphs": [{"qas": [{"question": "What type of training is available to learn how to prepare and administer COVID-19 vaccines?", "id": "100000000000000000003840", "answers": [{"text": "storage and handling requirements", "answer_start": 121}], "is_impossible": false}, {"question": "What is required to ensure vaccines are maintained within proper temperature ranges by using a digital data logger?", "id": "100000000000000000003841", "answers": [{"text": "storage and handling requirements. As a COVID-19 vaccination provider, you are required to ensure vaccines are maintained within proper temperature ranges by using a digital data logger (DDL) to monitor vaccine storage unit temperatures and recording temperatures daily", "answer_start": 121}], "is_impossible": false}, {"question": "What does a DDL stand for?", "id": "100000000000000000003843", "answers": [{"text": "digital data logger", "answer_start": 287}], "is_impossible": false}, {"question": "Where can you find more information about each vaccine?", "id": "100000000000000000003844", "answers": [{"text": "CDC\u2019s web pages", "answer_start": 428}], "is_impossible": false}, {"question": "What are the storage and handling requirements for COVID-19 vaccines?", "id": "100000000000000000003845", "answers": [{"text": "COVID-19 Vaccine Addendum", "answer_start": 555}], "is_impossible": false}], "context": "What training is available to learn how to prepare and administer COVID-19 vaccines? \uf1aa\nEach COVID-19 vaccine has its own storage and handling requirements. As a COVID-19 vaccination provider, you are\nrequired to ensure vaccines are maintained within proper temperature ranges by using a digital data logger (DDL) to\nmonitor vaccine storage unit temperatures and recording temperatures daily. Additional details are available on CDC\u2019s\nweb pages for each vaccine (U.S. COVID-19 Vaccine Product Information) and in the Vaccine Storage and Handling Toolkit\n, COVID-19 Vaccine Addendum. What are the storage and handling requirements for COVID-19 vaccines?"}]}, {"title": "c72a3636dbbe6c44e32c5491dc5786f1", "paragraphs": [{"qas": [{"question": "What are COVID-19 vaccination providers required to report?", "id": "100000000000000000003846", "answers": [{"text": "information on vaccine supply, vaccine administration, and vaccine adverse events", "answer_start": 58}], "is_impossible": false}, {"question": "What is critical to help stop?", "id": "100000000000000000003847", "answers": [{"text": "COVID-19 pandemic", "answer_start": 197}], "is_impossible": false}, {"question": "What does COVID Locating Health Provider Portal allow providers to do?", "id": "100000000000000000003848", "answers": [{"text": "report COVID-19 vaccine inventory daily", "answer_start": 271}], "is_impossible": false}, {"question": "Where can you find out more about the vaccine inventory reporting process?", "id": "100000000000000000003850", "answers": [{"text": "Vaccines.gov", "answer_start": 647}], "is_impossible": false}, {"question": "What is the name of the CDC's COVID-19 Vaccination Program?", "id": "100000000000000000003851", "answers": [{"text": "\uf20c COVID-19 vaccination providers are required to report information on vaccine supply, vaccine administration, and vaccine adverse events. Reporting this information is critical to help stop the COVID-19 pandemic. Vaccine supply All COVID-19 vaccination providers must report COVID-19 vaccine inventory daily in the COVID Locating Health Provider Portal", "answer_start": 1}], "is_impossible": false}], "context": "\uf1aa\n\uf20c\nCOVID-19 vaccination providers are required to report information on vaccine supply, vaccine administration, and vaccine\nadverse events. Reporting this information is critical to help stop the COVID-19 pandemic. Vaccine supply\nAll COVID-19 vaccination providers must report COVID-19 vaccine inventory daily in the COVID Locating Health Provider\nPortal. In some jurisdictions, providers may report vaccine inventory to the jurisdiction\u2019s IIS for the jurisdiction to upload\ninto the portal. If you have questions about the inventory reporting process for your jurisdiction, please contact your\njurisdiction\u2019s immunization program. Learn more at Vaccines.gov. Vaccine administration data\nWhat are the reporting requirements for the CDC COVID-19 Vaccination Program?"}]}, {"title": "8836df77dac9bb613eb939e19993f246", "paragraphs": [{"qas": [{"question": "What is the name of the facility where the vaccine was administered?", "id": "100000000000000000003854", "answers": [{"text": "location", "answer_start": 477}], "is_impossible": false}, {"question": "Where was the vaccine administered at?", "id": "100000000000000000003855", "answers": [{"text": "location/facility name/ID", "answer_start": 477}], "is_impossible": false}, {"question": "What is included in the administration address of the vaccine?", "id": "100000000000000000003856", "answers": [{"text": "company", "answer_start": 573}], "is_impossible": false}, {"question": "What is a CVX?", "id": "100000000000000000003858", "answers": [{"text": "product", "answer_start": 752}], "is_impossible": false}, {"question": "What is the name of the product?", "id": "100000000000000000003859", "answers": [{"text": "CVX", "answer_start": 747}], "is_impossible": false}], "context": "\uf1aa\f10/30/22, 9:17 AM FAQs About Implementing COVID-19 Vaccination Program in Provider Practices | CDC\nCOVID-19 vaccination providers, after administering a dose of COVID-19 vaccine, must record all information marked by\nan asterisk below (if it is not already recorded in the vaccine recipient\u2019s record) and report the following required vaccine\nadministration data, or other data elements if revised by CDC, to the appropriate entity noted in the agreement:\n1. Administered at location/facility name/ID\n2. Administered at location type\n3. Administration address (including company)*\n4. Recipient name and ID*\n5. Recipient date of birth*\n6. Recipient sex*\n7. Recipient race\n8. Recipient ethnicity\n9. Recipient address*\n10. Administration date*\n11. CVX (product)*\n12."}]}, {"title": "f2931ecf23270165c7bca23c540fe7cc", "paragraphs": [{"qas": [{"question": "What is NDC?", "id": "100000000000000000003860", "answers": [{"text": "national drug code", "answer_start": 5}], "is_impossible": false}, {"question": "What is MVX?", "id": "100000000000000000003861", "answers": [{"text": "manufacturer", "answer_start": 109}], "is_impossible": false}, {"question": "Where is the Vaccine administration site located?", "id": "100000000000000000003862", "answers": [{"text": "on the body", "answer_start": 363}], "is_impossible": false}, {"question": "What is the administration address of vaccines?", "id": "100000000000000000003863", "answers": [{"text": "Administering provider\u2019s address", "answer_start": 250}], "is_impossible": false}, {"question": "Where is the vaccine administration site located?", "id": "100000000000000000003864", "answers": [{"text": "on the body", "answer_start": 363}], "is_impossible": false}], "context": "NDC (national drug code)\n13. Dose number*\n14. Lot number (Unit of Use [UoU] or Unit of Sale [UoS])*\n15. MVX (manufacturer)*\n16. Sending organization (name of the agency submitting the report)\n17. Vaccine administering provider\u2019s name and suffix*\n18. Administering provider\u2019s address, if different from the administration address*\n19. Vaccine administration site (on the body)*\n20. Vaccine expiration date*\n21. Vaccine route of administration*\n22. Vaccine series\nFind more information about vaccine administration and reporting requirements."}]}, {"title": "15f8a7ddf88a7f37eba6b320a66b3777", "paragraphs": [{"qas": [{"question": "What are healthcare providers required to report to the VAERS?", "id": "100000000000000000003866", "answers": [{"text": "the following adverse events", "answer_start": 161}], "is_impossible": false}, {"question": "Vaccine administration errors that result in what?", "id": "100000000000000000003867", "answers": [{"text": "hospitalization or death", "answer_start": 376}], "is_impossible": false}, {"question": "What does COVID-19 result in?", "id": "100000000000000000003868", "answers": [{"text": "hospitalization or death", "answer_start": 376}], "is_impossible": false}, {"question": "What is an important medical event that may jeopardize the individual and require medical or surgical intervention to prevent one of the outcomes listed above?", "id": "100000000000000000003870", "answers": [{"text": "Congenital anomaly/birth defect", "answer_start": 704}], "is_impossible": false}], "context": "Vaccine adverse events\nHealthcare providers are required under Emergency Use Authorization (EUA) to report to the Vaccine Adverse Event\nReporting System (VAERS) the following adverse events (AEs) after COVID-19 vaccination (and other adverse events if\nlater revised by CDC):\nVaccine administration errors, whether associated with an AE or not\nCases of COVID-19 that result in hospitalization or death\nSerious AEs regardless of causality, defined by the U.S. Food and Drug Administration (FDA) as:\nDeath\nLife-threatening AE\nInpatient hospitalization or prolongation of existing hospitalization\nPersistent or significant incapacity or substantial disruption of the ability to conduct normal life functions\nCongenital anomaly/birth defect\nAn important medical event that, based on appropriate medical judgement, may jeopardize the individual and\nmay require medical or surgical intervention to prevent one of the outcomes listed above."}]}, {"title": "b1381b909bf80d20be72401c91061b7c", "paragraphs": [{"qas": [{"question": "What type of syndrome are healthcare providers encouraged to report to VAERS?", "id": "100000000000000000003871", "answers": [{"text": "multisystem inflammatory syndrome", "answer_start": 9}], "is_impossible": false}, {"question": "What are healthcare providers required to do?", "id": "100000000000000000003874", "answers": [{"text": "report to VAERS any additional clinically significant AEs following vaccination", "answer_start": 82}], "is_impossible": false}, {"question": "How is a CDC vaccine authorized?", "id": "100000000000000000003875", "answers": [{"text": "under an EUA", "answer_start": 530}], "is_impossible": false}], "context": "Cases of multisystem inflammatory syndrome\nHealthcare providers are encouraged to report to VAERS any additional clinically significant AEs following vaccination,\neven if they are not sure if vaccination caused the event. Also report any additional select AEs and/or any revised safety\nreporting requirements per FDA\u2019s conditions of authorized use of vaccine(s) throughout the duration of any COVID-19\n\uf209\n\uf209\f10/30/22, 9:17 AM FAQs About Implementing COVID-19 Vaccination Program in Provider Practices | CDC\nvaccine being authorized under an EUA. Vaccination provider requirements can be found at COVID-19 Vaccination Provider Requirements and Support. Yes. Healthcare providers are the most trusted source of health information for their patients."}]}, {"title": "bd6dea207e9084658c92626b6379728b", "paragraphs": [{"qas": [{"question": "What is a provider's recommendation?", "id": "100000000000000000003878", "answers": [{"text": "vaccine acceptance", "answer_start": 253}], "is_impossible": false}, {"question": "How can you help educate your patients, staff, families and communities?", "id": "100000000000000000003879", "answers": [{"text": "CDC has many resources", "answer_start": 274}], "is_impossible": false}, {"question": "What can you do if your patients are unvaccinated?", "id": "100000000000000000003880", "answers": [{"text": "provide guidance on where they can get vaccinated", "answer_start": 470}], "is_impossible": false}, {"question": "Where can you find vaccination sites?", "id": "100000000000000000003881", "answers": [{"text": "Vaccines.gov", "answer_start": 546}], "is_impossible": false}, {"question": "What website can you use to find COVID-19 vaccination sites?", "id": "100000000000000000003882", "answers": [{"text": "Vaccines.gov", "answer_start": 546}], "is_impossible": false}, {"question": "Who can you refer patients to?", "id": "100000000000000000003883", "answers": [{"text": "COVID-19 vaccination provider", "answer_start": 616}], "is_impossible": false}], "context": "Even if you are not\nparticipating in the CDC COVID-19 Vaccination Program, you play an important role in helping to educate and encourage\nyour patients and others to get vaccinated. A provider\u2019s recommendation has been shown to be an important factor in\nvaccine acceptance. CDC has many resources to assist you with educating your patients, staff, families, and communities. Check your patients\u2019 vaccination status at routine appointments and, if they are unvaccinated, provide guidance on where\nthey can get vaccinated. For example, you can use Vaccines.gov to locate vaccination sites or consider partnering with a\nCOVID-19 vaccination provider to whom you can refer patients."}]}, {"title": "cd13dc020514f9e272782bab1ccf695b", "paragraphs": [{"qas": [{"question": "What does VAERS stand for?", "id": "100000000000000000003885", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 88}], "is_impossible": false}, {"question": "What are VAERS required to report after COVID-19 vaccination?", "id": "100000000000000000003886", "answers": [{"text": "vaccine administration errors to VAERS, even if the error is not associated with an adverse event. They are also required to report certain adverse events", "answer_start": 262}], "is_impossible": false}], "context": "My facility does not stock vaccines. Are there other ways I can contribute? \uf1aa\nVisit the Vaccine Adverse Event Reporting System (VAERS ) for information about all reporting requirements or to\nsubmit a report. COVID-19 vaccination providers are required to report vaccine administration errors to VAERS, even if the error is not\nassociated with an adverse event. They are also required to report certain adverse events after COVID-19 vaccination\n(and other adverse events if later revised by CDC). How do I report a vaccine administration error or adverse event?"}]}, {"title": "29a000919d07acd8b87f5bc88f9603c2", "paragraphs": [{"qas": [{"question": "What is included in the ancillary supply kits for COVID-19 vaccines?", "id": "100000000000000000003888", "answers": [{"text": "a COVID-19 vaccination record card", "answer_start": 46}], "is_impossible": false}, {"question": "What does CDC's smartphone-based after-vaccination health program do?", "id": "100000000000000000003889", "answers": [{"text": "uses text messaging and web surveys to provide personalized health check-ins", "answer_start": 403}], "is_impossible": false}, {"question": "What does CDC post on its website in order to best implement the COVID-19 Vaccination Program?", "id": "100000000000000000003892", "answers": [{"text": "updates and amendments to the COVID-19 Provider Agreement", "answer_start": 653}], "is_impossible": false}], "context": "\uf1aa\n\uf209\nYou are required to provide patients with a COVID-19 vaccination record card, included in the ancillary supply kits for\nCOVID-19 vaccines, and an EUA Fact Sheet for Recipients and Caregivers for the vaccine product administered. Vaccination providers should also provide vaccine recipients with information about participating in v-safe, CDC\u2019s\nsmartphone-based after-vaccination health checker that uses text messaging and web surveys to provide personalized\nhealth check-ins. What information am I required to provide to patients? \uf1aa\nAs we learn more about COVID-19 vaccines and how to best implement the CDC COVID-19 Vaccination Program, CDC\nposts updates and amendments to the COVID-19 Provider Agreement on its website."}]}, {"title": "7343fab455296bf70dc78c58aeb341f5", "paragraphs": [{"qas": [{"question": "Who is responsible for checking this web page regularly for updates?", "id": "100000000000000000003893", "answers": [{"text": "COVID-19 vaccination providers", "answer_start": 0}], "is_impossible": false}, {"question": "What is required of COVID-19 vaccination providers?", "id": "100000000000000000003894", "answers": [{"text": "comply with these updates", "answer_start": 120}], "is_impossible": false}, {"question": "Who has a variety of educational materials and resources for you?", "id": "100000000000000000003895", "answers": [{"text": "CDC", "answer_start": 230}], "is_impossible": false}, {"question": "When was this page last reviewed?", "id": "100000000000000000003897", "answers": [{"text": "April 11, 2022", "answer_start": 555}], "is_impossible": false}], "context": "COVID-19 vaccination providers are\nresponsible for checking this web page regularly for any updates and are required to comply with these updates. How can I make sure I am complying with all components of the provider agreement? \uf1aa\nCDC has a variety of educational materials and resources for you and your patients. Visit Vaccine Recipient Education for\ninformation on communicating with patients about COVID-19 vaccines and educational materials for patients. My patients have a lot of questions. What resources can I refer them to? \uf1aa\nPage last reviewed: April 11, 2022"}]}, {"title": "633a4252d0bd151d009ddf902661bb59", "paragraphs": [{"qas": [{"question": "What can help protect you from getting very sick if you get COVID-19?", "id": "100000000000000000003898", "answers": [{"text": "Vaccination, past infection, or timely access to testing and treatment", "answer_start": 171}], "is_impossible": false}, {"question": "What are some factors that can affect your risk of Getting Very Sick from Vaccination, past infection or timely access to testing and treatment?", "id": "100000000000000000003899", "answers": [{"text": "COVID-19", "answer_start": 296}], "is_impossible": false}, {"question": "What can help you make decisions to protect yourself and others?", "id": "100000000000000000003902", "answers": [{"text": "Understanding your COVID-19 risk", "answer_start": 519}], "is_impossible": false}, {"question": "What is the COVID-19 risk?", "id": "100000000000000000003903", "answers": [{"text": "some people are more likely than others to get very sick if they get COVID-19. This includes people who are older, are immunocompromised, have certain disabilities, or have underlying health conditions", "answer_start": 316}], "is_impossible": false}], "context": "10/30/22, 9:38 AM Factors That Affect Your Risk of Getting Very Sick from COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nFactors That Affect Your Risk of Getting Very Sick from\nVaccination, past infection, or timely access to testing and treatment can help protect you from getting very sick if you get\nCOVID-19. However, some people are more likely than others to get very sick if they get COVID-19. This includes people who\nare older, are immunocompromised, have certain disabilities, or have underlying health conditions. Understanding your\nCOVID-19 risk and the risks that might affect others can help you make decisions to protect yourself and others."}]}, {"title": "11f9e21ab620a25beab0e66140311dbd", "paragraphs": [{"qas": [{"question": "What are older adults more likely than younger people to get very sick if they get COVID-19?", "id": "100000000000000000003904", "answers": [{"text": "50 years and older", "answer_start": 104}], "is_impossible": false}, {"question": "What do older adults need hospitalization, intensive care, or a ventilator?", "id": "100000000000000000003905", "answers": [{"text": "help them breathe", "answer_start": 328}], "is_impossible": false}, {"question": "What is the most common cause of COVID-19 deaths in people over 65?", "id": "100000000000000000003906", "answers": [{"text": "older than 65", "answer_start": 402}], "is_impossible": false}, {"question": "What type of care is needed to help a person breathe?", "id": "100000000000000000003907", "answers": [{"text": "intensive care, or a ventilator", "answer_start": 293}], "is_impossible": false}], "context": "Factors That Raise Your Risk of Getting Very Sick from COVID-19\nAge\nOlder adults (especially those ages 50 years and older, with risk\nincreasing with older age) are more likely than younger people to get\nvery sick if they get COVID-19. This means they are more likely to\nneed hospitalization, intensive care, or a ventilator to help them\nbreathe, or they could die. Most COVID-19 deaths occur in people\nolder than 65. See detailed information about hospitalization and death rates by age."}]}, {"title": "59956d1a8f1964c739e7b4c89547dc67", "paragraphs": [{"qas": [{"question": "What can make you more likely to get very sick if you get COVID-19?", "id": "100000000000000000003909", "answers": [{"text": "Having a weakened immune system", "answer_start": 46}], "is_impossible": false}, {"question": "How often is EVUSHELDTM given?", "id": "100000000000000000003911", "answers": [{"text": "every 6 months", "answer_start": 418}], "is_impossible": false}], "context": "Immunocompromised or a Weakened Immune System\nHaving a weakened immune system, also known as being\nimmunocompromised, can make you more likely to get very sick if\nyou get COVID-19. People who are immunocompromised, or who are\ntaking medicines that weaken their immune system, may not be\nprotected as well as others, even if they are up to date on their\nvaccines. EVUSHELD\u2122 is a medicine given by a healthcare provider\nevery 6 months to help prevent COVID-19 before you are exposed or\ntest positive for COVID-19. EVUSHELD\u2122 remains protective, but may\noffer less protection against certain strains of the Omicron variant."}]}, {"title": "d1fe10fb510fd5e6f238e957d73a839a", "paragraphs": [{"qas": [{"question": "What should you do even if EVUSHELDTM is provided?", "id": "100000000000000000003914", "answers": [{"text": "you take multiple prevention measures", "answer_start": 52}], "is_impossible": false}, {"question": "What is the best option for you?", "id": "100000000000000000003915", "answers": [{"text": "EVUSHELD\u2122", "answer_start": 138}], "is_impossible": false}, {"question": "Who can help protect you from getting very sick from COVID-19?", "id": "100000000000000000003916", "answers": [{"text": "Factors", "answer_start": 265}], "is_impossible": false}, {"question": "What can help protect you from getting very sick?", "id": "100000000000000000003917", "answers": [{"text": "Factors", "answer_start": 265}], "is_impossible": false}, {"question": "What is the EVUSHELDTM EUA Fact Sheet for Patients, Parents and Caregivers?", "id": "100000000000000000003918", "answers": [{"text": "COVID-19", "answer_start": 250}], "is_impossible": false}], "context": "It\nis important that even if EVUSHELD\u2122 is provided, you take multiple\nprevention measures. Talk to your healthcare provider about whether EVUSHELD\u2122 is the best option for you. 10/30/22, 9:38 AM Factors That Affect Your Risk of Getting Very Sick from COVID-19 | CDC\nFactors That Can Help Protect You from Getting Very Sick from\nDownload: EVUSHELD\u2122 EUA Fact Sheet for Patients, Parents and Caregivers \uf209\nLearn more about the importance of COVID-19 prevention, including developing a COVID-19 plan for people who are\nimmunocompromised."}]}, {"title": "e3cf365ab7e8b9d207c856323deb9593", "paragraphs": [{"qas": [{"question": "What may underlying health conditions you have affect your risk of becoming very sick if you get COVID-19?", "id": "100000000000000000003919", "answers": [{"text": "obesity or chronic obstructive pulmonary disorder", "answer_start": 89}], "is_impossible": false}, {"question": "The more health conditions that you have, the higher your risk?", "id": "100000000000000000003920", "answers": [{"text": "COVID-19", "answer_start": 194}], "is_impossible": false}, {"question": "What does severe heart disease increase your risk more than?", "id": "100000000000000000003922", "answers": [{"text": "high blood pressure", "answer_start": 390}], "is_impossible": false}], "context": "Underlying Health Conditions\nCertain underlying health conditions you have (for example, obesity\nor chronic obstructive pulmonary disorder) may affect your risk of\nbecoming very sick if you get COVID-19. Often, the more health conditions you have, the higher your risk. Certain conditions increase your risk more than others. For example,\nsevere heart disease increases your risk more than high blood\npressure. Learn more about how different underlying health conditions affect the chances of getting very sick or dying from\nCOVID-19. Vaccination\nCOVID-19 vaccines are safe and effective."}]}, {"title": "7fcf9dc4a5e1b4054b27f9e51a58f86f", "paragraphs": [{"qas": [{"question": "What is the best way to protect yourself from dying from COVID-19?", "id": "100000000000000000003924", "answers": [{"text": "Staying up to date with your COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "Booster doses can give you what?", "id": "100000000000000000003925", "answers": [{"text": "additional protection", "answer_start": 200}], "is_impossible": false}, {"question": "Who is far less likely to be hospitalized or die from COVID-19 than people the same age who have not been vaccinated?", "id": "100000000000000000003926", "answers": [{"text": "People who are vaccinated with all recommended vaccine doses", "answer_start": 304}], "is_impossible": false}], "context": "Staying up to date with your\nCOVID-19 vaccines is the best way to protect yourself and others\naround you from getting very sick, being hospitalized, or dying from\nCOVID-19. Booster doses can give you additional protection. They can\nhelp enhance or restore protection that might have decreased over\ntime. People who are vaccinated with all recommended vaccine doses,\nincluding boosters, are far less likely to be hospitalized or die from\nCOVID-19 than people the same age who have not been vaccinated or\nwho are not up to date on their COVID-19 vaccines."}]}, {"title": "1638a4e3c3977663774eb09f2326588a", "paragraphs": [{"qas": [{"question": "Who can still get very sick from COVID-19?", "id": "100000000000000000003927", "answers": [{"text": "older adults with multiple underlying health conditions or people who are immunocompromised", "answer_start": 75}], "is_impossible": false}, {"question": "What are free medications that can reduce your chances of getting very sick?", "id": "100000000000000000003928", "answers": [{"text": "severe illness and death", "answer_start": 365}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000003929", "answers": [{"text": "free medications", "answer_start": 302}], "is_impossible": false}, {"question": "What are free medications that can reduce your chances of severe illness and death?", "id": "100000000000000000003930", "answers": [{"text": "COVID-19", "answer_start": 292}], "is_impossible": false}], "context": "However, even\nthough vaccines reduce their risk, some people, particularly older\nadults with multiple underlying health conditions or people who are immunocompromised, can still get very sick from\nCOVID-19. Timely Testing and Treatment\nIf you are at increased risk for getting very sick from COVID-19, free medications are available that can reduce your\nchances of severe illness and death. It is important to get tested quickly if you think you are sick with COVID-19 because\nmost treatment needs to be started within a few days of infection."}]}, {"title": "ef086cd07c50fd30cc5358e4fa44031d", "paragraphs": [{"qas": [{"question": "What can help if you feel sick or are diagnosed with COVID-19?", "id": "100000000000000000003931", "answers": [{"text": "have a plan for what to do", "answer_start": 20}], "is_impossible": false}, {"question": "What can be a barrier to testing or treatment?", "id": "100000000000000000003932", "answers": [{"text": "transportation challenges or lack of insurance", "answer_start": 161}], "is_impossible": false}, {"question": "What does having a previous infection with the virus that causes COVID-19 offer?", "id": "100000000000000000003933", "answers": [{"text": "protection from future illness", "answer_start": 496}], "is_impossible": false}], "context": "It can also help to have a plan for what to do if you feel\nsick or are diagnosed with COVID-19, especially if you have barriers to testing or treatment, such as transportation\nchallenges or lack of insurance. 10/30/22, 9:38 AM Factors That Affect Your Risk of Getting Very Sick from COVID-19 | CDC\nFind free at-home tests , a Test to Treat location , or a community-based testing site near you. \uf209 \uf209 \uf209\nPrevious Infection\nHaving a previous infection with the virus that causes COVID-19 offers\nsome protection from future illness."}]}, {"title": "afe2b43bd387ec781852a7f4e5f4d28d", "paragraphs": [{"qas": [{"question": "What can happen to people who have had previous COVID infections?", "id": "100000000000000000003934", "answers": [{"text": "reinfected", "answer_start": 62}], "is_impossible": false}, {"question": "What is a risk to being repeatedly infected?", "id": "100000000000000000003935", "answers": [{"text": "the potential of longer term symptoms or development of post-COVID conditions", "answer_start": 264}], "is_impossible": false}, {"question": "What are term symptoms or development of post-COVID conditions?", "id": "100000000000000000003936", "answers": [{"text": "longer", "answer_start": 281}], "is_impossible": false}, {"question": "What are people with previous infections less likely to be hospitalized than those who are not vaccinated?", "id": "100000000000000000003937", "answers": [{"text": "vaccinated", "answer_start": 401}], "is_impossible": false}, {"question": "People who have had previous infections should still get what?", "id": "100000000000000000003938", "answers": [{"text": "vaccinated", "answer_start": 579}], "is_impossible": false}], "context": "However, people who have had\nprevious infections can still be reinfected and get severe COVID-19,\nespecially if their previous infection was months ago or with a\ndifferent variant (e.g., Delta variant). There are also risks to being\nrepeatedly infected, including the potential of longer term symptoms\nor development of post-COVID conditions. Studies show that people with previous infections who are vaccinated\nare less likely to be hospitalized than those with previous infections\nwho are not vaccinated. This means that people who have had\nprevious infection should still get vaccinated and boosted to increase\ntheir protection against COVID-19."}]}, {"title": "182c66d97b88efbffab996932e1375fa", "paragraphs": [{"qas": [{"question": "What is a safer way to build protection than getting sick with COVID-19?", "id": "100000000000000000003939", "answers": [{"text": "Getting a COVID-19 vaccination", "answer_start": 0}], "is_impossible": false}, {"question": "What can help protect you from getting very sick in the future?", "id": "100000000000000000003940", "answers": [{"text": "getting vaccinated after recovering from a previous COVID-19 infection", "answer_start": 109}], "is_impossible": false}, {"question": "Who might benefit from getting vaccinated after recovering from a previous infection?", "id": "100000000000000000003941", "answers": [{"text": "COVID-19 vaccination is a safer way to build protection than getting sick with COVID-19. Learn how getting vaccinated after recovering from a previous COVID-19 infection can help protect you from getting very sick in the future", "answer_start": 10}], "is_impossible": false}, {"question": "People with disabilities and those from certain racial and ethnic minority groups might be considered what?", "id": "100000000000000000003942", "answers": [{"text": "more likely to get very sick", "answer_start": 352}], "is_impossible": false}, {"question": "What might be more likely to get very sick and have adverse health outcomes from COVID-19 because of factors stemming from?", "id": "100000000000000000003943", "answers": [{"text": "People with disabilities and those from certain racial and ethnic minority groups might be more likely to get very sick and have adverse health outcomes from COVID-19 because of factors stemming from societal inequities", "answer_start": 261}], "is_impossible": false}], "context": "Getting a COVID-19 vaccination is a safer way to build protection than getting sick with\nCOVID-19. Learn how getting vaccinated after recovering from a previous COVID-19 infection can help protect you from getting\nvery sick in the future. Equity Considerations\nPeople with disabilities and those from certain racial and ethnic minority groups might be more likely to get very sick and\nhave adverse health outcomes from COVID-19 because of factors stemming from societal inequities [86KB, 5 pages]."}]}, {"title": "374a7b10e844f57a4f2193c8e4716db4", "paragraphs": [{"qas": [{"question": "What is the name of the strategy created by the CDC?", "id": "100000000000000000003945", "answers": [{"text": "COVID-19 Response Health Equity Strategy", "answer_start": 20}], "is_impossible": false}, {"question": "How many people have the opportunity to attain the highest level of health possible?", "id": "100000000000000000003946", "answers": [{"text": "all", "answer_start": 225}], "is_impossible": false}], "context": "CDC established the COVID-19 Response Health Equity Strategy: Accelerating Progress Towards Reducing COVID-19\nDisparities and Achieving Health Equity [86KB, 5 pages] and provides additional resources to advance the vision of all\npeople having the opportunity to attain the highest level of health possible. \uf20c\n\uf20c\nLast Updated Oct. 19, 2022"}]}, {"title": "32065d3deae20bb806afd7dec13dc1e5", "paragraphs": [{"qas": [{"question": "What are N95 respirators?", "id": "100000000000000000003948", "answers": [{"text": "free masks", "answer_start": 168}], "is_impossible": false}, {"question": "What is the name of the tool that shows pharmacies that provide free masks?", "id": "100000000000000000003949", "answers": [{"text": "Find Free Masks (N95 Respirators) | CDC Espa\u00f1ol | Other Languages Find Free Masks (N95 Respirators) This tool shows a list of pharmacies that provide free masks (N95 respirators). It does not show their current inventory. Please check with the location for availability. Need help finding free masks in the U.S.? Call 1-800-232-0233", "answer_start": 18}], "is_impossible": false}, {"question": "What is the name of the company that helps you find masks?", "id": "100000000000000000003951", "answers": [{"text": "1-800-232-0233", "answer_start": 336}], "is_impossible": false}, {"question": "How many digits are in the zip code of the mask?", "id": "100000000000000000003952", "answers": [{"text": "5", "answer_start": 444}], "is_impossible": false}], "context": "10/30/22, 9:40 AM Find Free Masks (N95 Respirators) | CDC\nEspa\u00f1ol | Other Languages\nFind Free Masks (N95 Respirators)\nThis tool shows a list of pharmacies that provide free masks (N95 respirators). It does not show their current inventory. Please\ncheck with the location for availability. Need help finding free masks in the U.S.? Call 1-800-232-0233 (TTY 1-888-720-7489)\nFind Free Masks\nPowered by VaccineFinder\nSearch for Free Masks\nZip Code\n5-digit Zip Code\nRelated Pages\nFree N95 Respirator Manufacturers\n\u203a\nHow to Use Your N95 Respirator\n\u203a\nUse and Care of Masks\n\u203a\nLast Updated Mar. 16, 2022"}]}, {"title": "3151a02baf3b98f241d0c4b7c895db6b", "paragraphs": [{"qas": [{"question": "What is the name of the company that distributes N95 respirators to pharmacies?", "id": "100000000000000000003954", "answers": [{"text": "The Strategic National Stockpile", "answer_start": 190}], "is_impossible": false}, {"question": "What are the manufacturer's instructions for your N95 model?", "id": "100000000000000000003955", "answers": [{"text": "specific manufacturer\u2019s instructions for your N95 model below. For information about how to use your N95 correctly, see How to Use Your N95 Respirator. \u2022", "answer_start": 325}], "is_impossible": false}, {"question": "What is the name of the free mask that you can find at a participating location?", "id": "100000000000000000003956", "answers": [{"text": "N95 respirators", "answer_start": 516}], "is_impossible": false}], "context": "10/30/22, 9:40 AM Free N95 Respirator Manufacturers | CDC\nEspa\u00f1ol | Other Languages\nFree N95 Respirator Manufacturers\nDistributed from the Strategic National Stockpile\nWhat You Need to Know\nThe Strategic National Stockpile has distributed N95 respirators to pharmacy\ndistribution centers throughout the country. You can find specific manufacturer\u2019s instructions for your N95 model below. For information about how to use your N95 correctly, see How to Use Your N95\nRespirator. \u2022\n\u2022\nFree Mask Locator\nFind free masks (N95 respirators) at a participating location near you."}]}, {"title": "41eebb2496bd6948d3a2a05d4bd9742a", "paragraphs": [{"qas": [{"question": "How do you find a mask near you?", "id": "100000000000000000003957", "answers": [{"text": "Or call 1-800-232-0233 (TTY 1-888-720-7489)", "answer_start": 21}], "is_impossible": false}, {"question": "What is the name of the company that offers Respirator User Instructions?", "id": "100000000000000000003958", "answers": [{"text": "CDC", "answer_start": 203}], "is_impossible": false}, {"question": "What will you be protected from if you wear an N95 with an exhalation valve?", "id": "100000000000000000003959", "answers": [{"text": "others who may have COVID-19", "answer_start": 476}], "is_impossible": false}, {"question": "If you have COVID-19, what will protect others from you?", "id": "100000000000000000003960", "answers": [{"text": "an N95", "answer_start": 528}], "is_impossible": false}, {"question": "An N95 without a valve may not protect others as well as what?", "id": "100000000000000000003961", "answers": [{"text": "N95", "answer_start": 631}], "is_impossible": false}], "context": "Find a Mask Near You Or call 1-800-232-0233 (TTY 1-888-720-7489)\nMODEL\nNIOSH APPROVAL\nRespirator User Instructions (3m.com) \uf20c \uf209\nMODEL\nNIOSH APPROVAL\f10/30/22, 9:40 AM Free N95 Respirator Manufacturers | CDC\nRespirator User Instructions (3m.com) \uf20c \uf209\nMODEL\nNIOSH APPROVAL\nand\nMODEL\nNIOSH APPROVAL\nGeneral and Occupational/Workplace 9205+ and 9210+ N95 Particulate\nRespirator User Instructions (3m.com) \uf20c \uf209\nIf you wear an N95 with an exhalation valve, you will be protected from others who may have COVID-19. If you have\nCOVID-19, an N95 will protect others from you; however, an N95 with a valve may not protect others as well as an N95\nwithout a valve."}]}, {"title": "e9a49d888c24b66041a80f38a71408f9", "paragraphs": [{"qas": [{"question": "What type of tape can be used to cover the valve?", "id": "100000000000000000003962", "answers": [{"text": "3M Multi-Use Duct Tape", "answer_start": 67}], "is_impossible": false}, {"question": "What is used to make the 3M Model 8511 as protective as an N95?", "id": "100000000000000000003963", "answers": [{"text": "3M Multi-Use Duct Tape", "answer_start": 67}], "is_impossible": false}], "context": "To make the 3M Model 8511 as protective as an N95 without a valve, 3M Multi-Use Duct Tape can be\nused to cover the valve in accordance with the manufacturer\u2019s instructions ."}]}, {"title": "d593cdb324f11d9699a1e14dbd01dbca", "paragraphs": [{"qas": [{"question": "What is the MODEL NIOSH APPROVAL 10/30/22, 9:40 AM Free N95 Respirator Manufacturers | CDC General and Occupational/Workplace 8511/8511P N95 Particulate Respirators User Instructions (3m.com)?", "id": "100000000000000000003964", "answers": [{"text": "Model 2201", "answer_start": 1014}], "is_impossible": false}, {"question": "What is Honeywell (formerly Sperian) Model 14110444?", "id": "100000000000000000003965", "answers": [{"text": "MODEL", "answer_start": 471}], "is_impossible": false}, {"question": "What is Honeywell formerly known as?", "id": "100000000000000000003966", "answers": [{"text": "Sperian", "answer_start": 498}], "is_impossible": false}, {"question": "What is the MODEL Honeywell?", "id": "100000000000000000003967", "answers": [{"text": "MODEL Honeywell Model DC300", "answer_start": 388}], "is_impossible": false}, {"question": "When was this MODEL last updated?", "id": "100000000000000000003968", "answers": [{"text": "Mar. 15, 2022", "answer_start": 1120}], "is_impossible": false}], "context": "\uf20c \uf209\nMODEL\nNIOSH APPROVAL\nGeneral and Occupational/Workplace 8511/8511P N95 Particulate Respirator\nUser Instructions (3m.com) \uf20c \uf209\nMODEL\nNIOSH APPROVAL\f10/30/22, 9:40 AM Free N95 Respirator Manufacturers | CDC\nGeneral and Occupational/Workplace 8511/8511P N95 Particulate Respirator\nUser Instructions (3m.com) \uf20c \uf209\nDraeger\nMODEL\nDraeger Model Xplore 1750\nNIOSH APPROVAL\nus.pdf \uf20c \uf209\nHoneywell\nMODEL\nHoneywell Model DC300\nNIOSH APPROVAL\norUserInstructions/8139Honeywell.pdf \uf20c \uf209\nMODEL\nHoneywell (formerly Sperian) Model 14110444\nNIOSH APPROVAL\nhttps://prod-edam.honeywell.com/content/dam/honeywell-edam/sps/his/en-\nus/products/respiratory-protection/documents/HS_one-\nfit_molded_cup_(niosh)_onefitn95%20donning%20instructions.pdf \uf20c \uf209\f10/30/22, 9:40 AM Free N95 Respirator Manufacturers | CDC\nMoldex\nMODEL\nMoldex Model 2207, low profile\nNIOSH APPROVAL\nhttps://www.moldex.com/wp-content/uploads/9702-773.pdf \uf20c \uf209\nMODEL\nMoldex Model 2200\nNIOSH APPROVAL\nhttps://www.moldex.com/wp-content/uploads/9702-773.pdf \uf20c \uf209\nMODEL\nMoldex Model 2201 (small)\nNIOSH APPROVAL\nhttps://www.moldex.com/wp-content/uploads/9702-773.pdf \uf20c \uf209\nLast Updated Mar. 15, 2022"}]}, {"title": "dfb7a6adaef64ae942fd901e4b208c8c", "paragraphs": [{"qas": [{"question": "What is one of CDC's core activities?", "id": "100000000000000000003969", "answers": [{"text": "Sharing timely and accurate information with the public", "answer_start": 264}], "is_impossible": false}, {"question": "What does CDC report online on COVID Data Tracker?", "id": "100000000000000000003970", "answers": [{"text": "COVID-19 vaccination data", "answer_start": 180}], "is_impossible": false}, {"question": "What provides the reliable data that can be reported by CDC?", "id": "100000000000000000003971", "answers": [{"text": "Timely and accurate reporting from jurisdictions", "answer_start": 353}], "is_impossible": false}], "context": "10/30/22, 9:35 AM Frequently Asked Questions about COVID-19 Vaccination Data | CDC\nEspa\u00f1ol | Other Languages\nFrequently Asked Questions about COVID-19\nVaccination Data\nCDC reports COVID-19 vaccination data online on COVID Data Tracker and in vaccination datasets. Sharing timely and\naccurate information with the public is one of CDC\u2019s core activities. Timely and accurate reporting from jurisdictions provides\nthe reliable data that can be reported by CDC. All reported numbers may change over time as updated data are continuously\nreported to CDC."}]}, {"title": "beec4948c607e2f3aacd5d8164988798", "paragraphs": [{"qas": [{"question": "What is the last part of the distribution process for COVID-19 vaccines?", "id": "100000000000000000003972", "answers": [{"text": "Vaccine delivery to provider locations", "answer_start": 275}], "is_impossible": false}, {"question": "What does the process of shipping vaccines to provider locations consist of?", "id": "100000000000000000003973", "answers": [{"text": "COVID-19 Vaccine Distribution and Tracking Vaccine Data Reporting Distribution", "answer_start": 0}], "is_impossible": false}, {"question": "What does VTrckS stand for?", "id": "100000000000000000003975", "answers": [{"text": "Vaccine Tracking System", "answer_start": 514}], "is_impossible": false}], "context": "COVID-19 Vaccine Distribution and Tracking\nVaccine Data Reporting\nDistribution is the process of shipping vaccines to provider locations, as directed by jurisdictions, federal agencies, and\npharmacy partners who are enrolled in the CDC COVID-19 Vaccination Provider Program. Vaccine delivery to provider\nlocations is the last part of the distribution process. How are COVID-19 vaccines distributed? \uf1aa\nJurisdictions (states, territories, tribes, and local entities), federal agencies, and pharmacy partners use the Vaccine\nTracking System (VTrckS) to order vaccines from the federal government. VTrckS records information such as vaccine\nmanufacturer, provider data, orders, shipments, and inventory."}]}, {"title": "61541e82ba7157ae8a9f01570eef5c0b", "paragraphs": [{"qas": [{"question": "What does Pfizer-BioNTech do with its COVID-19 vaccine?", "id": "100000000000000000003977", "answers": [{"text": "distributes and delivers doses", "answer_start": 162}], "is_impossible": false}, {"question": "How is distribution data reported to CDC?", "id": "100000000000000000003979", "answers": [{"text": "through a federal delivery system", "answer_start": 111}], "is_impossible": false}], "context": "With one exception, distribution and delivery of COVID-19\nvaccines and other routine vaccines are accomplished through a federal delivery system. Pfizer-BioNTech distributes and\ndelivers doses of its COVID-19 vaccine through its own delivery system. How are vaccine distribution data reported to CDC?"}]}, {"title": "c10abecffb6f2b7c4e937060b84b35a6", "paragraphs": [{"qas": [{"question": "Who records the data on doses of COVID-19?", "id": "100000000000000000003982", "answers": [{"text": "vaccination providers", "answer_start": 99}], "is_impossible": false}, {"question": "How are vaccine administration data reported to CDC?", "id": "100000000000000000003983", "answers": [{"text": "through multiple sources", "answer_start": 141}], "is_impossible": false}, {"question": "What provides an overarching view of the vaccine IT data systems?", "id": "100000000000000000003984", "answers": [{"text": "The COVID-19 Vaccination IT Overview", "answer_start": 629}], "is_impossible": false}, {"question": "What is the overarching view of the vaccine IT data systems and how they integrate to track COVID-19 vaccine distribution and administration?", "id": "100000000000000000003985", "answers": [{"text": "The COVID-19 Vaccination IT Overview", "answer_start": 629}], "is_impossible": false}], "context": "\uf1aa\nData on COVID-19 vaccine doses administered in the United States and territories are recorded by vaccination providers\nand reported to CDC through multiple sources, including:\nState, local, and territorial Immunization Information Systems (IISs)\nVaccine Administration Management System (VAMS), which supports vaccination clinics in jurisdictions, federal\nagencies, and multi-state healthcare organizations\nDirect data submissions to the COVID-19 Data Clearing House\nHow are vaccine administration data reported to CDC? \uf1aa\n\u2022\n\u2022\n\u2022\f10/30/22, 9:35 AM Frequently Asked Questions about COVID-19 Vaccination Data | CDC\nData Variations\nThe COVID-19 Vaccination IT Overview provides an overarching view of the vaccine IT data systems and how they\nintegrate to track COVID-19 vaccine distribution and administration."}]}, {"title": "70338208975c9e7591381d113b856f01", "paragraphs": [{"qas": [{"question": "What is the name of the data lake used by the CDC to receive, store, and analyze COVID-19 vaccine distribution and administration data?", "id": "100000000000000000003986", "answers": [{"text": "Immunization (IZ) Data Lake", "answer_start": 13}], "is_impossible": false}, {"question": "Data in the IZ Data Lake are deidentified, meaning they do not identify individuals who have been vaccinated.", "id": "100000000000000000003987", "answers": [{"text": "people", "answer_start": 232}], "is_impossible": false}, {"question": "What do data scientists make every effort to ensure?", "id": "100000000000000000003988", "answers": [{"text": "correct (validated) and that the system does not double-count doses or vaccination records", "answer_start": 346}], "is_impossible": false}], "context": "CDC uses the Immunization (IZ) Data Lake to receive, store, manage, and analyze COVID-19 vaccine distribution and\nadministration data from all sources. Data in the IZ Data Lake are deidentified, meaning they do not identify specific\npeople who have been vaccinated. CDC data scientists make every effort to ensure the data in the IZ Data Lake are\ncorrect (validated) and that the system does not double-count doses or vaccination records. (deduplication). CDC reports\nCOVID-19 vaccination data online on COVID Data Tracker and in vaccination datasets. How does CDC report vaccine distribution and administration data?"}]}, {"title": "bf813318d04b7d7dd65edd4ad61780c7", "paragraphs": [{"qas": [{"question": "What is the term for the number of vaccine doses that are not administered?", "id": "100000000000000000003990", "answers": [{"text": "wastage", "answer_start": 86}], "is_impossible": false}, {"question": "What is a small amount of vaccine that goes unused in any vaccination program?", "id": "100000000000000000003991", "answers": [{"text": "vaccine", "answer_start": 113}], "is_impossible": false}, {"question": "Where is this information not currently available?", "id": "100000000000000000003992", "answers": [{"text": "COVID Data Tracker", "answer_start": 216}], "is_impossible": false}, {"question": "Who collects data on COVID-19 vaccine doses?", "id": "100000000000000000003993", "answers": [{"text": "vaccination providers", "answer_start": 376}], "is_impossible": false}], "context": "\uf1aa\nCDC is tracking the number of manufactured vaccine doses that are not administered (wastage). A small amount of\nvaccine will go unused in any vaccination program. This information is not currently available on the COVID Data Tracker. Does CDC report COVID-19 vaccine wastage? \uf1aa\nData on COVID-19 vaccine doses administered in the United States are collected by the following vaccination providers:\npublic health jurisdictions, federal entities, healthcare providers, long-term care facilities, employers, retail pharmacies,\nand other businesses. These providers report COVID-19 vaccination data to CDC through multiple sources using various\nreporting methods."}]}, {"title": "3ee5d3bcad83570b2d350b2f34021875", "paragraphs": [{"qas": [{"question": "What does IIS stand for?", "id": "100000000000000000003996", "answers": [{"text": "jurisdictional Immunization Information Systems", "answer_start": 113}], "is_impossible": false}, {"question": "CDC makes every effort to reconcile doses administered through how many systems?", "id": "100000000000000000003997", "answers": [{"text": "more than one", "answer_start": 264}], "is_impossible": false}, {"question": "What are differences among states in the frequency of reporting?", "id": "100000000000000000003999", "answers": [{"text": "Each state or territorial health department is responsible for establishing internal operations and schedules for reporting data", "answer_start": 336}], "is_impossible": false}], "context": "Because CDC removes duplicate records, data presented on the COVID Data Tracker might differ\nfrom data listed in jurisdictional Immunization Information Systems (IIS) and dashboards. CDC makes every effort to\nreconcile doses administered that are reported through more than one system. How does CDC manage data from multiple sources? \uf1aa\nEach state or territorial health department is responsible for establishing internal operations and schedules for\nreporting data. As a result, there are differences among states in the frequency of reporting. Data on doses of vaccine delivered and administered include data received by CDC as of 6:00 am ET on\nWednesday, the day of weekly reporting."}]}, {"title": "12ed64e0d8ca9bd9de5bfeab481e6e3", "paragraphs": [{"qas": [{"question": "What can happen to vaccine data on different schedules?", "id": "100000000000000000004004", "answers": [{"text": "updated", "answer_start": 179}], "is_impossible": false}, {"question": "What can cause a delay between the time a vaccination record appears in a jurisdictional or federal system and when it is received by CDC?", "id": "100000000000000000004005", "answers": [{"text": "Data can be updated on different schedules and reflect data \u201cas of\u201d different dates or times of day", "answer_start": 167}], "is_impossible": false}, {"question": "What varies for each state?", "id": "100000000000000000004008", "answers": [{"text": "amount of lag time", "answer_start": 523}], "is_impossible": false}], "context": "Vaccination data in CDC\u2019s COVID Data Tracker are updated weekly on\nThursday between 1:30 pm and 8:00 pm ET. On federal holidays, updates will occur the following day. Data can be updated on different schedules and reflect data \u201cas of\u201d different dates or times of day. There can be a\ndelay between the time a vaccination record appears in a jurisdictional or federal system and when it is received\nby CDC. COVID Data Tracker\u2019s vaccination data typically have a lag time from vaccination data shown on a state\u2019s\nwebsite. The amount of lag time varies for each state."}]}, {"title": "3c1a6dbd41924be8a395c3084f4780e3", "paragraphs": [{"qas": [{"question": "What time is the reporting cutoff?", "id": "100000000000000000004009", "answers": [{"text": "6:00 am ET Wednesday", "answer_start": 97}], "is_impossible": false}, {"question": "How long are healthcare providers expected to report doses to federal, state, territorial, tribal, and local agencies?", "id": "100000000000000000004010", "answers": [{"text": "72 hours of administration", "answer_start": 265}], "is_impossible": false}, {"question": "How many doses are distributed and how many people are vaccinated?", "id": "100000000000000000004011", "answers": [{"text": "number", "answer_start": 345}], "is_impossible": false}, {"question": "What are the differences between the doses distributed and the number of people who are?", "id": "100000000000000000004012", "answers": [{"text": "significant differences between the number of doses distributed and the number of people who are vaccinated", "answer_start": 309}], "is_impossible": false}], "context": "This can be due to the factors described above, or because a\njurisdiction uploads data after the 6:00 am ET Wednesday reporting cutoff. Healthcare providers are expected to report doses administered to federal, state, territorial, tribal, and local\nagencies within 72 hours of administration. There are often significant differences between the number of doses\ndistributed and the number of people who are vaccinated."}]}, {"title": "f19ebe6e693b7faf2808a3bc7c9f4839", "paragraphs": [{"qas": [{"question": "What are the reporting limitations and variations in?", "id": "100000000000000000004015", "answers": [{"text": "COVID-19 vaccine data", "answer_start": 323}], "is_impossible": false}, {"question": "What are the reporting limitations and variations in COVID-19 vaccine data?", "id": "100000000000000000004016", "answers": [{"text": "the time it takes for doses delivered to be administered", "answer_start": 42}], "is_impossible": false}, {"question": "Where can you find the most complete and up-to-date data for a particular county or state?", "id": "100000000000000000004018", "answers": [{"text": "the relevant health department website", "answer_start": 643}], "is_impossible": false}], "context": "This is due to several factors, including the time it takes\nfor doses delivered to be administered, the time it takes for administered doses to be reported to CDC, and how\njurisdictions and federal pharmacy partners manage available vaccine stock to meet local demands. What are the reporting limitations and variations in COVID-19 vaccine data? \uf1aa\n\u2022\n\u2022\n\u2022\n\u2022\nWhy do data vary between the CDC COVID Data Tracker and state health department websites? \uf1aa\f10/30/22, 9:35 AM Frequently Asked Questions about COVID-19 Vaccination Data | CDC\nCDC Publicly Available Data\nFor the most complete and up-to-date data for any particular county or state, visit the relevant health department\nwebsite."}]}, {"title": "4eb62f3d1ae3860607ea9083e684acfa", "paragraphs": [{"qas": [{"question": "What do jurisdictions have more complete and updated data for?", "id": "100000000000000000004021", "answers": [{"text": "data elements (e.g., county of residence", "answer_start": 435}], "is_impossible": false}, {"question": "What allows them to characterize their population more fully than the CDC?", "id": "100000000000000000004022", "answers": [{"text": "Data completeness", "answer_start": 350}], "is_impossible": false}, {"question": "CDC COVID Data Tracker may appear artificially low due to systematic missing data reported to what agency?", "id": "100000000000000000004023", "answers": [{"text": "CDC", "answer_start": 688}], "is_impossible": false}], "context": "Vaccination data reported on the CDC COVID Data Tracker might differ from data reported by jurisdictions for a\nnumber of reasons. For example:\nData quality: CDC receives administration data across multiple jurisdictions with different reporting practices. To\nreduce potential duplication across systems, CDC reconciles these data prior to reporting. Data completeness: Jurisdictions may have more complete and updated data for certain data elements (e.g.,\ncounty of residence) that allow them to characterize their population more fully than the CDC. Thus, vaccination\ncoverage reported on the CDC COVID Data Tracker may appear artificially low due to systematic missing data\nreported to CDC."}]}, {"title": "f5646fbb07425daa93a2de4be216cf4e", "paragraphs": [{"qas": [{"question": "What may not be available to jurisdictions?", "id": "100000000000000000004025", "answers": [{"text": "data streams", "answer_start": 339}], "is_impossible": false}, {"question": "What is the name of the vaccine that is given to people receiving it?", "id": "100000000000000000004027", "answers": [{"text": "COVID-19", "answer_start": 669}], "is_impossible": false}, {"question": "Where does the recipient of the COVID-19 vaccine reside?", "id": "100000000000000000004028", "answers": [{"text": "jurisdiction", "answer_start": 693}], "is_impossible": false}], "context": "Data availability: Data on the CDC COVID Data Tracker represent all vaccine partners including jurisdictional\npartner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management\nAgency and Health Resources and Services Administration partner sites, and federal entity facilities. These\nadditional data streams may not be available to jurisdictions and therefore may not be included in totals\npresented on jurisdictional dashboards. Data definition: CDC\u2019s COVID Data Tracker attributes dose administrations to the jurisdiction (state, territory, tribe,\nor local entity) administering those doses and attributes people receiving COVID-19 vaccine to the jurisdiction\nwhere the vaccine recipient resides."}]}, {"title": "d5139f75c3023b0d49d881b429541016", "paragraphs": [{"qas": [{"question": "What is CDC based on data reported by jurisdictions that includes a dose number (first, second, booster or additional dose)?", "id": "100000000000000000004030", "answers": [{"text": "CDC estimates", "answer_start": 171}], "is_impossible": false}, {"question": "What is the population definition?", "id": "100000000000000000004032", "answers": [{"text": "CDC includes all age groups", "answer_start": 387}], "is_impossible": false}], "context": "Additionally, CDC estimates the number of people receiving at least one dose,\nthe number of people who are fully vaccinated, and the number of people with a booster dose. CDC estimates are\nbased on data reported by jurisdictions that includes a dose number (first, second, booster or additional dose). This may differ from how jurisdictions attribute their doses. Population definition: CDC includes all age groups in the Total Population calculations to provide a better measure\nof community immunity."}]}, {"title": "8d44277dd8c86429e83f2cc4503db643", "paragraphs": [{"qas": [{"question": "Who may use more targeted population counts for the denominators in their rate calculations?", "id": "100000000000000000004033", "answers": [{"text": "Jurisdictions", "answer_start": 0}], "is_impossible": false}, {"question": "What would result in values different than those reported on the CDC COVID Data Tracker?", "id": "100000000000000000004034", "answers": [{"text": "Jurisdictions may use more targeted population counts", "answer_start": 0}], "is_impossible": false}, {"question": "Between what hours does review and verification usually take place?", "id": "100000000000000000004036", "answers": [{"text": "1:30 pm and 8:00 pm ET", "answer_start": 323}], "is_impossible": false}, {"question": "What date does CDC begin reporting vaccine administration and delivery data?", "id": "100000000000000000004037", "answers": [{"text": "June 13, 2022", "answer_start": 363}], "is_impossible": false}, {"question": "On what day of the week do jurisdictions and other partners report vaccine administration data to CDC?", "id": "100000000000000000004038", "answers": [{"text": "Wednesdays", "answer_start": 494}], "is_impossible": false}], "context": "Jurisdictions may use more targeted population counts for the denominators in their rate\ncalculations (for example, people over age 18), which would result in values different than those reported on the\nCDC COVID Data Tracker\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nData will be updated weekly on Thursday after review and verification, usually between 1:30 pm and 8:00 pm ET. Note: Beginning June 13, 2022, instead of daily, jurisdictions and other partners report vaccine administration and\ndelivery data to CDC weekly on Wednesdays by 6:00 AM ET."}]}, {"title": "c3e45684d462e4ab0f2284136f24c7ba", "paragraphs": [{"qas": [{"question": "On what date will the COVID Data Tracker tabs be refreshed weekly?", "id": "100000000000000000004039", "answers": [{"text": "Thursday", "answer_start": 97}], "is_impossible": false}, {"question": "What is the name of the tabs that will be refreshed on Thursday by 8:00 PM ET?", "id": "100000000000000000004040", "answers": [{"text": "COVID Data Tracker", "answer_start": 45}], "is_impossible": false}, {"question": "What is the day of weekly reporting?", "id": "100000000000000000004042", "answers": [{"text": "Wednesday", "answer_start": 505}], "is_impossible": false}, {"question": "When will there be no updates on federal holidays?", "id": "100000000000000000004043", "answers": [{"text": "Wednesday", "answer_start": 505}], "is_impossible": false}, {"question": "When will data be updated?", "id": "100000000000000000004044", "answers": [{"text": "Thursday by 8:00 PM ET: Vaccinations in the United States, Vaccinations by County, Vaccination Trends, Vaccination Demographics, Vaccination Demographic Trends, Vaccination Equity, Vaccinations and Case Trends, Vaccinations and Other Outcomes . Weekly updates might be delayed due to delays in reporting. Data on doses of vaccine distributed and administered include data received by CDC as of 6:00 am ET on Wednesday, the day of weekly reporting. There will be no updates on federal holidays. Data will be updated the following day", "answer_start": 97}], "is_impossible": false}], "context": "As a result, instead of daily, the following COVID Data Tracker\ntabs will be refreshed weekly on Thursday by 8:00 PM ET: Vaccinations in the United States, Vaccinations by\nCounty, Vaccination Trends, Vaccination Demographics, Vaccination Demographic Trends, Vaccination\nEquity, Vaccinations and Case Trends, Vaccinations and Other Outcomes . Weekly updates might be delayed due to delays in reporting. Data on doses of vaccine distributed and administered include data received by CDC as of 6:00 am ET on\nWednesday, the day of weekly reporting. There will be no updates on federal holidays. Data will be updated the following day."}]}, {"title": "60d53522869375983a2bdb69da941c43", "paragraphs": [{"qas": [{"question": "Users can download daily cumulative data from what?", "id": "100000000000000000004046", "answers": [{"text": "CDC\u2019s COVID Data Tracker vaccination pages", "answer_start": 103}], "is_impossible": false}, {"question": "What can users also download manually or programmatically?", "id": "100000000000000000004047", "answers": [{"text": "historical COVID-19 vaccination data", "answer_start": 200}], "is_impossible": false}, {"question": "What is recommended for children of certain ages and all adults, including those who are pregnant?", "id": "100000000000000000004048", "answers": [{"text": "COVID-19 vaccination", "answer_start": 412}], "is_impossible": false}], "context": "How often are COVID-19 vaccination data updated? \uf1aa\n\u2022\n\u2022\n\u2022\nUsers can download daily cumulative data from CDC\u2019s COVID Data Tracker vaccination pages manually or\nprogrammatically. Users can also download historical COVID-19 vaccination data manually or programmatically. Where can I download COVID-19 data? \uf1aa\f10/30/22, 9:35 AM Frequently Asked Questions about COVID-19 Vaccination Data | CDC\nVaccination Information\nCOVID-19 vaccination is recommended for children of certain ages and all adults, including those who are pregnant. Learn more about staying up to date with COVID-19 vaccination. Who is eligible for a COVID-19 vaccine?"}]}, {"title": "c35f93eaef97ff338c7784b05b949b5a", "paragraphs": [{"qas": [{"question": "Where can you find answers to commonly asked questions about COVID-19 vaccination?", "id": "100000000000000000004050", "answers": [{"text": "CDC\u2019s Frequently Asked Questions about COVID-19 Vaccination page", "answer_start": 81}], "is_impossible": false}, {"question": "When was the last update for the CDC's Frequently Asked Questions about CoviD-19 Vaccination page?", "id": "100000000000000000004051", "answers": [{"text": "July 1, 2022", "answer_start": 221}], "is_impossible": false}], "context": "\uf1aa\nYou can find answers to commonly asked questions about COVID-19 vaccination on CDC\u2019s Frequently Asked Questions\nabout COVID-19 Vaccination page. Where can I find more information about COVID-19 vaccines? \uf1aa\nLast Updated July 1, 2022"}]}, {"title": "d4f43ea562d06564d9bf3ae9c4173ddb", "paragraphs": [{"qas": [{"question": "What are the most frequently asked questions about COVID-19 Vaccination?", "id": "100000000000000000004052", "answers": [{"text": "answers", "answer_start": 168}], "is_impossible": false}, {"question": "What does the emergence of COVID-19 variants emphasize?", "id": "100000000000000000004054", "answers": [{"text": "the importance of vaccination, boosters, and prevention efforts needed to protect against COVID-19", "answer_start": 587}], "is_impossible": false}, {"question": "What is the importance of vaccination, boosters, and prevention efforts to protect against?", "id": "100000000000000000004055", "answers": [{"text": "COVID-19", "answer_start": 677}], "is_impossible": false}], "context": "10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\nEspa\u00f1ol | Other Languages\nFrequently Asked Questions about COVID-19\nVaccination\nBelow are answers to commonly asked questions about COVID-19 vaccination. Have more questions? Visit How to Protect Yourself and Others. Boosters\nYes. Recent data suggest COVID-19 vaccine effectiveness at preventing infection or severe illness wanes over time,\nespecially for certain groups of people, such as people ages 65 years and older and people with immunocompromise. The emergence of COVID-19 variants further emphasizes the importance of vaccination, boosters, and prevention efforts\nneeded to protect against COVID-19."}]}, {"title": "cc5b22a0f15545533be9df232eb1616", "paragraphs": [{"qas": [{"question": "CDC recommends COVID-19 vaccines for everyone ages 6 months and older, and what for everyone 5 years and older?", "id": "100000000000000000004057", "answers": [{"text": "boosters", "answer_start": 209}], "is_impossible": false}, {"question": "What vaccines are working well to prevent severe illness, hospitalization, and death?", "id": "100000000000000000004060", "answers": [{"text": "COVID-19", "answer_start": 570}], "is_impossible": false}], "context": "Data show that an mRNA booster increases the immune response, which improves protection against getting a serious\nCOVID-19 infection. CDC recommends COVID-19 vaccines for everyone ages 6 months and older, and boosters for everyone 5 years and\nolder, if eligible. Learn more about COVID-19 vaccine recommendations, including recommendations for people who are moderately or\nseverely immunocompromised. Use CDC\u2019s COVID-19 Booster Tool to learn if and when you can get boosters to stay up to\ndate with your COVID-19 vaccines. Do I need a COVID-19 vaccine booster? \uf1aa\n\uf20c\nYes. COVID-19 vaccines are working well to prevent severe illness, hospitalization, and death."}]}, {"title": "3c03cf20eca31c9d5750c6056f784e05", "paragraphs": [{"qas": [{"question": "What are public health experts seeing reduced protection over time against mild and moderate disease?", "id": "100000000000000000004061", "answers": [{"text": "populations", "answer_start": 130}], "is_impossible": false}, {"question": "What do boosters use the same ingredients as?", "id": "100000000000000000004063", "answers": [{"text": "existing vaccines", "answer_start": 332}], "is_impossible": false}, {"question": "What are some of the side effects of a COVID-19 vaccine?", "id": "100000000000000000004064", "answers": [{"text": "pain, redness or swelling at the injection site, tiredness, headache, muscle pain, chills, fever, and nausea", "answer_start": 513}], "is_impossible": false}], "context": "However, public health\nexperts are seeing reduced protection over time against mild and moderate disease, especially among certain\npopulations. If we need a booster, are the vaccines working? \uf1aa\n\uf20c\nYes. COVID-19 boosters are the same ingredients (formulation) as the current COVID-19 vaccines. Do boosters use the same ingredients as existing vaccines? \uf1aa\f10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\nAdults and children may have some side effects from a COVID-19 vaccine, including pain, redness or swelling at the\ninjection site, tiredness, headache, muscle pain, chills, fever, and nausea. Serious side effects are rare, but may occur."}]}, {"title": "43fd357c7e9d87d671bfa705687a9d8d", "paragraphs": [{"qas": [{"question": "What are the risks to getting a booster?", "id": "100000000000000000004066", "answers": [{"text": "Yes, you are fully vaccinated even if you haven\u2019t gotten your booster yet", "answer_start": 43}], "is_impossible": false}, {"question": "What does this include when eligible?", "id": "100000000000000000004070", "answers": [{"text": "COVID-19 vaccinations", "answer_start": 321}], "is_impossible": false}, {"question": "Who is considered fully vaccinated if they don't get a booster?", "id": "100000000000000000004071", "answers": [{"text": "Yes, you are fully vaccinated even if you haven\u2019t gotten your booster yet. The definition of fully vaccinated does not include a COVID-19 booster. Fully vaccinated, however, is not the same as having the best protection", "answer_start": 43}], "is_impossible": false}], "context": "What are the risks to getting a booster? \uf1aa\nYes, you are fully vaccinated even if you haven\u2019t gotten your booster yet. The definition of fully vaccinated does not\ninclude a COVID-19 booster. Fully vaccinated, however, is not the same as having the best protection. People are best\nprotected when they stay up to date with COVID-19 vaccinations, which includes getting a booster when eligible. Am I still considered \u201cfully vaccinated\u201d if I don\u2019t get a booster? \uf1aa\nYes. You are up to date if you have completed a COVID-19 vaccine primary series and received the most recent booster\ndose recommended for you by CDC."}]}, {"title": "dde15a6efd232d0c1f80cd4a8a31fdb0", "paragraphs": [{"qas": [{"question": "What does the definition of \u201cup to date\u201d include?", "id": "100000000000000000004073", "answers": [{"text": "boosters", "answer_start": 44}], "is_impossible": false}, {"question": "How long should you get the mDNA booster at least 4 times?", "id": "100000000000000000004075", "answers": [{"text": "4 months", "answer_start": 327}], "is_impossible": false}, {"question": "What is the name of the vaccine?", "id": "100000000000000000004076", "answers": [{"text": "J&J/Janssen COVID-19", "answer_start": 148}], "is_impossible": false}, {"question": "How long after the most recent J&J/Janssen booster should you get the mRNA booster?", "id": "100000000000000000004077", "answers": [{"text": "4 months", "answer_start": 327}], "is_impossible": false}, {"question": "What did one CDC study find about adults who received the j&j/janssen COVID-19 vaccine as both their primary and booster:", "id": "100000000000000000004078", "answers": [{"text": "lower levels of protection against COVID-19-associated emergency department and urgent care visits during Omicron", "answer_start": 495}], "is_impossible": false}, {"question": "What is COVID-19-associated emergency department and urgent care visits during Omicron compared to adults who received an mRNA COMID-19 booster?", "id": "100000000000000000004079", "answers": [{"text": "lower levels of protection", "answer_start": 495}], "is_impossible": false}], "context": "Does the definition of \u201cup to date\u201d include boosters? \uf1aa\nPeople (except those who are moderately or severely immunocompromised) who first received a J&J/Janssen COVID-19\nvaccine and got it again for their booster may also receive a booster of an mRNA COVID-19 vaccine (Pfizer-BioNTech or\nModerna). Get the mRNA booster at least 4 months after the most recent J&J/Janssen booster. One CDC study found that adults who received the J&J/Janssen COVID-19 vaccine as both their primary and\nbooster had lower levels of protection against COVID-19-associated emergency department and urgent care visits\nduring Omicron compared to adults who received an mRNA COVID-19 booster."}]}, {"title": "e8a40a7e02b4c6070a616b8097c4e2b2", "paragraphs": [{"qas": [{"question": "What can you do to stay up to date with your COVID-19 vaccines?", "id": "100000000000000000004080", "answers": [{"text": "boosters", "answer_start": 65}], "is_impossible": false}, {"question": "Who may require that their workers be vaccinated?", "id": "100000000000000000004082", "answers": [{"text": "An employer", "answer_start": 270}], "is_impossible": false}, {"question": "What type of employer may require that their workers be vaccinated?", "id": "100000000000000000004083", "answers": [{"text": "employer", "answer_start": 273}], "is_impossible": false}, {"question": "What do you need to do to complete your primary series of vaccines?", "id": "100000000000000000004084", "answers": [{"text": "The number of vaccine doses", "answer_start": 483}], "is_impossible": false}], "context": "Use CDC\u2019s COVID-19 Booster Tool to learn if and when you can get boosters to stay up to date with your COVID-19\nvaccines. If I have received a J&J/Janssen COVID-19 vaccine and a J&J/Janssen COVID-19 booster, are\nadditional boosters recommended? \uf1aa\n\u2022\nGetting Your Vaccine\nAn employer may require that their workers be vaccinated. Check directly with your employer to see if they have any\nvaccination requirements or rules that apply to you. Am I required to get vaccinated for work? \uf1aa\nThe number of vaccine doses you need to complete your primary series depends on which vaccine you receive."}]}, {"title": "32c7cef9d6757a9571d6ae4274f09286", "paragraphs": [{"qas": [{"question": "What is the first and second dose of Moderna vaccine for people ages 6 months through 4 years?", "id": "100000000000000000004087", "answers": [{"text": "3-8 weeks apart", "answer_start": 177}], "is_impossible": false}, {"question": "How many weeks apart is the second and third dose of moderna vaccine?", "id": "100000000000000000004088", "answers": [{"text": "8", "answer_start": 225}], "is_impossible": false}, {"question": "How many doses of Novavax vaccine will I need to get to complete my primary series?", "id": "100000000000000000004089", "answers": [{"text": "2", "answer_start": 321}], "is_impossible": false}, {"question": "What vaccine is given 4-8 weeks apart for people ages 6 months and older?", "id": "100000000000000000004090", "answers": [{"text": "Moderna", "answer_start": 252}], "is_impossible": false}], "context": "2 doses of Pfizer-BioNTech vaccine 3\u20138* weeks apart for people 5 years and older, or\n3 doses of Pfizer-BioNTech\u202fvaccine\u202ffor ages 6 months through 4 years, first and second dose 3-8 weeks apart,\nsecond and third dose at least 8 weeks apart*. 2 doses of Moderna vaccine 4\u20138* weeks apart for people ages 6 months and older. 2 doses of Novavax vaccine 3 8* weeks apart for people ages 12 years and older\nHow many doses of COVID-19 vaccine will I need to get to complete my primary series?"}]}, {"title": "f2ff7e4c447c979544fad9cac009e141", "paragraphs": [{"qas": [{"question": "How many doses of Novavax vaccine are needed for people ages 12 and older?", "id": "100000000000000000004091", "answers": [{"text": "2", "answer_start": 86}], "is_impossible": false}, {"question": "What is another name for Johnson & Johnson's Janssen vaccine?", "id": "100000000000000000004092", "answers": [{"text": "J&J/Janssen", "answer_start": 205}], "is_impossible": false}, {"question": "Who is responsible for administering the vaccine for you?", "id": "100000000000000000004093", "answers": [{"text": "healthcare or vaccine provider", "answer_start": 270}], "is_impossible": false}, {"question": "How many vaccine doses are needed to get the COVID-19 Vaccination?", "id": "100000000000000000004094", "answers": [{"text": "2", "answer_start": 86}], "is_impossible": false}, {"question": "People who are moderate or severely immunocompromised may have a different immune response after what?", "id": "100000000000000000004096", "answers": [{"text": "COVID- 19 vaccination", "answer_start": 507}], "is_impossible": false}], "context": "\uf1aa\n\u2022\n\u2022\n\u2022\f10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\n2 doses of Novavax vaccine 3-8* weeks apart for people ages 12 years and older. 1 dose of Johnson & Johnson\u2019s Janssen (J&J/Janssen) vaccine for people ages 18 and older. *Talk to your healthcare or vaccine provider about the timing for the second dose in your primary series. You\nshould not get the second dose early. People who are moderately or severely immunocompromised may have a different immune response following COVID-\n19 vaccination. Please see specific COVID-19 vaccination guidance for people who are moderately or severely\nimmunocompromised. \u2022\n\u2022\nNo."}]}, {"title": "42371bc17e60cd751fe3ea94c87ff25e", "paragraphs": [{"qas": [{"question": "What might be updated as more information becomes available?", "id": "100000000000000000004099", "answers": [{"text": "If you receive your second dose of a COVID-19 vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "What does your provider cannot give you a dose of that does not follow its specific vaccine product guidelines and requirements?", "id": "100000000000000000004100", "answers": [{"text": "vaccine", "answer_start": 432}], "is_impossible": false}], "context": "If you receive your second dose of a COVID-19 vaccine at any time after the recommended date, you do not have to\nrestart the vaccine series. This guidance might be updated as more information becomes available. Learn more about staying up to date with your COVID-19 vaccines. If I didn\u2019t get my second dose of a 2-dose COVID-19 vaccine within the recommended time, do I\nneed to start over? \uf1aa\nYour provider cannot give you a dose of vaccine that does not follow its specific vaccine product guidelines and\nrequirements."}]}, {"title": "74aa44cbad90eafddda8b509bee65a39", "paragraphs": [{"qas": [{"question": "What must all COVID-19 vaccine providers in the US be enrolled in?", "id": "100000000000000000004101", "answers": [{"text": "CDC COVID-19 Vaccination Program", "answer_start": 76}], "is_impossible": false}, {"question": "What must vaccine providers sign to participate in this program?", "id": "100000000000000000004102", "answers": [{"text": "an agreement that states they will only administer COVID- 19 vaccines in accordance with program requirements and recommendations", "answer_start": 165}], "is_impossible": false}, {"question": "What is the acronym for the Advisory Committee on Immunization Practices?", "id": "100000000000000000004103", "answers": [{"text": "ACIP", "answer_start": 369}], "is_impossible": false}, {"question": "What are the guidelines for the administration of COVID-19 vaccines based on?", "id": "100000000000000000004105", "answers": [{"text": "safety and efficacy data", "answer_start": 637}], "is_impossible": false}], "context": "All COVID-19 vaccine providers in the United States must be enrolled in the CDC COVID-19 Vaccination\nProgram. To participate in this program, vaccine providers sign an agreement that states they will only administer COVID-\n19 vaccines in accordance with program requirements and recommendations including those of CDC, the Advisory\nCommittee on Immunization Practices (ACIP), and the U.S. Food and Drug Administration (FDA). Your provider can\nrefer to the CDC Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States for specific information\non administration of COVID-19 vaccines. These guidelines are based on safety and efficacy data and are updated as new\ninformation becomes available."}]}, {"title": "e3b070129df4f168c1cc33602890c57b", "paragraphs": [{"qas": [{"question": "What is the term for a dose of COVID-19 vaccine that does not follow vaccination guidelines?", "id": "100000000000000000004106", "answers": [{"text": "off-label\u201d use", "answer_start": 127}], "is_impossible": false}, {"question": "Scientists are monitoring how long the protection of the vaccine lasts?", "id": "100000000000000000004107", "answers": [{"text": "answer undefined", "answer_start": 127}], "is_impossible": false}, {"question": "What does CDC recommend for everyone ages 6 months and older?", "id": "100000000000000000004110", "answers": [{"text": "COVID-19 vaccines", "answer_start": 476}], "is_impossible": false}, {"question": "For everyone 5 years and older, what is recommended?", "id": "100000000000000000004111", "answers": [{"text": "boosters", "answer_start": 536}], "is_impossible": false}, {"question": "What is the age limit for COVID-19 boosters?", "id": "100000000000000000004112", "answers": [{"text": "5 years and older", "answer_start": 558}], "is_impossible": false}], "context": "Can I ask my healthcare provider for a dose of COVID-19 vaccine that does not follow vaccination\nguidelines, sometimes called \u201coff-label\u201d use? \uf1aa\n\uf209\nScientists are monitoring how long COVID-19 vaccine protection lasts. COVID-19 vaccines work well to prevent severe\nillness, hospitalization, and death. However, public health experts are seeing decreases in the protection COVID-19\nvaccines provide over time, especially for certain groups of people. Due to this, CDC recommends COVID-19 vaccines for\neveryone ages 6 months and older, and boosters for everyone 5 years and older, if eligible. Learn more about COVID-19\nbooster recommendations, including recommendations for people who are moderately or severely\nimmunocompromised."}]}, {"title": "ef1022d8241df8a54d5901a7e854b5a8", "paragraphs": [{"qas": [{"question": "How long does protection from a COVID-19 vaccine last?", "id": "100000000000000000004114", "answers": [{"text": "\uf1aa", "answer_start": 147}], "is_impossible": false}, {"question": "How long are menstrual periods longer?", "id": "100000000000000000004116", "answers": [{"text": "Longer duration", "answer_start": 310}], "is_impossible": false}, {"question": "What does COVID-19 vaccine cause?", "id": "100000000000000000004117", "answers": [{"text": "fertility problems", "answer_start": 507}], "is_impossible": false}, {"question": "What is the term for a period of time between periods?", "id": "100000000000000000004118", "answers": [{"text": "menstrual cycle", "answer_start": 559}], "is_impossible": false}], "context": "CDC continues to review evidence and updates guidance as new information becomes available. How long does protection from a COVID-19 vaccine last? \uf1aa\nResults from recent research studies show that people who menstruate may observe small, temporary changes in\nmenstruation after COVID-19 vaccination, including:\nLonger duration of menstrual periods\nShorter intervals between periods\nHeavier bleeding than usual\nDespite these temporary changes in menstruation there is no evidence that COVID-19 vaccines cause fertility problems\nDo COVID-19 vaccines affect your menstrual cycle (period)?"}]}, {"title": "e902bd55ebfd0600bd3f69e221c1cda8", "paragraphs": [{"qas": [{"question": "What does not cause fertility problems?", "id": "100000000000000000004119", "answers": [{"text": "COVID 19 vaccines", "answer_start": 161}], "is_impossible": false}, {"question": "What should parents and caregivers get Vaccinated for?", "id": "100000000000000000004120", "answers": [{"text": "their child vaccinated as soon as vaccines are available to them", "answer_start": 357}], "is_impossible": false}, {"question": "What provides the best protection against serious illness if a child gets infected with COVID-19?", "id": "100000000000000000004122", "answers": [{"text": "Getting vaccinated", "answer_start": 423}], "is_impossible": false}], "context": "\uf1aa\n\u2022\n\u2022\n\u2022\f10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\nDespite these temporary changes in menstruation, there is no evidence that COVID 19 vaccines cause fertility problems. Learn more about COVID-19 vaccination for people who would like to have a baby. Getting Children and Teens Vaccinated\nParents and caregivers should get their child vaccinated as soon as vaccines are available to them. Getting vaccinated\nprovides the best protection against serious illness if a child gets infected with the virus that causes COVID-19."}]}, {"title": "d7fb3b1aa2632fd5c34ec8adb9610fdc", "paragraphs": [{"qas": [{"question": "What is the only way to know how a child will be affected by COVID-19?", "id": "100000000000000000004123", "answers": [{"text": "get them vaccinated", "answer_start": 247}], "is_impossible": false}, {"question": "Why is it important to get your child vaccinated?", "id": "100000000000000000004125", "answers": [{"text": "to protect them against severe illness", "answer_start": 287}], "is_impossible": false}, {"question": "Who can you call to find your child's booster?", "id": "100000000000000000004128", "answers": [{"text": "1-800-232-0233", "answer_start": 445}], "is_impossible": false}], "context": "Since there\nis no way to tell in advance how children, who are not moderately or severely immunocompromised, or those who may\nbe immunocompromised. A child can be immunocompromised and still healthy, will be affected by COVID-19 it\u2019s\nimportant to get them vaccinated as soon as possible to protect them against severe illness. To find your child a COVID-19\nvaccine or booster near you:\u202fSearch\u202fvaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. Should parents and caregivers wait for updated or additional vaccines, if a child is low risk for\ninfection?"}]}, {"title": "358b231a04b97433089c9ab2fc447569", "paragraphs": [{"qas": [{"question": "There is no federal legal requirement for a parent, guardian, or caregiver to consent for what?", "id": "100000000000000000004130", "answers": [{"text": "COVID-19", "answer_start": 92}], "is_impossible": false}, {"question": "What is not required for select age groups?", "id": "100000000000000000004131", "answers": [{"text": "consent", "answer_start": 198}], "is_impossible": false}, {"question": "How long have local laws and policies around minor consent for vaccination existed?", "id": "100000000000000000004132", "answers": [{"text": "a long time", "answer_start": 371}], "is_impossible": false}, {"question": "What will also apply to COVID-19 vaccination of children?", "id": "100000000000000000004133", "answers": [{"text": "State or local laws and policies, as well as vaccine provider policies", "answer_start": 245}], "is_impossible": false}, {"question": "For information on caregiver consent, visit what website?", "id": "100000000000000000004134", "answers": [{"text": "COVID-19 Vaccination for People Experiencing Homelessness: Frequently Asked Questions", "answer_start": 544}], "is_impossible": false}], "context": "\uf1aa\nThere is no federal legal requirement for a parent, guardian, or caregiver to consent for COVID-19 or any other\nvaccination. However, depending on each state or local law, this does not mean that consent is not required for select\nage groups. State or local laws and policies, as well as vaccine provider policies, around minor consent for vaccination\nhave existed for a long time and will also apply to COVID-19 vaccination of children. For information on caregiver consent on COVID-19 vaccination for youth experiencing homelessness, visit\u202fCOVID-19\nVaccination for People Experiencing Homelessness: Frequently Asked Questions."}]}, {"title": "f93367caba36382671ade48983500d03", "paragraphs": [{"qas": [{"question": "What does a parent or guardian have to give before a child or teen can receive a COVID-19 vaccine?", "id": "100000000000000000004135", "answers": [{"text": "consent", "answer_start": 39}], "is_impossible": false}, {"question": "What does the vaccines that are currently available do not use?", "id": "100000000000000000004136", "answers": [{"text": "live virus that causes COVID-19", "answer_start": 170}], "is_impossible": false}, {"question": "What does COVID-19 teach the body to fight?", "id": "100000000000000000004137", "answers": [{"text": "the virus", "answer_start": 329}], "is_impossible": false}, {"question": "What does the body get rid of within a few days after vaccination?", "id": "100000000000000000004138", "answers": [{"text": "the harmless spike protein", "answer_start": 381}], "is_impossible": false}], "context": "Does a parent or guardian have to give consent before a child or teen can receive a COVID-19\nvaccine? \uf1aa\nNo. COVID-19 vaccines that are currently available do not use the live virus that causes COVID-19. These vaccines work by\nusing a harmless piece of spike protein from the virus causing COVID-19 to teach the body how to fight the virus that\ncauses it. The body then gets rid of the harmless spike protein within a few days after vaccination. Can children and teens get COVID-19 from a COVID-19 vaccine?"}]}, {"title": "9d2990d9c99cd5b0e33ff1d708e9c7a1", "paragraphs": [{"qas": [{"question": "What are the same active ingredients as the COVID-19 vaccines for adults?", "id": "100000000000000000004139", "answers": [{"text": "The COVID-19 vaccines for children", "answer_start": 2}], "is_impossible": false}, {"question": "How were the smaller doses tested?", "id": "100000000000000000004141", "answers": [{"text": "rigorously", "answer_start": 216}], "is_impossible": false}, {"question": "What are the same ones that are given to adults?", "id": "100000000000000000004143", "answers": [{"text": "COVID-19 vaccines", "answer_start": 6}], "is_impossible": false}, {"question": "When were COVID-19 vaccines developed?", "id": "100000000000000000004144", "answers": [{"text": "quickly", "answer_start": 510}], "is_impossible": false}], "context": "\uf1aa\nThe COVID-19 vaccines for children have the same active ingredients as the vaccines given to adults. However, children\nreceive a smaller and more age-appropriate dose that is right for them. The smaller doses were rigorously tested and\nfound to create the needed immune response for each age group. Making it important for our child to get the vaccine\nmade for their age group. Are the COVID-19 vaccines for children the same ones that are given to adults? \uf1aa\nSafety\nAlthough COVID-19 vaccines were developed quickly, research and development on vaccines like these have been\nunderway for decades."}]}, {"title": "fd9a56f4d4d29289e24bb26813176283", "paragraphs": [{"qas": [{"question": "Why were the phases overlapped?", "id": "100000000000000000004149", "answers": [{"text": "to speed up the process", "answer_start": 432}], "is_impossible": false}, {"question": "What agency reviews vaccines before they are available to people?", "id": "100000000000000000004150", "answers": [{"text": "Food and Drug Administration (FDA)", "answer_start": 566}], "is_impossible": false}, {"question": "Who reviews data from clinical trials?", "id": "100000000000000000004152", "answers": [{"text": "U.S. Food and Drug Administration (FDA)", "answer_start": 561}], "is_impossible": false}], "context": "All vaccine development steps were taken to ensure COVID-19 vaccine safety and effectiveness,\nAre COVID-19 vaccines safe even though the vaccines were developed rapidly? \uf1aa\f10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\ny p p y ,\nincluding:\nClinical Trials \u2013 All vaccines in the United States must go through three phases of clinical trials to ensure they are\nsafe and effective. The phases overlapped to speed up the process, but all phases were completed. Authorization or Approval \u2013 Before vaccines are available to people, the U.S. Food and Drug Administration (FDA)\nreviews data from clinical trials."}]}, {"title": "dafd3a0cc942630d28cc9b8750a3bcc", "paragraphs": [{"qas": [{"question": "What does EUA stand for?", "id": "100000000000000000004154", "answers": [{"text": "Emergency Use Authorizations", "answer_start": 89}], "is_impossible": false}, {"question": "How is safety and effectiveness monitored?", "id": "100000000000000000004155", "answers": [{"text": "Vaccine Monitoring Systems", "answer_start": 169}], "is_impossible": false}, {"question": "Hundreds of millions of vaccines are monitored for what?", "id": "100000000000000000004156", "answers": [{"text": "safety and effectiveness", "answer_start": 309}], "is_impossible": false}, {"question": "How many people in the U.S. have received COVID-19 vaccines?", "id": "100000000000000000004157", "answers": [{"text": "Hundreds of millions", "answer_start": 335}], "is_impossible": false}, {"question": "CDC and FDA continue to provide updated information on the safety of what?", "id": "100000000000000000004158", "answers": [{"text": "U.S. authorized or approved COVID-19 vaccines", "answer_start": 496}], "is_impossible": false}], "context": "FDA has determined COVID-19 vaccines meet FDA\u2019s standards and has granted\nthose vaccines Emergency Use Authorizations (EUAs) or full FDA approval. Tracking Safety Using Vaccine Monitoring Systems \u2013 Like every other vaccine approved for use in the United States,\nCOVID-19 vaccines continue to be monitored for safety and effectiveness. Hundreds of millions of people in the\nUnited States have safely received COVID-19 vaccines. CDC and FDA continue to provide updated information on\nthe safety of U.S. authorized or approved COVID-19 vaccines using data from several monitoring systems. Learn more about developing COVID-19 vaccines. \u2022\n\u2022\n\uf209\n\u2022\nVaccine ingredients vary by manufacturer."}]}, {"title": "7b1d2e06e9d98f6c2ac982916d057523", "paragraphs": [{"qas": [{"question": "What does none of the COVID-19 vaccines contain?", "id": "100000000000000000004161", "answers": [{"text": "eggs, gelatin, latex, or preservatives. All COVID-19 vaccines are free from metals, such as iron, nickel, cobalt, lithium, and rare earth alloys. They are also free from manufactured products such as microelectronics, electrodes, carbon nanotubes, and nanowire semiconductors. None of the COVID-19 vaccines authorized or approved in the United States contain any live virus", "answer_start": 29}], "is_impossible": false}, {"question": "What metals are included in the vaccines?", "id": "100000000000000000004162", "answers": [{"text": "iron, nickel, cobalt, lithium, and rare earth alloys", "answer_start": 121}], "is_impossible": false}, {"question": "Other than microelectronics, electrodes, carbon nanotubes, and nanowire semiconductors, what other manufactured product is included?", "id": "100000000000000000004163", "answers": [{"text": "manufactured products", "answer_start": 198}], "is_impossible": false}, {"question": "What does not contain live virus in the COVID-19 vaccines?", "id": "100000000000000000004164", "answers": [{"text": "the COVID-19 vaccines authorized or approved in the United States", "answer_start": 314}], "is_impossible": false}], "context": "None of the vaccines contain eggs, gelatin, latex, or preservatives. All COVID-19\nvaccines are free from metals, such as iron, nickel, cobalt, lithium, and rare earth alloys. They are also free from\nmanufactured products such as microelectronics, electrodes, carbon nanotubes, and nanowire semiconductors. None of\nthe COVID-19 vaccines authorized or approved in the United States contain any live virus."}]}, {"title": "ed2c8e92d5a1748bdfd7facb06907e8a", "paragraphs": [{"qas": [{"question": "What are the ingredients in COVID-19 vaccines?", "id": "100000000000000000004166", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 \u2022", "answer_start": 383}], "is_impossible": false}, {"question": "What is recommended for people who are pregnant, breastfeeding, or trying to get pregnant?", "id": "100000000000000000004167", "answers": [{"text": "COVID-19 vaccination", "answer_start": 399}], "is_impossible": false}], "context": "To learn more about the ingredients in authorized or approved COVID-19 vaccines, see\nPfizer-BioNTech COVID-19 Vaccine Overview and Safety\nModerna COVID-19 Vaccine Overview and Safety\nJohnson & Johnson\u2019s Janssen COVID-19 Vaccine Overview and Safety\nNovavax COVID-19 Vaccine Overview and Safety\nIngredients Included in COVID-19 Vaccines\nWhat are the ingredients in COVID-19 vaccines? \uf1aa\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nYes, COVID-19 vaccination is recommended for people who are pregnant, breastfeeding, or trying to get pregnant now, as\nwell as people who might become pregnant in the future."}]}, {"title": "7d3ac66eafa9b457f8ed6ccee87d1b24", "paragraphs": [{"qas": [{"question": "What does COVID-19 vaccination during pregnancy help prevent?", "id": "100000000000000000004169", "answers": [{"text": "severe illness and death", "answer_start": 239}], "is_impossible": false}, {"question": "What is the name of the CDC\u2019s smartphone-based system for vaccinating pregnant women?", "id": "100000000000000000004172", "answers": [{"text": "v-safe", "answer_start": 608}], "is_impossible": false}, {"question": "What is the name of the CDC\u2019s smartphone-based system?", "id": "100000000000000000004173", "answers": [{"text": "v-safe", "answer_start": 608}], "is_impossible": false}], "context": "People with COVID-19 during pregnancy are more likely to\ndeliver a preterm (earlier than 37 weeks) or stillborn infant and may also be more likely to have other pregnancy\ncomplications. COVID-19 vaccination during pregnancy helps:\nPrevent severe illness and death in people who are pregnant\nProtect babies younger than 6 months old from hospitalization caused by COVID-19\nLearn more about vaccination considerations and the safety and effectiveness of COVID-19 vaccinations for people who\nare pregnant or breastfeeding. If you are pregnant and have received a COVID-19 vaccine, we encourage you to enroll in v-safe, CDC\u2019s smartphone-based\nsystem that provides personalized health check-ins after vaccination."}]}, {"title": "cfa4669faf889d1b0c4b4c5372683213", "paragraphs": [{"qas": [{"question": "What has been established to gather information on the health of pregnant people who have received a COVID-19 vaccine?", "id": "100000000000000000004175", "answers": [{"text": "v-safe pregnancy registry", "answer_start": 2}], "is_impossible": false}, {"question": "What is the purpose of the v-safe pregnancy registry?", "id": "100000000000000000004176", "answers": [{"text": "to gather information on the health of pregnant people who have received a COVID-19 vaccine", "answer_start": 49}], "is_impossible": false}, {"question": "What can make children and teens very sick and sometimes requires treatment in a hospital?", "id": "100000000000000000004177", "answers": [{"text": "COVID-19", "answer_start": 373}], "is_impossible": false}, {"question": "What can help keep them from getting really sick if they do get vaccinated against COVID-19?", "id": "100000000000000000004178", "answers": [{"text": "Getting eligible children and teens vaccinated against COVID-19", "answer_start": 468}], "is_impossible": false}, {"question": "What is one way to keep them from getting really sick if they get COVID-19?", "id": "100000000000000000004179", "answers": [{"text": "Getting eligible children and teens vaccinated against COVID-19 can help keep them from getting really sick if they do get COVID-19, including protecting them from short and long-term complications and hospitalization", "answer_start": 468}], "is_impossible": false}, {"question": "What is another way to protect them from short and long term complications and hospitalization?", "id": "100000000000000000004180", "answers": [{"text": "Getting eligible children and teens vaccinated against COVID-19", "answer_start": 468}], "is_impossible": false}], "context": "A v-safe pregnancy registry has been established to\ngather information on the health of pregnant people who have received a COVID-19 vaccine. If I am pregnant or planning to become pregnant, can I get a COVID-19 vaccine? \uf1aa\n\u2022\n\u2022\nWhy should my children and teens get vaccinated against COVID-19? \uf1aa\f10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\nCOVID-19 can make children and teens very sick and sometimes requires treatment in a hospital. Getting eligible children\nand teens vaccinated against COVID-19 can help keep them from getting really sick if they do get COVID-19, including\nprotecting them from short and long-term complications and hospitalization."}]}, {"title": "171a6f28a9cfb409ceda09fa2d9557c4", "paragraphs": [{"qas": [{"question": "What can help keep children in school or daycare?", "id": "100000000000000000004181", "answers": [{"text": "Vaccinating children", "answer_start": 0}], "is_impossible": false}, {"question": "The benefits of COVID-19 vaccination outweigh the known and potential risks?", "id": "100000000000000000004182", "answers": [{"text": "Vaccinating children can also help keep them in school or daycare and safely participating in sports, playdates, and other group activities. The benefits of COVID-19 vaccination outweigh the known and potential risks. CDC recommends COVID-19 vaccines for everyone ages 6 months and older", "answer_start": 0}], "is_impossible": false}, {"question": "What does CDC recommend for everyone ages 6 months and older?", "id": "100000000000000000004183", "answers": [{"text": "COVID-19 vaccines", "answer_start": 233}], "is_impossible": false}, {"question": "How many things about the COVID-19 Vaccine for Children do you need to know?", "id": "100000000000000000004184", "answers": [{"text": "6", "answer_start": 353}], "is_impossible": false}, {"question": "What tool does the CDC use to help you learn if and when your child can get boosters?", "id": "100000000000000000004185", "answers": [{"text": "COVID-19 Booster Tool", "answer_start": 413}], "is_impossible": false}], "context": "Vaccinating children can also help keep\nthem in school or daycare and safely participating in sports, playdates, and other group activities. The benefits of COVID-19 vaccination outweigh the known and potential risks. CDC recommends COVID-19 vaccines for\neveryone ages 6 months and older, and boosters for everyone 5 years and older, if eligible. Learn 6 Things About the COVID-19 Vaccine for Children. Use CDC\u2019s COVID-19 Booster Tool to learn if and when your child or teen can get boosters to stay up to date with their\nCOVID-19 vaccines."}]}, {"title": "b26917d604cfcfd903ff70726a903bcd", "paragraphs": [{"qas": [{"question": "Compared to people who are up to date with their COVID-19 vaccinations, unvaccinated people are more likely to get what?", "id": "100000000000000000004187", "answers": [{"text": "COVID-19", "answer_start": 260}], "is_impossible": false}, {"question": "What vaccine is not 100% effective at preventing infection?", "id": "100000000000000000004188", "answers": [{"text": "COVID-19", "answer_start": 384}], "is_impossible": false}, {"question": "Who is more likely to be hospitalized with COVID-19?", "id": "100000000000000000004189", "answers": [{"text": "unvaccinated people", "answer_start": 218}], "is_impossible": false}], "context": "Preparing for Your Vaccine\nCOVID-19 vaccination significantly lowers your risk of severe illness, hospitalization, and death if you get infected. Compared to people who are up to date with their COVID-19 vaccinations, unvaccinated people are more likely to get\nCOVID-19, much more likely to be hospitalized with COVID-19, and much more likely to die from COVID-19. Like all vaccines, COVID-19 vaccines are not 100% effective at preventing infection. Some people who are up to date with\ntheir COVID-19 vaccinations will get COVID-19 breakthrough infection."}]}, {"title": "ea4537acb479769079ccbf098f72bb6c", "paragraphs": [{"qas": [{"question": "What does staying up to date with your COVID-19 vaccinations mean?", "id": "100000000000000000004190", "answers": [{"text": "you are less likely to have a breakthrough infection", "answer_start": 71}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000004193", "answers": [{"text": "SARS-CoV-2", "answer_start": 359}], "is_impossible": false}], "context": "However, staying up to date with your COVID-19\nvaccinations means that you are less likely to have a breakthrough infection and, if you do get sick, you are less likely to\nget severely ill or die. Staying up to date with COVID-19 vaccination also means you are less likely to spread the disease to\nothers and increases your protection against new variants of SARS-CoV-2, the virus that causes COVID-19. Why should I get vaccinated if I might get COVID-19 anyway? \uf1aa\nThere is no recommended waiting period between getting a COVID-19 vaccine and other vaccines."}]}, {"title": "683571660a4d5d6e8894917e28b10b39", "paragraphs": [{"qas": [{"question": "What type of vaccine can you get at the same time?", "id": "100000000000000000004197", "answers": [{"text": "COVID- 19", "answer_start": 14}], "is_impossible": false}, {"question": "What is the way our bodies develop protection known as?", "id": "100000000000000000004198", "answers": [{"text": "an immune response", "answer_start": 190}], "is_impossible": false}, {"question": "What are generally the same when given alone or with other vaccines?", "id": "100000000000000000004199", "answers": [{"text": "the way our bodies develop protection, known as an immune response, and possible side effects", "answer_start": 142}], "is_impossible": false}, {"question": "What should you get even if you already had COVID-19?", "id": "100000000000000000004200", "answers": [{"text": "a COVID-19 vaccine", "answer_start": 442}], "is_impossible": false}, {"question": "What is another name for COVID-19?", "id": "100000000000000000004201", "answers": [{"text": "flu", "answer_start": 64}], "is_impossible": false}, {"question": "What does getting a vaccine after you recover from a covid-19 infection provide?", "id": "100000000000000000004202", "answers": [{"text": "added protection against COVID-19", "answer_start": 573}], "is_impossible": false}], "context": "You can get a COVID-\n19 vaccine and other vaccines, including a flu vaccine, at the same visit. Experience with other vaccines has shown that\nthe way our bodies develop protection, known as an immune response, and possible side effects after getting vaccinated\nare generally the same when given alone or with other vaccines. Do I need to wait after getting a flu vaccine or another vaccine before getting a COVID-19 vaccine? \uf1aa\nYou should get a COVID-19 vaccine even if you already had COVID-19. Getting a COVID-19 vaccine after you recover from COVID-19 infection provides added protection against COVID-19."}]}, {"title": "16fbdbdb85a5db3a55401076248314bc", "paragraphs": [{"qas": [{"question": "What may you consider delaying your vaccine by 3 months from when your symptoms started?", "id": "100000000000000000004203", "answers": [{"text": "when you received a positive test", "answer_start": 111}], "is_impossible": false}, {"question": "What is more likely to get COVID-19 again than those who get vaccinated after their recovery?", "id": "100000000000000000004205", "answers": [{"text": "People who already had COVID-19 and do not get vaccinated after their recovery", "answer_start": 146}], "is_impossible": false}], "context": "You may consider delaying your vaccine by 3 months from when your symptoms started or, if you had no symptoms,\nwhen you received a positive test. People who already had COVID-19 and do not get vaccinated after their recovery are more likely to get COVID-19\nagain than those who get vaccinated after their recovery. Learn more about the benefits of getting a COVID-19 vaccine. If I already had COVID-19 and recovered, do I still need to get a COVID-19 vaccine? \uf1aa\nCan I get vaccinated against COVID-19 while I am currently sick with COVID-19?"}]}, {"title": "70782590b2a3c214cd7da9aa704eceb1", "paragraphs": [{"qas": [{"question": "People who have symptoms will end isolation at a different time than people who don't have what?", "id": "100000000000000000004210", "answers": [{"text": "symptoms", "answer_start": 257}], "is_impossible": false}, {"question": "What is another term for people who have been vaccinated but get COVID-19 before getting any additional or booster doses?", "id": "100000000000000000004211", "answers": [{"text": "vaccinated", "answer_start": 308}], "is_impossible": false}], "context": "\uf1aa\f10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\nNo. You should wait to be vaccinated until after you\u202fcomplete your isolation period. People who have symptoms will end\nisolation at a different time than people who do not have symptoms. This also applies to people who have been\nvaccinated but get COVID-19 before getting any additional or booster doses. Additionally, you may consider delaying your\nnext vaccine (primary dose or booster) by 3 months from when your symptoms started or, if you had no symptoms, when\nyou received a positive test."}]}, {"title": "646645fc9bca4128a626599f13637de3", "paragraphs": [{"qas": [{"question": "What is the reason people should wait to seek vaccination?", "id": "100000000000000000004215", "answers": [{"text": "avoid potentially exposing healthcare personnel and others during the vaccination visit", "answer_start": 117}], "is_impossible": false}, {"question": "Who can potentially expose healthcare personnel and others during the vaccination visit?", "id": "100000000000000000004216", "answers": [{"text": "People who have had a known COVID-19 exposure", "answer_start": 0}], "is_impossible": false}, {"question": "What type of vaccine can you get depending on your age?", "id": "100000000000000000004217", "answers": [{"text": "COVID-19", "answer_start": 511}], "is_impossible": false}, {"question": "How many doses of the COVID-19 vaccine do people need?", "id": "100000000000000000004218", "answers": [{"text": "booster doses", "answer_start": 345}], "is_impossible": false}], "context": "People who have had a known COVID-19 exposure should not seek vaccination until their\u202fquarantine period\u202fhas ended to\navoid potentially exposing healthcare personnel and others during the vaccination visit. This recommendation to wait\nalso applies to people with a known COVID-19 exposure who have received their first dose and need additional or\nbooster doses. Learn more about how to stay up to date with your COVID-19 vaccines. Yes, depending on your age, for your primary series you can choose which type of COVID-19 vaccine to get."}]}, {"title": "14f60da20baf05d226781c519fe51e96", "paragraphs": [{"qas": [{"question": "What type of vaccine is available by age?", "id": "100000000000000000004220", "answers": [{"text": "COVID-19", "answer_start": 21}], "is_impossible": false}, {"question": "How can you choose which type of COVID-19 vaccine booster to get?", "id": "100000000000000000004221", "answers": [{"text": "depending on your age", "answer_start": 39}], "is_impossible": false}, {"question": "What can you do if you are getting a booster?", "id": "100000000000000000004222", "answers": [{"text": "you may be able to choose which type of COVID-19 vaccine booster to get", "answer_start": 118}], "is_impossible": false}, {"question": "Who can reissue a CDC COVID-19 Vaccination card?", "id": "100000000000000000004225", "answers": [{"text": "your vaccination provider", "answer_start": 453}], "is_impossible": false}], "context": "If you are\ngetting a COVID-19 booster, depending on your age and which type of COVID-19 vaccine you have already had, you may\nbe able to choose which type of COVID-19 vaccine booster to get. Learn more about which vaccine is available by age and how to stay up to date with your COVID-19 vaccination. Can I choose which COVID-19 vaccine I get? \uf1aa\nAfter Your Vaccine\nIf you have lost your CDC COVID-19 Vaccination card or don\u2019t have a copy of it, contact your vaccination provider directly\nto request a new vaccination card. They may be able to reissue a CDC COVID-19 Vaccination card."}]}, {"title": "d40bc9d29f212d32a228c67b8cd300ce", "paragraphs": [{"qas": [{"question": "What can you do if you can't contact your vaccination provider directly?", "id": "100000000000000000004226", "answers": [{"text": "contact your state health department\u2019s immunization information system (IIS).", "answer_start": 135}], "is_impossible": false}, {"question": "What is a digital or paper copy of your full vaccination record?", "id": "100000000000000000004228", "answers": [{"text": "Your state\u2019s IIS cannot issue you a vaccination card, but they can provide a digital or paper copy of your full vaccination record, including your COVID-19 vaccinations", "answer_start": 213}], "is_impossible": false}], "context": "If you cannot contact your vaccination provider directly or your vaccination provider cannot reissue a CDC COVID-\n19 Vaccination card, contact your state health department\u2019s immunization information system (IIS). Your state\u2019s IIS\ncannot issue you a vaccination card, but they can provide a digital or paper copy of your full vaccination record,\nincluding your COVID-19 vaccinations. If you need another COVID-19 vaccine dose and are unable to get a copy of your vaccination card or vaccination\nrecord, talk to a vaccination provider to learn about your possible options."}]}, {"title": "51159230085127eb04e8052539ffc605", "paragraphs": [{"qas": [{"question": "What can you get from a QR code or digital copy of your CDC COVID-19 Vaccination card?", "id": "100000000000000000004231", "answers": [{"text": "a physical card", "answer_start": 164}], "is_impossible": false}, {"question": "CDC does not provide the white CDC COVID-19 Vaccination card to people and does not maintain what?", "id": "100000000000000000004232", "answers": [{"text": "vaccination records", "answer_start": 388}], "is_impossible": false}], "context": "Some vaccination providers and health departments may offer you access to a QR code or digital copy of your CDC\nCOVID-19 Vaccination card in addition to giving you a physical card. Contact your vaccination provider or local\nhealth department to learn if you can get a digital copy of your card. CDC does not provide the white CDC COVID-19 Vaccination card to people and does not maintain vaccination records. CDC distributes the white CDC COVID-19 Vaccination cards to vaccination providers and only a vaccination provider can\ngive you this card. How can I get a new CDC COVID-19 Vaccination card?"}]}, {"title": "7dde4846513ba46cdc8eb10a5f0ab624", "paragraphs": [{"qas": [{"question": "What do you need to wear if you are up to date on your COVID-19 vaccinations?", "id": "100000000000000000004234", "answers": [{"text": "a mask", "answer_start": 96}], "is_impossible": false}, {"question": "What is recommended for wearing a mask in outdoor settings?", "id": "100000000000000000004235", "answers": [{"text": "\u2022 Generally, if you are up to date on your COVID-19 vaccinations", "answer_start": 5}], "is_impossible": false}, {"question": "What do I do when I am vaccinated?", "id": "100000000000000000004238", "answers": [{"text": "avoid close contact with others", "answer_start": 439}], "is_impossible": false}], "context": "\uf1aa\n\u2022\n\u2022\n\u2022\nGenerally, if you are up to date on your COVID-19 vaccinations, you do not need to wear a mask in outdoor settings. Check your local COVID-19 Community Level for recommendations on when to wear a mask indoors and additional\nprecautions you can take to protect yourself from COVID-19. If you are immunocompromised or more likely to get very\nsick from COVID-19, learn more about how to protect yourself. Do I need to wear a mask and avoid close contact with others if I am vaccinated? \uf1aa\nSh ld I k if I h k i t ?"}]}, {"title": "f4c0431617e6a61268c803c018aba665", "paragraphs": [{"qas": [{"question": "What may not be as strong as in people who are not immunocompromised?", "id": "100000000000000000004239", "answers": [{"text": "your immune response", "answer_start": 160}], "is_impossible": false}, {"question": "What is your county\u2019s COVID-19 Community Level?", "id": "100000000000000000004240", "answers": [{"text": "Check your county\u2019s COVID-19 Community Level for recommendations on whether you should wear a mask", "answer_start": 270}], "is_impossible": false}, {"question": "What can you wear to protect yourself from COVID-19?", "id": "100000000000000000004241", "answers": [{"text": "a mask", "answer_start": 362}], "is_impossible": false}, {"question": "What is recommended to wear a mask in your county?", "id": "100000000000000000004242", "answers": [{"text": "COVID-19 Community Level", "answer_start": 290}], "is_impossible": false}, {"question": "How can you choose to wear the mask at any time?", "id": "100000000000000000004243", "answers": [{"text": "based on your own level of comfort and personal risk", "answer_start": 482}], "is_impossible": false}, {"question": "What is the name of the vaccine for people who are immunocompromised?", "id": "100000000000000000004245", "answers": [{"text": "COVID-19", "answer_start": 553}], "is_impossible": false}], "context": "10/30/22, 9:18 AM Frequently Asked Questions about COVID-19 Vaccination | CDC\nIf you have a condition or are taking medications that weaken your immune system, your immune response to COVID-19\nvaccination may not be as strong as in people who are not immunocompromised. Check your county\u2019s COVID-19\nCommunity Level for recommendations on whether you should wear a mask and additional actions you can take to\nprotect yourself from COVID-19. You may choose to wear a mask at any time based on your own level of comfort and\npersonal risk. Learn more about COVID-19 vaccinations for people who are moderately or severely immunocompromised."}]}, {"title": "6b0acd31a8405ff01feed8d224a3a7fc", "paragraphs": [{"qas": [{"question": "What should I wear if I have a weak immune system?", "id": "100000000000000000004246", "answers": [{"text": "a mask", "answer_start": 14}], "is_impossible": false}, {"question": "What is the name of the Vaccines for People Who Were Vaccinated Abroad?", "id": "100000000000000000004248", "answers": [{"text": "COVID-19", "answer_start": 292}], "is_impossible": false}, {"question": "Where did I get my proof of vaccination?", "id": "100000000000000000004249", "answers": [{"text": "another country. How do I transfer my proof of vaccination from that country to get a proof of vaccination card in the United States", "answer_start": 369}], "is_impossible": false}, {"question": "What does it depend on to get a proof of vaccine in the US?", "id": "100000000000000000004250", "answers": [{"text": "a number of factors", "answer_start": 519}], "is_impossible": false}], "context": "Should I wear a mask if I have a weak immune system? \uf1aa\nThe white CDC COVID-19 vaccination cards are only issued to people vaccinated in the United States. However, there are\nseveral ways you can update your records with vaccines you received while outside the United States. Learn more about\nCOVID-19 Vaccines for People Who Were Vaccinated Abroad. I was vaccinated in another country. How do I transfer my proof of vaccination from that country\nto get a proof of vaccination card in the United States? \uf1aa\nIt depends on a number of factors."}]}, {"title": "2a8b9f744f931c21871767b58cb8725e", "paragraphs": [{"qas": [{"question": "What is the name of the Vaccine Administration Management System?", "id": "100000000000000000004251", "answers": [{"text": "VAMS", "answer_start": 247}], "is_impossible": false}, {"question": "When was the last update for COVID-19 vaccines?", "id": "100000000000000000004252", "answers": [{"text": "Oct. 13, 2022", "answer_start": 407}], "is_impossible": false}], "context": "Learn more about COVID-19 Vaccines for People Who Were Vaccinated Abroad. Am I considered fully vaccinated if I was vaccinated in another country? \uf1aa\nAnswers to more questions about:\nIsolation\nVaccines.gov\nVaccine Administration Management System (VAMS)\nV-safe after Vaccination Health Checker\n\u2022\n\u2022\n\u2022\n\u2022\nRelated Pages\nFAQs about Vaccination in Children\n\u203a\nMyths and Facts about COVID-19 Vaccines\n\u203a\nLast Updated Oct. 13, 2022"}]}, {"title": "c4e33aac3e286af79e1c3ed226e85b4a", "paragraphs": [{"qas": [{"question": "What is an important tool to help protect you from severe illness, hospitalization, and death?", "id": "100000000000000000004254", "answers": [{"text": "COVID-19 vaccination", "answer_start": 168}], "is_impossible": false}], "context": "10/30/22, 9:30 AM Getting Your COVID-19 Vaccine | CDC\nEspa\u00f1ol | Other Languages\nGetting Your COVID-19 Vaccine\nEveryone 6 Months and Older Should Get a COVID-19 Vaccine\nCOVID-19 vaccination has many benefits and is an important tool to help protect you from severe illness, hospitalization, and\ndeath. Getting a COVID-19 vaccine after having COVID-19\nEven if you or your child have had COVID-19, you should still get yourself or your child vaccinated. Getting a COVID-19 vaccine after having COVID-19 provides added protection against the virus that causes COVID-19."}]}, {"title": "ebb6a12ee4d57677dbf2f97f51ef4e70", "paragraphs": [{"qas": [{"question": "Who is more likely to get COVID-19 again than those who get vaccinated after their recovery?", "id": "100000000000000000004258", "answers": [{"text": "People who already had COVID-19 and do not get vaccinated after their recovery", "answer_start": 0}], "is_impossible": false}], "context": "People who already had COVID-19 and do not get vaccinated after their recovery are more likely to get COVID-19 again\nthan those who get vaccinated after their recovery. If you were given monoclonal antibodies or convalescent plasma while sick with COVID-19 you do not need to wait to get\nvaccinated. \u2022\n\u2022\n\u2022\nWhen you can wait\n\uf1aa\nIf you recently had COVID-19, you may consider delaying your next vaccine dose (primary dose or booster) by 3\nmonths from when:\nyour symptoms started,\nyou first received a positive test if you had no symptoms."}]}, {"title": "8901f72331c0bced4c7ebb3b2cbad1c0", "paragraphs": [{"qas": [{"question": "What can happen after just having had COVID-19?", "id": "100000000000000000004263", "answers": [{"text": "Getting COVID-19 again", "answer_start": 0}], "is_impossible": false}, {"question": "What is not common in the weeks to months after you had it?", "id": "100000000000000000004264", "answers": [{"text": "Getting COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "Why get a vaccine sooner rather than later?", "id": "100000000000000000004265", "answers": [{"text": "your own personal risk of having severe health concerns", "answer_start": 188}], "is_impossible": false}, {"question": "When should you wait?", "id": "100000000000000000004267", "answers": [{"text": "9:30 AM", "answer_start": 388}], "is_impossible": false}, {"question": "What should you do if you have symptoms?", "id": "100000000000000000004268", "answers": [{"text": "Symptoms are gone", "answer_start": 537}], "is_impossible": false}, {"question": "Who recommends that you wait to get your vaccinated?", "id": "100000000000000000004269", "answers": [{"text": "until: Symptoms are gone (if you had symptoms) and Your isolation guidelines have been met", "answer_start": 530}], "is_impossible": false}], "context": "Getting COVID-19 again soon after just having had COVID-19 can happen but is not common in the weeks to months\nafter you had it. Reasons to get a vaccine sooner rather than later include:\nyour own personal risk of having severe health concerns,\nyour local COVID-19 community level, and\nthe most common COVID-19 variant currently causing illness\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nWhen you should wait\n\uf1aa\f10/30/22, 9:30 AM Getting Your COVID-19 Vaccine | CDC\nIf you have COVID-19 People who have COVID-19 and are in isolation,\nshould wait to get vaccinated until:\nSymptoms are gone (if you had symptoms) and\nYour isolation guidelines have been met."}]}, {"title": "491a7a4f0b9aab0d3f2aee53e7be6bc5", "paragraphs": [{"qas": [{"question": "How long has it been since the date of diagnosis of MIS-A?", "id": "100000000000000000004272", "answers": [{"text": "90 days", "answer_start": 223}], "is_impossible": false}, {"question": "Who should you talk to if you have questions about getting a COVID-19 vaccine?", "id": "100000000000000000004273", "answers": [{"text": "your doctor", "answer_start": 290}], "is_impossible": false}, {"question": "What is the name of the website that can help you find a vaccination near you?", "id": "100000000000000000004275", "answers": [{"text": "vaccines.gov", "answer_start": 447}], "is_impossible": false}, {"question": "What does OTC stand for?", "id": "100000000000000000004276", "answers": [{"text": "over-the-counter", "answer_start": 585}], "is_impossible": false}, {"question": "Ibuprofen, aspirin, and acetaminophen are examples of what?", "id": "100000000000000000004277", "answers": [{"text": "over-the-counter (OTC) medicines", "answer_start": 585}], "is_impossible": false}], "context": "\u2022\n\u2022\nIf you have multisystem inflammatory\nsyndrome\nChildren and adults who have (or have recently had)\nmultisystem inflammatory syndrome (MIS), should\nwait to get vaccinated until:\nRecovering from being sick and\nIt has been 90 days since the date of diagnosis of\nMIS-A or MIS-C.\n\u2022\n\u2022\nTalk to your doctor if you have questions about getting a COVID-19 vaccine. \uf19c Find COVID-19 Vaccines or Boosters\nTo find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-\n232-0233. Find a Vaccine or Booster\nBefore the Vaccination\nIt is not known how over-the-counter (OTC) medicines, such as ibuprofen, aspirin, or acetaminophen, might affect how well\nthe vaccine works."}]}, {"title": "cb3ffcb2db9932526a1627056375abe6", "paragraphs": [{"qas": [{"question": "What may you be able to take to reduce fever or pain after you get your vaccine?", "id": "100000000000000000004278", "answers": [{"text": "medications", "answer_start": 39}], "is_impossible": false}, {"question": "What should you not take if you don't regularly take over-the-counter medications?", "id": "100000000000000000004279", "answers": [{"text": "before you get a COVID-19 vaccination", "answer_start": 258}], "is_impossible": false}], "context": "You may be able to take these types of medications to reduce fever or pain after you get your vaccine to\nrelieve any pain or discomfort resulting from possible side effects. If you do not regularly take over-the-counter medications, you should not take them before you get a COVID-19\nvaccination. Taking one of the following medications regularly is not, on its own, a reason to avoid getting your COVID-19 vaccination:\nOver-the-counter medications (non-prescription)\nNon-steroidal anti-inflammatory drugs (NSAIDs) (naproxen, ibuprofen, aspirin, etc.) Acetaminophen (Tylenol, etc.)"}]}, {"title": "77f0cf42de33ef88370e954176c4d8f6", "paragraphs": [{"qas": [{"question": "Who can you talk to if you have questions about medications that you are taking?", "id": "100000000000000000004285", "answers": [{"text": "your healthcare or vaccination provider", "answer_start": 677}], "is_impossible": false}], "context": "Biologics or biologic response modifiers that treat autoimmune\u202fdiseases\nChemotherapy or other cancer treatment medications\nAntiviral medication\nAntibiotics\nStatins\nIf you regularly take over-the-counter medications, you should keep taking them before you get\nvaccinated. \uf1aa\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:30 AM Getting Your COVID-19 Vaccine | CDC\nBlood pressure medications/antihypertensives (amlodipine, lisinopril, etc.) Diuretics\nThyroid medications\nAntidepressants\nMetformin\nDiabetic medications\nInsulin\nSteroids (prednisone, etc.) This is not a complete list. These are some examples of common medications. If you have questions about medications that you are taking, talk to your healthcare or vaccination provider."}]}, {"title": "3a4873159e9da79fe784ed631e3f34ba", "paragraphs": [{"qas": [{"question": "What is the best timing for you to get your vaccine?", "id": "100000000000000000004287", "answers": [{"text": "COVID-19 vaccine effectiveness", "answer_start": 143}], "is_impossible": false}, {"question": "How can you get a COVID-19 vaccine with routine medical procedures and screenings?", "id": "100000000000000000004288", "answers": [{"text": "You can combine most procedures, screenings, and vaccinations at the same appointment", "answer_start": 321}], "is_impossible": false}, {"question": "What can you combine with your routine medical procedures and screenings?", "id": "100000000000000000004289", "answers": [{"text": "vaccinations", "answer_start": 370}], "is_impossible": false}, {"question": "What is the name of a vaccine that can be used at the same time?", "id": "100000000000000000004292", "answers": [{"text": "flu", "answer_start": 590}], "is_impossible": false}], "context": "If you are taking medications that suppress the immune system, you should talk to your healthcare provider about what\nis currently known about COVID-19 vaccine effectiveness. Ask about the best timing for you to get your vaccine. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nGet a COVID-19 vaccine with your routine medical procedures and screenings\nYou can combine most procedures, screenings, and vaccinations at the same appointment when you get your COVID-19\nvaccination. Talk to your healthcare provider if you have questions. Children, teens, and adults may get a COVID-19 vaccine and other vaccines, including a flu vaccine, at the same time."}]}, {"title": "a29cc507c9120d57280609f848bff08f", "paragraphs": [{"qas": [{"question": "What will the experience of getting a COVID-19 vaccine be similar to?", "id": "100000000000000000004294", "answers": [{"text": "that of getting routine vaccines", "answer_start": 233}], "is_impossible": false}, {"question": "Where can you request accommodations?", "id": "100000000000000000004295", "answers": [{"text": "COVID-19 vaccination sites", "answer_start": 296}], "is_impossible": false}, {"question": "What can people with disabilities use to get help with COVID-19 vaccinations?", "id": "100000000000000000004296", "answers": [{"text": "Vaccine Disability Information and Access Line", "answer_start": 516}], "is_impossible": false}], "context": "Preparing children and teens for vaccination\nIf you are getting your child or teen vaccinated learn how you can support them and talk to them about what to expect. The\nexperience of getting a COVID-19 vaccine will be very similar to that of getting routine vaccines. Requesting accommodations at COVID-19 vaccination sites\nWhen making an appointment or arriving for vaccination, you can let staff and/or volunteers know you or your child\nmight need some accommodations. People with disabilities can use the COVID-19 Vaccine Disability Information and Access Line (DIAL) to get help with\nCOVID-19 vaccinations."}]}, {"title": "73264bfd7bc941e3b8b1519b4aacd26c", "paragraphs": [{"qas": [{"question": "What does PEG stand for?", "id": "100000000000000000004297", "answers": [{"text": "polyethylene glycol", "answer_start": 212}], "is_impossible": false}, {"question": "What is the name of the vaccine that you should not get?", "id": "100000000000000000004298", "answers": [{"text": "Pfizer-BioNTech or Moderna COVID-19", "answer_start": 261}], "is_impossible": false}, {"question": "Who should you talk to if you have an allergic reaction to a previous dose?", "id": "100000000000000000004299", "answers": [{"text": "your doctor", "answer_start": 56}], "is_impossible": false}, {"question": "What vaccine should you not get if you are allergic to polysorbate?", "id": "100000000000000000004300", "answers": [{"text": "Novavax or J&J/Janssen COVID-19", "answer_start": 357}], "is_impossible": false}], "context": "If you have allergies related to vaccines\n\u2022\n\u2022 \uf209\nTalk to your doctor if you:\nhave had a severe allergic reaction to a previous dose to learn if you should get a different type of COVID-19\nvaccine,\nare allergic to polyethylene glycol (PEG) and you should not get Pfizer-BioNTech or Moderna COVID-19 vaccine,\nare allergic to polysorbate and you should not get Novavax or J&J/Janssen COVID-19 vaccine\nif you are allergic to other types of vaccines or injectable medications for other diseases."}]}, {"title": "ea9e91a966fd5535c8acbe3fd5e6f6f4", "paragraphs": [{"qas": [{"question": "What is an immediate allergic reaction to a COVID- 19 vaccine?", "id": "100000000000000000004302", "answers": [{"text": "a reaction that started within 4 hours of getting vaccinated", "answer_start": 51}], "is_impossible": false}, {"question": "How long after getting vaccinated does an allergic reaction start?", "id": "100000000000000000004303", "answers": [{"text": "4 hours", "answer_start": 82}], "is_impossible": false}, {"question": "What is the term for an immediate reaction?", "id": "100000000000000000004304", "answers": [{"text": "allergic reaction", "answer_start": 32}], "is_impossible": false}, {"question": "Who can refer you to another dose of the same vaccine under certain conditions?", "id": "100000000000000000004305", "answers": [{"text": "Your doctor", "answer_start": 282}], "is_impossible": false}, {"question": "What may your doctor refer you to for more care or advice?", "id": "100000000000000000004306", "answers": [{"text": "an allergy and immunology specialist", "answer_start": 311}], "is_impossible": false}, {"question": "What should you get vaccinated for if you have allergies that are not related to vaccines?", "id": "100000000000000000004307", "answers": [{"text": "injectable medications", "answer_start": 559}], "is_impossible": false}, {"question": "What are food, pet, venom, environmental, or latex allergies?", "id": "100000000000000000004309", "answers": [{"text": "injectable medications", "answer_start": 559}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\nIf you had an immediate allergic reaction (a reaction that started within 4 hours of getting vaccinated) to a COVID-\n19 vaccine, but the reaction was not considered severe by a medical professional, you can receive another dose of\nthe same vaccine under certain conditions. Your doctor may refer you to an allergy and immunology specialist for\nmore care or advice. \u2022\f10/30/22, 9:30 AM Getting Your COVID-19 Vaccine | CDC\nIf you have allergies not related to vaccines\nYou should get vaccinated if you have allergies that are not related to vaccines or injectable medications such as food, pet,\nvenom, environmental, or latex allergies."}]}, {"title": "cae289fbaa2ca9cbf83c5d1411955591", "paragraphs": [{"qas": [{"question": "Who can also get vaccinated?", "id": "100000000000000000004310", "answers": [{"text": "People with a history of allergies to medications taken by mouth or a family history of severe allergic reactions", "answer_start": 0}], "is_impossible": false}, {"question": "What should you discuss with your doctor to determine which vaccine is best for you?", "id": "100000000000000000004312", "answers": [{"text": "If you have had an immediate allergic reaction", "answer_start": 139}], "is_impossible": false}, {"question": "Where should you receive a paper or electronic version of a fact sheet?", "id": "100000000000000000004313", "answers": [{"text": "At the Vaccination Site", "answer_start": 364}], "is_impossible": false}], "context": "People with a history of allergies to medications taken by mouth or a family history\nof severe allergic reactions can also get vaccinated. If you have had an immediate allergic reaction\u2014even if it was not severe\u2014to a vaccine or injectable therapy for\nanother disease, you should discuss this with your doctor to determine which COVID-19 vaccine is best for you. \u2022\nAt the Vaccination Site\nYou should receive a paper or electronic version of a fact sheet that tells you more about the COVID-19 vaccine you or\nyour child received."}]}, {"title": "329e71d4eb9e15145d58670b20dd8592", "paragraphs": [{"qas": [{"question": "What does each approved and authorized COVID-19 vaccine have?", "id": "100000000000000000004314", "answers": [{"text": "its own fact sheet", "answer_start": 50}], "is_impossible": false}, {"question": "What is the name of the fact sheet that contains information to help you understand the risks and benefits of the vaccine?", "id": "100000000000000000004315", "answers": [{"text": "COVID-19 vaccine", "answer_start": 29}], "is_impossible": false}, {"question": "There is no charge for what?", "id": "100000000000000000004316", "answers": [{"text": "your COVID-19 vaccine", "answer_start": 181}], "is_impossible": false}, {"question": "What is the cost of the COVID-19 vaccine?", "id": "100000000000000000004317", "answers": [{"text": "free", "answer_start": 229}], "is_impossible": false}, {"question": "What is a scam?", "id": "100000000000000000004318", "answers": [{"text": "If anyone asks you to pay for a COVID-19 vaccine", "answer_start": 414}], "is_impossible": false}, {"question": "Who pays for a vaccine in the United States?", "id": "100000000000000000004320", "answers": [{"text": "taxpayer dollars", "answer_start": 271}], "is_impossible": false}, {"question": "a COVID-19 Vaccine Stay on site to be monitored for how long?", "id": "100000000000000000004321", "answers": [{"text": "at least 15 minutes", "answer_start": 544}], "is_impossible": false}], "context": "Each approved and authorized COVID-19 vaccine has its own fact sheet that contains information to\nhelp you understand the risks and benefits of that vaccine. There is no charge for your COVID-19 vaccine. Your COVID-19 vaccine is free. COVID-19 vaccines are paid for with\ntaxpayer dollars and are given free of charge to all people living in the United States, regardless of health insurance or\nimmigration status. If anyone asks you to pay for a COVID-19 vaccine, it\u2019s a scam . After Getting a COVID-19 Vaccine\nStay on site to be monitored for at least 15 minutes."}]}, {"title": "13549cfb73762eee481fcf3c595e049d", "paragraphs": [{"qas": [{"question": "What should you do if you get your first dose of COVID-19?", "id": "100000000000000000004322", "answers": [{"text": "Make sure your vaccination provider updates your vaccination card", "answer_start": 0}], "is_impossible": false}, {"question": "Adverse effects and severe allergic reactions are rare, what are they?", "id": "100000000000000000004324", "answers": [{"text": "serious safety problems", "answer_start": 265}], "is_impossible": false}, {"question": "What is the name of the smartphone-based tool that provides quick and confidential health check-ins via text messages and web surveys?", "id": "100000000000000000004325", "answers": [{"text": "V-safe", "answer_start": 386}], "is_impossible": false}, {"question": "What are rare?", "id": "100000000000000000004326", "answers": [{"text": "Adverse effects (serious safety problems) and severe allergic reactions", "answer_start": 248}], "is_impossible": false}], "context": "Make sure your vaccination provider updates your vaccination card\n(or gives you one if this is your first dose). Stay up to date with the recommended COVID-19 vaccines and\nboosters. You may experience side effects after getting a COVID-19 vaccine. Adverse effects (serious safety problems) and severe allergic\nreactions are rare. To report any side effects, you can sign up for v-safe. V-safe is a\nsmartphone-based tool that provides quick and confidential health check-ins via text messages and web surveys so you\ncan quickly and easily share with CDC how you or your dependent feel after getting a COVID-19 vaccine."}]}, {"title": "a5d4fed986b6d8bb6c5aad0fb784c310", "paragraphs": [{"qas": [{"question": "Who can fill in information about your shot?", "id": "100000000000000000004330", "answers": [{"text": "your provider", "answer_start": 240}], "is_impossible": false}, {"question": "What can you do if you didn't receive a CDC COVID-19 vaccination card at your first appointment?", "id": "100000000000000000004332", "answers": [{"text": "contact the vaccination provider site where you got your first shot to find out how you can get a vaccination card", "answer_start": 456}], "is_impossible": false}], "context": "\u2022\n\u2022\n\uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nWatch Video: Use v-safe to tell CDC how you\u2019re feeling after COVID-19 vaccination [00:00:34]\nYour CDC COVID-19 Vaccination Card\nBring your card to your appointment whenever you get a primary\nseries dose or booster so that your provider can fill in information\nabout your shot. If your vaccine card is full, your vaccine provider can give you another\ncard. If you did not receive a CDC COVID-19 vaccination card at your first\nappointment, contact the vaccination provider site where you got\nyour first shot to find out how you can get a vaccination card."}]}, {"title": "f332803fbf9407cd8ddd9c6d1f61b28a", "paragraphs": [{"qas": [{"question": "How do you take a picture of your card after each vaccination appointment as a backup copy?", "id": "100000000000000000004335", "answers": [{"text": "\u2022", "answer_start": 269}], "is_impossible": false}, {"question": "What is a QR code or digital copy of your COVID-19 vaccination card?", "id": "100000000000000000004336", "answers": [{"text": "\u2022 \u2022\f10/30/22, 9:30 AM Getting Your COVID-19 Vaccine | CDC Some vaccination providers and health departments may offer you access to a QR code or digital copy of your COVID-19 vaccination card in addition to giving you a physical CDC COVID-19 vaccination card", "answer_start": 269}], "is_impossible": false}, {"question": "What do some providers and health departments offer you?", "id": "100000000000000000004337", "answers": [{"text": "access to a QR code or digital copy of your COVID-19 vaccination card", "answer_start": 392}], "is_impossible": false}], "context": "You\ncan also contact your state health department to get a copy of your\nvaccination record. Keep your CDC COVID-19 vaccination card for proof of vaccination. Consider taking a picture of your card after each of\nyour COVID-19 vaccination appointments as a backup copy. \u2022\n\u2022\n\u2022\f10/30/22, 9:30 AM Getting Your COVID-19 Vaccine | CDC\nSome vaccination providers and health departments may offer you access to a QR code or digital copy of your COVID-19\nvaccination card in addition to giving you a physical CDC COVID-19 vaccination card."}]}, {"title": "3541149f8b5ca7c3cc8fda331689b8f1", "paragraphs": [{"qas": [{"question": "How can you update your U.S. vaccination record?", "id": "100000000000000000004339", "answers": [{"text": "If you were vaccinated abroad", "answer_start": 122}], "is_impossible": false}, {"question": "Where can you find fake CDC COVID-19 vaccination cards?", "id": "100000000000000000004341", "answers": [{"text": "Fraud Alert: COVID-19 Scams or call 1-800-HHS-TIPS", "answer_start": 302}], "is_impossible": false}, {"question": "Who can you contact to request a vaccination card or to get a copy of your vaccination record?", "id": "100000000000000000004342", "answers": [{"text": "your vaccination provider", "answer_start": 400}], "is_impossible": false}, {"question": "If you cannot contact your vaccination provider site directly, what should you do?", "id": "100000000000000000004343", "answers": [{"text": "contact your state health department\u2019s immunization information system (IIS).", "answer_start": 573}], "is_impossible": false}, {"question": "What is the acronym for the immunization information system?", "id": "100000000000000000004344", "answers": [{"text": "IIS", "answer_start": 645}], "is_impossible": false}], "context": "Contact your vaccination provider or\nlocal health department to learn if a digital copy of your card is available to you. If you were vaccinated abroad there are ways you can update your U.S. vaccination record. To report suspicious activity involving fake CDC COVID-19 vaccination cards, please visit Fraud Alert: COVID-19 Scams\nor call 1-800-HHS-TIPS. \u2022\n\u2022\n\u2022 \uf209\nWhat if you lose your card? \uf1aa\nContact your vaccination provider directly to request a vaccination card or to get a copy of your vaccination\nrecord. If you cannot contact your vaccination provider site directly, contact your state health department\u2019s\nimmunization information system (IIS)."}]}, {"title": "7f5e1b24692cfe47491e824dabd7b212", "paragraphs": [{"qas": [{"question": "What must Vaccination providers report to their IIS and related systems?", "id": "100000000000000000004345", "answers": [{"text": "COVID-19 vaccinations", "answer_start": 34}], "is_impossible": false}, {"question": "What can you do if you are unable to get a copy of your vaccination card or vaccination record?", "id": "100000000000000000004347", "answers": [{"text": "talk to a vaccination provider", "answer_start": 336}], "is_impossible": false}], "context": "Vaccination providers must report COVID-19 vaccinations to their IIS\nand related systems. Your state\u2019s IIS cannot issue you a vaccination card, but they can provide a digital or\npaper copy of your vaccination record. If you need another COVID-19 vaccine dose and are unable to get a copy of your vaccination card or\nvaccination record, talk to a vaccination provider. If you have additional questions about vaccination records, please contact your state health department. Your local\nor state health department can also provide more information about the laws or regulations in your area."}]}, {"title": "df5784616b9a240c5b0cdcfd6d9c27d", "paragraphs": [{"qas": [{"question": "Who can give you this card?", "id": "100000000000000000004350", "answers": [{"text": "a vaccination provider", "answer_start": 119}], "is_impossible": false}, {"question": "What is a vaccine record sometimes called?", "id": "100000000000000000004351", "answers": [{"text": "immunization record", "answer_start": 290}], "is_impossible": false}, {"question": "What is the name of the record that provides a history of all the vaccines you received?", "id": "100000000000000000004353", "answers": [{"text": "immunization record", "answer_start": 290}], "is_impossible": false}, {"question": "A COVID-19 vaccination card is only for what vaccination?", "id": "100000000000000000004354", "answers": [{"text": "COVID-19", "answer_start": 491}], "is_impossible": false}], "context": "CDC does not provide the white CDC COVID-19 vaccination card to people and does not maintain vaccination\nrecords. Only a vaccination provider can give you this card. \u2022\n\u2022\n\u2022\nWhat is the difference between a vaccine record and a COVID-19 vaccination card? \uf1aa\nA vaccine record (sometimes called immunization record) provides a history of all the vaccines you received. This record may be required for certain jobs, travel abroad, or a school registration. A COVID-19 vaccination card is only for COVID-19 vaccination and is given to you when you get your COVID-19\nvaccine."}]}, {"title": "476a1ddff74850e3a8f567be18492876", "paragraphs": [{"qas": [{"question": "Who can access vaccination certificates in VAMS?", "id": "100000000000000000004355", "answers": [{"text": "Healthcare professionals", "answer_start": 29}], "is_impossible": false}, {"question": "What do you need to get after your 1st dose of the vaccine?", "id": "100000000000000000004357", "answers": [{"text": "a different vaccine product", "answer_start": 316}], "is_impossible": false}, {"question": "When was the last update for the COVID-19 Vaccine?", "id": "100000000000000000004358", "answers": [{"text": "Sept. 22, 2022", "answer_start": 400}], "is_impossible": false}], "context": "\u2022\n\u2022\n\uf2ff For Healthcare Workers\nHealthcare professionals registered in Vaccine Administration Management System (VAMS) can access\nvaccination certificates in VAMS. \uf263 Stay Up to Date with COVID-19 Vaccines and Boosters\nWhen do you need to schedule your next shot? Do you or your child need to get a booster? Can you get a different vaccine product after your 1st dose? Stay Up to Date\n\u2022\n\u2022\n\u2022\nLast Updated Sept. 22, 2022\f10/30/22, 9:30 AM Getting Your COVID-19 Vaccine | CDC"}]}, {"title": "753bba8beefa815b4236e1a57a2c2c05", "paragraphs": [{"qas": [{"question": "What does CDC use to understand how well COVID-19 vaccines are working in real-world conditions over time?", "id": "100000000000000000004360", "answers": [{"text": "multi-layered approach", "answer_start": 343}], "is_impossible": false}, {"question": "What does CDC use in real-world conditions over time?", "id": "100000000000000000004361", "answers": [{"text": "multi-layered approach", "answer_start": 343}], "is_impossible": false}, {"question": "What can provide signals of potential changes in vaccine effectiveness?", "id": "100000000000000000004362", "answers": [{"text": "Analyses of surveillance data", "answer_start": 458}], "is_impossible": false}, {"question": "How can these signals be further studied?", "id": "100000000000000000004363", "answers": [{"text": "through more robust, controlled vaccine effectiveness studies", "answer_start": 599}], "is_impossible": false}], "context": "10/30/22, 9:33 AM How CDC Monitors Vaccine Effectiveness | CDC\nEspa\u00f1ol | Other Languages\nHow CDC Monitors Vaccine Effectiveness\nSurveillance data allow us to monitor rates of COVID-19 cases, hospitalizations, and deaths by vaccination status. To understand how well COVID-19 vaccines are working in real-world conditions over time, CDC uses a multi-layered\napproach, which includes ongoing analyses of surveillance data and studies of vaccine effectiveness. Analyses of surveillance data can provide signals of\npotential changes in vaccine effectiveness. \uf41a\nThese signals can then be further studied through more\nrobust, controlled vaccine effectiveness studies\nconducted by CDC and partners."}]}, {"title": "5577480c46a5acfee6fdf12376e57ba1", "paragraphs": [{"qas": [{"question": "What helps us understand how well COVID-19 vaccines are working in different groups of people?", "id": "100000000000000000004364", "answers": [{"text": "vaccine effectiveness studies", "answer_start": 6}], "is_impossible": false}, {"question": "What is a measure of how well vaccination protects people against infection, symptomatic illness, hospitalization and death?", "id": "100000000000000000004365", "answers": [{"text": "Vaccine effectiveness", "answer_start": 199}], "is_impossible": false}, {"question": "How does CDC monitor COVID-19 cases, hospitalizations, and deaths by vaccination status?", "id": "100000000000000000004366", "answers": [{"text": "vaccine effectiveness studies help us better understand how well COVID-19 vaccines are working in different groups of people, against different health outcomes, and against different variants. Vaccine effectiveness is a measure of how well vaccination protects people against infection, symptomatic illness, hospitalization, and death. Monitoring Data Based on Vaccination Status Learn about how CDC monitors COVID-19 cases, hospitalizations, and deaths by vaccination status How to Study Vaccine Effectiveness", "answer_start": 6}], "is_impossible": false}, {"question": "When was CDC's last update?", "id": "100000000000000000004367", "answers": [{"text": "June 23, 2022", "answer_start": 589}], "is_impossible": false}, {"question": "How does the CDC study Vaccine Effectiveness?", "id": "100000000000000000004368", "answers": [{"text": "COVID-19 vaccine effectiveness", "answer_start": 545}], "is_impossible": false}], "context": "\uf465\nThe vaccine effectiveness studies help us better understand how well COVID-19 vaccines are working in different groups of\npeople, against different health outcomes, and against different variants. Vaccine effectiveness is a measure of how well\nvaccination protects people against infection, symptomatic illness, hospitalization, and death. Monitoring Data Based on Vaccination Status\nLearn about how CDC monitors COVID-19 cases,\nhospitalizations, and deaths by vaccination status\nHow to Study Vaccine Effectiveness\nLearn about how CDC studies COVID-19 vaccine\neffectiveness\nLast Updated June 23, 2022"}]}, {"title": "3ef967a2d03857af92ff7fe465ea4fee", "paragraphs": [{"qas": [{"question": "What can be breathed in by other people or land on their eyes, noses, or mouth?", "id": "100000000000000000004370", "answers": [{"text": "droplets and very small particles that contain the virus. These droplets and particles", "answer_start": 149}], "is_impossible": false}, {"question": "What may COVID-19 land on?", "id": "100000000000000000004371", "answers": [{"text": "their eyes, noses, or mouth", "answer_start": 282}], "is_impossible": false}, {"question": "What can anyone infected with the virus spread?", "id": "100000000000000000004372", "answers": [{"text": "even if they do NOT have symptoms", "answer_start": 421}], "is_impossible": false}, {"question": "Who can spread the virus?", "id": "100000000000000000004373", "answers": [{"text": "Anyone infected with COVID-19", "answer_start": 376}], "is_impossible": false}], "context": "10/30/22, 9:37 AM How Coronavirus Spreads | CDC\nEspa\u00f1ol | Other Languages\nHow COVID-19 Spreads\nCOVID-19 spreads when an infected person breathes out droplets and very small particles that contain the virus. These\ndroplets and particles can be breathed in by other people or land on their eyes, noses, or mouth. In some circumstances, they\nmay contaminate surfaces they touch. Anyone infected with COVID-19 can spread it, even if they do NOT have symptoms. \uf549 About Variants\nMany viruses are constantly changing, including the virus that causes COVID-19."}]}, {"title": "482b8793d0d444f7defc28b69816fb86", "paragraphs": [{"qas": [{"question": "What can COVID-19 and Animals spread from people to animals in some situations?", "id": "100000000000000000004374", "answers": [{"text": "Pet cats and dogs can sometimes become infected by people with COVID-19", "answer_start": 295}], "is_impossible": false}, {"question": "What can pets become infected by people with COVID-19?", "id": "100000000000000000004375", "answers": [{"text": "Pet cats and dogs", "answer_start": 295}], "is_impossible": false}], "context": "These changes occur over\ntime and can lead to the emergence of variants that may have new characteristics, including different ways\nof spreading. Learn more about what you can do to protect yourself and others. COVID-19 and Animals\nCOVID-19 can spread from people to animals in some situations. Pet cats and dogs can sometimes become infected by\npeople with COVID-19. Learn what you should do if you have pets. COVID-19 County Check\nFind community levels and prevention steps by county. Data updated weekly."}]}, {"title": "f9d4c983a205a40a24be9ecab2cc78d2", "paragraphs": [{"qas": [{"question": "What is not evidence to suggest that handling food or consuming food can spread COVID-19?", "id": "100000000000000000004377", "answers": [{"text": "Follow food safety guidelines", "answer_start": 166}], "is_impossible": false}, {"question": "Do not wash produce with soap, bleach, sanitizer, alcohol, or any other chemical?", "id": "100000000000000000004378", "answers": [{"text": "There is no evidence to suggest that handling food or consuming food can spread COVID-19. Follow food safety guidelines", "answer_start": 76}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19 that has not been detected in drinking water?", "id": "100000000000000000004379", "answers": [{"text": "There is also no current evidence that people can get COVID-19 by drinking water. The virus", "answer_start": 349}], "is_impossible": false}], "context": "Select a Location (all fields required)\nState County Go\nFood and Water\nFood\nThere is no evidence to suggest that handling food or consuming food can spread COVID-19. Follow food safety guidelines\nwhen handling and cleaning fresh produce. Do not wash produce with soap, bleach, sanitizer, alcohol, disinfectant, or any\nother chemical. Drinking Water\nThere is also no current evidence that people can get COVID-19 by drinking water. The virus that causes COVID-19 has not\nbeen detected in drinking water."}]}, {"title": "26dbfcb20606be19a757f3e01cf8a1d4", "paragraphs": [{"qas": [{"question": "What should conventional water treatment methods remove or kill the virus that causes COVID-19?", "id": "100000000000000000004380", "answers": [{"text": "filtration and disinfection", "answer_start": 46}], "is_impossible": false}, {"question": "There are no scientific reports of what virus spreading?", "id": "100000000000000000004381", "answers": [{"text": "Coronavirus Spreads | CDC Natural Bodies of Water (Lakes, Oceans, Rivers) There are no scientific reports of the virus that causes COVID-19", "answer_start": 208}], "is_impossible": false}], "context": "Conventional water treatment methods that use filtration and disinfection, such as those in\nmost municipal drinking water systems, should remove or kill the virus that causes COVID-19.\u200b\f10/30/22, 9:37 AM How Coronavirus Spreads | CDC\nNatural Bodies of Water (Lakes, Oceans, Rivers)\nThere are no scientific reports of the virus that causes COVID-19 spreading to people through the water in lakes, oceans,\nrivers, or other natural bodies of water. Wastewater\nGenetic material from the virus that causes COVID-19 has been found in untreated wastewater (also referred to as \u201csewage\u201d)."}]}, {"title": "383396efe7a737edfe2db6358a3625b2", "paragraphs": [{"qas": [{"question": "What does wastewater treatment plants use to remove and degrade many viruses and bacteria?", "id": "100000000000000000004384", "answers": [{"text": "chemical and other disinfection processes", "answer_start": 169}], "is_impossible": false}, {"question": "What is the virus that causes COVID-19 inactivated by?", "id": "100000000000000000004385", "answers": [{"text": "disinfection methods used in wastewater treatment", "answer_start": 313}], "is_impossible": false}, {"question": "What is inactivated by the disinfection methods used in wastewater treatment?", "id": "100000000000000000004386", "answers": [{"text": "The virus that causes COVID-19", "answer_start": 260}], "is_impossible": false}, {"question": "How does COVID-19 spread?", "id": "100000000000000000004387", "answers": [{"text": "direct exposure to treated or untreated wastewater", "answer_start": 85}], "is_impossible": false}], "context": "There is no information to date that anyone has become sick with COVID-19 because of direct exposure to treated or\nuntreated wastewater. Wastewater treatment plants use chemical and other disinfection processes to remove and degrade\nmany viruses and bacteria. The virus that causes COVID-19 is inactivated by the disinfection methods used in\nwastewater treatment. More Information\nASL Video Series: How does COVID-19 Spread? Last Updated Aug. 11, 2022"}]}, {"title": "bda5da7e4a33a783e31fc636e168bbca", "paragraphs": [{"qas": [{"question": "What are some other ways you can look for vaccine providers in the United States?", "id": "100000000000000000004390", "answers": [{"text": "Ask your doctor, pharmacist, or community health center, or visit their website", "answer_start": 268}], "is_impossible": false}, {"question": "Where can you find a doctor, pharmacist, or community health center?", "id": "100000000000000000004391", "answers": [{"text": "visit their website", "answer_start": 328}], "is_impossible": false}], "context": "10/30/22, 9:27 AM How Do I Find a COVID-19 Vaccine? | CDC\nEspa\u00f1ol | Other Languages\nHow Do I Find a COVID-19 Vaccine or Booster? Find COVID-19 Vaccines or Boosters Near You\nThere are several other ways you can look for vaccine providers near you in the United States. Ask your doctor, pharmacist, or community health center, or visit their website. Contact your state health department. Check your local pharmacy\u2019s website to see if vaccination appointments are available. Some pharmacies may offer\nvaccines to those who walk-in without making an appointment ahead of time."}]}, {"title": "1f9f1aa94c25162c35a38ad43c272a7f", "paragraphs": [{"qas": [{"question": "Who can help you get a COVID-19 vaccine?", "id": "100000000000000000004394", "answers": [{"text": "your healthcare provider or your state or local health department", "answer_start": 29}], "is_impossible": false}, {"question": "Who can advocate for homebound people or provide home health services?", "id": "100000000000000000004396", "answers": [{"text": "Contact groups", "answer_start": 227}], "is_impossible": false}, {"question": "Who can be reached at 1-800-677-1116?", "id": "100000000000000000004397", "answers": [{"text": "The Aging Network", "answer_start": 333}], "is_impossible": false}, {"question": "What does DIAL stand for?", "id": "100000000000000000004398", "answers": [{"text": "Disability Information and Access Line", "answer_start": 443}], "is_impossible": false}], "context": "If You Are Homebound\nContact your healthcare provider or your state or local health department for information about getting a COVID-19\nvaccine. In many states, you may also dial 211 to connect to essential community services. Contact groups that are advocates for people who are homebound or that provide home health services. Call The Aging Network at 1-800-677-1116. Search for services by ZIP code with the Eldercare Locator . Contact the Disability Information and Access Line (DIAL) at 1-888-677-1199. Call the hotline for Medicare recipients at 1-800-633-4227 (TTY 1-877-486-2048)."}]}, {"title": "6e4bcc62ff5845afd3cac29737b53157", "paragraphs": [{"qas": [{"question": "How do you schedule a vaccine appointment?", "id": "100000000000000000004402", "answers": [{"text": "visit a vaccine provider\u2019s online scheduling services", "answer_start": 229}], "is_impossible": false}, {"question": "Who can verify, reschedule, or cancel a COVID-19 vaccination appointment?", "id": "100000000000000000004404", "answers": [{"text": "the location that set up your appointment", "answer_start": 461}], "is_impossible": false}, {"question": "Where can you get your vaccines at different locations?", "id": "100000000000000000004405", "answers": [{"text": "Search vaccines.gov", "answer_start": 45}], "is_impossible": false}, {"question": "Most vaccination providers schedule appointments online.", "id": "100000000000000000004406", "answers": [{"text": "\u2022 \u2022", "answer_start": 121}], "is_impossible": false}, {"question": "What do most vaccination providers schedule online?", "id": "100000000000000000004407", "answers": [{"text": "appointments", "answer_start": 668}], "is_impossible": false}, {"question": "What is the name of the vaccination provider that schedules an appointment for a COVID-19 vaccine?", "id": "100000000000000000004408", "answers": [{"text": "online scheduling services. If you have a question about scheduling your appointment contact the vaccination provider directly. To verify, reschedule, or cancel a COVID-19 vaccination appointment, contact the location that set up your appointment. You can get your vaccines at different locations. CDC cannot schedule, verify, reschedule, or cancel a vaccination appointment. Most vaccination providers schedule appointments online", "answer_start": 256}], "is_impossible": false}], "context": "To find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n- \uf209\n- \uf209\n- \uf209\n-\nScheduling Vaccination Appointments\nTo schedule your COVID-19 vaccine appointment, visit a vaccine provider\u2019s online\nscheduling services. If you have a question about scheduling your appointment contact\nthe vaccination provider directly. To verify, reschedule, or cancel a COVID-19 vaccination appointment, contact the\nlocation that set up your appointment. You can get your vaccines at different locations. CDC cannot schedule, verify, reschedule, or cancel a vaccination appointment. Most vaccination providers schedule appointments online. \u2022\n\u2022\f10/30/22, 9:27 AM How Do I Find a COVID-19 Vaccine?"}]}, {"title": "62bfb1c9ef621bd5ddcc1a68db150e55", "paragraphs": [{"qas": [{"question": "What do you need to wait to get vaccinated after getting COVID-19?", "id": "100000000000000000004409", "answers": [{"text": "getting treatment", "answer_start": 105}], "is_impossible": false}, {"question": "What is the name of the vaccination that was last updated on Sept. 15, 2022?", "id": "100000000000000000004411", "answers": [{"text": "COVID-19", "answer_start": 93}], "is_impossible": false}, {"question": "What is another name for COVID-19?", "id": "100000000000000000004412", "answers": [{"text": "\u2022 \u2022 Resources Related Pages Safety of COVID-19 Vaccines \u203a Stay Up to Date with Your Vaccines", "answer_start": 260}], "is_impossible": false}], "context": "| CDC\n\uf263 Learn About Getting Your Vaccine\nDo you need to wait to get vaccinated after getting COVID-19 or getting treatment for COVID-19? How can you prepare for vaccination? What can you expect during and after your vaccination? Getting Your COVID-19 Vaccine\n\u2022\n\u2022\n\u2022\nResources\nRelated Pages\nSafety of COVID-19 Vaccines\n\u203a\nStay Up to Date with Your Vaccines\n\u203a\nLast Updated Sept. 15, 2022"}]}, {"title": "17140cb86dfeda80f98d96ac8cf37717", "paragraphs": [{"qas": [{"question": "What do CDC's Community Levels provide information about?", "id": "100000000000000000004414", "answers": [{"text": "the amount of severe illness in the community", "answer_start": 331}], "is_impossible": false}, {"question": "What helps you decide when to take action to protect yourself and others?", "id": "100000000000000000004416", "answers": [{"text": "COVID-19 Community Levels", "answer_start": 279}], "is_impossible": false}], "context": "10/30/22, 9:39 AM How to Protect Yourself and Others | CDC\nEspa\u00f1ol | Other Languages\nHow to Protect Yourself and Others\nCOVID-19 Prevention Actions\nThere are many ways your actions can help protect you, your household, and your community from severe illness from\nCOVID-19. CDC\u2019s COVID-19 Community Levels provide information about the amount of severe illness in the community\nwhere you are located to help you decide when to take action to protect yourself and others. COVID-19 County Check\nFind community levels and prevention steps by county. Data updated weekly."}]}, {"title": "96b30132289c43497aca14e0ae5d619", "paragraphs": [{"qas": [{"question": "What does CDC recommend at all COVID-19 Community Levels?", "id": "100000000000000000004418", "answers": [{"text": "Staying Up to Date with COVID-19 Vaccines", "answer_start": 273}], "is_impossible": false}, {"question": "What should you do if you have COVID-19 and are at high risk of getting very sick?", "id": "100000000000000000004420", "answers": [{"text": "Staying Home If You Have Suspected or Confirmed Seeking Treatment", "answer_start": 449}], "is_impossible": false}, {"question": "How can you avoid contact with people who have Suspected or Are at High Risk of Getting Very Sick?", "id": "100000000000000000004422", "answers": [{"text": "\u2022 \u2022", "answer_start": 630}], "is_impossible": false}, {"question": "Who has Suspected or Stayed Up to Date with COVID-19 Vaccines?", "id": "100000000000000000004424", "answers": [{"text": "\u2022", "answer_start": 630}], "is_impossible": false}], "context": "Select a Location (all fields required)\nState County Go\nPrevention Actions to Use at All COVID-19 Community Levels\nIn addition to basic health and hygiene practices, like handwashing, CDC recommends some prevention actions at all COVID-\n19 Community Levels, which include:\nStaying Up to Date with COVID-19 Vaccines\nImproving Ventilation\nGetting Tested for COVID-19 If Needed\nFollowing Recommendations for What to Do If You\nHave Been Exposed\n\u2022\n\u2022\n\u2022\n\u2022\nStaying Home If You Have Suspected or Confirmed\nSeeking Treatment If You Have COVID-19 and Are at\nHigh Risk of Getting Very Sick\nAvoiding Contact with People Who Have Suspected or\n\u2022\n\u2022\n\u2022\nStaying Up to Date with COVID-19 Vaccines\nCOVID-19 vaccines help your body develop protection from the virus that causes COVID-19."}]}, {"title": "1c36194a2630164aa436c499aacad280", "paragraphs": [{"qas": [{"question": "Who recommends everyone get a booster and stay up-to-date on their vaccines?", "id": "100000000000000000004426", "answers": [{"text": "CDC", "answer_start": 223}], "is_impossible": false}, {"question": "What is the name of the medicine that you can take before you are exposed to COVID-19 vaccines?", "id": "100000000000000000004427", "answers": [{"text": "EVUSHELD\u2122", "answer_start": 558}], "is_impossible": false}, {"question": "What is EVUSHELDTM?", "id": "100000000000000000004428", "answers": [{"text": "medicine", "answer_start": 542}], "is_impossible": false}, {"question": "What is the name of the drug that you can take before you are exposed to COVID-19?", "id": "100000000000000000004429", "answers": [{"text": "EVUSHELD\u2122", "answer_start": 558}], "is_impossible": false}], "context": "Although vaccinated people\nsometimes get infected with the virus that causes COVID-19, staying up to date on COVID-19 vaccines significantly lowers\nthe risk of getting very sick, being hospitalized, or dying from COVID-19. CDC recommends that everyone who is\neligible get a booster and stay up to date on their COVID-19 vaccines, especially people with weakened immune systems. If you are moderately or severely immunocompromised or severely allergic to COVID-19 vaccines: Talk with a healthcare\nprovider about whether you are eligible for a medicine called EVUSHELD\u2122 that you can take before you are exposed or\ntest positive for COVID-19."}]}, {"title": "c3452c088fd81c5c5be0465c3496fc9", "paragraphs": [{"qas": [{"question": "How many different antibodies does EVUSHELDTM contain?", "id": "100000000000000000004430", "answers": [{"text": "two", "answer_start": 23}], "is_impossible": false}, {"question": "How often is EVusHELD given to you by your healthcare provider?", "id": "100000000000000000004431", "answers": [{"text": "every 6 months", "answer_start": 89}], "is_impossible": false}, {"question": "What is the name of the medicine that contains two different antibodies?", "id": "100000000000000000004432", "answers": [{"text": "EVUSHELD\u2122", "answer_start": 105}], "is_impossible": false}, {"question": "What is the name of the CDC EVUSHELDTM EUA Fact Sheet for Patients, Parents and Caregivers?", "id": "100000000000000000004433", "answers": [{"text": "How to Protect Yourself and Others", "answer_start": 388}], "is_impossible": false}, {"question": "How do you find COVID-19 vaccine locations near you?", "id": "100000000000000000004434", "answers": [{"text": "Search vaccines.gov", "answer_start": 538}], "is_impossible": false}, {"question": "What is your ZIP code?", "id": "100000000000000000004435", "answers": [{"text": "438829", "answer_start": 581}], "is_impossible": false}], "context": "This medicine contains two different antibodies and is given by your healthcare provider every\n6 months. EVUSHELD\u2122 may offer less protection against certain strains of the Omicron variant. It is important that even\nif you receive EVUSHELD\u2122, you take multiple prevention measures. See additional information for making a COVID-19\nplan to protect yourself from infection. 10/30/22, 9:39 AM How to Protect Yourself and Others | CDC\nEVUSHELD\u2122 EUA Fact Sheet for Patients, Parents and Caregivers \uf209\nTo find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233."}]}, {"title": "16d18fe762f809fd57993be2e9317cf1", "paragraphs": [{"qas": [{"question": "What is the term for moving air into, out of, or within a room?", "id": "100000000000000000004436", "answers": [{"text": "ventilation", "answer_start": 59}], "is_impossible": false}], "context": "Improving Ventilation and Spending Time Outdoors\nImproving ventilation (moving air into, out of, or within a room) and filtration (trapping particles on a filter to remove\nthem from the air) can help prevent virus particles from accumulating in indoor air. Improving ventilation and filtration\ncan help protect you from getting infected with and spreading the virus that causes COVID-19. Spending time outside\nwhen possible instead of inside can also help: Viral particles spread between people more readily indoors than outdoors. Actions that can improve ventilation and filtration include:\nBringing in as much outdoor air as possible\u2014for example, opening windows."}]}, {"title": "dafe607ba86ffa2f795216d67da6ede2", "paragraphs": [{"qas": [{"question": "What does HVAC stand for?", "id": "100000000000000000004442", "answers": [{"text": "heating, ventilation, and air conditioning", "answer_start": 34}], "is_impossible": false}, {"question": "What can you use to improve air flow in your home or school?", "id": "100000000000000000004445", "answers": [{"text": "CDC\u2019s interactive ventilation tools", "answer_start": 469}], "is_impossible": false}], "context": "Increasing air filtration in your heating, ventilation, and air conditioning (HVAC) system, such as by changing filters\nfrequently and using filters that are properly fitted and provide higher filtration. Using portable high-efficiency particulate air (HEPA) cleaners. Turning on exhaust fans and using other fans to improve air flow. Turning your thermostat to the \u201cON\u201d position instead of \u201cAUTO\u201d to ensure your HVAC system provides continuous\nairflow and filtration. CDC\u2019s interactive ventilation tools can help you see how much you can improve ventilation in your home or school."}]}, {"title": "2d6d3598289d5e399eae1cdc6ae5cd04", "paragraphs": [{"qas": [{"question": "What is a better way to protect yourself and others?", "id": "100000000000000000004447", "answers": [{"text": "Moving indoor activities outdoors", "answer_start": 69}], "is_impossible": false}, {"question": "Why are you less likely to be infected with COVID-19 during outdoor activities?", "id": "100000000000000000004448", "answers": [{"text": "virus particles do not build up in the air outdoors as much as they do indoors", "answer_start": 186}], "is_impossible": false}, {"question": "What does not build up in the air outdoors as much as they do indoors?", "id": "100000000000000000004449", "answers": [{"text": "virus particles", "answer_start": 186}], "is_impossible": false}, {"question": "What may be available to certain entities to make ventilation improvements?", "id": "100000000000000000004451", "answers": [{"text": "Financial support", "answer_start": 374}], "is_impossible": false}, {"question": "What does a viral test tell you if you are infected with the virus that causes COVID-19?", "id": "100000000000000000004452", "answers": [{"text": "Get tested if you have COVID-19 symptoms", "answer_start": 518}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:39 AM How to Protect Yourself and Others | CDC\nMoving indoor activities outdoors\nYou are less likely to be infected with COVID-19 during outdoor activities because virus particles do not build up in the air\noutdoors as much as they do indoors. As the COVID-19 Community Level rises, consider increasing the number of group\nactivities you move outside. Financial support may be available to certain entities, like schools, to make ventilation improvements. \uf209\nGetting Tested for COVID-19 If Needed\nGet tested if you have COVID-19 symptoms. A viral test tells you if you are infected with the virus that causes COVID-19."}]}, {"title": "65bec555558bce677a123477e9f42136", "paragraphs": [{"qas": [{"question": "How many types of viral tests are there?", "id": "100000000000000000004453", "answers": [{"text": "two", "answer_start": 10}], "is_impossible": false}, {"question": "What are the two types of rapid tests?", "id": "100000000000000000004454", "answers": [{"text": "laboratory tests", "answer_start": 52}], "is_impossible": false}, {"question": "Where do laboratory tests use samples from?", "id": "100000000000000000004455", "answers": [{"text": "your nose or throat, or saliva", "answer_start": 105}], "is_impossible": false}, {"question": "What is CDC's Viral Testing Tool?", "id": "100000000000000000004456", "answers": [{"text": "an online, mobile-friendly tool", "answer_start": 332}], "is_impossible": false}], "context": "There are two types of viral tests: rapid tests and laboratory tests. These tests might use samples from your nose or\nthroat, or saliva. Knowing if you are infected with the virus that causes COVID-19 allows you to take care of yourself and\ntake actions to reduce the chance that you will infect others. CDC\u2019s Viral Testing Tool is an online, mobile-friendly tool that asks a series of questions and recommends actions and\nresources based on your responses. It can help you interpret what your test result means. You can also access tests the following ways:\nOrder free self-tests at COVIDtests.gov ."}]}, {"title": "16b2b0423fa0a7281b57ece13713d4cf", "paragraphs": [{"qas": [{"question": "How many self-tests will Medicare cover each calendar month?", "id": "100000000000000000004460", "answers": [{"text": "8", "answer_start": 174}], "is_impossible": false}, {"question": "What is the name of the FDA website?", "id": "100000000000000000004462", "answers": [{"text": "list of authorized tests", "answer_start": 362}], "is_impossible": false}, {"question": "What may reimburse the cost of purchasing self-tests?", "id": "100000000000000000004463", "answers": [{"text": "Private health insurance", "answer_start": 257}], "is_impossible": false}, {"question": "Who can you call for more options?", "id": "100000000000000000004465", "answers": [{"text": "your local health department", "answer_start": 460}], "is_impossible": false}], "context": "Free tests are also available through local health departments. If you have Medicare Part B, including those enrolled in a Medicare Advantage plan, Medicare will cover up to 8\nfree self-tests each calendar month from participating pharmacies and providers. Private health insurance may\nalso reimburse the cost of purchasing self-tests. Visit FDA\u2019s website for a list of authorized tests. Call your healthcare provider, visit a community testing site , or call your local health department for more\noptions."}]}, {"title": "94b76987f6660d64caaa4eea67bd6a3b", "paragraphs": [{"qas": [{"question": "What is a good way to protect yourself and others?", "id": "100000000000000000004468", "answers": [{"text": "wearing a high-quality mask", "answer_start": 305}], "is_impossible": false}], "context": "\u2022 \uf209\n\u2022\n\uf209\n\u2022 \uf209\f10/30/22, 9:39 AM How to Protect Yourself and Others | CDC\nFollowing Recommendations for What to Do If You Have Been Exposed\nIf you were exposed to someone with\nCOVID-19, you may have been infected\nwith the virus. Follow CDC\u2019s\nrecommendations for what to do if you\nwere exposed. This includes wearing a\nhigh-quality mask when indoors\naround others (including inside your\nhome) for 10 days, testing, and\nmonitoring yourself for symptoms. Staying Home When You Have Suspected or Confirmed COVID-19\nIf you have COVID-19, you can spread it to others, even if you do not have symptoms."}]}, {"title": "af861ab341708d39362e5c591b1226ed", "paragraphs": [{"qas": [{"question": "What should you do if you have symptoms?", "id": "100000000000000000004471", "answers": [{"text": "get tested and stay home until you have your results", "answer_start": 22}], "is_impossible": false}, {"question": "What is a good mask to wear when you have a virus?", "id": "100000000000000000004473", "answers": [{"text": "high-quality mask", "answer_start": 323}], "is_impossible": false}, {"question": "What does COVID-19 affect?", "id": "100000000000000000004474", "answers": [{"text": "more,\u202fdepending on how the virus affects you) and wearing a high-quality mask when indoors around others for a period of time. 10/30/22, 9:39 AM How to Protect Yourself and Others | CDC Seeking Treatment If You Have COVID-19 and Are at High Risk of Getting Very Sick", "answer_start": 262}], "is_impossible": false}, {"question": "What are very sick effective treatments now widely available and free?", "id": "100000000000000000004476", "answers": [{"text": "eligible", "answer_start": 600}], "is_impossible": false}, {"question": "What may be eligible for?", "id": "100000000000000000004477", "answers": [{"text": "Effective treatments", "answer_start": 530}], "is_impossible": false}], "context": "If you have symptoms, get tested\nand stay home until you have your results. If you have tested positive (even without symptoms), follow CDC\u2019s\u202fisolation\nrecommendations. These recommendations include staying home and away from others for at least 5 days (possibly\nmore,\u202fdepending on how the virus affects you) and wearing a high-quality mask when indoors around others for a period\nof time. 10/30/22, 9:39 AM How to Protect Yourself and Others | CDC\nSeeking Treatment If You Have COVID-19 and Are at High Risk of Getting Very Sick\nEffective treatments are now widely\navailable and free, and you may be\neligible."}]}, {"title": "de030e96fb0a49c1acf7f7514940a15", "paragraphs": [{"qas": [{"question": "What can you do if you don't have timely access to a healthcare provider?", "id": "100000000000000000004478", "answers": [{"text": "check if a Test to Treat", "answer_start": 279}], "is_impossible": false}, {"question": "Where can you get tested and have your prescription filled at one location?", "id": "100000000000000000004480", "answers": [{"text": "a healthcare provider (either onsite or by telehealth", "answer_start": 383}], "is_impossible": false}], "context": "Contact your healthcare provider,\nhealth department, or\nCommunity Health Center to\nlearn about treatment options. Don\u2019t delay! Treatment must be\nstarted within a few days after\nyou first develop symptoms to be\neffective. If you don\u2019t have timely access to\na healthcare provider, check if a\nTest to Treat location is in\nyour community. You can get\ntested, receive a prescription\nfrom a healthcare provider (either\nonsite or by telehealth), and have it filled all at one location. \u2022\n\uf209\n\u2022\n\u2022\n\uf209\nAvoiding Contact with People Who Have Suspected or Confirmed COVID-19\nAvoiding contact with people who have COVID-19, whether or not they feel sick, can reduce your risk of catching the virus\nfrom them."}]}, {"title": "90bf0c15511b37bdb5de7f400ee7fd73", "paragraphs": [{"qas": [{"question": "What should you avoid being around a person who has COVID-19 until they can safely end home isolation?", "id": "100000000000000000004483", "answers": [{"text": "If possible", "answer_start": 0}], "is_impossible": false}, {"question": "What is a good way to prevent sick people?", "id": "100000000000000000004486", "answers": [{"text": "practicing hand hygiene", "answer_start": 304}], "is_impossible": false}], "context": "If possible, avoid being around a person who has COVID-19 until they can safely end home isolation. Sometimes it may not be practical for you to stay away from a person who has COVID-19 or you may want to help take\ncare of them. In those situations, use as many prevention strategies as you can, such as practicing hand hygiene,\nconsistently and correctly wearing a high-quality mask, improving ventilation, and keeping your distance, when possible,\nfrom the person who is sick or who tested positive."}]}, {"title": "d722d3f2852c312bbaa46f904c12f826", "paragraphs": [{"qas": [{"question": "What are some additional prevention actions that may be done at any level?", "id": "100000000000000000004487", "answers": [{"text": "COVID-19 Community Levels", "answer_start": 259}], "is_impossible": false}, {"question": "Wearing Masks or Respirators Increasing Space and Distance CDC recommends what?", "id": "100000000000000000004488", "answers": [{"text": "COVID-19 Community Levels", "answer_start": 259}], "is_impossible": false}, {"question": "What are Respirators made to protect you by fitting closely on the skin?", "id": "100000000000000000004489", "answers": [{"text": "N95) are made to protect you by fitting closely on the face to filter out particles", "answer_start": 588}], "is_impossible": false}, {"question": "What is an example of a Respirator that is made to provide a higher level of protection?", "id": "100000000000000000004490", "answers": [{"text": "N95", "answer_start": 588}], "is_impossible": false}, {"question": "What virus causes COVID- 19?", "id": "100000000000000000004492", "answers": [{"text": "Respirators", "answer_start": 562}], "is_impossible": false}], "context": "10/30/22, 9:39 AM How to Protect Yourself and Others | CDC\nPrevention Actions to Add as Needed\nThere are some additional prevention actions that may be done at any level, but CDC especially recommends considering in\ncertain circumstances or at medium or high\u202fCOVID-19 Community Levels. Wearing Masks or Respirators\nIncreasing Space and Distance\n\u2022\n\u2022\nWearing Masks or Respirators\nMasks are made to contain droplets\nand particles that you breathe, cough,\nor sneeze out. A variety of masks are\navailable. Some masks provide a\nhigher level of protection than others. Respirators (for example, N95) are\nmade to protect you by fitting closely\non the face to filter out particles,\nincluding the virus that causes COVID-\n19."}]}, {"title": "ab70edfe1f3559fc965dcdb3138d619f", "paragraphs": [{"qas": [{"question": "What is the name of a respirator that provides higher protection than a mask?", "id": "100000000000000000004494", "answers": [{"text": "N95", "answer_start": 139}], "is_impossible": false}, {"question": "What do small particles that people breathe out can contain viruses?", "id": "100000000000000000004495", "answers": [{"text": "Respirators", "answer_start": 114}], "is_impossible": false}, {"question": "What can you wear that fits closely to your face?", "id": "100000000000000000004496", "answers": [{"text": "Respirators (for example, N95) provide higher protection than masks. When wearing a mask or respirator", "answer_start": 114}], "is_impossible": false}], "context": "They can also block droplets and\nparticles you breathe, cough, or\nsneeze out so you do not spread them\nto others. Respirators (for example,\nN95) provide higher protection than\nmasks. When wearing a mask or respirator\n(for example, N95), it is most important to choose one that you can wear correctly, that fits closely to your face over your\nmouth and nose, that provides good protection, and that is comfortable for you. Increasing Space and Distance\nSmall particles that people breathe out can contain virus particles."}]}, {"title": "6710d6b2af86b559eeb1e9d27c6b5a73", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000004497", "answers": [{"text": "high risk", "answer_start": 458}], "is_impossible": false}, {"question": "How do you avoid being exposed to the virus?", "id": "100000000000000000004498", "answers": [{"text": "avoid crowded areas or keep distance between yourself and others", "answer_start": 172}], "is_impossible": false}, {"question": "What are people who are at high risk for getting very sick from COVID- 19 in settings where there are multiple risks?", "id": "100000000000000000004500", "answers": [{"text": "avoid crowded areas, or keep distance between yourself and others", "answer_start": 346}], "is_impossible": false}, {"question": "What does CDC avoid crowded areas?", "id": "100000000000000000004501", "answers": [{"text": "How to Protect Yourself and Others | CDC avoid crowded areas, or keep distance between yourself and others", "answer_start": 305}], "is_impossible": false}, {"question": "How sick is a person who has COVID- 19 in settings where there are multiple risks?", "id": "100000000000000000004502", "answers": [{"text": "high risk", "answer_start": 458}], "is_impossible": false}], "context": "The closer you are to a greater number of people, the\nmore likely you are to be exposed to the virus that causes COVID-19. To avoid this possible exposure, you may want to\navoid crowded areas or keep distance between yourself and others These actions also protect people who are at high\f10/30/22, 9:39 AM How to Protect Yourself and Others | CDC\navoid crowded areas, or keep distance between yourself and others. These actions also protect people who are at high\nrisk for getting very sick from COVID-\n19 in settings where there are multiple\nrisks for exposure."}]}, {"title": "be4a361cc469d56aa01fb904fc5f9c85", "paragraphs": [{"qas": [{"question": "What is the purpose of masks?", "id": "100000000000000000004503", "answers": [{"text": "to Control the Spread of SARS-CoV-2", "answer_start": 232}], "is_impossible": false}], "context": "Additional Resources\nCOVID-19 Community Levels\nScience Brief: SARS-CoV-2 Transmission\nScience Brief: Indicators for Monitoring COVID-19 Community Levels and Making Public Health Recommendations\nScience Brief: Community Use of Masks to Control the Spread of SARS-CoV-2\nScience Brief: COVID-19 Vaccines and Vaccination\nLast Updated Oct. 19, 2022"}]}, {"title": "79af8c9a0547488b9e816942ef181900", "paragraphs": [{"qas": [{"question": "What can wear an N95 make it harder to breathe?", "id": "100000000000000000004507", "answers": [{"text": "N95s must form a seal to the face to work properly. This is especially important for people at increased risk for severe disease", "answer_start": 128}], "is_impossible": false}, {"question": "If you have heart or lung problems, talk to your doctor before using what?", "id": "100000000000000000004508", "answers": [{"text": "an N95", "answer_start": 373}], "is_impossible": false}, {"question": "What may some N95s contain in the straps?", "id": "100000000000000000004509", "answers": [{"text": "latex", "answer_start": 403}], "is_impossible": false}, {"question": "What is the name of the latex allergy?", "id": "100000000000000000004510", "answers": [{"text": "natural rubber", "answer_start": 436}], "is_impossible": false}], "context": "10/30/22, 9:40 AM How to Use Your N95 Respirator | CDC\nHow to Use Your N95 Respirator\nWear Your N95 Properly So It Is Effective\nN95s must form a seal to the face to work properly. This is especially important for people at increased risk for\nsevere disease. Wearing an N95 can make it harder to breathe. If you have heart or lung problems, talk to your\ndoctor before using an N95. Some N95s may contain latex in the straps. If you have natural rubber latex allergies, see the manufacturers\u2019\nwebsite for information about your specific model."}]}, {"title": "3b9ea6ab6fcfc171553923ac8f72d5c7", "paragraphs": [{"qas": [{"question": "How many head straps does your N95 have?", "id": "100000000000000000004511", "answers": [{"text": "two", "answer_start": 251}], "is_impossible": false}, {"question": "How many pages are in the How to Use Your N95 Respirator PDF?", "id": "100000000000000000004512", "answers": [{"text": "2", "answer_start": 154}], "is_impossible": false}, {"question": "How many head straps does the N95 have?", "id": "100000000000000000004513", "answers": [{"text": "two", "answer_start": 251}], "is_impossible": false}, {"question": "How do you wash your hands?", "id": "100000000000000000004514", "answers": [{"text": "clean, dry hands", "answer_start": 369}], "is_impossible": false}, {"question": "What should you do if your N95 is damaged?", "id": "100000000000000000004515", "answers": [{"text": "do not use it", "answer_start": 489}], "is_impossible": false}], "context": "For specific manufacturer\u2019s instructions for your N95 model, see Free N95 Respirator Manufacturers. \u2022\n\u2022\nDownload: How to Use Your N95 Respirator [483 KB, 2 pages]\n\uf2dc \uf20c\nYour N95 may look different than the one in these pictures. As long as your N95 has two head straps (not ear loops),\nthese basic instructions apply. Wash Your Hands\n\uf1ae\nIt is best to put on your N95 with clean, dry hands. Check Your N95\n\uf1af\nAlways inspect the N95 for damage before use. If it\nappears damaged, dirty, or damp, do not use it."}]}, {"title": "90be8ef4540671cf4fb8cf73d36dcba0", "paragraphs": [{"qas": [{"question": "What is a nose piece bar on the N95?", "id": "100000000000000000004516", "answers": [{"text": "foam", "answer_start": 125}], "is_impossible": false}, {"question": "How do you know if the top end of your N95 is at your fingertips?", "id": "100000000000000000004518", "answers": [{"text": "use the text written on it", "answer_start": 189}], "is_impossible": false}, {"question": "Where should you place the N95 under your chin with the nose piece bar at the top?", "id": "100000000000000000004520", "answers": [{"text": "the top", "answer_start": 319}], "is_impossible": false}, {"question": "When you pull the top strap over your head, where should it be placed?", "id": "100000000000000000004521", "answers": [{"text": "near the crown", "answer_start": 374}], "is_impossible": false}, {"question": "Where should the straps be placed?", "id": "100000000000000000004522", "answers": [{"text": "near the crown. Then, pull the bottom strap over and place it at the back of your neck, below your ears", "answer_start": 374}], "is_impossible": false}, {"question": "Where should you place the strap?", "id": "100000000000000000004523", "answers": [{"text": "under your chin", "answer_start": 276}], "is_impossible": false}, {"question": "What should you not do?", "id": "100000000000000000004524", "answers": [{"text": "Do not crisscross the straps", "answer_start": 479}], "is_impossible": false}], "context": "Put on the N95\n\uf1b0\f10/30/22, 9:40 AM How to Use Your N95 Respirator | CDC\nHold the N95 in your hand with the nose piece bar (or\nfoam) at your fingertips. If yours does not have a nose\npiece, use the text written on it to be sure the top end is\nat your fingertips. Place the N95 under your chin with the nose piece bar at\nthe top. Pull the top strap over your head, placing it near the\ncrown. Then, pull the bottom strap over and place it at\nthe back of your neck, below your ears. Do not\ncrisscross the straps."}]}, {"title": "d0cbdf5060a2fbfab19a6955b1a19d6a", "paragraphs": [{"qas": [{"question": "What must your N95 form to your face?", "id": "100000000000000000004525", "answers": [{"text": "a seal", "answer_start": 240}], "is_impossible": false}, {"question": "How do you mold the nose piece to your nose?", "id": "100000000000000000004526", "answers": [{"text": "Press down on both sides", "answer_start": 119}], "is_impossible": false}, {"question": "What must pass through the N95 and not around its edges?", "id": "100000000000000000004528", "answers": [{"text": "Your breath", "answer_start": 278}], "is_impossible": false}, {"question": "Jewelry, glasses, and facial hair can cause gaps between your face and the edge of what?", "id": "100000000000000000004529", "answers": [{"text": "the mask", "answer_start": 425}], "is_impossible": false}], "context": "Make sure the straps lay flat and\nare not twisted. Place your fingertips from both hands at the top of the\nnose piece. Press down on both sides of the nose piece\nto mold it to the shape of your nose. Keep Your N95 Snug\n\uf1b1\nYour N95 must form a seal to your face to work properly. Your breath must pass through the N95 and not around its\nedges. Jewelry, glasses, and facial hair can cause gaps between your face and the edge of the mask. The N95 works better\nif you are clean shaven."}]}, {"title": "27006fb9eef6b33ff9f774d8cf0e82ff", "paragraphs": [{"qas": [{"question": "What can happen if your N95 is too big, too small, or it was not put on correctly?", "id": "100000000000000000004530", "answers": [{"text": "Gaps", "answer_start": 0}], "is_impossible": false}, {"question": "What can you do to check for gaps?", "id": "100000000000000000004531", "answers": [{"text": "gently place your hands on the N95", "answer_start": 106}], "is_impossible": false}, {"question": "What do you feel leaking out from the edges of the N95?", "id": "100000000000000000004533", "answers": [{"text": "air", "answer_start": 208}], "is_impossible": false}, {"question": "If you cannot get a tight seal, try a different size or what?", "id": "100000000000000000004534", "answers": [{"text": "style", "answer_start": 313}], "is_impossible": false}], "context": "Gaps can also occur if your N95 is too big, too small, or it was not put on correctly. To check for gaps, gently place your hands on the N95,\ncovering as much of it as possible, then breathe out. If\nyou feel air leaking out from the edges of the N95, or if\nIf you cannot get a tight seal, try a different size or style."}]}, {"title": "24e9ddf52e9b176502323c9d346ee36a", "paragraphs": [{"qas": [{"question": "What type of glasses do you wear and they fog up?", "id": "100000000000000000004536", "answers": [{"text": "y g g , you are wearing glasses", "answer_start": 173}], "is_impossible": false}, {"question": "If you can't get your N95 sealed against your face, what is better?", "id": "100000000000000000004537", "answers": [{"text": "a cloth", "answer_start": 111}], "is_impossible": false}, {"question": "How do you check for gaps on your N95?", "id": "100000000000000000004538", "answers": [{"text": "every time you put on your N95", "answer_start": 296}], "is_impossible": false}, {"question": "What should you wash your hands with after you remove the N95?", "id": "100000000000000000004539", "answers": [{"text": "soap and water", "answer_start": 393}], "is_impossible": false}, {"question": "How much alcohol should be in your hand sanitizer?", "id": "100000000000000000004540", "answers": [{"text": "60%", "answer_start": 447}], "is_impossible": false}], "context": "Even if you cannot get the N95 sealed against your face,\nit will provide protection that is likely better than a cloth\f10/30/22, 9:40 AM How to Use Your N95 Respirator | CDC\ny g g ,\nyou are wearing glasses and they fog up, it is not snug. Adjust the N95 and try again. p p y\nmask. Check for gaps every time you put on your N95. Remove the N95\n\uf1b2\nAfter you remove your N95, wash your hands with soap and water, or hand sanitizer containing at least 60% alcohol if\nsoap is not available."}]}, {"title": "36d23e1640f133553a33a5ebfacf9387", "paragraphs": [{"qas": [{"question": "When to Replace Your N95 Do not wash your N95 or put it in the oven or microwave to try to sterilize it?", "id": "100000000000000000004541", "answers": [{"text": "when the straps are stretched out and it no longer fits snugly against your face or when it becomes wet, dirty, or damaged", "answer_start": 121}], "is_impossible": false}, {"question": "When the straps are stretched out and it no longer fits snugly against your face, what should you do?", "id": "100000000000000000004542", "answers": [{"text": "Replace the N95 when the straps are stretched out and it no longer fits snugly against your face or when it becomes wet, dirty, or damaged. Throw it in the trash", "answer_start": 105}], "is_impossible": false}, {"question": "What do you do when a mask becomes wet, dirty, or damaged?", "id": "100000000000000000004543", "answers": [{"text": "Throw it in the trash", "answer_start": 245}], "is_impossible": false}, {"question": "Where do you throw it in the trash?", "id": "100000000000000000004544", "answers": [{"text": "when the straps are stretched out and it no longer fits snugly against your face or when it becomes wet, dirty, or damaged. Throw it in the trash", "answer_start": 121}], "is_impossible": false}, {"question": "When was the last update for the N95 Respirator Manufacturers?", "id": "100000000000000000004545", "answers": [{"text": "Mar. 16, 2022", "answer_start": 364}], "is_impossible": false}], "context": "When to Replace Your N95\nDo not wash your N95 or put it in the oven or microwave to try to sterilize it. Replace the N95 when the straps are\nstretched out and it no longer fits snugly against your face or when it becomes wet, dirty, or damaged. Throw it in the\ntrash. Related Pages\nFree N95 Respirator Manufacturers\n\u203a\nTypes of Masks and Respirators\n\u203a\nLast Updated Mar. 16, 2022"}]}, {"title": "26c0eea2ac407954ff8d6973423f6c57", "paragraphs": [{"qas": [{"question": "If you test positive and are an older adult or someone at high risk of getting very sick, what may be available?", "id": "100000000000000000004547", "answers": [{"text": "treatment", "answer_start": 211}], "is_impossible": false}, {"question": "What should you do immediately after a positive test?", "id": "100000000000000000004549", "answers": [{"text": "Contact a healthcare provider", "answer_start": 239}], "is_impossible": false}, {"question": "What must be started within the first few days to be effective?", "id": "100000000000000000004550", "answers": [{"text": "Treatment", "answer_start": 493}], "is_impossible": false}], "context": "10/30/22, 9:41 AM If You Are Sick or Caring for Someone | CDC\nIf You Are Sick or Caring for Someone\nIf you test positive and are an older adult or someone who is at high risk of getting very sick from COVID-19, treatment\nmay be available. Contact a healthcare provider right away after a positive test to determine if you are eligible, even if\nyour symptoms are mild right now. You can also visit a Test to Treat location and, if eligible, receive a prescription\nfrom a provider. Don\u2019t delay: Treatment must be started within the first few days to be effective."}]}, {"title": "addd3fd77a3372831869f2d59d6c7111", "paragraphs": [{"qas": [{"question": "What to do if you are sick when to isolate Caring for someone at home Potential Treatment for Severe Illness What is the Long-Term Effects of Getting Sick Again After You Are Sick?", "id": "100000000000000000004551", "answers": [{"text": "Reinfection", "answer_start": 188}], "is_impossible": false}, {"question": "When was the Last Updated Aug. 11, 2022?", "id": "100000000000000000004552", "answers": [{"text": "Don\u2019t Delay: Test Soon and Treat Early", "answer_start": 252}], "is_impossible": false}], "context": "\uf209\nWhat to Do If You Are Sick\nWhen to Isolate\nCaring for Someone at Home\nPotential Treatment for Severe Illness\nCaring for Yourself and Others\n\uf1aa\n\uf1aa\n\uf1aa\n\uf1aa\nLong-Term Effects\nGetting Sick Again (Reinfection)\nAfter You Are Sick\n\uf1aa\n\uf1aa\nRelated Pages and Resources\nDon\u2019t Delay: Test Soon and Treat Early | Spanish Version\n\u203a \uf20c \uf20c\nSymptoms\n\u203a\nTesting\n\u203a\nLast Updated Aug. 11, 2022"}]}, {"title": "a05bf554bd5787730e7fca4de7021cdb", "paragraphs": [{"qas": [{"question": "What can help you keep COVID-19 from spreading?", "id": "100000000000000000004554", "answers": [{"text": "Improving ventilation", "answer_start": 234}], "is_impossible": false}, {"question": "What can good ventilation and other preventive actions do to prevent you and others from getting and spreading?", "id": "100000000000000000004556", "answers": [{"text": "COVID-19 and other respiratory viruses", "answer_start": 573}], "is_impossible": false}, {"question": "What can help prevent you and others from getting and spreading COVID-19?", "id": "100000000000000000004557", "answers": [{"text": "Good ventilation", "answer_start": 459}], "is_impossible": false}], "context": "10/30/22, 9:40 AM Improving Ventilation in Your Home | CDC\nEspa\u00f1ol | Other Languages\nImproving Ventilation in Your Home\nVentilate your home by getting fresh air into your home, filtering the air that is there, and improving air flow. Improving\nventilation can help you reduce virus particles in your home and keep COVID-19 from spreading. You may or may not know if\nsomeone in your home or if a visitor to your home has COVID-19 or other respiratory viruses. Good ventilation, along with\nother preventive actions, can help prevent you and others from getting and spreading COVID-19 and other respiratory\nviruses."}]}, {"title": "56af41fe55da8372d4662c1fcbfedcce", "paragraphs": [{"qas": [{"question": "How can you decrease the level of COVID-19 virus particles during and after a guest visits your home?", "id": "100000000000000000004558", "answers": [{"text": "Interactive Ventilation Tool", "answer_start": 0}], "is_impossible": false}, {"question": "What will help you clear out virus particles in your home faster?", "id": "100000000000000000004559", "answers": [{"text": "Using as many ways", "answer_start": 267}], "is_impossible": false}, {"question": "How can you decrease particles even more by continuing to ventilate after a visitor leaves?", "id": "100000000000000000004560", "answers": [{"text": "Interactive Ventilation Tool", "answer_start": 0}], "is_impossible": false}, {"question": "Ventilation: moves air into, out of, or into what?", "id": "100000000000000000004561", "answers": [{"text": "within a room", "answer_start": 561}], "is_impossible": false}, {"question": "What is an example of an extra hour?", "id": "100000000000000000004562", "answers": [{"text": "ventilate after a visitor leaves", "answer_start": 458}], "is_impossible": false}, {"question": "Ventilation moves air into, out of, or within what room?", "id": "100000000000000000004563", "answers": [{"text": "a room", "answer_start": 568}], "is_impossible": false}], "context": "Interactive Ventilation Tool\nUse this tool to learn how you can decrease the level of COVID-19 virus particles during and after a guest visits\nyour home. Get Started\nHow to Improve Ventilation in Your Home\nHere are some ways you can improve ventilation in your home. Using as many\nways as you can (open windows, use air filters, and turn on fans) will help clear out\nvirus particles in your home faster. You can decrease particles even more by\ncontinuing to ventilate after a visitor leaves (for example, an extra hour). Ventilation: moves air into, out of,\nor within a room."}]}, {"title": "81f7e2a8b5d5182e57d36a841567d2b5", "paragraphs": [{"qas": [{"question": "What does filtering do?", "id": "100000000000000000004564", "answers": [{"text": "Traps particles on a filter to remove them from the air", "answer_start": 12}], "is_impossible": false}, {"question": "What helps keep virus particles from accumulating inside?", "id": "100000000000000000004565", "answers": [{"text": "Bringing fresh, outdoor air", "answer_start": 120}], "is_impossible": false}, {"question": "How much fresh air does bringing fresh, outdoor air into your home help?", "id": "100000000000000000004566", "answers": [{"text": "keep virus particles from accumulating inside", "answer_start": 169}], "is_impossible": false}, {"question": "Even having a window cracked open slightly can help what?", "id": "100000000000000000004568", "answers": [{"text": "more fresh air to move inside", "answer_start": 458}], "is_impossible": false}], "context": "Filtration: Traps particles on a filter\nto remove them from the air. Bring as much fresh air into your home as possible\nBringing fresh, outdoor air into your home helps keep virus particles from accumulating inside. If it\u2019s safe to do so, open doors and windows as much as you can to bring in fresh, outdoor air. While it\u2019s better to\nopen them widely, even having a window cracked open slightly can help. If you can, open multiple doors and windows to allow more fresh air to move inside."}]}, {"title": "96c7fc6ec5146462fe8798125ce80094", "paragraphs": [{"qas": [{"question": "What is the risk of falling, people with asthma or other respiratory conditions, or poor air quality?", "id": "100000000000000000004571", "answers": [{"text": "young children or pets in your home", "answer_start": 84}], "is_impossible": false}, {"question": "What is another way to reduce virus particles in the air?", "id": "100000000000000000004572", "answers": [{"text": "air filtration and bathroom and stove exhaust fans", "answer_start": 341}], "is_impossible": false}], "context": "Do not open windows and doors if doing so is unsafe for you or others (for example, young children or pets in\nyour home, risk of falling, people in the home with asthma or other respiratory conditions, poor air quality). If opening windows or doors is unsafe, consider other approaches for reducing virus particles in the air, such as\nusing air filtration and bathroom and stove exhaust fans. Use fans to move virus particles in the air from inside your home to outside. Don\u2019t leave fans unattended with\nyoung children."}]}, {"title": "bc6ad91c697964c0816045c44ad333b6", "paragraphs": [{"qas": [{"question": "What is an HVAC system with air ducts that go through the home called?", "id": "100000000000000000004574", "answers": [{"text": "air conditioning system", "answer_start": 162}], "is_impossible": false}, {"question": "What can be used to help trap virus particles?", "id": "100000000000000000004575", "answers": [{"text": "pleated filters", "answer_start": 552}], "is_impossible": false}, {"question": "What is more efficient than ordinary furnace filters?", "id": "100000000000000000004576", "answers": [{"text": "Pleated filters", "answer_start": 570}], "is_impossible": false}, {"question": "Where can you set the fan to the \"on\" position?", "id": "100000000000000000004577", "answers": [{"text": "In homes where the HVAC fan operation can be controlled by a thermostat", "answer_start": 312}], "is_impossible": false}, {"question": "Where can pleated filters be found?", "id": "100000000000000000004579", "answers": [{"text": "hardware stores", "answer_start": 655}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nFilter the air in your home\nIf your home has a central heating,\f10/30/22, 9:40 AM Improving Ventilation in Your Home | CDC\nView Larger\nventilation, and air conditioning\nsystem (HVAC, a system with air ducts\nthat go throughout the home) that has\na filter, do the following to help trap\nvirus particles:\nIn homes where the HVAC fan\noperation can be controlled by a\nthermostat, set the fan to the \u201con\u201d\nposition instead of \u201cauto\u201d when\nyou have visitors. This allows the\nfan to run continuously, even if\nheating or air conditioning is not\non. Use pleated filters . Pleated\nfilters are more efficient than\nordinary furnace filters and can\nbe found in hardware stores."}]}, {"title": "766f69d878380ca42ad36a2f8fa3bbc1", "paragraphs": [{"qas": [{"question": "What should you do to replace the filter yourself?", "id": "100000000000000000004580", "answers": [{"text": "Follow the manufacturer\u2019s instructions", "answer_start": 0}], "is_impossible": false}, {"question": "How often should you change your filter?", "id": "100000000000000000004581", "answers": [{"text": "every three months", "answer_start": 178}], "is_impossible": false}, {"question": "What type of air cleaner can provide filtration if you don't have an HVAC system?", "id": "100000000000000000004583", "answers": [{"text": "portable high-efficiency particulate air (HEPA) cleaner", "answer_start": 437}], "is_impossible": false}], "context": "Follow the manufacturer\u2019s\ninstructions to replace the filter\nyourself or ask a professional for\nhelp. Make sure the filter is installed\nproperly (see figure). Change your filter every three\nmonths or according to the\nmanufacturer\u2019s instructions. Ideally, have the ventilation\nsystem inspected and adjusted by\na professional every year to make\nsure it is operating efficiently. \uf21b\n\u2022\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\nConsider using a portable air cleaner\nUsing a portable high-efficiency particulate air (HEPA) cleaner can provide filtration if you don\u2019t have an HVAC system or\ncan improve filtration if you do have an HVAC system."}]}, {"title": "3abcd993268f24ae83aa63b5df9744ed", "paragraphs": [{"qas": [{"question": "What are the most efficient filters on the market for trapping particles that people exhale?", "id": "100000000000000000004584", "answers": [{"text": "HEPA cleaner", "answer_start": 166}], "is_impossible": false}, {"question": "When choosing a HEPA cleaner, choose one that is the right size for the room?", "id": "100000000000000000004585", "answers": [{"text": "particles", "answer_start": 62}], "is_impossible": false}, {"question": "What is the Clean Air Delivery Rate?", "id": "100000000000000000004586", "answers": [{"text": "CADR) that meets or exceeds the square footage of the room(s) in which it will be used", "answer_start": 280}], "is_impossible": false}, {"question": "What does CADR stand for?", "id": "100000000000000000004587", "answers": [{"text": "Clean Air Delivery Rate", "answer_start": 255}], "is_impossible": false}, {"question": "The larger the CADR, the faster it will clean the air?", "id": "100000000000000000004588", "answers": [{"text": "faster", "answer_start": 392}], "is_impossible": false}], "context": "They are the most efficient filters on the market for trapping\nparticles that people exhale when breathing, talking, singing, coughing, and sneezing. When choosing a HEPA cleaner, select one that is the right size for the room(s). Look for one that has a Clean Air Delivery\nRate (CADR) that meets or exceeds the square footage of the room(s) in which it will be used. The larger the CADR, the\nfaster it will clean the air. See EPA\u2019s Guide to Air Cleaners in the Home for more information."}]}, {"title": "a759939f87859ba932744a15bd598fc0", "paragraphs": [{"qas": [{"question": "What do stove exhaust fans do?", "id": "100000000000000000004589", "answers": [{"text": "help move air outside. Although some stove exhaust fans don\u2019t send the air to the outside", "answer_start": 191}], "is_impossible": false}, {"question": "What can help move air outside of your home?", "id": "100000000000000000004590", "answers": [{"text": "Exhaust fans", "answer_start": 114}], "is_impossible": false}], "context": "\uf209\nTurn on the exhaust fan in your bathroom and kitchen\f10/30/22, 9:40 AM Improving Ventilation in Your Home | CDC\nExhaust fans above your stovetop and in your bathroom that vent outdoors can help move air outside. Although some\nstove exhaust fans don\u2019t send the air to the outside, they can still improve air flow and keep virus particles from being\nconcentrated in one place. Keep the exhaust fan turned on over your stovetop and in your bathroom if you have visitors in your home."}]}, {"title": "277073a1d59274c183f424f6a7c8c9ba", "paragraphs": [{"qas": [{"question": "What is the purpose of keeping the exhaust fans on for an hour after visitors leave your home?", "id": "100000000000000000004593", "answers": [{"text": "to help remove virus particles", "answer_start": 70}], "is_impossible": false}, {"question": "What will leave your home faster than with poor ventilation?", "id": "100000000000000000004595", "answers": [{"text": "virus particles", "answer_start": 192}], "is_impossible": false}, {"question": "How can you use a fan to improve air flow?", "id": "100000000000000000004596", "answers": [{"text": "Place a fan as close as possible to an open window blowing outside. This helps get rid of virus particles in your home by blowing air outside. Even without an open window, fans can improve air flow. Point fans away from people", "answer_start": 333}], "is_impossible": false}], "context": "Keep the exhaust fans turned on for an hour after your visitors leave to help remove virus particles that might still\nbe in the air. [PNG - 225 KB]\nWith good ventilation, the concentration of virus particles in the air will be lower and they will leave your home\nfaster than with poor ventilation. \uf20a\n\u2022\n\u2022\nUse fans to improve air flow\nPlace a fan as close as possible to an open window blowing outside. This helps get rid of virus particles in your\nhome by blowing air outside. Even without an open window, fans can improve air flow. Point fans away from people."}]}, {"title": "c0c97af98369419263a3fe9e0bdeeb6d", "paragraphs": [{"qas": [{"question": "Use ceiling fans to help improve air flow in the home whether or not windows are open?", "id": "100000000000000000004599", "answers": [{"text": "\u2022 \u2022", "answer_start": 159}], "is_impossible": false}, {"question": "Limit the number of visitors in your home and the time spent inside what?", "id": "100000000000000000004600", "answers": [{"text": "\u2022", "answer_start": 159}], "is_impossible": false}, {"question": "How many people are in your home?", "id": "100000000000000000004601", "answers": [{"text": "more", "answer_start": 237}], "is_impossible": false}, {"question": "How can virus particles accumulate?", "id": "100000000000000000004602", "answers": [{"text": "The more people inside your home", "answer_start": 233}], "is_impossible": false}, {"question": "What can you do to reduce the amount of virus particles in the air?", "id": "100000000000000000004603", "answers": [{"text": "Limit the number of visitors in your home", "answer_start": 334}], "is_impossible": false}], "context": "Pointing fans toward people can blow contaminated air directly at them. Use ceiling fans to help improve air flow in the home whether or not windows are open. \u2022\n\u2022\n\u2022\nLimit the number of visitors in your home and the time spent inside\nThe more people inside your home, and the longer they stay, the more virus particles can accumulate. Limit the number of visitors in your home to reduce the accumulation of virus particles in the air."}]}, {"title": "d4b0e91073ef31f95bccea77981f580f", "paragraphs": [{"qas": [{"question": "What do you gather in larger rooms or areas where people can be spaced apart and keep visits short?", "id": "100000000000000000004604", "answers": [{"text": "Improving Ventilation in Your Home", "answer_start": 107}], "is_impossible": false}, {"question": "What are additional recommendations for preventing the spread of?", "id": "100000000000000000004605", "answers": [{"text": "COVID-19", "answer_start": 299}], "is_impossible": false}, {"question": "When was the last update of this page made?", "id": "100000000000000000004607", "answers": [{"text": "June 29, 2022", "answer_start": 415}], "is_impossible": false}], "context": "Gather in larger rooms or areas where people can be spaced apart and keep visits short\n\u2022\f10/30/22, 9:40 AM Improving Ventilation in Your Home | CDC\nGather in larger rooms or areas where people can be spaced apart and keep visits short. Follow additional recommendations for preventing the spread of COVID-19. \u2022\n\u2022\nRelated Pages\nVentilation in Buildings\n\u203a\nVentilation in Schools and Childcare Programs\n\u203a\nLast Updated June 29, 2022"}]}, {"title": "81089b699b38110a7eb908ae7af13085", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000004609", "answers": [{"text": "virus particles", "answer_start": 170}], "is_impossible": false}, {"question": "What can help prevent you from getting and spreading COVID-19?", "id": "100000000000000000004611", "answers": [{"text": "Good ventilation", "answer_start": 354}], "is_impossible": false}], "context": "10/30/22, 9:41 AM Interactive Home Ventilation Tool | CDC\nEspa\u00f1ol | Other Languages\nInteractive Home Ventilation Tool\nSmall particles that people breathe out can contain virus particles, including the virus that causes COVID-19. If a guest visits\nyour home, improving ventilation (air flow) can help prevent virus particles from accumulating in the air. Good ventilation,\nalong with other preventive actions, like staying 6 feet apart and correctly wearing masks, can help prevent you from getting\nand spreading COVID-19. \uf5bd We need your feedback! Help us improve this tool by taking a quick survey after using the tool below."}]}, {"title": "12b378508207299df85df41e494cd004", "paragraphs": [{"qas": [{"question": "How can I decrease the level of virus particles during and after a guest visits my home?", "id": "100000000000000000004615", "answers": [{"text": "Select the options below to see how particle levels change as you adjust ventilation settings", "answer_start": 89}], "is_impossible": false}, {"question": "Select the options below to see how particle levels change as you adjust what?", "id": "100000000000000000004616", "answers": [{"text": "ventilation settings", "answer_start": 162}], "is_impossible": false}], "context": "How can I decrease the level of virus particles during and after a guest visits my home? Select the options below to see how particle levels change as you adjust ventilation settings. (To create additional scenarios, including to adjust the length of the visit and size of the home, see the expanded model from the National\nInstitute of Standards and Technology.)"}]}, {"title": "6d57f818975b1b16dcb3c73b72909e61", "paragraphs": [{"qas": [{"question": "What is MERV 13?", "id": "100000000000000000004618", "answers": [{"text": "Premium", "answer_start": 151}], "is_impossible": false}, {"question": "How much particle reduction was achieved in your home by 1 hour?", "id": "100000000000000000004619", "answers": [{"text": "0%", "answer_start": 208}], "is_impossible": false}, {"question": "What is the default imageminSvgo?", "id": "100000000000000000004620", "answers": [{"text": "require(\"imagemin-svgo", "answer_start": 407}], "is_impossible": false}, {"question": "How much particle reduction achieved in your home by using ventilation?", "id": "100000000000000000004621", "answers": [{"text": "0%", "answer_start": 460}], "is_impossible": false}, {"question": "How long can you continue to ventilate for?", "id": "100000000000000000004622", "answers": [{"text": "an extra hour", "answer_start": 662}], "is_impossible": false}], "context": "Submit\nHVAC Operation\nOff/Not applicable\nFilter (Skip if no HVAC system)\nPortable HEPA Air Cleaner\nNo\nOpen Window\nNo\nExtra hour of ventilation\nYes\n\uf62b\n\uf62b Premium (MERV 13)\n\uf62b\n\uf62b\n\uf62b\nYour Results\nEnd of 4-hour visit\n0% particle reduction achieved in your home by\n1 Hour Later\n0% particle reduction achieved in your home by\f10/30/22, 9:41 AM Interactive Home Ventilation Tool | CDC\nconst { default: imageminSvgo } = require(\"imagemin-svgo\");\nDownload Data [CSV \u2013 2 KB]\n0% particle reduction achieved in your home by\nusing ventilation. ;\n0% particle reduction achieved in your home by\nusing ventilation. You can decrease particles even more\nby continuing to ventilate for an extra hour."}]}, {"title": "318d62b3859febe5d57535667016c177", "paragraphs": [{"qas": [{"question": "What does the risk of getting COVID-19 vary according to?", "id": "100000000000000000004623", "answers": [{"text": "individual susceptibility", "answer_start": 49}], "is_impossible": false}, {"question": "The fewer virus particles in the air, the better what?", "id": "100000000000000000004624", "answers": [{"text": "The risk of getting COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "What does this tool use modeling data from?", "id": "100000000000000000004625", "answers": [{"text": "National Institute of Standards and Technology", "answer_start": 247}], "is_impossible": false}, {"question": "What are the results of our model?", "id": "100000000000000000004626", "answers": [{"text": "estimates", "answer_start": 311}], "is_impossible": false}, {"question": "How long is a visitor in a 1,000 square foot space?", "id": "100000000000000000004627", "answers": [{"text": "4 hours", "answer_start": 406}], "is_impossible": false}], "context": "The risk of getting COVID-19 varies according to individual susceptibility and the number of virus particles to which a\nperson is exposed. The fewer virus particles in the air, the better. Model assumptions\n\uf1aa\nThis tool uses modeling data from the National Institute of Standards and Technology. The results are estimates and\nmight not be exact in the real world. Our model assumes a visitor is staying for 4 hours in a 1,000 square-foot space and\nis not wearing a mask."}]}, {"title": "e0ac9c05f47644460f01970713aa1ce1", "paragraphs": [{"qas": [{"question": "How many square feet is the size of an average one bedroom apartment?", "id": "100000000000000000004629", "answers": [{"text": "1,000", "answer_start": 26}], "is_impossible": false}, {"question": "The first panel shows particle reduction based on levels that would be in the air at the end of what?", "id": "100000000000000000004630", "answers": [{"text": "4-hour visit", "answer_start": 249}], "is_impossible": false}, {"question": "What does the second panel show 1 hour after the visitor leaves?", "id": "100000000000000000004631", "answers": [{"text": "particle reduction", "answer_start": 286}], "is_impossible": false}, {"question": "If the \u201cOpen Window\u201d option is selected as \u201cYes,\u201d the tool assumes how many open windows?", "id": "100000000000000000004632", "answers": [{"text": "one single", "answer_start": 405}], "is_impossible": false}, {"question": "What is a scenario with no open windows, no HEPA air cleaner, and no HVAC system use?", "id": "100000000000000000004633", "answers": [{"text": "All scenarios are compared against", "answer_start": 429}], "is_impossible": false}], "context": "This size is used because 1,000 square feet is the size of an average one-bedroom apartment in\nthe United States, or about one floor of a larger home. The first panel shows particle reduction based on levels that would\nbe in the air at the end of a 4-hour visit. The second panel shows particle reduction 1 hour after the visitor leaves. If the \u201cOpen Window\u201d option is selected as \u201cYes,\u201d the tool assumes one single open window. All scenarios are compared\nagainst a scenario with no open windows, no HEPA air cleaner, and no HVAC system use."}]}, {"title": "e1ff85db33f78e670b9ecacff0035afd", "paragraphs": [{"qas": [{"question": "What filter does a regular filter rely on?", "id": "100000000000000000004635", "answers": [{"text": "MERV 6 filtration", "answer_start": 113}], "is_impossible": false}], "context": "For this model, a \u201cpremium\u201d\nfilter is based on one rated for MERV 13 filtration and \u201cregular\u201d filter is based on MERV 6 filtration. Learn more about\nHVAC filters and portable air cleaners. Visit Ventilation in Buildings (item #3 in Ventilation FAQs) to learn more about\nMERV ratings. Last Updated Feb. 9, 2022"}]}, {"title": "a494d52febdeb2724bc588cef8e3ebd8", "paragraphs": [{"qas": [{"question": "When was the last update for the COVID-19 Vaccines?", "id": "100000000000000000004637", "answers": [{"text": "October 19, 2022", "answer_start": 359}], "is_impossible": false}, {"question": "What is the name of the monovalent Novavax vaccine?", "id": "100000000000000000004638", "answers": [{"text": "Janssen COVID-19", "answer_start": 497}], "is_impossible": false}, {"question": "What is a reason for the limited amount of Novavax Covid-19 booster dose?", "id": "100000000000000000004641", "answers": [{"text": "risk of thrombosis with thrombocytopenia syndrome (TTS) following receipt of the vaccine: When there is a contraindication to mRNA", "answer_start": 659}], "is_impossible": false}, {"question": "What is the risk of thrombosis with TTS after receipt of the vaccine?", "id": "100000000000000000004642", "answers": [{"text": "certain limited situations", "answer_start": 621}], "is_impossible": false}, {"question": "What is a contraindication to mRNA?", "id": "100000000000000000004643", "answers": [{"text": "Moderna or Pfizer-BioNTech", "answer_start": 797}], "is_impossible": false}, {"question": "What is a component of an mRNA COVID-19 vaccine?", "id": "100000000000000000004644", "answers": [{"text": "contraindication", "answer_start": 765}], "is_impossible": false}, {"question": "What should recipients be informed about?", "id": "100000000000000000004646", "answers": [{"text": "Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines are recommended over Janssen COVID-19 Vaccine", "answer_start": 1229}], "is_impossible": false}, {"question": "Moderna, Novavax, and Janssen are all what?", "id": "100000000000000000004647", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 808}], "is_impossible": false}, {"question": "What is the name of the company that recommends Moderna, Novavax and Pfizer-BioNTech?", "id": "100000000000000000004649", "answers": [{"text": "Janssen", "answer_start": 497}], "is_impossible": false}], "context": "10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations Home\nInterim Clinical Considerations for Use of COVID-19\nVaccines: Appendices, References, and Previous\nUpdates\nSummary of recent changes (last updated October 19, 2022):\nGuidance for use of a monovalent Novavax COVID-19 booster dose in people ages 18 years and older in limited\nsituations\nJanssen COVID-19 Vaccine is authorized for adults ages 18 years and older for the primary series dose and 1 booster dose in\ncertain limited situations due to the risk of thrombosis with thrombocytopenia syndrome (TTS) following receipt of the\nvaccine:\nWhen there is a contraindication to mRNA (i.e., Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction after a previous dose or to a component of an mRNA COVID-19 vaccine) (see Table 4)\nWhen a person would otherwise remain unvaccinated for COVID-19 due to limited access to other COVID-19 vaccines\nWhen a person wants to receive Janssen COVID-19 Vaccine despite the safety concerns identified\nCOVID-19 vaccine recipients should be informed that Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines are\nrecommended over Janssen COVID-19 Vaccine."}]}, {"title": "13447810da183628f0ab34b66d3749b9", "paragraphs": [{"qas": [{"question": "Who should seek immediate medical care should symptoms develop?", "id": "100000000000000000004651", "answers": [{"text": "People who elect to receive Janssen COVID-19 Vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "Adults ages 18 and older are recommended to receive 1 dose of what vaccine?", "id": "100000000000000000004652", "answers": [{"text": "Janssen COVID-19", "answer_start": 28}], "is_impossible": false}, {"question": "How many doses of mRNA are recommended for ages 18 years and older?", "id": "100000000000000000004653", "answers": [{"text": "bivalent", "answer_start": 413}], "is_impossible": false}, {"question": "How long after the primary dose is it recommended to receive a booster dose?", "id": "100000000000000000004654", "answers": [{"text": "2 months", "answer_start": 378}], "is_impossible": false}, {"question": "What type of booster dose is recommended?", "id": "100000000000000000004655", "answers": [{"text": "bivalent mRNA", "answer_start": 413}], "is_impossible": false}], "context": "People who elect to receive Janssen COVID-19 Vaccine should be informed\nabout the risk and symptoms of TTS (see below), as well as the need to seek immediate medical care should symptoms\ndevelop. Vaccination schedule\nPeople who are not moderately or severely immunocompromised\nAdults ages 18 years and older are recommended to receive 1 primary dose and 1 booster dose at least 2 months after\nthe primary dose. A bivalent mRNA booster dose is recommended."}]}, {"title": "e9d0a64ff097f130fd7de4dbc95502ad", "paragraphs": [{"qas": [{"question": "How many doses of the COVID-19 vaccine are recommended for people with immunocompromised conditions?", "id": "100000000000000000004656", "answers": [{"text": "1 primary dose", "answer_start": 114}], "is_impossible": false}, {"question": "How are the primary series dose and the additional dose separated?", "id": "100000000000000000004657", "answers": [{"text": "by at least 4 weeks", "answer_start": 326}], "is_impossible": false}, {"question": "Who is recommended to receive a booster dose?", "id": "100000000000000000004658", "answers": [{"text": "Adults ages 18 years and older", "answer_start": 56}], "is_impossible": false}, {"question": "How long are the primary series dose and the additional dose separated?", "id": "100000000000000000004660", "answers": [{"text": "4 weeks", "answer_start": 338}], "is_impossible": false}, {"question": "How long is the booster dose administered?", "id": "100000000000000000004661", "answers": [{"text": "2 months", "answer_start": 389}], "is_impossible": false}, {"question": "What are the safety considerations in Appendix A?", "id": "100000000000000000004662", "answers": [{"text": "People who are moderately or severely immunocompromised", "answer_start": 0}], "is_impossible": false}], "context": "People who are moderately or severely immunocompromised\nAdults ages 18 years and older are recommended to receive 1 primary dose, a second (additional) dose using a\nmonovalent mRNA COVID-19 vaccine, and 1 booster dose; a bivalent mRNA booster dose is recommended. The primary\nseries dose and the additional dose are separated by at least 4 weeks. The booster dose is administered at least 2\nmonths after the additional dose. Safety considerations\nAppendices\nAppendix A."}]}, {"title": "d067d6d3c14effc2af7c3a9c9e5d3a14", "paragraphs": [{"qas": [{"question": "What is the name of the CDC's guideline for use of Janssen COVID-19 Vaccine?", "id": "100000000000000000004663", "answers": [{"text": "Interim Clinical Considerations", "answer_start": 65}], "is_impossible": false}, {"question": "What is a summary of the contraindications and precautions to Janssen CoviD-19 vaccination?", "id": "100000000000000000004664", "answers": [{"text": "Table A", "answer_start": 371}], "is_impossible": false}, {"question": "What is the name of the table that summarizes the information about the COVID-19 vaccination?", "id": "100000000000000000004665", "answers": [{"text": "Table A", "answer_start": 371}], "is_impossible": false}], "context": "Guidance for use of Janssen COVID-19 Vaccine\n\uf209\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nContraindications and precautions\nTable A. Contraindications and precautions to Janssen COVID-19 vaccination\nContraindications and precautions to Janssen COVID-19 vaccination are summarized in Table A; see Contraindications and\nprecautions to COVID-19 vaccination for additional information (e.g., people with a history of allergic reactions)."}]}, {"title": "9c17953f397e97eb535dad8bff204b4e", "paragraphs": [{"qas": [{"question": "What does TTS stand for?", "id": "100000000000000000004667", "answers": [{"text": "Thrombosis with thrombocytopenia syndrome", "answer_start": 321}], "is_impossible": false}, {"question": "What is Thrombosis with thrombocytopenia syndrome?", "id": "100000000000000000004668", "answers": [{"text": "booster vaccination with a bivalent mRNA COVID-19 vaccine", "answer_start": 404}], "is_impossible": false}, {"question": "What is the acronym for thrombocytopenia syndrome?", "id": "100000000000000000004669", "answers": [{"text": "Thrombosis", "answer_start": 321}], "is_impossible": false}], "context": "Medical condition or history Guidance Recommended action(s)\nTTS following receipt of a previous Janssen COVID-19 Vaccine (or other\nCOVID-19 vaccines not currently authorized in the United States that\nare based on adenovirus vectors, e.g., AstraZeneca)\nContraindication Do not vaccinate with Janssen COVID-19 Vaccine. See\nThrombosis with thrombocytopenia syndrome (TTS) section\n(below) for information on booster vaccination with a bivalent\nmRNA COVID-19 vaccine. History of an episode of an immune-mediated syndrome characterized\nby thrombosis and thrombocytopenia, such as spontaneous or classic\nHIT\nNot\nrecommended\nDo not vaccinate with Janssen COVID-19 Vaccine. These people\nshould receive an mRNA or Novavax COVID-19 vaccine."}]}, {"title": "7364b9e0a1d394868b7233619157772a", "paragraphs": [{"qas": [{"question": "How long after receipt of Janssen COVID-19 Vaccine is GBS not recommended?", "id": "100000000000000000004672", "answers": [{"text": "6 weeks", "answer_start": 11}], "is_impossible": false}, {"question": "What does TTS stand for?", "id": "100000000000000000004675", "answers": [{"text": "thrombosis with thrombocytopenia syndrome", "answer_start": 316}], "is_impossible": false}, {"question": "What is the abbreviation for heparin-induced thrombocytopenia?", "id": "100000000000000000004676", "answers": [{"text": "HIT", "answer_start": 359}], "is_impossible": false}, {"question": "What were the most commonly reported systemic reactions?", "id": "100000000000000000004678", "answers": [{"text": "Fatigue and headache", "answer_start": 657}], "is_impossible": false}], "context": "GBS within 6 weeks after receipt of Janssen COVID-19 Vaccine Not\nrecommended\nDo not vaccinate with Janssen COVID-19 Vaccine. These people\nshould receive a booster dose using a bivalent mRNA COVID-19\nvaccine. History of GBS Precaution See FAQs and GBS section (below) for additional information. Abbreviations: TTS = thrombosis with thrombocytopenia syndrome; HIT = heparin-induced thrombocytopenia; GBS = Guillain-Barr\u00e9 syndrome\nPost-vaccination symptoms\nIn clinical trials of Janssen COVID-19 Vaccine, pain at the injection site was the most frequently reported local reaction among\nvaccine recipients; erythema and swelling were reported less frequently. Fatigue and headache were the most commonly\nreported systemic reactions."}]}, {"title": "dafbcd76a994eaa901c263798c2927a", "paragraphs": [{"qas": [{"question": "What is the syndrome that includes acute venous or arterial thrombosis?", "id": "100000000000000000004682", "answers": [{"text": "Thrombosis with thrombocytopenia syndrome", "answer_start": 195}], "is_impossible": false}, {"question": "What does the syndrome include in patients with no recent known exposure to heparin?", "id": "100000000000000000004683", "answers": [{"text": "acute venous or arterial thrombosis and new onset thrombocytopenia", "answer_start": 280}], "is_impossible": false}, {"question": "Evidence supports a causal relationship between what vaccine and TTS?", "id": "100000000000000000004684", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 501}], "is_impossible": false}], "context": "Most systemic symptoms were mild to moderate in severity and resolved within 1\u20132 days. Overall, symptoms were more frequent in people ages 18\u201359 years compared to people ages 60 years and older. Thrombosis with thrombocytopenia syndrome (TTS)\nTTS is a rare syndrome that includes acute venous or arterial thrombosis and new onset thrombocytopenia in patients with\nno recent known exposure to heparin. Although the condition is rare, currently available evidence supports a causal\nrelationship between Janssen COVID-19 Vaccine and TTS."}]}, {"title": "2e08668b3d718a9c1468ddc5c11090c7", "paragraphs": [{"qas": [{"question": "What has been reported in males and females following administration of Janssen COVID-19 Vaccine?", "id": "100000000000000000004685", "answers": [{"text": "Cases of TTS", "answer_start": 0}], "is_impossible": false}, {"question": "What is the highest risk of TTS in females ages 30-49 years?", "id": "100000000000000000004686", "answers": [{"text": "deaths", "answer_start": 24}], "is_impossible": false}, {"question": "Who should be informed about the risk and symptoms of the TTS that could occur after vaccination?", "id": "100000000000000000004687", "answers": [{"text": "All people who elect to receive Janssen COVID-19 Vaccine", "answer_start": 177}], "is_impossible": false}, {"question": "What is the typical timeframe for symptoms of TTS after vaccination?", "id": "100000000000000000004688", "answers": [{"text": "within 2 weeks after receipt", "answer_start": 334}], "is_impossible": false}, {"question": "What is another name for Moderna or Pfizer-BioNTech?", "id": "100000000000000000004689", "answers": [{"text": "mRNA", "answer_start": 471}], "is_impossible": false}, {"question": "Novavax COVID-19 is an alternative to what?", "id": "100000000000000000004690", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 552}], "is_impossible": false}, {"question": "What does this guidance apply to both the primary and booster doses of Janssen COVID-19 Vaccine?", "id": "100000000000000000004691", "answers": [{"text": "the availability of mRNA (i.e., Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines instead of Janssen COVID-19 Vaccine", "answer_start": 451}], "is_impossible": false}], "context": "Cases of TTS, including deaths, following administration of Janssen\nCOVID-19 Vaccine have been reported in males and females, with the highest risk in females ages 30\u201349 years. All people who elect to receive Janssen COVID-19 Vaccine should be informed about the risk and symptoms of TTS that could\noccur after vaccination (typically within 2 weeks after receipt), the need to seek immediate medical care should such\nsymptoms develop at any time, and the availability of mRNA (i.e., Moderna or Pfizer-BioNTech) and Novavax COVID-19\nvaccines instead of Janssen COVID-19 Vaccine. This guidance applies to both the primary and booster doses of Janssen COVID-\n19 Vaccine."}]}, {"title": "6ea2c5fb8403b3d410327811519c3cea", "paragraphs": [{"qas": [{"question": "What should people seek medical attention for if they develop any of the following symptoms?", "id": "100000000000000000004692", "answers": [{"text": "Shortness of breath", "answer_start": 96}], "is_impossible": false}, {"question": "Is it contraindicated to administer Janssen COVID-19 Vaccine to people with a history of TTS?", "id": "100000000000000000004694", "answers": [{"text": "It is contraindicated", "answer_start": 297}], "is_impossible": false}, {"question": "What is not FDA-authorized or FDA-approved in the United States?", "id": "100000000000000000004695", "answers": [{"text": "AstraZeneca\u2019s COVID-19 Vaccine", "answer_start": 502}], "is_impossible": false}], "context": "People should seek medical attention immediately if they develop any of the following symptoms:\nShortness of breath\nChest pain\nLeg swelling\nPersistent abdominal pain\nSevere or persistent headaches or blurred vision\nEasy bruising or tiny blood spots under the skin beyond the site of the injection\nIt is contraindicated to administer Janssen COVID-19 Vaccine to people with a history of TTS following receipt of the Janssen\nCOVID-19 Vaccine or any other adenovirus vector-based COVID-19 vaccines (e.g., AstraZeneca\u2019s COVID-19 Vaccine, which is\nnot FDA-authorized or FDA-approved in the United States)."}]}, {"title": "7855d3c51fb972a2fb05e5b06278365", "paragraphs": [{"qas": [{"question": "How long after their dose of Janssen COVID-19 Vaccine are people recommended to receive a bivalent mRNA booster dose?", "id": "100000000000000000004696", "answers": [{"text": "2 months", "answer_start": 78}], "is_impossible": false}, {"question": "Who may assist with decisions about using an mRNA COVID-19 vaccine as a booster and the timing of the booster vaccination?", "id": "100000000000000000004698", "answers": [{"text": "a hematologist or other specialists", "answer_start": 287}], "is_impossible": false}], "context": "These people are recommended to receive a bivalent mRNA\nbooster dose at least 2 months following their dose of Janssen COVID-19 Vaccine and after their clinical condition has\nstabilized. Prior to booster vaccination, a conversation between the patient and their clinical team, including a hematologist or\nother specialists, may assist with decisions about using an mRNA COVID-19 vaccine as a booster and the timing of the booster\nvaccination."}]}, {"title": "fa99a1d1e2d835afb4f6be2acc7f55f", "paragraphs": [{"qas": [{"question": "What should clinicians consult for information on the diagnosis and treatment of suspected TTS cases?", "id": "100000000000000000004699", "answers": [{"text": "American Society of Hematology", "answer_start": 44}], "is_impossible": false}, {"question": "Who should report any occurrence of TTS to VAERS?", "id": "100000000000000000004700", "answers": [{"text": "Clinicians", "answer_start": 0}], "is_impossible": false}, {"question": "What is the acronym for Interim Clinical Considerations for Use of COVID-19?", "id": "100000000000000000004701", "answers": [{"text": "treatment of suspected cases of TTS", "answer_start": 324}], "is_impossible": false}, {"question": "What vaccine appears to be similar to TTS?", "id": "100000000000000000004702", "answers": [{"text": "Janssen COVID-19", "answer_start": 523}], "is_impossible": false}, {"question": "What is the mechanism of TTS associated with the Janssen COVID-19 vaccine unclear?", "id": "100000000000000000004703", "answers": [{"text": "it appears to be similar to another rare immune-mediated syndrome, spontaneous heparin-induced thrombocytopenia", "answer_start": 560}], "is_impossible": false}, {"question": "What is another rare immune-mediated syndrome?", "id": "100000000000000000004704", "answers": [{"text": "spontaneous heparin-induced thrombocytopenia", "answer_start": 627}], "is_impossible": false}], "context": "Clinicians should consult guidance from the American Society of Hematology for information on the diagnosis and\ntreatment of suspected cases of TTS and report any occurrence of TTS to VAERS\n\uf209\n\uf209\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\ntreatment of suspected cases of TTS, and report any occurrence of TTS to VAERS . People with a history of thrombosis or risk factors for thrombosis\nAlthough the mechanism of TTS associated with the Janssen COVID-19 Vaccine is unclear, it appears to be similar to another\nrare immune-mediated syndrome, spontaneous heparin-induced thrombocytopenia (HIT)."}]}, {"title": "7a1f79f3ebcee566a1ba70a5e94935ac", "paragraphs": [{"qas": [{"question": "Who should not receive the Janssen COVID-19 Vaccine?", "id": "100000000000000000004706", "answers": [{"text": "People with a history of an episode of an immune-mediated syndrome", "answer_start": 0}], "is_impossible": false}, {"question": "What should people with a history of an episode of an immune-mediated syndrome characterized by thrombosis and thombocytopenia not receive?", "id": "100000000000000000004707", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 172}], "is_impossible": false}, {"question": "Who should receive the Novavax Covid-19 vaccine?", "id": "100000000000000000004708", "answers": [{"text": "People with a history of an episode of an immune-mediated syndrome characterized by thrombosis and thrombocytopenia, such as spontaneous or classic HIT, should not receive Janssen COVID-19 Vaccine. These people", "answer_start": 0}], "is_impossible": false}, {"question": "What is Guillain-Barr\u00e9 syndrome?", "id": "100000000000000000004710", "answers": [{"text": "GBS", "answer_start": 546}], "is_impossible": false}, {"question": "What vaccine did not increase the risk of TTS?", "id": "100000000000000000004711", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 172}], "is_impossible": false}, {"question": "How many GBS cases were observed after Janssen COVID-19 vaccination?", "id": "100000000000000000004712", "answers": [{"text": "proportionally more", "answer_start": 650}], "is_impossible": false}], "context": "People with a history of an episode of an immune-mediated syndrome characterized by thrombosis and thrombocytopenia,\nsuch as spontaneous or classic HIT, should not receive Janssen COVID-19 Vaccine. These people should receive a currently\nFDA-approved or FDA-authorized mRNA (i.e., Moderna or Pfizer-BioNTech) or Novavax COVID-19 vaccine. Available evidence does not indicate that other thromboembolic conditions (e.g., inherited or acquired thrombophilia,\npregnancy, hormonal contraception use) increase the risk of TTS. Guillain-Barr\u00e9 syndrome (GBS)\nVaccine safety monitoring suggests an elevated risk of GBS after Janssen COVID-19 vaccination with proportionally more\nGBS cases observed after Janssen COVID-19 vaccination compared with mRNA COVID-19 vaccination."}]}, {"title": "812c133bd0265286a28dca7f10737a5d", "paragraphs": [{"qas": [{"question": "Most GBS reports have been in what gender?", "id": "100000000000000000004715", "answers": [{"text": "males", "answer_start": 175}], "is_impossible": false}], "context": "The highest risk has\nbeen observed in people ages 40\u201364 years, with symptoms of GBS beginning within 42 days after Janssen COVID-19\nvaccination; most GBS reports have been in males."}]}, {"title": "d99b0fadd3157f8277f7905d02c267c6", "paragraphs": [{"qas": [{"question": "What is tingling sensations especially in the legs or arms that is worsening and spreading to other parts of the body?", "id": "100000000000000000004717", "answers": [{"text": "Weakness", "answer_start": 119}], "is_impossible": false}, {"question": "What is a precaution for receiving a subsequent dose of Janssen COVID-19 Vaccine?", "id": "100000000000000000004718", "answers": [{"text": "Development of GBS", "answer_start": 429}], "is_impossible": false}, {"question": "How long after receipt of the vaccine should people develop GBS?", "id": "100000000000000000004719", "answers": [{"text": "6 weeks", "answer_start": 598}], "is_impossible": false}, {"question": "What is an example of an inability to move eyes?", "id": "100000000000000000004720", "answers": [{"text": "Double vision", "answer_start": 339}], "is_impossible": false}, {"question": "How many weeks after receipt of Janssen COVID-19 Vaccine should not receive another dose of what vaccine?", "id": "100000000000000000004721", "answers": [{"text": "6", "answer_start": 598}], "is_impossible": false}], "context": "People should seek medical attention immediately if they develop any of the following symptoms after receiving Janssen\nWeakness or tingling sensations, especially in the legs or arms, that is worsening and spreading to other parts of the\nbody\nDifficulty walking\nDifficulty with facial movements, including speaking, chewing, or swallowing\nDouble vision or inability to move eyes\nDifficulty with bladder control or bowel function\nDevelopment of GBS after receipt of Janssen COVID-19 Vaccine is a precaution for receiving subsequent dose(s) of Janssen\nCOVID-19 Vaccine. People who develop GBS within 6 weeks after receipt of Janssen COVID-19 Vaccine should not receive\nanother dose of Janssen COVID-19 Vaccine."}]}, {"title": "550b7f366c552a2ec89173f8d57136ef", "paragraphs": [{"qas": [{"question": "What should be used for any subsequent (i.e., booster) doses?", "id": "100000000000000000004722", "answers": [{"text": "A bivalent mRNA COVID-19 vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "Who should strongly consider using an mRNA COVID-19 vaccine for subsequent doses in people who had GBS onset beyond 6 weeks after receipt of Janssen CoviD-19 Vaccine?", "id": "100000000000000000004723", "answers": [{"text": "Providers", "answer_start": 90}], "is_impossible": false}, {"question": "What should any occurrence of GBS after COVID-19 vaccination be reported to?", "id": "100000000000000000004724", "answers": [{"text": "VAERS", "answer_start": 343}], "is_impossible": false}, {"question": "What depends on the number and type of vaccine received for the primary series and/or booster dose?", "id": "100000000000000000004725", "answers": [{"text": "The recommendations for people vaccinated outside of the United States", "answer_start": 374}], "is_impossible": false}], "context": "A bivalent mRNA COVID-19 vaccine should be used for any subsequent (i.e.,\nbooster) doses. Providers should also strongly consider using an mRNA COVID-19 vaccine for subsequent doses in people\nwho had GBS onset beyond 6 weeks after receipt of Janssen COVID-19 Vaccine. Any occurrence of GBS following COVID-19\nvaccination should be reported to VAERS. \uf209\n\uf20c\nTable of Contents \uf426\nThe recommendations for people vaccinated outside of the United States depend on the number and type of vaccine(s)\nreceived for the primary series and/or booster dose(s)."}]}, {"title": "a056ce0c9a20d14eb7efaade73833523", "paragraphs": [{"qas": [{"question": "For additional guidance on primary and booster vaccination, see guidance for people who initiated vaccination outside of what country?", "id": "100000000000000000004728", "answers": [{"text": "the United States", "answer_start": 44}], "is_impossible": false}, {"question": "Who is advised on primary and booster vaccinations?", "id": "100000000000000000004729", "answers": [{"text": "people who are not moderately or severely immunocompromised", "answer_start": 359}], "is_impossible": false}, {"question": "What is the guidance for people who are not moderate or severely immunocompromised?", "id": "100000000000000000004730", "answers": [{"text": "primary and booster vaccination", "answer_start": 309}], "is_impossible": false}, {"question": "Where did people receive the COVID-19 vaccine outside of the United States?", "id": "100000000000000000004731", "answers": [{"text": "Table B", "answer_start": 493}], "is_impossible": false}, {"question": "What is the name of the vaccine that is FDA-approved or FDA-authorized?", "id": "100000000000000000004732", "answers": [{"text": "COVID-19", "answer_start": 587}], "is_impossible": false}], "context": "People who initiated vaccination outside of the United States are\nconsidered to be up to date with their COVID-19 vaccines when they have completed the recommended actions described\nbelow. Age-appropriate Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccine products can be used. For additional\nguidance on primary and booster vaccination, see guidance for people who are not moderately or severely\nimmunocompromised and guidance for people who are moderately or severely immunocompromised. Table B. People who received COVID-19 vaccine outside the United States\nTable B.1. Received a COVID-19 vaccine that is FDA-approved or FDA-authorized\nVaccination history Recommended actions\nReceived all recommended primary dose(s) Do not repeat primary series."}]}, {"title": "f914d31ce21d13345694fdc8ed49695b", "paragraphs": [{"qas": [{"question": "What should you do if you are eligible for a booster dose of COVID-19?", "id": "100000000000000000004733", "answers": [{"text": "Administer a bivalent mRNA booster dose if eligible. * Appendix B. People who received COVID-19 vaccine outside the United States \u2020\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC Vaccination history Recommended actions Received a partial mRNA (i.e., Moderna or Pfizer-BioNTech) or Novavax COVID-19 vaccine primary series Do not restart primary series", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the partial mRNA or Novavax vaccine?", "id": "100000000000000000004734", "answers": [{"text": "Moderna or Pfizer-BioNTech", "answer_start": 334}], "is_impossible": false}, {"question": "What is the name of the mRNA or Novavax COVID-19 vaccine primary series?", "id": "100000000000000000004735", "answers": [{"text": "Moderna or Pfizer-BioNTech", "answer_start": 334}], "is_impossible": false}, {"question": "Do not restart primary series.", "id": "100000000000000000004736", "answers": [{"text": "10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC Vaccination history Recommended actions Received a partial mRNA (i.e., Moderna or Pfizer-BioNTech) or Novavax COVID-19 vaccine primary series Do not restart primary series. Complete primary series as close to the recommended time as possible", "answer_start": 131}], "is_impossible": false}, {"question": "Administer what if eligible?", "id": "100000000000000000004738", "answers": [{"text": "bivalent mRNA booster dose", "answer_start": 541}], "is_impossible": false}, {"question": "Dosage after completion of primary series?", "id": "100000000000000000004739", "answers": [{"text": "Received a monovalent booster dose", "answer_start": 583}], "is_impossible": false}, {"question": "Do you need to administer a bivalent mRNA booster dose?", "id": "100000000000000000004740", "answers": [{"text": "Received a monovalent booster dose(s) after completion of primary series Administer a bivalent mRNA booster dose if eligible", "answer_start": 582}], "is_impossible": false}], "context": "Administer a bivalent mRNA booster dose if eligible. *\nAppendix B. People who received COVID-19 vaccine outside the United\nStates\n\u2020\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nVaccination history Recommended actions\nReceived a partial mRNA (i.e., Moderna or Pfizer-BioNTech) or Novavax\nCOVID-19 vaccine primary series\nDo not restart primary series. Complete primary series as close to the recommended time as\npossible with the same vaccine. Administer a bivalent mRNA booster dose if eligible. *\nReceived a monovalent booster dose(s) after completion of primary series Administer a bivalent mRNA booster dose if eligible."}]}, {"title": "d3292438ff5b60c13da4032b6e7c2c4f", "paragraphs": [{"qas": [{"question": "What type of mRNA booster did I receive after the primary series?", "id": "100000000000000000004741", "answers": [{"text": "bivalent", "answer_start": 13}], "is_impossible": false}, {"question": "Who approved or authorized the use of the vaccine for emergency use?", "id": "100000000000000000004743", "answers": [{"text": "FDA", "answer_start": 367}], "is_impossible": false}, {"question": "Do not repeat what?", "id": "100000000000000000004744", "answers": [{"text": "if booster dose contained the original SARS-CoV-2 strain and Omicron BA.4/BA.5 variants", "answer_start": 93}], "is_impossible": false}, {"question": "Administer a bivalent mRNA booster dose if eligible?", "id": "100000000000000000004745", "answers": [{"text": "Do not repeat primary series", "answer_start": 467}], "is_impossible": false}, {"question": "Complete the primary series with Moderna, Novavax or what other vaccine?", "id": "100000000000000000004746", "answers": [{"text": "Pfizer- BioNTech", "answer_start": 655}], "is_impossible": false}, {"question": "What is the name of the vaccine that should be used as soon as possible?", "id": "100000000000000000004747", "answers": [{"text": "COVID-19", "answer_start": 284}], "is_impossible": false}, {"question": "Which vaccines should be given as close as possible to the recommended time?", "id": "100000000000000000004748", "answers": [{"text": "Moderna, Novavax, or Pfizer- BioNTech", "answer_start": 634}], "is_impossible": false}, {"question": "Novavax or Pfizer- BioNTech vaccines must be administered as close to what time limit?", "id": "100000000000000000004749", "answers": [{"text": "the recommended time as possible", "answer_start": 700}], "is_impossible": false}], "context": "*\nReceived a bivalent mRNA booster dose after completion of the primary\nseries\nDo not repeat if booster dose contained the original SARS-CoV-2 strain\nand Omicron BA.4/BA.5 variants\nFor other bivalent mRNA vaccines, see Special situation (after table\nfootnotes). Table B.2. Received a COVID-19 vaccine listed for emergency use by WHO but not approved or authorized by FDA\nVaccination history Recommended actions\nReceived all recommended primary doses for that vaccine Do not repeat primary series. Administer a bivalent mRNA booster dose if eligible. *\nReceived partial primary series for that vaccine Complete the primary series with Moderna, Novavax, or Pfizer-\nBioNTech vaccine dose(s) as close to the recommended time as\npossible."}]}, {"title": "6959e4ee5fbee286181636c0d34bd5a1", "paragraphs": [{"qas": [{"question": "What type of booster dose is given if you are eligible?", "id": "100000000000000000004751", "answers": [{"text": "bivalent mRNA", "answer_start": 75}], "is_impossible": false}, {"question": "How long does it take to receive a monovalent booster dose?", "id": "100000000000000000004752", "answers": [{"text": "28 days. Administer a bivalent mRNA booster dose if eligible. * Received a monovalent booster dose after completion of primary series", "answer_start": 53}], "is_impossible": false}, {"question": "Who lists COVID-19 vaccines for emergency use?", "id": "100000000000000000004753", "answers": [{"text": "WHO", "answer_start": 376}], "is_impossible": false}, {"question": "How many doses of the vaccine are not FDA-approved or FDA-authorized?", "id": "100000000000000000004754", "answers": [{"text": "one", "answer_start": 390}], "is_impossible": false}, {"question": "Do not repeat what if you are eligible?", "id": "100000000000000000004755", "answers": [{"text": "primary series", "answer_start": 530}], "is_impossible": false}], "context": "Space from the last WHO-EUL vaccine dose by at least 28\ndays. Administer a bivalent mRNA booster dose if eligible. *\nReceived a monovalent booster dose after completion of primary series Administer a bivalent mRNA booster dose if eligible. *\nTable B.3. Received a heterologous primary series or booster dose composed of doses of a COVID-19 vaccine listed for\nemergency use by WHO, at least one of which is not FDA-approved or FDA-authorized\nVaccination history Recommended actions\nReceived a complete primary series Do not repeat primary series. Administer a bivalent mRNA booster dose if eligible."}]}, {"title": "725efdf0c25249c8f0a16349d0c2a1b7", "paragraphs": [{"qas": [{"question": "What type of booster dose did the recipient receive after the primary series?", "id": "100000000000000000004756", "answers": [{"text": "monovalent", "answer_start": 13}], "is_impossible": false}, {"question": "How many doses of COVID-19 vaccines were not FDA-authorized, FDA-approved or listed for emergency use by WHO?", "id": "100000000000000000004757", "answers": [{"text": "Received all or some of the recommended doses", "answer_start": 138}], "is_impossible": false}, {"question": "Who recommends emergency use of vaccines?", "id": "100000000000000000004759", "answers": [{"text": "WHO", "answer_start": 292}], "is_impossible": false}, {"question": "Do not count doses received toward vaccination in the US?", "id": "100000000000000000004760", "answers": [{"text": "Received any number and combination of vaccine doses", "answer_start": 336}], "is_impossible": false}, {"question": "Start primary series at least how many days after the last dose of vaccine?", "id": "100000000000000000004761", "answers": [{"text": "28", "answer_start": 477}], "is_impossible": false}, {"question": "Administer a bivalent mRNA booster dose if eligible.", "id": "100000000000000000004762", "answers": [{"text": "Received a monovalent booster dose after completion of primary series", "answer_start": 1}], "is_impossible": false}], "context": "*\nReceived a monovalent booster dose after completion of primary series Administer a bivalent mRNA booster dose if eligible. *\nTable B.4. Received all or some of the recommended doses of COVID-19 vaccines that are NOT FDA-authorized, FDA-\napproved, or among those listed for emergency use by WHO\nVaccination history Recommended actions\nReceived any number and combination of vaccine doses Do not count doses received toward vaccination in the US. Start primary series at least 28 days after the last dose of vaccine. Administer a bivalent mRNA booster dose if eligible."}]}, {"title": "c8b3a6ba7cc39f126a1f82647be73d46", "paragraphs": [{"qas": [{"question": "What type of booster dose may be used in limited situations?", "id": "100000000000000000004766", "answers": [{"text": "monovalent Novavax", "answer_start": 184}], "is_impossible": false}, {"question": "How long after the last dose is the Novavax booster dose administered?", "id": "100000000000000000004767", "answers": [{"text": "6 months", "answer_start": 428}], "is_impossible": false}], "context": "*\nPeople ages 5 years and older who received a COVID-19 vaccine that is FDA-authorized, FDA-approved, or listed for emergency use by WHO\nshould receive 1 bivalent mRNA booster dose. A monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people ages 18 years and\nolder who have not received any previous booster dose(s). The Novavax booster dose is administered at least 6 months after the last primary\nseries dose."}]}, {"title": "e3f9626519a8540093aadcf9232facaa", "paragraphs": [{"qas": [{"question": "Who has not evaluated the efficacy or safety of the vaccines?", "id": "100000000000000000004769", "answers": [{"text": "CDC or ACIP", "answer_start": 154}], "is_impossible": false}, {"question": "Do not administer a second bivalent mRNA booster dose if the person previously received a bivalent Moderna or Pfizer-BioNTech?", "id": "100000000000000000004770", "answers": [{"text": "COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}], "context": "COVID-19 vaccines that are listed for emergency use by WHO , but are not approved or authorized by FDA, have not been evaluated for\nefficacy or safety by CDC or ACIP. Special situation: Do not administer a second bivalent mRNA booster dose if the person previously received a bivalent\nModerna or Pfizer-BioNTech booster dose containing the original SARS-CoV-2 strain and Omicron BA.1 variant."}]}, {"title": "d920ff3811c1a21245de71e73a449394", "paragraphs": [{"qas": [{"question": "Who received the COVID-19 vaccine as part of a clinical trial?", "id": "100000000000000000004772", "answers": [{"text": "U.S. trial participants", "answer_start": 250}], "is_impossible": false}, {"question": "Who received all the recommended primary series doses?", "id": "100000000000000000004773", "answers": [{"text": "U.S. trial participants", "answer_start": 250}], "is_impossible": false}, {"question": "Who has independently confirmed the efficacy of COVID-19 vaccines?", "id": "100000000000000000004774", "answers": [{"text": "U.S. data and safety monitoring board or equivalent", "answer_start": 460}], "is_impossible": false}, {"question": "What is the name of the U.S. data and safety monitoring board or equivalent?", "id": "100000000000000000004775", "answers": [{"text": "\u2020 \u2020 \u2021 \u2020 \u2020 * \u2020 \u2021 \uf209 Table of Contents \uf426 Appendix C. People who received COVID-19 vaccine as part of a clinical trial\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC U.S. trial participants, along with non-U.S.-based participants in the same trial, who received all the recommended primary series doses of a vaccine that is not listed for emergency use by WHO but for which a U.S. data and safety monitoring board or equivalent has independently confirmed efficacy are considered up to date with their COVID-19 vaccines when they have received a bivalent mRNA booster dose", "answer_start": 3}], "is_impossible": false}, {"question": "Who is not listed for emergency use?", "id": "100000000000000000004776", "answers": [{"text": "\u2020 \u2020 \u2021 \u2020 \u2020 * \u2020", "answer_start": 3}], "is_impossible": false}, {"question": "What is the name of the mRNA booster given to COVID-19 vaccines?", "id": "100000000000000000004777", "answers": [{"text": "bivalent", "answer_start": 630}], "is_impossible": false}], "context": "\u2020\n\u2021\n\u2020\n\u2020\n\u2021\n\u2020\n\u2020\n*\n\u2020\n\u2021 \uf209\nTable of Contents \uf426\nAppendix C. People who received COVID-19 vaccine as part of a clinical\ntrial\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nU.S. trial participants, along with non-U.S.-based participants in the same trial, who received all the recommended primary\nseries doses of a vaccine that is not listed for emergency use by WHO but for which a U.S. data and safety monitoring board\nor equivalent has independently confirmed efficacy are considered up to date with their COVID-19 vaccines when they have\nreceived a bivalent mRNA booster dose."}]}, {"title": "98b11cde318360cf129dfe9a67be0922", "paragraphs": [{"qas": [{"question": "What is the only vaccine that meets the criteria for people ages 18 and older?", "id": "100000000000000000004779", "answers": [{"text": "Medicago COVID-19", "answer_start": 23}], "is_impossible": false}, {"question": "How many doses of a primary series are detailed in guidance for people who are moderately or severely immunocompromised?", "id": "100000000000000000004781", "answers": [{"text": "third", "answer_start": 190}], "is_impossible": false}, {"question": "What do people who plan to receive a third primary dose through a clinical trial need to know about?", "id": "100000000000000000004782", "answers": [{"text": "booster doses", "answer_start": 492}], "is_impossible": false}, {"question": "What are people who are not moderately or severely immunocompromised?", "id": "100000000000000000004783", "answers": [{"text": "booster doses", "answer_start": 492}], "is_impossible": false}], "context": "At this time, only the Medicago COVID-19 Vaccine in people ages 18 years and older\nmeet these criteria. Moderately or severely immunocompromised clinical trial participants should receive a third primary dose of an mRNA\nvaccine 28 days after receiving the second vaccine dose of a primary series as detailed in guidance for people who are\nmoderately or severely immunocompromised, unless they have received or plan to receive a third primary dose through a\nclinical trial. For information on booster doses, see guidance for people who are not moderately or severely immunocompromised and\nguidance for people who are moderately or severely immunocompromised."}]}, {"title": "b221052100e20135834f0b0c2b519be", "paragraphs": [{"qas": [{"question": "What is the term for any preventable event that may cause or lead to inappropriate use of vaccine or patient harm?", "id": "100000000000000000004784", "answers": [{"text": "vaccine administration error", "answer_start": 22}], "is_impossible": false}, {"question": "Who should inform the recipient of the vaccine administration error?", "id": "100000000000000000004785", "answers": [{"text": "Inform the recipient of the vaccine administration error. Consult with the state immunization program and/or immunization information system (IIS)", "answer_start": 186}], "is_impossible": false}, {"question": "What is IIS?", "id": "100000000000000000004786", "answers": [{"text": "immunization information system", "answer_start": 296}], "is_impossible": false}, {"question": "What is another name for immunization information system?", "id": "100000000000000000004787", "answers": [{"text": "IIS", "answer_start": 329}], "is_impossible": false}, {"question": "What does VAERS stand for?", "id": "100000000000000000004788", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 475}], "is_impossible": false}], "context": "Table of Contents \uf426\nA vaccine administration error is any preventable event that may cause or lead to inappropriate use of vaccine or patient\nharm. For all vaccine administration errors:\nInform the recipient of the vaccine administration error. Consult with the state immunization program and/or immunization information system (IIS) to determine how the dose\nshould be entered into the IIS, both as an administered dose and to account for inventory. Report the error to the Vaccine Adverse Event Reporting System (VAERS), unless otherwise indicated in the table. Providers are required to report all COVID-19 vaccine administration errors\u2014even those not associated with an adverse\nevent\u2014to VAERS."}]}, {"title": "14cc9653da9f9b4a3a6384605ae8ad90", "paragraphs": [{"qas": [{"question": "How do you file an electronic report?", "id": "100000000000000000004791", "answers": [{"text": "see the VAERS website", "answer_start": 37}], "is_impossible": false}, {"question": "What is the name of the CDC's vaccine administration web page?", "id": "100000000000000000004794", "answers": [{"text": "Vaccine Administration", "answer_start": 221}], "is_impossible": false}, {"question": "What is a job aid for preventing errors?", "id": "100000000000000000004795", "answers": [{"text": "CDC\u2019s vaccine administration web page, including a job aid for preventing errors. Follow the revaccination guidance in the table below, using an age-appropriate COVID-19 vaccine product", "answer_start": 366}], "is_impossible": false}, {"question": "What is the recommended schedule of subsequent dose(s)?", "id": "100000000000000000004797", "answers": [{"text": "continue with the recommended schedule of subsequent dose(s) unless otherwise noted", "answer_start": 558}], "is_impossible": false}], "context": "To file an electronic report, please see the VAERS website . Determine how the error occurred and implement strategies to prevent it from happening again. A discussion on\nstrategies to prevent errors can be found in the \u201cVaccine Administration\u201d chapter of Epidemiology and Prevention of\nVaccine-Preventable Diseases (Pink Book). Additional resources can be found on CDC\u2019s vaccine administration web page,\nincluding a job aid for preventing errors. Follow the revaccination guidance in the table below, using an age-appropriate COVID-19 vaccine product. Then continue\nwith the recommended schedule of subsequent dose(s) unless otherwise noted (see footnotes to this Appendix)."}]}, {"title": "6ce8bfc5b07d7d0a94dbf55fae02358", "paragraphs": [{"qas": [{"question": "Why do some experts suggest delaying the repeat dose for 8 weeks after the invalid dose?", "id": "100000000000000000004798", "answers": [{"text": "the potential for increased reactogenicity", "answer_start": 128}], "is_impossible": false}, {"question": "What is the rare risk of myocarditis and pericardiitis from an mRNA COVID-19 vaccine?", "id": "100000000000000000004799", "answers": [{"text": "males ages 12\u201339 years", "answer_start": 396}], "is_impossible": false}, {"question": "What should be taken into consideration when recommending a longer interval of vaccination?", "id": "100000000000000000004800", "answers": [{"text": "Individual risk for COVID-19", "answer_start": 421}], "is_impossible": false}, {"question": "What are two groups at increased risk for myocarditis?", "id": "100000000000000000004801", "answers": [{"text": "males ages 12\u201339 years", "answer_start": 396}], "is_impossible": false}], "context": "For doses recommended to be repeated, some experts suggest delaying the repeat dose for 8 weeks after the\ninvalid dose based on the potential for increased reactogenicity and the rare risk of myocarditis and pericarditis\nfrom an mRNA COVID-19 vaccine (i.e., Moderna or Pfizer-BioNTech) or Novavax COVID-19 Vaccine, particularly in\ngroups at increased risk for myocarditis and pericarditis (e.g., males ages 12\u201339 years). Individual risk for COVID-19\nand the likelihood for an adverse event following COVID-19 vaccination should be taken into consideration when\nrecommending a longer interval."}]}, {"title": "58638f226e1a3258109d6a5322110a39", "paragraphs": [{"qas": [{"question": "The recommendations in the table below apply to all COVID-19 vaccines and all doses?", "id": "100000000000000000004803", "answers": [{"text": "primary series and booster dose), unless otherwise stated", "answer_start": 281}], "is_impossible": false}, {"question": "What are the two main doses of COVID-19 vaccines?", "id": "100000000000000000004804", "answers": [{"text": "primary series and booster dose", "answer_start": 282}], "is_impossible": false}, {"question": "What is another name for site other than the deltoid muscle or vastus lateralis muscle?", "id": "100000000000000000004805", "answers": [{"text": "Incorrect site", "answer_start": 502}], "is_impossible": false}], "context": "It is acceptable to administer the repeat dose at an interval earlier than 8 weeks if\nthe interval is not sooner than the minimal interval noted in this table. The recommendations in the table below apply to all FDA-approved or FDA-authorized COVID-19 vaccines and all doses (i.e.,\nprimary series and booster dose), unless otherwise stated. Table D. Interim recommendations for COVID-19 vaccine administration errors and deviations\nType Administration error/deviation Interim recommendation\nSite/route Incorrect site (i.e., site other than the\ndeltoid muscle or vastus lateralis\nmuscle)\nDo not repeat dose."}]}, {"title": "83d309657e74429d974743799c64c876", "paragraphs": [{"qas": [{"question": "What should be referenced for detailed information on storage and handling, dosing and schedule, dose preparation, and administration of COVID-19 vaccines?", "id": "100000000000000000004806", "answers": [{"text": "The FDA-issued Fact Sheet for Healthcare Providers Administering Vaccines", "answer_start": 57}], "is_impossible": false}, {"question": "The information provided below on managing vaccine administration errors should not be interpreted as what?", "id": "100000000000000000004807", "answers": [{"text": "a recommendation or promotion of unauthorized use of the vaccines", "answer_start": 384}], "is_impossible": false}, {"question": "What should not be interpreted as a recommendation or promotion of unauthorized use of the vaccines?", "id": "100000000000000000004808", "answers": [{"text": "The information provided below on managing vaccine administration errors", "answer_start": 282}], "is_impossible": false}, {"question": "Who should not repeat dose?", "id": "100000000000000000004809", "answers": [{"text": "Incorrect route", "answer_start": 653}], "is_impossible": false}, {"question": "Do not repeat what?", "id": "100000000000000000004810", "answers": [{"text": "dose", "answer_start": 704}], "is_impossible": false}], "context": "Appendix D. Vaccine administration errors and deviations\nThe FDA-issued Fact Sheet for Healthcare Providers Administering Vaccines should be referenced for detailed\ninformation on storage and handling, dosing and schedule, dose preparation, and administration of COVID-19 vaccines. The information provided below on managing vaccine administration errors should not be interpreted as a\nrecommendation or promotion of unauthorized use of the vaccines. \uf209\n\uf209\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nType Administration error/deviation Interim recommendation\nmuscle)\nIncorrect route (e.g., subcutaneous) Do not repeat dose. Inform the recipient of the potential for local and systemic adverse\nevents."}]}, {"title": "2e4b123147526e90f8b3c8a9020f205e", "paragraphs": [{"qas": [{"question": "Do not give another dose at this time?", "id": "100000000000000000004812", "answers": [{"text": "Age Unauthorized age group", "answer_start": 0}], "is_impossible": false}, {"question": "Do not repeat what?", "id": "100000000000000000004814", "answers": [{"text": "dose", "answer_start": 271}], "is_impossible": false}, {"question": "What is the minimum interval for repeating a vaccine dose?", "id": "100000000000000000004815", "answers": [{"text": "no", "answer_start": 477}], "is_impossible": false}, {"question": "What can happen if a half-volume dose of vaccine is administered to a patient recommended for the full volume?", "id": "100000000000000000004816", "answers": [{"text": "another half-volume dose can be administered on the same clinic day", "answer_start": 603}], "is_impossible": false}, {"question": "How many doses of vaccine can count as 1 full dose of the vaccine?", "id": "100000000000000000004817", "answers": [{"text": "2", "answer_start": 680}], "is_impossible": false}], "context": "Age Unauthorized age group (recipients\nyounger than age 6 months)\nDo not give another dose at this time. *\nProduct and dosage Higher-than-authorized dose\nadministered (e.g., incorrect dose\nvolume, incorrect product resulting in\nhigher-than-authorized dose)\nDo not repeat dose. Lower-than-authorized dose\nadministered (e.g., leaked out of the\nsyringe, equipment failure, recipient\npulled away, incorrect product resulting\nin lower-than-authorized dose)\nRepeat dose immediately (no minimum interval). However, if a half-volume dose of vaccine is administered to a patient\nrecommended for the full volume, another half-volume dose can be\nadministered on the same clinic day, and the 2 doses can count as 1 full\ndose."}]}, {"title": "830755304e11c6da375dc07017995208", "paragraphs": [{"qas": [{"question": "Bivalent Pfizer-BioNTech vaccine: Do not repeat what?", "id": "100000000000000000004818", "answers": [{"text": "dose", "answer_start": 113}], "is_impossible": false}, {"question": "Bivalent Moderna vaccine: Repeat 1 monovalent dose immediately (no minimum interval) because administration of the booster dose will result in a lower-than-authorized dose?", "id": "100000000000000000004819", "answers": [{"text": "Do not repeat dose", "answer_start": 99}], "is_impossible": false}, {"question": "Do not repeat what?", "id": "100000000000000000004820", "answers": [{"text": "dose", "answer_start": 413}], "is_impossible": false}, {"question": "Providers may administer 1 bivalent booster dose as a repeat dose based on clinical judgement and what else?", "id": "100000000000000000004821", "answers": [{"text": "patient preference", "answer_start": 526}], "is_impossible": false}, {"question": "Space the repeat dose after the dose given in error by at least how long?", "id": "100000000000000000004822", "answers": [{"text": "2 months", "answer_start": 624}], "is_impossible": false}], "context": "Bivalent vaccine incorrectly\nadministered for the primary series\nBivalent Pfizer-BioNTech vaccine: Do not repeat dose. Bivalent Moderna vaccine: Repeat 1 monovalent dose immediately (no\nminimum interval) because administration of the booster dose will\nresult in a lower-than-authorized dose. Monovalent vaccine incorrectly\nadministered for a booster dose (if\nbivalent booster indicated)\nIn general, do not repeat dose. However, providers may administer 1 bivalent booster dose as a repeat\ndose based on clinical judgement and patient preference. In this case,\nspace the repeat dose after the dose given in error by at least 2 months."}]}, {"title": "5e1624af5a72c2e5175eb7eec3ef9e6a", "paragraphs": [{"qas": [{"question": "What should you do if the manufacturer does not have data to support the stability of the vaccine?", "id": "100000000000000000004824", "answers": [{"text": "repeat the dose immediately", "answer_start": 259}], "is_impossible": false}, {"question": "Dose administered past the expiration/beyond-use date?", "id": "100000000000000000004825", "answers": [{"text": "vaccine", "answer_start": 169}], "is_impossible": false}, {"question": "Dose administered past the expiration/beyond-use date Contact the manufacturer for information on what?", "id": "100000000000000000004826", "answers": [{"text": "the stability of the vaccine", "answer_start": 149}], "is_impossible": false}, {"question": "If the manufacturer does not have data to support the stability of the vaccine, repeat the dose immediately (no minimum interval).", "id": "100000000000000000004827", "answers": [{"text": "Storage and handling", "answer_start": 0}], "is_impossible": false}], "context": "Storage and handling Dose administered after improper\nstorage and handling (i.e., temperature\nexcursion)\nContact the manufacturer for information on the stability of the\nvaccine. If the manufacturer does not have data to support the stability\nof the vaccine, repeat the dose immediately (no minimum interval). Dose administered past the\nexpiration/beyond-use date\nContact the manufacturer for information on the stability of the\nvaccine. If the manufacturer does not have data to support the stability\nof the vaccine, repeat the dose immediately (no minimum interval). Intervals Any COVID-19 dose administered prior\nto the minimum interval\nRepeat dose."}]}, {"title": "fdf9d0c094625b619e2005c0f71b9c2a", "paragraphs": [{"qas": [{"question": "What does EVUSHELDTM stand for?", "id": "100000000000000000004828", "answers": [{"text": "Tixagevimab/cilgavimab", "answer_start": 307}], "is_impossible": false}, {"question": "What is the minimum interval for repeating the dose after the dose given in error?", "id": "100000000000000000004829", "answers": [{"text": "at least the minimum interval", "answer_start": 51}], "is_impossible": false}, {"question": "Do not repeat any dose of COVID-19 vaccine after the recommended interval?", "id": "100000000000000000004830", "answers": [{"text": "There is no maximum interval", "answer_start": 210}], "is_impossible": false}, {"question": "How many days after the first dose of vaccine should a repeat vaccine be administered?", "id": "100000000000000000004833", "answers": [{"text": "28", "answer_start": 529}], "is_impossible": false}], "context": "Space repeat dose after the dose given in error by at least\nthe minimum interval (Table 2 and Table 3). Any COVID-19 vaccine dose\nadministered at any interval after the\nrecommended interval\nDo not repeat dose. There is no maximum interval. This deviation from CDC guidance does not require VAERS reporting. Tixagevimab/cilgavimab (EVUSHELD\u2122)\nadministered less than 14 days after\nIn general, do not repeat vaccine dose. However, based on clinical\njudgement, a repeat dose of vaccine may be administered at an interval\nof at least 28 days after the dose of vaccine."}]}, {"title": "a28f680046709802f027c6792254bfac", "paragraphs": [{"qas": [{"question": "What is considered a complete primary series provided the indicated number of doses is administered?", "id": "100000000000000000004834", "answers": [{"text": "Any combination of Moderna, Novavax, or Pfizer-BioNTech vaccines", "answer_start": 144}], "is_impossible": false}, {"question": "What vaccine is administered as a single-dose series if the Janssen vaccine is given?", "id": "100000000000000000004835", "answers": [{"text": "COVID-19", "answer_start": 31}], "is_impossible": false}, {"question": "What counts as a single-dose series?", "id": "100000000000000000004836", "answers": [{"text": "Janssen vaccine", "answer_start": 308}], "is_impossible": false}, {"question": "Children ages 6 months-4 years who receive different mRNA products for the first 2 doses should follow a 3-dose schedule?", "id": "100000000000000000004837", "answers": [{"text": "3-dose schedule", "answer_start": 557}], "is_impossible": false}, {"question": "What should be administered 8 weeks after the second dose?", "id": "100000000000000000004838", "answers": [{"text": "A third dose of either mRNA vaccine", "answer_start": 575}], "is_impossible": false}, {"question": "How many doses of either mRNA vaccine should be given?", "id": "100000000000000000004839", "answers": [{"text": "third", "answer_start": 577}], "is_impossible": false}, {"question": "What should complete the 3-dose primary series?", "id": "100000000000000000004840", "answers": [{"text": "A third dose of either mRNA vaccine", "answer_start": 575}], "is_impossible": false}], "context": "Mixed primary series Incorrect COVID-19 vaccine product\ninadvertently administered as part of a\n2- or 3-dose primary series\nDo not repeat dose. Any combination of Moderna, Novavax, or Pfizer-BioNTech vaccines is\nconsidered a complete primary series provided the indicated number of\ndoses is administered. If Janssen vaccine is administered, this counts as a single-dose series and\nno more primary doses are indicated. Children ages 6 months\u20134 years who receive different mRNA products\nfor the first 2 doses of an mRNA COVID-19 vaccine series should follow a\n3-dose schedule. A third dose of either mRNA vaccine should be\nadministered 8 weeks after the second dose to complete the 3-dose\nprimary series."}]}, {"title": "1add7f94d3c87d0bcf5b24ff8ae4dc2c", "paragraphs": [{"qas": [{"question": "What age range can receive a booster dose of COVID-19?", "id": "100000000000000000004841", "answers": [{"text": "5\u201317 years", "answer_start": 14}], "is_impossible": false}, {"question": "What is the only diluent that can be administered?", "id": "100000000000000000004842", "answers": [{"text": "Pfizer-BioNTech formulation only [orange cap and maroon cap]) ONLY diluent administered (i.e., sterile 0.9% sodium chloride", "answer_start": 176}], "is_impossible": false}], "context": "Children ages 5\u201317 years who receive a mixed mRNA COVID-19 vaccine\nprimary series can follow the Pfizer-BioNTech COVID-19 Vaccine\nschedule and receive a booster dose. Diluent (Pfizer-BioNTech\nformulation only [orange\ncap and maroon cap])\nONLY diluent administered (i.e., sterile\n0.9% sodium chloride)\nAdminister the authorized dose immediately (no minimum interval). No diluent, resulting in higher than\nauthorized dose\nDo not repeat dose. Inform the recipient of the potential for local and\nsystemic adverse events. Incorrect diluent type (e.g., sterile water,\nbacteriostatic 0.9% sodium chloride)\nContact the manufacturer for information on the stability of the\nvaccine."}]}, {"title": "6efad447f9a574daabb725227106f291", "paragraphs": [{"qas": [{"question": "What if the manufacturer does not have information to support the stability of the vaccine?", "id": "100000000000000000004846", "answers": [{"text": "repeat the dose immediately", "answer_start": 87}], "is_impossible": false}, {"question": "What is the minimum interval for repeating the dose?", "id": "100000000000000000004847", "answers": [{"text": "no minimum interval). Vaccine is mixed with too little diluent Do not repeat dose. Inform the recipient of the potential for local and systemic adverse events \u2020\u2021 \u2021\u00a7 \u00a7 \u00b6 \u00a7 \u00b6 \u00a7 # \u00a7 \u00a7 \u2020 \u00b6 \u00a7 \u2020\f10/30/22, 9:16 AM", "answer_start": 116}], "is_impossible": false}, {"question": "What is used to mix multiple vials of vaccine?", "id": "100000000000000000004849", "answers": [{"text": "Single-use vial of diluent", "answer_start": 606}], "is_impossible": false}], "context": "If the manufacturer does not have information to support the\nstability of the vaccine, repeat the dose immediately (no minimum\ninterval). Vaccine is mixed with too little diluent Do not repeat dose. Inform the recipient of the potential for local and\nsystemic adverse events\n\u2020\u2021\n\u2021\u00a7\n\u00a7\n\u00b6\n\u00a7\n\u00b6\n\u00a7\n# \u00a7\n\u00a7\n\u2020\n\u00b6\n\u00a7\n\u2020\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nType Administration error/deviation Interim recommendation\nsystemic adverse events. Vaccine is mixed with too much diluent Repeat dose immediately (no minimum interval). Single-use vial of diluent is used to mix\nmultiple vials of vaccine\nDo not repeat dose. Inform patient of the potential for bacterial\ninfection."}]}, {"title": "65fb74791543d9171c4393376d50ac5b", "paragraphs": [{"qas": [{"question": "What should not be mixed with diluent?", "id": "100000000000000000004850", "answers": [{"text": "gray cap", "answer_start": 70}], "is_impossible": false}, {"question": "What should the manufacturer do if they do not have information to support the stability of the vaccine?", "id": "100000000000000000004851", "answers": [{"text": "repeat the dose immediately", "answer_start": 313}], "is_impossible": false}, {"question": "Do not repeat the dose immediately (no minimum interval)?", "id": "100000000000000000004854", "answers": [{"text": "If the manufacturer does not have information to support the stability of the vaccine", "answer_start": 226}], "is_impossible": false}], "context": "Diluent (Pfizer-BioNTech\nthat should not be mixed\nwith diluent, i.e., gray\ncap)\nVaccine is mixed with any diluent (i.e.,\nany type or volume of diluent)\nContact the manufacturer for information on the stability of the\nvaccine. If the manufacturer does not have information to support the\nstability of the vaccine, repeat the dose immediately (no minimum\ninterval). Do not administer the second dose until the person becomes eligible to receive vaccination (either by reaching the authorized age or if the\nauthorization is extended to include additional age groups), even if this results in the second dose being administered after the recommended\ninterval between doses."}]}, {"title": "b10f2434ba780c088dd5466a6afa6da1", "paragraphs": [{"qas": [{"question": "What should be assessed on a case-by-case basis?", "id": "100000000000000000004859", "answers": [{"text": "if local or systemic side effects", "answer_start": 9}], "is_impossible": false}, {"question": "What should local or systemic side effects following vaccination be considered?", "id": "100000000000000000004860", "answers": [{"text": "clinically concerning (outside of the expected side effect profile), lead to serious adverse reactions, or are ongoing at the time of the subsequent dose, this dose might be delayed, but this decision should be assessed on a case-by-case basis", "answer_start": 69}], "is_impossible": false}, {"question": "What are the dosing options for children who turn from age 4 years to 5 years?", "id": "100000000000000000004861", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 398}], "is_impossible": false}], "context": "However, if local or systemic side effects following vaccination are clinically concerning (outside of the expected side\neffect profile), lead to serious adverse reactions, or are ongoing at the time of the subsequent dose, this dose might be delayed, but this\ndecision should be assessed on a case-by-case basis. For FDA EUA dosing options for children who turn from age 4 years to 5 years (i.e., Pfizer-BioNTech), age 5 years to 6 years (i.e., Moderna), and\nage 11 years to 12 years (i.e., Moderna and Pfizer-BioNTech) during vaccination, see Transitioning from a younger to older age group."}]}, {"title": "d4f4e189529498328c64058f0883e693", "paragraphs": [{"qas": [{"question": "What does VAERS reporting not indicate?", "id": "100000000000000000004864", "answers": [{"text": "If the dosing is in accordance with the FDA EUA", "answer_start": 0}], "is_impossible": false}, {"question": "Why do some experts suggest delaying the repeat dose for 8 weeks after the invalid dose?", "id": "100000000000000000004865", "answers": [{"text": "the potential for increased reactogenicity", "answer_start": 207}], "is_impossible": false}, {"question": "What are two examples of mRNA and Novavax COVID-19 vaccines?", "id": "100000000000000000004866", "answers": [{"text": "Moderna or Pfizer-BioNTech", "answer_start": 317}], "is_impossible": false}, {"question": "What is the age range of males at increased risk for myocarditis and pericardiitis?", "id": "100000000000000000004867", "answers": [{"text": "12\u201339 years", "answer_start": 468}], "is_impossible": false}, {"question": "The risk for an adverse event following vaccination should be taken into consideration.", "id": "100000000000000000004868", "answers": [{"text": "rare risk of myocarditis and pericarditis from mRNA (i.e., Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines, particularly in groups at increased risk for myocarditis and pericarditis (e.g., males ages 12\u201339 years). Individual risk for COVID-19 and the likelihood for an adverse event following vaccination should be taken into consideration when recommending a longer interval", "answer_start": 257}], "is_impossible": false}, {"question": "What should be taken into consideration when recommending a longer interval?", "id": "100000000000000000004869", "answers": [{"text": "Individual risk for COVID-19", "answer_start": 482}], "is_impossible": false}], "context": "If the\ndosing is in accordance with the FDA EUA, it is not considered an error and VAERS reporting is not indicated. Some experts suggest delaying the repeat dose for 8 weeks after the invalid dose based on the potential for increased reactogenicity and the\nrare risk of myocarditis and pericarditis from mRNA (i.e., Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines, particularly in groups at\nincreased risk for myocarditis and pericarditis (e.g., males ages 12\u201339 years). Individual risk for COVID-19 and the likelihood for an adverse\nevent following vaccination should be taken into consideration when recommending a longer interval."}]}, {"title": "6b2f5455665dc1904fbbcb9d10ef0459", "paragraphs": [{"qas": [{"question": "What is the current manufacturer contact information?", "id": "100000000000000000004871", "answers": [{"text": "Janssen", "answer_start": 235}], "is_impossible": false}, {"question": "What is the US Toll Free number?", "id": "100000000000000000004872", "answers": [{"text": "1-800-565-4008", "answer_start": 259}], "is_impossible": false}, {"question": "How long before the minimum interval can vaccine doses be counted?", "id": "100000000000000000004873", "answers": [{"text": "4 days", "answer_start": 441}], "is_impossible": false}, {"question": "What does not need to be repeated?", "id": "100000000000000000004874", "answers": [{"text": "Vaccine doses", "answer_start": 408}], "is_impossible": false}], "context": "It is acceptable to administer the repeat\ndose at an interval earlier than 8 weeks if the interval is not sooner than the minimal interval noted in this table. As of the date of this update, current manufacturer contact information is:\nJanssen: US Toll Free: 1-800-565-4008; US Toll: 1-908-455-9922\nPlease see the package inserts and EUA provider factsheets for the most up-to-date manufacturer information. Vaccine doses administered up to 4 days before the minimum interval may be counted and do not need to be repeated."}]}, {"title": "55e3a610558a605c673477db1e3aa203", "paragraphs": [{"qas": [{"question": "What does CDC CONTRAINDICATION TO COVID-19 VACCINATION PRECAUTION TO?", "id": "100000000000000000004875", "answers": [{"text": "NO CONTRAINDICATION", "answer_start": 462}], "is_impossible": false}, {"question": "What is a history of after non-COVID-19 vaccines or injectable therapies?", "id": "100000000000000000004878", "answers": [{"text": "Anaphylaxis", "answer_start": 754}], "is_impossible": false}, {"question": "What is an example of an allergy-related contraindication to one type of COVID-19 vaccine?", "id": "100000000000000000004879", "answers": [{"text": "NO CONTRAINDICATION OR PRECAUTION TO COVID-19 VACCINATION History of the following: Severe allergic reaction (e.g., anaphylaxis", "answer_start": 461}], "is_impossible": false}, {"question": "How long does it take for an allergic reaction to occur after a previous dose?", "id": "100000000000000000004880", "answers": [{"text": "4 hours", "answer_start": 854}], "is_impossible": false}, {"question": "What is a precaution to people who have a history of?", "id": "100000000000000000004881", "answers": [{"text": "allergies or allergic reactions", "answer_start": 223}], "is_impossible": false}], "context": "\u00a7\n\u00b6\n\u00a7\n*\n\u2020\n\u2021\n\u00a7\n\u00b6\n\uf209 \uf209\n#\nTable of Contents \uf426\nCONTRAINDICATION TO COVID-19\nVACCINATION PRECAUTION TO COVID-19 VACCINATION\nNO CONTRAINDICATION OR\nPRECAUTION TO COVID-19\nVACCINATION\nAppendix E. Triage of people with a history of allergies or allergic reactions\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nCONTRAINDICATION TO COVID-19\nVACCINATION PRECAUTION TO COVID-19 VACCINATION\nNO CONTRAINDICATION OR\nPRECAUTION TO COVID-19\nVACCINATION\nHistory of the following:\nSevere allergic reaction (e.g.,\nanaphylaxis) after a previous\ndose or to a component of a\nKnown (diagnosed) allergy to a\ncomponent of a COVID-19\nvaccine\nAmong people without a contraindication, a history\nof:\nAnaphylaxis after non-COVID-19 vaccines or\ninjectable therapies\nNon-severe, immediate (onset within 4 hours)\nallergic reaction after a previous dose of\nNote: People with an allergy-related\ncontraindication to one type of COVID-19 vaccine\nhave a precaution to the other types of COVID-19\nvaccines."}]}, {"title": "94cef21a51aa1aa4f87ffef98adb5e5a", "paragraphs": [{"qas": [{"question": "What is an alternate vaccine type if age appropriate?", "id": "100000000000000000004883", "answers": [{"text": "Do not vaccinate", "answer_start": 137}], "is_impossible": false}, {"question": "What can be consulted for a full list of ingredients?", "id": "100000000000000000004884", "answers": [{"text": "COVID-19 vaccine-specific FDA fact sheets and U.S. COVID-19 Vaccine Product Information", "answer_start": 485}], "is_impossible": false}, {"question": "People with a contraindication to one of the mRNA COVID-19 vaccines should not receive what?", "id": "100000000000000000004885", "answers": [{"text": "doses", "answer_start": 709}], "is_impossible": false}], "context": "Among people without a\ncontraindication or precaution,\na history of:\nAny allergy not listed as a\ncontraindication or\nprecaution\nActions:\nDo not vaccinate\nConsider referral to allergist-\nimmunologist\nConsider alternate vaccine type if\nage appropriate\nActions:\nRisk assessment\nShould consider a 30-minute observation\nperiod\nConsider referral to allergist-immunologist\nActions:\nProceed with vaccination\nShould consider a 15-\nminute observation\nperiod per General Best\nPractice Guidelines\nCOVID-19 vaccine-specific FDA fact sheets and U.S. COVID-19 Vaccine Product Information can be consulted for a full list of ingredients. People with a contraindication to one of the mRNA COVID-19 vaccines should not receive doses of either of the mRNA vaccines."}]}, {"title": "1cef68ecbd3bf796cb522e52f21a8c61", "paragraphs": [{"qas": [{"question": "What is a non-severe allergic reaction?", "id": "100000000000000000004890", "answers": [{"text": "Urticaria (hives) beyond the injection site", "answer_start": 417}], "is_impossible": false}], "context": "Severe allergic reactions include:\nPossible anaphylaxis, a progressive life-threatening reaction that typically includes urticaria but also with other symptoms such as\nwheezing, difficulty breathing, or low blood pressure\nAny angioedema affecting the airway (i.e., tongue, uvula, or larynx)\nDiffuse rash which also involves mucosal surfaces (e.g., Stevens-Johnson Syndrome)\nNon-severe allergic reactions may include:\nUrticaria (hives) beyond the injection site\nAngioedema (visible swelling) involving lips, facial skin, or skin in other locations."}]}, {"title": "2bf00e47d8e9c90c7b963320908c810b", "paragraphs": [{"qas": [{"question": "What is considered a severe allergic reaction?", "id": "100000000000000000004893", "answers": [{"text": "angioedema affecting the airway", "answer_start": 10}], "is_impossible": false}, {"question": "What is an angioedema affecting the airway?", "id": "100000000000000000004894", "answers": [{"text": "severe allergic reaction", "answer_start": 125}], "is_impossible": false}, {"question": "Who can perform a more detailed risk assessment for COVID-19 vaccine receipt?", "id": "100000000000000000004895", "answers": [{"text": "allergist-immunologist", "answer_start": 510}], "is_impossible": false}, {"question": "What is a component of a vaccine that elicited an allergic reaction?", "id": "100000000000000000004896", "answers": [{"text": "COVID-19 vaccine", "answer_start": 314}], "is_impossible": false}], "context": "NOTE: Any angioedema affecting the airway (i.e., tongue,\nuvula, or larynx) would NOT be in this category and is considered a severe allergic reaction\nPeople with a history of anaphylaxis after a non-COVID-19 vaccine or injectable therapy that contains multiple components, one or more of\nwhich is a component of a COVID-19 vaccine, but it is unknown which component elicited the allergic reaction, have a precaution to vaccination\nwith that COVID-19 vaccine. These people may benefit from consultation with an allergist-immunologist who can perform a more detailed risk\nassessment for COVID-19 vaccine receipt."}]}, {"title": "4580398250753900391dea4c7f5fb66", "paragraphs": [{"qas": [{"question": "What should people who have a history of an immediate, non-severe allergic reaction after one type of COVID-19 vaccine do?", "id": "100000000000000000004897", "answers": [{"text": "vaccination with a subsequent dose of that same type of COVID-19 vaccine should only be undertaken in an appropriate setting under the supervision of a health care provider", "answer_start": 108}], "is_impossible": false}, {"question": "Who is experienced in the management of severe allergic reactions?", "id": "100000000000000000004898", "answers": [{"text": "health care provider", "answer_start": 260}], "is_impossible": false}, {"question": "What is an ingredient in both mRNA COVID-19 vaccines?", "id": "100000000000000000004899", "answers": [{"text": "Polyethylene glycol", "answer_start": 462}], "is_impossible": false}, {"question": "What is a component in Novavax and Janssen COVID-19 vaccine?", "id": "100000000000000000004900", "answers": [{"text": "polysorbate 80", "answer_start": 541}], "is_impossible": false}, {"question": "Who is experienced in managing severe allergic reactions?", "id": "100000000000000000004901", "answers": [{"text": "health care provider", "answer_start": 260}], "is_impossible": false}, {"question": "What is an ingredient in Novavax and Janssen COVID-19 vaccines?", "id": "100000000000000000004902", "answers": [{"text": "polysorbate 80", "answer_start": 541}], "is_impossible": false}], "context": "For people with a history of an immediate, non-severe allergic reaction after one type of COVID-19 vaccine, vaccination with a subsequent dose\nof that same type of COVID-19 vaccine should only be undertaken in an appropriate setting under the supervision of a health care provider\nexperienced in the management of severe allergic reactions. Administering a different type of COVID-19 vaccine is another option; this can be\ndone in the usual vaccination setting. Polyethylene glycol (PEG) is an ingredient in both mRNA COVID-19 vaccines, and polysorbate 80 is an ingredient in Novavax and Janssen\nCOVID-19 vaccines."}]}, {"title": "bd893d9b5c0a0bd2f30703fd2f6615ab", "paragraphs": [{"qas": [{"question": "What are PEG and polysorbate structurally related to?", "id": "100000000000000000004903", "answers": [{"text": "cross-reactive hypersensitivity between these compounds", "answer_start": 50}], "is_impossible": false}, {"question": "What is a contraindication to both Novavax and Janssen COVID-19 vaccines?", "id": "100000000000000000004904", "answers": [{"text": "People with a known allergy to polysorbate", "answer_start": 117}], "is_impossible": false}, {"question": "What is a contraindication to one type of COVID-19 vaccine?", "id": "100000000000000000004905", "answers": [{"text": "a precaution to the others", "answer_start": 551}], "is_impossible": false}, {"question": "What is a precaution to the others?", "id": "100000000000000000004907", "answers": [{"text": "an allergy-related contraindication to one type of COVID-19 vaccine", "answer_start": 480}], "is_impossible": false}], "context": "PEG and polysorbate are structurally related, and cross-reactive hypersensitivity between these compounds may occur. People with a known allergy to polysorbate have a contraindication to both Novavax and Janssen COVID-19 vaccines and a precaution to\nmRNA COVID-19 vaccines (i.e., Moderna or Pfizer-BioNTech). ll h ll l d d f h h\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nIn all other cases, an allergy-related contraindication to one type of COVID-19 vaccine is a precaution to the others. For people with these precautions, referral to an allergist-immunologist should be considered."}]}, {"title": "1d8b969a4c91427645fdb2891bbf1caf", "paragraphs": [{"qas": [{"question": "What can be used to help a vaccination provider conduct a risk assessment?", "id": "100000000000000000004911", "answers": [{"text": "The following considerations", "answer_start": 17}], "is_impossible": false}, {"question": "What is the risk of exposure to SARS-CoV-2 virus?", "id": "100000000000000000004912", "answers": [{"text": "because of occupational or institutional setting", "answer_start": 240}], "is_impossible": false}, {"question": "Risk of severe disease or death due to what?", "id": "100000000000000000004913", "answers": [{"text": "COVID-19", "answer_start": 329}], "is_impossible": false}, {"question": "What is the unknown risk of anaphylaxis following COVID-19 vaccination?", "id": "100000000000000000004914", "answers": [{"text": "a person with a history of anaphylaxis after other vaccines or injectable therapies", "answer_start": 458}], "is_impossible": false}, {"question": "What may help to clarify the risk assessment?", "id": "100000000000000000004915", "answers": [{"text": "Consultation with an allergist-immunologist", "answer_start": 568}], "is_impossible": false}, {"question": "What can an allergist-immunologist help with?", "id": "100000000000000000004916", "answers": [{"text": "clarify the risk assessment", "answer_start": 624}], "is_impossible": false}], "context": "Risk assessment: The following considerations can be used to help the vaccination provider conduct a risk assessment for vaccination in\npeople with a precaution to vaccination because of allergy:\nRisk of exposure to SARS-CoV-2 virus (e.g., because of occupational or institutional setting)\nRisk of severe disease or death due to COVID-19 (e.g., because of age, underlying medical conditions)\nThe unknown risk of anaphylaxis following COVID-19 vaccination in a person with a history of anaphylaxis after other vaccines or\ninjectable therapies (Appendix E, footnote 3). Consultation with an allergist-immunologist may help to clarify the risk assessment for these\npeople."}]}, {"title": "aff22404c30f84162684c76505243562", "paragraphs": [{"qas": [{"question": "What is the ability of the patient to be vaccinated in a setting where appropriate medical care is immediately available for anaphylaxis?", "id": "100000000000000000004917", "answers": [{"text": "vaccination should only be undertaken in an appropriate setting under the supervision of a healthcare professional experienced in the management of severe allergic reactions", "answer_start": 462}], "is_impossible": false}, {"question": "What should people with an immediate, non-severe allergic reaction receive?", "id": "100000000000000000004919", "answers": [{"text": "vaccination", "answer_start": 396}], "is_impossible": false}], "context": "Ability of the patient to be vaccinated in a setting where appropriate medical care is immediately available for anaphylaxis. For people\nwith a contraindication due to allergy to one type of COVID-19 vaccine who are receiving another type that has been deemed a precaution\nand for people with an immediate, non-severe allergic reaction after a previous dose of COVID-19 vaccine who are receiving vaccination\nwith a subsequent dose of that COVID-19 vaccine type, vaccination should only be undertaken in an appropriate setting under the\nsupervision of a healthcare professional experienced in the management of severe allergic reactions."}]}, {"title": "d272798ca3007800bb74c15ba1da23ea", "paragraphs": [{"qas": [{"question": "What is the name of the book that provides information on the management of anaphylaxis?", "id": "100000000000000000004922", "answers": [{"text": "Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination", "answer_start": 53}], "is_impossible": false}, {"question": "What does the book Preparing for the Potential Management of Anaphylactic Syndrome after COVID-19 contain?", "id": "100000000000000000004923", "answers": [{"text": "laboratory evaluation of people who experience anaphylaxis after vaccination", "answer_start": 138}], "is_impossible": false}], "context": "For information on the management\nof anaphylaxis see Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination and laboratory evaluation of\npeople who experience anaphylaxis after vaccination."}]}, {"title": "ac96b3af539102d1d31897d51f67e71d", "paragraphs": [{"qas": [{"question": "What is the Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of?", "id": "100000000000000000004924", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 1741}], "is_impossible": false}, {"question": "What year was the Interim Recommendation for Use of Janssen COVID-19 Vaccine issued?", "id": "100000000000000000004926", "answers": [{"text": "2021", "answer_start": 475}], "is_impossible": false}, {"question": "What year did the Advisory Committee on Immunization Practices update its recommendations for use of the Janssen (Johnson & Johnson) Covid-19 vaccine?", "id": "100000000000000000004927", "answers": [{"text": "2021", "answer_start": 2002}], "is_impossible": false}, {"question": "What is Thrombocytopenia Syndrome?", "id": "100000000000000000004928", "answers": [{"text": "Vaccine Recipients", "answer_start": 683}], "is_impossible": false}, {"question": "When did the Advisory Committee on Immunization Practices update the use of COVID-19 Vaccines?", "id": "100000000000000000004930", "answers": [{"text": "July 2021", "answer_start": 1322}], "is_impossible": false}, {"question": "Who recommended the use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged 16 Years?", "id": "100000000000000000004932", "answers": [{"text": "Advisory Committee on Immunization Practices", "answer_start": 1422}], "is_impossible": false}, {"question": "When did the Advisory Committee on Immunization Practices recommend additional primary and booster doses?", "id": "100000000000000000004933", "answers": [{"text": "2021", "answer_start": 1652}], "is_impossible": false}, {"question": "What is the Advisory Committee on Immunization Practices' recommendation for use of Moderna COVID-19 Vaccine in Adults Aged 18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA?", "id": "100000000000000000004937", "answers": [{"text": "Interim", "answer_start": 102}], "is_impossible": false}, {"question": "What is the name of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years?", "id": "100000000000000000004938", "answers": [{"text": "Interim Recommendations", "answer_start": 2422}], "is_impossible": false}, {"question": "When is the date of the Interim Recommendations of the Advised Committee for Immunization?", "id": "100000000000000000004939", "answers": [{"text": "December 2020", "answer_start": 186}], "is_impossible": false}, {"question": "What is the age range of the Novavax COVID-19 Vaccine in children?", "id": "100000000000000000004940", "answers": [{"text": "\u226518 years", "answer_start": 2748}], "is_impossible": false}, {"question": "When is the Interim Recommendation of the Advisory Committee on Immunization Practices for Use of a new vaccine issued?", "id": "100000000000000000004941", "answers": [{"text": "July 2022", "answer_start": 2775}], "is_impossible": false}], "context": "Table of Contents \uf426\nReferences and Previous Updates\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine \u2014 United States, December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021\nUpdated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson\n& Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine\nRecipients\u2014United States, April 2021\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine in Adolescents Aged 12\u201315 years \u2014 United States, May 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021\nUse of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and\nmRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization\nPractices \u2014 United States, July 2021\nUse of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged \u226516 Years: Recommendations of the Advisory Committee\non Immunization Practices \u2014 United States, September 2021\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendations for Additional Primary and Booster\nDoses of COVID-19 Vaccines \u2014 United States, 2021\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine in Children Aged 5\u201311 Years \u2014 United States, November 2021\nUse of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory\nCommittee on Immunization Practices \u2014 United States, December 2021\nThe Advisory Committee on Immunization Practices\u2019 Recommendation for Use of Moderna COVID-19 Vaccine in Adults\nAged \u226518 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-\nReferences\n\uf1aa\n\uf20c\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\n19 Vaccines \u2014 United States, February 2022\nInterim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-\nBioNTech COVID-19 Vaccines in Children Aged 6 Months\u20135 Years \u2014 United States, June 2022\nInterim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19\nVaccine in Persons Aged \u226518 years \u2014 United States, July 2022."}]}, {"title": "7610c9453c1dee5e9c5be1b2db0032bd", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine Fact Sheet for Healthcare Providers?", "id": "100000000000000000004942", "answers": [{"text": "Moderna", "answer_start": 79}], "is_impossible": false}, {"question": "Which company is listed on cdc.gov as having an emergency use instruction for healthcare providers?", "id": "100000000000000000004944", "answers": [{"text": "Moderna", "answer_start": 467}], "is_impossible": false}, {"question": "What are the Emergency Use Instructions for Healthcare Providers?", "id": "100000000000000000004945", "answers": [{"text": "Moderna COVID-19 Vaccine for Primary, Additional, and/or Booster Doses", "answer_start": 467}], "is_impossible": false}, {"question": "What is the ACIP General Best Practice Guidelines for Immunization Interim considerations: preparing for the potential management of anaphylaxis after COVID-19 vaccination?", "id": "100000000000000000004946", "answers": [{"text": "\uf209", "answer_start": 709}], "is_impossible": false}, {"question": "How many bivalent mRNA boosters are recommended for people ages 5 years and older?", "id": "100000000000000000004947", "answers": [{"text": "1", "answer_start": 802}], "is_impossible": false}, {"question": "What do these recommendations replace all prior booster recommendations for this age group?", "id": "100000000000000000004948", "answers": [{"text": "COVID-19 booster recommendations for people ages 5 years and older to receive 1 bivalent mRNA booster", "answer_start": 724}], "is_impossible": false}, {"question": "How many people should receive a bivalent Moderna booster dose?", "id": "100000000000000000004949", "answers": [{"text": "6\u201317 years", "answer_start": 1082}], "is_impossible": false}, {"question": "What is recommended for use of a bivalent Pfizer-BioNTech booster dose in people ages 5-11 years?", "id": "100000000000000000004950", "answers": [{"text": "New COVID-19 booster recommendations for people ages 5 years and older to receive 1 bivalent mRNA booster", "answer_start": 720}], "is_impossible": false}, {"question": "Reorganization and consolidation of what to enhance usability?", "id": "100000000000000000004951", "answers": [{"text": "Interim Clinical Considerations", "answer_start": 1226}], "is_impossible": false}], "context": "Pfizer-BioNTech COVID-19 Vaccine Fact Sheet for Healthcare Providers (fda.gov)\nModerna COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers (fda.gov)\nNovavax COVID-19 Vaccine, Adjuvanted | FDA\nJanssen COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers (fda.gov)\nEmergency Use Instructions for Healthcare Providers: Pfizer-BioNTech COVID-19 Vaccine for Primary, Additional,\nand/or Booster Doses (cdc.gov)\nEmergency Use Instructions for Healthcare Providers: Moderna COVID-19 Vaccine for Primary, Additional, and/or\nBooster Doses (cdc.gov)\nACIP General Best Practice Guidelines for Immunization\nInterim considerations: preparing for the potential management of anaphylaxis after COVID-19 vaccination\n\uf209\n\uf209\n\uf209\n\uf209\n\uf20c\n\uf20c\nNew COVID-19 booster recommendations for people ages 5 years and older to receive 1 bivalent mRNA booster after\ncompletion of a monovalent primary series or previously received monovalent booster dose(s); these\nrecommendations replace all prior booster recommendations for this age group\nRecommendations for use of a bivalent Moderna booster dose in people ages 6\u201317 years\nRecommendations for use of a bivalent Pfizer-BioNTech booster dose in people ages 5\u201311 years\nReorganization and consolidation of the Interim Clinical Considerations to enhance usability."}]}, {"title": "bc7e374511195d8af634fdb4686cf1f1", "paragraphs": [{"qas": [{"question": "What vaccination schedules and guidance are unchanged?", "id": "100000000000000000004952", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the vaccine that is still in effect?", "id": "100000000000000000004953", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}], "context": "COVID-19 vaccination\nschedules and guidance are unchanged."}]}, {"title": "7de9f22477057e8b1d31fb4de7860d72", "paragraphs": [{"qas": [{"question": "What does the new booster recommendation replace?", "id": "100000000000000000004955", "answers": [{"text": "all prior booster recommendations", "answer_start": 158}], "is_impossible": false}, {"question": "How many boosters did the previous booster recommendation recommend?", "id": "100000000000000000004956", "answers": [{"text": "1", "answer_start": 73}], "is_impossible": false}, {"question": "Who should receive a bivalent Moderna booster?", "id": "100000000000000000004957", "answers": [{"text": "people ages 18 years and older", "answer_start": 273}], "is_impossible": false}, {"question": "What is the acronym for multisystem inflammatory syndrome?", "id": "100000000000000000004958", "answers": [{"text": "MIS", "answer_start": 557}], "is_impossible": false}, {"question": "How many doses of Pfizer-BioNTech booster do people need?", "id": "100000000000000000004960", "answers": [{"text": "second", "answer_start": 1972}], "is_impossible": false}, {"question": "Who is recommended to use a bivalent booster dose?", "id": "100000000000000000004961", "answers": [{"text": "adults ages 50 years and older", "answer_start": 2835}], "is_impossible": false}, {"question": "What is the name of the vaccine used in adults ages 18 and older?", "id": "100000000000000000004964", "answers": [{"text": "Novavax COVID-19", "answer_start": 1151}], "is_impossible": false}, {"question": "How old is the population of adults who have COVID-19?", "id": "100000000000000000004966", "answers": [{"text": "50 years and older", "answer_start": 2847}], "is_impossible": false}, {"question": "How old is the guidance on COVID-19 vaccination?", "id": "100000000000000000004967", "answers": [{"text": "50 years and older", "answer_start": 2847}], "is_impossible": false}, {"question": "How old are children and adolescents ages 6-17 years?", "id": "100000000000000000004969", "answers": [{"text": "New guidance for use of Moderna COVID-19 Vaccine in children and adolescents ages 6\u201317 years New guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "answer_start": 1386}], "is_impossible": false}, {"question": "Where is the Pfizer-BioNTech COVID-19 Vaccine used in children?", "id": "100000000000000000004970", "answers": [{"text": "5\u201311 years", "answer_start": 1901}], "is_impossible": false}, {"question": "What is the age range for vaccination in children ages 6 months to 4 years?", "id": "100000000000000000004971", "answers": [{"text": "\u20135 years", "answer_start": 1644}], "is_impossible": false}, {"question": "What is a new section on COVID-19 vaccination recommendations and schedules added to?", "id": "100000000000000000004972", "answers": [{"text": "Special populations for infants and young children", "answer_start": 1761}], "is_impossible": false}, {"question": "Who is the new section for Special populations for infants and young children?", "id": "100000000000000000004973", "answers": [{"text": "adults ages 50 years and older who are not moderately or severely immunocompromised may choose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster dose Added guidance that people ages 18\u201349 years", "answer_start": 2835}], "is_impossible": false}, {"question": "What is the age range for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose in children ages 5-11 years?", "id": "100000000000000000004974", "answers": [{"text": "6 months\u20134 years", "answer_start": 1553}], "is_impossible": false}, {"question": "What should people ages 12 years and older receive?", "id": "100000000000000000004975", "answers": [{"text": "1 bivalent mRNA booster", "answer_start": 73}], "is_impossible": false}, {"question": "What are people who are moderately or severely immunocompromised treated with?", "id": "100000000000000000004977", "answers": [{"text": "B-cell- depleting therapies", "answer_start": 2211}], "is_impossible": false}, {"question": "What is the acronym for multisystem inflammatory syndrome in children and adults?", "id": "100000000000000000004978", "answers": [{"text": "MIS-C", "answer_start": 2337}], "is_impossible": false}, {"question": "How is primary series vaccination after SARS-CoV-2 infection?", "id": "100000000000000000004979", "answers": [{"text": "Updated guidance", "answer_start": 2363}], "is_impossible": false}, {"question": "What type of vaccine is recommended for people 12 years and older who are moderate or severe?", "id": "100000000000000000004981", "answers": [{"text": "mRNA COVID-19 vaccine", "answer_start": 2746}], "is_impossible": false}, {"question": "How long after the first Janssen booster dose did the mRNA COVID-19 vaccine last?", "id": "100000000000000000004987", "answers": [{"text": "4 months", "answer_start": 2777}], "is_impossible": false}, {"question": "What is the dosage volume of Moderna COVID-19 Vaccine?", "id": "100000000000000000004989", "answers": [{"text": "6 months\u20135 years", "answer_start": 1636}], "is_impossible": false}], "context": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster after\ncompletion of a monovalent primary series; it replaces all prior booster recommendations for this age group\nRecommendations for use of a bivalent Moderna booster dose in people ages 18 years and older\nRecommendations for use of a bivalent Pfizer-BioNTech booster dose in people ages 12 years and older\nUpdated guidance for observation periods following COVID-19 vaccination\nUpdated guidance on COVID-19 vaccination and multisystem inflammatory syndrome (MIS) in children (MIS-C) and in\nadults (MIS-A)\nGuidance for primary series vaccination using Novavax COVID-19 Vaccine in adolescents ages 12\u201317 years\nReorganization of Janssen COVID-19 Vaccine guidance into an appendix\nUpdated guidance on COVID-19 vaccination following exposure to SARS-CoV-2\nGuidance for primary series vaccination using Novavax COVID-19 Vaccine in adults ages 18 years and older\nPrevious Updates\n\uf1aa\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nGuidance for primary series vaccination using Novavax COVID-19 Vaccine in adults ages 18 years and older\nUpdated guidance on COVID-19 vaccination and myocarditis and pericarditis\nNew clinical considerations for coadministration of mRNA COVID-19 vaccines and orthopoxvirus vaccines\nNew guidance for use of Moderna COVID-19 Vaccine in children and adolescents ages 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children\nNew guidance for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose in children ages 5\u201311 years\nUpdated guidance that the following people should receive a second COVID-19 booster dose:\nPeople ages 12 years and older who are moderately or severely immunocompromised\nPeople ages 50 years and older\nUpdated guidance for people who are moderately or severely immunocompromised and are treated with B-cell-\ndepleting therapies\nClarification of COVID-19 vaccination guidance for multisystem inflammatory syndrome in children (MIS-C) and adults\n(MIS-A)\nUpdated guidance for primary series vaccination after SARS-CoV-2 infection\nAdded considerations for the option to receive a second COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 vaccination after SARS-CoV-2 infection\nAdded guidance that people ages 12 years and older who are moderately or severely immunocompromised may\nchoose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster\ndose\nAdded guidance that adults ages 50 years and older who are not moderately or severely immunocompromised may\nchoose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster\ndose\nAdded guidance that people ages 18\u201349 years who are not moderately or severely immunocompromised and who\nreceived Janssen COVID-19 Vaccine as both their primary series dose and booster dose may receive a second booster\ndose using an mRNA COVID-19 vaccine at least 4 months after the first Janssen booster dose\nFurther clarification of safety issues including those related to multisystem inflammatory syndrome in children (MIS-C)\nand adults (MIS-A) and myocarditis\nUpdated information on the availability of Moderna COVID-19 Vaccine supplied in a vial with a red cap (0.25 mL\ndosage volume) and Moderna COVID-19 Vaccine supplied in a vial with a blue cap (0.5 mL dosage volume) for\nadministration of a 50 \u00b5g booster dose."}]}, {"title": "84849a679dcd8639044483bf4f0f2e03", "paragraphs": [{"qas": [{"question": "How long is the interval between the first and second doses of a primary mRNA vaccine?", "id": "100000000000000000004991", "answers": [{"text": "8-week", "answer_start": 28}], "is_impossible": false}, {"question": "How many doses of the mRNA vaccine primary series should immunocompromised people receive?", "id": "100000000000000000004994", "answers": [{"text": "3", "answer_start": 368}], "is_impossible": false}, {"question": "How long should the interval between the completion of the primary series and the booster dose be?", "id": "100000000000000000004995", "answers": [{"text": "5 months", "answer_start": 1377}], "is_impossible": false}, {"question": "What is the new guidance to shorten?", "id": "100000000000000000004996", "answers": [{"text": "3 months", "answer_start": 577}], "is_impossible": false}, {"question": "How long does it take to get vaccinated against COVID-19?", "id": "100000000000000000004997", "answers": [{"text": "5 months", "answer_start": 1377}], "is_impossible": false}, {"question": "How many doses of the Janssen Vaccine primary series should be received?", "id": "100000000000000000004998", "answers": [{"text": "3", "answer_start": 753}], "is_impossible": false}, {"question": "What is the total number of doses to be up to date?", "id": "100000000000000000004999", "answers": [{"text": "3", "answer_start": 753}], "is_impossible": false}, {"question": "What is no longer necessary to delay COVID-19 vaccination after receipt of monoclonal antibodies or convalescent plasma Updated guidance on receiving a booster dose if vaccinated outside of the United States Updated contraindication and precaution section to include history of myocarditis or pericardiitis after an mRNA CoviD-19 vaccine as a precaution Reorganized and condensed multiple sections", "id": "100000000000000000005001", "answers": [{"text": "Updated guidance", "answer_start": 778}], "is_impossible": false}, {"question": "What is the age range for use of the Pfizer-BioNTech COVID-19 Vaccine as booster in people ages 12-17 years?", "id": "100000000000000000005003", "answers": [{"text": "12 years and older", "answer_start": 1902}], "is_impossible": false}, {"question": "How long after completion of a primary series of vaccines is a booster dose required?", "id": "100000000000000000005004", "answers": [{"text": "5 months", "answer_start": 1377}], "is_impossible": false}, {"question": "What is another name for Pfizer-BioNTech or Moderna?", "id": "100000000000000000005006", "answers": [{"text": "mRNA vaccine", "answer_start": 1408}], "is_impossible": false}, {"question": "What was updated for use of an additional primary dose for people ages 5-11 years?", "id": "100000000000000000005007", "answers": [{"text": "guidance", "answer_start": 1474}], "is_impossible": false}, {"question": "Who was not FDA- authorized or approved for COVID-19 vaccines?", "id": "100000000000000000005008", "answers": [{"text": "Updated recommendations for people who received COVID-19 vaccines outside the United States", "answer_start": 1643}], "is_impossible": false}, {"question": "What is the second formulation of the Pfizer-BioNTech COVID-19 Vaccine authorized for use in persons ages 12 and older?", "id": "100000000000000000005009", "answers": [{"text": "Moderna", "answer_start": 3186}], "is_impossible": false}, {"question": "What is RPR?", "id": "100000000000000000005011", "answers": [{"text": "Rapid Plasma Reagin", "answer_start": 2085}], "is_impossible": false}, {"question": "Who received a COVID-19 vaccine booster dose?", "id": "100000000000000000005013", "answers": [{"text": "12\u201317 years", "answer_start": 1285}], "is_impossible": false}, {"question": "What is the name of the section on People who received the vaccine outside the United States?", "id": "100000000000000000005014", "answers": [{"text": "Updated guidance", "answer_start": 2474}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine in children aged 5-11 years?", "id": "100000000000000000005016", "answers": [{"text": "Moderna", "answer_start": 3186}], "is_impossible": false}, {"question": "What is the name of the new section on Considerations for mRNA COVID-19 vaccines?", "id": "100000000000000000005018", "answers": [{"text": "Pfizer-BioNTech and Moderna", "answer_start": 3166}], "is_impossible": false}, {"question": "Who received the COVID-19 vaccine as part of a clinical trial in the United States?", "id": "100000000000000000005020", "answers": [{"text": "People", "answer_start": 3442}], "is_impossible": false}, {"question": "What type of person is considered to be at risk for getting the SARS-CoV-2 vaccine?", "id": "100000000000000000005021", "answers": [{"text": "moderately or severely immunocompromised", "answer_start": 266}], "is_impossible": false}, {"question": "Where was the COV-19 vaccine used?", "id": "100000000000000000005023", "answers": [{"text": "outside the United States", "answer_start": 2542}], "is_impossible": false}, {"question": "What is included in the table in Appendix A: Vaccine administration errors and deviations?", "id": "100000000000000000005025", "answers": [{"text": "Updated information", "answer_start": 2179}], "is_impossible": false}, {"question": "How is the triage of people with a history of allergies or allergic reactions handled?", "id": "100000000000000000005026", "answers": [{"text": "Appendix B", "answer_start": 3779}], "is_impossible": false}, {"question": "What is the guidance in section on Considerations for use of a CoviD-19 booster dose?", "id": "100000000000000000005028", "answers": [{"text": "Updated guidance on receiving a booster dose if vaccinated outside the United States", "answer_start": 922}], "is_impossible": false}], "context": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States\nUpdated guidance in section on People who received COVID-19 as part of a clinical trial\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nRecommendations and clinical guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children aged 5-11 years\nincluding updated section on Vaccination of children and adolescents\nUpdated guidance on COVID-19 vaccine dosing and schedule\nUpdated guidance for myocarditis and pericarditis after mRNA COVID-19 vaccination in new section on Considerations\nfor mRNA COVID-19 vaccines: Pfizer-BioNTech and Moderna\nNew guidance for people who received passive antibody products in section on COVID-19 vaccination and SARS-CoV-2\ninfection\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States\nUpdated guidance in section on People who received COVID-19 as part of a clinical trial in the United States\nUpdated guidance on Considerations for COVID-19 vaccination in moderately and severely immunocompromised\npeople\nUpdated guidance in section on Contraindications and precautions\nUpdated Table in Appendix A: Vaccine administration errors and deviations\nUpdated Appendix B: Triage of people with a history of allergies or allergic reactions\nUpdated Appendix C: Ingredients included in COVID-19 vaccines\nUpdated Appendix D: Potential characteristics of allergic reactions, vasovagal reactions, and vaccine side effects\nfollowing COVID-19 vaccination\nUpdated guidance in section on Considerations for use of a COVID-19 booster dose."}]}, {"title": "a7f3e32a6322f818bb0b8073a2a2a694", "paragraphs": [{"qas": [{"question": "What is updated in section on Dosage and schedule?", "id": "100000000000000000005030", "answers": [{"text": "guidance", "answer_start": 76}], "is_impossible": false}, {"question": "Who is vaccinated for prevention of COV-19 outside of the US?", "id": "100000000000000000005031", "answers": [{"text": "People", "answer_start": 168}], "is_impossible": false}, {"question": "Who has received passive antibody products?", "id": "100000000000000000005033", "answers": [{"text": "People", "answer_start": 471}], "is_impossible": false}, {"question": "What is the section on Considerations for COVID-19 revaccination called?", "id": "100000000000000000005035", "answers": [{"text": "vaccination in moderately and severely immunocompromised people", "answer_start": 678}], "is_impossible": false}, {"question": "What are the two types of people with severe immunocompromised?", "id": "100000000000000000005036", "answers": [{"text": "moderately", "answer_start": 694}], "is_impossible": false}], "context": "New section added on Overview of COVID-19 vaccines recommendations. Updated guidance in section on COVID-19 vaccine dosage and schedule. Updated guidance in section on People vaccinated for prevention of COVID-19 outside the United States. Updated guidance in section on COVID-19 vaccination and SARS-CoV-2 infection for People with prior or current SARS-\nCoV-2 infection; People with a history of multisystem inflammatory syndrome in children (MIS-C) or adults (MIS-A);\nPeople who received passive antibody products; and Vaccinated people who subsequently develop COVID-19. New guidance on Considerations for COVID-19 revaccination in the section on Considerations for COVID-19\nvaccination in moderately and severely immunocompromised people."}]}, {"title": "cdc01e85c2a29acc82a0cdd4ad13d9a0", "paragraphs": [{"qas": [{"question": "What has been updated in Appendix A: Vaccine administration errors and deviations?", "id": "100000000000000000005037", "answers": [{"text": "Table", "answer_start": 8}], "is_impossible": false}, {"question": "What is a new section on Considerations for use of a Pfizer-BioNTech COVID-19 vaccination booster dose after completion of the primary vaccine series?", "id": "100000000000000000005038", "answers": [{"text": "Vaccine administration errors and deviations", "answer_start": 29}], "is_impossible": false}, {"question": "What is the name of the new section on Vaccinating people with a known COVID-19 exposure?", "id": "100000000000000000005040", "answers": [{"text": "COVID-19 outbreaks", "answer_start": 409}], "is_impossible": false}], "context": "Updated Table in Appendix A: Vaccine administration errors and deviations. New section on Considerations for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose after completion of a\nPfizer-BioNTech primary vaccine series. Updated information in the section on COVID-19 vaccination and SARS-CoV-2 infection. Updated information in the section on Vaccinating people with a known COVID-19 exposure or during COVID-19\noutbreaks. New section on Vaccinating people receiving medical care unrelated to COVID-19. New section on Vaccinating people undergoing SARS-CoV-2 screening."}]}, {"title": "14b1ff12f832ede0e4bfaa27b6e3f713", "paragraphs": [{"qas": [{"question": "Who recommended the use of the Pfizer-BioNTech COVID-19 vaccine in persons aged 16 years?", "id": "100000000000000000005043", "answers": [{"text": "Advisory Committee on Immunization Practices", "answer_start": 4}], "is_impossible": false}, {"question": "What is the name of the new Advisory Committee on Immunization Practices?", "id": "100000000000000000005044", "answers": [{"text": "ACIP", "answer_start": 50}], "is_impossible": false}, {"question": "What is the name of the section on Considerations for use of an additional dose of COVID-19 vaccine?", "id": "100000000000000000005045", "answers": [{"text": "Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC Updated information in the section on Considerations for use of an additional dose of COVID 19 vaccine following a primary vaccine series", "answer_start": 483}], "is_impossible": false}, {"question": "What was the date of the update to the information in the Background section?", "id": "100000000000000000005046", "answers": [{"text": "10/30/22", "answer_start": 465}], "is_impossible": false}, {"question": "What is the name of the section on Considerations for use of an additional dose of COVID 19 vaccine?", "id": "100000000000000000005047", "answers": [{"text": "Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC Updated information in the section on Considerations for use of an additional dose of COVID 19 vaccine following a primary vaccine series", "answer_start": 483}], "is_impossible": false}], "context": "New Advisory Committee on Immunization Practices (ACIP) recommendation for use of the U.S. Food and Drug\nAdministration (FDA)-approved Pfizer-BioNTech (COMIRNATY) COVID-19 Vaccine in persons aged \u226516 years. Updated information in Key points to reflect currently available evidence. Updated information on COVID-19 vaccines in the Background section. Updated information in the section on Considerations for use of an additional dose of COVID-19 vaccine following a\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated information in the section on Considerations for use of an additional dose of COVID 19 vaccine following a\nprimary vaccine series."}]}, {"title": "14eecd75bfdb5a337ba0880ac882b2eb", "paragraphs": [{"qas": [{"question": "What is the new section on people vaccinated for COVID-19 as part of a clinical trial in the US?", "id": "100000000000000000005048", "answers": [{"text": "Updated laboratory testing information on timing of immune-based tests for tuberculosis infection in relation to COVID-19 vaccine administration. New section on people vaccinated for COVID-19 as part of a clinical trial in the United States. Updated considerations for use of an additional mRNA COVID-19 vaccine dose", "answer_start": 0}], "is_impossible": false}, {"question": "What is the new section on considerations for use of an additional dose of COVID-19 vaccine for immunocompromised people?", "id": "100000000000000000005049", "answers": [{"text": "mRNA", "answer_start": 290}], "is_impossible": false}, {"question": "What is the initial dose after an initial 2-dose mRNA COVID-19 primary vaccine series for immunocompromised people?", "id": "100000000000000000005050", "answers": [{"text": "COVID-19 vaccine dose", "answer_start": 541}], "is_impossible": false}], "context": "Updated laboratory testing information on timing of immune-based tests for tuberculosis infection in relation to\nCOVID-19 vaccine administration. New section on people vaccinated for COVID-19 as part of a clinical trial in the United States. Updated considerations for use of an additional mRNA COVID-19 vaccine dose after an initial 2-dose COVID-19 mRNA\nvaccine series for immunocompromised people. New section on considerations for use of an additional dose of COVID-19 vaccine. New section on considerations for use of an additional mRNA COVID-19 vaccine dose after an initial 2-dose mRNA\nCOVID-19 primary vaccine series for immunocompromised people."}]}, {"title": "aba0e3e3b4f0283b6ea857101f35196b", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that has been updated for people who are pregnant, lactating, trying to get pregnant now or might become pregnant in the future?", "id": "100000000000000000005051", "answers": [{"text": "COVID-19", "answer_start": 158}], "is_impossible": false}, {"question": "What vaccine was updated in people with a history of Guillain-Barr\u00e9 syndrome?", "id": "100000000000000000005052", "answers": [{"text": "COVID-19", "answer_start": 158}], "is_impossible": false}, {"question": "Where is information on vaccine administration errors and deviations from Appendix A?", "id": "100000000000000000005053", "answers": [{"text": "Table", "answer_start": 315}], "is_impossible": false}, {"question": "What was added to considerations for vaccination of people with certain underlying medical conditions?", "id": "100000000000000000005055", "answers": [{"text": "New section on considerations for use of mRNA COVID-19 vaccines", "answer_start": 440}], "is_impossible": false}], "context": "Updated considerations for people who are pregnant, lactating, trying to get pregnant now, or might become\npregnant in the future. Updated considerations for COVID-19 vaccination in people with a history of Guillain-Barr\u00e9 syndrome. Updated information on vaccine administration errors and deviations in Appendix A (Table). Updated considerations regarding mRNA vaccine dosing intervals. Updated considerations for immunocompromised people. New section on considerations for use of mRNA COVID-19 vaccines in people with a history of myocarditis or\npericarditis added to considerations for vaccination of people with certain underlying medical conditions."}]}, {"title": "65b7b078f5cca0f7158a77ccf9943829", "paragraphs": [{"qas": [{"question": "What was added to patient counseling?", "id": "100000000000000000005056", "answers": [{"text": "New information on the occurrence of myocarditis or pericarditis", "answer_start": 0}], "is_impossible": false}, {"question": "What did new information on the occurrence of myocarditis after vaccination with mRNA COVID-19 vaccines add to?", "id": "100000000000000000005057", "answers": [{"text": "patient counseling", "answer_start": 124}], "is_impossible": false}, {"question": "Where is the updated data on local and systemic symptoms following vaccination?", "id": "100000000000000000005060", "answers": [{"text": "patient counseling section", "answer_start": 514}], "is_impossible": false}], "context": "New information on the occurrence of myocarditis or pericarditis following vaccination with mRNA COVID-19 vaccines\nadded to patient counseling. Information on cases of myocarditis and pericarditis occurring after mRNA COVID-19 vaccination, particularly in\nadolescents and young adults. Information on the efficacy of the Pfizer-BioNTech COVID-19 Vaccine in adolescents aged 12\u201315 years in patient\ncounseling section. Updated data on local and systemic symptoms following vaccination with mRNA COVID-19 vaccines in patient\ncounseling section."}]}, {"title": "1c66731b2555b63d3a90ee978358f02e", "paragraphs": [{"qas": [{"question": "What is the lack of metals in the vaccines in Appendix C?", "id": "100000000000000000005062", "answers": [{"text": "Updated list of ingredients", "answer_start": 237}], "is_impossible": false}, {"question": "What age group was included in the updated information for authorized age groups?", "id": "100000000000000000005064", "answers": [{"text": "adolescents aged 12\u201315 years", "answer_start": 430}], "is_impossible": false}, {"question": "Who updated information on coadministration of COVID-19 Vaccines?", "id": "100000000000000000005065", "answers": [{"text": "CDC", "answer_start": 626}], "is_impossible": false}, {"question": "What did the CDC update about coadministration of COVID-19 vaccines?", "id": "100000000000000000005066", "answers": [{"text": "information on coadministration of COVID-19 vaccines with other vaccines", "answer_start": 638}], "is_impossible": false}], "context": "Clarification in contraindications and precautions and Appendix B of guidance for people with a history of an\nimmediate allergic reaction to a vaccine or injectable therapy that contains a component also contained in a COVID-19\nvaccine. Updated list of ingredients in COVID-19 vaccines (i.e., lack of metals) in Appendix C.\nCorrection of footnote numbering. Updated information for authorized age groups to include vaccination of adolescents aged 12\u201315 years with Pfizer-\nBioNTech COVID-19 Vaccine. 10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated information on coadministration of COVID-19 vaccines with other vaccines."}]}, {"title": "d19f379531d904caae147e93d10bcf11", "paragraphs": [{"qas": [{"question": "What is the recommendation for timing of COVID-19 vaccine administration?", "id": "100000000000000000005068", "answers": [{"text": "Updated", "answer_start": 171}], "is_impossible": false}, {"question": "Who updated information on vaccination of children and adolescents?", "id": "100000000000000000005069", "answers": [{"text": "The Advisory Committee on Immunization Practices", "answer_start": 367}], "is_impossible": false}, {"question": "What is recommended for all people 16 years and older?", "id": "100000000000000000005071", "answers": [{"text": "COVID-19 vaccination", "answer_start": 532}], "is_impossible": false}, {"question": "What is the name of the Janssen COVID-19 Vaccine?", "id": "100000000000000000005072", "answers": [{"text": "Johnson & Johnson", "answer_start": 476}], "is_impossible": false}], "context": "A new section on persons with a history of multisystem inflammatory syndrome added to considerations for\nvaccination of people with certain underlying medical conditions. Updated recommendation for timing of COVID-19 vaccine administration in persons with a history of heparin-induced\nthrombocytopenia. Updated information on vaccination of children and adolescents. The Advisory Committee on Immunization Practices\u2019 updated interim recommendation for the use of the Janssen\n(Johnson & Johnson) COVID-19 Vaccine. Clarification that COVID-19 vaccination is recommended for all people 16 years and older added to key points and\nvaccine administration. Updated information about the Janssen COVID-19 Vaccine added to background."}]}, {"title": "678700057f7b460300a54ddd2a2378be", "paragraphs": [{"qas": [{"question": "What should people with prolonged post-COVID-19 symptoms be offered?", "id": "100000000000000000005073", "answers": [{"text": "COVID-19 vaccination", "answer_start": 359}], "is_impossible": false}, {"question": "What is the new section added for people vaccinated with COVID19 vaccines not authorized in the United States?", "id": "100000000000000000005074", "answers": [{"text": "Clarification on COVID-19 vaccination and SARS-CoV-2 infection", "answer_start": 232}], "is_impossible": false}, {"question": "What should post-COVID-19 symptoms be offered?", "id": "100000000000000000005075", "answers": [{"text": "COVID-19 vaccination", "answer_start": 359}], "is_impossible": false}, {"question": "What new section added on antiviral therapy?", "id": "100000000000000000005076", "answers": [{"text": "People with prolonged post-COVID-19 symptoms should be offered COVID-19 vaccination. New section added on antiviral therapy and COVID-19 vaccination", "answer_start": 296}], "is_impossible": false}, {"question": "Who added information on requesting a consultation from the Clinical Immunization Safety Assessment COVIDvax project?", "id": "100000000000000000005077", "answers": [{"text": "to considerations for vaccination of people with certain underlying medical conditions", "answer_start": 558}], "is_impossible": false}, {"question": "What is a consideration for the use of the Janssen COVID-19 Vaccine in certain populations?", "id": "100000000000000000005078", "answers": [{"text": "vaccination of people with certain underlying medical conditions", "answer_start": 581}], "is_impossible": false}], "context": "Requirements to be considered fully vaccinated added to vaccine administration and interchangeability of COVID-19\nvaccine products. New section added for people vaccinated with COVID-19 vaccines not authorized in the United States. Clarification on COVID-19 vaccination and SARS-CoV-2 infection. People with prolonged post-COVID-19 symptoms\nshould be offered COVID-19 vaccination. New section added on antiviral therapy and COVID-19 vaccination. Information on requesting a consultation from the Clinical Immunization Safety Assessment COVIDvax project added\nto considerations for vaccination of people with certain underlying medical conditions. New section added on considerations for use of the Janssen COVID-19 Vaccine in certain populations."}]}, {"title": "771d812ecdb2db9ca9cb1926af97310d", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine added to patient counseling?", "id": "100000000000000000005079", "answers": [{"text": "Janssen COVID-19", "answer_start": 297}], "is_impossible": false}, {"question": "What was added to patient counseling?", "id": "100000000000000000005081", "answers": [{"text": "axillary lymphadenopathy", "answer_start": 189}], "is_impossible": false}, {"question": "What does CVST stand for?", "id": "100000000000000000005083", "answers": [{"text": "cerebral venous sinus thrombosis", "answer_start": 670}], "is_impossible": false}, {"question": "What is the thrombocytopenia associated with?", "id": "100000000000000000005084", "answers": [{"text": "cerebral venous sinus thrombosis", "answer_start": 670}], "is_impossible": false}], "context": "Updated information and recommendations for vaccination of pregnant or lactating people. Updated recommendations for vaccination of children and adolescents. Updated information related to axillary lymphadenopathy added to patient counseling for mRNA COVID-19 vaccines. Updated information on the Janssen COVID-19 Vaccine added to patient counseling. Updated recommendations related to contraindications (polysorbate allergy) and precautions (most people with a\nprecaution can and should be administered vaccine) for COVID-19 vaccines. Recommended pause in the use of Janssen (Johnson & Johnson) COVID-19 Vaccine. Recommendations for clinicians related to occurrence of cerebral venous sinus thrombosis (CVST) with\nthrombocytopenia after receipt of Janssen COVID-19 Vaccine."}]}, {"title": "d3c330b99b9e2f703e61788f22f77285", "paragraphs": [{"qas": [{"question": "What has been moved to: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html?", "id": "100000000000000000005085", "answers": [{"text": "Public health recommendations for vaccinated people", "answer_start": 0}], "is_impossible": false}, {"question": "What was added for use of Janssen (Johnson & Johnson) COVID-19 Vaccine?", "id": "100000000000000000005086", "answers": [{"text": "Clinical considerations", "answer_start": 156}], "is_impossible": false}, {"question": "What was updated about mRNA COVID-19 vaccines?", "id": "100000000000000000005087", "answers": [{"text": "contraindications and precautions", "answer_start": 431}], "is_impossible": false}, {"question": "What is updated about interpretation of SARS-CoV-2 antibody test results after vaccination?", "id": "100000000000000000005088", "answers": [{"text": "contraindications and precautions to mRNA COVID-19 vaccines. Updated information", "answer_start": 431}], "is_impossible": false}, {"question": "What is the name of the CDC's Appendix A?", "id": "100000000000000000005090", "answers": [{"text": "Interim Clinical Considerations for Use of COVID-19 Vaccines", "answer_start": 720}], "is_impossible": false}], "context": "Public health recommendations for vaccinated people have been moved to: https://www.cdc.gov/coronavirus/2019-\nncov/vaccines/fully-vaccinated-guidance.html. Clinical considerations added for use of Janssen (Johnson & Johnson) COVID-19 Vaccine. Updated recommendations for fully vaccinated people who subsequently develop COVID-19. Updated recommendations related to COVID-19 vaccination timing for immunocompromised people. Updated contraindications and precautions to mRNA COVID-19 vaccines. Updated information on interpretation of SARS-CoV-2 antibody test results after vaccination. New recommendations for preventing, reporting, and managing mRNA COVID-19 vaccine administration errors\n(Appendix A)\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\n(Appendix A). Clarification on contraindications and precautions."}]}, {"title": "890361374dd2a4c6d09da4f23f84081e", "paragraphs": [{"qas": [{"question": "Who has a known (diagnosed) allergy to PEG, another mRNA vaccine component, or polysorbate?", "id": "100000000000000000005091", "answers": [{"text": "contraindication to vaccination", "answer_start": 103}], "is_impossible": false}, {"question": "What is a contraindication to vaccination?", "id": "100000000000000000005092", "answers": [{"text": "People with a known (diagnosed) allergy to PEG", "answer_start": 0}], "is_impossible": false}, {"question": "People with a reaction to a vaccine or injectable therapy that contains multiple components have what?", "id": "100000000000000000005093", "answers": [{"text": "a precaution to vaccination", "answer_start": 385}], "is_impossible": false}, {"question": "What is updated on delayed injection-site reactions after the first dose of mRNA vaccine?", "id": "100000000000000000005095", "answers": [{"text": "Updated quarantine recommendations for vaccinated people", "answer_start": 596}], "is_impossible": false}], "context": "People with a known (diagnosed) allergy to PEG, another mRNA\nvaccine component, or polysorbate, have a contraindication to vaccination. People with a reaction to a vaccine or\ninjectable therapy that contains multiple components, one of which is PEG, another mRNA vaccine component or\npolysorbate, but in whom it is unknown which component elicited the immediate allergic reaction have a precaution\nto vaccination. Updated information on delayed, local injection-site reactions after the first mRNA vaccine dose. These reactions are\nneither a contraindication nor a precaution to the second dose. Updated quarantine recommendations for vaccinated people."}]}, {"title": "634bf682b8752d90e7f91c915d7dc4a1", "paragraphs": [{"qas": [{"question": "Who will no longer be required to quarantine following an exposure to someone with COVID-19?", "id": "100000000000000000005096", "answers": [{"text": "Fully vaccinated people who meet criteria", "answer_start": 0}], "is_impossible": false}, {"question": "What are additional considerations for patients and residents in healthcare settings?", "id": "100000000000000000005097", "answers": [{"text": "Additional information and updated recommendations for testing for TB infection", "answer_start": 221}], "is_impossible": false}, {"question": "When was the last time the testing was done?", "id": "100000000000000000005100", "answers": [{"text": "October 19, 2022", "answer_start": 482}], "is_impossible": false}], "context": "Fully vaccinated people who meet criteria will no longer\nbe required to quarantine following an exposure to someone with COVID-19. Additional considerations for patients\nand residents in healthcare settings are provided. Additional information and updated recommendations for testing for TB infection. TB testing can be done before or at\nthe same time as mRNA COVID-19 vaccination, or otherwise delayed for \u22654 weeks after the completion of mRNA\nCOVID-19 vaccination. Last Reviewed: October 19, 2022"}]}, {"title": "39a4139d58a3df206d6591c8807e77be", "paragraphs": [{"qas": [{"question": "What language does CDC Espaol speak?", "id": "100000000000000000005101", "answers": [{"text": "CDC Espa\u00f1ol", "answer_start": 71}], "is_impossible": false}, {"question": "Who is included on this page?", "id": "100000000000000000005102", "answers": [{"text": "U.S. citizens", "answer_start": 221}], "is_impossible": false}, {"question": "What are non-U.S. citizens?", "id": "100000000000000000005103", "answers": [{"text": "not U.S. immigrants", "answer_start": 327}], "is_impossible": false}, {"question": "What do non-U.S. citizens who are not US immigrants need to do to protect themselves and others from COVID-19?", "id": "100000000000000000005104", "answers": [{"text": "Get up to date with your COVID-19 vaccines", "answer_start": 413}], "is_impossible": false}, {"question": "What should you wear in travel and public transportation settings?", "id": "100000000000000000005106", "answers": [{"text": "masks", "answer_start": 555}], "is_impossible": false}, {"question": "What do countries have to do to get tested after arriving?", "id": "100000000000000000005107", "answers": [{"text": "their own entry and exit requirements", "answer_start": 652}], "is_impossible": false}], "context": "10/30/22, 9:43 AM International Travel to and from the United States | CDC\nEspa\u00f1ol | Other Languages\nInternational Travel to and from the United States\nALL TRAVELERS\nThis page is for all international travelers including U.S. citizens, U.S. nationals, U.S. lawful permanent residents,\nimmigrants, and non-U.S. citizens who are not U.S. immigrants. What You Need to Know\nProtect yourself and others from COVID-19:\nGet up to date with your COVID-19 vaccines before you travel. Consider getting tested before travel. Follow CDC\u2019s recommendations for wearing masks in travel and public transportation settings. Get tested after arrival. Countries may have their own entry and exit requirements ."}]}, {"title": "fdedd72111b1570f15fc3115058a3a5", "paragraphs": [{"qas": [{"question": "Who must show proof of being fully vaccinated with the primary series of an accepted COVID-19 vaccine before you board your flight to the United States?", "id": "100000000000000000005108", "answers": [{"text": "Non-U.S. citizen, non-U.S. immigrants", "answer_start": 0}], "is_impossible": false}, {"question": "How do you get up to date with your COVID-19 vaccines?", "id": "100000000000000000005110", "answers": [{"text": "before you travel", "answer_start": 328}], "is_impossible": false}], "context": "Non-U.S. citizen, non-U.S. immigrants: You must show proof of being fully vaccinated with the primary series of an\naccepted COVID-19 vaccine before you board your flight to the United States. Only limited exceptions apply. \uf209\nBefore You Leave the United States\nMake sure to plan ahead:\nGet up to date with your COVID-19 vaccines before you travel. Find out when you can get your booster and where to get a vaccine or booster. COVID-19 vaccines are effective at protecting people\u2014especially those who are boosted\u2014 from getting seriously ill,\nbeing hospitalized, and even dying."}]}, {"title": "b6032cf44c48a3a3abecba440ad05a58", "paragraphs": [{"qas": [{"question": "What does COVID-19 require for land travel and at ferry terminals?", "id": "100000000000000000005113", "answers": [{"text": "U.S. Department of Homeland Security\u2019s Fact Sheet: Guidance for Travelers to Enter the U.S.", "answer_start": 408}], "is_impossible": false}, {"question": "What does the Department of Homeland Security's Fact Sheet: Guidance for Travelers to Enter the U.S. at Land Ports of Entry and Ferry Terminals contain?", "id": "100000000000000000005114", "answers": [{"text": "COVID-19 requirements", "answer_start": 336}], "is_impossible": false}], "context": "Follow all requirements of transportation operators (such as airlines, cruise lines, buses) and any requirements,\nincluding mask wearing proof of vaccination or testing at your destination\n\uf1c8\nGet Started\nTravel Assessment\nA tool to help you know the requirements to board a flight to the United States. Land Travel\nFor information about COVID-19 requirements for land travel and at ferry terminals, visit the U.S. Department of\nHomeland Security\u2019s Fact Sheet: Guidance for Travelers to Enter the U.S. at Land Ports of Entry and Ferry Terminals."}]}, {"title": "1364a9b9f9fb7c24fe7bd129372f4b7a", "paragraphs": [{"qas": [{"question": "What does CDC include when traveling to and from the United States?", "id": "100000000000000000005115", "answers": [{"text": "mask wearing, proof of vaccination, or testing at your destination", "answer_start": 89}], "is_impossible": false}, {"question": "What may differ from U.S. requirements in other countries?", "id": "100000000000000000005116", "answers": [{"text": "Requirements", "answer_start": 158}], "is_impossible": false}], "context": "\uf209\n\uf209\f10/30/22, 9:43 AM International Travel to and from the United States | CDC\nincluding mask wearing, proof of vaccination, or testing at your destination . Requirements in other countries may differ from U.S. requirements. If you do not follow your destination\u2019s\nrequirements, you may be denied entry and required to return to the United States. If you have a weakened immune system or are at increased risk for severe disease, take multiple prevention steps to\nprovide additional layers of protection from COVID-19 even if you are up to date with your COVID-19 vaccines."}]}, {"title": "f0d974964914ca23d8c299c651f94d94", "paragraphs": [{"qas": [{"question": "What should you do if you are visiting someone who is at higher risk of getting sick from COVID-19?", "id": "100000000000000000005119", "answers": [{"text": "learn how to protect them", "answer_start": 288}], "is_impossible": false}, {"question": "What should you do to protect them?", "id": "100000000000000000005121", "answers": [{"text": "If you will be visiting someone who is at higher risk of getting very sick from COVID-19, learn how to protect them. During Travel \uf209 \uf3c0 Testing RECOMMENDED Consider getting tested with a viral test", "answer_start": 198}], "is_impossible": false}, {"question": "How close to the time of departure is it recommended to get tested with a viral test?", "id": "100000000000000000005122", "answers": [{"text": "no more than 3 days", "answer_start": 442}], "is_impossible": false}, {"question": "Do you know your test results before you travel?", "id": "100000000000000000005123", "answers": [{"text": "Make sure you know your test results before travel", "answer_start": 478}], "is_impossible": false}], "context": "Talk to your healthcare provider about your risk before travel and consider delaying travel to areas with high\nCOVID-19 levels. Even if you are up to date, you should know what precautions to take. If you will be visiting someone who is at higher risk of getting very sick from COVID-19, learn how to protect them. During Travel\n\uf209\n\uf3c0 Testing\nRECOMMENDED\nConsider getting tested with a viral test as close to the time of departure as possible (no more than 3\ndays) before travel. Make sure you know your test results before travel. Don\u2019t travel if your test result is positive."}]}, {"title": "d1eae314ffc3139ee604f34f59308999", "paragraphs": [{"qas": [{"question": "Where can you find a U.S. COVID-19 testing location near you?", "id": "100000000000000000005125", "answers": [{"text": "use a self-test", "answer_start": 50}], "is_impossible": false}, {"question": "How long has it been since you've had COIVD-19?", "id": "100000000000000000005127", "answers": [{"text": "90 days", "answer_start": 111}], "is_impossible": false}, {"question": "What do you need to wear to continue wearing my mask?", "id": "100000000000000000005129", "answers": [{"text": "high-quality mask or respirator", "answer_start": 508}], "is_impossible": false}, {"question": "What type of mask or respirator should you wear during a trip?", "id": "100000000000000000005131", "answers": [{"text": "high-quality", "answer_start": 508}], "is_impossible": false}, {"question": "How long should you be able to wear a mask?", "id": "100000000000000000005132", "answers": [{"text": "full duration of your trip", "answer_start": 575}], "is_impossible": false}], "context": "Find a U.S. COVID-19 testing location near you or use a self-test. If you already had COVID-19 within the past 90 days, see specific testing recommendations. \uf209\nCan I travel if ...? I am sick with or tested positive for COVID-19 and\nam recommended to isolate. Do NOT travel. Follow recommendations for isolation. I have ended isolation but still need to continue\nwearing my mask per CDC\u2019s guidance. Do not travel on public transportation such as\nairplanes, buses, and trains if you will not be able\nto wear a high-quality mask or respirator when\naround others indoors for the full duration of your\ntrip."}]}, {"title": "d9eb3610e76b711ee436d30d98d73748", "paragraphs": [{"qas": [{"question": "What should you wear if you travel?", "id": "100000000000000000005133", "answers": [{"text": "high-quality mask or respirator", "answer_start": 22}], "is_impossible": false}, {"question": "How many days have you been exposed to a person with COV-19?", "id": "100000000000000000005135", "answers": [{"text": "10", "answer_start": 251}], "is_impossible": false}, {"question": "Do not travel on public transportation if you will not be able to wear a high-quality mask or what?", "id": "100000000000000000005137", "answers": [{"text": "respirator", "answer_start": 484}], "is_impossible": false}], "context": "If you travel, wear a high-quality mask or\nrespirator the entire time you are around others\nindoors. Traveling by private vehicle (if possible) can lower\nthe chances of spreading COVID-19 to others. I was exposed to a person with COVID-19 in the\npast 10 days. Follow CDC guidance, including getting tested at\nleast 5 full days after your last exposure. Do not travel on public transportation such as\nairplanes, buses, and trains if you will not be able\nto wear a high-quality mask or respirator when\naround others indoors for the full duration of your\ntrip."}]}, {"title": "cec591363ae1a3aaf03586bbbb70d3e5", "paragraphs": [{"qas": [{"question": "What can lower the chances of spreading COVID-19 to others?", "id": "100000000000000000005139", "answers": [{"text": "Traveling by private vehicle", "answer_start": 101}], "is_impossible": false}, {"question": "What should you wear before you travel to the United States?", "id": "100000000000000000005141", "answers": [{"text": "high-quality mask or respirator", "answer_start": 22}], "is_impossible": false}, {"question": "What does CDC recommend that you wear in public transportation settings?", "id": "100000000000000000005142", "answers": [{"text": "masks", "answer_start": 431}], "is_impossible": false}], "context": "If you travel, wear a high-quality mask or\nrespirator the entire time you are around others\nindoors. Traveling by private vehicle (if possible) can lower\nthe chances of spreading COVID-19 to others. 10/30/22, 9:43 AM International Travel to and from the United States | CDC\nProtect Yourself and Others\nBefore You Travel to the United States\nAfter Arrival in the United States\n\uf48e RECOMMENDED\nFollow CDC\u2019s recommendations for wearing masks in travel and public transportation settings. Follow recommendations for protecting yourself and others. Follow all\u202frecommendations and requirements at your destination ."}]}, {"title": "a06fd7cd2f1fdb69f8e690abc43b2f4c", "paragraphs": [{"qas": [{"question": "Who is required to provide contact information to before boarding flights to the United States?", "id": "100000000000000000005143", "answers": [{"text": "All air passengers to the United States are required to provide contact information to airlines", "answer_start": 49}], "is_impossible": false}, {"question": "What does this strengthen?", "id": "100000000000000000005144", "answers": [{"text": "a travel process already in place to rapidly identify and contact people in the U.S.", "answer_start": 208}], "is_impossible": false}, {"question": "What is the name of a communicable disease in the U.S.?", "id": "100000000000000000005145", "answers": [{"text": "COVID-19", "answer_start": 354}], "is_impossible": false}, {"question": "Who has access to travelers' contact information?", "id": "100000000000000000005147", "answers": [{"text": "U.S. federal, state, territorial and local health departments, and agencies", "answer_start": 416}], "is_impossible": false}], "context": "\uf209\n\uf195 Contact Information \u2013 ALL Travelers\nREQUIRED\nAll air passengers to the United States are required to provide contact information to airlines before boarding\nflights to the United States. This strengthens a travel process already in place to rapidly identify and contact people in the U.S. who\nmay have been exposed to a communicable disease, such as COVID-19. Access to travelers\u2019 contact information will allow U.S. federal, state, territorial and local health\ndepartments, and agencies to share appropriate health and public health information necessary to help\nkeep the public safe."}]}, {"title": "f08f2ca798532ba8a5c500c39d36fde1", "paragraphs": [{"qas": [{"question": "How many days before travel should you get tested with a viral test?", "id": "100000000000000000005149", "answers": [{"text": "3", "answer_start": 140}], "is_impossible": false}, {"question": "What should you do if you have already had a virus in the past 90 days?", "id": "100000000000000000005150", "answers": [{"text": "Don\u2019t travel", "answer_start": 306}], "is_impossible": false}, {"question": "What should you know about your test results before you travel?", "id": "100000000000000000005151", "answers": [{"text": "Make sure you know your test results before travel. Don\u2019t travel if your test result is positive", "answer_start": 254}], "is_impossible": false}, {"question": "Do you travel if your test result is positive?", "id": "100000000000000000005152", "answers": [{"text": "Don\u2019t", "answer_start": 306}], "is_impossible": false}, {"question": "What is required of all non-U.S. citizens traveling to the United States by air?", "id": "100000000000000000005153", "answers": [{"text": "to show proof of being fully vaccinated against COVID-19", "answer_start": 525}], "is_impossible": false}, {"question": "What is required to be fully vaccinated against COVID-19?", "id": "100000000000000000005154", "answers": [{"text": "All non-U.S. citizen, non-U.S. immigrants traveling to the United States", "answer_start": 432}], "is_impossible": false}, {"question": "How many exceptions apply?", "id": "100000000000000000005155", "answers": [{"text": "Only limited", "answer_start": 583}], "is_impossible": false}], "context": "\uf3c0 Testing \u2013 ALL Travelers\nRECOMMENDED\nConsider getting tested with a viral test as close to the time of departure as possible (no more than 3\ndays) before travel. If you already had COVID-19 within the past 90 days, see specific testing recommendations. Make sure you know your test results before travel. Don\u2019t travel if your test result is positive. Non-U.S. Citizen, Non-U.S. Immigrants\nProof of Vaccination\nREQUIRED\nAir Travel: All non-U.S. citizen, non-U.S. immigrants traveling to the United States by air are required to show proof of\nbeing fully vaccinated against COVID-19. Only limited exceptions apply. Learn more about this requirement and accepted\nvaccines."}]}, {"title": "189d359660fb2e9f00d5a85d594792be", "paragraphs": [{"qas": [{"question": "What may you have to state you have arranged to take?", "id": "100000000000000000005158", "answers": [{"text": "protective measures", "answer_start": 345}], "is_impossible": false}, {"question": "What is the requirement for proof of COVID-19 Vaccination?", "id": "100000000000000000005159", "answers": [{"text": "sign an attestation (legal statement) before you board your flight to the United States stating you meet the exception. Depending on the type of exception, you may also have to state you have arranged to take certain protective measures. For more information see Requirement for Proof of COVID-19 Vaccination for Air Passengers", "answer_start": 128}], "is_impossible": false}], "context": "If you are not fully vaccinated and allowed to travel to the United States by air through an exception, you will be required\nto sign an attestation (legal statement) before you board your flight to the United States stating you meet the exception. Depending on the type of exception, you may also have to state you have arranged to take certain protective measures. For more information see Requirement for Proof of COVID-19 Vaccination for Air Passengers."}]}, {"title": "b6a476f906c0f3a3795a0b1b5ab969ba", "paragraphs": [{"qas": [{"question": "How long after arriving in the U.S. can you get tested with a viral test?", "id": "100000000000000000005160", "answers": [{"text": "3-5 days", "answer_start": 167}], "is_impossible": false}, {"question": "How long have you been exposed to a person with COIVD-19?", "id": "100000000000000000005164", "answers": [{"text": "90 days", "answer_start": 302}], "is_impossible": false}, {"question": "What is a person with COVID-19?", "id": "100000000000000000005165", "answers": [{"text": "COVID-19 symptoms", "answer_start": 370}], "is_impossible": false}, {"question": "Follow all state, tribal, local and territorial recommendations after arrival?", "id": "100000000000000000005166", "answers": [{"text": "RECOMMENDED G t t t d ith i l t t 3 5 d ft i l", "answer_start": 15}], "is_impossible": false}], "context": "\uf3c0 ALL Travelers\nRECOMMENDED\nG t t t d ith i l t t 3 5 d ft i l\f10/30/22, 9:43 AM International Travel to and from the United States | CDC\nGet tested with a viral test 3-5 days after arrival. Find a U.S. COVID-19 testing location near you or use a self-test. If you already had COVID-19 within the past 90 days, see specific testing recommendations. Monitor yourself for COVID-19 symptoms. Follow additional guidance if you know you were exposed to a person with COVID-19. Follow all state, tribal, local and territorial recommendations or requirements after arrival."}]}, {"title": "3d11ea823d5fc6a632867a31452b4a8b", "paragraphs": [{"qas": [{"question": "What should you do if you are going to be around someone who is at higher risk of getting very sick with COVID-19?", "id": "100000000000000000005167", "answers": [{"text": "consider additional precautions", "answer_start": 96}], "is_impossible": false}, {"question": "If Your Test Result is Positive or You Develop COVID-19 Symptoms Isolate yourself to protect others from getting infected with what?", "id": "100000000000000000005168", "answers": [{"text": "COVID-19", "answer_start": 86}], "is_impossible": false}, {"question": "What are non-U.S. citizens who are not fully vaccinated and allowed to travel to the United States by air through an exception required to do?", "id": "100000000000000000005169", "answers": [{"text": "follow requirements of the attestation they signed before boarding their flight", "answer_start": 455}], "is_impossible": false}, {"question": "What must non-US immigrants follow requirements of before boarding their flight?", "id": "100000000000000000005170", "answers": [{"text": "the attestation they signed", "answer_start": 478}], "is_impossible": false}, {"question": "What is required of Air Passengers before boarding their flight?", "id": "100000000000000000005171", "answers": [{"text": "attestation they signed", "answer_start": 482}], "is_impossible": false}], "context": "If you are going to be around someone who is at higher risk of getting very sick with COVID-19, consider\nadditional precautions. \uf209\nIf Your Test Result is Positive or You Develop COVID-19 Symptoms\nIsolate yourself to protect others from getting infected. Learn what to do and when it is safe to be around others. Non-U.S. Citizen, Non-U.S. immigrants who are not fully vaccinated and allowed to travel to the United States by air\nthrough an exception must follow requirements of the attestation they signed before boarding their flight. For more\ninformation, see Requirement for Proof of COVID-19 Vaccination for Air Passengers."}]}, {"title": "f53ba657d303fecda7c765091481c25c", "paragraphs": [{"qas": [{"question": "CDC continues to recommend that people wear what type of masks in public transportation?", "id": "100000000000000000005175", "answers": [{"text": "high-quality", "answer_start": 353}], "is_impossible": false}], "context": "Summary of Recent Changes\nUpdates as of April 18, 2022\nAs a result of a court order, effective immediately and as of April 18, 2022, CDC\u2019s January 29, 2021 Order requiring\nmasks on public transportation conveyances and at transportation hubs is no longer in effect. Therefore, CDC will not\nenforce the Order. CDC continues to recommend that people wear high-quality masks in indoor public transportation\nsettings at this time."}]}, {"title": "6a9c6ee3c0a0720ba70e6c4d0cbee99d", "paragraphs": [{"qas": [{"question": "What is required proof of COVID-19 Vaccination?", "id": "100000000000000000005176", "answers": [{"text": "Frequently Asked Questions about Travel", "answer_start": 56}], "is_impossible": false}, {"question": "Who is responsible for information about what you can and cannot bring back from your trip?", "id": "100000000000000000005178", "answers": [{"text": "US Customs and Border Protection", "answer_start": 314}], "is_impossible": false}, {"question": "When was the last update for the TSA?", "id": "100000000000000000005180", "answers": [{"text": "Aug. 24, 2022", "answer_start": 552}], "is_impossible": false}], "context": "More Information\nRequired Proof of COVID-19 Vaccination\nFrequently Asked Questions about Travel and COVID-19\nHealth Information for International Destinations\nDomestic Travel During COVID-19\nUS State Department Travel Site : Safety and security information by country, passport, visas, and entry/exit\nrequirements\nUS Customs and Border Protection : Information about what you can and cannot bring back from your trip abroad\nUS Embassies : In-country contacts\nTransportation Security Administration (TSA) : Information about flying\n\uf209\n\uf209\n\uf209\n\uf209\nLast Updated Aug. 24, 2022"}]}, {"title": "7f99ac9975f6bf190c748d5c44b441de", "paragraphs": [{"qas": [{"question": "What is VAERS?", "id": "100000000000000000005182", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 333}], "is_impossible": false}, {"question": "Who requires healthcare professionals to report to VAERS certain serious adverse events?", "id": "100000000000000000005184", "answers": [{"text": "U.S. Food and Drug Administration", "answer_start": 553}], "is_impossible": false}, {"question": "What does VAERS require healthcare professionals to report after COVID-19 vaccination?", "id": "100000000000000000005185", "answers": [{"text": "serious adverse events and hospitalizations", "answer_start": 654}], "is_impossible": false}], "context": "10/30/22, 9:31 AM Investigating Long-Term Effects of Myocarditis | CDC\nEspa\u00f1ol | Other Languages\nInvestigating Long-Term Effects of Myocarditis\nHow CDC Is Investigating Myocarditis Health Effects after COVID-19 Vaccination\nParticipating in the Survey\nHow did CDC get my contact information? CDC got your contact information from the Vaccine Adverse Event Reporting System (VAERS ), a secure system that\ncontains information needed to check in with patients to see how they are recovering after they experience a serious event\nfollowing vaccination. The U.S. Food and Drug Administration (FDA) requires healthcare professionals to report to VAERS certain serious adverse\nevents and hospitalizations that occur after COVID-19 vaccination."}]}, {"title": "3f1fa694601df5f1f775053e3be95e61", "paragraphs": [{"qas": [{"question": "What is the purpose of the COVID-19 vaccines?", "id": "100000000000000000005186", "answers": [{"text": "helps us get a more complete picture of the risks and benefits of COVID-19 vaccination", "answer_start": 138}], "is_impossible": false}, {"question": "Who is conducting surveys of?", "id": "100000000000000000005188", "answers": [{"text": "patients (or their parents or guardians) and healthcare providers", "answer_start": 277}], "is_impossible": false}], "context": "How is CDC using my information? The information you provide will contribute to what we know about the safety of COVID-19 vaccines, which helps us get a\nmore complete picture of the risks and benefits of COVID-19 vaccination. What You Need to Know\nCDC is conducting surveys of patients (or their parents or guardians) and healthcare providers to gather\ninformation about myocarditis after COVID-19 vaccination. CDC is contacting people who meet the case definition for myocarditis following COVID-19 vaccination."}]}, {"title": "3593ddc92f8ee1cbbf9c977ca94449da", "paragraphs": [{"qas": [{"question": "What is the name of the system that reports people who have been reported to the Vaccine Adverse Event Reporting System?", "id": "100000000000000000005192", "answers": [{"text": "VAERS", "answer_start": 175}], "is_impossible": false}, {"question": "What does CDC do to support the diagnosis of myocarditis and rule out other causes?", "id": "100000000000000000005193", "answers": [{"text": "Medical tests", "answer_start": 357}], "is_impossible": false}, {"question": "How many days have passed since symptoms began?", "id": "100000000000000000005194", "answers": [{"text": "90", "answer_start": 512}], "is_impossible": false}], "context": "\u2022\n\u2022\nCDC is contacting people who meet the case definition for myocarditis following COVID-19 vaccination and have been\nreported to the Vaccine Adverse Event Reporting System (VAERS). To meet the case definition, people must have had:\nSymptoms such as chest pain, shortness of breath, and feelings of having a fast-beating, fluttering, or pounding\nheart and\nMedical tests to support the diagnosis of myocarditis and rule out other causes. CDC will contact people with myocarditis reported to VAERS after at least 90 days have passed since myocarditis\nsymptoms began and will publish data as it becomes available."}]}, {"title": "f9a90311601a83f6e08320378c968b2", "paragraphs": [{"qas": [{"question": "What will be kept private to the extent allowable under the law?", "id": "100000000000000000005196", "answers": [{"text": "Personal information and responses", "answer_start": 131}], "is_impossible": false}, {"question": "When a patient is a minor, a parent or legal guardian will be invited what?", "id": "100000000000000000005197", "answers": [{"text": "participate on their behalf", "answer_start": 301}], "is_impossible": false}, {"question": "Who will be invited to participate on their behalf?", "id": "100000000000000000005198", "answers": [{"text": "a parent or legal guardian", "answer_start": 255}], "is_impossible": false}, {"question": "What will be kept private and information about your case combined with information from other participants?", "id": "100000000000000000005199", "answers": [{"text": "Personal details that could identify you", "answer_start": 415}], "is_impossible": false}, {"question": "What information will not be included in any reports?", "id": "100000000000000000005200", "answers": [{"text": "your name and any identifying information", "answer_start": 579}], "is_impossible": false}], "context": "People may get a letter in the mail or receive a phone call from CDC asking questions about their myocarditis and\nmedical history. Personal information and responses will be kept private to the extent allowable under the law. When the patient is\na minor, a parent or legal guardian will be invited to participate on their behalf. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf209\n\uf209\f10/30/22, 9:31 AM Investigating Long-Term Effects of Myocarditis | CDC\nPersonal details that could identify you will be kept private and information about your case will be combined with\ninformation from other participants. This means your name and any identifying information will not be included in any\nreports."}]}, {"title": "37202414135829f322ab4bcd44939b6c", "paragraphs": [{"qas": [{"question": "Who will use this information to guide recommendations on the safe use of COVID-19 vaccines?", "id": "100000000000000000005201", "answers": [{"text": "CDC and FDA", "answer_start": 0}], "is_impossible": false}, {"question": "Who will be looking at health effects after receiving an mRNA vaccine?", "id": "100000000000000000005202", "answers": [{"text": "scientists", "answer_start": 181}], "is_impossible": false}, {"question": "How does your heart recover from myocarditis?", "id": "100000000000000000005203", "answers": [{"text": "Changes in your health, physical ability, or quality of life How your heart recovers from myocarditis Why is CDC contacting my healthcare provider? Having information on medications you take and your test results can provide a more complete picture of your health following myocarditis. Your healthcare provider can provide this information, which is important as we try to understand more about myocarditis after COVID-19 vaccination", "answer_start": 235}], "is_impossible": false}, {"question": "Who can provide this information?", "id": "100000000000000000005205", "answers": [{"text": "Your healthcare provider", "answer_start": 522}], "is_impossible": false}, {"question": "What is important as we try to understand more about myocarditis after COVID-19 vaccination?", "id": "100000000000000000005206", "answers": [{"text": "Your healthcare provider can provide this information", "answer_start": 522}], "is_impossible": false}], "context": "CDC and FDA will use this information to guide recommendations on the safe use of COVID-19 vaccines. For you and others who experienced myocarditis after receiving an mRNA vaccine, scientists will be looking at health effects\nsuch as:\nChanges in your health, physical ability, or quality of life\nHow your heart recovers from myocarditis\nWhy is CDC contacting my healthcare provider? Having information on medications you take and your test results can provide a more complete picture of your health\nfollowing myocarditis. Your healthcare provider can provide this information, which is important as we try to understand\nmore about myocarditis after COVID-19 vaccination."}]}, {"title": "734e8cb9d5ebd3b4cd784816f4aad294", "paragraphs": [{"qas": [{"question": "How can you report health problems after COVID-19 vaccination to VAERS?", "id": "100000000000000000005207", "answers": [{"text": "by filling out an online form or a PDF form", "answer_start": 169}], "is_impossible": false}, {"question": "What does FDA require healthcare professionals to report?", "id": "100000000000000000005208", "answers": [{"text": "certain adverse events that occur after administering COVID-19 vaccine", "answer_start": 263}], "is_impossible": false}, {"question": "What is important to understanding the safety of COVID-19 vaccines as more people receive them over time?", "id": "100000000000000000005209", "answers": [{"text": "Reports to VAERS", "answer_start": 391}], "is_impossible": false}, {"question": "If you need assistance with reporting to VAERS, please email info@VAERS.org or call what number?", "id": "100000000000000000005211", "answers": [{"text": "1-800-822-7967", "answer_start": 602}], "is_impossible": false}], "context": "How to Report Health Problems after Vaccination\nYou or your healthcare professional can report any adverse events or health problems after COVID-19 vaccination to VAERS\nby filling out an online form or a PDF form . FDA requires healthcare professionals to report certain adverse events that occur after administering COVID-19 vaccine,\nbut anyone can submit a report to VAERS, including you. Reports to VAERS are important to understanding the safety of COVID-19 vaccines as more people receive them over time. If\nyou need further assistance with reporting to VAERS, please email info@VAERS.org or call 1-800-822-7967."}]}, {"title": "27509b9a58444e6d499c007c1523d6b5", "paragraphs": [{"qas": [{"question": "How long has it been since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study?", "id": "100000000000000000005212", "answers": [{"text": "90 days", "answer_start": 41}], "is_impossible": false}, {"question": "What is a case definition for myocarditis following mRNA COVID-19 Vaccination?", "id": "100000000000000000005213", "answers": [{"text": "COVID-19 Vaccine Safety Publications", "answer_start": 477}], "is_impossible": false}, {"question": "When was the last update for the COVID-19 vaccines?", "id": "100000000000000000005214", "answers": [{"text": "Sept. 23, 2022", "answer_start": 527}], "is_impossible": false}, {"question": "What is the name of the Vaccine Safety Publications?", "id": "100000000000000000005215", "answers": [{"text": "COVID-19", "answer_start": 477}], "is_impossible": false}], "context": "\u2022\n\u2022\n\uf209 \uf209\n\uf209\nPublications\nOutcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young\nadults in the USA: a follow-up surveillance study\n\u203a\n\uf209\nRelated Pages\nMyocarditis and Pericarditis Following mRNA COVID-19 Vaccination\n\u203a\nCOVID-19 Vaccine Safety and Monitoring\n\u203a\nBenefits of Getting a COVID-19 Vaccine\n\u203a\nMyths and Facts about COVID-19 Vaccines\n\u203a\nMore Information\nCase Definition for Myocarditis following mRNA COVID-19 Vaccination\nCOVID-19 Vaccine Safety Publications\nLast Updated Sept. 23, 2022"}]}, {"title": "712513a264623145ecc2ad4fd4df3bdf", "paragraphs": [{"qas": [{"question": "What is used to separate people with confirmed or suspected COVID-19 from those without?", "id": "100000000000000000005218", "answers": [{"text": "Isolation", "answer_start": 376}], "is_impossible": false}, {"question": "What do the recommendations do not change based on?", "id": "100000000000000000005219", "answers": [{"text": "COVID-19 Community Levels", "answer_start": 524}], "is_impossible": false}, {"question": "What are the Community Levels?", "id": "100000000000000000005220", "answers": [{"text": "COVID-19", "answer_start": 524}], "is_impossible": false}], "context": "10/30/22, 9:41 AM Isolation and Precautions for People with COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nIsolation and Precautions for People with COVID-19\nIf you have COVID-19, you can spread the virus to others. There are precautions you can take to prevent spreading it to\nothers: isolation, masking, and avoiding contact with people who are at high risk of getting very sick. Isolation is used to\nseparate people with confirmed or suspected COVID-19 from those without COVID-19. These recommendations do not change based on COVID-19 Community Levels. If you have COVID-19, also see additional\ninformation on treatments that may be available to you."}]}, {"title": "20c180dff81d128b4034c17e389b731f", "paragraphs": [{"qas": [{"question": "What is meant to supplement\u2014not replace any federal, state, local, territorial, or tribal health and safety laws?", "id": "100000000000000000005223", "answers": [{"text": "Ending Isolation and Precautions for People with COVID-19. This CDC guidance", "answer_start": 89}], "is_impossible": false}, {"question": "When should you isolate from others when you have COVID-19?", "id": "100000000000000000005224", "answers": [{"text": "Regardless of vaccination status", "answer_start": 299}], "is_impossible": false}], "context": "This information is intended for a general audience. Healthcare professionals should see Ending Isolation and Precautions for\nPeople with COVID-19. This CDC guidance is meant to supplement\u2014not replace\u2014any federal, state, local, territorial, or tribal\nhealth and safety laws, rules, and regulations. Regardless of vaccination status, you should isolate from others when you have COVID-19. You should also isolate if you are sick and suspect that you have COVID-19 but do not yet have test results. If your results are\npositive, follow the full isolation recommendations below. If your results are negative, you can end your isolation."}]}, {"title": "3d2e9cba304a305e50786f7d33ceb42d", "paragraphs": [{"qas": [{"question": "How is isolation counted when you have COVID-19?", "id": "100000000000000000005228", "answers": [{"text": "days", "answer_start": 48}], "is_impossible": false}, {"question": "What should you do if you were exposed to the disease?", "id": "100000000000000000005229", "answers": [{"text": "start taking precautions", "answer_start": 110}], "is_impossible": false}, {"question": "How is the Isolation and Exposure Calculator?", "id": "100000000000000000005230", "answers": [{"text": "A tool to help you determine if you need to isolate or take other steps to prevent spreading COVID-19", "answer_start": 172}], "is_impossible": false}], "context": "When you have COVID-19, isolation is counted in days, as follows:\nIf you were exposed to COVID-19, you should start taking precautions. \uf283 Isolation and Exposure Calculator\nA tool to help you determine if you need to isolate or take other steps to prevent spreading COVID-19."}]}, {"title": "28fcab701147e22aa62207d6bf6f1598", "paragraphs": [{"qas": [{"question": "What can you do if you test positive?", "id": "100000000000000000005232", "answers": [{"text": "stay home for at least 5 days and isolate from others in your home", "answer_start": 403}], "is_impossible": false}, {"question": "What should you do if you test positive for COVID-19?", "id": "100000000000000000005233", "answers": [{"text": "stay home for at least 5 days and isolate from others in your home", "answer_start": 403}], "is_impossible": false}, {"question": "How long should you stay home?", "id": "100000000000000000005234", "answers": [{"text": "at least 5 days", "answer_start": 417}], "is_impossible": false}, {"question": "What is the most likely time you are most infectious during these first 5 days?", "id": "100000000000000000005235", "answers": [{"text": "If you test positive for COVID-19, stay home for at least 5 days and isolate from others in your home", "answer_start": 368}], "is_impossible": false}], "context": "Isolation & Exposure\nFor Healthcare Professionals: Ending Isolation and Precautions for People with COVID-19\n\uf3b7\n\uf285 When to Isolate\n\uf6eb IF YOU TEST\nNegative\nYou can end your isolation\n\uf6ec IF YOU TEST\nPositive\nFollow the full isolation\nrecommendations below\nIf you had no symptoms If you had symptoms\f10/30/22, 9:41 AM Isolation and Precautions for People with COVID-19 | CDC\nIf you test positive for COVID-19, stay home for at least 5 days and isolate from others in your home. You are likely most infectious during these first 5 days. Wear a high-quality mask if you must be around others at home and in public."}]}, {"title": "297a9c38d2d8fb729c1c16ba510848d", "paragraphs": [{"qas": [{"question": "Do not travel. Stay home and separate from others as much as possible.", "id": "100000000000000000005238", "answers": [{"text": "Do not travel. Stay home and separate from others as much as possible. Use a separate bathroom", "answer_start": 101}], "is_impossible": false}, {"question": "Use a separate bathroom, if possible, what?", "id": "100000000000000000005239", "answers": [{"text": "Take steps to improve ventilation at home", "answer_start": 210}], "is_impossible": false}, {"question": "Take steps to improve what at home?", "id": "100000000000000000005240", "answers": [{"text": "ventilation", "answer_start": 232}], "is_impossible": false}, {"question": "If you have trouble breathing, seek emergency medical care immediately.", "id": "100000000000000000005243", "answers": [{"text": "emergency warning sign", "answer_start": 375}], "is_impossible": false}], "context": "Do not go places where you are unable to wear a mask. For travel guidance, see CDC\u2019s Travel webpage. Do not travel. Stay home and separate from others as much as possible. Use a separate bathroom, if possible. Take steps to improve ventilation at home, if possible. Don\u2019t share personal household items, like cups, towels, and utensils. Monitor your symptoms. If you have an emergency warning sign (like trouble breathing), seek emergency medical care\nimmediately. Learn more about what to do if you have COVID-19. End isolation based on how serious your COVID-19 symptoms were."}]}, {"title": "a70bd16f6c30b2b9e58c61000c04f94f", "paragraphs": [{"qas": [{"question": "What may persist for weeks or months after recovery?", "id": "100000000000000000005245", "answers": [{"text": "Loss of taste and smell", "answer_start": 0}], "is_impossible": false}], "context": "Loss of taste and smell may persist for weeks or months\nafter recovery and need not delay the end of isolation. If you had no symptoms\nYou may end isolation after day 5."}]}, {"title": "703c27228a24971bfd7b10e2027f8b2b", "paragraphs": [{"qas": [{"question": "What day is the day you were tested?", "id": "100000000000000000005247", "answers": [{"text": "Day 0", "answer_start": 54}], "is_impossible": false}, {"question": "How many days after you were tested does the clock restart at day 0?", "id": "100000000000000000005250", "answers": [{"text": "10", "answer_start": 233}], "is_impossible": false}, {"question": "Day 0 of isolation is the day of what?", "id": "100000000000000000005251", "answers": [{"text": "symptom onset", "answer_start": 361}], "is_impossible": false}, {"question": "What is the first full day after the day your symptoms started?", "id": "100000000000000000005252", "answers": [{"text": "Day 1", "answer_start": 415}], "is_impossible": false}, {"question": "How long are you fever-free?", "id": "100000000000000000005253", "answers": [{"text": "24 hours", "answer_start": 621}], "is_impossible": false}, {"question": "How long is it possible to end isolation?", "id": "100000000000000000005254", "answers": [{"text": "after day 5", "answer_start": 582}], "is_impossible": false}], "context": "If you had symptoms and:\nIf you had symptoms and had:\nDay 0 is the day you were tested (not the day you\nreceived your positive test result)\nDay 1 is the first full day following the day you were\ntested\nIf you develop symptoms within 10 days of when you\nwere tested, the clock restarts at day 0 on the day of\nsymptom onset\n\u2022\n\u2022\n\u2022\nDay 0 of isolation is the day of symptom onset,\nregardless of when you tested positive\nDay 1 is the first full day after the day your symptoms\nstarted\n\u2022\n\u2022\n\uf31a Isolation\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf318 Ending Isolation\nYour symptoms are improving\nYou may end isolation after day 5 if:\nYou are fever-free for 24 hours (without the use of\nfever-reducing medication)."}]}, {"title": "68159231a21d495e3aad16bca97208e9", "paragraphs": [{"qas": [{"question": "How long are you fever-free?", "id": "100000000000000000005255", "answers": [{"text": "24 hours", "answer_start": 84}], "is_impossible": false}], "context": "\u2022\nYour symptoms are not improving\nContinue to isolate until:\nYou are fever-free for 24 hours (without the use of\nfever-reducing medication). Your symptoms are improving. \u2022\nModerate illness (you experienced shortness of\nbreath or had difficulty breathing)\nYou need to isolate through day 10. Severe illness (you were hospitalized) or have a\nweakened immune system\nYou need to isolate through day 10. \u2022\f10/30/22, 9:41 AM Isolation and Precautions for People with COVID-19 | CDC\nRegardless of when you end isolation\nUntil at least day 11:\nAvoid being around people who are more likely to get very sick from COVID-19."}]}, {"title": "67c1aed00bc7ad0db1d81accf5721b8f", "paragraphs": [{"qas": [{"question": "What should you wear when you are indoors around others?", "id": "100000000000000000005261", "answers": [{"text": "a high-quality mask", "answer_start": 17}], "is_impossible": false}, {"question": "What should you do before ending isolation?", "id": "100000000000000000005265", "answers": [{"text": "Consult your doctor", "answer_start": 242}], "is_impossible": false}], "context": "Remember to wear a high-quality mask when indoors around others at home and in public. Do not go places where you are unable to wear a mask until you are able to discontinue masking (see below). For travel guidance, see CDC\u2019s Travel webpage. Consult your doctor before ending isolation. Ending isolation without a viral test may not be an\noption for you. \u2022\n\u2022\nIf you are unsure if your symptoms are moderate or severe or if you have a weakened immune system, talk to a\nhealthcare provider for further guidance."}]}, {"title": "e77b874d0a59b366f2c2c42ad2a3fbe2", "paragraphs": [{"qas": [{"question": "How many sequential negative tests are 48 hours apart?", "id": "100000000000000000005267", "answers": [{"text": "two", "answer_start": 257}], "is_impossible": false}, {"question": "What should you do if your antigen test results are positive?", "id": "100000000000000000005268", "answers": [{"text": "you may still be infectious", "answer_start": 397}], "is_impossible": false}, {"question": "How long should you wait before taking another test?", "id": "100000000000000000005269", "answers": [{"text": "48 hours", "answer_start": 479}], "is_impossible": false}, {"question": "What may mean you need to continue wearing a mask and testing beyond day 10?", "id": "100000000000000000005272", "answers": [{"text": "answer undefined", "answer_start": 585}], "is_impossible": false}], "context": "This may mean you need to continue wearing a mask and testing beyond day 10. As noted in the Food and Drug Administration labeling for authorized over-the-counter antigen tests, negative test results\ndo not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management\ndecisions, including infection control decisions. \uf309 Removing Your Mask\n\u2022\n\u2022\nAfter you have ended isolation, if your COVID-19 symptoms recur or worsen, restart your isolation at day 0. Talk to a\nhealthcare provider if you have questions about your symptoms or when to end isolation. Last Updated Aug. 11, 2022"}]}, {"title": "e3bb0499ad7790c27467bb4f1ed0049a", "paragraphs": [{"qas": [{"question": "Negative test results do not rule out what?", "id": "100000000000000000005274", "answers": [{"text": "SARS-CoV-2 infection", "answer_start": 216}], "is_impossible": false}, {"question": "What should you do if your COVID-19 symptoms recur or worsen?", "id": "100000000000000000005276", "answers": [{"text": "restart your isolation at day 0", "answer_start": 464}], "is_impossible": false}, {"question": "What do you need to know about your symptoms or when to end isolation?", "id": "100000000000000000005277", "answers": [{"text": "questions", "answer_start": 539}], "is_impossible": false}, {"question": "When was the last update made?", "id": "100000000000000000005278", "answers": [{"text": "Aug. 11, 2022", "answer_start": 608}], "is_impossible": false}], "context": "This may mean you need to continue wearing a mask and testing beyond day 10. As noted in the Food and Drug Administration labeling for authorized over-the-counter antigen tests, negative test results\ndo not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management\ndecisions, including infection control decisions. \uf309 Removing Your Mask\n\u2022\n\u2022\nAfter you have ended isolation, if your COVID-19 symptoms recur or worsen, restart your isolation at day 0. Talk to a\nhealthcare provider if you have questions about your symptoms or when to end isolation. Last Updated Aug. 11, 2022"}]}, {"title": "dd45ecd9917a18e715329c212dc97926", "paragraphs": [{"qas": [{"question": "What is the EUA for the Janssen COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019?", "id": "100000000000000000005279", "answers": [{"text": "EMERGENCY USE AUTHORIZATION", "answer_start": 41}], "is_impossible": false}, {"question": "Who is authorized for use in individuals 18 years of age and older?", "id": "100000000000000000005280", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 147}], "is_impossible": false}, {"question": "What can the Janssen COVID- 19 Vaccine cause with low levels of platelets?", "id": "100000000000000000005281", "answers": [{"text": "blood clots", "answer_start": 539}], "is_impossible": false}, {"question": "What are blood cells that help your body?", "id": "100000000000000000005282", "answers": [{"text": "platelets", "answer_start": 570}], "is_impossible": false}, {"question": "What are platelets?", "id": "100000000000000000005283", "answers": [{"text": "blood cells that help your body stop bleeding", "answer_start": 581}], "is_impossible": false}, {"question": "What do platelets help your body stop bleeding?", "id": "100000000000000000005284", "answers": [{"text": "blood cells", "answer_start": 581}], "is_impossible": false}], "context": "FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nEMERGENCY USE AUTHORIZATION (EUA) OF\nTHE JANSSEN COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019\nThe Janssen COVID-19 Vaccine is authorized for use in individuals 18 years of age and older for\nwhom other FDA-authorized or approved COVID-19 vaccines are not accessible or clinically\nappropriate, and for individuals 18 years of age and older who elect to receive the Janssen COVID-\n19 Vaccine because they would otherwise not receive a COVID-19 vaccine. The Janssen COVID-\n19 Vaccine can cause blood clots with low levels of platelets (blood cells that help your body stop\nbleeding), which may be fatal."}]}, {"title": "8f97d083bbf9a5ae19f0a8bb7714fba6", "paragraphs": [{"qas": [{"question": "What is COVID-19 caused by SARS-CoV-2?", "id": "100000000000000000005286", "answers": [{"text": "Coronavirus Disease 2019", "answer_start": 62}], "is_impossible": false}, {"question": "Why are you being offered the Janssen Vaccine?", "id": "100000000000000000005287", "answers": [{"text": "to prevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 because there is currently a pandemic of COVID-19", "answer_start": 51}], "is_impossible": false}, {"question": "What vaccine may prevent you from getting COVID-19?", "id": "100000000000000000005288", "answers": [{"text": "Janssen COVID-19", "answer_start": 300}], "is_impossible": false}, {"question": "What is the name of the Vaccine?", "id": "100000000000000000005289", "answers": [{"text": "Janssen COVID-19", "answer_start": 26}], "is_impossible": false}], "context": "You are being offered the Janssen COVID-19 Vaccine to prevent Coronavirus Disease 2019\n(COVID-19) caused by SARS-CoV-2 because there is currently a pandemic of COVID-19. This Fact Sheet contains information to help you understand the risks and benefits of receiving the\nJanssen COVID-19 Vaccine. The Janssen COVID-19 Vaccine may prevent you from getting COVID-19. Read this Fact Sheet for information about the Janssen COVID-19 Vaccine. Talk to the vaccination\nprovider if you have questions."}]}, {"title": "b06541b0a28343d8e6acd5e9fd2d880c", "paragraphs": [{"qas": [{"question": "Who has approved the Janssen COVID-19 Vaccine?", "id": "100000000000000000005291", "answers": [{"text": "FDA", "answer_start": 51}], "is_impossible": false}, {"question": "What is the age range of individuals who elect to receive the Novartis Covid-19 vaccine?", "id": "100000000000000000005292", "answers": [{"text": "18 years of age and older", "answer_start": 101}], "is_impossible": false}, {"question": "How many booster doses does a person receive after completing a primary vaccination with a different authorized or approved vaccine?", "id": "100000000000000000005294", "answers": [{"text": "single", "answer_start": 510}], "is_impossible": false}, {"question": "What does the Janssen COVID-19 Vaccine not protect?", "id": "100000000000000000005295", "answers": [{"text": "everyone", "answer_start": 670}], "is_impossible": false}], "context": "The Janssen COVID-19 Vaccine has received EUA from FDA to provide the following doses in\nindividuals 18 years of age and older for whom other FDA-authorized or approved COVID-19\nvaccines are not accessible or clinically appropriate, and in individuals 18 years of age and older\nwho elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a\n\u2022 A single dose primary vaccination. \u2022 A single booster dose after completing a primary vaccination with the Janssen COVID-19\nVaccine. \u2022 A single booster dose after completing primary vaccination with a different authorized or\napproved COVID-19 vaccine. The Janssen COVID-19 Vaccine may not protect everyone."}]}, {"title": "aba81c2c7887a27318130ba5ff3f6ae9", "paragraphs": [{"qas": [{"question": "What is SARS-CoV-2?", "id": "100000000000000000005297", "answers": [{"text": "coronavirus", "answer_start": 207}], "is_impossible": false}, {"question": "What is the most common type of illness that can affect other organs?", "id": "100000000000000000005299", "answers": [{"text": "respiratory", "answer_start": 387}], "is_impossible": false}, {"question": "How many days can symptoms of COVID-19 last?", "id": "100000000000000000005300", "answers": [{"text": "2 to 14", "answer_start": 568}], "is_impossible": false}, {"question": "How many days after exposure to the virus can symptoms appear?", "id": "100000000000000000005301", "answers": [{"text": "2 to 14", "answer_start": 568}], "is_impossible": false}, {"question": "How long can symptoms last?", "id": "100000000000000000005302", "answers": [{"text": "2 to 14 days", "answer_start": 568}], "is_impossible": false}], "context": "This Fact Sheet may have been updated. For the most recent Fact Sheet, please visit\nwww.janssencovid19vaccine.com. WHAT YOU NEED TO KNOW BEFORE YOU GET THIS VACCINE\nWHAT IS COVID-19? COVID-19 is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been\nseen before. You can get COVID-19 through contact with another person who has the virus. It is\npredominantly a respiratory illness that can affect other organs. People with COVID-19 have had\na wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms\nmay appear 2 to 14 days after exposure to the virus."}]}, {"title": "b4802340d189d2a538917f059728c02", "paragraphs": [{"qas": [{"question": "What is the name of the unapproved vaccine that may prevent COVID-19?", "id": "100000000000000000005303", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 254}], "is_impossible": false}], "context": "Common symptoms may include: fever or\nchills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or\nsmell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea. WHAT IS THE JANSSEN COVID-19 VACCINE? The Janssen COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19."}]}, {"title": "f580ff0a573f969ebcc2ffca7f9fdfaf", "paragraphs": [{"qas": [{"question": "What is the emergency use of the Janssen COVID-19 Vaccine?", "id": "100000000000000000005304", "answers": [{"text": "to prevent COVID-19", "answer_start": 87}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000005307", "answers": [{"text": "Emergency Use Authorization", "answer_start": 459}], "is_impossible": false}, {"question": "What is the name of the Fact Sheet that should be sent to your VACCINATION PROVIDEr before you get the JANSSEN COVID-19 VACCINE?", "id": "100000000000000000005308", "answers": [{"text": "Emergency Use Authorization", "answer_start": 459}], "is_impossible": false}], "context": "Under an EUA, the FDA has authorized the emergency use of the Janssen COVID-19 Vaccine to\nprevent COVID-19 in individuals 18 years of age and older for whom other FDA-authorized or\napproved COVID-19 vaccines are not accessible or clinically appropriate, and in individuals 18\nyears of age and older who elect to receive the Janssen COVID-19 Vaccine because they would\notherwise not receive a COVID-19 vaccine. For more information on EUA, see the \u201cWhat is an Emergency Use Authorization (EUA)?\u201d\nsection at the end of this Fact Sheet. WHAT SHOULD YOU MENTION TO YOUR VACCINATION PROVIDER BEFORE\nYOU GET THE JANSSEN COVID-19 VACCINE?"}]}, {"title": "86166b937a92f840b8bc67c8d86a3670", "paragraphs": [{"qas": [{"question": "What are blood cells that help your body stop bleeding called?", "id": "100000000000000000005309", "answers": [{"text": "platelets", "answer_start": 209}], "is_impossible": false}, {"question": "What are platelets?", "id": "100000000000000000005310", "answers": [{"text": "blood cells that help your body stop bleeding", "answer_start": 220}], "is_impossible": false}, {"question": "Who should get the JANSSEN COVID-19 VACCINE?", "id": "100000000000000000005311", "answers": [{"text": "\u2022 have any allergies, \u2022 have a fever, \u2022 have a bleeding disorder or are on a blood thinner, \u2022 have ever had a low level of platelets (blood cells that help your body stop bleeding), \u2022 are immunocompromised or are on a medicine that affects your immune system, \u2022 are pregnant or plan to become pregnant, \u2022 are breastfeeding, \u2022 have received another COVID-19 vaccine, \u2022 have ever fainted in association with an injection", "answer_start": 85}], "is_impossible": false}, {"question": "What is the name of the vaccine that helps your body stop bleeding?", "id": "100000000000000000005312", "answers": [{"text": "COVID-19", "answer_start": 434}], "is_impossible": false}], "context": "Tell the vaccination provider about all of your medical conditions, including if you:\n\u2022 have any allergies,\n\u2022 have a fever,\n\u2022 have a bleeding disorder or are on a blood thinner,\n\u2022 have ever had a low level of platelets (blood cells that help your body stop bleeding),\n\u2022 are immunocompromised or are on a medicine that affects your immune system,\n\u2022 are pregnant or plan to become pregnant,\n\u2022 are breastfeeding,\n\u2022 have received another COVID-19 vaccine,\n\u2022 have ever fainted in association with an injection. WHO SHOULD GET THE JANSSEN COVID-19 VACCINE?"}]}, {"title": "b73b947562cf26d427f43e39bc67c8ac", "paragraphs": [{"qas": [{"question": "Who elects to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a vaccine?", "id": "100000000000000000005314", "answers": [{"text": "individuals 18 years of age and older", "answer_start": 223}], "is_impossible": false}, {"question": "What should you not get if you: \u2022 had a severe allergic reaction after a previous dose of this vaccine; \u2022 had an allergic reaction to the vaccine; or received a Janssen Covid-19 vaccine for the first time?", "id": "100000000000000000005315", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 444}], "is_impossible": false}, {"question": "What was the previous dose of this vaccine?", "id": "100000000000000000005316", "answers": [{"text": "\u2022 had a severe allergic reaction", "answer_start": 476}], "is_impossible": false}], "context": "FDA has authorized the emergency use of the Janssen COVID-19 Vaccine in individuals 18 years\nof age and older for whom other FDA-authorized or approved COVID-19 vaccines are not\naccessible or clinically appropriate, and in individuals 18 years of age and older who elect to\nreceive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19\nvaccine. WHO SHOULD NOT GET THE JANSSEN COVID-19 VACCINE? You should not get the Janssen COVID-19 Vaccine if you:\n\u2022 had a severe allergic reaction after a previous dose of this vaccine. \u2022 had a severe allergic reaction to any ingredient of this vaccine."}]}, {"title": "12b69c1ea91a15a9389823a58a12f72a", "paragraphs": [{"qas": [{"question": "What is AstraZeneca's COVID-19 vaccine not authorized or approved in the US?", "id": "100000000000000000005319", "answers": [{"text": "as an injection into the muscle", "answer_start": 682}], "is_impossible": false}, {"question": "What is the Janssen COVID-19 VACCINE?", "id": "100000000000000000005320", "answers": [{"text": "recombinant, replication-incompetent adenovirus type 26 expressing the SARS-CoV-2 spike protein, citric acid monohydrate, trisodium citrate dihydrate, ethanol, 2-hydroxypropyl-\u03b2-cyclodextrin (HBCD), polysorbate-80, sodium chloride. HOW IS THE JANSSEN COVID -19 VACCINE GIVEN? The Janssen COVID-19 Vaccine will be given to you as an injection into the muscle", "answer_start": 356}], "is_impossible": false}, {"question": "What type of adenovirus type 26 expressing the SARS-CoV-2 spike protein?", "id": "100000000000000000005321", "answers": [{"text": "recombinant, replication-incompetent", "answer_start": 356}], "is_impossible": false}], "context": "\u2022 had a blood clot along with a low level of platelets (blood cells that help your body stop\nbleeding) following Janssen COVID-19 Vaccine or following AstraZeneca\u2019s COVID-19\nvaccine (not authorized or approved in the United States). WHAT ARE THE INGREDIENTS IN THE JANSSEN COVID-19 VACCINE? The Janssen COVID-19 Vaccine includes the following ingredients: recombinant,\nreplication-incompetent adenovirus type 26 expressing the SARS-CoV-2 spike protein, citric acid\nmonohydrate, trisodium citrate dihydrate, ethanol, 2-hydroxypropyl-\u03b2-cyclodextrin (HBCD),\npolysorbate-80, sodium chloride. HOW IS THE JANSSEN COVID -19 VACCINE GIVEN? The Janssen COVID-19 Vaccine will be given to you as an injection into the muscle."}]}, {"title": "41cd4f3a276d59d9bcb1871e0e32c0d6", "paragraphs": [{"qas": [{"question": "What is administered as a single dose of the Janssen COVID-19 Vaccine?", "id": "100000000000000000005323", "answers": [{"text": "Primary Vaccination", "answer_start": 0}], "is_impossible": false}, {"question": "How long after primary vaccination can a booster dose be given?", "id": "100000000000000000005324", "answers": [{"text": "two months", "answer_start": 181}], "is_impossible": false}, {"question": "What is the maximum number of booster doses?", "id": "100000000000000000005325", "answers": [{"text": "two months", "answer_start": 181}], "is_impossible": false}, {"question": "A single booster dose may be administered after how many months?", "id": "100000000000000000005326", "answers": [{"text": "two", "answer_start": 181}], "is_impossible": false}], "context": "Primary Vaccination\nThe Janssen COVID-19 Vaccine is administered as a single dose. Booster Dose\n\u2022 A single booster dose of the Janssen COVID-19 Vaccine may be administered at least two\nmonths after primary vaccination with the Janssen COVID-19 Vaccine. \u2022 A single booster dose of the Janssen COVID-19 Vaccine may be administered after completing\nprimary vaccination with a different authorized or approved COVID-19 vaccine. Please check\nwith your health care provider regarding timing of the booster dose. HAS THE JANSSEN COVID-19 VACCINE BEEN USED BEFORE? The Janssen COVID-19 Vaccine is an unapproved vaccine."}]}, {"title": "9c7c76a74973e8714d2d22cb1a1ececc", "paragraphs": [{"qas": [{"question": "When did millions of people receive the vaccine under EUA?", "id": "100000000000000000005329", "answers": [{"text": "February 27, 2021", "answer_start": 185}], "is_impossible": false}, {"question": "What has been shown to prevent?", "id": "100000000000000000005330", "answers": [{"text": "COVID-19", "answer_start": 314}], "is_impossible": false}, {"question": "Side effects that have been reported with the Janssen CovID-19 Vaccine include pain, redness of the skin and swelling?", "id": "100000000000000000005333", "answers": [{"text": "Injection site reactions", "answer_start": 524}], "is_impossible": false}], "context": "In clinical trials, more than 61,000\nindividuals 18 years of age and older have received the Janssen COVID-19 Vaccine. Millions of\nindividuals have received the vaccine under EUA since February 27, 2021. WHAT ARE THE BENEFITS OF THE JANSSEN COVID-19 VACCINE? The Janssen COVID-19 Vaccine has been shown to prevent COVID-19. The duration of protection\nagainst COVID-19 is currently unknown. WHAT ARE THE RISKS OF THE JANSSEN COVID-19 VACCINE? Side effects that have been reported with the Janssen COVID-19 Vaccine include:\n\u2022 Injection site reactions: pain, redness of the skin and swelling."}]}, {"title": "4f80ce6e2945a5c50b77624bb3f6855e", "paragraphs": [{"qas": [{"question": "What is a common side effect of hypoesthesia in the skin?", "id": "100000000000000000005335", "answers": [{"text": "decreased feeling", "answer_start": 211}], "is_impossible": false}, {"question": "What is the term for ringing in the ears?", "id": "100000000000000000005337", "answers": [{"text": "tinnitus", "answer_start": 318}], "is_impossible": false}, {"question": "What is tinnitus?", "id": "100000000000000000005338", "answers": [{"text": "Persistent ringing in the ears", "answer_start": 286}], "is_impossible": false}], "context": "\u2022 General side effects: headache, feeling very tired, muscle aches, nausea, and fever. \u2022 Swollen lymph nodes. \u2022 Blood clots. \u2022 Unusual feeling in the skin (such as tingling or a crawling feeling) (paresthesia), decreased feeling\nor sensitivity, especially in the skin (hypoesthesia). \u2022 Persistent ringing in the ears (tinnitus). \u2022 Diarrhea, vomiting. Severe Allergic Reactions\nThere is a remote chance that the Janssen COVID-19 Vaccine could cause a severe allergic\nreaction. A severe allergic reaction would usually occur within a few minutes to one hour after\ngetting a dose of the Janssen COVID-19 Vaccine."}]}, {"title": "f3370e74721aa1dbbc1308b6cc51777e", "paragraphs": [{"qas": [{"question": "What may your vaccination provider ask you to do for monitoring after vaccination?", "id": "100000000000000000005341", "answers": [{"text": "stay at the place where you received your vaccine", "answer_start": 58}], "is_impossible": false}, {"question": "What are signs of a severe allergic reaction?", "id": "100000000000000000005342", "answers": [{"text": "Difficulty breathing, \u2022 Swelling of your face and throat, \u2022 A fast heartbeat, \u2022 A bad rash all over your body, \u2022 Dizziness and weakness", "answer_start": 193}], "is_impossible": false}, {"question": "Blood clots with low levels of platelets have occurred in some people who have received what?", "id": "100000000000000000005343", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 581}], "is_impossible": false}, {"question": "Blood vessels in the brain, lungs, abdomen, and legs are surrounded by what type of blood cells?", "id": "100000000000000000005344", "answers": [{"text": "platelets", "answer_start": 471}], "is_impossible": false}, {"question": "Stop bleeding) have occurred in some people who have received the Janssen COVID-19 Vaccine?", "id": "100000000000000000005346", "answers": [{"text": "Blood clots involving blood vessels in the brain, lungs, abdomen, and legs along with low levels of platelets", "answer_start": 371}], "is_impossible": false}], "context": "For this reason, your vaccination provider may\nask you to stay at the place where you received your vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include:\n\u2022 Difficulty breathing,\n\u2022 Swelling of your face and throat,\n\u2022 A fast heartbeat,\n\u2022 A bad rash all over your body,\n\u2022 Dizziness and weakness. Blood Clots with Low Levels of Platelets\nBlood clots involving blood vessels in the brain, lungs, abdomen, and legs along with low levels\nof platelets (blood cells that help your body stop bleeding), have occurred in some people who\fhave received the Janssen COVID-19 Vaccine."}]}, {"title": "637f4246802ec5523e186a004a14db3c", "paragraphs": [{"qas": [{"question": "How long after the Janssen COVID-19 Vaccine did symptoms of low platelets and blood clots begin?", "id": "100000000000000000005347", "answers": [{"text": "one to two weeks", "answer_start": 100}], "is_impossible": false}, {"question": "What type of vaccine has been reported in males and females?", "id": "100000000000000000005348", "answers": [{"text": "Janssen COVID-19", "answer_start": 191}], "is_impossible": false}, {"question": "What has been the highest reporting in females ages 30 through 49 years?", "id": "100000000000000000005350", "answers": [{"text": "about 8 cases for every 1,000,000 vaccine doses administered", "answer_start": 380}], "is_impossible": false}, {"question": "How many cases for every 1,000,000 vaccine doses administered has been fatal?", "id": "100000000000000000005351", "answers": [{"text": "8", "answer_start": 386}], "is_impossible": false}], "context": "In people who developed these blood clots and\nlow levels of platelets, symptoms began approximately one to two weeks after vaccination. Blood\nclots with low levels of platelets following the Janssen COVID-19 Vaccine have been reported in\nmales and females, across a wide age range of individuals 18 years and older; reporting has been\nhighest in females ages 30 through 49 years (about 8 cases for every 1,000,000 vaccine doses\nadministered), and about 1 out of every 7 cases has been fatal."}]}, {"title": "a998c0b82196ff01a7bded813d072488", "paragraphs": [{"qas": [{"question": "What should you do if you have any of the following symptoms after receiving the Janssen COVID-19 Vaccine?", "id": "100000000000000000005352", "answers": [{"text": "seek medical attention", "answer_start": 11}], "is_impossible": false}, {"question": "What is ITP?", "id": "100000000000000000005353", "answers": [{"text": "a disorder that can cause easy or excessive bruising and bleeding due to very low levels of platelets", "answer_start": 415}], "is_impossible": false}], "context": "You should seek medical attention\nright away if you have any of the following symptoms after receiving the Janssen COVID-19\nVaccine:\n\u2022 Shortness of breath,\n\u2022 Chest pain,\n\u2022 Leg swelling,\n\u2022 Persistent abdominal pain,\n\u2022 Severe or persistent headaches or blurred vision,\n\u2022 Easy bruising or tiny blood spots under the skin beyond the site of the injection. Immune Thrombocytopenia (ITP)\nImmune Thrombocytopenia (ITP) is a disorder that can cause easy or excessive bruising and\nbleeding due to very low levels of platelets. ITP has occurred in some people who have received\nthe Janssen COVID-19 Vaccine."}]}, {"title": "eee0d44a3f3f124166b483813f5f3edb", "paragraphs": [{"qas": [{"question": "How many days did symptoms of ITP begin in most people?", "id": "100000000000000000005355", "answers": [{"text": "42", "answer_start": 47}], "is_impossible": false}, {"question": "What is the chance of having ITP occur?", "id": "100000000000000000005356", "answers": [{"text": "very low", "answer_start": 141}], "is_impossible": false}, {"question": "Who should you talk to before you get the Janssen COVID- 19 Vaccine?", "id": "100000000000000000005357", "answers": [{"text": "your vaccination provider", "answer_start": 200}], "is_impossible": false}, {"question": "What should you do if you develop any of the following symptoms after receiving the Janssen COVID-19 Vaccine?", "id": "100000000000000000005358", "answers": [{"text": "seek medical attention", "answer_start": 283}], "is_impossible": false}], "context": "In most of these people, symptoms began within 42 days following\nreceipt of the Janssen COVID-19 Vaccine. The chance of having this occur is very low. If you have\never had a diagnosis of ITP, talk to your vaccination provider before you get the Janssen COVID-\n19 Vaccine. You should seek medical attention right away if you develop any of the following\nsymptoms after receiving the Janssen COVID-19 Vaccine:\n\u2022 Easy or excessive bruising or tiny blood spots under the skin beyond the site of the injection,\n\u2022 Unusual or excessive bleeding."}]}, {"title": "9883be53e4116b1301dfc7c339740ea3", "paragraphs": [{"qas": [{"question": "What is Guillain Barr\u00e9 Syndrome?", "id": "100000000000000000005359", "answers": [{"text": "a neurological disorder", "answer_start": 49}], "is_impossible": false}, {"question": "How many days after receiving the Janssen COVID-19 Vaccine did symptoms begin in most people?", "id": "100000000000000000005361", "answers": [{"text": "42", "answer_start": 299}], "is_impossible": false}, {"question": "How many days after receipt of the Janssen COVID-19 Vaccine is the chance of having this happen?", "id": "100000000000000000005362", "answers": [{"text": "very low", "answer_start": 394}], "is_impossible": false}, {"question": "What are sensations in the legs or arms that are worsening and spreading to other parts of the body?", "id": "100000000000000000005364", "answers": [{"text": "Weakness or tingling", "answer_start": 542}], "is_impossible": false}], "context": "Guillain Barr\u00e9 Syndrome\nGuillain Barr\u00e9 syndrome (a neurological disorder in which the body\u2019s immune system damages\nnerve cells, causing muscle weakness and sometimes paralysis) has occurred in some people who\nhave received the Janssen COVID-19 Vaccine. In most of these people, symptoms began within\n42 days following receipt of the Janssen COVID-19 Vaccine. The chance of having this occur is\nvery low. You should seek medical attention right away if you develop any of the following\nsymptoms after receiving the Janssen COVID-19 Vaccine:\n\u2022 Weakness or tingling sensations, especially in the legs or arms, that\u2019s worsening and spreading\nto other parts of the body. \u2022 Difficulty walking."}]}, {"title": "51ef2bc3372d5657844283d9b4a4b4d", "paragraphs": [{"qas": [{"question": "What are some of the possible side effects of the Janssen COVID-19 Vaccine?", "id": "100000000000000000005366", "answers": [{"text": "Difficulty with bladder control or bowel function", "answer_start": 125}], "is_impossible": false}, {"question": "What is the name of the vaccine that can cause double vision or inability to move eyes?", "id": "100000000000000000005367", "answers": [{"text": "Janssen COVID-19", "answer_start": 230}], "is_impossible": false}, {"question": "If you experience a severe allergic reaction, call 9-1-1 or go to the nearest hospital.", "id": "100000000000000000005369", "answers": [{"text": "Call the vaccination provider or your healthcare provider", "answer_start": 496}], "is_impossible": false}, {"question": "What do you do if you have any side effects that do not go away?", "id": "100000000000000000005370", "answers": [{"text": "Call the vaccination provider or your healthcare provider", "answer_start": 496}], "is_impossible": false}], "context": "\u2022 Difficulty with facial movements, including speaking, chewing, or swallowing. \u2022 Double vision or inability to move eyes. \u2022 Difficulty with bladder control or bowel function. These may not be all the possible side effects of the Janssen COVID-19 Vaccine. Serious and\nunexpected effects may occur. The Janssen COVID-19 Vaccine is still being studied in clinical\ntrials. WHAT SHOULD I DO ABOUT SIDE EFFECTS? If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital. Call the vaccination provider or your healthcare provider if you have any side effects that bother\nyou or do not go away."}]}, {"title": "2ab73997fc3e387446cfa84b2171128e", "paragraphs": [{"qas": [{"question": "What is the VAERS toll-free number?", "id": "100000000000000000005372", "answers": [{"text": "1-800-822-7967", "answer_start": 117}], "is_impossible": false}, {"question": "Where can you report vaccine side effects?", "id": "100000000000000000005373", "answers": [{"text": "FDA/CDC Vaccine Adverse Event Reporting System", "answer_start": 31}], "is_impossible": false}, {"question": "What is the US Toll Free number for reporting side effects?", "id": "100000000000000000005375", "answers": [{"text": "1-800-565-4008", "answer_start": 484}], "is_impossible": false}], "context": "Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to\nhttps://vaers.hhs.gov/reportevent.html. Please include \u201cJanssen COVID-19 Vaccine EUA\u201d in the\nfirst line of box #18 of the report form. In addition, you can report side effects to Janssen Biotech, Inc. at the contact information provided\nbelow. e-mail Fax number Telephone numbers\nJNJvaccineAE@its.jnj.com 215-293-9955 US Toll Free: 1-800-565-4008\nYou may also be given an option to enroll in v-safe."}]}, {"title": "c863189f8953bd424517abccf22018c1", "paragraphs": [{"qas": [{"question": "What does V-Safe do to help CDC monitor the safety of COVID-19 vaccines?", "id": "100000000000000000005377", "answers": [{"text": "asks questions", "answer_start": 208}], "is_impossible": false}, {"question": "What does V-safe provide if participants report a significant health impact following COVID-19 vaccination?", "id": "100000000000000000005378", "answers": [{"text": "live telephone follow-up by CDC", "answer_start": 299}], "is_impossible": false}], "context": "V-safe is a new voluntary smartphone-based\ntool that uses text messaging and web surveys to check in with people who have been vaccinated\nto identify potential side effects after COVID-19 vaccination. V-safe asks questions that help CDC\nmonitor the safety of COVID-19 vaccines. V-safe also provides live telephone follow-up by CDC\nif participants report a significant health impact following COVID-19 vaccination. For more\ninformation on how to sign up, visit: www.cdc.gov/vsafe. WHAT IF I DECIDE NOT TO GET THE JANSSEN COVID-19 VACCINE? Under the EUA, there is an option to accept or refuse receiving the vaccine."}]}, {"title": "e94a57098c4a84b0d6c7a56d4069cd31", "paragraphs": [{"qas": [{"question": "What type of vaccine is COMIRNATY and SPIKEVAX?", "id": "100000000000000000005381", "answers": [{"text": "COVID-19 vaccines", "answer_start": 237}], "is_impossible": false}, {"question": "What is the name of the vaccine that is FDA-approved to prevent COVID-19?", "id": "100000000000000000005382", "answers": [{"text": "COMIRNATY and SPIKEVAX", "answer_start": 197}], "is_impossible": false}, {"question": "What is available under EUA?", "id": "100000000000000000005383", "answers": [{"text": "Other vaccines to prevent COVID-19", "answer_start": 256}], "is_impossible": false}, {"question": "What is only authorized if other COVID-19 vaccines are not accessible or clinically appropriate?", "id": "100000000000000000005384", "answers": [{"text": "The Janssen COVID-19 Vaccine", "answer_start": 319}], "is_impossible": false}], "context": "Should you decide not\nto receive the Janssen COVID-19 Vaccine, it will not change your standard medical care. ARE OTHER VACCINES AVAILABLE FOR PREVENTING COVID-19 BESIDES\nJANSSEN COVID-19 VACCINE? COMIRNATY and SPIKEVAX are FDA-approved COVID-19 vaccines. Other vaccines to\nprevent COVID-19 may be available under EUA. The Janssen COVID-19 Vaccine is only\nauthorized if other COVID-19 vaccines are not accessible or clinically appropriate, and for\nindividuals who elect to receive the Janssen COVID-19 Vaccine because they would otherwise\nnot receive a COVID-19 vaccine. CAN I RECEIVE THE JANSSEN COVID-19 VACCINE AT THE SAME TIME AS\nOTHER VACCINES?"}]}, {"title": "1c361e29f9436cfc4e51f5b68bfc402c", "paragraphs": [{"qas": [{"question": "What has not yet been submitted to FDA on administration of the Janssen COVID-19 Vaccine at the same time as other vaccines?", "id": "100000000000000000005385", "answers": [{"text": "Data", "answer_start": 0}], "is_impossible": false}, {"question": "What should you discuss with your healthcare provider if you are pregnant or breastfeeding?", "id": "100000000000000000005386", "answers": [{"text": "your options", "answer_start": 347}], "is_impossible": false}, {"question": "What is the name of the vaccine that does not contain SARS-CoV-2?", "id": "100000000000000000005387", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 65}], "is_impossible": false}, {"question": "What vaccine does not give you COVID-19?", "id": "100000000000000000005388", "answers": [{"text": "SARS-CoV-2", "answer_start": 493}], "is_impossible": false}], "context": "Data have not yet been submitted to FDA on administration of the Janssen COVID-19 Vaccine at\nthe same time as other vaccines. If you are considering receiving the Janssen COVID-19 Vaccine\nwith other vaccines, discuss your options with your healthcare provider. WHAT IF I AM PREGNANT OR BREASTFEEDING? If you are pregnant or breastfeeding, discuss your options with your healthcare provider. WILL THE JANSSEN COVID-19 VACCINE GIVE ME COVID-19? No. The Janssen COVID-19 Vaccine does not contain SARS-CoV-2 and cannot give you\nCOVID-19."}]}, {"title": "d7e7038f470864005402b44df6e16300", "paragraphs": [{"qas": [{"question": "What do you get when you receive the Janssen COVID-19 Vaccine?", "id": "100000000000000000005389", "answers": [{"text": "a vaccination card", "answer_start": 87}], "is_impossible": false}, {"question": "How do you scan the QR code?", "id": "100000000000000000005391", "answers": [{"text": "using your device", "answer_start": 314}], "is_impossible": false}, {"question": "What is the US Toll Free number for the Janssen COVID-19 vaccine?", "id": "100000000000000000005392", "answers": [{"text": "1-800-565-4008", "answer_start": 488}], "is_impossible": false}, {"question": "Where do you go to learn more?", "id": "100000000000000000005393", "answers": [{"text": "Ask the vaccination provider", "answer_start": 527}], "is_impossible": false}, {"question": "What is the name of the vaccine provider?", "id": "100000000000000000005394", "answers": [{"text": "Janssen COVID-19 Vaccine, you will get a vaccination card to document the name of the vaccine and date of when you received the vaccine. ADDITIONAL INFORMATION If you have questions or to access the most recent Janssen COVID-19 Vaccine Fact Sheets, scan the QR code using your device, visit the website or call the telephone numbers provided below. QR Code Fact Sheets Website Telephone numbers www.janssencovid19vaccine.com. US Toll Free: 1-800-565-4008 HOW CAN I LEARN MORE? \u2022 Ask", "answer_start": 48}], "is_impossible": false}, {"question": "What does FDA stand for?", "id": "100000000000000000005396", "answers": [{"text": "fda.gov", "answer_start": 653}], "is_impossible": false}, {"question": "Who can you contact for emergency use authorization?", "id": "100000000000000000005397", "answers": [{"text": "your local or state public health department", "answer_start": 777}], "is_impossible": false}], "context": "KEEP YOUR VACCINATION CARD\nWhen you receive the Janssen COVID-19 Vaccine, you will get a vaccination card to document\nthe name of the vaccine and date of when you received the vaccine. ADDITIONAL INFORMATION\nIf you have questions or to access the most recent Janssen COVID-19 Vaccine Fact Sheets, scan\nthe QR code using your device, visit the website or call the telephone numbers provided below. QR Code Fact Sheets Website Telephone numbers\nwww.janssencovid19vaccine.com. US Toll Free: 1-800-565-4008\nHOW CAN I LEARN MORE? \u2022 Ask the vaccination provider. \u2022 Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. \u2022 Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-\nregulatory-and-policy-framework/emergency-use-authorization. Contact your local or state public health department."}]}, {"title": "a634b6358767065c6d59b0da4e5b567f", "paragraphs": [{"qas": [{"question": "What is another name for the Immunization Information System?", "id": "100000000000000000005398", "answers": [{"text": "IIS", "answer_start": 185}], "is_impossible": false}, {"question": "What does IIS stand for?", "id": "100000000000000000005399", "answers": [{"text": "Immunization Information System", "answer_start": 152}], "is_impossible": false}, {"question": "Where is your vaccination information recorded?", "id": "100000000000000000005400", "answers": [{"text": "Immunization Information System", "answer_start": 152}], "is_impossible": false}, {"question": "What can't be charged for a dose of the COVID-19 VACCINE?", "id": "100000000000000000005401", "answers": [{"text": "the provider cannot charge you for a vaccine dose and you cannot be charged an out-of-pocket vaccine administration fee", "answer_start": 405}], "is_impossible": false}], "context": "WHERE WILL MY VACCINATION INFORMATION BE RECORDED? The vaccination provider may include your vaccination information in your state/local\njurisdiction\u2019s Immunization Information System (IIS) or other designated system. For more\ninformation about IISs visit: https://www.cdc.gov/vaccines/programs/iis/about.html. CAN I BE CHARGED AN ADMINISTRATION FEE FOR RECEIPT OF THE COVID-19\nVACCINE? No. At this time, the provider cannot charge you for a vaccine dose and you cannot be charged an\nout-of-pocket vaccine administration fee or any other fee if only receiving a COVID-19\nvaccination."}]}, {"title": "42094fb53aceac1bdf6ab50a767f9bd7", "paragraphs": [{"qas": [{"question": "Who may seek reimbursement from a program or plan that covers COVID-19 vaccine administration fees for the vaccine recipient?", "id": "100000000000000000005403", "answers": [{"text": "vaccination providers", "answer_start": 9}], "is_impossible": false}, {"question": "Who is responsible for identifying potential violations of this program?", "id": "100000000000000000005406", "answers": [{"text": "Office of the Inspector General", "answer_start": 455}], "is_impossible": false}, {"question": "Where can you contact the Office of the Inspector General?", "id": "100000000000000000005407", "answers": [{"text": "1-800-HHS-TIPS or TIPS.HHS.GOV", "answer_start": 537}], "is_impossible": false}], "context": "However, vaccination providers may seek appropriate reimbursement from a program\nor plan that covers COVID-19 vaccine administration fees for the vaccine recipient (private\ninsurance, Medicare, Medicaid, HRSA COVID-19 Uninsured Program for non-insured\nrecipients). WHERE CAN I REPORT CASES OF SUSPECTED FRAUD? Individuals becoming aware of any potential violations of the CDC COVID-19 Vaccination\nProgram requirements are encouraged to report them to the Office of the Inspector General, U.S.\nDepartment of Health and Human Services, at 1-800-HHS-TIPS or TIPS.HHS.GOV. WHAT IS THE COUNTERMEASURE INJURY COMPENSATION PROGRAM?"}]}, {"title": "8ece99c432b669758a884ab89a7bab1b", "paragraphs": [{"qas": [{"question": "What is the name of the federal program that may help pay for medical care and other specific expenses for people who have been seriously injured by medicines or vaccines?", "id": "100000000000000000005408", "answers": [{"text": "The Countermeasures Injury Compensation Program", "answer_start": 0}], "is_impossible": false}, {"question": "What is an emergency use authorization?", "id": "100000000000000000005411", "answers": [{"text": "EUA)? The United States FDA has made the Janssen COVID-19 Vaccine available under an emergency access mechanism", "answer_start": 488}], "is_impossible": false}, {"question": "What is the name of the emergency access mechanism?", "id": "100000000000000000005412", "answers": [{"text": "EUA", "answer_start": 610}], "is_impossible": false}], "context": "The Countermeasures Injury Compensation Program (CICP) is a federal program that may help\npay for costs of medical care and other specific expenses for certain people who have been\nseriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must\nbe submitted to the CICP within one (1) year from the date of receiving the vaccine. To learn more\nabout this program, visit www.hrsa.gov/cicp or call 1-855-266-2427. WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)? The United States FDA has made the Janssen COVID-19 Vaccine available under an emergency\naccess mechanism called an EUA."}]}, {"title": "dc52f40a626dae7da89b7c6bf62dc81b", "paragraphs": [{"qas": [{"question": "What criteria includes that there are no adequate, approved and available alternatives?", "id": "100000000000000000005418", "answers": [{"text": "certain criteria are met", "answer_start": 336}], "is_impossible": false}], "context": "The EUA is supported by a Secretary of Health and Human\nServices (HHS) declaration that circumstances exist to justify the emergency use of drugs and\nbiological products during the COVID-19 pandemic. The Janssen COVID-19 Vaccine has not undergone the same type of review as an FDA-approved\nor cleared product. FDA may issue an EUA when certain criteria are met, which includes that there\nare no adequate, approved, and available alternatives."}]}, {"title": "9abf4fc941148316598676e1e856535f", "paragraphs": [{"qas": [{"question": "What must be met to allow for the product to be used during the COVID-19 pandemic?", "id": "100000000000000000005422", "answers": [{"text": "the totality of scientific evidence available showing that the product may be effective to prevent COVID-19 during the COVID-19 pandemic and that the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria", "answer_start": 42}], "is_impossible": false}, {"question": "What is in effect for the duration of the declaration justifying emergency use of these products?", "id": "100000000000000000005423", "answers": [{"text": "The EUA for the Janssen COVID-19 Vaccine", "answer_start": 391}], "is_impossible": false}, {"question": "What happens if the use of these products is terminated or revoked?", "id": "100000000000000000005424", "answers": [{"text": "the products may no longer be used", "answer_start": 576}], "is_impossible": false}, {"question": "After which the products may no longer be used?", "id": "100000000000000000005425", "answers": [{"text": "COVID-19", "answer_start": 469}], "is_impossible": false}], "context": "In addition, the FDA decision is based on\nthe totality of scientific evidence available showing that the product may be effective to prevent\nCOVID-19 during the COVID-19 pandemic and that the known and potential benefits of the\nproduct outweigh the known and potential risks of the product. All of these criteria must be met to\nallow for the product to be used during the COVID-19 pandemic. The EUA for the Janssen COVID-19 Vaccine is in effect for the duration of the COVID-19\ndeclaration justifying emergency use of these products, unless terminated or revoked (after which\nthe products may no longer be used)."}]}, {"title": "13142adc2a6d97b936882fec094a2290", "paragraphs": [{"qas": [{"question": "What company is Janssen Biotech, Inc. a Janssen Pharmaceutical Company?", "id": "100000000000000000005426", "answers": [{"text": "Johnson & Johnson", "answer_start": 75}], "is_impossible": false}, {"question": "What is the US Toll Free: 1-800-565-4008?", "id": "100000000000000000005428", "answers": [{"text": "(908) 455-9922", "answer_start": 222}], "is_impossible": false}, {"question": "How was this Fact Sheet provided?", "id": "100000000000000000005429", "answers": [{"text": "electronic medical records/immunization information systems", "answer_start": 357}], "is_impossible": false}], "context": "Manufactured by:\nJanssen Biotech, Inc.\na Janssen Pharmaceutical Company of Johnson & Johnson\nHorsham, PA 19044, USA\n\u00a9 2021 Janssen Pharmaceutical Companies\nFor more information, call US Toll Free: 1-800-565-4008, US Toll: (908) 455-9922 or go to www.janssencovid19vaccine.com\n. Scan to capture that this Fact Sheet was provided to vaccine\nrecipient for the electronic medical records/immunization\ninformation systems."}]}, {"title": "1575ee05659aef74d368103775042db6", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000005430", "answers": [{"text": "Post-COVID Conditions", "answer_start": 32}], "is_impossible": false}, {"question": "What are post-COVID conditions?", "id": "100000000000000000005431", "answers": [{"text": "long COVID, long-haul COVID, post-acute COVID-19, post- acute sequelae of SARS CoV-2 infection (PASC), long-term effects of COVID, and chronic COVID", "answer_start": 393}], "is_impossible": false}, {"question": "What do people call post-COVID conditions by many names?", "id": "100000000000000000005432", "answers": [{"text": "long COVID", "answer_start": 393}], "is_impossible": false}, {"question": "What is PASC?", "id": "100000000000000000005433", "answers": [{"text": "post- acute sequelae of SARS CoV-2 infection", "answer_start": 443}], "is_impossible": false}, {"question": "Post- COVID can include a wide range of what?", "id": "100000000000000000005434", "answers": [{"text": "ongoing health problems", "answer_start": 615}], "is_impossible": false}, {"question": "How long can a person's health problems last?", "id": "100000000000000000005435", "answers": [{"text": "weeks, months, or longer", "answer_start": 666}], "is_impossible": false}], "context": "10/30/22, 9:42 AM Long COVID or Post-COVID Conditions | CDC\nEspa\u00f1ol | Other Languages\nLong COVID or Post-COVID Conditions\nDEFINITION\nPost-COVID Conditions\nSome people who have been infected with the virus that causes COVID-19 can experience long-term effects from their\ninfection, known as post-COVID conditions (PCC) or long COVID. People call post-COVID conditions by many names, including: long COVID, long-haul COVID, post-acute COVID-19, post-\nacute sequelae of SARS CoV-2 infection (PASC), long-term effects of COVID, and chronic COVID. What You Need to Know\nPost-COVID conditions can include a wide range of ongoing health problems; these conditions can last weeks,\nmonths, or longer."}]}, {"title": "a645430aaf469802deacc170dadfbf8", "paragraphs": [{"qas": [{"question": "Anyone who has been infected with the virus that causes COVID-19 can experience what condition?", "id": "100000000000000000005437", "answers": [{"text": "post-COVID conditions", "answer_start": 170}], "is_impossible": false}, {"question": "Who was vaccinated against COVID-19 and had breakthrough infections?", "id": "100000000000000000005439", "answers": [{"text": "People who are not vaccinated against COVID-19", "answer_start": 256}], "is_impossible": false}, {"question": "In some cases, a person with post-COVID conditions may not have tested positive for what?", "id": "100000000000000000005440", "answers": [{"text": "the virus", "answer_start": 637}], "is_impossible": false}], "context": "Post-COVID conditions are found more often in people who had severe COVID-19 illness, but anyone who has\nbeen infected with the virus that causes COVID-19 can experience post-COVID conditions, even people who had\nmild illness or no symptoms from COVID-19. People who are not vaccinated against COVID-19 and become infected might also be at higher risk of developing\npost-COVID conditions compared to people who were vaccinated and had breakthrough infections. While most people with post-COVID conditions have evidence of infection or COVID-19 illness, in some cases, a\nperson with post-COVID conditions may not have tested positive for the virus or known they were infected."}]}, {"title": "cbb5dd73dfc88a2c05369be523bd85df", "paragraphs": [{"qas": [{"question": "What are CDC and partners trying to understand about post-COVID conditions?", "id": "100000000000000000005441", "answers": [{"text": "who experiences post-COVID conditions and why", "answer_start": 54}], "is_impossible": false}, {"question": "What is a disability under the Americans with Disabilities Act?", "id": "100000000000000000005442", "answers": [{"text": "long COVID", "answer_start": 214}], "is_impossible": false}, {"question": "What is the acronym for the Americans with Disabilities Act?", "id": "100000000000000000005443", "answers": [{"text": "ADA", "answer_start": 338}], "is_impossible": false}, {"question": "What is a disability under the ADA?", "id": "100000000000000000005444", "answers": [{"text": "long COVID", "answer_start": 214}], "is_impossible": false}, {"question": "How do people experience post-COVID conditions?", "id": "100000000000000000005445", "answers": [{"text": "after being infected with the virus that causes COVID-19", "answer_start": 572}], "is_impossible": false}], "context": "CDC and partners are working to understand more about who experiences post-COVID conditions and why,\nincluding whether groups disproportionately impacted by COVID-19 are at higher risk. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\nAs of July 2021, \u201clong COVID,\u201d also known as post-COVID conditions, can be considered a disability under the Americans\nwith Disabilities Act (ADA). Learn more: Guidance on \u201cLong COVID\u201d as a Disability Under the ADA, Section \uf209\nAbout Long COVID or Post-COVID Conditions\nPost-COVID conditions are a wide range of new, returning, or ongoing health problems that people experience after being\ninfected with the virus that causes COVID-19."}]}, {"title": "6447be818d45ff6a92c3d972d38a7c51", "paragraphs": [{"qas": [{"question": "How long after infection do most people with COVID-19 get better?", "id": "100000000000000000005446", "answers": [{"text": "within a few days to a few weeks", "answer_start": 37}], "is_impossible": false}, {"question": "Anyone who was infected can experience what?", "id": "100000000000000000005448", "answers": [{"text": "post-COVID conditions", "answer_start": 235}], "is_impossible": false}, {"question": "What did most people with post-COVID conditions experience days after first learning they had COVID-19?", "id": "100000000000000000005449", "answers": [{"text": "symptoms", "answer_start": 309}], "is_impossible": false}, {"question": "What did some people who later experienced post-covid conditions do not know when they got infected?", "id": "100000000000000000005450", "answers": [{"text": "answer undefined", "answer_start": 309}], "is_impossible": false}, {"question": "There is no test to diagnose what?", "id": "100000000000000000005451", "answers": [{"text": "post-COVID conditions", "answer_start": 489}], "is_impossible": false}], "context": "Most people with COVID-19 get better within a few days to a few weeks after\ninfection, so at least four weeks after infection is the start of when post-COVID conditions could first be identified. Anyone\nwho was infected can experience post-COVID conditions. Most people with post-COVID conditions experienced symptoms\ndays after first learning they had COVID-19, but some people who later experienced post-COVID conditions did not know\nwhen they got infected. There is no test to diagnose post-COVID conditions, and people may have a wide variety of symptoms that could come from\nother health problems."}]}, {"title": "5d7ebaa5cf13a4057f3d96cec15cdd66", "paragraphs": [{"qas": [{"question": "What can make it difficult for healthcare providers to recognize post-COVID conditions?", "id": "100000000000000000005452", "answers": [{"text": "Symptoms", "answer_start": 388}], "is_impossible": false}, {"question": "What does your healthcare provider consider a diagnosis of?", "id": "100000000000000000005453", "answers": [{"text": "post-COVID conditions", "answer_start": 138}], "is_impossible": false}, {"question": "How long can symptoms of COVID-19 last after infection?", "id": "100000000000000000005454", "answers": [{"text": "more than four weeks or even months", "answer_start": 479}], "is_impossible": false}, {"question": "What can people with post-COVID conditions have?", "id": "100000000000000000005456", "answers": [{"text": "a wide range of symptoms", "answer_start": 440}], "is_impossible": false}, {"question": "What can sometimes go away or come back again?", "id": "100000000000000000005457", "answers": [{"text": "symptoms", "answer_start": 546}], "is_impossible": false}, {"question": "Post-COVID conditions may not affect everyone the same way?", "id": "100000000000000000005458", "answers": [{"text": "healthcare providers", "answer_start": 31}], "is_impossible": false}], "context": "This can make it difficult for healthcare providers to recognize post-COVID conditions. Your healthcare\nprovider considers a diagnosis of post-COVID conditions based on your health history, including if you had a diagnosis of\f10/30/22, 9:42 AM Long COVID or Post-COVID Conditions | CDC\nCOVID-19 either by a positive test or by symptoms or exposure, as well as doing a health examination. Symptoms\nPeople with post-COVID conditions can have a wide range of symptoms that can last more than four weeks or even months\nafter infection. Sometimes the symptoms can even go away or come back again. Post-COVID conditions may not affect everyone the same way."}]}, {"title": "e1906b68143bee3199382919547eab99", "paragraphs": [{"qas": [{"question": "How long can a person with COVID-19 illness have to live?", "id": "100000000000000000005460", "answers": [{"text": "weeks, months", "answer_start": 264}], "is_impossible": false}], "context": "People with post-COVID conditions may experience health\nproblems from different types and combinations of symptoms happening over different lengths of time. Most patients\u2019\nsymptoms slowly improve with time. However, for some people, post-COVID conditions can last weeks, months, or longer\nafter COVID-19 illness and can sometimes result in disability."}]}, {"title": "14b62f7fb00af6f5270cf309fa26e1d0", "paragraphs": [{"qas": [{"question": "What are symptoms that get worse after physical or mental effort also known as?", "id": "100000000000000000005462", "answers": [{"text": "post-exertional malaise", "answer_start": 208}], "is_impossible": false}, {"question": "What is heart palpitations also known as?", "id": "100000000000000000005463", "answers": [{"text": "Fast-beating or pounding heart", "answer_start": 332}], "is_impossible": false}, {"question": "What is brain fog sometimes referred to?", "id": "100000000000000000005464", "answers": [{"text": "Difficulty thinking or concentrating", "answer_start": 420}], "is_impossible": false}, {"question": "Sleep problems Dizziness when you stand up (lightheadedness) Pins-and-needles feelings Change in what?", "id": "100000000000000000005465", "answers": [{"text": "smell or taste", "answer_start": 602}], "is_impossible": false}, {"question": "What does the RECOVER Initiative seek to understand?", "id": "100000000000000000005467", "answers": [{"text": "how people recover from a COVID- 19 infection", "answer_start": 911}], "is_impossible": false}], "context": "People who experience post-COVID conditions most commonly report:\nGeneral symptoms\nTiredness or fatigue that interferes with daily life\nSymptoms that get worse after physical or mental effort (also known as \u201cpost-exertional malaise\u201d)\nFever\nRespiratory and heart symptoms\nDifficulty breathing or shortness of breath\nCough\nChest pain\nFast-beating or pounding heart (also known as heart palpitations)\nNeurological symptoms\nDifficulty thinking or concentrating (sometimes referred to as \u201cbrain fog\u201d)\nHeadache\nSleep problems\nDizziness when you stand up (lightheadedness)\nPins-and-needles feelings\nChange in smell or taste\nDepression or anxiety\nDigestive symptoms\nScience at CDC\nScientific evidence and studies behind long COVID\nScience behind Long COVID\nHow to Get Involved in Long COVID Research\nThe National Institutes of Health (NIH) is conducting a research project, called the RECOVER Initiative, to understand how people recover from a COVID-\n19 infection and why some people do not fully recover and develop long COVID or post-COVID conditions."}]}, {"title": "1612707761f38a28a2c7804eb99b047c", "paragraphs": [{"qas": [{"question": "Who is researching COVID to Enhance Recovery?", "id": "100000000000000000005468", "answers": [{"text": "\u2022 \u2022", "answer_start": 150}], "is_impossible": false}, {"question": "People with post-COVID conditions may experience many symptoms?", "id": "100000000000000000005469", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022", "answer_start": 130}], "is_impossible": false}, {"question": "What type of symptoms are hard to explain?", "id": "100000000000000000005470", "answers": [{"text": "post-COVID conditions", "answer_start": 384}], "is_impossible": false}, {"question": "People with COVID conditions may develop or continue to have symptoms that are hard to explain and manage.", "id": "100000000000000000005471", "answers": [{"text": "\u2022 \u2022", "answer_start": 150}], "is_impossible": false}, {"question": "What are routine blood tests, chest x-rays, and electrocardiograms normal?", "id": "100000000000000000005472", "answers": [{"text": "Clinical evaluations", "answer_start": 484}], "is_impossible": false}, {"question": "People with ME/CFS have symptoms similar to those reported by people with what other condition?", "id": "100000000000000000005473", "answers": [{"text": "myalgic encephalomyelitis/chronic fatigue syndrome", "answer_start": 659}], "is_impossible": false}, {"question": "What does ME/CFS stand for?", "id": "100000000000000000005474", "answers": [{"text": "myalgic encephalomyelitis/chronic fatigue syndrome", "answer_start": 659}], "is_impossible": false}, {"question": "What is the term for myalgic encephalomyelitis/chronic fatigue syndrome?", "id": "100000000000000000005475", "answers": [{"text": "ME/CFS", "answer_start": 651}], "is_impossible": false}], "context": "RECOVER: Researching COVID to Enhance Recovery \uf209\nPeople with post-COVID conditions (or long COVID) may experience many symptoms. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:42 AM Long COVID or Post-COVID Conditions | CDC\nDigestive symptoms\nDiarrhea\nStomach pain\nOther symptoms\nJoint or muscle pain\nRash\nChanges in menstrual cycles\nSymptoms that are hard to explain and manage\nPeople with post-COVID conditions may develop or continue to have symptoms that are hard to explain and manage. Clinical\nevaluations and results of routine blood tests, chest x-rays, and electrocardiograms may be normal. The symptoms are similar\nto those reported by people with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) and other poorly understood\nchronic illnesses that may occur after other infections."}]}, {"title": "2c75819791702422e73272887258e780", "paragraphs": [{"qas": [{"question": "Who may misunderstand people with COVID symptoms?", "id": "100000000000000000005476", "answers": [{"text": "their healthcare providers", "answer_start": 63}], "is_impossible": false}, {"question": "What can result in a long time for a person to get a diagnosis and receive appropriate care or treatment?", "id": "100000000000000000005477", "answers": [{"text": "People with these unexplained symptoms", "answer_start": 0}], "is_impossible": false}, {"question": "What are some health conditions experienced by some people who had severe COVID-19 illness?", "id": "100000000000000000005478", "answers": [{"text": "multiorgan effects or autoimmune conditions", "answer_start": 377}], "is_impossible": false}, {"question": "What can multiorgan effects involve many body systems?", "id": "100000000000000000005479", "answers": [{"text": "the heart, lung, kidney, skin, and brain", "answer_start": 543}], "is_impossible": false}], "context": "People with these unexplained symptoms may be misunderstood by\ntheir healthcare providers, which can result in a long time for them to get a diagnosis and receive appropriate care or\ntreatment. Review these tips to help prepare for a healthcare provider appointment for post-COVID conditions. Health conditions\nSome people, especially those who had severe COVID-19, experience multiorgan effects or autoimmune conditions with\nsymptoms lasting weeks or months after COVID-19 illness. Multiorgan effects can involve many body systems, including the\nheart, lung, kidney, skin, and brain."}]}, {"title": "dc0e73e1071a6f2bca19ac4d82354898", "paragraphs": [{"qas": [{"question": "What may people who have had COVID-19 be more likely to develop?", "id": "100000000000000000005480", "answers": [{"text": "new health conditions", "answer_start": 88}], "is_impossible": false}, {"question": "What does PICS refer to the health effects that may occur?", "id": "100000000000000000005481", "answers": [{"text": "when a person is in an intensive care unit", "answer_start": 338}], "is_impossible": false}, {"question": "What does PICS refer to?", "id": "100000000000000000005482", "answers": [{"text": "the health effects that may begin when a person is in an intensive care unit", "answer_start": 304}], "is_impossible": false}], "context": "As a result of these effects, people who have had COVID-19 may be more likely to develop\nnew health conditions such as diabetes, heart conditions, or neurological conditions compared with people who have not had\nCOVID-19. People experiencing any severe illness may develop health problems\nPICS refers to the health effects that may begin when a person is in an intensive care unit (ICU), and which may persist after a\nperson returns home. These effects can include muscle weakness, problems with thinking and judgment, and symptoms of\npost-traumatic stress disorder (PTSD). PTSD involves long-term reactions to a very stressful event."}]}, {"title": "965fb4f4e2d9af734ee8cd7af6fff3dd", "paragraphs": [{"qas": [{"question": "What are some people with post-COVID conditions have that are not explained by tests?", "id": "100000000000000000005487", "answers": [{"text": "symptoms", "answer_start": 252}], "is_impossible": false}, {"question": "People experiencing severe illness, hospitalization, or treatment may develop problems such as what?", "id": "100000000000000000005489", "answers": [{"text": "post-intensive care syndrome, or PICS", "answer_start": 462}], "is_impossible": false}, {"question": "Researchers are working to understand which people or groups of people are more likely to develop long COVID?", "id": "100000000000000000005490", "answers": [{"text": "\u2022", "answer_start": 203}], "is_impossible": false}, {"question": "Which people or groups of people are more likely to have post-COVID conditions?", "id": "100000000000000000005491", "answers": [{"text": "\u2022", "answer_start": 203}], "is_impossible": false}], "context": "For people who\nexperience PICS following a COVID-19 diagnosis, it is difficult to determine whether these health problems are caused by a\nsevere illness, the virus itself, or a combination of both. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\nSome people with post-COVID conditions have symptoms that are not explained by tests. Some people experience new health conditions after COVID-19 illness. People experiencing any severe illness, hospitalization, or treatment may develop problems such as post-intensive care\nsyndrome, or PICS. \uf209\nPeople More Likely to Develop Long COVID\nResearchers are working to understand which people or groups of people are more likely to have post-COVID conditions, and\nwhy."}]}, {"title": "b4535a6a5e16cdebb2a145e5197601b4", "paragraphs": [{"qas": [{"question": "What may some groups of people be affected more by?", "id": "100000000000000000005492", "answers": [{"text": "post-COVID conditions", "answer_start": 70}], "is_impossible": false}, {"question": "What might be more at risk than other groups for developing post-COVID conditions?", "id": "100000000000000000005493", "answers": [{"text": "people or groups", "answer_start": 144}], "is_impossible": false}, {"question": "What are people who have experienced more severe COVID-19 illness especially those who were hospitalized or needed intensive care?", "id": "100000000000000000005495", "answers": [{"text": "People who had underlying health conditions prior to COVID-19. People who did not get a COVID-19 vaccine", "answer_start": 512}], "is_impossible": false}, {"question": "What was the name of the vaccine that was not given to people who didn't get it?", "id": "100000000000000000005497", "answers": [{"text": "COVID-19", "answer_start": 600}], "is_impossible": false}], "context": "Studies have shown that some groups of people may be affected more by post-COVID conditions. These are examples\nand not a comprehensive list of people or groups who might be more at risk than other groups for developing post-COVID\nconditions:\nSome people may be more at risk for developing post-COVID conditions (or long COVID). 10/30/22, 9:42 AM Long COVID or Post-COVID Conditions | CDC\nPeople who have experienced more severe COVID-19 illness, especially those who were hospitalized or needed intensive\ncare. People who had underlying health conditions prior to COVID-19. People who did not get a COVID-19 vaccine."}]}, {"title": "f31d547d3b2e076ad4d021b0626f4dd5", "paragraphs": [{"qas": [{"question": "What is the acronym for multisystem inflammatory syndrome?", "id": "100000000000000000005498", "answers": [{"text": "MIS", "answer_start": 57}], "is_impossible": false}, {"question": "What may affect Populations at Risk for Long COVID?", "id": "100000000000000000005499", "answers": [{"text": "Health Inequities", "answer_start": 96}], "is_impossible": false}, {"question": "Why are people at increased risk of getting sick?", "id": "100000000000000000005500", "answers": [{"text": "because of where they live or work", "answer_start": 224}], "is_impossible": false}, {"question": "What may put some people from racial or ethnic minority groups at greater risk for developing post-COVID conditions?", "id": "100000000000000000005502", "answers": [{"text": "Health inequities", "answer_start": 299}], "is_impossible": false}], "context": "People who experience multisystem inflammatory syndrome (MIS) during or after COVID-19 illness. Health Inequities May Affect Populations at Risk for Long COVID\nSome people are at increased risk of getting sick from COVID-19 because of where they live or work, or because they can\u2019t get\nhealth care. Health inequities may put some people from racial or ethnic minority groups and some people with disabilities at\ngreater risk for developing post-COVID conditions. Scientists are researching some of those factors that may place these\ncommunities at higher risk of both getting infected or developing post-COVID conditions."}]}, {"title": "23ac0e85ff616858a07b48c76bb0489b", "paragraphs": [{"qas": [{"question": "What is the best way to prevent post-COVID conditions?", "id": "100000000000000000005503", "answers": [{"text": "to protect yourself and others from becoming infected", "answer_start": 322}], "is_impossible": false}, {"question": "Who is less likely to report post- COVID condition than people who are not vaccinated?", "id": "100000000000000000005504", "answers": [{"text": "people who are vaccinated but experience a breakthrough infection", "answer_start": 53}], "is_impossible": false}, {"question": "What is one way to prevent post-COVID conditions?", "id": "100000000000000000005505", "answers": [{"text": "to protect yourself and others from becoming infected", "answer_start": 322}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\nPreventing Long COVID\nResearch suggests that people who are vaccinated but experience a breakthrough infection are less likely to report post-\nCOVID conditions, compared to people who are unvaccinated. Learn more about protecting yourself and others from COVID-19. The best way to prevent post-COVID conditions is to protect yourself and others from becoming infected. For people who\nare eligible, getting vaccinated and staying up to date with vaccines against COVID-19 can help prevent COVID-19\ninfection and protect against severe illness."}]}, {"title": "931b0d1a12a013825da85a762dc3a07c", "paragraphs": [{"qas": [{"question": "What can people experiencing post-COVID conditions seek care from to come up with a personal medical management plan?", "id": "100000000000000000005508", "answers": [{"text": "a healthcare provider", "answer_start": 93}], "is_impossible": false}, {"question": "What can help improve their symptoms and quality of life?", "id": "100000000000000000005509", "answers": [{"text": "personal medical management plan", "answer_start": 133}], "is_impossible": false}, {"question": "How can you prepare for a healthcare provider appointment?", "id": "100000000000000000005510", "answers": [{"text": "Review these tips", "answer_start": 224}], "is_impossible": false}, {"question": "What is a healthcare provider appointment for for post-COVID conditions?", "id": "100000000000000000005511", "answers": [{"text": "personal medical management plan", "answer_start": 133}], "is_impossible": false}, {"question": "What are many support groups being organized that can help patients and their caregivers?", "id": "100000000000000000005512", "answers": [{"text": "post-COVID conditions", "answer_start": 52}], "is_impossible": false}], "context": "Living with Long COVID\nHowever, people experiencing post-COVID conditions can seek care from a healthcare provider to come up with a personal\nmedical management plan that can help improve their symptoms and quality of life. Review these tips to help prepare for a\nhealthcare provider appointment for post-COVID conditions. In addition, there are many support groups being organized that\ncan help patients and their caregivers. Although post-COVID conditions appear to be less common in children and adolescents than in adults, long-term effects after\nCOVID-19 do occur in children and adolescents."}]}, {"title": "d613b8d25607f829d1aba51ecb5d6fc4", "paragraphs": [{"qas": [{"question": "Talk to your doctor if you think you or your child has COVID or a post-COVID condition?", "id": "100000000000000000005515", "answers": [{"text": "Tips for Talking to Your Healthcare Provider about Post-COVID Conditions", "answer_start": 214}], "is_impossible": false}, {"question": "What does CDC use to estimate how many people experience post-COVID conditions?", "id": "100000000000000000005516", "answers": [{"text": "multiple approaches", "answer_start": 322}], "is_impossible": false}, {"question": "What can each approach provide to give us a better picture of?", "id": "100000000000000000005517", "answers": [{"text": "a piece of the puzzle", "answer_start": 430}], "is_impossible": false}], "context": "Living with a post-COVID condition can be hard, especially when there are no immediate answers or solutions. Talk to your doctor if you think you or your child has long COVID or a post-COVID condition. Learn more: Tips for\nTalking to Your Healthcare Provider about Post-COVID Conditions\n\uf3b7\nData for Long COVID\nCDC is using multiple approaches to estimate how many people experience post-COVID conditions. Each approach can\nprovide a piece of the puzzle to give us a better picture of who is experiencing post-COVID conditions."}]}, {"title": "268b2346cbb0264c04dcfed69b0a4c53", "paragraphs": [{"qas": [{"question": "How many people experience post-COVID conditions?", "id": "100000000000000000005521", "answers": [{"text": "The estimates for how many people experience post-COVID conditions can be quite different", "answer_start": 297}], "is_impossible": false}, {"question": "Who was included in the study?", "id": "100000000000000000005522", "answers": [{"text": "people who have been hospitalized, while others include people who were not hospitalized", "answer_start": 207}], "is_impossible": false}, {"question": "How did the study collect information?", "id": "100000000000000000005523", "answers": [{"text": "when", "answer_start": 450}], "is_impossible": false}], "context": "For example, some\nstudies look for the presence of post-COVID conditions based on self-reported symptoms, while others collect symptoms and\nconditions recorded in medical records. Some studies focus only on people who have been hospitalized, while others include\npeople who were not hospitalized. The estimates for how many people experience post-COVID conditions can be quite\ndifferent depending on who was included in the study, as well as how and when the study collected information."}]}, {"title": "3e18690b3efd16182f24d1aa1c384753", "paragraphs": [{"qas": [{"question": "Studies are in progress to better understand what?", "id": "100000000000000000005525", "answers": [{"text": "post-COVID conditions", "answer_start": 157}], "is_impossible": false}, {"question": "What percentage at one month or longer after infection?", "id": "100000000000000000005526", "answers": [{"text": "13.3%", "answer_start": 276}], "is_impossible": false}, {"question": "How much at three months or longer?", "id": "100000000000000000005527", "answers": [{"text": "2.5%", "answer_start": 321}], "is_impossible": false}, {"question": "Who is learning more about how new variants could potentially affect post-COVID symptoms?", "id": "100000000000000000005528", "answers": [{"text": "Scientists", "answer_start": 440}], "is_impossible": false}], "context": "Estimates of\nthe proportion of people who had COVID-19 that go on to experience post-COVID conditions can vary:\nStudies are in progress to better understand post-COVID conditions and how many people experience them. 10/30/22, 9:42 AM Long COVID or Post-COVID Conditions | CDC\n13.3% at one month or longer after infection\n2.5% at three months or longer, based on self-reporting\nMore than 30% at 6 months among patients who were hospitalized\nScientists are also learning more about how new variants could potentially affect post-COVID symptoms."}]}, {"title": "1352051624f663033e29f6c180003d", "paragraphs": [{"qas": [{"question": "What are we still learning to what extent certain groups are at higher risk?", "id": "100000000000000000005529", "answers": [{"text": "post- COVID conditions", "answer_start": 144}], "is_impossible": false}, {"question": "What will CDC continue to share with healthcare providers to help them evaluate and manage?", "id": "100000000000000000005531", "answers": [{"text": "information", "answer_start": 410}], "is_impossible": false}, {"question": "What is CDC working to: Better identify the most frequent symptoms and diagnoses experienced by patients with post-COVID conditions?", "id": "100000000000000000005532", "answers": [{"text": "CDC will continue to share information with healthcare providers", "answer_start": 383}], "is_impossible": false}], "context": "We are still learning\nto what extent certain groups are at higher risk, and if different groups of people tend to experience different types of post-\nCOVID conditions. These studies, including for example CDC\u2019s INSPIRE and NIH\u2019s RECOVER , will help us better understand\npost-COVID conditions and how healthcare providers can treat or support patients with these longer-term effects. CDC will\ncontinue to share information with healthcare providers to help them evaluate and manage these conditions. CDC is working to:\nBetter identify the most frequent symptoms and diagnoses experienced by patients with post-COVID conditions."}]}, {"title": "59a130f1c205431f0f0af76233f1c1e9", "paragraphs": [{"qas": [{"question": "How many people are affected by post-COVID conditions?", "id": "100000000000000000005533", "answers": [{"text": "how many", "answer_start": 18}], "is_impossible": false}, {"question": "How often do people who are infected with COVID-19 develop post-covid conditions afterward?", "id": "100000000000000000005534", "answers": [{"text": "how often", "answer_start": 77}], "is_impossible": false}, {"question": "What group might be more at risk?", "id": "100000000000000000005535", "answers": [{"text": "groups", "answer_start": 215}], "is_impossible": false}, {"question": "How do post-COVID conditions limit or restrict people's daily activity?", "id": "100000000000000000005537", "answers": [{"text": "Help understand", "answer_start": 300}], "is_impossible": false}, {"question": "What do groups that have been more affected by post- COVID condition lack access to?", "id": "100000000000000000005538", "answers": [{"text": "care and treatment for post- COVID conditions", "answer_start": 476}], "is_impossible": false}], "context": "Better understand how many people are affected by post-COVID conditions, and how often people who are infected with\nCOVID-19 develop post-COVID conditions afterwards. Better understand risk factors, including which groups might be more at risk, and if different groups experience different\nsymptoms. Help understand how post-COVID conditions limit or restrict people\u2019s daily activity. Help identify groups that have been more affected by post-COVID conditions, lack access to care and treatment for post-\nCOVID conditions, or experience stigma. Better understand the role vaccination plays in preventing post-COVID conditions."}]}, {"title": "861b5b6e0b67ee216978fc8eab856df8", "paragraphs": [{"qas": [{"question": "CDC and other federal agencies are working to learn more about what?", "id": "100000000000000000005540", "answers": [{"text": "the short- and long-term health effects associated with COVID-19", "answer_start": 299}], "is_impossible": false}, {"question": "Who gets them and why?", "id": "100000000000000000005542", "answers": [{"text": "COVID-19", "answer_start": 355}], "is_impossible": false}, {"question": "What is a disability under the ADA?", "id": "100000000000000000005543", "answers": [{"text": "Long COVID", "answer_start": 607}], "is_impossible": false}, {"question": "When was the last update for Post-COVID Conditions?", "id": "100000000000000000005544", "answers": [{"text": "Sept. 1, 2022", "answer_start": 712}], "is_impossible": false}], "context": "Collaborate with professional medical groups to develop and offer clinical guidance and other educational materials for\nhealthcare providers, patients, and the public. \u2022\n\u2022\n\u2022\nCDC and other federal agencies, as well as academic institutions and research organizations, are working to learn more\nabout the short- and long-term health effects associated with COVID-19 , who gets them and why. \uf209\n\uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nRelated Pages\nFor Healthcare Professionals\nCaring for People with Post-COVID Conditions\n\u203a\nPreparing for Appointments for Post-COVID Conditions\n\u203a\nResearching COVID to Enhance Recovery\n\u203a \uf209\nGuidance on \u201cLong COVID\u201d as a Disability Under the ADA\n\u203a \uf209\nPost-COVID Conditions: Healthcare Providers\n\u203a\nLast Updated Sept. 1, 2022"}]}, {"title": "a99fd1bc45d7cb7a7fd65bd7759ba8b2", "paragraphs": [{"qas": [{"question": "What is better than no mask?", "id": "100000000000000000005546", "answers": [{"text": "any mask", "answer_start": 250}], "is_impossible": false}, {"question": "When worn correctly, masks and respirators are effective at what?", "id": "100000000000000000005549", "answers": [{"text": "reducing transmission of SARS-CoV-2", "answer_start": 494}], "is_impossible": false}], "context": "10/30/22, 9:39 AM Masks and Respirators\nEspa\u00f1ol | Other Languages\nTypes of Masks and Respirators\nSummary of Recent Changes\nKey Messages:\nMasking is a critical public health tool for preventing spread of COVID-19, and it is important to remember that any mask\nis better than no mask. To protect yourself and others from COVID-19, CDC continues to recommend that you wear the most protective mask\nyou can that fits well and that you will wear consistently. Masks and respirators are effective at reducing transmission of SARS-CoV-2, the virus that causes COVID-19, when worn\nconsistently and correctly."}]}, {"title": "c49dfe8bdf58433c8f9ddcea1742c140", "paragraphs": [{"qas": [{"question": "What is the most important part of a high risk situation?", "id": "100000000000000000005553", "answers": [{"text": "Wearing a highly protective mask or respirator", "answer_start": 415}], "is_impossible": false}], "context": "Some masks and respirators offer higher levels of protection than others, and some may be harder to tolerate or wear\nconsistently than others. It is most important to wear a well-fitting mask or respirator correctly that is comfortable for\nyou and that provides good protection. While all masks and respirators provide some level of protection, properly fitting respirators provide the highest level of\nprotection. Wearing a highly protective mask or respirator may be most important for certain higher risk situations, or by\nsome people at increased risk for severe disease."}]}, {"title": "ac6702fc32e686836114dc33aa351893", "paragraphs": [{"qas": [{"question": "What do the CDC's mask recommendations provide?", "id": "100000000000000000005554", "answers": [{"text": "information that people can use to improve how well their masks protect them", "answer_start": 35}], "is_impossible": false}, {"question": "What can people use to improve how well their masks protect them?", "id": "100000000000000000005555", "answers": [{"text": "CDC\u2019s mask recommendations", "answer_start": 0}], "is_impossible": false}, {"question": "What can provide varying degrees of protection?", "id": "100000000000000000005556", "answers": [{"text": "Masks and respirators", "answer_start": 259}], "is_impossible": false}, {"question": "What are well-fitting National Institute for Occupational Safety and Health approved respirators offering?", "id": "100000000000000000005557", "answers": [{"text": "the most protection", "answer_start": 434}], "is_impossible": false}], "context": "CDC\u2019s mask recommendations provide information that people can use to improve how well their masks protect them. This page describes different types of masks and respirators that you can use to protect yourself and others from getting and\nspreading COVID-19. Masks and respirators can provide varying degrees of protection, with well-fitting National Institute for\nOccupational Safety and Health (NIOSH)-approved respirators offering the most protection."}]}, {"title": "ed9de254fc10d81009c9870fb72b2497", "paragraphs": [{"qas": [{"question": "What is a critical public health issue?", "id": "100000000000000000005558", "answers": [{"text": "Masking", "answer_start": 0}], "is_impossible": false}, {"question": "What are N95s and KN95s a specific type of?", "id": "100000000000000000005559", "answers": [{"text": "respirators", "answer_start": 140}], "is_impossible": false}, {"question": "Which type of respirator should be prioritized for healthcare?", "id": "100000000000000000005560", "answers": [{"text": "surgical N95s", "answer_start": 257}], "is_impossible": false}, {"question": "Some types of masks and respirators provide more protection to the wearer than others What is the name of the document that explains how to use your N95 correctly?", "id": "100000000000000000005562", "answers": [{"text": "How to Use Your N95 Respirator", "answer_start": 590}], "is_impossible": false}], "context": "Masking is a critical public health\nAdded information to present similar content for masks and respirators\nClarified that people can choose respirators such as N95s and KN95s, including removing concerns related to supply\nshortages for N95s\nClarified that \u201csurgical N95s\u201d are a specific type of respirator that should be prioritized for healthcare settings\nClarified that some types of masks and respirators provide more protection to the wearer than others\nView Previous Updates\nUpdates as of January 28, 2022\n\uf1aa\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nFor information about how to use your N95 correctly, see How to Use Your N95 Respirator."}]}, {"title": "3adb19fb409ce8856c6b0c92c671ef72", "paragraphs": [{"qas": [{"question": "What is a tool for preventing spread of COVID-19?", "id": "100000000000000000005563", "answers": [{"text": "Masks and Respirators", "answer_start": 18}], "is_impossible": false}, {"question": "What is better than no mask?", "id": "100000000000000000005564", "answers": [{"text": "any mask", "answer_start": 117}], "is_impossible": false}, {"question": "What type of masks are made to contain droplets and particles?", "id": "100000000000000000005566", "answers": [{"text": "Masks and Respirators", "answer_start": 396}], "is_impossible": false}], "context": "10/30/22, 9:39 AM Masks and Respirators\ntool for preventing spread of COVID-19, and it is important to remember that any mask is better than no mask. This page\npresents options in order of least to most protective. To protect yourself and others from COVID-19, CDC continues to\nrecommend that you wear the most protective mask you can that fits well and that you will wear consistently. Types of Masks and Respirators\nMasks are made to contain droplets and particles you breathe, cough, or sneeze out."}]}, {"title": "e7fbc97737cc38b1919a217ded85554d", "paragraphs": [{"qas": [{"question": "Respirators are made to protect you by filtering the air and fitting closely on the face to filter out what?", "id": "100000000000000000005567", "answers": [{"text": "particles", "answer_start": 253}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000005568", "answers": [{"text": "virus", "answer_start": 277}], "is_impossible": false}, {"question": "If a respirator fits closely to the face, it can also provide you some protection from particles spread by others.", "id": "100000000000000000005569", "answers": [{"text": "virus", "answer_start": 277}], "is_impossible": false}, {"question": "What can a filter contain?", "id": "100000000000000000005570", "answers": [{"text": "droplets and particles you breathe, cough, or sneeze out", "answer_start": 328}], "is_impossible": false}], "context": "If they fit closely to the face, they\ncan also provide you some protection from particles spread by others, including the virus that causes COVID-19. Respirators are made to protect you by filtering the air and fitting closely on the face to filter out particles, including the\nvirus that causes COVID-19. They can also contain droplets and particles you breathe, cough, or sneeze out so you do not\nspread them to others."}]}, {"title": "26e0fabeb8b9777dbc09cfa026fdbffa", "paragraphs": [{"qas": [{"question": "What are respirators called?", "id": "100000000000000000005571", "answers": [{"text": "specialized filtering masks", "answer_start": 84}], "is_impossible": false}, {"question": "What type of mask provides the least protection?", "id": "100000000000000000005572", "answers": [{"text": "Loosely woven cloth products", "answer_start": 224}], "is_impossible": false}, {"question": "How do respirators differ from masks?", "id": "100000000000000000005574", "answers": [{"text": "different levels of protection depending on the type of mask and how they are used", "answer_start": 140}], "is_impossible": false}, {"question": "How are disposable surgical masks and KN95s fitted?", "id": "100000000000000000005577", "answers": [{"text": "well-fitting", "answer_start": 336}], "is_impossible": false}], "context": "Choosing a Mask or Respirator for Different Situations\nMasks and respirators (i.e., specialized filtering masks such as \u201cN95s\u201d) can provide different levels of protection depending on\nthe type of mask and how they are used. Loosely woven cloth products provide the least protection, layered finely woven\nproducts offer more protection, well-fitting disposable surgical masks and KN95s offer even more protection, and well-fitting\nNIOSH-approved respirators (including N95s) offer the highest level of protection."}]}, {"title": "5a2efd2b389bb5483a63a882498baf18", "paragraphs": [{"qas": [{"question": "What should be comfortable enough when worn properly?", "id": "100000000000000000005579", "answers": [{"text": "Whatever product you choose, it should provide a good fit (i.e., fitting closely on the face without any gaps along the edges or around the nose) and be comfortable enough when worn properly (covering your nose and mouth) so that you can keep it on when you need to. Learn how to improve how well your mask protects you by visiting CDC\u2019s Improve How Your Mask Protects You page. A respirator", "answer_start": 0}], "is_impossible": false}, {"question": "What does a respirator have better of?", "id": "100000000000000000005580", "answers": [{"text": "filtration", "answer_start": 403}], "is_impossible": false}, {"question": "What can provide a higher level of protection than a cloth or procedural mask?", "id": "100000000000000000005582", "answers": [{"text": "A respirator", "answer_start": 379}], "is_impossible": false}], "context": "Whatever product you choose, it should provide a good fit (i.e., fitting closely on the face without any gaps along the edges or\naround the nose) and be comfortable enough when worn properly (covering your nose and mouth) so that you can keep it on\nwhen you need to. Learn how to improve how well your mask protects you by visiting CDC\u2019s Improve How Your Mask Protects\nYou page. A respirator has better filtration, and if worn properly the whole time it is in use, can provide a higher level of protection than\na cloth or procedural mask."}]}, {"title": "bd7923450a7f5f6c43dec83c153f7682", "paragraphs": [{"qas": [{"question": "What will make a mask or respirator less effective if it fits poorly or if you wear it improperly or take it off frequently?", "id": "100000000000000000005583", "answers": [{"text": "protection", "answer_start": 229}], "is_impossible": false}, {"question": "Individuals may consider the situation and other factors when choosing what?", "id": "100000000000000000005584", "answers": [{"text": "a mask or respirator", "answer_start": 189}], "is_impossible": false}, {"question": "When caring for someone who is sick with COVID-19?", "id": "100000000000000000005585", "answers": [{"text": "protection", "answer_start": 229}], "is_impossible": false}, {"question": "Who is at increased risk for severe illness?", "id": "100000000000000000005586", "answers": [{"text": "people who are immunocompromised, older adults, and people with certain underlying medical conditions", "answer_start": 355}], "is_impossible": false}, {"question": "People who are immunocompromised, older adults, and people with certain underlying medical conditions are examples of what?", "id": "100000000000000000005587", "answers": [{"text": "If you are at increased risk for severe illness", "answer_start": 293}], "is_impossible": false}, {"question": "What type of mask is not always worn by everyone?", "id": "100000000000000000005589", "answers": [{"text": "respirator", "answer_start": 10}], "is_impossible": false}], "context": "A mask or respirator will be less effective if it fits poorly or if you wear it improperly or take it off\nfrequently. Individuals may consider the situation and other factors when choosing a mask or respirator that offers greater\nprotection. When caring for someone who is sick with COVID-19. If you are at increased risk for severe illness, for example, people who are immunocompromised, older adults, and\npeople with certain underlying medical conditions. When working at a job where you interact with large numbers of the public, especially when not everyone is consistently\nwearing a mask."}]}, {"title": "9be5bb9415187ac38f465a22052e7cff", "paragraphs": [{"qas": [{"question": "Bus drivers and grocery store workers are examples of what?", "id": "100000000000000000005590", "answers": [{"text": "Masks", "answer_start": 356}], "is_impossible": false}, {"question": "When riding on planes, buses, trains or other forms of public transportation for a long period of time on crowded conveyances?", "id": "100000000000000000005591", "answers": [{"text": "on crowded conveyances. When physical distancing is not possible", "answer_start": 176}], "is_impossible": false}, {"question": "If physical distancing is not possible or when you are in crowded indoor or outdoor public settings?", "id": "100000000000000000005592", "answers": [{"text": "If you are not up to date on COVID-19 vaccinations", "answer_start": 304}], "is_impossible": false}, {"question": "What can leak in and out around the edges of a mask?", "id": "100000000000000000005593", "answers": [{"text": "air with respiratory droplets", "answer_start": 423}], "is_impossible": false}, {"question": "What can happen if you are not up to date on COVID-19 vaccinations?", "id": "100000000000000000005594", "answers": [{"text": "physical distancing is not possible or when you are in crowded indoor or outdoor public settings", "answer_start": 206}], "is_impossible": false}], "context": "For example, bus drivers and grocery store workers. When riding on planes, buses, trains, or other forms of public transportation, especially if it is for a long period of time\non crowded conveyances. When physical distancing is not possible or when you are in crowded indoor or outdoor public settings. If you are not up to date on COVID-19 vaccinations. Masks\nWhen choosing a mask, look at how well it fits. Gaps can let air with respiratory droplets leak in and out around the edges of\nthe mask."}]}, {"title": "383930507c8ae2275c00b716c42adb99", "paragraphs": [{"qas": [{"question": "How do you check if your mask fits snugly over your nose, mouth and chin?", "id": "100000000000000000005597", "answers": [{"text": "cupping your hands around the outside edges", "answer_start": 200}], "is_impossible": false}, {"question": "By cupping your hands around the outside edges of the mask, what should you do?", "id": "100000000000000000005598", "answers": [{"text": "Check for gaps", "answer_start": 182}], "is_impossible": false}, {"question": "Make sure no air is flowing from the area near your eyes or from where?", "id": "100000000000000000005599", "answers": [{"text": "the sides of the mask", "answer_start": 322}], "is_impossible": false}], "context": "Gaps can be caused by choosing the wrong size or type of mask and when a mask is worn with facial hair. It is important to check that it fits snugly over your nose, mouth, and chin. Check for gaps by cupping your hands around the outside edges of the mask. Make sure no air is flowing from the area near your eyes or from the sides of the mask."}]}, {"title": "f40649f89fb77f0f6ee9d630cb74cd52", "paragraphs": [{"qas": [{"question": "What can be made from a variety of fabrics?", "id": "100000000000000000005601", "answers": [{"text": "Cloth Masks", "answer_start": 231}], "is_impossible": false}, {"question": "What types of cloth masks are available?", "id": "100000000000000000005602", "answers": [{"text": "many types", "answer_start": 285}], "is_impossible": false}], "context": "If the mask has a good fit, you will feel warm air come through the front of the mask and may be able to see the mask\nmaterial move in and out with each breath. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nCloth Masks\f10/30/22, 9:39 AM Masks and Respirators\nCloth Masks can be made from a variety of fabrics and many types of cloth masks are available."}]}, {"title": "d903d96298b039f6972fdd3d9fb4692c", "paragraphs": [{"qas": [{"question": "What do you wear over your nose, mouth, and chin to prevent leaks?", "id": "100000000000000000005603", "answers": [{"text": "cloth masks", "answer_start": 5}], "is_impossible": false}, {"question": "Do NOT wear cloth masks with Gaps around the sides of the face or nose?", "id": "100000000000000000005605", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022", "answer_start": 207}], "is_impossible": false}, {"question": "What type of masks are widely available?", "id": "100000000000000000005606", "answers": [{"text": "Disposable procedure masks", "answer_start": 446}], "is_impossible": false}, {"question": "What are disposable procedure masks sometimes referred to as?", "id": "100000000000000000005607", "answers": [{"text": "surgical masks or medical procedure masks", "answer_start": 529}], "is_impossible": false}], "context": "Wear cloth masks with\nA proper fit over your nose, mouth, and chin to prevent leaks\nMultiple layers of tightly woven, breathable fabric\nNose wire\nFabric that blocks light when held up to bright light source\n\u2022\n\u2022\n\u2022\n\u2022\nDo NOT wear cloth masks with\nGaps around the sides of the face or nose\nExhalation valves, vents, or other openings (see example)\nSingle-layer fabric or those made of thin fabric that don\u2019t block light\nWet or dirty material\n\u2022\n\u2022\n\u2022\n\u2022\nDisposable procedure masks are widely available. They are sometimes referred to as surgical masks or medical procedure\nmasks."}]}, {"title": "59ce7155cbb7bbb6ec08595e2bf6e843", "paragraphs": [{"qas": [{"question": "What should you wear to prevent leaks?", "id": "100000000000000000005608", "answers": [{"text": "A proper fit over your nose, mouth, and chin", "answer_start": 41}], "is_impossible": false}, {"question": "What is the name of the non-woven material used to protect your nose?", "id": "100000000000000000005609", "answers": [{"text": "nose wire", "answer_start": 144}], "is_impossible": false}, {"question": "Do not wear procedure masks with Gaps around the sides of the face?", "id": "100000000000000000005610", "answers": [{"text": "answer undefined", "answer_start": 144}], "is_impossible": false}, {"question": "How can you have a better fit?", "id": "100000000000000000005611", "answers": [{"text": "cloth and disposable masks", "answer_start": 325}], "is_impossible": false}, {"question": "What is the difference between a disposable mask and a cloth mask?", "id": "100000000000000000005613", "answers": [{"text": "extra protection", "answer_start": 303}], "is_impossible": false}, {"question": "For disposable procedure masks, fold and tuck what under the edges?", "id": "100000000000000000005616", "answers": [{"text": "the unneeded material", "answer_start": 611}], "is_impossible": false}], "context": "Procedure Masks\nWear procedure masks with\nA proper fit over your nose, mouth, and chin to prevent leaks\nMultiple layers of non-woven material\nA nose wire\n\u2022\n\u2022\n\u2022\nDo NOT wear procedure masks with\nGaps around the sides of the face or nose (see example)\nWet or dirty material\n\u2022\n\u2022\nWays to have better fit and extra protection with cloth and disposable masks\nWear two masks (disposable mask underneath AND cloth mask on top)\nCombine either a cloth mask or disposable mask with a fitter or brace\nKnot and tuck ear loops of a 3-ply mask where they join the edge of the\nmask\nFor disposable procedure masks, fold and tuck the unneeded\nmaterial under the edges."}]}, {"title": "bc2ec5955752e80a315ed67f4616f2b3", "paragraphs": [{"qas": [{"question": "What are some masks designed and tested to ensure they perform at a consistent level?", "id": "100000000000000000005617", "answers": [{"text": "Masks and Respirators", "answer_start": 171}], "is_impossible": false}, {"question": "What are masks labeled to tell you what standard they meet?", "id": "100000000000000000005618", "answers": [{"text": "Masks that Meet a Standard MEETS ASTM F3502 MEETS WORKPLACE PERFORMANCE MEETS WORKPLACE PERFORMANCE PLUS", "answer_start": 360}], "is_impossible": false}, {"question": "What are the masks that meet a standard MEETS WORKPLACE PERFORMANCE?", "id": "100000000000000000005619", "answers": [{"text": "ASTM F3502", "answer_start": 393}], "is_impossible": false}], "context": "(For instructions, see the following\nUse masks that attach behind the neck and head with either elastic\nbands or ties (instead of ear loops)\n\u2022\n\u2022\n\u2022\n-\n\uf209\n\u2022\f10/30/22, 9:39 AM Masks and Respirators\nSome masks are designed and tested to ensure they perform at a consistent level. These masks are labeled to tell you what\nstandard they meet. These masks are labeled:\nMasks that Meet a Standard\nMEETS ASTM F3502\nMEETS WORKPLACE PERFORMANCE\nMEETS WORKPLACE PERFORMANCE PLUS\nThese are new standards. Lists of masks that meet these standards and more\ninformation on their availability can be found on the NIOSH Personal Protective\nEquipment Information (PPE-Info) webpage."}]}, {"title": "e9f6253e43062db5a49447162e76ab40", "paragraphs": [{"qas": [{"question": "What do the markings on masks indicate?", "id": "100000000000000000005621", "answers": [{"text": "they are authentic", "answer_start": 61}], "is_impossible": false}], "context": "These masks have markings printed\non the product to indicate they are authentic. Follow manufacturer\u2019s instructions on how to wear, store, and clean or properly\ndispose of the mask. These should be worn according to the manufacturer\u2019s\ninstructions without modifications."}]}, {"title": "d4816e2ebfc46a774b6a93889c043e3b", "paragraphs": [{"qas": [{"question": "What should you wear over your nose and mouth to prevent leaks?", "id": "100000000000000000005623", "answers": [{"text": "masks that meet a standard with A proper fit", "answer_start": 5}], "is_impossible": false}, {"question": "What should not be worn if it is hard to breathe while wearing a mask?", "id": "100000000000000000005624", "answers": [{"text": "masks", "answer_start": 154}], "is_impossible": false}, {"question": "What should include information on how to wear, store, and clean the respirator?", "id": "100000000000000000005627", "answers": [{"text": "manufacturer instructions", "answer_start": 467}], "is_impossible": false}], "context": "Wear masks that meet a standard with\nA proper fit over your nose and mouth to prevent leaks\nMultiple layers of non-woven material\nA nose wire\nDo NOT wear masks that meet a standard\nIf it is hard to breathe while wearing them\nIf they are wet or dirty\nWith other masks or respirators\nAs a replacement for NIOSH-approved respiratory protection when required\nby your job\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nRespirators\nWhen choosing a respirator, look at how well it fits and read the manufacturer instructions. These instructions should include\ninformation on how to wear, store, and clean or properly dispose of the respirator."}]}, {"title": "5827963d8e080d29eb49f91709e31073", "paragraphs": [{"qas": [{"question": "What do respirators have on the product to indicate they are authentic?", "id": "100000000000000000005628", "answers": [{"text": "markings printed", "answer_start": 17}], "is_impossible": false}, {"question": "What do N95 and KN95 markings indicate?", "id": "100000000000000000005629", "answers": [{"text": "Respirators have markings printed on the product to indicate they are authentic", "answer_start": 0}], "is_impossible": false}, {"question": "How do you wear your respirator?", "id": "100000000000000000005630", "answers": [{"text": "properly", "answer_start": 169}], "is_impossible": false}, {"question": "Gaps can let air with respiratory droplets leak in and out around the edges of what?", "id": "100000000000000000005631", "answers": [{"text": "the respirator", "answer_start": 291}], "is_impossible": false}, {"question": "Droplets leak in and out around the edges of what?", "id": "100000000000000000005632", "answers": [{"text": "Respirators have markings printed on the product to indicate they are authentic, see appropriate N95 markings and KN95 markings. It is important to wear your respirator properly, so it forms a seal to your face. Gaps can let air with respiratory droplets leak in and out around the edges of the respirator", "answer_start": 0}], "is_impossible": false}], "context": "Respirators have markings printed on the\nproduct to indicate they are authentic, see appropriate N95 markings and KN95 markings. It is important to wear your respirator properly, so it forms a seal to your face. Gaps can let air with respiratory droplets leak\nin and out around the edges of the respirator. Gaps can be caused by choosing the wrong size or type of respirator or when a\nrespirator is worn with facial hair. For information about how to use your N95 correctly, see How to Use Your N95\nRespirator."}]}, {"title": "a47258bdeddcad4f4267098715b39e7f", "paragraphs": [{"qas": [{"question": "What are most publicly available respirators?", "id": "100000000000000000005635", "answers": [{"text": "disposable", "answer_start": 206}], "is_impossible": false}, {"question": "When should disposable respirators be discarded?", "id": "100000000000000000005636", "answers": [{"text": "when they are dirty, damaged, or difficult to breathe through", "answer_start": 241}], "is_impossible": false}, {"question": "What are the most widely available respirators that meet KP100, P2, P3, PFF2, PFF3, R95 and Special?", "id": "100000000000000000005638", "answers": [{"text": "KP100, P2, P3, PFF2, PFF3, R95, and Special. What to know about international respirators", "answer_start": 541}], "is_impossible": false}, {"question": "What are international respirators designed to?", "id": "100000000000000000005639", "answers": [{"text": "standards that do not often have a quality requirement", "answer_start": 653}], "is_impossible": false}, {"question": "What does not often have a quality requirement?", "id": "100000000000000000005640", "answers": [{"text": "international respirators", "answer_start": 606}], "is_impossible": false}], "context": "The information on this page is about N95 respirators but also applies to international respirators, like KN95\nrespirators. \uf20a\f10/30/22, 9:39 AM Masks and Respirators\nMost publicly available respirators are disposable and should be discarded when they are dirty, damaged, or difficult to\nbreathe through. More information on these two types of respirators is provided below. Respirators that Meet International Standards\nSome respirators are designed and tested to meet international standards. The most widely available respirators that meet\nKP100, P2, P3, PFF2, PFF3, R95, and Special. What to know about international respirators\nThey are designed to standards that do not often have a quality requirement."}]}, {"title": "e03d25f3d9e0b80e8be563fd4defde50", "paragraphs": [{"qas": [{"question": "What do respirators seal tightly to your face when fitted properly?", "id": "100000000000000000005642", "answers": [{"text": "filter varying levels of particles in the air", "answer_start": 5}], "is_impossible": false}], "context": "They filter varying levels of particles in the air depending on the standard they are designed to meet. They seal tightly to your face when fitted properly. It is important to pick a respirator that fits your face and seals well since not all fit the same."}]}, {"title": "12d10aa73462009a56179df9abfd329f", "paragraphs": [{"qas": [{"question": "What percentage of KN95 respirators are poor quality?", "id": "100000000000000000005644", "answers": [{"text": "60%", "answer_start": 320}], "is_impossible": false}, {"question": "What are factors to consider when purchasing an international respirator?", "id": "100000000000000000005647", "answers": [{"text": "Using a poor-quality product may not provide the level of protection indicated", "answer_start": 464}], "is_impossible": false}, {"question": "What provides reliable information to guide you?", "id": "100000000000000000005648", "answers": [{"text": "This webpage and a webinar", "answer_start": 621}], "is_impossible": false}], "context": "Do NOT wear international respirators\nIf they have exhalation valves, vents, or other openings\nIf it is hard to breathe while wearing them\nIf they are wet or dirty\nWith other masks or respirators\nAs a replacement for NIOSH-approved respiratory protection when required by your job\nst\nPoor quality KN95 respirators\nAbout 60% of KN95 respirators NIOSH evaluated during the COVID-19 pandemic in 2020 and 2021 did not meet\nthe requirements that they intended to meet. Using a poor-quality product may not provide the level of protection indicated. Learn about factors to consider when purchasing an international respirator. This webpage and a webinar provide\nreliable information to guide you."}]}, {"title": "fda65f6c8a820c6ae814683afc89fdaa", "paragraphs": [{"qas": [{"question": "What are NIOSH-approved respirators?", "id": "100000000000000000005649", "answers": [{"text": "filtering facepiece respirators", "answer_start": 80}], "is_impossible": false}, {"question": "What is the most widely used N95 respirator?", "id": "100000000000000000005650", "answers": [{"text": "R100", "answer_start": 133}], "is_impossible": false}, {"question": "What should be prioritized for use by healthcare personnel?", "id": "100000000000000000005652", "answers": [{"text": "N95 respirators", "answer_start": 379}], "is_impossible": false}, {"question": "What is a special subtype of N95 respirators that provide additional protection against hazards present during medical procedures?", "id": "100000000000000000005653", "answers": [{"text": "surgical", "answer_start": 369}], "is_impossible": false}, {"question": "Who must follow an Occupational Safety and Health (OSHA) respiratory program?", "id": "100000000000000000005654", "answers": [{"text": "Employers who want to distribute N95 respirators to employees", "answer_start": 600}], "is_impossible": false}], "context": "\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nNIOSH-Approved Respirators\nNIOSH approves many types of filtering facepiece respirators. The most widely\nand R100) offer the same or better protection as an N95 respirator. Lists of\nrespirators that are NIOSH-approved can be found on the NIOSH-Approved\nParticulate Filtering Facepiece Respirators webpage. CDC recommends that specially labeled \u201csurgical\u201d N95 respirators \u2014 a special\nsubtype of N95 respirators that provide additional protection against hazards\npresent during medical procedures, such as blood splatter \u2014 should be prioritized\nfor use by healthcare personnel. Employers who want to distribute N95 respirators to employees shall follow an\nOccupational Safety and Health (OSHA) respiratory protection program ."}]}, {"title": "33f5c1db3b26671e26bcc2eb77c5c284", "paragraphs": [{"qas": [{"question": "What do NIOSH-approved respirators provide?", "id": "100000000000000000005656", "answers": [{"text": "the highest level of protection from particles", "answer_start": 96}], "is_impossible": false}, {"question": "What is the highest level of protection from particles?", "id": "100000000000000000005657", "answers": [{"text": "When worn consistently and properly", "answer_start": 46}], "is_impossible": false}, {"question": "How are masks and respirators made?", "id": "100000000000000000005658", "answers": [{"text": "seal tightly to your face when fitted properly", "answer_start": 350}], "is_impossible": false}, {"question": "Respirators approved by NIOSH are evaluated against what US standard?", "id": "100000000000000000005661", "answers": [{"text": "quality requirement", "answer_start": 589}], "is_impossible": false}, {"question": "What are approved by NIOSH evaluated against?", "id": "100000000000000000005662", "answers": [{"text": "a specific US standard", "answer_start": 550}], "is_impossible": false}], "context": "What to know about NIOSH-approved respirators\nWhen worn consistently and properly, they provide the highest level of protection from particles, including the\nvirus that causes COVID-19. Additionally, they contain your respiratory droplets and particles so you do not expose\n\uf209\n\u2022\f10/30/22, 9:39 AM Masks and Respirators\ny, y y p y p p y p\nothers. They seal tightly to your face when fitted properly. It is important to pick a respirator that fits your face and seals well since not all fit the same. Respirators approved by NIOSH are evaluated against a specific US standard that includes a quality requirement."}]}, {"title": "af0aed89422a5a608967c4c84ee89e2", "paragraphs": [{"qas": [{"question": "What type of respirator with a valve may not protect others as well as a respirator without one?", "id": "100000000000000000005665", "answers": [{"text": "N95 or other filtering facepiece", "answer_start": 129}], "is_impossible": false}, {"question": "How do you make a filtering facepiece respirator with a valve as protective as one without one?", "id": "100000000000000000005666", "answers": [{"text": "follow the manufacturer\u2019s instructions for covering the valve", "answer_start": 333}], "is_impossible": false}, {"question": "What is the manufacturer's instructions for covering the valve?", "id": "100000000000000000005667", "answers": [{"text": "To make a filtering facepiece respirator with a valve as protective as one without a valve, follow", "answer_start": 241}], "is_impossible": false}], "context": "They filter at least 95% of particles in the air when approved by NIOSH and when you have a proper fit. If you have COVID-19, an N95 or other filtering facepiece respirator with a valve may not protect others as well as\none without a valve. To make a filtering facepiece respirator with a valve as protective as one without a valve,\nfollow the manufacturer\u2019s instructions for covering the valve."}]}, {"title": "f322337e4b79e0b369309a74d26a267e", "paragraphs": [{"qas": [{"question": "What should children wear when the COVID-19 Community Level is high?", "id": "100000000000000000005668", "answers": [{"text": "masks", "answer_start": 231}], "is_impossible": false}, {"question": "What are the CDC recommendations for?", "id": "100000000000000000005669", "answers": [{"text": "masking in K-12 schools and Early Care and Education (ECE) programs", "answer_start": 347}], "is_impossible": false}, {"question": "What are the recommendations for masking in K-12 schools?", "id": "100000000000000000005670", "answers": [{"text": "CDC", "answer_start": 321}], "is_impossible": false}, {"question": "What should schools and ECE programs support?", "id": "100000000000000000005671", "answers": [{"text": "anyone who chooses to wear a mask at low or medium COVID-19 Community Levels", "answer_start": 456}], "is_impossible": false}, {"question": "The benefits of mask-wearing are well-established.", "id": "100000000000000000005672", "answers": [{"text": "answer undefined", "answer_start": 456}], "is_impossible": false}, {"question": "What are NIOSH-approved respirators for children?", "id": "100000000000000000005674", "answers": [{"text": "N95s", "answer_start": 681}], "is_impossible": false}], "context": "Do NOT wear NIOSH-approved respirators\nIf it is hard to breathe while wearing them\nIf they are wet or dirty\nWith other masks or respirators\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nConsiderations for Children\nMasks\nAnyone ages 2 years or older should wear masks in indoor public spaces when the COVID-19 Community Level is high. Learn\nmore about CDC\u2019s recommendations for masking in K-12 schools and Early Care and Education (ECE) programs. Schools and\nECE programs should support anyone who chooses to wear a mask at low or medium COVID-19 Community Levels. The\nbenefits of mask-wearing are well-established. Respirators\nParents and caregivers may have questions about NIOSH-approved respirators (such as N95s) for children."}]}, {"title": "acdb289ceca1fc562ce1a06f176e6575", "paragraphs": [{"qas": [{"question": "What should not be worn by children younger than 2 years?", "id": "100000000000000000005676", "answers": [{"text": "Masks and respirators", "answer_start": 198}], "is_impossible": false}, {"question": "How long does it take for a child to wear a mask or respirator?", "id": "100000000000000000005677", "answers": [{"text": "2 years", "answer_start": 264}], "is_impossible": false}, {"question": "What might happen to a poorly fitting or uncomfortable respirator that is worn incorrectly or removed often?", "id": "100000000000000000005678", "answers": [{"text": "reduce its intended benefits", "answer_start": 477}], "is_impossible": false}, {"question": "What does not impair vision?", "id": "100000000000000000005679", "answers": [{"text": "Choose a size that fits over the child\u2019s nose and under the chin", "answer_start": 507}], "is_impossible": false}], "context": "Although\nrespirators may be available in smaller sizes, they are typically designed to be used by adults in workplaces, and therefore\nhave not been tested for broad use in children. Selecting Masks\nMasks and respirators should not be worn by children younger than 2 years. Choose a high-quality and comfortable mask or respirator that your child can wear properly. A poorly fitting or\nuncomfortable mask or respirator might be worn incorrectly or removed often, and that would reduce its intended\nbenefits. Choose a size that fits over the child\u2019s nose and under the chin but does not impair vision."}]}, {"title": "8f4fbfd4a2e4d168f3ddc7e7533ca53c", "paragraphs": [{"qas": [{"question": "What may feel different if your child is used to wearing a regular cloth or disposable procedure masks?", "id": "100000000000000000005682", "answers": [{"text": "masks and respirators", "answer_start": 143}], "is_impossible": false}, {"question": "What type of procedure masks are available?", "id": "100000000000000000005683", "answers": [{"text": "disposable", "answer_start": 236}], "is_impossible": false}, {"question": "What should you ask your child's healthcare provider before they use methods to improve mask fit?", "id": "100000000000000000005684", "answers": [{"text": "If your child has a medical condition", "answer_start": 283}], "is_impossible": false}], "context": "Follow the user instructions for the mask or respirator. These instructions may show how to make sure the product fits\nproperly. Some types of masks and respirators may feel different if your child is used to wearing a regular cloth or disposable\nprocedure masks. Safety precautions\nIf your child has a medical condition, such as a heart or lung problem, ask their healthcare provider before they use\nmethods to improve mask fit or use an ASTM F3502 mask or a respirator."}]}, {"title": "fcd5e4e6853426099d117e135e7a1a68", "paragraphs": [{"qas": [{"question": "What should your child do if they have a hard time breathing?", "id": "100000000000000000005685", "answers": [{"text": "continue to follow CDC guidance", "answer_start": 231}], "is_impossible": false}, {"question": "What should you consult your healthcare provider if symptoms do not resolve?", "id": "100000000000000000005688", "answers": [{"text": "They should continue to follow CDC guidance to protect themselves and others", "answer_start": 219}], "is_impossible": false}], "context": "If your child has a hard time breathing, gets dizzy, or has other symptoms while you are trying to get the mask to fit\nbetter or when using an ASTM F3502 mask or a respirator, choose a regular cloth or disposable mask. They should\ncontinue to follow CDC guidance to protect themselves and others. Consult your healthcare provider if these symptoms\ndo not resolve."}]}, {"title": "d14e0e1394eccd0892f1210899e494ad", "paragraphs": [{"qas": [{"question": "What is one of the benefits of wearing a mask?", "id": "100000000000000000005690", "answers": [{"text": "protects you", "answer_start": 158}], "is_impossible": false}, {"question": "What is an alternative type of mask that may be helpful when interacting with certain groups of people?", "id": "100000000000000000005692", "answers": [{"text": "Clear masks", "answer_start": 445}], "is_impossible": false}, {"question": "What are cloth masks with a clear plastic panel made of?", "id": "100000000000000000005693", "answers": [{"text": "Clear masks", "answer_start": 445}], "is_impossible": false}, {"question": "What kind of mask was the FDA cleared for?", "id": "100000000000000000005694", "answers": [{"text": "transparent medical mask", "answer_start": 870}], "is_impossible": false}, {"question": "What type of people need to see the proper shape of the mouth for making appropriate vowel sounds?", "id": "100000000000000000005695", "answers": [{"text": "People with disabilities", "answer_start": 724}], "is_impossible": false}], "context": "\u2022\n\u2022\n-\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:39 AM Masks and Respirators\nAlternative Masks for Special Situations\nFor more information on science behind improving how your mask protects you, see:\nEfficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols\n\u2014 United States, 2021\nMaximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission\nand Exposure, 2021\nClear masks or cloth masks with a clear plastic panel are an alternative type of\nmask that may be helpful when interacting with certain groups of people, such\nas:\nPeople who are deaf or hard of hearing\nYoung children or students learning to read\nStudents learning a new language\nPeople with disabilities\nPeople who need to see the proper shape of the mouth for making appropriate vowel sounds\nThe FDA cleared for marketing a transparent medical mask."}]}, {"title": "106786a9a8fd9e6eab14bbd39f51a0f1", "paragraphs": [{"qas": [{"question": "What should you make sure does not collect on the inside of the mask?", "id": "100000000000000000005697", "answers": [{"text": "Excess moisture", "answer_start": 63}], "is_impossible": false}, {"question": "As of September 23, 2021 Added a section on considerations for what?", "id": "100000000000000000005698", "answers": [{"text": "children", "answer_start": 218}], "is_impossible": false}, {"question": "When did minor updates to the sections on Cloth Masks and Disposable Masks occur?", "id": "100000000000000000005699", "answers": [{"text": "September 10, 2021", "answer_start": 233}], "is_impossible": false}, {"question": "What is a term for Respirators that meet international standards?", "id": "100000000000000000005700", "answers": [{"text": "KN95s", "answer_start": 446}], "is_impossible": false}, {"question": "What are NIOSH-approved respirators?", "id": "100000000000000000005701", "answers": [{"text": "N95 respirators", "answer_start": 555}], "is_impossible": false}, {"question": "How has the availability of N95 respirators increased?", "id": "100000000000000000005702", "answers": [{"text": "significantly", "answer_start": 585}], "is_impossible": false}, {"question": "What is the name of the section that has been updated in the last few months?", "id": "100000000000000000005703", "answers": [{"text": "Choosing a Mask or Respirator for Different Situations", "answer_start": 705}], "is_impossible": false}, {"question": "When was the last update for the section on Alternative Masks for Special Situations?", "id": "100000000000000000005704", "answers": [{"text": "Sept. 8, 2022", "answer_start": 965}], "is_impossible": false}], "context": "If you use this type of mask, make sure\nYou can breathe easily\nExcess moisture does not collect on the inside of the mask\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nPrevious Updates\nAs of September 23, 2021\nAdded section on considerations for children\nAs of September 10, 2021\nMade minor updates to the sections on Cloth Masks and Disposable Masks\nUpdated the section on Masks that Meet a Standard\nAdded section about Respirators that Meet International Standards (e.g., KN95s)\nAdded considerations for use of NIOSH-approved respirators because the availability of NIOSH-approved N95\nrespirators has increased significantly over the last several months\nAdded section on Alternative Masks for Special Situations\nUpdated section on Choosing a Mask or Respirator for Different Situations\nUpdates from Previous Content\n\uf1aa\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nRelated Pages\nYour Guide to Masks\n\u203a\f10/30/22, 9:39 AM Masks and Respirators\nImprove How Your Mask Protects You\n\u203a\nHow to Use Your N95 Respirator\n\u203a\nLast Updated Sept. 8, 2022"}]}, {"title": "b8d01a499de538f81b41b1e7c28122ef", "paragraphs": [{"qas": [{"question": "What is the name of the Emergency Use Instructions Fact Sheet for Recipients and Caregivers?", "id": "100000000000000000005705", "answers": [{"text": "Moderna COVID-19 Vaccine EUI Recipient Fact Sheet", "answer_start": 0}], "is_impossible": false}, {"question": "Who issued the EUI?", "id": "100000000000000000005707", "answers": [{"text": "Centers for Disease Control and Prevention (CDC)", "answer_start": 289}], "is_impossible": false}, {"question": "What is the name of the vaccine manufactured by Moderna?", "id": "100000000000000000005709", "answers": [{"text": "COVID-19", "answer_start": 8}], "is_impossible": false}], "context": "Moderna COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022\nEmergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers:\nModerna COVID-19 Vaccine for Primary and/or Additional Doses\nThis Fact Sheet describes Emergency Use Instructions (EUI) that have been issued by the Centers for\nDisease Control and Prevention (CDC) to provide information about the primary and additional doses of the\nCOVID-19 vaccine by Moderna that go beyond its FDA-approved labeling."}]}, {"title": "a768b1ab3b1a14ccf8af8d43dbd2a082", "paragraphs": [{"qas": [{"question": "What is one of the uses under EUI?", "id": "100000000000000000005710", "answers": [{"text": "longer interval between primary doses of the COVID-19 vaccine", "answer_start": 54}], "is_impossible": false}, {"question": "Who approved the use of the COVID-19 vaccine?", "id": "100000000000000000005711", "answers": [{"text": "Food and Drug Administration (FDA", "answer_start": 253}], "is_impossible": false}, {"question": "Who is responsible for the use of the Janssen (Johnson & Johnson) COVID-19 vaccine in immunocompromised individuals?", "id": "100000000000000000005712", "answers": [{"text": "Moderna", "answer_start": 119}], "is_impossible": false}, {"question": "What is the name of the vaccine used by Moderna under EUI?", "id": "100000000000000000005713", "answers": [{"text": "COVID-19", "answer_start": 99}], "is_impossible": false}], "context": "These uses under EUI include, but\nare not limited to, longer interval between primary doses of the COVID-19 vaccine by Moderna, use in\ncertain individuals who received primary vaccination with certain COVID-19 vaccines not authorized or\napproved by the Food and Drug Administration (FDA) for such use and in immunocompromised individuals\nwho received one primary dose of the Janssen (Johnson & Johnson) COVID-19 Vaccine. See below for more\ninformation on the uses of the COVID-19 vaccine by Moderna under EUI."}]}, {"title": "3359f7059d6ee9a192661952eb940956", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that Moderna or Pfizer-BioNTech can provide?", "id": "100000000000000000005714", "answers": [{"text": "COVID-19", "answer_start": 128}], "is_impossible": false}, {"question": "Who issues EUI?", "id": "100000000000000000005716", "answers": [{"text": "CDC", "answer_start": 315}], "is_impossible": false}, {"question": "What does EUI stand for?", "id": "100000000000000000005717", "answers": [{"text": "Emergency Use Instructions", "answer_start": 263}], "is_impossible": false}, {"question": "What are EUI issued by?", "id": "100000000000000000005718", "answers": [{"text": "CDC", "answer_start": 315}], "is_impossible": false}], "context": "If you are 12 years and older and you are receiving vaccination for uses provided under EUI, you have a\nchoice of receiving the COVID-19 vaccine by either Moderna or Pfizer-BioNTech (see the Pfizer-BioNTech\nEUI Fact Sheet for Recipients and Caregivers). What are Emergency Use Instructions (EUI)? EUI are issued by CDC to provide information about emergency use of FDA-approved (licensed) medical\nproducts that may not be included in or differ in some way from the information provided in the FDA-\napproved labeling (package insert). EUI consist of fact sheets for healthcare providers and recipients."}]}, {"title": "321660c366153a5f6b676ee5055dfc39", "paragraphs": [{"qas": [{"question": "What is the brand name of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005721", "answers": [{"text": "Spikevax", "answer_start": 140}], "is_impossible": false}, {"question": "What does the EUI stand for?", "id": "100000000000000000005722", "answers": [{"text": "to provide information about this vaccine for the below uses that extend beyond its FDA-approved labeling", "answer_start": 231}], "is_impossible": false}, {"question": "The EUI stands for what?", "id": "100000000000000000005723", "answers": [{"text": "to provide information about this vaccine for the below uses that extend beyond its FDA-approved labeling", "answer_start": 231}], "is_impossible": false}, {"question": "What are the uses of the COVID-19 vaccine?", "id": "100000000000000000005724", "answers": [{"text": "to prevent COVID-19 in persons ages 18 years and older. CDC is issuing EUI to provide information about this vaccine for the below uses that extend beyond its FDA-approved labeling", "answer_start": 156}], "is_impossible": false}, {"question": "What is the name of the vaccine that can be received by Moderna under the EUI?", "id": "100000000000000000005725", "answers": [{"text": "COVID-19", "answer_start": 31}], "is_impossible": false}], "context": "Why is CDC issuing EUI for the COVID-19 vaccine by Moderna? The COVID-19 vaccine by Moderna is an FDA-approved COVID-19 vaccine (brand name Spikevax, mRNA) to\nprevent COVID-19 in persons ages 18 years and older. CDC is issuing EUI to provide information about this\nvaccine for the below uses that extend beyond its FDA-approved labeling (see \u201cWho can receive primary,\nadditional, and/or booster dose(s) of the COVID-19 vaccine by Moderna under the EUI?\u201d)."}]}, {"title": "8f66197ac74b5b05161effd3fdeb0aeb", "paragraphs": [{"qas": [{"question": "What can be used as an alternative mRNA COVID-19 vaccine?", "id": "100000000000000000005726", "answers": [{"text": "The COVID-19 vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the COVID-19 vaccine by Pfizer-BioNTech under EUI?", "id": "100000000000000000005728", "answers": [{"text": "Coronavirus disease 2019", "answer_start": 327}], "is_impossible": false}, {"question": "What can a severe illness lead to?", "id": "100000000000000000005732", "answers": [{"text": "death", "answer_start": 627}], "is_impossible": false}], "context": "The COVID-19\nvaccine by Pfizer-BioNTech can also be used under EUI for similar uses as an alternative mRNA COVID-19\nvaccine (see the Pfizer-BioNTech EUI Fact Sheet for Recipients), and the same or similar recommendations\nin this EUI also apply to the use of the COVID-19 vaccine by Pfizer-BioNTech under EUI. What is COVID-19? Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a coronavirus called SARS-CoV-2. It\nis predominantly a respiratory illness that can also affect other organs. People with SARS-CoV-2 infection\nhave reported a wide range of symptoms, from no symptoms to severe illness leading to death."}]}, {"title": "553ce19789e4fe122c2a18637e6b4cd5", "paragraphs": [{"qas": [{"question": "Symptoms may appear 2 to 14 days after exposure to what virus?", "id": "100000000000000000005733", "answers": [{"text": "fever or chills, cough, shortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea", "answer_start": 84}], "is_impossible": false}, {"question": "Who can receive the primary and additional doses of the COVID-19 vaccine by Moderna under the EUI?", "id": "100000000000000000005735", "answers": [{"text": "People", "answer_start": 368}], "is_impossible": false}, {"question": "What is the name of the vaccine that Moderna can provide?", "id": "100000000000000000005736", "answers": [{"text": "COVID-19", "answer_start": 325}], "is_impossible": false}], "context": "Symptoms\nmay appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills, cough,\nshortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat,\ncongestion or runny nose, nausea or vomiting, and diarrhea. Who can receive primary and additional dose(s) of the COVID-19 vaccine by Moderna under the EUI? People who can receive the COVID-19 vaccine by Moderna under EUI are described below."}]}, {"title": "e0b29c85e2b8d9d3b51ed6a60be8e814", "paragraphs": [{"qas": [{"question": "Who is at higher risk of myocarditis?", "id": "100000000000000000005738", "answers": [{"text": "People ages 12 years and older", "answer_start": 2}], "is_impossible": false}, {"question": "When should people age 12 and older receive their second dose of vaccine?", "id": "100000000000000000005740", "answers": [{"text": "4 weeks", "answer_start": 284}], "is_impossible": false}, {"question": "How many weeks after the initial dose should people receive the second first dose of vaccination?", "id": "100000000000000000005741", "answers": [{"text": "4", "answer_start": 284}], "is_impossible": false}], "context": "\u2022 People ages 12 years and older, especially those at higher risk of myocarditis associated with mRNA\nCOVID-19 vaccines, may receive the second primary dose of the COVID-19 vaccine by Moderna 4\u20138\nweeks after the first primary dose. The second dose should not be received earlier than 4 weeks\nafter the first dose."}]}, {"title": "73c6b609b5b60678be76da67bb556a09", "paragraphs": [{"qas": [{"question": "Who may receive a second dose of SARS-CoV-2 after a deferral period of 3 months from symptom onset or positive test?", "id": "100000000000000000005742", "answers": [{"text": "People ages 12 years and older", "answer_start": 2}], "is_impossible": false}, {"question": "People ages 12 years and older who received an incomplete primary dose series may receive what?", "id": "100000000000000000005743", "answers": [{"text": "a second primary dose", "answer_start": 83}], "is_impossible": false}, {"question": "What is the first dose of a 2-dose primary series?", "id": "100000000000000000005744", "answers": [{"text": "incomplete primary dose series", "answer_start": 258}], "is_impossible": false}, {"question": "When should a recipient receive a primary dose of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005745", "answers": [{"text": "9/02/2022 Page 2 of 4 least 28 days ago", "answer_start": 458}], "is_impossible": false}], "context": "\u2022 People ages 12 years and older who recently had SARS-CoV-2 infection may receive a second\nprimary dose after a deferral period of 3 months from symptom onset or positive test (if infection\nwas asymptomatic)\n\u2022 People ages 12 years and older who received an incomplete primary dose series (only the first dose\nof a 2-dose primary series) with certain non-FDA authorized or approved COVID-19 vaccines at\fModerna COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022 Page 2 of 4\nleast 28 days ago should receive a primary dose of the COVID-19 vaccine by Moderna to complete\nthe series."}]}, {"title": "f58c82f36721e70a6c0ddab51217b83e", "paragraphs": [{"qas": [{"question": "How long ago did people receive their primary vaccination with certain non-FDA authorized or approved COVID-19 vaccines?", "id": "100000000000000000005748", "answers": [{"text": "28 days", "answer_start": 259}], "is_impossible": false}, {"question": "Who should receive an additional (third) primary dose of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005749", "answers": [{"text": "People ages 12 years and older", "answer_start": 69}], "is_impossible": false}, {"question": "What vaccine should people ages 12 years and older receive at least 28 days ago?", "id": "100000000000000000005750", "answers": [{"text": "COVID-19", "answer_start": 327}], "is_impossible": false}, {"question": "What is the third primary dose of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005751", "answers": [{"text": "o o o People ages 12 years and older who are moderately or severely immunocompromised and received their primary vaccination with certain non-FDA authorized or approved COVID-19 vaccines at least 28 days ago should receive an additional", "answer_start": 62}], "is_impossible": false}, {"question": "What should people ages 18 years and older with a moderate or severe immunocompromising condition receive at least 28 days after receiving the Janssen CoviD-19 Vaccine primary dose?", "id": "100000000000000000005752", "answers": [{"text": "an additional dose", "answer_start": 522}], "is_impossible": false}], "context": "\u2022 For people who are moderately or severely immunocompromised:\no\no\no\nPeople ages 12 years and older who are moderately or severely immunocompromised and\nreceived their primary vaccination with certain non-FDA authorized or approved COVID-19\nvaccines at least 28 days ago should receive an additional (third) primary dose of the\nCOVID-19 vaccine by Moderna. People ages 18 years and older with a moderately or severely immunocompromising\ncondition who received a primary dose of the Janssen COVID-19 Vaccine should receive an\nadditional dose with the COVID-19 vaccine by Moderna at least 28 days after receiving the\nJanssen COVID-19 Vaccine primary dose."}]}, {"title": "1a50e35676b683d748eae4e2e0af1e2a", "paragraphs": [{"qas": [{"question": "What should people who received a booster dose with an authorized COVID-19 vaccine receive at least 2 months after the booster dose?", "id": "100000000000000000005754", "answers": [{"text": "Moderna", "answer_start": 200}], "is_impossible": false}, {"question": "What is the age range of people who receive a second dose of the Janssen CoviD-19 Vaccine?", "id": "100000000000000000005755", "answers": [{"text": "12 years and older", "answer_start": 262}], "is_impossible": false}, {"question": "Who recommends that people receive an additional dose with the COVID-19 vaccine at least two months after receiving the booster?", "id": "100000000000000000005756", "answers": [{"text": "Moderna", "answer_start": 200}], "is_impossible": false}, {"question": "How old are people who have a moderate or severe immunocompromising condition?", "id": "100000000000000000005757", "answers": [{"text": "12 years and older", "answer_start": 262}], "is_impossible": false}, {"question": "What should patients with a moderate or severe immunocompromising condition receive?", "id": "100000000000000000005758", "answers": [{"text": "revaccinated with the COVID-19 vaccine", "answer_start": 454}], "is_impossible": false}, {"question": "Who should be revaccinated with the COVID-19 vaccine?", "id": "100000000000000000005759", "answers": [{"text": "People ages 12 years and older", "answer_start": 250}], "is_impossible": false}], "context": "People who already received a booster dose with\nan authorized COVID-19 vaccine after receiving the Janssen COVID-19 Vaccine primary\ndose should receive an additional dose with the COVID-19 vaccine by Moderna at least 2\nmonths after the booster dose. People ages 12 years and older with a moderately or severely immunocompromising\ncondition who received primary dose(s) of COVID-19 vaccine prior to or during certain\ntherapies (indicated below) should be revaccinated with the COVID-19 vaccine by\nModerna, regardless of which vaccine was received initially."}]}, {"title": "95658bc65bb9d06dd083f4f8f307bdc1", "paragraphs": [{"qas": [{"question": "How long after completion of the B-cell-depleting therapy is the recommended interval for starting revaccinate?", "id": "100000000000000000005761", "answers": [{"text": "6 months", "answer_start": 163}], "is_impossible": false}, {"question": "What is a hematopoietic cell transplant?", "id": "100000000000000000005762", "answers": [{"text": "HCT", "answer_start": 322}], "is_impossible": false}], "context": "\u25aa Received COVID-19 vaccine dose(s) during treatment with B-cell-depleting\ntherapies over a limited period: the suggested interval to start revaccination is\nabout 6 months after completion of the B-cell-depleting therapy\n\u25aa Received COVID-19 vaccine dose(s) prior to or during treatment with\nhematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)-T-cell\ntherapy: revaccination at least 3 months after treatment\nThe COVID-19 vaccine by Pfizer-BioNTech can also be used under EUI for similar uses in persons ages 12\nyears and older as an alternative mRNA COVID-19 vaccine (see the Pfizer-BioNTech EUI Fact Sheet for\nRecipients)."}]}, {"title": "74ead9bcacbae811fa152e2cd1640263", "paragraphs": [{"qas": [{"question": "What is a booster dose?", "id": "100000000000000000005768", "answers": [{"text": "primary", "answer_start": 72}], "is_impossible": false}, {"question": "Who should NOT get the COVID-19 vaccine by Moderna?", "id": "100000000000000000005769", "answers": [{"text": "moderately and severely immunocompromised persons", "answer_start": 187}], "is_impossible": false}], "context": "Talk to your healthcare provider about if and when you should receive a primary, additional and/or a\nbooster dose. See CDC\u2019s Interim Clinical Considerations for additional information on moderately and\nseverely immunocompromised persons recommended for an additional primary dose and populations\neligible for a booster dose. Who should NOT get the COVID-19 vaccine by Moderna?"}]}, {"title": "280365e44750fd07f4dd883d6512d94a", "paragraphs": [{"qas": [{"question": "What should you not get if you: \u2022 Had a severe allergic reaction after a previous dose of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005770", "answers": [{"text": "Tell your vaccination provider the name, number of doses, and date(s)", "answer_start": 313}], "is_impossible": false}, {"question": "What should I mention to the vaccination provider before getting the vaccine?", "id": "100000000000000000005771", "answers": [{"text": "Tell your vaccination provider the name, number of doses, and date(s) of COVID-19 vaccine(s) you received previously", "answer_start": 313}], "is_impossible": false}, {"question": "What did your provider tell your provider about the vaccine you received?", "id": "100000000000000000005774", "answers": [{"text": "the name, number of doses, and date(s", "answer_start": 344}], "is_impossible": false}], "context": "You should not get the vaccine if you:\n\u2022 Had a severe allergic reaction after a previous dose of the COVID-19 vaccine by Moderna\n\u2022 Had a severe allergic reaction to any ingredient of the COVID-19 vaccine by Moderna\nWhat should I mention to the vaccination provider before getting the COVID-19 vaccine by Moderna? Tell your vaccination provider the name, number of doses, and date(s) of COVID-19 vaccine(s) you received\npreviously."}]}, {"title": "84f000d703a4d7a39d89b5b3f907b0ec", "paragraphs": [{"qas": [{"question": "What is the term for inflammation of the heart muscle?", "id": "100000000000000000005775", "answers": [{"text": "myocarditis", "answer_start": 96}], "is_impossible": false}, {"question": "What is pericarditis?", "id": "100000000000000000005776", "answers": [{"text": "inflammation of the lining outside the heart", "answer_start": 160}], "is_impossible": false}, {"question": "Are you immunocompromised or are you on a medicine that can help you?", "id": "100000000000000000005777", "answers": [{"text": "affects your immune system", "answer_start": 324}], "is_impossible": false}, {"question": "How is the COVID-19 vaccine by Moderna given?", "id": "100000000000000000005778", "answers": [{"text": "as an injection into the muscle", "answer_start": 564}], "is_impossible": false}, {"question": "What is the name of the vaccine given as an injection?", "id": "100000000000000000005779", "answers": [{"text": "COVID-19", "answer_start": 527}], "is_impossible": false}, {"question": "What is the name of the vaccine Moderna uses?", "id": "100000000000000000005781", "answers": [{"text": "COVID-19 vaccine by Moderna is given as an injection into the muscle", "answer_start": 527}], "is_impossible": false}], "context": "Also, mention all of your medical conditions, including if you:\n\u2022 Have any allergies\n\u2022 Have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining\noutside the heart)\n\u2022 Have a fever\n\u2022 Have a bleeding disorder or are on a blood thinner\n\u2022 Are immunocompromised or are on a medicine that affects your immune system\n\u2022 Have ever fainted in association with an injection\fModerna COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022 Page 3 of 4\nHow is the COVID-19 vaccine by Moderna given? COVID-19 vaccine by Moderna is given as an injection into the muscle."}]}, {"title": "ee808d18ac83a219778293338062229", "paragraphs": [{"qas": [{"question": "When did the vaccine become available in the U.S.?", "id": "100000000000000000005784", "answers": [{"text": "December 18, 2020", "answer_start": 161}], "is_impossible": false}, {"question": "What are the risks of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005789", "answers": [{"text": "non-FDA authorized or approved COVID-19 vaccine or Janssen COVID-19 Vaccine", "answer_start": 518}], "is_impossible": false}], "context": "Has the COVID-19 vaccine by Moderna been used before? Yes. Millions of people have received this vaccine in the United States since it became available starting\nDecember 18, 2020. Also, in clinical trials, approximately 15,400 people 18 ages years and older received at\nleast 1 dose of the vaccine and approximately 2,500 people ages 12\u201317 years received a primary series of\nthe vaccine. There have been some studies in people who received the COVID-19 vaccine by Moderna after\ncompleting a primary vaccination with a non-FDA authorized or approved COVID-19 vaccine or Janssen\nCOVID-19 Vaccine. What are the risks of the COVID-19 vaccine by Moderna?"}]}, {"title": "33d76e35ac8bc79ed8316d68ce7175ff", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that Moderna uses as an extra dose?", "id": "100000000000000000005791", "answers": [{"text": "COVID-19", "answer_start": 41}], "is_impossible": false}, {"question": "What is the name of the vaccine used for primary vaccination?", "id": "100000000000000000005792", "answers": [{"text": "COVID-19", "answer_start": 41}], "is_impossible": false}, {"question": "What are the side effects of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005793", "answers": [{"text": "injection site pain, tenderness and swelling of the lymph nodes in the same arm of the injection, swelling (hardness), and redness; fatigue; headache; muscle pain; joint pain; chills; nausea and vomiting; fever; and rash", "answer_start": 365}], "is_impossible": false}], "context": "Limited data are available on use of the COVID-19 vaccine by Moderna as an additional primary dose in\npeople who completed their primary vaccination with a non-FDA authorized or approved COVID-19\nvaccine, or as an additional dose for individuals who received Janssen COVID-19 Vaccine for primary\nvaccination. Side effects of the COVID-19 vaccine by Moderna include injection site pain, tenderness and\nswelling of the lymph nodes in the same arm of the injection, swelling (hardness), and redness; fatigue;\nheadache; muscle pain; joint pain; chills; nausea and vomiting; fever; and rash."}]}, {"title": "971c1e7c74f8f6e9d6de5956b1f158b2", "paragraphs": [{"qas": [{"question": "What did some people have that affected their ability to do daily activities?", "id": "100000000000000000005795", "answers": [{"text": "side effects", "answer_start": 67}], "is_impossible": false}], "context": "Common side effects\nreported were mostly mild, but some people had side effects that affected their ability to do daily\nactivities. Cases of myocarditis and pericarditis have rarely been reported in some people. Cases have occurred\npredominantly in adolescents and young adult males within the first week after the second dose of vaccine. There is evidence from multiple sources that suggest a higher risk for myocarditis following Moderna\ncompared to Pfizer-BioNTech vaccination; however, it is not possible to directly compare the risk in people\nages 12\u201317 years."}]}, {"title": "86d1974990b3269ef1f4f7b404c7f475", "paragraphs": [{"qas": [{"question": "What is included in the package insert for Spikevax and in the EUA Fact Sheet for Recipients and Caregivers?", "id": "100000000000000000005799", "answers": [{"text": "Additional information on the common and serious side effects", "answer_start": 0}], "is_impossible": false}, {"question": "What vaccine has been shown to be effective in preventing COVID-19?", "id": "100000000000000000005801", "answers": [{"text": "COVID-19 vaccine by Moderna", "answer_start": 341}], "is_impossible": false}], "context": "Additional information on the common and serious side effects of the COVID-19 vaccine by Moderna can\nbe found in the package insert for Spikevax and in the EUA Fact Sheet for Recipients and Caregivers. Moderna COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022 Page 4 of 4\nWhat are the benefits of the COVID-19 vaccine by Moderna? The COVID-19 vaccine by Moderna has been shown in clinical studies to be effective in preventing COVID-\n19."}]}, {"title": "4a658080ff7548f1552508cf50602e98", "paragraphs": [{"qas": [{"question": "How long after the first dose does receiving a second dose of COVID-19 vaccine reduce risk of myocarditis?", "id": "100000000000000000005804", "answers": [{"text": "4\u20138 weeks", "answer_start": 69}], "is_impossible": false}, {"question": "What could improve protection against COVID-19?", "id": "100000000000000000005806", "answers": [{"text": "Primary, additional, and/or booster doses of the COVID-19 vaccine by Moderna as described under EUI may help to increase immune response in people, which could improve protection against COVID-19. Similarly, for individuals who received the Janssen Vaccine for primary vaccination, an additional primary or second booster dose of the COVID-19 vaccine", "answer_start": 213}], "is_impossible": false}, {"question": "Moderna could improve protection against what disease?", "id": "100000000000000000005808", "answers": [{"text": "myocarditis", "answer_start": 123}], "is_impossible": false}], "context": "Receiving the second primary dose of the COVID-19 vaccine by Moderna 4\u20138 weeks after the first dose\nmay reduce the risk of myocarditis and result in greater immune response and better protection against\nCOVID-19. Primary, additional, and/or booster doses of the COVID-19 vaccine by Moderna as described\nunder EUI may help to increase immune response in people, which could improve protection against\nCOVID-19. Similarly, for individuals who received the Janssen Vaccine for primary vaccination, an additional\nprimary or second booster dose of the COVID-19 vaccine by Moderna could improve protection against\nCOVID-19. The COVID-19 vaccine by Moderna may not protect everyone."}]}, {"title": "615ad3d60ca5cf567cdaba8761e3ec14", "paragraphs": [{"qas": [{"question": "What is the risk and benefit of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005809", "answers": [{"text": "Risks and Benefits of the COVID-19 vaccine by Moderna? The FDA approved the COVID-19 vaccine by Moderna to prevent COVID-19 based on safety and efficacy data available from clinical trials. Additionally, the FDA issued an Emergency Use Authorization of the COVID-19 vaccine by Moderna as an additional primary or a booster dose, determining, among other things, that the known and potential benefits of vaccination outweigh the known and potential risks of the vaccine", "answer_start": 13}], "is_impossible": false}, {"question": "What was the reason for the FDA's approval of the vaccine?", "id": "100000000000000000005810", "answers": [{"text": "to prevent COVID-19", "answer_start": 117}], "is_impossible": false}, {"question": "Who issued an Emergency Use Authorization?", "id": "100000000000000000005811", "answers": [{"text": "the FDA", "answer_start": 217}], "is_impossible": false}, {"question": "How did the FDA determine the safety and efficacy of the vaccination?", "id": "100000000000000000005812", "answers": [{"text": "clinical trials", "answer_start": 186}], "is_impossible": false}, {"question": "What does Moderna determine about the benefits of vaccination?", "id": "100000000000000000005815", "answers": [{"text": "outweigh the known and potential risks of the vaccine", "answer_start": 428}], "is_impossible": false}], "context": "What are the Risks and Benefits of the COVID-19 vaccine by Moderna? The FDA approved the COVID-19 vaccine by Moderna to prevent COVID-19 based on safety and efficacy\ndata available from clinical trials. Additionally, the FDA issued an Emergency Use Authorization of the\nCOVID-19 vaccine by Moderna as an additional primary or a booster dose, determining, among other\nthings, that the known and potential benefits of vaccination outweigh the known and potential risks of the\nvaccine."}]}, {"title": "c0bc0226ecc90c9ff4a68952e2a93eee", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine used by Moderna?", "id": "100000000000000000005816", "answers": [{"text": "COVID-19", "answer_start": 47}], "is_impossible": false}, {"question": "What could the use of the COVID-19 vaccine do?", "id": "100000000000000000005817", "answers": [{"text": "help improve or restore protection", "answer_start": 113}], "is_impossible": false}], "context": "Based on available information, the use of the COVID-19 vaccine by Moderna as described in this\nFact Sheet could help improve or restore protection that may not have been sufficient or may have\ndecreased over time after the primary vaccination. What alternative choices are available for primary and/or additional doses other than the COVID-19\nvaccine by Moderna? Currently, the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine are the only FDA-\napproved COVID-19 vaccines for which EUI provide information about primary and/or additional doses\nfollowing the COVID-19 vaccine that you received."}]}, {"title": "295ceb7472ba317feb7046f37fb1eba3", "paragraphs": [{"qas": [{"question": "What may not be available to you if you are vaccinated outside of the United States?", "id": "100000000000000000005819", "answers": [{"text": "the vaccine you initially received", "answer_start": 200}], "is_impossible": false}, {"question": "What is your choice to receive or not receive?", "id": "100000000000000000005820", "answers": [{"text": "COVID-19 vaccine", "answer_start": 312}], "is_impossible": false}, {"question": "What is your choice to receive or not receive the COVID-19 vaccine by Moderna?", "id": "100000000000000000005821", "answers": [{"text": "as a primary and/or additional dose", "answer_start": 340}], "is_impossible": false}, {"question": "What will not change your standard medical care if you decide not to receive it?", "id": "100000000000000000005822", "answers": [{"text": "COVID-19 vaccine", "answer_start": 312}], "is_impossible": false}], "context": "If vaccinated outside of the United States or through a\nclinical trial and the COVID-19 vaccine you initially received for primary vaccination is not authorized or\napproved in the United States, then the vaccine you initially received may not be available to you. It is your choice to receive or not receive the COVID-19 vaccine by Moderna as a primary and/or additional\ndose. Should you decide not to receive it, it will not change your standard medical care. Will I get a vaccination card?"}]}, {"title": "de96005b9df085709bc4649392faf86", "paragraphs": [{"qas": [{"question": "What do you get when you receive the COVID-19 vaccine from Moderna?", "id": "100000000000000000005823", "answers": [{"text": "a vaccination card", "answer_start": 116}], "is_impossible": false}, {"question": "What is the Countermeasures Injury Compensation Program?", "id": "100000000000000000005824", "answers": [{"text": "a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines", "answer_start": 329}], "is_impossible": false}, {"question": "How long must a claim be submitted to the CICP?", "id": "100000000000000000005825", "answers": [{"text": "within one (1) year", "answer_start": 576}], "is_impossible": false}], "context": "When you are administered a primary, additional, or a booster dose of the COVID-19 vaccine by Moderna,\nyou will get a vaccination card to document when you received the shot. You should keep your vaccination\ncard. What is the Countermeasures Injury Compensation Program? The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs\nof medical care and other specific expenses of certain people who have been seriously injured by certain\nmedicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one\n(1) year from the date of receiving the vaccine."}]}, {"title": "6100d6f23fe6e784762655e6f94e68b1", "paragraphs": [{"qas": [{"question": "Who can help you learn more about the cicp program?", "id": "100000000000000000005826", "answers": [{"text": "Ask the vaccination provider", "answer_start": 107}], "is_impossible": false}, {"question": "Where can you find the CDC's website?", "id": "100000000000000000005827", "answers": [{"text": "https://www.cdc.gov/coronavirus/2019-ncov/index.html", "answer_start": 152}], "is_impossible": false}, {"question": "What is the name of the website that you can visit to learn more?", "id": "100000000000000000005828", "answers": [{"text": "www.hrsa.gov", "answer_start": 40}], "is_impossible": false}], "context": "To learn more about this program, visit www.hrsa.gov/cicp/\nor call 1-855-266-2427. How can I learn more? \u2022 Ask the vaccination provider. \u2022 Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. \u2022 Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-\nand-policy-framework/emergency-use-authorization. \u2022 Contact your local or state public health department."}]}, {"title": "6c566646fc0104e56dd987264489398f", "paragraphs": [{"qas": [{"question": "What is the name of the CDC's Emergency Use Instructions for Healthcare Providers?", "id": "100000000000000000005830", "answers": [{"text": "EUI", "answer_start": 282}], "is_impossible": false}, {"question": "What is the name of the COVID-19 vaccine?", "id": "100000000000000000005832", "answers": [{"text": "Spikevax", "answer_start": 360}], "is_impossible": false}], "context": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nEmergency Use Instructions for Healthcare Providers:\nModerna COVID-19 Vaccine for Primary and/or Additional Doses\nThe Centers for Disease Control and Prevention (CDC) is issuing Emergency Use Instructions (EUI) to provide\ninformation about the use of the COVID-19 vaccine by Moderna (Spikevax), which is approved (licensed) by the\nFood and Drug Administration (FDA) for the prevention of COVID-19 in individuals ages 18 years and older.1\nThe CDC-issued EUI provide information for the use of this vaccine that are beyond the FDA-approved labeling."}]}, {"title": "186da31aa8e17121a5e617a7eec3c7d7", "paragraphs": [{"qas": [{"question": "What do the CDC-issued EUI provide information on?", "id": "100000000000000000005834", "answers": [{"text": "uses of the COVID-19 vaccine", "answer_start": 56}], "is_impossible": false}, {"question": "What is the longer interval between the first and second dose of the Moderna COVID-19 vaccine for persons ages 12 years and older?", "id": "100000000000000000005835", "answers": [{"text": "4\u20138 weeks", "answer_start": 124}], "is_impossible": false}], "context": "The CDC-issued EUI provide information on the following uses of the COVID-19 vaccine by Moderna for:\n\u2022 A longer interval of 4\u20138 weeks between the first and second primary dose of Moderna COVID-19\nvaccine for persons ages 12 years and older, particularly for individuals at higher risk of mRNA COVID-\n19 vaccine-associated myocarditis."}]}, {"title": "fdd8ae11e376145337d963be8a9a5e06", "paragraphs": [{"qas": [{"question": "How long is it necessary to delay the second dose in people with asymptomatic SARS infection?", "id": "100000000000000000005837", "answers": [{"text": "3 months", "answer_start": 112}], "is_impossible": false}, {"question": "What are some conditions that may require a secondary dose in persons with incomplete primary series?", "id": "100000000000000000005838", "answers": [{"text": "immunocompromising conditions", "answer_start": 241}], "is_impossible": false}, {"question": "What is the name of the non-FDA authorized or approved COVID-19 vaccine?", "id": "100000000000000000005839", "answers": [{"text": "Janssen (Johnson & Johnson) COVID-19 Vaccine", "answer_start": 586}], "is_impossible": false}], "context": "\u2022 Delaying the second primary dose in persons ages 12 years and older who recently had SARS-CoV-2\ninfection, by 3 months from symptom onset or positive test (if infection was asymptomatic)\n\u2022 Primary dose(s), including for those with certain immunocompromising conditions or those with\nincomplete primary series, for persons ages 12 years and older who received primary vaccination with\ncertain non-FDA authorized or approved COVID-19 vaccines2. \u2022 An additional dose in persons ages 18 years and older with certain immunocompromising conditions\nwho received primary vaccination with the Janssen (Johnson & Johnson) COVID-19 Vaccine."}]}, {"title": "9d98b3374a420a7007fd2dd4ebfcb805", "paragraphs": [{"qas": [{"question": "Who received the primary dose(s) of Covid-19 vaccine during treatment with B-cell-depleting therapies?", "id": "100000000000000000005842", "answers": [{"text": "moderately or severely immunocompromised persons ages 12 years and older", "answer_start": 19}], "is_impossible": false}, {"question": "What is another term for CAR-T-cell therapy?", "id": "100000000000000000005844", "answers": [{"text": "chimeric antigen receptor", "answer_start": 441}], "is_impossible": false}, {"question": "Pfizer-BioNTech's COVID-19 vaccine allows similar uses as what other vaccine?", "id": "100000000000000000005845", "answers": [{"text": "Moderna", "answer_start": 605}], "is_impossible": false}], "context": "\u2022 Revaccination of moderately or severely immunocompromised persons ages 12 years and older who\nreceived certain therapies (indicated below) and received primary dose(s) of COVID-19 vaccine prior to\nor during treatment. o\no\nReceived COVID-19 vaccine dose(s) during treatment with B-cell-depleting therapies over a\nlimited period\nReceived COVID-19 vaccine dose(s) prior to or during treatment involving hematopoietic cell\ntransplant (HCT) or chimeric antigen receptor (CAR)-T-cell therapy\nThe COVID-19 vaccine by Pfizer-BioNTech under EUI also allow similar uses as an alternative mRNA COVID-19\nvaccine to Moderna, and the same or similar recommendations in the EUI also apply to the use of the COVID-\n19 vaccine by Pfizer-BioNTech under EUI."}]}, {"title": "7da129c72d73e8f8adc2a3577f6ee622", "paragraphs": [{"qas": [{"question": "What does CDC's Interim Clinical Considerations provide for specific recommendations on use of the vaccine by Moderna?", "id": "100000000000000000005848", "answers": [{"text": "allowed under the EUI", "answer_start": 192}], "is_impossible": false}, {"question": "The Spikevax package insert contains information about what vaccine?", "id": "100000000000000000005849", "answers": [{"text": "COVID-19", "answer_start": 252}], "is_impossible": false}, {"question": "When was the EUA Prescribing Information issued?", "id": "100000000000000000005851", "answers": [{"text": "2022", "answer_start": 404}], "is_impossible": false}, {"question": "Who issued the EUI for the COVID-19 vaccine?", "id": "100000000000000000005852", "answers": [{"text": "CDC", "answer_start": 435}], "is_impossible": false}], "context": "See the Pfizer-BioNTech COVID-19 EUI Fact Sheet for Healthcare\nProviders. Refer to CDC\u2019s Interim Clinical Considerations for specific recommendations on use of the COVID-19 vaccine by\nModerna allowed under the EUI. For additional information about the COVID-19 vaccine by Moderna COVID-\n19, refer to the Spikevax package insert or the Full Emergency Use Authorization (EUA) Prescribing Information\n(FDA, 2022). What are EUI and why is CDC issuing EUI for the COVID-19 vaccine by Moderna?"}]}, {"title": "6328b70b8965440a33b0154c86539a06", "paragraphs": [{"qas": [{"question": "What year did the Pandemic and All-Hazards Preparedness Reauthorization Act include a new provision that allowed for the issuance of EUI to permit CDC to inform healthcare providers and recipients about certain uses of FDA-approved or cleared medical products?", "id": "100000000000000000005853", "answers": [{"text": "2013", "answer_start": 3}], "is_impossible": false}], "context": "In 2013, the Pandemic and All-Hazards Preparedness Reauthorization Act included a new provision that\nallowed for the issuance of EUI to permit CDC to inform healthcare providers and recipients about certain uses\nof FDA-approved or cleared medical products. Specifically, EUI inform healthcare providers and recipients\nabout such products\u2019 approved, licensed, or cleared conditions of use. The CDC Director has statutory (legal)\nauthority to create, issue, and disseminate EUI before or during an emergency. 1 Spikevax is the proprietary name for the product licensed under the Biologics License Application (BLA)."}]}, {"title": "1dd87d5d8de81c6c308fc3d4f1d2a0f5", "paragraphs": [{"qas": [{"question": "Since when has the Moderna COVID-19 Vaccine been available?", "id": "100000000000000000005856", "answers": [{"text": "December 18, 2020", "answer_start": 54}], "is_impossible": false}, {"question": "What is the EUA?", "id": "100000000000000000005857", "answers": [{"text": "Emergency Use Authorization", "answer_start": 85}], "is_impossible": false}, {"question": "How long has the approved formulation of Spikevax been in use?", "id": "100000000000000000005858", "answers": [{"text": "\u2265 12 years", "answer_start": 209}], "is_impossible": false}, {"question": "What does the EUI refer to this vaccine as by Moderna?", "id": "100000000000000000005860", "answers": [{"text": "COVID-19", "answer_start": 396}], "is_impossible": false}], "context": "The Moderna COVID-19 Vaccine has been\navailable since December 18, 2020, pursuant to Emergency Use Authorization (EUA). The approved formulation of Spikevax and the FDA-authorized\nModerna COVID-19 Vaccine for \u2265 12 years are the same formulation. Because of these features, and because Spikevax may be commonly referred to as\nthe \u201cModerna COVID-19 Vaccine,\u201d these EUI refer to this vaccine as the COVID-19 vaccine by Moderna."}]}, {"title": "83719aa1f49dfd9345442ac151fbcf46", "paragraphs": [{"qas": [{"question": "What is a non-FDA authorized or approved COVID-19 vaccine listed for?", "id": "100000000000000000005861", "answers": [{"text": "emergency use", "answer_start": 71}], "is_impossible": false}, {"question": "What is a non-placebo part of a clinical trial within or outside of the United States?", "id": "100000000000000000005863", "answers": [{"text": "WHO-EUL COVID-19 vaccine", "answer_start": 394}], "is_impossible": false}], "context": "2 A non-FDA authorized or approved COVID-19 vaccine that is listed for emergency use by the World Health Organization, or is included in CDC\u2019s\nTechnical Instructions for Implementing Presidential Proclamation Advancing Safe Resumption of Global Travel During the COVID-19 Pandemic and\nCDC\u2019s Order, or that is a non-placebo part of a clinical trial within or outside the United States that is a WHO-EUL COVID-19 vaccine or a vaccine that is\nnot listed for emergency use by WHO but for which a U.S. data and safety monitoring board or equivalent has independently confirmed efficacy in the\nUnited States (hereinafter \u201cnon-FDA authorized or approved COVID-19 vaccines\u201d)."}]}, {"title": "9f12a9568347dd5e969ec05d5e7b85cc", "paragraphs": [{"qas": [{"question": "When was the COVID-19 vaccine approved by the FDA?", "id": "100000000000000000005866", "answers": [{"text": "January 31, 2022", "answer_start": 135}], "is_impossible": false}, {"question": "What is the purpose of the EUIs?", "id": "100000000000000000005868", "answers": [{"text": "to provide information about use of the COVID-19 vaccine by Moderna for primary and/or additional booster that extend beyond its FDA-approved labeling", "answer_start": 284}], "is_impossible": false}, {"question": "What is the name of the vaccine manufactured by Moderna?", "id": "100000000000000000005870", "answers": [{"text": "COVID-19", "answer_start": 8}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000005871", "answers": [{"text": "2-dose primary series", "answer_start": 157}], "is_impossible": false}], "context": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nThe COVID-19 vaccine by Moderna was approved by the FDA on January 31, 2022 as a 2-dose primary series\nfor active immunization to prevent COVID-19 in persons ages 18 years and older. CDC is issuing these EUI to\nprovide information about use of the COVID-19 vaccine by Moderna for primary and/or additional booster that\nextend beyond its FDA-approved labeling as described further under \u201cWho can receive the COVID-19 vaccine\nby Moderna\u201d and \u201cWhat are the doses and intervals of the COVID-19 vaccine by Moderna for primary and/or\nadditional doses\u201d. What is COVID-19?"}]}, {"title": "d1463a6001d7b79125627be6e5ab33f2", "paragraphs": [{"qas": [{"question": "What is the name of the new coronavirus that causes Coronavirus disease 2019?", "id": "100000000000000000005872", "answers": [{"text": "SARS-CoV-2", "answer_start": 94}], "is_impossible": false}, {"question": "When did Coronavirus Disease 2019 first appear?", "id": "100000000000000000005873", "answers": [{"text": "late 2019", "answer_start": 122}], "is_impossible": false}, {"question": "What is CoronaVirus disease 2019 primarily a respiratory illness that can affect other organs?", "id": "100000000000000000005874", "answers": [{"text": "infectious disease", "answer_start": 42}], "is_impossible": false}, {"question": "How many days after exposure to the virus can symptoms appear?", "id": "100000000000000000005875", "answers": [{"text": "2 to 14", "answer_start": 342}], "is_impossible": false}, {"question": "What are symptoms of the virus?", "id": "100000000000000000005876", "answers": [{"text": "fever or chills, cough, shortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea", "answer_start": 405}], "is_impossible": false}, {"question": "What are the symptoms of COVID-19?", "id": "100000000000000000005878", "answers": [{"text": "fever or chills, cough, shortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea", "answer_start": 405}], "is_impossible": false}, {"question": "What is the name of the vaccine that Moderna offers?", "id": "100000000000000000005879", "answers": [{"text": "COVID-19", "answer_start": 612}], "is_impossible": false}], "context": "Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the novel coronavirus, SARS-CoV-2,\nthat emerged in late 2019. It is predominantly a respiratory illness that can affect other organs. People with\nSARS-CoV-2 infection have reported a wide range of symptoms, ranging from no symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include fever or chills, cough,\nshortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat,\ncongestion or runny nose, nausea or vomiting, and diarrhea. Who can receive the COVID-19 vaccine by Moderna?"}]}, {"title": "a43ba393ce41195c5305c84c03eeeea", "paragraphs": [{"qas": [{"question": "Who can receive the COVID-19 vaccine by Moderna under EUI?", "id": "100000000000000000005880", "answers": [{"text": "Persons ages 12 years and older", "answer_start": 272}], "is_impossible": false}, {"question": "Persons ages 12 years and older are particularly at risk for what?", "id": "100000000000000000005882", "answers": [{"text": "mRNA COVID-19 vaccine- associated myocarditis", "answer_start": 342}], "is_impossible": false}, {"question": "Who may receive a second dose of the COVID-19 vaccine after a longer interval of 4-8 weeks following the first primary dose?", "id": "100000000000000000005883", "answers": [{"text": "Persons ages 12 years and older", "answer_start": 272}], "is_impossible": false}], "context": "The below describes who can receive the COVID-19 vaccine by Moderna under EUI. The COVID-19 vaccine by\nPfizer-BioNTech can also be used under EUI for similar uses as an alternative mRNA COVID-19 vaccine (see the\nPfizer-BioNTech EUI Fact Sheet for Healthcare Providers). \u2022 Persons ages 12 years and older, particularly those at higher risk of mRNA COVID-19 vaccine-\nassociated myocarditis, may receive a second primary dose of the COVID-19 vaccine by Moderna after\na longer interval of 4\u20138 weeks following the first primary dose."}]}, {"title": "9a11056c0f7f6649d1abfff85db55d90", "paragraphs": [{"qas": [{"question": "Who may receive the second primary dose after a deferral period of 3 months from symptom onset or positive test (if infection was asymptomatic)?", "id": "100000000000000000005884", "answers": [{"text": "Persons ages 12 years and older", "answer_start": 2}], "is_impossible": false}, {"question": "Persons ages 12 and older who received an incomplete primary series may receive what?", "id": "100000000000000000005885", "answers": [{"text": "a primary dose of the COVID-19 vaccine by Moderna", "answer_start": 417}], "is_impossible": false}, {"question": "What is the name of the non-FDA authorized or approved COVID-19 vaccine?", "id": "100000000000000000005886", "answers": [{"text": "Moderna", "answer_start": 460}], "is_impossible": false}], "context": "\u2022 Persons ages 12 years and older who recently had SARS-CoV-2 infection may receive the second\nprimary dose after a deferral period of 3 months from symptom onset or positive test (if infection was\nasymptomatic)\n\u2022 Persons ages 12 years and older who received an incomplete primary series (e.g., only the first dose of\n2-dose primary series) with certain non-FDA authorized or approved COVID-19 vaccines should receive\na primary dose of the COVID-19 vaccine by Moderna."}]}, {"title": "99a851a9a11e38f61ceecfb4297f5a61", "paragraphs": [{"qas": [{"question": "What age group should receive an additional primary dose of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005888", "answers": [{"text": "Ages 18 years and older", "answer_start": 267}], "is_impossible": false}, {"question": "What should age 12 years and older receive?", "id": "100000000000000000005891", "answers": [{"text": "an additional primary dose of the COVID-19 vaccine by Moderna", "answer_start": 204}], "is_impossible": false}, {"question": "Who should be revaccinated with the CoviD-19 vaccine?", "id": "100000000000000000005892", "answers": [{"text": "Ages 12 years and older", "answer_start": 430}], "is_impossible": false}, {"question": "What should be revaccinated with the COVID-19 vaccine by Moderna for any doses received before or during treatment?", "id": "100000000000000000005893", "answers": [{"text": "Ages 12 years and older", "answer_start": 430}], "is_impossible": false}], "context": "\u2022 For certain moderately or severely immunocompromised persons:\no\no\no\nAges 12 years and older who received primary vaccination with certain non-FDA authorized or\napproved COVID-19 vaccines should receive an additional primary dose of the COVID-19\nvaccine by Moderna. Ages 18 years and older who received primary vaccination with the Janssen COVID-19 Vaccine\nshould receive an additional dose with the COVID-19 vaccine by Moderna. Ages 12 years and older who received certain therapies (indicated below) and received\nprimary dose(s) of COVID-19 vaccine prior to or during treatment should be revaccinated with\nthe COVID-19 vaccine by Moderna for any doses received before or during treatment."}]}, {"title": "479720cb8b781a7a72f9a69245a5f3cf", "paragraphs": [{"qas": [{"question": "What are the doses and intervals of the COVID-19 vaccine by Moderna for primary and/or additional doses?", "id": "100000000000000000005894", "answers": [{"text": "100 \u03bcg in 0.5 mL", "answer_start": 374}], "is_impossible": false}, {"question": "How long after the first primary dose of the COVID-19 vaccine should the second primary dose be given?", "id": "100000000000000000005895", "answers": [{"text": "4\u20138 weeks", "answer_start": 510}], "is_impossible": false}, {"question": "Who makes the vaccines?", "id": "100000000000000000005898", "answers": [{"text": "Moderna", "answer_start": 269}], "is_impossible": false}, {"question": "In what form is the vaccine manufactured?", "id": "100000000000000000005899", "answers": [{"text": "red-capped multidose vial", "answer_start": 396}], "is_impossible": false}], "context": "\u25aa Received COVID-19 vaccine dose(s) during treatment with B-cell-depleting therapies\nover a limited period\n\u25aa Received COVID-19 vaccine dose(s) prior to or during treatment involving HCT or CAR-\nT-cell therapy\nWhat are the doses and intervals of the COVID-19 vaccine by Moderna for primary and/or additional doses? \u2022 A second primary dose of the COVID-19 vaccine by Moderna (100 \u03bcg in 0.5 mL from red-capped\nmultidose vial) should be administered intramuscularly to persons ages 12 years and older; this may be\n4\u20138 weeks after the first primary dose."}]}, {"title": "f7b186d8e28ed7e7e4a801e441b13680", "paragraphs": [{"qas": [{"question": "How many weeks after the first dose is the approved interval?", "id": "100000000000000000005900", "answers": [{"text": "4", "answer_start": 25}], "is_impossible": false}, {"question": "What may be optimal for some people?", "id": "100000000000000000005901", "answers": [{"text": "8- week interval", "answer_start": 62}], "is_impossible": false}], "context": "The approved interval is 4 weeks after the first dose, but an 8-\nweek interval may be optimal for some people."}]}, {"title": "9603684575703ec666611a674d5326ed", "paragraphs": [{"qas": [{"question": "How long may a second dose of the COVID-19 vaccine be delayed?", "id": "100000000000000000005902", "answers": [{"text": "3 months", "answer_start": 127}], "is_impossible": false}, {"question": "What should be administered intramuscularly to persons ages 12 years and older at least 28 days after primary vaccination with certain non-FDA authorized or approved COVID-19 vaccines?", "id": "100000000000000000005906", "answers": [{"text": "A primary dose, including as an additional primary dose for those with certain immunocompromising conditions, of the COVID-19 vaccine", "answer_start": 355}], "is_impossible": false}], "context": "\u2022 A second primary dose of the COVID-19 vaccine by Moderna (100 \u03bcg in 0.5 mL from red-capped\nmultidose vial) may be delayed by 3 months from symptom onset or positive test (if infection was\nasymptomatic) in persons ages 12 years and older who recently had SARS-CoV-2 infection\fModerna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\n\u2022 A primary dose, including as an additional primary dose for those with certain immunocompromising\nconditions, of the COVID-19 vaccine by Moderna (100 \u03bcg in 0.5 mL from red-capped multidose vial)\nshould be administered intramuscularly to persons ages 12 years and older at least 28 days after\nprimary vaccination with certain non-FDA authorized or approved COVID-19 vaccines."}]}, {"title": "d55ac82c4a5527830e1449f14aa1a7a4", "paragraphs": [{"qas": [{"question": "How long after a primary dose of the Janssen COVID- 19 Vaccine should an additional dose be given?", "id": "100000000000000000005907", "answers": [{"text": "28 days", "answer_start": 235}], "is_impossible": false}, {"question": "How many doses of the COVID-19 vaccine should be given intramuscularly for persons ages 18 and older with certain immunocompromising conditions?", "id": "100000000000000000005908", "answers": [{"text": "100 \u03bcg in 0.5 mL from red-capped multidose vial) should be administered intramuscularly for persons ages 18 years and older with certain immunocompromising conditions at least 28 days", "answer_start": 59}], "is_impossible": false}], "context": "\u2022 An additional dose with the COVID-19 vaccine by Moderna (100 \u03bcg in 0.5 mL from red-capped\nmultidose vial) should be administered intramuscularly for persons ages 18 years and older with\ncertain immunocompromising conditions at least 28 days after a primary dose with the Janssen COVID-\n19 Vaccine (e.g., 1 primary dose of the Janssen COVID-19 Vaccine followed by an additional dose with\nan mRNA COVID-19 vaccine at least 28 days after the primary dose)."}]}, {"title": "612bd8ce839b1f7e6f5ef70ed0aa8f6e", "paragraphs": [{"qas": [{"question": "How many g in 0.5 mL from red-capped bottles of moderna vaccine?", "id": "100000000000000000005912", "answers": [{"text": "100 \u03bcg", "answer_start": 268}], "is_impossible": false}, {"question": "What is the dose of the COVID-19 vaccine by Moderna?", "id": "100000000000000000005913", "answers": [{"text": "100 \u03bcg in 0.5 mL from red-capped multidose vial", "answer_start": 268}], "is_impossible": false}, {"question": "What is recommended for persons ages 12 and older?", "id": "100000000000000000005915", "answers": [{"text": "Revaccination with the COVID-19 vaccine", "answer_start": 361}], "is_impossible": false}], "context": "People who received both 1\nprimary dose and 1 booster dose of the Janssen COVID-19 Vaccine or 1 primary dose of the Janssen\nCOVID-19 Vaccine followed by 1 booster dose of an mRNA COVID-19 vaccine should receive an\nadditional dose with the COVID-19 vaccine by Moderna (100 \u03bcg in 0.5 mL from red-capped multidose\nvial) at least 2 months after the booster dose. \u2022 Revaccination with the COVID-19 vaccine by Moderna for any primary doses received before or during\ntreatment with certain therapies (indicated below) for persons ages 12 years and older."}]}, {"title": "4831277fa5421d4483651c6fc206f73b", "paragraphs": [{"qas": [{"question": "What is the suggested interval to start revaccination?", "id": "100000000000000000005916", "answers": [{"text": "about 6 months", "answer_start": 159}], "is_impossible": false}, {"question": "How long after the completion of the B-cell-depleting therapy is the recommended interval?", "id": "100000000000000000005917", "answers": [{"text": "6 months", "answer_start": 165}], "is_impossible": false}, {"question": "What does CDC recommend after receiving the COVID-19 vaccine?", "id": "100000000000000000005918", "answers": [{"text": "revaccination at least 3 months", "answer_start": 318}], "is_impossible": false}, {"question": "Refer to CDC's Interim Clinical Considerations for specific and the latest dosing recommendations?", "id": "100000000000000000005920", "answers": [{"text": "o o", "answer_start": 0}], "is_impossible": false}], "context": "o\no\nReceived COVID-19 vaccine dose(s) during treatment with B-cell-depleting therapies over a\nlimited period: the suggested interval to start revaccination is about 6 months after\ncompletion of the B-cell-depleting therapy\nReceived COVID-19 vaccine dose(s) prior to or during treatment with HCT or CAR-T-cell\ntherapy: revaccination at least 3 months after treatment\nRefer to CDC\u2019s Interim Clinical Considerations for specific and the latest dosing recommendations (e.g., number\nof doses, dosing intervals, revaccination) that may vary for individuals with certain medical conditions and/or in\ncertain circumstances, which differ from or extend beyond the FDA-authorized and/or FDA-approved labeling."}]}, {"title": "eeeac3d0833410ffd405d4e54c52a490", "paragraphs": [{"qas": [{"question": "What are the latest dosing recommendations for COVID-19?", "id": "100000000000000000005921", "answers": [{"text": "Table 3 COVID-19 vaccination schedule for moderately or severely immunocompromised people in CDC\u2019s Interim Clinical Considerations", "answer_start": 4}], "is_impossible": false}, {"question": "What is the age limit for administering the COVID-19 vaccine by Moderna outside of the FDA-authorized or FDA-approved?", "id": "100000000000000000005922", "answers": [{"text": "12 years and older", "answer_start": 275}], "is_impossible": false}, {"question": "What are the dosing intervals for the COVID-19 vaccine based on?", "id": "100000000000000000005924", "answers": [{"text": "clinical judgment", "answer_start": 442}], "is_impossible": false}, {"question": "When is the benefit of vaccination deemed to outweigh the potential and unknown risks?", "id": "100000000000000000005925", "answers": [{"text": "when the benefits of vaccination are deemed to outweigh the potential and unknown risks for the recipient", "answer_start": 460}], "is_impossible": false}], "context": "See Table 3 COVID-19 vaccination schedule for moderately or severely immunocompromised people in CDC\u2019s\nInterim Clinical Considerations for the latest dosing recommendations. On a case-by-case basis, providers of\nmoderately or severely immunocompromised patients who are ages 12 years and older may administer the\nCOVID-19 vaccine by Moderna outside of the FDA-authorized or FDA-approved labeling and CDC recommended\ndosing intervals based on clinical judgment when the benefits of vaccination are deemed to outweigh the\npotential and unknown risks for the recipient. What are the formulations of the COVID-19 vaccine by Moderna that these EUI apply to?"}]}, {"title": "42edf0fbf8d69352aa6ea46593df7892", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine manufactured by Moderna?", "id": "100000000000000000005926", "answers": [{"text": "COVID-19", "answer_start": 53}], "is_impossible": false}, {"question": "How many mL of vaccine does Moderna's COVID-19 vaccine contain?", "id": "100000000000000000005927", "answers": [{"text": "5.5 or 7.5 mL", "answer_start": 133}], "is_impossible": false}, {"question": "When was the EUA and FDA-licensed under BLA licensed?", "id": "100000000000000000005931", "answers": [{"text": "January 31, 2022", "answer_start": 303}], "is_impossible": false}, {"question": "What is the primary dose of the vaccine in 0.5 mL?", "id": "100000000000000000005932", "answers": [{"text": "100 \u03bcg", "answer_start": 362}], "is_impossible": false}, {"question": "How many doses does the vaccine provide in the booster dose?", "id": "100000000000000000005933", "answers": [{"text": "50 \u03bcg in 0.25 mL", "answer_start": 399}], "is_impossible": false}, {"question": "Multidose vials have the same formulation and can be used interchangeably without presenting any safety or effectiveness concerns?", "id": "100000000000000000005935", "answers": [{"text": "FDA has explained that the FDA-approved Spikevax", "answer_start": 418}], "is_impossible": false}], "context": "The EUI apply to the FDA-approved formulation of the COVID-19 vaccine by Moderna (supplied in a red-capped\nmultidose vial containing 5.5 or 7.5 mL of vaccine). The formulation supplied in a red-capped multidose vial is\nthe same formulation that is FDA-authorized under EUA and FDA-licensed under BLA on January 31, 2022. This\nformulation provides primary doses (100 \u03bcg in 0.5 mL) and booster doses (50 \u03bcg in 0.25 mL). FDA has\nexplained that the FDA-approved Spikevax and the EUA-authorized Moderna COVID-19 Vaccine supplied in\nred-capped multidose vials have the same formulation and can be used interchangeably without presenting\nany safety or effectiveness concerns."}]}, {"title": "1d7866fa1ee30f10d8ad4007e4f2f605", "paragraphs": [{"qas": [{"question": "What is supplied in a multiple-dose vial with a dark blue cap and a label with gray border?", "id": "100000000000000000005937", "answers": [{"text": "Moderna COVID-19 Vaccine, Bivalent", "answer_start": 28}], "is_impossible": false}, {"question": "What is the name of the vaccine manufactured by Moderna?", "id": "100000000000000000005938", "answers": [{"text": "COVID-19 Vaccine, Bivalent", "answer_start": 36}], "is_impossible": false}, {"question": "What are some of the side effects of the COVID-19 vaccine?", "id": "100000000000000000005939", "answers": [{"text": "injection site pain, fatigue, headache, muscle pain, joint pain, chills, nausea, vomiting, axillary swelling/tenderness, fever, injection site swelling, injection site redness, and rash", "answer_start": 398}], "is_impossible": false}, {"question": "What are two possible side effects of the COVID-19 vaccine?", "id": "100000000000000000005940", "answers": [{"text": "injection site pain, fatigue, headache, muscle pain, joint pain, chills, nausea, vomiting, axillary swelling/tenderness, fever, injection site swelling, injection site redness, and rash", "answer_start": 398}], "is_impossible": false}], "context": "The EUI do not apply to the Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5), which is\nsupplied in a multiple-dose vial with a dark blue cap and a label with a gray border. What are the common side effects with the COVID-19 vaccine by Moderna? Adverse reactions following administration of the vaccine that have been reported in clinical trials and/or post\nauthorization include injection site pain, fatigue, headache, muscle pain, joint pain, chills, nausea, vomiting,\naxillary swelling/tenderness, fever, injection site swelling, injection site redness, and rash. What are possible serious side effects with the COVID-19 vaccine by Moderna?"}]}, {"title": "d3968154498ced594150c18a16876036", "paragraphs": [{"qas": [{"question": "What is the name of the Vaccine EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000005941", "answers": [{"text": "Moderna COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "What age group has the highest risk of myocarditis?", "id": "100000000000000000005942", "answers": [{"text": "males 18 through 24 years of age", "answer_start": 315}], "is_impossible": false}, {"question": "What is the age range of the COVID-19 vaccine?", "id": "100000000000000000005943", "answers": [{"text": "under 40 years of age", "answer_start": 484}], "is_impossible": false}], "context": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nAnaphylaxis and other severe allergic reactions, myocarditis, pericarditis, and syncope have been reported\nfollowing administration of the vaccine outside of clinical trials. The observed risk of myocarditis and\npericarditis is highest in males 18 through 24 years of age. Some observational analyses of postmarketing data\nsuggest that there may be an increased risk of myocarditis and pericarditis in males under 40 years of age\nfollowing the second dose of the COVID-19 vaccine by Moderna relative to other authorized or approved\nmRNA COVID-19 vaccines."}]}, {"title": "64a0218e45732c78ee7b566dc7fb502e", "paragraphs": [{"qas": [{"question": "What is limited in postmarketing data following a booster dose of mRNA vaccines?", "id": "100000000000000000005945", "answers": [{"text": "myocarditis risk", "answer_start": 119}], "is_impossible": false}, {"question": "What does available evidence suggest about a lower myocarditis risk following booster dose?", "id": "100000000000000000005946", "answers": [{"text": "lower myocarditis risk following a booster dose relative to the risk following the primary series second dose", "answer_start": 113}], "is_impossible": false}, {"question": "Who should not receive the COVID-19 vaccine by Moderna?", "id": "100000000000000000005947", "answers": [{"text": "myocarditis", "answer_start": 119}], "is_impossible": false}], "context": "Although postmarketing data following a booster dose of mRNA vaccines are\nlimited, available evidence suggests a lower myocarditis risk following a booster dose relative to the risk\nfollowing the primary series second dose. Who should not receive the COVID-19 vaccine by Moderna?"}]}, {"title": "3bc48e874fdffbd0ba69f90470209ba2", "paragraphs": [{"qas": [{"question": "Do not administer the COVID-19 vaccine to persons with a known history of a severe allergic reaction to a previous dose or any component of the vaccine?", "id": "100000000000000000005948", "answers": [{"text": "Contraindications, and Warnings and Precautions sections in the Spikevax package insert or Full EUA Prescribing Information", "answer_start": 186}], "is_impossible": false}, {"question": "What section of the Spikevax package insert contains warnings and precautions?", "id": "100000000000000000005949", "answers": [{"text": "Contraindications, and Warnings", "answer_start": 186}], "is_impossible": false}, {"question": "What should be provided to persons receiving a primary or additional dose of the COVID-19 vaccine by Moderna as described in the EUI?", "id": "100000000000000000005950", "answers": [{"text": "Provide the EUI Fact Sheet for Recipients and Caregivers", "answer_start": 622}], "is_impossible": false}, {"question": "What does the EUI provide for recipients and caregivers?", "id": "100000000000000000005952", "answers": [{"text": "Fact Sheet", "answer_start": 638}], "is_impossible": false}], "context": "Do not administer the COVID-19 vaccine by Moderna to persons with known history of a severe allergic reaction\n(e.g., anaphylaxis) to a previous dose or any component of the vaccine (see Contraindications, and Warnings\nand Precautions sections in the Spikevax package insert or Full EUA Prescribing Information as well as CDC\u2019s\nInterim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United\nStates for additional considerations). What information should be provided to persons receiving a primary or additional dose of the COVID-19\nvaccine by Moderna as described in the EUI? \u2022 Provide the EUI Fact Sheet for Recipients and Caregivers."}]}, {"title": "961b1c9a33b8a62d5624249883ed331a", "paragraphs": [{"qas": [{"question": "What is the name of the CDC's COVID-19 Vaccination Record Card?", "id": "100000000000000000005953", "answers": [{"text": "by Moderna", "answer_start": 209}], "is_impossible": false}, {"question": "What does Moderna do with the lot number and date of administration of the vaccine?", "id": "100000000000000000005954", "answers": [{"text": "Provide a CDC COVID-19 Vaccination Record Card", "answer_start": 2}], "is_impossible": false}, {"question": "What is v-safe?", "id": "100000000000000000005956", "answers": [{"text": "a voluntary smartphone-based tool that uses text messaging and web surveys to check in with people who have been vaccinated to identify potential side effects after COVID- 19 vaccination", "answer_start": 363}], "is_impossible": false}, {"question": "What does CDC monitor?", "id": "100000000000000000005958", "answers": [{"text": "safety of COVID-19 vaccines", "answer_start": 599}], "is_impossible": false}, {"question": "What is the name of the website that provides information on the safety of COVID-19 vaccines?", "id": "100000000000000000005959", "answers": [{"text": "www.cdc.gov/vsafe", "answer_start": 657}], "is_impossible": false}], "context": "\u2022 Provide a CDC COVID-19 Vaccination Record Card to the recipient or their caregiver with the lot number\nand date of administration recorded for the primary, additional, or booster dose of the COVID-19 vaccine\nby Moderna. \u2022 Provide the v-safe information sheet to vaccine recipients/caregivers and encourage vaccine recipients\nto participate in v-safe. V-safe is a voluntary smartphone-based tool that uses text messaging and web\nsurveys to check in with people who have been vaccinated to identify potential side effects after COVID-\n19 vaccination. V-safe asks questions that help CDC monitor the safety of COVID-19 vaccines. For more\ninformation, visit: www.cdc.gov/vsafe."}]}, {"title": "b00d48381af2270901d7bd14fe1b8b3", "paragraphs": [{"qas": [{"question": "What has not systematically evaluated the safety, immunogenicity, and efficacy of an additional dose of the vaccine?", "id": "100000000000000000005961", "answers": [{"text": "CDC", "answer_start": 202}], "is_impossible": false}, {"question": "Moderna provides an additional dose of the COVID-19 vaccine after receiving a primary vaccination with a non-FDA authorized or approved vaccine?", "id": "100000000000000000005962", "answers": [{"text": "CDC has not systematically evaluated", "answer_start": 202}], "is_impossible": false}, {"question": "What is the most evidence of using a booster dose after primary vaccination?", "id": "100000000000000000005963", "answers": [{"text": "COVID-19 vaccine by Moderna for additional primary doses in people who received a primary vaccination with non-FDA authorized or approved COVID- CDC has not systematically evaluated the safety, immunogenicity, and efficacy of an additional dose of the COVID-19 vaccine by Moderna following receipt of primary vaccination with a non-FDA authorized or approved COVID-19 vaccine", "answer_start": 57}], "is_impossible": false}], "context": "What is the available supporting evidence for use of the COVID-19 vaccine by Moderna for additional\nprimary doses in people who received a primary vaccination with non-FDA authorized or approved COVID-\nCDC has not systematically evaluated the safety, immunogenicity, and efficacy of an additional dose of the\nCOVID-19 vaccine by Moderna following receipt of primary vaccination with a non-FDA authorized or approved\nCOVID-19 vaccine. Most evidence is with use of a booster dose after primary vaccination."}]}, {"title": "9bc64bc2bcfffca49695499f4769304d", "paragraphs": [{"qas": [{"question": "What are IgG and neutralizing antibodies?", "id": "100000000000000000005966", "answers": [{"text": "binding", "answer_start": 327}], "is_impossible": false}, {"question": "How many months earlier was an mRNA vaccine used?", "id": "100000000000000000005967", "answers": [{"text": "3", "answer_start": 300}], "is_impossible": false}, {"question": "What were levels of binding (IgG) and neutralizing antibodies?", "id": "100000000000000000005968", "answers": [{"text": "higher", "answer_start": 419}], "is_impossible": false}], "context": "Studies of COVID-19\nvaccine boosting in the United Kingdom have shown that a third dose of AstraZeneca, Moderna, or Pfizer-\nBioNTech COVID-19 vaccines successfully boosted immune responses in people who had been primed with\ntwo doses of Pfizer-BioNTech or AstraZeneca COVID-19 vaccines approximately 3 months earlier. Levels of\nbinding (IgG) and neutralizing antibodies, including against Delta variant, were generally higher when an mRNA\nvaccine was used as either a heterologous or homologous boost (Munro et al., 2021))."}]}, {"title": "7cc4f9ff58eede95b5747f07ae2cf178", "paragraphs": [{"qas": [{"question": "What was the most reactogenic of all mRNA vaccines?", "id": "100000000000000000005969", "answers": [{"text": "COVID-19", "answer_start": 257}], "is_impossible": false}, {"question": "WHO\u2019s Strategic Advisory Group of Experts on Immunization has noted that data are currently limited on the safety, immunogenicity, and effectiveness of what?", "id": "100000000000000000005972", "answers": [{"text": "heterologous versus homologous additional doses", "answer_start": 500}], "is_impossible": false}, {"question": "Evidence suggests that use of a heterologous vaccine for an additional dose may be safe and effective?", "id": "100000000000000000005973", "answers": [{"text": "more immunogenic", "answer_start": 641}], "is_impossible": false}, {"question": "What may be more immunogenic than a homologous series of vaccines?", "id": "100000000000000000005974", "answers": [{"text": "heterologous vaccine", "answer_start": 590}], "is_impossible": false}], "context": "Frequencies of local and\nsystemic adverse reactions in the 7 days post booster vaccination were higher with heterologous than\nhomologous boosters and in those aged under 70 years when compared to older recipients. Among all mRNA\nvaccines, the 100 microgram COVID-19 vaccine by Moderna was the most reactogenic (Munro et al., 2021). WHO\u2019s Strategic Advisory Group of Experts (SAGE) on Immunization has noted that although data are currently\nlimited on the safety, immunogenicity, and effectiveness of heterologous versus homologous additional doses,\nevolving evidence suggests that use of a heterologous vaccine for an additional dose may be more\nimmunogenic than a homologous series."}]}, {"title": "7947b28018d3446d5c5a7671ea88931c", "paragraphs": [{"qas": [{"question": "Who has advised countries to consider heterologous additional doses based on supply availability?", "id": "100000000000000000005975", "answers": [{"text": "WHO", "answer_start": 215}], "is_impossible": false}, {"question": "What is the WHO recommendation for an additional dose in certain immunocompromised people?", "id": "100000000000000000005976", "answers": [{"text": "2-dose primary series, WHO has advised that countries can consider heterologous additional doses based on supply availability", "answer_start": 192}], "is_impossible": false}, {"question": "How many countries are using boosters after non-FDA approved or approved COVID-19 vaccines?", "id": "100000000000000000005977", "answers": [{"text": "More than 80", "answer_start": 415}], "is_impossible": false}], "context": "In its recommendations for an additional dose in certain\nimmunocompromised people and in people aged 60 years and over who received Sinopharm BIBP or Sinovac-\nCoronaVac COVID-19 vaccines as a 2-dose primary series, WHO has advised that countries can consider\nheterologous additional doses based on supply availability (WHO SAGE, 2021a-c). Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nMore than 80 countries are using boosters after non-FDA authorized or approved COVID-19 vaccines."}]}, {"title": "84758391539a84fd83599665b4c5927a", "paragraphs": [{"qas": [{"question": "Which countries recommend an additional primary series and/or booster dose based on their reviews of available data?", "id": "100000000000000000005979", "answers": [{"text": "the United Kingdom (JCVI, 2021a-b), Canada (National Advisory Committee on Vaccination, 2021), Germany, and France", "answer_start": 18}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000005980", "answers": [{"text": "epidemiology", "answer_start": 358}], "is_impossible": false}], "context": "Countries such as the United Kingdom (JCVI, 2021a-b), Canada (National Advisory Committee on Vaccination,\n2021), Germany, and France have recommended heterologous dosing, including with use of the Moderna\nCOVID-19 vaccine, for an additional primary series and/or booster dose based on their reviews of available\nimmunological and safety data, as well as the epidemiology of COVID-19 and other contextual factors."}]}, {"title": "b3690b41cd13e5ac7275542d1e0aa57a", "paragraphs": [{"qas": [{"question": "How much mRNA does the Moderna COVID-19 Vaccine contain?", "id": "100000000000000000005982", "answers": [{"text": "0.25 mL [50 \u03bcg", "answer_start": 45}], "is_impossible": false}, {"question": "How is the effectiveness of a booster dose determined from immunogenicity data?", "id": "100000000000000000005984", "answers": [{"text": "Effectiveness of a Moderna COVID-19 Vaccine (0.25 mL [50 \u03bcg of mRNA]) booster dose in individuals who completed primary vaccination with another authorized or approved COVID-19 vaccine (homologous or heterologous booster dose) is inferred from immunogenicity data supporting effectiveness", "answer_start": 0}], "is_impossible": false}, {"question": "Where was the Phase 1/2 open-label clinical trial conducted?", "id": "100000000000000000005987", "answers": [{"text": "United States", "answer_start": 553}], "is_impossible": false}], "context": "Effectiveness of a Moderna COVID-19 Vaccine (0.25 mL [50 \u03bcg of mRNA]) booster dose in individuals who\ncompleted primary vaccination with another authorized or approved COVID-19 vaccine (homologous or\nheterologous booster dose) is inferred from immunogenicity data supporting effectiveness of a Moderna\nCOVID-19 Vaccine (0.25 mL [50 \u03bcg of mRNA]) booster dose administered following completion of a Moderna\nCOVID-19 Vaccine primary series and from immunogenicity data from an independent Phase 1/2 open-label\nclinical trial (NCT04889209) conducted in the United States that evaluated a booster dose (0.5 mL [100 \u03bcg of\nmRNA]) of the Moderna COVID-19 Vaccine."}]}, {"title": "52c4ac1005af8269b93508226e1411c4", "paragraphs": [{"qas": [{"question": "What was the range of 12 to 20 weeks for adults who had no history of SARS-CoV-2 infection?", "id": "100000000000000000005989", "answers": [{"text": "12 weeks (range 12 to 20 weeks) prior to enrollment", "answer_start": 232}], "is_impossible": false}, {"question": "What was the ratio of the vaccines given to those who had no history of SARS-CoV-2 infection?", "id": "100000000000000000005991", "answers": [{"text": "1:1:1", "answer_start": 352}], "is_impossible": false}], "context": "In this study, adults who had completed primary vaccination with a\nModerna COVID-19 Vaccine 2-dose series (N=151), a Janssen COVID-19 Vaccine single dose (N=156), or a\nPfizer-BioNTech COVID-19 Vaccine 2-dose series (N=151) at least 12 weeks (range 12 to 20 weeks) prior to\nenrollment and who reported no history of SARS-CoV-2 infection were randomized 1:1:1 to receive a booster\ndose of one of three vaccines: Moderna COVID-19 Vaccine, Janssen COVID-19 Vaccine, or Pfizer-BioNTech\nCOVID-19 Vaccine."}]}, {"title": "3658d5eec6c958880730bc5717688f0f", "paragraphs": [{"qas": [{"question": "On Day 15, what was the response to the Moderna COVID-19 Vaccine?", "id": "100000000000000000005994", "answers": [{"text": "booster", "answer_start": 267}], "is_impossible": false}, {"question": "What is the dose of Moderna COVID-19 Vaccine?", "id": "100000000000000000005995", "answers": [{"text": "0.5 mL", "answer_start": 317}], "is_impossible": false}, {"question": "What was demonstrated regardless of primary vaccination?", "id": "100000000000000000005996", "answers": [{"text": "A booster response to the Moderna COVID-19 Vaccine", "answer_start": 265}], "is_impossible": false}], "context": "Neutralizing antibody titers, as measured by a pseudovirus neutralization assay using a\nlentivirus expressing the SARS-CoV-2 Spike protein with D614G mutation, were assessed on Day 1 prior to\nadministration of the booster dose and on Day 15 after the booster dose. A booster response to the Moderna\nCOVID-19 Vaccine (0.5 mL [100 \u03bcg of mRNA]) was demonstrated regardless of primary vaccination. Recent studies indicate that additional doses in people who are moderately or severely immunocompromised\nare safe and can increase antibody response."}]}, {"title": "1f3a19713c2790a34e04a208241595ef", "paragraphs": [{"qas": [{"question": "How long after a 3rd dose does a 4th mRNA dose last?", "id": "100000000000000000005997", "answers": [{"text": "1\u20132 months", "answer_start": 154}], "is_impossible": false}, {"question": "When did the NIH mix-and-match study demonstrate safety and immunogenicity of a booster dose in the general population?", "id": "100000000000000000005999", "answers": [{"text": "when administered at intervals as short as 3 months", "answer_start": 407}], "is_impossible": false}], "context": "Small studies in solid organ transplant recipients in Toulouse,\nStrasbourg, and Baltimore demonstrate immunogenicity of a 4th mRNA dose when administered 1\u20132 months\nafter the 3rd dose (Kamar et al., 2021; Benotmane et al., preprint; Alejo et al., 2021). Multiple studies,\nincluding COV-BOOST and the NIH mix-and-match study demonstrated safety and immunogenicity of a booster\ndose in the general population when administered at intervals as short as 3 months following a 2-dose primary\nseries (Munro et al., 2021; Atmar et al., preprint). Finally, multiple countries have implemented booster doses\nat least 3 months after primary vaccination in the general population (e.g., UK, Germany, Netherlands)."}]}, {"title": "a05d1dac5f838d06416cab02d8ced4f8", "paragraphs": [{"qas": [{"question": "What is the length of the interval between the first and second dose of the mRNA vaccine?", "id": "100000000000000000006002", "answers": [{"text": "8 weeks", "answer_start": 74}], "is_impossible": false}, {"question": "What may reduce the risk of myocarditis and result in greater immunogenicity and effectiveness?", "id": "100000000000000000006003", "answers": [{"text": "an interval longer than 4 weeks between primary series doses", "answer_start": 189}], "is_impossible": false}, {"question": "What may be limited by delaying the second dose beyond an interval of 8 weeks?", "id": "100000000000000000006005", "answers": [{"text": "the benefit", "answer_start": 433}], "is_impossible": false}], "context": "What is the available supporting evidence for a longer/extended interval (8 weeks) between the first and\nsecond dose in the mRNA vaccine primary series schedule? New evidence suggests that an interval longer than 4 weeks between primary series doses may reduce the risk\nof myocarditis and result in greater immunogenicity and effectiveness, such that there may be greater benefits\nand fewer risks with this dosing interval; however, the benefit of delaying the second dose beyond an interval\nof 8 weeks may be limited."}]}, {"title": "3aaecdf33deffb9b0f5f536685432f50", "paragraphs": [{"qas": [{"question": "What does VE stand for?", "id": "100000000000000000006006", "answers": [{"text": "vaccine effectiveness", "answer_start": 74}], "is_impossible": false}, {"question": "How long is the interval between the first and second dose of the mRNA primary series?", "id": "100000000000000000006007", "answers": [{"text": "longer", "answer_start": 113}], "is_impossible": false}, {"question": "What was higher after an extended dosing interval?", "id": "100000000000000000006008", "answers": [{"text": "Neutralizing antibody titers", "answer_start": 193}], "is_impossible": false}, {"question": "What is the standard 3-4 week interval for vaccines?", "id": "100000000000000000006009", "answers": [{"text": "2021; Grunau 2021; Amirthalingam, 2021; Parry, 2022", "answer_start": 353}], "is_impossible": false}, {"question": "What was the standard interval for vaccinations in 2021?", "id": "100000000000000000006010", "answers": [{"text": "3\u20134 week", "answer_start": 327}], "is_impossible": false}], "context": "Several studies provide evidence that indicate greater immunogenicity and vaccine effectiveness (VE) following\na longer interval between the first and second dose of the mRNA primary series. \u2022 Neutralizing antibody titers were higher following an extended dosing (6-14 weeks) interval with\nmRNA vaccine, compared to a standard 3\u20134 week interval (Payne, 2021; Grunau 2021; Amirthalingam,\n2021; Parry, 2022)."}]}, {"title": "a97eb644265b8733f5c89ec26114d784", "paragraphs": [{"qas": [{"question": "How long did the Pfizer-BioNTech COVID-19 Vaccine last?", "id": "100000000000000000006011", "answers": [{"text": "6\u201314 week", "answer_start": 206}], "is_impossible": false}, {"question": "What was the duration of the extended dosing interval?", "id": "100000000000000000006012", "answers": [{"text": "6\u201314 week", "answer_start": 206}], "is_impossible": false}, {"question": "How many weeks after the second dose did people who received the Ppfizer Covid-19 vaccination have higher neutralizing antibody titers and antigen-specific B cell responses?", "id": "100000000000000000006013", "answers": [{"text": "4", "answer_start": 295}], "is_impossible": false}, {"question": "Who observed sustained B and T cell responses?", "id": "100000000000000000006014", "answers": [{"text": "o Investigators", "answer_start": 471}], "is_impossible": false}, {"question": "What may the longer interval between vaccine doses promote?", "id": "100000000000000000006015", "answers": [{"text": "efficient T cell expansion and long-term memory cell persistence", "answer_start": 597}], "is_impossible": false}], "context": "\u2022 Among an observational cohort of SARS-CoV-2 infection na\u00efve health care workers (n=334) in the\nUnited Kingdom, persons who received Pfizer-BioNTech COVID-19 Vaccine following an extended\ndosing interval (6\u201314 week) had higher neutralizing antibody titers and antigen-specific B cell\nresponses 4 weeks after their second dose, compared to persons with a short interval (3\u20134 week)\n(Payne, 2021). Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\no Investigators observed sustained B and T cell responses, noting that the longer interval\nbetween vaccine doses may promote efficient T cell expansion and long-term memory cell\npersistence (Payne, 2021)."}]}, {"title": "ffcb7a456fb47caeaffcb7299a6e7ec7", "paragraphs": [{"qas": [{"question": "What did a large test-negative design study to evaluate VE among adults aged 18 years in British Columbia and Quebec, Canada show?", "id": "100000000000000000006016", "answers": [{"text": "two-dose mRNA VE against infection and hospitalization was significantly higher", "answer_start": 123}], "is_impossible": false}, {"question": "When did Amirthalingam say that VE was higher with longer intervals?", "id": "100000000000000000006020", "answers": [{"text": "2021", "answer_start": 562}], "is_impossible": false}], "context": "\u2022 In a large test-negative design study to evaluate VE among adults aged \u226518 years in British Columbia\nand Quebec, Canada, two-dose mRNA VE against infection and hospitalization was significantly higher\nwith a longer dosing interval (7\u20138 weeks vs. 3\u20134 weeks) (Skowronski, 2021). VE appeared to plateau at\nthe 7\u20138 week interval. \u2022 A test-negative case control study among adults aged 50\u201389 years in England demonstrated that\nPfizer-BioNTech VE was higher with longer (>6 weeks) intervals compared to short (3\u20134 weeks)\nintervals for all age groups (Amirthalingam, 2021)."}]}, {"title": "f3caa1152e06ada95f9fd8415a4c368f", "paragraphs": [{"qas": [{"question": "What might a longer interval between the first and second dose of mRNA vaccines improve?", "id": "100000000000000000006021", "answers": [{"text": "safety", "answer_start": 81}], "is_impossible": false}, {"question": "What may improve safety for young men?", "id": "100000000000000000006022", "answers": [{"text": "A longer interval between the first and second dose of mRNA vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "What were the reported rates of myocarditis among all people in 2021?", "id": "100000000000000000006023", "answers": [{"text": "greater", "answer_start": 375}], "is_impossible": false}, {"question": "What was the interval between doses 1 and 2 for both Moderna and Moderna?", "id": "100000000000000000006025", "answers": [{"text": "\u22658 weeks", "answer_start": 476}], "is_impossible": false}], "context": "A longer interval between the first and second dose of mRNA vaccines may improve safety, especially for\nyoung men. \u2022 In an unpublished (preprint) retrospective population-based cohort using Canada\u2019s provincial vaccine\nregistry and passive vaccine safety surveillance between December 2020 and September 2021,\nreported rates of myocarditis/pericarditis among all persons were greater with shorter intervals (3\u20134\nweeks) between dose 1 and dose 2 compared to extended intervals (\u22658 weeks) for both Moderna\n(Buchan, preprint)."}]}, {"title": "9d1fc862ddffa9a9e602edc8bab856e1", "paragraphs": [{"qas": [{"question": "How long did it take for people to get their second vaccine?", "id": "100000000000000000006026", "answers": [{"text": "\u22658 weeks", "answer_start": 128}], "is_impossible": false}, {"question": "What are some of the countries that have recommended extended mRNA vaccines?", "id": "100000000000000000006027", "answers": [{"text": "Australia, Canada, Denmark, Finland, France, Germany, Norway, Taiwan, and the United Kingdom", "answer_start": 292}], "is_impossible": false}, {"question": "How long does it take to get myocarditis?", "id": "100000000000000000006028", "answers": [{"text": "\u22658 weeks", "answer_start": 128}], "is_impossible": false}, {"question": "Which countries have recommended extended mRNA vaccine primary series dosing for all persons or specific sub-groups?", "id": "100000000000000000006029", "answers": [{"text": "Australia, Canada, Denmark, Finland, France, Germany, Norway, Taiwan, and the United Kingdom", "answer_start": 292}], "is_impossible": false}], "context": "\u2022 The lower reported rates of myocarditis/pericarditis among persons receiving their second vaccine\ndose at extended intervals (\u22658 weeks) was observed across schedules of mRNA vaccine primary series\n(i.e., Pfizer-Pfizer, Moderna-Moderna, Pfizer-Moderna) (Buchan, preprint). Countries such as Australia, Canada, Denmark, Finland, France, Germany, Norway, Taiwan, and the United\nKingdom have recommended extended mRNA vaccine primary series dosing for all persons or specific sub-\ngroups, based on their reviews of available immunological, safety, and effectiveness data, as well as the\nepidemiology of COVID-19, operational considerations, and other contextual factors."}]}, {"title": "a9e328d73539692a05e628069d31eab", "paragraphs": [{"qas": [{"question": "What is the longest interval of 3 months?", "id": "100000000000000000006033", "answers": [{"text": "6 months", "answer_start": 343}], "is_impossible": false}, {"question": "What does a longer interval of at least 3 or 6 months between infection and vaccination allow for?", "id": "100000000000000000006034", "answers": [{"text": "improve immune response", "answer_start": 390}], "is_impossible": false}, {"question": "What does the longer interval allow for the immune response to mature and avoid interference from the vaccine?", "id": "100000000000000000006035", "answers": [{"text": "3 or 6 months", "answer_start": 338}], "is_impossible": false}, {"question": "Multiple large-scale studies have observed decreased risk of what?", "id": "100000000000000000006036", "answers": [{"text": "subsequent infection with antigenically similar variants", "answer_start": 597}], "is_impossible": false}], "context": "What is the available supporting evidence for delaying a second primary dose in people who recently had\nSARS-CoV-2 infection by 3 months from symptom onset or positive test (if infection was asymptomatic)? SARS-CoV-2 infection induces a robust humoral and cellular immune response (CDC, 2021). Additionally, a\nlonger interval of at least 3 or 6 months between infection and vaccination may improve immune response by\nallowing time for the response to mature and avoiding interference from the vaccine (Abu-Raddad L, 2021;\nZhong, 2021). Multiple large-scale studies have observed decreased risk of subsequent infection with\nantigenically similar variants by 80-93% for months after infection (CDC, 2021)."}]}, {"title": "46892bc58560e1a55300c577a2b84108", "paragraphs": [{"qas": [{"question": "What is the duration of protection variable?", "id": "100000000000000000006039", "answers": [{"text": "robustness", "answer_start": 138}], "is_impossible": false}, {"question": "How can the circulating variant impact level of protection?", "id": "100000000000000000006040", "answers": [{"text": "individual-level factors", "answer_start": 285}], "is_impossible": false}, {"question": "What increased during the Omicron wave?", "id": "100000000000000000006042", "answers": [{"text": "overall risk of reinfection", "answer_start": 386}], "is_impossible": false}, {"question": "Protection from infection or vaccination was less robust than against previous variants?", "id": "100000000000000000006043", "answers": [{"text": "overall risk of reinfection increased during the Omicron wave", "answer_start": 386}], "is_impossible": false}], "context": "Delaying vaccination for 3\nmonths after infection may therefore help to maximize protection with minimal risk to the individual. However, robustness and duration of protection is variable (National Collaborating Center for Methods and\nTools, 2021). The circulating variant, as well as individual-level factors such as age and comorbidities, can\nimpact level of protection. For example, overall risk of reinfection increased during the Omicron wave, and\nprotection from infection or vaccination, was less robust than against previous variants (Pulliam et al., 2022)."}]}, {"title": "fa0f1ce78d7be1681d336b50f98ea0f9", "paragraphs": [{"qas": [{"question": "Vaccination continues to be recommended regardless of the option for delaying vaccination after infection?", "id": "100000000000000000006044", "answers": [{"text": "protection following infection, necessitating an interval that balances the benefits and risks of delaying vaccination after infection at a population level. Vaccination continues to be recommended regardless of the option for delaying vaccination after infection. Numerous immunologic studies and a growing number of epidemiologic studies have shown that vaccinating previously infected individuals", "answer_start": 99}], "is_impossible": false}, {"question": "What does delaying vaccination after infection do?", "id": "100000000000000000006045", "answers": [{"text": "enhances their immune response", "answer_start": 514}], "is_impossible": false}], "context": "Additionally, some populations (e.g., older adults, immunocompromised) may have decreased levels of\nprotection following infection, necessitating an interval that balances the benefits and risks of delaying\nvaccination after infection at a population level. Vaccination continues to be recommended regardless of the option for delaying vaccination after infection. Numerous immunologic studies and a growing number of epidemiologic studies have shown that vaccinating\npreviously infected individuals significantly enhances their immune response and effectively reduces the risk of\nsubsequent infection, including in the setting of increased circulation of more infectious variants (CDC, 2021)."}]}, {"title": "c1b571df1cbb67c5d053581bf6eaee81", "paragraphs": [{"qas": [{"question": "What is the current status of the Moderna Covid-19 Vaccine EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000006048", "answers": [{"text": "09/02/22", "answer_start": 234}], "is_impossible": false}, {"question": "What influences vaccine immunogenicity?", "id": "100000000000000000006051", "answers": [{"text": "The timing of vaccination relative to therapy", "answer_start": 476}], "is_impossible": false}, {"question": "At least how long after therapy has vaccination shown improved serocontversion?", "id": "100000000000000000006052", "answers": [{"text": "6 months", "answer_start": 578}], "is_impossible": false}], "context": "What is the available supporting evidence for revaccination of people who received COVID-19 vaccine during\nB-cell-depleting therapy administered over a limited period? Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nStudies of people on B-cell-depleting therapies indicate patients do not achieve adequate seroconversion or\nhave a decreased odds ratio of seroconversion if they were vaccinated during therapy (Haggenberg, 2022a;\nHaggenberg, 2022b).The timing of vaccination relative to therapy influences vaccine immunogenicity;\nvaccination at least 6 months after therapy has demonstrated improved seroconversion (Kornek, 2022;\nSchietzel, 2022, Disanto, 2021)."}]}, {"title": "906c769a657770a043c2edf1525c13c8", "paragraphs": [{"qas": [{"question": "What is the risk-benefit of the COVID-19 vaccine by Moderna?", "id": "100000000000000000006054", "answers": [{"text": "Primary or Additional, Vaccination for Individuals", "answer_start": 206}], "is_impossible": false}, {"question": "What is unknown about vaccine-induced protection from primary vaccination with COVID-19 vaccines?", "id": "100000000000000000006055", "answers": [{"text": "The duration", "answer_start": 278}], "is_impossible": false}, {"question": "Moderna's benefit in preventing severe COVID-19 was supported by what FDA approval?", "id": "100000000000000000006057", "answers": [{"text": "Efficacy data from clinical studies of 2-dose primary series", "answer_start": 381}], "is_impossible": false}], "context": "The option to be revaccinated for people who received vaccination during\ntherapy would allow the opportunity to develop a more sufficient immune response. Risk\u2010Benefit of the COVID-19 vaccine by Moderna as Primary or Additional, Vaccination for Individuals\nDescribed in the EUI\nThe duration of vaccine-induced protection from primary vaccination with COVID-19 vaccines is unknown. Efficacy data from clinical studies of 2-dose primary series supported benefit of the COVID-19 vaccine by\nModerna in preventing severe COVID-19 and supported its FDA approval."}]}, {"title": "7903f734dfee2f80b6d44b55b42fdba", "paragraphs": [{"qas": [{"question": "How many mL of mRNA did immunocompromised adults receive?", "id": "100000000000000000006059", "answers": [{"text": "0.5 mL", "answer_start": 165}], "is_impossible": false}, {"question": "What were the rates of local or systemic adverse events with 50 g booster dose?", "id": "100000000000000000006060", "answers": [{"text": "comparable", "answer_start": 274}], "is_impossible": false}, {"question": "What was comparable to those observed after Dose 2 of the primary series?", "id": "100000000000000000006061", "answers": [{"text": "Rates of local or systemic adverse events", "answer_start": 203}], "is_impossible": false}], "context": "Effectiveness of an additional\nprimary dose of the COVID-19 vaccine by Moderna is inferred from immunogenicity data in\nimmunocompromised adults who received a third 0.5 mL (100 \u03bcg of mRNA) primary dose. Rates of local or\nsystemic adverse events with 50 \u03bcg booster dose were comparable to those observed after Dose 2 of the\nprimary series (Miller, 2021; Das, 2021). Available data on the safety or efficacy of a Moderna COVID-19 vaccine dose after receipt of a non-FDA\nauthorized or approved COVID-19 vaccine are limited."}]}, {"title": "e5c70eec49bb94ec4a3f145fd6620896", "paragraphs": [{"qas": [{"question": "What might have waned over time in people with immunocompromising conditions?", "id": "100000000000000000006064", "answers": [{"text": "primary vaccination", "answer_start": 253}], "is_impossible": false}, {"question": "What is being revised to no longer provide for certain booster dose uses of the COVID-19 vaccine by Moderna?", "id": "100000000000000000006065", "answers": [{"text": "EUI", "answer_start": 424}], "is_impossible": false}], "context": "However, based on available information, it appears\nreasonable to anticipate that known and potential risks of an additional primary dose of the COVID-19 vaccine\nby Moderna may be outweighed by its likely benefit to enhance or restore protection by the primary\nvaccination, which might have waned over time, especially in people with immunocompromising conditions or\ntaking immunosuppressive medications. In addition, these EUI are being revised to no longer provide for certain booster dose uses of the COVID-19\nvaccine by Moderna."}]}, {"title": "1bba07a3a20c32cbaebfd5b2a5bb51e6", "paragraphs": [{"qas": [{"question": "What is being revised to no longer provide for the use of the monovalent COVID-19 vaccine by Moderna for certain booster dose uses?", "id": "100000000000000000006069", "answers": [{"text": "EUI", "answer_start": 19}], "is_impossible": false}, {"question": "What are the only FDA-approved vaccines for which EUI provides for primary, additional, and/or booster dose administration?", "id": "100000000000000000006070", "answers": [{"text": "Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine", "answer_start": 297}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech vaccine?", "id": "100000000000000000006071", "answers": [{"text": "COVID-19", "answer_start": 342}], "is_impossible": false}], "context": "Accordingly, these EUI are being revised to no longer provide for the use of the\nmonovalent COVID-19 vaccine by Moderna for certain booster dose uses. Refer to the CDC\u2019s Interim Clinical Considerations for Use of COVID-19 Vaccines for additional information. Available Alternatives\nCurrently, the Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine are the only FDA-approved\nvaccines for which EUI provide for primary, additional, and/or booster dose administration."}]}, {"title": "d2cdebb82e1afc9954b8d6e74f11a673", "paragraphs": [{"qas": [{"question": "What does VAERS stand for?", "id": "100000000000000000006072", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 133}], "is_impossible": false}, {"question": "What is VAERS?", "id": "100000000000000000006074", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 133}], "is_impossible": false}, {"question": "What does MIS stand for?", "id": "100000000000000000006076", "answers": [{"text": "Multisystem Inflammatory Syndrome", "answer_start": 391}], "is_impossible": false}, {"question": "Where can you submit reports of COVID-19?", "id": "100000000000000000006077", "answers": [{"text": "online at https://vaers.hhs.gov/reportevent.html", "answer_start": 557}], "is_impossible": false}, {"question": "When was the EUI Healthcare Providers Fact Sheet released?", "id": "100000000000000000006078", "answers": [{"text": "09/02/22", "answer_start": 673}], "is_impossible": false}, {"question": "What is the number for reporting to VAERS?", "id": "100000000000000000006079", "answers": [{"text": "1-800-822-7967", "answer_start": 735}], "is_impossible": false}], "context": "Reporting Adverse Event or Medication Errors\nThe vaccination provider is responsible for mandatory reporting of the following to the Vaccine Adverse Event\nReporting System (VAERS):\n\u2022 vaccine administration errors whether or not associated with an adverse event,\n\u2022 serious adverse events (irrespective of attribution to vaccination),\n\u2022 cases of myocarditis\n\u2022 cases of pericarditis\n\u2022 cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and\n\u2022 cases of COVID-19 that result in hospitalization or death. Complete and submit reports to VAERS online at https://vaers.hhs.gov/reportevent.html. Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nFor further assistance with reporting to VAERS call 1-800-822-7967."}]}, {"title": "e04808227774c5991dfc7ec3e49b2d30", "paragraphs": [{"qas": [{"question": "What did Abu-Raddad L, Chemaitelly H, Ayoub HH, et al. Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar?", "id": "100000000000000000006080", "answers": [{"text": "JAMA. 2021;326(19):1930-1939", "answer_start": 172}], "is_impossible": false}, {"question": "JAMA. 2021;326(19):1930-1939.", "id": "100000000000000000006081", "answers": [{"text": "Abu-Raddad L, Chemaitelly H, Ayoub HH, et al. Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar", "answer_start": 11}], "is_impossible": false}, {"question": "What did Alejo J. do?", "id": "100000000000000000006082", "answers": [{"text": "Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine", "answer_start": 219}], "is_impossible": false}, {"question": "Atmar, R.L., et al. Heterologous SARS-CoV-2 Booster Vaccinations \u2013 Preliminary Report.", "id": "100000000000000000006085", "answers": [{"text": "medRxiv Preprint", "answer_start": 568}], "is_impossible": false}], "context": "References\nAbu-Raddad L, Chemaitelly H, Ayoub HH, et al. Association of Prior SARS-CoV-2 Infection With Risk of\nBreakthrough Infection Following mRNA Vaccination in Qatar. JAMA. 2021;326(19):1930-1939. Alejo J., et al. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant\nRecipients: A Case Series. Transplantation 2021;105(21):e280-e281. Amirthalingam G, Bernal, JL, Andrews, NJ, et al. Serological responses and vaccine effectiveness for extended\nAtmar, R.L., et al. Heterologous SARS-CoV-2 Booster Vaccinations \u2013 Preliminary Report. medRxiv Preprint."}]}, {"title": "1f359e13dcfb58aa9f2bab70b274c08e", "paragraphs": [{"qas": [{"question": "What does a fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improve in kidney transplant recipients?", "id": "100000000000000000006086", "answers": [{"text": "serum neutralization against the delta variant", "answer_start": 139}], "is_impossible": false}, {"question": "What is the name of the CDC's science brief on SARS-CoV-2 infection-induced and vaccine-induced immunity?", "id": "100000000000000000006089", "answers": [{"text": "Science Brief", "answer_start": 374}], "is_impossible": false}, {"question": "How much Booster Dose of Moderna COVID-19 Vaccine in Individuals 18 Years of Age?", "id": "100000000000000000006090", "answers": [{"text": "50 \u00b5g", "answer_start": 472}], "is_impossible": false}], "context": "Benotmane, I., Bruel T., Planas, D., Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273\nSARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients. Buchan SA, et al. Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by\nvaccine product, schedule and interval. CDC. Science Brief: SARS-CoV-2 infection-induced and vaccine-induced immunity. 2021. Das, R. Update on 50 \u00b5g Booster Dose of Moderna COVID-19 Vaccine in Individuals \u226518 Years of Age."}]}, {"title": "a52be3ac8ad6e86e27739d1422319ff8", "paragraphs": [{"qas": [{"question": "What is the name of the Advisory Committee on Immunization Practices meeting held on November 19, 2021?", "id": "100000000000000000006091", "answers": [{"text": "Disanto G, Sacco R, Bernasconi, E. Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis", "answer_start": 72}], "is_impossible": false}, {"question": "When is the Emergency Use Authorization of the Modernia COviD-19 Revised?", "id": "100000000000000000006094", "answers": [{"text": "January 3, 2022", "answer_start": 473}], "is_impossible": false}, {"question": "How long is the Severe Acute Respiratory Syndrome Coronavirus 2 vaccine dosing interval?", "id": "100000000000000000006095", "answers": [{"text": "6- to 7-Week", "answer_start": 552}], "is_impossible": false}, {"question": "What is the SARS-CoV-2 vaccine?", "id": "100000000000000000006096", "answers": [{"text": "Severe Acute Respiratory Syndrome Coronavirus 2", "answer_start": 579}], "is_impossible": false}, {"question": "Where is the Haggenburg location?", "id": "100000000000000000006097", "answers": [{"text": "Haggenburg S", "answer_start": 695}], "is_impossible": false}, {"question": "What is the Vaccine Dosing Interval?", "id": "100000000000000000006099", "answers": [{"text": "6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2", "answer_start": 552}], "is_impossible": false}, {"question": "Haggenburg S, Hofsink Q, et al.", "id": "100000000000000000006100", "answers": [{"text": "Advisory Committee on Immunization Practices meeting", "answer_start": 0}], "is_impossible": false}], "context": "Advisory\nCommittee on Immunization Practices meeting, November 19, 2021:\nDisanto G, Sacco R, Bernasconi, E. Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing\nWith Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis. JAMA Neurology. 2021;78(12):1529-1531. FDA. Fact Sheet for Healthcare Providers Administering Vaccine. Emergency Use Authorization of the Moderna\nCOVID-19 Vaccine to Prevent Coronavirus Disease 2019, Revised January 3, 2022\nGrunau B et al. A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute\nRespiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval. Clin Infect Dis. 2021 Nov 30:\nHaggenburg S, Hofsink Q, Lissenberg-Witte BI, et al."}]}, {"title": "1a4e9e05ee49d22341b856ca1920dccd", "paragraphs": [{"qas": [{"question": "How many doses of mRNA-1273 vaccine do most immunocompromised hematology patients receive?", "id": "100000000000000000006101", "answers": [{"text": "Three-dose", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the vaccine that provides sufficient antibody response in majority of immunocomromised patients?", "id": "100000000000000000006102", "answers": [{"text": "mRNA-1273", "answer_start": 11}], "is_impossible": false}, {"question": "When did Blood Advances publish a report on the immunization response in adults?", "id": "100000000000000000006103", "answers": [{"text": "2022", "answer_start": 349}], "is_impossible": false}, {"question": "Where did the Joint Committee on the Immunization of Immunized Adults publish their report?", "id": "100000000000000000006104", "answers": [{"text": "London", "answer_start": 590}], "is_impossible": false}, {"question": "What is the name of the Joint Committee on Vaccination and Immunisation (JCVI) statement regarding a COVID-19 booster vaccine programme for winter 2021 to 2022?", "id": "100000000000000000006105", "answers": [{"text": "Joint Committee on Vaccination and Immunisation (JCVI). JCVI statement regarding a COVID-19 booster vaccine programme for winter 2021 to 2022. London (United Kingdom): Department of Health & Social Care", "answer_start": 446}], "is_impossible": false}, {"question": "What is the acronym for JCVI?", "id": "100000000000000000006107", "answers": [{"text": "Joint Committee on Vaccination and Immunisation", "answer_start": 447}], "is_impossible": false}, {"question": "Where is the Department of Health & Social Care located?", "id": "100000000000000000006108", "answers": [{"text": "London", "answer_start": 590}], "is_impossible": false}, {"question": "When is the last day of the month for the third primary dose vaccination?", "id": "100000000000000000006109", "answers": [{"text": "1 Sept 2021", "answer_start": 844}], "is_impossible": false}], "context": "Three-dose mRNA-1273 vaccination schedule: sufficient\nantibody response in majority of immunocompromised hematology patients. medRxiv. 2022a. Preprint. doi:\nHaggenburg S, Lissenberg-Witte B.I, van Binnendijk RS., et al. Quantitative analysis of mRNA-1273 COVID-19\nvaccination response in immunocompromised adult hematology patients. Blood Advances. 2022;6(5):1537-\n1546. Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nJoint Committee on Vaccination and Immunisation (JCVI). JCVI statement regarding a COVID-19 booster\nvaccine programme for winter 2021 to 2022. London (United Kingdom): Department of Health & Social Care;\nprogramme-for-winter-2021-to-2022. Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London\n(United Kingdom): Department of Health & Social Care; 1 Sept 2021.\nimmunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-\nprimary-dose-vaccination."}]}, {"title": "e2e73e6638bf0f354ffa4b8576a0e254", "paragraphs": [{"qas": [{"question": "Infection Diseases 2021;4(11):e2136030.", "id": "100000000000000000006111", "answers": [{"text": "recipients of a solid organ transplant. Infection Diseases 2021;4(11):e2136030. Kornek B, Leutmezer F, Rommer PS, et al. B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients", "answer_start": 102}], "is_impossible": false}, {"question": "What is the name of the Advisory Committee on Immunization Practices meeting held on October 21, 2021?", "id": "100000000000000000006112", "answers": [{"text": "Munro, Alasdair PS", "answer_start": 512}], "is_impossible": false}], "context": "Kamar, N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA-based vaccine in\nrecipients of a solid organ transplant. Infection Diseases 2021;4(11):e2136030. Kornek B, Leutmezer F, Rommer PS, et al. B Cell Depletion and SARS-CoV-2 Vaccine Responses in\nNeuroimmunologic Patients. Annals of Neurology. 2022;91:342-352. Miller, Jacqueline. Safety and Immunogenicity of a 50 \u00b5g Booster Dose of Moderna COVID-19 Vaccine. Advisory Committee on Immunization Practices meeting, October 21, 2021:\nMunro, Alasdair PS, et al."}]}, {"title": "d89b817d008e2febf87f6bf394cb2d3a", "paragraphs": [{"qas": [{"question": "Where did the National Advisory Committee on Vaccination publish guidance on booster doses?", "id": "100000000000000000006116", "answers": [{"text": "The Lancet", "answer_start": 218}], "is_impossible": false}, {"question": "Who issued guidance on booster COVID- 19 vaccine doses in Canada?", "id": "100000000000000000006117", "answers": [{"text": "National Advisory Committee on Vaccination", "answer_start": 237}], "is_impossible": false}, {"question": "What is the name of the organization that issued the Guidance on booster doses?", "id": "100000000000000000006118", "answers": [{"text": "National Advisory Committee on Vaccination", "answer_start": 237}], "is_impossible": false}, {"question": "Who has had a prior, confirmed COVID-19 infection?", "id": "100000000000000000006121", "answers": [{"text": "persons", "answer_start": 688}], "is_impossible": false}, {"question": "Where is McMaster University located?", "id": "100000000000000000006122", "answers": [{"text": "Hamilton", "answer_start": 749}], "is_impossible": false}], "context": "\"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet (2021). National Advisory Committee on Vaccination. An Advisory Committee Statement: Guidance on booster COVID-\n19 vaccine doses in Canada. Public Health Agency of Canada; 3 Dec 2021.\nhttps://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-\nvaccine-doses.pdf\nNational Collaborating Centre for Methods and Tools. Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19 infection?. Hamilton (ON): McMaster University; 2021. Available from: https://www.nccmt.ca/covid-\n19/covid-19-rapid-evidence-service/36."}]}, {"title": "a5c39cc095d0ba7819577ae5aed01eef", "paragraphs": [{"qas": [{"question": "How does extended interval BNT162b2 vaccination enhance peak antibody?", "id": "100000000000000000006123", "answers": [{"text": "Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine", "answer_start": 144}], "is_impossible": false}, {"question": "Why is increased risk of SARS-CoV-2 reinfection associated?", "id": "100000000000000000006126", "answers": [{"text": "emergence of the Omicron variant in South Africa", "answer_start": 370}], "is_impossible": false}, {"question": "What is increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa?", "id": "100000000000000000006127", "answers": [{"text": "emergence of the Omicron variant in South Africa. 2022", "answer_start": 370}], "is_impossible": false}, {"question": "How many patients did a systematic review and meta-analysis of 1342 patients with anti-CD20 therapies include?", "id": "100000000000000000006128", "answers": [{"text": "patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients. Infections. 2022;8:e002036", "answer_start": 578}], "is_impossible": false}, {"question": "What is the doi:10.1136/rmdopen-2021-002036?", "id": "100000000000000000006129", "answers": [{"text": "8:e002036", "answer_start": 687}], "is_impossible": false}], "context": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPayne RP, Longet S, Austin JA, et al. 2021. Immunogenicity of standard and extended dosing intervals of\nBNT162b2 mRNA vaccine. Cell. doi: 10.1016/j.cell.2021.10.011\nPulliam JRC, van Schalkwyk C, Govender N, et al. Increased risk of SARS-CoV-2 reinfection associated with\nemergence of the Omicron variant in South Africa. 2022. https://doi.org/10.1101/2021.11.11.21266068\nSchietzel S, Anderegg M, Limacher A, et al. Humoral and cellular immune responses on SARS-CoV-2 vaccines in\npatients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients. Infections. 2022;8:e002036. doi:10.1136/rmdopen-2021-002036."}]}, {"title": "4730984234387cb0d5f009e969ff6816", "paragraphs": [{"qas": [{"question": "What is the moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000006130", "answers": [{"text": "Skowronski DM", "answer_start": 75}], "is_impossible": false}, {"question": "What is Skowronski DM. 2021?", "id": "100000000000000000006131", "answers": [{"text": "MedRxiv preprint", "answer_start": 97}], "is_impossible": false}, {"question": "Who developed the inactivated COVID-19 vaccine?", "id": "100000000000000000006134", "answers": [{"text": "Sinovac Interim guidance", "answer_start": 736}], "is_impossible": false}, {"question": "When was CoronaVac developed?", "id": "100000000000000000006135", "answers": [{"text": "21 October 2021", "answer_start": 770}], "is_impossible": false}, {"question": "What is the name of the inactivated COVID-19 vaccine?", "id": "100000000000000000006136", "answers": [{"text": "CoronaVac", "answer_start": 712}], "is_impossible": false}, {"question": "Who developed CoronaVac?", "id": "100000000000000000006137", "answers": [{"text": "Sinovac", "answer_start": 736}], "is_impossible": false}, {"question": "When was CoronaVac updated?", "id": "100000000000000000006138", "answers": [{"text": "21 October 2021", "answer_start": 770}], "is_impossible": false}], "context": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM. 2021, MedRxiv preprint. Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules\nand extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada. WHO Strategic Advisory Group of Experts on Immunization (SAGE). Interim recommendations for an extended\nprimary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised\npersons;.updated 26 October 2021. Geneva: World Health Organization; 2021.\nimmunocompromised-persons. WHO Strategic Advisory Group of Experts on Immunization (SAGE). Interim recommendations for use of the\ninactivated COVID-19 vaccine, CoronaVac, developed by Sinovac Interim guidance; updated 21 October 2021. Geneva: World Health Organization; 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-\nvaccines-SAGE_recommendation-Sinovac-CoronaVac-2021.1."}]}, {"title": "219a9f7018cbfba24fde0b2336e2d853", "paragraphs": [{"qas": [{"question": "WHO Strategic Advisory Group of Experts on Immunization (SAGE) developed what vaccine?", "id": "100000000000000000006139", "answers": [{"text": "COVID-19", "answer_start": 115}], "is_impossible": false}], "context": "WHO Strategic Advisory Group of Experts on Immunization (SAGE). Interim recommendations for use of the\ninactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm; updated 28\nOctober 2021. Geneva: World Health Organization; 2021. https://www.who.int/publications/i/item/WHO-\n2019-nCoV-vaccines-SAGE-recommendation-BIBP. Zhong D, Xiao S, Debes AK, Egbert ER, Caturegli P, Colantuoni E, et al. Durability of Antibody Levels After\nVaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection. JAMA. 2021 Dec"}]}, {"title": "c13590d2d26ccd158af4ccd266c5ef55", "paragraphs": [{"qas": [{"question": "What does CDC use to monitor rates of COVID-19 cases, hospitalizations, and deaths by vaccination status?", "id": "100000000000000000006143", "answers": [{"text": "public health surveillance data", "answer_start": 215}], "is_impossible": false}, {"question": "What do participating health departments, hospitals, and long-term care facilities report?", "id": "100000000000000000006144", "answers": [{"text": "public health surveillance data", "answer_start": 215}], "is_impossible": false}, {"question": "What can monitoring COVID-19 cases, hospitalizations, and deaths by vaccination status do?", "id": "100000000000000000006145", "answers": [{"text": "help identify overall patterns or trends", "answer_start": 560}], "is_impossible": false}, {"question": "What can help identify overall patterns or trends?", "id": "100000000000000000006146", "answers": [{"text": "Monitoring rates of COVID-19 cases, hospitalizations, and deaths by vaccination status over time", "answer_start": 422}], "is_impossible": false}], "context": "10/30/22, 9:33 AM Monitoring COVID-19 Cases, Hospitalizations, and Deaths by Vaccination Status | CDC\nEspa\u00f1ol | Other Languages\nMonitoring COVID-19 Cases, Hospitalizations, and\nDeaths by Vaccination Status\nCDC uses public health surveillance data reported by participating health departments, hospitals, and long-term care facilities\nto monitor rates of COVID-19 cases, hospitalizations, and deaths by vaccination status. Monitoring rates of COVID-19 cases, hospitalizations, and deaths by vaccination status over time, as well as by age and\nvaccine type, can help identify overall patterns or trends."}]}, {"title": "fe7923af2c6991935380b103b58525a2", "paragraphs": [{"qas": [{"question": "What can provide signals of potential changes in vaccine effectiveness?", "id": "100000000000000000006147", "answers": [{"text": "This information", "answer_start": 0}], "is_impossible": false}, {"question": "What can be further studied through more robust, controlled vaccine effectiveness studies?", "id": "100000000000000000006148", "answers": [{"text": "signals of potential changes in vaccine effectiveness", "answer_start": 29}], "is_impossible": false}, {"question": "CDC analyzes surveillance data by vaccination status to better understand patterns of what?", "id": "100000000000000000006149", "answers": [{"text": "COVID-19", "answer_start": 288}], "is_impossible": false}, {"question": "What is the difference between people who are vaccinated and people that aren't?", "id": "100000000000000000006151", "answers": [{"text": "unvaccinated", "answer_start": 333}], "is_impossible": false}], "context": "This information can provide signals of potential changes in vaccine effectiveness that can be further studied through more\nrobust, controlled vaccine effectiveness studies, which are ongoing at CDC. \uf294 CDC analyzes surveillance data by vaccination status to\nBetter understand patterns of COVID-19 among people who are vaccinated and unvaccinated. Identify signals of potential changes in vaccine effectiveness, which can be confirmed through more\nrobust studies."}]}, {"title": "b31fc24ec3daa090c596c0bb33ee91d5", "paragraphs": [{"qas": [{"question": "How many state and local health departments does CDC collaborate with to monitor COVID-19 cases and deaths by vaccination status?", "id": "100000000000000000006153", "answers": [{"text": "more than 30", "answer_start": 201}], "is_impossible": false}, {"question": "What is used to monitor rates of COVID-19 cases and deaths by vaccination status?", "id": "100000000000000000006154", "answers": [{"text": "Case surveillance", "answer_start": 161}], "is_impossible": false}, {"question": "How many regions of the country does CDC have access to?", "id": "100000000000000000006158", "answers": [{"text": "all regions", "answer_start": 599}], "is_impossible": false}], "context": "\u2022\n\u2022\nCDC uses the following platforms and methods to collect and\nanalyze surveillance data on COVID-19 cases, hospitalizations,\nand deaths by vaccination status:\nCase surveillance\nCDC collaborates with more than 30 state and local health departments that routinely link case surveillance, immunization\nregistry, and vital registration data to monitor rates of COVID-19 cases and deaths by vaccination status, including receipt of\nbooster doses. These rates are published monthly on COVID Data Tracker. Data from the participating health departments represent more than 70% of the U.S. population and all regions of the\ncountry. The volume of this data allows CDC to analyze rare outcomes over time, like COVID-19-associated deaths."}]}, {"title": "b1d29528122107e030b5b917d24fbc2d", "paragraphs": [{"qas": [{"question": "What can provide signals of potential changes in vaccine effectiveness?", "id": "100000000000000000006159", "answers": [{"text": "analyses", "answer_start": 21}], "is_impossible": false}, {"question": "What is the name of the population-based, sentinel surveillance system that collects reports of laboratory-confirmed COVID-19-associated hospitalizations in 99 counties in 14 states?", "id": "100000000000000000006161", "answers": [{"text": "COVID-NET", "answer_start": 330}], "is_impossible": false}, {"question": "How much of the U.S. population is covered by CoviD-NET?", "id": "100000000000000000006162", "answers": [{"text": "10%", "answer_start": 535}], "is_impossible": false}, {"question": "What does CDC publish weekly rates of?", "id": "100000000000000000006163", "answers": [{"text": "laboratory-confirmed COVID-19 hospitalizations by vaccination status", "answer_start": 695}], "is_impossible": false}, {"question": "CDC publishes weekly rates of laboratory-confirmed COVID-19 hospitalizations by vaccination status on what tool?", "id": "100000000000000000006164", "answers": [{"text": "COVID Data Tracker", "answer_start": 767}], "is_impossible": false}], "context": "However,\nwhile these analyses can provide signals of potential changes in vaccine effectiveness, they cannot control for some variables\nthat could impact the results \u2013 for example, underlying medical conditions from prior infection. COVID-NET\nCDC monitors rates of COVID-19 hospitalizations by vaccination status using COVID-NET. COVID-NET is a population-based,\nsentinel surveillance system that collects reports of laboratory-confirmed COVID-19-associated hospitalizations in 99 counties\nin 14 states. COVID-NET covers approximately 10% of the U.S. population. 10/30/22, 9:33 AM Monitoring COVID-19 Cases, Hospitalizations, and Deaths by Vaccination Status | CDC\nCDC publishes weekly rates of laboratory-confirmed COVID-19 hospitalizations by vaccination status on COVID Data Tracker."}]}, {"title": "e922f7907c79c833c68c957f316fba74", "paragraphs": [{"qas": [{"question": "How often is the National Healthcare Safety Network updated?", "id": "100000000000000000006165", "answers": [{"text": "monthly", "answer_start": 20}], "is_impossible": false}, {"question": "What is the name of the network of medical facilities?", "id": "100000000000000000006167", "answers": [{"text": "National Healthcare Safety Network", "answer_start": 219}], "is_impossible": false}, {"question": "What is the possibility of getting COVID-19 after getting vaccinated?", "id": "100000000000000000006169", "answers": [{"text": "Vaccine Breakthrough Infections", "answer_start": 330}], "is_impossible": false}], "context": "The data is updated monthly. National Healthcare Safety Network\nInfections in long-term care facility residents by vaccination status are reported through a network of approximately 15,000\nmedical facilities called the National Healthcare Safety Network (NHSN). An analysis of this data was published in CDC\u2019s\nMMWR. Related Pages\nVaccine Breakthrough Infections: The Possibility of Getting COVID-19 after Getting Vaccinated\n\u203a\nCOVID-19 Vaccine Breakthrough Case Investigation and Reporting\n\u203a\nCases and Deaths by Vaccination Status\n\u203a\nHospitalizations by Vaccination Status\n\u203a\nCDC\u2019s MMWR: Published analyses of case surveillance data by vaccination status for periods of Delta variant and\nOmicron variant\n\u203a\nLast Updated June 23, 2022"}]}, {"title": "de1d80bff6b92148bee49d2351f32d74", "paragraphs": [{"qas": [{"question": "What does CDC continuously monitor to understand how COVID-19 vaccines protect people in real-world conditions?", "id": "100000000000000000006170", "answers": [{"text": "vaccine effectiveness", "answer_start": 268}], "is_impossible": false}, {"question": "What vaccines protect people in real-world conditions?", "id": "100000000000000000006172", "answers": [{"text": "COVID-19", "answer_start": 308}], "is_impossible": false}], "context": "10/30/22, 9:33 AM Monitoring COVID-19 Vaccine Effectiveness | CDC\nEspa\u00f1ol | Other Languages\nMonitoring COVID-19 Vaccine Effectiveness\nWhy CDC Tracks How Well the Vaccines Are Working\nCDC is reviewing this page to align with updated guidance. CDC continuously monitors vaccine effectiveness to understand how COVID-19 vaccines protect people in real-world\nconditions. Vaccine effectiveness is a measure of how well vaccination protects people against infection, symptomatic illness,\nhospitalization, and death."}]}, {"title": "559dfc34e66415901d64fe89ff38667f", "paragraphs": [{"qas": [{"question": "CDC monitors COVID-19 vaccine effectiveness to understand how well the vaccines work?", "id": "100000000000000000006173", "answers": [{"text": "Protect different age groups", "answer_start": 80}], "is_impossible": false}, {"question": "What is the risk of infection, including infection without symptoms?", "id": "100000000000000000006174", "answers": [{"text": "Lower", "answer_start": 314}], "is_impossible": false}, {"question": "What is the term for multisystem inflammatory syndrome?", "id": "100000000000000000006176", "answers": [{"text": "MIS", "answer_start": 590}], "is_impossible": false}, {"question": "How do people who have received one or more booster doses perform?", "id": "100000000000000000006177", "answers": [{"text": "Provide long- and short-term protection", "answer_start": 632}], "is_impossible": false}, {"question": "What do you need to do to help with booster doses?", "id": "100000000000000000006179", "answers": [{"text": "Adjust vaccine recommendations", "answer_start": 813}], "is_impossible": false}, {"question": "How do you help with vaccine policy?", "id": "100000000000000000006180", "answers": [{"text": "Adjust vaccine recommendations", "answer_start": 813}], "is_impossible": false}, {"question": "What are variants of the COVID-19 virus called?", "id": "100000000000000000006181", "answers": [{"text": "Viruses are constantly changing to create new types", "answer_start": 1087}], "is_impossible": false}], "context": "CDC monitors COVID-19 vaccine effectiveness to understand how well the vaccines:\nProtect different age groups, such as children, adolescents, and adults, including adults ages 65 and older\nProtect specific groups, such as people with underlying health conditions or healthcare workers\nProtect against new variants\nLower the risk of infection, including infection without symptoms\nProtect against milder COVID-19 illness\nPrevent more serious outcomes, such as hospitalization or death\nPrevent complications from COVID-19, such as post-COVID conditions and multisystem inflammatory syndrome\n(MIS)\nPrevent spreading COVID-19 to others\nProvide long- and short-term protection\nPerform among people who have received one or more booster doses\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nAssessing How Vaccines Work in the Real World Helps Us:\nAdjust vaccine recommendations,\nas needed, such as booster doses\n\uf263\nGuide vaccine policy and vaccine\ndistribution\n\uf260\nInform development of vaccine\ntechnologies\n\uf33d\nCOVID-19 Vaccines and New Variants of the Virus\f10/30/22, 9:33 AM Monitoring COVID-19 Vaccine Effectiveness | CDC\nViruses are constantly changing to create new types of the virus, called variants."}]}, {"title": "f7d86cae7db93b0be2703d3537aec4d1", "paragraphs": [{"qas": [{"question": "CDC will continue to monitor vaccine effectiveness to see what impact, if any, variants have?", "id": "100000000000000000006184", "answers": [{"text": "COVID-19 vaccines work in real-world conditions", "answer_start": 359}], "is_impossible": false}, {"question": "What does CDC monitor to see if any variants have an impact on how well COVID-19 vaccines work in real-world conditions?", "id": "100000000000000000006185", "answers": [{"text": "vaccine effectiveness", "answer_start": 282}], "is_impossible": false}], "context": "So far, research shows that the COVID-19\nvaccines used in the United States continue to protect against severe disease, hospitalization, and death from known\ncirculating variants. They may not be as effective in preventing infection from these variants. CDC will continue to monitor\nvaccine effectiveness to see what impact, if any, variants have on how well COVID-19 vaccines work in real-world conditions. How CDC Monitors COVID-19 Vaccine Effectiveness\nCDC uses multiple strategies to monitor how well COVID-19 vaccines are working in real-world conditions. Last Updated June 23, 2022"}]}, {"title": "85a96d45e288ca22d7199e85cbab090b", "paragraphs": [{"qas": [{"question": "When does the body's immune system cause inflammation?", "id": "100000000000000000006188", "answers": [{"text": "in response to an infection or some other trigger", "answer_start": 344}], "is_impossible": false}, {"question": "What causes inflammation in response to an infection or some other trigger?", "id": "100000000000000000006189", "answers": [{"text": "the body\u2019s immune system", "answer_start": 299}], "is_impossible": false}], "context": "10/30/22, 9:31 AM Myocarditis and Pericarditis After mRNA COVID-19 Vaccination | CDC\nEspa\u00f1ol | Other Languages\nMyocarditis and Pericarditis After mRNA COVID-19\nVaccination\nMyocarditis is inflammation of the heart muscle. Pericarditis is inflammation of the outer lining of the heart. In both cases, the body\u2019s immune system causes inflammation in response to an infection or some other trigger. Learn\nmore about myocarditis and pericarditis. Both myocarditis and pericarditis have the following symptoms:\nChest pain\nShortness of breath\nFeelings of having a fast-beating, fluttering, or pounding heart\nMyocarditis and pericarditis have rarely been reported."}]}, {"title": "7d1683d1b0faea180c835c80ca13a2ed", "paragraphs": [{"qas": [{"question": "How long after mRNA COVID-19 vaccination have cases of myocarditis been reported?", "id": "100000000000000000006191", "answers": [{"text": "several days", "answer_start": 90}], "is_impossible": false}, {"question": "How often after the second dose do patients with pericarditia respond to medicine and rest?", "id": "100000000000000000006193", "answers": [{"text": "within a week", "answer_start": 206}], "is_impossible": false}, {"question": "Who should consult with those who have been diagnosed with myocarditis?", "id": "100000000000000000006196", "answers": [{"text": "cardiologist", "answer_start": 525}], "is_impossible": false}, {"question": "What is the name of the CDC's partner that is actively monitoring reports of myocarditis after COVID-19 vaccination?", "id": "100000000000000000006197", "answers": [{"text": "Pfizer-BioNTech or Moderna). More often after the second dose Usually within a week of vaccination Most patients with myocarditis or pericarditis who received care responded well to medicine and rest and felt better quickly. Patients can usually return to their normal daily activities after their symptoms improve. Those who have been diagnosed with myocarditis should consult with their cardiologist (heart doctor) about return to exercise or sports. CDC", "answer_start": 136}], "is_impossible": false}], "context": "When reported, the cases have especially been in adolescents and\nyoung adult males within several days after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna). More often after the second dose\nUsually within a week of vaccination\nMost patients with myocarditis or pericarditis who received care responded well to medicine and rest and felt better\nquickly. Patients can usually return to their normal daily activities after their symptoms improve. Those who have been diagnosed with myocarditis should consult with their cardiologist (heart doctor) about return to\nexercise or sports. CDC and its partners are actively monitoring reports of myocarditis and pericarditis after COVID-19 vaccination."}]}, {"title": "cd8f7ab86219d64ab495a13541eea902", "paragraphs": [{"qas": [{"question": "What is Myocarditis after mRNA COVID-19 Vaccination?", "id": "100000000000000000006202", "answers": [{"text": "Pericarditis", "answer_start": 701}], "is_impossible": false}], "context": "Active\nmonitoring includes reviewing data and medical records and evaluating the relationship to COVID-19 vaccination. Information about CDC\u2019s ongoing study of myocarditis after COVID-19 vaccination can be found here: Investigating Long-\nTerm Effects of Myocarditis | CDC\n\u2022\n\uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nSeek medical care if you or your child have any of the specific or general symptoms of myocarditis or pericarditis\nespecially if it\u2019s within a week after COVID-19 vaccination. Healthcare Providers: For additional recommendations and clinical guidance, visit Clinical Considerations: Myocarditis after\nmRNA COVID-19 Vaccines. Should I Still Get Myself or My Child Vaccinated? 10/30/22, 9:31 AM Myocarditis and Pericarditis After mRNA COVID-19 Vaccination | CDC\nYes."}]}, {"title": "d85ff6f2a85146d81a13e5f0a6660545", "paragraphs": [{"qas": [{"question": "What is the known risk of having a rare adverse reaction to vaccination?", "id": "100000000000000000006204", "answers": [{"text": "myocarditis or pericarditis", "answer_start": 359}], "is_impossible": false}, {"question": "What is the risk of having a rare adverse reaction to vaccination?", "id": "100000000000000000006205", "answers": [{"text": "the possible risk of myocarditis or pericarditis", "answer_start": 339}], "is_impossible": false}, {"question": "What is important if you have already gotten the first dose of Pfizer-BioNTech or Moderna vaccine?", "id": "100000000000000000006206", "answers": [{"text": "to get the second dose", "answer_start": 568}], "is_impossible": false}, {"question": "What is important to get unless a vaccination provider or your doctor tells you not to get it?", "id": "100000000000000000006207", "answers": [{"text": "the second dose", "answer_start": 575}], "is_impossible": false}], "context": "CDC continues to recommend that everyone ages 6 months and older get vaccinated for COVID-19. The known risks of\nCOVID-19 illness and its related, possibly severe complications, such as long-term health problems, hospitalization, and even\ndeath, far outweigh the potential risks of having a rare adverse reaction to vaccination, including the possible risk of\nmyocarditis or pericarditis. If you have already gotten the first dose of Pfizer-BioNTech or Moderna vaccine, or if your child has already gotten the first\ndose of the Pfizer-BioNTech vaccine, it\u2019s important to get the second dose unless a vaccination provider or your doctor tells\nyou not to get it."}]}, {"title": "9dad4321a1014af3a30ba578c61a258", "paragraphs": [{"qas": [{"question": "What should you do if you have concerns about COVID-19 vaccination?", "id": "100000000000000000006208", "answers": [{"text": "talk with your healthcare provider or your child\u2019s doctor, nurse, or clinic", "answer_start": 49}], "is_impossible": false}], "context": "If you have concerns about COVID-19 vaccination, talk with your healthcare provider or your child\u2019s doctor, nurse, or clinic. If you have any health problems after vaccination, report them to\u202fVAERS . \uf209\nLast Updated Sept. 27, 2022"}]}, {"title": "a5b4e41f15a08f4d1d937534762c2ef9", "paragraphs": [{"qas": [{"question": "What can help stop common myths and rumors?", "id": "100000000000000000006211", "answers": [{"text": "Accurate vaccine information", "answer_start": 130}], "is_impossible": false}, {"question": "What are some of the myths and facts about COVID-19 vaccination?", "id": "100000000000000000006213", "answers": [{"text": "Below", "answer_start": 379}], "is_impossible": false}, {"question": "What is the most common misconception about the vaccines?", "id": "100000000000000000006214", "answers": [{"text": "The ingredients in COVID-19 vaccines are dangerous", "answer_start": 490}], "is_impossible": false}, {"question": "How many of the ingredients in the vaccine are also ingredients?", "id": "100000000000000000006215", "answers": [{"text": "Nearly all", "answer_start": 548}], "is_impossible": false}, {"question": "How many of the ingredients in COVID-19 vaccines are also ingredients in many foods?", "id": "100000000000000000006216", "answers": [{"text": "Nearly all", "answer_start": 548}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nEspa\u00f1ol | Other Languages\nMyths and Facts about COVID-19 Vaccines\nAccurate vaccine information is critical and can help stop common myths and rumors. It can be difficult to know which\nsources of information you can trust. Learn more about finding credible vaccine information. Bust Common Myths and Learn the Facts\nBelow are myths and facts about COVID-19 vaccination. Have more questions? Visit FAQs about Vaccination. MYTH: The ingredients in COVID-19 vaccines are dangerous. FACT: Nearly all the ingredients in COVID-19 vaccines are also ingredients in many foods \u2013 fats, sugars, and\nsalts."}]}, {"title": "40e632ea2ea2c9797fb9988af7945c2c", "paragraphs": [{"qas": [{"question": "What does mRNA stand for?", "id": "100000000000000000006218", "answers": [{"text": "messenger RNA", "answer_start": 107}], "is_impossible": false}, {"question": "What is the name of the vaccine that contains a harmless version of a virus unrelated to the virus that causes COVID-19?", "id": "100000000000000000006219", "answers": [{"text": "Johnson & Johnson/Janssen COVID-19", "answer_start": 136}], "is_impossible": false}, {"question": "What are the pieces of COVID-19 called?", "id": "100000000000000000006220", "answers": [{"text": "spike protein", "answer_start": 408}], "is_impossible": false}, {"question": "What is the name of the vaccine that would discard any information that cells no longer need?", "id": "100000000000000000006222", "answers": [{"text": "Novavax COVID-19", "answer_start": 267}], "is_impossible": false}], "context": "Exact vaccine ingredients vary by\nmanufacturer. Pfizer-BioNTech and\nModerna COVID-19 vaccines also\ncontain messenger RNA (mRNA) and\nthe Johnson & Johnson/Janssen\nCOVID-19 vaccine contains a\nharmless version of a virus unrelated\nto the virus that causes COVID-19. The Novavax COVID-19 vaccine\nincludes harmless pieces (proteins) of\nthe virus that causes COVID-19; they\nare pieces of what is often called the\n\u201cspike protein.\u201d These give\ninstructions to cells in your body to\ncreate an immune response. This\nresponse helps protect you from\ngetting sick with COVID-19 in the\nfuture. After the body produces an\nimmune response, it discards all the\nvaccine ingredients just as it would discard any information that cells no longer need."}]}, {"title": "4833a72ce2f9469e377f35d8c08b9f2a", "paragraphs": [{"qas": [{"question": "What is a part of normal body functioning?", "id": "100000000000000000006223", "answers": [{"text": "This process", "answer_start": 0}], "is_impossible": false}, {"question": "What does not contain preservatives, tissues, antibiotics, food proteins, medicines, latex, or metals?", "id": "100000000000000000006224", "answers": [{"text": "COVID-19 vaccines", "answer_start": 51}], "is_impossible": false}, {"question": "What is a safer and more dependable way to build immunity?", "id": "100000000000000000006225", "answers": [{"text": "Getting a COVID-19 vaccination", "answer_start": 539}], "is_impossible": false}, {"question": "What is the name of the company that makes the COVID-19 vaccine?", "id": "100000000000000000006226", "answers": [{"text": "Pfizer", "answer_start": 326}], "is_impossible": false}], "context": "This process is a part of normal\nbody functioning. COVID-19 vaccines do NOT contain ingredients like preservatives, tissues (like aborted fetal cells), antibiotics, food\nproteins, medicines, latex, or metals. 10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nLearn more about what ingredients are and are not in Pfizer-BioNTech, Moderna, Novavax, or Johnson &\nJohnson/Janssen COVID-19 vaccines. MYTH: The natural immunity I get from being sick with COVID-19 is better than the immunity I\nget from COVID-19 vaccination. FACT: Getting a COVID-19 vaccination is a safer and more dependable way to build immunity to COVID-19 than\ngetting sick with COVID-19."}]}, {"title": "5b8df3b1729d37c7ea2fd8ca7c045f9a", "paragraphs": [{"qas": [{"question": "What gives most people a high level of protection against the virus?", "id": "100000000000000000006229", "answers": [{"text": "Getting a COVID-19 vaccine", "answer_start": 115}], "is_impossible": false}, {"question": "How much more likely are people who don't get vaccinated after their recovery to get COVID-19?", "id": "100000000000000000006230", "answers": [{"text": "2 times", "answer_start": 401}], "is_impossible": false}, {"question": "What is one of the most effective ways to prevent people from getting the COVID-19 vaccine?", "id": "100000000000000000006232", "answers": [{"text": "All COVID-19 vaccines", "answer_start": 499}], "is_impossible": false}, {"question": "What is COVID-19 effective at preventing?", "id": "100000000000000000006233", "answers": [{"text": "COVID-19", "answer_start": 590}], "is_impossible": false}], "context": "COVID-19 vaccination causes a more predictable immune response than infection with the virus that causes COVID-19. Getting a COVID-19 vaccine gives most people a high level of protection against COVID-19 and can provide added\nprotection for people who already had COVID-19. One study showed that, for people who already had COVID-19, those\nwho do not get vaccinated after their recovery are more than 2 times as likely to get COVID-19 again than those who get\nfully vaccinated after their recovery. All COVID-19 vaccines currently available in the United States are effective at preventing COVID-19."}]}, {"title": "f36404dbd5702bf86fef0d37a75d8936", "paragraphs": [{"qas": [{"question": "What is the term for protection from future illness?", "id": "100000000000000000006234", "answers": [{"text": "natural immunity", "answer_start": 92}], "is_impossible": false}, {"question": "What is a safer way to prevent future illness if you get a COVID-19 vaccination?", "id": "100000000000000000006235", "answers": [{"text": "build protection", "answer_start": 332}], "is_impossible": false}, {"question": "What is a safer way to build protection than getting sick with COVID-19?", "id": "100000000000000000006236", "answers": [{"text": "Getting a COVID-19 vaccination", "answer_start": 278}], "is_impossible": false}, {"question": "What helps protect you by creating an antibody response without you having to experience sickness?", "id": "100000000000000000006237", "answers": [{"text": "COVID-19 vaccination", "answer_start": 382}], "is_impossible": false}], "context": "Getting sick with\nCOVID-19 can offer some protection from future illness, sometimes called \u201cnatural immunity,\u201d but the level of\nprotection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since\ntheir infection, and their age. Getting a COVID-19 vaccination is also a safer way to build protection than getting sick with COVID-19. COVID-19\nvaccination helps protect you by creating an antibody response without you having to experience sickness. Getting\nvaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from\nCOVID-19."}]}, {"title": "e5b4320338a742b052dffb8217943de6", "paragraphs": [{"qas": [{"question": "What can you spread to others if you get sick?", "id": "100000000000000000006239", "answers": [{"text": "COVID-19", "answer_start": 162}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19 infection?", "id": "100000000000000000006240", "answers": [{"text": "Myths and Facts about COVID-19 Vaccines | CDC MYTH: COVID-19 vaccines cause variants. FACT: COVID-19 vaccines do not create or cause variants", "answer_start": 356}], "is_impossible": false}, {"question": "What does the CDC MYTH about COVID-19 vaccines do?", "id": "100000000000000000006241", "answers": [{"text": "cause variants", "answer_start": 426}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000006243", "answers": [{"text": "Myths and Facts about COVID-19 Vaccines | CDC MYTH: COVID-19 vaccines cause variants. FACT: COVID-19 vaccines do not create or cause variants", "answer_start": 356}], "is_impossible": false}], "context": "Getting sick with COVID-19 can cause severe illness or death, and we can\u2019t reliably predict who will have mild or\nsevere illness. If you get sick, you can spread COVID-19 to others. You can also continue to have long-term health issues\nafter COVID-19 infection. Learn about why you should get vaccinated even if you already had COVID-19. 10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nMYTH: COVID-19 vaccines cause variants. FACT: COVID-19 vaccines do not create or cause variants of the virus that causes COVID-19. Instead, COVID-19\nvaccines can help prevent new variants from emerging."}]}, {"title": "52129cca219a220ea14e2628a4d272a7", "paragraphs": [{"qas": [{"question": "What happens when COVID-19 constantly changes through a natural ongoing process of mutation?", "id": "100000000000000000006244", "answers": [{"text": "New variants", "answer_start": 0}], "is_impossible": false}, {"question": "High vaccination coverage in a population reduces the spread of what?", "id": "100000000000000000006246", "answers": [{"text": "the virus", "answer_start": 268}], "is_impossible": false}, {"question": "What helps prevent new variants from emerging?", "id": "100000000000000000006247", "answers": [{"text": "High vaccination coverage", "answer_start": 204}], "is_impossible": false}, {"question": "Who recommends COVID-19 vaccines for everyone ages 6 months and older?", "id": "100000000000000000006248", "answers": [{"text": "CDC", "answer_start": 324}], "is_impossible": false}, {"question": "What is the acronym for the Vaccine Adverse Event Reporting System?", "id": "100000000000000000006249", "answers": [{"text": "VAERS", "answer_start": 553}], "is_impossible": false}], "context": "New variants of a virus happen because the virus that causes COVID-19 constantly changes through a natural ongoing\nprocess of mutation (change). As the virus spreads, it has more opportunities to change. High vaccination coverage in a\npopulation reduces the spread of the virus and helps prevent new variants from emerging. CDC recommends COVID-19\nvaccines for everyone ages 6 months and older, and boosters for everyone 5 years and older, if eligible. Learn more about variants. MYTH: All events reported to the Vaccine Adverse Event Reporting System (VAERS) are caused\nby vaccination."}]}, {"title": "e2c3cbe58dc80dec1f0bc1b55b4e5bd", "paragraphs": [{"qas": [{"question": "Who can report adverse events to VAERS?", "id": "100000000000000000006250", "answers": [{"text": "Anyone", "answer_start": 6}], "is_impossible": false}, {"question": "What can't determine if the reported adverse event was caused by a COVID-19 vaccination?", "id": "100000000000000000006251", "answers": [{"text": "VAERS data", "answer_start": 120}], "is_impossible": false}, {"question": "Vaccine safety experts study these adverse events and look for unusual high numbers of what?", "id": "100000000000000000006253", "answers": [{"text": "health problems", "answer_start": 417}], "is_impossible": false}], "context": "FACT: Anyone can report events to VAERS, even if it is not clear whether a vaccine caused the problem. Because of this, VAERS data alone cannot determine if the reported adverse event was caused by a COVID-19\nvaccination. Some VAERS reports may contain information that is incomplete,\ninaccurate, coincidental, or unverifiable. Vaccine safety experts study\nthese adverse events and look for unusually high numbers of health\nproblems, or a pattern of problems, after people receive a particular\nvaccine."}]}, {"title": "33d98e760b265771a71027413a432fa8", "paragraphs": [{"qas": [{"question": "What does not necessarily mean that a vaccine caused a health problem?", "id": "100000000000000000006256", "answers": [{"text": "Reports of adverse events", "answer_start": 262}], "is_impossible": false}, {"question": "What is the mRNA vaccine not considered?", "id": "100000000000000000006257", "answers": [{"text": "a vaccine", "answer_start": 467}], "is_impossible": false}, {"question": "Which vaccines work differently than other types of vaccines?", "id": "100000000000000000006258", "answers": [{"text": "mRNA vaccines", "answer_start": 484}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nRecently, the number of deaths reported to VAERS following COVID-\n19 vaccination has been misinterpreted and misreported as if this\nnumber means deaths that were proven to be caused by vaccination. Reports of adverse events to VAERS following vaccination, including\ndeaths, do not necessarily mean that a vaccine caused a health\nproblem. Learn more about VAERS. MYTH: The mRNA vaccine is not considered a vaccine. FACT: mRNA vaccines, such as Pfizer-BioNTech and Moderna, work differently than other types of vaccines,\nbut they still trigger an immune response inside your body."}]}, {"title": "f770a4d2b33cd2272d8b06ef5e131993", "paragraphs": [{"qas": [{"question": "What does the mRNA vaccines not contain?", "id": "100000000000000000006260", "answers": [{"text": "live virus", "answer_start": 132}], "is_impossible": false}, {"question": "What is found on the surface of the virus that causes COVID-19?", "id": "100000000000000000006261", "answers": [{"text": "spike protein", "answer_start": 216}], "is_impossible": false}, {"question": "On the surface of the virus that causes COVID-19, what do cells display it on?", "id": "100000000000000000006262", "answers": [{"text": "spike protein", "answer_start": 216}], "is_impossible": false}, {"question": "When an immune response begins, what are antibodies produced?", "id": "100000000000000000006263", "answers": [{"text": "the same response that happens in a natural infection", "answer_start": 525}], "is_impossible": false}], "context": "This type of vaccine is new, but research and\ndevelopment on it has been underway for\ndecades. The mRNA vaccines do not contain any live\nvirus. Instead, they work by teaching our cells to\nmake a harmless piece of a \u201cspike protein,\u201d\nwhich is found on the surface of the virus that\ncauses COVID-19. After making the protein\npiece, cells display it on their surface. Our\nimmune system then recognizes that it does\nnot belong there and responds to get rid of it. When an immune response begins, antibodies\nare produced, creating the same response that\nhappens in a natural infection."}]}, {"title": "86e15df0236d3cc15c9dc68540e22d71", "paragraphs": [{"qas": [{"question": "What type of vaccines use a weakened version of the germ that the vaccine protects against?", "id": "100000000000000000006264", "answers": [{"text": "measles and flu vaccines", "answer_start": 150}], "is_impossible": false}, {"question": "How do measles and flu vaccines work?", "id": "100000000000000000006265", "answers": [{"text": "use a piece of, or weakened version of, the germ that the vaccine protects against", "answer_start": 50}], "is_impossible": false}, {"question": "What do you make when a small part of the virus is introduced to your body?", "id": "100000000000000000006266", "answers": [{"text": "antibodies", "answer_start": 261}], "is_impossible": false}, {"question": "What do you do when COVID-19 vaccines are introduced to your body?", "id": "100000000000000000006267", "answers": [{"text": "make antibodies", "answer_start": 256}], "is_impossible": false}, {"question": "What do antibodies help protect against?", "id": "100000000000000000006268", "answers": [{"text": "future infection", "answer_start": 296}], "is_impossible": false}], "context": "In contrast to mRNA vaccines, many other\nvaccines use a piece of, or weakened version of, the germ that the vaccine protects against. This is how the measles and\nflu vaccines work. When a weakened or small part of the virus is introduced to your body, you make antibodies to help\nprotect against future infection. Learn more about how mRNA COVID-19 vaccines work. MYTH: COVID-19 vaccines contain microchips. FACT: COVID-19 vaccines do not contain microchips. Vaccines are developed to fight against disease and are\nnot administered to track your movement."}]}, {"title": "2783fab90228130146bf571ed6098d53", "paragraphs": [{"qas": [{"question": "What does COVID-19 work by stimulating your immune system to produce antibodies?", "id": "100000000000000000006269", "answers": [{"text": "Vaccines work by stimulating your immune system to produce antibodies, exactly like it would if you were exposed to the disease", "answer_start": 64}], "is_impossible": false}, {"question": "After getting vaccinated, you develop immunity to what disease without having to get it first?", "id": "100000000000000000006270", "answers": [{"text": "COVID-19 Vaccines | CDC Vaccines work by stimulating your immune system to produce antibodies, exactly like it would if you were exposed to the disease", "answer_start": 40}], "is_impossible": false}, {"question": "What does receiving a COVID-19 vaccine not make you magnetic?", "id": "100000000000000000006271", "answers": [{"text": "at the site of vaccination", "answer_start": 532}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nVaccines work by stimulating your immune system to produce antibodies, exactly like it would if you were exposed to the\ndisease. After getting vaccinated, you develop immunity to that disease, without having to get the disease first. Learn more about the ingredients in the COVID-19 vaccinations authorized for use in the United States. MYTH: Receiving a COVID-19 vaccine can make you magnetic. FACT: Receiving a COVID-19 vaccine will not make you magnetic, including at the site of vaccination which is\nusually your arm. vaccines\ndo not\ncontain\ningredient\ns that can\nproduce\nan\nelectroma\ngnetic field\nat the site\nof your\ninjection."}]}, {"title": "ba6be2f95278b443b9b66abd248dad88", "paragraphs": [{"qas": [{"question": "What are all COVID- vaccines free from?", "id": "100000000000000000006274", "answers": [{"text": "metals", "answer_start": 33}], "is_impossible": false}, {"question": "What are the ingredients in the vaccinatio ns authorized for use in the United States?", "id": "100000000000000000006275", "answers": [{"text": "mRNA and viral vector vaccines", "answer_start": 565}], "is_impossible": false}, {"question": "What is a live weakened version of the virus?", "id": "100000000000000000006277", "answers": [{"text": "Vaccine shedding", "answer_start": 306}], "is_impossible": false}, {"question": "What are the two types of COVID-19 vaccines available?", "id": "100000000000000000006278", "answers": [{"text": "mRNA and viral vector vaccines", "answer_start": 565}], "is_impossible": false}], "context": "All COVID-\nvaccines\nare free\nfrom\nmetals. 10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nLearn\nmore\nabout\nthe ingredi\nents in the\nvaccinatio\nns\nauthorized\nfor use in\nthe United\nStates. MYTH: COVID-19 vaccines authorized for use in the United States shed or release their\ncomponents. FACT: Vaccine shedding is the release or discharge of any of the vaccine components in or outside of the body\nand can only occur when a vaccine contains a live weakened version of the virus. None of the vaccines authorized for use in the U.S. contain a live virus. mRNA and viral vector vaccines are the two types of currently\nauthorized COVID-19 vaccines available."}]}, {"title": "387244b6291eddd26f607d902e2a1c05", "paragraphs": [{"qas": [{"question": "What is delivering instructions to our cells to start building protection against the virus that causes COVID-19?", "id": "100000000000000000006280", "answers": [{"text": "genetic material", "answer_start": 271}], "is_impossible": false}, {"question": "What does the body discard after producing an immune response?", "id": "100000000000000000006281", "answers": [{"text": "all the vaccine ingredients", "answer_start": 491}], "is_impossible": false}, {"question": "What is a part of normal body functioning?", "id": "100000000000000000006282", "answers": [{"text": "After the body produces an immune response, it discards all the vaccine ingredients", "answer_start": 435}], "is_impossible": false}], "context": "Learn more about mRNA and\u200b viral vector COVID-19 vaccines. MYTH: COVID-19 vaccines can alter my DNA. FACT: COVID-19 vaccines do not change or interact with your DNA in any way. Both messenger RNA (mRNA) and viral vector COVID-19 vaccines work\nby delivering instructions (genetic material) to our cells to start\nbuilding protection against the virus that causes COVID-19. 10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nAfter the body produces an immune response, it discards all the\nvaccine ingredients just as it would discard any information that cells\nno longer need. This process is a part of normal body functioning."}]}, {"title": "8aa72b1af65e90713668bb4fb4f2a5af", "paragraphs": [{"qas": [{"question": "What is the nucleus of your cells where your DNA is kept?", "id": "100000000000000000006283", "answers": [{"text": "the nucleus", "answer_start": 61}], "is_impossible": false}, {"question": "What do mRNA vaccines deliver to your cells?", "id": "100000000000000000006284", "answers": [{"text": "nucleus", "answer_start": 64}], "is_impossible": false}, {"question": "The vector virus does not have the machinery needed to integrate what?", "id": "100000000000000000006285", "answers": [{"text": "its genetic material into our DNA", "answer_start": 328}], "is_impossible": false}, {"question": "What type of virus does not have the machinery needed to integrate its genetic material into our DNA?", "id": "100000000000000000006286", "answers": [{"text": "vector virus", "answer_start": 267}], "is_impossible": false}], "context": "The genetic material delivered by mRNA vaccines never enters the\nnucleus of your cells, which is where your DNA is kept. Viral vector\nCOVID-19 vaccines deliver genetic material to the cell nucleus to allow\nour cells to build protection against COVID-19. However, the vector\nvirus does not have the machinery needed to integrate its genetic\nmaterial into our DNA, so it cannot alter our DNA. Learn more about how COVID-19 vaccines work. MYTH: A COVID-19 vaccine can make me sick with COVID-19."}]}, {"title": "9ca68d19a603dc5adc6404f494a16304", "paragraphs": [{"qas": [{"question": "What does none of the authorized COVID-19 vaccines in the United States contain?", "id": "100000000000000000006288", "answers": [{"text": "the live virus", "answer_start": 84}], "is_impossible": false}, {"question": "What does the vaccine not make you sick with?", "id": "100000000000000000006289", "answers": [{"text": "COVID-19", "answer_start": 159}], "is_impossible": false}, {"question": "What is one of the symptoms of COVID-19?", "id": "100000000000000000006291", "answers": [{"text": "fever", "answer_start": 322}], "is_impossible": false}, {"question": "What is another sign that the body is building protection against the virus?", "id": "100000000000000000006292", "answers": [{"text": "symptoms", "answer_start": 304}], "is_impossible": false}], "context": "FACT: Because none of the authorized COVID-19 vaccines in the United States contain the live virus that causes\nCOVID-19, the vaccine cannot make you sick with COVID-19. COVID-19 vaccines teach our immune systems how to recognize and\nfight the virus that causes COVID-19. Sometimes this process can\ncause symptoms, such as fever. These symptoms are normal and are\nsigns that the body is building protection against the virus that causes\nCOVID-19. Learn more about how COVID-19 vaccines work."}]}, {"title": "a656a102ea0ec3ea43d84f8acc5a6dad", "paragraphs": [{"qas": [{"question": "What is recommended for people who are pregnant, trying to get pregnant, or might become pregnant in the future?", "id": "100000000000000000006293", "answers": [{"text": "COVID-19 vaccination", "answer_start": 22}], "is_impossible": false}, {"question": "What is the term for problems trying to get pregnant?", "id": "100000000000000000006295", "answers": [{"text": "fertility problems", "answer_start": 399}], "is_impossible": false}, {"question": "What does COVID-19 vaccine cause?", "id": "100000000000000000006296", "answers": [{"text": "fertility problems", "answer_start": 399}], "is_impossible": false}], "context": "Other Myths and Facts\nCOVID-19 vaccination is recommended for people who are pregnant, trying to get pregnant now, or might become\npregnant in the future, as well as their partners. Learn more about COVID-19 vaccines and people who would like to have a baby. MYTH: COVID-19 vaccines will affect my fertility. \uf1aa\nFACT: Currently no evidence shows that any vaccines, including COVID-19 vaccines, cause fertility\nproblems (problems trying to get pregnant) in women or men."}]}, {"title": "40a79cddef89d530d8915ccf6a4e0bb6", "paragraphs": [{"qas": [{"question": "Stress, changes in your schedule, problems with sleep, and changes in diet and exercise can all affect what?", "id": "100000000000000000006298", "answers": [{"text": "menstrual cycles", "answer_start": 87}], "is_impossible": false}, {"question": "What can also affect the menstruation cycle?", "id": "100000000000000000006299", "answers": [{"text": "Infections", "answer_start": 203}], "is_impossible": false}, {"question": "Who received a COVID-19 vaccine will affect my menstrual cycle?", "id": "100000000000000000006300", "answers": [{"text": "Being near someone", "answer_start": 254}], "is_impossible": false}, {"question": "What is the goal of your body developing an immune response to vaccination?", "id": "100000000000000000006301", "answers": [{"text": "you may test positive on some antibody tests", "answer_start": 516}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nMany things can affect menstrual cycles, including stress, changes in\nyour schedule, problems with sleep, and changes in diet or exercise. Infections may also affect menstrual cycles. MYTH: Being near someone who received a COVID-19 vaccine will affect my menstrual cycle. \uf1aa\nFACT: Your menstrual cycle cannot be affected by being near someone who received a COVID-19 vaccine. If your body develops an immune response to vaccination, which is\nthe goal, you may test positive on some antibody tests."}]}, {"title": "61c2724e55857fe06399db210f64599", "paragraphs": [{"qas": [{"question": "Antibody tests indicate that you had a previous infection and that you may have some level of protection against what?", "id": "100000000000000000006302", "answers": [{"text": "the virus", "answer_start": 108}], "is_impossible": false}, {"question": "Learn more about the possibility of COVID-19 illness after vaccination.", "id": "100000000000000000006303", "answers": [{"text": "Antibody tests", "answer_start": 0}], "is_impossible": false}, {"question": "What will getting a vaccine cause me to test positive on a viral test?", "id": "100000000000000000006304", "answers": [{"text": "MYTH", "answer_start": 191}], "is_impossible": false}, {"question": "What are viral tests used for?", "id": "100000000000000000006306", "answers": [{"text": "see if you have a current infection", "answer_start": 402}], "is_impossible": false}, {"question": "When was the last update of the CDC Related Pages?", "id": "100000000000000000006308", "answers": [{"text": "July 20, 2022", "answer_start": 623}], "is_impossible": false}], "context": "Antibody tests\nindicate you had a previous infection and that you may have some\nlevel of protection against the virus. Learn more about the possibility of COVID-19 illness after vaccination. MYTH: Getting a COVID-19 vaccine will cause me to test positive on a viral test. \uf1aa\nFACT: None of the authorized and recommended COVID-19 vaccines can cause you to test positive on viral\ntests, which are used to see if you have a current infection.\u200b\f10/30/22, 9:34 AM Myths and Facts about COVID-19 Vaccines | CDC\nRelated Pages\nFrequently Asked Questions about Vaccination\n\u203a\nKey Things to Know about COVID-19 Vaccines\n\u203a\nLast Updated July 20, 2022"}]}, {"title": "85fe249c5ed5a967b10dfecc679dd3e4", "paragraphs": [{"qas": [{"question": "What is the Healthcare Appointment Checklist (Espaol \u2013 72 KB)?", "id": "100000000000000000006312", "answers": [{"text": "PDF", "answer_start": 483}], "is_impossible": false}, {"question": "What is completed on your appointment day?", "id": "100000000000000000006313", "answers": [{"text": "paperwork", "answer_start": 578}], "is_impossible": false}], "context": "10/30/22, 9:42 AM Patient Tips: Healthcare Provider Appointments for Post-COVID Conditions | CDC\nEspa\u00f1ol | Other Languages\nPatient Tips: Healthcare Provider Appointments for\nPost-COVID Conditions\nBefore Your Appointment\nWhat You Need to Know\nPreparing for an appointment can make all the difference in getting the proper evaluation, diagnosis, and\ntreatment. To help get the most out of appointments for post-COVID conditions, download the Healthcare Appointment\nChecklist (Espa\u00f1ol [PDF \u2013 72 KB]). Try to arrive early or log on a few minutes ahead of the appointment and ensure paperwork is completed on your\nappointment day. After visiting your healthcare provider, review your notes to prepare for your next appointment."}]}, {"title": "39288f8f077a22fb6ed55463d7e14b7b", "paragraphs": [{"qas": [{"question": "What can you do if you think you or a loved one may have a post-COVID condition?", "id": "100000000000000000006316", "answers": [{"text": "taking a few steps to prepare for your meeting with a healthcare provider", "answer_start": 204}], "is_impossible": false}, {"question": "What do you play a vital role in helping healthcare providers understand?", "id": "100000000000000000006318", "answers": [{"text": "your or your family member\u2019s symptoms", "answer_start": 439}], "is_impossible": false}], "context": "\u2022\n\u2022\n\uf20c\n\u2022\n\u2022\nIf you think you or a loved one may have a post-COVID condition (new or persistent conditions occurring 4 or more weeks\nafter initial infection with SARS-CoV-2, the virus that causes COVID-19), taking a few steps to prepare for your meeting\nwith a healthcare provider can make all the difference in getting the proper medical evaluation, diagnosis, and treatment. You play a vital role in helping healthcare providers understand your or your family member\u2019s symptoms and how they\naffect your daily life."}]}, {"title": "b2d242090ec0a65a4047bfba5ff7435b", "paragraphs": [{"qas": [{"question": "What is a brief history that summarizes your medical history?", "id": "100000000000000000006320", "answers": [{"text": "Write Down Your History", "answer_start": 273}], "is_impossible": false}, {"question": "What do you write down to summarize your experience with COVID-19 and post-COVID conditions?", "id": "100000000000000000006321", "answers": [{"text": "brief history", "answer_start": 307}], "is_impossible": false}], "context": "Printable Version: Preparing for Your Appointment | Espa\u00f1ol [PDF \u2013 372 KB]\n\uf189 \uf20c\nList Your Healthcare Providers\nPrepare a list of your current and past healthcare providers and your current and past medical conditions, especially if\nyou are seeing a new healthcare provider. Write Down Your History\nPrepare a brief history that summarizes your experience with COVID-19 and post-COVID conditions."}]}, {"title": "4619bd1b3ce4468c1a5a60e00ca986d0", "paragraphs": [{"qas": [{"question": "What is a list of prior treatments and diagnostic tests related to your post-COVID symptoms?", "id": "100000000000000000006322", "answers": [{"text": "what makes your symptoms worse", "answer_start": 342}], "is_impossible": false}, {"question": "What is the date of onset of original COVID-19 illness?", "id": "100000000000000000006323", "answers": [{"text": "- - -", "answer_start": 376}], "is_impossible": false}, {"question": "What makes your symptoms worse?", "id": "100000000000000000006325", "answers": [{"text": "a list of prior treatments and diagnostic tests", "answer_start": 231}], "is_impossible": false}, {"question": "How often do symptoms occur?", "id": "100000000000000000006326", "answers": [{"text": "how you have been feeling", "answer_start": 633}], "is_impossible": false}, {"question": "What are some examples of your best and worst days?", "id": "100000000000000000006327", "answers": [{"text": "- - -", "answer_start": 376}], "is_impossible": false}], "context": "For example, write\ndown a list of the symptoms you think started after your COVID-19 infection:\nthe date of onset of original COVID-19 illness and/or positive COVID-19 test, if known\nwhen your post-COVID condition symptoms started\na list of prior treatments and diagnostic tests related to your post-COVID symptoms (blood work, x-rays, etc.) what makes your symptoms worse\n\u2022\n\u2022\n-\n-\n-\n-\f10/30/22, 9:42 AM Patient Tips: Healthcare Provider Appointments for Post-COVID Conditions | CDC\ny y p\nhow the symptoms affect your activities, including challenges that effect daily living, working, attending school, etc. how often symptoms occur\nhow you have been feeling\ntry to describe examples of your best and worst days."}]}, {"title": "ce49d051adc3fc2ec968df2b2366ec0e", "paragraphs": [{"qas": [{"question": "What are some of your most important issues sometimes referred to as?", "id": "100000000000000000006328", "answers": [{"text": "chief complaints", "answer_start": 61}], "is_impossible": false}, {"question": "What do most healthcare providers ask you to provide at each appointment?", "id": "100000000000000000006329", "answers": [{"text": "a list of medications and supplements you are taking", "answer_start": 130}], "is_impossible": false}, {"question": "Who can help keep track of your medications and supplements?", "id": "100000000000000000006330", "answers": [{"text": "Bringing your list with you", "answer_start": 272}], "is_impossible": false}, {"question": "Who can help you take notes and remember what was discussed at the appointment while it\u2019s still fresh in your mind?", "id": "100000000000000000006332", "answers": [{"text": "a trusted family member or friend", "answer_start": 400}], "is_impossible": false}, {"question": "What was discussed at the appointment while it was still fresh in your mind?", "id": "100000000000000000006333", "answers": [{"text": "a Family Member or Friend Consider discussing your appointment with a trusted family member or friend", "answer_start": 332}], "is_impossible": false}], "context": "Select your most important issues (sometimes referred to as\n\u201cchief complaints\u201d) and write them down\nList Your Medications\nPrepare a list of medications and supplements you are taking. Most healthcare providers will ask you to provide this\ninformation at each appointment. Bringing your list with you will help keep track. Talk with a Family Member or Friend\nConsider discussing your appointment with a trusted family member or friend immediately before and after you see\nyour healthcare provider. This person can help you take notes and remember what was discussed at the appointment\nwhile it\u2019s still fresh in your mind."}]}, {"title": "1f47486fda250b86002fb547c56edaff", "paragraphs": [{"qas": [{"question": "If your healthcare provider\u2019s office policy allows it, consider bringing them to your appointment with you.", "id": "100000000000000000006334", "answers": [{"text": "- - -", "answer_start": 613}], "is_impossible": false}, {"question": "What type of healthcare professional could you meet with?", "id": "100000000000000000006335", "answers": [{"text": "doctor", "answer_start": 161}], "is_impossible": false}, {"question": "What may take more than one appointment to evaluate potential post-COVID symptoms?", "id": "100000000000000000006336", "answers": [{"text": "The provider you meet with could be a doctor, nurse, nurse practitioner, physician assistant, or other type of healthcare professional. It may take more than one appointment to evaluate potential post-COVID symptoms and determine an accurate diagnosis to better manage and treat your symptoms", "answer_start": 123}], "is_impossible": false}, {"question": "What may your provider ask about your medical history, current symptoms and quality of life?", "id": "100000000000000000006338", "answers": [{"text": "It may take more than one appointment to evaluate potential post-COVID symptoms and determine an accurate diagnosis to better manage and treat your symptoms. Your provider may ask questions about your medical history, current symptoms, and quality of life. Depending on your symptoms, they may run tests", "answer_start": 259}], "is_impossible": false}, {"question": "What are tests used to determine?", "id": "100000000000000000006339", "answers": [{"text": "a diagnosis", "answer_start": 576}], "is_impossible": false}], "context": "If your healthcare provider\u2019s office policy allows it, consider bringing them to your\nappointment with you. What to Expect\nThe provider you meet with could be a doctor, nurse, nurse practitioner, physician assistant, or other type of healthcare\nprofessional. It may take more than one appointment to evaluate potential post-COVID symptoms and determine an accurate\ndiagnosis to better manage and treat your symptoms. Your provider may ask questions about your medical history, current\nsymptoms, and quality of life. Depending on your symptoms, they may run tests to determine a diagnosis and plan for\ntreatment. -\n-\n-\n-\n\u2022\n\u2022\nHealthcare providers are still learning about post-COVID conditions."}]}, {"title": "a2863c6a8500676b8321bf8a37e97940", "paragraphs": [{"qas": [{"question": "What is CDC trying to determine about long-term effects?", "id": "100000000000000000006341", "answers": [{"text": "how common", "answer_start": 35}], "is_impossible": false}, {"question": "What should you do on the day of your appointment?", "id": "100000000000000000006343", "answers": [{"text": "try to arrive a little early", "answer_start": 242}], "is_impossible": false}, {"question": "What can you do if your provider is running late?", "id": "100000000000000000006344", "answers": [{"text": "use the time to make sure your paperwork or forms have been filled out and the front desk has your correct information", "answer_start": 406}], "is_impossible": false}, {"question": "What should you do for telemedicine appointments?", "id": "100000000000000000006345", "answers": [{"text": "call in or log on a few minutes ahead of the appointment", "answer_start": 306}], "is_impossible": false}], "context": "CDC continues to work to determine how common\nthese long-term effects are, who is most likely to get them, how long the symptoms typically last, and whether symptoms\neventually resolve. During Your Appointment\nOn the day of your appointment, try to arrive a little early or, for telemedicine appointments, call in or log on a few\nminutes ahead of the appointment. If your provider is running late, you can use the time to make sure your paperwork or\nforms have been filled out and the front desk has your correct information."}]}, {"title": "ddbe91e1b949ffb156c019a962e22e53", "paragraphs": [{"qas": [{"question": "What can be the most valuable part of a visit?", "id": "100000000000000000006350", "answers": [{"text": "talking to your provider", "answer_start": 9}], "is_impossible": false}, {"question": "What should you sign if your provider still needs any of your past medical records?", "id": "100000000000000000006351", "answers": [{"text": "required forms", "answer_start": 161}], "is_impossible": false}, {"question": "What do you do if the answers are not clear to you?", "id": "100000000000000000006353", "answers": [{"text": "clarify the answers", "answer_start": 456}], "is_impossible": false}], "context": "Focus on talking to your provider as this can be the most valuable part of the visit. If your provider still needs any of your\npast medical records, ask to sign required forms to give your permission to have these records sent. Ask & Answer Questions\n\u2022\n\u2022\f10/30/22, 9:42 AM Patient Tips: Healthcare Provider Appointments for Post-COVID Conditions | CDC\nAsk questions, starting with the most important ones. Don\u2019t hesitate to ask your healthcare provider to clarify the\nanswers if they are not clear to you."}]}, {"title": "98abd760f74c65fa3c450969e3e8006", "paragraphs": [{"qas": [{"question": "What do you discuss with your provider about your illness?", "id": "100000000000000000006354", "answers": [{"text": "activity levels", "answer_start": 28}], "is_impossible": false}, {"question": "How do you explain how you feel?", "id": "100000000000000000006355", "answers": [{"text": "Be straightforward", "answer_start": 206}], "is_impossible": false}, {"question": "What should you bring to your provider to write down instructions?", "id": "100000000000000000006357", "answers": [{"text": "pencil and paper", "answer_start": 445}], "is_impossible": false}, {"question": "What can you use to take notes?", "id": "100000000000000000006358", "answers": [{"text": "hand-held device", "answer_start": 501}], "is_impossible": false}], "context": "Be prepared to discuss your activity levels, what activities make your illness worse, and any medications that seem to\nimprove or worsen the symptoms. Answer the provider\u2019s questions. Explain how you feel. Be straightforward, and don\u2019t be embarrassed to talk about\nanything. Let your provider know if there have been any changes to your prescribed medications and supplements. Know Your Next Steps\nMake sure you understand the next steps. Bring pencil and paper to write down instructions or use your hand-held\ndevice for notes. Repeat back what the provider has told you to check for understanding."}]}, {"title": "d67bebac569654e2fefdc81d10dc2b23", "paragraphs": [{"qas": [{"question": "What would you ask if I went to the lab with this paperwork?", "id": "100000000000000000006361", "answers": [{"text": "\u201cSo, I should go to the lab next week with this paperwork to get my blood drawn?\u201d", "answer_start": 29}], "is_impossible": false}, {"question": "What should you ask the provider to write down for you?", "id": "100000000000000000006362", "answers": [{"text": "any instructions, medication names, etc.,", "answer_start": 351}], "is_impossible": false}, {"question": "If you have changes to your treatment plan, make sure you understand what to do?", "id": "100000000000000000006363", "answers": [{"text": "new medication, ask why it is being given and what you should expect by taking this new medication", "answer_start": 488}], "is_impossible": false}, {"question": "For new medication, ask why is it being given?", "id": "100000000000000000006364", "answers": [{"text": "what you should expect by taking this new medication", "answer_start": 534}], "is_impossible": false}, {"question": "What should you ask when taking a new medication?", "id": "100000000000000000006365", "answers": [{"text": "why it is being given and what you should expect", "answer_start": 508}], "is_impossible": false}, {"question": "What is the name of the new medication you are taking?", "id": "100000000000000000006366", "answers": [{"text": "ask why it is being given and what you should expect by taking this new medication", "answer_start": 504}], "is_impossible": false}], "context": "(For example, you might ask:\n\u201cSo, I should go to the lab next week with this paperwork to get my blood drawn?\u201d). Additional questions could include:\nWill I need additional tests? When and how will I get test results? When should I return for another visit? Ask for a Summary\nAsk for an appointment summary. You can also ask the provider to write down any instructions, medication names, etc.,\nfor you. If there are changes to your treatment plan, make sure you understand what to do. For new medication, ask why\nit is being given and what you should expect by taking this new medication."}]}, {"title": "c9e7d47e28db236a49b28951693ce58c", "paragraphs": [{"qas": [{"question": "What can help you get the most out of your appointments?", "id": "100000000000000000006367", "answers": [{"text": "reviewing your appointment notes", "answer_start": 189}], "is_impossible": false}, {"question": "What can you do if you have been diagnosed with a post-COVID condition?", "id": "100000000000000000006368", "answers": [{"text": "reviewing your appointment notes and preparing for your next one can help you get the most out of your appointments", "answer_start": 189}], "is_impossible": false}, {"question": "What do you do after your appointment?", "id": "100000000000000000006369", "answers": [{"text": "reviewing your appointment notes", "answer_start": 189}], "is_impossible": false}, {"question": "What is a good way to keep track of your appointments?", "id": "100000000000000000006370", "answers": [{"text": "reviewing your appointment notes and preparing for your next one can help you get the most out of your appointments. Printable Version: After Your Appointment | Espa\u00f1ol [PDF \u2013 370 KB] \uf189 \uf20c \uf20c Track Your Appointments Make appointments for follow up and any additional testing. Record future appointments on your calendar", "answer_start": 189}], "is_impossible": false}, {"question": "How do you record future appointments on your calendar?", "id": "100000000000000000006371", "answers": [{"text": "Ask a friend or family member to put the appointment(s) on their calendars", "answer_start": 508}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n-\n\u2022\nAfter Your Appointment\nIf you have been diagnosed with a post-COVID condition or are waiting to hear back from your provider about a post-\nCOVID conditions diagnosis, reviewing your appointment notes and preparing for your next one can help you get the\nmost out of your appointments. Printable Version: After Your Appointment | Espa\u00f1ol [PDF \u2013 370 KB]\n\uf189 \uf20c \uf20c\nTrack Your Appointments\nMake appointments for follow up and any additional testing. Record future appointments on your calendar. Ask a friend or family member to put the appointment(s) on their\ncalendars as well."}]}, {"title": "a7e9b606956152408ae3cfb3bd3b0092", "paragraphs": [{"qas": [{"question": "Who will call or email you with an appointment reminder?", "id": "100000000000000000006372", "answers": [{"text": "the provider\u2019s office", "answer_start": 4}], "is_impossible": false}, {"question": "What should you do to document your experiences?", "id": "100000000000000000006374", "answers": [{"text": "Continue to record symptoms in a journal", "answer_start": 321}], "is_impossible": false}, {"question": "How do you document your symptoms?", "id": "100000000000000000006375", "answers": [{"text": "in a journal", "answer_start": 349}], "is_impossible": false}, {"question": "What journal do you keep if you can?", "id": "100000000000000000006376", "answers": [{"text": "record symptoms in a journal", "answer_start": 333}], "is_impossible": false}], "context": "Ask the provider\u2019s office if they will call or email you with an appointment reminder. Work with Your Healthcare Provider\nIf you are confused or don\u2019t remember something your provider said, call the provider\u2019s office for clarification. Follow your provider\u2019s instructions as closely as you can. Document Your Experiences\nContinue to record symptoms in a journal, if possible."}]}, {"title": "225fd30e1866eb863f97e978a93a9a4a", "paragraphs": [{"qas": [{"question": "What do some people with post-COVID conditions find helpful to include?", "id": "100000000000000000006377", "answers": [{"text": "whether symptoms have improved which treatments have improved symptoms any side effects", "answer_start": 67}], "is_impossible": false}, {"question": "What has improved the symptoms of COVID?", "id": "100000000000000000006378", "answers": [{"text": "which treatments", "answer_start": 98}], "is_impossible": false}, {"question": "What did your healthcare provider give you feedback about?", "id": "100000000000000000006379", "answers": [{"text": "how recommended interventions have worked for you", "answer_start": 362}], "is_impossible": false}], "context": "Some people with post-COVID conditions find it helpful to include:\nwhether symptoms have improved\nwhich treatments have improved symptoms\nany side effects\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n-\f10/30/22, 9:42 AM Patient Tips: Healthcare Provider Appointments for Post-COVID Conditions | CDC\nany other new symptoms or changes\nMake a note to give your healthcare provider feedback about how recommended interventions have worked for you. Write down any issues you did not have time to talk about at the last appointment. Keep track of medications, vitamins, herbs, supplements, and over-the-counter drugs you take, using a current\nmedications and supplements list."}]}, {"title": "c57d3aff8fa831944fd81ab931072b2e", "paragraphs": [{"qas": [{"question": "What should your provider share if the expected window for receiving the results has passed?", "id": "100000000000000000006382", "answers": [{"text": "any test results", "answer_start": 30}], "is_impossible": false}, {"question": "What is the Healthcare Appointment Checklist for Post-COVID Conditions?", "id": "100000000000000000006385", "answers": [{"text": "before your next appointment", "answer_start": 600}], "is_impossible": false}, {"question": "What are the conditions before your next appointment?", "id": "100000000000000000006386", "answers": [{"text": "Post-COVID Conditions", "answer_start": 578}], "is_impossible": false}, {"question": "What are many instructions for?", "id": "100000000000000000006387", "answers": [{"text": "follow-up appointments", "answer_start": 681}], "is_impossible": false}], "context": "Remind your provider to share any test results if the expected window for receiving the results has passed. Set Goals with Your Healthcare Provider\nYour provider may run tests that return normal results. This does not change the existence, severity, or importance of\nyour symptoms or conditions. Healthcare providers and patients are encouraged to set achievable goals through shared\ndecision-making and to approach treatment by focusing on specific symptoms or conditions. Review the Healthcare Appointment Checklist\nConsider reviewing the Healthcare Appointment Checklist for Post-COVID Conditions before your next appointment\n(Espa\u00f1ol [PDF \u2013 72 KB]). Many instructions apply to follow-up appointments."}]}, {"title": "6309407c0234ff58026407c814d1d45c", "paragraphs": [{"qas": [{"question": "What is the last date the CHECKLIST Healthcare Appointment Checklist for Post-COVID Conditions was updated?", "id": "100000000000000000006388", "answers": [{"text": "July 11, 2022", "answer_start": 109}], "is_impossible": false}], "context": "-\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022 \uf20c\nCHECKLIST\nHealthcare Appointment Checklist\nfor Post-COVID Conditions\nView PDF\n\uf20c\nLast Updated July 11, 2022"}]}, {"title": "f340a0b795ebba6fe9080708b0e6aeac", "paragraphs": [{"qas": [{"question": "Who is more likely to get sick with COVID-19 or be sick for a longer period?", "id": "100000000000000000006389", "answers": [{"text": "Some people who are immunocompromised", "answer_start": 176}], "is_impossible": false}, {"question": "Who can be immunocompromised due to a medical condition or from receipt of immunosuppressive medications or treatments?", "id": "100000000000000000006391", "answers": [{"text": "People", "answer_start": 320}], "is_impossible": false}, {"question": "Who can you talk to if you have another medical condition?", "id": "100000000000000000006392", "answers": [{"text": "your healthcare provider", "answer_start": 458}], "is_impossible": false}], "context": "10/30/22, 9:38 AM People Who Are Immunocompromised | CDC\nEspa\u00f1ol | Other Languages\nPeople Who Are Immunocompromised\nKnow how to protect yourself and what to do if you get sick\nSome people who are immunocompromised (have a weakened immune system) are more likely to get sick with COVID-19 or\nbe sick for a longer period. People can be immunocompromised either due to a medical condition or from receipt of\nimmunosuppressive medications or treatments. Talk to your healthcare provider if you have another medical condition or are on medication that may not be reflected above."}]}, {"title": "cf736b83e63eaf5cbf130ec663bc40ca", "paragraphs": [{"qas": [{"question": "What is important to have if you are immunocompromised?", "id": "100000000000000000006393", "answers": [{"text": "a COVID-19 plan", "answer_start": 92}], "is_impossible": false}, {"question": "How do you prevent, diagnose, and treat COVID-19?", "id": "100000000000000000006395", "answers": [{"text": "plan", "answer_start": 241}], "is_impossible": false}, {"question": "What do you build a plan for preventing, diagnosing, and treating?", "id": "100000000000000000006396", "answers": [{"text": "COVID", "answer_start": 288}], "is_impossible": false}, {"question": "How can you act quickly if you are exposed, develop symptoms or test positive?", "id": "100000000000000000006397", "answers": [{"text": "COVID-19 plan", "answer_start": 233}], "is_impossible": false}], "context": "If you or someone you live or spend time with is immunocompromised, it is important to have a COVID-19 plan to protect\nyourself from infection and prepare for what to do if you get sick. Information on this page can help you build a COVID-19\nplan for preventing, diagnosing, and treating COVID, so you know what to do and can act quickly if you\u2019re exposed, develop\nsymptoms, or test positive and when COVID-19 levels are increasing in your community."}]}, {"title": "15afeb4c7b78571f63a78c00e41e94f2", "paragraphs": [{"qas": [{"question": "What is effective at protecting people from getting seriously ill, being hospitalized, and even dying?", "id": "100000000000000000006398", "answers": [{"text": "COVID-19 vaccines", "answer_start": 41}], "is_impossible": false}, {"question": "What is best when you stay up to date with your COVID-19 vaccines?", "id": "100000000000000000006399", "answers": [{"text": "you are protected", "answer_start": 232}], "is_impossible": false}], "context": "Stay up to date on COVID-19 vaccinations\nCOVID-19 vaccines are effective at protecting people\u2014especially those who are up to date\u2014 from getting seriously ill, being\nhospitalized, and even dying. As with vaccines for other diseases, you are protected best when you stay up to date with your\nCOVID-19 vaccines. The people you live or spend time with can help protect you and themselves by staying up to date on their\nCOVID-19 vaccines too."}]}, {"title": "5cb03253fcc7e4d7c436677149b9630a", "paragraphs": [{"qas": [{"question": "What are examples of medical conditions or treatments that may result in moderate to severe immunocompromise?", "id": "100000000000000000006401", "answers": [{"text": "Active treatment for solid tumor and hematologic malignancies", "answer_start": 132}], "is_impossible": false}, {"question": "What is active treatment for for solid tumor and hematologic malignancies?", "id": "100000000000000000006402", "answers": [{"text": "Hematologic malignancies associated with poor responses to COVID-19 vaccines", "answer_start": 194}], "is_impossible": false}, {"question": "How long does it take for a hematopoietic stem cell transplant to be successful?", "id": "100000000000000000006404", "answers": [{"text": "2 years", "answer_start": 601}], "is_impossible": false}, {"question": "What is a common variable immunodeficiency disease?", "id": "100000000000000000006405", "answers": [{"text": "Moderate or severe primary immunodeficiency", "answer_start": 665}], "is_impossible": false}, {"question": "What is an advanced or untreated HIV infection?", "id": "100000000000000000006407", "answers": [{"text": "people with HIV and CD4 cell counts less than 200/mm3", "answer_start": 874}], "is_impossible": false}, {"question": "What is a cancer chemotherapeutic agent classified as severely immunosuppressive?", "id": "100000000000000000006410", "answers": [{"text": "tumor necrosis factor (TNF) blockers", "answer_start": 1342}], "is_impossible": false}, {"question": "What are biologic agents that are immunosuppressive or immunomodulatory?", "id": "100000000000000000006413", "answers": [{"text": "chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant", "answer_start": 508}], "is_impossible": false}, {"question": "When you have received all doses in the primary series and all boosters recommended for you?", "id": "100000000000000000006414", "answers": [{"text": "You are up to date with your COVID-19 vaccines", "answer_start": 1548}], "is_impossible": false}], "context": "Examples of medical conditions or treatments that may result in moderate to severe immunocompromise include but are not\nlimited to:\nActive treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines regardless of current treatment status\n(e.g., chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute leukemia)\nReceipt of solid-organ transplant or an islet transplant and taking immunosuppressive therapy\nReceipt of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease, severe combined\nimmunodeficiency, DiGeorge syndrome, Wiskott-Aldrich syndrome)\nAdvanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3, history of an AIDS-\ndefining illness without immune reconstitution, or clinical manifestations of symptomatic HIV)\nActive treatment with high-dose corticosteroids (i.e., 20 or more mg of prednisone or equivalent per day when\nadministered for 2 or more weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs,\ncancer chemotherapeutic agents classified as severely immunosuppressive, tumor necrosis factor (TNF) blockers, and\nother biologic agents that are immunosuppressive or immunomodulatory\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nHow to Protect Yourself\f10/30/22, 9:38 AM People Who Are Immunocompromised | CDC\nYou are up to date with your COVID-19 vaccines when you have received all doses in the primary series and all boosters\nrecommended for you, when eligible."}]}, {"title": "f6f3b567c57c7229f2447bef44d3c950", "paragraphs": [{"qas": [{"question": "What may not be as strong as in people who are not immunocompromised?", "id": "100000000000000000006415", "answers": [{"text": "immune response to COVID-19 vaccination", "answer_start": 11}], "is_impossible": false}, {"question": "What are different recommendations for COVID-19 vaccines?", "id": "100000000000000000006416", "answers": [{"text": "boosters", "answer_start": 184}], "is_impossible": false}, {"question": "What type of mask or respirator should you wear?", "id": "100000000000000000006418", "answers": [{"text": "high quality", "answer_start": 547}], "is_impossible": false}, {"question": "Properly fitting respirators provide what level of protection?", "id": "100000000000000000006419", "answers": [{"text": "highest", "answer_start": 621}], "is_impossible": false}, {"question": "What are two things you should avoid?", "id": "100000000000000000006421", "answers": [{"text": "poorly ventilated or crowded indoor settings", "answer_start": 656}], "is_impossible": false}], "context": "Since your immune response to COVID-19 vaccination may not be as strong as in people\nwho are not immunocompromised, you have different recommendations for COVID-19 vaccines, including boosters. Learn\nmore about COVID-19 vaccine recommendations for people who are moderately or severely immunocompromised. COVID-19 pre-exposure prophylaxis\nTake extra precautions\nEven if you stay up to date on COVID-19 vaccines and receive Evusheld , taking multiple prevention steps can provide\nadditional layers of protection from COVID-19. Wear a well-fitting, high quality mask or respirator. Properly fitting respirators provide the highest level of protection. Avoid poorly ventilated or crowded indoor settings."}]}, {"title": "19ebe365fb9b6eeaa829c4155e60241a", "paragraphs": [{"qas": [{"question": "How much alcohol does a hand sanitizer contain?", "id": "100000000000000000006422", "answers": [{"text": "60%", "answer_start": 163}], "is_impossible": false}, {"question": "What should you do if you get sick with COVID-19?", "id": "100000000000000000006423", "answers": [{"text": "prepared and know what to do if you get sick with COVID-19. Don\u2019t delay seeking medical care", "answer_start": 197}], "is_impossible": false}, {"question": "What do you need to do if you get sick with COVID-19?", "id": "100000000000000000006424", "answers": [{"text": "prepared", "answer_start": 197}], "is_impossible": false}, {"question": "What will help you decide when to add layers of protection?", "id": "100000000000000000006426", "answers": [{"text": "Knowing your community levels", "answer_start": 442}], "is_impossible": false}, {"question": "What do you decide when to add layers of protection?", "id": "100000000000000000006427", "answers": [{"text": "wearing a mask", "answer_start": 532}], "is_impossible": false}], "context": "When indoors with others, try to improve ventilation as much as possible. Wash your hands often with soap and water or use a hand sanitizer that contains at least 60% alcohol. It\u2019s important to be prepared and know what to do if you get sick with COVID-19. Don\u2019t delay seeking medical care. Be\nprepared by understanding the following steps:\nWhat you can do now\nKnow the symptoms of COVID-19. Learn how to check your COVID-19 Community Level. Knowing your community levels will help you decide when to add\nlayers of protection, like wearing a mask."}]}, {"title": "6f76cdd9d0576bcf3921b0449b1ac9b1", "paragraphs": [{"qas": [{"question": "Order free at-home tests to have when you need them?", "id": "100000000000000000006429", "answers": [{"text": "Know how to get tested as soon as possible if you develop symptoms", "answer_start": 0}], "is_impossible": false}, {"question": "Check with your health insurance, Medicaid, or Medicare plan to learn what tests are available?", "id": "100000000000000000006430", "answers": [{"text": "If you need more tests", "answer_start": 121}], "is_impossible": false}, {"question": "Who authorized EVUSHELD as pre-exposure prophylaxis?", "id": "100000000000000000006432", "answers": [{"text": "U.S. Food and Drug Administration", "answer_start": 392}], "is_impossible": false}, {"question": "What type of medicine is given before you are exposed to or test positive for COVID-19?", "id": "100000000000000000006433", "answers": [{"text": "EVUSHELD", "answer_start": 362}], "is_impossible": false}], "context": "Know how to get tested as soon as possible if you develop symptoms. Order free at-home tests to have when you need them. If you need more tests, check with your health\ninsurance, Medicaid, or Medicare plan to learn what tests are available . To find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. EVUSHELD is authorized by the U.S. Food and Drug Administration (FDA) as pre-exposure prophylaxis to prevent\nCOVID-19. It is a medicine containing antibodies and is given before you are exposed to or test positive for COVID-19."}]}, {"title": "f29a42dfa53194cc1e701b0239e32f57", "paragraphs": [{"qas": [{"question": "People who could have a history of severe adverse reaction to the COVID-19 vaccine or its components could have what?", "id": "100000000000000000006435", "answers": [{"text": "EVUSHELD", "answer_start": 0}], "is_impossible": false}, {"question": "What does EVUSHELD still protect people from getting?", "id": "100000000000000000006436", "answers": [{"text": "COVID-19", "answer_start": 415}], "is_impossible": false}, {"question": "How many strains of the Omicron variant is EVusHELD able to protect against?", "id": "100000000000000000006437", "answers": [{"text": "three", "answer_start": 466}], "is_impossible": false}, {"question": "What are the strains BA.4.6, BF.7, and BA.2.75.2?", "id": "100000000000000000006438", "answers": [{"text": "three", "answer_start": 466}], "is_impossible": false}], "context": "EVUSHELD continues to be authorized for people who are moderately to severely immunocompromised and may not\nbe able to mount an adequate response to the COVID-19 vaccine, and for people who could have a history of severe\nadverse reaction to the COVID-19 vaccine or its components. If you\u2019re eligible for a vaccine, we encourage you to talk with\nyour healthcare provider. EVUSHELD still protects people from getting COVID-19, but it may offer less protection against three strains (BA.4.6,\nBF.7, and BA.2.75.2) of the Omicron variant."}]}, {"title": "b8a2503efb63b5f2fd312b133c9e4de3", "paragraphs": [{"qas": [{"question": "What should you continue to do if you develop symptoms of COVID-19?", "id": "100000000000000000006439", "answers": [{"text": "undergoing testing and seeking medical attention", "answer_start": 121}], "is_impossible": false}, {"question": "Who will determine whether you are eligible for EVUSHELD?", "id": "100000000000000000006440", "answers": [{"text": "Your healthcare provider", "answer_start": 266}], "is_impossible": false}, {"question": "Who will determine if you are eligible for EVUSHELD?", "id": "100000000000000000006441", "answers": [{"text": "Your healthcare provider", "answer_start": 266}], "is_impossible": false}], "context": "Even if you receive EVUSHELD , you should continue to take the necessary\nsteps to protect yourself and others, including undergoing testing and seeking medical attention if you develop\nsymptoms of COVID-19, as well as starting treatment for COVID-19 as appropriate. Your healthcare provider will determine if you are eligible for EVUSHELD . Talk to your healthcare provider about\nwhether EVUSHELD is the best option for you."}]}, {"title": "a498e79b77d2c1ec0e7d0e136f7b1288", "paragraphs": [{"qas": [{"question": "What do people who are immunocompromised know?", "id": "100000000000000000006444", "answers": [{"text": "Know where free or low-cost testing locations are near you", "answer_start": 208}], "is_impossible": false}, {"question": "What do you need to know in case you need a different provider?", "id": "100000000000000000006445", "answers": [{"text": "Have an updated list of all your current medications", "answer_start": 426}], "is_impossible": false}, {"question": "What are some ways to reach a healthcare provider right away?", "id": "100000000000000000006446", "answers": [{"text": "after hours or weekends", "answer_start": 354}], "is_impossible": false}, {"question": "What should you do if you were exposed to COVID-19?", "id": "100000000000000000006447", "answers": [{"text": "stay home", "answer_start": 592}], "is_impossible": false}], "context": "Download: Evusheld EUA Fact Sheet for Patients, Parents and Caregivers\nTM\nTM\nTM\nTM\nTM\nTM\n\uf2dc TM \uf209\nTM\n\u2022\n\u2022\n\u2022\n\u2022\nKnow What to Do If You Get Sick\n\u2022\n\u2022\n\u2022\n- \uf209\n\uf209\f10/30/22, 9:38 AM People Who Are Immunocompromised | CDC\nKnow where free or low-cost testing locations are near you so you know where to go. Know how to reach a healthcare provider right away, including after hours or weekends. Ask them about telehealth\nappointment options. Have an updated list of all your current medications in case you need to see a different provider. What to do if you were exposed to COVID-19\nDetermine if you should stay home."}]}, {"title": "7c18530bb7d88fee325160db8f587f57", "paragraphs": [{"qas": [{"question": "Do not wear a high quality mask for how long?", "id": "100000000000000000006450", "answers": [{"text": "10 full days", "answer_start": 194}], "is_impossible": false}, {"question": "What can you do to get tested right away?", "id": "100000000000000000006452", "answers": [{"text": "Stay home", "answer_start": 367}], "is_impossible": false}], "context": "Monitor your health for COVID-19 symptoms and get tested at least 5 days after you had close contact with someone\nwith COVID-19, even if you don\u2019t develop symptoms. Wear a high quality mask for 10 full days any time you are around others inside your home or in public. Do not go to\nplaces where you are unable to wear a mask. What to do if you have COVID-19 symptoms\nStay home. Get tested right away. Use a self-test at home or find a testing location near you."}]}, {"title": "f43695bc8a080c3dfc545d5906ef526f", "paragraphs": [{"qas": [{"question": "What can be done by onsite or by telehealth?", "id": "100000000000000000006458", "answers": [{"text": "receive a prescription from a healthcare provider", "answer_start": 468}], "is_impossible": false}], "context": "What to do if you test positive for COVID-19\nEffective treatments are now widely available and free, and you may be eligible. Contact your healthcare provider, health department, or Community Health Center to learn about treatment\noptions. Don\u2019t delay! Treatment must be started soon after you first develop symptoms to be effective. If you don\u2019t have timely access to a healthcare provider, check if a Test to Treat location is in your community. You\ncan get tested, receive a prescription from a healthcare provider (either onsite or by telehealth), and have it filled all at\none location."}]}, {"title": "93197097f97b8fb0365a0a34b5403a07", "paragraphs": [{"qas": [{"question": "Isolate until it\u2019s safe to be around others.", "id": "100000000000000000006459", "answers": [{"text": "CDC recommends that you isolate for at least 10 and up to 20 days", "answer_start": 45}], "is_impossible": false}, {"question": "Check with your healthcare provider to learn when you can be around what?", "id": "100000000000000000006461", "answers": [{"text": "others", "answer_start": 180}], "is_impossible": false}, {"question": "What should you do if you develop symptoms that are severe?", "id": "100000000000000000006462", "answers": [{"text": "Call your healthcare provider", "answer_start": 211}], "is_impossible": false}, {"question": "What should you do if you develop symptoms that are severe or concerning to you?", "id": "100000000000000000006463", "answers": [{"text": "Call your healthcare provider", "answer_start": 211}], "is_impossible": false}, {"question": "If you notice emergency warning signs, call 911 or call ahead to where?", "id": "100000000000000000006464", "answers": [{"text": "your local emergency facility", "answer_start": 368}], "is_impossible": false}, {"question": "What is available for people who are more likely to get very sick?", "id": "100000000000000000006466", "answers": [{"text": "oral antiviral and monoclonal antibody treatments", "answer_start": 434}], "is_impossible": false}, {"question": "Learn more about what?", "id": "100000000000000000006467", "answers": [{"text": "COVID-19 treatment", "answer_start": 564}], "is_impossible": false}], "context": "Isolate until it\u2019s safe to be around others. CDC recommends that you isolate for at least 10 and up to 20 days. Check with\nyour healthcare provider to learn when you can be around others. Monitor your symptoms. Call your healthcare provider if you develop symptoms that are severe or concerning to you. If\nyou notice emergency warning signs, call 911 or call ahead to your local emergency facility. If you test positive for COVID-19, oral antiviral and monoclonal antibody treatments are available for people who are more\nlikely to get very sick. Learn more about COVID-19 treatment."}]}, {"title": "672f40d9c944281ead8c0b26aacf6cbc", "paragraphs": [{"qas": [{"question": "What must be started right away to be effective?", "id": "100000000000000000006468", "answers": [{"text": "Treatment", "answer_start": 13}], "is_impossible": false}, {"question": "Talk to your healthcare provider about what options are best for you?", "id": "100000000000000000006469", "answers": [{"text": "treatment options are best for you. - \uf209", "answer_start": 111}], "is_impossible": false}, {"question": "Antiviral treatments may help your body fight what?", "id": "100000000000000000006470", "answers": [{"text": "COVID-19", "answer_start": 281}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000006471", "answers": [{"text": "SARS-CoV-2", "answer_start": 306}], "is_impossible": false}, {"question": "How can you stop the SARS-CoV-2 virus from multiplying?", "id": "100000000000000000006472", "answers": [{"text": "answer undefined", "answer_start": 306}], "is_impossible": false}], "context": "Don\u2019t delay: Treatment must be started right away to be effective. Talk to your healthcare provider about what treatment\noptions are best for you. - \uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n\u2022\nLearn How to Get Treatment Quickly\nAntiviral treatments\nAntiviral treatments may help your body fight COVID-19 by stopping the SARS-CoV-2 virus (the virus that causes COVID-19)\nfrom multiplying in your body or by lowering the amount of the virus within your body. You can get a prescription from your\nhealthcare provider or a Test to Treat location ."}]}, {"title": "74a24ee4d27d4185e037c57edf089348", "paragraphs": [{"qas": [{"question": "What can be taken at home?", "id": "100000000000000000006473", "answers": [{"text": "Oral antivirals", "answer_start": 0}], "is_impossible": false}, {"question": "What must be given within 5 days after the first symptoms of COVID-19 appear?", "id": "100000000000000000006474", "answers": [{"text": "Oral antivirals", "answer_start": 0}], "is_impossible": false}, {"question": "What can limit the amount of the virus within your body?", "id": "100000000000000000006476", "answers": [{"text": "Monoclonal antibodies can block the virus that causes COVID-19 from entering cells in your body", "answer_start": 197}], "is_impossible": false}, {"question": "What must be prescribed and administered by a healthcare provider within 7 days after first symptoms of COVID-19 appear?", "id": "100000000000000000006477", "answers": [{"text": "Monoclonal antibodies \uf209 \uf209\f10/30/22, 9:38 AM People Who Are Immunocompromised | CDC Monoclonal antibodies", "answer_start": 114}], "is_impossible": false}], "context": "Oral antivirals can be taken at home and must be given within 5 days after\nthe first symptoms of COVID-19 appear. Monoclonal antibodies\n\uf209\n\uf209\f10/30/22, 9:38 AM People Who Are Immunocompromised | CDC\nMonoclonal antibodies can block the virus that causes COVID-19 from entering cells in your body, which can limit the\namount of the virus within your body. These must be prescribed and administered by a healthcare provider within 7 days\nafter first symptoms of COVID-19 appear. Make a COVID-19 plan now so you\u2019re prepared. Consider the ways you will protect yourself and how to be prepared if you get\nsick with COVID-19."}]}, {"title": "d9d7eb56b1509cfff2daeebc12307964", "paragraphs": [{"qas": [{"question": "What should your plan include in case you get COVID-19?", "id": "100000000000000000006479", "answers": [{"text": "What you\u2019re doing to protect yourself and prepare", "answer_start": 120}], "is_impossible": false}, {"question": "Who should you talk to about your plan?", "id": "100000000000000000006481", "answers": [{"text": "your family, friends, and healthcare provider", "answer_start": 299}], "is_impossible": false}, {"question": "What do you do if you test positive for COVID-19?", "id": "100000000000000000006482", "answers": [{"text": "3", "answer_start": 250}], "is_impossible": false}, {"question": "What can help you if you get sick?", "id": "100000000000000000006484", "answers": [{"text": "supplies", "answer_start": 563}], "is_impossible": false}, {"question": "What can identify supplies you may need?", "id": "100000000000000000006485", "answers": [{"text": "others may help you if you get sick", "answer_start": 510}], "is_impossible": false}], "context": "Include how you will adjust your plan if the COVID-19 situation changes in your community. Your plan should include:\n1. What you\u2019re doing to protect yourself and prepare (in case you get COVID)\n2. What you\u2019ll do if you\u2019re exposed or develop symptoms\n3. What you\u2019ll do if you test positive\nTalk with your family, friends, and healthcare provider about your plan\nShare your COVID-19 plan with your family, friends, and healthcare providers so they can support your prevention and\npreparation steps. Consider how others may help you if you get sick and identify the supplies you may need."}]}, {"title": "dc3317d94154967ff452ad112e9196cf", "paragraphs": [{"qas": [{"question": "What is a major health concern?", "id": "100000000000000000006486", "answers": [{"text": "COVID-19", "answer_start": 235}], "is_impossible": false}, {"question": "What can be stressful to manage?", "id": "100000000000000000006488", "answers": [{"text": "COVID-19", "answer_start": 235}], "is_impossible": false}, {"question": "What can help minimize stress?", "id": "100000000000000000006489", "answers": [{"text": "Understanding what you can do to protect yourself and what to do if you get sick", "answer_start": 312}], "is_impossible": false}, {"question": "What happens if you test positive for COVID-19?", "id": "100000000000000000006491", "answers": [{"text": "get treated quickly", "answer_start": 478}], "is_impossible": false}, {"question": "What are monoclonal antibodies?", "id": "100000000000000000006492", "answers": [{"text": "work, childcare, and other responsibilities that may cause stress if you were to become sick. COVID-19 remains a major health concern and this can be stressful to manage. Understanding what you can do to protect yourself and what to do if you get sick can help minimize that stress. Take as many steps as you can to prevent COVID-19 and get treated quickly if you test positive for COVID-19", "answer_start": 140}], "is_impossible": false}], "context": "Be sure to stick\nto your treatment plans, your routine healthcare appointments, and have all your prescriptions filled. Plan for options for\nwork, childcare, and other responsibilities that may cause stress if you were to become sick. COVID-19 remains a major health concern and this can be stressful to manage. Understanding what you can do to protect\nyourself and what to do if you get sick can help minimize that stress. Take as many steps as you can to prevent COVID-19 and\nget treated quickly if you test positive for COVID-19. \uf209\nBuild Your Personal COVID-19 Plan\nMore Information\nWhat Are Monoclonal Antibodies?"}]}, {"title": "ddd85976ef4bd5700ce6384cbe76c028", "paragraphs": [{"qas": [{"question": "What is Monoclonal Antibody Therapy for COVID-19?", "id": "100000000000000000006493", "answers": [{"text": "What Is It and How Does It Work?", "answer_start": 42}], "is_impossible": false}], "context": "Monoclonal Antibody Therapy for COVID-19: What Is It and\nHow Does It Work? [00:01:04]\nIsolation and Exposure Calculator\nCOVID-19 Test to Treat Locator\nCOVID-19 Therapeutics Locator\nFind a COVID-19 Vaccine\nDon\u2019t Delay: Test Soon and Treat Early [1 page, 262 KB]\n| Additional Languages\n\uf209\n\uf209\n\uf209\n\uf209\n\uf20c\nLast Updated Oct. 19, 2022"}]}, {"title": "70470d44e6154b978c4d6ac695cd9e23", "paragraphs": [{"qas": [{"question": "What can you wear in public indoor spaces?", "id": "100000000000000000006496", "answers": [{"text": "a mask or respirator", "answer_start": 208}], "is_impossible": false}], "context": "10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nEspa\u00f1ol | Other Languages\nPeople with Certain Medical Conditions\nOverview\nIf you or your family member are at high risk for severe illness, wear a mask or respirator with greater protection in\npublic indoor spaces if you are in an area with a high COVID-19 Community Level. Talk with your healthcare provider\nabout wearing a mask in a medium COVID-19 Community Level. If you test positive and are an older adult or someone who is at high risk of getting very sick from COVID-19, treatment is\navailable."}]}, {"title": "c2ef094eb03df79cbdad198a54794bf8", "paragraphs": [{"qas": [{"question": "What can you do if you are eligible to receive a prescription from a healthcare provider?", "id": "100000000000000000006500", "answers": [{"text": "visit a Test to Treat location", "answer_start": 152}], "is_impossible": false}, {"question": "What must be started within the first few days to be effective?", "id": "100000000000000000006501", "answers": [{"text": "Treatment", "answer_start": 254}], "is_impossible": false}, {"question": "Who should see Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19 for more detailed information?", "id": "100000000000000000006502", "answers": [{"text": "Healthcare professionals", "answer_start": 378}], "is_impossible": false}], "context": "Contact a healthcare provider right away after a positive test to determine if you are eligible, even if your\nsymptoms are mild right now. You can also visit a Test to Treat location and, if eligible, receive a prescription from a\nprovider. Don\u2019t delay: Treatment must be started within the first few days to be effective. \uf209\nThis information is intended for a general audience. Healthcare professionals should see Underlying Medical Conditions\nAssociated with Higher Risk for Severe COVID-19 for more detailed information."}]}, {"title": "5238ab434cde377559e94876435778df", "paragraphs": [{"qas": [{"question": "What is a person with any of the medical conditions listed below more likely to get very sick with COVID-19?", "id": "100000000000000000006503", "answers": [{"text": "If you have one of these conditions, talk with your healthcare provider about how best to protect yourself from severe illness", "answer_start": 126}], "is_impossible": false}, {"question": "What should you do if you have one of these conditions?", "id": "100000000000000000006504", "answers": [{"text": "talk with your healthcare provider", "answer_start": 163}], "is_impossible": false}, {"question": "Talk to your healthcare provider about what?", "id": "100000000000000000006506", "answers": [{"text": "how best to protect yourself from severe illness from COVID-19. The list below does not include all possible conditions that put you at higher risk of severe illness from COVID-19. If you have questions about a condition not included on this list", "answer_start": 204}], "is_impossible": false}], "context": "What You Need To Know\nA person with any of the medical conditions listed below is more likely to get very sick with COVID-19. If you have\none of these conditions, talk with your healthcare provider about how best to protect yourself from severe illness\nfrom COVID-19. The list below does not include all possible conditions that put you at higher risk of severe illness from COVID-19. If\nyou have questions about a condition not included on this list, talk to your healthcare provider about how best to\nmanage your condition and protect yourself from COVID-19."}]}, {"title": "23e30014754e0087e43b9e76b536caf7", "paragraphs": [{"qas": [{"question": "What is important if you are older or have severe health conditions or more than one health condition?", "id": "100000000000000000006508", "answers": [{"text": "Staying up to date with COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "What are the two types of COVID-19 vaccines?", "id": "100000000000000000006510", "answers": [{"text": "primary series and booster", "answer_start": 336}], "is_impossible": false}], "context": "Staying up to date with COVID-19 vaccines, getting doses of EVUSHELD if eligible, and following preventive\nmeasures for COVID-19 are important. This is especially important if you are older or have severe health\nconditions or more than one health condition, including those on the list below. Approved and authorized COVID-19 vaccines (primary series and booster) are safe and effective. Some people who are immunocompromised, or people with weakened immune systems, may be eligible for an\nadditional primary dose of COVID-19 vaccine."}]}, {"title": "9a26576bedcb19f44dc8f74bc141c3f3", "paragraphs": [{"qas": [{"question": "What is a person with any of the conditions listed below more likely to get from COVID-19?", "id": "100000000000000000006512", "answers": [{"text": "very sick", "answer_start": 178}], "is_impossible": false}, {"question": "Who is more likely to get hospitalized?", "id": "100000000000000000006515", "answers": [{"text": "Older adults", "answer_start": 447}], "is_impossible": false}, {"question": "What percentage of COVID-19 deaths occur in people over 65?", "id": "100000000000000000006516", "answers": [{"text": "81%", "answer_start": 526}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022 TM\n\u2022\n\u2022\f10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nBased on the current evidence, a person with any of the conditions listed below is more likely to get very sick from COVID-19. This means that a person with one or more of these conditions who gets very sick from COVID-19 (has severe illness from\nCOVID-19) is more likely to:\nBe hospitalized\nNeed intensive care\nRequire a ventilator to help them breathe\nDie\nIn addition:\nOlder adults are at highest risk of getting very sick from COVID-19. More than 81% of COVID-19 deaths occur in people\nover age 65."}]}, {"title": "53d706cb807fe5d878478f1fd0a0e316", "paragraphs": [{"qas": [{"question": "How many times higher is the number of deaths among people over 65 than among people ages 18-29 years?", "id": "100000000000000000006517", "answers": [{"text": "97", "answer_start": 49}], "is_impossible": false}, {"question": "What is the risk of getting very sick?", "id": "100000000000000000006519", "answers": [{"text": "increased risk of getting very sick or dying from COVID-19", "answer_start": 267}], "is_impossible": false}], "context": "The number of deaths among people over age 65 is 97 times higher than the number of deaths among\npeople ages 18-29 years. A person\u2019s risk of severe illness from COVID-19 increases as the number of underlying medical conditions they have\nincreases. Some people are at increased risk of getting very sick or dying from COVID-19 because of where they live or work, or\nbecause they can\u2019t get health care. This includes many people from racial and ethnic minority groups and people with\ndisabilities. Studies have shown people from racial and ethnic minority groups are also dying from COVID-19 at younger ages."}]}, {"title": "3273a3fb8cf6eca76db879a4155a671f", "paragraphs": [{"qas": [{"question": "People with disabilities are more likely than those without disabilities to have what?", "id": "100000000000000000006524", "answers": [{"text": "chronic health conditions", "answer_start": 252}], "is_impossible": false}, {"question": "What are shared group settings also called?", "id": "100000000000000000006525", "answers": [{"text": "congregate", "answer_start": 314}], "is_impossible": false}, {"question": "What is another name for shared group settings?", "id": "100000000000000000006526", "answers": [{"text": "congregate", "answer_start": 314}], "is_impossible": false}, {"question": "What are some people with disabilities more likely to get?", "id": "100000000000000000006527", "answers": [{"text": "COVID-19", "answer_start": 471}], "is_impossible": false}], "context": "People in racial and ethnic minority groups are often younger when they develop chronic medical conditions and\nmay be more likely to have more than one medical condition. People with disabilities are more likely than those without disabilities to have chronic health conditions, live in\nshared group (also called \u201ccongregate\u201d) settings, and face more barriers in accessing health care. Studies have\nshown that some people with certain disabilities are more likely to get COVID-19 and have worse outcomes. Staying up to date with COVID-19 vaccines and taking COVID-19 prevention actions are important."}]}, {"title": "c5d5e52b81fe3ea36fbc6fcb3637776c", "paragraphs": [{"qas": [{"question": "What can having cancer make you more likely to get very sick from COVID-19?", "id": "100000000000000000006530", "answers": [{"text": "Treatments for many types of cancer", "answer_start": 403}], "is_impossible": false}, {"question": "What can treatment for many types of cancer weaken your body's ability to fight off?", "id": "100000000000000000006531", "answers": [{"text": "disease", "answer_start": 483}], "is_impossible": false}], "context": "This is especially important\nif you are older or have severe health conditions or more than one health condition, including those on this list. Learn more\nabout how CDC develops COVID-19 vaccination recommendations. If you have a medical condition, learn more about Actions\nYou Can Take. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\nMedical Conditions\nCancer\nHaving cancer can make you more likely to get very sick from COVID-19. Treatments for many types of cancer can weaken\nyour body\u2019s ability to fight off disease. At this time, based on available studies, having a history of cancer may increase your\nrisk. Get more information:\nThe conditions on this list are in alphabetical order."}]}, {"title": "2cf36221c0ec3d36088fcbec15216084", "paragraphs": [{"qas": [{"question": "CDC completed a review for each medical condition on this list to ensure that they met criteria for inclusion on what list?", "id": "100000000000000000006534", "answers": [{"text": "They are not in order of risk", "answer_start": 0}], "is_impossible": false}, {"question": "What medical condition may not be included on the list below?", "id": "100000000000000000006538", "answers": [{"text": "Rare medical conditions", "answer_start": 504}], "is_impossible": false}], "context": "They are not in order of risk. CDC completed a review for each medical condition on this list. This was done to ensure that these conditions met\ncriteria for inclusion on this list. CDC conducts ongoing reviews of additional underlying conditions. If other\nmedical conditions have enough evidence, they might be added to the list. Because we are learning more about COVID-19 every day, this list does not include all medical conditions that\nplace a person at higher risk of severe illness from COVID-19. Rare medical conditions, including many conditions\nthat mostly affect children, may not be included on the list below."}]}, {"title": "d235d7cb5649a4cdcd4231694566771f", "paragraphs": [{"qas": [{"question": "What is a person with a condition that is not listed may be at greater risk of getting sick from COVID-19 than other people who do not have the condition?", "id": "100000000000000000006539", "answers": [{"text": "risk", "answer_start": 270}], "is_impossible": false}, {"question": "What is important to talk with your healthcare provider about your risk?", "id": "100000000000000000006541", "answers": [{"text": "A person with a condition that is not listed may still be at greater risk of getting very sick from COVID-19", "answer_start": 42}], "is_impossible": false}, {"question": "What can having chronic kidney disease make you more likely to get sick from COVID-19?", "id": "100000000000000000006542", "answers": [{"text": "any stage", "answer_start": 485}], "is_impossible": false}], "context": "We will update the list as we learn more. A person with a condition that is not listed may still be at greater risk of getting very sick from COVID-19 than\nother people who do not have the condition. It is important that you talk with your healthcare provider about your\nrisk. \u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nCancer\nCOVID-19: What People with Cancer Should Know \u2013 National Cancer Institute\nChronic kidney disease\nHaving chronic kidney disease of any stage can make you more likely to get very sick from COVID-19."}]}, {"title": "649a862f4f5bebd9bc4d37e7b3166beb", "paragraphs": [{"qas": [{"question": "What is cirrhosis?", "id": "100000000000000000006543", "answers": [{"text": "scarring of the liver", "answer_start": 349}], "is_impossible": false}, {"question": "What is the name of the disease that can cause scarring of the liver?", "id": "100000000000000000006544", "answers": [{"text": "cirrhosis", "answer_start": 335}], "is_impossible": false}, {"question": "What is scarring of the liver called?", "id": "100000000000000000006545", "answers": [{"text": "cirrhosis", "answer_start": 335}], "is_impossible": false}], "context": "Get more information:\nChronic kidney disease\nNational Kidney Foundation: Kidney disease and COVID-19\nChronic liver disease\nHaving chronic liver disease can make you more likely to get very sick from COVID-19. Chronic liver disease can include\nalcohol-related liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis, and cirrhosis (or scarring of the liver). Get more information:\nLiver Disease\nAmerican Liver Foundation: Your Liver & COVID-19\nChronic lung diseases\nHaving a chronic lung disease can make you more likely to get very sick from COVID-19."}]}, {"title": "49ee8a95dfa3fa0e3033ee3d44b6d3c8", "paragraphs": [{"qas": [{"question": "What is pulmonary embolism?", "id": "100000000000000000006549", "answers": [{"text": "blood clot in the lungs", "answer_start": 413}], "is_impossible": false}, {"question": "What is high blood pressure in the lungs called?", "id": "100000000000000000006550", "answers": [{"text": "Pulmonary hypertension", "answer_start": 438}], "is_impossible": false}, {"question": "What organs can make you more likely to get very sick from COVID-19?", "id": "100000000000000000006551", "answers": [{"text": "kidney, liver, intestines, heart, and pancreas", "answer_start": 742}], "is_impossible": false}], "context": "Chronic lung diseases can include:\nAsthma, if it\u2019s moderate to severe\nBronchiectasis (thickening of the lungs\u2019 airways)\nBronchopulmonary dysplasia (chronic lung disease affecting newborns)\nChronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis\nHaving damaged or scarred lung tissue known as interstitial lung disease (including idiopathic pulmonary fibrosis)\nPulmonary embolism (blood clot in the lungs)\nPulmonary hypertension (high blood pressure in the lungs)\nGet more information:\nCOPD\nAsthma\nPeople with Moderate to Severe Asthma\nAmerican Lung Association: Controlling Chronic Lung Diseases Amid COVID-19\nCystic fibrosis\nHaving cystic fibrosis, with or without lung or other solid organ transplant (like kidney, liver, intestines, heart, and pancreas)\ncan make you more likely to get very sick from COVID-19."}]}, {"title": "b741f22ba02b38272aa1563857647b42", "paragraphs": [{"qas": [{"question": "What is COVID-19?", "id": "100000000000000000006552", "answers": [{"text": "Cystic fibrosis CF and Coronavirus", "answer_start": 22}], "is_impossible": false}, {"question": "What can have neurological conditions, such as dementia, make you more likely to get very sick?", "id": "100000000000000000006553", "answers": [{"text": "COVID-19", "answer_start": 359}], "is_impossible": false}], "context": "Get more information:\nCystic fibrosis\nCF and Coronavirus (COVID-19) | Cystic Fibrosis Foundation (cff.org)\n\u2022\n\u2022 \uf209\n\u2022\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022\n\u2022 \uf209\f10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nDementia or other neurological conditions\nHaving neurological conditions, such as dementia, can make you more likely to get very sick from COVID-19. Get more information:\nDementia\nAlzheimer\u2019s Association: COVID-19, Alzheimer\u2019s and Dementia\nDiabetes (type 1 or type 2)\nHaving either type 1 or type 2 diabetes can make you more likely to get very sick from COVID-19."}]}, {"title": "34a2726c580fe282fbb53550db6e3aeb", "paragraphs": [{"qas": [{"question": "What type of disability makes it more likely for people with diabetes to get sick from COVID-19?", "id": "100000000000000000006555", "answers": [{"text": "People with any type of disability that makes it more difficult to do certain activities or interact with the world around them, including people who need help with self-care or daily activities People with attention-deficit/hyperactivity disorder (ADHD) People with cerebral palsy People with birth defects People with intellectual and developmental disabilities People with learning disabilities People with spinal cord injuries People with Down syndrome Get more information: People with Disabilities | COVID-19 Heart conditions Having heart conditions", "answer_start": 332}], "is_impossible": false}, {"question": "How can people with underlying medical conditions, living in congregated settings, or systemic health and social inequities be more susceptible to getting sick from CoviD19?", "id": "100000000000000000006557", "answers": [{"text": "Having heart conditions", "answer_start": 864}], "is_impossible": false}, {"question": "What are people with any type of disability that makes it more difficult to do certain activities or interact with the world around them?", "id": "100000000000000000006558", "answers": [{"text": "people who need help with self-care or daily activities", "answer_start": 471}], "is_impossible": false}, {"question": "People with attention-deficit/hyperactivity disorder (ADHD) People with cerebral palsy People with birth defects People with intellectual and developmental disabilities People with learning disabilities", "id": "100000000000000000006559", "answers": [{"text": "Diabetes American Diabetes Association: How COVID-19 Impacts People with Diabetes Disabilities People with some types of disabilities may be more likely to get very sick from COVID-19 because of underlying medical conditions, living in congregate settings, or systemic health and social inequities, including: People with any type of disability that makes it more difficult to do certain activities or interact with the world around them, including people who need help with self-care or daily activities People with attention-deficit/hyperactivity disorder (ADHD) People with cerebral palsy People with birth defects People with intellectual and developmental disabilities People with learning disabilities People with spinal cord injuries People with Down syndrome Get more information: People with Disabilities | COVID-19 Heart conditions Having heart conditions", "answer_start": 21}], "is_impossible": false}, {"question": "Who has intellectual and developmental disabilities?", "id": "100000000000000000006560", "answers": [{"text": "People with cerebral palsy People with birth defects", "answer_start": 587}], "is_impossible": false}, {"question": "Who has spinal cord injuries?", "id": "100000000000000000006561", "answers": [{"text": "People with Down syndrome", "answer_start": 763}], "is_impossible": false}, {"question": "What can heart conditions make you more likely to get sick from COVID-19?", "id": "100000000000000000006562", "answers": [{"text": "heart failure, coronary artery disease, cardiomyopathies, and possibly high blood pressure (hypertension)", "answer_start": 896}], "is_impossible": false}], "context": "Get more information:\nDiabetes\nAmerican Diabetes Association: How COVID-19 Impacts People with Diabetes\nDisabilities\nPeople with some types of disabilities may be more likely to get very sick from COVID-19 because of underlying medical\nconditions, living in congregate settings, or systemic health and social inequities, including:\nPeople with any type of disability that makes it more difficult to do certain activities or interact with the world around\nthem, including people who need help with self-care or daily activities\nPeople with attention-deficit/hyperactivity disorder (ADHD)\nPeople with cerebral palsy\nPeople with birth defects\nPeople with intellectual and developmental disabilities\nPeople with learning disabilities\nPeople with spinal cord injuries\nPeople with Down syndrome\nGet more information:\nPeople with Disabilities | COVID-19\nHeart conditions\nHaving heart conditions such as heart failure, coronary artery disease, cardiomyopathies, and possibly high blood pressure\n(hypertension) can make you more likely to get very sick from COVID-19."}]}, {"title": "c0bd90a1d6d9b6add8dada7bdb8691af", "paragraphs": [{"qas": [{"question": "When was the last time people with certain medical conditions received CDC HIV Infection Interim Guidance?", "id": "100000000000000000006565", "answers": [{"text": "10/30/22", "answer_start": 292}], "is_impossible": false}], "context": "Get more information:\nHeart Disease\nAmerican Heart Association: COVID-19\nNHLBI Information & Resources on COVID-19\nHIV infection\nHaving HIV (Human Immunodeficiency Virus) can make you more likely to get very sick from COVID-19. Get more information:\n\u2022\n\u2022 \uf209\n\u2022\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022 \uf209\f10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nHIV Infection\nInterim Guidance for COVID-19 and Persons with HIV\nImmunocompromised condition or weakened immune system\nSome people are immunocompromised or have a weakened immune system because of a medical condition or a treatment\nfor a condition."}]}, {"title": "a70eee88bab6dc32a55056e5e984266a", "paragraphs": [{"qas": [{"question": "What are people who have cancer who are on chemotherapy?", "id": "100000000000000000006567", "answers": [{"text": "or who have had a solid organ transplant", "answer_start": 62}], "is_impossible": false}, {"question": "What is another name for a solid organ transplant?", "id": "100000000000000000006568", "answers": [{"text": "kidney transplant or heart transplant", "answer_start": 111}], "is_impossible": false}, {"question": "Corticosteroids weaken what?", "id": "100000000000000000006569", "answers": [{"text": "their immune system", "answer_start": 305}], "is_impossible": false}, {"question": "What can long-term use of corticosteroids lead to?", "id": "100000000000000000006570", "answers": [{"text": "secondary or acquired immunodeficiency", "answer_start": 358}], "is_impossible": false}, {"question": "What is one example of a weakened immune system?", "id": "100000000000000000006571", "answers": [{"text": "Primary immunodeficiency", "answer_start": 565}], "is_impossible": false}], "context": "This includes people who have cancer and are on chemotherapy, or who have had a solid organ transplant,\nlike a kidney transplant or heart transplant, and are taking medication to keep their transplant. Other people have to use\ncertain types of medicines for a long time, like corticosteroids, that weaken their immune system. Such long-term uses can\nlead to secondary or acquired immunodeficiency. Other people have a weakened immune system because of a life-long\ncondition. For example, some people inherit problems with their immune system. One example is called Primary\nimmunodeficiency."}]}, {"title": "8b5f43954d1a80ed7e7bced9073c4d0f", "paragraphs": [{"qas": [{"question": "People who are taking medicines that weaken their immune system may not be protected even if they are up to date on their vaccines?", "id": "100000000000000000006573", "answers": [{"text": "immunocompromised", "answer_start": 6}], "is_impossible": false}], "context": "Being immunocompromised can make you more likely to get very sick from COVID-19 or be sick for a\nlonger period of time. People who are immunocompromised or are taking medicines that weaken their immune system may not be protected even\nif they are up to date on their vaccines. Talk with your healthcare provider about wearing a mask in a medium COVID-19\nCommunity Level and what additional precautions may be necessary in medium or high COVID-19 Community Levels."}]}, {"title": "26540191e18c3d19336c523591947fb2", "paragraphs": [{"qas": [{"question": "What can mood disorders, including depression, and schizophrenia spectrum disorders, make you more likely to get sick from COVID-19?", "id": "100000000000000000006575", "answers": [{"text": "very sick", "answer_start": 290}], "is_impossible": false}, {"question": "What is the National Institute of Mental Health Shareable Resources on Coping with?", "id": "100000000000000000006576", "answers": [{"text": "COVID-19", "answer_start": 415}], "is_impossible": false}, {"question": "What is the name of the National Institute of Mental Health (NIMH) Shareable Resources on Coping with COVID-19?", "id": "100000000000000000006577", "answers": [{"text": "mood disorders", "answer_start": 183}], "is_impossible": false}, {"question": "What should people who are moderately or severely immunocompromised get after completing the primary vaccination series?", "id": "100000000000000000006578", "answers": [{"text": "an additional primary dose and a booster", "answer_start": 605}], "is_impossible": false}, {"question": "What may differ in people who are moderately or severely immunocompromised?", "id": "100000000000000000006579", "answers": [{"text": "the immune response following COVID-19 vaccination", "answer_start": 655}], "is_impossible": false}], "context": "Get more information:\nTypes of Primary Immune Deficiency Diseases\nJeffrey Modell Foundation\nImmune Deficiency Foundation\nPrimary Immunodeficiency (PI)\nMental health conditions\nHaving mood disorders, including depression, and schizophrenia spectrum disorders can make you more likely to get very\nsick from COVID-19. Get more information:\nNational Institute of Mental Health (NIMH) Shareable Resources on Coping with COVID-19\nNational Institute of Mental Health (NIMH) Depression\n\u2022\n\u2022 \uf209\nAfter completing the primary vaccination series, some people who are moderately or severely immunocompromised\nshould get an additional primary dose and a booster. Because the immune response following COVID-19 vaccination may\ndiffer in people who are moderately or severely immunocompromised, specific guidance has been developed."}]}, {"title": "e194c5ddc9557a415ff8a922e60b39a1", "paragraphs": [{"qas": [{"question": "What is COVID-19 Preventive Medication?", "id": "100000000000000000006581", "answers": [{"text": "Pre-exposure prophylaxis", "answer_start": 32}], "is_impossible": false}, {"question": "What is EVUSHELD?", "id": "100000000000000000006582", "answers": [{"text": "a medicine that can help protect you from getting COVID-19", "answer_start": 70}], "is_impossible": false}], "context": "COVID-19 Preventive Medication (Pre-exposure prophylaxis)\nEVUSHELD is a medicine that can help protect you from getting COVID-19."}]}, {"title": "bd2c40c38e704520d38165b2affdc0cc", "paragraphs": [{"qas": [{"question": "How often can you be eligible for EVUSHELD?", "id": "100000000000000000006583", "answers": [{"text": "every 6 months", "answer_start": 33}], "is_impossible": false}, {"question": "Are you moderately or severely immunocompromised?", "id": "100000000000000000006584", "answers": [{"text": "may not mount an adequate immune response to COVID- 19 vaccination OR have a history of severe allergic reactions to COVID-19 vaccines", "answer_start": 105}], "is_impossible": false}, {"question": "What does EVUSHELD contain?", "id": "100000000000000000006586", "answers": [{"text": "different antibodies", "answer_start": 453}], "is_impossible": false}, {"question": "What is the weight of an adult or adolescent weighing at least 88 pounds or 40 kg?", "id": "100000000000000000006587", "answers": [{"text": "12 years and older", "answer_start": 380}], "is_impossible": false}, {"question": "Who gives you EVusHELD before you are exposed or test positive for COVID-19?", "id": "100000000000000000006588", "answers": [{"text": "your healthcare provider", "answer_start": 490}], "is_impossible": false}], "context": "You may be eligible for EVUSHELD\nevery 6 months if you:\nAre moderately or severely immunocompromised and may not mount an adequate immune response to COVID-\n19 vaccination OR have a history of severe allergic reactions to COVID-19 vaccines, and\nDo not currently have COVID-19 and have not recently had close contact with someone with COVID-19, and\nAre an adult or adolescent ages 12 years and older weighing at least 88 pounds (40 kg)\nEVUSHELD contains different antibodies and is given by your healthcare provider before you are exposed or test\npositive for COVID-19. EVUSHELD may offer less protection against certain strains of the Omicron variant."}]}, {"title": "79047b57c4c3c98fc43fb53ed946345b", "paragraphs": [{"qas": [{"question": "What can provide additional layers of protection from COVID-19?", "id": "100000000000000000006590", "answers": [{"text": "taking multiple prevention steps", "answer_start": 109}], "is_impossible": false}, {"question": "What should you undergo and seek medical attention for?", "id": "100000000000000000006591", "answers": [{"text": "if you develop symptoms of COVID-19", "answer_start": 347}], "is_impossible": false}, {"question": "What should you do if you develop symptoms of COVID-19?", "id": "100000000000000000006592", "answers": [{"text": "undergo testing and seek medical attention", "answer_start": 304}], "is_impossible": false}], "context": "Talk to your\nhealthcare provider to find out if this option is right for you. Even if you receive EVUSHELD , taking multiple prevention\nsteps, such as wearing a high-quality mask or respirator and improving ventilation, can provide additional layers of\nprotection from COVID-19. Additionally, you should undergo testing and seek medical attention if you develop symptoms\nof COVID-19, as well as start treatment for COVID-19 as appropriate."}]}, {"title": "a15c6a144e37f8bdc4535eb348b6f0c0", "paragraphs": [{"qas": [{"question": "What can make you more likely to get very sick from COVID-19?", "id": "100000000000000000006595", "answers": [{"text": "Overweight (defined as a body mass index (BMI) is 25 kg/m or higher, but under 30 kg/m ), obesity (BMI is 30 kg/m or higher, but under 40 kg/m ), or severe obesity", "answer_start": 200}], "is_impossible": false}, {"question": "What increases sharply with higher BMI?", "id": "100000000000000000006596", "answers": [{"text": "The risk of severe illness from COVID-19", "answer_start": 449}], "is_impossible": false}], "context": "TM \uf209 TM\n\u2022\n\u2022\n\u2022\nTM\nTM\nTM\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n\u2022 \uf209\n\u2022 \uf209\f10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nNational Institute of Mental Health (NIMH) Depression\nMood Disorders\nOverweight and obesity\nOverweight (defined as a body mass index (BMI) is 25 kg/m or higher, but under 30 kg/m ), obesity (BMI is 30 kg/m or\nhigher, but under 40 kg/m ), or severe obesity (BMI is 40 kg/m or higher), can make you more likely to get very sick from\nCOVID-19. The risk of severe illness from COVID-19 increases sharply with higher BMI."}]}, {"title": "f9f8ec3e9ae8602f460e9a9503ae45e9", "paragraphs": [{"qas": [{"question": "What are people who do little or no physical activity more likely to get sick from COVID-19 than those who are physically active?", "id": "100000000000000000006597", "answers": [{"text": "Obesity Action Coalition: COVID-19 and Obesity Physical inactivity People who do little or no physical activity are more likely to get very sick from COVID-19 than those who are physically active. Being physically active is important to being healthy", "answer_start": 81}], "is_impossible": false}, {"question": "What is important to being healthy?", "id": "100000000000000000006598", "answers": [{"text": "Being physically active", "answer_start": 278}], "is_impossible": false}], "context": "Get more information:\nOverweight & Obesity\nObesity, Race/Ethnicity, and COVID-19\nObesity Action Coalition: COVID-19 and Obesity\nPhysical inactivity\nPeople who do little or no physical activity are more likely to get very sick from COVID-19 than those who are physically active. Being physically active is important to being healthy."}]}, {"title": "a79e091119c8946d075f706101d5ed8c", "paragraphs": [{"qas": [{"question": "What is the 2nd edition of Physical Activity Physical Activity Guidelines for Americans?", "id": "100000000000000000006599", "answers": [{"text": "Move Your Way Active People, Healthy Nation", "answer_start": 239}], "is_impossible": false}, {"question": "How do you increase your physical activity?", "id": "100000000000000000006600", "answers": [{"text": "Strategies", "answer_start": 285}], "is_impossible": false}, {"question": "What does the National Center on Health, Physical Activity and Disability \u2013 Building Healthy Inclusive do?", "id": "100000000000000000006601", "answers": [{"text": "Strategies to Increase Physical Activity", "answer_start": 285}], "is_impossible": false}, {"question": "What are pregnant people more likely to get from COVID-19 than non-pregnant people?", "id": "100000000000000000006602", "answers": [{"text": "very sick", "answer_start": 548}], "is_impossible": false}, {"question": "How long after end of pregnancy do pregnant people have to wait to get sick?", "id": "100000000000000000006603", "answers": [{"text": "42 days", "answer_start": 489}], "is_impossible": false}], "context": "Get more information on physical activity and health, physical activity\nrecommendations, how to become more active, and how to create activity-friendly communities:\nPhysical Activity\nPhysical Activity Guidelines for Americans, 2nd edition\nMove Your Way\nActive People, Healthy Nation : Strategies to Increase Physical Activity\nNational Center on Health, Physical Activity and Disability \u2013 Building Healthy Inclusive Communities\nPregnancy\nPregnant and recently pregnant people (for at least 42 days following end of pregnancy) are more likely to get very sick from\nCOVID-19 compared with non-pregnant people."}]}, {"title": "f9349ef4b4acb92a2b6ff14272f6c426", "paragraphs": [{"qas": [{"question": "What is thalassemia?", "id": "100000000000000000006606", "answers": [{"text": "inherited red blood cell disorders", "answer_start": 268}], "is_impossible": false}, {"question": "What can smoking, current or former, make you more likely to get very sick from COVID-19?", "id": "100000000000000000006607", "answers": [{"text": "cigarette", "answer_start": 468}], "is_impossible": false}, {"question": "If you currently smoke, quit.", "id": "100000000000000000006608", "answers": [{"text": "quit", "answer_start": 565}], "is_impossible": false}, {"question": "What if you used to smoke, don't start again?", "id": "100000000000000000006609", "answers": [{"text": "quit", "answer_start": 565}], "is_impossible": false}], "context": "Get more information:\nPregnant and Recently Pregnant People\nToolkit for Pregnant People and New Parents\nInvestigating the Impact of COVID-19 during Pregnancy\nSickle cell disease or thalassemia\nHaving hemoglobin blood disorders like sickle cell disease or thalassemia (inherited red blood cell disorders) can make you\nmore likely to get very sick from COVID-19. Get more information:\nSickle Cell Disease\nThalassemia\nSmoking, current or former\nBeing a current or former cigarette smoker can make you more likely to get very sick from COVID-19. If you currently smoke,\nquit. If you used to smoke, don\u2019t start again. If you\u2019ve never smoked, don\u2019t start."}]}, {"title": "2349ee6e6d34acd219b9b76439185e75", "paragraphs": [{"qas": [{"question": "What is a solid organ or blood stem cell transplant?", "id": "100000000000000000006610", "answers": [{"text": "bone marrow transplants", "answer_start": 348}], "is_impossible": false}, {"question": "What can make you more likely to get very sick from COVID-19?", "id": "100000000000000000006613", "answers": [{"text": "Having had a solid organ or blood stem cell transplant", "answer_start": 277}], "is_impossible": false}, {"question": "What can make you more likely to get sick from COVID-19?", "id": "100000000000000000006616", "answers": [{"text": "Having had a solid organ or blood stem cell transplant", "answer_start": 277}], "is_impossible": false}], "context": "Get more information:\n\uf209\n\u2022 \uf209\n\u2022\n\u2022\n\u2022 \uf209\n\u2022\n\u2022 \uf209\n\u2022 \u00ae \uf209\n\u2022 SM\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nGet more information:\nSmoking & Tobacco Use\nTips From Former Smokers\nHealth Benefits of Quitting Smoking\nSolid organ or blood stem cell transplant\nHaving had a solid organ or blood stem cell transplant, which includes bone marrow transplants, can make you more likely to\nget very sick from COVID-19. Get more information:\nTransplant Safety\nCOVID-19 Resources for Transplant Community\nStroke or cerebrovascular disease\nHaving cerebrovascular disease, such as having a stroke which affects blood flow to the brain, can make you more likely to get\nvery sick from COVID-19."}]}, {"title": "188f0bf9b820b27e2e055ec58daa4e72", "paragraphs": [{"qas": [{"question": "What can have a substance use disorder make you more likely to get very sick from COVID-19?", "id": "100000000000000000006617", "answers": [{"text": "alcohol, opioid, or cocaine use disorder) can make you more likely to get very sick from COVID-19. Get more information: How to Recognize a Substance Use Disorder Drug Overdose Tuberculosis Having tuberculosis", "answer_start": 152}], "is_impossible": false}, {"question": "How to Recognize a Substance Use Disorder Drug Overdose What is tuberculosis?", "id": "100000000000000000006618", "answers": [{"text": "TB", "answer_start": 363}], "is_impossible": false}, {"question": "What is TB?", "id": "100000000000000000006619", "answers": [{"text": "tuberculosis", "answer_start": 349}], "is_impossible": false}, {"question": "What can make you more likely to get very sick from COVID-19?", "id": "100000000000000000006620", "answers": [{"text": "Having a substance use disorder", "answer_start": 111}], "is_impossible": false}], "context": "Get more information:\nStroke\nCOVID19 Stroke Podcast Series for Patients and Caregivers\nSubstance use disorders\nHaving a substance use disorder (such as alcohol, opioid, or cocaine use disorder) can make you more likely to get very sick\nfrom COVID-19. Get more information:\nHow to Recognize a Substance Use Disorder\nDrug Overdose\nTuberculosis\nHaving tuberculosis (TB) can make you more likely to get very sick from COVID-19. Get more information:\nBasic TB Facts\nPublic Health Emergencies\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n\u2022\n\u2022\nAdditional Information on Children and Teens\nCurrent evidence suggests that children with medical complexity, with genetic, neurologic, or metabolic conditions, or with\ncongenital heart disease can be at increased risk for getting very sick from COVID-19."}]}, {"title": "bffd8a4f18b59dae09d7581b1b25da05", "paragraphs": [{"qas": [{"question": "Children with obesity, diabetes, asthma, chronic lung disease, sickle cell disease, or immunocompromised can also be at what risk?", "id": "100000000000000000006622", "answers": [{"text": "increased risk", "answer_start": 143}], "is_impossible": false}, {"question": "Children with underlying medical conditions are at an increased risk for getting very sick compared to children without what?", "id": "100000000000000000006623", "answers": [{"text": "underlying medical conditions", "answer_start": 348}], "is_impossible": false}, {"question": "What is the name of the CDC's website for getting sick from COVID-19?", "id": "100000000000000000006625", "answers": [{"text": "People with Certain Medical Conditions", "answer_start": 397}], "is_impossible": false}], "context": "Like adults, children with obesity,\ndiabetes, asthma or chronic lung disease, sickle cell disease, or who are immunocompromised can also be at increased risk\nPeople of all ages, including children, can get very sick from COVID-19. Children with underlying medical conditions are at\nincreased risk for getting very sick compared to children without underlying medical conditions. 10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nfor getting very sick from COVID-19. Check out COVID-19 Vaccines for Children and Teens for more information on vaccination\ninformation for children."}]}, {"title": "d4fedf3721d6a4e13b733b05ae5980ba", "paragraphs": [{"qas": [{"question": "What is important to protect yourself and others by taking COVID-19 prevention actions?", "id": "100000000000000000006626", "answers": [{"text": "Stay up to date with your COVID-19 vaccines", "answer_start": 148}], "is_impossible": false}, {"question": "What should you do if you have symptoms?", "id": "100000000000000000006627", "answers": [{"text": "Get tested", "answer_start": 212}], "is_impossible": false}, {"question": "What do you wear if you have COVID-19 and are at high risk of getting very sick?", "id": "100000000000000000006628", "answers": [{"text": "a mask or respirator", "answer_start": 511}], "is_impossible": false}, {"question": "What is a mask or respirator?", "id": "100000000000000000006629", "answers": [{"text": "Wear", "answer_start": 506}], "is_impossible": false}, {"question": "How do you protect yourself from people who have suspected or confirmed COVID-19?", "id": "100000000000000000006630", "answers": [{"text": "COVID-19 prevention actions", "answer_start": 119}], "is_impossible": false}, {"question": "What is the name of the vaccine that your state, tribal, local, or territorial health department has information on?", "id": "100000000000000000006631", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}], "context": "COVID-19 Vaccines for Children and Teens\nActions You Can Take\nIt is important to protect yourself and others by taking COVID-19 prevention actions:\nStay up to date with your COVID-19 vaccines\nImprove ventilation\nGet tested if you have symptoms\nFollow recommendations for what to do if you have been exposed\nStay home if you have suspected or confirmed COVID-19\nSeek treatment if you have COVID-19 and are at high risk of getting very sick\nAvoid contact with people who have suspected or confirmed COVID-19\nWear a mask or respirator\nIncrease space and distance\nPlease contact your state, tribal, local, or territorial health department for more information on COVID-19 vaccination in your\narea."}]}, {"title": "d21b78be144c5b557652872bf36f8596", "paragraphs": [{"qas": [{"question": "Stay up to date with your COVID-19 vaccines.", "id": "100000000000000000006633", "answers": [{"text": "medical conditions", "answer_start": 37}], "is_impossible": false}, {"question": "If you get sick and think that you may have COVID-19, what do you discuss with your healthcare provider?", "id": "100000000000000000006636", "answers": [{"text": "steps you can take to manage your health and risks", "answer_start": 500}], "is_impossible": false}], "context": "It is also important for people with medical conditions and their healthcare providers to work together and manage\nthose conditions carefully and safely. Stay up to date with your COVID-19 vaccines. If you have a medical condition, the\nfollowing are actions you can take based on your medical conditions and other risk factors. Seek care when needed\nCall your healthcare provider if you have any concerns about your medical conditions or if you get sick and think that you\nmay have COVID-19. Discuss steps you can take to manage your health and risks. If you need emergency help, call 911\nright away."}]}, {"title": "b57bb983bf875e8528270b0f50d080e0", "paragraphs": [{"qas": [{"question": "What do emergency departments, urgent care, clinics and your healthcare provider have to protect you from getting COVID-19 if you need care?", "id": "100000000000000000006639", "answers": [{"text": "infection prevention plans", "answer_start": 153}], "is_impossible": false}, {"question": "Do you need to change your treatment plan?", "id": "100000000000000000006640", "answers": [{"text": "do not change your treatment plan without talking to your healthcare provider", "answer_start": 309}], "is_impossible": false}, {"question": "Have at least a 30-day supply of what?", "id": "100000000000000000006642", "answers": [{"text": "prescription and non-prescription medicines", "answer_start": 421}], "is_impossible": false}, {"question": "Talk to a healthcare provider, insurer, or what other person about getting an extra supply of prescription medicines?", "id": "100000000000000000006643", "answers": [{"text": "pharmacist", "answer_start": 508}], "is_impossible": false}, {"question": "How long is it possible to take to get your prescription medications?", "id": "100000000000000000006645", "answers": [{"text": "more than 30 days", "answer_start": 557}], "is_impossible": false}], "context": "Do not delay getting care for your medical condition because of COVID-19. Emergency departments, urgent care, clinics,\nand your healthcare provider have infection prevention plans to help protect you from getting COVID-19 if you need\ncare. Continue medications and preventive care\nContinue your medicines and do not change your treatment plan without talking to your healthcare provider. Have at least a 30-day supply of prescription and non-prescription medicines. Talk to a healthcare provider, insurer, or\npharmacist about getting an extra supply (i.e., more than 30 days) of prescription medicines, if possible, to reduce your\ntrips to the pharmacy."}]}, {"title": "8ecf27d49e7b9b98861671bc34560491", "paragraphs": [{"qas": [{"question": "What is a good way to keep your medical condition under control?", "id": "100000000000000000006646", "answers": [{"text": "Follow your current treatment plan", "answer_start": 0}], "is_impossible": false}, {"question": "What should you do when possible to keep appointments with your healthcare provider?", "id": "100000000000000000006647", "answers": [{"text": "keep your appointments (e.g., vaccinations and blood pressure checks", "answer_start": 207}], "is_impossible": false}, {"question": "Who should you check for vaccinations and blood pressure?", "id": "100000000000000000006648", "answers": [{"text": "your healthcare provider", "answer_start": 282}], "is_impossible": false}, {"question": "What can you learn about stress and coping?", "id": "100000000000000000006650", "answers": [{"text": "Check with your healthcare provider about safety precautions for office visits and ask about telemedicine or virtual healthcare appointment options. Learn about stress and coping. You may feel increased stress during this pandemic", "answer_start": 308}], "is_impossible": false}, {"question": "What can be helpful to talk with a professional?", "id": "100000000000000000006651", "answers": [{"text": "counselor, therapist, psychologist, or psychiatrist", "answer_start": 657}], "is_impossible": false}], "context": "Follow your current treatment plan (e.g., Asthma Action Plan, dialysis schedule, blood sugar testing, nutrition, and\nexercise recommendations) to keep your medical condition(s) under control. When possible, keep your appointments (e.g., vaccinations and blood pressure checks) with your healthcare provider. Check with your healthcare provider about safety precautions for office visits and ask about telemedicine or virtual\nhealthcare appointment options. Learn about stress and coping. You may feel increased stress during this pandemic. Fear and anxiety can be\noverwhelming and cause strong emotions. It can be helpful to talk with a professional like a counselor, therapist,\npsychologist, or psychiatrist."}]}, {"title": "b3795b0197bba243ae164d4ce5ad1d14", "paragraphs": [{"qas": [{"question": "What are two examples of non-perishable food choices?", "id": "100000000000000000006655", "answers": [{"text": "kidney diet and KCER 3-Day Emergency Diet Plan , diabetic diet", "answer_start": 436}], "is_impossible": false}], "context": "Ask your primary care provider if you would like to speak with a professional. Getting\nregular exercise and being physically active is also a great way to reduce stress. Accommodate dietary needs and avoid triggers\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:38 AM People with Certain Medical Conditions | CDC\nHave non-perishable food choices such as canned goods available that meet your needs based on your medical\ncondition (e.g., kidney diet and KCER 3-Day Emergency Diet Plan , diabetic diet)."}]}, {"title": "d010e80043b2a3392173b5ca167f2636", "paragraphs": [{"qas": [{"question": "What can you avoid by having someone clean and disinfect your house for you?", "id": "100000000000000000006657", "answers": [{"text": "asthma triggers", "answer_start": 74}], "is_impossible": false}, {"question": "How can you prevent pain crises?", "id": "100000000000000000006658", "answers": [{"text": "avoid possible sickle cell disease triggers", "answer_start": 175}], "is_impossible": false}, {"question": "What language is the PDF in?", "id": "100000000000000000006660", "answers": [{"text": "Spanish", "answer_start": 371}], "is_impossible": false}], "context": "Know the triggers for your condition and avoid when possible (e.g., avoid asthma triggers by having another member of\nyour household clean and disinfect your house for you or avoid possible sickle cell disease triggers to prevent pain\ncrises). \u2022\n\uf209\n\u2022\nAdditional Resources\nDon\u2019t Delay: Test Soon and Treat Early\nFile Details: 361 KB, 1 page\nView PDF in English\nView PDF in Spanish\n\uf20c\n\uf20c\nLast Updated Oct. 19, 2022"}]}, {"title": "55067cb68aa7542e3e5f30302330dfad", "paragraphs": [{"qas": [{"question": "What is the risk of severe illness from COVID-19?", "id": "100000000000000000006662", "answers": [{"text": "People with moderate-to-severe or uncontrolled asthma are more likely to be hospitalized", "answer_start": 258}], "is_impossible": false}, {"question": "What type of asthma is more likely to be hospitalized from COVID-19?", "id": "100000000000000000006664", "answers": [{"text": "moderate-to-severe or uncontrolled asthma", "answer_start": 270}], "is_impossible": false}, {"question": "How do you keep your asthma under control?", "id": "100000000000000000006666", "answers": [{"text": "following your asthma action plan", "answer_start": 492}], "is_impossible": false}, {"question": "What is another word for corticosteroids?", "id": "100000000000000000006668", "answers": [{"text": "steroids", "answer_start": 632}], "is_impossible": false}, {"question": "How do you use your inhaler?", "id": "100000000000000000006669", "answers": [{"text": "steroids", "answer_start": 613}], "is_impossible": false}], "context": "10/30/22, 9:39 AM People with Moderate to Severe Asthma | CDC\nEspa\u00f1ol | Other Languages\nPeople with Moderate to Severe Asthma\nThis information is based on what we currently know about the spread and severity of COVID-19. Risk of severe illness from COVID-19\nPeople with moderate-to-severe or uncontrolled asthma are more likely to be hospitalized from COVID-19. Take steps to\nprotect yourself. Vaccine information for COVID-19\nFollow your Asthma Action Plan\nKeep your asthma under control by following your asthma action plan. Avoid your asthma triggers. Continue current medications, including any inhalers with steroids in them (\u201csteroids\u201d is another word for\ncorticosteroids). Know how to use your inhaler."}]}, {"title": "18a6e731d2d8a2d8da1cf1bb697bfdca", "paragraphs": [{"qas": [{"question": "What is an emergency supply of?", "id": "100000000000000000006670", "answers": [{"text": "prescription medications", "answer_start": 206}], "is_impossible": false}, {"question": "How many days of non-prescription medications should you have on hand in case of an emergency?", "id": "100000000000000000006671", "answers": [{"text": "30", "answer_start": 281}], "is_impossible": false}], "context": "Do not stop any medications or change your asthma treatment plan without talking to your healthcare provider. Talk to your healthcare provider, insurer, and pharmacist about creating an emergency supply of prescription\nmedications, such as asthma inhalers. Make sure that you have 30 days of non-prescription medications and supplies on\nhand in case you need to stay home for a long time. Be careful around cleaning agents and disinfectants\nCDC is reviewing this page to align with updated guidance."}]}, {"title": "3048b1c6b2ce9a694cc7a6bd3bf83170", "paragraphs": [{"qas": [{"question": "What kind of vaccine information is particularly important for older adults and long term care facility residents?", "id": "100000000000000000006675", "answers": [{"text": "COVID-19 Vaccines Information for Specific Groups", "answer_start": 0}], "is_impossible": false}, {"question": "What is especially important for people with asthma?", "id": "100000000000000000006676", "answers": [{"text": "Flu vaccination", "answer_start": 402}], "is_impossible": false}, {"question": "What does CDC recommend to reduce your chance of an asthma attack while cleaning your home and facility?", "id": "100000000000000000006677", "answers": [{"text": "\u2022", "answer_start": 472}], "is_impossible": false}], "context": "COVID-19 Vaccines Information for Specific Groups\nVaccine information for older adults, long-term care facility residents, people with underlying medical conditions, people\nat high risk for severe illness, people with disabilities, and more. COVID-19 Vaccine Information\nCOVID-19 Vaccine Information: Vaccine Considerations for People with Underlying Medical Conditions | CDC\nAdditional Consideration: Flu vaccination is especially important for people with asthma\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:39 AM People with Moderate to Severe Asthma | CDC\nFollow the recommendations below to reduce your chance of an asthma\nattack while cleaning. Follow recommendations for cleaning your home and\nin your facility."}]}, {"title": "602ffdc92cc490a9bf5d94f15a47a9cf", "paragraphs": [{"qas": [{"question": "If you have asthma, ask an adult to clean and disinfect surfaces and objects for you.", "id": "100000000000000000006678", "answers": [{"text": "close to your phone", "answer_start": 473}], "is_impossible": false}, {"question": "Where do you stay when cleaners or disinfectants are being used?", "id": "100000000000000000006679", "answers": [{"text": "another room", "answer_start": 109}], "is_impossible": false}, {"question": "When do you use cleaning agents and disinfectant only when necessary?", "id": "100000000000000000006680", "answers": [{"text": "right after their use", "answer_start": 172}], "is_impossible": false}, {"question": "How can high-touch surfaces and objects be cleaned effectively?", "id": "100000000000000000006681", "answers": [{"text": "with soap and water", "answer_start": 337}], "is_impossible": false}, {"question": "What is the name of the urgent care or health facility that provides nebulizer/asthma treatments?", "id": "100000000000000000006682", "answers": [{"text": "Make a list of the urgent care or health facilities near you", "answer_start": 358}], "is_impossible": false}, {"question": "What can you do if you have an asthma attack?", "id": "100000000000000000006683", "answers": [{"text": "move away from the trigger", "answer_start": 524}], "is_impossible": false}, {"question": "Where can you move away from the trigger?", "id": "100000000000000000006684", "answers": [{"text": "the cleaning agent or disinfectant or the area that was disinfected", "answer_start": 560}], "is_impossible": false}], "context": "If you have asthma:\nAsk an adult without asthma to clean and disinfect surfaces and objects for you. Stay in another room when cleaners or disinfectants are being used and right after their use. Use cleaning agents and disinfectant only when necessary. In routine situations, high-touch surfaces and objects\nmight be cleaned effectively with soap and water. Make a list of the urgent care or health facilities near you that provides nebulizer/asthma treatments and keep it\nclose to your phone. If you have an asthma attack, move away from the trigger, such as the cleaning agent or disinfectant or the area\nthat was disinfected."}]}, {"title": "8194fc5c6e614919732662bdddea7a75", "paragraphs": [{"qas": [{"question": "What should the person cleaning and disinfecting use?", "id": "100000000000000000006685", "answers": [{"text": "Choose disinfectants that are less likely to cause an asthma attack, using the U.S. Environmental Protection Agency (EPA)\u2019s list of approved products", "answer_start": 111}], "is_impossible": false}, {"question": "What is the EPA's list of approved disinfectants?", "id": "100000000000000000006686", "answers": [{"text": "Products with hydrogen peroxide (no stronger than 3%) or ethanol (ethyl alcohol).", "answer_start": 272}], "is_impossible": false}, {"question": "What is hydrogen peroxide no stronger than?", "id": "100000000000000000006687", "answers": [{"text": "3%)", "answer_start": 322}], "is_impossible": false}, {"question": "What is ethanol?", "id": "100000000000000000006688", "answers": [{"text": "ethyl alcohol", "answer_start": 338}], "is_impossible": false}, {"question": "Sodium hypochlorite is also known as what?", "id": "100000000000000000006689", "answers": [{"text": "bleach", "answer_start": 570}], "is_impossible": false}], "context": "Follow your Asthma Action Plan. Call 911 for medical emergencies. The person cleaning and disinfecting should:\nChoose disinfectants that are less likely to cause an asthma attack, using the U.S. Environmental Protection Agency\n(EPA)\u2019s list of approved products , such as:\nProducts with hydrogen peroxide (no stronger than 3%) or ethanol (ethyl alcohol). Ensure that products with\nhydrogen peroxide do not contain other chemicals that can trigger asthma attacks such as peroxyacetic acid\nor peracetic acid. Limit use of chemicals that can trigger asthma attacks, such as bleach (sodium hypochlorite) or quaternary\nammonium compounds (for example, benzalkonium chloride), and do not use them in enclosed spaces."}]}, {"title": "d90133b395fb02a9b58f0864293ee25a", "paragraphs": [{"qas": [{"question": "What do you do to reduce exposure to asthma triggers?", "id": "100000000000000000006692", "answers": [{"text": "Follow additional precautions for cleaning and disinfecting places", "answer_start": 0}], "is_impossible": false}, {"question": "Do you read and follow the directions on the product label?", "id": "100000000000000000006693", "answers": [{"text": "Always read and follow the directions on the product label", "answer_start": 176}], "is_impossible": false}, {"question": "What should you wear to protect yourself from splashes?", "id": "100000000000000000006694", "answers": [{"text": "skin protection such as gloves and consider eye protection", "answer_start": 291}], "is_impossible": false}, {"question": "What is the term for air flow?", "id": "100000000000000000006695", "answers": [{"text": "ventilation", "answer_start": 424}], "is_impossible": false}, {"question": "How much water should you use for dilution?", "id": "100000000000000000006696", "answers": [{"text": "at room temperature", "answer_start": 494}], "is_impossible": false}, {"question": "Do NOT mix chemical products.", "id": "100000000000000000006698", "answers": [{"text": "Use water at room temperature for dilution (unless stated otherwise on the label). Do NOT mix chemical products. Label diluted cleaning solutions", "answer_start": 484}], "is_impossible": false}, {"question": "Do NOT label diluted cleaning solutions.", "id": "100000000000000000006699", "answers": [{"text": "chemical products", "answer_start": 578}], "is_impossible": false}], "context": "Follow additional precautions for cleaning and disinfecting places where people with asthma might be, to reduce\nexposure to asthma triggers. Use products safely and correctly:\nAlways read and follow the directions on the product label to ensure you are using it safely and effectively. Wear skin protection such as gloves and consider eye protection to protect yourself against splashes. Make sure there is enough air flow (ventilation). Use only the amount recommended on the label. Use water at room temperature for dilution (unless stated otherwise on the label). Do NOT mix chemical products. Label diluted cleaning solutions."}]}, {"title": "2a8cb96f3fc1334fae021242f77ae3c9", "paragraphs": [{"qas": [{"question": "What does the EPA say to label diluted cleaning solutions?", "id": "100000000000000000006700", "answers": [{"text": "6 steps for Safe and Effective Disinfectant Use", "answer_start": 310}], "is_impossible": false}, {"question": "Who should you call if you feel ill?", "id": "100000000000000000006703", "answers": [{"text": "your healthcare provider", "answer_start": 381}], "is_impossible": false}], "context": "Spray or pour spray products onto a cleaning cloth or paper towel instead of spraying the product directly onto the\ncleaning surface (if the product label allows). Store products safely and correctly\nStore and use chemicals out of the reach of children and pets. Label diluted cleaning solutions. Follow EPA\u2019s 6 steps for Safe and Effective Disinfectant Use . If you feel ill\nCall your healthcare provider to ask about your symptoms. If you don\u2019t have a healthcare provider, contact your nearest\ncommunity health center or health department. Remember to call 911 for medical emergencies."}]}, {"title": "3936dded58c81a4a1f8b5f6ffcdfa6bc", "paragraphs": [{"qas": [{"question": "What can you do to help yourself cope?", "id": "100000000000000000006707", "answers": [{"text": "Take steps", "answer_start": 88}], "is_impossible": false}], "context": "Cleaning and Disinfecting Your Home\n\u2022\n-\n-\n-\n-\n-\n\u2022\n-\n\uf209\n\u2022\n-\n-\n\u2022\n-\n-\n-\n-\n-\n-\n-\n\u2022\n-\n-\n- \uf209\n\uf209\nTake steps to help yourself cope with stress and anxiety\nIt is natural for some people to feel concerned or stressed as more cases of COVID-19 are discovered and our\ncommunities act to combat the spread of disease. Strong emotions can trigger an asthma attack."}]}, {"title": "87fa2ec2d125250103c780e387759d83", "paragraphs": [{"qas": [{"question": "What is COVID-19?", "id": "100000000000000000006708", "answers": [{"text": "CDC Coping with a Disaster or Traumatic Event", "answer_start": 176}], "is_impossible": false}, {"question": "What is the EXHALE Guide for People With Asthma, Their Families, and Their Children?", "id": "100000000000000000006709", "answers": [{"text": "1.5 MB, 8 pages", "answer_start": 355}], "is_impossible": false}, {"question": "How many pages is the EXHALE Guide for People With Asthma, Their Families, and Their Caregivers?", "id": "100000000000000000006710", "answers": [{"text": "8", "answer_start": 363}], "is_impossible": false}], "context": "For more information on coping with a disaster or traumatic event, visit\n\u2022\n\u2022\f10/30/22, 9:39 AM People with Moderate to Severe Asthma | CDC\np g ,\nStress and Coping | COVID-19 | CDC\nCoping with a Disaster or Traumatic Event | CDC Emergency Preparedness & Response\nPatient resources\nEXHALE Guide for People With Asthma, Their Families, and Their Caregivers [1.5 MB, 8 pages]\nAllergy and Asthma Network\nAsthma and Allergy Foundation of America\nNational Environmental Education Foundation\nAdditional resources for schools and childcare programs\nFor information on administering asthma medication in schools, K-12 Schools and Childcare Programs\n-\n-\n\u2022 \uf20c\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\nLast Updated Apr. 7, 2022"}]}, {"title": "c3774fa8a643432ffa21b12ec8f6e362", "paragraphs": [{"qas": [{"question": "What is the name of the PFIZER-BIONTECH COVID-19 VACCINE?", "id": "100000000000000000006713", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 326}], "is_impossible": false}, {"question": "WHAT is the BIVALENT version of the Pfizer-Bontech Covid-19 Vaccine?", "id": "100000000000000000006714", "answers": [{"text": "ORIGINAL AND OMICRON BA.4/BA.5", "answer_start": 136}], "is_impossible": false}, {"question": "What are the names of the two vaccines that are being offered to your child?", "id": "100000000000000000006715", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine1 or the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)2", "answer_start": 326}], "is_impossible": false}, {"question": "What is being offered to prevent Coronavirus Disease 2019?", "id": "100000000000000000006716", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine1 or the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)2, hereafter referred to as the Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 326}], "is_impossible": false}], "context": "FACT SHEET FOR RECIPIENTS AND CAREGIVERS ABOUT THE\nPFIZER-BIONTECH COVID-19 VACCINE AND THE PFIZER-BIONTECH COVID-19\nVACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) TO PREVENT\nCORONAVIRUS DISEASE 2019 (COVID-19) FOR USE IN INDIVIDUALS\n5 THROUGH 11 YEARS OF AGE\nFOR 5 THROUGH 11 YEARS OF AGE\nYour child is being offered the Pfizer-BioNTech COVID-19 Vaccine1 or the\nPfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)2,\nhereafter referred to as the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to\nprevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2."}]}, {"title": "a6e28801cfc0a6dc68c03098ed44bbbd", "paragraphs": [{"qas": [{"question": "What does EUA stand for?", "id": "100000000000000000006718", "answers": [{"text": "Emergency Use Authorization", "answer_start": 277}], "is_impossible": false}, {"question": "What is the purpose of EUA for the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000006719", "answers": [{"text": "to provide: \uf0b7 a 2-dose primary series to individuals 5 through 11 years of age", "answer_start": 360}], "is_impossible": false}, {"question": "What is the name of the monovalent vaccine?", "id": "100000000000000000006720", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 557}], "is_impossible": false}, {"question": "What type of vaccine encodes the spike protein of only the Original SARS-CoV-2?", "id": "100000000000000000006722", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 557}], "is_impossible": false}], "context": "This Fact Sheet for Recipients and Caregivers comprises the Fact Sheet for the\nauthorized Pfizer-BioNTech COVID-19 Vaccine3,4 and the Pfizer-BioNTech\nCOVID-19 Vaccine, Bivalent for use in individuals 5 through 11 years of age. The Pfizer-BioNTech COVID-19 Vaccine has received Emergency Use\nAuthorization (EUA) from the U.S. Food and Drug Administration (FDA) to\nprovide:\n\uf0b7 a 2-dose primary series to individuals 5 through 11 years of age. \uf0b7 a third primary series dose to individuals 5 through 11 years of age with\ncertain kinds of immunocompromise. 1 The Pfizer-BioNTech COVID-19 Vaccine, a monovalent vaccine, encodes the spike protein of only the\nOriginal SARS-CoV-2."}]}, {"title": "d141814cacba15499d2ac45c8eec434c", "paragraphs": [{"qas": [{"question": "What does the Pfizer-BioNTech COVID-19 Vaccine, Bivalent encode?", "id": "100000000000000000006723", "answers": [{"text": "the spike protein", "answer_start": 57}], "is_impossible": false}, {"question": "What is the spike protein of the Original SARS-CoV-2 and the Omicron BA.4/BA.5?", "id": "100000000000000000006724", "answers": [{"text": "The Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 2}], "is_impossible": false}, {"question": "Who may receive this Fact Sheet even if your child is 4 years old?", "id": "100000000000000000006725", "answers": [{"text": "Children who will turn from 4 years to 5 years of age", "answer_start": 209}], "is_impossible": false}, {"question": "How many doses of the Pfizer-BioNTech COVID-19 Vaccine are approved for use in individuals 5 to 11 years of age?", "id": "100000000000000000006726", "answers": [{"text": "2", "answer_start": 317}], "is_impossible": false}], "context": "2 The Pfizer-BioNTech COVID-19 Vaccine, Bivalent encodes the spike protein of the Original\nSARS-CoV-2 and the Omicron BA.4/BA.5 SARS-CoV-2. 3 You may receive this Fact Sheet even if your child is 4 years old. Children who will turn from 4 years to\n5 years of age between any doses in the primary series may receive a 2-dose primary series with the\nPfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 5 through 11 years of age."}]}, {"title": "f6aaedfff362e93bf37d59de602a1dfa", "paragraphs": [{"qas": [{"question": "How many doses of the Pfizer-BioNTech COVID-19 Vaccine are approved for use in individuals 6 months through 4 years of age?", "id": "100000000000000000006727", "answers": [{"text": "2 and/or 3. 4", "answer_start": 365}], "is_impossible": false}, {"question": "How old is a child who receives this Fact Sheet eligible for?", "id": "100000000000000000006730", "answers": [{"text": "12 years old", "answer_start": 433}], "is_impossible": false}], "context": "Children\nwho will turn from 4 years to 5 years of age between any doses in the primary series, and who initiated a\n3-dose primary series with the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals\n6 months through 4 years of age, may receive the Pfizer-BioNTech COVID-19 Vaccine authorized for use\nin individuals 5 through 11 years of age for doses 2 and/or 3. 4 You may receive this Fact Sheet even if your child is 12 years old."}]}, {"title": "16ffc8a033c1962d1962db280c10d038", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 5 to 11 years of age?", "id": "100000000000000000006731", "answers": [{"text": "COMIRNATY", "answer_start": 259}], "is_impossible": false}, {"question": "What is COMIRNATY?", "id": "100000000000000000006732", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 270}], "is_impossible": false}], "context": "Children who will turn from 11 years\nto 12 years of age between doses in the primary regimen may receive, for any dose in the primary series,\neither: (1) the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 5 through 11 years of\nage; or (2) COMIRNATY (COVID-19 Vaccine, mRNA) or the Pfizer-BioNTech COVID-19 Vaccine\nauthorized for use in individuals 12 years of age and older."}]}, {"title": "3c36af5c64d1511ef3fd10b80e8cdcc6", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent?", "id": "100000000000000000006735", "answers": [{"text": "\uf0b7 a single booster dose to individuals 5 through 11 years of age at least 2 months", "answer_start": 91}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000006736", "answers": [{"text": "single booster dose", "answer_start": 96}], "is_impossible": false}, {"question": "How long does it take for a single booster dose to be given to individuals 5-11 years of age?", "id": "100000000000000000006737", "answers": [{"text": "2 months", "answer_start": 353}], "is_impossible": false}, {"question": "How long after receiving the most recent booster dose is a single booster dose given to individuals 5 through 11 years of age?", "id": "100000000000000000006738", "answers": [{"text": "2 months", "answer_start": 353}], "is_impossible": false}, {"question": "What type of vaccine is approved for use with a monovalent COVID-19?", "id": "100000000000000000006739", "answers": [{"text": "2 months", "answer_start": 165}], "is_impossible": false}], "context": "The Pfizer-BioNTech COVID-19 Vaccine, Bivalent has received EUA from FDA to\nprovide either:\n\uf0b7 a single booster dose to individuals 5 through 11 years of age at least\n2 months after completion of primary vaccination with any authorized or\napproved monovalent5 COVID-19 vaccine; or\n\uf0b7 a single booster dose to individuals 5 through 11 years of age at least\n2 months after receipt of the most recent booster dose with any\nauthorized or approved monovalent COVID-19 vaccine."}]}, {"title": "fd944896a257056439619b04e36ca1e1", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000006740", "answers": [{"text": "Bivalent", "answer_start": 164}], "is_impossible": false}, {"question": "What is the name of the coronavirus that causes COVID-19?", "id": "100000000000000000006743", "answers": [{"text": "SARS-CoV-2", "answer_start": 558}], "is_impossible": false}, {"question": "What is SARS-CoV-2?", "id": "100000000000000000006744", "answers": [{"text": "coronavirus", "answer_start": 539}], "is_impossible": false}, {"question": "How can you get COVID-19?", "id": "100000000000000000006746", "answers": [{"text": "through contact with another person who has the virus", "answer_start": 591}], "is_impossible": false}], "context": "This Fact Sheet contains information to help you understand the risks and benefits of\nthe Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent, which your child may receive because there is currently a pandemic of\nCOVID-19. Talk to your child\u2019s vaccination provider if you have questions. This Fact Sheet may have been updated. For the most recent Fact Sheet, please see\nwww.cvdvaccine.com. WHAT YOU NEED TO KNOW BEFORE YOUR CHILD GETS ANY OF THESE\nVACCINES\nWHAT IS COVID-19? COVID-19 disease is caused by a coronavirus called SARS-CoV-2. You can get\nCOVID-19 through contact with another person who has the virus."}]}, {"title": "93003feee612119b9922b936f0f01c08", "paragraphs": [{"qas": [{"question": "What is COVID-19 primarily a respiratory illness?", "id": "100000000000000000006747", "answers": [{"text": "virus", "answer_start": 255}], "is_impossible": false}, {"question": "What can affect other organs?", "id": "100000000000000000006748", "answers": [{"text": "a respiratory illness", "answer_start": 20}], "is_impossible": false}, {"question": "Who has had a wide range of symptoms?", "id": "100000000000000000006750", "answers": [{"text": "People with COVID-19", "answer_start": 72}], "is_impossible": false}, {"question": "What is the name of the section at the end of this Fact Sheet?", "id": "100000000000000000006752", "answers": [{"text": "Emergency Use Authorization", "answer_start": 516}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000006753", "answers": [{"text": "Emergency Use Authorization", "answer_start": 516}], "is_impossible": false}], "context": "It is predominantly a\nrespiratory illness that can affect other organs. People with COVID-19 have had a wide\nrange of symptoms reported, ranging from mild symptoms to severe illness leading to\ndeath. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may\ninclude: fever or chills; cough; shortness of breath; fatigue; muscle or body aches;\nheadache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or\nvomiting; diarrhea. For more information on EUA, see the \u201cWhat is an Emergency Use Authorization\n(EUA)?\u201d section at the end of this Fact Sheet."}]}, {"title": "66477e70697d9034a7001fd217304343", "paragraphs": [{"qas": [{"question": "What is the term for inflammation of the heart muscle?", "id": "100000000000000000006754", "answers": [{"text": "myocarditis", "answer_start": 238}], "is_impossible": false}, {"question": "If your child has any allergies, what should you tell them about?", "id": "100000000000000000006756", "answers": [{"text": "all of your child\u2019s medical conditions", "answer_start": 143}], "is_impossible": false}, {"question": "What is the term for inflammation of the lining outside of the heart?", "id": "100000000000000000006757", "answers": [{"text": "pericarditis", "answer_start": 288}], "is_impossible": false}], "context": "WHAT SHOULD YOU MENTION TO YOUR CHILD\u2019S VACCINATION PROVIDER\nBEFORE YOUR CHILD GETS ANY OF THESE VACCINES? Tell the vaccination provider about all of your child\u2019s medical conditions,\nincluding if your child:\n\uf0b7 has any allergies\n\uf0b7 has had myocarditis (inflammation of the heart muscle) or pericarditis\n(inflammation of the lining outside the heart)\n\uf0b7 has a fever\n\uf0b7 has a bleeding disorder or is on a blood thinner\n5 Monovalent refers to any authorized or approved COVID-19 vaccine that contains or encodes the spike protein\nof only the Original SARS-CoV-2."}]}, {"title": "f2621e37427aaf2dc5e61323f516bda4", "paragraphs": [{"qas": [{"question": "What does the Pfizer-BioNTech COVID-19 Vaccine have to do with your child?", "id": "100000000000000000006759", "answers": [{"text": "as an injection into the muscle", "answer_start": 354}], "is_impossible": false}, {"question": "What is the name of the vaccine that is given to your child as a vaccine?", "id": "100000000000000000006760", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 242}], "is_impossible": false}, {"question": "How is the Pfizer-BioNTech COVID-19 Vaccine, Bivalent administered?", "id": "100000000000000000006761", "answers": [{"text": "as an injection into the muscle", "answer_start": 354}], "is_impossible": false}, {"question": "What is the primary series of the vaccine?", "id": "100000000000000000006762", "answers": [{"text": "The Pfizer-BioNTech COVID-19", "answer_start": 403}], "is_impossible": false}, {"question": "How many days after the second dose may a primary series dose be administered to individuals with certain kinds of immunocompromise?", "id": "100000000000000000006764", "answers": [{"text": "28", "answer_start": 593}], "is_impossible": false}], "context": "\uf0b7 is immunocompromised or is on a medicine that affects your child\u2019s immune\nsystem\n\uf0b7 is pregnant\n\uf0b7 is breastfeeding\n\uf0b7 has received another COVID-19 vaccine\n\uf0b7 has ever fainted in association with an injection\nHOW ARE THESE VACCINES GIVEN? The Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent will be given to your child as an injection into the muscle. Primary Series: The Pfizer-BioNTech COVID-19 Vaccine is given for the primary series. The vaccine is administered as a 2-dose series, 3 weeks apart. A third primary series\ndose may be administered at least 28 days after the second dose to individuals with\ncertain kinds of immunocompromise."}]}, {"title": "89642f6fa65615e9c069c0d0fe25030b", "paragraphs": [{"qas": [{"question": "When is the Pfizer-BioNTech COVID-19 Vaccine, Bivalent administered as a single booster dose?", "id": "100000000000000000006765", "answers": [{"text": "2 months", "answer_start": 111}], "is_impossible": false}, {"question": "How long after the completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine is the Booster Dose administered?", "id": "100000000000000000006766", "answers": [{"text": "2 months", "answer_start": 111}], "is_impossible": false}, {"question": "What should your child not get?", "id": "100000000000000000006769", "answers": [{"text": "any of these vaccines", "answer_start": 501}], "is_impossible": false}, {"question": "What was the previous dose of the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000006770", "answers": [{"text": "\uf0b7 completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine; or \uf0b7 receipt of the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine", "answer_start": 126}], "is_impossible": false}, {"question": "What had a severe allergic reaction to any ingredient in these vaccines?", "id": "100000000000000000006771", "answers": [{"text": "your child", "answer_start": 526}], "is_impossible": false}], "context": "Booster Dose:\nThe Pfizer-BioNTech COVID-19 Vaccine, Bivalent is administered as a single booster\ndose at least 2 months after:\n\uf0b7 completion of primary vaccination with any authorized or approved monovalent\nCOVID-19 vaccine; or\n\uf0b7 receipt of the most recent booster dose with any authorized or approved\nmonovalent COVID-19 vaccine. The vaccine may not protect everyone. WHO SHOULD NOT GET THE PFIZER-BIONTECH COVID-19 VACCINE OR THE\nPFIZER-BIONTECH COVID-19 VACCINE, BIVALENT? Your child should not get any of these vaccines if your child:\n\uf0b7 had a severe allergic reaction after a previous dose of the Pfizer-BioNTech\nCOVID-19 Vaccine. \uf0b7 had a severe allergic reaction to any ingredient in these vaccines."}]}, {"title": "5cbc011a82c6a3cab48273fb448381cf", "paragraphs": [{"qas": [{"question": "What are the ingredients in the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000006772", "answers": [{"text": "mRNA, lipids (((4- and cholesterol), tromethamine, tromethamine hydrochloride, sucrose, and sodium chloride", "answer_start": 167}], "is_impossible": false}, {"question": "What is the name of the mRNA, lipids, tromethamine hydrochloride, sucrose, and sodium chloride that are included in both the pfizer and biontech vaccinates?", "id": "100000000000000000006773", "answers": [{"text": "Bivalent", "answer_start": 122}], "is_impossible": false}, {"question": "How many people between the ages of 5 and 11 have received a dose of a vaccine?", "id": "100000000000000000006774", "answers": [{"text": "3,100", "answer_start": 349}], "is_impossible": false}, {"question": "How long have millions of people received a dose of a vaccine under EUA since December 11, 2020?", "id": "100000000000000000006777", "answers": [{"text": "mRNA, lipids (((4- and cholesterol), tromethamine, tromethamine hydrochloride, sucrose, and sodium chloride", "answer_start": 167}], "is_impossible": false}], "context": "WHAT ARE THE INGREDIENTS IN THESE VACCINES? The Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent include the following ingredients: mRNA, lipids (((4-\nand cholesterol), tromethamine, tromethamine hydrochloride, sucrose, and sodium\nchloride. HAVE THESE VACCINES BEEN USED BEFORE? In a clinical trial, approximately 3,100 individuals 5 through 11 years of age have\nreceived at least 1 dose of the Pfizer-BioNTech COVID-19 Vaccine. Millions of\nindividuals have received the Pfizer-BioNTech COVID-19 Vaccine under EUA since\nDecember 11, 2020."}]}, {"title": "9ed655183eb8523e4013e621c713e0b0", "paragraphs": [{"qas": [{"question": "What is the difference in the Omicron component of the Bivalent vaccine?", "id": "100000000000000000006780", "answers": [{"text": "different", "answer_start": 205}], "is_impossible": false}, {"question": "How many people over 55 years of age received a dose of a bivalent vaccine in a trial?", "id": "100000000000000000006781", "answers": [{"text": "300", "answer_start": 35}], "is_impossible": false}, {"question": "What has been shown to prevent COVID-19?", "id": "100000000000000000006783", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 279}], "is_impossible": false}, {"question": "What has FDA authorized the Pfizer-BioNTech Covid-19 Vaccine, Bivalent to provide better protection against?", "id": "100000000000000000006784", "answers": [{"text": "COVID-19 caused by the Omicron variant of SARS-CoV-2", "answer_start": 451}], "is_impossible": false}, {"question": "What is the remote chance that these vaccines could cause a severe allergic reaction?", "id": "100000000000000000006785", "answers": [{"text": "RISKS", "answer_start": 584}], "is_impossible": false}], "context": "In a clinical trial, approximately 300 individuals greater than 55 years of age received\n1 dose of a bivalent vaccine that differs from the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent in that it contains a different Omicron component. WHAT ARE THE BENEFITS OF THESE VACCINES? The Pfizer-BioNTech COVID-19 Vaccine has been shown to prevent COVID-19. FDA\nhas authorized the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to provide better\nprotection against COVID-19 caused by the Omicron variant of SARS-CoV-2. The duration of protection against COVID-19 is currently unknown. WHAT ARE THE RISKS OF THESE VACCINES? There is a remote chance that these vaccines could cause a severe allergic reaction."}]}, {"title": "d5c269fcd1e24bfb2290cd9941cadee8", "paragraphs": [{"qas": [{"question": "What would happen within a few minutes to 1 hour after getting a dose of a vaccine?", "id": "100000000000000000006786", "answers": [{"text": "A severe allergic reaction", "answer_start": 0}], "is_impossible": false}, {"question": "What may your child's vaccination provider ask your child to stay at the place where they received the vaccine for monitoring after vaccination?", "id": "100000000000000000006787", "answers": [{"text": "A severe allergic reaction", "answer_start": 0}], "is_impossible": false}, {"question": "What are signs of a severe allergic reaction?", "id": "100000000000000000006788", "answers": [{"text": "Difficulty breathing \uf0b7 Swelling of the face and throat", "answer_start": 314}], "is_impossible": false}, {"question": "Inflammation of the lining outside the heart is what?", "id": "100000000000000000006790", "answers": [{"text": "pericarditis", "answer_start": 495}], "is_impossible": false}], "context": "A\nsevere allergic reaction would usually occur within a few minutes to 1 hour after getting\na dose. For this reason, your child\u2019s vaccination provider may ask your child to stay at\nthe place where your child received the vaccine for monitoring after vaccination. Signs\nof a severe allergic reaction can include:\n\uf0b7 Difficulty breathing\n\uf0b7 Swelling of the face and throat\n\uf0b7 A fast heartbeat\n\uf0b7 A bad rash all over the body\n\uf0b7 Dizziness and weakness\nMyocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the\nlining outside the heart) have occurred in some people who have received the\nPfizer-BioNTech COVID-19 Vaccine."}]}, {"title": "6c5173ed30f29a30b4447c8e360f12b4", "paragraphs": [{"qas": [{"question": "What is the chance of having a second dose of a vaccine occur in most people?", "id": "100000000000000000006792", "answers": [{"text": "very low", "answer_start": 142}], "is_impossible": false}, {"question": "How long after receiving the second vaccine do symptoms begin?", "id": "100000000000000000006793", "answers": [{"text": "within a few days", "answer_start": 40}], "is_impossible": false}], "context": "In most of these people, symptoms began within a\nfew days following receipt of the second dose of vaccine. The chance of having this\noccur is very low."}]}, {"title": "a9dccee40e52ba6b8cff55569c992d83", "paragraphs": [{"qas": [{"question": "What should you do if your child has any of the following symptoms after receiving the vaccine?", "id": "100000000000000000006794", "answers": [{"text": "seek medical attention right away", "answer_start": 11}], "is_impossible": false}, {"question": "What are some of the side effects that have been reported with these vaccines?", "id": "100000000000000000006795", "answers": [{"text": "Severe allergic reactions", "answer_start": 292}], "is_impossible": false}, {"question": "What is a non-severe allergic reaction?", "id": "100000000000000000006796", "answers": [{"text": "rash, itching, hives, or swelling of the face", "answer_start": 358}], "is_impossible": false}, {"question": "What is the name of the inflammation of the heart muscle?", "id": "100000000000000000006797", "answers": [{"text": "Myocarditis", "answer_start": 406}], "is_impossible": false}, {"question": "How is Pericarditis defined?", "id": "100000000000000000006798", "answers": [{"text": "inflammation of the lining outside the heart", "answer_start": 469}], "is_impossible": false}, {"question": "What is lymphadenopathy?", "id": "100000000000000000006799", "answers": [{"text": "Swollen lymph nodes", "answer_start": 683}], "is_impossible": false}, {"question": "What is Fainting in association with injection of the vaccine?", "id": "100000000000000000006800", "answers": [{"text": "Arm pain", "answer_start": 766}], "is_impossible": false}], "context": "You should seek medical attention right away if your child has any of\nthe following symptoms after receiving the vaccine:\n\uf0b7 Chest pain\n\uf0b7 Shortness of breath\n\uf0b7 Feelings of having a fast-beating, fluttering, or pounding heart\nSide effects that have been reported with these vaccines include:\n\uf0b7 Severe allergic reactions\n\uf0b7 Non-severe allergic reactions such as rash, itching, hives, or swelling of the face\n\uf0b7 Myocarditis (inflammation of the heart muscle)\n\uf0b7 Pericarditis (inflammation of the lining outside the heart)\n\uf0b7 Injection site pain\n\uf0b7 Tiredness\n\uf0b7 Headache\n\uf0b7 Muscle pain\f\uf0b7 Chills\n\uf0b7 Joint pain\n\uf0b7 Fever\n\uf0b7 Injection site swelling\n\uf0b7 Injection site redness\n\uf0b7 Nausea\n\uf0b7 Feeling unwell\n\uf0b7 Swollen lymph nodes (lymphadenopathy)\n\uf0b7 Decreased appetite\n\uf0b7 Diarrhea\n\uf0b7 Vomiting\n\uf0b7 Arm pain\n\uf0b7 Fainting in association with injection of the vaccine\nThese may not be all the possible side effects of these vaccines."}]}, {"title": "b031dc1608a13f31b39ea1d82b4bca69", "paragraphs": [{"qas": [{"question": "What are the possible side effects of vaccines still being studied?", "id": "100000000000000000006801", "answers": [{"text": "Serious and unexpected side effects", "answer_start": 0}], "is_impossible": false}, {"question": "What should you do if your child experiences a severe allergic reaction?", "id": "100000000000000000006802", "answers": [{"text": "call 9-1-1, or go to the nearest hospital", "answer_start": 207}], "is_impossible": false}, {"question": "What is the VAERS toll-free number?", "id": "100000000000000000006804", "answers": [{"text": "1-800-822-7967", "answer_start": 510}], "is_impossible": false}], "context": "Serious and\nunexpected side effects may occur. The possible side effects of these vaccines are still\nbeing studied. WHAT SHOULD I DO ABOUT SIDE EFFECTS? If your child experiences a severe allergic reaction, call 9-1-1, or go to the nearest\nhospital. Call the vaccination provider or your child\u2019s healthcare provider if your child has any\nside effects that bother your child or do not go away. Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System\n(VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to\nhttps://vaers.hhs.gov/reportevent.html."}]}, {"title": "8b6436824727aed824a2be9dd4bfbbd4", "paragraphs": [{"qas": [{"question": "What can you report to Pfizer Inc. at the contact information provided below?", "id": "100000000000000000006807", "answers": [{"text": "side effects", "answer_start": 183}], "is_impossible": false}, {"question": "What is v-safe?", "id": "100000000000000000006808", "answers": [{"text": "a voluntary smartphone-based tool", "answer_start": 353}], "is_impossible": false}, {"question": "What does V-safe use to check in with people who have been vaccinated?", "id": "100000000000000000006809", "answers": [{"text": "text messaging and web surveys", "answer_start": 397}], "is_impossible": false}], "context": "Please include \u201cPfizer-BioNTech COVID-19\nVaccine EUA\u201d or \u201cPfizer-BioNTech COVID-19 Vaccine, Bivalent EUA\u201d in the first line of\nbox #18 of the report form. In addition, you can report side effects to Pfizer Inc. at the contact information provided\nbelow. Website Fax number Telephone number\nYou may also be given an option to enroll in v-safe. V-safe is a voluntary\nsmartphone-based tool that uses text messaging and web surveys to check in with\npeople who have been vaccinated to identify potential side effects after COVID-19\nvaccination. V-safe asks questions that help CDC monitor the safety of COVID-19\nvaccines."}]}, {"title": "f2cb64ec01af3ef53125df67eee4287c", "paragraphs": [{"qas": [{"question": "Where can you sign up for V-Safe?", "id": "100000000000000000006811", "answers": [{"text": "www.cdc.gov", "answer_start": 219}], "is_impossible": false}, {"question": "What is the name of the vaccine that PFIZER-BIONTECH provides for children?", "id": "100000000000000000006812", "answers": [{"text": "COVID-19", "answer_start": 340}], "is_impossible": false}, {"question": "What is another name for PFIZER-BIONTECH COVID-19 VACCINE?", "id": "100000000000000000006813", "answers": [{"text": "BIVALENT", "answer_start": 358}], "is_impossible": false}], "context": "V-safe also provides second-dose reminders if needed and live telephone\nfollow-up by CDC if participants report a significant health impact following COVID-19\nvaccination. For more information on how to sign up, visit: www.cdc.gov/vsafe. WHAT IF I DECIDE NOT TO HAVE MY CHILD GET THE PFIZER-BIONTECH\nCOVID-19 VACCINE OR THE PFIZER-BIONTECH COVID-19 VACCINE, BIVALENT? Under the EUA, there is an option to accept or refuse receiving any of these vaccines. Should you decide for your child not to receive any of these vaccines, it will not change\nyour child\u2019s standard medical care."}]}, {"title": "c4f67a28d4488ceeb534cf00d1b05149", "paragraphs": [{"qas": [{"question": "What is the Omicron component of SARS-CoV-2 in bivalent vaccines?", "id": "100000000000000000006816", "answers": [{"text": "PFIZER-BIONTECH COVID-19 VACCINE, BIVALENT AT THE SAME TIME", "answer_start": 349}], "is_impossible": false}, {"question": "What is the name of the PFIZER-BIONTECH COVID-19 VACCINE, Bivalent at the same time as other vaccines?", "id": "100000000000000000006817", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 534}], "is_impossible": false}, {"question": "What has not yet been submitted to FDA on administration of the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000006818", "answers": [{"text": "Data", "answer_start": 429}], "is_impossible": false}], "context": "ARE OTHER CHOICES AVAILABLE FOR PREVENTING COVID-19 BESIDES THE\nPFIZER-BIONTECH COVID-19 VACCINE OR THE PFIZER-BIONTECH COVID-19\nVACCINE, BIVALENT? Other vaccines to prevent COVID-19 may be available under EUA, including bivalent\nvaccines that contain Omicron component of SARS-CoV-2. CAN MY CHILD RECEIVE THE PFIZER-BIONTECH COVID-19 VACCINE OR THE\nPFIZER-BIONTECH COVID-19 VACCINE, BIVALENT AT THE SAME TIME AS\nOTHER VACCINES? Data have not yet been submitted to FDA on administration of the Pfizer-BioNTech\nCOVID-19 Vaccine or the Pfizer-BioNTech COVID-19 Vaccine, Bivalent at the same\ntime with other vaccines."}]}, {"title": "1dd4fb814e35492ac20a0b03c1eafdbb", "paragraphs": [{"qas": [{"question": "What is a third option for your child if they are immunocompromised?", "id": "100000000000000000006820", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 381}], "is_impossible": false}, {"question": "What is the third primary series dose of the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000006821", "answers": [{"text": "If your child is immunocompromised", "answer_start": 255}], "is_impossible": false}], "context": "If you are considering having your child receive the\nPfizer-BioNTech COVID-19 Vaccine or the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent with other vaccines, discuss the options with your child\u2019s healthcare provider. WHAT IF MY CHILD IS IMMUNOCOMPROMISED? If your child is immunocompromised, you may be given the option to have your child\nreceive a third primary series dose of the Pfizer-BioNTech COVID-19 Vaccine. Individuals 5 through 11 years of age may receive a booster dose with the\nPfizer-BioNTech COVID-19 Vaccine, Bivalent."}]}, {"title": "2636c9b88cd2e33ea2f2405ecd2dcf37", "paragraphs": [{"qas": [{"question": "What may not provide full immunity to COVID-19 in people who are immunocompromised?", "id": "100000000000000000006823", "answers": [{"text": "Vaccinations", "answer_start": 0}], "is_impossible": false}, {"question": "What should your child maintain physical precautions to help prevent?", "id": "100000000000000000006824", "answers": [{"text": "COVID-19", "answer_start": 181}], "is_impossible": false}, {"question": "Who should be vaccinated as appropriate?", "id": "100000000000000000006825", "answers": [{"text": "your child\u2019s close contacts", "answer_start": 204}], "is_impossible": false}, {"question": "What do you need to discuss if your child is pregnant or breastfeeding?", "id": "100000000000000000006826", "answers": [{"text": "options with your healthcare provider", "answer_start": 364}], "is_impossible": false}, {"question": "What do you get when your child gets the first COVID-19 vaccine?", "id": "100000000000000000006828", "answers": [{"text": "a vaccination card", "answer_start": 626}], "is_impossible": false}], "context": "Vaccinations may not provide full\nimmunity to COVID-19 in people who are immunocompromised, and you should\ncontinue to have your child maintain physical precautions to help prevent COVID-19. In addition, your child\u2019s close contacts should be vaccinated as appropriate. WHAT ABOUT PREGNANCY OR BREASTFEEDING? If your child is pregnant or breastfeeding, discuss the options with your healthcare\nprovider. WILL THESE VACCINES GIVE MY CHILD COVID-19? No. These vaccines do not contain SARS-CoV-2 and cannot give your child COVID-19. KEEP YOUR CHILD\u2019S VACCINATION CARD\nWhen your child gets the first COVID-19 vaccine, you will get a vaccination card."}]}, {"title": "a3b7d0642ecafbe24abc57f5e6852ba7", "paragraphs": [{"qas": [{"question": "What should you bring with you when your child returns from school?", "id": "100000000000000000006829", "answers": [{"text": "the card", "answer_start": 18}], "is_impossible": false}, {"question": "What is the global website Telephone number?", "id": "100000000000000000006830", "answers": [{"text": "www.cvdvaccine.com", "answer_start": 272}], "is_impossible": false}, {"question": "What is the name of the website where you can learn more?", "id": "100000000000000000006832", "answers": [{"text": "cvdvaccine.com", "answer_start": 276}], "is_impossible": false}, {"question": "What may your provider include your child's vaccination information in?", "id": "100000000000000000006835", "answers": [{"text": "Immunization Information System", "answer_start": 781}], "is_impossible": false}], "context": "Remember to bring the card when your child returns. ADDITIONAL INFORMATION\nIf you have questions, visit the website or call the telephone number provided below. To access the most recent Fact Sheets, please scan the QR code provided below. Global website Telephone number\nwww.cvdvaccine.com\nHOW CAN I LEARN MORE? \uf0b7 Ask the vaccination provider. \uf0b7 Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. \uf0b7 Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-\nlegal-regulatory-and-policy-framework/emergency-use-authorization. \uf0b7 Contact your local or state public health department. WHERE WILL MY CHILD\u2019S VACCINATION INFORMATION BE RECORDED? The vaccination provider may include your child\u2019s vaccination information in your\nstate/local jurisdiction\u2019s Immunization Information System (IIS) or other designated\nsystem."}]}, {"title": "cc2879556fcebf869662b9bde44179c5", "paragraphs": [{"qas": [{"question": "What will ensure that your child receives the same vaccine when your child returns for the second dose of the primary series?", "id": "100000000000000000006837", "answers": [{"text": "IISs", "answer_start": 153}], "is_impossible": false}, {"question": "What does the provider cannot charge you for a vaccine dose?", "id": "100000000000000000006839", "answers": [{"text": "out-of-pocket vaccine administration fee", "answer_start": 376}], "is_impossible": false}, {"question": "What can you not be charged if only receiving a COVID-19 vaccination?", "id": "100000000000000000006840", "answers": [{"text": "an out-of-pocket vaccine administration fee", "answer_start": 373}], "is_impossible": false}], "context": "This will ensure that your child receives the same vaccine when your child\nreturns for the second dose of the primary series. For more information about IISs visit:\nhttps://www.cdc.gov/vaccines/programs/iis/about.html. CAN I BE CHARGED AN ADMINISTRATION FEE FOR RECEIPT OF THESE\nNo. At this time, the provider cannot charge you for a vaccine dose and you cannot be\ncharged an out-of-pocket vaccine administration fee or any other fee if only receiving a\nCOVID-19 vaccination."}]}, {"title": "99f95b08b9381ec9c076c4b05afcdbad", "paragraphs": [{"qas": [{"question": "Who can seek reimbursement for COVID-19 vaccine administration fees?", "id": "100000000000000000006841", "answers": [{"text": "vaccination providers", "answer_start": 9}], "is_impossible": false}, {"question": "What does HRSA cover for non-insured recipients?", "id": "100000000000000000006842", "answers": [{"text": "COVID-19 Uninsured Program", "answer_start": 254}], "is_impossible": false}, {"question": "Who should individuals become aware of any potential violations of the COVID-19 vaccination program requirements report them to?", "id": "100000000000000000006845", "answers": [{"text": "Office of the Inspector General", "answer_start": 500}], "is_impossible": false}, {"question": "What does the Office of the Inspector General do?", "id": "100000000000000000006846", "answers": [{"text": "report them", "answer_start": 481}], "is_impossible": false}], "context": "However, vaccination providers may seek appropriate\nreimbursement from a program or plan that covers COVID-19 vaccine administration\nfees for the vaccine recipient (private insurance, Medicare, Medicaid, Health\nResources & Services Administration [HRSA] COVID-19 Uninsured Program for\nnon-insured recipients). WHERE CAN I REPORT CASES OF SUSPECTED FRAUD? Individuals becoming aware of any potential violations of the CDC COVID-19\nVaccination Program requirements are encouraged to report them to the Office of the\nInspector General, U.S. Department of Health and Human Services, at\n1-800-HHS-TIPS or https://TIPS.HHS.GOV. WHAT IS THE COUNTERMEASURES INJURY COMPENSATION PROGRAM?"}]}, {"title": "5ba56a4adaa3f39d7d4a102fb40ddf29", "paragraphs": [{"qas": [{"question": "How long must a claim be submitted to the CICP?", "id": "100000000000000000006848", "answers": [{"text": "within one (1) year", "answer_start": 307}], "is_impossible": false}, {"question": "How long must a vaccine be submitted to the CICP?", "id": "100000000000000000006849", "answers": [{"text": "within one (1) year", "answer_start": 307}], "is_impossible": false}, {"question": "What is an EUA?", "id": "100000000000000000006850", "answers": [{"text": "EMERGENCY USE AUTHORIZATION", "answer_start": 461}], "is_impossible": false}, {"question": "What is the current pandemic of COVID-19?", "id": "100000000000000000006852", "answers": [{"text": "public health emergencies", "answer_start": 605}], "is_impossible": false}, {"question": "What is an example of a public health emergency?", "id": "100000000000000000006853", "answers": [{"text": "COVID-19 pandemic", "answer_start": 652}], "is_impossible": false}], "context": "The Countermeasures Injury Compensation Program (CICP) is a federal program that\nmay help pay for costs of medical care and other specific expenses of certain people\fwho have been seriously injured by certain medicines or vaccines, including these\nvaccines. Generally, a claim must be submitted to the CICP within one (1) year from the\ndate of receiving the vaccine. To learn more about this program, visit\nwww.hrsa.gov/cicp/ or call 1-855-266-2427. WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)? An EUA is a mechanism to facilitate the availability and use of medical products,\nincluding vaccines, during public health emergencies, such as the current COVID-19\npandemic."}]}, {"title": "46dc87713ede3cbf016b05805902b557", "paragraphs": [{"qas": [{"question": "What is supported by a Secretary of Health and Human Services declaration that circumstances exist to justify the emergency use of drugs and biological products during the COVID-19 pandemic?", "id": "100000000000000000006854", "answers": [{"text": "An EUA", "answer_start": 0}], "is_impossible": false}, {"question": "What does HHS stand for?", "id": "100000000000000000006855", "answers": [{"text": "Secretary of Health and Human Services", "answer_start": 25}], "is_impossible": false}, {"question": "What criteria includes that there are no adequate, approved and available alternatives?", "id": "100000000000000000006857", "answers": [{"text": "certain criteria are met", "answer_start": 341}], "is_impossible": false}], "context": "An EUA is supported by a Secretary of Health and Human Services (HHS)\ndeclaration that circumstances exist to justify the emergency use of drugs and\nbiological products during the COVID-19 pandemic. A product authorized for\nemergency use has not undergone the same type of review by FDA as an\nFDA-approved product. FDA may issue an EUA when certain criteria are met, which includes that there are no\nadequate, approved, and available alternatives."}]}, {"title": "faa7382f468a195b015974e35a75e984", "paragraphs": [{"qas": [{"question": "What is the FDA's decision based on?", "id": "100000000000000000006858", "answers": [{"text": "the totality of the scientific evidence available", "answer_start": 42}], "is_impossible": false}, {"question": "What do the benefits of the product outweigh the risks of?", "id": "100000000000000000006859", "answers": [{"text": "COVID-19 pandemic", "answer_start": 165}], "is_impossible": false}, {"question": "What is in effect for the duration of the EUA declaration justifying emergency use of the product?", "id": "100000000000000000006861", "answers": [{"text": "An EUA", "answer_start": 395}], "is_impossible": false}, {"question": "What happens to a product unless it is terminated or revoked?", "id": "100000000000000000006862", "answers": [{"text": "may no longer be used", "answer_start": 560}], "is_impossible": false}, {"question": "What happens after which the product may no longer be used?", "id": "100000000000000000006863", "answers": [{"text": "terminated or revoked", "answer_start": 513}], "is_impossible": false}], "context": "In addition, the FDA decision is based\non the totality of the scientific evidence available showing that the product may be\neffective to prevent COVID-19 during the COVID-19 pandemic and that the known and\npotential benefits of the product outweigh the known and potential risks of the product. All of these criteria must be met to allow for the product to be used during the\nCOVID-19 pandemic. An EUA is in effect for the duration of the COVID-19 EUA declaration justifying\nemergency use of this product, unless terminated or revoked (after which the product\nmay no longer be used)."}]}, {"title": "368403645025e18b0870c8faac727607", "paragraphs": [{"qas": [{"question": "Who manufactured this Fact Sheet?", "id": "100000000000000000006864", "answers": [{"text": "Pfizer Inc", "answer_start": 101}], "is_impossible": false}, {"question": "Who was the manufacturer of the Fact Sheet that was manufactured by Pfizer Inc?", "id": "100000000000000000006866", "answers": [{"text": "BioNTech Manufacturing GmbH", "answer_start": 17}], "is_impossible": false}], "context": "Manufactured for\nBioNTech Manufacturing GmbH\nAn der Goldgrube 12\n55131 Mainz, Germany\nManufactured by\nPfizer Inc., New York, NY 10017\nScan to capture that this Fact Sheet was provided to vaccine\nrecipient for the electronic medical records/immunization\ninformation systems."}]}, {"title": "4b51db16e7554cb6eb1ed0cda9972d7", "paragraphs": [{"qas": [{"question": "When was the original CDC-issued EUI Fact Sheet issued?", "id": "100000000000000000006868", "answers": [{"text": "11/17/2021", "answer_start": 96}], "is_impossible": false}, {"question": "What does EUI stand for?", "id": "100000000000000000006869", "answers": [{"text": "Emergency Use Instructions", "answer_start": 278}], "is_impossible": false}, {"question": "Who issued the Emergency Use Instructions?", "id": "100000000000000000006870", "answers": [{"text": "Centers for Disease Control and Prevention (CDC)", "answer_start": 340}], "is_impossible": false}], "context": "Pfizer-BioNTech COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nEmergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers:\nPfizer-BioNTech COVID-19 Vaccine for Primary and/or Additional Doses\nThis Fact Sheet describes Emergency Use Instructions (EUI) that have been issued by the Centers for\nDisease Control and Prevention (CDC) to provide information about the primary and additional doses of the\nCOVID-19 vaccine by Pfizer-BioNTech that go beyond its FDA-approved labeling."}]}, {"title": "c44433889a682c27c3d67736e2561b71", "paragraphs": [{"qas": [{"question": "What is the name of the company that makes the COVID-19 vaccine?", "id": "100000000000000000006872", "answers": [{"text": "Pfizer- BioNTech", "answer_start": 119}], "is_impossible": false}, {"question": "What does EUI cover?", "id": "100000000000000000006873", "answers": [{"text": "longer interval between primary doses of the COVID-19 vaccine", "answer_start": 54}], "is_impossible": false}, {"question": "Who is responsible for the longer interval between primary doses of the vaccine by Pfizer BioNTech?", "id": "100000000000000000006874", "answers": [{"text": "certain individuals who received primary vaccination with certain COVID-19 vaccines not authorized or approved by the Food and Drug Administration (FDA)", "answer_start": 144}], "is_impossible": false}, {"question": "How many doses of the Janssen COVID-19 Vaccine did immunocompromised individuals receive?", "id": "100000000000000000006875", "answers": [{"text": "one", "answer_start": 360}], "is_impossible": false}, {"question": "What is the name of the vaccine used by Pfizer-BioNTech under EUI?", "id": "100000000000000000006876", "answers": [{"text": "COVID-19", "answer_start": 99}], "is_impossible": false}], "context": "These uses under EUI\ninclude, but are not limited to, longer interval between primary doses of the COVID-19 vaccine by Pfizer-\nBioNTech, use in certain individuals who received primary vaccination with certain COVID-19 vaccines not\nauthorized or approved by the Food and Drug Administration (FDA) for such use and in\nimmunocompromised individuals who received one primary dose of the Janssen COVID-19 Vaccine. See\nbelow for more information on the uses of the COVID-19 vaccine by Pfizer-BioNTech under EUI."}]}, {"title": "19dfed1e36123eba31c2dfc4b3b92fd5", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that Pfizer-BioNTech or Moderna offers?", "id": "100000000000000000006877", "answers": [{"text": "COVID-19", "answer_start": 128}], "is_impossible": false}, {"question": "What are Emergency Use Instructions?", "id": "100000000000000000006878", "answers": [{"text": "fact sheets for healthcare providers and recipients", "answer_start": 541}], "is_impossible": false}, {"question": "What does EUI stand for?", "id": "100000000000000000006879", "answers": [{"text": "Emergency Use Instructions", "answer_start": 255}], "is_impossible": false}, {"question": "What are EUI issued by?", "id": "100000000000000000006880", "answers": [{"text": "CDC", "answer_start": 307}], "is_impossible": false}, {"question": "EUI are issued to provide information about what?", "id": "100000000000000000006881", "answers": [{"text": "emergency use of FDA-approved (licensed) medical products that may not be included in or differ in some way from the information provided in the FDA- approved labeling (package insert).", "answer_start": 340}], "is_impossible": false}, {"question": "What do EUI consist of?", "id": "100000000000000000006882", "answers": [{"text": "fact sheets for healthcare providers and recipients", "answer_start": 541}], "is_impossible": false}], "context": "If you are 12 years and older and you are receiving vaccination for uses provided under EUI, you have a\nchoice of receiving the COVID-19 vaccine by either Pfizer-BioNTech or Moderna (see the Moderna EUI Fact\nSheet for Recipients and Caregivers). What are Emergency Use Instructions (EUI)? EUI are issued by CDC to provide information about emergency use of FDA-approved (licensed) medical\nproducts that may not be included in or differ in some way from the information provided in the FDA-\napproved labeling (package insert). EUI consist of fact sheets for healthcare providers and recipients."}]}, {"title": "a924421e839bf3c2f0d7664851029a45", "paragraphs": [{"qas": [{"question": "What is the brand name of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000006883", "answers": [{"text": "Comirnaty", "answer_start": 156}], "is_impossible": false}, {"question": "What does the EUI stand for?", "id": "100000000000000000006884", "answers": [{"text": "to provide information about this vaccine for the below uses that extend beyond its FDA-approved labeling", "answer_start": 248}], "is_impossible": false}, {"question": "How old are people ages 16 and older who are vaccinated?", "id": "100000000000000000006885", "answers": [{"text": "to provide information about this vaccine for the below uses that extend beyond its FDA-approved labeling", "answer_start": 248}], "is_impossible": false}, {"question": "Who is the manufacturer of the Comirnaty, mRNA vaccine?", "id": "100000000000000000006886", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 51}], "is_impossible": false}, {"question": "Who can receive the COVID-19 vaccine under the EUI?", "id": "100000000000000000006887", "answers": [{"text": "to provide information about this vaccine for the below uses that extend beyond its FDA-approved labeling", "answer_start": 248}], "is_impossible": false}, {"question": "What is the name of the vaccine that Pfizer-BioNTech is a part of?", "id": "100000000000000000006888", "answers": [{"text": "COVID-19", "answer_start": 72}], "is_impossible": false}], "context": "Why is CDC issuing EUI for the COVID-19 vaccine by Pfizer-BioNTech? The COVID-19 vaccine by Pfizer-BioNTech is an FDA-approved COVID-19 vaccine (brand name Comirnaty,\nmRNA) to prevent COVID-19 in persons ages 16 years and older. CDC is issuing EUI to provide information\nabout this vaccine for the below uses that extend beyond its FDA-approved labeling (see \u201cWho can receive\nprimary, additional, and/or booster dose(s) of the COVID-19 vaccine by Pfizer-BioNTech under the EUI?\u201d)."}]}, {"title": "4bd610196254becc9ef9dd539aacf1c4", "paragraphs": [{"qas": [{"question": "What can be used as an alternative mRNA COVID-19 vaccine under EUI?", "id": "100000000000000000006889", "answers": [{"text": "Moderna", "answer_start": 24}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000006891", "answers": [{"text": "Coronavirus disease 2019", "answer_start": 303}], "is_impossible": false}], "context": "The COVID-19 vaccine by Moderna can also be used under EUI for similar uses as an alternative mRNA\nCOVID-19 vaccine (see the Moderna EUI Fact Sheet for Recipients), and the same or similar\nrecommendations in this EUI also apply to the use of the COVID-19 vaccine by Moderna under EUI. What is COVID-19? Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a coronavirus called SARS-CoV-2. It\nis predominantly a respiratory illness that can affect other organs. People with SARS-CoV-2 infection have\nreported a wide range of symptoms, from no symptoms to severe illness leading to death."}]}, {"title": "3fd225756f69d5dec3a5e87247099ef0", "paragraphs": [{"qas": [{"question": "Symptoms may appear 2 to 14 days after exposure to what virus?", "id": "100000000000000000006896", "answers": [{"text": "breath", "answer_start": 120}], "is_impossible": false}], "context": "Symptoms may\nappear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills, cough, shortness of\nbreath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or\nrunny nose, nausea or vomiting, and diarrhea. Who can receive primary and additional dose(s) of the COVID-19 vaccine by Pfizer-BioNTech under the\nEUI? People who can receive the COVID-19 vaccine by Pfizer-BioNTech under EUI are described below."}]}, {"title": "d8993c76e37f8c487ac4b6f31a202cf", "paragraphs": [{"qas": [{"question": "Who may receive the second primary dose of the COVID-19 vaccine 3-8 weeks after the first primary dose?", "id": "100000000000000000006900", "answers": [{"text": "People ages 12 years and older", "answer_start": 2}], "is_impossible": false}, {"question": "What should not be received earlier than 3 weeks after the first dose?", "id": "100000000000000000006902", "answers": [{"text": "The second dose", "answer_start": 241}], "is_impossible": false}], "context": "\u2022 People ages 12 years and older, especially those at higher risk of myocarditis associated with mRNA\nCOVID-19 vaccines, may receive the second primary dose of the COVID-19 vaccine by Pfizer-\nBioNTech 3\u20138 weeks after the first primary dose. The second dose should not be received earlier\nthan 3 weeks after the first dose."}]}, {"title": "16646ef014a40117af791bcbfd6b3c8f", "paragraphs": [{"qas": [{"question": "Who may receive a second dose of the SARS-CoV-2 vaccine?", "id": "100000000000000000006903", "answers": [{"text": "People ages 12 years and older", "answer_start": 2}], "is_impossible": false}, {"question": "What is the deferral period for people who recently had SARS CoV-2 infection?", "id": "100000000000000000006904", "answers": [{"text": "3 months", "answer_start": 132}], "is_impossible": false}, {"question": "How long ago did people receive an incomplete primary dose series with certain non-FDA authorized or approved vaccines?", "id": "100000000000000000006908", "answers": [{"text": "28 days", "answer_start": 517}], "is_impossible": false}], "context": "\u2022 People ages 12 years and older who recently had SARS-CoV-2 infection may receive a second\nprimary dose after a deferral period of 3 months from symptom onset or positive test (if infection\nwas asymptomatic)\fPfizer-BioNTech COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\n\u2022 People ages 12 years and older who received an incomplete primary dose series (only the first\ndose of a 2-dose primary series) with certain non-FDA authorized or approved COVID-19 vaccines\nat least 28 days ago should receive a primary dose of the COVID-19 vaccine by Pfizer-BioNTech to\ncomplete the series."}]}, {"title": "80a54ae20a643b634f49736bce960dfe", "paragraphs": [{"qas": [{"question": "What should people who are moderately or severely immunocompromised receive?", "id": "100000000000000000006910", "answers": [{"text": "o o o People ages 12 years and older who are moderately or severely immunocompromised and received their primary vaccination with certain non-FDA authorized or approved COVID-19 vaccines at least 28 days ago should receive an additional (third) primary dose of the COVID-19 vaccine by Pfizer-BioNTech", "answer_start": 62}], "is_impossible": false}, {"question": "What is the third primary dose of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000006913", "answers": [{"text": "o o o", "answer_start": 62}], "is_impossible": false}, {"question": "What should people ages 18 years and older with a moderate or severe immunocompromising condition receive at least 28 days after receiving the Janssen CoviD-19 Vaccine primary dose?", "id": "100000000000000000006914", "answers": [{"text": "an additional dose", "answer_start": 530}], "is_impossible": false}, {"question": "How many days after receiving the Janssen COVID-19 Vaccine primary dose?", "id": "100000000000000000006915", "answers": [{"text": "28", "answer_start": 603}], "is_impossible": false}], "context": "\u2022 For people who are moderately or severely immunocompromised:\no\no\no\nPeople ages 12 years and older who are moderately or severely immunocompromised and\nreceived their primary vaccination with certain non-FDA authorized or approved COVID-19\nvaccines at least 28 days ago should receive an additional (third) primary dose of the\nCOVID-19 vaccine by Pfizer-BioNTech. People ages 18 years and older with a moderately or severely immunocompromising\ncondition who received a primary dose of the Janssen COVID-19 Vaccine should receive an\nadditional dose with the COVID-19 vaccine by Pfizer-BioNTech at least 28 days after\nreceiving the Janssen COVID-19 Vaccine primary dose."}]}, {"title": "e5ecc0f0d8c8bc58ac94c6a031460e59", "paragraphs": [{"qas": [{"question": "What should people who received a booster dose with an authorized COVID-19 vaccine receive at least 2 months after the booster dose?", "id": "100000000000000000006916", "answers": [{"text": "an additional dose", "answer_start": 152}], "is_impossible": false}, {"question": "What is the name of the company that manufactures the COVID-19 vaccine?", "id": "100000000000000000006917", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 200}], "is_impossible": false}, {"question": "Who makes the COVIV-19 vaccine for people 12 years and older?", "id": "100000000000000000006919", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 200}], "is_impossible": false}, {"question": "What is the name of the company that provides the COVID-19 vaccine?", "id": "100000000000000000006920", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 200}], "is_impossible": false}, {"question": "What should be given to patients with a moderate or severe immunocompromising condition who received the first dose of the vaccine prior to or during certain therapies?", "id": "100000000000000000006921", "answers": [{"text": "revaccinated with the COVID-19 vaccine", "answer_start": 462}], "is_impossible": false}], "context": "People who already received a\nbooster dose with an authorized COVID-19 vaccine after receiving the Janssen COVID-19\nVaccine primary dose should receive an additional dose with the COVID-19 vaccine by\nPfizer-BioNTech at least 2 months after the booster dose. People ages 12 years and older with a moderately or severely immunocompromising\ncondition who received primary dose(s) of COVID-19 vaccine prior to or during certain\ntherapies (indicated below) should be revaccinated with the COVID-19 vaccine by Pfizer-\nBioNTech, regardless of which vaccine was received initially."}]}, {"title": "531e3feba2281612ec1044a35773faad", "paragraphs": [{"qas": [{"question": "What is the suggested interval to start revaccination?", "id": "100000000000000000006922", "answers": [{"text": "about 6 months", "answer_start": 157}], "is_impossible": false}, {"question": "How long after completion of the B-cell-depleting therapy is the recommended interval for starting revaccinate?", "id": "100000000000000000006923", "answers": [{"text": "6 months", "answer_start": 163}], "is_impossible": false}, {"question": "What is a hematopoietic cell transplant?", "id": "100000000000000000006924", "answers": [{"text": "HCT", "answer_start": 322}], "is_impossible": false}, {"question": "What is another name for chimeric antigen receptor-T-cell therapy?", "id": "100000000000000000006925", "answers": [{"text": "hematopoietic cell transplant", "answer_start": 291}], "is_impossible": false}, {"question": "How long after treatment is revaccination required?", "id": "100000000000000000006926", "answers": [{"text": "3 months", "answer_start": 401}], "is_impossible": false}, {"question": "What vaccine can be used for similar uses in persons ages 12 and older?", "id": "100000000000000000006927", "answers": [{"text": "COVID-19", "answer_start": 430}], "is_impossible": false}], "context": "\u25aa Received COVID-19 vaccine dose(s) during treatment with B-cell-depleting\ntherapies over a limited period: the suggested interval to start revaccination is\nabout 6 months after completion of the B-cell-depleting therapy\n\u25aa Received COVID-19 vaccine dose(s) prior to or during treatment with\nhematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)-T-cell\ntherapy: revaccination at least 3 months after treatment\nThe COVID-19 vaccine by Moderna can also be used under EUI for similar uses in persons ages 12 years and\nolder as an alternative mRNA COVID-19 vaccine (see the Moderna EUI Fact Sheet for Recipients)."}]}, {"title": "f7257dd3a0d4d65c0b7be48567bb3cac", "paragraphs": [{"qas": [{"question": "Who should NOT get the COVID-19 vaccine?", "id": "100000000000000000006928", "answers": [{"text": "moderately and severely immunocompromised persons", "answer_start": 188}], "is_impossible": false}, {"question": "What is the name of the CDC's Interim Clinical Considerations?", "id": "100000000000000000006929", "answers": [{"text": "moderately and severely immunocompromised persons", "answer_start": 188}], "is_impossible": false}, {"question": "What is the name of the vaccine by Pfizer-BioNTech?", "id": "100000000000000000006930", "answers": [{"text": "COVID-19", "answer_start": 349}], "is_impossible": false}], "context": "Talk to your healthcare provider about if and when you should receive a primary, additional, and/or a\nbooster dose. See CDC\u2019s Interim Clinical Considerations for additional information on moderately and\nseverely immunocompromised persons recommended for an additional primary dose and populations\neligible for a booster dose. Who should NOT get the COVID-19 vaccine by Pfizer-BioNTech?"}]}, {"title": "af0480ae13741e2fbc296c12c1426ed3", "paragraphs": [{"qas": [{"question": "What is the name of the company that makes the COVID-19 vaccine?", "id": "100000000000000000006934", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 121}], "is_impossible": false}, {"question": "What do you need to tell your provider before you get the vaccine by Pfizer-BioNTech?", "id": "100000000000000000006935", "answers": [{"text": "the name, number of doses, and date(s) of COVID-19 vaccine(s) you received previously", "answer_start": 368}], "is_impossible": false}], "context": "You should not get the vaccine if you:\n\u2022 Had a severe allergic reaction after a previous dose of the COVID-19 vaccine by Pfizer-BioNTech\n\u2022 Had a severe allergic reaction to any ingredient of the COVID-19 vaccine by Pfizer-BioNTech\nWhat should I mention to the vaccination provider before getting the COVID-19 vaccine by Pfizer-BioNTech? Tell your vaccination provider the name, number of doses, and date(s) of COVID-19 vaccine(s) you received\npreviously."}]}, {"title": "167c332009e6e416a008d679d23f3f7", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine EUI Recipient Fact Sheet?", "id": "100000000000000000006939", "answers": [{"text": "as an injection into the muscle", "answer_start": 611}], "is_impossible": false}, {"question": "When was the original CDC-issued fact sheet issued?", "id": "100000000000000000006940", "answers": [{"text": "11/17/2021", "answer_start": 500}], "is_impossible": false}, {"question": "What is given as an injection into the body?", "id": "100000000000000000006941", "answers": [{"text": "COVID-19 vaccine", "answer_start": 523}], "is_impossible": false}, {"question": "What is given as an injection into the muscle?", "id": "100000000000000000006942", "answers": [{"text": "COVID-19 vaccine", "answer_start": 566}], "is_impossible": false}, {"question": "What company makes the COVID-19 vaccine?", "id": "100000000000000000006943", "answers": [{"text": "Pfizer-BioNTech given? COVID-19 vaccine by Pfizer-BioNTech is given as an injection into the muscle", "answer_start": 543}], "is_impossible": false}], "context": "Also, mention all of your medical conditions, including if you:\n\u2022 Have any allergies\n\u2022 Have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining\noutside the heart)\n\u2022 Have a fever\n\u2022 Have a bleeding disorder or are on a blood thinner\n\u2022 Are immunocompromised or are on a medicine that affects your immune system\n\u2022 Have ever fainted in association with an injection\fPfizer-BioNTech COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nHow is the COVID-19 vaccine by Pfizer-BioNTech given? COVID-19 vaccine by Pfizer-BioNTech is given as an injection into the muscle."}]}, {"title": "ce022185500042314f8802d6201d1e60", "paragraphs": [{"qas": [{"question": "How many people have received the COVID-19 vaccine in the US?", "id": "100000000000000000006944", "answers": [{"text": "Millions", "answer_start": 67}], "is_impossible": false}, {"question": "In clinical trials, how many people ages 12 and older received at least 1 dose of the vaccine?", "id": "100000000000000000006946", "answers": [{"text": "23,000", "answer_start": 231}], "is_impossible": false}], "context": "Has the COVID-19 vaccine by Pfizer-BioNTech been used before? Yes. Millions of people have received this vaccine in the United States since it became available starting in\nmid-December 2020. Also, in clinical trials, approximately 23,000 people ages 12 years and older received\nat least 1 dose of the vaccine. There have been some studies in people who received the COVID-19 vaccine\nby Pfizer-BioNTech after completing a primary vaccination with a non-FDA authorized or approved COVID-\n19 vaccine or Janssen COVID-19 Vaccine. What are the risks of the COVID-19 vaccine by Pfizer-BioNTech?"}]}, {"title": "bd25788b87c3627e6b1c6e4befba88da", "paragraphs": [{"qas": [{"question": "What is the name of the non-FDA authorized or approved vaccine used for primary vaccination?", "id": "100000000000000000006951", "answers": [{"text": "COVID-19 vaccine", "answer_start": 195}], "is_impossible": false}, {"question": "Who provides data on the side effects of the Janssen CoviD-19 Vaccine?", "id": "100000000000000000006952", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 365}], "is_impossible": false}, {"question": "What is the name of the vaccine used for primary vaccination?", "id": "100000000000000000006953", "answers": [{"text": "COVID-19", "answer_start": 41}], "is_impossible": false}, {"question": "What are the side effects of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000006954", "answers": [{"text": "injection site pain, fatigue, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, malaise, swollen lymph nodes (lymphadenopathy), decreased appetite, rash, arm pain, diarrhea, and vomiting", "answer_start": 389}], "is_impossible": false}], "context": "Limited data are available on use of the COVID-19 vaccine by Pfizer-BioNTech as an additional primary dose\nin people who completed their primary vaccination with a non-FDA authorized or approved COVID-19\nvaccine, or as an additional primary dose for individuals who received Janssen COVID-19 Vaccine for\nprimary vaccination. Side effects of the COVID-19 vaccine by Pfizer-BioNTech include injection site pain,\nfatigue, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness,\nnausea, malaise, swollen lymph nodes (lymphadenopathy), decreased appetite, rash, arm pain, diarrhea,\nand vomiting."}]}, {"title": "1d4974ebafc6ef10c7f030962e5c315c", "paragraphs": [{"qas": [{"question": "What were the most common side effects reported?", "id": "100000000000000000006955", "answers": [{"text": "mild", "answer_start": 41}], "is_impossible": false}, {"question": "What did some people have that affected their ability to do daily activities?", "id": "100000000000000000006956", "answers": [{"text": "side effects", "answer_start": 67}], "is_impossible": false}, {"question": "What is included in the package insert for Comirnaty and in the EUA Fact Sheet?", "id": "100000000000000000006960", "answers": [{"text": "Additional information on the common and serious side effects", "answer_start": 339}], "is_impossible": false}, {"question": "What are the benefits of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000006961", "answers": [{"text": "serious side effects", "answer_start": 380}], "is_impossible": false}], "context": "Common side effects reported were mostly mild, but some people had side effects that\naffected their ability to do daily activities. Cases of myocarditis and pericarditis have rarely been reported\nin some people. Cases have occurred predominantly in adolescents and young adult males within the first\nweek after the second dose of vaccine. Additional information on the common and serious side effects of the COVID-19 vaccine by Pfizer-BioNTech\ncan be found in the package insert for Comirnaty and in the EUA Fact Sheet for Recipients and Caregivers. What are the benefits of the COVID-19 vaccine by Pfizer-BioNTech?"}]}, {"title": "465fa531797b3644d7fa1cb77a3dd17", "paragraphs": [{"qas": [{"question": "What vaccine has been shown to be effective in preventing COVID-19?", "id": "100000000000000000006962", "answers": [{"text": "COVID-19 vaccine by Pfizer-BioNTech", "answer_start": 4}], "is_impossible": false}, {"question": "How long after receiving the first dose of the COVID-19 vaccine may reduce the risk of myocarditis?", "id": "100000000000000000006963", "answers": [{"text": "3\u20138 weeks", "answer_start": 192}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COVID-19 vaccine?", "id": "100000000000000000006964", "answers": [{"text": "COVID-19", "answer_start": 104}], "is_impossible": false}], "context": "The COVID-19 vaccine by Pfizer-BioNTech has been shown in clinical studies to be effective in preventing\nCOVID-19. Receiving the second primary dose of the COVID-19 vaccine by Pfizer-BioNTech 3\u20138 weeks after\nthe first dose may reduce the risk of myocarditis and result in greater immune response and better\nprotection against COVID-19. Primary, additional, and/or booster doses of the COVID-19 vaccine by Pfizer-\nBioNTech as described under EUI may help to increase immune response in people, which could improve\nprotection against COVID-19."}]}, {"title": "1aee85db34074444211d6feda1b4de1b", "paragraphs": [{"qas": [{"question": "The FDA approved what vaccine?", "id": "100000000000000000006968", "answers": [{"text": "COVID-19", "answer_start": 379}], "is_impossible": false}, {"question": "What is the name of the vaccine by Pfizer-BioNTech?", "id": "100000000000000000006969", "answers": [{"text": "COVID-19", "answer_start": 137}], "is_impossible": false}, {"question": "What did the FDA approve of the COVID-19 vaccine?", "id": "100000000000000000006970", "answers": [{"text": "to prevent COVID-19", "answer_start": 415}], "is_impossible": false}], "context": "Similarly, for individuals who received the Janssen vaccine for primary\nvaccination, an additional primary or second booster dose of the COVID-19 vaccine by Pfizer-BioNTech\ncould improve protection against COVID-19. The COVID-19 vaccine by Pfizer-BioNTech may not protect\neveryone. What are the Risks and Benefits of the COVID-19 vaccine by Pfizer-BioNTech? The FDA approved the COVID-19 vaccine by Pfizer-BioNTech to prevent COVID-19 based on safety and\nefficacy data available from clinical trials."}]}, {"title": "26cfe5c281702f62d8241d1463767acd", "paragraphs": [{"qas": [{"question": "Who issued an Emergency Use Authorization of the COVID-19 vaccine?", "id": "100000000000000000006971", "answers": [{"text": "the FDA", "answer_start": 14}], "is_impossible": false}, {"question": "What did the FDA determine outweigh the known and potential risks of vaccination?", "id": "100000000000000000006972", "answers": [{"text": "benefits", "answer_start": 209}], "is_impossible": false}, {"question": "The use of what vaccine is based on available information?", "id": "100000000000000000006973", "answers": [{"text": "COVID-19", "answer_start": 67}], "is_impossible": false}, {"question": "What company developed the COVID-19 vaccine?", "id": "100000000000000000006974", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 87}], "is_impossible": false}, {"question": "What is the name of the company that makes the COVID-19 vaccine?", "id": "100000000000000000006976", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 87}], "is_impossible": false}], "context": "Additionally, the FDA issued an Emergency Use Authorization of\nthe COVID-19 vaccine by Pfizer-BioNTech as an additional primary or a booster dose, determining, among\nother things, that the known and potential benefits of vaccination outweigh the known and potential risks\nof the vaccine. Based on available information, the use of the COVID-19 vaccine by Pfizer-BioNTech as\ndescribed in this Fact Sheet could help improve or restore protection that may not have been sufficient or\nmay have decreased over time after the primary vaccination. What alternative choices are available for primary and/or additional doses other than the COVID-19\nvaccine by Pfizer-BioNTech?"}]}, {"title": "78d57b61740fbf5725940ae91c7e6952", "paragraphs": [{"qas": [{"question": "What are the only vaccines approved by the FDA for COVID-19?", "id": "100000000000000000006977", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine", "answer_start": 15}], "is_impossible": false}, {"question": "What information does EUI provide about primary and/or additional doses?", "id": "100000000000000000006978", "answers": [{"text": "COVID-19 vaccines", "answer_start": 104}], "is_impossible": false}, {"question": "What may not be available to you if you were vaccinated outside of the U.S. or through a clinical trial?", "id": "100000000000000000006980", "answers": [{"text": "the vaccine you initially received", "answer_start": 552}], "is_impossible": false}, {"question": "If the COVID-19 vaccine you initially received for primary vaccination is not authorized or approved in the United States, what is the reason for that?", "id": "100000000000000000006981", "answers": [{"text": "If vaccinated outside of the United States or through a clinical trial and the COVID-19 vaccine you initially received for primary vaccination is not authorized or approved in the United States, then the vaccine you initially received may not be available to you", "answer_start": 352}], "is_impossible": false}], "context": "Currently, the Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine are the only FDA-\napproved COVID-19 vaccines for which EUI provide information about primary and/or additional doses\fPfizer-BioNTech COVID-19 Vaccine EUI Recipient Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nfollowing the COVID-19 vaccine that you received. If vaccinated outside of the United States or through a\nclinical trial and the COVID-19 vaccine you initially received for primary vaccination is not authorized or\napproved in the United States, then the vaccine you initially received may not be available to you."}]}, {"title": "c8f04349a9020296eb3a3f46942a6292", "paragraphs": [{"qas": [{"question": "What is your choice to receive or not receive the COVID-19 vaccine by Pfizer-BioNTech as a primary and/or additional dose?", "id": "100000000000000000006982", "answers": [{"text": "a vaccination card", "answer_start": 361}], "is_impossible": false}, {"question": "What do you get when you receive the COVID-19 vaccine from Pfizer- BioNTech?", "id": "100000000000000000006984", "answers": [{"text": "a vaccination card", "answer_start": 361}], "is_impossible": false}], "context": "It is your choice to receive or not receive the COVID-19 vaccine by Pfizer-BioNTech as a primary and/or\nadditional dose. Should you decide not to receive it, it will not change your standard medical care. Will I get a vaccination card? When you are administered a primary, additional, or a booster dose of the COVID-19 vaccine by Pfizer-\nBioNTech, you will get a vaccination card to document when you received the shot. You should keep your\nvaccination card. What is the Countermeasures Injury Compensation Program?"}]}, {"title": "78cab76378eb5827b589b018e3ec2936", "paragraphs": [{"qas": [{"question": "What is the name of the federal program that may help pay for costs of medical care?", "id": "100000000000000000006987", "answers": [{"text": "The Countermeasures Injury Compensation Program", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the program that provides vaccines?", "id": "100000000000000000006991", "answers": [{"text": "Countermeasures Injury Compensation Program", "answer_start": 4}], "is_impossible": false}, {"question": "Where can you find more information about the vaccine program?", "id": "100000000000000000006992", "answers": [{"text": "\u2022 Ask the vaccination provider", "answer_start": 470}], "is_impossible": false}, {"question": "Where can you find information about coronavirus?", "id": "100000000000000000006993", "answers": [{"text": "Visit CDC", "answer_start": 504}], "is_impossible": false}, {"question": "Who can you contact for emergency use authorization?", "id": "100000000000000000006995", "answers": [{"text": "your local or state public health department", "answer_start": 724}], "is_impossible": false}], "context": "The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs\nof medical care and other specific expenses of certain people who have been seriously injured by certain\nmedicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one\n(1) year from the date of receiving the vaccine. To learn more about this program, visit www.hrsa.gov/cicp/\nor call 1-855-266-2427. How can I learn more? \u2022 Ask the vaccination provider. \u2022 Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. \u2022 Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-\nand-policy-framework/emergency-use-authorization. \u2022 Contact your local or state public health department."}]}, {"title": "db766d90a6564ce8e5bc0bb1fa1c0672", "paragraphs": [{"qas": [{"question": "What are the possible side effects after getting a COVID-19 vaccine?", "id": "100000000000000000006996", "answers": [{"text": "mild, temporary, and like those experienced after routine vaccinations. They can vary across different age groups. What You Need to Know Side effects after getting a COVID-19 vaccine can vary from person to person. Some people experience a little discomfort and can continue to go about their day. Others have side effects that affect their ability to do daily activities", "answer_start": 233}], "is_impossible": false}, {"question": "What is the common side effect after a vaccination?", "id": "100000000000000000006997", "answers": [{"text": "mild, temporary", "answer_start": 233}], "is_impossible": false}, {"question": "After a routine vaccination, what are the side effects like?", "id": "100000000000000000006998", "answers": [{"text": "mild, temporary", "answer_start": 233}], "is_impossible": false}, {"question": "What can vary across different age groups?", "id": "100000000000000000006999", "answers": [{"text": "Side effects", "answer_start": 180}], "is_impossible": false}, {"question": "What can side effects after getting a COVID-19 vaccine vary from person to person?", "id": "100000000000000000007000", "answers": [{"text": "Some people experience a little discomfort and can continue to go about their day", "answer_start": 448}], "is_impossible": false}, {"question": "What do some people have that affect their ability to do daily activities?", "id": "100000000000000000007002", "answers": [{"text": "side effects", "answer_start": 543}], "is_impossible": false}, {"question": "What usually go away in a few days?", "id": "100000000000000000007003", "answers": [{"text": "Side effects", "answer_start": 606}], "is_impossible": false}], "context": "10/30/22, 9:30 AM Possible Side Effects After Getting a COVID-19 Vaccine | CDC\nEspa\u00f1ol | Other Languages\nPossible Side Effects After Getting a COVID-19 Vaccine\nCommon Side Effects\nSide effects after a COVID-19 vaccination tend to be mild, temporary, and like those experienced after routine vaccinations. They can vary across different age groups. What You Need to Know\nSide effects after getting a COVID-19 vaccine can vary from person to person. Some people experience a little discomfort and can continue to go about their day. Others have side effects that\naffect their ability to do daily activities. Side effects generally go away in a few days."}]}, {"title": "9f4379e3fef80ddb42f2fc025b2902e6", "paragraphs": [{"qas": [{"question": "What are serious health problems?", "id": "100000000000000000007005", "answers": [{"text": "Adverse events", "answer_start": 121}], "is_impossible": false}, {"question": "How long do adverse events usually occur after getting a vaccine?", "id": "100000000000000000007006", "answers": [{"text": "within six weeks", "answer_start": 232}], "is_impossible": false}], "context": "Even if you don\u2019t experience any side effects, your body is building protection against the virus that causes COVID-\n19. Adverse events (serious health problems) are rare but can cause long-term health problems. They usually happen\nwithin six weeks of getting a vaccine."}]}, {"title": "12bfb4d5b33cc5c7eaa699cf6dc72b80", "paragraphs": [{"qas": [{"question": "What are some common side effects after the second dose of a shot?", "id": "100000000000000000007007", "answers": [{"text": "Pain, swelling, and redness", "answer_start": 304}], "is_impossible": false}, {"question": "What is the age range of children and teens between 6 months and 17 years?", "id": "100000000000000000007008", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022", "answer_start": 1}], "is_impossible": false}, {"question": "What are some side effects after getting a COVID-19 Vaccine?", "id": "100000000000000000007010", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022 AGE GROUP Side effects are more common after the second dose and can include: Pain, swelling, and redness on the arm where the shot was given Tiredness Headache Muscle or joint pain Chills Swollen lymph nodes \u2022 \u2022 \u2022 \u2022 \u2022 \u2022", "answer_start": 217}], "is_impossible": false}, {"question": "What is the name of the CDC-affiliated vaccine?", "id": "100000000000000000007011", "answers": [{"text": "COVID-19", "answer_start": 531}], "is_impossible": false}, {"question": "After a second shot or booster, what are reactions reported?", "id": "100000000000000000007012", "answers": [{"text": "similar to those after the two-dose or single-dose primary shots", "answer_start": 637}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nChildren and teens ages 6 months\u201317 years\n\uf1aa\nAGE GROUP\nCommon side effects can include:\nPain on the leg or arm where the shot was given\nSwollen lymph nodes\nIrritability or crying\nSleepiness\nLoss of appetite\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nAGE GROUP\nSide effects are more common after the second dose\nand can include:\nPain, swelling, and redness on the arm where the\nshot was given\nTiredness\nHeadache\nMuscle or joint pain\nChills\nSwollen lymph nodes\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nAdults 18 years and older\n\uf1aa\f10/30/22, 9:30 AM Possible Side Effects After Getting a COVID-19 Vaccine | CDC\nAfter a second shot or booster\nReactions reported after getting a booster shot are similar to those after the two-dose or single-dose primary shots. Most side\neffects were mild to moderate."}]}, {"title": "c930a2d10df8393161d1283e93604e97", "paragraphs": [{"qas": [{"question": "What are the most common side effects of injections?", "id": "100000000000000000007014", "answers": [{"text": "Fever Headache", "answer_start": 46}], "is_impossible": false}, {"question": "If possible, get some what?", "id": "100000000000000000007017", "answers": [{"text": "rest", "answer_start": 322}], "is_impossible": false}, {"question": "What should you do to reduce discomfort from fever?", "id": "100000000000000000007018", "answers": [{"text": "Drink plenty of fluids", "answer_start": 361}], "is_impossible": false}, {"question": "What is the name of the OTC medicine that is only for people 18 years or older?", "id": "100000000000000000007019", "answers": [{"text": "aspirin", "answer_start": 515}], "is_impossible": false}], "context": "The most commonly reported side effects were:\nFever\nHeadache\nFatigue (tiredness)\nPain at the injection site\nHelpful tips to relieve side effects\nAdults\nTo relieve pain or swelling on the arm where you got the shot:\nApply a clean, cool, wet washcloth over the area. Use or keep moving your arm. Also, if possible, get some rest. To reduce discomfort from fever:\nDrink plenty of fluids,\nDress in comfortable clothes,\nTalk to your doctor about taking over-the-counter (OTC) medicine, such as ibuprofen, acetaminophen, aspirin (only for\npeople ages 18 years or older), or antihistamines."}]}, {"title": "b677a633b34a569e69de5108d7bb9315", "paragraphs": [{"qas": [{"question": "What might OTC medicines affect how well the vaccine works?", "id": "100000000000000000007021", "answers": [{"text": "it is not known", "answer_start": 99}], "is_impossible": false}, {"question": "Ask your child\u2019s healthcare provider for advice on using what?", "id": "100000000000000000007022", "answers": [{"text": "non-aspirin pain reliever", "answer_start": 242}], "is_impossible": false}, {"question": "What is a non-aspirin pain reliever?", "id": "100000000000000000007023", "answers": [{"text": "comfort your child after vaccination", "answer_start": 320}], "is_impossible": false}, {"question": "What can you do to comfort your child after vaccination?", "id": "100000000000000000007024", "answers": [{"text": "at home", "answer_start": 308}], "is_impossible": false}], "context": "It is not recommended to take these medicines before vaccination to try to prevent side effects as it is not known\nhow OTC medicines might affect how well the vaccine works. Children\nAsk your child\u2019s healthcare provider for advice on using a non-aspirin pain reliever and learn about other steps you can take\nat home to comfort your child after vaccination."}]}, {"title": "713441d591e0902d0bab3fcc4688df8", "paragraphs": [{"qas": [{"question": "What is a side effect of getting a COVID-19 vaccine?", "id": "100000000000000000007025", "answers": [{"text": "severe allergic reactions", "answer_start": 555}], "is_impossible": false}, {"question": "How long does it take for a shot to get better?", "id": "100000000000000000007026", "answers": [{"text": "24 hours", "answer_start": 390}], "is_impossible": false}, {"question": "What is the name of the vaccine you got?", "id": "100000000000000000007027", "answers": [{"text": "COVID-19", "answer_start": 301}], "is_impossible": false}, {"question": "What happens after 24 hours after the shot was given?", "id": "100000000000000000007028", "answers": [{"text": "worse", "answer_start": 378}], "is_impossible": false}, {"question": "What is rare after COVID-19 Vaccination?", "id": "100000000000000000007029", "answers": [{"text": "Adverse events, including severe allergic reactions", "answer_start": 529}], "is_impossible": false}], "context": "On the arm where you got the shot:\nPain\nRedness\nSwelling\n\u2022\n\u2022\n\u2022\nThroughout the rest of your body:\nTiredness\nHeadache\nMuscle pain\nChills\nFever\nNausea\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n\uf3b6 Call a doctor or healthcare provider about a side effect if:\f10/30/22, 9:30 AM Possible Side Effects After Getting a COVID-19 Vaccine | CDC\n\uf3b6\nRedness or tenderness where the shot was given gets worse after 24 hours\nSide effects are worrying or do not seem to be going away after a few days\n\u2022\n\u2022\nAdverse Events after COVID-19 Vaccination Are Rare\nAdverse events, including severe allergic reactions, after COVID-19 vaccination are rare but can happen."}]}, {"title": "78f1466a201c92713b96625a335a75b6", "paragraphs": [{"qas": [{"question": "What should you do if you think you or your child might be having a severe allergic reaction?", "id": "100000000000000000007031", "answers": [{"text": "seek immediate medical care by calling 911", "answer_start": 244}], "is_impossible": false}, {"question": "What can you do if you have an allergic reaction?", "id": "100000000000000000007032", "answers": [{"text": "calling 911", "answer_start": 275}], "is_impossible": false}, {"question": "What is the name of the smartphone-based tool that provides quick and confidential health check-ins?", "id": "100000000000000000007033", "answers": [{"text": "V-safe", "answer_start": 490}], "is_impossible": false}, {"question": "What kind of health check-ins does the tool provide?", "id": "100000000000000000007034", "answers": [{"text": "quick and confidential", "answer_start": 533}], "is_impossible": false}, {"question": "What type of messages are sent to the tool?", "id": "100000000000000000007035", "answers": [{"text": "text", "answer_start": 577}], "is_impossible": false}], "context": "For this reason,\neveryone who receives a COVID-19 vaccine is monitored by their vaccination provider for at least 15 minutes. After leaving a vaccination provider site, if you think you or your child might be having a severe allergic reaction, seek\nimmediate medical care by calling 911. Learn more about what you can do if you have an allergic reaction. Reporting Side Effects and Adverse Events\nUse v-safe or the Vaccine Adverse Event Reporting System (VAERS) to report your side effects:\nV-safe, a smartphone-based tool, provides quick and confidential health check-ins via text messages and web surveys."}]}, {"title": "ce1211ac80ee864ab8da4aa59c621861", "paragraphs": [{"qas": [{"question": "What is the purpose of the Vaccine Adverse Event Reporting System?", "id": "100000000000000000007036", "answers": [{"text": "to report a side effect, adverse event, or reaction from COVID-19 vaccine", "answer_start": 205}], "is_impossible": false}, {"question": "When do you need to schedule your next shot?", "id": "100000000000000000007039", "answers": [{"text": "\u2022 \uf209 \uf263 Stay Up to Date with COVID-19 Vaccines and Boosters When do you need to schedule your next shot? Do you or your child need to get a booster? Can you get a different vaccine product after your 1st dose", "answer_start": 281}], "is_impossible": false}, {"question": "Do you or your child need to get a booster?", "id": "100000000000000000007040", "answers": [{"text": "When do you need to schedule your next shot", "answer_start": 340}], "is_impossible": false}], "context": "It\ndoes this so you can quickly and easily share with CDC how you or your child feel after getting a COVID-19 vaccine. Vaccine Adverse Event Reporting System can be used by you or your healthcare provider to report a side effect,\nadverse event, or reaction from COVID-19 vaccine. \u2022\n\u2022 \uf209\n\uf263 Stay Up to Date with COVID-19 Vaccines and Boosters\nWhen do you need to schedule your next shot? Do you or your child need to get a booster? Can you get a different vaccine product after your 1st dose?"}]}, {"title": "84806c39fbfb485bf5e6a55d1817939c", "paragraphs": [{"qas": [{"question": "What to Expect after Getting a COVID-19 Vaccine Fact sheet for healthcare workers to give after vaccination?", "id": "100000000000000000007041", "answers": [{"text": "\u2022 \u2022 \u2022 Resources Fact Sheet", "answer_start": 15}], "is_impossible": false}, {"question": "How to Protect Yourself and Others  Safety of COVID-19 Vaccines  Last Updated Sept. 14, 2022?", "id": "100000000000000000007042", "answers": [{"text": "Benefits of Getting a COVID-19 Vaccine \u203a", "answer_start": 285}], "is_impossible": false}], "context": "Stay Up to Date\n\u2022\n\u2022\n\u2022\nResources\nFact Sheet\n\uf1aa\nView PDF\nWhat to Expect after Getting a COVID-19 Vaccine\nFact sheet for healthcare workers to give after vaccination. File Details: 199 KB, 1 page\nRelated Pages\f10/30/22, 9:30 AM Possible Side Effects After Getting a COVID-19 Vaccine | CDC\nBenefits of Getting a COVID-19 Vaccine\n\u203a\nHow to Protect Yourself and Others\n\u203a\nSafety of COVID-19 Vaccines\n\u203a\nLast Updated Sept. 14, 2022"}]}, {"title": "814a32a4107f3194dd9dcc719cd5b1d2", "paragraphs": [{"qas": [{"question": "What is a high risk area for spreading the virus to other people?", "id": "100000000000000000007044", "answers": [{"text": "Community Level", "answer_start": 348}], "is_impossible": false}, {"question": "Who should wear a mask indoors in public in areas with a high COVID-19 Community Level?", "id": "100000000000000000007045", "answers": [{"text": "People who are pregnant or have other conditions that could put them at higher risk for severe illness should speak with their healthcare provider", "answer_start": 365}], "is_impossible": false}, {"question": "What should people who are pregnant or have other conditions that could put them at higher risk for severe illness speak with their healthcare provider about?", "id": "100000000000000000007046", "answers": [{"text": "wearing a mask", "answer_start": 518}], "is_impossible": false}], "context": "10/30/22, 9:39 AM Pregnant and Recently Pregnant People | CDC\nEspa\u00f1ol | Other Languages\nPregnant and Recently Pregnant People\nAt Increased Risk for Severe Illness from COVID-19\nWhat You Need to Know\nTo maximize protection from variants and prevent possibly spreading the virus to others, wear a mask indoors in\npublic in areas with a high COVID-19 Community Level. People who are pregnant or have other conditions that\ncould put them at higher risk for severe illness should speak with their healthcare provider about wearing a mask\nin public indoor spaces at the medium COVID-19 Community Level."}]}, {"title": "c9e3970da65966336f3e147a354c3679", "paragraphs": [{"qas": [{"question": "What can affect your pregnancy and developing baby?", "id": "100000000000000000007048", "answers": [{"text": "complications", "answer_start": 257}], "is_impossible": false}, {"question": "What can further increase the risk of getting very sick from COVID-19 during or recently after pregnancy?", "id": "100000000000000000007049", "answers": [{"text": "Having certain underlying medical conditions", "answer_start": 323}], "is_impossible": false}, {"question": "How long after end of pregnancy can you expect to get very sick?", "id": "100000000000000000007050", "answers": [{"text": "42 days", "answer_start": 518}], "is_impossible": false}], "context": "Although the overall risks are low, if you are pregnant or were recently pregnant, you are more likely to get very\nsick from COVID-19 compared to people who are not pregnant. Additionally, if you have COVID-19 during\npregnancy, you are at increased risk of complications that can affect your pregnancy and developing baby. Having certain underlying medical conditions, and other factors, including age, can further increase the risk for\ngetting very sick from COVID-19 during or recently after pregnancy (for at least 42 days following end of\npregnancy)."}]}, {"title": "2d00362ec0d6ed5d634ced0696953bfe", "paragraphs": [{"qas": [{"question": "Who should take steps to protect themselves from getting sick with COVID-19?", "id": "100000000000000000007051", "answers": [{"text": "People who are pregnant or recently pregnant", "answer_start": 0}], "is_impossible": false}, {"question": "What is increased risk of if you are pregnant or were recently pregnant?", "id": "100000000000000000007052", "answers": [{"text": "Severe Illness", "answer_start": 182}], "is_impossible": false}, {"question": "Pregnancy causes changes in the body that could make it easier to get very sick from respiratory viruses like what?", "id": "100000000000000000007054", "answers": [{"text": "COVID-19", "answer_start": 469}], "is_impossible": false}, {"question": "What can continue after pregnancy?", "id": "100000000000000000007055", "answers": [{"text": "changes in the body", "answer_start": 485}], "is_impossible": false}], "context": "People who are pregnant or recently pregnant and those who live with or visit them should take steps to protect\nthemselves from getting sick with COVID-19. \u2022\n\u2022\n\u2022\n\u2022\nIncreased Risk of Severe Illness\nIf you are pregnant or were recently pregnant, you are more likely to get\nseverely ill from COVID-19 compared to people who are not pregnant. Pregnancy causes changes in the body that could make it easier to get\nvery sick from respiratory viruses like the one that causes COVID-19. These changes in the body can continue after pregnancy."}]}, {"title": "1562292f81cf8744d08029eb25639568", "paragraphs": [{"qas": [{"question": "What can happen to people with severe illness who become ill?", "id": "100000000000000000007057", "answers": [{"text": "die", "answer_start": 223}], "is_impossible": false}, {"question": "Why is pregnancy included in the list of underlying medical conditions that increase the risk of severe illness?", "id": "100000000000000000007058", "answers": [{"text": "conditions", "answer_start": 291}], "is_impossible": false}, {"question": "What is the name of the condition that increases a person's risk of severe illness?", "id": "100000000000000000007059", "answers": [{"text": "pregnancy", "answer_start": 236}], "is_impossible": false}], "context": "Severe illness means that a person with COVID-19 may need:\nHospitalization\nAdmission into an intensive care unit (ICU)\nA ventilator or special equipment to help them breathe\nPeople with COVID-19 who become severely ill can die. See why pregnancy is included in the list of underlying medical\nconditions that increase a person\u2019s risk of severe illness from COVID-19."}]}, {"title": "a4b59719c379192ca6f7dfaffd176f98", "paragraphs": [{"qas": [{"question": "What can increase the risk for getting very sick from COVID-19 during or recently after pregnancy?", "id": "100000000000000000007060", "answers": [{"text": "Having certain underlying medical conditions", "answer_start": 159}], "is_impossible": false}, {"question": "What can cause the risk to get very sick?", "id": "100000000000000000007061", "answers": [{"text": "Having certain underlying medical conditions", "answer_start": 159}], "is_impossible": false}, {"question": "How old are people who are pregnant or recently pregnant?", "id": "100000000000000000007062", "answers": [{"text": "25 years", "answer_start": 291}], "is_impossible": false}, {"question": "What is difficult or not possible to avoid contact with people who might be sick with COVID-19 Being part of some racial and ethnic minority?", "id": "100000000000000000007063", "answers": [{"text": "Working in places", "answer_start": 442}], "is_impossible": false}, {"question": "What are some racial and ethnic minority groups put at increased risk of getting sick from COVID-19 because of?", "id": "100000000000000000007064", "answers": [{"text": "health inequities they face", "answer_start": 697}], "is_impossible": false}, {"question": "What are people with COVID-19 more likely to experience during pregnancy?", "id": "100000000000000000007066", "answers": [{"text": "complications", "answer_start": 832}], "is_impossible": false}, {"question": "What can affect their pregnancy and developing baby?", "id": "100000000000000000007067", "answers": [{"text": "complications", "answer_start": 832}], "is_impossible": false}], "context": "Certain factors can increase risk\nOther factors can further increase the risk for getting very sick from COVID-19 during or recently after pregnancy, such as:\nHaving certain underlying medical conditions\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:39 AM Pregnant and Recently Pregnant People | CDC\nBeing older than 25 years\nLiving or working in a community with high numbers of COVID-19 cases\nLiving or working in a community with low levels of COVID-19 vaccination\nWorking in places where it is difficult or not possible to avoid contact with people who might be sick with COVID-19\nBeing part of some racial and ethnic minority groups, which have been put at increased risk of getting sick from COVID-\n19 because of the health inequities they face\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nEffect on Pregnancy Outcomes\nPeople with COVID-19 during pregnancy are more likely to experience complications that can affect their pregnancy and\ndeveloping baby compared to people without COVID-19 during pregnancy."}]}, {"title": "8e84b8cc49e274229d8edf7297e4c7cf", "paragraphs": [{"qas": [{"question": "What increases the risk of delivering a preterm (earlier than 37 weeks) or stillborn infant?", "id": "100000000000000000007068", "answers": [{"text": "COVID-19", "answer_start": 13}], "is_impossible": false}, {"question": "People with COVID-19 during pregnancy may be more likely to have other pregnancy complications?", "id": "100000000000000000007069", "answers": [{"text": "increases the risk of delivering a preterm (earlier than 37 weeks) or stillborn infant", "answer_start": 38}], "is_impossible": false}, {"question": "What are the outcomes among pregnant women with COVID-19?", "id": "100000000000000000007071", "answers": [{"text": "birth and infant", "answer_start": 251}], "is_impossible": false}, {"question": "What is recommended for everyone aged 6 months and older?", "id": "100000000000000000007072", "answers": [{"text": "COVID-19 vaccination", "answer_start": 345}], "is_impossible": false}, {"question": "Who should get boosters when it is time to get one?", "id": "100000000000000000007073", "answers": [{"text": "everyone aged 6 months and older", "answer_start": 385}], "is_impossible": false}], "context": "For example, COVID-19 during pregnancy\nincreases the risk of delivering a preterm (earlier than 37 weeks) or stillborn infant. People with COVID-19 during pregnancy\nmay also be more likely to have other pregnancy complications. See the latest data on birth and infant outcomes among pregnant women with COVID-19. COVID-19 Vaccines and Pregnancy\nCOVID-19 vaccination is recommended for everyone aged 6 months and older, including\u202fpeople who are pregnant,\nbreastfeeding,\u202ftrying to get pregnant now, or might become pregnant in the future. This recommendation includes getting\nboosters when it is time to get one."}]}, {"title": "ee431996004004b15c3e5a2235e69b8c", "paragraphs": [{"qas": [{"question": "What prevents severe illness, hospitalizations, and death?", "id": "100000000000000000007074", "answers": [{"text": "Getting vaccinated", "answer_start": 123}], "is_impossible": false}, {"question": "People who have not received a COVID-19 vaccine should get vaccinated as soon as possible and continue masking?", "id": "100000000000000000007075", "answers": [{"text": "Getting vaccinated prevents severe illness, hospitalizations, and death. People who have not received a COVID-19 vaccine should get vaccinated as soon as possible and continue masking. To maximize protection from variants and prevent possibly spreading the virus to others, people who are up to date with their COVID-19 vaccines should wear a mask indoors in public in areas with a high COVID-19 Community Level", "answer_start": 123}], "is_impossible": false}, {"question": "What should people who are up to date with their COVID-19 vaccine wear?", "id": "100000000000000000007076", "answers": [{"text": "a mask", "answer_start": 464}], "is_impossible": false}], "context": "If you have questions about getting vaccinated, talking with your healthcare professional\nmight help, but is not required. Getting vaccinated prevents severe illness, hospitalizations, and death. People who have not received a COVID-19 vaccine\nshould get vaccinated as soon as possible and continue masking. To maximize protection from variants and prevent possibly\nspreading the virus to others, people who are up to date with their COVID-19 vaccines should wear a mask indoors in public in\nareas with a high COVID-19 Community Level. With the emergence of variants, this is more urgent than ever."}]}, {"title": "d1dbd3fe5644afe29b6c75d06cfff52", "paragraphs": [{"qas": [{"question": "What is the name of the company that can help you get your COVID-19 vaccine?", "id": "100000000000000000007080", "answers": [{"text": "MotherToBaby", "answer_start": 283}], "is_impossible": false}, {"question": "Who can you contact if you are pregnant?", "id": "100000000000000000007081", "answers": [{"text": "MotherToBaby", "answer_start": 283}], "is_impossible": false}, {"question": "What language are MotherToBaby experts available to answer questions in?", "id": "100000000000000000007082", "answers": [{"text": "English or Spanish", "answer_start": 355}], "is_impossible": false}], "context": "Learn more\nabout what you can do\u202fwhen you have been fully vaccinated when you are up to date with your COVID-19 vaccines. If you are pregnant and have questions about COVID-19 vaccine\nIf you would like to speak to someone about COVID-19 vaccination during pregnancy, you can contact MotherToBaby. MotherToBaby experts are available to answer questions in English or Spanish by phone or chat. The free and\nconfidential service is available Monday\u2013Friday 8am\u20135pm (local time)."}]}, {"title": "3f47099e7298dea3a6173f309c89b16f", "paragraphs": [{"qas": [{"question": "What is one way to reach MotherToBaby?", "id": "100000000000000000007084", "answers": [{"text": "Chat live or send an email", "answer_start": 22}], "is_impossible": false}, {"question": "How do you reduce your risk of getting COVID-19?", "id": "100000000000000000007085", "answers": [{"text": "take steps to protect themselves and others", "answer_start": 223}], "is_impossible": false}, {"question": "What should you do if you or someone in your household is sick with COVID-19?", "id": "100000000000000000007087", "answers": [{"text": "follow guidance for isolation", "answer_start": 492}], "is_impossible": false}, {"question": "Get vaccinated and stay up to date on what?", "id": "100000000000000000007088", "answers": [{"text": "COVID-19 vaccines", "answer_start": 612}], "is_impossible": false}, {"question": "What can you do to slow the spread of COVID-19?", "id": "100000000000000000007089", "answers": [{"text": "Get vaccinated", "answer_start": 569}], "is_impossible": false}], "context": "To reach MotherToBaby:\nChat live or send an email MotherToBaby\n\u2022\n\u2022 \uf209\nReducing Your Risk of Getting COVID-19\nIt is especially important for people who are or were recently pregnant, and those who live\nor visit with them, to take steps to protect themselves and others from getting COVID-19. Limit in-person interactions with people who might have been exposed to COVID-19,\nincluding people within your household, as much as possible. If you or someone in your\nhousehold is sick with COVID-19, follow guidance for isolation. Important Ways to Slow the Spread of COVID-19\nGet vaccinated and stay up to date on your COVID-19 vaccines. Find a\nvaccine."}]}, {"title": "2b5a364074c442661e11ea1e73b9478c", "paragraphs": [{"qas": [{"question": "What is the CDC test to prevent spread to?", "id": "100000000000000000007093", "answers": [{"text": "Pregnant and Recently Pregnant People", "answer_start": 181}], "is_impossible": false}, {"question": "How many feet apart from others who don\u2019t live with you?", "id": "100000000000000000007094", "answers": [{"text": "6", "answer_start": 264}], "is_impossible": false}, {"question": "Wash your hands often with what?", "id": "100000000000000000007095", "answers": [{"text": "soap and water", "answer_start": 341}], "is_impossible": false}, {"question": "Use what if soap and water aren\u2019t available?", "id": "100000000000000000007096", "answers": [{"text": "hand sanitizer", "answer_start": 361}], "is_impossible": false}, {"question": "Keep all of your healthcare appointments during and after pregnancy.", "id": "100000000000000000007097", "answers": [{"text": "\u2022 \u2022", "answer_start": 413}], "is_impossible": false}, {"question": "What is the name of your healthcare provider?", "id": "100000000000000000007098", "answers": [{"text": "\u2022 \u2022", "answer_start": 413}], "is_impossible": false}, {"question": "What type of appointments are recommended?", "id": "100000000000000000007099", "answers": [{"text": "\u2022 \u2022", "answer_start": 413}], "is_impossible": false}], "context": "Know when to wear a well-fitted mask to help protect yourself and others. Avoid crowds and poorly ventilated indoor spaces. Test to prevent spread to others\n\u2022\n\u2022\n\u2022\f10/30/22, 9:39 AM Pregnant and Recently Pregnant People | CDC\nTest to prevent spread to others. Stay 6 feet apart from others who don\u2019t live with you. Wash your hands often with soap and water. Use hand sanitizer if soap and\nwater aren\u2019t available. \u2022\n\u2022\n\u2022\nStaying Healthy During and After Your Pregnancy\nKeep all of your healthcare appointments during and after pregnancy. Visit with your healthcare provider for all\nrecommended appointments."}]}, {"title": "9e6701ec5a52977bd39f497dc6f1003", "paragraphs": [{"qas": [{"question": "What should you do if you're concerned about going to your appointments in person because of COVID-19?", "id": "100000000000000000007100", "answers": [{"text": "ask your healthcare professional what steps they are taking to protect patients from COVID-19, or ask about telemedicine options", "answer_start": 84}], "is_impossible": false}, {"question": "What is the name of a healthcare professional who is taking steps to protect patients?", "id": "100000000000000000007101", "answers": [{"text": "healthcare professional", "answer_start": 92}], "is_impossible": false}, {"question": "If you need help finding a health professional, contact what?", "id": "100000000000000000007102", "answers": [{"text": "your nearest hospital, clinic, community health center, or health department", "answer_start": 274}], "is_impossible": false}, {"question": "What is the best place to deliver a baby?", "id": "100000000000000000007103", "answers": [{"text": "trained healthcare professionals", "answer_start": 578}], "is_impossible": false}, {"question": "What is safest under the care of trained healthcare professionals?", "id": "100000000000000000007104", "answers": [{"text": "Delivering a baby", "answer_start": 525}], "is_impossible": false}, {"question": "When a baby is under the care of trained healthcare professionals, what is the safest place to be?", "id": "100000000000000000007105", "answers": [{"text": "Delivering", "answer_start": 525}], "is_impossible": false}], "context": "If you\u2019re concerned about going to your appointments in person because of COVID-19, ask your\nhealthcare professional what steps they are taking to protect patients from COVID-19, or ask about telemedicine options. If\nyou need help finding a healthcare professional, contact your nearest hospital, clinic, community health center, or health\ndepartment. Talk to your healthcare professional about how to stay healthy and take care of yourself and the baby. Ask any questions you have about the best place to deliver your baby. Delivering a baby is always safest under the care\nof trained healthcare professionals."}]}, {"title": "5a42cdc2acef93994c1652bb2f84b677", "paragraphs": [{"qas": [{"question": "What should you talk to your healthcare professional if you think you are experiencing depression during or after pregnancy?", "id": "100000000000000000007106", "answers": [{"text": "Get recommended vaccines", "answer_start": 125}], "is_impossible": false}, {"question": "Get a flu vaccine every year.", "id": "100000000000000000007108", "answers": [{"text": "your baby", "answer_start": 208}], "is_impossible": false}, {"question": "Who should also get vaccinated to protect themselves?", "id": "100000000000000000007109", "answers": [{"text": "Others living in your household", "answer_start": 249}], "is_impossible": false}, {"question": "Who should also get vaccinated to protect themselves and you?", "id": "100000000000000000007110", "answers": [{"text": "Others living in your household", "answer_start": 249}], "is_impossible": false}], "context": "You should also talk to your healthcare professional if you think you are experiencing depression during or after\npregnancy. Get recommended vaccines during pregnancy. These vaccines can help protect you and your baby. Get a flu vaccine every year. Others living in your household should also get vaccinated to protect themselves and\nyou. Get the Tdap vaccine to protect your baby against whooping cough, which can have similar symptoms to COVID-19. CDC recommends all pregnant people receive a Tdap vaccine during each pregnancy. In addition, everyone who is\naround the baby should be up to date with their whooping cough vaccine."}]}, {"title": "3cd729a404bcb4df0aff4604a911dd78", "paragraphs": [{"qas": [{"question": "What should you do if you think you may have COVID-19?", "id": "100000000000000000007115", "answers": [{"text": "Call your healthcare professional", "answer_start": 0}], "is_impossible": false}, {"question": "Emergency departments have steps in place to protect you from getting what?", "id": "100000000000000000007117", "answers": [{"text": "COVID-19", "answer_start": 291}], "is_impossible": false}, {"question": "What is in place to protect you from getting COVID-19 if you need medical care?", "id": "100000000000000000007118", "answers": [{"text": "Emergency departments", "answer_start": 221}], "is_impossible": false}, {"question": "If you need emergency help, call 911 right away.", "id": "100000000000000000007119", "answers": [{"text": "Emergency departments have steps in place to protect you from getting COVID-19 if you need medical care", "answer_start": 221}], "is_impossible": false}, {"question": "If someone else is driving you to the emergency department, call what?", "id": "100000000000000000007120", "answers": [{"text": "the emergency facility", "answer_start": 440}], "is_impossible": false}], "context": "Call your healthcare professional if you have any concerns about your pregnancy, if you get sick, or if you think that you\nmay have COVID-19. Do not delay getting emergency care because of worries about getting COVID-19. Emergency departments have steps in\nplace to protect you from getting COVID-19 if you need medical care. If you need emergency help, call 911 right away. If someone else is driving you to the emergency department, call\nthe emergency facility while you are on the way. If you must drive yourself, call before you start driving."}]}, {"title": "454cb2724ba238610fb484e06818f1ae", "paragraphs": [{"qas": [{"question": "If you experience any urgent maternal warning signs and symptoms, seek medical attention immediately.", "id": "100000000000000000007122", "answers": [{"text": "headache that won\u2019t go away, dizziness, fever, severe swelling of hand, face, arm or leg, trouble breathing, chest pain or fast-beating heart, severe nausea and throwing up, or vaginal bleeding or discharge during or after pregnancy). These symptoms could indicate a potentially life-threatening complication", "answer_start": 195}], "is_impossible": false}, {"question": "Hand, face, arm or leg, trouble breathing, chest pain or fast-beating heart, severe nausea and throwing up, or vaginal bleeding or discharge during or after pregnancy?", "id": "100000000000000000007123", "answers": [{"text": "severe swelling", "answer_start": 243}], "is_impossible": false}], "context": "Tell them that you are pregnant or were recently pregnant and are having an emergency. Seek medical care immediately if you experience any urgent maternal warning signs and symptoms (for example,\nheadache that won\u2019t go away, dizziness, fever, severe swelling of hand, face, arm or leg, trouble breathing, chest pain or\nfast-beating heart, severe nausea and throwing up, or vaginal bleeding or discharge during or after pregnancy). These\nsymptoms could indicate a potentially life-threatening complication."}]}, {"title": "691747821a5addb2fc220220138d7898", "paragraphs": [{"qas": [{"question": "How long does it take to contact a healthcare professional if your symptoms of COVID-19 are present?", "id": "100000000000000000007125", "answers": [{"text": "24 hours", "answer_start": 160}], "is_impossible": false}, {"question": "What do you learn about breastfeeding and caring for newborns when a mother has COVIDE-19? What is the name of the disease that causes you to feel sick?", "id": "100000000000000000007126", "answers": [{"text": "COVID-19", "answer_start": 106}], "is_impossible": false}, {"question": "What is the name of the virus that can be transmitted to babies by breast milk?", "id": "100000000000000000007128", "answers": [{"text": "COVID-19", "answer_start": 69}], "is_impossible": false}], "context": "\uf209\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n-\n-\n\u2022\nIf You Are Sick or Think You Were Exposed to COVID-19\nIf you have any symptoms of COVID-19, contact your healthcare professional within 24 hours, and follow steps for when you\nfeel sick. If you are diagnosed with COVID-19, learn about breastfeeding and caring for newborns when the mother has COVID-19. Current evidence suggests that breast milk is not likely to spread the virus to babies."}]}, {"title": "f8aa82fa833b00cf91bbc4fc8b551343", "paragraphs": [{"qas": [{"question": "How to Protect Yourself and Others?", "id": "100000000000000000007131", "answers": [{"text": "COVID-19 Toolkit for Pregnant People and New Parents \u203a COVID-19 Vaccines While Pregnant or Breastfeeding", "answer_start": 14}], "is_impossible": false}, {"question": "What is the name of the disease that affects pregnant women in the United States?", "id": "100000000000000000007132", "answers": [{"text": "SARS-CoV-2", "answer_start": 498}], "is_impossible": false}, {"question": "What are the symptoms of SARS-CoV-2 infection in pregnant women?", "id": "100000000000000000007133", "answers": [{"text": "Characteristics of Symptomatic Women of Reproductive Age", "answer_start": 415}], "is_impossible": false}], "context": "Related Pages\nCOVID-19 Toolkit for Pregnant People and New Parents\n\u203a\nCOVID-19 Vaccines While Pregnant or Breastfeeding\n\u203a\nBreastfeeding and Caring for Newborns if You Have COVID-19\n\u203a\nHow to Protect Yourself and Others\n\u203a\f10/30/22, 9:39 AM Pregnant and Recently Pregnant People | CDC\nWhat to Do If You Are Sick\n\u203a\nRelated Research and More Information\nRelated Research\nZambrano LD, Ellington S, Strid P, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with\nLaboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status \u2014 United States, January 22\u2013October 3, 2020. MMWR\nMorb Mortal Wkly Rep 2020;69:1641\u20131647. DOI: 10.15585/mmwr.mm6944e3."}]}, {"title": "fab4159cd7c7f9512437eb0d930c0f45", "paragraphs": [{"qas": [{"question": "What is a risk factor for illness severity among pregnant women with confirmed SARS-CoV-2 infection?", "id": "100000000000000000007136", "answers": [{"text": "Surveillance for Emerging Threats to Mothers and Babies Network", "answer_start": 367}], "is_impossible": false}, {"question": "How many state, local, and territorial hospitals are monitored by the Surveillance for Emerging Threats to Mothers and Babies Network?", "id": "100000000000000000007138", "answers": [{"text": "22", "answer_start": 432}], "is_impossible": false}, {"question": "What are the adverse pregnancy outcomes, maternal complications, and severe illness among U.S. delivery hospitalizations?", "id": "100000000000000000007139", "answers": [{"text": "COVID-19 diagnosis", "answer_start": 630}], "is_impossible": false}, {"question": "How many hospitalizations with and without a COVID-19 diagnosis were published?", "id": "100000000000000000007140", "answers": [{"text": "2021 May 12", "answer_start": 683}], "is_impossible": false}, {"question": "When was the online ahead of print publication?", "id": "100000000000000000007141", "answers": [{"text": "2021 May 12", "answer_start": 683}], "is_impossible": false}], "context": "Allotey, J., et al., Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in\npregnancy: living systematic review and meta-analysis. BMJ, 2020. 370: p. m3320. doi: 10.1136/bmj.m3320\nGalang RR, Newton SM, Woodworth KR, et al. Risk factors for illness severity among pregnant women with confirmed\nSARS-CoV-2 infection \u2013 Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial\nKo JY, DeSisto CL, Simeone RM, et al. Adverse pregnancy outcomes, maternal complications, and severe illness among\nU.S. delivery hospitalizations with and without a COVID-19 diagnosis [published online ahead of print, 2021 May 12]."}]}, {"title": "bd1b9e684f9debd9edf6e23ae06d78", "paragraphs": [{"qas": [{"question": "What did Clin Woodworth KR, Olsen EO, Neelam V, et al. do?", "id": "100000000000000000007142", "answers": [{"text": "Birth and Infant Outcomes", "answer_start": 46}], "is_impossible": false}, {"question": "When did SET-NET run its study?", "id": "100000000000000000007143", "answers": [{"text": "March 29\u2013October 14, 2020", "answer_start": 166}], "is_impossible": false}, {"question": "What was the risk for stillbirth among women with and without COVID-19 at delivery hospitalization?", "id": "100000000000000000007145", "answers": [{"text": "March 2020\u2013September 2021", "answer_start": 363}], "is_impossible": false}, {"question": "How many women with and without COVID-19 were at delivery hospitals in the United States between March 2020 and September 2021?", "id": "100000000000000000007146", "answers": [{"text": "Stillbirth", "answer_start": 269}], "is_impossible": false}], "context": "Clin\nWoodworth KR, Olsen EO, Neelam V, et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2\nInfection in Pregnancy \u2014 SET-NET, 16 Jurisdictions, March 29\u2013October 14, 2020. MMWR Morb Mortal Wkly Rep\nDeSisto CL, WallaceB, Simeone RM, et al. Risk for Stillbirth Among Women With and Without COVID-19 at Delivery\nHospitalization \u2014 United States, March 2020\u2013September 2021. MMWR Morb Mortal Wkly Rep 2021;70:1640-1645. More Information\nUrgent Maternal Warning Signs\n\uf209\n\uf209\n\uf209\nLast Updated Oct. 25, 2022"}]}, {"title": "410af1a82cb9565a85c3da89eddc6d3", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent?", "id": "100000000000000000007151", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 566}], "is_impossible": false}, {"question": "Which disease is Coronavirus Disease 2019 caused by?", "id": "100000000000000000007152", "answers": [{"text": "SARS-CoV-2", "answer_start": 668}], "is_impossible": false}], "context": "VACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY (COVID-19 VACCINE, mRNA), THE PFIZER-BIONTECH\nCOVID-19 VACCINE, AND THE PFIZER-BIONTECH COVID-19 VACCINE,\nBIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) TO PREVENT CORONAVIRUS\nDISEASE 2019 (COVID-19) FOR USE IN INDIVIDUALS 12 YEARS OF AGE AND\nOLDER\nFOR 12 YEARS OF AGE AND OLDER\nYou are being offered either COMIRNATY (COVID-19 Vaccine, mRNA), the\nPfizer-BioNTech COVID-19 Vaccine, or the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent (Original and Omicron BA.4/BA.5), hereafter referred to as the\nPfizer-BioNTech COVID-19 Vaccine, Bivalent, to prevent Coronavirus Disease\n2019 (COVID-19) caused by SARS-CoV-2."}]}, {"title": "42c7086de40a85c99e2cb1d06edba92e", "paragraphs": [{"qas": [{"question": "What is the name of the FDA-approved COVID-19 vaccine?", "id": "100000000000000000007155", "answers": [{"text": "COMIRNATY", "answer_start": 292}], "is_impossible": false}, {"question": "How old are individuals 12 years of age and older?", "id": "100000000000000000007156", "answers": [{"text": "Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, and also includes information about the U.S. Food and Drug Administration (FDA)-licensed vaccine, COMIRNATY (COVID-19 Vaccine, mRNA) for use in individuals 12 years of age and older1. The FDA-approved COMIRNATY", "answer_start": 5}], "is_impossible": false}, {"question": "What is COMIRNATY?", "id": "100000000000000000007157", "answers": [{"text": "an FDA-approved COVID-19 vaccine", "answer_start": 700}], "is_impossible": false}, {"question": "What is the name of the vaccine made by Pfizer for BioNTech?", "id": "100000000000000000007158", "answers": [{"text": "COMIRNATY", "answer_start": 661}], "is_impossible": false}], "context": "This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the\nFact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine and the\nPfizer-BioNTech COVID-19 Vaccine, Bivalent, and also includes information\nabout the U.S. Food and Drug Administration (FDA)-licensed vaccine,\nCOMIRNATY (COVID-19 Vaccine, mRNA) for use in individuals 12 years of age\nand older1. The FDA-approved COMIRNATY (COVID-19 Vaccine, mRNA) and the\nPfizer-BioNTech COVID-19 Vaccine authorized under Emergency Use\nAuthorization (EUA) for individuals 12 years of age and older, when prepared\naccording to their respective instructions for use, can be used interchangeably.2\nCOMIRNATY (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19\nvaccine made by Pfizer for BioNTech."}]}, {"title": "a07e2dadce1438ffcdbe6e59f97e9403", "paragraphs": [{"qas": [{"question": "How many doses is the Vaccine Information Factor approved for?", "id": "100000000000000000007159", "answers": [{"text": "2", "answer_start": 20}], "is_impossible": false}, {"question": "Who authorizes the third primary series dose?", "id": "100000000000000000007162", "answers": [{"text": "EUA", "answer_start": 131}], "is_impossible": false}, {"question": "What does immunocompromise stand for?", "id": "100000000000000000007163", "answers": [{"text": "COVID-19", "answer_start": 52}], "is_impossible": false}, {"question": "How old is a child who receives the vaccine information fact sheet?", "id": "100000000000000000007164", "answers": [{"text": "11 years old", "answer_start": 334}], "is_impossible": false}], "context": "It is approved as a 2-dose series for\nprevention of COVID-19 in individuals 12 years of age and older. It is also\nauthorized under EUA to provide:\n\uf0b7 a third primary series dose to individuals 12 years of age and older with\ncertain kinds of immunocompromise. 1 You may receive this Vaccine Information Fact Sheet even if your child is 11 years old."}]}, {"title": "2656f18b518bb203d3f7a1fc35dcff7d", "paragraphs": [{"qas": [{"question": "What is COMIRNATY?", "id": "100000000000000000007165", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 271}], "is_impossible": false}, {"question": "What is COVID-19 Vaccine authorized for use in individuals 5 through 11 years of age?", "id": "100000000000000000007166", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 159}], "is_impossible": false}], "context": "Children who\nwill turn from 11 years to 12 years of age between doses in the primary regimen may receive, for any\ndose in the primary regimen, either: (1) the Pfizer-BioNTech COVID-19 Vaccine authorized for use in\nindividuals 5 through 11 years of age; or (2) COMIRNATY (COVID-19 Vaccine, mRNA) or the Pfizer-\nBioNTech COVID-19 Vaccine authorized for use in individuals 12 years of age and older."}]}, {"title": "a87bf5db8c85f4212632ada0d0e3d503", "paragraphs": [{"qas": [{"question": "What is the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older?", "id": "100000000000000000007169", "answers": [{"text": "2-dose primary series", "answer_start": 382}], "is_impossible": false}, {"question": "What does COVID-19 Vaccine provide to individuals 12 years of age and older?", "id": "100000000000000000007170", "answers": [{"text": "2-dose primary series", "answer_start": 382}], "is_impossible": false}], "context": "2 When prepared according to their respective instructions for use, the FDA-approved COMIRNATY\n(COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine for individuals\n12 years of age and older can be used interchangeably without presenting any safety or effectiveness\nconcerns. The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to\nprovide:\n\uf0b7 a 2-dose primary series to individuals 12 years of age and older; and\n\uf0b7 a third primary series dose to individuals 12 years of age and older with\ncertain kinds of immunocompromise."}]}, {"title": "bf013e6e6a9053c87d040bed99f10643", "paragraphs": [{"qas": [{"question": "Who approved the EUA for the Pfizer-BioNTech COVID-19 Vaccine, Bivalent?", "id": "100000000000000000007172", "answers": [{"text": "FDA", "answer_start": 69}], "is_impossible": false}, {"question": "How long after completion of primary vaccination is a single booster dose given to individuals 12 years of age and older?", "id": "100000000000000000007173", "answers": [{"text": "2 months", "answer_start": 165}], "is_impossible": false}, {"question": "How long after receiving the most recent booster dose is a single booster dose given to individuals 12 years of age and older?", "id": "100000000000000000007174", "answers": [{"text": "2 months", "answer_start": 353}], "is_impossible": false}], "context": "The Pfizer-BioNTech COVID-19 Vaccine, Bivalent has received EUA from FDA\nto provide either:\n\uf0b7 a single booster dose to individuals 12 years of age and older at least\n2 months after completion of primary vaccination with any authorized\nor approved monovalent3 COVID-19 vaccine; or\n\uf0b7 a single booster dose to individuals 12 years of age and older at least\n2 months after receipt of the most recent booster dose with any\nauthorized or approved monovalent COVID-19 vaccine."}]}, {"title": "926f4f798459fe738bc0513734582010", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000007176", "answers": [{"text": "Bivalent", "answer_start": 222}], "is_impossible": false}, {"question": "What is the name of the coronavirus that causes COVID-19?", "id": "100000000000000000007177", "answers": [{"text": "SARS-CoV-2", "answer_start": 592}], "is_impossible": false}, {"question": "What is the name of the coronavirus?", "id": "100000000000000000007179", "answers": [{"text": "SARS-CoV-2", "answer_start": 592}], "is_impossible": false}, {"question": "How can you get COVID-19?", "id": "100000000000000000007180", "answers": [{"text": "through contact with another person who has the virus", "answer_start": 625}], "is_impossible": false}], "context": "This Vaccine Information Fact Sheet contains information to help you understand the\nrisks and benefits of COMIRNATY (COVID-19 Vaccine, mRNA), the Pfizer-BioNTech\nCOVID-19 Vaccine, and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, which you\nmay receive because there is currently a pandemic of COVID-19. Talk to your\nvaccination provider if you have questions. This Fact Sheet may have been updated. For the most recent Fact Sheet, please see\nwww.cvdvaccine.com. WHAT YOU NEED TO KNOW BEFORE YOU GET ANY OF THESE VACCINES\nWHAT IS COVID-19? COVID-19 disease is caused by a coronavirus called SARS-CoV-2. You can get\nCOVID-19 through contact with another person who has the virus."}]}, {"title": "dd0292f339a5fea0d1466465689c538e", "paragraphs": [{"qas": [{"question": "What can affect other organs?", "id": "100000000000000000007182", "answers": [{"text": "a respiratory illness", "answer_start": 20}], "is_impossible": false}, {"question": "Who has had a wide range of symptoms?", "id": "100000000000000000007184", "answers": [{"text": "People with COVID-19", "answer_start": 72}], "is_impossible": false}, {"question": "What is the name of the PFIZER-BIONTECH COVID-19 VACCINE?", "id": "100000000000000000007186", "answers": [{"text": "BIVALENT", "answer_start": 590}], "is_impossible": false}], "context": "It is predominantly a\nrespiratory illness that can affect other organs. People with COVID-19 have had a wide\nrange of symptoms reported, ranging from mild symptoms to severe illness leading to\ndeath. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may\ninclude: fever or chills; cough; shortness of breath; fatigue; muscle or body aches;\nheadache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or\nvomiting; diarrhea. HOW ARE COMIRNATY (COVID-19 VACCINE, mRNA), THE PFIZER-BIONTECH\nCOVID-19 VACCINE, AND THE PFIZER-BIONTECH COVID-19 VACCINE,\nBIVALENT RELATED?"}]}, {"title": "1355a1dd599dd9f33cc9f5e123d4d83c", "paragraphs": [{"qas": [{"question": "What is Pfizer-BioNTech COVID-19 Vaccine, Bivalent made in the same way?", "id": "100000000000000000007188", "answers": [{"text": "COMIRNATY", "answer_start": 246}], "is_impossible": false}, {"question": "What is the purpose of the Omicron component in the COVID-19 vaccine?", "id": "100000000000000000007190", "answers": [{"text": "to help prevent COVID-19", "answer_start": 478}], "is_impossible": false}, {"question": "What is an Emergency Use Authorization?", "id": "100000000000000000007191", "answers": [{"text": "EUA", "answer_start": 572}], "is_impossible": false}], "context": "COMIRNATY (COVID-19 Vaccine, mRNA) and the Pfizer-BioNTech COVID-19\nVaccine, when prepared according to their respective instructions for use, can be used\ninterchangeably. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is made in the\nsame way as COMIRNATY and Pfizer-BioNTech COVID-19 Vaccine but it also\n3 Monovalent refers to any authorized or approved COVID-19 vaccine that contains or encodes the spike protein\nof only the Original SARS-CoV-2. contains an Omicron component to help prevent COVID-19 caused by the Omicron\nvariant of SARS-CoV-2. For more information on EUA, see the \u201cWhat is an Emergency Use Authorization\n(EUA)?\u201d section at the end of this Fact Sheet."}]}, {"title": "86804d89add14413b902c7df04b07428", "paragraphs": [{"qas": [{"question": "What is the term for inflammation of the heart muscle?", "id": "100000000000000000007193", "answers": [{"text": "myocarditis", "answer_start": 209}], "is_impossible": false}, {"question": "What is pericarditis?", "id": "100000000000000000007194", "answers": [{"text": "inflammation of the lining outside the heart", "answer_start": 273}], "is_impossible": false}, {"question": "If you have a fever, what is it called?", "id": "100000000000000000007195", "answers": [{"text": "all of your medical conditions", "answer_start": 127}], "is_impossible": false}, {"question": "What is the lining outside of the heart called?", "id": "100000000000000000007196", "answers": [{"text": "all of your medical conditions", "answer_start": 127}], "is_impossible": false}, {"question": "Are you pregnant or plan to become pregnant?", "id": "100000000000000000007197", "answers": [{"text": "all of your medical conditions", "answer_start": 127}], "is_impossible": false}, {"question": "Have you ever fainted in association with a COVID-19 vaccine?", "id": "100000000000000000007198", "answers": [{"text": "Tell the vaccination provider about all of your medical conditions", "answer_start": 91}], "is_impossible": false}, {"question": "What type of vaccine did you receive?", "id": "100000000000000000007199", "answers": [{"text": "Tell the vaccination provider about all of your medical conditions", "answer_start": 91}], "is_impossible": false}, {"question": "How did you feel after receiving the COVID-19 vaccine?", "id": "100000000000000000007200", "answers": [{"text": "Tell the vaccination provider about all of your medical conditions", "answer_start": 91}], "is_impossible": false}], "context": "WHAT SHOULD YOU MENTION TO YOUR VACCINATION PROVIDER BEFORE\nYOU GET ANY OF THESE VACCINES? Tell the vaccination provider about all of your medical conditions, including if\nyou:\n\uf0b7 have any allergies\n\uf0b7 have had myocarditis (inflammation of the heart muscle) or pericarditis\n(inflammation of the lining outside the heart)\n\uf0b7 have a fever\n\uf0b7 have a bleeding disorder or are on a blood thinner\n\uf0b7 are immunocompromised or are on a medicine that affects your immune system\n\uf0b7 are pregnant or plan to become pregnant\n\uf0b7 are breastfeeding\n\uf0b7 have received another COVID-19 vaccine\n\uf0b7 have ever fainted in association with an injection\nHOW ARE THESE VACCINES GIVEN?"}]}, {"title": "d73ad47b44a6690ee13afa904358fe35", "paragraphs": [{"qas": [{"question": "What are the Pfizer-BioNTech COVID-19 Vaccine and COMIRNATY given for?", "id": "100000000000000000007202", "answers": [{"text": "Primary Series", "answer_start": 178}], "is_impossible": false}, {"question": "How many doses of a vaccine are there?", "id": "100000000000000000007204", "answers": [{"text": "2", "answer_start": 336}], "is_impossible": false}, {"question": "How many weeks apart is the second dose of the vaccine?", "id": "100000000000000000007205", "answers": [{"text": "3", "answer_start": 352}], "is_impossible": false}], "context": "The Pfizer-BioNTech COVID-19 Vaccine, the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent, or COMIRNATY (COVID-19 Vaccine, mRNA) will be given to you as an\ninjection into the muscle. Primary Series: The Pfizer-BioNTech COVID-19 Vaccine and COMIRNATY (COVID-19\nVaccine, mRNA) are given for the primary series. The vaccine is administered as a\n2-dose series, 3 weeks apart. A third primary series dose may be administered at least\n4 weeks after the second dose to individuals with certain kinds of immunocompromise."}]}, {"title": "589ea53368668397c4cf2ed7a8f8e5bb", "paragraphs": [{"qas": [{"question": "What is the Booster Dose of Pfizer-BioNTech COVID-19 Vaccine, Bivalent administered as?", "id": "100000000000000000007207", "answers": [{"text": "a single booster dose", "answer_start": 76}], "is_impossible": false}, {"question": "How long after completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine?", "id": "100000000000000000007208", "answers": [{"text": "2 months", "answer_start": 107}], "is_impossible": false}, {"question": "What is the name of the monovalent COVID-19 vaccine?", "id": "100000000000000000007210", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 14}], "is_impossible": false}], "context": "Booster Dose: Pfizer-BioNTech COVID-19 Vaccine, Bivalent is administered as a single\nbooster dose at least 2 months after:\n\uf0b7 completion of primary vaccination with any authorized or approved monovalent\nCOVID-19 vaccine; or\n\uf0b7 receipt of the most recent booster dose with any authorized or approved\nmonovalent COVID-19 vaccine\nThe vaccine may not protect everyone. WHO SHOULD NOT GET COMIRNATY (COVID-19 VACCINE, mRNA), THE\nPFIZER-BIONTECH COVID-19 VACCINE, OR THE PFIZER-BIONTECH COVID-19\nVACCINE, BIVALENT?"}]}, {"title": "c1dee9c542f570c18480cbfacbae0249", "paragraphs": [{"qas": [{"question": "What is COMIRNATY?", "id": "100000000000000000007212", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 118}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000007214", "answers": [{"text": "COMIRNATY (COVID-19 Vaccine, mRNA), Pfizer-BioNTech COVID-19 Vaccine, and Pfizer-BioNTech COVID-19 Vaccine, Bivalent", "answer_start": 296}], "is_impossible": false}, {"question": "What are the ingredients in COMIRNATY?", "id": "100000000000000000007215", "answers": [{"text": "mRNA and lipids", "answer_start": 450}], "is_impossible": false}], "context": "You should not get any of these vaccines if you:\n\uf0b7 had a severe allergic reaction after a previous dose of COMIRNATY (COVID-19\nVaccine, mRNA) or the Pfizer-BioNTech COVID-19 Vaccine\n\uf0b7 had a severe allergic reaction to any ingredient in these vaccines. WHAT ARE THE INGREDIENTS IN THESE VACCINES? COMIRNATY (COVID-19 Vaccine, mRNA), Pfizer-BioNTech COVID-19 Vaccine, and\nPfizer-BioNTech COVID-19 Vaccine, Bivalent include the following ingredients:\n\uf0b7 mRNA and lipids (((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-\n1,2-Distearoyl-sn-glycero-3-phosphocholine, and cholesterol)."}]}, {"title": "db9b0e98d8d63ea0a9a439c226dc2e75", "paragraphs": [{"qas": [{"question": "How many sets of additional ingredients does Pfizer-BioNTech COVID-19 Vaccine contain?", "id": "100000000000000000007216", "answers": [{"text": "1", "answer_start": 83}], "is_impossible": false}, {"question": "What is the name of the vaccine for individuals 12 years of age and older?", "id": "100000000000000000007217", "answers": [{"text": "COVID-19", "answer_start": 16}], "is_impossible": false}, {"question": "How many additional ingredients does COVID-19 Vaccine, mRNA contain?", "id": "100000000000000000007218", "answers": [{"text": "1", "answer_start": 610}], "is_impossible": false}, {"question": "What type of potassium phosphate is used?", "id": "100000000000000000007219", "answers": [{"text": "monobasic", "answer_start": 749}], "is_impossible": false}], "context": "Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older contains\n1 of the following sets of additional ingredients; ask the vaccination provider which\nversion is being administered:\n\uf0b7 potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic\nsodium phosphate dihydrate, and sucrose\nOR\n\uf0b7 tromethamine, tromethamine hydrochloride, and sucrose\nPfizer-BioNTech COVID-19 Vaccine, Bivalent for individuals 12 years of age and older\ncontains the following additional ingredients:\n\uf0b7 tromethamine, tromethamine hydrochloride, and sucrose\nCOMIRNATY (COVID-19 Vaccine, mRNA) contains 1 of the following sets of additional\ningredients; ask the vaccination provider which version is being administered:\n\uf0b7 potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic\nsodium phosphate dihydrate, and sucrose\nOR\n\uf0b7 tromethamine, tromethamine hydrochloride, and sucrose\nHAVE THESE VACCINES BEEN USED BEFORE?"}]}, {"title": "8285fc049b9102e9e928eeb0530fbc78", "paragraphs": [{"qas": [{"question": "How many people have received at least 1 dose of Pfizer-BioNTech COVID-19 Vaccine in clinical trials?", "id": "100000000000000000007221", "answers": [{"text": "23,000", "answer_start": 34}], "is_impossible": false}, {"question": "In a clinical trial, how many people greater than 55 years of age received one dose of PFIV?", "id": "100000000000000000007223", "answers": [{"text": "300", "answer_start": 291}], "is_impossible": false}, {"question": "How many doses of the bivalent vaccine were given to people over 55?", "id": "100000000000000000007226", "answers": [{"text": "one", "answer_start": 345}], "is_impossible": false}], "context": "In clinical trials, approximately 23,000 individuals 12 years of age and older have\nreceived at least 1 dose of Pfizer-BioNTech COVID-19 Vaccine. Millions of individuals\nhave received the Pfizer-BioNTech COVID-19 Vaccine under EUA since December 11,\n2020. In a clinical trial, approximately 300 individuals greater than 55 years of age received\none dose of a bivalent vaccine that differs from the Pfizer-BioNTech COVID-19\nVaccine, Bivalent in that it contains a different Omicron component. WHAT ARE THE BENEFITS OF THESE VACCINES? COMIRNATY (COVID-19 Vaccine, mRNA) and the Pfizer-BioNTech COVID-19 Vaccine\nhave been shown to prevent COVID-19."}]}, {"title": "a6b682c76e29065d80f77edac5acb3a4", "paragraphs": [{"qas": [{"question": "How long after getting a dose would a severe allergic reaction occur?", "id": "100000000000000000007230", "answers": [{"text": "within a few minutes to 1 hour", "answer_start": 389}], "is_impossible": false}], "context": "FDA has authorized Pfizer-BioNTech\nCOVID-19 Vaccine, Bivalent to provide better protection against COVID-19 caused by\nthe Omicron variant of SARS-CoV-2. The duration of protection against COVID-19 is currently unknown. WHAT ARE THE RISKS OF THESE VACCINES? There is a remote chance that these vaccines could cause a severe allergic reaction. A\nsevere allergic reaction would usually occur within a few minutes to 1 hour after getting\na dose. For this reason, your vaccination provider may ask you to stay at the place\nwhere you received your vaccine for monitoring after vaccination."}]}, {"title": "90ce8b14304ed81e21b517b535f79db5", "paragraphs": [{"qas": [{"question": "What are signs of a severe allergic reaction?", "id": "100000000000000000007232", "answers": [{"text": "Difficulty breathing", "answer_start": 51}], "is_impossible": false}, {"question": "What is the name of the inflammation of the heart muscle that can occur in some people who have received COMIRNATY?", "id": "100000000000000000007233", "answers": [{"text": "Myocarditis", "answer_start": 183}], "is_impossible": false}, {"question": "What is another name for COVID-19 Vaccine?", "id": "100000000000000000007234", "answers": [{"text": "COMIRNATY", "answer_start": 340}], "is_impossible": false}, {"question": "How long after receiving the second dose did symptoms begin in most of these people?", "id": "100000000000000000007236", "answers": [{"text": "within a few days", "answer_start": 561}], "is_impossible": false}, {"question": "How long after receiving the second dose of vaccine is the chance of having this happen?", "id": "100000000000000000007238", "answers": [{"text": "very low", "answer_start": 663}], "is_impossible": false}], "context": "Signs of a severe\nallergic reaction can include:\n\uf0b7 Difficulty breathing\n\uf0b7 Swelling of your face and throat\n\uf0b7 A fast heartbeat\n\uf0b7 A bad rash all over your body\n\uf0b7 Dizziness and weakness\nMyocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the\nlining outside the heart) have occurred in some people who have received\nCOMIRNATY (COVID-19 Vaccine, mRNA) or Pfizer-BioNTech COVID-19 Vaccine,\nmore commonly in adolescent males and adult males under 40 years of age than\namong females and older males. In most of these people, symptoms began within a\nfew days following receipt of the second dose of vaccine. The chance of having this\noccur is very low."}]}, {"title": "de8ecc05b066cda5781c485e7e74d701", "paragraphs": [{"qas": [{"question": "What are some of the side effects that have been reported with these vaccines?", "id": "100000000000000000007240", "answers": [{"text": "Severe allergic reactions", "answer_start": 286}], "is_impossible": false}, {"question": "What is a non-severe allergic reaction?", "id": "100000000000000000007241", "answers": [{"text": "rash, itching, hives, or swelling of the face", "answer_start": 352}], "is_impossible": false}, {"question": "What is the name of the inflammation of the heart muscle?", "id": "100000000000000000007242", "answers": [{"text": "Myocarditis", "answer_start": 400}], "is_impossible": false}, {"question": "Pericarditis is an inflammation of what part of the body?", "id": "100000000000000000007243", "answers": [{"text": "lining outside the heart", "answer_start": 483}], "is_impossible": false}, {"question": "Injection site swelling can cause what?", "id": "100000000000000000007244", "answers": [{"text": "Fever", "answer_start": 592}], "is_impossible": false}, {"question": "What is Lymphadenopathy?", "id": "100000000000000000007245", "answers": [{"text": "Swollen lymph nodes", "answer_start": 677}], "is_impossible": false}, {"question": "What is Fainting in association with injection of the vaccine?", "id": "100000000000000000007246", "answers": [{"text": "Arm pain", "answer_start": 760}], "is_impossible": false}], "context": "You should seek medical attention right away if you have any of the\nfollowing symptoms after receiving the vaccine:\n\uf0b7 Chest pain\n\uf0b7 Shortness of breath\n\uf0b7 Feelings of having a fast-beating, fluttering, or pounding heart\nSide effects that have been reported with these vaccines include:\n\uf0b7 Severe allergic reactions\n\uf0b7 Non-severe allergic reactions such as rash, itching, hives, or swelling of the face\n\uf0b7 Myocarditis (inflammation of the heart muscle)\n\uf0b7 Pericarditis (inflammation of the lining outside the heart)\n\uf0b7 Injection site pain\n\uf0b7 Tiredness\n\uf0b7 Headache\n\uf0b7 Muscle pain\n\uf0b7 Chills\n\uf0b7 Joint pain\n\uf0b7 Fever\n\uf0b7 Injection site swelling\n\uf0b7 Injection site redness\n\uf0b7 Nausea\n\uf0b7 Feeling unwell\n\uf0b7 Swollen lymph nodes (lymphadenopathy)\n\uf0b7 Decreased appetite\n\uf0b7 Diarrhea\n\uf0b7 Vomiting\n\uf0b7 Arm pain\n\uf0b7 Fainting in association with injection of the vaccine\fThese may not be all the possible side effects of these vaccines."}]}, {"title": "ab3d9a7c06877c116370641c6e20cf71", "paragraphs": [{"qas": [{"question": "What are the possible side effects of vaccines still being studied?", "id": "100000000000000000007247", "answers": [{"text": "Serious and unexpected side effects may occur", "answer_start": 0}], "is_impossible": false}, {"question": "What does VAERS stand for?", "id": "100000000000000000007249", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 403}], "is_impossible": false}, {"question": "What is the VAERS toll-free number?", "id": "100000000000000000007250", "answers": [{"text": "1-800-822-7967", "answer_start": 481}], "is_impossible": false}, {"question": "Where can you report vaccine side effects?", "id": "100000000000000000007251", "answers": [{"text": "FDA/CDC Vaccine Adverse Event Reporting System (VAERS).", "answer_start": 395}], "is_impossible": false}], "context": "Serious and\nunexpected side effects may occur. The possible side effects of these vaccines are still\nbeing studied. WHAT SHOULD I DO ABOUT SIDE EFFECTS? If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital. Call the vaccination provider or your healthcare provider if you have any side effects\nthat bother you or do not go away. Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System\n(VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to\nhttps://vaers.hhs.gov/reportevent.html."}]}, {"title": "52babc1f70a26e279370603f64201a83", "paragraphs": [{"qas": [{"question": "What is COMIRNATY?", "id": "100000000000000000007252", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 34}], "is_impossible": false}, {"question": "What is Pfizer-BioNTech COVID-19 Vaccine EUA?", "id": "100000000000000000007253", "answers": [{"text": "Bivalent", "answer_start": 138}], "is_impossible": false}, {"question": "Who can you report side effects to?", "id": "100000000000000000007254", "answers": [{"text": "Pfizer Inc.", "answer_start": 261}], "is_impossible": false}, {"question": "What is v-safe?", "id": "100000000000000000007255", "answers": [{"text": "a voluntary smartphone-based tool", "answer_start": 415}], "is_impossible": false}, {"question": "What does V-safe check in with people who have been vaccinated?", "id": "100000000000000000007256", "answers": [{"text": "to identify potential side effects", "answer_start": 539}], "is_impossible": false}], "context": "Please include either \u201cCOMIRNATY (COVID-19\nVaccine, mRNA)\u201d, \u201cPfizer-BioNTech COVID-19 Vaccine EUA\u201d, or \u201cPfizer-BioNTech\nCOVID-19 Vaccine, Bivalent EUA\u201d as appropriate, in the first line of box #18 of the\nreport form. In addition, you can report side effects to Pfizer Inc. at the contact information provided\nbelow. Website Fax number Telephone number\nYou may also be given an option to enroll in v-safe. V-safe is a voluntary\nsmartphone-based tool that uses text messaging and web surveys to check in with\npeople who have been vaccinated to identify potential side effects after COVID-19\nvaccination. V-safe asks questions that help CDC monitor the safety of COVID-19\nvaccines."}]}, {"title": "618fe55aa3276beebd0ee394efe9710d", "paragraphs": [{"qas": [{"question": "What does V-safe provide if participants report a significant health impact following a COVID-19 vaccination?", "id": "100000000000000000007258", "answers": [{"text": "second-dose reminders if needed and live telephone follow-up by CDC", "answer_start": 21}], "is_impossible": false}, {"question": "What does COMIRNATY stand for?", "id": "100000000000000000007259", "answers": [{"text": "COVID-19 VACCINE, mRNA", "answer_start": 277}], "is_impossible": false}, {"question": "What does the EUA allow you to do if you decide not to receive any of these vaccines?", "id": "100000000000000000007261", "answers": [{"text": "it will not change your standard medical care", "answer_start": 529}], "is_impossible": false}], "context": "V-safe also provides second-dose reminders if needed and live telephone\nfollow-up by CDC if participants report a significant health impact following COVID-19\nvaccination. For more information on how to sign up, visit: www.cdc.gov/vsafe. WHAT IF I DECIDE NOT TO GET COMIRNATY (COVID-19 VACCINE, mRNA), THE\nPFIZER-BIONTECH COVID-19 VACCINE, OR THE PFIZER-BIONTECH COVID-19\nVACCINE, BIVALENT? Under the EUA, it is your choice to receive or not receive any of these vaccines. Should\nyou decide not to receive any of these vaccines, it will not change your standard\nmedical care."}]}, {"title": "359b5e7bee18bb78ac6ca844abfe744a", "paragraphs": [{"qas": [{"question": "What is another choice for preventing COVID-19 BESIDES COMIRNATY?", "id": "100000000000000000007262", "answers": [{"text": "SPIKEVAX", "answer_start": 252}], "is_impossible": false}, {"question": "What is SPIKEVAX?", "id": "100000000000000000007263", "answers": [{"text": "an FDA-approved COVID-19 vaccine", "answer_start": 287}], "is_impossible": false}, {"question": "Under what may other vaccines be available?", "id": "100000000000000000007264", "answers": [{"text": "EUA", "answer_start": 379}], "is_impossible": false}], "context": "ARE OTHER CHOICES AVAILABLE FOR PREVENTING COVID-19 BESIDES\nCOMIRNATY (COVID-19 VACCINE, mRNA), THE PFIZER-BIONTECH COVID-19\nVACCINE, OR THE PFIZER-BIONTECH COVID-19 VACCINE, BIVALENT? For primary vaccination, another choice for preventing COVID-19 is SPIKEVAX\n(COVID-19 Vaccine, mRNA), an FDA-approved COVID-19 vaccine. Other vaccines to\nprevent COVID-19 may be available under EUA, including bivalent vaccines that\ncontain an Omicron component of SARS-CoV-2. CAN I RECEIVE COMIRNATY (COVID-19 VACCINE, mRNA), PFIZER-BIONTECH\nCOVID-19 VACCINE, OR THE PFIZER-BIONTECH COVID-19 VACCINE, BIVALENT\nAT THE SAME TIME AS OTHER VACCINES?"}]}, {"title": "2f1f4954af75db07f1627845c97c1436", "paragraphs": [{"qas": [{"question": "What has not yet been submitted to FDA on administration of COMIRNATY?", "id": "100000000000000000007267", "answers": [{"text": "Data", "answer_start": 0}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000007268", "answers": [{"text": "COMIRNATY", "answer_start": 61}], "is_impossible": false}, {"question": "What is another name for Pfizer-BioNTech COVID-19 Vaccine, Bivalent?", "id": "100000000000000000007269", "answers": [{"text": "COMIRNATY (COVID-19 Vaccine, mRNA), the Pfizer-BioNTech COVID-19 Vaccine, or the Pfizer-BioNTech COVID-19 Vaccine, Bivalent at the same time with other vaccines. If you are considering receiving COMIRNATY", "answer_start": 61}], "is_impossible": false}, {"question": "If you are immunocompromised, you may receive a third primary series dose of what?", "id": "100000000000000000007270", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 562}], "is_impossible": false}, {"question": "What is the name of the vaccine that can be given to individuals 12 years of age and older?", "id": "100000000000000000007272", "answers": [{"text": "COMIRNATY", "answer_start": 61}], "is_impossible": false}], "context": "Data have not yet been submitted to FDA on administration of COMIRNATY\n(COVID-19 Vaccine, mRNA), the Pfizer-BioNTech COVID-19 Vaccine, or the\nPfizer-BioNTech COVID-19 Vaccine, Bivalent at the same time with other vaccines. If\nyou are considering receiving COMIRNATY (COVID-19 Vaccine, mRNA), the\nPfizer-BioNTech COVID-19 Vaccine, or the Pfizer-BioNTech COVID-19 Vaccine,\nBivalent with other vaccines, discuss your options with your healthcare provider. WHAT IF I AM IMMUNOCOMPROMISED? If you are immunocompromised, you may receive a third primary series dose of\nPfizer-BioNTech COVID-19 Vaccine or COMIRNATY (COVID-19 Vaccine, mRNA). Individuals 12 years of age and older may receive a booster dose with\nPfizer-BioNTech COVID-19 Vaccine, Bivalent."}]}, {"title": "9c7030fb68db17a2f8cfa29b58a3182", "paragraphs": [{"qas": [{"question": "What should you continue to maintain to help prevent?", "id": "100000000000000000007275", "answers": [{"text": "physical precautions", "answer_start": 128}], "is_impossible": false}, {"question": "Who should be vaccinated as appropriate?", "id": "100000000000000000007276", "answers": [{"text": "Your close contacts", "answer_start": 175}], "is_impossible": false}, {"question": "If you are pregnant or breastfeeding, discuss your options with your healthcare provider.", "id": "100000000000000000007277", "answers": [{"text": "PREGNANT OR BREASTFEEDING", "answer_start": 245}], "is_impossible": false}, {"question": "What do these vaccines not contain?", "id": "100000000000000000007279", "answers": [{"text": "SARS-CoV-2", "answer_start": 434}], "is_impossible": false}], "context": "Vaccinations may not provide full\nimmunity to COVID-19 in people who are immunocompromised, and you should\ncontinue to maintain physical precautions to help prevent COVID-19. Your close\ncontacts should be vaccinated as appropriate. WHAT IF I AM PREGNANT OR BREASTFEEDING? If you are pregnant or breastfeeding, discuss your options with your healthcare\nprovider. WILL THESE VACCINES GIVE ME COVID-19? No. These vaccines do not contain SARS-CoV-2 and cannot give you COVID-19. KEEP YOUR VACCINATION CARD\nWhen you get your first COVID-19 vaccine, you will get a vaccination card. Remember\nto bring your card when you return."}]}, {"title": "c76f79771af495d682c997eb85324b77", "paragraphs": [{"qas": [{"question": "What is the global website Telephone number?", "id": "100000000000000000007281", "answers": [{"text": "www.cvdvaccine.com", "answer_start": 220}], "is_impossible": false}, {"question": "What is CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html?", "id": "100000000000000000007282", "answers": [{"text": "Visit CDC", "answer_start": 295}], "is_impossible": false}, {"question": "Where can your vaccination information be found?", "id": "100000000000000000007283", "answers": [{"text": "Immunization Information System (IIS) or other designated system", "answer_start": 713}], "is_impossible": false}, {"question": "Where can you find your vaccine information?", "id": "100000000000000000007284", "answers": [{"text": "Immunization Information System (IIS) or other designated system", "answer_start": 713}], "is_impossible": false}, {"question": "What is the name of the website where you can find your vaccination provider?", "id": "100000000000000000007285", "answers": [{"text": "www.cvdvaccine.com", "answer_start": 220}], "is_impossible": false}], "context": "ADDITIONAL INFORMATION\nIf you have questions, visit the website or call the telephone number provided below. To access the most recent Fact Sheets, please scan the QR code provided below. Global website Telephone number\nwww.cvdvaccine.com\fHOW CAN I LEARN MORE? \uf0b7 Ask the vaccination provider. \uf0b7 Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. \uf0b7 Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-\nlegal-regulatory-and-policy-framework/emergency-use-authorization. \uf0b7 Contact your local or state public health department. WHERE WILL MY VACCINATION INFORMATION BE RECORDED? The vaccination provider may include your vaccination information in your state/local\njurisdiction\u2019s Immunization Information System (IIS) or other designated system."}]}, {"title": "ce89d2dd3357bb668610b682e380c73", "paragraphs": [{"qas": [{"question": "What will ensure that you receive the same vaccine when you return for the second dose of the primary series?", "id": "100000000000000000007286", "answers": [{"text": "IISs", "answer_start": 137}], "is_impossible": false}, {"question": "Where can you find more information about IISs?", "id": "100000000000000000007287", "answers": [{"text": "https://www.cdc.gov/vaccines/programs/iis/about.html", "answer_start": 149}], "is_impossible": false}, {"question": "What can not charge you for a vaccine dose?", "id": "100000000000000000007288", "answers": [{"text": "the provider", "answer_start": 281}], "is_impossible": false}, {"question": "What is the name of the program for non-insured recipients of COVID-19?", "id": "100000000000000000007290", "answers": [{"text": "COVID-19 Uninsured Program", "answer_start": 714}], "is_impossible": false}], "context": "This\nwill ensure that you receive the same vaccine when you return for the second dose of\nthe primary series. For more information about IISs visit:\nhttps://www.cdc.gov/vaccines/programs/iis/about.html. CAN I BE CHARGED AN ADMINISTRATION FEE FOR RECEIPT OF THESE\nNo. At this time, the provider cannot charge you for a vaccine dose and you cannot be\ncharged an out-of-pocket vaccine administration fee or any other fee if only receiving a\nCOVID-19 vaccination. However, vaccination providers may seek appropriate\nreimbursement from a program or plan that covers COVID-19 vaccine administration\nfees for the vaccine recipient (private insurance, Medicare, Medicaid, Health\nResources & Services Administration [HRSA] COVID-19 Uninsured Program for\nnon-insured recipients)."}]}, {"title": "150f0947cafa92ec1b3abd7615375788", "paragraphs": [{"qas": [{"question": "Who can I report suspected violations of the CDC COVID-19 Vaccination Program requirements to?", "id": "100000000000000000007291", "answers": [{"text": "Office of the Inspector General", "answer_start": 190}], "is_impossible": false}, {"question": "What is the COUNTERMEASURES INJURY COMPENSATION PROGRAM?", "id": "100000000000000000007292", "answers": [{"text": "The Countermeasures Injury Compensation Program", "answer_start": 369}], "is_impossible": false}, {"question": "What is the name of the federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines?", "id": "100000000000000000007293", "answers": [{"text": "Countermeasures Injury Compensation Program", "answer_start": 373}], "is_impossible": false}], "context": "WHERE CAN I REPORT CASES OF SUSPECTED FRAUD? Individuals becoming aware of any potential violations of the CDC COVID-19\nVaccination Program requirements are encouraged to report them to the Office of the\nInspector General, U.S. Department of Health and Human Services, at\n1-800-HHS-TIPS or https://TIPS.HHS.GOV. WHAT IS THE COUNTERMEASURES INJURY COMPENSATION PROGRAM? The Countermeasures Injury Compensation Program (CICP) is a federal program that\nmay help pay for costs of medical care and other specific expenses of certain people\nwho have been seriously injured by certain medicines or vaccines, including these\nvaccines."}]}, {"title": "ff5029fc8397198214a791412d2c4e6e", "paragraphs": [{"qas": [{"question": "How long must a claim be submitted to the CICP?", "id": "100000000000000000007294", "answers": [{"text": "within one (1) year", "answer_start": 49}], "is_impossible": false}, {"question": "How long does an EUA last?", "id": "100000000000000000007296", "answers": [{"text": "one (1) year", "answer_start": 56}], "is_impossible": false}, {"question": "What is a mechanism to facilitate the availability and use of medical products during public health emergencies?", "id": "100000000000000000007297", "answers": [{"text": "EMERGENCY USE AUTHORIZATION", "answer_start": 203}], "is_impossible": false}, {"question": "What is supported by a Secretary of Health and Human Services declaration that circumstances exist to justify the emergency use of drugs and biological products?", "id": "100000000000000000007298", "answers": [{"text": "EUA", "answer_start": 416}], "is_impossible": false}], "context": "Generally, a claim must be submitted to the CICP within one (1) year from the\ndate of receiving the vaccine. To learn more about this program, visit\nwww.hrsa.gov/cicp/ or call 1-855-266-2427. WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)? An EUA is a mechanism to facilitate the availability and use of medical products,\nincluding vaccines, during public health emergencies, such as the current COVID-19\npandemic. An EUA is supported by a Secretary of Health and Human Services (HHS)\ndeclaration that circumstances exist to justify the emergency use of drugs and\nbiological products during the COVID-19 pandemic."}]}, {"title": "ec676b563e9e8a0197bc39be2be9b759", "paragraphs": [{"qas": [{"question": "What type of review by FDA does a product authorized for emergency use not undergo?", "id": "100000000000000000007299", "answers": [{"text": "the same type of review", "answer_start": 57}], "is_impossible": false}, {"question": "What is the criteria that FDA may issue an EUA when certain criteria are met?", "id": "100000000000000000007300", "answers": [{"text": "there are no adequate, approved, and available alternatives", "answer_start": 188}], "is_impossible": false}, {"question": "The FDA decision is based on what?", "id": "100000000000000000007301", "answers": [{"text": "the totality of the scientific evidence", "answer_start": 291}], "is_impossible": false}, {"question": "What did the FDA consider to be the best way to prevent COVID-19 during the pandemic?", "id": "100000000000000000007302", "answers": [{"text": "effective", "answer_start": 372}], "is_impossible": false}, {"question": "What was the FDA's decision based on?", "id": "100000000000000000007303", "answers": [{"text": "the totality of the scientific evidence available", "answer_start": 291}], "is_impossible": false}], "context": "A product authorized for\nemergency use has not undergone the same type of review by FDA as an\nFDA-approved product. FDA may issue an EUA when certain criteria are met, which includes that there are no\nadequate, approved, and available alternatives. In addition, the FDA decision is based\non the totality of the scientific evidence available showing that the product may be\neffective to prevent COVID-19 during the COVID-19 pandemic and that the known and\npotential benefits of the product outweigh the known and potential risks of the product."}]}, {"title": "69b225f5bd85478be9ee5376f0b4794c", "paragraphs": [{"qas": [{"question": "What must be met to allow for the product to be used during the COVID-19 pandemic?", "id": "100000000000000000007305", "answers": [{"text": "All of these criteria", "answer_start": 0}], "is_impossible": false}, {"question": "What is in effect for the duration of the EUA declaration justifying emergency use of the product?", "id": "100000000000000000007306", "answers": [{"text": "An EUA", "answer_start": 100}], "is_impossible": false}, {"question": "What is the name of the company that manufactures the vaccine?", "id": "100000000000000000007307", "answers": [{"text": "Pfizer Inc", "answer_start": 390}], "is_impossible": false}, {"question": "In what city is Pfizer Inc. located?", "id": "100000000000000000007309", "answers": [{"text": "New York", "answer_start": 404}], "is_impossible": false}], "context": "All of these criteria must be met to allow for the product to be used during the\nCOVID-19 pandemic. An EUA is in effect for the duration of the COVID-19 EUA declaration justifying\nemergency use of this product, unless terminated or revoked (after which the product\nmay no longer be used). Manufactured for\nBioNTech Manufacturing GmbH\nAn der Goldgrube 12\n55131 Mainz, Germany\nManufactured by\nPfizer Inc., New York, NY 10017\nScan to capture that this Fact Sheet was provided to vaccine\nrecipient for the electronic medical records/immunization\ninformation systems."}]}, {"title": "cbe10c3fcfb14784fc78c926c9d6c66b", "paragraphs": [{"qas": [{"question": "Most individuals will have some protection from what?", "id": "100000000000000000007312", "answers": [{"text": "repeat infections", "answer_start": 308}], "is_impossible": false}, {"question": "Reinfections do occur after what virus?", "id": "100000000000000000007313", "answers": [{"text": "COVID-19", "answer_start": 364}], "is_impossible": false}, {"question": "When do reinfections occur after COVID-19?", "id": "100000000000000000007314", "answers": [{"text": "10/30/22, 9:37 AM", "answer_start": 0}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Reinfections and COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nReinfections and COVID-19\nReinfection with the virus that causes COVID-19 means a person was infected, recovered, and then later became infected\nagain. After recovering from COVID-19, most individuals will have some protection from repeat infections. However,\nreinfections do occur after COVID-19. We are still learning more about these reinfections."}]}, {"title": "b46ccf0bfeb6c300a03360df1c5e38af", "paragraphs": [{"qas": [{"question": "How often do reinfections occur?", "id": "100000000000000000007316", "answers": [{"text": "CDC is using a range of data sources", "answer_start": 459}], "is_impossible": false}, {"question": "What is the risk of transmission to others after reinfection?", "id": "100000000000000000007317", "answers": [{"text": "CDC continues to work to better understand reinfections with COVID-19 to inform public health action", "answer_start": 357}], "is_impossible": false}, {"question": "What is the risk of reinfection when there is community spread of Omicron or other virus variants?", "id": "100000000000000000007320", "answers": [{"text": "CDC is using a range of data sources", "answer_start": 459}], "is_impossible": false}], "context": "Ongoing studies of COVID-19 are\nhelping us understand:\nHow often reinfections occur\nWho is at higher risk of reinfection\nHow soon reinfections take place after a previous infection\nThe severity (how serious the infection is) of reinfections compared with initial (the first) infections\nThe risk of transmission to others after reinfection\nWhat CDC is doing\nCDC continues to work to better understand reinfections with COVID-19 to inform public health action. CDC is using a range\nof data sources to assess how often reinfections occur, who is most at risk for reinfection, and the risk of reinfection when\nthere is community spread of Omicron or other virus variants."}]}, {"title": "cde7784f42df57503b8fc9be69f4c2c", "paragraphs": [{"qas": [{"question": "When was COVID-19 introduced?", "id": "100000000000000000007322", "answers": [{"text": "September 1, 2021", "answer_start": 276}], "is_impossible": false}, {"question": "What does CSTE stand for?", "id": "100000000000000000007323", "answers": [{"text": "Council of State and Territorial Epidemiologists", "answer_start": 64}], "is_impossible": false}, {"question": "What is CDC working with multiple public health jurisdictions to identify reinfections?", "id": "100000000000000000007325", "answers": [{"text": "collect and analyze the data", "answer_start": 503}], "is_impossible": false}], "context": "CDC has worked closely with public health jurisdictions and the\nCouncil of State and Territorial Epidemiologists (CSTE) to help states to count repeat infections in the same individuals over\ntime. An updated national surveillance case definition of COVID-19 was introduced on September 1, 2021, and includes criteria for\ncounting new infections (reinfections) after previous probable or confirmed infections. CDC is working with multiple public\nhealth jurisdictions that are identifying reinfections to collect and analyze the data."}]}, {"title": "7a65e652d4ac69900c7a4011dd6b0ee7", "paragraphs": [{"qas": [{"question": "CDC is publishing several analyses that use datasets from what sources?", "id": "100000000000000000007326", "answers": [{"text": "cohort studies", "answer_start": 85}], "is_impossible": false}, {"question": "What is an example of a cohort study?", "id": "100000000000000000007327", "answers": [{"text": "follow the same people over time", "answer_start": 107}], "is_impossible": false}, {"question": "How many States were infected with SARS-CoV-2 between January and September 2021?", "id": "100000000000000000007328", "answers": [{"text": "Nine", "answer_start": 620}], "is_impossible": false}, {"question": "What is the name of the vaccine that was tested in California and New York between May and November 2021 for COVID-19?", "id": "100000000000000000007329", "answers": [{"text": "SARS-CoV-2", "answer_start": 598}], "is_impossible": false}], "context": "CDC is publishing several analyses that use\ndatasets from various sources, including cohort studies (which follow the same people over time):\nEffectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19\u2013Associated Hospitalization Among Adults with\nPrevious SARS-CoV-2 Infection \u2014 United States, June 2021\u2013February 2022\nCOVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis \u2014 California and\nNew York, May\u2013November 2021\nLaboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19\u2013Like Illness with Infection-Induced or mRNA\nVaccine-Induced SARS-CoV-2 Immunity \u2014 Nine States, January\u2013September 2021\nReinfection with SARS-CoV-2 among previously infected healthcare personnel and first responders\nSuspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare\nFacilities, June 1, 2020- February 28, 2021."}]}, {"title": "3e53e9242c4ebdf0ae7522321a23dcab", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000007331", "answers": [{"text": "variants", "answer_start": 391}], "is_impossible": false}, {"question": "Who reduces the risk of reinfection with SARS CoV 2?", "id": "100000000000000000007333", "answers": [{"text": "Healthcare Workers and First Responders", "answer_start": 112}], "is_impossible": false}, {"question": "What does COVID-19 cause?", "id": "100000000000000000007334", "answers": [{"text": "risk of reinfection", "answer_start": 449}], "is_impossible": false}, {"question": "What can lead to the emergence of new strains of the virus?", "id": "100000000000000000007335", "answers": [{"text": "variants", "answer_start": 391}], "is_impossible": false}], "context": "Duration of Viral Nucleic Acid Shedding and Early Reinfection With Severe Respiratory Syndrome Coronavirus 2 in\nHealthcare Workers and First Responders\nReduced Risk of Reinfection with SARS CoV 2 After COVID 19 Vaccination Kentucky May June 2021\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf549 About Variants\nViruses are constantly changing, including the virus that causes COVID-19. These changes can lead to\nthe emergence of variants (new strains of the virus) that can increase the risk of reinfection."}]}, {"title": "9a5c433ba49fa205af53087fda60154e", "paragraphs": [{"qas": [{"question": "What did the CDC reduce the risk of after COVID-19 Vaccination?", "id": "100000000000000000007336", "answers": [{"text": "Reinfection with SARS-CoV-2", "answer_start": 86}], "is_impossible": false}, {"question": "What is the science brief on SARS-CoV-2 Infection-induced and Vaccine-induced Immunity?", "id": "100000000000000000007337", "answers": [{"text": "Interim Guidelines", "answer_start": 476}], "is_impossible": false}, {"question": "What is standardized surveillance case definition and national notification for 2019 novel coronavirus disease?", "id": "100000000000000000007338", "answers": [{"text": "Interim Guidelines for COVID-19 Antibody Testing", "answer_start": 476}], "is_impossible": false}, {"question": "What are the Interim Guidelines for COVID-19 Antibody Testing Science Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity?", "id": "100000000000000000007339", "answers": [{"text": "answer undefined", "answer_start": 476}], "is_impossible": false}], "context": "\uf209\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022\n\uf209\n\u2022\n\uf209\f10/30/22, 9:37 AM Reinfections and COVID-19 | CDC\nReduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination \u2014 Kentucky, May\u2013June 2021\nScience Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity\n\u2022\n\u2022\nMore Information\nAntibodies and COVID-19\nIsolation\nWhat to Do If Exposed\nMore Information for Health Professionals\nUpdate to the standardized surveillance case definition and national notification for 2019 novel coronavirus disease\nInterim Guidelines for COVID-19 Antibody Testing\nScience Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity\nInterim Clinical Considerations for Use of COVID-19 Vaccines\n\uf20c \uf209\nLast Updated Sept. 9, 2022"}]}, {"title": "fff7dc5b8c5e4d4507d4bacbf0b5c85f", "paragraphs": [{"qas": [{"question": "What is required for non-U.S. citizen, nonimmigrant passengers arriving from a foreign country to the United States by air?", "id": "100000000000000000007340", "answers": [{"text": "show proof of being fully vaccinated against COVID-19", "answer_start": 506}], "is_impossible": false}, {"question": "What are nonimmigrants?", "id": "100000000000000000007342", "answers": [{"text": "not a U.S. citizen, U.S. national, lawful permanent resident, or traveling to the United States on an immigrant visa", "answer_start": 370}], "is_impossible": false}, {"question": "What should you do before you travel by air to the United States from a foreign country?", "id": "100000000000000000007343", "answers": [{"text": "show proof of being fully vaccinated against COVID-19", "answer_start": 506}], "is_impossible": false}], "context": "10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nEspa\u00f1ol | Other Languages\nRequirement for Proof of COVID-19 Vaccination for Air\nPassengers\nRequired for non-U.S. citizen, nonimmigrant passengers arriving from a foreign country to the United States\nby air\nWhat You Need to Know\nIf you are a non-U.S. citizen who is a nonimmigrant (not a U.S. citizen, U.S. national, lawful permanent resident, or\ntraveling to the United States on an immigrant visa), you will need to show proof of being fully vaccinated against\nCOVID-19 before you travel by air to the United States from a foreign country."}]}, {"title": "8ca27d0c1a49b34acb615bd2bb4c9c4f", "paragraphs": [{"qas": [{"question": "What are some categories of noncitizen, nonimmigrants excepted from?", "id": "100000000000000000007344", "answers": [{"text": "this requirement", "answer_start": 63}], "is_impossible": false}, {"question": "When did the President issue a Proclamation to suspend and limit entry into the United States?", "id": "100000000000000000007345", "answers": [{"text": "October 25, 2021", "answer_start": 226}], "is_impossible": false}, {"question": "What is the term for non-immigrants who want to enter the United States by air travel?", "id": "100000000000000000007346", "answers": [{"text": "Covered individuals", "answer_start": 391}], "is_impossible": false}, {"question": "What does the term \"Covered individuals\" refer to?", "id": "100000000000000000007347", "answers": [{"text": "nonimmigrants", "answer_start": 360}], "is_impossible": false}], "context": "Some categories of noncitizen, nonimmigrants are excepted from this requirement. If you meet the criteria for one of\nthese categories, you will need to fulfill additional requirements to travel by air to the United States. On October 25, 2021, the President issued a Proclamation to suspend and limit entry into the United States for non-U.S.\ncitizens who are nonimmigrants, referred to as \u201cCovered individuals,\u201d seeking to enter the United States by air travel and are\nnot fully vaccinated against COVID-19."}]}, {"title": "6b266495fc8bf5e35940b06a60f1acdf", "paragraphs": [{"qas": [{"question": "When did CDC issue the Order: Implementing Presidential Proclamation on Safe Resumtion of Global Travel During the COVID-19 Pandemic?", "id": "100000000000000000007348", "answers": [{"text": "April 4, 2022", "answer_start": 188}], "is_impossible": false}, {"question": "What was the Amended Order to align post arrival public health requirements for excepted noncitizen nonimmigrants with?", "id": "100000000000000000007349", "answers": [{"text": "current CDC recommendations", "answer_start": 323}], "is_impossible": false}, {"question": "What are the requirements for excepted noncitizen nonimmigrants with current CDC recommendations?", "id": "100000000000000000007350", "answers": [{"text": "post arrival public health requirements", "answer_start": 240}], "is_impossible": false}, {"question": "When is this amendment effective?", "id": "100000000000000000007352", "answers": [{"text": "April 14, 2022", "answer_start": 660}], "is_impossible": false}, {"question": "What is the date of this amendment?", "id": "100000000000000000007353", "answers": [{"text": "April 14, 2022", "answer_start": 660}], "is_impossible": false}], "context": "On the same day, CDC issued the Order: Implementing Presidential Proclamation on\nSafe Resumption of Global Travel During the COVID-19 Pandemic to implement the President\u2019s direction. \uf209\nOn April 4, 2022, CDC issued an Amended Order to align post arrival public health requirements for excepted noncitizen\nnonimmigrants with current CDC recommendations. The Amended Order also clarifies that parents or guardians do not need\nto complete an attestation on behalf of children under 2 years of age; and formalizes other guidance described in Technical\nInstructions, announced in frequently asked questions, and in the attestation. This amendment is effective as of April 14, 2022\nat 12:01am EDT."}]}, {"title": "af0a51389f19c8e187124525040c30bc", "paragraphs": [{"qas": [{"question": "What do the Proclamation and CDC's Amended Order have no effect on?", "id": "100000000000000000007354", "answers": [{"text": "certain groups of non-citizens", "answer_start": 257}], "is_impossible": false}, {"question": "What are the exceptions for?", "id": "100000000000000000007355", "answers": [{"text": "Presidential Proclamation and Frequently Asked Questions", "answer_start": 337}], "is_impossible": false}, {"question": "Who are not included in the Presidential Proclamations and Frequently Asked Questions?", "id": "100000000000000000007356", "answers": [{"text": "non-citizens", "answer_start": 275}], "is_impossible": false}, {"question": "Which group of non-citizens are excluded?", "id": "100000000000000000007357", "answers": [{"text": "U.S. citizens, U.S. nationals, U.S. lawful permanent residents, immigrants, or, under certain circumstances, air crew members", "answer_start": 57}], "is_impossible": false}, {"question": "What are the exceptions to the Presidential Proclamation and Frequently Asked Questions?", "id": "100000000000000000007358", "answers": [{"text": "more information", "answer_start": 293}], "is_impossible": false}, {"question": "Are you fully vaccinated for Air Travel to the US?", "id": "100000000000000000007359", "answers": [{"text": "Are you Fully Vaccinated", "answer_start": 403}], "is_impossible": false}], "context": "The Proclamation and CDC\u2019s Amended Order do not apply to U.S. citizens, U.S. nationals, U.S. lawful permanent residents,\nimmigrants, or, under certain circumstances, air crew members. Additionally, the Proclamation and CDC\u2019s Amended Order\nhave no effect on certain groups of non-citizens. For more information, including exceptions, see Presidential Proclamation and Frequently Asked Questions below. \uf209\nAre you Fully Vaccinated for Air Travel to the United States?"}]}, {"title": "29e258fc7e95ae008d957d21560b3068", "paragraphs": [{"qas": [{"question": "How long after your first dose of an accepted single-dose vaccine are you considered to be fully vaccinated?", "id": "100000000000000000007360", "answers": [{"text": "2 weeks", "answer_start": 37}], "is_impossible": false}, {"question": "How many days after your second dose of a accepted 2-dose series are you still considered to have been fully vaccinated?", "id": "100000000000000000007361", "answers": [{"text": "2 weeks", "answer_start": 106}], "is_impossible": false}, {"question": "What vaccine is not a placebo?", "id": "100000000000000000007362", "answers": [{"text": "COVID-19", "answer_start": 244}], "is_impossible": false}, {"question": "How long after receiving the COVID-19 vaccine are you considered to have been fully vaccinated?", "id": "100000000000000000007363", "answers": [{"text": "2 weeks", "answer_start": 176}], "is_impossible": false}, {"question": "How many doses of any \u201cmix-and-match\u201d vaccines were administered at least 17 days apart?", "id": "100000000000000000007364", "answers": [{"text": "2", "answer_start": 332}], "is_impossible": false}, {"question": "What is not needed to meet this requirement?", "id": "100000000000000000007365", "answers": [{"text": "A booster dose", "answer_start": 521}], "is_impossible": false}], "context": "You are considered fully vaccinated:\n2 weeks (14 days) after your dose of an accepted single-dose vaccine\n2 weeks (14 days) after your second dose of an accepted 2-dose series\n2 weeks (14 days) after you received the full series of an accepted COVID-19 vaccine (not placebo) in a clinical trial\n2 weeks (14 days) after you received 2 doses of any \u201cmix-and-match\u201d combination of accepted COVID-19 vaccines\nadministered at least 17 days apart*\nIf you don\u2019t meet these requirements, you are NOT considered fully vaccinated. A booster dose is not needed to meet\nthis requirement."}]}, {"title": "a47e2ebfb129f28cfd66f63efe29272c", "paragraphs": [{"qas": [{"question": "What does not meet the definition of a person who has received only one dose of an accepted 2-dose series and has recovered?", "id": "100000000000000000007367", "answers": [{"text": "COVID-19", "answer_start": 181}], "is_impossible": false}, {"question": "Who is NOT considered fully vaccinated for travel to the US?", "id": "100000000000000000007368", "answers": [{"text": "A person who has received only one dose of an accepted 2-dose series and has recovered from COVID-19", "answer_start": 89}], "is_impossible": false}, {"question": "Who has not recommended the use of mix-and-match COVID-19 vaccine primary series?", "id": "100000000000000000007369", "answers": [{"text": "*CDC", "answer_start": 303}], "is_impossible": false}, {"question": "What is increasingly common in many countries outside of the US?", "id": "100000000000000000007370", "answers": [{"text": "mix-and-match COVID-19 vaccine primary series", "answer_start": 339}], "is_impossible": false}, {"question": "What vaccines will CDC accept for travel to the U.S.?", "id": "100000000000000000007371", "answers": [{"text": "COVID-19", "answer_start": 620}], "is_impossible": false}], "context": "10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nA person who has received only one dose of an accepted 2-dose series and has recovered from COVID-19 does not meet\nthis definition, and therefore is NOT considered fully vaccinated for travel to the United States. *CDC has not recommended the use of mix-and-match COVID-19 vaccine primary series. However, such strategies are\nincreasingly common in many countries outside of the United States. Therefore, for the purpose of interpreting\nvaccination records for travel to the United States, CDC will accept combinations of accepted COVID-19 vaccines."}]}, {"title": "84bb06e66df4819a7f2e20f8637b6ea9", "paragraphs": [{"qas": [{"question": "What is a green card holder?", "id": "100000000000000000007373", "answers": [{"text": "U.S. lawful permanent residents", "answer_start": 171}], "is_impossible": false}, {"question": "What does the Presidential Proclamation and CDC's Amended Order not apply to?", "id": "100000000000000000007374", "answers": [{"text": "U.S. citizens, U.S. nationals, or U.S. lawful permanent residents (Green Card holders).", "answer_start": 137}], "is_impossible": false}], "context": "U.S. Citizens, U.S. Nationals, and U.S. Lawful Permanent\nResidents\nThe Presidential Proclamation and CDC\u2019s Amended Order do not apply to U.S. citizens, U.S. nationals, or U.S. lawful\npermanent residents (Green Card holders). For additional information on actions to take before, during, and after international travel, visit International Travel to and\nfrom the United States. Immigrants and Other Non-affected Persons\nThe Presidential Proclamation and CDC\u2019s Amended Order do not apply to immigrants (including Special Immigrant Visa\nholders)."}]}, {"title": "b56f69c69c6f852adbe785d92c0b8203", "paragraphs": [{"qas": [{"question": "What is a non-US citizen who has a visa listed in \"Immigrant Visa Categories\" on the U.S. Department of State's webpage Directory of Visa Categories?", "id": "100000000000000000007375", "answers": [{"text": "immigrant", "answer_start": 3}], "is_impossible": false}, {"question": "What does not include K nonimmigrant visa holders?", "id": "100000000000000000007376", "answers": [{"text": "Immigrant Visa Categories", "answer_start": 63}], "is_impossible": false}], "context": "An immigrant is any non-U.S. citizen who has a visa listed in \u201cImmigrant Visa Categories\u201d on the U.S. Department of\nState\u2019s webpage\u202fDirectory of Visa Categories ; it does not include K nonimmigrant visa holders, who are Covered Individuals\n(see below)."}]}, {"title": "6a7fc181cbce8d7659e9d08f55332565", "paragraphs": [{"qas": [{"question": "What does the Presidential Proclamation and CDC\u2019s Amended Order have no effect on?", "id": "100000000000000000007377", "answers": [{"text": "non-U.S. citizens", "answer_start": 80}], "is_impossible": false}, {"question": "What are Non-U.S. citizens eligible for?", "id": "100000000000000000007378", "answers": [{"text": "asylum", "answer_start": 141}], "is_impossible": false}, {"question": "What is the status of a person with a follow-to-join visa?", "id": "100000000000000000007380", "answers": [{"text": "92 or 93", "answer_start": 492}], "is_impossible": false}], "context": "The Presidential Proclamation and CDC\u2019s Amended Order have no effect on several non-U.S. citizens, including:\nNon-U.S. citizens eligible for asylum;\nNon-U.S. citizens eligible for withholding of removal;\nNon-U.S. citizens eligible for protection under the regulations issued pursuant to the legislation implementing the\nConvention Against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment;\nNon-U.S. citizens admitted to the United States as refugees ;\nPersons\u202fwith\u202fa\u202fvisa 92 or 93 (Follow-to-Join) status; and\nNon-U.S. citizens granted parole into the United States."}]}, {"title": "2eb3718309c0ef4f657ed2b00051df0", "paragraphs": [{"qas": [{"question": "What are some categories of non-U.S. citizens subject to separate COVID-19 vaccination requirements?", "id": "100000000000000000007382", "answers": [{"text": "immigrant visa applicants/holders, refugees, parolees, and asylees", "answer_start": 57}], "is_impossible": false}, {"question": "Where can you find information on before, during and after international travel?", "id": "100000000000000000007385", "answers": [{"text": "International Travel to and from the United States", "answer_start": 448}], "is_impossible": false}], "context": "NOTE: Certain categories of non-U.S. citizens, including immigrant visa applicants/holders, refugees, parolees, and asylees,\nand those seeking to enter the United States by land or sea travel may be subject to separate COVID-19 vaccination\nrequirements. These individuals are advised to consult and become familiar with all applicable U.S. requirements for entry. For additional information on before, during, and after international travel, visit International Travel to and from the United\nStates."}]}, {"title": "74ceacfe73bacc8d6a01b07ddd719b57", "paragraphs": [{"qas": [{"question": "What does the Presidential Proclamation and CDC\u2019s Amended Order not apply to while on official duty status?", "id": "100000000000000000007386", "answers": [{"text": "crew members of airlines or other aircraft operators", "answer_start": 87}], "is_impossible": false}, {"question": "What does the Federal Aviation Administration do in coordination with the CDC?", "id": "100000000000000000007387", "answers": [{"text": "crewmember health", "answer_start": 315}], "is_impossible": false}], "context": "Air Crew Members\nThe Presidential Proclamation and CDC\u2019s Amended Order do not apply to crew members of airlines or other aircraft operators\nwhile on official duty status if such crewmembers and operators adhere to all industry standard protocols for the prevention\nof COVID-19 as set forth in relevant guidance for crewmember health issued by the CDC or by the Federal Aviation\nAdministration in coordination with the CDC. Please see the Technical Instructions for more information."}]}, {"title": "d2e711807b58df5de9e519a86a728f9f", "paragraphs": [{"qas": [{"question": "Who must show proof of being fully vaccinated against COVID-19 before boarding a flight to the United States from a foreign country?", "id": "100000000000000000007390", "answers": [{"text": "Noncitizens", "answer_start": 262}], "is_impossible": false}, {"question": "What are the criteria for an exception under the Proclamation and CDC\u2019s Amended Order?", "id": "100000000000000000007391", "answers": [{"text": "unless you meet", "answer_start": 596}], "is_impossible": false}], "context": "\uf209\n\uf209\nAircraft Operators/ Airlines/ Crew\nFor additional information, resources, and FAQs please visit the following webpages:\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nNoncitizens, Nonimmigrants (Covered Individuals)\nNoncitizens who are nonimmigrants and seeking to enter the United States by air are required to show proof of being fully\nvaccinated against COVID-19 before boarding a flight to the United States from a foreign country. If you are not fully vaccinated against COVID-19, you will NOT be allowed to board a flight to the United States, unless you\nmeet the criteria for an exception under the Proclamation and CDC\u2019s Amended Order."}]}, {"title": "805ac4926fff8147846358d85d1f21b3", "paragraphs": [{"qas": [{"question": "A booster dose is not needed to meet what requirement?", "id": "100000000000000000007392", "answers": [{"text": "this requirement", "answer_start": 37}], "is_impossible": false}], "context": "A booster dose is not needed to meet\nthis requirement."}]}, {"title": "3e65eb2434d859694ea4a805fa445be2", "paragraphs": [{"qas": [{"question": "What are the categories of noncitizen nonimmigrants that meet the criteria for an exception under the Proclamation and CDC\u2019s Amended Order?", "id": "100000000000000000007393", "answers": [{"text": "Persons on diplomatic or official foreign government travel", "answer_start": 135}], "is_impossible": false}, {"question": "Persons on diplomatic or official foreign government travel Who are under 18 years of age Persons with documented medical contraindications to receiving a COVID-19 vaccine Who are participants in certain covid-19 vaccine trials Who are issued a humanitarian or emergency exception?", "id": "100000000000000000007394", "answers": [{"text": "Children", "answer_start": 195}], "is_impossible": false}, {"question": "Who is eligible to receive the COVID-19 vaccine?", "id": "100000000000000000007395", "answers": [{"text": "Children under 18 years of age", "answer_start": 195}], "is_impossible": false}, {"question": "Who is not eligible to get the B-1 (business) or B-2 (tourism) visa?", "id": "100000000000000000007396", "answers": [{"text": "Persons with valid visas", "answer_start": 409}], "is_impossible": false}, {"question": "Who determines if the entry would be in the national interest?", "id": "100000000000000000007399", "answers": [{"text": "Secretary of State, Secretary of Transportation, or Secretary of Homeland Security", "answer_start": 839}], "is_impossible": false}, {"question": "What is the age of the spouse or children of the U.S. Armed Forces?", "id": "100000000000000000007400", "answers": [{"text": "under 18 years of age", "answer_start": 675}], "is_impossible": false}], "context": "Categories of noncitizen nonimmigrants that meet the criteria for an exception under the Proclamation and CDC\u2019s Amended\nOrder include:\nPersons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine\nParticipants in certain COVID-19 vaccine trials\nPersons issued a humanitarian or emergency exception\nPersons with valid visas [excluding B-1 (business) or B-2 (tourism) visas] who are citizens of a foreign country with limited\nCOVID-19 vaccine availability (See list for updates effective June 28, 2022)\nMembers of the U.S. Armed Forces or their spouses or children (under 18 years of age)\nSea crew members traveling with to a C-1 and D nonimmigrant visa\nPersons whose entry would be in the national interest, as determined by the Secretary of State, Secretary of\nTransportation, or Secretary of Homeland Security (or their designees)\nIf you travel by air to the United States under one of these exceptions, you will be required to attest that you are excepted\nfrom the requirement to present Proof of Being Fully Vaccinated Against COVID-19 based on one of the exceptions listed\nabove."}]}, {"title": "a5396fe729b8b948857ab99593fbdcb2", "paragraphs": [{"qas": [{"question": "What is required of you to self-quarantine for a COVID-19 viral test?", "id": "100000000000000000007404", "answers": [{"text": "documentation of having recovered from COVID-19 in the past 90 days", "answer_start": 194}], "is_impossible": false}, {"question": "How long will you self-quarantine if the result of the post-arrival viral test is negative?", "id": "100000000000000000007405", "answers": [{"text": "5 days", "answer_start": 302}], "is_impossible": false}, {"question": "What will self-isolate if the result of the post-arrival test is positive or if you develop COVID-19 symptoms?", "id": "100000000000000000007406", "answers": [{"text": "3", "answer_start": 467}], "is_impossible": false}], "context": "Based on the category of the exception, you may further be required to attest that:\n1. You will be tested with a COVID-19 viral test 3\u20135 days after arrival in the United States, unless you have documentation of\nhaving recovered from COVID-19 in the past 90 days;\n2. You will self-quarantine for a full 5 days, even if the test result to the post-arrival viral test is negative, unless you have\ndocumentation of having recovered from COVID-19 in the past 90 days; and\n3. You will self-isolate if the result of the post-arrival test is positive or if you develop COVID-19 symptoms."}]}, {"title": "175b5057f58acfffdf3ab1fda501738b", "paragraphs": [{"qas": [{"question": "How long do you have to be vaccinated against COVID-19?", "id": "100000000000000000007407", "answers": [{"text": "within 60 days", "answer_start": 270}], "is_impossible": false}, {"question": "How long can you stay in the United States?", "id": "100000000000000000007408", "answers": [{"text": "60 days", "answer_start": 103}], "is_impossible": false}, {"question": "What is required of you if you intend to stay longer than 60 days?", "id": "100000000000000000007409", "answers": [{"text": "to attest that You agree to be vaccinated against COVID-19", "answer_start": 144}], "is_impossible": false}, {"question": "Who should attest on behalf of a passenger under 18?", "id": "100000000000000000007410", "answers": [{"text": "A parent or other authorized person", "answer_start": 466}], "is_impossible": false}, {"question": "How many days after arriving in the United States should a person be vaccinated against COVID-19?", "id": "100000000000000000007411", "answers": [{"text": "60", "answer_start": 277}], "is_impossible": false}, {"question": "Who should attest on behalf of a passenger under 18 years old?", "id": "100000000000000000007412", "answers": [{"text": "A parent or other authorized person", "answer_start": 466}], "is_impossible": false}], "context": "Depending on the category of the exception, if you intend to stay in the United States for longer than 60 days you may\nadditionally be required to attest that\nYou agree to be vaccinated against COVID-19; and\nYou have arranged to become fully vaccinated against COVID-19 within 60 days of arriving in the United States, or as\nsoon thereafter as is medically appropriate. For more information about what each exception category has to attest to, see the attestation . A parent or other authorized person should attest on behalf of a passenger under 18 years old."}]}, {"title": "4f2da0fce33a0bd0445178d4355db283", "paragraphs": [{"qas": [{"question": "Who may attest on behalf of a passenger who is unable to sign their own attestation?", "id": "100000000000000000007413", "answers": [{"text": "An authorized person", "answer_start": 0}], "is_impossible": false}, {"question": "What age does not need to complete an attestation?", "id": "100000000000000000007415", "answers": [{"text": "Children under 2 years of age", "answer_start": 181}], "is_impossible": false}], "context": "An authorized person may\nattest on behalf of any passenger who is unable sign their own attestation (e.g., because they are too young, or because of\nphysical or mental impairment). Children under 2 years of age do not need to complete an attestation."}]}, {"title": "857585b4200a8cd4c0cfc48ef54579a0", "paragraphs": [{"qas": [{"question": "What is required by US federal law?", "id": "100000000000000000007417", "answers": [{"text": "all airlines or other aircraft operators will provide and collect the passenger attestation on behalf of the U S Government", "answer_start": 42}], "is_impossible": false}, {"question": "What is required for Non-U.S. citizen Air Passengers who Are Nonimmigrants Traveling to the United States?", "id": "100000000000000000007418", "answers": [{"text": "Proof of COVID-19 Vaccination", "answer_start": 401}], "is_impossible": false}, {"question": "What is CDC's Associated Amended Order Aircraft Operators/Airlines/Crew FAQs?", "id": "100000000000000000007419", "answers": [{"text": "Requirement for Proof of COVID-19 Vaccination for Non-U.S. citizen Air Passengers who Are Nonimmigrants Traveling to the United States", "answer_start": 385}], "is_impossible": false}], "context": "As required by United\nStates federal law, all airlines or other aircraft operators will provide and collect the passenger attestation on behalf of the\nU S Government\np g p g\nTechnical Instructions for Implementing Presidential Proclamation Advancing Safe Resumption of Global Travel During\nthe COVID-19 Pandemic and CDC\u2019s Associated Amended Order\nAircraft Operators/Airlines/Crew FAQs Requirement for Proof of COVID-19 Vaccination for Non-U.S. citizen Air\nPassengers who Are Nonimmigrants Traveling to the United States\n\uf20c\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nU.S. Government."}]}, {"title": "cf980971ea6ed383f2fc788e35a7467", "paragraphs": [{"qas": [{"question": "What should you do if you are a noncitizen nonimmigrant and are fully vaccinated?", "id": "100000000000000000007420", "answers": [{"text": "make sure your vaccine and proof of vaccination are acceptable to board a flight to the United States", "answer_start": 63}], "is_impossible": false}], "context": "If you are a noncitizen nonimmigrant and are fully vaccinated, make sure your vaccine and proof of vaccination are\nacceptable to board a flight to the United States. For additional information on recommendations and requirements before and during travel to the United States and after\narriving in the United States, visit International Travel to and from the United States. \uf1c8\nGet Started\nTravel Assessment\nA tool to help you know the requirements to board a flight to the United States."}]}, {"title": "3210bccadb9f998d228aa6dd9cd1d34d", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that has confirmed Efficacy?", "id": "100000000000000000007424", "answers": [{"text": "Clinical Trial Vaccines", "answer_start": 181}], "is_impossible": false}, {"question": "Which company approves Comirnaty?", "id": "100000000000000000007425", "answers": [{"text": "Pfizer", "answer_start": 373}], "is_impossible": false}, {"question": "What is a QR code for a COVID-19 vaccination certificate?", "id": "100000000000000000007427", "answers": [{"text": "Verifiable records", "answer_start": 595}], "is_impossible": false}, {"question": "What is an example of a non-verifiable paper record?", "id": "100000000000000000007428", "answers": [{"text": "Printout of COVID-19 vaccination record", "answer_start": 854}], "is_impossible": false}, {"question": "What is a mobile phone application without QR code 1?", "id": "100000000000000000007430", "answers": [{"text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate", "answer_start": 732}], "is_impossible": false}], "context": "Accepted COVID-19 Vaccines\nVaccines Approved or Authorized by\nthe U.S. Food and Drug\nAdministration\nVaccines Listed for Emergency Use\n(EUL) by the World Health\nOrganization\nCertain Clinical Trial Vaccines\nwhich Have Confirmed\nEfficacy\nSingle\ndose\nJanssen/J&J Janssen/J&J\nConvidecia (CanSinoBIO)\ndose\nseries\nComirnaty (Pfizer-BioNTech)\nSpikevax (Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech)\nSpikevax (Moderna)\nVaxzevria (AstraZeneca)\nCovaxin\nCovishield\nBIBP/Sinopharm\nCoronaVac (Sinovac)\nNuvaxovid (Novavax)\nCovovax\nMedicago\n\uf209\nAcceptable Proof of COVID-19 Vaccination\nDocumentation\nType Examples\nVerifiable\nrecords (digital\nor paper)\nVaccination certificate with QR code , digital pass via Smartphone application with QR code (e.g.,\nUnited Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)\nNon-verifiable\npaper records\nPrintout of COVID-19 vaccination record or a COVID-19 vaccination certificate issued at national or\nsubnational level or by an authorized vaccine provider (e.g., the CDC vaccination card)\nNon-verifiable\ndigital records\nDigital photos of vaccination card or record, downloaded vaccine record or vaccination certificate from\nofficial source (e.g., public health agency, government agency, or other authorized vaccine provider), or\na mobile phone application without QR code\n1."}]}, {"title": "b8bcb4e94d24f4632acb4d5f93c2e75a", "paragraphs": [{"qas": [{"question": "What does the QR code in a verifiable vaccination record link to?", "id": "100000000000000000007431", "answers": [{"text": "information confirming the credential was generated from an immunization record in an official database", "answer_start": 56}], "is_impossible": false}], "context": "The QR code in a verifiable vaccination record links to information confirming the credential was generated from an\nimmunization record in an official database and is protected from tampering."}]}, {"title": "f2d091e53e41f317bf9d8a164e22c4d7", "paragraphs": [{"qas": [{"question": "What must all forms of proof of COVID-19 vaccination have?", "id": "100000000000000000007432", "answers": [{"text": "Personal identifiers", "answer_start": 142}], "is_impossible": false}, {"question": "What must have been given a full 14 days before the day of vaccination?", "id": "100000000000000000007435", "answers": [{"text": "Your last dose", "answer_start": 550}], "is_impossible": false}], "context": "10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nAll forms of proof of COVID-19 vaccination must have\nPersonal identifiers (full name plus at least one other identifier such as date of birth or passport number) that match the\npersonal identifiers on the passenger\u2019s passport or other travel documents\nName of official source issuing the record (e.g., public health agency, government agency, or other authorized vaccine\nprovider)\nVaccine manufacturer and date(s) of vaccination\nHow the 14 days are calculated:\nYour last dose must have been given a full 14 days before the day you board your flight to the United States."}]}, {"title": "b6886050940f5b41a6fa6c896bd91b76", "paragraphs": [{"qas": [{"question": "When is the 14th day after the vaccination series was completed?", "id": "100000000000000000007438", "answers": [{"text": "October 15th", "answer_start": 161}], "is_impossible": false}, {"question": "What is the first day that you meet the 14 day requirement?", "id": "100000000000000000007439", "answers": [{"text": "October 15th", "answer_start": 161}], "is_impossible": false}, {"question": "What are you looking for?", "id": "100000000000000000007440", "answers": [{"text": "Frequently Asked Questions", "answer_start": 235}], "is_impossible": false}, {"question": "Who is considered a noncitizen nonimmigrant?", "id": "100000000000000000007442", "answers": [{"text": "anybody who is considered a noncitizen nonimmigrant and is traveling to the United States by air", "answer_start": 456}], "is_impossible": false}], "context": "You are considered fully vaccinated on the 14th day after the vaccination series was completed. For example, if your last\ndose was any time on October 1st, then October 15th would be the first day that you meet the 14-day requirement. Frequently Asked Questions\nWhat are you looking for? Enter a word or phrase to locate questions and answers that match. Overview\nThe requirements outlined in the Presidential Proclamation and CDC\u2019s Amended Order apply to anybody who is\nconsidered a noncitizen nonimmigrant and is traveling to the United States by air."}]}, {"title": "51d5b52dcc5c5bccb0efab1526b4f3a2", "paragraphs": [{"qas": [{"question": "What are covered individuals referred to as in the Proclamation and the Amended Order?", "id": "100000000000000000007443", "answers": [{"text": "Covered Individuals", "answer_start": 75}], "is_impossible": false}, {"question": "What are non-U.S. citizens seeking to enter the United States by air travel with a nonimmigrant visa listed in the Directory of Visa Categories?", "id": "100000000000000000007444", "answers": [{"text": "K nonimmigrant visa holders", "answer_start": 346}], "is_impossible": false}, {"question": "What does ESTA stand for?", "id": "100000000000000000007445", "answers": [{"text": "Electronic System for Travel Authorization", "answer_start": 469}], "is_impossible": false}, {"question": "What is the name of the website that lists nonimmigrant visa holders?", "id": "100000000000000000007446", "answers": [{"text": "Directory of Visa Categories", "answer_start": 304}], "is_impossible": false}, {"question": "What is the Guam- Commonwealth of the Northern Mariana Islands Visa Waiver Program?", "id": "100000000000000000007447", "answers": [{"text": "Any non-U.S. citizen seeking to enter the United States by air travel as a nonimmigrant", "answer_start": 556}], "is_impossible": false}, {"question": "Who is exempt from the general requirement to present a nonimmigrant visa for entering the United States by air travel?", "id": "100000000000000000007448", "answers": [{"text": "Any non-U.S. citizen", "answer_start": 730}], "is_impossible": false}, {"question": "What is the general requirement to present a nonimmigrant visa for admission?", "id": "100000000000000000007449", "answers": [{"text": "exempt", "answer_start": 850}], "is_impossible": false}], "context": "These people are referred to in the\nProclamation and the Amended Order as \u201cCovered Individuals.\u201d\nCovered Individuals include:\nAny non-U.S. citizen seeking to enter the United States by air travel with a nonimmigrant visa listed in \u201cNonimmigrant\nVisa Categories\u201d\u202fon the U.S. Department of State\u2019s webpage Directory of Visa Categories , as well as K\nnonimmigrant visa holders;\nAny non-U.S. citizen seeking to enter the United States by air travel who has been granted\u202fan\u202fElectronic System for\nTravel Authorization\u202f(ESTA)\u202fas\u202fpart of the\u202fVisa Waiver Program ;\nAny non-U.S. citizen seeking to enter the United States by air travel as a nonimmigrant under the Guam-\nCommonwealth of the Northern Mariana Islands Visa Waiver Program; and\nAny non-U.S. citizen otherwise seeking to enter the United States by air travel as a nonimmigrant in any other category\nexempt from the general requirement to present a nonimmigrant visa for admission (e.g., certain Canadian nationals)."}]}, {"title": "8f325a2b66bc9ebec08890bbf50961ba", "paragraphs": [{"qas": [{"question": "What are not Covered Individuals?", "id": "100000000000000000007451", "answers": [{"text": "U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants", "answer_start": 137}], "is_impossible": false}, {"question": "What does the Amended Order Implementing the Presidential Proclamation not apply to?", "id": "100000000000000000007452", "answers": [{"text": "U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants, are not Covered Individuals", "answer_start": 137}], "is_impossible": false}, {"question": "Who is required to provide proof of COVID-19 Vaccination?", "id": "100000000000000000007454", "answers": [{"text": "Air Passengers", "answer_start": 607}], "is_impossible": false}], "context": "Who must meet the requirements in the Presidential Proclamation and CDC\u2019s Amended Order to\nboard a plane to the United States? \uf1aa\n\uf209\n\uf209\nNo, U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants, are not Covered Individuals; therefore\nthe Presidential Proclamation and CDC\u2019s Amended Order Implementing the Presidential Proclamation do not apply. See\nImmigrants and Other Non affected Persons\nDo the Presidential Proclamation and CDC\u2019s Amended Order apply to U.S. citizens, lawful\npermanent residents, or immigrants? \uf1aa\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nImmigrants and Other Non-affected Persons."}]}, {"title": "1c2c07e041a24410f289b1b8ae05c943", "paragraphs": [{"qas": [{"question": "What does the Presidential Proclamation and CDC's Amended Order require?", "id": "100000000000000000007456", "answers": [{"text": "If you are a noncitizen who is a nonimmigrant and can show acceptable proof of vaccination with an accepted COVID-19 vaccine, and meet the definition of fully vaccinated", "answer_start": 0}], "is_impossible": false}, {"question": "What is the term for nonimmigrants allowed to board a flight to the United States if they can show proof of being fully vaccinated against COVID-19?", "id": "100000000000000000007457", "answers": [{"text": "Covered Individuals", "answer_start": 290}], "is_impossible": false}, {"question": "What does CDC\u2019s Order requiring proof of vaccination not apply to?", "id": "100000000000000000007458", "answers": [{"text": "Ukrainians", "answer_start": 497}], "is_impossible": false}], "context": "If you are a noncitizen who is a nonimmigrant and can show acceptable proof of vaccination with an accepted COVID-19\nvaccine, and meet the definition of fully vaccinated, you meet the requirements under the Presidential Proclamation and\nCDC\u2019s Amended Order. Are noncitizens, nonimmigrants (Covered Individuals) allowed to board a flight to the United\nStates if they can show proof of being fully vaccinated against COVID-19? \uf1aa\nCDC\u2019s Order requiring proof of COVID-19 vaccination does not apply to Ukrainians who are approved as part of the\nUniting for Ukraine program ."}]}, {"title": "1adbbd88be5b4ac1242e23df26054a13", "paragraphs": [{"qas": [{"question": "Who approved Ukrainians under the Uniting for Ukraine program?", "id": "100000000000000000007459", "answers": [{"text": "CDC", "answer_start": 6}], "is_impossible": false}, {"question": "Who has identified health requirements as a component of the program for Ukraine?", "id": "100000000000000000007460", "answers": [{"text": "Department of Homeland Security", "answer_start": 112}], "is_impossible": false}, {"question": "How many doses of COVID-19 vaccine do Ukrainians need?", "id": "100000000000000000007461", "answers": [{"text": "one", "answer_start": 269}], "is_impossible": false}, {"question": "What is the Ukraine program?", "id": "100000000000000000007464", "answers": [{"text": "Uniting for Ukraine program", "answer_start": 74}], "is_impossible": false}, {"question": "Where can you find information about Ukraine?", "id": "100000000000000000007465", "answers": [{"text": "DHS\u2019 website for the Uniting for Ukraine program . For information not found on DHS\u2019 website, please contact the USCIS Contact Center", "answer_start": 487}], "is_impossible": false}], "context": "While CDC\u2019s Order does not apply to Ukrainians who are approved under the Uniting for Ukraine program, the U.S.\nDepartment of Homeland Security (DHS) has identified health requirements as a component of the program, which\ninclude receiving measles, polio, and at least one dose of COVID-19 vaccine. For more information about the health\nrequirements of the program, how to apply to the program, and the processes to receive travel authorization to come to\nthe United States please visit DHS\u2019 website for the Uniting for Ukraine program . For information not found on DHS\u2019\nwebsite, please contact the USCIS Contact Center ."}]}, {"title": "b8de7dc869c24f8d03e7ac8837a81f27", "paragraphs": [{"qas": [{"question": "What is required of Ukrainians who are approved under the Uniting for Ukraine program?", "id": "100000000000000000007466", "answers": [{"text": "proof of COVID-19 vaccination", "answer_start": 27}], "is_impossible": false}, {"question": "What applies to any noncitizen nonimmigrant on a flight to the US from a foreign country?", "id": "100000000000000000007467", "answers": [{"text": "the Amended Order", "answer_start": 146}], "is_impossible": false}, {"question": "What means to separate and restrict the movement of people who were exposed?", "id": "100000000000000000007468", "answers": [{"text": "Quarantine", "answer_start": 502}], "is_impossible": false}, {"question": "What is the final destination or a connection to another country?", "id": "100000000000000000007469", "answers": [{"text": "the United States", "answer_start": 282}], "is_impossible": false}], "context": "Does CDC\u2019s Order requiring proof of COVID-19 vaccination apply to Ukrainians who are approved\nunder the Uniting for Ukraine program? \uf1aa\n\uf209\n\uf209\n\uf209\nYes, the Amended Order applies to any noncitizen nonimmigrant on a flight to the United States from a foreign country,\nregardless of whether the United States is the final destination or a connection to another country. If I am a noncitizen nonimmigrant connecting through the U.S. to another country, do I still have to\nshow proof of being fully vaccinated? \uf1aa\nQuarantine means to separate and restrict the movement of people who were exposed to a contagious disease to see if\nthey become sick."}]}, {"title": "230080a5b829e74d07a3744e320ffe4d", "paragraphs": [{"qas": [{"question": "What does the attestation require of a child after arriving in the United States?", "id": "100000000000000000007474", "answers": [{"text": "a COVID-19 viral test", "answer_start": 340}], "is_impossible": false}, {"question": "How many days after arrival in the U.S. does the child have to get a COVID-19 viral test?", "id": "100000000000000000007475", "answers": [{"text": "3-5", "answer_start": 362}], "is_impossible": false}], "context": "Isolation means to separate sick people with a contagious disease from people who are not sick. What is the difference between quarantine and isolation? \uf1aa\nChildren ages 2 through 17 years (minors) who are noncitizen nonimmigrants do not have to quarantine after arrival in\nthe United States; however, the attestation requires that they get a COVID-19 viral test 3-5 days after arrival. If a child, like\nany other traveler, tests positive for COVID-19 or develops COVID-19 symptoms, they should isolate for a full 5 calendar\ndays."}]}, {"title": "2a8e96be649f7c0aaae7c2d7dcbbd337", "paragraphs": [{"qas": [{"question": "What should children wear during their 5-day quarantine period?", "id": "100000000000000000007477", "answers": [{"text": "a well-fitting mask", "answer_start": 31}], "is_impossible": false}, {"question": "What should noncitizen, nonimmigrant children ages 2-17 wear when they arrive in the United States?", "id": "100000000000000000007478", "answers": [{"text": "a well-fitting mask", "answer_start": 31}], "is_impossible": false}, {"question": "How long is the quarantine in the US?", "id": "100000000000000000007479", "answers": [{"text": "5-day", "answer_start": 105}], "is_impossible": false}, {"question": "What is required to board a flight to the United States if you are not a U.S. citizen?", "id": "100000000000000000007480", "answers": [{"text": "show proof of being fully vaccinated with an accepted COVID-19 vaccine", "answer_start": 410}], "is_impossible": false}], "context": "They should also properly wear a well-fitting mask any time they must be around others during their full 5-day\nisolation period and for an additional 5 days after ending isolation. Does the attestation require noncitizen, nonimmigrant children ages 2-17 years old to quarantine\nfor 5 days when they arrive in the United States? \uf1aa\nNo, if you are not a U.S. citizen and are not an immigrant, you are required to show proof of being fully vaccinated with\nan accepted COVID-19 vaccine to board a flight to the United States."}]}, {"title": "4eabf671697f17c9387256a6a3a2ac7f", "paragraphs": [{"qas": [{"question": "If you do not meet the requirements to be fully vaccinated, you won't be able to board your flight to the United States unless you meet criteria for one of the exceptions.", "id": "100000000000000000007481", "answers": [{"text": "10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC of the exceptions.", "answer_start": 372}], "is_impossible": false}, {"question": "If you are not a U.S. citizen or lawful permanent resident, your child is what?", "id": "100000000000000000007482", "answers": [{"text": "U.S. citizen", "answer_start": 263}], "is_impossible": false}, {"question": "What is a requirement for proof of COVID-19 Vaccination for Air Passengers?", "id": "100000000000000000007483", "answers": [{"text": "CDC", "answer_start": 458}], "is_impossible": false}], "context": "If you do not meet the requirements to be\nconsidered fully vaccinated, you will not be able to board your flight to the United States, unless you meet criteria for one\nof the exceptions\nI am not a U.S. citizen or lawful permanent resident; however, my child is a U.S. citizen. Will I be\nable to board a flight to the United States based on my child\u2019s citizenship status? \uf1aa\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nof the exceptions."}]}, {"title": "267caadd3d1d2eb27887457aa202c9cb", "paragraphs": [{"qas": [{"question": "What do the requirements of the Presidential Proclamation and CDC\u2019s Amended Order apply to?", "id": "100000000000000000007484", "answers": [{"text": "air travel into the United States", "answer_start": 87}], "is_impossible": false}, {"question": "Where can you find information about COVID-19 requirements for land travel and ferry terminals?", "id": "100000000000000000007485", "answers": [{"text": "U.S. Department of Homeland Security\u2019s Fact Sheet: Guidance for Travelers to Enter the U.S. at Land Ports of Entry and Ferry Terminals", "answer_start": 212}], "is_impossible": false}, {"question": "What are the requirements of this Amended Order applicable to?", "id": "100000000000000000007486", "answers": [{"text": "land border crossings", "answer_start": 399}], "is_impossible": false}, {"question": "What are noncitizen nonimmigrant air passengers required to provide?", "id": "100000000000000000007487", "answers": [{"text": "proof of COVID-19 vaccination", "answer_start": 609}], "is_impossible": false}], "context": "No, the requirements of the Presidential Proclamation and CDC\u2019s Amended Order apply to air travel into the United\nStates For information about COVID-19 requirements for land travel and ferry terminals, visit the U.S. Department of\nHomeland Security\u2019s Fact Sheet: Guidance for Travelers to Enter the U.S. at Land Ports of Entry and Ferry Terminals. Do the requirements of this Amended Order apply to land border crossings or to persons arriving\nat seaports? \uf1aa\n\uf209\nYes, at this time all noncitizen nonimmigrant air passengers traveling to the United States, regardless of antibody status,\nare required to provide proof of COVID-19 vaccination."}]}, {"title": "ccdae1b9f56f267ab89c472e986d6c03", "paragraphs": [{"qas": [{"question": "What if I have tested positive for COVID-19 antibodies?", "id": "100000000000000000007489", "answers": [{"text": "A booster dose is not needed", "answer_start": 332}], "is_impossible": false}, {"question": "What does CDC\u2019s Amended Order only require that nonimmigrants are fully vaccinated with?", "id": "100000000000000000007490", "answers": [{"text": "the primary series of an accepted COVID-19 vaccine", "answer_start": 241}], "is_impossible": false}, {"question": "What does CDC\u2019s Amended Order require noncitizen nonimmigrants to be up to date with?", "id": "100000000000000000007492", "answers": [{"text": "COVID- 19 vaccines", "answer_start": 473}], "is_impossible": false}, {"question": "What is a booster dose when eligible to board a flight to the United States?", "id": "100000000000000000007493", "answers": [{"text": "COVID- 19", "answer_start": 473}], "is_impossible": false}], "context": "What if I have tested positive for COVID-19 antibodies or have recently recovered from COVID-19? Do I still need proof of vaccination? \uf1aa\nAt this time, CDC\u2019s Amended Order only requires that noncitizen nonimmigrants are fully vaccinated with the primary\nseries of an accepted COVID-19 vaccine to board a flight to the United States. A booster dose is not needed to meet this\nrequirement. Does CDC\u2019s Amended Order require noncitizen nonimmigrants to be up to date with their COVID-\n19 vaccines, which includes a booster dose when eligible, to board a flight to the United States?"}]}, {"title": "83f8cffca7db082b2f42b1731ab3bb64", "paragraphs": [{"qas": [{"question": "Who recommends that people stay up to date on their COVID-19 vaccines by getting booster shots when eligible?", "id": "100000000000000000007494", "answers": [{"text": "CDC", "answer_start": 2}], "is_impossible": false}, {"question": "What is keeping the requirement to only have to show proof of being fully vaccinated with a primary series of an accepted vaccine to board a plane?", "id": "100000000000000000007495", "answers": [{"text": "CDC\u2019s Amended Order", "answer_start": 121}], "is_impossible": false}, {"question": "What vaccine is accepted to board a flight to the U.S.?", "id": "100000000000000000007496", "answers": [{"text": "COVID-19 vaccines by getting booster shots when eligible. However, CDC\u2019s Amended Order is keeping the requirement to only have to show proof of being fully vaccinated with a primary series of an accepted COVID-19", "answer_start": 54}], "is_impossible": false}, {"question": "What is widely available for those eligible in the United States?", "id": "100000000000000000007497", "answers": [{"text": "booster doses", "answer_start": 334}], "is_impossible": false}, {"question": "Other countries do not offer booster doses because of what?", "id": "100000000000000000007499", "answers": [{"text": "limits on available vaccines", "answer_start": 550}], "is_impossible": false}, {"question": "Other countries don't offer what because of limitations on available vaccines?", "id": "100000000000000000007500", "answers": [{"text": "booster doses", "answer_start": 525}], "is_impossible": false}], "context": "\uf1aa\nCDC recommends that people stay up to date on their COVID-19 vaccines by getting booster shots when eligible. However, CDC\u2019s Amended Order is keeping the requirement to only have to show proof of being fully vaccinated with a\nprimary series of an accepted COVID-19 vaccine at this time to board a flight to the United States. While booster doses for COVID-19 vaccines approved or authorized by the Food and Drug Administration are widely\navailable for those eligible in the United States, many other countries do not offer booster doses because of limits on\navailable vaccines."}]}, {"title": "ae19ed671b5da9a416e7134c898fdfa9", "paragraphs": [{"qas": [{"question": "What is the only requirement for boarding a flight to the United States as a noncitizen nonimmigrant?", "id": "100000000000000000007501", "answers": [{"text": "being fully vaccinated", "answer_start": 99}], "is_impossible": false}, {"question": "What is required proof of being fully vaccinated but not up to date on boosters?", "id": "100000000000000000007502", "answers": [{"text": "Amended Order", "answer_start": 203}], "is_impossible": false}, {"question": "Who is considered fully vaccinated for the purposes of traveling to the United States 2 weeks after a dose of an accepted single-dose vaccine?", "id": "100000000000000000007503", "answers": [{"text": "People", "answer_start": 291}], "is_impossible": false}, {"question": "How long after the second dose of a accepted 2-dose vaccine series are people considered fully vaccined?", "id": "100000000000000000007504", "answers": [{"text": "2 weeks", "answer_start": 450}], "is_impossible": false}], "context": "Therefore, for the purpose of boarding a flight to the United States as a noncitizen nonimmigrant,\nbeing fully vaccinated will remain the only COVID-19 vaccination requirement at this time. Why does the Amended Order require proof of being fully vaccinated but not up to date on\nboosters? \uf1aa\nPeople are considered fully vaccinated for the purposes of traveling to the United States 2 weeks (14 days) after a dose of\nan accepted single-dose vaccine or 2 weeks (14 days) after the second dose of an accepted 2-dose vaccine series,\nregardless of prior COVID-19 disease history."}]}, {"title": "1747d462d4ec959f32128457bd3d086e", "paragraphs": [{"qas": [{"question": "What is considered to be fully vaccinated if you have received both doses of an accepted 2-dose vaccine series?", "id": "100000000000000000007505", "answers": [{"text": "regardless of how long it has been between doses", "answer_start": 69}], "is_impossible": false}, {"question": "What would be considered fully vaccinated under CDC's Amended Order?", "id": "100000000000000000007508", "answers": [{"text": "If you have received both doses of an accepted 2-dose vaccine series", "answer_start": 0}], "is_impossible": false}, {"question": "How many total doses of an accepted vaccine would you be considered to have received?", "id": "100000000000000000007509", "answers": [{"text": "two", "answer_start": 368}], "is_impossible": false}, {"question": "The second dose must be one of the accepted vaccines for you to be considered what?", "id": "100000000000000000007511", "answers": [{"text": "fully vaccinated", "answer_start": 529}], "is_impossible": false}, {"question": "What is one of the accepted vaccines for you to be considered fully vaccinated?", "id": "100000000000000000007512", "answers": [{"text": "2-dose vaccine series", "answer_start": 47}], "is_impossible": false}], "context": "If you have received both doses of an accepted 2-dose vaccine series,\nregardless of how long it has been between doses, you are considered fully vaccinated. This means if you received a\nsingle dose of an accepted 2-dose series and then a booster dose of an accepted vaccine, you would be considered fully\nvaccinated under CDC\u2019s Amended Order because you have received two total doses. The second dose does not have to\nbe the same vaccine as the first, but both doses must be one of the accepted vaccines for you to be considered fully\nvaccinated."}]}, {"title": "348c3837a80338dec87c071244021c1c", "paragraphs": [{"qas": [{"question": "What is the reason I am considered fully vaccinated in my country but not under CDC's Amended Order?", "id": "100000000000000000007514", "answers": [{"text": "I have recovered from COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "What agency approves emergency use?", "id": "100000000000000000007517", "answers": [{"text": "WHO", "answer_start": 651}], "is_impossible": false}, {"question": "What agency lists emergency use for use by WHO?", "id": "100000000000000000007518", "answers": [{"text": "Food and Drug Administration", "answer_start": 591}], "is_impossible": false}], "context": "I have recovered from COVID-19 and have received one dose of an accepted COVID-19 vaccine\ndose, and therefore am considered fully vaccinated in my country, but not under CDC\u2019s Amended\nOrder. Would I be considered fully vaccinated under CDC\u2019s Amended Order if I got a booster dose\nof an accepted COVID-19 vaccine? \uf1aa\nAre different formulations of vaccines considered acceptable proof of vaccination? \uf1aa\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nYes, different formulations of COVID-19 vaccines authorized for emergency use or approved by the U.S. Food and Drug\nAdministration\u202for listed for emergency use by WHO are accepted."}]}, {"title": "d29255e6eea236d531fc2465df471bdf", "paragraphs": [{"qas": [{"question": "What is one example of a Pfizer-BioNTech COVID-19 vaccine?", "id": "100000000000000000007519", "answers": [{"text": "COMIRNATY,\u202fTozinameran", "answer_start": 59}], "is_impossible": false}, {"question": "What are some examples of AstraZeneca-Oxford Covid-19 vaccines?", "id": "100000000000000000007520", "answers": [{"text": "Covishield,\u202fVaxzevria", "answer_start": 126}], "is_impossible": false}, {"question": "Airlines and other aircraft operators must be able to confirm proof of what?", "id": "100000000000000000007521", "answers": [{"text": "vaccination", "answer_start": 346}], "is_impossible": false}, {"question": "What should you do if your documents are in a language other than English?", "id": "100000000000000000007523", "answers": [{"text": "check with your airline or aircraft operator before travel", "answer_start": 534}], "is_impossible": false}], "context": "Examples include:\nPfizer-BioNTech COVID-19 vaccines (e.g., COMIRNATY,\u202fTozinameran)\nAstraZeneca-Oxford COVID-19 vaccines (e.g.,\u202fCovishield,\u202fVaxzevria)\nModerna\u202fCOVID-19 vaccine (e.g., Takeda,\u202fSpikevax)\nBharat Biotech International COVID-19 Vaccines (e.g., BBV152, COVAXIN)\np p\nAirlines and other aircraft operators must be able to confirm proof of vaccination and review other required information\nand should determine when translation is necessary for these purposes. If your documents are in a language other than\nEnglish, you should check with your airline or aircraft operator before travel. Does my proof of vaccination need to be in English?"}]}, {"title": "8471b1885556c9e97f4dbe76d98e5bb4", "paragraphs": [{"qas": [{"question": "What are the categories of noncitizen, nonimmigrants that meet the criteria for an exception under the proclamation and CDC\u2019s Amended Order?", "id": "100000000000000000007524", "answers": [{"text": "Persons on diplomatic or official foreign government travel", "answer_start": 149}], "is_impossible": false}, {"question": "What age are children under 18 years of age who have documented medical contraindications to receiving a COVID-19 vaccine?", "id": "100000000000000000007525", "answers": [{"text": "Members of the U.S. Armed Forces", "answer_start": 621}], "is_impossible": false}, {"question": "Who are persons issued a humanitarian or emergency exception?", "id": "100000000000000000007526", "answers": [{"text": "Persons with valid visas [excluding B-1 (business) or B-2 (tourism) visas] who are citizens of a foreign country with limited COVID-19 vaccine availability", "answer_start": 423}], "is_impossible": false}, {"question": "Who is eligible to receive the COVID-19 vaccine?", "id": "100000000000000000007527", "answers": [{"text": "Members of the U.S. Armed Forces", "answer_start": 621}], "is_impossible": false}, {"question": "When is the list of eligible people in the U.S. Armed Forces effective?", "id": "100000000000000000007529", "answers": [{"text": "April 14, 2022", "answer_start": 605}], "is_impossible": false}, {"question": "Who determines if the entry would be in the national interest?", "id": "100000000000000000007530", "answers": [{"text": "Secretary of State, Secretary of Transportation, or Secretary of Homeland Security", "answer_start": 852}], "is_impossible": false}, {"question": "What is the age of the spouse or children of the U.S. Armed Forces?", "id": "100000000000000000007531", "answers": [{"text": "under 18 years of age", "answer_start": 684}], "is_impossible": false}, {"question": "Who must show proof of being fully vaccinated before boarding a flight to the United States?", "id": "100000000000000000007532", "answers": [{"text": "If you are a noncitizen, nonimmigrant", "answer_start": 956}], "is_impossible": false}], "context": "\uf1aa\nExceptions\nCategories of noncitizen, nonimmigrants that meet the criteria for an exception under the proclamation and CDC\u2019s\nAmended Order include:\nPersons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine\nParticipants in certain COVID-19 vaccine trials\nPersons issued a humanitarian or emergency exception\nPersons with valid visas [excluding B-1 (business) or B-2 (tourism) visas] who are citizens of a foreign country with\nlimited COVID-19 vaccine availability (See list effective as of April 14, 2022)\nMembers of the U.S. Armed Forces or their spouses or children (under 18 years of age)\nSea crew members traveling pursuant to a C-1 and D nonimmigrant visa\nPersons whose entry would be in the national interest, as determined by the Secretary of State, Secretary of\nTransportation, or Secretary of Homeland Security (or their designees)\nIf you are a noncitizen, nonimmigrant who does not fall under any of these exceptions, you must show proof of being\nfully vaccinated before boarding a flight to the United States."}]}, {"title": "ad37c4df832bd4084335abdd034259fd", "paragraphs": [{"qas": [{"question": "Why are there no exceptions under the Presidential Proclamation and CDC\u2019s Amended Order?", "id": "100000000000000000007533", "answers": [{"text": "religious reasons or other moral convictions", "answer_start": 184}], "is_impossible": false}, {"question": "What is the exception to the proof of vaccination requirement?", "id": "100000000000000000007534", "answers": [{"text": "religious reasons or other moral convictions", "answer_start": 365}], "is_impossible": false}, {"question": "What is an exception to the proof of vaccination requirement under the Presidential Proclamation and CDC\u2019s Amended Order?", "id": "100000000000000000007535", "answers": [{"text": "religious reasons or other moral convictions", "answer_start": 365}], "is_impossible": false}, {"question": "What are some categories of persons traveling to the United States for reasons related to official foreign government travel?", "id": "100000000000000000007536", "answers": [{"text": "What do I need to show", "answer_start": 535}], "is_impossible": false}], "context": "Do I qualify for an exception or can I apply for an exception to the vaccine requirement? \uf1aa\nNo, there are no exceptions under the Presidential Proclamation and CDC\u2019s Amended Order for religious reasons or\nother moral convictions. Can I qualify for an exception to the proof of vaccination requirement under the Presidential\nProclamation and CDC\u2019s Amended Order for religious reasons or other moral convictions? \uf1aa\nCertain categories of persons traveling to the United States for reasons related to official foreign government travel or\nWhat do I need to show if I am on diplomatic or official foreign government travel?"}]}, {"title": "9f53f19a6747aaac7f75435f398b71a4", "paragraphs": [{"qas": [{"question": "What are the categories of nonimmigrant visas?", "id": "100000000000000000007540", "answers": [{"text": "A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official),", "answer_start": 149}], "is_impossible": false}, {"question": "What is the scope of Section 11 of the United Nations Headquarters Agreement?", "id": "100000000000000000007542", "answers": [{"text": "Any noncitizen whose travel", "answer_start": 459}], "is_impossible": false}, {"question": "What is a noncitizen seeking to enter as a NATO classification?", "id": "100000000000000000007543", "answers": [{"text": "NATO-6", "answer_start": 375}], "is_impossible": false}, {"question": "What is evidenced by a letter of invitation from the United Nations?", "id": "100000000000000000007544", "answers": [{"text": "Any noncitizen whose travel falls within the scope of Section 11 of the United Nations Headquarters Agreement or other travel pursuant to U.S. legal obligation", "answer_start": 459}], "is_impossible": false}], "context": "These categories are\nAny noncitizen seeking entry into or transiting the United States under one of the following nonimmigrant visa\nclassifications: A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official), E-1 (as an\nemployee of TECRO or TECO or the employee\u2019s immediate family members), G-1, G-2, G-3, G-4, NATO-1 through NATO-\n4, or NATO-6 (or seeking to enter as a nonimmigrant in one of those NATO classifications)\nAny noncitizen whose travel falls within the scope of Section 11 of the United Nations Headquarters Agreement or\nother travel pursuant to U.S. legal obligation (as evidenced by a letter of invitation from the United Nations or other\ndocumentation showing the purpose of such travel)."}]}, {"title": "1b1cba4be00be3bbdc1e4178269506d2", "paragraphs": [{"qas": [{"question": "If you have been invited by the United Nations, you will need a letter of invitation from what organization?", "id": "100000000000000000007546", "answers": [{"text": "United Nations", "answer_start": 286}], "is_impossible": false}, {"question": "What document will you need from the United Nations to show the purpose of your travel?", "id": "100000000000000000007547", "answers": [{"text": "a letter of invitation", "answer_start": 254}], "is_impossible": false}, {"question": "How long will you be required to self-quarantine after arriving in the US?", "id": "100000000000000000007548", "answers": [{"text": "5 days", "answer_start": 461}], "is_impossible": false}, {"question": "What country does not require you to attend official events or duties?", "id": "100000000000000000007549", "answers": [{"text": "the United States", "answer_start": 485}], "is_impossible": false}], "context": "You will need to show that you are traveling under one of the visa categories (listed above); or travel with an official letter,\nsuch as letter from the U.S. government or foreign government. If you have been invited by the United Nations, you will\nneed a letter of invitation from the United Nations or other documentation showing the purpose of such travel. You will also be required to complete the attestation, attesting to arranging to self-quarantine for 5 days after arrival in\nthe United States except when you must attend official diplomatic or foreign government events or duties."}]}, {"title": "b1ba2692d7f55f0a7f92eb3912a081d1", "paragraphs": [{"qas": [{"question": "How many days after arrival must you get a viral test?", "id": "100000000000000000007550", "answers": [{"text": "3-5", "answer_start": 52}], "is_impossible": false}, {"question": "What must you self-isolate if the results of the test are positive?", "id": "100000000000000000007551", "answers": [{"text": "viral test", "answer_start": 41}], "is_impossible": false}, {"question": "Who must show a letter documenting the medical contraindication to the airline or aircraft operator?", "id": "100000000000000000007552", "answers": [{"text": "a licensed physician", "answer_start": 202}], "is_impossible": false}, {"question": "What must clearly state that you have a medical contraindication to receiving a treatment?", "id": "100000000000000000007554", "answers": [{"text": "attest that you will get a viral test 3-5 days after arrival and will self-isolate if the results of the test are positive or if you develop COVID-19 symptoms. You must show a letter from a licensed physician documenting the medical contraindication to the airline or aircraft operator before boarding a flight to the United States. The letter Must be signed and dated on official letterhead", "answer_start": 13}], "is_impossible": false}, {"question": "What is a medical contraindication to receiving a COVID-19 vaccine?", "id": "100000000000000000007555", "answers": [{"text": "Must clearly state that you have a medical contraindication to receiving a COVID-19 vaccine", "answer_start": 509}], "is_impossible": false}], "context": "You must also\nattest that you will get a viral test 3-5 days after arrival and will self-isolate if the results of the test are positive or if you\ndevelop COVID-19 symptoms. You must show a letter from a licensed physician documenting the medical contraindication to the airline or aircraft\noperator before boarding a flight to the United States. The letter\nMust be signed and dated on official letterhead that contains contact information (name, address, and phone number)\nof a licensed healthcare provider. Must clearly state that you have a medical contraindication to receiving a COVID-19 vaccine."}]}, {"title": "2888de75067d252017d6845a1e33a193", "paragraphs": [{"qas": [{"question": "What must the name of the COVID- 19 vaccine product and the medical condition both be listed?", "id": "100000000000000000007556", "answers": [{"text": "anaphylaxis) after a previous dose or component of a COVID-19 vaccine or known allergy to a component of a COVID-19 vaccine. Must have sufficient personally identifiable information", "answer_start": 191}], "is_impossible": false}, {"question": "What are medical contraindications to COVID-19 vaccination?", "id": "100000000000000000007557", "answers": [{"text": "immediate or severe allergic reaction (e.g., anaphylaxis) after a previous dose or component of a COVID-19 vaccine or known allergy to a component of a COVID-19 vaccine", "answer_start": 147}], "is_impossible": false}, {"question": "What is required to confirm that the letter matches with your passport or other travel information?", "id": "100000000000000000007559", "answers": [{"text": "sufficient personally identifiable information", "answer_start": 327}], "is_impossible": false}], "context": "The name of the COVID-\n19 vaccine product and the medical condition must both be listed. Medical contraindications to COVID-19 vaccination include immediate or severe allergic reaction (e.g.,\nanaphylaxis) after a previous dose or component of a COVID-19 vaccine or known allergy to a component of a\nCOVID-19 vaccine. Must have sufficient personally identifiable information (full name plus at least one other identifier such as date of\nbirth or passport number) to confirm that the letter matches with your passport or other travel information."}]}, {"title": "771a3f244ae4132766e8399eb4291925", "paragraphs": [{"qas": [{"question": "What do you need to show if you have a medical contraindication to receiving a COVID-19 vaccine?", "id": "100000000000000000007560", "answers": [{"text": "your letter is in a language other than English, check with your airlines or aircraft operator to find out if translation of the letter is necessary for their review. What do I need to show if I have a medical contraindication to receiving a COVID-19 vaccine? \uf1aa CDC has provided a list of qualifying COVID-19 vaccine candidates", "answer_start": 3}], "is_impossible": false}, {"question": "What is the contraindication to receiving a COVID-19 vaccine?", "id": "100000000000000000007561", "answers": [{"text": "medical", "answer_start": 205}], "is_impossible": false}, {"question": "CDC has provided a list of what vaccine candidates that meet CDC's criteria for this exception?", "id": "100000000000000000007562", "answers": [{"text": "COVID-19", "answer_start": 303}], "is_impossible": false}], "context": "If your letter is in a language other than English, check with your airlines or aircraft operator to find out if translation of\nthe letter is necessary for their review. What do I need to show if I have a medical contraindication to receiving a COVID-19 vaccine? \uf1aa\nCDC has provided a list of qualifying COVID-19 vaccine candidates that meet CDC\u2019s criteria for this exception. Check the\nlist to see if the vaccine(s) used in the trial you participated in included."}]}, {"title": "530270efddf24e51ee98178e4beb4f40", "paragraphs": [{"qas": [{"question": "What do you need to show of your participation in a clinical trial?", "id": "100000000000000000007563", "answers": [{"text": "official documentation", "answer_start": 22}], "is_impossible": false}, {"question": "What is the name of the vaccine candidate that you participated in the clinical trial with?", "id": "100000000000000000007564", "answers": [{"text": "COVID-19", "answer_start": 267}], "is_impossible": false}, {"question": "How long has it been since you completed the series of the COVID-19 vaccine candidate?", "id": "100000000000000000007565", "answers": [{"text": "2 weeks", "answer_start": 513}], "is_impossible": false}], "context": "You will need to show official documentation (e.g., clinical trial letter, participant card, or modified vaccination card) of\nclinical trial participation that includes the following information:\nDocumentation you participated in a phase 3 trial of with a qualifying COVID-19 vaccine candidate\nDocumentation you received the full series of an active (non-placebo) qualifying COVID-19 vaccine candidate or an EUL\nvaccine, with the name of the vaccine product and the date(s) received (showing it has been at least 2 weeks since you\ncompleted the series)\nHow do I know if the vaccine trial I participated in is on the approved list for an exception?"}]}, {"title": "c4d0d245742922cb2be306321d402ad1", "paragraphs": [{"qas": [{"question": "What is required to show proof of COVID-19 Vaccination for Air Passengers?", "id": "100000000000000000007568", "answers": [{"text": "Personal identifiers in the clinical trial documentation", "answer_start": 151}], "is_impossible": false}, {"question": "Who may grant a humanitarian or emergency exception in very limited circumstances?", "id": "100000000000000000007571", "answers": [{"text": "CDC", "answer_start": 357}], "is_impossible": false}, {"question": "What is a life saving medical treatment?", "id": "100000000000000000007572", "answers": [{"text": "emergency medical evacuations", "answer_start": 522}], "is_impossible": false}, {"question": "What is another term for safety?", "id": "100000000000000000007573", "answers": [{"text": "violence", "answer_start": 601}], "is_impossible": false}, {"question": "Who is unable to become fully vaccinated before travel?", "id": "100000000000000000007574", "answers": [{"text": "an individual", "answer_start": 449}], "is_impossible": false}], "context": "What\ndocumentation do I need to show? \uf1aa\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\ncompleted the series)\nPersonal identifiers in the clinical trial documentation (full name plus at least one other identifier such as date of birth\nor passport number) that match with your passport or other travel documentation. CDC may grant a humanitarian or emergency exception in very limited circumstances only when an individual must travel\nto the United States to preserve health (e.g., emergency medical evacuations, life-saving medical treatment) or safety\n(e.g., violence) and is unable to become fully vaccinated before travel."}]}, {"title": "a19fad03499ff062db11588ea16fdec6", "paragraphs": [{"qas": [{"question": "Who will then transmit the information to the CDC for consideration?", "id": "100000000000000000007576", "answers": [{"text": "The embassy", "answer_start": 231}], "is_impossible": false}, {"question": "How do you apply for a humanitarian exception?", "id": "100000000000000000007577", "answers": [{"text": "Please review the procedures for applying for a humanitarian or emergency exception as listed on the webpage", "answer_start": 308}], "is_impossible": false}, {"question": "What is the name of the embassy or consulate where you will apply?", "id": "100000000000000000007578", "answers": [{"text": "U.S. embassy or consulate in or nearest the country from which they are departing for the United States. The embassy will then transmit the information to the CDC for consideration. Please review the procedures for applying for a humanitarian or emergency exception as listed on the webpage of the embassy", "answer_start": 126}], "is_impossible": false}], "context": "Individuals who fit the exception criteria described\nin the Presidential Proclamation and CDC\u2019s Amended Order may contact the U.S. embassy or consulate in or nearest\nthe country from which they are departing for the United States. The embassy will then transmit the information to the\nCDC for consideration. Please review the procedures for applying for a humanitarian or emergency exception as listed on the webpage of the\nembassy or consulate where you will apply."}]}, {"title": "1620785766891cb2aa2c48cc3c86283e", "paragraphs": [{"qas": [{"question": "What is the name of the embassy or consulate where you can find a list of humanitarian exception requests?", "id": "100000000000000000007579", "answers": [{"text": "https://www.usembassy.gov", "answer_start": 62}], "is_impossible": false}, {"question": "Where can you find the US Embassy?", "id": "100000000000000000007581", "answers": [{"text": "https://www.usembassy.gov", "answer_start": 62}], "is_impossible": false}, {"question": "What language is required for the request to be sent to CDC?", "id": "100000000000000000007582", "answers": [{"text": "English", "answer_start": 325}], "is_impossible": false}], "context": "This link will lead you to the relevant embassy or consulate:\nhttps://www.usembassy.gov\nTo facilitate the review of a humanitarian or emergency exception request, individuals should submit the following\ninformation to the embassy or consulate for transmission to the CDC. All information needs to be completed in full and in\nEnglish for the request to be sent to CDC."}]}, {"title": "885d50c51d6c4186ec7e5da45dcb81df", "paragraphs": [{"qas": [{"question": "What does ESTA stand for?", "id": "100000000000000000007583", "answers": [{"text": "Electronic System for Travel Authorization", "answer_start": 122}], "is_impossible": false}, {"question": "What is the name of the person on the passport used for travel?", "id": "100000000000000000007584", "answers": [{"text": "Nationality", "answer_start": 43}], "is_impossible": false}, {"question": "What is head of household if family unit US destination address?", "id": "100000000000000000007585", "answers": [{"text": "Email address of passenger", "answer_start": 264}], "is_impossible": false}], "context": "Name (family name/surname, given name)\nAge\nNationality on passport used for travel\nIndicate Visa Type or if passenger has Electronic System for Travel Authorization (ESTA)\nCell phone number (including country code) of passenger or head of household if family unit\nEmail address of passenger or head of household if family unit\nUS destination address\nIs US destination home address?"}]}, {"title": "18ccf06090c51d3e531a7744dc644a14", "paragraphs": [{"qas": [{"question": "How many doses of COVID-19 vaccines have been received to date?", "id": "100000000000000000007586", "answers": [{"text": "two", "answer_start": 299}], "is_impossible": false}, {"question": "What is the name of the vaccine if a two-dose series?", "id": "100000000000000000007587", "answers": [{"text": "second dose", "answer_start": 281}], "is_impossible": false}, {"question": "How many doses of vaccine does a person need to be vaccinated?", "id": "100000000000000000007588", "answers": [{"text": "two", "answer_start": 299}], "is_impossible": false}, {"question": "What is the purpose of travel to the US and a brief explanation of why urgent travel is needed?", "id": "100000000000000000007589", "answers": [{"text": "Justification for humanitarian or emergency exception to providing proof of being fully vaccinated", "answer_start": 439}], "is_impossible": false}, {"question": "Why is it necessary to provide proof of vaccination?", "id": "100000000000000000007590", "answers": [{"text": "vaccine availability, passenger ineligible for vaccine at location, insufficient time to become fully vaccinated", "answer_start": 545}], "is_impossible": false}, {"question": "What is one example of documentation to support justification?", "id": "100000000000000000007591", "answers": [{"text": "medical records, orders for emergency evacuation", "answer_start": 705}], "is_impossible": false}, {"question": "How do I apply for a humanitarian exception to the requirement for noncitizen nonimmigrants to show a pre-departure proof of COVID-19 vaccination?", "id": "100000000000000000007593", "answers": [{"text": "answer undefined", "answer_start": 755}], "is_impossible": false}], "context": "How do I apply for a humanitarian or emergency exception to the requirement for noncitizen\nnonimmigrants to show a pre-departure proof of COVID-19 vaccination? \uf1aa\n\uf209\n\uf209\nWhere can I find the list of countries with limited COVID-19 vaccine availability and how often is it\nupdated?"}]}, {"title": "d41fcbd358e37cacc3c8059cc7ef8f7c", "paragraphs": [{"qas": [{"question": "What is required to show proof of COVID-19 Vaccination for Air Passengers?", "id": "100000000000000000007594", "answers": [{"text": "passport or other proof of citizenship", "answer_start": 268}], "is_impossible": false}, {"question": "Where can you find the list of countries with limited COVID-19 vaccine availability?", "id": "100000000000000000007595", "answers": [{"text": "List of Foreign Countries with Limited COVID-19 Vaccine Availability", "answer_start": 175}], "is_impossible": false}, {"question": "What do you need to show a passport or other proof of?", "id": "100000000000000000007596", "answers": [{"text": "citizenship", "answer_start": 295}], "is_impossible": false}, {"question": "What type of visa is not a B-1 (business) or B-2 (tourism) visa?", "id": "100000000000000000007597", "answers": [{"text": "nonimmigrant visa", "answer_start": 363}], "is_impossible": false}, {"question": "What do I need to show I am from a country with limited COVID-19 vaccine availability?", "id": "100000000000000000007598", "answers": [{"text": "passport or other proof of citizenship", "answer_start": 268}], "is_impossible": false}], "context": "\uf1aa\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nYou can find the list of countries with limited COVID-19 vaccine availability here: List of Foreign Countries with Limited\nCOVID-19 Vaccine Availability\nYou will need to show\nA passport or other proof of citizenship from a country on the list provided by CDC; AND\nA valid nonimmigrant visa that is not a B-1 (business) or B-2 (tourism) visa. What documentation do I need to show that I am from a country with limited COVID-19 vaccine\navailability?"}]}, {"title": "6cdf118a1c2828c05378fe9ffee4be76", "paragraphs": [{"qas": [{"question": "What must you show to qualify for this exception?", "id": "100000000000000000007599", "answers": [{"text": "a passport or other proof of citizenship", "answer_start": 51}], "is_impossible": false}, {"question": "What is a country determined to have limited COVID-19 vaccine availability?", "id": "100000000000000000007600", "answers": [{"text": "you must show a passport or other proof of citizenship", "answer_start": 37}], "is_impossible": false}, {"question": "CDC uses vaccination coverage as a proxy indicator of what?", "id": "100000000000000000007601", "answers": [{"text": "vaccine availability", "answer_start": 388}], "is_impossible": false}, {"question": "CDC realizes that vaccine availability might be limited by multiple factors, including limited access, service delivery issues, and low vaccine supply relative to demand?", "id": "100000000000000000007602", "answers": [{"text": "vaccination coverage", "answer_start": 343}], "is_impossible": false}], "context": "\uf1aa\nNo, to qualify for this exception, you must show a passport or other proof of citizenship of a country determined to have\nlimited COVID-19 vaccine availability. What if I live in a country with low vaccination availability but my passport is from a country with\nhigh vaccination availability? Do I still qualify for an exception? \uf1aa\nCDC uses vaccination coverage as a proxy indicator of vaccine availability. CDC realizes that vaccine availability might be\nlimited by multiple factors, including limited access, service delivery issues, and low vaccine supply relative to demand."}]}, {"title": "2c8f2979f57d9d80947058c7ecd51587", "paragraphs": [{"qas": [{"question": "How often does OWID update the list of countries with limited vaccine availability?", "id": "100000000000000000007605", "answers": [{"text": "every three months", "answer_start": 400}], "is_impossible": false}, {"question": "What percentage of the population is fully vaccinated with available COVID-19 vaccines?", "id": "100000000000000000007608", "answers": [{"text": "10%", "answer_start": 83}], "is_impossible": false}], "context": "CDC considers a country to have limited COVID-19 vaccine availability if less than 10% of the total population has been\nfully vaccinated against COVID-19 with any vaccine, as reported in official source data in Our World in Data (OWID). CDC reviews OWID country-level data on the proportion of a population that is fully vaccinated and updates the list of\ncountries with limited vaccine availability every three months. If country data are missing from OWID, CDC reviews other\nofficial sources of information to determine a countries\u2019 vaccination coverage (percent of the population fully vaccinated\nwith available COVID-19 vaccines)."}]}, {"title": "692eec1de67564a3f54bd8f2d2126e5a", "paragraphs": [{"qas": [{"question": "What is a common access card?", "id": "100000000000000000007610", "answers": [{"text": "CAC", "answer_start": 207}], "is_impossible": false}, {"question": "How old is a member of the U.S. Armed Forces?", "id": "100000000000000000007611", "answers": [{"text": "under 18 years of age", "answer_start": 289}], "is_impossible": false}, {"question": "What is the age of a spouse or child under 18 years of age?", "id": "100000000000000000007612", "answers": [{"text": "U.S. military identification document", "answer_start": 123}], "is_impossible": false}], "context": "How does CDC determine whether a country is designated as having limited vaccine availability? \uf1aa\n\uf209\nYou will need to show a U.S. military identification document, such as a military ID or Common Access Card (CAC) or a\nDEERS ID Card, or other proof of status as a member or spouse or child (under 18 years of age) of a member of the U.S.\nArmed Forces. What documentation do I need if I am a member of the U.S. Armed Forces or a spouse or child\n(under 18 years of age) of someone who is a member of the U.S. Armed Forces?"}]}, {"title": "e66270e8f3a6353636ccf3a06d73ce20", "paragraphs": [{"qas": [{"question": "What type of letter is required from your employer?", "id": "100000000000000000007614", "answers": [{"text": "official", "answer_start": 52}], "is_impossible": false}, {"question": "What documents do I need if I am a sea crew member traveling with a C-1 and D nonimmigrant visa?", "id": "100000000000000000007616", "answers": [{"text": "An official letter from your employer (paper or digital) indicating your entry to or transit through the United States is required for the purpose of operating a vessel or return travel after disembarking the vessel consistent with your visa and official letter", "answer_start": 49}], "is_impossible": false}], "context": "\uf1aa\nYou will need to show\nYour C-1 and D visa; AND\nAn official letter from your employer (paper or digital) indicating your entry to or transit through the United States is\nrequired for the purpose of operating a vessel or return travel after disembarking the vessel consistent with your visa\nand official letter. What documentation do I need if I am a sea crew member traveling with a C-1 and D\nnonimmigrant visa?"}]}, {"title": "2f56306976c06fd725c2326789457f5c", "paragraphs": [{"qas": [{"question": "What is the requirement for proof of COVID-19 Vaccination for Air Passengers?", "id": "100000000000000000007617", "answers": [{"text": "10/30/22, 9:43 AM", "answer_start": 2}], "is_impossible": false}, {"question": "What does the requirement apply to sea crew/mariners entering the US as Covered Individuals who are not fully vaccinated against?", "id": "100000000000000000007618", "answers": [{"text": "COVID-19", "answer_start": 281}], "is_impossible": false}], "context": "\uf1aa\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nThe requirements for testing and quarantine post-arrival by air conveyance apply to sea crew/mariners entering the\nUnited States as Covered Individuals who are:\nnot fully vaccinated against COVID-19, and\nwithout documentation of having recovered from COVID-19 in the past 90 days. Sea crew members boarding cruise ships that are participating in CDC\u2019s COVID-19 Program for Cruise Ships must follow\napplicable guidance for testing and quarantine during and after embarking the cruise ship."}]}, {"title": "83c5d6f63169e7681e03423cebac5276", "paragraphs": [{"qas": [{"question": "What are crew members of all other vessels subject to?", "id": "100000000000000000007622", "answers": [{"text": "the testing and self-quarantine requirements of the attestation", "answer_start": 195}], "is_impossible": false}, {"question": "How long do fish remain in the U.S.?", "id": "100000000000000000007623", "answers": [{"text": "long as they remain in the United States, including U.S. waters", "answer_start": 262}], "is_impossible": false}], "context": "If crew will not be immediately\nembarking the cruise ship, then they must follow the requirements of the attestation prior to embarking the ship. Crew members of all other vessels are subject to the testing and self-quarantine requirements of the attestation as long\nas they remain in the United States, including U.S. waters."}]}, {"title": "420ed9323a7ae1ec8357f1d732675d63", "paragraphs": [{"qas": [{"question": "How long must a Mariner self-quarantine in a single-occupancy cabin with a private bathroom after arriving in the U.S.?", "id": "100000000000000000007624", "answers": [{"text": "5 days", "answer_start": 197}], "is_impossible": false}, {"question": "How long after arriving in the U.S. does a working quarantine stay on board the ship?", "id": "100000000000000000007625", "answers": [{"text": "5 days", "answer_start": 335}], "is_impossible": false}], "context": "Self-quarantine Requirements\nMariners who are embarking the ship the same day they arrive in the United States, must either:\nSelf-quarantine in a single-occupancy cabin with a private bathroom for 5 days after arriving in the United States\nor until the ship leaves U.S. waters, or\nMaintain a \u201cworking\u201d quarantine on board the ship for 5 days after arriving in the United States or until the ship\nleaves U.S. waters\nPlease see CDC\u2019s Interim Guidance for Ships on Managing Suspected or Confirmed Cases of Coronavirus\nDisease 2019 (COVID-19) for additional information regarding \u201cworking\u201d quarantines."}]}, {"title": "519b9c63ed274e31cc9e2ef0ab4efdb0", "paragraphs": [{"qas": [{"question": "What is the term for a hotel room?", "id": "100000000000000000007628", "answers": [{"text": "shoreside accommodations", "answer_start": 105}], "is_impossible": false}, {"question": "How long must a mariner self-quarantine in their hotel until boarding the ship?", "id": "100000000000000000007629", "answers": [{"text": "5 days", "answer_start": 155}], "is_impossible": false}, {"question": "How long does it take to get tested with a viral test after arriving in the US?", "id": "100000000000000000007630", "answers": [{"text": "3-5 days", "answer_start": 540}], "is_impossible": false}, {"question": "How many days after arrival in the U.S. do people test if they remain in the United States?", "id": "100000000000000000007631", "answers": [{"text": "3-5", "answer_start": 540}], "is_impossible": false}], "context": "Mariners who are not embarking the ship the day they arrive in the United States must self-quarantine in\nshoreside accommodations (i.e., a hotel room) for 5 days or until they board the ship. Mariners who will board the ship before the 5-day self-quarantine period is completed must self-quarantine\nin their hotel until boarding the ship. Once onboard, these mariners must follow one of the self-quarantine\noptions outlined above for the remainder of their quarantine period. Testing Requirements\nMariners must get tested with a viral test 3-5 days after arrival in the U.S. if they remain in the United States, including\nU.S. waters, at that time."}]}, {"title": "e4f0ad04d8d2e2b2814df314531f3352", "paragraphs": [{"qas": [{"question": "What type of testing facility can crew visit?", "id": "100000000000000000007632", "answers": [{"text": "shoreside", "answer_start": 106}], "is_impossible": false}, {"question": "Who can preform testing onboard?", "id": "100000000000000000007633", "answers": [{"text": "Operators can contract a 3 party", "answer_start": 186}], "is_impossible": false}, {"question": "What are COVID-19 self-tests sometimes called?", "id": "100000000000000000007634", "answers": [{"text": "home tests or at-home tests", "answer_start": 324}], "is_impossible": false}, {"question": "What should crew embark the vessel with their own?", "id": "100000000000000000007636", "answers": [{"text": "self-test", "answer_start": 403}], "is_impossible": false}, {"question": "How should sea crew members fulfill the requirements of attestation?", "id": "100000000000000000007638", "answers": [{"text": "Operators can provide crew with COVID-19 self-tests (sometimes referred to as home tests or at-home tests) or ask that crew embark the vessel with their own self-test", "answer_start": 246}], "is_impossible": false}], "context": "Non-cruise ship operators and mariners have several options to fulfill this requirement:\nCrew can visit a shoreside testing facility (e.g., testing at a pharmacy or healthcare facility)\nOperators can contract a 3 party to preform testing onboard\nOperators can provide crew with COVID-19 self-tests (sometimes referred to as home tests or at-home tests) or\nask that crew embark the vessel with their own self-test. CDC recommends that if self-tests are used, they should be conducted under supervision of tele-medicine\npersonnel. How should sea crew members fulfill the requirements of the attestation?"}]}, {"title": "96f046720d2f648a8c023d00f8941b3f", "paragraphs": [{"qas": [{"question": "What is needed to show my entry to the United States is in the U.S. national interest?", "id": "100000000000000000007640", "answers": [{"text": "an official U.S. Government letter (paper or digital) documenting approval of the exception", "answer_start": 27}], "is_impossible": false}, {"question": "What is an attestation subject to 18 U.S.C.  1001?", "id": "100000000000000000007642", "answers": [{"text": "a statement, writing, entry, or other representation", "answer_start": 369}], "is_impossible": false}, {"question": "Willfully providing false or misleading information may lead to what?", "id": "100000000000000000007643", "answers": [{"text": "criminal fines and imprisonment", "answer_start": 567}], "is_impossible": false}], "context": "\uf1aa\nrd\nYou will need to show an official U.S. Government letter (paper or digital) documenting approval of the exception. What documentation is needed to show my entry to the United States is in the U.S. national\ninterest? \uf1aa\nAttestations\nWhat is an attestation? \uf1aa\f10/30/22, 9:43 AM Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC\nAn attestation is a statement, writing, entry, or other representation subject to 18 U.S.C. \u00a7 1001 that confirms that the\ninformation provided is true. Willfully providing false or misleading information may lead to criminal fines and\nimprisonment."}]}, {"title": "384704d1c9ecb505b82eeb4dbcc4cd54", "paragraphs": [{"qas": [{"question": "All airlines or other aircraft operators will provide and collect the passenger attestation on behalf of whom?", "id": "100000000000000000007644", "answers": [{"text": "the U.S. Government", "answer_start": 105}], "is_impossible": false}, {"question": "Who will provide and collect the passenger attestation on behalf of the U.S. Government prior to boarding?", "id": "100000000000000000007646", "answers": [{"text": "All airlines or other aircraft operators", "answer_start": 0}], "is_impossible": false}, {"question": "What should you check with the airline or aircraft operator for your flight?", "id": "100000000000000000007647", "answers": [{"text": "how the airline or aircraft operator will collect your attestation", "answer_start": 454}], "is_impossible": false}, {"question": "What do air passengers need to do to provide an attestation?", "id": "100000000000000000007648", "answers": [{"text": "print the attestation posted on the CDC website", "answer_start": 535}], "is_impossible": false}, {"question": "What does the CDC do?", "id": "100000000000000000007649", "answers": [{"text": "print the attestation posted on the CDC website", "answer_start": 535}], "is_impossible": false}], "context": "All airlines or other aircraft operators will provide and collect the passenger attestation on behalf of the U.S. Government\nprior to boarding. How do air passengers provide an attestation? \uf1aa\nAs required by United States federal law, all airlines or other aircraft operators will provide and collect the passenger\nattestation on behalf of the U.S. Government prior to boarding. Please check with the airline or aircraft operator for your\nflight to learn how the airline or aircraft operator will collect your attestation. Do I have to print the attestation posted on the CDC website before coming the airport? How do\nair passengers provide an attestation?"}]}, {"title": "908a92a8feaf65d46ac0c813e3e4abae", "paragraphs": [{"qas": [{"question": "Noncitizen nonimmigrants that plan to take a connecting flight in the United States to another country are still required to complete and sign what?", "id": "100000000000000000007650", "answers": [{"text": "the attestation", "answer_start": 192}], "is_impossible": false}], "context": "\uf1aa\nNoncitizen nonimmigrants that plan to take a connecting flight in the United States to another country may continue on\ntheir itinerary; however, they are still required to complete and sign the attestation in case their travel plans are changed\nor delayed. If they take their connecting flight and leave the United States, they are no longer subject to the requirements\nof the attestation. I am taking a connecting flight through the United States but the attestation says I have to attest\nto self-quarantine for 5 days and get a viral COVID-19 test 3-5 days after arrival."}]}, {"title": "6f6f073271df462b0b5f0ba1d93a7168", "paragraphs": [{"qas": [{"question": "What do noncitizen nonimmigrants who are not fully vaccinated and meet an exception do not have to get a COVID-19 test?", "id": "100000000000000000007654", "answers": [{"text": "if they are in the United States less than 3 days", "answer_start": 175}], "is_impossible": false}, {"question": "Who must self-quarantine until they leave the United States?", "id": "100000000000000000007655", "answers": [{"text": "Noncitizen nonimmigrants", "answer_start": 64}], "is_impossible": false}, {"question": "Who must complete and sign the attestation in case their travel plans are changed or delayed?", "id": "100000000000000000007656", "answers": [{"text": "Noncitizen nonimmigrants", "answer_start": 64}], "is_impossible": false}, {"question": "If a person leaves the US less than 3 days after arrival, they are no longer subject to the requirements of what?", "id": "100000000000000000007657", "answers": [{"text": "Amended Order and attestation", "answer_start": 515}], "is_impossible": false}], "context": "Can I still take my\nconnecting flight to my next destination? \uf1aa\nNoncitizen nonimmigrants who are not fully vaccinated and meet an exception do not have to get a COVID-19 test if they\nare in the United States less than 3 days; however, they must self-quarantine until they leave the United States. They also\nmust complete and sign the attestation in case their travel plans are changed or delayed. If they leave the United States\nless than 3 days after arrival, they are no longer subject to the requirements of the Amended Order and attestation."}]}, {"title": "d488fa5804361db8a2c4953f62318a5d", "paragraphs": [{"qas": [{"question": "How long will I be in the United States?", "id": "100000000000000000007658", "answers": [{"text": "less than 3 days", "answer_start": 35}], "is_impossible": false}, {"question": "How long must I self-quarantine for to get my exception to travel?", "id": "100000000000000000007659", "answers": [{"text": "5 days", "answer_start": 125}], "is_impossible": false}, {"question": "What do I still have to do if I am going to be in the United States for less than 3 days?", "id": "100000000000000000007661", "answers": [{"text": "to quarantine and get a post-travel test", "answer_start": 209}], "is_impossible": false}], "context": "I will be in the United States for less than 3 days, but to get my exception to travel, I must attest to\nself-quarantine for 5 days and get a test 3-5 days after arriving in the United States. Do I still have\nto quarantine and get a post-travel test if I am going to be in the United States for less than 3\ndays? \uf1aa\nLast Updated July 14, 2022"}]}, {"title": "a146b983980ecd57d475b2c0634eafb1", "paragraphs": [{"qas": [{"question": "How many people in the US have received COVID-19 vaccines under the most intense safety monitoring in US history?", "id": "100000000000000000007663", "answers": [{"text": "Millions", "answer_start": 170}], "is_impossible": false}, {"question": "How many doses of the COVID-19 vaccine have been given in the United States from December 14, 2020?", "id": "100000000000000000007665", "answers": [{"text": "632 million", "answer_start": 508}], "is_impossible": false}, {"question": "What is recommended for everyone 6 months and older and boosters for everyone 5 years and older?", "id": "100000000000000000007666", "answers": [{"text": "COVID-19 vaccines", "answer_start": 313}], "is_impossible": false}, {"question": "What is the date of the end of the program?", "id": "100000000000000000007667", "answers": [{"text": "October 19, 2022", "answer_start": 615}], "is_impossible": false}, {"question": "What year does the program end?", "id": "100000000000000000007668", "answers": [{"text": "2022", "answer_start": 627}], "is_impossible": false}], "context": "10/30/22, 9:31 AM Safety of COVID-19 Vaccines | CDC\nEspa\u00f1ol | Other Languages\nSafety of COVID-19 Vaccines\nWhat You Need to Know\nCOVID-19 vaccines are safe and effective. Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring\nin US history. CDC recommends COVID-19 vaccines for everyone 6 months and older and boosters for everyone 5 years and\nolder, if eligible. \u2022\n\u2022\n\u2022\nHundreds of Millions of People Have Safely Received a COVID-19\nVaccine\nMore than 632 million doses of COVID-19 vaccine have been given in the United States from December 14, 2020, through\nOctober 19, 2022."}]}, {"title": "eb1ec9e768aae2251821e5d20eecb7b1", "paragraphs": [{"qas": [{"question": "Whose approval did the vaccines meet?", "id": "100000000000000000007672", "answers": [{"text": "Food and Drug Administration", "answer_start": 302}], "is_impossible": false}, {"question": "What is the acronym for emergency use authorization?", "id": "100000000000000000007673", "answers": [{"text": "EUA", "answer_start": 471}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000007674", "answers": [{"text": "emergency use authorization", "answer_start": 442}], "is_impossible": false}, {"question": "What vaccines will continue to undergo the most intensive safety monitoring in US history?", "id": "100000000000000000007676", "answers": [{"text": "Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen and Novavax COVID-19", "answer_start": 518}], "is_impossible": false}, {"question": "Novavax COVID-19 vaccines are going through what kind of safety monitoring?", "id": "100000000000000000007677", "answers": [{"text": "intensive", "answer_start": 638}], "is_impossible": false}], "context": "To view the current total number of COVID-19 vaccinations that have been administered in the United\nStates, please visit the CDC COVID Data Tracker. COVID-19 vaccines are safe and effective. COVID-19 vaccines were evaluated in tens of thousands of participants in clinical\ntrials. The vaccines met the Food and Drug Administration\u2019s (FDA\u2019s) rigorous scientific standards for safety, effectiveness, and\nmanufacturing quality needed to support emergency use authorization (EUA). Learn more about EUAs in this video. The Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen and Novavax COVID-19 vaccines will continue to undergo the\nmost intensive safety monitoring in US history."}]}, {"title": "ae27efcd50752fcd5a7781b13e260e80", "paragraphs": [{"qas": [{"question": "What is used to make sure that COVID-19 vaccines are safe?", "id": "100000000000000000007678", "answers": [{"text": "safety monitoring systems", "answer_start": 56}], "is_impossible": false}, {"question": "How should side effects affect the ability to do daily activities?", "id": "100000000000000000007680", "answers": [{"text": "they should go away within a few days", "answer_start": 321}], "is_impossible": false}, {"question": "What is the term for serious safety problems?", "id": "100000000000000000007682", "answers": [{"text": "Adverse Events", "answer_start": 425}], "is_impossible": false}, {"question": "What is a health problem that happens after vaccination considered?", "id": "100000000000000000007683", "answers": [{"text": "adverse event", "answer_start": 631}], "is_impossible": false}, {"question": "What is an adverse event?", "id": "100000000000000000007684", "answers": [{"text": "Any health problem", "answer_start": 564}], "is_impossible": false}], "context": "This monitoring includes using both established and new safety monitoring\nsystems to make sure that COVID-19 vaccines are safe. Common Side Effects\nSome people have side effects after getting their COVID-19 vaccine, while others might have no side effects. Side effects may\naffect the ability to do daily activities, but they should go away within a few days. Learn more about common side effects after\nCOVID-19 vaccination. Adverse Events (Serious Safety Problems) Are Rare\nIn rare cases, people have experienced serious health events after COVID-19 vaccination. Any health problem that happens\nafter vaccination is considered an adverse event."}]}, {"title": "8270d705bec56940ec2fcef14620b40c", "paragraphs": [{"qas": [{"question": "What can be caused by a coincidental event not related to the vaccine, such as an unrelated fever?", "id": "100000000000000000007686", "answers": [{"text": "An adverse event", "answer_start": 0}], "is_impossible": false}], "context": "An adverse event can be caused by the vaccine or can be caused by a\ncoincidental event not related to the vaccine, such as an unrelated fever, that happened following vaccination. \uf209\f10/30/22, 9:31 AM Safety of COVID-19 Vaccines | CDC\nTo date, the systems in place to monitor the safety of these vaccines have found four serious types of adverse events\nfollowing COVID-19 vaccination, with evidence that suggests, although rare, a link to certain types of COVID-19 vaccinations\nthat were administered."}]}, {"title": "8a32db8038628066eb9e74798b1f93bb", "paragraphs": [{"qas": [{"question": "What is rare after COVID-19 vaccination?", "id": "100000000000000000007689", "answers": [{"text": "Anaphylaxis", "answer_start": 190}], "is_impossible": false}, {"question": "What is a rare but serious adverse event that causes blood clots or issues with clotting?", "id": "100000000000000000007690", "answers": [{"text": "Thrombosis with Thrombocytopenia Syndrome", "answer_start": 320}], "is_impossible": false}, {"question": "Myocarditis is inflammation of what?", "id": "100000000000000000007692", "answers": [{"text": "heart muscle", "answer_start": 675}], "is_impossible": false}, {"question": "What is inflammation of the heart muscle called?", "id": "100000000000000000007693", "answers": [{"text": "Myocarditis", "answer_start": 640}], "is_impossible": false}, {"question": "What is pericarditis inflammation of?", "id": "100000000000000000007694", "answers": [{"text": "the outer lining of the heart", "answer_start": 725}], "is_impossible": false}], "context": "They are:\nAnaphylaxis\nAnaphylaxis is a severe type of allergic reaction with symptoms such as hives, difficulty breathing, low blood pressure, or\nsignificant swelling of the tongue or lips. Anaphylaxis after COVID-19 vaccination is rare. Learn more about COVID-19 vaccines\nand allergic reactions, including anaphylaxis. Thrombosis with Thrombocytopenia Syndrome (TTS)\nThrombosis with thrombocytopenia syndrome (TTS) is a rare but serious adverse event that causes blood clots or issues with\nclotting. TTS after COVID-19 vaccination is rare. Learn more about COVID-19 vaccines and adverse events, including TTS. Myocarditis and Pericarditis\nMyocarditis is inflammation of the heart muscle, and pericarditis is inflammation of the outer lining of the heart."}]}, {"title": "5386daa018657eb607bd87313b3f5cb6", "paragraphs": [{"qas": [{"question": "What is the rarest form of myocarditis after COVID-19 vaccination?", "id": "100000000000000000007695", "answers": [{"text": "pericarditis", "answer_start": 16}], "is_impossible": false}, {"question": "What is Guillain-Barr\u00e9 Syndrome (GBS)?", "id": "100000000000000000007696", "answers": [{"text": "a rare disorder where the body\u2019s immune system damages nerve cells, causing muscle weakness and sometimes paralysis", "answer_start": 224}], "is_impossible": false}, {"question": "When is GBS rare?", "id": "100000000000000000007698", "answers": [{"text": "after COVID-19 vaccination", "answer_start": 345}], "is_impossible": false}, {"question": "What is rare after COVID-19 vaccination?", "id": "100000000000000000007699", "answers": [{"text": "Myocarditis and pericarditis", "answer_start": 0}], "is_impossible": false}, {"question": "What does VAERS stand for?", "id": "100000000000000000007700", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 619}], "is_impossible": false}, {"question": "What is VAERS?", "id": "100000000000000000007701", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 619}], "is_impossible": false}], "context": "Myocarditis\nand pericarditis after COVID-19 vaccination are rare. Learn more about COVID-19 vaccines and adverse events, including\nmyocarditis and pericarditis. Guillain-Barr\u00e9 Syndrome (GBS)\nGuillain-Barr\u00e9 Syndrome (GBS) is a rare disorder where the body\u2019s immune system damages nerve cells, causing muscle\nweakness and sometimes paralysis. GBS after COVID-19 vaccination is rare. Learn more about COVID-19 vaccines and adverse\nevents, including GBS. Reports of Death Are Rare\nReports of death after COVID-19 vaccination are rare. FDA requires healthcare providers to report any death after COVID-19\nvaccination to the Vaccine Adverse Event Reporting System (VAERS) , even if it\u2019s unclear whether the vaccine was the\ncause."}]}, {"title": "1de308c4ab060740e905a63ed27ae789", "paragraphs": [{"qas": [{"question": "CDC and FDA review reports of death following COVID-19 vaccination and update information as it becomes available?", "id": "100000000000000000007703", "answers": [{"text": "becomes available", "answer_start": 235}], "is_impossible": false}, {"question": "Who continues to closely monitor the safety of the vaccine?", "id": "100000000000000000007706", "answers": [{"text": "CDC", "answer_start": 609}], "is_impossible": false}, {"question": "What is the name of the vaccine that CDC continues to closely monitor?", "id": "100000000000000000007707", "answers": [{"text": "COVID-19", "answer_start": 656}], "is_impossible": false}], "context": "Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine\ncaused a health problem. CDC and FDA review reports of death following COVID-19 vaccination and update information as it\nbecomes available. Learn more about adverse events, including reports of death, after COVID-19 vaccination. \uf209\nBenefits of Vaccination Outweigh the Risks\nSerious side effects that could cause a long-term health problem are extremely rare following any vaccination, including\nCOVID-19 vaccination. The benefits of COVID-19 vaccination outweigh the known and potential risks. CDC continues to closely monitor the safety of COVID-19 vaccines."}]}, {"title": "d8ab57b62f69b9f4e51190548b2aef1d", "paragraphs": [{"qas": [{"question": "What does v-safe stand for?", "id": "100000000000000000007709", "answers": [{"text": "smartphone-based system", "answer_start": 164}], "is_impossible": false}, {"question": "What does v-safe allow you to report to CDC after getting a COVID-19 vaccine?", "id": "100000000000000000007711", "answers": [{"text": "how you are feeling", "answer_start": 452}], "is_impossible": false}], "context": "Everyone who receives a COVID-19 vaccine can also\nparticipate in safety monitoring by enrolling themselves -or their children or dependents 6 months and older in a\nsmartphone-based system called v-safe and completing health check-ins after COVID-19 vaccination. Have you experienced a side effect following COVID-19 vaccination? Please report it to VAERS . In addition, enrolling yourself or your dependent in v-safe allows you to easily report to CDC how\nyou are feeling after getting a COVID-19 vaccine."}]}, {"title": "1009e6503e836968d153c949ad43a6df", "paragraphs": [{"qas": [{"question": "What is VaST?", "id": "100000000000000000007712", "answers": [{"text": "Vaccines Safety Technical Sub-Group", "answer_start": 33}], "is_impossible": false}, {"question": "What is VAERS?", "id": "100000000000000000007713", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 236}], "is_impossible": false}], "context": "\uf209\nMore Information\nACIP COVID-19 Vaccines Safety Technical Sub-Group (VaST)\nCOVID-19 Vaccine Safety Publications\f10/30/22, 9:31 AM Safety of COVID-19 Vaccines | CDC\nVaST Subgroup Technical Report\nv-safe After Vaccination Health Checker\nVaccine Adverse Event Reporting System (VAERS)\nLast Updated Oct. 24, 2022"}]}, {"title": "ae43e1e844d44d8ca6704d5d0ee4f4a9", "paragraphs": [{"qas": [{"question": "What are some of the side effects reported after the injection site?", "id": "100000000000000000007716", "answers": [{"text": "headache, fatigue, and soreness", "answer_start": 280}], "is_impossible": false}, {"question": "What should older people do to protect against COVID-19 and its potentially severe complications?", "id": "100000000000000000007719", "answers": [{"text": "get vaccinated", "answer_start": 561}], "is_impossible": false}], "context": "10/30/22, 9:32 AM Selected Adverse Events Reported after COVID-19 Vaccination | CDC\nEspa\u00f1ol | Other Languages\nSelected Adverse Events Reported after COVID-19\nVaccination\nSafety of COVID-19 Vaccines\nSome people have no side effects. Many people have reported side effects, such as headache, fatigue, and soreness at\nthe injection site, that are generally mild to moderate and go away within a few days. What You Need to Know\nCOVID-19 vaccines are safe and effective and severe reactions after vaccination are rare. CDC recommends everyone ages 5 years and older get vaccinated as soon as possible to protect against COVID-19 and\nits potentially severe complications."}]}, {"title": "510c609be46708b0aae6595e933552fc", "paragraphs": [{"qas": [{"question": "What type of vaccines are preferred?", "id": "100000000000000000007720", "answers": [{"text": "mRNA vaccines", "answer_start": 9}], "is_impossible": false}, {"question": "What is the most intense safety monitoring program in U.S. history?", "id": "100000000000000000007721", "answers": [{"text": "Johnson & Johnson\u2019s Janssen COVID-19 vaccine", "answer_start": 85}], "is_impossible": false}, {"question": "How many people have received COVID-19 vaccines?", "id": "100000000000000000007722", "answers": [{"text": "Millions", "answer_start": 168}], "is_impossible": false}, {"question": "What do CDC, FDA, and other federal agencies continue to monitor?", "id": "100000000000000000007723", "answers": [{"text": "the safety of COVID- 19 vaccines", "answer_start": 403}], "is_impossible": false}], "context": "Although mRNA vaccines (Pfizer-BioNTech or Moderna COVID-19 vaccines) are preferred, Johnson & Johnson\u2019s Janssen\nCOVID-19 vaccine may be considered in some situations. Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring\nprogram in U.S. history. CDC, the U.S. Food and Drug Administration (FDA), and other federal agencies continue to monitor the safety of COVID-\n19 vaccines. Adverse events described on this page have been reported to the Vaccine Adverse Event Reporting System (VAERS) . VAERS accepts reports of any adverse event following vaccination."}]}, {"title": "e8d3a1817ca6f0036aef14589a61df18", "paragraphs": [{"qas": [{"question": "How many cases of anaphylaxis have occurred per one million doses administered?", "id": "100000000000000000007726", "answers": [{"text": "5", "answer_start": 184}], "is_impossible": false}, {"question": "What is a severe type of allergic reaction?", "id": "100000000000000000007727", "answers": [{"text": "Anaphylaxis", "answer_start": 236}], "is_impossible": false}, {"question": "What can happen after any kind of vaccination?", "id": "100000000000000000007728", "answers": [{"text": "Anaphylaxis", "answer_start": 236}], "is_impossible": false}, {"question": "What is anaphylaxis?", "id": "100000000000000000007730", "answers": [{"text": "a severe type of allergic reaction", "answer_start": 249}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022 \uf209\n\u2022\nCDC is providing timely updates on the following adverse events of interest:\nAnaphylaxis after COVID-19 vaccination is rare and has occurred at a rate of approximately 5 cases per one million\nvaccine doses administered. Anaphylaxis, a severe type of allergic reaction, can occur after any kind of vaccination. If it happens, healthcare providers can effectively and immediately treat the reaction. Learn more about COVID-19\nvaccines and allergic reactions, including anaphylaxis."}]}, {"title": "44d6d08ab2f43590294900628b99563b", "paragraphs": [{"qas": [{"question": "What has the CDC made available to healthcare providers and the public?", "id": "100000000000000000007732", "answers": [{"text": "anaphylaxis", "answer_start": 59}], "is_impossible": false}, {"question": "When was the first dose of the Pfizer-BioNTech COVID-19 Vaccine reported?", "id": "100000000000000000007733", "answers": [{"text": "December 14, 2020-January 18,", "answer_start": 328}], "is_impossible": false}], "context": "CDC scientists have conducted detailed reviews of cases of anaphylaxis and made the information available to\nhealthcare providers and the public:\nAllergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine\nReports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US\u2014December 14, 2020-January 18,\nAllergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine\u2014 United\nThe benefits of COVID-19 vaccination continue to outweigh any potential risks."}]}, {"title": "9d86bebfda551d246d83a009349f95b", "paragraphs": [{"qas": [{"question": "What is thrombocytopenia syndrome?", "id": "100000000000000000007736", "answers": [{"text": "rare", "answer_start": 335}], "is_impossible": false}, {"question": "When was the first dose of the Pfizer-BioNTech Covid-19 Vaccine received?", "id": "100000000000000000007738", "answers": [{"text": "December 14-23, 2020", "answer_start": 224}], "is_impossible": false}, {"question": "How many cases of TTS have occurred per one million doses administered?", "id": "100000000000000000007739", "answers": [{"text": "4", "answer_start": 374}], "is_impossible": false}, {"question": "What is a rare but serious adverse event that causes blood clots in large blood vessels and low platelets?", "id": "100000000000000000007740", "answers": [{"text": "Thrombosis with thrombocytopenia syndrome", "answer_start": 245}], "is_impossible": false}, {"question": "A review of reports indicates a causal relationship between what vaccine and TTS?", "id": "100000000000000000007741", "answers": [{"text": "J&J/Janssen COVID-19", "answer_start": 623}], "is_impossible": false}, {"question": "Is there a causal relationship between the J&J/Janssen COVID-19 and TTS?", "id": "100000000000000000007742", "answers": [{"text": "A review of reports indicates a causal relationship", "answer_start": 559}], "is_impossible": false}], "context": "\u2022 -\n\u2022\n\uf209\n\u2022\n\uf209\n\u2022\f10/30/22, 9:32 AM Selected Adverse Events Reported after COVID-19 Vaccination | CDC\nAllergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine \u2014\nUnited States, December 14-23, 2020\nThrombosis with thrombocytopenia syndrome (TTS) after J&J/Janssen COVID-19 vaccination is rare and has\noccurred in approximately 4 cases per one million doses administered. TTS is a rare but serious adverse event that\ncauses blood clots in large blood vessels and low platelets (blood cells that help form clots). A review of reports indicates a causal relationship between the J&J/Janssen COVID-19 vaccine and TTS."}]}, {"title": "bf57ff7d438ce5a2dae51856e5e16117", "paragraphs": [{"qas": [{"question": "Who conducted detailed reviews of TTS cases?", "id": "100000000000000000007743", "answers": [{"text": "CDC scientists", "answer_start": 0}], "is_impossible": false}, {"question": "How large is the Guillain-Barr\u00e9 Syndrome?", "id": "100000000000000000007745", "answers": [{"text": "1.3 MB", "answer_start": 390}], "is_impossible": false}, {"question": "What is GBS in people who have received the J&J/Janssen COVID-19 vaccine?", "id": "100000000000000000007747", "answers": [{"text": "Guillain-Barr\u00e9 Syndrome (GBS) in people who have received the J&J/Janssen COVID-19 vaccine is rare", "answer_start": 408}], "is_impossible": false}, {"question": "GBS is a rare disorder where the body\u2019s immune system damages what?", "id": "100000000000000000007748", "answers": [{"text": "nerve cells", "answer_start": 570}], "is_impossible": false}, {"question": "How old are the majority of the cases of HIV?", "id": "100000000000000000007749", "answers": [{"text": "50 years and older", "answer_start": 674}], "is_impossible": false}], "context": "CDC\nscientists have conducted detailed reviews of TTS cases and made the information available to healthcare providers\nand the public:\nUS Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S\nCase Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination\u2014United States,\nUpdates on Thrombosis with Thrombocytopenia Syndrome (TTS) [1.3 MB, 39 Pages]\nGuillain-Barr\u00e9 Syndrome (GBS) in people who have received the J&J/Janssen COVID-19 vaccine is rare. GBS is a rare\ndisorder where the body\u2019s immune system damages nerve cells, causing muscle weakness and sometimes\nparalysis. GBS has largely been reported in men ages 50 years and older."}]}, {"title": "4556eb3592d528cfeaba174b71a312ce", "paragraphs": [{"qas": [{"question": "How many times higher was the rate of GBS after J&J/Janssen COVID- 19 vaccination?", "id": "100000000000000000007753", "answers": [{"text": "11", "answer_start": 294}], "is_impossible": false}, {"question": "What did the analysis find no increased risk of after Pfizer-BioNTech or Moderna?", "id": "100000000000000000007754", "answers": [{"text": "GBS", "answer_start": 395}], "is_impossible": false}, {"question": "CDC and FDA will continue to monitor for and evaluate reports of what?", "id": "100000000000000000007755", "answers": [{"text": "GBS", "answer_start": 523}], "is_impossible": false}, {"question": "What does GBS occur after after COVID-19 vaccination?", "id": "100000000000000000007756", "answers": [{"text": "11 times higher following J&J/Janssen COVID- 19 vaccination. The analysis found no increased risk", "answer_start": 294}], "is_impossible": false}], "context": "Based on a recent analysis of data from the Vaccine Safety Datalink, the rate of GBS within the first 21 days\nfollowing J&J/Janssen COVID-19 vaccination was found to be 21 times higher than after Pfizer-BioNTech or Moderna\n(mRNA COVID-19 vaccines). After the first 42 days, the rate of GBS was 11 times higher following J&J/Janssen COVID-\n19 vaccination. The analysis found no increased risk of GBS after Pfizer-BioNTech or Moderna (mRNA COVID-19\nvaccines). CDC and FDA will continue to monitor for and evaluate reports of GBS occurring after COVID-19\nvaccination and will share more information as it becomes available."}]}, {"title": "94a024b9e15fffc21e3a9a9ed986a572", "paragraphs": [{"qas": [{"question": "What are rare after COVID-19 vaccination?", "id": "100000000000000000007758", "answers": [{"text": "Myocarditis and pericarditis", "answer_start": 0}], "is_impossible": false}, {"question": "What is myocarditis inflammation of the heart muscle?", "id": "100000000000000000007759", "answers": [{"text": "Myocarditis", "answer_start": 66}], "is_impossible": false}, {"question": "How do most patients feel after receiving the Pfizer-BioNTech vaccine?", "id": "100000000000000000007760", "answers": [{"text": "better quickly", "answer_start": 301}], "is_impossible": false}, {"question": "What is Moderna?", "id": "100000000000000000007762", "answers": [{"text": "mRNA COVID-19 vaccines", "answer_start": 391}], "is_impossible": false}, {"question": "When was a review of vaccine safety data in VAERS conducted?", "id": "100000000000000000007763", "answers": [{"text": "December 2020\u2013August 2021", "answer_start": 513}], "is_impossible": false}], "context": "Myocarditis and pericarditis after COVID-19 vaccination are rare. Myocarditis is inflammation of the heart muscle,\nand pericarditis is inflammation of the outer lining of the heart. Most patients with myocarditis or pericarditis after\nCOVID-19 vaccination responded well to medicine and rest and felt better quickly. Most cases have been reported\nafter receiving Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines), particularly in male adolescents and young\nadults. A review of vaccine safety data in VAERS from December 2020\u2013August 2021 found a small but increased risk of\nmyocarditis after mRNA COVID-19 vaccines."}]}, {"title": "6172504579a2c342e05b2845a26e1624", "paragraphs": [{"qas": [{"question": "How many cases per one million doses of Pfizer-BioNTech vaccine were given?", "id": "100000000000000000007766", "answers": [{"text": "70.7", "answer_start": 229}], "is_impossible": false}, {"question": "How many vaccines are there in the 18-24 year period?", "id": "100000000000000000007768", "answers": [{"text": "Over 350 million", "answer_start": 0}], "is_impossible": false}, {"question": "What are vaccines safe for?", "id": "100000000000000000007770", "answers": [{"text": "children and adolescents", "answer_start": 665}], "is_impossible": false}, {"question": "What will the agency refocus on?", "id": "100000000000000000007771", "answers": [{"text": "enhanced surveillance and safety monitoring efforts", "answer_start": 606}], "is_impossible": false}], "context": "Over 350 million mRNA vaccines were given during the study period\nand CDC scientists found that rates of myocarditis were highest following the second dose of an mRNA vaccine\namong males in the following age groups:\n12\u201315 years (70.7 cases per one million doses of Pfizer-BioNTech)\n16\u201317 years (105.9 cases per one million doses of Pfizer-BioNTech)\n18\u201324 years (52.4 cases and 56.3 cases per million doses of Pfizer-BioNTech and Moderna, respectively)\nMultiple studies and reviews of data from vaccine safety monitoring systems continue to show that vaccines are safe. As\na result, the agency will refocus enhanced surveillance and safety monitoring efforts toward children and adolescents."}]}, {"title": "c78b999190cd0ce542250120a569658e", "paragraphs": [{"qas": [{"question": "How many preliminary VAERS reports were there as of October 20, 2022?", "id": "100000000000000000007772", "answers": [{"text": "1,036", "answer_start": 40}], "is_impossible": false}, {"question": "How many of the VAERS preliminary reports are still under review?", "id": "100000000000000000007773", "answers": [{"text": "253", "answer_start": 190}], "is_impossible": false}, {"question": "What type of testing has confirmed symptoms and diagnostics?", "id": "100000000000000000007774", "answers": [{"text": "provider interview or review of medical records", "answer_start": 267}], "is_impossible": false}, {"question": "How many reports have been verified to meet CDC's working case definition for myocarditis?", "id": "100000000000000000007775", "answers": [{"text": "687", "answer_start": 316}], "is_impossible": false}], "context": "As of October 20, 2022, there have been 1,036 preliminary reports in VAERS among people younger than age 18 years\nunder review for potential cases of myocarditis and pericarditis. Of these, 253 remain under review. Through\nconfirmation of symptoms and diagnostics by provider interview or review of medical records, 687 reports have been\nverified to meet CDC\u2019s working case definition for myocarditis. See below for counts of verified reports of myocarditis by\nage group."}]}, {"title": "ec309214fc62b71ce37398a74f5847db", "paragraphs": [{"qas": [{"question": "How many verified reports of myocarditis were there after 21638,046 doses administered?", "id": "100000000000000000007776", "answers": [{"text": "22", "answer_start": 12}], "is_impossible": false}, {"question": "How many confirmed reports of Myocardititis were found after 24480,644 doses?", "id": "100000000000000000007777", "answers": [{"text": "357", "answer_start": 96}], "is_impossible": false}, {"question": "What vaccines are authorized for younger children?", "id": "100000000000000000007778", "answers": [{"text": "COVID-19", "answer_start": 260}], "is_impossible": false}, {"question": "What will FDA continue to monitor for and evaluate reports of?", "id": "100000000000000000007779", "answers": [{"text": "myocarditis and pericarditis", "answer_start": 380}], "is_impossible": false}], "context": "5-11 years: 22 verified reports of myocarditis after 21,638,046 doses administered\n12-15 years: 357 verified reports of myocarditis after 24,480,644 doses administered\n16-17 years: 308 verified reports of myocarditis after 13,429,039 doses administered\nAs the COVID-19 vaccines are authorized for younger children, CDC and FDA will continue to monitor for and evaluate\nreports of myocarditis and pericarditis after COVID-19 vaccination and will share more information as it becomes\navailable. Learn more about myocarditis and pericarditis, including clinical considerations, after mRNA COVID-19\nvaccination. Reports of death after COVID-19 vaccination are rare."}]}, {"title": "c4043cb05b4e526ea60d21e718bac11b", "paragraphs": [{"qas": [{"question": "What does FDA require healthcare providers to report after COVID-19 vaccination to VAERS even if it\u2019s unclear whether the vaccine was the cause of death?", "id": "100000000000000000007781", "answers": [{"text": "any death", "answer_start": 44}], "is_impossible": false}, {"question": "When were vaccines administered in the United States?", "id": "100000000000000000007784", "answers": [{"text": "December 14, 2020", "answer_start": 608}], "is_impossible": false}, {"question": "When did vaccines begin to be given in the U.S?", "id": "100000000000000000007785", "answers": [{"text": "December 14, 2020", "answer_start": 608}], "is_impossible": false}], "context": "FDA requires healthcare providers to report any death after\nCOVID-19 vaccination to VAERS even if it\u2019s unclear whether the vaccine was the cause Reports of adverse events to\n\u2022\n-\n\u2022\n\uf209\n\u2022\n\uf209\n\u2022 \uf20c\n-\n-\n\uf209\n-\n-\n-\n-\f10/30/22, 9:32 AM Selected Adverse Events Reported after COVID-19 Vaccination | CDC\nCOVID-19 vaccination to VAERS, even if it s unclear whether the vaccine was the cause. Reports of adverse events to\nVAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem. More than 632 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020,\nthrough October 19, 2022."}]}, {"title": "4a183826afd544e1c47a16165ffaa06b", "paragraphs": [{"qas": [{"question": "How many preliminary reports of death did VAERS receive during this time?", "id": "100000000000000000007786", "answers": [{"text": "16,990", "answer_start": 33}], "is_impossible": false}, {"question": "How many deaths have VAERS identified as being related to J&J/Janssen COVID-19 vaccination?", "id": "100000000000000000007787", "answers": [{"text": "nine", "answer_start": 277}], "is_impossible": false}, {"question": "What is the name of the Vaccine Adverse Event Reporting System?", "id": "100000000000000000007788", "answers": [{"text": "VAERS", "answer_start": 559}], "is_impossible": false}, {"question": "When was VAERS last updated?", "id": "100000000000000000007789", "answers": [{"text": "Oct. 24, 2022", "answer_start": 659}], "is_impossible": false}], "context": "During this time, VAERS received 16,990 preliminary reports of death (0.0027%) among\npeople who received a COVID-19 vaccine. CDC and FDA clinicians review reports of death to VAERS including death\ncertificates, autopsy, and medical records. Continued monitoring has identified nine deaths causally associated with\nJ&J/Janssen COVID-19 vaccination. CDC and FDA continue to review reports of death following COVID-19 vaccination\nand update information as it becomes available. Related Pages\nSafety of COVID-19 Vaccines\n\u203a\nVaccine Adverse Event Reporting System (VAERS): What Reports Mean and How VAERS Works\n\u203a\nCOVID-19 Vaccine Safety Publications\n\u203a\nLast Updated Oct. 24, 2022"}]}, {"title": "4c658d5e64a825f97866a4b6f0212d48", "paragraphs": [{"qas": [{"question": "What do self-tests for COVID-19 give rapid results and can be taken anywhere?", "id": "100000000000000000007790", "answers": [{"text": "regardless of your vaccination status or whether or not you have symptoms", "answer_start": 324}], "is_impossible": false}, {"question": "CDC is reviewing this page to align with what?", "id": "100000000000000000007791", "answers": [{"text": "updated guidance", "answer_start": 197}], "is_impossible": false}, {"question": "What do COVID-19 give rapid results?", "id": "100000000000000000007792", "answers": [{"text": "Self-tests", "answer_start": 254}], "is_impossible": false}, {"question": "What are these tests sometimes called?", "id": "100000000000000000007793", "answers": [{"text": "home tests", "answer_start": 460}], "is_impossible": false}], "context": "10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nEspa\u00f1ol | Other Languages\nSelf-Testing At Home or Anywhere\nFor doing rapid COVID-19 tests anywhere\nCDC is reviewing this page to align with updated guidance. \uf6df What is a Self-Test or At-Home Test? Self-tests for COVID-19 give rapid results and can be taken anywhere, regardless of your vaccination status or\nwhether or not you have symptoms. They detect current infection and are sometimes also called \u201chome tests,\u201d \u201cat-home tests,\u201d or \u201cover-the-\ncounter (OTC) tests.\u201d\nThey give your result in a few minutes and are different from laboratory-based tests that may take days\nto return your result."}]}, {"title": "a44b5705e407aae7b8172582de5f025e", "paragraphs": [{"qas": [{"question": "Along with vaccination, wearing a well-fitted mask and physical distancing, what helps protect you and others?", "id": "100000000000000000007795", "answers": [{"text": "Self-tests", "answer_start": 0}], "is_impossible": false}, {"question": "Self-tests do not detect antibodies which would suggest a previous infection and they do not measure what?", "id": "100000000000000000007796", "answers": [{"text": "your level of immunity", "answer_start": 264}], "is_impossible": false}], "context": "Self-tests along with vaccination, wearing a well-fitted mask, and physical distancing, help protect you\nand others by reducing the chances of spreading COVID-19. Self-tests do not detect antibodies which would suggest a previous infection and they do not measure\nyour level of immunity."}]}, {"title": "f4ea37a646ebe595c8b74534d2549ab3", "paragraphs": [{"qas": [{"question": "When are you going to an indoor event or gathering?", "id": "100000000000000000007800", "answers": [{"text": "Immediately before the gathering", "answer_start": 334}], "is_impossible": false}, {"question": "What is important before gathering with people who are not up to date?", "id": "100000000000000000007802", "answers": [{"text": "You are going to an indoor event or a gathering Immediately before the gathering, or as close to the time of the event as possible This is especially important before gathering with individuals at risk of severe disease, older adults, those who are immunocompromised, or people who are not up to date on their COVID-19 vaccines", "answer_start": 286}], "is_impossible": false}, {"question": "Who are immunocompromised?", "id": "100000000000000000007803", "answers": [{"text": "older adults", "answer_start": 507}], "is_impossible": false}, {"question": "Who are people who are not up to date on their COVID-19 vaccines?", "id": "100000000000000000007804", "answers": [{"text": "children who cannot get vaccinated yet", "answer_start": 625}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\uf6e5 When To Take an At-Home COVID-19 Test\nTest Yourself If\u2026 Timing\nYou have any COVID-19 symptoms Immediately\nYou were exposed to someone with COVID-19 At least 5 days after your exposure\nIf you test negative for COVID-19, consider testing\nagain 1 to 2 days after your first test\nYou are going to an indoor event or a gathering Immediately before the gathering, or as close to\nthe time of the event as possible\nThis is especially important before gathering with\nindividuals at risk of severe disease, older adults,\nthose who are immunocompromised, or people\nwho are not up to date on their COVID-19\nvaccines, including children who cannot get\nvaccinated yet."}]}, {"title": "777ab7f6942c5e20d187979682e5b3c8", "paragraphs": [{"qas": [{"question": "When to Use a Self-Test | Espaol | 01:04:53 Watch Video: When To Use A Self Test \u2013 ASL | 02:02:32 How to Get an At-Home COVID-19 Test Buy tests online or in what location?", "id": "100000000000000000007806", "answers": [{"text": "pharmacies and retail stores", "answer_start": 301}], "is_impossible": false}, {"question": "How can you get an At-Home COVID-19 Test?", "id": "100000000000000000007807", "answers": [{"text": "Buy tests online or in pharmacies and retail stores", "answer_start": 278}], "is_impossible": false}, {"question": "Where can you find a list of authorized tests?", "id": "100000000000000000007809", "answers": [{"text": "FDA\u2019s website", "answer_start": 411}], "is_impossible": false}, {"question": "What is available through local health departments?", "id": "100000000000000000007810", "answers": [{"text": "Free tests", "answer_start": 457}], "is_impossible": false}], "context": "10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nLearn what to do if you test positive or test negative. \uf425\nWatch Video: When To Use a Self-Test [00:04:04] | Espa\u00f1ol [00:04:53]\nWatch Video: When To Use a Self-Test \u2013 ASL [00:02:32]\n\uf357\n\uf357\nHow to Get an At-Home COVID-19 Test\nBuy tests online or in pharmacies and retail stores. Private health insurance may reimburse the cost of\npurchasing self-tests. Visit FDA\u2019s website for a list of authorized tests. Free tests may also be available through local health departments."}]}, {"title": "d802cb3b95923ae4d7f51043a3cbe37f", "paragraphs": [{"qas": [{"question": "If you don't follow the manufacturer's instructions, your test result may be what?", "id": "100000000000000000007815", "answers": [{"text": "incorrect", "answer_start": 470}], "is_impossible": false}], "context": "If you\u2019re not able to obtain a self-test when you need it, you might also visit a community testing site, or\ncall your local health department for more options. \u2022\n\uf209\n\u2022\n\u2022\nFDA-Authorized Tests\n\uf6e0 How to Use an At-Home COVID-19 Test\nRead the complete manufacturer\u2019s instructions for use before using the test. To use an at-home test, you will collect a nasal specimen and then test that specimen. If you do not follow the manufacturer\u2019s instructions, your test result may be incorrect. Wash your hands before and after you collect a nasal specimen for your test."}]}, {"title": "b0d47303409f7129892e39b22b896ccf", "paragraphs": [{"qas": [{"question": "How to Use a Self-Test \u2013 ASL [00:03:08] | Espaol | 01:04:02] Need More Information?", "id": "100000000000000000007818", "answers": [{"text": "Watch Video: How To Use a Self-Test [00:03:08] | Espa\u00f1ol [00:04:02] Watch Video: How To Use a Self-Test \u2013 ASL [00:03:25] Need More Information? Find videos of manufacturer instructions for your specific self-test. \uf357 \uf357 What Your Test Results Mean \uf6ec IF YOUR TEST IS Positive", "answer_start": 5}], "is_impossible": false}, {"question": "What does your test detect?", "id": "100000000000000000007819", "answers": [{"text": "the virus", "answer_start": 297}], "is_impossible": false}, {"question": "What is recommended if you have an emergency?", "id": "100000000000000000007820", "answers": [{"text": "a N95 or KN95 respirator", "answer_start": 486}], "is_impossible": false}, {"question": "How long should you stay home?", "id": "100000000000000000007821", "answers": [{"text": "at least 5 days", "answer_start": 348}], "is_impossible": false}, {"question": "What should you wear when you are around others?", "id": "100000000000000000007822", "answers": [{"text": "a well-fitted mask", "answer_start": 433}], "is_impossible": false}, {"question": "What type of respirator is recommended?", "id": "100000000000000000007823", "answers": [{"text": "N95 or KN95", "answer_start": 488}], "is_impossible": false}, {"question": "What should you do if you have any emergency warning signs?", "id": "100000000000000000007824", "answers": [{"text": "seek emergency care immediately", "answer_start": 588}], "is_impossible": false}, {"question": "Who should you tell your healthcare provider?", "id": "100000000000000000007825", "answers": [{"text": "close contacts", "answer_start": 412}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\nWatch Video: How To Use a Self-Test [00:03:08] | Espa\u00f1ol [00:04:02]\nWatch Video: How To Use a Self-Test \u2013 ASL [00:03:25]\nNeed More Information? Find videos of manufacturer instructions for your specific self-test. \uf357\n\uf357\nWhat Your Test Results Mean\n\uf6ec IF YOUR TEST IS\nPositive\nThe test detected the virus and you have an infection. Stay home for at least 5 days and isolate from others in your home. Tell your close contacts. Wear a well-fitted mask when around others. If available, a N95 or KN95 respirator is\nrecommended. Watch for symptoms. If you have any emergency warning signs, seek emergency care immediately. Tell your healthcare provider."}]}, {"title": "5f4021cf2cf6b4612e399ac7967f8469", "paragraphs": [{"qas": [{"question": "What should you do if your symptoms get worse?", "id": "100000000000000000007826", "answers": [{"text": "Contact them as soon as possible", "answer_start": 0}], "is_impossible": false}, {"question": "What is a possible treatment for you?", "id": "100000000000000000007828", "answers": [{"text": "Self-Testing At Home or Anywhere", "answer_start": 248}], "is_impossible": false}, {"question": "What is a CDC medical condition?", "id": "100000000000000000007829", "answers": [{"text": "Self-Testing At Home or Anywhere", "answer_start": 248}], "is_impossible": false}, {"question": "What is another name for a series of self-tests?", "id": "100000000000000000007830", "answers": [{"text": "serial testing", "answer_start": 558}], "is_impossible": false}, {"question": "What is another name for serial testing?", "id": "100000000000000000007831", "answers": [{"text": "a series", "answer_start": 534}], "is_impossible": false}, {"question": "How many hours after the first test should you repeat the test?", "id": "100000000000000000007832", "answers": [{"text": "24 to 48", "answer_start": 603}], "is_impossible": false}], "context": "Contact them as soon as possible if:\nYour symptoms get worse. You are more likely to get very sick because you are an older adult or have an underlying\nmedical condition Possible treatment may be available for you\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n-\n-\f10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nmedical condition. Possible treatment may be available for you. You have questions about your isolation. -\n\uf6eb IF YOUR TEST IS\nNegative\nThe test did not detect the virus, but doesn\u2019t rule out an infection. Some self-tests are designed to be used in a series (also known as serial testing). Consider\nrepeating the test 24 to 48 hours later."}]}, {"title": "20d0ed1cba7f2dadb89b3fa602b88512", "paragraphs": [{"qas": [{"question": "What increases the confidence that you are not infected with the virus that causes COVID-19?", "id": "100000000000000000007833", "answers": [{"text": "Multiple negative tests", "answer_start": 0}], "is_impossible": false}, {"question": "If you think your test result may be incorrect, contact what?", "id": "100000000000000000007834", "answers": [{"text": "the test manufacturer", "answer_start": 172}], "is_impossible": false}, {"question": "What is CDC's Viral Testing Tool?", "id": "100000000000000000007835", "answers": [{"text": "an online, mobile-friendly tool", "answer_start": 575}], "is_impossible": false}, {"question": "What is the name of the tool that asks a series of questions?", "id": "100000000000000000007836", "answers": [{"text": "CDC\u2019s Viral Testing Tool", "answer_start": 547}], "is_impossible": false}, {"question": "What does the tool provide based on a user's responses?", "id": "100000000000000000007837", "answers": [{"text": "recommended actions and resources", "answer_start": 653}], "is_impossible": false}], "context": "Multiple negative tests increases the confidence that you\nare not infected with the virus that causes COVID-19. \u2022\n\u2022\nIf you think your test result may be incorrect, contact the test manufacturer for assistance, consider taking another\nat-home test, or contact a healthcare provider for help. Watch Video: How To Interpret Self-Test Results [00:04:15] | Espa\u00f1ol [00:05:17]\nWatch Video: How To Interpret Self-Test Positive Results - ASL [00:02:37]\nWatch Video: How To Interpret Self-Test Negative Results - ASL [00:03:00]\n\uf357\n\uf357\n\uf357\nNeed additional help? CDC\u2019s Viral Testing Tool is an online, mobile-friendly tool that asks a series of questions, and\nprovides recommended actions and resources based on a user\u2019s responses."}]}, {"title": "e1daaa32a7a2267bc4f318c6832e815c", "paragraphs": [{"qas": [{"question": "What are highly reliable results from self-tests?", "id": "100000000000000000007838", "answers": [{"text": "Positive", "answer_start": 18}], "is_impossible": false}, {"question": "Negative results from what do not rule out SARS-CoV-2 infection?", "id": "100000000000000000007839", "answers": [{"text": "self-tests", "answer_start": 94}], "is_impossible": false}, {"question": "A negative self test result may not be reliable especially if you have symptoms associated with what?", "id": "100000000000000000007840", "answers": [{"text": "COVID-19", "answer_start": 240}], "is_impossible": false}, {"question": "Who strongly encourages everyone who uses a self-test to report any positive results to their healthcare provider?", "id": "100000000000000000007843", "answers": [{"text": "CDC", "answer_start": 415}], "is_impossible": false}], "context": "Related Questions\nPositive results from self-tests are highly reliable. Negative results from self-tests do not rule out SARS-CoV-2 infection. A negative self-test result may not be reliable,\nespecially if you have symptoms associated with COVID-19. Invalid results from self-tests mean the test did not work properly, and a new test is needed to get an accurate result. Should I trust the results of a self-test? \uf1aa\nCDC strongly encourages everyone who uses a self-test to report any positive results to their healthcare provider."}]}, {"title": "df67f194f49fbdce07fc4c88dc5086aa", "paragraphs": [{"qas": [{"question": "The US Government does not want to construct any barriers that would deter what?", "id": "100000000000000000007846", "answers": [{"text": "the use of self-tests", "answer_start": 362}], "is_impossible": false}, {"question": "COVID-19 surveillance continues to be based on results from what?", "id": "100000000000000000007848", "answers": [{"text": "laboratory testing", "answer_start": 445}], "is_impossible": false}, {"question": "What is the primary role of case reporting?", "id": "100000000000000000007849", "answers": [{"text": "to allow public health agencies to take actions to mitigate disease spread", "answer_start": 503}], "is_impossible": false}, {"question": "Who is confident that situational reporting will help mitigate disease spread?", "id": "100000000000000000007850", "answers": [{"text": "CDC", "answer_start": 618}], "is_impossible": false}, {"question": "Who is confident that situational awareness remains strong without self-test results?", "id": "100000000000000000007851", "answers": [{"text": "CDC", "answer_start": 618}], "is_impossible": false}], "context": "Healthcare providers can ensure that those who have tested positive for COVID-19 receive the most appropriate medical\ncare, including specific treatments if necessary. In most jurisdictions, healthcare providers who\u202fdiagnose COVID-19 are required to report those cases to public health. The US Government\u202fdoes not want to construct any barriers that would deter the use of self-tests. COVID-19\nsurveillance\u202fcontinues to be based on results from laboratory testing. The primary role of case reporting is to allow public\nhealth agencies to take actions to mitigate disease spread. The public health community, including CDC, is confident that\nsituational awareness remains strong without receiving self-test results."}]}, {"title": "316913962989ad0f277f70c52acc277c", "paragraphs": [{"qas": [{"question": "Do I need to report the results from my self-test?", "id": "100000000000000000007852", "answers": [{"text": "Do I need to report the results from my self-test", "answer_start": 0}], "is_impossible": false}], "context": "Do I need to report the results from my self-test?"}]}, {"title": "899d2a18692aeb450cd2d2af150e8041", "paragraphs": [{"qas": [{"question": "What does CDC Print Resources Don't Delay: Test Soon and Treat Early do?", "id": "100000000000000000007853", "answers": [{"text": "customizable", "answer_start": 569}], "is_impossible": false}, {"question": "How many pages is the PDF?", "id": "100000000000000000007855", "answers": [{"text": "2", "answer_start": 375}], "is_impossible": false}, {"question": "How many MB does the PDF have?", "id": "100000000000000000007856", "answers": [{"text": "4", "answer_start": 369}], "is_impossible": false}, {"question": "How many pages are customizable?", "id": "100000000000000000007858", "answers": [{"text": "Using Your Self-Test", "answer_start": 546}], "is_impossible": false}, {"question": "When was the last update of the CDC's Using Your Self-Test?", "id": "100000000000000000007859", "answers": [{"text": "Sept. 6, 2022", "answer_start": 824}], "is_impossible": false}, {"question": "What is the name of the FDA-authorized At-Home Test?", "id": "100000000000000000007860", "answers": [{"text": "Helpful Links", "answer_start": 664}], "is_impossible": false}], "context": "\uf1aa\f10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nPrint Resources\nDon't Delay: Test Soon and Treat Early\n[PDF - 361 KB, 1 page]\n\uf20c\f10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nHow to Collect An Anterior Nasal Swab Specimen for COVID-19 Testing\n[PDF - 372 KB, 2 pages]\n\uf20c\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4 MB, 2 pages]\n\uf20c\f10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nUsing Your Self-Test\n[PDF - 295 KB, 1 page]\n\uf20c\f10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nUsing Your Self-Test - customizable\n[PDF - 279 KB, 1 Page]\n\uf20c\f10/30/22, 9:38 AM Self-Testing At Home or Anywhere | CDC\nHelpful Links\nFDA-Authorized At-Home Tests\nSymptoms of COVID-19\nUnderlying Medical Conditions\nTalking to Close Contacts\nQuarantine and Isolation\n\uf209\nLast Updated Sept. 6, 2022"}]}, {"title": "6455d1a58401ba4d1f2de11572896887", "paragraphs": [{"qas": [{"question": "What is the complete list of authorized tests?", "id": "100000000000000000007862", "answers": [{"text": "FDA.gov", "answer_start": 253}], "is_impossible": false}, {"question": "Where can you find CDC instructional videos?", "id": "100000000000000000007863", "answers": [{"text": "at home or anywhere", "answer_start": 332}], "is_impossible": false}, {"question": "When to use a self test and how to interpret results?", "id": "100000000000000000007864", "answers": [{"text": "10/30/22, 9:38 AM Self-Testing Videos | CDC Espa\u00f1ol | Other Languages Self-Testing Videos Manufacturer instructions for doing rapid COVID-19 tests Manufacturer Videos Below are the available instruction videos for using FDA-authorized self-tests. Visit FDA.gov for a complete list of authorized tests. Learn more about Self-Testing at home or anywhere and find CDC instructional videos", "answer_start": 0}], "is_impossible": false}], "context": "10/30/22, 9:38 AM Self-Testing Videos | CDC\nEspa\u00f1ol | Other Languages\nSelf-Testing Videos\nManufacturer instructions for doing rapid COVID-19 tests\nManufacturer Videos\nBelow are the available instruction videos for using FDA-authorized self-tests. Visit FDA.gov for a complete list of\nauthorized tests. Learn more about Self-Testing at home or anywhere and find CDC instructional videos, including when to use a self-test\nand how to interpret results."}]}, {"title": "9bb90e846b8209d65dcf5ae4c72dc05d", "paragraphs": [{"qas": [{"question": "BD Veritor Manufactured by BD Steps for testing What is the name of the at-home COVID-19 test?", "id": "100000000000000000007865", "answers": [{"text": "BD Veritor", "answer_start": 52}], "is_impossible": false}, {"question": "BinaxNow Manufactured by Abbott How to: A Guide for the BinxNOWTM COVIDR-19 Self-Test?", "id": "100000000000000000007866", "answers": [{"text": "BD Veritor", "answer_start": 1}], "is_impossible": false}, {"question": "Access Bio Carestart Antigen Home Test Kit \u2013 Instructional Video How to use the Celltrion DiaTrustTM Covid-19 Ag Home Test?", "id": "100000000000000000007867", "answers": [{"text": "FlowFlex", "answer_start": 554}], "is_impossible": false}, {"question": "What is the name of the CLINITEST Antigen Self-Test?", "id": "100000000000000000007869", "answers": [{"text": "COVID-19", "answer_start": 497}], "is_impossible": false}, {"question": "Who manufactures FlowFlex Antigen Rapid Test with Prefilled Extraction Buffer Tubes?", "id": "100000000000000000007870", "answers": [{"text": "ACON Laboratories", "answer_start": 580}], "is_impossible": false}, {"question": "Who manufactures the iHealth COVID-19 Antigen Rapid Test \u2013 Self-testing accessible to everyone?", "id": "100000000000000000007871", "answers": [{"text": "BD Sensor", "answer_start": 1085}], "is_impossible": false}, {"question": "InBios SCoV-2 Ag DetectTM Rapid Test Manufactured by What company?", "id": "100000000000000000007872", "answers": [{"text": "InBios", "answer_start": 827}], "is_impossible": false}, {"question": "Who makes the QuickVue?", "id": "100000000000000000007874", "answers": [{"text": "Quidel", "answer_start": 1000}], "is_impossible": false}, {"question": "Who manufactured the COVID-19 At-Home Test?", "id": "100000000000000000007875", "answers": [{"text": "BD Sensor", "answer_start": 1085}], "is_impossible": false}, {"question": "When was the last time the CDC updated its Self-Testing Videos?", "id": "100000000000000000007876", "answers": [{"text": "Feb. 10, 2022", "answer_start": 1191}], "is_impossible": false}], "context": "\uf209\nBD Veritor\nManufactured by BD\nSteps for testing \u2013 BD Veritor At-Home COVID-19 Test \uf209\nBinaxNow\nManufactured by Abbott\nHow To: A Guide for the BinaxNOW\u2122 COVID-19 Self-Test \uf209\nCarestart\nManufactured by Access Bio\nAccess Bio Carestart Antigen Home Test Kit \u2013 Instructional Video \uf209\nCelltrion DiaTrust\u2122\nManufactured by Celltrion USA\nHow to use the Celltrion DiaTrust\u2122 COVID-19 Ag Home Test \uf209\f10/30/22, 9:38 AM Self-Testing Videos | CDC\nCLINITEST\nManufactured by Siemens\nHow to use the CLINITEST\u00ae Rapid COVID-19 Antigen Self-Test (prefilled extraction tubes)\n\uf209\nFlowFlex\nManufactured by ACON Laboratories\nFlowFlex SARS-CoV-2 Antigen Rapid Test with Prefilled Extraction Buffer Tubes \uf209\niHealth\nManufactured by iHealth\niHealth COVID-19 Antigen Rapid Test \u2013 Self-testing accessible to everyone \uf209\nInBios SCoV-2 Ag Detect\u2122\nManufactured by InBios\nInBios SCoV-2 Ag Detect\u2122 Rapid Test \uf209\nInteliSwab\nManufactured by OraSure Technologies\nInteliSwab\u2122 COVID-19 Rapid Test Training Video (OTC) \uf209\nQuickVue\nManufactured by Quidel\nQuickVue At-Home (quickvueathome.com) \uf209\nCOVID-19 At-Home Test\nManufactured by BD Sensor\nHow to use the COVID-19 At-Home Test \uf209\f10/30/22, 9:38 AM Self-Testing Videos | CDC\nLast Updated Feb. 10, 2022"}]}, {"title": "91302acdc2fd07ba1804e3728126baa9", "paragraphs": [{"qas": [{"question": "What is the date range of the State of Vaccine Confidence Insights Report?", "id": "100000000000000000007877", "answers": [{"text": "May 3 \u2013 May 31, 2022", "answer_start": 56}], "is_impossible": false}, {"question": "What are the major themes identified from social media, news and other sources that may impact vaccine confidence?", "id": "100000000000000000007878", "answers": [{"text": "State of Vaccine Confidence Insights Report Date Range: May 3 \u2013 May 31, 2022 Summary Major themes identified from social media, news, and other sources that may impact vaccine confidence: Consumers continue to express their concerns about actual and potential COVID-19 vaccine side effects", "answer_start": 0}], "is_impossible": false}, {"question": "What do consumers continue to express their lack of concern about?", "id": "100000000000000000007879", "answers": [{"text": "COVID-19", "answer_start": 418}], "is_impossible": false}, {"question": "What do parents express concern and hesitation regarding?", "id": "100000000000000000007881", "answers": [{"text": "COVID-19 vaccination for children", "answer_start": 546}], "is_impossible": false}, {"question": "Consumers have questions about what?", "id": "100000000000000000007882", "answers": [{"text": "COVID-19 vaccines and monkeypox", "answer_start": 699}], "is_impossible": false}, {"question": "What do consumers have questions about?", "id": "100000000000000000007883", "answers": [{"text": "the relationship between COVID-19 vaccines and monkeypox", "answer_start": 674}], "is_impossible": false}], "context": "State of Vaccine Confidence\nInsights Report\nDate Range: May 3 \u2013 May 31, 2022\nSummary\nMajor themes identified from social media, news, and other sources that may impact\nvaccine confidence:\nConsumers continue to express their concerns about actual and potential COVID-19 vaccine\nside effects. Continuing and evolving themes that may impact vaccine confidence:\n\u0083 Consumers continue to express their lack of concern about COVID-19 despite rising cases\nand over 1 million dead Americans. \u0083 Parents continue to express concern and hesitation regarding COVID-19 vaccination for\nchildren. Emerging Misinformation Theme Affecting Vaccine Confidence:\n\u0083 Consumers have questions about the relationship between COVID-19 vaccines and\nmonkeypox. Ways public health and partners can take action."}]}, {"title": "5da2e6d2262b1a0d06ccf2bf5ee49a82", "paragraphs": [{"qas": [{"question": "What is one way to clarify the benefits of COVID-19 vaccines?", "id": "100000000000000000007885", "answers": [{"text": "boosters", "answer_start": 55}], "is_impossible": false}, {"question": "What will increase the chances that it is a mild case of COVID-19?", "id": "100000000000000000007887", "answers": [{"text": "vaccination", "answer_start": 286}], "is_impossible": false}, {"question": "What are vaccines still important in the prevention response?", "id": "100000000000000000007888", "answers": [{"text": "Develop and amplify messages", "answer_start": 350}], "is_impossible": false}, {"question": "What are local health departments, public health experts and healthcare workers to explain?", "id": "100000000000000000007891", "answers": [{"text": "absence of association between COVID-19 vaccines and monkeypox", "answer_start": 657}], "is_impossible": false}], "context": "\u0083 Clarify the benefits of COVID-19 vaccines, including boosters, in preventing severe disease. \u0083 Work with community members and trusted messengers to create and disseminate messages that explain that some side\neffects are normal and expected. If a vaccinated individual gets COVID-19, vaccination will increase the chances that it is a\nmild case. \u0083 Develop and amplify messages explaining why vaccines are still important in the COVID-19 prevention response. \u0083 Disseminate messages about community-level risk and corresponding COVID-19 mitigation measures. \u0083 Encourage local health departments, public health experts, and healthcare workers to explain the absence of association\nbetween COVID-19 vaccines and monkeypox."}]}, {"title": "7feabad28bc043524f2818aee1590d56", "paragraphs": [{"qas": [{"question": "What do you need to use when communicating about monkeypox?", "id": "100000000000000000007892", "answers": [{"text": "risk communication strategies", "answer_start": 17}], "is_impossible": false}, {"question": "What do messengers explain about the spread and outcomes of the infection?", "id": "100000000000000000007893", "answers": [{"text": "what is known and what is not known", "answer_start": 158}], "is_impossible": false}, {"question": "For findings and ways to act, see previous Insights Reports?", "id": "100000000000000000007894", "answers": [{"text": "our other reports", "answer_start": 282}], "is_impossible": false}, {"question": "What can CDC partners now report directly to CDC?", "id": "100000000000000000007895", "answers": [{"text": "vaccine rumors", "answer_start": 630}], "is_impossible": false}], "context": "\u0083 Utilize proper risk communication strategies when communicating about monkeypox, including tailored communication with\ntrusted messengers that explain both what is known and what is not known about the spread and outcomes of monkeypox\ninfection. For findings and ways to act from our other reports, see previous Insights Reports. Resources: The following link contains social media resources such as graphics, language, and social media calendars that our\npartners can use to address the issues raised in this report: https://centersfordiseasecontrol.sharefile.com/d-s085b6a2566b04a2\nSPECIAL UPDATE: CDC partners\ncan now report vaccine rumors\ndirectly to CDC."}]}, {"title": "ebba2d7d5adcd572d64c3d1122a4ad47", "paragraphs": [{"qas": [{"question": "How do you report a rumor?", "id": "100000000000000000007896", "answers": [{"text": "go to: www.cdc.gov/ report-rumors and start the subject line with: \"Rumors:\"", "answer_start": 19}], "is_impossible": false}, {"question": "Where do you start the subject line of a report?", "id": "100000000000000000007897", "answers": [{"text": "Rumors", "answer_start": 87}], "is_impossible": false}, {"question": "How many times have you heard it?", "id": "100000000000000000007898", "answers": [{"text": "how many times", "answer_start": 236}], "is_impossible": false}, {"question": "What is the major theme impacting vaccine confidence?", "id": "100000000000000000007899", "answers": [{"text": "Continuing and Evolving", "answer_start": 421}], "is_impossible": false}, {"question": "Consumers continue to express their concerns about what?", "id": "100000000000000000007901", "answers": [{"text": "COVID-19 vaccine side effects", "answer_start": 388}], "is_impossible": false}, {"question": "How many Americans died from COVID-19?", "id": "100000000000000000007902", "answers": [{"text": "1 million", "answer_start": 531}], "is_impossible": false}], "context": "To report a\nrumor, go to: www.cdc.gov/\nreport-rumors and start the\nsubject line with: \"Rumors:\"\nand in the question box, give\nas much information about the\nrumor as you can, including a\ndescription of the rumor, where\nyou heard it, and how many\ntimes you have heard it. 3 Major Theme Impacting Vaccine Confidence,\n4 Consumers continue to express their concerns about\nactual and potential COVID-19 vaccine side effects. 5 Continuing and Evolving Themes Impacting Vaccine\nConfidence\n5 Concern about COVID-19 despite rising cases and 1\nmillion dead Americans. 7 Parents continue to express concern and hesitation\nregarding COVID-19 vaccination in children."}]}, {"title": "945d94748e6f992932930e264990ca5a", "paragraphs": [{"qas": [{"question": "What is the purpose of the COVID-19 State of Vaccine Confidence Insights Report?", "id": "100000000000000000007905", "answers": [{"text": "By rapidly reviewing and analyzing numerous sources and inputs (see Appendix), the COVID-19 State of Vaccine Confidence Insights Report emphasizes major themes influencing COVID-19 vaccine hesitancy and uptake", "answer_start": 217}], "is_impossible": false}, {"question": "What are the major themes influencing COVID-19 vaccine hesitancy and uptake?", "id": "100000000000000000007907", "answers": [{"text": "the level and type of threat to vaccine confidence, degree of spread, and directionality", "answer_start": 455}], "is_impossible": false}], "context": "Centers for Disease Control & Prevention,\nCOVID-19 Response, Vaccine Task Force\nVaccine Confidence & Demand Team, Insights Unit\fCOVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAims and Methods\nBy rapidly reviewing and analyzing numerous sources and inputs (see Appendix), the COVID-19 State of Vaccine Confidence\nInsights Report emphasizes major themes influencing COVID-19 vaccine hesitancy and uptake. These are characterized by the\nlevel and type of threat to vaccine confidence, degree of spread, and directionality."}]}, {"title": "cbb9732fc493f66abfacb4c132aa6be5", "paragraphs": [{"qas": [{"question": "What is the purpose of the Insights Report?", "id": "100000000000000000007908", "answers": [{"text": "seeks to identify emerging issues of misinformation, disinformation, and places where intervention efforts can improve vaccine confidence across the United States", "answer_start": 143}], "is_impossible": false}, {"question": "What does the report seek to identify?", "id": "100000000000000000007909", "answers": [{"text": "emerging issues of misinformation, disinformation", "answer_start": 161}], "is_impossible": false}, {"question": "What may be underrepresented in this report?", "id": "100000000000000000007910", "answers": [{"text": "certain populations", "answer_start": 362}], "is_impossible": false}, {"question": "Images and quotes are illustrative examples and are not meant to cover all content related to what?", "id": "100000000000000000007911", "answers": [{"text": "highlighted themes", "answer_start": 521}], "is_impossible": false}], "context": "In addition, by examining how consumers\nthink and feel, the social processes, and the practical issues around vaccination, the Insights Report seeks to identify emerging\nissues of misinformation, disinformation, and places where intervention efforts can improve vaccine confidence across the\nUnited States. The information in this report is only a snapshot, and certain populations may be underrepresented. Images and quotes are\nillustrative examples and are not meant to comprehensively cover all content related to the highlighted themes. How do you classify this theme/information?"}]}, {"title": "f0a8b68ff3d46190479c8bea78577216", "paragraphs": [{"qas": [{"question": "How has the theme/idea changed over time?", "id": "100000000000000000007913", "answers": [{"text": "Variable reach and dissemination How has this theme/idea changed over time (since last report or over the course of multiple reports", "answer_start": 364}], "is_impossible": false}], "context": "High risk Moderate risk Low risk Positive sentiment\n\u0083 May lead to vaccine\nrefusals and decreased\nuptake\n\u0083 Wide reach, pervasive\n\u0083 Potential to trigger\nhesitancy to vaccination\n\u0083 Moderate reach, modest\ndissemination\n\u0083 Concerning, but low risk\nto vaccine confidence\n\u0083 Limited reach, limited\ndissemination\n\u0083 Could increase vaccine\nconfidence, intent, or\nmotivation\n\u0083 Variable reach and\ndissemination\nHow has this theme/idea changed over time (since last report or over the course of multiple reports)?"}]}, {"title": "b17fd51256dba419bf3ca66cc9b46578", "paragraphs": [{"qas": [{"question": "What is not gaining further traction and there has been no indication of additional activity?", "id": "100000000000000000007914", "answers": [{"text": "Decreasing Information", "answer_start": 94}], "is_impossible": false}, {"question": "What is the main theme impacting Vaccine Confidence?", "id": "100000000000000000007915", "answers": [{"text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022 Major Theme Impacting Vaccine Confidencea,b Consumers continue to express their concerns about actual and potential COVID-19 vaccine side effects", "answer_start": 205}], "is_impossible": false}, {"question": "Consumers continue to express their concerns about what?", "id": "100000000000000000007916", "answers": [{"text": "actual and potential COVID-19 vaccine side effects", "answer_start": 372}], "is_impossible": false}], "context": "Increasing\nInformation spreading rapidly\nStable\nInformation remaining\nconstant at prior level\nDecreasing\nInformation is not gaining further\ntraction and there has been no\nindication of additional activity\fCOVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nMajor Theme Impacting Vaccine Confidencea,b\nConsumers continue to express their concerns about actual and potential COVID-19\nvaccine side effects."}]}, {"title": "39d3a5b451736b829c3127bde9bde5b0", "paragraphs": [{"qas": [{"question": "What did the decision spur online conversations about?", "id": "100000000000000000007919", "answers": [{"text": "discussing the perceived lack of effectiveness of all COVID-19 vaccines", "answer_start": 614}], "is_impossible": false}, {"question": "What did this decision spur online conversations about?", "id": "100000000000000000007921", "answers": [{"text": "discussing the perceived lack of effectiveness of all COVID-19 vaccines", "answer_start": 614}], "is_impossible": false}, {"question": "How did the decision affect vaccine uptake?", "id": "100000000000000000007922", "answers": [{"text": "discouraging", "answer_start": 695}], "is_impossible": false}], "context": "Although some side effects from COVID-19 vaccines are normal and expected,1 concern about adverse events and long-term\neffects from the vaccine keep many from seeking COVID-19 vaccination.2,3 On May 5, 2022, the FDA limited the authorized\nuse of the Janssen COVID-19 Vaccine to individuals ages 18 years and older for whom other authorized or approved COVID-19\nvaccines are not accessible or clinically appropriate, and to individuals ages 18 years and older who elect to receive the Janssen\nCOVID-19 vaccine because they would otherwise not receive a COVID-19 vaccine.4 This decision spurred online conversations\ndiscussing the perceived lack of effectiveness of all COVID-19 vaccines, further discouraging vaccine uptake.5,6,7\nPerceptions, Concerns, and Threats to Vaccine Confidence\n\u0083 Hepatitis."}]}, {"title": "a85c3fe95a9cf056adbf6c4e84dab838", "paragraphs": [{"qas": [{"question": "Some consumers are concerned that rising hepatitis cases in children are caused by what?", "id": "100000000000000000007923", "answers": [{"text": "COVID-19 vaccines", "answer_start": 83}], "is_impossible": false}, {"question": "What vaccines have been ruled out because many children were too young to be eligible for vaccination at the time of rising cases?", "id": "100000000000000000007924", "answers": [{"text": "COVID-19", "answer_start": 186}], "is_impossible": false}], "context": "Some consumers are concerned that rising hepatitis cases in\nchildren are caused by COVID-19 vaccines.8,9,10 Although CDC includes\nCOVID-19 vaccination in its potential cause hypothesis, COVID-19 vaccines\nhave been ruled out because many children were too young to be eligible\nfor vaccination at the time of rising cases.11,12\n\u0083 Myocarditis."}]}, {"title": "7b8e6c1e95fef107f5d2ce01a4431f04", "paragraphs": [{"qas": [{"question": "What vaccine-related myocarditis is much lower for children than teens?", "id": "100000000000000000007925", "answers": [{"text": "COVID-19", "answer_start": 9}], "is_impossible": false}, {"question": "Personal anecdotes14 and reports of hospitalization15 continue to negatively impact what?", "id": "100000000000000000007926", "answers": [{"text": "vaccine confidence", "answer_start": 192}], "is_impossible": false}, {"question": "CDC and its partners are actively monitoring reports of what after COVID-19 vaccination?", "id": "100000000000000000007927", "answers": [{"text": "myocarditis and pericarditis", "answer_start": 277}], "is_impossible": false}, {"question": "What does CDC give regular public updates about?", "id": "100000000000000000007928", "answers": [{"text": "the risks of myocarditis and pericarditis", "answer_start": 376}], "is_impossible": false}, {"question": "What is the most common type of myocarditis after mRNA vaccination?", "id": "100000000000000000007929", "answers": [{"text": "adolescents and young adult males", "answer_start": 459}], "is_impossible": false}, {"question": "What type of vaccination is most common in adolescents and young adult males within several days after COVID-19 vaccination? What was the highest incidence of cardiac outcomes after a COVId-19 vaccination for males aged 12 to 17 years after the second dose?", "id": "100000000000000000007930", "answers": [{"text": "mRNA", "answer_start": 424}], "is_impossible": false}, {"question": "How many times higher was the risk for cardiac outcomes after SARS-CoV-2 infection than after the second vaccine dose?", "id": "100000000000000000007931", "answers": [{"text": "1.8\u20135.6", "answer_start": 781}], "is_impossible": false}, {"question": "Vaccine-acquired Immune Deficiency Syndrome and HIV?", "id": "100000000000000000007933", "answers": [{"text": "\u0083", "answer_start": 1067}], "is_impossible": false}], "context": "Although COVID-19 vaccine-related myocarditis is much\nlower for children than teens,13 personal anecdotes14 and reports of\nhospitalization15 following myocarditis continue to negatively impact\nvaccine confidence.16,17,18 CDC and its partners are actively monitoring\nreports of myocarditis and pericarditis after COVID-19 vaccination and CDC\ngives regular public updates about the risks of myocarditis and pericarditis\nafter mRNA vaccination, predominantly in adolescents and young adult\nmales within several days after COVID-19 vaccination.19\n\u0083 One CDC study found that \u201cthe incidence of cardiac outcomes after\nmRNA COVID-19 vaccination was highest for males aged 12\u201317 years after the second vaccine dose; however, within this\ndemographic group, the risk for cardiac outcomes was 1.8\u20135.6 times as high after SARS-CoV-2 infection than after the second\nvaccine dose.\u201d20 Another study \u201cfound that the risk for cardiac complications was significantly higher after SARS-CoV-2\ninfection than after mRNA COVID-19 vaccination for both males and females in all age groups.\u201d21\n\u0083 Vaccine-acquired Immune Deficiency Syndrome and HIV."}]}, {"title": "22db8bdc52ee6ba41f4a8efd756115ca", "paragraphs": [{"qas": [{"question": "What report detailed the evolution of the VAIDS narrative to concerns?", "id": "100000000000000000007935", "answers": [{"text": "The State of Vaccine Confidence Report", "answer_start": 139}], "is_impossible": false}, {"question": "Social media users are using false claims as a rationale to resist what?", "id": "100000000000000000007936", "answers": [{"text": "vaccination", "answer_start": 345}], "is_impossible": false}, {"question": "What does false claim use to resist vaccination?", "id": "100000000000000000007937", "answers": [{"text": "VAIDS narrative to concerns about HIV. Social media users are further bolstering this false claim, using it as a rationale", "answer_start": 212}], "is_impossible": false}, {"question": "What is the association between COVID-19 vaccines and risk for  Impaired Immunity?", "id": "100000000000000000007938", "answers": [{"text": "no", "answer_start": 381}], "is_impossible": false}], "context": "Online rumors continue to spread stating that COVID-19\nvaccines cause vaccine-acquired immune deficiency syndrome (VAIDS) and HIV.22,23,24 The State of Vaccine Confidence Report\n#24 detailed the evolution of the VAIDS narrative to concerns about HIV. Social media users are further bolstering this false\nclaim, using it as a rationale to resist vaccination.25,26 However, there is no association between COVID-19 vaccines and risk for\n\u0083 Impaired Immunity."}]}, {"title": "55082a6c150f125b6838ad20ba12fe2c", "paragraphs": [{"qas": [{"question": "Some social media users are sharing a pre-print manuscript of a study that has not been peer-reviewed28.", "id": "100000000000000000007939", "answers": [{"text": "claiming that mRNA vaccines harm long-term immunity", "answer_start": 103}], "is_impossible": false}, {"question": "What do some social media user's claim vaccines do more harm than infection-induced immunity?", "id": "100000000000000000007940", "answers": [{"text": "safety concerns", "answer_start": 184}], "is_impossible": false}, {"question": "CDC maintains COVID-19 vaccination causes a more predictable immune system?", "id": "100000000000000000007941", "answers": [{"text": "31,32 CDC maintains COVID-19 vaccination causes a more predictable immune response than infection with the virus that causes COVID-19", "answer_start": 292}], "is_impossible": false}, {"question": "What vaccine gives most people a high level of protection against COVID-19-related complications, hospitalizations, and deaths?", "id": "100000000000000000007942", "answers": [{"text": "COVID-19", "answer_start": 437}], "is_impossible": false}], "context": "Some social media users are sharing a pre-print manuscript of a study that has not been peer-reviewed28\nclaiming that mRNA vaccines harm long-term immunity.29,30 Due to this and other safety concerns, some social media users\nare claiming vaccines do more harm than infection-induced immunity.31,32 CDC maintains COVID-19 vaccination causes a more\npredictable immune response than infection with the virus that causes COVID-19. Getting a COVID-19 vaccine gives most\npeople a high level of protection against COVID-19-related complications, hospitalizations, and deaths.33\nFertility, reproductive health, and lactation."}]}, {"title": "c1c68f5b69c1b081afa0bf8cc07699d8", "paragraphs": [{"qas": [{"question": "Some consumers are hesitant to get the COVID-19 vaccine due to fear of what?", "id": "100000000000000000007943", "answers": [{"text": "long-term effects", "answer_start": 71}], "is_impossible": false}, {"question": "Some social media users are concerned about the effects vaccine can have on what kind of fetuses?", "id": "100000000000000000007944", "answers": [{"text": "fetuses", "answer_start": 226}], "is_impossible": false}, {"question": "Many studies have shown that what is safe for people who want to have a baby?", "id": "100000000000000000007945", "answers": [{"text": "COVID-19 vaccines", "answer_start": 272}], "is_impossible": false}, {"question": "What are people who would like to have a baby and carry no long-term effects on female reproductive systems?", "id": "100000000000000000007946", "answers": [{"text": "COVID-19 vaccines", "answer_start": 272}], "is_impossible": false}, {"question": "What can be found in this online document?", "id": "100000000000000000007947", "answers": [{"text": "Social media posts", "answer_start": 534}], "is_impossible": false}], "context": "Some consumers are\nhesitant to get the COVID-19 vaccine due to fear of long-term effects\non fertility,34,35 lactation,36 and pregnancy.37,38 Additionally, social media\nusers are concerned about the effects vaccine can have on fetuses.39,40,41\nMany studies have shown that COVID-19 vaccines are safe for people\nwho would like to have a baby and carry no long-term effects on\nfemale reproductive systems.42,43,44\naCitations in this report are illustrative examples and are not the total number of instances of the corresponding themes\nbSocial media posts referenced throughout this report can be found in this online document."}]}, {"title": "4b007c784767913ae076a7e2197f6975", "paragraphs": [{"qas": [{"question": "What is the date of the COVID-19 State of Vaccine Confidence Insights Report?", "id": "100000000000000000007948", "answers": [{"text": "October 10, 2022", "answer_start": 55}], "is_impossible": false}, {"question": "What do some consumers believe about the side effects listed in released Pfizer documents?", "id": "100000000000000000007949", "answers": [{"text": "Pfizer lied about the number of Pfizer-BioNTech COVID-19 vaccine-related adverse events", "answer_start": 241}], "is_impossible": false}, {"question": "Which company engaged in fraudulent and dishonest vaccine research?", "id": "100000000000000000007950", "answers": [{"text": "Pfizer", "answer_start": 216}], "is_impossible": false}, {"question": "What are some of the negative effects of the COVID-19 vaccine?", "id": "100000000000000000007951", "answers": [{"text": "fertility, pregnancy, and lactation", "answer_start": 432}], "is_impossible": false}, {"question": "What can public health and partners do to improve vaccine confidence?", "id": "100000000000000000007952", "answers": [{"text": "Clarify the benefits of COVID-19 vaccines", "answer_start": 554}], "is_impossible": false}], "context": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nIdentified misinformation themes that may impact vaccine confidencec\n\u0083 Some consumers believe that the COVID-19 side effects listed in released Pfizer documents45 prove Pfizer lied about the\nnumber of Pfizer-BioNTech COVID-19 vaccine-related adverse events,46 engaged in fraudulent and dishonest vaccine\nresearch,47,48 and this vaccine has negative impacts on fertility, pregnancy, and lactation.49,50\nWays public health and partners can take action to improve vaccine confidence\n\u0083 Clarify the benefits of COVID-19 vaccines, including boosters, in preventing severe disease."}]}, {"title": "6d0859c21fa8497620f27466c3a33aa0", "paragraphs": [{"qas": [{"question": "What do community members and trusted messengers need to create and disseminate messages that explain that some side effects are normal and expected?", "id": "100000000000000000007953", "answers": [{"text": "\u0083", "answer_start": 0}], "is_impossible": false}, {"question": "If a vaccinated individual gets COVID-19, vaccination will increase the chances that it is a mild case?", "id": "100000000000000000007954", "answers": [{"text": "mild case. \u0083", "answer_start": 241}], "is_impossible": false}, {"question": "What do messages debunking circulating misinformation do when the misinformation persists or has a high potential to impact vaccination uptake in your community?", "id": "100000000000000000007955", "answers": [{"text": "Disseminate", "answer_start": 255}], "is_impossible": false}, {"question": "What would be required, and this is why that is not likely?", "id": "100000000000000000007957", "answers": [{"text": "plausible biological mechanisms", "answer_start": 530}], "is_impossible": false}], "context": "\u0083 Work with community members and trusted messengers to create and disseminate messages that explain that some side\neffects are normal and expected. If a vaccinated individual gets COVID-19, vaccination will increase the chances that it is a\nmild case. \u0083 Disseminate messages debunking circulating misinformation when the misinformation persists or it has a high potential to\nimpact vaccination uptake in your community. Craft messages that use these evidence-based messaging strategies such as:\n\u0082 For XYZ to occur, these are the plausible biological mechanisms that would be required, and this is why that is not likely."}]}, {"title": "359166c9409a77049434a946349179cb", "paragraphs": [{"qas": [{"question": "What is not possible for vaccines to cause XYZ because of this reason?", "id": "100000000000000000007958", "answers": [{"text": "\u0082", "answer_start": 0}], "is_impossible": false}, {"question": "What did we look into by reviewing DATA SOURCE A and DATASOURCE B?", "id": "100000000000000000007959", "answers": [{"text": "XYZ", "answer_start": 92}], "is_impossible": false}, {"question": "What is XYZ and it is CAUSE, not the vaccine?", "id": "100000000000000000007960", "answers": [{"text": "We know what could cause XYZ", "answer_start": 167}], "is_impossible": false}, {"question": "Encourage healthcare workers and public health officials to be what about possible vaccine side effects?", "id": "100000000000000000007962", "answers": [{"text": "transparent", "answer_start": 336}], "is_impossible": false}], "context": "\u0082 It is not possible for the vaccines to cause XYZ because of this reason. \u0082 We looked into XYZ by reviewing DATA SOURCE A and DATA SOURCE B, and we didn\u2019t find it. \u0082 We know what could cause XYZ and it is CAUSE, not the vaccine. \u0082 There is no evidence that XYZ is true. \u0083 Encourage healthcare workers and public health officials to be transparent about possible vaccine side effects (myocarditis,\nfever, body aches, etc.)."}]}, {"title": "dd0818c0bade571e28c28592311798fb", "paragraphs": [{"qas": [{"question": "All social media posts that are used as citations in the identified misinformation sections can be found online through this link?", "id": "100000000000000000007964", "answers": [{"text": "cAll social media posts that are used as citations in the identified misinformation sections for this report can be found online through this link. COVID-19 State of Vaccine Confidence Insights Report", "answer_start": 213}], "is_impossible": false}, {"question": "What is the name of the state of vaccine confidence insights report?", "id": "100000000000000000007965", "answers": [{"text": "COVID-19", "answer_start": 361}], "is_impossible": false}, {"question": "When is the COVID-19 State of Vaccine Confidence Insight Report released?", "id": "100000000000000000007966", "answers": [{"text": "October 10, 2022", "answer_start": 416}], "is_impossible": false}, {"question": "What does the information highlighted below focus on?", "id": "100000000000000000007968", "answers": [{"text": "what is new or different from previous reports", "answer_start": 637}], "is_impossible": false}], "context": "Similarly, create communications materials showing the lack of evidence that COVID-19 vaccines are\nassociated with AIDS, hepatitis, impaired immunity, and long-term effects on fertility, pregnancy, and lactation. cAll social media posts that are used as citations in the identified misinformation sections for this report can be found online through\nthis link. COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nContinuing and Evolving Themes Impacting Vaccine Confidence\nThe themes below have been noted in previous reports and continue to undermine vaccine confidence. The information\nhighlighted below focuses on what is new or different from previous reports."}]}, {"title": "3d37f7bea7b1b1320fc685e980d1591f", "paragraphs": [{"qas": [{"question": "What do consumers continue to express their lack of concern about?", "id": "100000000000000000007969", "answers": [{"text": "COVID-19", "answer_start": 158}], "is_impossible": false}, {"question": "How many Americans died from COVID-19?", "id": "100000000000000000007970", "answers": [{"text": "1 million", "answer_start": 192}], "is_impossible": false}, {"question": "What is the peak of daily new infections during this reporting period on May 31, 2022?", "id": "100000000000000000007971", "answers": [{"text": "157,329", "answer_start": 279}], "is_impossible": false}], "context": "For additional context and previous\nrecommendations on these themes, see previous Insights Reports. Consumers continue to express their lack of concern about COVID-19 despite rising cases\nand 1 million dead Americans. CDC\u2019s COVID Data Tracker51 indicates a\npeak of approximately 157,329 daily new\ninfections during this reporting period\non May 31, 2022."}]}, {"title": "9f7f2b201160a8018760f15c5774fc3c", "paragraphs": [{"qas": [{"question": "What percentage of the population was in a'medium' or 'high' designation for COVID-19?", "id": "100000000000000000007972", "answers": [{"text": "55%", "answer_start": 172}], "is_impossible": false}, {"question": "What may be due to reports of waning COVID-19 vaccine- acquired immunity?", "id": "100000000000000000007974", "answers": [{"text": "Online discussions of current vaccine efficacy against dominant variants", "answer_start": 238}], "is_impossible": false}, {"question": "What is at the lowest point since July 2021?", "id": "100000000000000000007975", "answers": [{"text": "SARS-CoV-2", "answer_start": 622}], "is_impossible": false}], "context": "Although current\ncases are a fraction of the peak daily\nnew infection during the Omicron wave\n(daily cases exceeded 800,000),52 CDC\nCOVID-19 Community Levels for more\nthan 55% of the population were in a\n\u2018medium\u2019 or \u2018high\u2019 designation.53\nOnline discussions of current vaccine efficacy against dominant variants may be due to reports of waning COVID-19 vaccine-\nacquired immunity,54,55 breakthrough infection and death,56 and research supporting such claims.57 Despite increasing numbers\nof cases58 and domestic COVID-19-attributed deaths surpassing 1 million individuals,d general consumer awareness and\nconcern regarding SARS-CoV-2 is at the lowest point since July 2021."}]}, {"title": "4f4311cdb48efa3a92f87fa0246c7c47", "paragraphs": [{"qas": [{"question": "According to a Meltwater trends analysis, how much did news coverage decrease?", "id": "100000000000000000007978", "answers": [{"text": "17%", "answer_start": 205}], "is_impossible": false}, {"question": "Recent polling indicates fewer than a 5% decrease in what?", "id": "100000000000000000007979", "answers": [{"text": "Google searches related to the COVID-19 vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "What percentage of people were fully vaccinated?", "id": "100000000000000000007984", "answers": [{"text": "66.7%", "answer_start": 591}], "is_impossible": false}, {"question": "When did the intention to vaccinate maintain a consistent cadence?", "id": "100000000000000000007985", "answers": [{"text": "August 2021", "answer_start": 715}], "is_impossible": false}], "context": "Google searches related to the COVID-19 vaccine during\nthis reporting period remained low relative to other topics such as Uvalde, TX, and monkeypox.e According to a Meltwater\ntrends analysis, there was a 17% decrease in news coverage and 45% decrease in social media mentions of COVID-19 vaccines.f\nRecent polling indicates fewer than a third of domestic consumers report being \u201csomewhat\u201d or \u201cvery\u201d worried about contracting\nAdditionally, sources indicate vaccine uptake plateauing,g as of May 31, 2022, COVID Data Tracker reported that 77.9% of\npeople had received at least one shot60 and 66.7% were fully vaccinated.61 Reported intention to vaccinate maintains a similarly\nconsistent cadence since approximately August 2021.c,62,63\nThe FDA64 and CDC65 strengthened recommendations and expansion of booster eligibility."}]}, {"title": "9e77253d2d43898902afdbda36a3daaa", "paragraphs": [{"qas": [{"question": "What showed a decreasing interest in booster information from a recent peak at the end of March 2022?", "id": "100000000000000000007988", "answers": [{"text": "Google searches", "answer_start": 31}], "is_impossible": false}, {"question": "Perceptions, Concerns, and Threats to what?", "id": "100000000000000000007989", "answers": [{"text": "Vaccine Confidence", "answer_start": 195}], "is_impossible": false}], "context": "This did not positively impact\nGoogle searches, which showed a decreasing interest in booster information, from a recent peak at the end of March 2022.66,67\nPerceptions, Concerns, and Threats to Vaccine Confidence\n\u0083 Competing national events,68 continued rollback of mitigation measures,69 and consistently decreasing coverage from social\nmedia, news media, and political sources70,71,72 may lessen the frequency and impact of COVID-19-specific information for\nconsumers."}]}, {"title": "c87152cfdd9b703032da2b45b8fd10f2", "paragraphs": [{"qas": [{"question": "What do consumers question about the effectiveness of COVID-19 vaccines73?", "id": "100000000000000000007991", "answers": [{"text": "stories of breakthrough infections persist", "answer_start": 211}], "is_impossible": false}, {"question": "What do reports of decreased efficacy against new dominant variants76 and waning vaccine immunity appear to negatively impact?", "id": "100000000000000000007992", "answers": [{"text": "consumer confidence", "answer_start": 403}], "is_impossible": false}, {"question": "What appears to negatively impact consumer confidence in COVID-19 vaccines79 and pharmaceutical brands?", "id": "100000000000000000007993", "answers": [{"text": "vaccines\u2019 decreased efficacy against new dominant variants", "answer_start": 281}], "is_impossible": false}, {"question": "Online consumers continue to question whether testing81 and wastewater surveillance methods are effective or accurate?", "id": "100000000000000000007994", "answers": [{"text": "82", "answer_start": 595}], "is_impossible": false}, {"question": "Why is it still necessary to receive a COVID-19 vaccine or a booster dose?", "id": "100000000000000000007995", "answers": [{"text": "high rates of cases and previous infection", "answer_start": 673}], "is_impossible": false}], "context": "dTanaq Social Listening Report\neGoogle Trends\nfMeltwater\ngHHS CET Wave 63\fCOVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\n\u0083 Consumers question the effectiveness of COVID-19 vaccines73 as stories of breakthrough infections persist.74,75 Moreover,\nreports of vaccines\u2019 decreased efficacy against new dominant variants76 and waning vaccine immunity77,78 appear to negatively\nimpact consumer confidence in COVID-19 vaccines79 and pharmaceutical brands.80\n\u0083 Online consumers continue to question whether testing81 and wastewater surveillance methods are effective or accurate.82,83\nCommonly asked questions and queries from the publich\n\u0083 With reports of high rates of cases and previous infection,84,85 is it still necessary to receive a primary series of a COVID-19\nvaccine or a booster dose?"}]}, {"title": "e812ca827f8fb579e665d596463d8f0c", "paragraphs": [{"qas": [{"question": "What vaccines are effective at protecting you from severe outcomes and death from the virus that causes COVID-19?", "id": "100000000000000000007996", "answers": [{"text": "COVID-19", "answer_start": 2}], "is_impossible": false}, {"question": "What is an important tool to help us get back to normal?", "id": "100000000000000000007997", "answers": [{"text": "Vaccination", "answer_start": 165}], "is_impossible": false}, {"question": "When making decisions about community-level and individual-level prevention strategies, health officials, stakeholders and individuals might consider using the COVID-19 Community Levels approaches within their local context?", "id": "100000000000000000007999", "answers": [{"text": "\u0082 COVID-19 vaccines are effective at protecting you from severe outcomes and death from the virus that causes COVID-19, even if you have had COVID-19 in the past.86 Vaccination is an important tool to help us get back to normal.87 \u0083 Should masks still be worn in indoor public places?88 \u0082", "answer_start": 0}], "is_impossible": false}], "context": "\u0082 COVID-19 vaccines are effective at protecting you from severe outcomes and death from the virus that causes COVID-19,\neven if you have had COVID-19 in the past.86 Vaccination is an important tool to help us get back to normal.87\n\u0083 Should masks still be worn in indoor public places?88\n\u0082 When making decisions about community-level and individual-level prevention strategies, health officials, stakeholders\nand individuals might consider using the CDC\u2019s COVID-19 Community Levels approaches within their local context."}]}, {"title": "47213e6ead2c3ba6dc02d55366f7ddf3", "paragraphs": [{"qas": [{"question": "What can layer prevention strategies help limit?", "id": "100000000000000000008000", "answers": [{"text": "severe disease", "answer_start": 175}], "is_impossible": false}, {"question": "What does CDC recommend using to help determine which prevention measures to use?", "id": "100000000000000000008001", "answers": [{"text": "county COVID-19 Community Levels", "answer_start": 273}], "is_impossible": false}, {"question": "What are Community Levels to help determine?", "id": "100000000000000000008002", "answers": [{"text": "COVID-19 prevention measures", "answer_start": 330}], "is_impossible": false}, {"question": "What should masks90,91 and vaccines92,93 still be used for when traveling?", "id": "100000000000000000008005", "answers": [{"text": "personal mitigation measures", "answer_start": 693}], "is_impossible": false}], "context": "Layered\nprevention strategies, such as staying up to date with vaccines, screening and testing in high-risk settings, improving\nventilation, and wearing masks, can help limit severe disease and reduce the potential for strain on the healthcare system. CDC recommends using county COVID-19 Community Levels to help determine which COVID-19 prevention measures\nto use for individuals and communities. COVID-19 Community Levels do not apply in healthcare settings like hospitals\nand nursing homes. Healthcare settings are recommended to continue to follow CDC\u2019s infection prevention and control\nrecommendations for healthcare workers.89\n\u0083 Should masks90,91 and vaccines92,93 still be utilized as personal mitigation measures when traveling?"}]}, {"title": "bc4153d0c65d00313c7fb444c867cde5", "paragraphs": [{"qas": [{"question": "What helps your body develop protection from the virus that causes COVID-19?", "id": "100000000000000000008006", "answers": [{"text": "COVID-19 vaccines", "answer_start": 2}], "is_impossible": false}, {"question": "Vaccinated people sometimes get infected with what virus?", "id": "100000000000000000008007", "answers": [{"text": "COVID-19", "answer_start": 168}], "is_impossible": false}, {"question": "What significantly lowers the risk of getting very sick, being hospitalized, or dying from the disease?", "id": "100000000000000000008008", "answers": [{"text": "staying up to date on COVID-19 vaccines", "answer_start": 178}], "is_impossible": false}, {"question": "Who recommends that everyone who gets vaccinated stay up-to-date on vaccinations?", "id": "100000000000000000008009", "answers": [{"text": "CDC", "answer_start": 314}], "is_impossible": false}, {"question": "Who recommends that everyone who is eligible get a booster and stay up to date on their COVID-19 vaccines?", "id": "100000000000000000008010", "answers": [{"text": "CDC", "answer_start": 314}], "is_impossible": false}, {"question": "What can layer prevention strategies like staying upto date with vaccines and wearing masks help prevent?", "id": "100000000000000000008011", "answers": [{"text": "COVID-19", "answer_start": 580}], "is_impossible": false}], "context": "\u0082 COVID-19 vaccines help your body develop protection from the virus that causes COVID-19. Although vaccinated people\nsometimes get infected with the virus that causes COVID-19, staying up to date on COVID-19 vaccines significantly lowers\nthe risk of getting very sick, being hospitalized, or dying from COVID-19. CDC recommends that everyone who is eligible get\na booster and stay up to date on their COVID-19 vaccines, especially people with weakened immune systems.94\n\u0082 Layered prevention strategies \u2014 like staying up to date with vaccines and wearing masks \u2014 can help prevent COVID-19 and\nreduce the potential for strain on the healthcare system."}]}, {"title": "88125204df946730bab17dae13d0f91c", "paragraphs": [{"qas": [{"question": "What are available here?", "id": "100000000000000000008014", "answers": [{"text": "Mask use recommendations", "answer_start": 68}], "is_impossible": false}], "context": "Wear a mask with the best fit, protection, and comfort for you.95\n\u0082 Mask use recommendations are available here."}]}, {"title": "12467700fda7f733335adc4547fec4af", "paragraphs": [{"qas": [{"question": "What are some misinformation themes that may impact vaccine confidence?", "id": "100000000000000000008015", "answers": [{"text": "Some consumers believe that natural immunity is superior to vaccine-induced immunity", "answer_start": 70}], "is_impossible": false}, {"question": "What do some consumers believe is superior to vaccine-induced immunity?", "id": "100000000000000000008016", "answers": [{"text": "natural immunity", "answer_start": 98}], "is_impossible": false}, {"question": "Some social media users state that the Pfizer vaccine is only between 1 and what percent at preventing illness97?", "id": "100000000000000000008017", "answers": [{"text": "12", "answer_start": 312}], "is_impossible": false}, {"question": "What do some social media users believe SARS-CoV-2 is the same as?", "id": "100000000000000000008019", "answers": [{"text": "influenza", "answer_start": 654}], "is_impossible": false}, {"question": "How can public health and partners improve vaccine confidence?", "id": "100000000000000000008022", "answers": [{"text": "Develop and amplify messages explaining why vaccines are still important in the COVID-19 prevention response", "answer_start": 855}], "is_impossible": false}, {"question": "What are vaccines still important in the COVID-19 prevention response?", "id": "100000000000000000008023", "answers": [{"text": "Develop and amplify messages", "answer_start": 855}], "is_impossible": false}], "context": "Identified misinformation themes that may impact vaccine confidence\n\u0083 Some consumers believe that natural immunity is superior to vaccine-induced immunity despite the health risks associated\nwith getting SARS-CoV-2.96\n\u0083 Some social media users state that the efficacy of the Pfizer vaccine is only between 1 and 12 percent at preventing illness97\nwhile leaving out the additional context that the vaccine-acquired immunity decreases with time, the vaccines are less\neffective against some variants of SARS-CoV-2, and, most importantly, the vaccine provides protection against severe illness.98\n\u0083 Some social media users believe SARS-CoV-2 is the same as influenza.99\n\u0083 Some social media users believe COVID-19 vaccines are causing a surge in the number of COVID-19 cases.100\nWays public health and partners can take action to improve vaccine confidence\n\u0083 Develop and amplify messages explaining why vaccines are still important in the COVID-19 prevention response."}]}, {"title": "70cc0c104b5cb77cbdfb39444e221c22", "paragraphs": [{"qas": [{"question": "What do employers offer to get vaccines and recover from side effects?", "id": "100000000000000000008024", "answers": [{"text": "time off", "answer_start": 210}], "is_impossible": false}, {"question": "What does the public need to know about the effectiveness of COVID-19 vaccines?", "id": "100000000000000000008025", "answers": [{"text": "Monitor and update the public on the COVID-19 vaccines\u2019 effectiveness against variants", "answer_start": 268}], "is_impossible": false}, {"question": "What does the public need to know about the effectiveness of the COVID-19 vaccine?", "id": "100000000000000000008026", "answers": [{"text": "Monitor and update", "answer_start": 268}], "is_impossible": false}], "context": "\u0083 Disseminate messages about community-level risk and corresponding COVID-19 mitigation measures. \u0083 Continue to encourage vaccinations and staying up to date with vaccine boosters by suggesting employers offer time off to\nget vaccines and recover from side effects. \u0083 Monitor and update the public on the COVID-19 vaccines\u2019 effectiveness against variants and communicate any concerns in\nreal time. \u0083 Create messages that encourage people who are vaccinated to support their friends and family to get the COVID-19 vaccines."}]}, {"title": "58a3a3357244926daf54bffc0b1a0678", "paragraphs": [{"qas": [{"question": "What do parents continue to express concern and hesitation regarding?", "id": "100000000000000000008028", "answers": [{"text": "COVID-19 vaccination in children", "answer_start": 244}], "is_impossible": false}, {"question": "As of June 18, 2022, everyone 6 months and older is recommended to what?", "id": "100000000000000000008029", "answers": [{"text": "Moderna or Pfizer-BioNTech COVID-19 vaccine", "answer_start": 351}], "is_impossible": false}, {"question": "Who recommends getting a moderna or Pfizer-BioNTech COVID-19 vaccine?", "id": "100000000000000000008030", "answers": [{"text": "everyone 6 months and older", "answer_start": 299}], "is_impossible": false}], "context": "hThese questions come from online data sources such as social media, news stories, Google Trends, and CDC-INFO\fCOVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nParents continue to express concern and hesitation regarding COVID-19 vaccination in\nchildren. As of June 18, 2022, everyone 6 months and older is recommended to get a Moderna or Pfizer-BioNTech COVID-19 vaccine."}]}, {"title": "3ab36ff161581e6f6781179c2ca2b8ac", "paragraphs": [{"qas": [{"question": "When did the FDA amend the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine?", "id": "100000000000000000008031", "answers": [{"text": "May 17, 2022", "answer_start": 3}], "is_impossible": false}, {"question": "How long did it take for children to receive a single booster dose of the Ppfizer BioNTech CoviD-19 vaccine?", "id": "100000000000000000008032", "answers": [{"text": "five months", "answer_start": 179}], "is_impossible": false}, {"question": "Who reviews and evaluates data concerning the safety, effectiveness, and safety of the vaccine?", "id": "100000000000000000008033", "answers": [{"text": "The FDA committee", "answer_start": 254}], "is_impossible": false}, {"question": "What does VRBPAC stand for?", "id": "100000000000000000008034", "answers": [{"text": "Vaccines and Related Biological Products Advisory Committee", "answer_start": 383}], "is_impossible": false}, {"question": "When will the VARBPAC meet to discuss the emergency use authorization of COVID-19 vaccines?", "id": "100000000000000000008035", "answers": [{"text": "June 14\u201315, 2022", "answer_start": 453}], "is_impossible": false}, {"question": "On what date did the Advisory Committee on Immunization Practices (ACIP) issue interim recommendations?", "id": "100000000000000000008036", "answers": [{"text": "June 17, 2022", "answer_start": 553}], "is_impossible": false}, {"question": "What did some parents express enthusiasm and relief about?", "id": "100000000000000000008038", "answers": [{"text": "childhood vaccination", "answer_start": 869}], "is_impossible": false}, {"question": "What percentage say they plan to wait and see how the vaccine is working for others?", "id": "100000000000000000008040", "answers": [{"text": "38%", "answer_start": 1073}], "is_impossible": false}, {"question": "What percentage of people say they won't get their child vaccinated?", "id": "100000000000000000008041", "answers": [{"text": "27%", "answer_start": 1146}], "is_impossible": false}, {"question": "What percentage say they will only do so if they are required?", "id": "100000000000000000008042", "answers": [{"text": "11%", "answer_start": 1211}], "is_impossible": false}, {"question": "Myocarditis may negatively impact what?", "id": "100000000000000000008043", "answers": [{"text": "vaccine uptake", "answer_start": 1400}], "is_impossible": false}, {"question": "Some consumers believe vaccines are unnecessary because COVID-19 rarely affects what group?", "id": "100000000000000000008045", "answers": [{"text": "this group", "answer_start": 1505}], "is_impossible": false}, {"question": "Why are cases of hepatitis in children rising globally?", "id": "100000000000000000008048", "answers": [{"text": "COVID-19 vaccines", "answer_start": 1824}], "is_impossible": false}, {"question": "What do some believe are caused by COVID-19 vaccines?", "id": "100000000000000000008049", "answers": [{"text": "With cases of hepatitis in children rising globally", "answer_start": 1739}], "is_impossible": false}, {"question": "What does wearing a well-fitting mask or respirator reduce the risk of spreading?", "id": "100000000000000000008051", "answers": [{"text": "the virus that causes COVID-19", "answer_start": 2160}], "is_impossible": false}, {"question": "What causes COVID-19?", "id": "100000000000000000008052", "answers": [{"text": "cases of hepatitis in children rising globally", "answer_start": 1744}], "is_impossible": false}], "context": "On May 17, 2022, the FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine, authorizing\na single booster dose for children ages 5-11 years at least five months after completion of a primary series with the same\nvaccine.101 The FDA committee that reviews and evaluates data concerning the safety, effectiveness, and appropriate use of\nvaccines, VRBPAC (Vaccines and Related Biological Products Advisory Committee), meet on June 14\u201315, 2022 to discuss the\nemergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022, the Advisory Committee on Immunization\nPractices (ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5\nyears and the Pfizer COVID-19 vaccine\nfor use in children ages 6 months to 4\nyears.103 Some parents have expressed\nenthusiasm and relief about childhood\nvaccination.104,105,106 However, a recent\nKaiser Family Foundation (KFF) poll\nfound that only 18% of parents with\nchildren younger than 5 years will get\ntheir child vaccinated right away, while\n38% say they plan to wait and see how\nthe vaccine is working for others, 27%\nsay they will definitely not get their child\nvaccinated, and 11% say they will only do\nso if they are required.107,108\nPerceptions, Concerns, and Threats to Vaccine Confidence\n\u0083 Concerns about side effects, such as myocarditis, may negatively impact vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group.111,112\n\u0083 Some believe infection-induced immunity protects children better than vaccines.113,114\n\u0083 Some social media users do not think there is enough data to support vaccination against COVID-19 in children.115,116,117\n\u0083 With cases of hepatitis in children rising globally, some believe they are caused by COVID-19 vaccines.118,119,120\n\u0083 Some are concerned that immunity from vaccines decreases rapidly in adolescents.122,123\nCommonly asked questions and queries from the public\n\u0083 Should children under the age of 5 years still wear masks?i\n\u0082 Wearing a well-fitting mask or respirator consistently and correctly reduces the risk of spreading the virus that causes\nCOVID-19."}]}, {"title": "db7735eceaff19064ef2772c5109eefe", "paragraphs": [{"qas": [{"question": "What is recommended at a high COVID-19 Community Level?", "id": "100000000000000000008053", "answers": [{"text": "universal indoor masking", "answer_start": 36}], "is_impossible": false}, {"question": "To ensure that students, including those with disabilities, are able to access in-person learning?", "id": "100000000000000000008055", "answers": [{"text": "reasonable modifications or accommodations", "answer_start": 217}], "is_impossible": false}], "context": "At a high COVID-19 Community Level, universal indoor masking in schools and ECE programs is recommended,\nas it is in the community at-large. Schools with students at risk for getting very sick with COVID-19 must make reasonable\nmodifications or accommodations when necessary to ensure that all students, including those with disabilities, are able\nto access in-person learning."}]}, {"title": "c81ca55af39eef53942def692fb4b3fd", "paragraphs": [{"qas": [{"question": "What may be difficult for very young children or for some children with disabilities who cannot safely wear a mask?", "id": "100000000000000000008057", "answers": [{"text": "mask use", "answer_start": 8}], "is_impossible": false}, {"question": "What is another prevention strategy when the COVID-19 Community Level is medium or high or in response to an outbreak?", "id": "100000000000000000008058", "answers": [{"text": "improving ventilation and avoiding crowding", "answer_start": 277}], "is_impossible": false}], "context": "Because mask use is not recommended for children ages younger than 2 years and may be\ndifficult for very young children or for some children with disabilities who cannot safely wear a mask, ECE programs and\nK-12 schools may need to consider other prevention strategies\u2014such as improving ventilation and avoiding crowding\u2014\nwhen the COVID-19 Community Level is medium or high or in response to an outbreak."}]}, {"title": "780d0963ec74509f98a75332ea904054", "paragraphs": [{"qas": [{"question": "What type of masks may be used by K-12 schools or ECE programs to meet the needs of the families they serve?", "id": "100000000000000000008059", "answers": [{"text": "universal indoor", "answer_start": 53}], "is_impossible": false}, {"question": "There is no evidence that COVID-19 vaccine causes what?", "id": "100000000000000000008061", "answers": [{"text": "hepatitis", "answer_start": 328}], "is_impossible": false}, {"question": "What vaccine does not cause hepatitis in children?", "id": "100000000000000000008062", "answers": [{"text": "COVID-19", "answer_start": 304}], "is_impossible": false}, {"question": "What virus has been detected in nearly half of the children and continues to be detected?", "id": "100000000000000000008063", "answers": [{"text": "Adenovirus", "answer_start": 502}], "is_impossible": false}, {"question": "How many of the children have been diagnosed with the disease?", "id": "100000000000000000008064", "answers": [{"text": "There is no evidence that COVID-19 vaccine causes hepatitis.125 CDC continues to examine possible causes, including testing for and ruling out some of the viruses that commonly cause hepatitis (hepatitis A, B, C, D, and E). Adenovirus has been detected in nearly half", "answer_start": 278}], "is_impossible": false}], "context": "K-12 schools or ECE programs may\nchoose to implement universal indoor mask use to meet the needs of the families they serve, which could include people at\nrisk for getting very sick with COVID-19.124\n\u0083 Is the COVID-19 vaccine the cause of recent hepatitis cases in children?d\n\u0082 There is no evidence that COVID-19 vaccine causes hepatitis.125 CDC continues to examine possible causes, including testing\nfor and ruling out some of the viruses that commonly cause hepatitis (hepatitis A, B, C, D, and E). Adenovirus has been\ndetected in nearly half of the children and continues to be investigated as a candidate for the underlying cause."}]}, {"title": "961f0f6a8a30fd5c9e7976b53cf6702", "paragraphs": [{"qas": [{"question": "What type of tests are being conducted to look more closely at the virus genome and other potential pathogens?", "id": "100000000000000000008065", "answers": [{"text": "laboratory tests", "answer_start": 7}], "is_impossible": false}], "context": "Further\nlaboratory tests are being conducted to look more closely at the virus genome and other potential pathogens, such as\niCDC-INFO\fCOVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nSARS-CoV-2."}]}, {"title": "fcacd500182eb07cf3c3ce1689d66336", "paragraphs": [{"qas": [{"question": "Who is communicating with key medical groups?", "id": "100000000000000000008067", "answers": [{"text": "CDC", "answer_start": 13}], "is_impossible": false}, {"question": "As of June 18, 2022, everyone ages 6 months and older is recommended to get a Moderna or Pfizer-BioNTech COVID-19 Identified misinformation themes that may impact vaccine confidence?", "id": "100000000000000000008071", "answers": [{"text": "126 \u0083 When will vaccines be available for children ages 5 years and younger?d \u0082 As of June 18, 2022, everyone ages 6 months and older is recommended to get a Moderna or Pfizer-BioNTech COVID-19 Identified misinformation themes that may impact vaccine confidence \u0083 Some social media users believe authorizing vaccines in children is only a ploy for pharmaceutical companies to make", "answer_start": 196}], "is_impossible": false}, {"question": "Some social media users believe authorizing vaccines in children is what?", "id": "100000000000000000008072", "answers": [{"text": "a ploy for pharmaceutical companies to make", "answer_start": 533}], "is_impossible": false}, {"question": "What do some social media users claim COVID-19 cases in children are always mild?", "id": "100000000000000000008073", "answers": [{"text": "authorizing vaccines in children is only a ploy for pharmaceutical companies to make", "answer_start": 492}], "is_impossible": false}, {"question": "Encourage primary care providers and other medical professionals who care for children to explain the benefits of what to parents?", "id": "100000000000000000008075", "answers": [{"text": "COVID-19 vaccination", "answer_start": 865}], "is_impossible": false}, {"question": "What should children explain to parents and guardians about the benefits of COVID-19 vaccination?", "id": "100000000000000000008076", "answers": [{"text": "Encourage primary care providers and other medical professionals who care for children to explain the benefits of COVID-19 vaccination to parents and guardians", "answer_start": 751}], "is_impossible": false}], "context": "In addition, CDC is communicating with key medical groups and continues to provide updated reporting and\nlaboratory guidance for clinicians who may identify hepatitis of unknown cause in children.126\n\u0083 When will vaccines be available for children ages 5 years and younger?d\n\u0082 As of June 18, 2022, everyone ages 6 months and older is recommended to get a Moderna or Pfizer-BioNTech COVID-19\nIdentified misinformation themes that may impact vaccine confidence\n\u0083 Some social media users believe authorizing vaccines in children is only a ploy for pharmaceutical companies to make\n\u0083 Some social media users claim that COVID-19 cases in children are always mild.129,130,131 w\nWays public health and partners can take action to improve vaccine confidence\n\u0083 Encourage primary care providers and other medical professionals who care for children to explain the benefits of COVID-19\nvaccination to parents and guardians."}]}, {"title": "1eb03ed46f2f515659e5c1aa64add309", "paragraphs": [{"qas": [{"question": "What is the absence of an association between hepatitis and COVID-19 vaccines?", "id": "100000000000000000008078", "answers": [{"text": "Clarify", "answer_start": 115}], "is_impossible": false}, {"question": "When will the State of Vaccine Confidence Insights Report be released?", "id": "100000000000000000008079", "answers": [{"text": "October 10, 2022", "answer_start": 249}], "is_impossible": false}], "context": "\u0083 Develop communications materials detailing the benefits of vaccination compared to infection-induced immunity. \u0083 Clarify the absence of an association between hepatitis and COVID-19 vaccines. COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nEmerging Misinformation Theme Affecting Vaccine Confidence\nConsumers have questions about the relationship between COVID-19 vaccines and\nmonkeypox."}]}, {"title": "58cf2d7cebd2d3f1ebb17db0f1e1874", "paragraphs": [{"qas": [{"question": "On what date did a U.S. resident test positive for monkeypox after returning to the United States from Canada?", "id": "100000000000000000008080", "answers": [{"text": "May 18, 2022", "answer_start": 3}], "is_impossible": false}, {"question": "What is a completely different virus than the viruses that cause COVID-19 or measles?", "id": "100000000000000000008082", "answers": [{"text": "Monkeypox virus", "answer_start": 224}], "is_impossible": false}, {"question": "What do some consumers believe there is a link between COVID-19 vaccines and monkeypox?", "id": "100000000000000000008083", "answers": [{"text": "Perceptions, Concerns, and Threats to Vaccine Confidence", "answer_start": 324}], "is_impossible": false}, {"question": "What are some of the common questions and queries from the public?", "id": "100000000000000000008084", "answers": [{"text": "Who is at risk for monkeypox", "answer_start": 525}], "is_impossible": false}, {"question": "What group of people are most likely to contract monkeypox in 2022?", "id": "100000000000000000008085", "answers": [{"text": "gay, bisexual, and other men who have sex with men", "answer_start": 576}], "is_impossible": false}], "context": "On May 18, 2022, a U.S. resident tested positive for monkeypox after returning to the United States from Canada.132 As of\nSeptember 14, 2022, the CDC reports 24,846 confirmed cases of monkeypox with cases in every state.133 Monkeypox virus is a\ncompletely different virus than the viruses that cause COVID-19 or measles.134\nPerceptions, Concerns, and Threats to Vaccine Confidence\n\u0083 Some consumers believe there is a link between COVID-19 vaccines and monkeypox.135,136\nCommonly asked questions and queries from the public\n\u0083 Who is at risk for monkeypox?d\n\u0082 Data suggest that gay, bisexual, and other men who have sex with men make up the majority of cases in the 2022\nmonkeypox outbreak."}]}, {"title": "45f13b3020a1568355a13aa67c5fcdd0", "paragraphs": [{"qas": [{"question": "How can monkeypox spread to anyone?", "id": "100000000000000000008086", "answers": [{"text": "through close, personal, often skin-to-skin contact", "answer_start": 40}], "is_impossible": false}, {"question": "What is the name of the butthole?", "id": "100000000000000000008090", "answers": [{"text": "anus", "answer_start": 337}], "is_impossible": false}, {"question": "What kind of blisters or pimples can cause the rash to be painful?", "id": "100000000000000000008093", "answers": [{"text": "pimples or blisters", "answer_start": 538}], "is_impossible": false}], "context": "However, monkeypox can spread to anyone through close, personal, often skin-to-skin contact. Anyone who has been in close contact with someone who has monkeypox is at risk.137\n\u0083 How do I know if I have monkeypox?d\n\u0082 People with monkeypox can get a rash that may be located on or near the genitals (penis, testicles, labia, and vagina) or\nanus (butthole) and could be on other areas like the hands, feet, chest, face, or mouth. \u008f The rash will go through several stages, including scabs, before healing. \u008f The rash can initially look like pimples or blisters and may be painful or itchy."}]}, {"title": "553a751b1d7cd95714b7e01750284cc9", "paragraphs": [{"qas": [{"question": "What are some of the other symptoms of monkeypox?", "id": "100000000000000000008094", "answers": [{"text": "Fever", "answer_start": 45}], "is_impossible": false}, {"question": "What do others only experience?", "id": "100000000000000000008098", "answers": [{"text": "a rash", "answer_start": 397}], "is_impossible": false}, {"question": "What should you do if you are in close contact with someone who has monkeypox?", "id": "100000000000000000008100", "answers": [{"text": "talk to your healthcare provider", "answer_start": 585}], "is_impossible": false}], "context": "\u0082 Other symptoms of monkeypox can include:\n\u008f Fever\n\u008f Chills\n\u008f Swollen lymph nodes\n\u008f Exhaustion\n\u008f Muscle aches and backache\n\u008f Headache\n\u008f Respiratory symptoms (e.g., sore throat, nasal congestion, or cough)\n\u0082 You may experience all or only a few symptoms\n\u008f Sometimes people have flu-like symptoms before the rash. \u008f Some people get a rash first, followed by other symptoms. \u008f Others only experience a rash.138\n\u0083 Are there any travel restrictions due to monkeypox? d\n\u0082 Recommendation for travelers:139\n\u008f If you have monkeypox symptoms or had close contact with someone who\nhas monkeypox, talk to your healthcare provider."}]}, {"title": "4293e587c0bafb469c261c09ec69b76", "paragraphs": [{"qas": [{"question": "Do not have fever or respiratory symptoms such as sore throat, nasal congestion, or cough?", "id": "100000000000000000008102", "answers": [{"text": "If you have monkeypox", "answer_start": 88}], "is_impossible": false}, {"question": "What do you cover your rash and wear?", "id": "100000000000000000008103", "answers": [{"text": "a well-fitting mask", "answer_start": 266}], "is_impossible": false}, {"question": "What is the most up to date information about monkeypox?", "id": "100000000000000000008104", "answers": [{"text": "https://www.cdc.gov/poxvirus/monkeypox/travel/index.html", "answer_start": 348}], "is_impossible": false}], "context": "If you have symptoms, do not\ntravel until you confirm that you do not have monkeypox. \u008f If you have monkeypox and must travel:\n\u00bb Make sure that you do not have fever or respiratory symptoms such as sore\nthroat, nasal congestion, or cough. \u00bb Cover your rash and wear a well-fitting mask. \u00bb Take additional steps to prevent spread to others. \u008f Visit https://www.cdc.gov/poxvirus/monkeypox/travel/index.html for the most up to date information. \u0083 Is there a monkeypox vaccine? If so, will everyone need it?"}]}, {"title": "bebbc954039d75f7ea4a15a490bd4a4f", "paragraphs": [{"qas": [{"question": "How many vaccines may be used for the prevention of monkeypox disease?", "id": "100000000000000000008105", "answers": [{"text": "Two", "answer_start": 2}], "is_impossible": false}, {"question": "What is the vaccine approved for?", "id": "100000000000000000008106", "answers": [{"text": "prevention of monkeypox disease", "answer_start": 106}], "is_impossible": false}, {"question": "How long should the monkeypox vaccine be given?", "id": "100000000000000000008108", "answers": [{"text": "within 4 days", "answer_start": 306}], "is_impossible": false}, {"question": "What is recommended to prevent onset of the disease?", "id": "100000000000000000008109", "answers": [{"text": "monkeypox vaccine be given within 4 days from the date of exposure", "answer_start": 279}], "is_impossible": false}], "context": "\u0082 Two vaccines may be used for the prevention of monkeypox disease:\n\u008f JYNNEOS vaccine is approved for the prevention of monkeypox disease. \u008f ACAM2000 vaccine was made available for use against monkeypox under an Expanded Access Investigational New Drug\n\u0082 CDC recommends that the monkeypox vaccine be given within 4 days from the date of exposure in order to prevent onset\nof the disease."}]}, {"title": "2d8339a16d87e5208f6012f1c2d71222", "paragraphs": [{"qas": [{"question": "What may reduce the symptoms of disease but may not prevent the disease?", "id": "100000000000000000008112", "answers": [{"text": "vaccination", "answer_start": 55}], "is_impossible": false}, {"question": "What is the highest potential for exposure to monkeypox?", "id": "100000000000000000008113", "answers": [{"text": "Monkeypox PrEP", "answer_start": 213}], "is_impossible": false}, {"question": "What is a new diagnosis of one or more nationally reported sexually transmitted diseases?", "id": "100000000000000000008114", "answers": [{"text": "More than one sex partner", "answer_start": 592}], "is_impossible": false}, {"question": "What is a transmitted disease?", "id": "100000000000000000008115", "answers": [{"text": "monkeypox", "answer_start": 789}], "is_impossible": false}, {"question": "How many sex partners have had in the past 6 months?", "id": "100000000000000000008116", "answers": [{"text": "More than one", "answer_start": 592}], "is_impossible": false}, {"question": "What do some social media users believe COVID-19 vaccines weaken the body\u2019s immune system?", "id": "100000000000000000008118", "answers": [{"text": "making vaccinated individuals more susceptible to monkeypox", "answer_start": 1080}], "is_impossible": false}, {"question": "What do some social media users believe is the cause of monkey pox? What do social media user believe is being used to scare people now that COVID-19 is not seen as a threat?", "id": "100000000000000000008120", "answers": [{"text": "COVID-19 vaccines", "answer_start": 1205}], "is_impossible": false}, {"question": "What social media users believe pharmaceutical companies are trying to create a monkeypox pandemic?", "id": "100000000000000000008121", "answers": [{"text": "to increase", "answer_start": 1460}], "is_impossible": false}, {"question": "What can public health and partners do to improve vaccine confidence?", "id": "100000000000000000008122", "answers": [{"text": "take action", "answer_start": 1508}], "is_impossible": false}, {"question": "Encourage local health departments, public health experts, and healthcare workers to explain the absence of association between COVID-19 vaccines and what?", "id": "100000000000000000008123", "answers": [{"text": "monkeypox", "answer_start": 1702}], "is_impossible": false}], "context": "If given between 4\u201314 days after the date of exposure, vaccination may reduce the symptoms of disease, but\nmay not prevent the disease.141\fCOVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\n\u0082 Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox such as:142\n\u008f Gay, bisexual, and other men who have sex with men, transgender or nonbinary people who in the past 6 months have\nhad\n\u00bb A new diagnosis of one or more nationally reportable sexually transmitted diseases (i.e., acute HIV, chancroid,\nchlamydia, gonorrhea, or syphilis)\n\u00bb More than one sex partner\n\u008f People who have had any of the following in the past 6 months:\n\u00bb Sex at a commercial sex venue\n\u00bb Sex in association with a large public event in a geographic area where monkeypox transmission is occurring\n\u008f Sexual partners of people with the above risks\n\u008f People who anticipate experiencing the above risks\nIdentified misinformation themes that may impact vaccine confidence\n\u0083 Some social media users believe COVID-19 vaccines weaken the body\u2019s immune system, making vaccinated individuals more\nsusceptible to monkeypox.143,144\n\u0083 Some social media users believe monkeypox is caused by COVID-19 vaccines.145,146\n\u0083 Some social media users believe monkeypox is being used to scare people now that COVID-19 is not seen as a threat.147,148\n\u0083 Some social media users believe pharmaceutical companies are attempting to create a monkeypox pandemic to increase\nWays public health and partners can take action to improve vaccine confidence\n\u0083 Encourage local health departments, public health experts, and healthcare workers to explain the absence of association\nbetween COVID-19 vaccines and monkeypox."}]}, {"title": "a14be2767063b1b291b96de167f4e23a", "paragraphs": [{"qas": [{"question": "What is the date of the COVID-19 State of Vaccine Confidence Insights Report?", "id": "100000000000000000008127", "answers": [{"text": "October 10, 2022", "answer_start": 55}], "is_impossible": false}, {"question": "What type of sources are listed in the State of Vaccine Confidence Inslights Report | October 10, 2022 Appendix: Inputs and Sources Type Input Cadence Sources Tactics for Utilization Social Media Listening & Media Monitoring Communication Surveillance Report Daily on weekdays", "id": "100000000000000000008128", "answers": [{"text": "Input Cadence", "answer_start": 106}], "is_impossible": false}, {"question": "What is the acronym for the Office of the Associate Director of Communication?", "id": "100000000000000000008129", "answers": [{"text": "OADC", "answer_start": 546}], "is_impossible": false}, {"question": "What does CDC-INFO Metrics Weekly report on?", "id": "100000000000000000008131", "answers": [{"text": "\u0082CDC-INFO inquiry line list \u0082Prepared response (PR) usage report \u0082Cross-compare PR usage with inquiry theme analysis \u0082Sentiment analysis \u0082Identify information gaps/voids VTF Media Requests Weekly", "answer_start": 938}], "is_impossible": false}, {"question": "What does VTF Media Requests weekly report on on on how to identify information gaps/voids?", "id": "100000000000000000008132", "answers": [{"text": "Leading indicator for news coverage", "answer_start": 1160}], "is_impossible": false}, {"question": "What is the name of the research poll that focuses on vaccine hesitancy?", "id": "100000000000000000008133", "answers": [{"text": "Research Poll Review Weekly", "answer_start": 1401}], "is_impossible": false}, {"question": "What are some of the socio-behavior indicators related to vaccination?", "id": "100000000000000000008134", "answers": [{"text": "motivation and intention", "answer_start": 1560}], "is_impossible": false}, {"question": "What is the name of the report that identifies barriers to vaccination?", "id": "100000000000000000008136", "answers": [{"text": "Literature Review Weekly", "answer_start": 1598}], "is_impossible": false}, {"question": "Where is the content insights report Biweekly?", "id": "100000000000000000008138", "answers": [{"text": "Facebook", "answer_start": 2038}], "is_impossible": false}, {"question": "What are threats and data deficits?", "id": "100000000000000000008139", "answers": [{"text": "Vaccine narratives", "answer_start": 2262}], "is_impossible": false}], "context": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence Sources Tactics for Utilization\nSocial Media\nListening\n& Media\nMonitoring\nCommunication\nSurveillance Report\nDaily on\nweekdays\n\u0082Google news\n\u0082Meltwater\n\u0082CrowdTangle\n\u0082Native platform searches\n\u0082Share of voice topic analysis to identify\nthemes\n\u0082Emerging topics\nMeltwater Daily \u0082Facebook, Twitter, Instagram\n\u0082Blogs\n\u0082News media\n\u0082Online forums\n\u0082Share of voice topic analysis\n\u0082Emerging theme topics\n\u0082Identify high reach/velocity topics\nOADC (Office of the\nAssociate Director of\nCommunication) Channel\nCOVID-19 Post metrics\nWeekly \u0082Sprout Social\n\u0082Native OADC account analytics\n\u0082Analyze # of posts, topics\n\u0082Success of messages, # of impressions,\nreach, # engagements\nOADC Channel Comment\nAnalysis\nDaily on\nweekdays\n\u0082Native platform searches \u0082Sentiment analysis\n\u0082Identify message gaps/voids\nDirect Reports\nCDC-INFO Metrics Weekly \u0082CDC-INFO inquiry line list\n\u0082Prepared response (PR) usage report\n\u0082Cross-compare PR usage with inquiry\ntheme analysis\n\u0082Sentiment analysis\n\u0082Identify information gaps/voids\nVTF Media Requests Weekly \u0082Media request line list \u0082Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly \u0082Top pages\n\u0082Google search queries\n\u0082Top FAQs\n\u0082Referring domains\n\u0082Identify information gaps/voids,\n\u0082Identify keywords/search terms, changes in\nweb traffic\nResearch\nPoll Review Weekly \u0082Harris Poll, PEW research, Gallup Poll,\nKFF\n\u0082New data related to vaccine\nhesitancy\n\u0082Identify socio-behavior indicators related\nto motivation and intention to vaccinate\nLiterature Review Weekly \u0082PubMed, LitCovid, ProQuest Central,\nAltmetric\n\u0082New data related to vaccine\nhesitancy\n\u0082Identify current vaccination intention\n\u0082Identify barriers to vaccination\nThird Party\nReports\nTanaq Social Listening\n+Media Monitoring Report\nWeekly \u0082Meltwater\n\u0082Sprout Social\n\u0082First Draft\n\u0082Native platform searches\n\u0082Trending topics\n\u0082Demographic and geographic\nconversation monitoring\nCrowdTangle content\ninsights report\nBiweekly \u0082Facebook \u0082Top pages (voices), groups\n\u0082General trends/sentiment analysis\n\u0082News analysis through posts\nUniversity of Washington\nSt. Louis iHeard\nWeekly \u0082Proprietary methods \u0082Survey results\n\u0082Emerging threats and data deficits\n\u0082Vaccine narratives\nProject VCTR Weekly \u0082Proprietary methods \u0082National and regional trends in negative\nattitudes toward vaccination\n\u0082Conversations around Legislation\nVirality Project Weekly \u0082Proprietary methods \u0082Mis- and disinformation trends related to"}]}, {"title": "3bf2eff2399cec68700ce42ca8a13e30", "paragraphs": [{"qas": [{"question": "What did the CDC recommend everyone stay up to date with?", "id": "100000000000000000008141", "answers": [{"text": "COVID-19 vaccines", "answer_start": 373}], "is_impossible": false}, {"question": "What was updated on September 2, 2022?", "id": "100000000000000000008142", "answers": [{"text": "bivalent) boosters", "answer_start": 273}], "is_impossible": false}, {"question": "When were bivalent boosters available?", "id": "100000000000000000008143", "answers": [{"text": "September 2, 2022", "answer_start": 309}], "is_impossible": false}, {"question": "Who recommends everyone stay up to date with their age group?", "id": "100000000000000000008145", "answers": [{"text": "CDC", "answer_start": 328}], "is_impossible": false}], "context": "10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nEspa\u00f1ol | Other Languages\nStay Up to Date with COVID-19 Vaccines Including\nBoosters\nRecommendations for Novavax booster doses were recently updated. Read more. What You Need to Know\nUpdated (bivalent) boosters became available September 2, 2022. CDC recommends everyone stay up to date with COVID-19 vaccines for their age group:\nChildren and teens ages 6 months\u201317 years\nAdults ages 18 years and older\nGetting a COVID-19 vaccine after you recover from COVID-19 infection provides added protection against COVID-\n19."}]}, {"title": "a6799919ef8d906978791d595696c7a1", "paragraphs": [{"qas": [{"question": "How long should you wait for your next dose of COVID-19 vaccine?", "id": "100000000000000000008146", "answers": [{"text": "3 months", "answer_start": 108}], "is_impossible": false}, {"question": "What is another term for a booster dose?", "id": "100000000000000000008147", "answers": [{"text": "primary dose", "answer_start": 80}], "is_impossible": false}, {"question": "Who has different recommendations for the vaccines?", "id": "100000000000000000008148", "answers": [{"text": "People who are moderately or severely immunocompromised", "answer_start": 218}], "is_impossible": false}, {"question": "How long can you delay your next vaccine dose if you have no symptoms?", "id": "100000000000000000008149", "answers": [{"text": "3 months", "answer_start": 108}], "is_impossible": false}, {"question": "What type of people have different recommendations for COVID-19 vaccines?", "id": "100000000000000000008150", "answers": [{"text": "People who are moderately or severely immunocompromised", "answer_start": 218}], "is_impossible": false}, {"question": "What may be updated as the CDC continues to monitor the latest data?", "id": "100000000000000000008151", "answers": [{"text": "COVID-19 vaccine and booster recommendations", "answer_start": 328}], "is_impossible": false}], "context": "If you recently had COVID-19, you may consider delaying your next vaccine dose (primary dose or booster) by 3\nmonths from when your symptoms started or, if you had no symptoms, when you first received a positive test. People who are moderately or severely immunocompromised have different recommendations for COVID-19\nvaccines. COVID-19 vaccine and booster recommendations may be updated as CDC continues to monitor the latest COVID-\n19 data."}]}, {"title": "3e4be242b2dda8ac9193b8560a468c1e", "paragraphs": [{"qas": [{"question": "How long has it been since the last dose of the COVID-19 vaccine?", "id": "100000000000000000008152", "answers": [{"text": "2 months", "answer_start": 180}], "is_impossible": false}, {"question": "How many updated boosters are recommended for some people?", "id": "100000000000000000008153", "answers": [{"text": "one", "answer_start": 125}], "is_impossible": false}, {"question": "Who recommends that people age 5 years and older receive one updated booster?", "id": "100000000000000000008154", "answers": [{"text": "CDC", "answer_start": 67}], "is_impossible": false}, {"question": "What is the term for an updated booster if it has been at least 2 months since their last dose?", "id": "100000000000000000008155", "answers": [{"text": "bivalent", "answer_start": 138}], "is_impossible": false}, {"question": "What is another name for a monovalent booster?", "id": "100000000000000000008156", "answers": [{"text": "original", "answer_start": 286}], "is_impossible": false}, {"question": "How many original boosters are there?", "id": "100000000000000000008158", "answers": [{"text": "more than one", "answer_start": 339}], "is_impossible": false}, {"question": "What are effective at protecting people from getting seriously ill, being hospitalized, and dying?", "id": "100000000000000000008159", "answers": [{"text": "COVID-19 vaccines", "answer_start": 552}], "is_impossible": false}], "context": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022\n\u2022\n\uf3ba Updated Boosters Are Recommended for Some People\nCDC recommends that people ages 5 years and older receive one updated (bivalent) booster if it has been at\nleast 2 months since their last COVID-19 vaccine dose, whether that was:\nTheir final primary series dose, or\nAn original (monovalent) booster\nPeople who have gotten more than one original (monovalent) booster are also recommended to get an\nupdated (bivalent) booster. \u2022\n\u2022\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nAbout COVID-19 Vaccines\nCOVID-19 vaccines available in the United States are effective at protecting people from getting seriously ill, being\nhospitalized, and dying."}]}, {"title": "24ae80d65b27d4b8acdfe801ecaeff87", "paragraphs": [{"qas": [{"question": "How many COVID-19 vaccines are approved or authorized in the US?", "id": "100000000000000000008160", "answers": [{"text": "Four", "answer_start": 173}], "is_impossible": false}, {"question": "What are the updated (bivalent) boosters called?", "id": "100000000000000000008162", "answers": [{"text": "\u201cbivalent", "answer_start": 520}], "is_impossible": false}], "context": "As with other vaccine-preventable diseases, you are protected best from COVID-19 when you stay up\nto date with the recommended vaccinations, including recommended boosters. Four COVID-19 vaccines are approved or authorized in the United States:\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen (J&J/Janssen) (However, CDC recommends that the J&J/Janssen COVID-19 vaccine only be\nconsidered in certain situations, due to safety concerns.) Updated (Bivalent) Boosters\nThe updated (bivalent) boosters are called \u201cbivalent\u201d because they protect against both the original virus that causes COVID-\n19 and the Omicron variant BA.4 and BA.5. Previous boosters are called \u201cmonovalent\u201d because they were designed to protect against the original virus that causes\nCOVID-19."}]}, {"title": "9fa641c42af8e0d308c0be4221905ead", "paragraphs": [{"qas": [{"question": "What are the different versions of COVID-19 that have developed over time called?", "id": "100000000000000000008167", "answers": [{"text": "variants", "answer_start": 234}], "is_impossible": false}, {"question": "What do Pfizer and Moderna call their boosters?", "id": "100000000000000000008171", "answers": [{"text": "bivalent", "answer_start": 83}], "is_impossible": false}, {"question": "If you have completed a primary series and received the most recent booster dose recommended, what is it?", "id": "100000000000000000008173", "answers": [{"text": "You are up to date with your COVID-19 vaccines", "answer_start": 427}], "is_impossible": false}, {"question": "What is the most recent booster dose recommended for you by CDC?", "id": "100000000000000000008174", "answers": [{"text": "You are up to date with your COVID-19 vaccines if you have completed a COVID-19 vaccine primary series", "answer_start": 427}], "is_impossible": false}], "context": "They also provide some protection against Omicron, but not as much as the updated (bivalent) boosters. The virus that causes COVID-19 has changed over time. The different versions of the virus that have developed over time are\ncalled variants. Learn more about variants of the COVID-19 virus. Two COVID-19 vaccine manufacturers, Pfizer and Moderna, have developed updated (bivalent) COVID-19 boosters. When Are You Up to Date? You are up to date with your COVID-19 vaccines if you have completed a COVID-19 vaccine primary series and received the\nmost recent booster dose recommended for you by CDC."}]}, {"title": "ef990b64941a5c70403844363fb4fbf1", "paragraphs": [{"qas": [{"question": "What is your age?", "id": "100000000000000000008176", "answers": [{"text": "1. Your age", "answer_start": 60}], "is_impossible": false}, {"question": "What is an important part of protecting yourself from getting seriously ill or dying from COVID-19?", "id": "100000000000000000008180", "answers": [{"text": "Boosters", "answer_start": 467}], "is_impossible": false}, {"question": "What are boosters recommended for?", "id": "100000000000000000008181", "answers": [{"text": "most people", "answer_start": 597}], "is_impossible": false}], "context": "COVID-19 vaccine recommendations are based on three things:\n1. Your age\n2. The vaccine you first received, and\n3. The length of time since your last dose\nPeople who are moderately or severely immunocompromised have different recommendations for COVID-19 vaccines. You are still up to date if you receive all COVID-19 vaccine doses recommended for you and then become ill with COVID-19. You do not need to be immediately revaccinated or receive an additional booster. Boosters are an important part of protecting yourself from getting seriously ill or dying from\nCOVID-19. They are recommended for most people."}]}, {"title": "ed7e80cbe7af35c02dee8c38fc89e092", "paragraphs": [{"qas": [{"question": "Use this tool to determine when or if you can get one or more COVID-19 boosters?", "id": "100000000000000000008184", "answers": [{"text": "Find Out When to Get a Booster This tool is intended to help you make decisions about getting COVID-19 vaccinations", "answer_start": 97}], "is_impossible": false}, {"question": "What is this tool intended to help you make decisions about?", "id": "100000000000000000008185", "answers": [{"text": "getting COVID-19 vaccinations", "answer_start": 183}], "is_impossible": false}], "context": "Use this tool to determine when or if you (or your child) can get one or more COVID-19\nboosters. Find Out When to Get a Booster\nThis tool is intended to help you make decisions about getting COVID-19 vaccinations. It should not be used to\ndiagnose or treat COVID-19."}]}, {"title": "d908577a188309e1b3ab87d7bef17508", "paragraphs": [{"qas": [{"question": "Who can get their Booster?", "id": "100000000000000000008186", "answers": [{"text": "\u2022 \u2022 \u2022", "answer_start": 42}], "is_impossible": false}, {"question": "How long should you delay your next dose of COVID-19?", "id": "100000000000000000008188", "answers": [{"text": "3 months", "answer_start": 374}], "is_impossible": false}, {"question": "What is less likely in the weeks to months after infection?", "id": "100000000000000000008189", "answers": [{"text": "Reinfection", "answer_start": 484}], "is_impossible": false}], "context": "\uf426\nFind Out When You Can Get Your Booster\n\u2022\n\u2022\n\u2022\n\u2022\nFor Healthcare Workers: Learn more about COVID-19 vaccine schedules\n\uf2ff\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nGetting Vaccines If You Had or Currently Have COVID-19\nIf you recently had COVID-19, you may consider delaying your next vaccine dose (whether a primary dose or booster) by 3\nmonths from when your symptoms started or, if you had no symptoms, when you first received a positive test. Reinfection is less likely in the weeks to months after infection."}]}, {"title": "4823ba88b9211b9337a53e8c05265b2d", "paragraphs": [{"qas": [{"question": "What could be a reason to get a vaccine sooner rather than later?", "id": "100000000000000000008190", "answers": [{"text": "personal risk of severe disease, or risk of disease in a loved one or close contact, local COVID-19 Community Level", "answer_start": 34}], "is_impossible": false}, {"question": "What is the most common COVID-19 variant currently causing illness?", "id": "100000000000000000008191", "answers": [{"text": "COVID-19 Community Level", "answer_start": 125}], "is_impossible": false}, {"question": "What is the age range of children and teens between 6 months and 17 years for Healthcare Workers?", "id": "100000000000000000008192", "answers": [{"text": "6 months\u201317 years For Healthcare Workers: Learn more about COVID 19", "answer_start": 299}], "is_impossible": false}, {"question": "What does the dose of COVID-19 vaccine based on on the day of vaccination?", "id": "100000000000000000008193", "answers": [{"text": "age", "answer_start": 424}], "is_impossible": false}, {"question": "Children get a smaller dose of what vaccine than teens and adults?", "id": "100000000000000000008194", "answers": [{"text": "COVID-19 vaccine dosage is based on age on the day of vaccination, not on size or weight. Children get a smaller dose of COVID-19", "answer_start": 388}], "is_impossible": false}], "context": "However, certain factors, such as personal risk of severe\ndisease, or risk of disease in a loved one or close contact, local COVID-19 Community Level, and the most common COVID-19\nvariant currently causing illness, could be reasons to get a vaccine sooner rather than later. Children and teens ages 6 months\u201317 years\nFor Healthcare Workers: Learn more about COVID 19 vaccine schedules. \uf2ff\nCOVID-19 vaccine dosage is based on age on the day of vaccination, not on size or weight. Children get a smaller dose of\nCOVID-19 vaccine than teens and adults based on their age group."}]}, {"title": "9e41e4d67e72379f0353b240a04c461c", "paragraphs": [{"qas": [{"question": "Pfizer-BioNTech PRIMARY SERIES 3-8 weeks after 1st dose What is not recommended for this age group at this time?", "id": "100000000000000000008196", "answers": [{"text": "booster", "answer_start": 268}], "is_impossible": false}, {"question": "What is the name of the UPDATED (BIVALENT) BOOSTER?", "id": "100000000000000000008198", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 483}], "is_impossible": false}, {"question": "Children ages 6-11 years can get what?", "id": "100000000000000000008200", "answers": [{"text": "Pfizer- BioNTech or Moderna booster", "answer_start": 677}], "is_impossible": false}], "context": "AGE GROUP\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech\nPRIMARY SERIES\nAt least 8 weeks after 2nd dose\nUp to Date: 2 weeks after 3rd dose, since a booster is not recommended for this age group at this time\nMore details: Staying up to date\nPfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster, children age 5\nyears can only get a Pfizer-\nBioNTech booster, and children\nages 6\u201311 years can get a Pfizer-\nBioNTech or Moderna booster."}]}, {"title": "2da94c75a8b46c2400ea6a6a224e1500", "paragraphs": [{"qas": [{"question": "What is the name of the CDC AGE GROUP Pfizer-BioNTech Vaccine Overview?", "id": "100000000000000000008201", "answers": [{"text": "Moderna", "answer_start": 621}], "is_impossible": false}, {"question": "How long after your first dose is the PRIMARY SERIES?", "id": "100000000000000000008202", "answers": [{"text": "4\u20138 weeks", "answer_start": 677}], "is_impossible": false}, {"question": "What is Moderna UPDATED?", "id": "100000000000000000008203", "answers": [{"text": "BIVALENT) BOOSTER", "answer_start": 409}], "is_impossible": false}, {"question": "Up to Date: Immediately after you have received the most recent booster recommended for you Up to date: 4-8 weeks after your first dose What is the name of the moderna PRIMARY SERIES?", "id": "100000000000000000008205", "answers": [{"text": "Moderna PRIMARY SERIES", "answer_start": 631}], "is_impossible": false}, {"question": "How many weeks after 1st dose of Pfizer-BioNTech UPDATED (BIVALENT) BOOSTER can children 5 years of age get a booster at least 2 months after their 2nd dose?", "id": "100000000000000000008206", "answers": [{"text": "4\u20138", "answer_start": 677}], "is_impossible": false}], "context": "Up to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nAGE GROUP\nPfizer-BioNTech Vaccine Overview\nPfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\nAGE GROUP\nAGE GROUP\nModerna\n\uf1aa\nModerna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech\nUPDATED (BIVALENT) BOOSTER\nChildren 5 years of age can get a\nPfizer-BioNTech booster at least\n2 months after their 2nd dose."}]}, {"title": "a5cefb788905018301e1bb3628531b12", "paragraphs": [{"qas": [{"question": "What is up to date two weeks after completing the 2nd dose of their primary series?", "id": "100000000000000000008208", "answers": [{"text": "Children 6 months to 4 years of age", "answer_start": 78}], "is_impossible": false}, {"question": "Who received a Moderna primary series are up to date immediately after they have received the most recent booster recommended for them?", "id": "100000000000000000008210", "answers": [{"text": "Children 5 years of age", "answer_start": 194}], "is_impossible": false}], "context": "(Children 6 months to 4 years\nare not recommended for a\nbooster.) Up to Date: Children 6 months to 4 years of age are up to date two weeks after completing the 2nd dose of their\nprimary series. Children 5 years of age who received a Moderna primary series are up to date immediately after they\nhave received the most recent booster recommended for them."}]}, {"title": "fa6b166b4ab2dffcbd6c88fb9946040c", "paragraphs": [{"qas": [{"question": "How long after 1st dose will you be able to stay up to date?", "id": "100000000000000000008211", "answers": [{"text": "4\u20138 weeks", "answer_start": 79}], "is_impossible": false}, {"question": "What is the name of the Vaccine that you can get your 2nd dose of?", "id": "100000000000000000008212", "answers": [{"text": "Pfizer-BioNTech or Moderna UPDATED (BIVALENT) BOOSTER", "answer_start": 140}], "is_impossible": false}, {"question": "What age group is Novavax not authorized as a booster dose at this time?", "id": "100000000000000000008214", "answers": [{"text": "18 years and older", "answer_start": 336}], "is_impossible": false}], "context": "More details: Staying up to date\nModerna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd\nprimary series dose\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nAdults ages 18 years and older\nModerna Vaccine Overview\nUp to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\nAGE GROUP\nNovavax is not authorized as a booster dose at this time."}]}, {"title": "3f14f7c137c499480998a84382756b76", "paragraphs": [{"qas": [{"question": "Novavax PRIMARY SERIES 3-8 weeks after 1st dose Up to date: Immediately after you have received the most recent booster recommended for you What is the AGE GROUP 18 YEARS AND OLDER Pfizer-BioNTech Vaccine Overview", "id": "100000000000000000008215", "answers": [{"text": "Pfizer-Bio", "answer_start": 571}], "is_impossible": false}, {"question": "What is the AGE GROUP 18 YEARS AND OLDER Pfizer-BioNTech Vaccine Overview 3-8 weeks after 1st dose?", "id": "100000000000000000008216", "answers": [{"text": "Moderna", "answer_start": 951}], "is_impossible": false}, {"question": "How long after 1st dose are the PRIMARY SERIES?", "id": "100000000000000000008219", "answers": [{"text": "4\u20138 weeks", "answer_start": 1007}], "is_impossible": false}, {"question": "What is a Moderna UPDATED (BIVALENT) BOOSTER?", "id": "100000000000000000008220", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 142}], "is_impossible": false}, {"question": "What is Novavax not authorized as a booster dose at this time?", "id": "100000000000000000008221", "answers": [{"text": "Novavax \uf1aa AGE GROUP", "answer_start": 1311}], "is_impossible": false}], "context": "Novavax Vaccine Overview\nNovavax\n\uf1aa\nNovavax\nPRIMARY SERIES\nNovavax\nPRIMARY SERIES\n3-8 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd\nprimary series dose\nUp to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\nAGE GROUP\n18 YEARS AND OLDER\nPfizer-BioNTech Vaccine Overview\nPfizer-BioNTech\n\uf1aa\nPfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd\nprimary series dose or last\nbooster\nUp to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nAGE GROUP\n18 YEARS AND OLDER\nModerna Vaccine Overview\nModerna\n\uf1aa\nModerna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd\nprimary series dose or last\nbooster\nUp to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\nNovavax\n\uf1aa\nAGE GROUP\n18 YEARS AND OLDER\nNovavax is not authorized as a booster dose at this time."}]}, {"title": "4ea2fcffd4de7c00bcac1d9e4aebe3b4", "paragraphs": [{"qas": [{"question": "How long after your 2nd dose is it recommended to get your booster?", "id": "100000000000000000008224", "answers": [{"text": "2 months", "answer_start": 170}], "is_impossible": false}, {"question": "What are the AGE GROUP 18 YEARS AND OLDER?", "id": "100000000000000000008225", "answers": [{"text": "Johnson & Johnson's Janssen", "answer_start": 388}], "is_impossible": false}, {"question": "What is the AGE GROUP 18 YEARS AND OLDER?", "id": "100000000000000000008226", "answers": [{"text": "Johnson & Johnson's Janssen", "answer_start": 388}], "is_impossible": false}, {"question": "What company is J&J/Janssen Pfizer-BioNTech or Moderna?", "id": "100000000000000000008227", "answers": [{"text": "Johnson & Johnson's Janssen", "answer_start": 388}], "is_impossible": false}, {"question": "How do you get your 2nd dose?", "id": "100000000000000000008228", "answers": [{"text": "Talk to your healthcare or vaccine provider", "answer_start": 562}], "is_impossible": false}], "context": "Novavax\nPRIMARY SERIES\nNovavax\nPRIMARY SERIES\n3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd\nprimary series dose\nNovavax Vaccine Overview\nUp to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nJ&J/Janssen\nPfizer-BioNTech or Moderna\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nGetting your 2nd dose: Talk to your healthcare or vaccine provider about the timing for the 2nd dose in your primary series."}]}, {"title": "8c1cd5ea7378862dc09d746be19ccddb", "paragraphs": [{"qas": [{"question": "How long after the 1st dose should people consider getting the 2nd primary Pfizer-BioNTech, Moderna, or Novavax?", "id": "100000000000000000008229", "answers": [{"text": "8 weeks", "answer_start": 160}], "is_impossible": false}, {"question": "What may increase how much protection the vaccines offer?", "id": "100000000000000000008230", "answers": [{"text": "A longer time between the 1st and 2nd primary doses", "answer_start": 188}], "is_impossible": false}], "context": "People ages 6 months through 64 years, and especially males ages 12 through 39 years, may consider getting the 2nd\nprimary Pfizer-BioNTech, Moderna, or Novavax 8 weeks after the 1st dose. A longer time between the 1st and 2nd primary doses may increase how much protection the vaccines offer, and\nfurther minimize the rare risk of myocarditis and pericarditis."}]}, {"title": "80f2a62d93d01f09109482c00d04ec06", "paragraphs": [{"qas": [{"question": "Who should get the second dose of the Pfizer-BioNTech COVID-19 vaccine 3 weeks after the first dose?", "id": "100000000000000000008232", "answers": [{"text": "Anyone wanting protection due to high levels of community transmission, people ages 65 years and older", "answer_start": 0}], "is_impossible": false}, {"question": "Who is more likely to get very sick from COVIDE-19?", "id": "100000000000000000008234", "answers": [{"text": "people ages 65 years and older", "answer_start": 72}], "is_impossible": false}, {"question": "How long after the first dose does Moderna COVID-19 vaccine last?", "id": "100000000000000000008236", "answers": [{"text": "4 weeks", "answer_start": 298}], "is_impossible": false}, {"question": "What if you have completed your primary series but are not yet eligible for a booster?", "id": "100000000000000000008238", "answers": [{"text": "Staying up to date: If you have completed your primary series, but are not yet eligible for a booster, you are also considered up to date", "answer_start": 409}], "is_impossible": false}, {"question": "Are you still eligible for a booster?", "id": "100000000000000000008239", "answers": [{"text": "not yet eligible for a booster", "answer_start": 480}], "is_impossible": false}, {"question": "Are you considered up to date?", "id": "100000000000000000008240", "answers": [{"text": "If you have completed your primary series, but are not yet eligible for a booster, you are also considered up to date", "answer_start": 429}], "is_impossible": false}], "context": "Anyone wanting protection due to high levels of community transmission, people ages 65 years and older, or people\nwho are more likely to get very sick from COVID-19, should get the second dose of:\nPfizer-BioNTech COVID-19 vaccine 3 weeks (or 21 days) after the first dose. Moderna COVID-19 vaccine 4 weeks (or 28 days) after the first dose. Novavax COVID-19 vaccine 3 weeks (or 21 days) after the first dose. Staying up to date: If you have completed your primary series, but are not yet eligible for a booster, you are also considered\nup to date."}]}, {"title": "3d799e3d4fe5a46785ec4be53c93dd92", "paragraphs": [{"qas": [{"question": "How long after you have received the most recent booster recommended for you?", "id": "100000000000000000008242", "answers": [{"text": "Immediately", "answer_start": 172}], "is_impossible": false}, {"question": "What does CDC not recommend mixing products for?", "id": "100000000000000000008243", "answers": [{"text": "your primary series doses", "answer_start": 399}], "is_impossible": false}, {"question": "What should you get if you received Pfizer-BioNTech, Moderna, or Novavax for the first dose of your first series dose?", "id": "100000000000000000008245", "answers": [{"text": "the same product for all following primary series doses", "answer_start": 537}], "is_impossible": false}, {"question": "Who recommends mixing boosters for people ages 5 and older?", "id": "100000000000000000008246", "answers": [{"text": "CDC", "answer_start": 356}], "is_impossible": false}, {"question": "What is the age range for boosters?", "id": "100000000000000000008247", "answers": [{"text": "5 and older", "answer_start": 672}], "is_impossible": false}], "context": "J&J/Janssen Vaccine Overview\nJ&J/Janssen\nPRIMARY SERIES\nPfizer BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 1 dose\nor last booster\nst\nUp to Date: Immediately after you have received the most recent booster recommended for you\nMore details: Staying up to date\n\u2022\n-\n\u2022\n-\n-\n-\nMixing COVID-19 Vaccine Products\nDo Not Mix Primary Series\nCDC does not recommend mixing products for your primary series doses. If you received Pfizer-BioNTech, Moderna, or\nNovavax for the first dose of your primary series, you should get the same product for all following primary series doses. Mixing Boosters\nThe following information applies to boosters for people ages 5 and older."}]}, {"title": "29905df143a5fea778d559b7f132c24a", "paragraphs": [{"qas": [{"question": "Who can no longer get an original (monovalent) mRNA booster?", "id": "100000000000000000008251", "answers": [{"text": "Children age 5 years old", "answer_start": 296}], "is_impossible": false}, {"question": "Who can get a different product for their updated (bivalent) booster than they received for their primary series?", "id": "100000000000000000008252", "answers": [{"text": "People ages 6 years and older", "answer_start": 434}], "is_impossible": false}], "context": "Children under age 5 years are not recommended\nto receive a booster at this time. Children age 5 years old are only currently recommended to receive the updated (bivalent) Pfizer-BioNTech booster, and\nthey can get this booster whether they received the Pfizer-BioNTech or Moderna primary series. Children age 5 years old can no longer get an original (monovalent) mRNA (Pfizer-BioNTech or Moderna) booster. Children age 5 years old\n\uf1aa\nPeople ages 6 years and older can get a different product for their updated (bivalent) booster than they received for their\nprimary series or last booster."}]}, {"title": "88d0ae01304e444453b61269c71cc7b7", "paragraphs": [{"qas": [{"question": "Who can no longer get an original (monovalent) mRNA?", "id": "100000000000000000008253", "answers": [{"text": "People ages 6 years and older", "answer_start": 0}], "is_impossible": false}, {"question": "What do people who are vaccinated outside of the US depend on?", "id": "100000000000000000008255", "answers": [{"text": "whether: The vaccine(s) received are accepted in the United States as valid vaccinations", "answer_start": 331}], "is_impossible": false}, {"question": "What is the primary series completed and if eligible, a booster dose was received?", "id": "100000000000000000008256", "answers": [{"text": "The vaccine(s) received are accepted in the United States as valid vaccinations", "answer_start": 340}], "is_impossible": false}], "context": "People ages 6 years and older can no longer get an original (monovalent) mRNA (Pfizer-\nPeople ages 6 years and older\n\uf1aa\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nVaccination Received Outside the United States\nSpecific recommendations for people vaccinated outside the United States depend on whether:\nThe vaccine(s) received are accepted in the United States as valid vaccinations\nThe primary series was completed and, if eligible, a booster dose was received\nThese recommendations apply only to people who are not moderately or severely immunocompromised. BioNTech or Moderna) booster."}]}, {"title": "73cfb7863df134baa3e5a40d88baaa7f", "paragraphs": [{"qas": [{"question": "What website can you use to find COVID-19 vaccine locations near you?", "id": "100000000000000000008258", "answers": [{"text": "vaccines.gov", "answer_start": 52}], "is_impossible": false}, {"question": "What is the ZIP code of your ZIP code?", "id": "100000000000000000008259", "answers": [{"text": "438829", "answer_start": 88}], "is_impossible": false}, {"question": "What can you expect during and after your vaccination?", "id": "100000000000000000008261", "answers": [{"text": "\u2022 \u2022 \u2022 \u2022", "answer_start": 374}], "is_impossible": false}], "context": "To find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. \uf263 Learn About Getting Your Vaccine\nDo you need to wait to get vaccinated after getting COVID-19 or getting treatment for COVID-19? How can you prepare for vaccination? What can you expect during and after your vaccination? Getting Your COVID-19 Vaccine\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nIf You Receive a Vaccine That is Not in the U.S."}]}, {"title": "c2338c68b82f4e014d882c6c49026e75", "paragraphs": [{"qas": [{"question": "Wait at least 28 days after the last dose of what vaccine?", "id": "100000000000000000008263", "answers": [{"text": "COVID-19", "answer_start": 102}], "is_impossible": false}, {"question": "If the FDA has not approved or authorized a vaccine what may be limited data available?", "id": "100000000000000000008264", "answers": [{"text": "COVID-19 vaccine", "answer_start": 339}], "is_impossible": false}], "context": "Accepted List Above\nWait at least 28 days after the last dose you received of that vaccine then start COVID-19 vaccination over with a\nCOVID-19 vaccine that has been approved or authorized by the FDA. If the FDA has not approved or authorized a vaccine there may be limited data available or reviewed on the safety or\neffectiveness of the COVID-19 vaccine."}]}, {"title": "19c5516633a9a86e2b762b9de7f58e29", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine approved or authorized by the U.S. Food and Drug Administration?", "id": "100000000000000000008266", "answers": [{"text": "COVID-19", "answer_start": 0}], "is_impossible": false}, {"question": "What are the vaccines listed for emergency use by the World Health Organization (WHO)?", "id": "100000000000000000008267", "answers": [{"text": "those that are listed above", "answer_start": 347}], "is_impossible": false}], "context": "COVID-19 vaccines available abroad that are accepted in the United States as valid vaccinations\n\uf1aa\nVaccines approved or authorized by the U.S. Food and Drug Administration (FDA) currently include:\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen\nVaccines listed for emergency use by the World Health Organization (WHO) currently include those that are listed\nabove and the following:\nAstraZeneca/Oxford vaccine\nSinopharm\nSinovac\nCOVAXIN\nCovovax\nCanSino\n\u2022\n\u2022\n\u2022\n\u2022\n\uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf209\n\u2022\n\u2022\f10/30/22, 9:27 AM Stay Up to Date with COVID-19 Vaccines Including Boosters | CDC\nHow to Complete a Primary Series\nReceive 1 dose of a single-dose accepted COVID-19 vaccine\nReceive 2 doses of a 2-dose accepted COVID-19 vaccine\nCDC does not recommend mixing different COVID-19 vaccines for the primary series, but CDC is aware that mixing\nCOVID-19 vaccines for the primary series is increasingly common in many countries outside the United States."}]}, {"title": "c76bc663339eb5ab16894147773578f4", "paragraphs": [{"qas": [{"question": "What is a mixed primary series?", "id": "100000000000000000008272", "answers": [{"text": "two different COVID-19 vaccines", "answer_start": 62}], "is_impossible": false}, {"question": "How many different COVID-19 vaccines did people receive?", "id": "100000000000000000008273", "answers": [{"text": "two", "answer_start": 62}], "is_impossible": false}, {"question": "What is the best way to get the same dose of Moderna, Novavax, or Pfizer-BioNTech?", "id": "100000000000000000008274", "answers": [{"text": "get the same vaccine again", "answer_start": 292}], "is_impossible": false}, {"question": "What is the best way to get the same vaccine again to complete the primary series?", "id": "100000000000000000008275", "answers": [{"text": "If you got 1 dose of Moderna, Novavax, or Pfizer-BioNTech", "answer_start": 220}], "is_impossible": false}, {"question": "If you are not yet eligible for a booster, you are considered what?", "id": "100000000000000000008276", "answers": [{"text": "up to date", "answer_start": 448}], "is_impossible": false}], "context": "Therefore,\npeople who receive a mixed primary series, meaning two different COVID-19 vaccines, have completed the series. If You Started But Didn\u2019t Complete a Primary Series\nYou will need to complete the primary series. If you got 1 dose of Moderna, Novavax, or Pfizer-BioNTech, it is best to\nget the same vaccine again to complete the primary series. After Completing a Primary Series\nIf you are not yet eligible for a booster, you are considered up to date."}]}, {"title": "22e121230cb6a59f60ff38750a91a742", "paragraphs": [{"qas": [{"question": "What is recommended for you based on your age and the appropriate time has passed since completing the primary series?", "id": "100000000000000000008277", "answers": [{"text": "booster recommended for you as soon as a booster", "answer_start": 42}], "is_impossible": false}, {"question": "The white CDC COVID-19 vaccination cards are issued only in what country?", "id": "100000000000000000008278", "answers": [{"text": "United States", "answer_start": 345}], "is_impossible": false}, {"question": "What are the white CDC COVID-19 vaccination cards only issued to?", "id": "100000000000000000008279", "answers": [{"text": "people vaccinated in the United States", "answer_start": 320}], "is_impossible": false}, {"question": "What does CDC recommend that people vaccinated outside of the US keep as proof of vaccination?", "id": "100000000000000000008280", "answers": [{"text": "their documentation", "answer_start": 432}], "is_impossible": false}], "context": "Otherwise, stay up to date by getting the booster\nrecommended for you as soon as a booster is recommended for you based on your age and the appropriate time has\npassed since completing the primary series. \u2022\n\u2022\n\u2022\nProof of vaccination card in the United States\n\uf1aa\nThe white CDC COVID-19 vaccination cards are issued only to people vaccinated in the United States. CDC\nrecommends that people vaccinated outside of the United States keep their documentation of being vaccinated in\nanother country as proof of vaccination. CDC does\u202fnot\u202fkeep vaccination records nor determine how vaccination\nrecords are used."}]}, {"title": "aa5beebd1e4b056cd6657675bf130d07", "paragraphs": [{"qas": [{"question": "Who can update their records with vaccines they received while outside of the United States?", "id": "100000000000000000008282", "answers": [{"text": "Contacting the\u202fimmunization information system (IIS)\u202fin their state", "answer_start": 99}], "is_impossible": false}, {"question": "Who can contact their healthcare provider or local or state immunization program through their state health department?", "id": "100000000000000000008283", "answers": [{"text": "People can update their records with vaccines they received while outside of the United States by: Contacting the\u202fimmunization information system (IIS)\u202fin their state", "answer_start": 0}], "is_impossible": false}, {"question": "Who can learn more about the recommendations for people vaccinated outside of the US?", "id": "100000000000000000008284", "answers": [{"text": "Healthcare Workers", "answer_start": 338}], "is_impossible": false}, {"question": "When was the Interim Clinical Considerations last updated?", "id": "100000000000000000008286", "answers": [{"text": "Oct. 14, 2022", "answer_start": 574}], "is_impossible": false}], "context": "People can update their records with vaccines they received while outside of the United States by:\nContacting the\u202fimmunization information system (IIS)\u202fin their state. Contacting their healthcare provider or local or state immunization program through their\u202fstate\u2019s health\ndepartment. \u2022\n\u2022\nLearn more about\u202fCOVID-19 vaccination cards. For Healthcare Workers: Learn more about the recommendations for people vaccinated outside of the United States. \uf2ff For Healthcare and Public Health\nUse of COVID-19 Vaccines in the United States: Interim Clinical Considerations\nLast Updated Oct. 14, 2022"}]}, {"title": "8f8fbeea9fce98a9eba119c7ee521c81", "paragraphs": [{"qas": [{"question": "What do people with COVID-19 have a wide range of?", "id": "100000000000000000008287", "answers": [{"text": "symptoms", "answer_start": 138}], "is_impossible": false}, {"question": "How long may symptoms appear after exposure to the virus?", "id": "100000000000000000008288", "answers": [{"text": "2-14 days", "answer_start": 224}], "is_impossible": false}, {"question": "What can anyone have?", "id": "100000000000000000008289", "answers": [{"text": "mild to severe symptoms", "answer_start": 279}], "is_impossible": false}, {"question": "How can symptoms vary depending on vaccination status?", "id": "100000000000000000008292", "answers": [{"text": "Symptoms may change with new COVID-19 variants", "answer_start": 354}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Symptoms of COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nSymptoms of COVID-19\nPeople with COVID-19 have had a wide range of symptoms reported \u2013 ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. Anyone can have mild to severe symptoms. This list does not include all possible symptoms. Symptoms may change with new COVID-19 variants and can vary depending\non vaccination status. CDC will continue to update this list as we learn more about COVID-19."}]}, {"title": "1646f2dc75ca1f4513b42e0b6a153d90", "paragraphs": [{"qas": [{"question": "What type of people are at higher risk for getting very sick from COVID- 19?", "id": "100000000000000000008293", "answers": [{"text": "Older adults", "answer_start": 0}], "is_impossible": false}, {"question": "How old are people who have underlying medical conditions like heart or lung disease or diabetes?", "id": "100000000000000000008295", "answers": [{"text": "Older adults", "answer_start": 0}], "is_impossible": false}], "context": "Older adults and people who\nhave underlying medical conditions like heart or lung disease or diabetes are at higher risk for getting very sick from COVID-\n19. Possible symptoms include:\nFever or chills\nCough\nShortness of breath or difficulty breathing\nFatigue\nMuscle or body aches\nHeadache\nNew loss of taste or smell\nSore throat\nCongestion or runny nose\nNausea or vomiting\nDiarrhea\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nFeeling Sick?"}]}, {"title": "4c329053c5cd464dd5391014f4912a1a", "paragraphs": [{"qas": [{"question": "What is the name of the CDC\u2019s isolation guidance?", "id": "100000000000000000008297", "answers": [{"text": "COVID-19", "answer_start": 94}], "is_impossible": false}, {"question": "What type of pain or pressure is present in the chest?", "id": "100000000000000000008299", "answers": [{"text": "Persistent", "answer_start": 306}], "is_impossible": false}, {"question": "If someone is showing any of these signs, call 911 or what?", "id": "100000000000000000008301", "answers": [{"text": "call ahead to your local emergency facility", "answer_start": 524}], "is_impossible": false}, {"question": "What is the name of the emergency facility that you are seeking care for?", "id": "100000000000000000008302", "answers": [{"text": "your local emergency facility", "answer_start": 538}], "is_impossible": false}], "context": "If you are experiencing any of these symptoms, consider the following options:\nGet tested for COVID-19\nIf you have already tested positive for COVID-19, learn more about CDC\u2019s isolation guidance\n\u2022\n\u2022\nWhen to Seek Emergency Medical Attention\nLook for emergency warning signs* for COVID 19:\nTrouble breathing\nPersistent pain or pressure in the chest\nNew confusion\nInability to wake or stay awake\nPale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone\nIf someone is showing any of these signs, call 911 or call ahead to your local emergency facility. Notify the operator that\nyou are seeking care for someone who has or may have COVID-19."}]}, {"title": "e33806ba0f3d9889a82ed7ab424cfe45", "paragraphs": [{"qas": [{"question": "What are two contagious respiratory illnesses?", "id": "100000000000000000008304", "answers": [{"text": "Influenza (Flu) and COVID-19", "answer_start": 229}], "is_impossible": false}, {"question": "What is the difference between flu and COVID-19?", "id": "100000000000000000008305", "answers": [{"text": "You cannot tell the difference between flu and COVID-19 by symptoms alone", "answer_start": 467}], "is_impossible": false}, {"question": "What is the name of the coronavirus that causes COVID-19?", "id": "100000000000000000008306", "answers": [{"text": "SARS-CoV-2", "answer_start": 400}], "is_impossible": false}, {"question": "What tests can differentiate between flu and COVID-19 at the same time?", "id": "100000000000000000008309", "answers": [{"text": "PCR tests", "answer_start": 589}], "is_impossible": false}], "context": "*This list is not all possible symptoms. Please call your medical provider for any other symptoms that are severe or\nconcerning to you. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:37 AM Symptoms of COVID-19 | CDC\n\uf277 Difference Between Flu and COVID-19\nInfluenza (Flu) and COVID-19 are both contagious respiratory illnesses, but they are caused by different\nviruses. COVID-19 is caused by infection with a coronavirus named SARS-CoV-2, and flu is caused by infection\nwith influenza viruses. You cannot tell the difference between flu and COVID-19 by symptoms alone because\nsome of the symptoms are the same. Some PCR tests can differentiate between flu and COVID-19 at the\nsame time."}]}, {"title": "ede00e9b246f86bc50da6400c5f2103d", "paragraphs": [{"qas": [{"question": "What type of tests are available in many testing locations?", "id": "100000000000000000008311", "answers": [{"text": "flu and COVID-19", "answer_start": 71}], "is_impossible": false}, {"question": "If you have symptoms of both viruses, ask a healthcare provider about getting tested for which?", "id": "100000000000000000008312", "answers": [{"text": "flu and COVID-19", "answer_start": 166}], "is_impossible": false}, {"question": "What is a symptom of Coronavirus?", "id": "100000000000000000008313", "answers": [{"text": "ASL", "answer_start": 310}], "is_impossible": false}, {"question": "When was the last time the information on COVID-19 was updated?", "id": "100000000000000000008315", "answers": [{"text": "Oct. 26, 2022", "answer_start": 472}], "is_impossible": false}], "context": "If one of these tests is not available, many testing locations provide flu and COVID-19 tests\nseparately. Talk to a healthcare provider about getting tested for both flu and COVID-19 if you have\nsymptoms. Learn more\nResources\nPrint Resources\n\uf1aa\n\uf20c\nVideos\n\uf1aa\nSymptoms of COVID-19\nVideo Length: 00:00:21\nWatch Video\nASL Symptoms of Coronavirus\nVideo Length: 00:09:25\nWatch Video\nMore Information\nUnderstanding Your Risk\nHealthcare Workers: Information on COVID-19\nLast Updated Oct. 26, 2022\f10/30/22, 9:37 AM Symptoms of COVID-19 | CDC"}]}, {"title": "3ebbfceec4ae529a78c6019aac229e33", "paragraphs": [{"qas": [{"question": "What is the name of the coronavirus disease 2019?", "id": "100000000000000000008316", "answers": [{"text": "COVID-19", "answer_start": 319}], "is_impossible": false}, {"question": "Who is the most trusted source of information on vaccines?", "id": "100000000000000000008317", "answers": [{"text": "vaccine recipients", "answer_start": 342}], "is_impossible": false}, {"question": "What is COVID-19?", "id": "100000000000000000008318", "answers": [{"text": "coronavirus disease 2019", "answer_start": 293}], "is_impossible": false}, {"question": "What do you do to help vaccine recipients understand the importance of vaccination?", "id": "100000000000000000008320", "answers": [{"text": "most-trusted source of information on vaccines", "answer_start": 362}], "is_impossible": false}], "context": "10/30/22, 9:17 AM Talking to Recipients about COVID-19 Vaccination | CDC\nVaccines & Immunizations\nVaccines & Immunizations\nVaccines & Immunizations Home\nVaccine Recipient Education\nQuick References for COVID-19 Vaccine Recipients Who Want More Information\nMany people have questions about the coronavirus disease 2019 (COVID-19) vaccines. As vaccine recipients\u2019 most-trusted\nsource of information on vaccines, you play a critical role in helping vaccine recipients understand the importance of\nvaccination and that COVID-19 vaccines are safe and effective. The following resources will help you share clear and accurate information about COVID-19 vaccines, raise awareness\nabout the benefits of vaccination, and address common questions and concerns about what to expect when getting\nvaccinated."}]}, {"title": "dc771e0712b140693e2662031fa48b46", "paragraphs": [{"qas": [{"question": "How to Talk with Parents about COVID- Tips for Pediatricians, Family Medicine Practitioners, and Other Pediatric Providers?", "id": "100000000000000000008323", "answers": [{"text": "Communication Resources", "answer_start": 0}], "is_impossible": false}, {"question": "What is an introduction to motivational interviewing for healthcare professionals?", "id": "100000000000000000008324", "answers": [{"text": "Communication Resources for Healthcare Providers and Staff How to Talk with Parents about COVID- Tips for Pediatricians, Family Medicine Practitioners, and Other Pediatric Providers \uf426 Talking with Patients about COVID-19 Vaccination An Introduction to Motivational Interviewing for Healthcare Professionals \uf426 COVID-19 Vaccine FAQs", "answer_start": 0}], "is_impossible": false}, {"question": "What are some tips for Healthcare Providers & Clinical Staff about COVID-19 Vaccine Misinformation?", "id": "100000000000000000008325", "answers": [{"text": "Communicating accurate information, responding to gaps, and confronting", "answer_start": 624}], "is_impossible": false}, {"question": "What is a good way to address misinformation about the vaccine?", "id": "100000000000000000008326", "answers": [{"text": "Communicating accurate information", "answer_start": 624}], "is_impossible": false}, {"question": "How do you tailor information about the vaccination to your specific audience?", "id": "100000000000000000008327", "answers": [{"text": "Communication Resources for Healthcare Providers and Staff How to Talk with Parents about COVID- Tips for Pediatricians, Family Medicine Practitioners, and Other Pediatric Providers \uf426 Talking with Patients about COVID-19 Vaccination An Introduction to Motivational Interviewing for Healthcare Professionals \uf426 COVID-19 Vaccine FAQs for Healthcare Professionals Answers to common clinical questions you or your patients may have about COVID-19 vaccines \uf426 Talking to Patients with Intellectual and Developmental Disabilities about Tips for Healthcare Providers & Clinical Staff \uf426 How to Address COVID-19 Vaccine Misinformation Communicating accurate information, responding to gaps, and confronting misinformation \uf426 How to Tailor COVID-19 Information to Your Specific Audience Understanding your audience, creating messages and materials, and getting feedback", "answer_start": 0}], "is_impossible": false}, {"question": "What do you and your organization do to support COVID-19 recipient vaccination education?", "id": "100000000000000000008328", "answers": [{"text": "Share Your Story!", "answer_start": 859}], "is_impossible": false}], "context": "Communication Resources for Healthcare Providers and Staff\nHow to Talk with Parents about COVID-\nTips for Pediatricians, Family Medicine\nPractitioners, and Other Pediatric Providers\n\uf426 Talking with Patients about COVID-19\nVaccination\nAn Introduction to Motivational\nInterviewing for Healthcare Professionals\n\uf426\nCOVID-19 Vaccine FAQs for Healthcare\nProfessionals\nAnswers to common clinical questions you\nor your patients may have about COVID-19\nvaccines\n\uf426 Talking to Patients with Intellectual\nand Developmental Disabilities about\nTips for Healthcare Providers & Clinical Staff\n\uf426\nHow to Address COVID-19 Vaccine\nMisinformation\nCommunicating accurate information,\nresponding to gaps, and confronting\nmisinformation\n\uf426 How to Tailor COVID-19 Information to\nYour Specific Audience\nUnderstanding your audience, creating\nmessages and materials, and getting\nfeedback\n\uf426\nShare Your Story! What are you or your organization doing to support COVID-19 recipient\nvaccination education?"}]}, {"title": "c50ddaac2ab3006487405c8dbca3ab5d", "paragraphs": [{"qas": [{"question": "What is the name of the page where you could share your story about COVID-19 Vaccines?", "id": "100000000000000000008329", "answers": [{"text": "COVID-19 Vaccine Community Features page", "answer_start": 66}], "is_impossible": false}, {"question": "Who can share their story with ISDcomm@cdc.gov?", "id": "100000000000000000008330", "answers": [{"text": "you could see it on our COVID-19 Vaccine Community Features page", "answer_start": 42}], "is_impossible": false}, {"question": "What is the acronym for the American College of Obstetricians and Gynecologists?", "id": "100000000000000000008331", "answers": [{"text": "Vaccine Confidence Training", "answer_start": 517}], "is_impossible": false}], "context": "Share your story with ISDcomm@cdc.gov and you could\nsee it on our COVID-19 Vaccine Community Features page. 10/30/22, 9:17 AM Talking to Recipients about COVID-19 Vaccination | CDC\nAdditional Resources\nInteractive COVID-19 Vaccine Conversations Module for\nHealthcare Professionals\nHow to Talk About COVID-19 Vaccines with Friends and\nFamily\nMyths and Facts about COVID-19 Vaccines\nHow COVID-19 Vaccines Were Developed\nSafety of COVID-19 Vaccines\nHow Schools Can Support COVID-19 Vaccines\nAbout mRNA COVID-19 Vaccines\nVaccine Confidence Training (American College of\nObstetricians and Gynecologists) \uf209\nPage last reviewed: April 14, 2022"}]}, {"title": "dfe057c09719f5ae7959b33729b33399", "paragraphs": [{"qas": [{"question": "What is your approach to a conversation with patients and families who are hesitant about COVID-19 vaccination?", "id": "100000000000000000008333", "answers": [{"text": "CDC Vaccines & Immunizations Vaccines & Immunizations Vaccines & Immunizations Home Talking with Patients about COVID-19 Vaccination An Introduction to Motivational Interviewing for Healthcare Professionals As a trusted source of health information and healing, your approach to a conversation with patients and families who are hesitant about receiving COVID-19 vaccines can influence their willingness to consider vaccination", "answer_start": 69}], "is_impossible": false}, {"question": "What can a conversation with patients and families who are hesitant about receiving COVID-19 vaccines influence?", "id": "100000000000000000008334", "answers": [{"text": "their willingness to consider vaccination", "answer_start": 455}], "is_impossible": false}, {"question": "Be compassionate, show empathy, and be curious about the reasons why the patient feels what?", "id": "100000000000000000008336", "answers": [{"text": "the way they do", "answer_start": 696}], "is_impossible": false}, {"question": "Be curious about the reasons why a patient feels the way they do?", "id": "100000000000000000008337", "answers": [{"text": "genuinely", "answer_start": 638}], "is_impossible": false}], "context": "10/30/22, 9:18 AM Talking with Patients about COVID-19 Vaccination | CDC\nVaccines & Immunizations\nVaccines & Immunizations\nVaccines & Immunizations Home\nTalking with Patients about COVID-19 Vaccination\nAn Introduction to Motivational Interviewing for Healthcare Professionals\nAs a trusted source of health information and healing, your approach to a conversation with patients and families who are\nhesitant about receiving COVID-19 vaccines can influence their willingness to consider vaccination. Here are four steps to apply motivational interviewing rapidly (1\u20135 minutes) during a patient visit. Be compassionate, show empathy, and be genuinely curious about the reasons why the patient feels the way they do."}]}, {"title": "935edbdeaf2d182bd0c80925ee304fdb", "paragraphs": [{"qas": [{"question": "What can influence how patients view vaccines?", "id": "100000000000000000008338", "answers": [{"text": "culture, family dynamics, and circumstances", "answer_start": 16}], "is_impossible": false}, {"question": "What do not work?", "id": "100000000000000000008339", "answers": [{"text": "Arguing and debating", "answer_start": 117}], "is_impossible": false}, {"question": "Taking a strong initial stand may also backfire with people who have concerns about vaccines.", "id": "100000000000000000008340", "answers": [{"text": "Arguing and debating do not work. Taking a strong initial stand may also backfire, especially with people who have concerns about vaccines. Start by asking permission to discuss vaccines. Say something like, \u201cIf it is okay with you, I would like to spend a few minutes", "answer_start": 117}], "is_impossible": false}, {"question": "What is the name of the vaccine that a patient would like to discuss with their family?", "id": "100000000000000000008341", "answers": [{"text": "COVID-19", "answer_start": 400}], "is_impossible": false}, {"question": "If the patient says no, respect what?", "id": "100000000000000000008342", "answers": [{"text": "that", "answer_start": 468}], "is_impossible": false}], "context": "Be sensitive to culture, family dynamics, and circumstances that may influence how patients view vaccines. Remember: Arguing and debating do not work. Taking a strong initial stand may also backfire, especially with people\nwho have concerns about vaccines. Start by asking permission to discuss vaccines. Say something like, \u201cIf it is okay with you, I would like to spend a few minutes\ntalking about COVID-19 vaccines and your family.\u201d\nIf the patient says no, respect that."}]}, {"title": "d65e177620d359a8f6a5d388bc12639c", "paragraphs": [{"qas": [{"question": "What could you do based on the patient\u2019s demonstrated emotions and your assessment of the patient's worldview and values?", "id": "100000000000000000008343", "answers": [{"text": "spend several minutes curiously exploring why the patient doesn\u2019t want to talk about it", "answer_start": 272}], "is_impossible": false}, {"question": "If the patient says yes to talking about vaccines, move to what step?", "id": "100000000000000000008346", "answers": [{"text": "Step 3", "answer_start": 566}], "is_impossible": false}], "context": "Option 1: Move on and say, \u201cI respect that, and because I care about your overall health, maybe we could talk about\nthe vaccines at a future time.\u201d\nOption 2: Based on the patient\u2019s demonstrated emotions and your assessment of the patient\u2019s worldview and\nvalues, you could spend several minutes curiously exploring why the patient doesn\u2019t want to talk about it. The goal\nis to understand, not to change their mind. Remember: These conversations may take time, and they may continue over multiple visits. If the patient says yes to talking about the vaccines, move to Step 3."}]}, {"title": "7ec367cf56bb927be47941cdd980cbfd", "paragraphs": [{"qas": [{"question": "How do you apply Motivational Interviewing During a Patient Visit?", "id": "100000000000000000008349", "answers": [{"text": "Step 1: Embrace an attitude of empathy and collaboration", "answer_start": 64}], "is_impossible": false}, {"question": "What do you do Step 1: Embrace an attitude of empathy and collaboration Step 2: Ask permission to discuss vaccines?", "id": "100000000000000000008350", "answers": [{"text": "Motivational Interviewing", "answer_start": 15}], "is_impossible": false}, {"question": "On a scale of 1 to 10, how likely are you to get a COVID-19 vaccine?", "id": "100000000000000000008351", "answers": [{"text": "already have an appointment to get vaccinated", "answer_start": 373}], "is_impossible": false}, {"question": "Where does curiosity come in?", "id": "100000000000000000008353", "answers": [{"text": "4", "answer_start": 509}], "is_impossible": false}, {"question": "What comes in when curiosity comes in?", "id": "100000000000000000008354", "answers": [{"text": "4", "answer_start": 509}], "is_impossible": false}, {"question": "What can you say?", "id": "100000000000000000008355", "answers": [{"text": "\u201cOkay, why 4?", "answer_start": 559}], "is_impossible": false}], "context": "\uf209\nHow to Apply Motivational Interviewing During a Patient Visit\nStep 1: Embrace an attitude of empathy and collaboration\nStep 2: Ask permission to discuss vaccines\f10/30/22, 9:18 AM Talking with Patients about COVID-19 Vaccination | CDC\nAsk the patient a scaled question. For example, \u201cOn a scale of 1 to 10, how likely are you to get a COVID-19 vaccine?\u201d (1 =\nnever; 10 = already have an appointment to get vaccinated). Then explore both sides of whatever number is given. Example: Let\u2019s assume someone says 4. This is where curiosity comes in. You can say, \u201cOkay, why 4?"}]}, {"title": "1c40d9fe48b30347cd94e096845a1658", "paragraphs": [{"qas": [{"question": "What would help you move to a 5 or 6?", "id": "100000000000000000008356", "answers": [{"text": "lower number", "answer_start": 14}], "is_impossible": false}, {"question": "What does talking about getting vaccinated do?", "id": "100000000000000000008358", "answers": [{"text": "changes how they process their choices", "answer_start": 305}], "is_impossible": false}, {"question": "Ask them to express their vaccination benefits out loud.", "id": "100000000000000000008361", "answers": [{"text": "People hesitant about vaccines usually have more practice explaining why they haven\u2019t gotten vaccinated", "answer_start": 378}], "is_impossible": false}], "context": "And why not a lower\nnumber?\u201d Let them answer, and ask a follow-up question like, \u201cWhat would help you move to a 5 or 6?\u201d\nThe goal is to help the patient become more open to moving toward higher numbers\u2014in other words, getting vaccinated. You want them to talk about this out loud because talking actually changes how they process their choices and can\ndevelop forward momentum. People hesitant about vaccines usually have more practice explaining why they haven\u2019t gotten vaccinated, so it\u2019s good to\nreverse that. Ask them to express their vaccination benefits out loud."}]}, {"title": "c79fd3a56b4997fabfe4764634627567", "paragraphs": [{"qas": [{"question": "What is important to show support for the patient?", "id": "100000000000000000008363", "answers": [{"text": "to incorporate their personal values and the health needs of their family and community as they make their decision", "answer_start": 240}], "is_impossible": false}], "context": "Be compassionate and curious about the patient\u2019s mixed feelings, both the part of them that wants to trust that getting a\nvaccine is important and safe and the other part that feels hesitant. It is important to show support for the patient to\nincorporate their personal values and the health needs of their family and community as they make their decision. If a patient asks a question about vaccine safety, vaccine risks, or their health or mental health, respond within the\nboundaries of your competence, ethics, and scope of practice."}]}, {"title": "b19d3bbdc7bf48a4faa7389e8515f6ea", "paragraphs": [{"qas": [{"question": "What should the patient provide as needed?", "id": "100000000000000000008367", "answers": [{"text": "scientific information", "answer_start": 106}], "is_impossible": false}, {"question": "Refer the patient to resources on the CDC website.", "id": "100000000000000000008368", "answers": [{"text": "information", "answer_start": 116}], "is_impossible": false}, {"question": "What type of health care provider should a person speak with?", "id": "100000000000000000008369", "answers": [{"text": "medical or mental", "answer_start": 322}], "is_impossible": false}], "context": "If you feel competent and aware of how to answer the patient\u2019s question, respond with empathy and provide scientific\ninformation as needed. Refer the patient to resources on the CDC website, which are listed below. If the patient\u2019s question is outside of your competence or awareness, recommend that they speak with their medical or\nmental health provider or a knowledgeable expert, as needed."}]}, {"title": "e9d7be2d74929ffcec0790275c728a2f", "paragraphs": [{"qas": [{"question": "What is the name of the person who created the content for the American Psychological Association?", "id": "100000000000000000008371", "answers": [{"text": "Jared Skillings", "answer_start": 61}], "is_impossible": false}, {"question": "What are some common questions about COVID-19 Vaccines?", "id": "100000000000000000008373", "answers": [{"text": "Frequently Asked Questions about COVID-19 Vaccines Answering Patients\u2019 Questions About COVID-19 Vaccine and Vaccination", "answer_start": 419}], "is_impossible": false}], "context": "Content developed by the American Psychological Association (Jared Skillings, PhD, ABPP; Erin Swedish, PhD; Robin McLeod, PhD; Mitch Prinstein, PhD, ABPP;\nand Stephen Gillaspy, PhD) in partnership with U.S. Centers for Disease Control and Prevention\nStep 3: Motivational interviewing\nStep 4: Respond to questions about vaccines, health, or mental health\nAdditional Resources:\nKey Things to Know about COVID-19 Vaccines\nFrequently Asked Questions about COVID-19 Vaccines\nAnswering Patients\u2019 Questions About COVID-19 Vaccine and Vaccination\nTalking with Parents About COVID-19 Vaccination\nHow to Tailor COVID-19 Information for Your Specific Audience\nHow to Address COVID-19 Misinformation\nPage last reviewed: November 3, 2021"}]}, {"title": "b2bd758ed542393c9a2b2762c8574bf6", "paragraphs": [{"qas": [{"question": "What is important for healthcare professionals to receive the training needed to effectively meet the demands of their roles?", "id": "100000000000000000008376", "answers": [{"text": "Training and Education for COVID-19 Vaccination", "answer_start": 18}], "is_impossible": false}, {"question": "What will be needed to implement COVID-19 vaccination efforts?", "id": "100000000000000000008378", "answers": [{"text": "A variety of healthcare professionals and personnel", "answer_start": 453}], "is_impossible": false}], "context": "10/30/22, 9:17 AM Training and Education for COVID-19 Vaccination | CDC\nVaccines & Immunizations\nVaccines & Immunizations Home\nTraining and Education\nIt\u2019s important healthcare professionals receive the training\nneeded to effectively meet the demands of their roles. Training must be ongoing as new COVID-19 vaccines become\navailable and as vaccine recommendations evolve when we\nlearn more about the vaccines and how to improve the\nvaccination process. A variety of healthcare professionals and personnel will be needed to implement COVID-19 vaccination efforts."}]}, {"title": "50829584ed1dd038c13c4a2a4e700f42", "paragraphs": [{"qas": [{"question": "What kind of support staff are not licensed to administer vaccines but can assist with vaccine preparation and cold chain management?", "id": "100000000000000000008380", "answers": [{"text": "Medical support staff", "answer_start": 118}], "is_impossible": false}], "context": "These\ninclude:\nExperienced vaccinators\nVaccinators who have not administered vaccines in the past 12 months or longer\nMedical support staff (not licensed to administer vaccines but can assist with vaccine preparation and cold chain\nmanagement)\nAdministrative support staff (can assist with cold chain management, data reporting, and distribution of required\nmaterials to vaccine recipients)\nTraining is important not only for those who will prepare and administer vaccine, but also for those responsible for other\ncritical, mandatory functions, including protecting the vaccine cold chain, inputting required data, and ensuring vaccine\nrecipients receive documentation of vaccination."}]}, {"title": "4cf236f6436c6e90a28157d6a2ceb011", "paragraphs": [{"qas": [{"question": "Who needs to be trained?", "id": "100000000000000000008382", "answers": [{"text": "all healthcare staff members", "answer_start": 295}], "is_impossible": false}, {"question": "Guidance for vaccine storage, handling, preparation and administration may differ for each vaccine product?", "id": "100000000000000000008384", "answers": [{"text": "all healthcare staff members", "answer_start": 295}], "is_impossible": false}, {"question": "All healthcare staff members need training in what?", "id": "100000000000000000008385", "answers": [{"text": "COVID-19 vaccination", "answer_start": 341}], "is_impossible": false}, {"question": "What do members need to be trained in?", "id": "100000000000000000008386", "answers": [{"text": "all healthcare staff members need training in COVID-19 vaccination", "answer_start": 295}], "is_impossible": false}, {"question": "How is a vaccine stored, handled, prepared, and administered?", "id": "100000000000000000008388", "answers": [{"text": "all healthcare staff members", "answer_start": 295}], "is_impossible": false}], "context": "Who needs to be trained\n\uf1aa\nIt is critical that healthcare professionals and personnel are familiar with the specific COVID-19 vaccine product(s) in their\nfacility\u2019s inventory. Guidance for vaccine storage, handling, preparation, and administration may differ for each vaccine\nproduct. Therefore, all healthcare staff members need training in COVID-19 vaccination even if they are already\nadministering routinely recommended vaccines. While many practices are the same for all vaccines, whenever a new\nvaccine is introduced to the U.S. market, there are nuances that healthcare professionals must become familiar with to\nensure the vaccine is stored, handled, prepared, and administered correctly."}]}, {"title": "e35a277d424b480aadfd0555bb53ba9d", "paragraphs": [{"qas": [{"question": "What do vaccine manufacturers, CDC, other federal entities, public health agencies, and professional organizations provide?", "id": "100000000000000000008389", "answers": [{"text": "training resources", "answer_start": 128}], "is_impossible": false}, {"question": "What is a component of COVID-19 Vaccination | CDC observation component and competency assessment?", "id": "100000000000000000008391", "answers": [{"text": "Training and Education", "answer_start": 403}], "is_impossible": false}], "context": "Vaccine manufacturers, CDC, other federal entities, public health agencies, and professional organizations provide a\nvariety of training resources, including print materials, training modules, webinars, seminars, and videos. For healthcare\nprofessionals who will be preparing and administering vaccine, it is essential that training programs also include an\nTraining recommendations\n\uf1aa\f10/30/22, 9:17 AM Training and Education for COVID-19 Vaccination | CDC\nobservation component and competency assessment. The following sections describe trainings and competencies\nhealthcare professionals need based on their roles and experience to ensure the vaccine cold chain is protected and\nvaccines are administered safely to recipients."}]}, {"title": "69a11cef940340adf40b8b63607c9d79", "paragraphs": [{"qas": [{"question": "What is the name of the Vaccination Provider Training?", "id": "100000000000000000008393", "answers": [{"text": "COVID-19", "answer_start": 91}], "is_impossible": false}, {"question": "What are the Strategies for Sharps Disposal Container Use During Supply Shortages?", "id": "100000000000000000008394", "answers": [{"text": "Trainings, Webinars", "answer_start": 0}], "is_impossible": false}, {"question": "How long have you not administered the COVID-19 vaccine?", "id": "100000000000000000008396", "answers": [{"text": "physicians, nurses, or practical nurses who are licensed/previously licensed to administer COVID-19 vaccine but have not done so in the last 12 months", "answer_start": 643}], "is_impossible": false}, {"question": "What are Vaccination support workers not licensed to do?", "id": "100000000000000000008397", "answers": [{"text": "administer vaccine", "answer_start": 839}], "is_impossible": false}, {"question": "What is the name of the CDC training module for the vaccine product(s) in your facility?", "id": "100000000000000000008398", "answers": [{"text": "COVID-19", "answer_start": 995}], "is_impossible": false}, {"question": "What is another name for vaccine administration training?", "id": "100000000000000000008399", "answers": [{"text": "Vaccine Administration", "answer_start": 1187}], "is_impossible": false}], "context": "Trainings, Webinars, and Reference Materials\n\uf17f Training Programs and Reference\nMaterials\n\uf53e COVID-19 Vaccination Provider\nTraining\n\uf519 Strategies for Sharps Disposal\nContainer Use During Supply\nShortages\n\uf4b0 Training Modules For COVID-19\nVaccination\n\uf4e6 COVID-19 Vaccine Webinar Series\n\uf69e Safe and Proper Sharps Disposal\nDuring the COVID-19 Mass Vaccination\nCampaign\nTraining Required by Professional Qualification\nFind the training and core competencies you will need by clicking on your professional qualification below:\nHealthcare professionals who have administered vaccine in the last 12 months\nHealthcare professionals or retired (past 5 years) physicians, nurses, or practical nurses who are licensed/previously\nlicensed to administer COVID-19 vaccine but have not done so in the last 12 months\nVaccination support workers (not licensed to administer vaccine) qualified to prepare, store, handle, or transport vaccine\nAdministration support staff qualified to store, handle, or transport vaccine\nCOVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nCDC Training Module(s) for the\nvaccine product(s) in your facility\nIf needed: You Call the Shots: Vaccine\nAdministration\nOr other vaccine administration\ntraining offered by a worksite, state or\nlocal health department, medical\nprofessional organization, or\nmedical/nursing school within the last\n12 months."}]}, {"title": "1408849e1c843e540e83d9a89da8b724", "paragraphs": [{"qas": [{"question": "What is the name of the training offered by a worksite, state or local health department, medical professional organization, or medical/nursing school?", "id": "100000000000000000008401", "answers": [{"text": "Vaccine Storage and Handling", "answer_start": 31}], "is_impossible": false}], "context": "If needed: You Call the Shots: Vaccine\nStorage and Handling\nOr other vaccine storage and handling\ntraining offered by a worksite, state or\nlocal health department, medical\nprofessional organization, or\nmedical/nursing school within the last\n12 months."}]}, {"title": "d4def4b2bddee5abf21ff8930ddef5a0", "paragraphs": [{"qas": [{"question": "How many months have healthcare professionals administered vaccines in the last 12 months?", "id": "100000000000000000008402", "answers": [{"text": "10/30/22", "answer_start": 77}], "is_impossible": false}, {"question": "What is the name of the CDC's training and education for COVID-19 Vaccination?", "id": "100000000000000000008403", "answers": [{"text": "Training Module", "answer_start": 794}], "is_impossible": false}, {"question": "Where is relevant information for the vaccine product(s) in your facility?", "id": "100000000000000000008404", "answers": [{"text": "CDC Training Module", "answer_start": 790}], "is_impossible": false}, {"question": "What is the name of the training module for the vaccine product(s) in your facility?", "id": "100000000000000000008405", "answers": [{"text": "CDC", "answer_start": 790}], "is_impossible": false}, {"question": "What is required for vaccine recipients?", "id": "100000000000000000008406", "answers": [{"text": "additional information", "answer_start": 585}], "is_impossible": false}, {"question": "What are the modules for the vaccine product(s) in your facility called?", "id": "100000000000000000008407", "answers": [{"text": "CDC Training Module", "answer_start": 790}], "is_impossible": false}, {"question": "What is another name for vaccine administration?", "id": "100000000000000000008408", "answers": [{"text": "Vaccine Administration", "answer_start": 888}], "is_impossible": false}], "context": "Healthcare professionals who have administered vaccine in the last 12\nmonths\f10/30/22, 9:17 AM Training and Education for COVID-19 Vaccination | CDC\nCOVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nCore Competencies:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers for the vaccine product(s) in\nyour facility\nClinical considerations\nStorage and handling requirements\nPreparation requirements\nAdministration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements\nRequired and additional information for vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\n\uf209\n\uf20c\nCOVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nCDC Training Module(s) for the\nvaccine product(s) in your facility\nIf needed: You Call the Shots: Vaccine\nAdministration\nOr other vaccine administration\ntraining offered by a worksite, state or\nlocal health department, medical\nprofessional organization, or\nmedical/nursing school within the last\n12 months."}]}, {"title": "4d735e9f499518e3ac4ad9a72fcbce12", "paragraphs": [{"qas": [{"question": "How long have retired physicians, nurses, or practical nurses been retired?", "id": "100000000000000000008410", "answers": [{"text": "past 5 years", "answer_start": 486}], "is_impossible": false}, {"question": "How long have retired nurses been licensed to administer the COVID-19 vaccine?", "id": "100000000000000000008411", "answers": [{"text": "12 months", "answer_start": 641}], "is_impossible": false}, {"question": "What is a vaccination support worker qualified to prepare, store, handle, or transport?", "id": "100000000000000000008412", "answers": [{"text": "vaccine", "answer_start": 864}], "is_impossible": false}, {"question": "What is the name of the CDC training module for the vaccine product(s) in your facility?", "id": "100000000000000000008414", "answers": [{"text": "COVID-19", "answer_start": 944}], "is_impossible": false}, {"question": "What is the name of the training offered by a worksite, state or local health department, medical professional organization, or medical/nursing school?", "id": "100000000000000000008416", "answers": [{"text": "COVID-19", "answer_start": 655}], "is_impossible": false}], "context": "Core Competencies:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers for the vaccine product(s) in\nyour facility\nClinical considerations\nStorage and handling requirements\nPreparation requirements\nAdministration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements\nRequired and additional information for vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nHealthcare professionals or retired (past 5 years) physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19 vaccine but have not done so in the last 12 months\n\uf209\n\uf20c\nCOVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nVaccination support workers (not licensed to administer vaccine) qualified\nto prepare, store, handle, or transport vaccine\f10/30/22, 9:17 AM Training and Education for COVID-19 Vaccination | CDC\nCOVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nCDC Training Module(s) for the\nvaccine product(s) in your facility\nIf needed: You Call the Shots: Vaccine\nAdministration\nOr other vaccine administration\ntraining offered by a worksite, state or\nlocal health department, medical\nprofessional organization, or\nmedical/nursing school within the last\n12 months."}]}, {"title": "204555b3f1c2763fa294637d83e83f5d", "paragraphs": [{"qas": [{"question": "What is recommended for storing and handling vaccines?", "id": "100000000000000000008417", "answers": [{"text": "You Call the Shots: Vaccine Storage and Handling", "answer_start": 45}], "is_impossible": false}, {"question": "What is a vaccine storage and handling training offered by a worksite?", "id": "100000000000000000008418", "answers": [{"text": "12 months", "answer_start": 274}], "is_impossible": false}], "context": "Recommended if storing and handling\nvaccine: You Call the Shots: Vaccine\nStorage and Handling\nOr other vaccine storage and handling\ntraining offered by a worksite, state or\nlocal health department, medical\nprofessional organization, or\nmedical/nursing school within the last\n12 months."}]}, {"title": "e4642dde22d5c71f0909a4a9f389e5ac", "paragraphs": [{"qas": [{"question": "What is recommended if storing and handling vaccines?", "id": "100000000000000000008421", "answers": [{"text": "You Call the Shots: Vaccine Storage and Handling", "answer_start": 609}], "is_impossible": false}], "context": "Core Competencies:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers for the vaccine product(s) in\nyour facility\nPreparation requirements\nStorage and handling requirements\nTransport guidance\nVaccination documentation and reporting requirements\nRequired and additional information for vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\n\uf209\n\uf20c\nCOVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nCDC Training Module(s) for the\nvaccine product(s) in your facility\nn/a Recommended if storing and handling\nvaccine: You Call the Shots: Vaccine\nStorage and Handling\nOr other vaccine storage and handling\ntraining offered by a worksite, state or\nlocal health department, medical\nprofessional organization, or\nmedical/nursing school within the last\n12 months."}]}, {"title": "1a9958fcce12535af67d3902b7a59f70", "paragraphs": [{"qas": [{"question": "What is required and additional information for vaccine recipients?", "id": "100000000000000000008424", "answers": [{"text": "Core Competencies Based on Role: Relevant information contained in the EUA Fact Sheet(s) for Healthcare Providers for the vaccine product(s) in your facility Storage and handling requirements Transport guidance Vaccination documentation and reporting requirements", "answer_start": 0}], "is_impossible": false}, {"question": "Who is qualified to store, handle or transport vaccine?", "id": "100000000000000000008425", "answers": [{"text": "Administration support staff", "answer_start": 384}], "is_impossible": false}, {"question": "What type of staff is qualified to store, handle, or transport vaccine?", "id": "100000000000000000008426", "answers": [{"text": "Administration support", "answer_start": 384}], "is_impossible": false}, {"question": "What is the Interim Guidance for Immunization Services During the Pandemic?", "id": "100000000000000000008427", "answers": [{"text": "Patient Safety Checklist", "answer_start": 606}], "is_impossible": false}, {"question": "What is CDC's Patient Safety Checklist for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations?", "id": "100000000000000000008428", "answers": [{"text": "Training and Education for COVID-19 Vaccination", "answer_start": 725}], "is_impossible": false}], "context": "Core Competencies Based on Role:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements\nTransport guidance\nVaccination documentation and reporting requirements\nRequired and additional information for vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff qualified to store, handle, or transport\nvaccine\n\uf209\n\uf20c\nAdditional Resources:\nCOVID-19 Vaccination Clinical & Professional Resources\nInterim Guidance for Immunization Services During the Pandemic\nPatient Safety Checklist for Vaccination Clinics Held at Satellite Temporary or Off-Site Locations \uf20c\f10/30/22, 9:17 AM Training and Education for COVID-19 Vaccination | CDC\nPatient Safety Checklist for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations\nNational Forum on COVID-19 Vaccine: Resources Page\nVaccine Confidence Training (American College of Obstetricians and Gynecologists)\n\uf20c\n\uf209\nPage last reviewed: April 14, 2022"}]}, {"title": "c9a1150ab2699f259f29d232f40edfd6", "paragraphs": [{"qas": [{"question": "What is CDC reviewing to align with updated guidance?", "id": "100000000000000000008431", "answers": [{"text": "this page", "answer_start": 93}], "is_impossible": false}, {"question": "What do you can do to protect yourself and your loved ones from COVID-19?", "id": "100000000000000000008432", "answers": [{"text": "Stop the Spread", "answer_start": 135}], "is_impossible": false}, {"question": "Who should you know about Omicron?", "id": "100000000000000000008433", "answers": [{"text": "Omicron Variant Learn what you should know about Omicron and other COVID-19 variants", "answer_start": 228}], "is_impossible": false}, {"question": "How does COVID-19 spread?", "id": "100000000000000000008434", "answers": [{"text": "Stop the Spread Learn what you can do to protect yourself and your loved ones from COVID-19. Omicron Variant Learn what you should know about Omicron and other COVID-19 variants. About Variants How COVID-19 Spreads Getting Sick Again (Reinfection) Variants of the Virus Map of Variant Proportions in the US \uf1aa \uf1aa", "answer_start": 135}], "is_impossible": false}, {"question": "What is another term for getting sick again?", "id": "100000000000000000008435", "answers": [{"text": "Reinfection", "answer_start": 370}], "is_impossible": false}, {"question": "How do you protect yourself?", "id": "100000000000000000008436", "answers": [{"text": "Stop the Spread Learn what you can do to protect yourself and your loved ones from COVID-19. Omicron Variant Learn what you should know about Omicron and other COVID-19 variants. About Variants How COVID-19 Spreads Getting Sick Again (Reinfection) Variants of the Virus Map of Variant Proportions in the US \uf1aa \uf1aa \uf1aa \uf1aa How to Protect Yourself Protect Yourself Wear a Mask", "answer_start": 135}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Transmission | CDC\nEspa\u00f1ol | Other Languages\nTransmission\nCDC is reviewing this page to align with updated guidance. Stop the Spread\nLearn what you can do to protect yourself and your loved ones from COVID-19. Omicron Variant\nLearn what you should know about Omicron and other COVID-19 variants. About Variants\nHow COVID-19 Spreads\nGetting Sick Again (Reinfection)\nVariants of the Virus\nMap of Variant Proportions in the US\n\uf1aa\n\uf1aa\n\uf1aa\n\uf1aa\nHow to Protect Yourself\nProtect Yourself\nWear a Mask\nIf You Are Sick\nWhen to wear a mask\nWear a mask with the best fit, protection, and comfort for you."}]}, {"title": "943e5da90b42d7d62c890c991a650605", "paragraphs": [{"qas": [{"question": "What should you wear if the COVID-19 Community Level is high?", "id": "100000000000000000008437", "answers": [{"text": "a well-fitting mask or respirator", "answer_start": 44}], "is_impossible": false}, {"question": "What can you do if you are sick and need to be around others?", "id": "100000000000000000008438", "answers": [{"text": "wear a mask", "answer_start": 211}], "is_impossible": false}, {"question": "What should you wear when the COVID-19 Community Level is medium or high?", "id": "100000000000000000008440", "answers": [{"text": "a well-fitting mask or respirator", "answer_start": 44}], "is_impossible": false}, {"question": "What is a well-fitting mask or respirator if you are at high risk of getting very sick?", "id": "100000000000000000008441", "answers": [{"text": "wear a mask", "answer_start": 211}], "is_impossible": false}], "context": "\u2022\f10/30/22, 9:37 AM Transmission | CDC\nWear a well-fitting mask or respirator when the COVID-19 Community Level is high. If you are sick and need to be around others, or are caring for someone who has COVID-19, wear a mask. If you are at high risk of getting very sick, wear a well-fitting mask or respirator when the COVID-19 Community Level\nis medium or high. \u2022\n\u2022\n\u2022\nHave questions about getting or spreading COVID-19 after being vaccinated? Learn more about COVID-19 vaccine myths and facts. Last Updated July 12, 2021"}]}, {"title": "e73999cb7f181a4b6233af82e02a2eaa", "paragraphs": [{"qas": [{"question": "What is a tool to help you know the requirements to board a flight to the United States?", "id": "100000000000000000008442", "answers": [{"text": "Travel Assessment", "answer_start": 260}], "is_impossible": false}, {"question": "What are the exceptions to the requirement for proof of COVID-19 Vaccination for Air Passengers?", "id": "100000000000000000008445", "answers": [{"text": "Only limited", "answer_start": 547}], "is_impossible": false}], "context": "10/30/22, 9:42 AM Travel | CDC\nEspa\u00f1ol | Other Languages\nTravel\nFind a COVID-19 vaccine or booster near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. Domestic Travel\n\uf698 International Travel\n\uf1c8 Cruise Ship Travel\n\uf4fc\n\uf1c8\nGet Started\nTravel Assessment\nA tool to help you know the requirements to board a flight to the United States. Travel Requirements for Non-U.S. Citizen, Non-U.S. Immigrants\nYou must be fully vaccinated with the primary series of an accepted COVID-19 vaccine to travel to the United States by\nplane. Only limited exceptions apply. For more information, see Requirement for Proof of COVID-19 Vaccination for Air\nPassengers."}]}, {"title": "b38b3bb92eb3d50ab555c6dd437333a3", "paragraphs": [{"qas": [{"question": "What is CDC's order requiring masks on public transportation conveyances and at transportation hubs no longer in effect?", "id": "100000000000000000008446", "answers": [{"text": "January 29, 2021 Order requiring masks on public transportation conveyances and at transportation hubs is no longer in effect. Therefore, CDC will not enforce the Order", "answer_start": 104}], "is_impossible": false}, {"question": "What does CDC continue to recommend that people wear?", "id": "100000000000000000008447", "answers": [{"text": "masks", "answer_start": 318}], "is_impossible": false}, {"question": "What does the CDC continue to recommend that people wear in public transportation settings at this time?", "id": "100000000000000000008448", "answers": [{"text": "masks", "answer_start": 318}], "is_impossible": false}, {"question": "What is the name of the data tracker for COVID-19?", "id": "100000000000000000008449", "answers": [{"text": "United States", "answer_start": 478}], "is_impossible": false}, {"question": "Who is recommended to wear a mask?", "id": "100000000000000000008450", "answers": [{"text": "CDC continues to recommend that people wear masks in indoor public transportation settings", "answer_start": 274}], "is_impossible": false}, {"question": "What is the name of the disease that I am sick with or tested positive for?", "id": "100000000000000000008451", "answers": [{"text": "COVID-19", "answer_start": 586}], "is_impossible": false}, {"question": "What should I do?", "id": "100000000000000000008452", "answers": [{"text": "Do NOT travel", "answer_start": 626}], "is_impossible": false}], "context": "Mask Recommendation\nAs a result of a court order, effective immediately and as of April 18, 2022, CDC\u2019s January 29, 2021 Order requiring masks\non public transportation conveyances and at transportation hubs is no longer in effect. Therefore, CDC will not enforce\nthe Order. CDC continues to recommend that people wear masks in indoor public transportation settings at this time. Safer Travel\nTravel FAQs\f10/30/22, 9:42 AM Travel | CDC\nMask Recommendation\nCOVID-19 Data Tracker: United States\nHow to Protect Yourself and Others\nCan I travel if ...? I am sick with or tested positive for COVID-19 and\nam recommended to isolate. Do NOT travel. Follow recommendations for isolation."}]}, {"title": "68385e71b80aaa94cd5f598ccf52b118", "paragraphs": [{"qas": [{"question": "Do not travel on public transportation if you will not be able to wear a high-quality mask or respirator when around others?", "id": "100000000000000000008455", "answers": [{"text": "indoors for the full duration of your trip", "answer_start": 247}], "is_impossible": false}, {"question": "What should you wear if you travel?", "id": "100000000000000000008456", "answers": [{"text": "high-quality mask or respirator", "answer_start": 313}], "is_impossible": false}, {"question": "What can lower the chances of spreading COVID-19 to others?", "id": "100000000000000000008457", "answers": [{"text": "Traveling by private vehicle", "answer_start": 392}], "is_impossible": false}], "context": "I have ended isolation but still need to continue\nwearing my mask per CDC\u2019s guidance. Do not travel on public transportation such as\nairplanes, buses, and trains if you will not be able\nto wear a high-quality mask or respirator when\naround others indoors for the full duration of your\ntrip. If you travel, wear a high-quality mask or\nrespirator the entire time you are around others\nindoors. Traveling by private vehicle (if possible) can lower\nthe chances of spreading COVID-19 to others. I was exposed to a person with COVID-19 in the\npast 10 days."}]}, {"title": "7364302006445fd24cfc49bbcc16b3e7", "paragraphs": [{"qas": [{"question": "Do not travel on public transportation if you will not be able to wear a high-quality mask or respirator when around others?", "id": "100000000000000000008460", "answers": [{"text": "indoors for the full duration of your trip", "answer_start": 254}], "is_impossible": false}, {"question": "What should you wear if you travel?", "id": "100000000000000000008461", "answers": [{"text": "high-quality mask or respirator", "answer_start": 320}], "is_impossible": false}, {"question": "How can you use the poster if your test is positive?", "id": "100000000000000000008463", "answers": [{"text": "airport testing sites", "answer_start": 602}], "is_impossible": false}, {"question": "What can be used as a resource for airport testing sites?", "id": "100000000000000000008464", "answers": [{"text": "COVID-19 Test is Positive This poster", "answer_start": 505}], "is_impossible": false}], "context": "Follow CDC guidance, including getting tested at\nleast 5 full days after your last exposure. Do not travel on public transportation such as\nairplanes, buses, and trains if you will not be able\nto wear a high-quality mask or respirator when\naround others indoors for the full duration of your\ntrip. If you travel, wear a high-quality mask or\nrespirator the entire time you are around others\nindoors. Traveling by private vehicle (if possible) can lower\nthe chances of spreading COVID-19 to others. If Your COVID-19 Test is Positive\nThis poster is available to download and can be used as a resource for airport\ntesting sites."}]}, {"title": "bcfe599263cfb4de3591f2db5540bcac", "paragraphs": [{"qas": [{"question": "What should travelers do if their COVID-19 test is positive?", "id": "100000000000000000008465", "answers": [{"text": "actions", "answer_start": 32}], "is_impossible": false}, {"question": "What language does the poster remind travelers to take if they have a positive test?", "id": "100000000000000000008466", "answers": [{"text": "English", "answer_start": 93}], "is_impossible": false}, {"question": "Who is providing the COVID-19 vaccine free of charge to all people living in the U.S.?", "id": "100000000000000000008467", "answers": [{"text": "The federal government", "answer_start": 318}], "is_impossible": false}], "context": "The poster reminds travelers of actions they should take if their\nCOVID-19 test is positive. English [PDF \u2013 408 KB, 1 page]\nSpanish [PDF \u2013 416 KB, 1 page]\nEnglish [PDF \u2013 435 KB, 1 page]\nSpanish [PDF \u2013 436 KB, 1 page]\n\uf20c\n\uf20c\n\uf20c\n\uf20c\f10/30/22, 9:42 AM Travel | CDC\np [ , p g ]\nSafe, Easy, Free, and Nearby COVID-19 Vaccination\nThe federal government is providing the vaccine free of charge to all people living in the U.S., regardless of their\nimmigration or health insurance status."}]}, {"title": "488702a6ae244598b7544a4224e47b65", "paragraphs": [{"qas": [{"question": "What is the name of CDC's public health messaging system?", "id": "100000000000000000008468", "answers": [{"text": "travelers at specific airports, seaports, and land borders where most international travelers enter or leave the United States", "answer_start": 115}], "is_impossible": false}, {"question": "Who does CDC partner with to post this information?", "id": "100000000000000000008470", "answers": [{"text": "US Customs and Border Protection", "answer_start": 309}], "is_impossible": false}, {"question": "What is the acronym for US Customs and Border Protection?", "id": "100000000000000000008471", "answers": [{"text": "CBP", "answer_start": 343}], "is_impossible": false}, {"question": "What is TSA?", "id": "100000000000000000008472", "answers": [{"text": "Transportation Security Administration", "answer_start": 353}], "is_impossible": false}], "context": "COVID-19 Vaccines Are Free\nTravel Health Alerts\nCDC\u2019s public health messaging system offers up-to-date messages to travelers\nat specific airports, seaports, and land borders where most international\ntravelers enter or leave the United States. This is the latest information posted by CDC, in partnership with US Customs\nand Border Protection (CBP), the Transportation Security Administration (TSA)\nand other port-of-entry partners."}]}, {"title": "c07d7fcb1594964fc442b239d9a9d39", "paragraphs": [{"qas": [{"question": "What language is tested for COVID-19?", "id": "100000000000000000008473", "answers": [{"text": "Spanish", "answer_start": 54}], "is_impossible": false}, {"question": "What language does testing travel health alert come in?", "id": "100000000000000000008474", "answers": [{"text": "English [JPG \u2013 1.06 MB] | Spanish", "answer_start": 28}], "is_impossible": false}, {"question": "How many MB of JPG is in Spanish?", "id": "100000000000000000008475", "answers": [{"text": "1.16", "answer_start": 69}], "is_impossible": false}, {"question": "Which language is in English?", "id": "100000000000000000008476", "answers": [{"text": "Spanish", "answer_start": 54}], "is_impossible": false}, {"question": "What are the latest reports on COVID-19?", "id": "100000000000000000008478", "answers": [{"text": "travel information related to this outbreak", "answer_start": 685}], "is_impossible": false}], "context": "Testing Travel Health Alert\nEnglish [JPG \u2013 1.06 MB] | Spanish [JPG \u2013 1.16 MB]\n\uf20a \uf20a\nFor Air Carriers and Airports\nInterim Guidance for Airlines and Airline Crew\nInterim Guidance for Transporting by Air People with\nCOVID-19 or Possible Exposure\nFor Ships\nMaritime Guidance\nShip Crew Well-Being During COVID-19\nWorker Safety Guidance\nResources for Transportation Industry\nSocial Media MMWR\f10/30/22, 9:42 AM Travel | CDC\nFacebook\nCDC Travelers\u2019 Health\nCDC GOV\nTwitter\nFollow CDC Travel\nFollow CDC GOV\nCDC\u2019s primary vehicle for scientific public health\ninformation and recommendations. See the latest\nCOVID-19 reports. Stay informed\nTravelers\u2019 Health\nGet the latest updates on COVID-19 and travel information\nrelated to this outbreak."}]}, {"title": "c8b6bfdd7528c369af74a6f6d86e299e", "paragraphs": [{"qas": [{"question": "What is the acronym for Emergency Partners Information Connection?", "id": "100000000000000000008479", "answers": [{"text": "EPIC", "answer_start": 62}], "is_impossible": false}, {"question": "What does EPIC stand for?", "id": "100000000000000000008480", "answers": [{"text": "Emergency Partners Information Connection", "answer_start": 19}], "is_impossible": false}], "context": "Stay informed with Emergency Partners Information\nConnection (EPIC) Newsletters\nStay informed about ways to keep yourself and your loved\nones safe when a public health emergency happens. Sign\nup for EPIC newsletters and announcements. Last Updated Sept. 8, 2022"}]}, {"title": "16fc1a58de600ebe144f8a27c79387ae", "paragraphs": [{"qas": [{"question": "What does CDC Espaol do?", "id": "100000000000000000008483", "answers": [{"text": "CDC Espa\u00f1ol", "answer_start": 67}], "is_impossible": false}, {"question": "What should you wear the entire time you are around others indoors?", "id": "100000000000000000008485", "answers": [{"text": "a high-quality mask or respirator", "answer_start": 499}], "is_impossible": false}, {"question": "When is it safe for you to remove your mask around others?", "id": "100000000000000000008486", "answers": [{"text": "until", "answer_start": 579}], "is_impossible": false}], "context": "10/30/22, 9:43 AM Travel: Frequently Asked Questions and Answers | CDC\nEspa\u00f1ol | Other Languages\nTravel: Frequently Asked Questions and Answers\nGeneral\nCheck CDC\u2019s Domestic Travel or International Travel pages for the latest recommendations for travelers. Travel is any trip that involves leaving your community. Transportation within your community for errands and work\ntransit is not considered travel. What is travel? \uf1aa\nYes, you can travel once you have ended isolation. However, you should wear a high-quality mask or respirator the entire\ntime you are around others indoors until it\u2019s safe for you to remove your mask around others."}]}, {"title": "c27226441bb65dfadff372c466f2ea71", "paragraphs": [{"qas": [{"question": "Do not travel on public transportation if you will not be able to wear a high-quality mask or what?", "id": "100000000000000000008487", "answers": [{"text": "respirator", "answer_start": 131}], "is_impossible": false}, {"question": "Find out when you can travel and steps to take to protect others during your trip.", "id": "100000000000000000008488", "answers": [{"text": "Do not travel on public transportation such as airplanes, buses, and trains if you will not be able to wear a high-quality mask or respirator when around others indoors for the full duration of your trip", "answer_start": 0}], "is_impossible": false}, {"question": "What should you do if you've had COVID-19 in the past 90 days?", "id": "100000000000000000008489", "answers": [{"text": "see specific testing recommendations before you travel", "answer_start": 328}], "is_impossible": false}, {"question": "If you test positive during your trip, what do you do?", "id": "100000000000000000008491", "answers": [{"text": "do not travel", "answer_start": 558}], "is_impossible": false}, {"question": "What drug did I recently have?", "id": "100000000000000000008492", "answers": [{"text": "COVID-19", "answer_start": 507}], "is_impossible": false}], "context": "Do not travel on public\ntransportation such as airplanes, buses, and trains if you will not be able to wear a high-quality mask or respirator when\naround others indoors for the full duration of your trip. Find out when you can travel and steps to take to protect others\nduring you trip. If you had COVID-19 in the past 90 days, see specific testing recommendations before you travel. Follow other travel recommendations and requirements for domestic and international travel. Can I travel if I recently had COVID-19? \uf1aa\nIf you test positive during your trip, do not travel and follow recommendations for isolation."}]}, {"title": "13975bab99e3364bcabb647914b1179", "paragraphs": [{"qas": [{"question": "What type of mask or respirator do you need to wear when traveling back home?", "id": "100000000000000000008494", "answers": [{"text": "high-quality", "answer_start": 187}], "is_impossible": false}, {"question": "What is the best way to travel back home after you have ended isolation?", "id": "100000000000000000008495", "answers": [{"text": "if you are able to wear a high-quality mask or respirator", "answer_start": 161}], "is_impossible": false}, {"question": "What should your travel companions follow for people who have been exposed?", "id": "100000000000000000008496", "answers": [{"text": "CDC travel guidance", "answer_start": 400}], "is_impossible": false}, {"question": "What should I do if I test positive during travel?", "id": "100000000000000000008498", "answers": [{"text": "once you have ended isolation", "answer_start": 122}], "is_impossible": false}], "context": "Remember, requirements\nand recommendations in other countries may differ from the United States. You can travel back home once you have ended isolation but only if you are able to wear a high-quality mask or respirator\nwhen around others indoors for the full duration of your trip. If not, do not travel until it\u2019s safe for you to remove your mask around others. Your travel companions should follow CDC travel guidance for people who have been exposed. If you are in another\ncountry, also follow local guidance. What should I do if I test positive during travel? When can I travel back home?"}]}, {"title": "4bbfdbce6119498e1ac7524da67d090a", "paragraphs": [{"qas": [{"question": "Who is required to have proof of COVID-19 vaccination for air passengers?", "id": "100000000000000000008502", "answers": [{"text": "travel companions", "answer_start": 14}], "is_impossible": false}, {"question": "Who can you protect yourself from?", "id": "100000000000000000008505", "answers": [{"text": "COVID-19", "answer_start": 69}], "is_impossible": false}, {"question": "What are two ways to stay up to date with your COVID-19 vaccines?", "id": "100000000000000000008506", "answers": [{"text": "wearing a high-quality mask", "answer_start": 613}], "is_impossible": false}], "context": "What should my\ntravel companions do? \uf1aa\nHow can I protect myself from COVID-19 when using different types of transportation? \uf1aa\f10/30/22, 9:43 AM Travel: Frequently Asked Questions and Answers | CDC\nAir Travel\nFor additional FAQs on the vaccine requirement before air travel to the U.S., visit Requirement for Proof of COVID-19\nVaccination for Air Passengers. Maintaining distance between yourself and others is often difficult on public transportation. People may not be able to\navoid crowding on airplanes, trains, or buses. Protect yourself from COVID-19 by staying up to date with your COVID-19 vaccines and by wearing a high-quality mask on\npublic transportation."}]}, {"title": "ff65cd2c1e04d061f49b0e0f04972934", "paragraphs": [{"qas": [{"question": "Who should wear a high-quality mask or respirator in indoor areas of public transportation?", "id": "100000000000000000008507", "answers": [{"text": "Everyone aged 2 years or older", "answer_start": 0}], "is_impossible": false}, {"question": "What should all travelers wear in locations that are crowded or poorly ventilated?", "id": "100000000000000000008508", "answers": [{"text": "a high-quality mask or respirator", "answer_start": 78}], "is_impossible": false}, {"question": "What are crowded or poorly ventilated such as airport jetways?", "id": "100000000000000000008509", "answers": [{"text": "transportation hubs (such as airports, stations, and seaports", "answer_start": 201}], "is_impossible": false}, {"question": "What should all travelers take steps to protect themselves and others?", "id": "100000000000000000008510", "answers": [{"text": "wear a high-quality mask or respirator", "answer_start": 73}], "is_impossible": false}, {"question": "What are the requirements for air passengers flying to the United States?", "id": "100000000000000000008512", "answers": [{"text": "vaccination", "answer_start": 551}], "is_impossible": false}, {"question": "What are other issues related to COVID- 19?", "id": "100000000000000000008513", "answers": [{"text": "vaccination requirements for air passengers flying to the United States", "answer_start": 551}], "is_impossible": false}], "context": "Everyone aged 2 years or older, regardless of vaccination status, should wear a high-quality mask\nor respirator in indoor areas of public transportation (such as airplanes, trains, buses, ferries) and transportation hubs\n(such as airports, stations, and seaports), especially in locations that are crowded or poorly ventilated such as airport\njetways. All travelers should take steps to protect themselves and others. CDC does not reimburse or help travelers get reimbursements for travel expenses as a result of canceled or delayed\ntravel because of vaccination requirements for air passengers flying to the United States or other issues related to COVID-\n19."}]}, {"title": "fe8451fd4a2c81c7c1cd6d0a5d47ee0f", "paragraphs": [{"qas": [{"question": "What can trip cancellation insurance protect in the event of an international outbreak?", "id": "100000000000000000008514", "answers": [{"text": "your financial investment in a trip", "answer_start": 199}], "is_impossible": false}, {"question": "What is CDC's Travelers' Health website?", "id": "100000000000000000008515", "answers": [{"text": "trip cancellation insurance can protect your financial investment in a trip if you need to change your itinerary in the event of an international outbreak. Visit CDC\u2019s Travelers\u2019 Health website if you\u2019d like to learn more about travel insurance", "answer_start": 159}], "is_impossible": false}, {"question": "What is CDC's Travelers' Health website about?", "id": "100000000000000000008516", "answers": [{"text": "trip cancellation insurance can protect your financial investment in a trip if you need to change your itinerary in the event of an international outbreak. Visit CDC\u2019s Travelers\u2019 Health website if you\u2019d like to learn more about travel insurance", "answer_start": 159}], "is_impossible": false}, {"question": "What does CDC do if you cancel or delay travel because of vaccination requirements?", "id": "100000000000000000008517", "answers": [{"text": "help me get a refund for travel expenses", "answer_start": 452}], "is_impossible": false}], "context": "While some companies may base their policies on CDC\u2019s travel recommendations or requirements, each company\nestablishes its own refund policies. In some cases, trip cancellation insurance can protect your financial investment in a trip if you need to change your\nitinerary in the event of an international outbreak. Visit CDC\u2019s Travelers\u2019 Health website if you\u2019d like to learn more about\ntravel insurance, including trip cancellation insurance. Can CDC help me get a refund for travel expenses if I cancel or delay travel because of vaccination\nrequirements or other issues related to COVID-19?"}]}, {"title": "f47c5db6e1f37e332dcce5681e54205e", "paragraphs": [{"qas": [{"question": "What is the full name of a passenger on their passport?", "id": "100000000000000000008519", "answers": [{"text": "address while in the United States", "answer_start": 200}], "is_impossible": false}, {"question": "What does failure to provide complete and accurate information result in?", "id": "100000000000000000008521", "answers": [{"text": "criminal penalties", "answer_start": 538}], "is_impossible": false}], "context": "\uf1aa\nAir passengers are required to provide the following contact information, to the extent that it exists, within 72 hours\nbefore their flight\u2019s departure: full name (as it appears on their passport), address while in the United States, primary\ncontact phone number, secondary or emergency contact phone number, and email address. Passengers must also:\nAcknowledge that the obligation to provide complete and accurate information is a U.S. government requirement and\nthat failure to provide complete and accurate information may result in criminal penalties. Confirm the information they provided is complete and accurate."}]}, {"title": "de28d13041713de626c6d8a6b9c491e1", "paragraphs": [{"qas": [{"question": "According to CDC protocols, what happens if a sick traveler has a fever?", "id": "100000000000000000008525", "answers": [{"text": "risk to others on board the airplane, CDC works with local and state health departments and international public health agencies to contact exposed passengers and crew", "answer_start": 340}], "is_impossible": false}, {"question": "What does CDC do if a sick traveler has a contagious disease that is a risk to others on board the airplane?", "id": "100000000000000000008526", "answers": [{"text": "CDC works with local and state health departments and international public health agencies to contact exposed passengers and crew", "answer_start": 378}], "is_impossible": false}, {"question": "What does the CDC work with local and state health departments and international public health agencies?", "id": "100000000000000000008527", "answers": [{"text": "contact exposed passengers and crew", "answer_start": 472}], "is_impossible": false}], "context": "What contact information am I required to provide to airlines and aircraft operators before I board\na flight to the United States? \uf1aa\nUnder current federal regulations, pilots must report all illnesses and deaths to CDC before arriving to a U.S. destination. According to CDC protocols, if a sick traveler has a contagious disease that is a risk to others on board the airplane, CDC\nworks with local and state health departments and international public health agencies to contact exposed passengers\nand crew."}]}, {"title": "7b1c4f4f0d51653d5e6adc549dfb036f", "paragraphs": [{"qas": [{"question": "What should you do if you are exposed to a sick traveler on a flight?", "id": "100000000000000000008528", "answers": [{"text": "Be sure to give the airline your current contact information", "answer_start": 0}], "is_impossible": false}], "context": "Be sure to give the airline your current contact information when booking your ticket so you can be notified if you are\nexposed to a sick traveler on a flight. What happens if there is a sick passenger on an international or domestic flight? \uf1aa\f10/30/22, 9:43 AM Travel: Frequently Asked Questions and Answers | CDC\nLand Travel\nCruise Travel\nFor more information, see the CDC webpage Protecting Travelers\u2019 Health from Airport to Community: Investigating\nContagious Diseases on Flights."}]}, {"title": "71b164736fd0f6bc7c2a1dcb37b33691", "paragraphs": [{"qas": [{"question": "What are the requirements for land travel?", "id": "100000000000000000008531", "answers": [{"text": "COVID-19", "answer_start": 22}], "is_impossible": false}, {"question": "What is the chance of getting COVID-19 on cruise ships?", "id": "100000000000000000008532", "answers": [{"text": "high", "answer_start": 324}], "is_impossible": false}, {"question": "What is a high chance of getting COVID-19 on cruise ships?", "id": "100000000000000000008533", "answers": [{"text": "the virus spreads easily between people in close quarters on board ships", "answer_start": 337}], "is_impossible": false}, {"question": "Which group of people should avoid traveling on cruise ship?", "id": "100000000000000000008535", "answers": [{"text": "People who are not up to date with their COVID-19 vaccines", "answer_start": 543}], "is_impossible": false}], "context": "For information about COVID-19 requirements for land travel, visit the U.S. Department of Homeland Security\u2019s Fact\nSheet: Guidance for Travelers to Enter the U.S. at Land Ports of Entry and Ferry Terminals . What are the requirements for international land travel? \uf1aa\n\uf209\nYes. The chance of getting COVID-19 on cruise ships is high because the virus spreads easily between people in close\nquarters on board ships. For this reason, CDC recommends the following groups of people avoid traveling on cruise\nships, including river cruises, worldwide:\nPeople who are not up to date with their COVID-19 vaccines."}]}, {"title": "a2f28305da35046ef4d2049f09b424e2", "paragraphs": [{"qas": [{"question": "What are some serious chronic medical conditions such as heart disease, chronic lung disease, and diabetes?", "id": "100000000000000000008538", "answers": [{"text": "Older adults and adults of any age with serious chronic medical conditions such as heart disease, chronic lung disease", "answer_start": 93}], "is_impossible": false}, {"question": "Who has underlying medical conditions?", "id": "100000000000000000008539", "answers": [{"text": "Children", "answer_start": 227}], "is_impossible": false}, {"question": "Can traveling on a cruise increase my risk of getting COVID-19?", "id": "100000000000000000008540", "answers": [{"text": "Children with underlying medical conditions", "answer_start": 227}], "is_impossible": false}, {"question": "What does a cruise increase my risk of getting?", "id": "100000000000000000008541", "answers": [{"text": "COVID-19", "answer_start": 326}], "is_impossible": false}, {"question": "When was COVID-19 last updated?", "id": "100000000000000000008542", "answers": [{"text": "Sept. 8, 2022", "answer_start": 351}], "is_impossible": false}], "context": "People with an increased risk of severe illness, regardless of vaccination status, including\nOlder adults and adults of any age with serious chronic medical conditions such as heart disease, chronic lung\ndisease, and diabetes. Children with underlying medical conditions. Can traveling on a cruise increase my risk of getting COVID-19? \uf1aa\nLast Updated Sept. 8, 2022"}]}, {"title": "c2f28caf96a0b9910502b911411a29de", "paragraphs": [{"qas": [{"question": "What can you learn about how COVID-19 spreads and the factors that can increase or decrease that risk?", "id": "100000000000000000008543", "answers": [{"text": "informed choices", "answer_start": 218}], "is_impossible": false}, {"question": "What is written in past tense?", "id": "100000000000000000008544", "answers": [{"text": "The questions below", "answer_start": 236}], "is_impossible": false}, {"question": "What should you do if multiple factors below indicate higher transmission risk?", "id": "100000000000000000008545", "answers": [{"text": "follow the steps for what to do if you are exposed", "answer_start": 456}], "is_impossible": false}, {"question": "What can you ask yourself about future interactions with someone with COVID-19?", "id": "100000000000000000008546", "answers": [{"text": "prevention actions to take", "answer_start": 621}], "is_impossible": false}, {"question": "Ask yourself the same questions about future interactions with others to help you decide what to do?", "id": "100000000000000000008547", "answers": [{"text": "prevention actions", "answer_start": 621}], "is_impossible": false}], "context": "10/30/22, 9:38 AM Understanding Exposure Risks | CDC\nEspa\u00f1ol | Other Languages\nUnderstanding Exposure Risks\nLearning about how COVID-19 spreads and the factors that can increase or decrease that risk can help you make informed\nchoices. The questions below are written in past tense to help you assess the likelihood that you were infected when you were around\na person with COVID-19. If multiple factors below indicate higher transmission risk, you should follow the steps for what to do\nif you are exposed. You can also ask yourself the same questions, but about future interactions with others, to help you decide what prevention\nactions to take."}]}, {"title": "d409f5c95c7c684a1b37f6ee63289275", "paragraphs": [{"qas": [{"question": "What should you do if multiple factors below indicate higher transmission risk?", "id": "100000000000000000008548", "answers": [{"text": "adding more prevention actions", "answer_start": 81}], "is_impossible": false}, {"question": "How long were you with the infected person?", "id": "100000000000000000008549", "answers": [{"text": "Length of time", "answer_start": 165}], "is_impossible": false}, {"question": "Activities like coughing, singing, shouting, or breathing heavily increase the risk of what?", "id": "100000000000000000008553", "answers": [{"text": "transmission", "answer_start": 702}], "is_impossible": false}], "context": "If multiple factors below indicate higher transmission risk, you should consider adding more prevention\nactions. Factors that lower or increase risk of transmission\nLength of time: How long were you with the infected person? Longer exposure time increases the risk of transmission (for example, contact longer than 15 minutes is more likely to result\nin transmission than two minutes of contact). Shorter exposure time\nLower Risk\nMedium exposure time\nModerate Risk\nLonger exposure time\nHigher Risk\nCough or heavy breathing: Was the infected person coughing, singing, shouting, or breathing\nheavily? Activities like coughing, singing, shouting, or breathing heavily due to exertion increase the risk of transmission."}]}, {"title": "fdd12473f5dec69eca28cc75218ae277", "paragraphs": [{"qas": [{"question": "What does being around people who are symptomatic increase?", "id": "100000000000000000008554", "answers": [{"text": "the risk of transmission", "answer_start": 224}], "is_impossible": false}, {"question": "What increases the risk of transmission?", "id": "100000000000000000008555", "answers": [{"text": "Being around people who are symptomatic", "answer_start": 174}], "is_impossible": false}, {"question": "Did you or the infected person wear a respirator or both?", "id": "100000000000000000008556", "answers": [{"text": "Masks", "answer_start": 296}], "is_impossible": false}, {"question": "If one person was wearing a mask, what is the risk of transmission?", "id": "100000000000000000008558", "answers": [{"text": "decreased", "answer_start": 468}], "is_impossible": false}, {"question": "What is a significant decrease if both people were wearing masks?", "id": "100000000000000000008559", "answers": [{"text": "the risk", "answer_start": 518}], "is_impossible": false}, {"question": "How is risk lower if the mask or respirator is worn?", "id": "100000000000000000008560", "answers": [{"text": "a type that offers greater protection", "answer_start": 603}], "is_impossible": false}, {"question": "What type of mask or respirator offers greater protection?", "id": "100000000000000000008561", "answers": [{"text": "mask", "answer_start": 581}], "is_impossible": false}], "context": "Less Moderate Elevated\f10/30/22, 9:38 AM Understanding Exposure Risks | CDC\nLower Risk Moderate Risk Higher Risk\nSymptoms: Did the infected person have symptoms at the time? Being around people who are symptomatic increases the risk of transmission. i\nNo symptoms\nLower Risk\nSymptoms\nHigher Risk\nMasks: Were you or the infected person or both wearing a respirator (for example, N95) or high-\nquality mask? If one person was wearing a mask, the risk of transmission is decreased, and if both people were wearing masks, the risk\nis substantially decreased. Risk is also lower if the mask or respirator is a type that offers greater protection."}]}, {"title": "dbf0f795b97953006f5d419f046501fb", "paragraphs": [{"qas": [{"question": "How well-ventilated was the space?", "id": "100000000000000000008562", "answers": [{"text": "Ventilation and filtration", "answer_start": 175}], "is_impossible": false}, {"question": "What can be lower exposure risk than being outside?", "id": "100000000000000000008563", "answers": [{"text": "Ventilation and filtration: How well-ventilated was the space? More outdoor air can decrease the risk of transmission. Being outside would be lower exposure risk than being indoors, even with good ventilation and filtration", "answer_start": 175}], "is_impossible": false}, {"question": "What would be lower risk than being indoors with poor ventilation or filtration?", "id": "100000000000000000008564", "answers": [{"text": "Being outside", "answer_start": 294}], "is_impossible": false}], "context": "Yes, both masked\nLower Risk\nOnly one masked\nModerate Risk\nNeither masked\nHigher Risk\f10/30/22, 9:38 AM Understanding Exposure Risks | CDC\nLower Risk Moderate Risk Higher Risk\nVentilation and filtration: How well-ventilated was the space? More outdoor air can decrease the risk of transmission. Being outside would be lower exposure risk than being indoors, even\nwith good ventilation and filtration; both of those options would be lower risk than being indoors with poor ventilation or\nfiltration. See the Interactive Home Ventilation Tool. Outdoors\nLower Risk\nWell-ventilated indoors\nModerate Risk\nPoorly ventilated indoors\nHigher Risk\nDistance: How close was the infected person to you?"}]}, {"title": "9a17b13c1ed8c7b93cd2990a9e3ad708", "paragraphs": [{"qas": [{"question": "How does being closer to someone with COVID-19 increase the risk of transmission?", "id": "100000000000000000008566", "answers": [{"text": "Crowded settings", "answer_start": 90}], "is_impossible": false}, {"question": "What is the lowest risk moderate risk Moderate risk Very close or touching?", "id": "100000000000000000008568", "answers": [{"text": "Lower Risk Moderately close", "answer_start": 182}], "is_impossible": false}], "context": "Being closer to someone who is infected with COVID-19 increases the risk of transmission. Crowded settings can raise your\nlikelihood of being close to someone with COVID-19. Distant\nLower Risk\nModerately close\nModerate Risk\nVery close or touching\nHigher Risk\ni \uf209\nLast Updated Aug. 11, 2022"}]}, {"title": "cba32339c28ab29995e0a4b017887787", "paragraphs": [{"qas": [{"question": "What do different types of vaccines work in different ways?", "id": "100000000000000000008570", "answers": [{"text": "to offer protection", "answer_start": 355}], "is_impossible": false}, {"question": "What type of vaccine can't give you COVID-19?", "id": "100000000000000000008571", "answers": [{"text": "COVID-19", "answer_start": 388}], "is_impossible": false}, {"question": "What must be followed before new vaccines are made available for use?", "id": "100000000000000000008572", "answers": [{"text": "various steps", "answer_start": 474}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Understanding How COVID-19 Vaccines Work | CDC\nEspa\u00f1ol | Other Languages\nUnderstanding How COVID-19 Vaccines Work\nHow COVID-19 Vaccines Work\nWhat You Need to Know\nCOVID-19 vaccines help our bodies develop immunity to the virus that causes COVID-19 without us having to get the\nillness. Different types of vaccines work in different ways to offer protection. None of the COVID-19 vaccines can give you COVID-19. Bringing new vaccines to the public involves various steps, all which must be followed before they are made\navailable for use."}]}, {"title": "a47b59fb0176d83589534ddb95a562ca", "paragraphs": [{"qas": [{"question": "What vaccines help our bodies develop immunity to the virus that causes COVID-19 without us having to get the illness?", "id": "100000000000000000008573", "answers": [{"text": "COVID-19", "answer_start": 8}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\nCOVID-19 vaccines help our bodies develop immunity to the virus that causes COVID-19 without us having to get the\nillness. Different types of vaccines work in different ways to offer protection. But with all types\nof vaccines, the body is left with a supply of \u201cmemory\u201d T-lymphocytes as well as B-\nlymphocytes that will remember how to fight that virus in the future. It typically takes a few weeks after vaccination for the body to produce T-lymphocytes\nand B-lymphocytes."}]}, {"title": "ce8af0675926f711fd05c1bef254ba1f", "paragraphs": [{"qas": [{"question": "What can happen to a person who is infected with COVID-19 just before or just after vaccination?", "id": "100000000000000000008576", "answers": [{"text": "get sick", "answer_start": 141}], "is_impossible": false}, {"question": "What is one of the symptoms that can occur after the process of building immunity?", "id": "100000000000000000008577", "answers": [{"text": "fever", "answer_start": 308}], "is_impossible": false}, {"question": "What are symptoms of building immunity?", "id": "100000000000000000008578", "answers": [{"text": "fever", "answer_start": 308}], "is_impossible": false}, {"question": "What are the three types of mRNA approved for use in the United States?", "id": "100000000000000000008581", "answers": [{"text": "mRNA", "answer_start": 587}], "is_impossible": false}, {"question": "What is the name of the protein subunit that is approved or authorized for use?", "id": "100000000000000000008582", "answers": [{"text": "mRNA", "answer_start": 587}], "is_impossible": false}], "context": "Therefore, it is possible that a person could be infected with the\nvirus that causes COVID-19 just before or just after vaccination and then get sick\nbecause the vaccine did not have enough time to provide protection. Sometimes after vaccination, the process of building immunity can cause symptoms,\nsuch as fever. These symptoms are normal signs the body is building immunity. Types of Vaccines: mRNA, Viral Vector, and Protein Subunit\nFacts about COVID-19 Vaccines\nCurrently, there are three main types of COVID-19 vaccines that are approved or authorized for use in the United States:\nmRNA, viral vector, and protein subunit."}]}, {"title": "bb8968bb502073a319a87520d6afbab", "paragraphs": [{"qas": [{"question": "What do vaccines do not use?", "id": "100000000000000000008585", "answers": [{"text": "any live virus", "answer_start": 176}], "is_impossible": false}, {"question": "What triggers an immune response inside our bodies?", "id": "100000000000000000008588", "answers": [{"text": "mRNA vaccines use mRNA", "answer_start": 424}], "is_impossible": false}], "context": "Each type of vaccine prompts our bodies to recognize and help protect us from\nthe virus that causes COVID-19. None of these vaccines can give you COVID-19. Vaccines do not use any live virus\f10/30/22, 9:34 AM Understanding How COVID-19 Vaccines Work | CDC\nmRNA vaccines (Pfizer-BioNTech or Moderna)\nTo trigger an immune response, many vaccines put a weakened or inactivated germ into our bodies. Not mRNA vaccines. Instead, mRNA vaccines use mRNA created in a laboratory to teach our cells how to make a protein\u2014or even just a piece of a\nprotein\u2014that triggers an immune response inside our bodies."}]}, {"title": "5e2d843ecca2747ffff96ecfb129681a", "paragraphs": [{"qas": [{"question": "What helps protect us from getting sick from a germ in the future?", "id": "100000000000000000008590", "answers": [{"text": "antibodies", "answer_start": 37}], "is_impossible": false}, {"question": "Pfizer-BioNTech and Moderna Research have been studying and working with mRNA vaccines for decades?", "id": "100000000000000000008591", "answers": [{"text": "antibodies", "answer_start": 37}], "is_impossible": false}, {"question": "What has been studied before for flu, Zika, rabies, and cytomegalovirus?", "id": "100000000000000000008592", "answers": [{"text": "mRNA vaccines", "answer_start": 270}], "is_impossible": false}, {"question": "What can't cause infection with COVID-19 or other viruses?", "id": "100000000000000000008595", "answers": [{"text": "Vaccines", "answer_start": 544}], "is_impossible": false}], "context": "This immune response, which produces antibodies, is what\nhelps protect us from getting sick from that germ in the future. About Pfizer-BioNTech and Moderna\nResearch for mRNA technology\nResearchers have been studying and working with mRNA vaccines for decades . In fact, mRNA vaccines have been studied before for flu, Zika, rabies, and cytomegalovirus (CMV). Beyond vaccines, cancer research has also used mRNA to trigger the immune system to target specific cancer cells. Protein subunit vaccines (Novavax)\nVaccines do not use any live virus. Vaccines cannot cause infection with the virus that causes COVID-19 or other viruses."}]}, {"title": "71c0430a3740d750b7b9feb944866d16", "paragraphs": [{"qas": [{"question": "What does not affect or interact with our DNA?", "id": "100000000000000000008596", "answers": [{"text": "vaccines", "answer_start": 51}], "is_impossible": false}, {"question": "Where are mRNA COVID-19 vaccines given?", "id": "100000000000000000008598", "answers": [{"text": "upper arm muscle or upper thigh", "answer_start": 249}], "is_impossible": false}, {"question": "What is the name of the harmless protein produced by the mRNA after vaccination?", "id": "100000000000000000008599", "answers": [{"text": "spike protein", "answer_start": 483}], "is_impossible": false}, {"question": "Where is the spike protein found?", "id": "100000000000000000008600", "answers": [{"text": "on the surface of the virus", "answer_start": 525}], "is_impossible": false}, {"question": "What protein is found on the surface of the virus that causes COVID-19?", "id": "100000000000000000008601", "answers": [{"text": "spike protein. The spike protein", "answer_start": 483}], "is_impossible": false}], "context": "They do not affect or interact with our DNA. These vaccines do not enter the nucleus of the cell where our DNA (genetic material) is located, so it cannot\nchange or influence our genes. \u2022\n\u2022\n\u2022\n\uf426\n\uf209\n\u2022\n\u2022 \uf209\nFirst, mRNA COVID-19 vaccines are given in the upper arm muscle or upper thigh, depending on the age of who is\ngetting vaccinated. After vaccination, the mRNA will enter the muscle cells. Once inside, they use the cells\u2019 machinery to produce a\nharmless piece of what is called the spike protein. The spike protein is found on the surface of the virus that causes\nCOVID-19."}]}, {"title": "33ba2922112722c51a5c9c8bead79166", "paragraphs": [{"qas": [{"question": "What does the body leave as waste?", "id": "100000000000000000008603", "answers": [{"text": "mRNA", "answer_start": 58}], "is_impossible": false}, {"question": "How does the immune system recognize that the protein doesn't belong there?", "id": "100000000000000000008604", "answers": [{"text": "triggers our immune system to produce antibodies and activate other immune cells", "answer_start": 245}], "is_impossible": false}, {"question": "What triggers our immune system to produce antibodies and activate other immune cells?", "id": "100000000000000000008605", "answers": [{"text": "Our immune system recognizes that the protein does not belong there", "answer_start": 171}], "is_impossible": false}, {"question": "What might your body do if you got sick with COVID-19?", "id": "100000000000000000008606", "answers": [{"text": "Our immune system recognizes that the protein does not belong there. This triggers our immune system to produce antibodies and activate other immune cells", "answer_start": 171}], "is_impossible": false}, {"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000008607", "answers": [{"text": "infection", "answer_start": 520}], "is_impossible": false}], "context": "After the protein piece is made, our cells break down the mRNA and remove it, leaving the body as waste. Next, our cells display the spike protein piece on their surface. Our immune system recognizes that the protein does\nnot belong there. This triggers our immune system to produce antibodies and activate other immune cells to fight\noff what it thinks is an infection. This is what your body might do if you got sick with COVID-19. At the end of the process, our bodies have learned how to help protect against future infection with the virus that\ncauses COVID-19."}]}, {"title": "9700838d6813b762ec5aaa97fded10ed", "paragraphs": [{"qas": [{"question": "What are normal signs that the body is building protection?", "id": "100000000000000000008609", "answers": [{"text": "Any side effects", "answer_start": 159}], "is_impossible": false}, {"question": "How do COVID-19 vaccines work?", "id": "100000000000000000008610", "answers": [{"text": "FACTSHEET", "answer_start": 292}], "is_impossible": false}, {"question": "What is the spike protein?", "id": "100000000000000000008611", "answers": [{"text": "Protein subunit vaccines contain pieces (proteins) of the virus that causes COVID-19. These virus pieces", "answer_start": 507}], "is_impossible": false}], "context": "The benefit is that people get this protection from a vaccine, without ever having to risk the\npotentially serious consequences of getting sick with COVID-19. Any side effects from getting the vaccine are normal\nsigns the body is building protection. How mRNA COVID-19 vaccines work\n\uf1aa\n\u2022\n\u2022\n\u2022\n\u2022\nFACTSHEET\nHow mRNA COVID-19 Vaccines Work\nPDF infographic explaining how mRNA COVID-19 vaccines work. English [128 KB, 1 page]\nOther Languages\n\u2022 \uf20c\n\u2022\f10/30/22, 9:34 AM Understanding How COVID-19 Vaccines Work | CDC\nProtein subunit vaccines contain pieces (proteins) of the virus that causes COVID-19. These virus pieces are the spike protein."}]}, {"title": "ebf85775c6fffda39647e1f4e8c44fa", "paragraphs": [{"qas": [{"question": "What does the vaccine contain that helps the immune system respond to the spike protein in the future?", "id": "100000000000000000008612", "answers": [{"text": "an adjuvant", "answer_start": 52}], "is_impossible": false}, {"question": "What is the adjuvant called in the vaccine?", "id": "100000000000000000008613", "answers": [{"text": "helps the immune system respond to that spike protein in the future", "answer_start": 69}], "is_impossible": false}, {"question": "Once the immune systems know how to respond to spike protein, they will be able to react to what?", "id": "100000000000000000008614", "answers": [{"text": "the actual virus spike protein", "answer_start": 257}], "is_impossible": false}], "context": "The vaccine also contains another ingredient called an adjuvant that helps the immune system respond to that spike protein\nin the future. Once the immune system knows how to respond to the spike protein, the immune system will be able to\nrespond quickly to the actual virus spike protein and protect you against COVID-19. About Novavax\nResearch for protein subunit technology\nProtein subunit vaccines have been used for years. More than 30 years ago, a hepatitis B vaccine became the first protein subunit vaccine to be approved for use in\npeople in the United States."}]}, {"title": "1265ff3241abb6fd6a36118be634227d", "paragraphs": [{"qas": [{"question": "What is another example of protein subunit vaccines used today?", "id": "100000000000000000008617", "answers": [{"text": "whooping cough vaccines", "answer_start": 69}], "is_impossible": false}, {"question": "What do viral vector COVID-19 vaccines use to deliver important instructions to our cells?", "id": "100000000000000000008618", "answers": [{"text": "a modified version of a different virus (a vector virus", "answer_start": 181}], "is_impossible": false}, {"question": "How many scientific studies of viral vector vaccines have been done and published around the world?", "id": "100000000000000000008619", "answers": [{"text": "hundreds", "answer_start": 370}], "is_impossible": false}, {"question": "Some vaccines recently used for what outbreak have used viral vector technology?", "id": "100000000000000000008620", "answers": [{"text": "Ebola", "answer_start": 505}], "is_impossible": false}, {"question": "What type of vaccines have been focused on against Zika, flu, and HIV?", "id": "100000000000000000008622", "answers": [{"text": "viral vector", "answer_start": 588}], "is_impossible": false}], "context": "Another example of other protein subunit vaccines used today include whooping cough vaccines. Viral vector vaccines (Johnson & Johnson\u2019s Janssen)\nViral vector COVID-19 vaccines use a modified version of a different virus (a vector virus) to deliver important instructions to\nour cells. About Johnson & Johnson's Janssen\nResearch for viral vector technology\nFor decades, hundreds of scientific studies of viral vector vaccines have been done and published around the world. Some vaccines recently used for Ebola outbreaks have used viral vector technology. Several studies have focused on viral vector vaccines against other diseases such as Zika, flu, and HIV."}]}, {"title": "e2bac44944c7bf43f4031c60c838dc60", "paragraphs": [{"qas": [{"question": "Where are protein subunit COVID-19 vaccines given?", "id": "100000000000000000008624", "answers": [{"text": "in the upper arm muscle", "answer_start": 192}], "is_impossible": false}, {"question": "What does our immune system recognize after vaccination?", "id": "100000000000000000008625", "answers": [{"text": "these proteins do not belong there", "answer_start": 313}], "is_impossible": false}, {"question": "What is another ingredient in a vaccine called?", "id": "100000000000000000008626", "answers": [{"text": "the adjuvant", "answer_start": 384}], "is_impossible": false}, {"question": "What helps our immune system produce antibodies and activate other immune cells?", "id": "100000000000000000008627", "answers": [{"text": "the adjuvant", "answer_start": 384}], "is_impossible": false}, {"question": "What might your body do if you got sick with COVID-19?", "id": "100000000000000000008628", "answers": [{"text": "activate other immune cells to fight off what it thinks is an infection", "answer_start": 448}], "is_impossible": false}], "context": "Besides being used in vaccines, viral vectors have also been studied for gene therapy, to treat cancer, and for molecular\nbiology research. \uf426\n\u2022 \uf209\n\u2022\nProtein subunit COVID-19 vaccines are given in the upper arm muscle. After vaccination, nearby cells pick up these\nproteins. Next, our immune system recognizes that these proteins do not belong there. Another ingredient in the vaccine, the\nadjuvant, helps our immune system to produce antibodies and activate other immune cells to fight off what it thinks\nis an infection. This is what your body might do if you got sick with COVID-19."}]}, {"title": "c215d088de150978e1efa18f506833b6", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000008629", "answers": [{"text": "\u2022 \u2022", "answer_start": 429}], "is_impossible": false}, {"question": "What do people get from a vaccine without risking the consequences of getting sick with the virus?", "id": "100000000000000000008630", "answers": [{"text": "protection", "answer_start": 169}], "is_impossible": false}, {"question": "Who has learned how to help protect against future infection with the disease?", "id": "100000000000000000008631", "answers": [{"text": "our bodies", "answer_start": 27}], "is_impossible": false}, {"question": "What are the consequences of getting sick with COVID-19?", "id": "100000000000000000008632", "answers": [{"text": "potentially serious", "answer_start": 228}], "is_impossible": false}], "context": "At the end of the process, our bodies have learned how to help protect against future infection with the virus that\ncauses COVID-19. The benefit is that people get this protection from a vaccine, without ever having to risk the\npotentially serious consequences of getting sick with COVID-19. Many side effects from getting the vaccine are\nnormal signs the body is building protection. How protein subunit COVID-19 vaccines work\n\uf1aa\n\u2022\n\u2022\n\u2022\nFACTSHEET\nHow Protein Subunit COVID-19 Vaccines Work\nPDF infographic explaining how Protein Subunit COVID-19 vaccines work."}]}, {"title": "d3ded76c938113350be0a569071255b6", "paragraphs": [{"qas": [{"question": "What is the vector virus in the vaccine not the virus that causes COVID-19?", "id": "100000000000000000008635", "answers": [{"text": "a different, harmless virus", "answer_start": 250}], "is_impossible": false}, {"question": "What does COVID-19 cause?", "id": "100000000000000000008636", "answers": [{"text": "answer undefined", "answer_start": 250}], "is_impossible": false}, {"question": "Where is the spike protein found?", "id": "100000000000000000008637", "answers": [{"text": "on the surface of the virus", "answer_start": 426}], "is_impossible": false}, {"question": "What does the virus use to produce a harmless piece of?", "id": "100000000000000000008638", "answers": [{"text": "spike protein", "answer_start": 384}], "is_impossible": false}, {"question": "When a spike protein piece is made, what happens to the vector virus?", "id": "100000000000000000008639", "answers": [{"text": "remove it", "answer_start": 557}], "is_impossible": false}], "context": "English [953 KB, 1 page]\n\u2022 \uf20c\n\uf426\n\uf209\n\u2022\n\u2022\n\u2022\f10/30/22, 9:34 AM Understanding How COVID-19 Vaccines Work | CDC\nViral vector COVID-19 vaccines are given in a muscle in the upper arm. The vector virus in the vaccine is not the virus\nthat causes COVID-19, but a different, harmless virus. It enters the muscle cells and uses the cells\u2019 machinery to\nproduce a harmless piece of what is called a spike protein. The spike protein is found on the surface of the virus that\ncauses COVID-19. After the spike protein piece is made, our cells break down the vector virus and remove it."}]}, {"title": "627af4531bf2074203bd3bf708d3ddac", "paragraphs": [{"qas": [{"question": "What triggers our immune system to produce antibodies and activate other immune cells to fight off infection?", "id": "100000000000000000008641", "answers": [{"text": "spike protein", "answer_start": 28}], "is_impossible": false}, {"question": "What does your body do if you get sick with COVID-19?", "id": "100000000000000000008642", "answers": [{"text": "temporary", "answer_start": 344}], "is_impossible": false}, {"question": "At the end of the immune building process, our bodies have learned how to protect against what?", "id": "100000000000000000008643", "answers": [{"text": "future infection", "answer_start": 451}], "is_impossible": false}], "context": "Next, our cells display the spike protein on their surface. Our immune system recognizes that the spike protein does\nnot belong there. This triggers our immune system to produce antibodies and activate other immune cells to fight\noff what it is an infection. This response is similar to what your body does if you get sick with COVID-19, but is\ntemporary. At the end of the immune building process, our bodies have learned how to help protect against future infection\nwith the virus that causes COVID-19."}]}, {"title": "b4bff841119ea0fec16136df7b409eba", "paragraphs": [{"qas": [{"question": "What is a normal sign the body is building protection from COVID-19?", "id": "100000000000000000008644", "answers": [{"text": "Any side effects", "answer_start": 139}], "is_impossible": false}, {"question": "What was developed rapidly, but all steps have been taken to develop them?", "id": "100000000000000000008645", "answers": [{"text": "COVID-19 vaccines", "answer_start": 314}], "is_impossible": false}, {"question": "What is the acronym for the U.S. Food and Drug Administration?", "id": "100000000000000000008646", "answers": [{"text": "FDA", "answer_start": 565}], "is_impossible": false}, {"question": "How are vaccines distributed outside of clinical trials?", "id": "100000000000000000008647", "answers": [{"text": "monitoring systems", "answer_start": 653}], "is_impossible": false}, {"question": "What are monitoring systems used to make sure that COVID-19 vaccines are safe?", "id": "100000000000000000008649", "answers": [{"text": "As vaccines are distributed outside of clinical trials", "answer_start": 597}], "is_impossible": false}], "context": "People get this protection from a vaccine, without ever having to risk the\npotentially serious consequences of getting sick with COVID-19. Any side effects from getting the vaccine are normal\nsigns the body is building protection. How viral vector COVID-19 vaccines work\n\uf1aa\n\u2022\n\u2022\n\u2022\nDeveloping COVID-19 Vaccines\nWhile COVID-19 vaccines were developed rapidly, all steps have been taken to ensure their safety and effectiveness. Bringing\na new vaccine to the public involves many steps including:\nvaccine development,\nclinical trials,\nU.S. Food and Drug Administration (FDA) authorization or approval. As vaccines are distributed outside of clinical trials, monitoring systems are used to make sure that COVID-19 vaccines are\nsafe."}]}, {"title": "e20ccb0f914fa2ddd701d7ee489effaf", "paragraphs": [{"qas": [{"question": "Where are new vaccines first developed?", "id": "100000000000000000008650", "answers": [{"text": "laboratories", "answer_start": 66}], "is_impossible": false}, {"question": "What is COVID-19 related to?", "id": "100000000000000000008653", "answers": [{"text": "SARS-CoV-2, the virus that causes COVID-19, is related to these other coronaviruses", "answer_start": 278}], "is_impossible": false}, {"question": "How many phases of clinical trials do vaccines go through after initial laboratory development?", "id": "100000000000000000008654", "answers": [{"text": "three", "answer_start": 591}], "is_impossible": false}, {"question": "What do trials do to make sure they are safe and effective?", "id": "100000000000000000008656", "answers": [{"text": "vaccines go through three phases of clinical trials", "answer_start": 571}], "is_impossible": false}, {"question": "What have trials been skipped?", "id": "100000000000000000008657", "answers": [{"text": "No trial phases", "answer_start": 665}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\nInitial Development\n\uf1aa\n\uf33d New vaccines are first developed in laboratories. Scientists have been working for many years to develop\nvaccines against coronaviruses, such as those that cause severe acute respiratory syndrome (SARS) and\nMiddle East respiratory syndrome (MERS). SARS-CoV-2, the virus that causes COVID-19, is related to these\nother coronaviruses. The knowledge that was gained through past research on coronavirus vaccines\nhelped speed up the initial development of the current COVID-19 vaccines. Clinical Trials\n\uf1aa\n\uf3ba After initial laboratory development, vaccines go through three phases of clinical trials to make sure they\nare safe and effective. No trial phases have been skipped."}]}, {"title": "3be5daa19daae36c683110f834c52005", "paragraphs": [{"qas": [{"question": "Which vaccines are safe?", "id": "100000000000000000008660", "answers": [{"text": "COVID-19", "answer_start": 312}], "is_impossible": false}, {"question": "What does the FDA assess before making vaccines available to people in real world settings?", "id": "100000000000000000008662", "answers": [{"text": "the findings from clinical trials", "answer_start": 594}], "is_impossible": false}], "context": "The clinical trials for COVID-19 vaccines have involved tens of thousands of volunteers of different ages,\nraces, and ethnicities. Clinical trials for vaccines compare outcomes (such as how many people get sick) between people who\nare vaccinated and people who are not. Results from these trials have shown that COVID-19 vaccines are\nsafe and effective, especially against severe illness, hospitalization, and death. 10/30/22, 9:34 AM Understanding How COVID-19 Vaccines Work | CDC\nAuthorization or Approval\n\uf1aa\n\uf2a7 Before vaccines are made available to people in real-world settings, FDA assesses the findings from\nclinical trials."}]}, {"title": "8cdbf14b8489b08b6a344c38d5d48b7b", "paragraphs": [{"qas": [{"question": "Which vaccines met FDA's safety and effectiveness standards?", "id": "100000000000000000008663", "answers": [{"text": "COVID-19", "answer_start": 32}], "is_impossible": false}, {"question": "What did the EUAs allow the vaccines to be quickly distributed for use?", "id": "100000000000000000008664", "answers": [{"text": "COVID-19 vaccines met FDA\u2019s safety and effectiveness standards and granted those vaccines Emergency Use Authorizations (EUAs) . The EUAs allowed the vaccines to be quickly distributed for use while maintaining the same high safety standards required for all vaccines", "answer_start": 32}], "is_impossible": false}], "context": "Initially, they determined that COVID-19 vaccines met FDA\u2019s safety and effectiveness\nstandards and granted those vaccines Emergency Use Authorizations (EUAs) . The EUAs allowed the\nvaccines to be quickly distributed for use while maintaining the same high safety standards required for\nall vaccines. Learn more in this video about EUAs. FDA has granted full approval for some COVID-19 vaccines. Before granting approval, FDA reviewed\nevidence that built on the data and information submitted to support the EUA."}]}, {"title": "42e6088990689e1b8f53c2767ceb3125", "paragraphs": [{"qas": [{"question": "What are some of the details of the manufacturing process?", "id": "100000000000000000008667", "answers": [{"text": "preclinical and clinical trial data and information", "answer_start": 15}], "is_impossible": false}, {"question": "How many people in the United States have received COVID-19 vaccines under the most intense safety monitoring in U.S. history?", "id": "100000000000000000008668", "answers": [{"text": "Hundreds of millions", "answer_start": 480}], "is_impossible": false}, {"question": "What does FDA require of an approved product?", "id": "100000000000000000008669", "answers": [{"text": "safety, effectiveness, and manufacturing quality", "answer_start": 281}], "is_impossible": false}, {"question": "What is the most intense safety monitoring in U.S. history?", "id": "100000000000000000008670", "answers": [{"text": "COVID-19 vaccines", "answer_start": 546}], "is_impossible": false}, {"question": "What do several monitoring systems continue to track?", "id": "100000000000000000008671", "answers": [{"text": "outcomes from COVID-19 vaccines", "answer_start": 667}], "is_impossible": false}], "context": "This included:\npreclinical and clinical trial data and information,\nas well as details of the manufacturing process,\nvaccine testing results to ensure vaccine quality, and\ninspections of the sites where the vaccine is made. These vaccines were found to meet the high standards for safety, effectiveness, and manufacturing\nquality FDA requires of an approved product. Learn more about the process for FDA approval . \uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\uf209\nTracking Safety Using Vaccine Monitoring Systems\n\uf1aa\n\uf128 Hundreds of millions of people in the United States have received COVID-19 vaccines under the most\nintense safety monitoring in U.S. history. Several monitoring systems continue to track outcomes from COVID-19 vaccines to ensure their safety."}]}, {"title": "9762102c8f891da0a4e341ecf6fe8a73", "paragraphs": [{"qas": [{"question": "What are some common side effects after COVID-19 vaccination?", "id": "100000000000000000008672", "answers": [{"text": "pain or swelling at the injection site, a headache, chills, or fever", "answer_start": 113}], "is_impossible": false}, {"question": "What are normal signs that your body is building protection?", "id": "100000000000000000008673", "answers": [{"text": "common side effects", "answer_start": 60}], "is_impossible": false}], "context": "Some people have no side effects. Many people have reported common side effects after COVID-19\nvaccination, like pain or swelling at the injection site, a headache, chills, or fever. These reactions are\ncommon and are normal signs that your body is building protection. Reports of serious adverse events after vaccination are rare. CDC and FDA continue to closely monitor\nseveral reporting systems, like the\nVaccine Adverse Event Reporting System (VAERS),\nVaccine Safety Datalink (VSD), and\nv-safe, which help look for safety issues now that the vaccines are being given to patients in real-\nworld settings across the country."}]}, {"title": "96f9106399c29b9c4969d56bfa3d64af", "paragraphs": [{"qas": [{"question": "Who provides timely updates on serious adverse events after COVID-19 vaccination?", "id": "100000000000000000008677", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "How long do you need to wait to get vaccinated?", "id": "100000000000000000008678", "answers": [{"text": "\u2022", "answer_start": 360}], "is_impossible": false}, {"question": "What can you expect during and after your COVID-19 vaccination?", "id": "100000000000000000008679", "answers": [{"text": "serious adverse events", "answer_start": 40}], "is_impossible": false}, {"question": "When was the last update for the Coronavirus Vaccine Development Process: How Was Time Saved?", "id": "100000000000000000008680", "answers": [{"text": "Sept. 16, 2022", "answer_start": 635}], "is_impossible": false}], "context": "CDC provides timely updates on selected serious adverse events reported after COVID-19 vaccination. \u2022\n\u2022\n\u2022\n\uf263 Learn About Getting Your Vaccine\nDo you need to wait to get vaccinated after getting COVID-19 or getting treatment for COVID-19? How can you prepare for vaccination? What can you expect during and after your vaccination? Getting Your COVID-19 Vaccine\n\u2022\n\u2022\n\u2022\f10/30/22, 9:34 AM Understanding How COVID-19 Vaccines Work | CDC\nResources\n\uf2ff For Healthcare and Public Health\nCOVID-19 Clinical and Professional Resources\nMore Information\nCoronaviruses\nVaccine Development Process: How Was Time Saved [779 KB, 1 Page]\n\uf209\n\uf20c \uf209\nLast Updated Sept. 16, 2022"}]}, {"title": "b4150daaa123a73ba08e93f3b919e0a2", "paragraphs": [{"qas": [{"question": "What can COVID-19 cause symptoms to range from mild to very severe?", "id": "100000000000000000008681", "answers": [{"text": "the disease", "answer_start": 120}], "is_impossible": false}, {"question": "What can certain settings and activities make people more likely to get very sick with?", "id": "100000000000000000008682", "answers": [{"text": "COVID-19. We also know that certain settings and activities can make you more likely to get infected with the virus that causes COVID-19", "answer_start": 263}], "is_impossible": false}, {"question": "What can certain settings and activities make you more likely to get infected with?", "id": "100000000000000000008683", "answers": [{"text": "the virus that causes COVID-19", "answer_start": 369}], "is_impossible": false}], "context": "10/30/22, 9:38 AM Understanding Risk | CDC\nEspa\u00f1ol | Other Languages\nUnderstanding Risk\nCOVID-19 can affect anyone, and the disease can cause symptoms ranging from mild to very severe. We know that certain\nthings can make people more likely to get very sick with COVID-19. We also know that certain settings and activities can make\nyou more likely to get infected with the virus that causes COVID-19. Understanding Your Risk Helps You Make Decisions\nUnderstanding the risk of COVID-19 for yourself and those around you can help you make informed decisions to keep\nyou safe and healthy."}]}, {"title": "6db0404cf47f3de821c33f1af6ae434c", "paragraphs": [{"qas": [{"question": "What is the risk of Getting Very Sick Information for Specific Groups Older Adults People Who Are Immunocompromised People with Medical Conditions People with Asthma Pregnant and Recently Pregnancy People?", "id": "100000000000000000008688", "answers": [{"text": "\uf266", "answer_start": 319}], "is_impossible": false}, {"question": "What are Infection, Hospitalization, and Death Age Group Rate Ratios?", "id": "100000000000000000008689", "answers": [{"text": "Race and Ethnicity Rate Ratios", "answer_start": 593}], "is_impossible": false}, {"question": "What are Race and Ethnicity rate ratios Last Updated Aug. 11, 2022?", "id": "100000000000000000008690", "answers": [{"text": "Age Group Rate Ratios", "answer_start": 571}], "is_impossible": false}], "context": "If you have risk factors, have a COVID-19 plan in place in case you get sick, and discuss that plan\nwith your healthcare provider and those close to you. Learn what extra precautions you can take to protect yourself and\nothers in settings that make you more likely to be exposed to COVID-19. \uf3c2 Risk of Getting COVID-19\n\uf266 Risk of Getting Very Sick\nInformation for Specific Groups\nOlder Adults\nPeople Who Are Immunocompromised\nPeople with Medical Conditions\nPeople with Asthma\nPregnant and Recently Pregnant People\n\uf419 Risk for COVID-19 Infection, Hospitalization, and Death\nAge Group Rate Ratios Race and Ethnicity Rate Ratios\nLast Updated Aug. 11, 2022"}]}, {"title": "4bb6dd3e8090ac98397371276a8dd774", "paragraphs": [{"qas": [{"question": "What is being tracked in the United States and globally during this pandemic?", "id": "100000000000000000008693", "answers": [{"text": "Numerous variants of the virus that causes COVID-19", "answer_start": 258}], "is_impossible": false}, {"question": "What is each branch on a tree slightly different than the others?", "id": "100000000000000000008694", "answers": [{"text": "By comparing the branches, scientists can label them according to the differences", "answer_start": 531}], "is_impossible": false}], "context": "10/30/22, 9:37 AM Understanding Variants | CDC\nUnderstanding Variants\nThe virus that causes COVID-19 is constantly changing, and new variants of the virus are expected to occur. Sometimes\nnew variants emerge and disappear. Other times, new variants persist. Numerous variants of the virus that causes\nCOVID-19 are being tracked in the United States and globally during this pandemic. How Variants Work\nIf you think about a virus like a tree growing and branching out; each branch on the tree is slightly different than the\nothers. By comparing the branches, scientists can label them according to the differences."}]}, {"title": "8e385ce00d6e109a38768946761ce8f5", "paragraphs": [{"qas": [{"question": "What do some variations allow the virus to do?", "id": "100000000000000000008697", "answers": [{"text": "spread more easily or make it resistant to treatments or vaccines", "answer_start": 143}], "is_impossible": false}, {"question": "How must variants be monitored?", "id": "100000000000000000008698", "answers": [{"text": "more carefully", "answer_start": 243}], "is_impossible": false}, {"question": "What can be monitored by comparing differences in physical traits?", "id": "100000000000000000008699", "answers": [{"text": "Variants Change As the virus spreads, it has new opportunities to change and may become more difficult to stop. These changes", "answer_start": 263}], "is_impossible": false}, {"question": "What are changes in genetic code from one variant to another?", "id": "100000000000000000008700", "answers": [{"text": "mutations", "answer_start": 512}], "is_impossible": false}], "context": "These small differences, or\nvariants, have been studied and identified since the beginning of the pandemic. Some variations allow the virus to spread more easily or make it resistant to treatments or vaccines. Those variants must\nbe monitored more carefully. How Variants Change\nAs the virus spreads, it has new opportunities to change and may become more difficult to stop. These changes can be\nmonitored by comparing differences in physical traits (such as resistance to treatment) or changes in genetic code\n(mutations) from one variant to another."}]}, {"title": "52cb524f893d274c015b75a2928cd9da", "paragraphs": [{"qas": [{"question": "What can scientists do by studying each variant and understanding differences?", "id": "100000000000000000008701", "answers": [{"text": "monitor, and often predict, whether a variant is more dangerous than others", "answer_start": 95}], "is_impossible": false}, {"question": "Scientists can often predict whether a variant is more dangerous than others?", "id": "100000000000000000008702", "answers": [{"text": "By studying each variant", "answer_start": 18}], "is_impossible": false}, {"question": "What can be used to track the spread of COVID-19?", "id": "100000000000000000008703", "answers": [{"text": "Scientists can also use this information", "answer_start": 172}], "is_impossible": false}, {"question": "Get vaccinated and stay up to date on what?", "id": "100000000000000000008704", "answers": [{"text": "COVID-19 vaccines", "answer_start": 336}], "is_impossible": false}, {"question": "What can you do to help prevent the spread of COVID-19?", "id": "100000000000000000008705", "answers": [{"text": "Get vaccinated and stay up to date on your COVID-19 vaccines. Find a vaccine. Know when to wear a well-fitted mask to help protect yourself and others. Avoid crowds and poorly ventilated indoor spaces", "answer_start": 293}], "is_impossible": false}, {"question": "What should you wear to help protect yourself and others?", "id": "100000000000000000008706", "answers": [{"text": "well-fitted mask", "answer_start": 391}], "is_impossible": false}, {"question": "How far apart from others should you stay?", "id": "100000000000000000008707", "answers": [{"text": "6 feet", "answer_start": 534}], "is_impossible": false}, {"question": "How far apart from people who don\u2019t live with you?", "id": "100000000000000000008708", "answers": [{"text": "6 feet", "answer_start": 534}], "is_impossible": false}], "context": "What We Are Doing\nBy studying each variant and understanding these differences, scientists can monitor, and often predict, whether a\nvariant is more dangerous than others. Scientists can also use this information to track the spread of a variant. Important Ways to Slow the Spread of COVID-19\nGet vaccinated and stay up to date on your COVID-19 vaccines. Find a vaccine. Know when to wear a well-fitted mask to help protect yourself and others. Avoid crowds and poorly ventilated indoor spaces. Test to prevent spread to others. Stay 6 feet apart from others who don\u2019t live with you."}]}, {"title": "5d4f5b7e3b2cb4a360fb1a2a1ab95fa8", "paragraphs": [{"qas": [{"question": "What do you use if soap and water aren\u2019t available?", "id": "100000000000000000008710", "answers": [{"text": "hand sanitizer", "answer_start": 47}], "is_impossible": false}, {"question": "When was the CDC last updated?", "id": "100000000000000000008711", "answers": [{"text": "Aug. 6, 2021", "answer_start": 170}], "is_impossible": false}], "context": "Wash your hands often with soap and water. Use hand sanitizer if soap and water aren\u2019t available. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:37 AM Understanding Variants | CDC\nLast Updated Aug. 6, 2021"}]}, {"title": "b0332df72643cd3b67bd857eb35f32c0", "paragraphs": [{"qas": [{"question": "What is better than no mask?", "id": "100000000000000000008713", "answers": [{"text": "any mask", "answer_start": 212}], "is_impossible": false}, {"question": "What type of mask does wearing a protective mask help you wear?", "id": "100000000000000000008714", "answers": [{"text": "high-quality", "answer_start": 345}], "is_impossible": false}], "context": "10/30/22, 9:39 AM Use Masks to Slow the Spread of COVID-19\nEspa\u00f1ol | Other Languages\nMasks\nWear a Mask to Protect Yourself and Others\nMasking is a critical public health tool and it is important to remember that any mask\nis better than no mask. Wear the most protective mask you can that fits well and that you will wear\nconsistently. Wearing a high-quality mask along with vaccination, self-testing, and physical\ndistancing, helps protect you and others by reducing the chance of spreading COVID-\n19."}]}, {"title": "8748e43d1432e08a998d616c8be8d42b", "paragraphs": [{"qas": [{"question": "What can you use to protect yourself and others?", "id": "100000000000000000008716", "answers": [{"text": "Masks and Respirators Learn about different types of masks and respirators", "answer_start": 6}], "is_impossible": false}, {"question": "What is a consideration for people with disabilities?", "id": "100000000000000000008717", "answers": [{"text": "masks", "answer_start": 177}], "is_impossible": false}, {"question": "Where can you find free masks?", "id": "100000000000000000008718", "answers": [{"text": "at a participating location near you", "answer_start": 355}], "is_impossible": false}, {"question": "When was the last mask update?", "id": "100000000000000000008721", "answers": [{"text": "Aug. 12, 2021", "answer_start": 475}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\nMasks and Respirators\nLearn about different types of masks and respirators\nyou can use to protect yourself and others\nYour Guide to Masks\nLearn the proper use and care of masks, including\nconsiderations for people with disabilities\nHow to Use Your N95 Respirator\nFree N95 Respirator Manufacturers\nFree Mask Locator\nFind free masks (N95 respirators) at a participating location near you. Find a Mask Near You Or call 1-800-232-0233 (TTY 1-888-720-7489)\n\uf1aa\n\uf1aa\nLast Updated Aug. 12, 2021"}]}, {"title": "eaed3a149cdc4ec6b9f05042fdc4e9ca", "paragraphs": [{"qas": [{"question": "What is a good way to prevent infection?", "id": "100000000000000000008722", "answers": [{"text": "staying up to date on vaccines and wearing masks", "answer_start": 228}], "is_impossible": false}, {"question": "How do you protect yourself from infections?", "id": "100000000000000000008724", "answers": [{"text": "Layered prevention strategies", "answer_start": 191}], "is_impossible": false}, {"question": "What can help prevent severe illness and reduce the potential for strain on the healthcare system?", "id": "100000000000000000008725", "answers": [{"text": "Layered prevention strategies", "answer_start": 191}], "is_impossible": false}, {"question": "What can wear a mask with the best fit, protection and comfort for you?", "id": "100000000000000000008726", "answers": [{"text": "Use and Care of Masks | CDC Espa\u00f1ol | Other Languages Use and Care of Masks Wear a mask with the best fit, protection, and comfort for you When to Wear a Mask or Respirator Layered prevention strategies", "answer_start": 18}], "is_impossible": false}], "context": "10/30/22, 9:40 AM Use and Care of Masks | CDC\nEspa\u00f1ol | Other Languages\nUse and Care of Masks\nWear a mask with the best fit, protection, and comfort for you\nWhen to Wear a Mask or Respirator\nLayered prevention strategies \u2014 like staying up to date on vaccines and wearing masks \u2014 can help prevent severe illness and\nreduce the potential for strain on the healthcare system. Wear a mask with the best fit, protection, and comfort for you."}]}, {"title": "3e5fcbdde489fa1686b83a4824a69835", "paragraphs": [{"qas": [{"question": "What can help protect you and others from COVID-19?", "id": "100000000000000000008728", "answers": [{"text": "Masks", "answer_start": 169}], "is_impossible": false}, {"question": "What are the types of masks and respirators used for?", "id": "100000000000000000008729", "answers": [{"text": "prevention steps to take based on the latest data. Masks can help protect you and others from COVID-19. Learn more about different types of masks and respirators and how to get the best fit", "answer_start": 118}], "is_impossible": false}, {"question": "At All COVID-19 Community Levels People may choose to mask at any time.", "id": "100000000000000000008730", "answers": [{"text": "\u2022 Medium or High", "answer_start": 511}], "is_impossible": false}, {"question": "What is recommended in indoor public transportation settings?", "id": "100000000000000000008731", "answers": [{"text": "Masks", "answer_start": 381}], "is_impossible": false}, {"question": "What type of mask or respirator should you wear if you are at risk for getting very sick?", "id": "100000000000000000008732", "answers": [{"text": "high-quality", "answer_start": 582}], "is_impossible": false}], "context": "Know the COVID-19 Community Level where you live\nCOVID-19 Community Levels are a tool to help communities decide what prevention steps to take based on the latest data. Masks can help protect you and others from COVID-19. Learn more about different types of masks and respirators and\nhow to get the best fit. At All COVID-19 Community Levels\nPeople may choose to mask at any time. Masks are recommended in indoor public transportation settings\nand may be required in other places by local or state authorities. \u2022\nMedium or High\nIf you are at high risk for getting very sick, wear a high-quality mask or respirator."}]}, {"title": "30d8468f0f5882abc3b352f3074f4d1e", "paragraphs": [{"qas": [{"question": "What should you do if you have household or social contact with someone at high risk getting very sick?", "id": "100000000000000000008733", "answers": [{"text": "consider self-testing to detect infection before contact and consider wearing a mask when indoors with them", "answer_start": 85}], "is_impossible": false}, {"question": "Wear a mask when indoors with them?", "id": "100000000000000000008734", "answers": [{"text": "\u2022 High", "answer_start": 195}], "is_impossible": false}, {"question": "If you are high risk for getting sick, what should you avoid?", "id": "100000000000000000008735", "answers": [{"text": "non-essential indoor activities in public", "answer_start": 305}], "is_impossible": false}, {"question": "What is a risk factor for getting very sick?", "id": "100000000000000000008736", "answers": [{"text": "infection", "answer_start": 117}], "is_impossible": false}], "context": "If you have household or social contact with someone at high risk getting very sick, consider self-testing to\ndetect infection before contact and consider wearing a mask when indoors with them. \u2022\n\u2022\nHigh\nWear a high-quality mask or respirator. If you are high risk for getting very sick, consider avoiding non-essential indoor activities in public where\nyou could be exposed. \u2022\n\u2022\nCOVID-19 County Check\nFind community levels and prevention steps by county. Data updated weekly."}]}, {"title": "41987febffadb48539a25f623109f6fb", "paragraphs": [{"qas": [{"question": "What is important to wear when you are sick or caring for someone who is sick with COVID 19 When caring 10/30/22, 9:40 AM Use and Care of Masks | CDC", "id": "100000000000000000008738", "answers": [{"text": "a mask or respirator", "answer_start": 80}], "is_impossible": false}, {"question": "What is important to wear when you are sick or caring for someone who is sick with COVID-19?", "id": "100000000000000000008739", "answers": [{"text": "a mask or respirator", "answer_start": 80}], "is_impossible": false}, {"question": "What will provide you the best level of protection when caring for a person who's sick with CDC?", "id": "100000000000000000008740", "answers": [{"text": "a respirator", "answer_start": 388}], "is_impossible": false}], "context": "Select a Location (all fields required)\nState County Go\nIt is important to wear a mask or respirator when you are sick or caring for someone who is sick with COVID 19 When caring\f10/30/22, 9:40 AM Use and Care of Masks | CDC\nIt is important to wear a mask or respirator when you are sick or caring for someone who is sick with COVID-19. When caring\nfor someone who is sick with COVID-19, a respirator will provide you the best level of protection."}]}, {"title": "7d1e1541d319416ab02b8197e77c063f", "paragraphs": [{"qas": [{"question": "Who should talk to their healthcare provider about COVID-19?", "id": "100000000000000000008742", "answers": [{"text": "People at increased risk", "answer_start": 246}], "is_impossible": false}, {"question": "What should they wear when the COVID-19 Community Level is medium?", "id": "100000000000000000008744", "answers": [{"text": "a mask or respirator", "answer_start": 410}], "is_impossible": false}, {"question": "Who should talk to about wearing a mask or respirator?", "id": "100000000000000000008745", "answers": [{"text": "their healthcare provider", "answer_start": 326}], "is_impossible": false}], "context": "Considerations for specific groups of people\nPeople at higher risk for severe illness\nSome people are more likely to become very sick with COVID-19\nPeople who are older\nPeople with certain medical conditions\nPregnant and recently pregnant people\nPeople at increased risk, and those who live with or visit them, should\nTalk to their healthcare provider about whether they and the people\naround them should wear a mask or respirator when the COVID-19\nCommunity Level is medium."}]}, {"title": "476aa136efffa2322b4ed7ea06b5c2bb", "paragraphs": [{"qas": [{"question": "Children ages 2 years and older can wear what to protect themselves and others from?", "id": "100000000000000000008747", "answers": [{"text": "masks or respirators", "answer_start": 161}], "is_impossible": false}, {"question": "What is a high-quality and comfortable mask that your child can wear properly?", "id": "100000000000000000008748", "answers": [{"text": "respirator", "answer_start": 276}], "is_impossible": false}, {"question": "What should your child wear properly?", "id": "100000000000000000008749", "answers": [{"text": "Choose a high-quality and comfortable mask or respirator", "answer_start": 230}], "is_impossible": false}, {"question": "What might be worn incorrectly or removed often?", "id": "100000000000000000008750", "answers": [{"text": "A poorly fitting or uncomfortable mask or respirator", "answer_start": 322}], "is_impossible": false}, {"question": "How should a child wear a mask or respirator?", "id": "100000000000000000008751", "answers": [{"text": "properly", "answer_start": 312}], "is_impossible": false}, {"question": "What is under the chin but does not impair vision?", "id": "100000000000000000008752", "answers": [{"text": "Choose a size", "answer_start": 464}], "is_impossible": false}, {"question": "Follow the user instructions for the mask or what?", "id": "100000000000000000008753", "answers": [{"text": "respirator", "answer_start": 602}], "is_impossible": false}], "context": "Wear a mask or respirator that provides them with greater protection when the COVID-19 Community Level is high\nChildren\nChildren ages 2 years and older can wear masks or respirators to protect themselves and others from COVID-19. Choose a high-quality and comfortable mask or respirator that your child can wear properly. A poorly fitting or uncomfortable\nmask or respirator might be worn incorrectly or removed often, and that would reduce its intended benefits. Choose a size that fits over the child\u2019s nose and under the chin but does not impair vision. Follow the user instructions for the mask or respirator."}]}, {"title": "b40742461863a8531b39fe33ca869cf8", "paragraphs": [{"qas": [{"question": "What is the name of a NIOSH-approved respirator?", "id": "100000000000000000008754", "answers": [{"text": "N95s", "answer_start": 341}], "is_impossible": false}, {"question": "What are some of the differences between cloth and disposable procedure masks?", "id": "100000000000000000008755", "answers": [{"text": "Some types of masks and respirators may feel different", "answer_start": 132}], "is_impossible": false}, {"question": "What are KN95s and KF94s?", "id": "100000000000000000008757", "answers": [{"text": "international respirators", "answer_start": 352}], "is_impossible": false}], "context": "These instructions may show how to make sure the product fits\nproperly. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:40 AM Use and Care of Masks | CDC\nSome types of masks and respirators may feel different if your child is used to wearing cloth or disposable procedure\nmasks. Parents and caregivers may have questions about NIOSH-approved respirators (such as N95s), and international respirators\n(such as KN95s and KF94s) for children. Although respirators may be available in smaller sizes, they are typically designed to\nbe used by adults in workplaces, and therefore may not have been tested for broad use in children."}]}, {"title": "13b188d26445b678daf203cfcc5e41cb", "paragraphs": [{"qas": [{"question": "What should you do if someone has trouble breathing or dizziness?", "id": "100000000000000000008762", "answers": [{"text": "choose a cloth or disposable mask", "answer_start": 384}], "is_impossible": false}], "context": "Safety precautions\nIf your child has a medical condition, such as a heart or lung problem, ask their healthcare provider before they use\nmethods to improve mask fit or use an ASTM F3502 mask or a respirator. If your child has a hard time breathing, gets dizzy, or has other symptoms while you are trying to get the mask to fit\nbetter or when using an ASTM F3502 mask or a respirator, choose a cloth or disposable mask. They should continue to\nprotect themselves and others. Consult your healthcare provider if these symptoms do not resolve."}]}, {"title": "3e3fb6de1448d390532a3966d36a397c", "paragraphs": [{"qas": [{"question": "What group of people may find it difficult to wear a mask?", "id": "100000000000000000008764", "answers": [{"text": "People with disabilities Certain groups of people may find it difficult to wear a mask, including people of any age with certain disabilities", "answer_start": 0}], "is_impossible": false}, {"question": "People with disabilities may have difficulty understanding the importance of mask wearing for what reason?", "id": "100000000000000000008765", "answers": [{"text": "protection", "answer_start": 273}], "is_impossible": false}, {"question": "What can people with disabilities or their caregivers assess if they need to wear a mask?", "id": "100000000000000000008766", "answers": [{"text": "difficulty controlling behavior to keep the mask in place", "answer_start": 295}], "is_impossible": false}], "context": "People with disabilities\nCertain groups of people may find it difficult to wear a mask, including\npeople of any age with certain disabilities. Challenges may be caused by being sensitive to materials on the face,\ndifficulty understanding the importance of mask wearing for protection,\nor having difficulty controlling behavior to keep the mask in place. People with certain disabilities or their caregivers can assess whether they need to wear a mask."}]}, {"title": "acd2700d073990d78ef7865cf26c6b72", "paragraphs": [{"qas": [{"question": "What should a person wear to avoid drooling or having excess saliva on their mask?", "id": "100000000000000000008767", "answers": [{"text": "a clear mask", "answer_start": 329}], "is_impossible": false}, {"question": "What type of mask can help protect you and others while you travel?", "id": "100000000000000000008771", "answers": [{"text": "high-quality mask", "answer_start": 579}], "is_impossible": false}, {"question": "What is the latest recommendation for wearing a mask while traveling?", "id": "100000000000000000008772", "answers": [{"text": "Wearing a high-quality mask", "answer_start": 569}], "is_impossible": false}], "context": "They should do this by\nconsidering the person\u2019s ability to:\nWear a mask correctly (proper mask size and fit)\nAvoid frequent touching of the mask and face\nLimit sucking, drooling, or having excess saliva on the mask\nRemove the mask without assistance\nPeople who are deaf or hard of hearing\nThese individuals may consider:\nWearing a clear mask or a cloth mask with a clear panel\nIf a clear mask is not available, using written communication, closed\ncaptioning, or decreasing background noise to make communication\npossible while wearing a mask that blocks lips\nTravelers\nWearing a high-quality\nmask while you travel\ncan help protect you\nand others. Learn about the latest\nrecommendation for\nwearing masks during\ntravel."}]}, {"title": "6130c676393d3082b034e99070c85b6c", "paragraphs": [{"qas": [{"question": "What does a cloth mask need to be sealed in?", "id": "100000000000000000008774", "answers": [{"text": "plastic bag", "answer_start": 278}], "is_impossible": false}, {"question": "What is a good way to store a mask that is wet or dirty?", "id": "100000000000000000008775", "answers": [{"text": "sealed plastic bag", "answer_start": 271}], "is_impossible": false}, {"question": "What type of bag can a cloth mask be stored in if it's dry and clean?", "id": "100000000000000000008776", "answers": [{"text": "a breathable", "answer_start": 408}], "is_impossible": false}, {"question": "What type of bag is used to keep it clean between uses?", "id": "100000000000000000008777", "answers": [{"text": "breathable bag", "answer_start": 409}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:40 AM Use and Care of Masks | CDC\nHow to Care for Your Mask\nCorrect and consistent care for your mask helps to provide the best protection\nHow to take off your mask\n1. For reusable cloth masks\nIf your cloth mask is wet or dirty, put it in a sealed plastic bag\nuntil you can wash it. This will keep it from getting moldy. If your cloth mask is dry and clean, you can store it in a\nbreathable bag (like a paper or mesh fabric bag) to keep it clean\nbetween uses in the same day."}]}, {"title": "52e33308e569765789851daee8697c88", "paragraphs": [{"qas": [{"question": "What should be washed at least once a day?", "id": "100000000000000000008778", "answers": [{"text": "Cloth masks", "answer_start": 0}], "is_impossible": false}, {"question": "Wash or sanitize your hands after removing any mask?", "id": "100000000000000000008780", "answers": [{"text": "masks by hand or use a washer and dryer. 2", "answer_start": 121}], "is_impossible": false}, {"question": "What should you do after you eat or drink?", "id": "100000000000000000008781", "answers": [{"text": "put the mask back on with the same side facing out", "answer_start": 439}], "is_impossible": false}], "context": "Cloth masks should be washed at least once a day or as soon as\nthey become wet or dirty. You can either wash and dry your\nmasks by hand or use a washer and dryer. 2. Wash or sanitize your hands after removing any mask. Taking off your mask while you eat or drink\nIf you are taking off your mask to eat or drink outside of your home, you can place it somewhere safe to keep it clean, such as\nyour pocket, purse, or paper bag. After eating, put the mask back on with the same side facing out."}]}, {"title": "43ed18643c179378a0839de6447b27bd", "paragraphs": [{"qas": [{"question": "What should you wash or sanitize after taking off your mask and after putting it back on?", "id": "100000000000000000008785", "answers": [{"text": "your hands", "answer_start": 28}], "is_impossible": false}, {"question": "What should you replace a wet or dirty mask with?", "id": "100000000000000000008788", "answers": [{"text": "dry, clean mask", "answer_start": 512}], "is_impossible": false}, {"question": "What is the name of the mask that you replace with a dry mask?", "id": "100000000000000000008789", "answers": [{"text": "clean mask", "answer_start": 517}], "is_impossible": false}], "context": "Be sure to wash or\nsanitize your hands again after taking off your mask and after putting your mask back on. When to throw away or change your mask\nDisposable masks should be thrown away after they\u2019re worn once. If you use respirators, check the manufacturer\u2019s instructions to learn how long they can be worn before they should be\nthrown away. Disposable masks and respirators\u202fthat become wet or dirty should be thrown away in the trash right away. Do not\ncontinue to wear a wet or dirty mask. Replace it with a dry, clean mask."}]}, {"title": "6d6182949270e8c213462ac97144be25", "paragraphs": [{"qas": [{"question": "What are disposable masks and cloth masks?", "id": "100000000000000000008790", "answers": [{"text": "Untie the strings behind your head or stretch the ear loops and fold the outside corners together", "answer_start": 34}], "is_impossible": false}, {"question": "What do you do with the strings behind your head or stretch the ear loops and fold the outside corners together?", "id": "100000000000000000008791", "answers": [{"text": "Untie", "answer_start": 34}], "is_impossible": false}, {"question": "Respirators: Follow the manufacturer\u2019s instructions.", "id": "100000000000000000008792", "answers": [{"text": "\u2022", "answer_start": 186}], "is_impossible": false}, {"question": "What is a building entrance poster reminding people to wear?", "id": "100000000000000000008793", "answers": [{"text": "masks", "answer_start": 378}], "is_impossible": false}, {"question": "How many pages?", "id": "100000000000000000008794", "answers": [{"text": "10/30/22", "answer_start": 425}], "is_impossible": false}, {"question": "When was the last update for the N95 Respirator?", "id": "100000000000000000008795", "answers": [{"text": "Sept. 9, 2022", "answer_start": 564}], "is_impossible": false}], "context": "Disposable masks and cloth masks: Untie the strings behind your head or stretch the ear loops and fold the outside\ncorners together. Respirators: Follow the manufacturer\u2019s instructions. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nPrint Resources\nHow to Take Off a Mask\nPrevent getting sick mask guide\nFile Details: 488 KB, 1 page\nView PDF \uf20c\nPlease Wear a Mask\nBuilding entrance poster reminding people to wear masks. File Details: 159 KB, 1 page\nView PDF \uf20c\f10/30/22, 9:40 AM Use and Care of Masks | CDC\n\uf20c\nRelated Pages\nTypes of Masks and Respirators\n\u203a\nHow to Use an N95 Respirator\n\u203a\nLast Updated Sept. 9, 2022"}]}, {"title": "1b65fe9c0705b94194545314f70489e", "paragraphs": [{"qas": [{"question": "What is not subject to copyright?", "id": "100000000000000000008796", "answers": [{"text": "Most of the information on the CDC and ATSDR websites", "answer_start": 94}], "is_impossible": false}, {"question": "What kind of permission does a federal government website have?", "id": "100000000000000000008798", "answers": [{"text": "copyright", "answer_start": 257}], "is_impossible": false}, {"question": "What types of materials may a government website contain?", "id": "100000000000000000008799", "answers": [{"text": "public domain and copyright- protected materials", "answer_start": 364}], "is_impossible": false}, {"question": "Why are some resources restricted in their use?", "id": "100000000000000000008801", "answers": [{"text": "they were developed by government contractors or grantees, or have been licensed by a third party", "answer_start": 522}], "is_impossible": false}, {"question": "Who developed the software?", "id": "100000000000000000008802", "answers": [{"text": "government contractors or grantees", "answer_start": 545}], "is_impossible": false}, {"question": "Who licensed the software to a third party?", "id": "100000000000000000008803", "answers": [{"text": "government contractors or grantees", "answer_start": 545}], "is_impossible": false}], "context": "10/30/22, 9:25 AM Use of Agency Materials | Other | CDC\nUsing CDC.gov\nUse of Agency Materials\nMost of the information on the CDC and ATSDR websites is not subject to copyright, is in the public domain, and may be freely\nused or reproduced without obtaining copyright permission. There are, however, a few exceptions. A federal government website may have a mix of public domain and copyright-\nprotected materials. First, some resources, as well as images, on the CDC and ATSDR websites are restricted in their use\nbecause they were developed by government contractors or grantees, or have been licensed by a third party."}]}, {"title": "e1dbb862c21ad1d66f63fdd8bb57d678", "paragraphs": [{"qas": [{"question": "What does the U.S. government work designation not apply to?", "id": "100000000000000000008804", "answers": [{"text": "works of state and local governments", "answer_start": 63}], "is_impossible": false}, {"question": "What may work of state and local governments be protected by?", "id": "100000000000000000008805", "answers": [{"text": "copyright", "answer_start": 158}], "is_impossible": false}, {"question": "Copyright-protected materials featured on the CDC and ATSDR websites should include a what?", "id": "100000000000000000008808", "answers": [{"text": "copyright statement", "answer_start": 515}], "is_impossible": false}], "context": "Second, the\nU.S. government work designation does not apply to works of state and local governments; works of state and local\ngovernments may be protected by copyright. Third, copyright laws also differ internationally. While U.S. federal copyright\nlaws may not protect U.S. government works outside the United States, the work may still be protected under the copyright\nlaws of other countries when used in these jurisdictions. Copyright-protected materials featured on the CDC and ATSDR\nwebsites should include a copyright statement. However, if in doubt, please write to the contact point for that site."}]}, {"title": "cd3023aaa5c6b5bf102cf8dd0c2cc7b7", "paragraphs": [{"qas": [{"question": "What must clearly state the materials were developed by?", "id": "100000000000000000008810", "answers": [{"text": "CDC ATSDR and/or HHS", "answer_start": 258}], "is_impossible": false}, {"question": "What must you use to clearly indicate that your use of the material does not imply endorsement by CDC, ATSDR, HHS or the United States Government of you, your company?", "id": "100000000000000000008811", "answers": [{"text": "a disclaimer", "answer_start": 352}], "is_impossible": false}], "context": "The following requirements must be followed to utilize CDC\u2019s public domain content:\n1) Attribution to the agency that developed the material must be provided in your use of the materials. Such attribution\nshould clearly state the materials were developed by CDC ATSDR and/or HHS (e.g., \u201cSource: CDC\u201d; \u201cMaterials developed by\nCDC\u201d);\n2) You must utilize a disclaimer which clearly indicates that your use of the material, including any links to the materials on the\nCDC, ATSDR or HHS websites, does not imply endorsement by CDC, ATSDR, HHS or the United States Government of you,\nyour company, product, facility, service or enterprise."}]}, {"title": "a635762013f108bb9cb6c97f4938e378", "paragraphs": [{"qas": [{"question": "What must be prominently and unambiguously displayed?", "id": "100000000000000000008813", "answers": [{"text": "disclaimers", "answer_start": 9}], "is_impossible": false}, {"question": "What does not constitute endorsement or recommendation by the U.S. Government, Department of Health and Human Services, or Centers for Disease Control and Prevention?", "id": "100000000000000000008814", "answers": [{"text": "Reference to specific commercial products, manufacturers, companies, or trademarks", "answer_start": 77}], "is_impossible": false}, {"question": "How may you change the substantive content of the materials?", "id": "100000000000000000008815", "answers": [{"text": "not", "answer_start": 337}], "is_impossible": false}, {"question": "What must you state is otherwise available on the agency website for no charge?", "id": "100000000000000000008816", "answers": [{"text": "the material", "answer_start": 417}], "is_impossible": false}], "context": "All such disclaimers must be prominently and unambiguously displayed\n(e.g., \u201cReference to specific commercial products, manufacturers, companies, or trademarks does not constitute its\nendorsement or recommendation by the U.S. Government, Department of Health and Human Services, or Centers for\nDisease Control and Prevention;\n3) You may not change the substantive content of the materials; and\n4) You must state that the material is otherwise available on the agency website for no charge. Note: Many of CDC\u2019s on-line publications are continually updated as the agency learns more about a specific disease or\ncondition."}]}, {"title": "49eca868224160330a6f91000451385f", "paragraphs": [{"qas": [{"question": "What can result in out-of-date information being offered to users?", "id": "100000000000000000008818", "answers": [{"text": "sites that copy and re-post CDC materials fail to check for updates", "answer_start": 14}], "is_impossible": false}, {"question": "What should link to CDC, ATSDR or HHS content open up?", "id": "100000000000000000008820", "answers": [{"text": "a new browser window to our site/page", "answer_start": 381}], "is_impossible": false}, {"question": "What should not appear within the original window, framed by the existing site?", "id": "100000000000000000008821", "answers": [{"text": "CDC content", "answer_start": 420}], "is_impossible": false}], "context": "Occasionally, sites that copy and re-post CDC materials fail to check for updates, which may result in out-of-date\ninformation being offered to users. For that reason, we urge you to link directly to our resource documents rather than re-\nposting. If you do re-post, please check back periodically to see if there are revisions. Linking to CDC, ATSDR or HHS content should open up a new browser window to our site/page. CDC content should not\nappear within the original window, framed by the existing site."}]}, {"title": "eb4afa1a9fa78a003e96323f6c8ce896", "paragraphs": [{"qas": [{"question": "What are the CDC and ATSDR logos and marks designed to signify?", "id": "100000000000000000008822", "answers": [{"text": "official agency products, activities, representatives, and facilities", "answer_start": 287}], "is_impossible": false}, {"question": "What is the name of the U.S. government property?", "id": "100000000000000000008823", "answers": [{"text": "The CDC", "answer_start": 9}], "is_impossible": false}, {"question": "Who should never use logos or marks to misrepresent the purpose, character, statements or policies of the agency?", "id": "100000000000000000008826", "answers": [{"text": "outside parties", "answer_start": 537}], "is_impossible": false}, {"question": "What do outside parties do to misrepresent the purpose, character, statements or policies of agencies?", "id": "100000000000000000008827", "answers": [{"text": "never be used", "answer_start": 520}], "is_impossible": false}], "context": "CDC LOGO\nThe CDC and/or ATSDR logo and other related CDC, ATSDR or Department of Health and Human Services (HHS) logos and\nmarks are U.S. government property and may not be used without express written permission from CDC, ATSDR and/or HHS. These logos and marks are designed to signify official agency products, activities, representatives, and facilities. They should\nnever be used to promote or suggest endorsement of non-CDC, ATSDR or HHS companies, activities, products, events,\nfacilities or services. They should never be used by outside parties to misrepresent the purpose, character, statements or\npolicies of the agencies."}]}, {"title": "60210fd3b9539b7ae6be919d462a7f9a", "paragraphs": [{"qas": [{"question": "What may be subject to civil money penalties under 42 U.S.C. Section 1320b-10?", "id": "100000000000000000008829", "answers": [{"text": "Any misrepresentation or misappropriation of the agency\u2019s materials, positions or logo/marks in publications sold for profit", "answer_start": 13}], "is_impossible": false}, {"question": "When was the last time the page last reviewed?", "id": "100000000000000000008830", "answers": [{"text": "May 27 2021", "answer_start": 389}], "is_impossible": false}], "context": "Please note: Any misrepresentation or misappropriation of the agency\u2019s materials, positions or logo/marks in publications\nsold for profit will be referred to the HHS Office of the Inspector General (and possibly law enforcement and other entities) for\ninvestigation and possible enforcement and may be subject to civil money penalties under 42 U.S.C. Section 1320b-10. Page last reviewed: May 27 2021\f10/30/22, 9:25 AM Use of Agency Materials | Other | CDC\nPage last reviewed: May 27, 2021"}]}, {"title": "ed29307f41bcaf7dca82f4a6fd46c52", "paragraphs": [{"qas": [{"question": "How do you feel after getting the COVID-19 vaccine?", "id": "100000000000000000008831", "answers": [{"text": "V-safe", "answer_start": 413}], "is_impossible": false}, {"question": "How can you get started with v-safe?", "id": "100000000000000000008833", "answers": [{"text": "Get your smartphone", "answer_start": 146}], "is_impossible": false}, {"question": "What helps us monitor the safety of COVID-19 vaccines for everyone?", "id": "100000000000000000008834", "answers": [{"text": "Your participation in v-safe", "answer_start": 305}], "is_impossible": false}, {"question": "What provides personalized and confidential health check-ins?", "id": "100000000000000000008835", "answers": [{"text": "V-safe", "answer_start": 413}], "is_impossible": false}, {"question": "How do you feel after getting a COVID-19 vaccine?", "id": "100000000000000000008836", "answers": [{"text": "V-safe", "answer_start": 413}], "is_impossible": false}], "context": "10/30/22, 9:31 AM V-safe After Vaccination Health Checker | CDC\nEspa\u00f1ol | Other Languages\nV-safe After Vaccination Health Checker\nGet vaccinated. Get your smartphone. Get started with v-safe. Use your smartphone to tell CDC how you, or your dependent, feel after getting any dose of the COVID-19 vaccine. Your\nparticipation in v-safe helps us monitor the safety of COVID-19 vaccines for everyone. What is v-safe? V-safe provides personalized and confidential health check-ins via text messages and web surveys so you can quickly and\neasily share with CDC how you, or your dependent, feel after getting a COVID-19 vaccine."}]}, {"title": "11855ce3b635bcb628835d840c6f8342", "paragraphs": [{"qas": [{"question": "What does this information help CDC monitor in near real time?", "id": "100000000000000000008837", "answers": [{"text": "the safety of COVID-19 vaccines", "answer_start": 35}], "is_impossible": false}, {"question": "What is fast and easy to enroll in?", "id": "100000000000000000008838", "answers": [{"text": "COVID-19 vaccines", "answer_start": 49}], "is_impossible": false}], "context": "This information helps CDC monitor\nthe safety of COVID-19 vaccines in near real time. V-safe features:\nEnrolling is fast and easy!"}]}, {"title": "9b33c983027c777909964a5913c345c8", "paragraphs": [{"qas": [{"question": "What languages are available for you to sign up for?", "id": "100000000000000000008840", "answers": [{"text": "English, Spanish, Chinese, Korean, and Vietnamese", "answer_start": 315}], "is_impossible": false}, {"question": "How do you feel after first, second, and booster doses?", "id": "100000000000000000008841", "answers": [{"text": "\u2022 \u2022 \u2022", "answer_start": 366}], "is_impossible": false}, {"question": "How can you enroll in v-safe after any dose of COVID-19 vaccine?", "id": "100000000000000000008844", "answers": [{"text": "by using your smartphone", "answer_start": 696}], "is_impossible": false}, {"question": "What is the name of the app that you can use to check for vaccination?", "id": "100000000000000000008845", "answers": [{"text": "V-safe After Vaccination Health Checker", "answer_start": 573}], "is_impossible": false}, {"question": "How do you check if a vaccine has been given?", "id": "100000000000000000008846", "answers": [{"text": "Sign up during the waiting period", "answer_start": 0}], "is_impossible": false}], "context": "Sign up during the waiting period after you get any dose of COVID-19 vaccine or at any time\nafter vaccination\nAdd a dependent and complete health check-ins on their behalf\nEnter and report how you, or your dependent, feel after first, second, additional, and booster doses\nAvailable in multiple languages including English, Spanish, Chinese, Korean, and Vietnamese\n\u2022\n\u2022\n\u2022\n\u2022\nPlease note:\nV-safe is not an official record of being vaccinated against COVID-19\nV-safe does not give medical advice\nV-safe cannot schedule COVID-19 vaccination appointments\n\u2022\n\u2022\n\u2022\f10/30/22, 9:31 AM V-safe After Vaccination Health Checker | CDC\nEnroll in v-safe\nYou can enroll in v-safe after any dose of COVID-19 vaccine by using your smartphone and going to vsafe.cdc.gov."}]}, {"title": "3757103854b0f7dd3d6db8f7a719a0ea", "paragraphs": [{"qas": [{"question": "What does having a vaccination record card help you remember?", "id": "100000000000000000008847", "answers": [{"text": "which vaccine you received and when", "answer_start": 65}], "is_impossible": false}, {"question": "What age must a child be added to a vaccine record card?", "id": "100000000000000000008849", "answers": [{"text": "16 years", "answer_start": 271}], "is_impossible": false}, {"question": "Children under what age must be added to a parent or guardian's v-safe account?", "id": "100000000000000000008850", "answers": [{"text": "16 years", "answer_start": 271}], "is_impossible": false}, {"question": "How can you add a dependent to your existing account or create a new account if you don't have one yet?", "id": "100000000000000000008851", "answers": [{"text": "existing account or create a new account if you don\u2019t have one yet. All v-safe communications will be sent to the parent\u2019s or guardian\u2019s smartphone", "answer_start": 367}], "is_impossible": false}, {"question": "All communications will be sent to who's smartphone?", "id": "100000000000000000008852", "answers": [{"text": "the parent\u2019s or guardian", "answer_start": 478}], "is_impossible": false}], "context": "Have your\nvaccination record card available to help you remember which vaccine you received and when. Add a Dependent in v-safe\nYou can add any dependent (family member, friend, or individual who relies on you for support) who is vaccinated in v-safe. Children under age 16 years must be added to a parent or guardian\u2019s v-safe account. You can add a dependent to your\nexisting account or create a new account if you don\u2019t have one yet. All v-safe communications will be sent to the parent\u2019s or\nguardian\u2019s smartphone."}]}, {"title": "83add000389acc93161703fde67073cd", "paragraphs": [{"qas": [{"question": "During the first week after each vaccination, what will v-safe send you to ask how you are feeling?", "id": "100000000000000000008854", "answers": [{"text": "a text message", "answer_start": 243}], "is_impossible": false}, {"question": "Who may call to get more information about you?", "id": "100000000000000000008856", "answers": [{"text": "someone from CDC", "answer_start": 380}], "is_impossible": false}], "context": "Creating an account to add a dependent does not require that you enter your own vaccination information or complete\nhealth check-ins for yourself. What Happens After I Enroll? During the first week after each vaccination, v-safe will send you a text message each day to ask how you are feeling. After\nthat, you will receive occasional health check-ins. Depending on your answers, someone from CDC may call to get more\ninformation. You can opt out at any time. Your personal information in v-safe is protected so it\u2019s safe and private*."}]}, {"title": "34c7a3f5fea59fa321f7745aafd0609a", "paragraphs": [{"qas": [{"question": "What does v-safe do if you report that you are pregnant at the time of or after vaccination?", "id": "100000000000000000008857", "answers": [{"text": "may contact you", "answer_start": 336}], "is_impossible": false}, {"question": "Who may contact you after your COVID-19 vaccination?", "id": "100000000000000000008858", "answers": [{"text": "the CDC COVID-19 Pregnancy Registry staff", "answer_start": 293}], "is_impossible": false}], "context": "Watch Video: Share Your COVID-19 Vaccination Experience with v-safe [00:00:31]\n\uf357\f10/30/22, 9:31 AM V-safe After Vaccination Health Checker | CDC\nWill I Ever be Contacted by v-safe Staff? If you enroll in v-safe and report that you are pregnant at the time of vaccination or after vaccination, the CDC COVID-19\nPregnancy Registry staff* may contact you. If you have symptoms or health problems that concern you at any time following COVID-19 vaccination, please contact your\nhealthcare professional. *Abt Associates\nhas been\ncontracted by the\nCDC to contact\nparticipants for\nCDC\u2019s v-safe COVID-\nPregnancy Registry."}]}, {"title": "f981f8a5dec2a4434d3d5a40b6e3d7bd", "paragraphs": [{"qas": [{"question": "What is the name of the website that can help you find v-safe locations?", "id": "100000000000000000008861", "answers": [{"text": "vaccines.gov", "answer_start": 52}], "is_impossible": false}, {"question": "When is live support available?", "id": "100000000000000000008862", "answers": [{"text": "Monday-Friday", "answer_start": 348}], "is_impossible": false}, {"question": "What time of day is live v-safe support available?", "id": "100000000000000000008863", "answers": [{"text": "Monday-Friday", "answer_start": 348}], "is_impossible": false}, {"question": "What is the most popular day to contact live support?", "id": "100000000000000000008864", "answers": [{"text": "Monday-Friday", "answer_start": 348}], "is_impossible": false}, {"question": "When was the last update for V-safe?", "id": "100000000000000000008865", "answers": [{"text": "July 18, 2022", "answer_start": 614}], "is_impossible": false}], "context": "To find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233. Contact Form\nHave questions about v-safe or need help? If you have questions or need assistance with v-safe, these resources can help:\nV-safe Frequently Asked Questions and Troubleshooting\nContact live v-safe support:\nAvailable Monday-Friday 8:00 AM \u2013 8:00 PM ET\n\u2022\n\u2022\n\uf209\nRelated Pages\nHow to Enroll or Access Your v-safe Account\n\u203a\nHow to Add a Dependent in v-safe\n\u203a\nHow to Complete a v-safe Check-In\n\u203a\nV-safe Print Resources\n\u203a\nV-safe Frequently Asked Questions and Troubleshooting\n\u203a\nLast Updated July 18, 2022"}]}, {"title": "7d2a662905d7d8a41558eba607da00e7", "paragraphs": [{"qas": [{"question": "What is the name of the CDC's Vaccines & Immunizations strategy for Adults?", "id": "100000000000000000008866", "answers": [{"text": "COVID-19", "answer_start": 44}], "is_impossible": false}, {"question": "What are the Vaccinate with Confidence strategies for children and adolescents?", "id": "100000000000000000008867", "answers": [{"text": "COVID-19", "answer_start": 44}], "is_impossible": false}, {"question": "How do you build trust in the vaccine, vaccinator, and system?", "id": "100000000000000000008868", "answers": [{"text": "take visible actions", "answer_start": 386}], "is_impossible": false}, {"question": "What steps do you take to build trust?", "id": "100000000000000000008869", "answers": [{"text": "visible actions", "answer_start": 391}], "is_impossible": false}, {"question": "How does the process for authorizing, approving, making recommendations for, monitoring the safety of, distributing, allocating and administering COVID-19 vaccines work?", "id": "100000000000000000008870", "answers": [{"text": "Communicate transparently", "answer_start": 553}], "is_impossible": false}, {"question": "What does monitoring the safety of COVID-19 vaccines include?", "id": "100000000000000000008871", "answers": [{"text": "data handling", "answer_start": 753}], "is_impossible": false}], "context": "10/30/22, 9:24 AM Vaccinate with Confidence COVID-19 Vaccines Strategy for Adults | CDC\nVaccines & Immunizations\nVaccines & Immunizations\nVaccinate with Confidence COVID-19 Vaccines Strategy\nfor Adults\nSee Resources section below for Vaccinate with Confidence strategies for children and adolescents. Build Trust\nShare clear, complete, and accurate messages about COVID-19 vaccines and\ntake visible actions to build trust in the vaccine, the vaccinator, and the system\nin coordination with federal, state, and local agencies and partners. Action Steps:\nCommunicate transparently about the process for authorizing ,\napproving, making recommendations for, monitoring the safety of,\ndistributing, allocating, and administering COVID-19 vaccines, including\ndata handling."}]}, {"title": "f50dc4c0d9c390322fd2767eb556255e", "paragraphs": [{"qas": [{"question": "What is one way to help stop the spread of misinformation?", "id": "100000000000000000008872", "answers": [{"text": "social media platforms, partners, and trusted messengers", "answer_start": 193}], "is_impossible": false}, {"question": "How do healthcare personnel promote confidence in their decision to get vaccinated?", "id": "100000000000000000008873", "answers": [{"text": "Empower Healthcare Personnel", "answer_start": 253}], "is_impossible": false}, {"question": "What are some ways to help prevent misinformation from spreading?", "id": "100000000000000000008874", "answers": [{"text": "social media platforms, partners, and trusted messengers", "answer_start": 193}], "is_impossible": false}, {"question": "What should healthcare systems and medical practices be aware of when recommending vaccination to their patients?", "id": "100000000000000000008875", "answers": [{"text": "new vaccine technologies, and the benefits of vaccination", "answer_start": 611}], "is_impossible": false}, {"question": "What are the steps to ensure a clear understanding of vaccine development and approval processes and new vaccine technologies?", "id": "100000000000000000008876", "answers": [{"text": "Engage national professional associations, health systems, and healthcare personnel often and early", "answer_start": 427}], "is_impossible": false}, {"question": "What do healthcare systems and medical practices need to do to build a culture that builds confidence in COVID-19 vaccination?", "id": "100000000000000000008877", "answers": [{"text": "equipped", "answer_start": 722}], "is_impossible": false}], "context": "Provide regular updates on: benefits, safety, side effects and effectiveness;\nclearly communicate what is not known. Proactively address and help stop the spread and harm of misinformation\nvia social media platforms, partners, and trusted messengers. \uf209\nEmpower Healthcare Personnel\nPromote confidence among healthcare personnel* in their decision to get\nvaccinated and to recommend vaccination to their patients. Action Steps:\nEngage national professional associations, health systems, and healthcare\npersonnel often and early to ensure a clear understanding of the vaccine\ndevelopment and approval processes , new vaccine technologies, and\nthe benefits of vaccination. Ensure healthcare systems and medical practices are equipped to create a\nculture that builds confidence in COVID-19 vaccination."}]}, {"title": "5eb6a1eb10baa64d77c7c9f58310b900", "paragraphs": [{"qas": [{"question": "What should healthcare professionals do to have empathetic vaccine conversations with their patients?", "id": "100000000000000000008878", "answers": [{"text": "Strengthen the capacity", "answer_start": 0}], "is_impossible": false}, {"question": "What can healthcare professionals address myths and common questions about vaccines?", "id": "100000000000000000008879", "answers": [{"text": "provide tailored vaccine information", "answer_start": 150}], "is_impossible": false}, {"question": "Vaccinate with Confidence Vaccines Strategy for Adults | CDC *Healthcare Personnel = All staff working in what?", "id": "100000000000000000008880", "answers": [{"text": "healthcare settings", "answer_start": 395}], "is_impossible": false}, {"question": "What is the term for all staff working in healthcare settings?", "id": "100000000000000000008881", "answers": [{"text": "Healthcare Personnel", "answer_start": 351}], "is_impossible": false}, {"question": "What does Engage Communities and Individuals use to listen, build trust and increase collaboration?", "id": "100000000000000000008882", "answers": [{"text": "two- way communication", "answer_start": 698}], "is_impossible": false}], "context": "Strengthen the capacity of healthcare professionals to have empathetic\nvaccine conversations with their patients, address myths and common\nquestions, provide tailored vaccine information to patients, and use\nmotivational interviewing techniques when needed. \uf209\n\uf20c\f10/30/22, 9:24 AM Vaccinate with Confidence COVID-19 Vaccines Strategy for Adults | CDC\n*Healthcare Personnel = All staff working in healthcare settings, including\nphysicians, Physician Assistants/Nurse Practitioners, nurses, allied health\nprofessionals, pharmacists, support staff, social workers, and community\nhealth workers. Engage Communities and Individuals\nEngage communities in a sustainable, equitable, and inclusive way\u2014using two-\nway communication to listen, build trust, and increase collaboration."}]}, {"title": "7425074c928278b0fb0a3d0703c3da43", "paragraphs": [{"qas": [{"question": "Work with health departments and national partners to engage communities around vaccine confidence and service delivery strategies?", "id": "100000000000000000008884", "answers": [{"text": "Empower vaccine recipients to share their personal stories and reasons for vaccination within their circles of influence. Work with health departments and national partners to engage communities around vaccine confidence and service delivery strategies, including adaptation of vaccination provider sites to meet community needs", "answer_start": 14}], "is_impossible": false}, {"question": "Collaborate with trusted messengers to tailor vaccination provider sites to meet what needs?", "id": "100000000000000000008885", "answers": [{"text": "community", "answer_start": 327}], "is_impossible": false}], "context": "Action Steps:\nEmpower vaccine recipients to share their personal stories and reasons\nfor vaccination within their circles of influence. Work with health departments and national partners to engage\ncommunities around vaccine confidence and service delivery strategies,\nincluding adaptation of vaccination provider sites to meet community\nneeds. Collaborate with trusted messengers\u2014such as faith-based and community\nleaders\u2014to tailor and share culturally relevant messages and materials\nwith diverse communities."}]}, {"title": "89b3a54591bf10e472a4d62ca88b79cb", "paragraphs": [{"qas": [{"question": "How to Build Confidence in COVID-19 Vaccines: A Short Guide for Immunization Coordinators in Medical Centers and Clinics", "id": "100000000000000000008887", "answers": [{"text": "Guide: How to Build Confidence in COVID-19 Vaccines: A Short Guide for Immunization Coordinators in Medical Centers and Clinics Guide Companion Tool: Communications and Confidence Readiness Checklist (Appendix A) Guide Companion Tool: The COVID-19 Vaccine Confidence Conversation Starter (Appendix B) \uf20c \uf20c \uf20c", "answer_start": 71}], "is_impossible": false}], "context": "Downloadable Resources\nStrategy: COVID-19 Vaccinate with Confidence PDF\nGuide: How to Build Confidence in COVID-19 Vaccines: A Short Guide for Immunization Coordinators in Medical Centers\nand Clinics\nGuide Companion Tool: Communications and Confidence Readiness Checklist (Appendix A)\nGuide Companion Tool: The COVID-19 Vaccine Confidence Conversation Starter (Appendix B)\n\uf20c\n\uf20c\n\uf20c\n\uf20c\nPage last reviewed: November 3, 2021"}]}, {"title": "839557399dba7df50ca68c9a6f0226ff", "paragraphs": [{"qas": [{"question": "What type of dialysis centers might be operated by corporate chains?", "id": "100000000000000000008893", "answers": [{"text": "your local dialysis centers", "answer_start": 84}], "is_impossible": false}, {"question": "What do you need to know about dialysis clinics?", "id": "100000000000000000008895", "answers": [{"text": "their needs, priorities, and barriers to vaccination", "answer_start": 347}], "is_impossible": false}, {"question": "What are the barriers to vaccination among patients and healthcare personnel?", "id": "100000000000000000008896", "answers": [{"text": "needs, priorities", "answer_start": 353}], "is_impossible": false}, {"question": "How do you know if a clinic is a COVID-19 vaccination provider?", "id": "100000000000000000008897", "answers": [{"text": "Make sure each dialysis clinic in your jurisdiction", "answer_start": 441}], "is_impossible": false}], "context": "Reach out to dialysis clinics where you do not have an established contact. Some of your local dialysis centers might be\noperated by corporate chains. For these centers, jurisdictions can opt to coordinate with national or regional corporate\nleaders to reach their respective clinic sites. Work collaboratively with dialysis clinics to understand their needs, priorities, and barriers to vaccination among patients\nand healthcare personnel. Make sure each dialysis clinic in your jurisdiction is enrolled as a COVID-19 vaccination provider."}]}, {"title": "57fa1fb446b9241963f04e14a17cd92a", "paragraphs": [{"qas": [{"question": "What is important to vaccinate patients?", "id": "100000000000000000008899", "answers": [{"text": "doses", "answer_start": 61}], "is_impossible": false}, {"question": "How many doses are needed for vaccinating patients and healthcare personnel?", "id": "100000000000000000008900", "answers": [{"text": "number", "answer_start": 51}], "is_impossible": false}, {"question": "How old is 62 years old?", "id": "100000000000000000008901", "answers": [{"text": "The median", "answer_start": 226}], "is_impossible": false}, {"question": "What is the hospitalization rate for people on Dialysis who get COV19?", "id": "100000000000000000008903", "answers": [{"text": "50%", "answer_start": 437}], "is_impossible": false}, {"question": "How much mortality rate does COV-19 have?", "id": "100000000000000000008904", "answers": [{"text": "20%\u201330%", "answer_start": 467}], "is_impossible": false}, {"question": "Vaccinating this population addresses what issue?", "id": "100000000000000000008905", "answers": [{"text": "health equity", "answer_start": 532}], "is_impossible": false}], "context": "Work with dialysis clinic leaders to establish the number of doses needed to vaccinate patients and healthcare personnel\nand determine a timeline for allocating these doses. Why is it important to vaccinate dialysis patients? The median age of patients on dialysis is 62 years. Due to age and health status, dialysis patients are at high risk for\nserious illness and death related to COVID-19; people on dialysis who get COVID-19 have a 50% hospitalization rate and a\n20%\u201330% mortality rate. Vaccinating this population addresses a health equity issue."}]}, {"title": "93139a624fa3bd6a89f0b80c5afb7070", "paragraphs": [{"qas": [{"question": "What disproportionately affects racial and ethnic minorities?", "id": "100000000000000000008906", "answers": [{"text": "Chronic kidney disease", "answer_start": 0}], "is_impossible": false}, {"question": "What percentage of patients on dialysis are Black?", "id": "100000000000000000008907", "answers": [{"text": "34%", "answer_start": 80}], "is_impossible": false}, {"question": "What is a lifesaving, essential treatment that must be done 3 times per week for most patients?", "id": "100000000000000000008908", "answers": [{"text": "Dialysis", "answer_start": 433}], "is_impossible": false}, {"question": "What is nonelective and cannot be delayed?", "id": "100000000000000000008909", "answers": [{"text": "Dialysis", "answer_start": 433}], "is_impossible": false}, {"question": "What are dialysis clinics able to serve?", "id": "100000000000000000008910", "answers": [{"text": "patients whether they have COVID-19 or not", "answer_start": 618}], "is_impossible": false}], "context": "Chronic kidney disease disproportionately affects racial and\nethnic minorities; 34% of patients on dialysis are Black and 19% are Hispanic. Many dialysis clinics deliver care to patients\n\uf656 Federal Vaccine Allocation\nGet more information about a federal partnership with dialysis organizations. 10/30/22, 9:21 AM Vaccinating Dialysis Patients and Healthcare Personnel | CDC\nin communities that have been hit hardest by this pandemic. Dialysis is a lifesaving, essential treatment that must be done 3 times per week for most patients. Because these services\nare nonelective and cannot be delayed, dialysis clinics serve patients whether they have COVID-19 or not."}]}, {"title": "c4b624600a0ee9b1884094ba4e17a54d", "paragraphs": [{"qas": [{"question": "Who can be easily reached for COVID-19 vaccination?", "id": "100000000000000000008913", "answers": [{"text": "Dialysis patients", "answer_start": 236}], "is_impossible": false}, {"question": "What kind of infrastructure does a dialysis clinic have?", "id": "100000000000000000008914", "answers": [{"text": "extensive operational, logistical, and IT infrastructure", "answer_start": 333}], "is_impossible": false}], "context": "This creates a\nhigh-risk environment for other dialysis patients and healthcare personnel and underscores the importance of\nvaccination to protect everyone in these clinics. Why vaccinate patients while they are at the dialysis clinic? Dialysis patients can be easily reached for COVID-19 vaccination at dialysis clinics, which have extensive operational,\nlogistical, and IT infrastructure to serve as capable vaccine providers. Many dialysis patients are accustomed to receiving routine vaccinations at the dialysis clinic."}]}, {"title": "82346f83941dd66898d97f257df97f6", "paragraphs": [{"qas": [{"question": "What could be done to increase vaccination rates for this high-risk population?", "id": "100000000000000000008916", "answers": [{"text": "By offering COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "Patients on dialysis are often medically frail and what might be challenging for them?", "id": "100000000000000000008917", "answers": [{"text": "impractical for them to seek out venues separate from the dialysis clinic to receive COVID-19 vaccines", "answer_start": 332}], "is_impossible": false}], "context": "By offering COVID-19\nvaccines in a setting where patients are comfortable with trusted and trained vaccinators, it might be possible to\nincrease vaccination rates for this high-risk population and ensure patients receive a complete vaccination series. Patients on dialysis are often medically frail, and it might be challenging and impractical for them to seek out venues\nseparate from the dialysis clinic to receive COVID-19 vaccines. Currently, dialysis providers are reporting low COVID-19 vaccination coverage among their patients because of\nchallenges with getting vaccines. Why is it important to vaccinate dialysis healthcare personnel?"}]}, {"title": "643cbd5abd6c5e65ebedcba77d064b6", "paragraphs": [{"qas": [{"question": "Who considers dialysis healthcare personnel a priority population for vaccination?", "id": "100000000000000000008920", "answers": [{"text": "Advisory Committee on Immunization Practices (ACIP).", "answer_start": 90}], "is_impossible": false}, {"question": "What is the acronym for the Advisory Committee on Immunization Practices?", "id": "100000000000000000008921", "answers": [{"text": "ACIP", "answer_start": 136}], "is_impossible": false}, {"question": "Dialysis providers are currently reporting low COVID-19 vaccination coverage among their healthcare personnel because of challenges with what?", "id": "100000000000000000008922", "answers": [{"text": "obtaining vaccines", "answer_start": 280}], "is_impossible": false}, {"question": "Most dialysis clinics are not affiliated with what?", "id": "100000000000000000008923", "answers": [{"text": "hospitals", "answer_start": 454}], "is_impossible": false}, {"question": "The convenience of having vaccine offered at their workplace might improve vaccination coverage?", "id": "100000000000000000008924", "answers": [{"text": "Healthcare personnel working at outpatient dialysis clinics", "answer_start": 300}], "is_impossible": false}, {"question": "SARS-CoV-2 is the virus that causes COVID- 19.", "id": "100000000000000000008925", "answers": [{"text": "Dialysis healthcare personnel", "answer_start": 562}], "is_impossible": false}, {"question": "Dialysis healthcare personnel might have high-risk exposures to what virus?", "id": "100000000000000000008926", "answers": [{"text": "SARS-CoV-2", "answer_start": 640}], "is_impossible": false}, {"question": "What does COVID- 19 cause?", "id": "100000000000000000008927", "answers": [{"text": "SARS-CoV-2", "answer_start": 640}], "is_impossible": false}, {"question": "How close to their patients are they in close proximity to for extended periods of time?", "id": "100000000000000000008928", "answers": [{"text": "(<6 feet", "answer_start": 738}], "is_impossible": false}], "context": "Dialysis healthcare personnel are considered a priority population for vaccination by the Advisory Committee on\nImmunization Practices (ACIP). Dialysis providers are currently reporting low COVID-19 vaccination coverage among their healthcare personnel because\nof challenges with obtaining vaccines. Healthcare personnel working at outpatient dialysis clinics might have difficulty accessing vaccine because most dialysis\nclinics are not affiliated with hospitals. The convenience of having vaccine offered at their workplace might improve\nvaccination coverage. Dialysis healthcare personnel might have high-risk, work-related exposures to SARS-CoV-2, the virus that causes COVID-\n19, because their work involves being in close proximity (<6 feet) to their patients for extended periods of time."}]}, {"title": "b206cfb580fc33cb5e29b168c00ebc86", "paragraphs": [{"qas": [{"question": "What is the name of the Vaccine Adverse Event Reporting System?", "id": "100000000000000000008932", "answers": [{"text": "VAERS", "answer_start": 58}], "is_impossible": false}, {"question": "What type of event is encouraged even if it is not clear if the vaccine caused the health problem?", "id": "100000000000000000008935", "answers": [{"text": "medically important adverse event", "answer_start": 605}], "is_impossible": false}], "context": "10/30/22, 9:32 AM Vaccine Adverse Event Reporting System (VAERS) | CDC\nEspa\u00f1ol | Other Languages\nVaccine Adverse Event Reporting System (VAERS)\nHow Reports Come into VAERS\nThere are two ways to report an adverse event to VAERS: report online or report using a writable pdf form. If you need\nfurther assistance with reporting to VAERS, please email info@VAERS.org or call 1-800-822-7967. For healthcare providers \u2013 Under Emergency Use Authorization, FDA requires healthcare professionals to report to VAERS\ncertain adverse events that occur after COVID-19 vaccination. CDC also encourages reporting of any medically important\nadverse event even if it isn\u2019t clear if the vaccine caused the health problem."}]}, {"title": "bfdfca0b4505a210897d3cb4d428a751", "paragraphs": [{"qas": [{"question": "What is a serious adverse event after vaccination?", "id": "100000000000000000008936", "answers": [{"text": "Permanent disability", "answer_start": 247}], "is_impossible": false}], "context": "Learn more about\u202fselected adverse events\u202freported to VAERS. How VAERS Reports Are Reviewed\nVaccine safety experts review all reports of serious adverse events submitted to VAERS. A serious adverse event after\nvaccination is something that causes:\nPermanent disability\nHospitalization or an extended hospital stay (if vaccinated while in the hospital)\nLife-threatening illness\nBirth defects (congenital anomalies)\nDeath\nImportant Things To Know About VAERS\nVAERS is an early warning system used to monitor adverse events that happen after vaccination. VAERS is the\nfrontline system of a comprehensive vaccine safety monitoring program in the United States."}]}, {"title": "aa08ce482c0614ba4cb904e4fe9df7de", "paragraphs": [{"qas": [{"question": "What does VAERS give vaccine safety experts?", "id": "100000000000000000008942", "answers": [{"text": "valuable information", "answer_start": 237}], "is_impossible": false}, {"question": "What can VAERS assess?", "id": "100000000000000000008943", "answers": [{"text": "vaccine safety concerns", "answer_start": 286}], "is_impossible": false}, {"question": "When a health problem is reported to VAERS, that doesn\u2019t mean that the vaccine caused the problem?", "id": "100000000000000000008945", "answers": [{"text": "If a health problem is reported to VAERS, that doesn\u2019t mean that the vaccine caused the problem", "answer_start": 536}], "is_impossible": false}], "context": "VAERS is one of several systems CDC and the U.S. Food and Drug Administration (FDA) use to help ensure vaccines\nused in the United States, including COVID-19 vaccines, are closely monitored for safety. VAERS gives vaccine safety experts valuable information so they can assess possible vaccine safety concerns,\nincluding for the new COVID-19 vaccines. VAERS is especially useful for detecting unusual or unexpected patterns of health problems (also called \u201cadverse\nevents\u201d) that might indicate a possible safety problem with a vaccine. If a health problem is reported to VAERS, that doesn\u2019t mean that the vaccine caused the problem."}]}, {"title": "482997e889a803a2e0dc00baf6df5eb6", "paragraphs": [{"qas": [{"question": "How many people in the United States have received at least one dose of COVID-19 vaccine?", "id": "100000000000000000008946", "answers": [{"text": "Hundreds of millions", "answer_start": 138}], "is_impossible": false}, {"question": "What do VAERS warn vaccine safety experts of?", "id": "100000000000000000008948", "answers": [{"text": "potential problems that they may need to assess", "answer_start": 35}], "is_impossible": false}, {"question": "What are the majority of reports to VAERS after COVID-19 vaccination?", "id": "100000000000000000008949", "answers": [{"text": "non-serious adverse events", "answer_start": 313}], "is_impossible": false}, {"question": "What does CDC provide timely updates on?", "id": "100000000000000000008950", "answers": [{"text": "selected adverse events reported after COVID-19 vaccination", "answer_start": 372}], "is_impossible": false}], "context": "It warns\nvaccine safety experts of potential problems that they may need to assess, and it alerts them to take further\naction, as needed. Hundreds of millions of people in the United States have received at least one dose of COVID-19 vaccine. The\nmajority of reports to VAERS after COVID-19 vaccination have been non-serious adverse events. CDC provides timely updates on selected adverse events reported after COVID-19 vaccination."}]}, {"title": "3b38425610a8af91fe5d1a21625e8c96", "paragraphs": [{"qas": [{"question": "What is VAERS?", "id": "100000000000000000008951", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 48}], "is_impossible": false}, {"question": "What does VAERS stand for?", "id": "100000000000000000008952", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 48}], "is_impossible": false}, {"question": "Why are VAERS reports available to the public?", "id": "100000000000000000008953", "answers": [{"text": "to protect privacy and confidentiality", "answer_start": 322}], "is_impossible": false}, {"question": "What does not include information that could identify the person?", "id": "100000000000000000008955", "answers": [{"text": "VAERS reports", "answer_start": 275}], "is_impossible": false}, {"question": "VAERS cannot be used to determine what?", "id": "100000000000000000008956", "answers": [{"text": "if a vaccine caused or contributed to an adverse event or illness", "answer_start": 501}], "is_impossible": false}, {"question": "What may some reports contain that is incomplete, inaccurate, coincidental, or unverifiable?", "id": "100000000000000000008957", "answers": [{"text": "information", "answer_start": 593}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n-\n\u2022\n\u2022\n\uf209 \uf209\n\uf209\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:32 AM Vaccine Adverse Event Reporting System (VAERS) | CDC\nWhen VAERS staff members follow-up on a report of a serious adverse event, they ask for the patient\u2019s medical\nrecords related to the event to learn more about what happened. VAERS reports are available to the public, but to protect privacy and confidentiality they do not include information that could\nidentify the person. VAERS Limitations\nVAERS reports alone generally cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. Some reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable."}]}, {"title": "cad25871946a42e2659d82147f8b7707", "paragraphs": [{"qas": [{"question": "What is one reason VAERS reports may be subject to biases?", "id": "100000000000000000008959", "answers": [{"text": "voluntary", "answer_start": 162}], "is_impossible": false}, {"question": "How should data from VAERS be interpreted?", "id": "100000000000000000008960", "answers": [{"text": "always", "answer_start": 247}], "is_impossible": false}, {"question": "How long is VAERS and Vaccine Safety: How It Works Video Length: 00:02:04 Watch Video  For Providers and Jurisdictions 10 things healthcare providers need to know?", "id": "100000000000000000008962", "answers": [{"text": "00:04:44", "answer_start": 547}], "is_impossible": false}, {"question": "What do providers need to know about VAERS COVID-19 Clinical Resources?", "id": "100000000000000000008963", "answers": [{"text": "10", "answer_start": 602}], "is_impossible": false}], "context": "VAERS reports often lack\ncontextual information, such as total vaccinations given or information on unvaccinated groups for comparison. Most reports\nto VAERS are voluntary, which means they may be subject to biases. Data from VAERS reports should always be interpreted\nwith these limitations in mind. Learn more about how VAERS helps to monitor vaccine safety. Learn More about VAERS\nVIDEO\nVAERS and Vaccine Safety: How It Works\nVideo Length: 00:02:04\nWatch Video\nVIDEO\nVaccine Safety Monitoring Information for Healthcare Providers\nVideo Length: 00:04:44\nWatch Video\n\uf2ff For Providers and Jurisdictions\n10 Things Healthcare Providers Need to Know About VAERS\nCOVID-19 Clinical Resources\n\u2022\n\u2022\nLast Updated Aug. 25, 2021"}]}, {"title": "5e71a07a7146768648e74a2c4fd7ce98", "paragraphs": [{"qas": [{"question": "What is the name of the v-safe COVID-19 Vaccine Pregnancy Registry?", "id": "100000000000000000008964", "answers": [{"text": "Vaccine Pregnancy Registry", "answer_start": 18}], "is_impossible": false}, {"question": "When is the periconception period?", "id": "100000000000000000008965", "answers": [{"text": "within 30 days before last menstrual period", "answer_start": 241}], "is_impossible": false}, {"question": "How long before the last menstrual period does it take for people to receive a dose of a vaccine to be vaccinated?", "id": "100000000000000000008966", "answers": [{"text": "30 days", "answer_start": 248}], "is_impossible": false}, {"question": "Who can participate in the v-safe COVID-19 Vaccine Pregnancy Registry?", "id": "100000000000000000008967", "answers": [{"text": "people who received any dose of COVID-19 vaccine in the periconception period (within 30 days before last menstrual period) or during pregnancy", "answer_start": 162}], "is_impossible": false}, {"question": "What must pregnant people who want to participate be enrolled in?", "id": "100000000000000000008968", "answers": [{"text": "v-safe", "answer_start": 438}], "is_impossible": false}, {"question": "What does the registry staff call a pregnant woman to learn more about?", "id": "100000000000000000008969", "answers": [{"text": "their pregnancy course and outcome", "answer_start": 633}], "is_impossible": false}], "context": "10/30/22, 9:32 AM Vaccine Pregnancy Registry | CDC\nEspa\u00f1ol | Other Languages\nV-safe COVID-19 Vaccine Pregnancy Registry\nParticipation in the Registry\nCDC invites people who received any dose of COVID-19 vaccine in the periconception period (within 30 days before last\nmenstrual period) or during pregnancy to participate in the v-safe COVID-19 Vaccine Pregnancy Registry. Pregnant people who would like to participate must be enrolled in v-safe. If people enrolled in v-safe report that they were pregnant at the time of vaccination or became pregnant shortly\nafter vaccination, the registry staff* may call them to learn more about their pregnancy course and outcome."}]}, {"title": "9e859f1f2637bd5f2b44ec146f9cad0d", "paragraphs": [{"qas": [{"question": "What does the V-safe COVID-19 Vaccine Pregnancy Registry use?", "id": "100000000000000000008971", "answers": [{"text": "text messaging and web surveys", "answer_start": 223}], "is_impossible": false}, {"question": "How long does it take for participants to self-identify as pregnant?", "id": "100000000000000000008973", "answers": [{"text": "within 30 days of vaccination", "answer_start": 488}], "is_impossible": false}, {"question": "What type of health check-ins do participants receive after vaccination?", "id": "100000000000000000008975", "answers": [{"text": "v-safe", "answer_start": 567}], "is_impossible": false}], "context": "Even if you are no longer pregnant, you may still be eligible to enroll in the registry. \u2022\n\u2022\n\u2022\nV-safe and the V-safe COVID-19 Vaccine Pregnancy Registry:\nWhat\u2019s the Difference? v-safe is a smartphone-based system that uses text messaging and web surveys to provide personalized health check-ins\nafter you receive a COVID-19 vaccine. The v-safe COVID-19 Vaccine Pregnancy Registry is for v-safe participants who self-\nidentify as pregnant at the time of vaccination or shortly thereafter (within 30 days of vaccination). The registry activities are in\naddition to the v-safe after vaccination health check-ins that participants receive via text message."}]}, {"title": "8f1689c0d75763d958c3e5570088c838", "paragraphs": [{"qas": [{"question": "Who will contact people by phone to invite them to participate in the registry?", "id": "100000000000000000008977", "answers": [{"text": "Abt Associates", "answer_start": 78}], "is_impossible": false}, {"question": "How many times will people who enroll in the Registry receive calls from Abt Associates?", "id": "100000000000000000008978", "answers": [{"text": "several times", "answer_start": 292}], "is_impossible": false}, {"question": "When will participants be asked questions about their pregnancy and medical history?", "id": "100000000000000000008980", "answers": [{"text": "After delivery", "answer_start": 462}], "is_impossible": false}], "context": "What to Expect If You Participate in the Registry\nPhone Call Health Check-ins\nAbt Associates , the registry staff contracted by CDC, will contact people by phone to invite them to participate in the\nregistry. People who choose to enroll in the registry will receive calls from Abt Associates several times throughout their pregnancy for\nadditional health check-ins. During these check-ins, they will be asked questions about their pregnancy and medical history. After delivery, participants might be contacted for more information when their babies are about three months old."}]}, {"title": "cc4935a135e2124423641382243836ea", "paragraphs": [{"qas": [{"question": "Personal information and responses given to the registry are what?", "id": "100000000000000000008982", "answers": [{"text": "confidential", "answer_start": 306}], "is_impossible": false}, {"question": "What is confidential and will be protected to the full extent allowed by law?", "id": "100000000000000000008983", "answers": [{"text": "Personal information and responses given to the registry", "answer_start": 246}], "is_impossible": false}, {"question": "What provides a complete picture of your pregnancy?", "id": "100000000000000000008984", "answers": [{"text": "Having information on details, like medications or clinical laboratory results", "answer_start": 377}], "is_impossible": false}], "context": "Requesting Permission to Contact Your Healthcare Provider\nParticipants will also be asked if they would be willing to provide permission for Pregnancy Registry staff to review their\nmedical records for additional details about their pregnancies. Personal information and responses given to the registry are\nconfidential and will be protected to the full extent allowed by law. Having information on details, like medications or clinical\nlaboratory results, provides a complete picture of your pregnancy. Your healthcare provider(s) can help provide this\ninformation, which is important as we try to understand more about COVID-19 vaccination during pregnancy."}]}, {"title": "a7e2d6335e67bf5a8e1bd1e6d81a8b68", "paragraphs": [{"qas": [{"question": "Who will not be contacted to participate in pregnancy surveys?", "id": "100000000000000000008988", "answers": [{"text": "all people reporting pregnancy", "answer_start": 275}], "is_impossible": false}, {"question": "Who can opt out at any time?", "id": "100000000000000000008989", "answers": [{"text": "Participants are not paid for their participation in the registry", "answer_start": 200}], "is_impossible": false}, {"question": "What do people feel good about participating in?", "id": "100000000000000000008990", "answers": [{"text": "activities to help answer critical scientific questions", "answer_start": 478}], "is_impossible": false}], "context": "If you choose\nnot to give your permission for CDC to access medical records, you can still participate in the registry. \uf209\f10/30/22, 9:32 AM Vaccine Pregnancy Registry | CDC\nParticipation Is Voluntary\nParticipants are not paid for their participation in the registry, and not all people reporting pregnancy will be contacted to\nparticipate. Participation is completely voluntary, and you can opt out at any time. However, in general, many people feel\ngood about participating in activities to help answer critical scientific questions, which can help inform recommendations for\nthe public. Registry Data Collection and Use\nWho Is Participating in the Registry\nCDC is currently enrolling eligible participants."}]}, {"title": "e26614bd91d69ed1bc1c316b820723f1", "paragraphs": [{"qas": [{"question": "What is the purpose of the information collected by CDC?", "id": "100000000000000000008993", "answers": [{"text": "to guide recommendations on COVID-19 vaccination during pregnancy", "answer_start": 401}], "is_impossible": false}, {"question": "How will the information you provide be used to educate the public?", "id": "100000000000000000008994", "answers": [{"text": "evaluated", "answer_start": 228}], "is_impossible": false}, {"question": "Who will use this information to guide recommendations on COVID-19 vaccination during pregnancy?", "id": "100000000000000000008995", "answers": [{"text": "CDC and the Food and Drug Administration (FDA)", "answer_start": 354}], "is_impossible": false}], "context": "As of May 2, 2022, the registry has enrolled 23,779 pregnant people in the\nUnited States. Why CDC Is Collecting Registry Information\nIf you participate in the registry, the information you and other participants provide will be evaluated and used to educate the\npublic about COVID-19 vaccines and pregnancy. In addition, this information will be used by CDC and the Food and Drug\nAdministration (FDA) to guide recommendations on COVID-19 vaccination during pregnancy."}]}, {"title": "37b688768e0cd37234f4a0afc1f5f557", "paragraphs": [{"qas": [{"question": "Pregnancy outcomes, like miscarriage and stillbirth, are some of the health effects that scientists will be looking at What are some pregnancy complications, like preeclampsia and gestational diabetes?", "id": "100000000000000000008997", "answers": [{"text": "Problems with the newborn, like preterm delivery, poor growth, or birth defects", "answer_start": 188}], "is_impossible": false}, {"question": "Preterm delivery, poor growth, or birth defects are examples of what?", "id": "100000000000000000008998", "answers": [{"text": "Problems with the newborn", "answer_start": 188}], "is_impossible": false}, {"question": "What system does the CDC use to keep personal information secure?", "id": "100000000000000000008999", "answers": [{"text": "CDC system that employs strict security measures to keep personally identifiable information private", "answer_start": 304}], "is_impossible": false}, {"question": "What does a system that employs strict security measures to keep personal information private employ?", "id": "100000000000000000009000", "answers": [{"text": "Data for the registry are kept on a CDC", "answer_start": 268}], "is_impossible": false}, {"question": "What will not be included in any reports?", "id": "100000000000000000009001", "answers": [{"text": "Your name and any identifying information", "answer_start": 406}], "is_impossible": false}], "context": "Specific health effects that scientists will be looking at include:\nPregnancy outcomes, like miscarriage and stillbirth\nPregnancy complications, like preeclampsia and gestational diabetes\nProblems with the newborn, like preterm delivery, poor growth, or birth defects\nData for the registry are kept on a CDC system that employs strict security measures to keep personally identifiable\ninformation private. Your name and any identifying information will not be included in any reports. Your responses and\npersonal information will be protected to the full extent allowed by law."}]}, {"title": "73b74d40846f1b580c3b46fd0d95fbc9", "paragraphs": [{"qas": [{"question": "When did CDC release the first U.S. data on the safety of mRNA COVID-19 vaccines administered during pregnancy?", "id": "100000000000000000009002", "answers": [{"text": "April 2021", "answer_start": 43}], "is_impossible": false}, {"question": "What did the analyses of data from three vaccine safety-related databases include?", "id": "100000000000000000009003", "answers": [{"text": "v-safe COVID-19 Pregnancy Registry", "answer_start": 243}], "is_impossible": false}], "context": "How CDC Is Using Data from the Registry\nIn April 2021, CDC released the first U.S. data on the safety of mRNA COVID-19 vaccines administered during pregnancy\nbased on analyses of data from three vaccine safety-related databases, including the v-safe COVID-19 Pregnancy Registry. The\nanalyses did not identify any safety concerns for pregnant people who were vaccinated or for their babies. Additional follow-\nup is needed, particularly among those vaccinated in the first or second trimesters of pregnancy; however, these preliminary\nfindings continue to indicate COVID-19 vaccines are safe and effective."}]}, {"title": "9aa95aa455da0a4d2b1679cf27954658", "paragraphs": [{"qas": [{"question": "What is the name of the Advisory Committee on Immunization Practices meetings?", "id": "100000000000000000009006", "answers": [{"text": "ACIP", "answer_start": 139}], "is_impossible": false}, {"question": "What is expected to take some time to gather data on the potential effects of COVID-19 vaccination during pregnancy?", "id": "100000000000000000009007", "answers": [{"text": "natural length of pregnancy", "answer_start": 281}], "is_impossible": false}, {"question": "What are people being vaccinated at different times during their pregnancies?", "id": "100000000000000000009008", "answers": [{"text": "COVID-19", "answer_start": 203}], "is_impossible": false}, {"question": "Who will share results as they are made available?", "id": "100000000000000000009009", "answers": [{"text": "CDC", "answer_start": 396}], "is_impossible": false}, {"question": "What are the authorized COVID-19 vaccines not thought to be?", "id": "100000000000000000009010", "answers": [{"text": "a risk", "answer_start": 630}], "is_impossible": false}, {"question": "What is not thought to be a risk to lactating people or their breastfeeding babies?", "id": "100000000000000000009011", "answers": [{"text": "COVID-19 vaccines", "answer_start": 590}], "is_impossible": false}], "context": "Data collected from the registry is also presented in published reports and at publicly open Advisory Committee on\nImmunization Practices (ACIP) meetings. However, gathering data on potential effects of COVID-19 vaccination during\npregnancy is expected to take some time given the natural length of pregnancy. In addition, people are being vaccinated at\ndifferent times during their pregnancies. CDC will share results as they are made available. \u2022\n\u2022\n\u2022\n\uf20c\n\uf209\n\uf209\nVaccine Safety Monitoring in People Who Are Breastfeeding\nBased on how these vaccines build protection in the body, the authorized COVID-19 vaccines are not thought to be a risk to\nlactating people or their breastfeeding babies."}]}, {"title": "f7a37712fecb3af94c1dcd30210c1bb", "paragraphs": [{"qas": [{"question": "What does the Pregnancy Registry not look at?", "id": "100000000000000000009012", "answers": [{"text": "COVID-19 vaccination and breastfeeding", "answer_start": 49}], "is_impossible": false}, {"question": "Other researchers across the nation are working to better understand what?", "id": "100000000000000000009013", "answers": [{"text": "COVID-19 vaccination and breastfeeding", "answer_start": 158}], "is_impossible": false}, {"question": "What is the risk of spontaneous abortion of COVID-19 vaccine safety in pregnancy?", "id": "100000000000000000009014", "answers": [{"text": "Receipt of mRNA COVID-19 Vaccines and Risk of Spontaneous Abortion COVID-19 vaccine safety in pregnancy: Updates from the v-safe COVID-19 vaccine pregnancy registry (ACIP meeting slides) Updates on COVID-19 and Pregnancy (ACIP meeting slides) \u2022 \uf209", "answer_start": 311}], "is_impossible": false}, {"question": "What does VAERS collect reports of?", "id": "100000000000000000009015", "answers": [{"text": "possible adverse events that happen after vaccination", "answer_start": 676}], "is_impossible": false}], "context": "Although the Pregnancy Registry does not look at COVID-19 vaccination and\nbreastfeeding, other researchers across the nation are working to better understand COVID-19 vaccination and\nbreastfeeding. Pregnancy Registry-Related Publications\nPreliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons\nReceipt of mRNA COVID-19 Vaccines and Risk of Spontaneous Abortion\nCOVID-19 vaccine safety in pregnancy: Updates from the v-safe COVID-19 vaccine pregnancy registry (ACIP\nmeeting slides)\nUpdates on COVID-19 and Pregnancy (ACIP meeting slides)\n\u2022 \uf209\n\u2022 \uf209\n\u2022 \uf20c\n\u2022 \uf20c\f10/30/22, 9:32 AM Vaccine Pregnancy Registry | CDC\nHow to Report Adverse Events\nVAERS collects reports of possible adverse events that happen after vaccination."}]}, {"title": "4c7bee00129c4760419038feacead074", "paragraphs": [{"qas": [{"question": "What are the two ways to report an adverse event to VAER?", "id": "100000000000000000009018", "answers": [{"text": "report online or report using a writable pdf form", "answer_start": 186}], "is_impossible": false}, {"question": "How many ways do patients, parents, caregivers, healthcare providers, and vaccine manufacturers submit reports?", "id": "100000000000000000009019", "answers": [{"text": "two", "answer_start": 140}], "is_impossible": false}, {"question": "What does FDA require healthcare providers to report to VAERS after COVID-19 vaccination?", "id": "100000000000000000009020", "answers": [{"text": "certain adverse events", "answer_start": 465}], "is_impossible": false}, {"question": "What is a medically important adverse event even if it isn\u2019t clear if the vaccine caused the health problem?", "id": "100000000000000000009022", "answers": [{"text": "COVID-19 vaccination", "answer_start": 505}], "is_impossible": false}], "context": "Anyone can submit a report to VAERS ,\nincluding patients, parents or caregivers, healthcare providers, and vaccine manufacturers. There are two ways to report an adverse event to VAERS: report online or report using a writable pdf form . If you need\nfurther assistance with reporting to VAERS, please email info@VAERS.org or call 1-800-822-7967. For healthcare providers \u2013 Under Emergency Use Authorization, FDA requires healthcare professionals to report to VAERS\ncertain adverse events that occur after COVID-19 vaccination. CDC also encourages reporting of any medically important\nadverse event even if it isn\u2019t clear if the vaccine caused the health problem."}]}, {"title": "51ac75dbc5e043e8df2c7fcf749ce259", "paragraphs": [{"qas": [{"question": "What is a benefit of getting a COVID-19 Vaccine?", "id": "100000000000000000009025", "answers": [{"text": "While Pregnant or Breastfeeding", "answer_start": 273}], "is_impossible": false}, {"question": "What is the name of the data tracker?", "id": "100000000000000000009026", "answers": [{"text": "COVID Data Tracker: COVID-19 Vaccination Among Pregnant People", "answer_start": 390}], "is_impossible": false}, {"question": "When was the last update?", "id": "100000000000000000009027", "answers": [{"text": "July 18, 2022", "answer_start": 468}], "is_impossible": false}], "context": "Learn more about selected adverse events reported to VAERS. Updates on COVID 19 and Pregnancy (ACIP meeting slides)\nMonitoring the safety of COVID-19 vaccines in pregnancy in the U.S.\n\u2022 \uf20c\n\u2022 \uf209\n\uf209\n\uf209 \uf209\n\uf209\nRelated Pages\nCOVID-19 Vaccine Safety and Monitoring\n\u203a\nCOVID-19 Vaccines While Pregnant or Breastfeeding\n\u203a\nBenefits of Getting a COVID-19 Vaccine\n\u203a\nMyths and Facts about COVID-19 Vaccines\n\u203a\nCOVID Data Tracker: COVID-19 Vaccination Among Pregnant People\n\u203a\nLast Updated July 18, 2022"}]}, {"title": "e6e26db058fb913691392f28655f6a73", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000009028", "answers": [{"text": "SARS-CoV-2", "answer_start": 497}], "is_impossible": false}, {"question": "What is being tracked in the United States and globally during this pandemic?", "id": "100000000000000000009029", "answers": [{"text": "Numerous variants of the virus that causes COVID-19", "answer_start": 98}], "is_impossible": false}, {"question": "Who is working with public health officials to monitor the spread of all variants?", "id": "100000000000000000009030", "answers": [{"text": "CDC", "answer_start": 224}], "is_impossible": false}, {"question": "Who monitors the spread of SARS-CoV-2?", "id": "100000000000000000009031", "answers": [{"text": "CDC is working with public health officials", "answer_start": 224}], "is_impossible": false}], "context": "10/30/22, 9:36 AM Variants of the Virus | CDC\nVariants of the Virus\nVariants in the United States\nNumerous variants of the virus that causes COVID-19 are being tracked in the United States and globally during this\npandemic. CDC is working with public health officials to monitor the spread of all variants and provide an estimate of how\ncommon they are in the nation and at the regional level. This data can change over time as more information is available. What You Need to Know\nNew variants of SARS-CoV-2, the virus that causes COVID-19, are expected to occur."}]}, {"title": "284ef2458eabb1d3f3645f32b606688f", "paragraphs": [{"qas": [{"question": "Who is working with state and local public health officials to monitor the spread of all variants?", "id": "100000000000000000009033", "answers": [{"text": "CDC", "answer_start": 0}], "is_impossible": false}, {"question": "The Omicron variant continues to spread throughout communities and can infect people who have been vaccinated or have previously had what?", "id": "100000000000000000009034", "answers": [{"text": "COVID-19", "answer_start": 232}], "is_impossible": false}, {"question": "What reduces your risk of severe illness, hospitalization, and death from COVID-19?", "id": "100000000000000000009036", "answers": [{"text": "Staying up to date with your COVID-19 vaccines", "answer_start": 242}], "is_impossible": false}, {"question": "What may be different between lineages that affect the behavior of the virus?", "id": "100000000000000000009038", "answers": [{"text": "Omicron variant, like other variants, is made up of a number of lineages and sublineages. These lineages are often very similar to each other; however, there may be differences", "answer_start": 435}], "is_impossible": false}], "context": "CDC is working with state and local public health officials to monitor the spread of all variants. The Omicron variant continues to spread throughout communities and can infect people who have been\nvaccinated or have previously had COVID-19. Staying up to date with your COVID-19 vaccines reduces your risk of severe illness, hospitalization, and death from\nCOVID-19. \u2022\n\u2022\n\u2022\n\u2022\nVARIANT OF CONCERN\nOmicron\nOriginal Lineage: B.1.1.529\nThe Omicron variant, like other variants, is made up of a number of lineages and sublineages. These lineages are often very similar to each other; however, there may be differences between lineages that\naffect the behavior of the virus."}]}, {"title": "57588ff8c678e37105e0ff13257d6b4b", "paragraphs": [{"qas": [{"question": "What is the most common variant of O micron that spreads more easily than earlier variants?", "id": "100000000000000000009040", "answers": [{"text": "Delta", "answer_start": 147}], "is_impossible": false}, {"question": "Who can spread the O. coli virus to others?", "id": "100000000000000000009041", "answers": [{"text": "Anyone with Omicron infection", "answer_start": 162}], "is_impossible": false}, {"question": "What can Omicron cause even in people who have recovered from COVID-19 vaccination status?", "id": "100000000000000000009042", "answers": [{"text": "reinfection", "answer_start": 332}], "is_impossible": false}, {"question": "What can affect the presence and severity of symptoms?", "id": "100000000000000000009043", "answers": [{"text": "COVID-19 vaccination status, other health conditions, age, and history of prior infection", "answer_start": 436}], "is_impossible": false}], "context": "Visit CDC\u2019s COVID Data Tracker for the most current data on circulating\nvariants. Omicron spreads more easily than earlier variants, including the Delta variant. Anyone with Omicron infection, regardless of vaccination status or whether or not they have symptoms, can\nspread the virus to others. Data suggest that Omicron can cause reinfection, even in people who have\nrecovered from COVID-19. Symptoms are similar to previous variants\nCOVID-19 vaccination status, other health conditions, age, and history of prior infection can affect the presence\nand severity of symptoms."}]}, {"title": "b7d75a69d072c6876bfe147f681fa4ca", "paragraphs": [{"qas": [{"question": "What causes less severe illness and death in general?", "id": "100000000000000000009044", "answers": [{"text": "Omicron", "answer_start": 0}], "is_impossible": false}, {"question": "A surge in cases may lead to increases in what?", "id": "100000000000000000009045", "answers": [{"text": "hospitalizations and deaths", "answer_start": 126}], "is_impossible": false}, {"question": "Vaccines help prevent severe illness, hospitalizations, and death What is expected in people who are vaccinated?", "id": "100000000000000000009046", "answers": [{"text": "Breakthrough infections", "answer_start": 221}], "is_impossible": false}, {"question": "The emergence of what further emphasizes the importance of vaccination?", "id": "100000000000000000009047", "answers": [{"text": "Omicron variant", "answer_start": 309}], "is_impossible": false}, {"question": "What does the emergence of the Omicron variant further emphasize the importance of?", "id": "100000000000000000009048", "answers": [{"text": "vaccination and boosters", "answer_start": 362}], "is_impossible": false}, {"question": "Antiviral treatments are effective what?", "id": "100000000000000000009049", "answers": [{"text": "10/30/22, 9:36 AM Variants of the Virus", "answer_start": 423}], "is_impossible": false}, {"question": "What do some variations of the virus allow to spread more easily or make it resistant to treatments?", "id": "100000000000000000009051", "answers": [{"text": "vaccines", "answer_start": 694}], "is_impossible": false}], "context": "Omicron causes less severe illness and death in general, according to data\nHowever, a surge in cases may lead to increases in hospitalizations and deaths. Vaccines help prevent severe illness, hospitalizations, and death\nBreakthrough infections in people who are vaccinated are expected. The emergence of the Omicron variant\nfurther emphasizes the importance of vaccination and boosters. Antiviral treatments are effective\f10/30/22, 9:36 AM Variants of the Virus | CDC\nVariants Are Expected\nViruses constantly change through mutation and sometimes these mutations result in a new variant of the virus. Some\nvariations allow the virus to spread more easily or make it resistant to treatments or vaccines."}]}, {"title": "bc60d80e8a293cb2ef4c63561a0f540d", "paragraphs": [{"qas": [{"question": "What may become harder to stop as the virus spreads?", "id": "100000000000000000009052", "answers": [{"text": "it may change", "answer_start": 22}], "is_impossible": false}, {"question": "What can a surge in cases do to healthcare resources?", "id": "100000000000000000009053", "answers": [{"text": "put more strain on healthcare resources, and potentially lead to more deaths", "answer_start": 286}], "is_impossible": false}, {"question": "What does CDC use to quickly identify and track COVID-19 variants?", "id": "100000000000000000009055", "answers": [{"text": "viral genomic surveillance", "answer_start": 393}], "is_impossible": false}, {"question": "What may lead to more cases of COVID-19?", "id": "100000000000000000009057", "answers": [{"text": "Some variants spread more easily and quickly than others", "answer_start": 535}], "is_impossible": false}], "context": "As the virus spreads, it may\nchange and may become harder to stop. Regardless of the variant, a surge in cases can impact healthcare resources\nEven if a variant causes less severe disease in general, an increase in the total number of cases could cause an increase in\nhospitalizations, put more strain on healthcare resources, and potentially lead to more deaths. Monitoring Variants\nCDC uses viral genomic surveillance to quickly identify and track COVID-19 variants, and acts upon these findings to best\nprotect the public\u2019s health. Some variants spread more easily and quickly than others, which may lead to more cases of\nCOVID-19."}]}, {"title": "57a5b9e06fa78f1096619ede4d153b8c", "paragraphs": [{"qas": [{"question": "Scientists monitor all variants but may classify some as what?", "id": "100000000000000000009058", "answers": [{"text": "Variants Being Monitored", "answer_start": 65}], "is_impossible": false}, {"question": "Variants Being Monitored \u2013 No risk to public health; Circulating at very low levels in the United States Variants of Interest \u2013 Potential impact on spread, severity, testing, treatment, and vaccinations; Evidence it has caused an increase proportion of cases or unique outbreak?", "id": "100000000000000000009059", "answers": [{"text": "Variants Being Monitored \u2013 No risk to public health; Circulating at very low levels in the United States Variants of Interest", "answer_start": 66}], "is_impossible": false}, {"question": "What does CDC use in the United States?", "id": "100000000000000000009060", "answers": [{"text": "viral genomic surveillance", "answer_start": 644}], "is_impossible": false}, {"question": "What does CDC use to track COVID-19 variants?", "id": "100000000000000000009062", "answers": [{"text": "viral genomic surveillance", "answer_start": 644}], "is_impossible": false}, {"question": "What is the purpose of using viral genomic surveillance?", "id": "100000000000000000009063", "answers": [{"text": "to best protect the public\u2019s health", "answer_start": 752}], "is_impossible": false}], "context": "Scientists monitor all variants but may classify certain ones as:\nVariants Being Monitored \u2013 No risk to public health; Circulating at very low levels in the United States\nVariants of Interest \u2013 Potential impact on spread, severity, testing, treatment, and vaccinations; Evidence it has caused an\nincrease proportion of cases or unique outbreak clusters\nVariants of Concern \u2013 Evidence of impact on spread, severity, testing, treatment, and vaccination\nVariants of High Consequence \u2013 Clear evidence of significant impact on spread and severity, and reduction of\neffectiveness of testing, treatment, and vaccination\nIn the United States, CDC uses viral genomic surveillance to track COVID-19 variants, to more quickly identify and act upon\nthese findings to best protect the public\u2019s health."}]}, {"title": "4248f61d2295e30c9650bca0c8c68501", "paragraphs": [{"qas": [{"question": "CDC established multiple ways to connect and share viral genomic sequence data within what?", "id": "100000000000000000009064", "answers": [{"text": "publicly accessible databases", "answer_start": 176}], "is_impossible": false}, {"question": "What do public health agencies work with healthcare providers to ensure?", "id": "100000000000000000009065", "answers": [{"text": "effective treatments are used appropriately to treat patients", "answer_start": 395}], "is_impossible": false}, {"question": "What do public health agencies work with to ensure that effective treatments are used appropriately to treat patients?", "id": "100000000000000000009066", "answers": [{"text": "healthcare providers", "answer_start": 359}], "is_impossible": false}], "context": "CDC established multiple ways to connect and share viral genomic sequence\ndata being produced by CDC, public health laboratories, and commercial diagnostic laboratories within publicly accessible\ndatabases. Learn More About Tracking Variants\nSome, but not all, monoclonal antibody treatments remain effective against Omicron. Public health agencies\nwork with healthcare providers to ensure that effective treatments are used appropriately to treat patients. We Have the Tools to Fight Variants\nThe following pages cover more detailed information about specific key prevention actions which can help fight variants. Vaccines Masks Testing Ventilation\n\u2022\n\u2022\n\u2022\n\u2022\n\uf3c4 Definitions &\nClassifications\n\uf3c0 Tracking &\nSurveillance\n\uf251 US & Global\nVariant Data\nLast Updated Aug. 11, 2021"}]}, {"title": "4008f49379223befe21edd348233411f", "paragraphs": [{"qas": [{"question": "What is the purpose of the COVID-19 Viral Testing Tool?", "id": "100000000000000000009070", "answers": [{"text": "to help both healthcare providers and individuals understand COVID-19 testing options", "answer_start": 156}], "is_impossible": false}, {"question": "What does the CDC recommend for a test result?", "id": "100000000000000000009071", "answers": [{"text": "actions and resources", "answer_start": 554}], "is_impossible": false}, {"question": "What is the name of the tool that asks a series of questions?", "id": "100000000000000000009072", "answers": [{"text": "COVID-19 Viral Testing Tool", "answer_start": 92}], "is_impossible": false}], "context": "10/30/22, 9:38 AM Viral Testing Tool | CDC\nEspa\u00f1ol | Other Languages\nViral Testing Tool\nThe COVID-19 Viral Testing Tool is an interactive web tool designed to help both healthcare providers and individuals\nunderstand COVID-19 testing options. This tool provides relevant, actionable information for people to make informed\ndecisions about which test they may need. Once you have a test result, the tool will walk you through CDC recommendations\nfor that test result. This online, mobile-friendly tool asks a series of questions, and provides recommended actions and resources based on the\nuser\u2019s responses."}]}, {"title": "687f168908e53985e7fdc999d8c0951d", "paragraphs": [{"qas": [{"question": "What does Rescission: Requirement for Negative Pre-Departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for all Airline or Other Aircraft Passengers Arriving into the United States from Any Foreign Country do?", "id": "100000000000000000009074", "answers": [{"text": "no longer require air passengers traveling from a foreign country to the United States to show a negative COVID-19 viral test or documentation of recovery from COVID-19 before they board their flight", "answer_start": 46}], "is_impossible": false}, {"question": "What does COVID-19 mean?", "id": "100000000000000000009077", "answers": [{"text": "viral test or documentation of recovery from COVID-19 before they board their flight. For more information, see Rescission: Requirement for Negative Pre-Departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for all Airline or Other Aircraft Passengers Arriving into the United States from Any Foreign Country", "answer_start": 161}], "is_impossible": false}], "context": "\uf106 As of 12:01AM ET on June 12, 2022, CDC will no longer require air passengers traveling from a foreign\ncountry to the United States to show a negative COVID-19 viral test or documentation of recovery from\nCOVID-19 before they board their flight. For more information, see Rescission: Requirement for Negative\nPre-Departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for all Airline or Other\nAircraft Passengers Arriving into the United States from Any Foreign Country. Learn when you should get tested for COVID-19, how you can find tests, and what your test\nresult means."}]}, {"title": "e1a31bb41d4e174a495d66fb74973ea", "paragraphs": [{"qas": [{"question": "What do you do if you are sick?", "id": "100000000000000000009078", "answers": [{"text": "Self-testing", "answer_start": 80}], "is_impossible": false}, {"question": "When was the last time the Viral Testing Tool was updated?", "id": "100000000000000000009079", "answers": [{"text": "Dec. 6, 2021", "answer_start": 106}], "is_impossible": false}, {"question": "What is the name of the tool that you can use to test for symptoms?", "id": "100000000000000000009080", "answers": [{"text": "Viral Testing Tool", "answer_start": 0}], "is_impossible": false}], "context": "Viral Testing Tool\nMore Information\nSymptoms\nTesting\nWhat to Do If You Are Sick\nSelf-testing\nLast Updated Dec. 6, 2021\f10/30/22, 9:38 AM Viral Testing Tool | CDC\np"}]}, {"title": "4bc4fb342bed8ca5e2a193c6a525b9c5", "paragraphs": [{"qas": [{"question": "Who recommends wearing a high-quality mask or respirator over the nose and mouth in indoor areas of public transportation?", "id": "100000000000000000009081", "answers": [{"text": "CDC", "answer_start": 235}], "is_impossible": false}, {"question": "What are some examples of public transportation hubs?", "id": "100000000000000000009083", "answers": [{"text": "airports, stations, and seaports", "answer_start": 444}], "is_impossible": false}, {"question": "What is a good place to wear a mask?", "id": "100000000000000000009086", "answers": [{"text": "airport jetways", "answer_start": 766}], "is_impossible": false}], "context": "10/30/22, 9:43 AM Wearing Masks in Travel and Public Transportation Settings | CDC\nEspa\u00f1ol | Other Languages\nWearing Masks in Travel and Public Transportation\nSettings\nFor people aged 2 years or older\u2014\nincluding passengers and workers\u2014CDC\nrecommends properly wearing a high-\nquality mask or respirator over the nose\nand mouth in indoor areas of public\ntransportation (such as airplanes, trains,\nbuses, ferries) and transportation hubs\n(such as airports, stations, and seaports). When people properly wear a high-quality\nmask or respirator, they protect\nthemselves and those around them, and\nhelp keep travel and public transportation\nsafer for everyone. Wearing a high-quality\nmask or respirator is most beneficial in\ncrowded or poorly ventilated locations,\nsuch as airport jetways."}]}, {"title": "6cd8df5727be91f4b0c15a005af9bdd3", "paragraphs": [{"qas": [{"question": "What does CDC encourage operators of public transportation and transportation hubs to support?", "id": "100000000000000000009087", "answers": [{"text": "mask wearing by all people, including employees", "answer_start": 90}], "is_impossible": false}, {"question": "What is CDC's public health recommendation based on?", "id": "100000000000000000009088", "answers": [{"text": "currently available data", "answer_start": 189}], "is_impossible": false}, {"question": "What are the current trends in COVID-19 Community Levels within the United States?", "id": "100000000000000000009089", "answers": [{"text": "projections of COVID-19 trends in the coming months", "answer_start": 438}], "is_impossible": false}], "context": "CDC also\nencourages operators of public\ntransportation and transportation hubs to\nsupport mask wearing by all people, including employees. This public health recommendation is based on the currently available data, including an understanding of domestic and\nglobal epidemiology, circulating variants and their impact on disease severity and vaccine effectiveness, current trends in\nCOVID-19 Community Levels within the United States, and projections of COVID-19 trends in the coming months."}]}, {"title": "3d16439daae7a90de0a471eea812230a", "paragraphs": [{"qas": [{"question": "What is one of the multiple prevention steps that people can take to protect themselves and others in travel and transportation settings?", "id": "100000000000000000009090", "answers": [{"text": "wearing a high-quality mask or respirator", "answer_start": 95}], "is_impossible": false}, {"question": "What should people follow any requirements and recommendations of state, tribal, local, etc?", "id": "100000000000000000009091", "answers": [{"text": "authorities at international destinations, and operators of public transportation or transportation hubs", "answer_start": 383}], "is_impossible": false}, {"question": "What is the name of the book that provides information about safe travel during the pandemic?", "id": "100000000000000000009092", "answers": [{"text": "Domestic Travel During COVID-19", "answer_start": 554}], "is_impossible": false}], "context": "Along with staying up to date with their COVID-19 vaccines, avoiding crowds, and hand-washing, wearing a high-quality mask\nor respirator is one of multiple prevention steps that people can take to protect themselves and others in travel and\ntransportation settings. People should also follow any requirements and recommendations of state, tribal, local, and territorial authorities, authorities\nat international destinations, and operators of public transportation or transportation hubs. For more information about safer travel during the pandemic, see Domestic Travel During COVID-19 and International Travel."}]}, {"title": "86164e088743d34afb82d96f017fbe46", "paragraphs": [{"qas": [{"question": "What is CDC's January 29, 2021 Order requiring masks on public transportation conveyances and at transportation hubs?", "id": "100000000000000000009094", "answers": [{"text": "CDC will not enforce the Order", "answer_start": 224}], "is_impossible": false}, {"question": "What does CDC continue to recommend that people wear?", "id": "100000000000000000009095", "answers": [{"text": "masks", "answer_start": 300}], "is_impossible": false}, {"question": "What does CDC continue to recommend that people wear in indoor public transportation settings?", "id": "100000000000000000009096", "answers": [{"text": "masks", "answer_start": 300}], "is_impossible": false}, {"question": "What is recommended for everyone aged 2 years or older when indoors on public transportation?", "id": "100000000000000000009097", "answers": [{"text": "Properly wearing a high-quality mask or respirator", "answer_start": 471}], "is_impossible": false}, {"question": "What is the age limit for people who are 2 years or older when in public transportation?", "id": "100000000000000000009098", "answers": [{"text": "2021", "answer_start": 98}], "is_impossible": false}], "context": "\uf106 As a result of a court order, effective immediately and as of April 18, 2022, CDC\u2019s January 29, 2021 Order\nrequiring masks on public transportation conveyances and at transportation hubs is no longer in effect. Therefore, CDC will not enforce the Order. CDC continues to recommend that people wear masks in indoor\npublic transportation settings at this time. 10/30/22, 9:43 AM Wearing Masks in Travel and Public Transportation Settings | CDC\nFrequently Asked Questions\nProperly wearing a high-quality mask or respirator is recommended for everyone aged 2 years or older when indoors on\npublic transportation and at transportation hubs."}]}, {"title": "b7e00cf616ad25c09d573c589cd25977", "paragraphs": [{"qas": [{"question": "What is especially important to wear when public transportation is crowded?", "id": "100000000000000000009099", "answers": [{"text": "a mask", "answer_start": 35}], "is_impossible": false}, {"question": "What are areas that are poorly ventilated?", "id": "100000000000000000009100", "answers": [{"text": "public transportation or transportation hubs are crowded", "answer_start": 61}], "is_impossible": false}], "context": "It is especially important to wear a mask:\nDuring times when public transportation or transportation hubs are crowded\nIn areas that are poorly ventilated."}]}, {"title": "711071d46d0e34ef70587cbb5a395a98", "paragraphs": [{"qas": [{"question": "What is an example of a poorly ventilated area?", "id": "100000000000000000009101", "answers": [{"text": "airport jetways", "answer_start": 77}], "is_impossible": false}, {"question": "What are examples of small enclosed spaces?", "id": "100000000000000000009102", "answers": [{"text": "airport jetways", "answer_start": 77}], "is_impossible": false}, {"question": "When is the ventilation system off?", "id": "100000000000000000009103", "answers": [{"text": "Public transportation during periods", "answer_start": 93}], "is_impossible": false}, {"question": "What is the Community Level in the area you are located in?", "id": "100000000000000000009105", "answers": [{"text": "COVID-19", "answer_start": 470}], "is_impossible": false}, {"question": "What is a high (applies to US locations only?", "id": "100000000000000000009107", "answers": [{"text": "COVID-19 Community Level", "answer_start": 470}], "is_impossible": false}], "context": "Examples of poorly ventilated areas include:\nSmall, enclosed spaces, such as airport jetways\nPublic transportation during periods when the ventilation system is off and windows are closed (e.g., when the\nengine is turned off on an airplane)\nDuring international travel and in transportation hubs that serve international travelers\nIf you are at high risk for getting very sick from COVID-19, or if you live with or have social contact with someone at\nhigh risk\nWhen the COVID-19 Community Level in the area you are located in is high (applies to US locations only)\nWhen should I wear a mask in travel and public transportation settings?"}]}, {"title": "915af6be2725c9ce91c7c0f20bc36a40", "paragraphs": [{"qas": [{"question": "What should you do if you are sick, tested positive, or were exposed to COVID-19?", "id": "100000000000000000009108", "answers": [{"text": "Can I Travel If", "answer_start": 69}], "is_impossible": false}, {"question": "What is the chance for exposure to COVID-19?", "id": "100000000000000000009110", "answers": [{"text": "Using public transportation and being in transportation hubs can involve spending long periods of time in areas that may be crowded or poorly ventilated", "answer_start": 86}], "is_impossible": false}], "context": "\uf1aa\nIf you are sick, tested positive, or were exposed to COVID-19, see Can I Travel If. Using public transportation and being in transportation hubs can involve spending long periods of time in areas that\nmay be crowded or poorly ventilated, increasing chance for exposure to COVID-19. People on public transportation may not have the option to avoid being around people who are not wearing masks by\ndisembarking or relocating to another area, such as on an airplane during flight, or on a bus or train while it is in\nmotion."}]}, {"title": "f78d64b62130ff220e127d31aed8f0d7", "paragraphs": [{"qas": [{"question": "Children younger than 6 months old might not be able to get what vaccine?", "id": "100000000000000000009113", "answers": [{"text": "COVID-19", "answer_start": 234}], "is_impossible": false}, {"question": "What vaccines are available to children under the age of 6 months?", "id": "100000000000000000009114", "answers": [{"text": "COVID-19 vaccines", "answer_start": 234}], "is_impossible": false}], "context": "Some people using public transport or working in transportation settings (or someone they live or have social\ncontact with) might have a weakened immune system or be at increased risk for severe illness. Some might not be able to get COVID-19 vaccines, including children younger than 6 months old. Some of these people may have no alternative to public transportation. People from countries or US communities with different levels of COVID-19 or circulating variants mix in travel and\npublic transportation settings."}]}, {"title": "ab47cb40621bc91213a6fe60dbe0e7fb", "paragraphs": [{"qas": [{"question": "What can lead to spreading across the United States and around the world?", "id": "100000000000000000009116", "answers": [{"text": "an exposure in a transportation hub or on public transportation", "answer_start": 57}], "is_impossible": false}, {"question": "What is still recommended in travel and public transportation but not other community settings?", "id": "100000000000000000009117", "answers": [{"text": "masks", "answer_start": 195}], "is_impossible": false}, {"question": "What do you do during off-peak times when public transportation and hubs are likely to be less crowded?", "id": "100000000000000000009118", "answers": [{"text": "Consider traveling", "answer_start": 294}], "is_impossible": false}, {"question": "Open windows to improve ventilation if you are on a mode of public transportation where this is an option?", "id": "100000000000000000009119", "answers": [{"text": "masks", "answer_start": 195}], "is_impossible": false}, {"question": "Visit Domestic Travel During COVID-19 and International Travel for additional information?", "id": "100000000000000000009120", "answers": [{"text": "you can protect yourself and others during travel", "answer_start": 592}], "is_impossible": false}, {"question": "What are two ways you can protect yourself and others during travel?", "id": "100000000000000000009121", "answers": [{"text": "Domestic Travel During COVID-19 and International Travel", "answer_start": 515}], "is_impossible": false}], "context": "These people also depart to many different locations, so an exposure in a\ntransportation hub or on public transportation can lead to spread across the United States and around the world. Why are masks still recommended in travel and public transportation but not in other community\nsettings? \uf1aa\nConsider traveling during off-peak times when public transportation and hubs are likely to be less crowded. Open windows to improve ventilation if you are on a mode of public transportation where this is an option. Visit Domestic Travel During COVID-19 and International Travel for additional ways you can protect yourself and\nothers during travel."}]}, {"title": "1d9a84a48c228dd001eef0403c29ec98", "paragraphs": [{"qas": [{"question": "What should K-12 schools and early education settings follow in their travel and transportation settings?", "id": "100000000000000000009123", "answers": [{"text": "guidance", "answer_start": 262}], "is_impossible": false}], "context": "What are other ways I can reduce risk in travel and transportation settings? \uf1aa\nDoes CDC recommend masks on school buses? \uf1aa\f10/30/22, 9:43 AM Wearing Masks in Travel and Public Transportation Settings | CDC\nK-12 schools and early education settings should follow guidance for schools according to the COVID-19 Community\nLevel in their area with respect to mask wearing on buses or vans. Does CDC recommend masks on school buses? \uf1aa\nOperators of Conveyances and Transportation Hubs\nOperators of conveyances and transportation hubs can take steps to help keep travel and public transportation safer for\neveryone."}]}, {"title": "3c4f13d76babaa79a58028adbc3e0081", "paragraphs": [{"qas": [{"question": "What should everyone wear on conveyances and in transportation hubs for?", "id": "100000000000000000009125", "answers": [{"text": "masks or respirators", "answer_start": 19}], "is_impossible": false}, {"question": "What must an employer follow if an employer allows voluntary use of filtering facepiece respirators?", "id": "100000000000000000009126", "answers": [{"text": "29 CFR 1910.134(c)(2) requirements for voluntary respirator use", "answer_start": 236}], "is_impossible": false}, {"question": "What is one way to improve ventilation?", "id": "100000000000000000009128", "answers": [{"text": "Keep conveyance ventilation systems on when passengers and workers are on board", "answer_start": 322}], "is_impossible": false}, {"question": "How are hand sanitizer dispensers made available?", "id": "100000000000000000009130", "answers": [{"text": "Promote hand hygiene", "answer_start": 538}], "is_impossible": false}], "context": "Support wearing of masks or respirators on conveyances and in transportation hubs for everyone aged 2 years or\nolder, including employees. If an employer allows voluntary use of filtering facepiece respirators, the employer must follow 29 CFR\n1910.134(c)(2) requirements for voluntary respirator use. Improve ventilation. Keep conveyance ventilation systems on when passengers and workers are on board, including during\nembarkation and disembarkation processes. Open windows on conveyances where feasible. Reduce crowding where feasible. Promote hand hygiene, such as making hand sanitizer dispensers available and ensuring they are kept filled and\nworking."}]}, {"title": "6a8262c7e4999a5381da9121a1eadfb8", "paragraphs": [{"qas": [{"question": "What is the CDC's recommendation for wearing a mask or respirator over the nose and mouth in public transportation?", "id": "100000000000000000009131", "answers": [{"text": "high-quality", "answer_start": 75}], "is_impossible": false}, {"question": "How large is the size of the mask?", "id": "100000000000000000009133", "answers": [{"text": "8.5 W x 11 H", "answer_start": 372}], "is_impossible": false}, {"question": "When was the image last updated?", "id": "100000000000000000009135", "answers": [{"text": "Sept. 8, 2022", "answer_start": 425}], "is_impossible": false}], "context": "\uf209\n[PDF - 439 KB]\n\uf20c\nMasks Are Recommended\nCDC recommends properly wearing a high-quality mask or respirator over the nose and\nmouth in indoor areas of public transportation and transportation hubs. Airplane:\nEnglish\nSpanish\nTrain:\nEnglish\nSpanish\nBus:\nEnglish\nSpanish\n\uf20c\n\uf20c\n\uf20c\n\uf20c\n\uf20c\n\uf20c\n\uf20c\n\uf20c\n\uf20c\n\uf20c\n\uf20c\f10/30/22, 9:43 AM Wearing Masks in Travel and Public Transportation Settings | CDC\n8.5 W x 11 H [PDF \u2013 304 KB, 1 Page]\n\uf20c\n\uf20c\nLast Updated Sept. 8, 2022"}]}, {"title": "ad14600400c3c3242576b2e10ea897e0", "paragraphs": [{"qas": [{"question": "What should you do if you test positive for COVID-19?", "id": "100000000000000000009137", "answers": [{"text": "treatment is available", "answer_start": 215}], "is_impossible": false}, {"question": "If you are an older adult and are at high risk of getting very sick from COVID-19, what can you do?", "id": "100000000000000000009138", "answers": [{"text": "treatment is available", "answer_start": 215}], "is_impossible": false}, {"question": "What can you do to determine if you are eligible?", "id": "100000000000000000009140", "answers": [{"text": "Contact a healthcare provider", "answer_start": 239}], "is_impossible": false}, {"question": "Where can you get a prescription?", "id": "100000000000000000009141", "answers": [{"text": "Test to Treat location and, if eligible, receive a prescription from a provider", "answer_start": 399}], "is_impossible": false}, {"question": "What must be started within the first few days to be effective?", "id": "100000000000000000009142", "answers": [{"text": "Treatment", "answer_start": 493}], "is_impossible": false}], "context": "10/30/22, 9:41 AM What to Do If You Are Sick | CDC\nEspa\u00f1ol | Other Languages\nWhat to Do If You Are Sick\nIf you test positive and are an older adult or someone who is at high risk of getting very sick from COVID-19, treatment is\navailable. Contact a healthcare provider right away after a positive test to determine if you are eligible, even if your\nsymptoms are mild right now. You can also visit a Test to Treat location and, if eligible, receive a prescription from a\nprovider. Don\u2019t delay: Treatment must be started within the first few days to be effective."}]}, {"title": "502fb04190e7c3d292478a4405db2604", "paragraphs": [{"qas": [{"question": "What is COVID-19?", "id": "100000000000000000009143", "answers": [{"text": "If you have a fever, cough, or other symptoms", "answer_start": 2}], "is_impossible": false}, {"question": "Most people have mild illness and are able to recover at home.", "id": "100000000000000000009144", "answers": [{"text": "answer undefined", "answer_start": 2}], "is_impossible": false}, {"question": "If you have an emergency warning sign, call what?", "id": "100000000000000000009145", "answers": [{"text": "911", "answer_start": 257}], "is_impossible": false}, {"question": "What should you do if you have trouble breathing?", "id": "100000000000000000009146", "answers": [{"text": "call 911", "answer_start": 252}], "is_impossible": false}, {"question": "What can you do to help prevent the spread of COVID-19?", "id": "100000000000000000009147", "answers": [{"text": "If you test positive for COVID-19 or have symptoms, regardless of vaccination status, follow the steps below to care for yourself and to help protect other people in your home and community", "answer_start": 327}], "is_impossible": false}], "context": "\uf209\nIf you have a fever, cough, or other symptoms, you might have COVID-19. Most people have mild illness and are able to\nrecover at home. If you are sick:\nKeep track of your symptoms. If you have an emergency warning sign (including trouble breathing), call 911. \u2022\n\u2022\nSteps to help prevent the spread of COVID-19 if you are sick\nIf you test positive for COVID-19 or have symptoms, regardless of vaccination status, follow the steps below to care for\nyourself and to help protect other people in your home and community."}]}, {"title": "9224e8e9be384d38fbf2b4e356e3eddb", "paragraphs": [{"qas": [{"question": "How long do most people with COVID-19 have mild illness and can recover at home?", "id": "100000000000000000009148", "answers": [{"text": "5 days and isolate from others in your home. Most people with COVID-19 have mild illness and can recover at home without medical care", "answer_start": 46}], "is_impossible": false}, {"question": "Do not visit public areas and do not go to places where you are unable to wear what?", "id": "100000000000000000009150", "answers": [{"text": "mask", "answer_start": 314}], "is_impossible": false}, {"question": "Get rest and stay hydrated.", "id": "100000000000000000009151", "answers": [{"text": "Take care of yourself", "answer_start": 319}], "is_impossible": false}, {"question": "Take what to help you feel better?", "id": "100000000000000000009152", "answers": [{"text": "over-the-counter medicines", "answer_start": 375}], "is_impossible": false}, {"question": "Stay in touch with what doctor before you get medical care?", "id": "100000000000000000009153", "answers": [{"text": "Call", "answer_start": 483}], "is_impossible": false}, {"question": "What do you need to do before you get medical care?", "id": "100000000000000000009154", "answers": [{"text": "Call", "answer_start": 483}], "is_impossible": false}, {"question": "What is the name of the person who can help you?", "id": "100000000000000000009155", "answers": [{"text": "your doctor", "answer_start": 470}], "is_impossible": false}], "context": "\uf31a Stay home for at least 5 days\nStay home for 5 days and isolate from others in your home. Most people with COVID-19 have mild\nillness and can recover at home without medical care. Do not leave your home, except to get medical\ncare. Do not visit public areas and do not go to places where you are unable to wear a mask\nTake care of yourself. Get rest and stay hydrated. Take over-the-counter medicines, such as\nacetaminophen, to help you feel better. Stay in touch with your doctor. Call before you get medical care."}]}, {"title": "fd329412efe75e0252851dce7cab1378", "paragraphs": [{"qas": [{"question": "What should you do if you have trouble breathing?", "id": "100000000000000000009156", "answers": [{"text": "get care", "answer_start": 11}], "is_impossible": false}, {"question": "Avoid public transportation, ride-sharing, and what else if possible?", "id": "100000000000000000009158", "answers": [{"text": "taxis", "answer_start": 194}], "is_impossible": false}, {"question": "What should you use if possible?", "id": "100000000000000000009160", "answers": [{"text": "a separate bathroom", "answer_start": 542}], "is_impossible": false}, {"question": "What should you do if you have pets in your home?", "id": "100000000000000000009161", "answers": [{"text": "stay in a specific room and away from other people and pets in your home. If possible, you should use a separate bathroom", "answer_start": 440}], "is_impossible": false}, {"question": "If possible, you should use what?", "id": "100000000000000000009162", "answers": [{"text": "a separate bathroom", "answer_start": 542}], "is_impossible": false}], "context": "Be sure to get care if you have trouble\nbreathing, or have any other emergency warning signs, or if you think it is an emergency. Do not travel and avoid public transportation, ride-sharing, or taxis if possible. \u2022\n\u2022\n\u2022\n\u2022\n\uf283 Isolation and Exposure Calculator\nA tool to help you determine if you need to isolate or take other steps to prevent spreading COVID-19. Isolation & Exposure\n\uf3c0 Separate yourself from other people\nAs much as possible, stay in a specific room and away from other people and pets in your home. If possible,\nyou should use a separate bathroom."}]}, {"title": "624014b17abac4096af9ee255e55fbf9", "paragraphs": [{"qas": [{"question": "What should you wear if you need to be around other people or animals?", "id": "100000000000000000009163", "answers": [{"text": "a well-fitting mask", "answer_start": 81}], "is_impossible": false}, {"question": "How long can an infected person spread COVID-19?", "id": "100000000000000000009164", "answers": [{"text": "48 hours", "answer_start": 271}], "is_impossible": false}, {"question": "How long does it take for an infected person to spread COVID-19?", "id": "100000000000000000009165", "answers": [{"text": "48 hours", "answer_start": 271}], "is_impossible": false}, {"question": "How many days does it usually take for a person to have any symptoms or tests positive?", "id": "100000000000000000009166", "answers": [{"text": "2 days", "answer_start": 284}], "is_impossible": false}], "context": "If you need to be around other people or animals in or outside of the\nhome, wear a well-fitting mask. 10/30/22, 9:41 AM What to Do If You Are Sick | CDC\nTell your close contacts that they may have been exposed to COVID-19. An infected person can spread\nCOVID-19 starting 48 hours (or 2 days) before the person has any symptoms or tests positive. By letting your\nclose contacts know they may have been exposed to COVID-19, you are helping to protect everyone. See COVID-19 and Animals if you have questions about pets."}]}, {"title": "6f526486869d858fe1b7fec56f3a2bad", "paragraphs": [{"qas": [{"question": "Who may call you if you are diagnosed with COVID-19?", "id": "100000000000000000009168", "answers": [{"text": "someone from the health department", "answer_start": 36}], "is_impossible": false}, {"question": "What is the purpose of the call?", "id": "100000000000000000009169", "answers": [{"text": "to slow the spread", "answer_start": 101}], "is_impossible": false}, {"question": "How do you monitor your symptoms?", "id": "100000000000000000009170", "answers": [{"text": "\u2022 \uf399", "answer_start": 122}], "is_impossible": false}, {"question": "What may your local health authorities give instructions on checking your symptoms and reporting information?", "id": "100000000000000000009172", "answers": [{"text": "\u2022", "answer_start": 401}], "is_impossible": false}, {"question": "When to seek emergency medical attention Look for what?", "id": "100000000000000000009173", "answers": [{"text": "emergency warning signs", "answer_start": 454}], "is_impossible": false}], "context": "If you are diagnosed with COVID-19, someone from the health department may call you. Answer the\ncall to slow the spread. \u2022\n\u2022\n\uf399 Monitor your symptoms\nSymptoms of COVID-19 include fever, cough, or other symptoms. Follow care instructions from your healthcare provider and local health department. Your local health\nauthorities may give instructions on checking your symptoms and reporting information. \u2022\n\u2022\nWhen to seek emergency medical attention\nLook for emergency warning signs* for COVID-19."}]}, {"title": "7ae209c31f8a880b3dafd4c18c189de1", "paragraphs": [{"qas": [{"question": "What should you do if you have any other symptoms that are severe or concerning to you?", "id": "100000000000000000009177", "answers": [{"text": "call your medical provider", "answer_start": 313}], "is_impossible": false}, {"question": "If you are seeking care for someone who has or may have COVID-19, call 911 or call ahead to what facility?", "id": "100000000000000000009178", "answers": [{"text": "your local emergency facility", "answer_start": 427}], "is_impossible": false}, {"question": "What should you do before visiting your doctor?", "id": "100000000000000000009180", "answers": [{"text": "Call ahead", "answer_start": 558}], "is_impossible": false}], "context": "If someone is showing any of these signs, seek\nemergency medical care immediately:\nTrouble breathing\nPersistent pain or pressure in the chest\nNew confusion\nInability to wake or stay awake\nPale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone\n*This list is not all possible symptoms. Please call your medical provider for any other symptoms that are\nsevere or concerning to you. Call 911 or call ahead to your local emergency facility: Notify the operator that you are seeking care for\nsomeone who has or may have COVID-19. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf33f Call ahead before visiting your doctor\nCall ahead."}]}, {"title": "23c402b8f0d1ad219b664018d6410ee7", "paragraphs": [{"qas": [{"question": "How are many routine care appointments being postponed?", "id": "100000000000000000009181", "answers": [{"text": "by phone or telemedicine", "answer_start": 65}], "is_impossible": false}, {"question": "What should you tell your doctor if you have COVID-19?", "id": "100000000000000000009182", "answers": [{"text": "\u2022", "answer_start": 289}], "is_impossible": false}, {"question": "How will the office protect themselves and other patients?", "id": "100000000000000000009183", "answers": [{"text": "If you have a medical appointment that cannot be postponed, call your doctor\u2019s office, and tell them you have or may have COVID-19", "answer_start": 91}], "is_impossible": false}, {"question": "What does the office protect themselves and other patients?", "id": "100000000000000000009184", "answers": [{"text": "\u2022 \u2022", "answer_start": 288}], "is_impossible": false}, {"question": "What should you wear if you must be around other people or animals, including pets?", "id": "100000000000000000009185", "answers": [{"text": "a mask", "answer_start": 352}], "is_impossible": false}], "context": "Many medical visits for routine care are being postponed or done by phone or telemedicine. If you have a medical appointment that cannot be postponed, call your doctor\u2019s office, and tell them you\nhave or may have COVID-19. This will help the office protect themselves and other patients. \u2022\n\u2022\n\uf309 If you are sick, wear a well-fitting mask\nYou should wear a mask if you must be around other people or animals, including pets (even at home). Wear a mask with the best fit, protection, and comfort for you. You don\u2019t need to wear the mask if you are alone."}]}, {"title": "c2a03ff81cc2ef3c35a191b3d8833ace", "paragraphs": [{"qas": [{"question": "How far away from other people should you stay?", "id": "100000000000000000009188", "answers": [{"text": "6 feet", "answer_start": 142}], "is_impossible": false}, {"question": "What should not be placed on young children under 2 years?", "id": "100000000000000000009190", "answers": [{"text": "Masks", "answer_start": 219}], "is_impossible": false}], "context": "If you can\u2019t put on a mask (because of trouble\nbreathing, for example), cover your coughs and sneezes in some other way. Try to stay at least 6 feet\naway from other people. This will help protect the people around you. Masks should not be placed on young children under age 2 years, anyone who has trouble breathing, or\nanyone who is not able to remove the mask without help. \u2022\n\u2022\n\u2022\n\u2022\n\uf277 Cover your coughs and sneezes\nCover your mouth and nose with a tissue when you cough or sneeze."}]}, {"title": "8075e5d732f330668cef39c568d54a92", "paragraphs": [{"qas": [{"question": "What should you do if you're sick?", "id": "100000000000000000009192", "answers": [{"text": "Immediately wash your hands with soap and water", "answer_start": 144}], "is_impossible": false}, {"question": "How much alcohol does an alcohol-based hand sanitizer contain?", "id": "100000000000000000009195", "answers": [{"text": "60%", "answer_start": 331}], "is_impossible": false}, {"question": "Wash your hands often for at least how long?", "id": "100000000000000000009196", "answers": [{"text": "20 seconds", "answer_start": 205}], "is_impossible": false}], "context": "Throw away used tissues in a lined trash can\n\u2022\f10/30/22, 9:41 AM What to Do If You Are Sick | CDC\nThrow away used tissues in a lined trash can. Immediately wash your hands with soap and water for at least 20 seconds. If soap and water are not\navailable, clean your hands with an alcohol-based hand sanitizer that contains at least 60% alcohol. \u2022\n\u2022\n\uf304 Clean your hands often\nWash your hands often with soap and water for at least 20 seconds. This is especially important after\nblowing your nose, coughing, or sneezing; going to the bathroom; and before eating or preparing food."}]}, {"title": "fb153dc2238b24df400a80d405bc3125", "paragraphs": [{"qas": [{"question": "What should you use if soap and water are not available?", "id": "100000000000000000009200", "answers": [{"text": "hand sanitizer", "answer_start": 4}], "is_impossible": false}, {"question": "What is the best option if your hands are visibly dirty?", "id": "100000000000000000009202", "answers": [{"text": "Soap and water", "answer_start": 202}], "is_impossible": false}, {"question": "What should you avoid touching with unwashed hands?", "id": "100000000000000000009203", "answers": [{"text": "your eyes, nose, and mouth", "answer_start": 292}], "is_impossible": false}, {"question": "Do not share dishes, drinking glasses, cups, eating utensils, towels, or bedding with other people in your home?", "id": "100000000000000000009204", "answers": [{"text": "\u2022 \u2022 \u2022", "answer_start": 360}], "is_impossible": false}, {"question": "How do you clean the items after using them?", "id": "100000000000000000009205", "answers": [{"text": "soap and water or put in the dishwasher", "answer_start": 571}], "is_impossible": false}], "context": "Use hand sanitizer if soap and water are not available. Use an alcohol-based hand sanitizer with at least\n60% alcohol, covering all surfaces of your hands and rubbing them together until they feel dry. Soap and water are the best option, especially if hands are visibly dirty. Avoid touching your eyes, nose, and mouth with unwashed hands. Handwashing Tips\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf262 Avoid sharing personal household items\nDo not share dishes, drinking glasses, cups, eating utensils, towels, or bedding with other people in your\nhome. Wash these items thoroughly after using them with soap and water or put in the dishwasher."}]}, {"title": "96c66ad20b1bd9a8cd54fbc12fd21d96", "paragraphs": [{"qas": [{"question": "How often should you clean and disinfect high-touch surfaces in your home?", "id": "100000000000000000009206", "answers": [{"text": "regularly", "answer_start": 34}], "is_impossible": false}, {"question": "What is a common way to clean high touch surfaces in a shared space?", "id": "100000000000000000009207", "answers": [{"text": "disinfect", "answer_start": 54}], "is_impossible": false}, {"question": "How should you disinfect items in shared spaces?", "id": "100000000000000000009208", "answers": [{"text": "after each use by the person who is ill", "answer_start": 261}], "is_impossible": false}, {"question": "Who should only clean and disinfect the area around you?", "id": "100000000000000000009209", "answers": [{"text": "a caregiver or other person", "answer_start": 336}], "is_impossible": false}, {"question": "How long should you wear a mask before entering, cleaning, and disinfecting shared spaces?", "id": "100000000000000000009211", "answers": [{"text": "at least several hours", "answer_start": 536}], "is_impossible": false}], "context": "\u2022\n\u2022\n\uf1b8 Clean surfaces in your home regularly\nClean and disinfect high-touch surfaces (for example, doorknobs, tables, handles, light switches, and\ncountertops) in your \u201csick room\u201d and bathroom. In shared spaces, you should clean and disinfect\nsurfaces and items after each use by the person who is ill. If you are sick and cannot clean, a caregiver or other person should only clean and disinfect the area\naround you (such as your bedroom and bathroom) on an as needed basis. Your caregiver/other person\nshould wait as long as possible (at least several hours) and wear a mask before entering, cleaning, and\ndisinfecting shared spaces that you use."}]}, {"title": "da390299092298a09545c175d5415fc", "paragraphs": [{"qas": [{"question": "What do you use to clean and disinfect areas that may have blood, stool, or body fluids on them?", "id": "100000000000000000009212", "answers": [{"text": "household cleaners and disinfectants", "answer_start": 82}], "is_impossible": false}, {"question": "What do many products recommend keeping the surface wet with a disinfectant for?", "id": "100000000000000000009215", "answers": [{"text": "a certain period of time", "answer_start": 482}], "is_impossible": false}], "context": "Clean and disinfect areas that may have blood, stool, or body fluids on them. Use household cleaners and disinfectants. Clean visible dirty surfaces with household cleaners\ncontaining soap or detergent. Then, use a household disinfectant. Use a product from EPA\u2019s List N: Disinfectants for Coronavirus (COVID-19)\nBe sure to follow the instructions on the label to ensure safe and effective use of the product. Many products recommend keeping the surface wet with a disinfectant for a certain period of\ntime (look at \u201ccontact time\u201d on the product label)."}]}, {"title": "53bc5e4a5ffa3004a0d8d9989802959a", "paragraphs": [{"qas": [{"question": "What type of protective equipment may you need to wear?", "id": "100000000000000000009216", "answers": [{"text": "personal protective equipment, such as gloves", "answer_start": 26}], "is_impossible": false}, {"question": "How long should you wash your hands after disinfecting?", "id": "100000000000000000009217", "answers": [{"text": "20 seconds", "answer_start": 195}], "is_impossible": false}, {"question": "What is the term for air flow in your home?", "id": "100000000000000000009219", "answers": [{"text": "ventilation", "answer_start": 277}], "is_impossible": false}, {"question": "How do you clear out COVID-19 virus particles in the air?", "id": "100000000000000000009221", "answers": [{"text": "by opening windows, using air filters, and turning on fans", "answer_start": 429}], "is_impossible": false}, {"question": "What is a tool to learn how to improve air flow in your home?", "id": "100000000000000000009222", "answers": [{"text": "interactive", "answer_start": 511}], "is_impossible": false}], "context": "You may also need to wear personal protective equipment, such as gloves, depending on the\ndirections on the product label. Immediately after disinfecting, wash your hands with soap and water for 20 seconds. \u2022\n\u2022\n\u2022\n\u2022\n- \u2022 \uf209\n\u2022\n\u2022\n\u2022\nTake steps to improve ventilation at home\nImprove ventilation (air flow) at home to help prevent from spreading COVID-19 to other people in your\nhousehold. Clear out COVID-19 virus particles in the air by opening windows, using air filters, and turning on fans in\nyour home. Use this interactive tool to learn how to improve air flow in your home."}]}, {"title": "c6b31849f0c1d74de6e8a263521ba262", "paragraphs": [{"qas": [{"question": "What is different for different situations after being sick with COVID-19?", "id": "100000000000000000009223", "answers": [{"text": "Deciding when you can be around others", "answer_start": 69}], "is_impossible": false}, {"question": "What can safely end home isolation?", "id": "100000000000000000009224", "answers": [{"text": "\u2022 \u2022 \uf318 When you can be around others after being sick with COVID-19 Deciding when you can be around others is different for different situations. Find out when you can safely end home isolation\f10/30/22, 9:41 AM What to Do If You Are Sick", "answer_start": 1}], "is_impossible": false}, {"question": "Who can you contact for questions about your care?", "id": "100000000000000000009226", "answers": [{"text": "your healthcare provider or state or local health department", "answer_start": 320}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\uf318 When you can be around others after being sick with COVID-19\nDeciding when you can be around others is different for different situations. Find out when you can safely\nend home isolation\f10/30/22, 9:41 AM What to Do If You Are Sick | CDC\nend home isolation. For any additional questions about your care, contact your healthcare provider or state or local health department."}]}, {"title": "a43e02e6a6e00207823f7e1f7ab9a446", "paragraphs": [{"qas": [{"question": "What is the length of the video?", "id": "100000000000000000009227", "answers": [{"text": "00:01:32", "answer_start": 100}], "is_impossible": false}, {"question": "How many KB, 1 page is in Don't delay?", "id": "100000000000000000009230", "answers": [{"text": "361", "answer_start": 270}], "is_impossible": false}], "context": "Video and Print Resources\nWatch Video\n10 Things You Can Do to Manage\nCOVID-19 at Home\nVideo Length: 00:01:32\n[PDF - 484 KB, 1 page]\n10 Things You Can Do to Manage\nYour COVID-19 Symptoms at\nHome\nFile Details: 484 KB, 1 page\nView PDF in English\nOther Languages\n\uf20c\n\uf20c\n[PDF - 361 KB, 1 page]\nDon\u2019t Delay: Test Soon and Treat\nEarly\nFile Details: 361 KB, 1 page\nView PDF in English\nAdditional Languages\n\uf20c\n\uf20c\nMore Information\nTravelers\nSpecific Groups of People\nPeople Who Are Sick\nHealthcare Professionals\nHealth Departments\nLaboratories\nLast Updated Mar. 22, 2022"}]}, {"title": "af0579d5016a237e369b3168cb73eb19", "paragraphs": [{"qas": [{"question": "What should you do if you have tested positive for COVID-19?", "id": "100000000000000000009231", "answers": [{"text": "isolate immediately", "answer_start": 233}], "is_impossible": false}, {"question": "What is the Isolation and Exposure Calculator?", "id": "100000000000000000009232", "answers": [{"text": "A tool to help you determine if you need to isolate or take other steps to prevent spreading COVID-19", "answer_start": 290}], "is_impossible": false}], "context": "10/30/22, 9:41 AM What to Do If You Were Exposed to COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nWhat to Do If You Were Exposed to COVID-19\nAbout Being Exposed to COVID-19\nIf you have tested positive or are showing symptoms of COVID-19, isolate immediately. \uf283 Isolation and Exposure Calculator\nA tool to help you determine if you need to isolate or take other steps to prevent spreading COVID-19."}]}, {"title": "3261f15f153fe2a588816136afdea97d", "paragraphs": [{"qas": [{"question": "What is the name of the virus that causes COVID-19?", "id": "100000000000000000009234", "answers": [{"text": "exposed to the virus", "answer_start": 33}], "is_impossible": false}, {"question": "Who told you that you were exposed to the virus?", "id": "100000000000000000009235", "answers": [{"text": "a healthcare provider or public health authority", "answer_start": 96}], "is_impossible": false}, {"question": "What should you do if you have had a previous infection?", "id": "100000000000000000009236", "answers": [{"text": "exposed to the virus that causes COVID-19 or have been told by a healthcare provider or public health authority that you were exposed, here are the steps", "answer_start": 33}], "is_impossible": false}, {"question": "How does COVID-19 spread?", "id": "100000000000000000009237", "answers": [{"text": "risk of spread higher or lower", "answer_start": 341}], "is_impossible": false}, {"question": "What are the factors that make risk of spread higher or lower?", "id": "100000000000000000009238", "answers": [{"text": "how COVID-19 spreads", "answer_start": 294}], "is_impossible": false}], "context": "Isolation & Exposure\nIf you were exposed to the virus that causes COVID-19 or have been told by a healthcare provider or public health authority\nthat you were exposed, here are the steps that you should take, regardless of your vaccination status or if you have had a\nprevious infection. Learn how COVID-19 spreads and the factors that make risk of spread higher or lower."}]}, {"title": "f9ef0bb91da748378cff444f80b58a58", "paragraphs": [{"qas": [{"question": "What should you wear immediately after you find out you were exposed to COVID-19?", "id": "100000000000000000009239", "answers": [{"text": "a mask", "answer_start": 69}], "is_impossible": false}, {"question": "What day is the day of your last exposure to someone with COV19?", "id": "100000000000000000009240", "answers": [{"text": "Day 0", "answer_start": 143}], "is_impossible": false}, {"question": "Day 1 is the first full day after what?", "id": "100000000000000000009241", "answers": [{"text": "your last exposure", "answer_start": 241}], "is_impossible": false}, {"question": "How many full days can you still continue precautions?", "id": "100000000000000000009242", "answers": [{"text": "10", "answer_start": 287}], "is_impossible": false}, {"question": "What can you still develop after you have been exposed to COVID-19?", "id": "100000000000000000009243", "answers": [{"text": "up to 10 days", "answer_start": 331}], "is_impossible": false}, {"question": "What are symptoms of fever?", "id": "100000000000000000009244", "answers": [{"text": "100.4\u00b0F or greater", "answer_start": 416}], "is_impossible": false}, {"question": "Who recommends wearing a mask or respirator?", "id": "100000000000000000009246", "answers": [{"text": "any time you are around others inside your home or indoors in public", "answer_start": 562}], "is_impossible": false}, {"question": "What is the name of a respirator that should be worn when you're outside?", "id": "100000000000000000009248", "answers": [{"text": "N95", "answer_start": 557}], "is_impossible": false}], "context": "After Being Exposed to COVID-19\n\uf285 START PRECAUTIONS\nImmediately\nWear a mask as soon as you find out you were exposed\nStart counting from Day 1\nDay 0 is the day of your last exposure to someone with COVID-19\nDay 1 is the first full day after your last exposure\n\u2022\n\u2022\n\uf309 CONTINUE PRECAUTIONS\n10 Full Days\nYou can still develop COVID-19 up to 10 days after you have been exposed\nTake Precautions Watch for symptoms\nfever (100.4\u00b0F or greater)\ncough\n\u2022\f10/30/22, 9:41 AM What to Do If You Were Exposed to COVID-19 | CDC\nWear a high-quality mask or respirator (e.g., N95) any\ntime you are around others inside your home or indoors\nin public\nDo not go places where you are unable to wear a\nmask."}]}, {"title": "4839977b0e4457e4f6e3f3970e75b5b3", "paragraphs": [{"qas": [{"question": "What is CDC\u2019s Travel webpage?", "id": "100000000000000000009249", "answers": [{"text": "travel guidance", "answer_start": 4}], "is_impossible": false}, {"question": "What are people who are more likely to get very sick from COVID-19?", "id": "100000000000000000009250", "answers": [{"text": "\u2022 \u2022 \u2022", "answer_start": 416}], "is_impossible": false}, {"question": "What should you do if your test result is positive?", "id": "100000000000000000009252", "answers": [{"text": "follow the isolation recommendations", "answer_start": 375}], "is_impossible": false}, {"question": "How long after your last exposure should you get tested?", "id": "100000000000000000009253", "answers": [{"text": "5 full days", "answer_start": 458}], "is_impossible": false}], "context": "For travel guidance, see CDC\u2019s Travel\nwebpage. Take extra precautions if you will be around people who\nare more likely to get very sick from COVID-19. More about how to protect yourself and others\n\u2022\n\uf426\ncough\nshortness of breath\nother COVID-19 symptoms\nIf you develop symptoms\nisolate immediately\nget tested\nstay home until you know the result\nIf your test result is positive, follow the isolation\nrecommendations. \u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\uf3c0 GET TESTED\nGet tested at least 5 full days after your last exposure\nTest even if you don\u2019t develop symptoms. If you already had COVID-19 within the past 90 days, see specific testing recommendations."}]}, {"title": "6c5a7c370bb262832218829b3fcb0dc1", "paragraphs": [{"qas": [{"question": "How long can you be able to develop COVID-19?", "id": "100000000000000000009255", "answers": [{"text": "up to 10 days", "answer_start": 168}], "is_impossible": false}, {"question": "What should you do if you test negative?", "id": "100000000000000000009256", "answers": [{"text": "Continue taking precautions", "answer_start": 23}], "is_impossible": false}, {"question": "What does the Food and Drug Administration label for authorized over-the-counter antigen tests?", "id": "100000000000000000009257", "answers": [{"text": "negative test results do not rule out SARS-CoV-2 infection", "answer_start": 386}], "is_impossible": false}, {"question": "Negative test results do not rule out what?", "id": "100000000000000000009258", "answers": [{"text": "SARS-CoV-2 infection", "answer_start": 424}], "is_impossible": false}, {"question": "What is recommended for children under 2 years and younger or for people with some disabilities?", "id": "100000000000000000009260", "answers": [{"text": "Masks", "answer_start": 572}], "is_impossible": false}], "context": "\uf6eb IF YOU TEST\nNegative\nContinue taking precautions through day\nWear a high-quality mask when\naround others at home and indoors\nin public\nYou can still develop COVID-19 up to 10\ndays after you have been exposed. \u2022\n\uf6ec IF YOU TEST\nPositive\nIsolate immediately\n*About negative test results\nAs noted in the Food and Drug Administration labeling for authorized over-the-counter antigen tests, negative test results do\nnot rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions,\nincluding infection control decisions. Masks are not recommended for children under ages 2 years and younger, or for people with some disabilities."}]}, {"title": "3e861300b3accf28bde928dd491af717", "paragraphs": [{"qas": [{"question": "What should be used to avoid transmission during these 10 days?", "id": "100000000000000000009261", "answers": [{"text": "improving ventilation", "answer_start": 34}], "is_impossible": false}], "context": "Other prevention actions (such\nas improving ventilation) should be used to avoid transmission during these 10 days. Last Updated Aug. 24, 2022"}]}, {"title": "9a9919ab5c560e670d89f7b3702c0db1", "paragraphs": [{"qas": [{"question": "What can COVID-19 make children and teens of any age very sick?", "id": "100000000000000000009263", "answers": [{"text": "CDC Espa\u00f1ol | Other Languages Why Children and Teens Should Get Vaccinated Against What You Need to Know COVID-19 can make children and teens of any age very sick and can sometimes require treatment in a hospital", "answer_start": 82}], "is_impossible": false}, {"question": "What can sometimes require treatment in a hospital?", "id": "100000000000000000009264", "answers": [{"text": "COVID-19", "answer_start": 187}], "is_impossible": false}, {"question": "Some children and teens have even died from what?", "id": "100000000000000000009265", "answers": [{"text": "COVID-19 can make children and teens of any age very sick and can sometimes require treatment in a hospital. Some children and teens have even died from COVID-19", "answer_start": 187}], "is_impossible": false}, {"question": "What benefit of COVID-19 vaccines is that those vaccinated get protection without risking the potentially serious consequences of getting sick?", "id": "100000000000000000009266", "answers": [{"text": "The benefit of COVID-19 vaccines, like other vaccines", "answer_start": 350}], "is_impossible": false}, {"question": "How do you protect children from severe disease, hospitalization, or death by getting them vaccinated against COVID-19?", "id": "100000000000000000009267", "answers": [{"text": "Help", "answer_start": 529}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Why Children and Teens Should Get Vaccinated Against COVID-19 | CDC\nEspa\u00f1ol | Other Languages\nWhy Children and Teens Should Get Vaccinated Against\nWhat You Need to Know\nCOVID-19 can make children and teens of any age very sick and can sometimes require treatment in a hospital. Some children and teens have even died from COVID-19. The benefit of COVID-19 vaccines, like other vaccines, is that those vaccinated get protection without risking the\npotentially serious consequences of getting sick with COVID-19. Help protect children from severe disease, hospitalization, or death by getting them vaccinated against COVID-19."}]}, {"title": "a4a772ad1e01962840e2a88de88f8e5b", "paragraphs": [{"qas": [{"question": "What is an important tool to help protect everyone 6 months and older from COVID-19 and its complications?", "id": "100000000000000000009268", "answers": [{"text": "COVID-19 vaccination", "answer_start": 30}], "is_impossible": false}, {"question": "What can help keep them from getting really sick if they do get COVID-19?", "id": "100000000000000000009269", "answers": [{"text": "Getting children and teens vaccinated against COVID-19", "answer_start": 153}], "is_impossible": false}, {"question": "What can help relieve the strain on families by providing greater confidence in children participating in childcare, school, and other activities?", "id": "100000000000000000009270", "answers": [{"text": "Vaccinating children", "answer_start": 277}], "is_impossible": false}, {"question": "Follow all current prevention measures recommended by CDC and based on latest COVID-19 Community Level data?", "id": "100000000000000000009271", "answers": [{"text": "\u2022", "answer_start": 1}], "is_impossible": false}, {"question": "What is COVID-19 Community Level data?", "id": "100000000000000000009272", "answers": [{"text": "latest", "answer_start": 547}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\nHelp Protect Your Child\nCOVID-19 vaccination is an important tool to help protect everyone 6 months and older from COVID-19 and its complications. Getting children and teens vaccinated against COVID-19 can help keep them from getting really sick if they do get COVID-19. Vaccinating children can also help relieve the strain on families by providing greater confidence in children participating in\nchildcare, school, and other activities. After vaccination, continue to follow all current prevention measures recommended by CDC and based on latest COVID-\n19 Community Level data. Learn more about\u202fprotecting your family from COVID-19."}]}, {"title": "394be57f78697202f69f02cb69df3254", "paragraphs": [{"qas": [{"question": "What can children and teens get very sick from COVID-19?", "id": "100000000000000000009274", "answers": [{"text": "Have both short- and long-term health problems", "answer_start": 123}], "is_impossible": false}, {"question": "What can kids and teens of all ages get sick from?", "id": "100000000000000000009275", "answers": [{"text": "COVID-19", "answer_start": 114}], "is_impossible": false}, {"question": "Who is not able to tell in advance how children or teenagers will be affected by the disease?", "id": "100000000000000000009277", "answers": [{"text": "Those with underlying medical conditions or who have a weakened immune system", "answer_start": 283}], "is_impossible": false}, {"question": "Who is more likely to get severely ill from COVID-19?", "id": "100000000000000000009278", "answers": [{"text": "Those with underlying medical conditions or who have a weakened immune system", "answer_start": 283}], "is_impossible": false}, {"question": "Who has underlying medical conditions or a weakened immune system?", "id": "100000000000000000009279", "answers": [{"text": "Those with underlying medical conditions", "answer_start": 283}], "is_impossible": false}], "context": "Impact of COVID-19 in Children and Teens\nJust like adults, children and teens of all ages can:\nGet very sick from COVID-19\nHave both short- and long-term health problems\nSpread COVID-19 to others\nThere is no way to tell in advance how children or teens will be affected by COVID-19. Those with underlying medical\nconditions or who have a weakened immune system are more likely to get severely ill from COVID-19."}]}, {"title": "ce624d2a8a477c2ffa863490f4d56d0c", "paragraphs": [{"qas": [{"question": "What can happen to those without underlying medical conditions?", "id": "100000000000000000009281", "answers": [{"text": "severe illness and be hospitalized", "answer_start": 336}], "is_impossible": false}, {"question": "How many children younger than 18 years old hospitalized with COVID-19 have no underlying conditions?", "id": "100000000000000000009282", "answers": [{"text": "1 in 3", "answer_start": 395}], "is_impossible": false}, {"question": "Where is the data about risk factors for severe COVID-19 in children published?", "id": "100000000000000000009284", "answers": [{"text": "Pediatrics", "answer_start": 573}], "is_impossible": false}, {"question": "What is the name of the publication that publishes weekly summaries of COVID-19 hospitalization data?", "id": "100000000000000000009285", "answers": [{"text": "COVID-NET", "answer_start": 710}], "is_impossible": false}], "context": "Some examples of\nconditions that can make children more likely to get severe COVID-19 include:\nAsthma or chronic lung disease\nDiabetes\nObesity\nSickle cell disease\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\f10/30/22, 9:34 AM Why Children and Teens Should Get Vaccinated Against COVID-19 | CDC\nHowever, those without underlying medical conditions can also experience severe illness and be hospitalized. In fact,\napproximately 1 in 3 children younger than 18 years old hospitalized with COVID-19 have no underlying conditions. Read the data about risk factors for severe COVID-19 in children published in Pediatrics, childhood COVID-19-related\nhospitalizations published in MMWR, and weekly summaries of COVID-19 hospitalization data through COVID-NET."}]}, {"title": "cf28268da492e4412c7b6749b26d1e14", "paragraphs": [{"qas": [{"question": "What does MIS-C stand for?", "id": "100000000000000000009286", "answers": [{"text": "multisystem inflammatory syndrome in children", "answer_start": 186}], "is_impossible": false}, {"question": "What is the name of the condition in which different body parts become inflamed?", "id": "100000000000000000009287", "answers": [{"text": "MIS-C", "answer_start": 241}], "is_impossible": false}, {"question": "When did COVID-19 cause multisystem inflammatory syndrome in children?", "id": "100000000000000000009288", "answers": [{"text": "children", "answer_start": 222}], "is_impossible": false}, {"question": "How many cases of MIS-C have been reported since the beginning of the pandemic?", "id": "100000000000000000009289", "answers": [{"text": "thousands", "answer_start": 427}], "is_impossible": false}, {"question": "What age group are most frequently affected by MIS -C?", "id": "100000000000000000009290", "answers": [{"text": "Children ages 5 through 11 years", "answer_start": 475}], "is_impossible": false}], "context": "\uf209\nVaccination Helps Prevent Multisystem Inflammatory Syndrome\nin Children (MIS-C) Associated with COVID-19\nChildren and teens who get COVID-19 can develop serious complications, such as multisystem inflammatory syndrome in\nchildren (MIS-C). MIS-C is a condition where different body parts become inflamed, including the heart, lungs, kidneys, brain,\nskin, eyes, or gastrointestinal organs. Since the beginning of the pandemic, thousands of cases of MIS-C have been reported. Children ages 5 through 11 years are\nmost frequently affected by MIS-C, with almost half of all reported cases occurring in children in this age group."}]}, {"title": "eb447d35f14e501a49b130d0944f89cf", "paragraphs": [{"qas": [{"question": "Who are disproportionately affected by MIS-C?", "id": "100000000000000000009292", "answers": [{"text": "Hispanic or Latino and non-Hispanic Black children", "answer_start": 12}], "is_impossible": false}, {"question": "How much did COVID-19 vaccination reduce the likelihood of msc in children ages 12 to 18 years?", "id": "100000000000000000009293", "answers": [{"text": "91%.", "answer_start": 199}], "is_impossible": false}, {"question": "What percentage of children hospitalized with mSc were not vaccinated from July to December 2021?", "id": "100000000000000000009294", "answers": [{"text": "95%", "answer_start": 246}], "is_impossible": false}], "context": "In addition,\nHispanic or Latino and non-Hispanic Black children are disproportionately affected by MIS-C.\nCOVID-19 vaccination reduced the likelihood of MIS-C in children ages 12 through 18 years by 91%. Data from July to\nDecember 2021 show that 95% of children ages 12 through 18 years hospitalized with MIS-C were not vaccinated. CDC is\ncollecting data on how well COVID-19 vaccination works against MIS-C in younger children. As more children under 12\nyears old get vaccinated, CDC will be able to analyze and share those data."}]}, {"title": "23a6591132487e73438bf73c7e6e4987", "paragraphs": [{"qas": [{"question": "What can occur after COVID-19 or MIS-C?", "id": "100000000000000000009299", "answers": [{"text": "physical and mental health complications", "answer_start": 195}], "is_impossible": false}, {"question": "After a severe infection, what is another name for a rash?", "id": "100000000000000000009301", "answers": [{"text": "MIS-C", "answer_start": 366}], "is_impossible": false}], "context": "Children and Teens Can Experience Ongoing Health Problems\nAfter getting COVID-19, children and teens can also experience a wide range of new, returning, or ongoing health problems. These include physical and mental health complications that may occur four or more weeks after initial infection. These\ncomplications can appear after mild or severe COVID-19, or after MIS-C. Symptoms Post COVID-19 Vaccination Symptoms Post COVID-19 Infection\nCough\nMuscle and joint pain\nHeadache\nTrouble falling or staying asleep\nTrouble concentrating\nLimitations in physical activity\nFeeling distressed about symptoms\nMental health challenges\nDecreased school or daycare attendance\nMissed opportunities for participation in sports,\nplaydates, or other activities\nLearn more about post-COVID conditions."}]}, {"title": "4a8b06ce80902ea67228b46eb9bd9b5a", "paragraphs": [{"qas": [{"question": "Who should still get vaccinated after having been infected with the virus that causes COVID-19?", "id": "100000000000000000009303", "answers": [{"text": "Children and Teens", "answer_start": 20}], "is_impossible": false}, {"question": "How long can a child's next dose be delayed?", "id": "100000000000000000009305", "answers": [{"text": "3 months", "answer_start": 406}], "is_impossible": false}], "context": "\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\n\u2022\nChildren and Teens Who Have Already Had COVID-19 Should Still\nGet Vaccinated\nOngoing study of data show evidence that people can get added protection by getting vaccinated after having been infected\nwith the virus that causes COVID-19. Even if a child has had COVID-19, they should still get vaccinated. For children who have\nbeen infected with COVID-19, their next dose can be delayed 3 months from when symptoms started or, if they did not have\nsymptoms, when they received a positive test. This possible delay can happen with a primary dose or a booster dose."}]}, {"title": "876d3bc711fc1d0a83c3db40bb94d881", "paragraphs": [{"qas": [{"question": "Read the science about immunity from what infection and vaccination?", "id": "100000000000000000009308", "answers": [{"text": "COVID-19", "answer_start": 123}], "is_impossible": false}, {"question": "Who should be vaccinated against COVID-19?", "id": "100000000000000000009309", "answers": [{"text": "Children and Teens", "answer_start": 22}], "is_impossible": false}, {"question": "When was the last update of the COVID-19 Vaccine Recommendations?", "id": "100000000000000000009310", "answers": [{"text": "July 21, 2022", "answer_start": 439}], "is_impossible": false}], "context": "10/30/22, 9:34 AM Why Children and Teens Should Get Vaccinated Against COVID-19 | CDC\nRead the science about immunity from COVID-19 infection and vaccination. Related Pages\n6 Things to Know About COVID-19 Vaccination for Children\n\u203a\nFrequently Asked Questions about COVID-19 Vaccination for Children and Teens\n\u203a\nGetting Children and Teens Vaccinated Against COVID-19\n\u203a\nCOVID-19 Vaccine Recommendations for Children and Teens\n\u203a\nLast Updated July 21, 2022"}]}, {"title": "6f7d0911851c531ce0cdec89401c204d", "paragraphs": [{"qas": [{"question": "What does this checklist help patients and caregivers get the most out of?", "id": "100000000000000000009312", "answers": [{"text": "appointments with healthcare providers", "answer_start": 262}], "is_impossible": false}, {"question": "Who needs paperwork signed before the appointment?", "id": "100000000000000000009313", "answers": [{"text": "Ask the new provider\u2019s office", "answer_start": 352}], "is_impossible": false}, {"question": "What is signed so your medical records can be sent to them directly?", "id": "100000000000000000009314", "answers": [{"text": "paperwork", "answer_start": 395}], "is_impossible": false}, {"question": "Keep a journal or a list for a week or two to document your activities, symptoms, and what?", "id": "100000000000000000009315", "answers": [{"text": "their severity", "answer_start": 548}], "is_impossible": false}, {"question": "What do you describe your best and worst days?", "id": "100000000000000000009317", "answers": [{"text": "Prepare a brief report", "answer_start": 613}], "is_impossible": false}, {"question": "Make a list of what?", "id": "100000000000000000009318", "answers": [{"text": "your current medications/supplements", "answer_start": 736}], "is_impossible": false}], "context": "Healthcare Appointment Checklist for Post-COVID\nConditions | COVID-19 |\nAccessible link: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/post-COVID-appointment/index.html\nThis checklist is designed to help patients and caregivers get the most out of appointments with healthcare providers for post-COVID conditions. Before the Appointment\n\nAsk the new provider\u2019s office if they\nneed paperwork signed so your medical\nrecords can be sent to\nthem directly. Keep a journal or a list for a week\nor two to document your activities,\nsymptoms, their severity, and anything\nthat made you feel better or worse. Prepare a brief report that summarizes\nyour experience and symptoms and\ndescribes your best and worst days. Make a list of your current\nmedications/supplements."}]}, {"title": "e522cbbbfade3e21d6f3e0530fbe1dc6", "paragraphs": [{"qas": [{"question": "What do you make a list of to ask your healthcare provider?", "id": "100000000000000000009319", "answers": [{"text": "questions", "answer_start": 15}], "is_impossible": false}, {"question": "What is a priority for you in case time is limited?", "id": "100000000000000000009320", "answers": [{"text": "ones", "answer_start": 72}], "is_impossible": false}, {"question": "How do you remember your conversation with your healthcare professional?", "id": "100000000000000000009321", "answers": [{"text": "taking notes or bringing a friend", "answer_start": 212}], "is_impossible": false}, {"question": "Who can you bring to your appointment?", "id": "100000000000000000009322", "answers": [{"text": "a friend", "answer_start": 237}], "is_impossible": false}, {"question": "What are the most important symptoms or issues you'd like to discuss?", "id": "100000000000000000009323", "answers": [{"text": "Tell your provider", "answer_start": 326}], "is_impossible": false}, {"question": "How do you discuss your level of activity?", "id": "100000000000000000009325", "answers": [{"text": "Share your medication/supplement list. Discuss your level of activity. Ask your own questions", "answer_start": 439}], "is_impossible": false}, {"question": "What are some of the next steps to follow-up?", "id": "100000000000000000009326", "answers": [{"text": "tests, follow-up, referrals, and future appointments", "answer_start": 625}], "is_impossible": false}, {"question": "What do you ask for?", "id": "100000000000000000009327", "answers": [{"text": "an appointment summary", "answer_start": 687}], "is_impossible": false}], "context": "Make a list of questions to ask your\nhealthcare provider. Identify which\nones are a priority for you (in case\ntime is limited). Make a plan for remembering your\nconversation with your healthcare\nprovider \u2014 e.g., taking notes or\nbringing a friend. If needed, arrange transportation to\nyour appointment. During the Appointment\n\nTell your provider the most important\nsymptoms or issues you\u2019d like\nto discuss. Answer the provider\u2019s questions. Share your medication/supplement list. Discuss your level of activity. Ask your own questions, starting with\nyour priorities and issues. Make sure you understand the\nnext steps, such as tests, follow-up,\nreferrals, and future appointments. Ask for an appointment summary."}]}, {"title": "440a14df37910f5343b695ce454f9ee0", "paragraphs": [{"qas": [{"question": "What should you ask the provider to write down or print out?", "id": "100000000000000000009328", "answers": [{"text": "any instructions, medication names, or diagnoses", "answer_start": 55}], "is_impossible": false}, {"question": "What should the provider do after the appointment?", "id": "100000000000000000009329", "answers": [{"text": "Make appointments for follow up", "answer_start": 128}], "is_impossible": false}, {"question": "What is on your provider's calendar?", "id": "100000000000000000009331", "answers": [{"text": "Record future appointments", "answer_start": 161}], "is_impossible": false}], "context": "If\nneeded, ask the provider to write down\nor print out any instructions, medication\nnames, or diagnoses. After the Appointment\n\nMake appointments for follow up. Record future appointments,\nincluding tests, in your calendar. If\nothers will go with you or drive you to\nfuture appointments, make sure the\nappointments are on their calendars too. Follow your provider\u2019s instructions to\nthe best of your ability. Contact your provider\u2019s office with any\nquestions or clarifications. Continue to record symptoms and\nkeep your journal, so you can refer\nto updates or changes during your\nnext appointment. Update and keep track of medications\nand supplements. For more information on post-COVID conditions, please visit\nhttps://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html."}]}, {"title": "97a3ad9986328c9c323e4ba3f251cb18", "paragraphs": [{"qas": [{"question": "What is SPIKEVAX?", "id": "100000000000000000009335", "answers": [{"text": "COVID-19 VACCINE, mRNA", "answer_start": 77}], "is_impossible": false}, {"question": "What is MODERNA COVID-19 VACCINE, BIVALENT?", "id": "100000000000000000009336", "answers": [{"text": "ORIGINAL AND OMICRON", "answer_start": 168}], "is_impossible": false}, {"question": "What is the purpose of Moderna COVID-19 Vaccine, Bivalent?", "id": "100000000000000000009337", "answers": [{"text": "to prevent Coronavirus Disease 2019", "answer_start": 455}], "is_impossible": false}, {"question": "What is Coronavirus Disease 2019 caused by?", "id": "100000000000000000009338", "answers": [{"text": "SARS-CoV-2", "answer_start": 512}], "is_impossible": false}], "context": "VACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND\nCAREGIVERS\nABOUT SPIKEVAX (COVID-19 VACCINE, mRNA), MODERNA COVID-19 VACCINE,\nAND MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON\nFOR 6 YEARS OF AGE AND OLDER\nYou or your child are being offered either SPIKEVAX (COVID-19 Vaccine, mRNA),\nModerna COVID-19 Vaccine, or Moderna COVID-19 Vaccine, Bivalent (Original and\nOmicron BA.4/BA.5), hereafter referred to as Moderna COVID-19 Vaccine, Bivalent, to\nprevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2."}]}, {"title": "ceefe54fcc480ebe53e3ca4ba72c2ab1", "paragraphs": [{"qas": [{"question": "What does SPIKEVAX stand for?", "id": "100000000000000000009340", "answers": [{"text": "FDA-licensed vaccine", "answer_start": 278}], "is_impossible": false}, {"question": "Which two vaccines can be used interchangeably?", "id": "100000000000000000009344", "answers": [{"text": "SPIKEVAX (COVID-19 Vaccine, mRNA) and the Moderna COVID- 19 Vaccine authorized for Emergency Use Authorization (EUA)", "answer_start": 402}], "is_impossible": false}, {"question": "What is SPIKEVAX?", "id": "100000000000000000009346", "answers": [{"text": "an FDA-approved COVID-19 vaccine", "answer_start": 690}], "is_impossible": false}, {"question": "What is the name of the vaccine made by ModernaTX, Inc.?", "id": "100000000000000000009347", "answers": [{"text": "SPIKEVAX", "answer_start": 653}], "is_impossible": false}], "context": "This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact\nSheet for the authorized Moderna COVID-19 Vaccine and the authorized Moderna\nCOVID-19 Vaccine, Bivalent for use in individuals 6 years of age and older, and also\nincludes information about the FDA-licensed vaccine, SPIKEVAX (COVID-19 Vaccine,\nmRNA) for use in individuals 12 years of age and older.1\nThe FDA-approved SPIKEVAX (COVID-19 Vaccine, mRNA) and the Moderna COVID-\n19 Vaccine authorized for Emergency Use Authorization (EUA) for individuals 12 years of\nage and older can be used interchangeably, when used according to their respective\ninstructions for use.2\nSPIKEVAX (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made\nby ModernaTX, Inc."}]}, {"title": "c0cc9c53df437da8b64cb626ec076ba5", "paragraphs": [{"qas": [{"question": "What is the purpose of the two-dose series?", "id": "100000000000000000009349", "answers": [{"text": "prevention of COVID-19", "answer_start": 40}], "is_impossible": false}], "context": "It is approved as a two-dose series for prevention of COVID-19 in\nindividuals 18 years of age and older. It is also authorized under EUA to provide:\n\u2022 a two-dose primary series to individuals 12 years through 17 years of age; and\n\u2022 a third primary series dose to individuals 12 years of age and older who have been\ndetermined to have certain kinds of immunocompromise. 1 You may receive this Fact Sheet even if your child is 5 years old."}]}, {"title": "4fdbda72fca4a2ffff9ab66c32d5c4b5", "paragraphs": [{"qas": [{"question": "What is SPIKEVAX?", "id": "100000000000000000009356", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 359}], "is_impossible": false}], "context": "Children who will turn from 11 years to 12 years of age between doses in the primary series may receive, for any\ndose in the primary series, either: (1) the Moderna COVID-19 Vaccine authorized for use in individuals 6 years\nthrough 11 years of age; or (2) Moderna COVID-19 Vaccine authorized for use in individuals 12 years of age and\nolder; or (3) SPIKEVAX (COVID-19 Vaccine, mRNA)."}]}, {"title": "7fa4ec28ee947be14736e651b62630df", "paragraphs": [{"qas": [{"question": "What is SPIKEVAX?", "id": "100000000000000000009358", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 25}], "is_impossible": false}, {"question": "How long does it take to administer the dose of the vaccine to people 6 years and older with immunocompromise?", "id": "100000000000000000009362", "answers": [{"text": "third", "answer_start": 481}], "is_impossible": false}], "context": "2 FDA-approved SPIKEVAX (COVID-19 Vaccine, mRNA) and one presentation of the EUA-authorized Moderna\nCOVID-19 Vaccine (supplied in vials with red caps and labels with a light blue border) can be used interchangeably\nfor the primary series for individuals 12 years of age and older without presenting any safety or effectiveness\nconcerns. The Moderna COVID-19 Vaccine has received EUA from FDA to provide:\n\u2022 a two-dose primary series to individuals 6 years of age and older; and\n\u2022 a third primary series dose to individuals 6 years of age and older with certain kinds\nof immunocompromise."}]}, {"title": "201fd7fa71880da87f9e1fdde77e9ef0", "paragraphs": [{"qas": [{"question": "What does Moderna COVID-19 Vaccine, Bivalent receive from FDA?", "id": "100000000000000000009363", "answers": [{"text": "EUA", "answer_start": 48}], "is_impossible": false}, {"question": "How long after completion of primary vaccination is a single booster dose given to individuals 6 years of age and older?", "id": "100000000000000000009364", "answers": [{"text": "2 months", "answer_start": 153}], "is_impossible": false}, {"question": "How long after receiving the most recent booster dose is a single booster dose given to individuals 6 years of age and older?", "id": "100000000000000000009365", "answers": [{"text": "2 months", "answer_start": 340}], "is_impossible": false}], "context": "Moderna COVID-19 Vaccine, Bivalent has received EUA from FDA to provide either:\n\u2022 a single booster dose to individuals 6 years of age and older at least 2 months after\ncompletion of primary vaccination with any authorized or approved monovalent3\nCOVID-19 vaccine; or\n\u2022 a single booster dose to individuals 6 years of age and older at least 2 months after\nreceipt of the most recent booster dose with any authorized or approved monovalent\nCOVID-19 vaccine."}]}, {"title": "2c2c6fc066bcaf84ebeaa3f0705e3ad", "paragraphs": [{"qas": [{"question": "What is SPIKEVAX?", "id": "100000000000000000009366", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 116}], "is_impossible": false}, {"question": "What is Moderna COVID-19 Vaccine?", "id": "100000000000000000009367", "answers": [{"text": "Bivalent", "answer_start": 197}], "is_impossible": false}, {"question": "What is Moderna COVID-19 Vaccine, Bivalent?", "id": "100000000000000000009368", "answers": [{"text": "pandemic of COVID-19", "answer_start": 272}], "is_impossible": false}, {"question": "What do YOU NEED TO KNOW BEFORE YOU OR YOUR CHILD GET THIS VACCINE?", "id": "100000000000000000009370", "answers": [{"text": "COVID-19", "answer_start": 670}], "is_impossible": false}], "context": "This Vaccine Information Fact Sheet contains information to help you understand the risks and\nbenefits of SPIKEVAX (COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, and\nModerna COVID-19 Vaccine, Bivalent, which you or your child may receive because there is\ncurrently a pandemic of COVID-19. Talk to the vaccination provider if you have questions. SPIKEVAX (COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, and Moderna\nCOVID-19 Vaccine, Bivalent may not protect everyone. This Fact Sheet may have been updated. For the most recent Fact Sheet, please visit\nwww.modernatx.com/covid19vaccine-eua. WHAT YOU NEED TO KNOW BEFORE YOU OR YOUR CHILD GET THIS\nVACCINE\nWHAT IS COVID-19?"}]}, {"title": "6f2941ef3cd666aa0e88e0e4e0807b5e", "paragraphs": [{"qas": [{"question": "What is the name of the coronavirus that causes COVID-19?", "id": "100000000000000000009371", "answers": [{"text": "SARS-CoV-2", "answer_start": 43}], "is_impossible": false}, {"question": "How can you get COV-19 from someone who has the virus?", "id": "100000000000000000009373", "answers": [{"text": "through contact with another person who has the virus", "answer_start": 127}], "is_impossible": false}, {"question": "What is COVID- 19?", "id": "100000000000000000009374", "answers": [{"text": "coronavirus called SARS-CoV-2", "answer_start": 24}], "is_impossible": false}, {"question": "How long after exposure to the virus do symptoms appear?", "id": "100000000000000000009375", "answers": [{"text": "2 to 14 days", "answer_start": 386}], "is_impossible": false}, {"question": "What are some of the symptoms of the virus?", "id": "100000000000000000009376", "answers": [{"text": "fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea", "answer_start": 450}], "is_impossible": false}], "context": "COVID-19 is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not\nbeen seen before. You can get COVID-19 through contact with another person who has the\nvirus. It is predominantly a respiratory illness that can affect other organs. People with COVID-\n19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or\nchills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or\nsmell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea."}]}, {"title": "4983b411e01832d342fe1d72cd08800b", "paragraphs": [{"qas": [{"question": "What is MODERNA COVID-19 VACCINE'S BIVALENT'S name?", "id": "100000000000000000009381", "answers": [{"text": "SPIKEVAX", "answer_start": 8}], "is_impossible": false}, {"question": "Moderna Covid-19 Vaccine, Bivalent is made in the same way as what?", "id": "100000000000000000009382", "answers": [{"text": "3", "answer_start": 271}], "is_impossible": false}, {"question": "What vaccine contains the spike protein of only the Original SARS-CoV-2?", "id": "100000000000000000009383", "answers": [{"text": "Monovalent", "answer_start": 274}], "is_impossible": false}], "context": "HOW ARE SPIKEVAX (COVID-19 VACCINE, mRNA), MODERNA COVID-19\nVACCINE, AND MODERNA COVID-19 VACCINE, BIVALENT RELATED? SPIKEVAX (COVID-19 Vaccine, mRNA) and Moderna COVID-19 Vaccine can be used\ninterchangeably.4 Moderna COVID-19 Vaccine, Bivalent is made in the same way as\n3 Monovalent refers to any authorized or approved COVID-19 vaccine that contains or encodes the spike protein of\nonly the Original SARS-CoV-2."}]}, {"title": "5fb51f0addb9a9768ba7efb7928c9b43", "paragraphs": [{"qas": [{"question": "How many FDA-approved SPIKEVAX doses does Moderna COVID-19 Vaccine have?", "id": "100000000000000000009385", "answers": [{"text": "4", "answer_start": 0}], "is_impossible": false}, {"question": "How many EUA-authorized presentations of Moderna CoviD-19 vaccine are available?", "id": "100000000000000000009386", "answers": [{"text": "one", "answer_start": 53}], "is_impossible": false}, {"question": "What does the Omicron component in Moderna covid-19 vaccine contain?", "id": "100000000000000000009387", "answers": [{"text": "help prevent COVID-19", "answer_start": 299}], "is_impossible": false}, {"question": "Omicron component to help prevent COVID-19 caused by what variant of SARS-CoV-2?", "id": "100000000000000000009388", "answers": [{"text": "Omicron", "answer_start": 335}], "is_impossible": false}, {"question": "What should you ment to the VACCINATION PROVIDER BEFORE YOU OR YOUR CHILD GET ANY OF THESE VACCINS?", "id": "100000000000000000009389", "answers": [{"text": "Emergency Use Authorization", "answer_start": 415}], "is_impossible": false}], "context": "4 FDA-approved SPIKEVAX (COVID-19 Vaccine, mRNA) and one presentation of the EUA-authorized Moderna\nCOVID-19 Vaccine (supplied in vials with red caps and labels with a light blue border) can be used interchangeably\fSPIKEVAX and Moderna COVID-19 Vaccine, but it also contains an Omicron component to\nhelp prevent COVID-19 caused by the Omicron variant of SARS-CoV-2. For more information on EUA, see the \u201cWhat is an Emergency Use Authorization (EUA)?\u201d\nsection at the end of this Fact Sheet. WHAT SHOULD YOU MENTION TO THE VACCINATION PROVIDER BEFORE\nYOU OR YOUR CHILD GET ANY OF THESE VACCINES?"}]}, {"title": "90960c6c2dd17c5e1c030beac9697fb1", "paragraphs": [{"qas": [{"question": "What is the term for inflammation of the heart muscle?", "id": "100000000000000000009390", "answers": [{"text": "myocarditis", "answer_start": 148}], "is_impossible": false}, {"question": "What is pericarditis?", "id": "100000000000000000009391", "answers": [{"text": "inflammation of the lining outside the heart", "answer_start": 212}], "is_impossible": false}, {"question": "If you have a fever, what is it called?", "id": "100000000000000000009392", "answers": [{"text": "\u2022 have a bleeding disorder", "answer_start": 272}], "is_impossible": false}, {"question": "What is an immunocompromised condition?", "id": "100000000000000000009394", "answers": [{"text": "medicine", "answer_start": 362}], "is_impossible": false}, {"question": "Are you pregnant or plan to become pregnant?", "id": "100000000000000000009395", "answers": [{"text": "\u2022 are pregnant", "answer_start": 419}], "is_impossible": false}, {"question": "Have you ever fainted in association with an injection?", "id": "100000000000000000009396", "answers": [{"text": "COVID-19 vaccine", "answer_start": 505}], "is_impossible": false}, {"question": "What is the acronym for MODERNA COVID-19 VACCINE?", "id": "100000000000000000009397", "answers": [{"text": "BIVALENT", "answer_start": 684}], "is_impossible": false}, {"question": "Who should not get SPIKEVAX?", "id": "100000000000000000009398", "answers": [{"text": "your or your child", "answer_start": 43}], "is_impossible": false}], "context": "Tell the vaccination provider about all of your or your child\u2019s medical conditions, including if\nyou or your child:\n\u2022 have any allergies\n\u2022 have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of\nthe lining outside the heart)\n\u2022 have a fever\n\u2022 have a bleeding disorder or are on a blood thinner\n\u2022 are immunocompromised or are on a medicine that affects your or your child\u2019s immune\nsystem\n\u2022 are pregnant or plan to become pregnant\n\u2022 are breastfeeding\n\u2022 have received another COVID-19 vaccine\n\u2022 have ever fainted in association with an injection\nWHO SHOULD NOT GET SPIKEVAX (COVID-19 VACCINE, mRNA), MODERNA\nCOVID-19 VACCINE, OR MODERNA COVID-19 VACCINE, BIVALENT?"}]}, {"title": "ece61975a4cd294fe623ad488fdb3c65", "paragraphs": [{"qas": [{"question": "What is another name for Moderna COVID-19 Vaccine?", "id": "100000000000000000009399", "answers": [{"text": "SPIKEVAX", "answer_start": 135}], "is_impossible": false}, {"question": "What should you not get if you or your child had a severe allergic reaction after a previous dose of?", "id": "100000000000000000009400", "answers": [{"text": "any of these vaccines", "answer_start": 33}], "is_impossible": false}, {"question": "What is the mRNA of SPIKEVAX?", "id": "100000000000000000009401", "answers": [{"text": "COVID-19 Vaccine", "answer_start": 320}], "is_impossible": false}, {"question": "What are the ingredients in Moderna COVID-19 Vaccine?", "id": "100000000000000000009402", "answers": [{"text": "messenger ribonucleic acid", "answer_start": 445}], "is_impossible": false}, {"question": "What are acetic acid and sucrose?", "id": "100000000000000000009404", "answers": [{"text": "tromethamine, tromethamine hydrochloride, acetic acid, sodium acetate trihydrate", "answer_start": 624}], "is_impossible": false}], "context": "You or your child should not get any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction after a previous dose of SPIKEVAX (COVID-19 Vaccine,\nmRNA) or Moderna COVID-19 Vaccine\n\u2022 had a severe allergic reaction to any ingredient in these vaccines\nWHAT ARE THE INGREDIENTS IN THESE VACCINES? SPIKEVAX (COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, and Moderna\nCOVID-19 Vaccine, Bivalent contain the following ingredients: messenger ribonucleic acid\n(mRNA), lipids (SM-102, polyethylene glycol [PEG] 2000 dimyristoyl glycerol [DMG],\ncholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC]), tromethamine,\ntromethamine hydrochloride, acetic acid, sodium acetate trihydrate, and sucrose. HOW ARE THESE VACCINES GIVEN?"}]}, {"title": "cd854c8ebb1d921807242687b0dc65d", "paragraphs": [{"qas": [{"question": "What is the primary series of SPIKEVAX?", "id": "100000000000000000009405", "answers": [{"text": "COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, or Moderna COVID- 19 Vaccine, Bivalent will be given to you or your child as an injection into the muscle. for the primary series for individuals 12 years of age and older", "answer_start": 10}], "is_impossible": false}, {"question": "How many doses of Moderna COVID-19 Vaccine are given as a two-dose series?", "id": "100000000000000000009407", "answers": [{"text": "1 month apart", "answer_start": 408}], "is_impossible": false}], "context": "SPIKEVAX (COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, or Moderna COVID-\n19 Vaccine, Bivalent will be given to you or your child as an injection into the muscle. for the primary series for individuals 12 years of age and older without presenting any safety or effectiveness\nconcerns. Primary Series: SPIKEVAX (COVID-19 Vaccine, mRNA) and Moderna COVID-19 Vaccine\nare administered as a two-dose series, 1 month apart. A third primary series dose may be\nadministered at least 1 month after the second dose to individuals with certain kinds of\nimmunocompromise."}]}, {"title": "4bd5b01dc863231b3292d11876d6891b", "paragraphs": [{"qas": [{"question": "What is administered as a single booster dose at least 2 months after completion of primary vaccination?", "id": "100000000000000000009409", "answers": [{"text": "Moderna COVID-19 Vaccine, Bivalent", "answer_start": 14}], "is_impossible": false}, {"question": "How many people have received the Moderna COVID-19 Vaccine since December 18, 2020?", "id": "100000000000000000009411", "answers": [{"text": "Millions", "answer_start": 357}], "is_impossible": false}], "context": "Booster Dose: Moderna COVID-19 Vaccine, Bivalent is administered as a single booster dose at\nleast 2 months after:\n\u2022 completion of primary vaccination with any authorized or approved monovalent COVID-\n19 vaccine; or\n\u2022 receipt of the most recent booster dose with any authorized or approved monovalent\nCOVID-19 vaccine. HAVE THESE VACCINES BEEN USED BEFORE? Millions of individuals 18 years of age and older have received the Moderna COVID-19 Vaccine\nunder EUA since December 18, 2020."}]}, {"title": "70cf37a3dd7a93ece48c02c924f342ed", "paragraphs": [{"qas": [{"question": "How many people have received at least 1 dose of Moderna COVID-19 Vaccine in clinical trials?", "id": "100000000000000000009412", "answers": [{"text": "approximately 30,000", "answer_start": 20}], "is_impossible": false}, {"question": "How many individuals are 12 years of age and older in a clinical trial?", "id": "100000000000000000009413", "answers": [{"text": "30,000", "answer_start": 34}], "is_impossible": false}, {"question": "Which vaccine contains a different Omicron component?", "id": "100000000000000000009416", "answers": [{"text": "Bivalent", "answer_start": 407}], "is_impossible": false}, {"question": "SPIKEVAX and Moderna COVID-19 Vaccine have been shown to prevent what?", "id": "100000000000000000009417", "answers": [{"text": "COVID-19", "answer_start": 598}], "is_impossible": false}], "context": "In clinical trials, approximately 30,000 individuals 12\nyears of age and older, 4,000 individuals 6 years through 11 years of age, and 5,000 individuals 6\nmonths through 5 years of age have received at least 1 dose of Moderna COVID-19 Vaccine. In a clinical trial, approximately 400 individuals 18 years of age and older received 1 dose of a\nbivalent vaccine that differs from the Moderna COVID-19 Vaccine, Bivalent in that it contains a\ndifferent Omicron component. WHAT ARE THE BENEFITS OF THESE VACCINES? SPIKEVAX (COVID-19 Vaccine, mRNA) and Moderna COVID-19 Vaccine have been shown\nto prevent COVID-19."}]}, {"title": "97da7ca71189e77f56f49df66a1b7296", "paragraphs": [{"qas": [{"question": "What is the name of the Omicron variant of SARS-CoV-2?", "id": "100000000000000000009419", "answers": [{"text": "There is a remote chance that these vaccines could cause a severe allergic reaction", "answer_start": 249}], "is_impossible": false}, {"question": "The duration of protection is currently unknown.", "id": "100000000000000000009420", "answers": [{"text": "There is a remote chance that these vaccines could cause a severe allergic reaction", "answer_start": 249}], "is_impossible": false}, {"question": "What are the risks of these vaccines?", "id": "100000000000000000009421", "answers": [{"text": "There is a remote chance that these vaccines could cause a severe allergic reaction", "answer_start": 249}], "is_impossible": false}, {"question": "What could a vaccine cause?", "id": "100000000000000000009422", "answers": [{"text": "severe allergic reaction", "answer_start": 308}], "is_impossible": false}, {"question": "What would usually occur within a few minutes to one hour after getting a dose of the vaccine?", "id": "100000000000000000009423", "answers": [{"text": "A severe allergic reaction", "answer_start": 334}], "is_impossible": false}, {"question": "Where did you or your child receive the vaccine for monitoring after vaccination?", "id": "100000000000000000009424", "answers": [{"text": "There is a remote chance that these vaccines could cause a severe allergic reaction", "answer_start": 249}], "is_impossible": false}], "context": "FDA has authorized Moderna COVID-19 Vaccine, Bivalent to provide\nbetter protection against COVID-19 caused by the Omicron variant of SARS-CoV-2. The duration of protection against COVID-19 is currently unknown. WHAT ARE THE RISKS OF THESE VACCINES? There is a remote chance that these vaccines could cause a severe allergic reaction. A severe\nallergic reaction would usually occur within a few minutes to one hour after getting a dose. For\nthis reason, the vaccination provider may ask you or your child to stay at the place where you or\nyour child received the vaccine for monitoring after vaccination."}]}, {"title": "63aecc6aa5a55ff95579367e76cb8c2a", "paragraphs": [{"qas": [{"question": "What are signs of a severe allergic reaction?", "id": "100000000000000000009425", "answers": [{"text": "Difficulty breathing", "answer_start": 51}], "is_impossible": false}, {"question": "What is Myocarditis?", "id": "100000000000000000009426", "answers": [{"text": "inflammation of the heart muscle", "answer_start": 196}], "is_impossible": false}, {"question": "Inflammation of the lining outside of the heart is what?", "id": "100000000000000000009427", "answers": [{"text": "pericarditis", "answer_start": 234}], "is_impossible": false}, {"question": "What is SPIKEVAX?", "id": "100000000000000000009428", "answers": [{"text": "COVID-19 Vaccine, mRNA", "answer_start": 351}], "is_impossible": false}, {"question": "What is Moderna COVID-19 Vaccine?", "id": "100000000000000000009429", "answers": [{"text": "SPIKEVAX", "answer_start": 341}], "is_impossible": false}, {"question": "How long after receiving the second dose of the vaccine do symptoms begin in most people?", "id": "100000000000000000009430", "answers": [{"text": "within a few days", "answer_start": 531}], "is_impossible": false}, {"question": "How many days after receipt of the second dose of the vaccine is there a very low chance of having this happen?", "id": "100000000000000000009431", "answers": [{"text": "within a few days", "answer_start": 531}], "is_impossible": false}], "context": "Signs of a severe allergic\nreaction can include:\n\u2022 Difficulty breathing\n\u2022 Swelling of your face and throat\n\u2022 A fast heartbeat\n\u2022 A bad rash all over your body\n\u2022 Dizziness and weakness\nMyocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining\noutside the heart) have occurred in some people who have received SPIKEVAX (COVID-19\nVaccine, mRNA) or Moderna COVID-19 Vaccine, more commonly in adult males under 40\nyears of age than among females and older males. In most of these people, symptoms began\nwithin a few days following receipt of the second dose of the vaccine. The chance of having this\foccur is very low."}]}, {"title": "36337480369bcdb21d40ca56ea52c885", "paragraphs": [{"qas": [{"question": "What should you do if you or your child have any of the following symptoms after receiving the vaccine?", "id": "100000000000000000009432", "answers": [{"text": "seek medical attention right away", "answer_start": 11}], "is_impossible": false}, {"question": "What is the name for swelling of the lymph nodes in the same arm of the injection?", "id": "100000000000000000009435", "answers": [{"text": "hardness", "answer_start": 438}], "is_impossible": false}, {"question": "What is a term for inflammation of the lining outside the heart?", "id": "100000000000000000009438", "answers": [{"text": "Pericarditis", "answer_start": 729}], "is_impossible": false}, {"question": "Fainting in association with injection of the vaccine may not be what?", "id": "100000000000000000009439", "answers": [{"text": "all the possible side effects", "answer_start": 862}], "is_impossible": false}], "context": "You should seek medical attention right away if you or your child have any of\nthe following symptoms after receiving the vaccine:\n\u2022 Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding heart\nSide effects that have been reported in clinical trials with these vaccines include:\n\u2022 Injection site reactions: pain, tenderness and swelling of the lymph nodes in the same arm\nof the injection, swelling (hardness), and redness\n\u2022 General side effects: fatigue, headache, muscle pain, joint pain, chills, nausea and\nvomiting, fever, and rash\nSide effects that have been reported during post-authorization use include:\n\u2022 Severe allergic reactions\n\u2022 Myocarditis (inflammation of the heart muscle)\n\u2022 Pericarditis (inflammation of the lining outside the heart)\n\u2022 Fainting in association with injection of the vaccine\nThese may not be all the possible side effects of these vaccines."}]}, {"title": "67afa00590fa84f47447a1b550d67176", "paragraphs": [{"qas": [{"question": "What are the possible side effects of vaccines still being studied?", "id": "100000000000000000009440", "answers": [{"text": "Serious and unexpected side effects", "answer_start": 0}], "is_impossible": false}, {"question": "What is VAERS?", "id": "100000000000000000009442", "answers": [{"text": "Vaccine Adverse Event Reporting System", "answer_start": 447}], "is_impossible": false}, {"question": "What is the VAERS toll-free number?", "id": "100000000000000000009443", "answers": [{"text": "1-800-822-7967", "answer_start": 525}], "is_impossible": false}], "context": "Serious and unexpected side\neffects may occur. The possible side effects of these vaccines are still being studied. WHAT SHOULD I DO ABOUT SIDE EFFECTS? If you or your child experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital. Call the vaccination provider or your or your child\u2019s healthcare provider if you or your child\nhave any side effects that bother you or do not go away. Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System\n(VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to\nhttps://vaers.hhs.gov/reportevent.html."}]}, {"title": "9927a5023011596b9b1cc234f205018f", "paragraphs": [{"qas": [{"question": "How can you report side effects to ModernaTX, Inc?", "id": "100000000000000000009447", "answers": [{"text": "at 1-866-MODERNA (1-866-663- 3762).", "answer_start": 261}], "is_impossible": false}, {"question": "What is v-safe?", "id": "100000000000000000009448", "answers": [{"text": "a voluntary smartphone-based tool", "answer_start": 360}], "is_impossible": false}, {"question": "What does V-safe use to check in with people who have been vaccinated?", "id": "100000000000000000009449", "answers": [{"text": "text messaging and web surveys", "answer_start": 404}], "is_impossible": false}], "context": "Please include either \u201cSPIKEVAX (COVID-19 Vaccine,\nmRNA)\u201d, \u201cModerna COVID-19 Vaccine EUA,\u201d or \u201cModerna COVID-19 Vaccine, Bivalent\nEUA\u201d, as appropriate, in the first line of box #18 of the report form. In addition, you can report side effects to ModernaTX, Inc. at 1-866-MODERNA (1-866-663-\n3762). You may also be given an option to enroll in v-safe. V-safe is a voluntary smartphone-based tool\nthat uses text messaging and web surveys to check in with people who have been vaccinated to\nidentify potential side effects after COVID-19 vaccination. V-safe asks questions that help CDC\nmonitor the safety of COVID-19 vaccines."}]}, {"title": "8a4402d74079db8bf63887c64880009", "paragraphs": [{"qas": [{"question": "What does V-safe provide if participants report a significant health impact following COVID-19 vaccination?", "id": "100000000000000000009451", "answers": [{"text": "second-dose reminders if needed and live telephone follow-up by CDC", "answer_start": 21}], "is_impossible": false}, {"question": "What is another name for MODERNA COVID-19 VACCINE?", "id": "100000000000000000009453", "answers": [{"text": "BIVALENT", "answer_start": 384}], "is_impossible": false}, {"question": "What will not change the standard medical care?", "id": "100000000000000000009455", "answers": [{"text": "Should you decide not to receive, or for your child not to receive, any of these vaccines", "answer_start": 471}], "is_impossible": false}, {"question": "What will happen if you receive any of these vaccines?", "id": "100000000000000000009456", "answers": [{"text": "it will not change the standard medical care", "answer_start": 562}], "is_impossible": false}], "context": "V-safe also provides second-dose reminders if needed\nand live telephone follow-up by CDC if participants report a significant health impact following\nCOVID-19 vaccination. For more information on how to sign up, visit: www.cdc.gov/vsafe. WHAT IF I DECIDE NOT TO GET OR NOT TO HAVE MY CHILD GET SPIKEVAX\n(COVID-19 VACCINE, mRNA), MODERNA COVID-19 VACCINE, OR MODERNA\nCOVID-19 VACCINE, BIVALENT? Under the EUA, there is an option to accept or refuse receiving the vaccine. Should you decide\nnot to receive, or for your child not to receive, any of these vaccines, it will not change the\nstandard medical care."}]}, {"title": "874972f3245a35aa69dc57ab1eabd314", "paragraphs": [{"qas": [{"question": "What is another name for COVID-19 BESIDES SPIKEVAX?", "id": "100000000000000000009457", "answers": [{"text": "MODERNA COVID-19 VACCINE, OR MODERNA COVID-19 VACCINE, BIVALENT? For primary vaccination in individuals 12 years of age and older, another choice for preventing COVID-19 is COMIRNATY", "answer_start": 95}], "is_impossible": false}, {"question": "What is COMIRNATY?", "id": "100000000000000000009458", "answers": [{"text": "an FDA-approved COVID-19 vaccine", "answer_start": 304}], "is_impossible": false}, {"question": "For individuals 6 years of age and older, other options are available for what?", "id": "100000000000000000009459", "answers": [{"text": "vaccines to prevent COVID-19", "answer_start": 386}], "is_impossible": false}, {"question": "What is the name of the vaccine that can be used to prevent COVID-19?", "id": "100000000000000000009460", "answers": [{"text": "COMIRNATY", "answer_start": 268}], "is_impossible": false}, {"question": "How old are individuals who are 6 years of age and older?", "id": "100000000000000000009461", "answers": [{"text": "12 years of age and older, another choice for preventing COVID-19 is COMIRNATY (COVID-19 Vaccine, mRNA), an FDA-approved COVID-19 vaccine. For individuals 6 years of age and older, other vaccines to prevent COVID-19 may be available under EUA", "answer_start": 199}], "is_impossible": false}, {"question": "What are bivalent vaccines that contain an Omicron component of SARS- CoV-2 called?", "id": "100000000000000000009462", "answers": [{"text": "SPIKEVAX", "answer_start": 59}], "is_impossible": false}, {"question": "MODERNA COVID-19 VACCINE, BIVALENT AT THE SAME TIME AS OTHER VACCINS?", "id": "100000000000000000009463", "answers": [{"text": "SPIKEVAX (COVID-19 VACCINE, mRNA), MODERNA COVID-19 VACCINE, OR MODERNA COVID-19 VACCINE, BIVALENT? For primary vaccination in individuals 12 years of age and older, another choice for preventing COVID-19 is COMIRNATY (COVID-19 Vaccine, mRNA), an FDA-approved COVID-19 vaccine. For individuals 6 years of age and older, other vaccines to prevent COVID-19 may be available under EUA, including bivalent vaccines that contain an Omicron component of SARS- CoV-2. CAN I OR MY CHILD RECEIVE SPIKEVAX", "answer_start": 59}], "is_impossible": false}], "context": "ARE OTHER CHOICES AVAILABLE FOR PREVENTING COVID-19 BESIDES\nSPIKEVAX (COVID-19 VACCINE, mRNA), MODERNA COVID-19 VACCINE, OR\nMODERNA COVID-19 VACCINE, BIVALENT? For primary vaccination in individuals 12 years of age and older, another choice for preventing\nCOVID-19 is COMIRNATY (COVID-19 Vaccine, mRNA), an FDA-approved COVID-19\nvaccine. For individuals 6 years of age and older, other vaccines to prevent COVID-19 may be\navailable under EUA, including bivalent vaccines that contain an Omicron component of SARS-\nCoV-2. CAN I OR MY CHILD RECEIVE SPIKEVAX (COVID-19 VACCINE, mRNA),\nMODERNA COVID-19 VACCINE, OR MODERNA COVID-19 VACCINE, BIVALENT\nAT THE SAME TIME AS OTHER VACCINES?"}]}, {"title": "eb696975e84e3ad6d261eaf9c34e1c0b", "paragraphs": [{"qas": [{"question": "What has not yet been submitted to FDA on administration of SPIKEVAX at the same time as other vaccines?", "id": "100000000000000000009464", "answers": [{"text": "Data", "answer_start": 0}], "is_impossible": false}, {"question": "What are you considering receiving or having your child receive?", "id": "100000000000000000009465", "answers": [{"text": "SPIKEVAX", "answer_start": 61}], "is_impossible": false}, {"question": "What is another name for Moderna COVID-19 Vaccine?", "id": "100000000000000000009466", "answers": [{"text": "SPIKEVAX", "answer_start": 61}], "is_impossible": false}, {"question": "What is a third primary series dose of Moderna?", "id": "100000000000000000009468", "answers": [{"text": "SPIKEVAX (COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, or Moderna COVID-19 Vaccine, Bivalent at the same time as other vaccines. If you are considering receiving or having your child receive SPIKEVAX (COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, or Moderna COVID- 19 Vaccine, Bivalent with other vaccines, discuss your options with your or your child\u2019s healthcare provider. WHAT IF I AM, OR MY CHILD IS, IMMUNOCOMPROMISED? If you are, or your child is, immunocompromised", "answer_start": 61}], "is_impossible": false}, {"question": "What is SPIKEVAX?", "id": "100000000000000000009469", "answers": [{"text": "COVID-19 Vaccine", "answer_start": 71}], "is_impossible": false}], "context": "Data have not yet been submitted to FDA on administration of SPIKEVAX (COVID-19\nVaccine, mRNA), Moderna COVID-19 Vaccine, or Moderna COVID-19 Vaccine, Bivalent at\nthe same time as other vaccines. If you are considering receiving or having your child receive\nSPIKEVAX (COVID-19 Vaccine, mRNA), Moderna COVID-19 Vaccine, or Moderna COVID-\n19 Vaccine, Bivalent with other vaccines, discuss your options with your or your child\u2019s\nhealthcare provider. WHAT IF I AM, OR MY CHILD IS, IMMUNOCOMPROMISED? If you are, or your child is, immunocompromised, you or your child may receive a third primary\nseries dose of Moderna COVID-19 Vaccine or SPIKEVAX (COVID-19 Vaccine, mRNA)."}]}, {"title": "2451ed561f6b5c3c57fdf0e5e01a7121", "paragraphs": [{"qas": [{"question": "What should your close contacts be vaccinated as?", "id": "100000000000000000009473", "answers": [{"text": "appropriate", "answer_start": 345}], "is_impossible": false}, {"question": "What can not be given to you or your child?", "id": "100000000000000000009477", "answers": [{"text": "COVID-19", "answer_start": 634}], "is_impossible": false}], "context": "Individuals 6 years of age and older may receive a booster dose with Moderna COVID-19\nVaccine, Bivalent. Vaccinations may not provide full immunity to COVID-19 in people who are\nimmunocompromised; therefore, you or your child should continue to maintain physical\nprecautions to help prevent COVID-19. Your close contacts should be vaccinated as appropriate. WHAT ABOUT PREGNANCY OR BREASTFEEDING? If you are, or your child is, pregnant or breastfeeding, discuss the options with your healthcare\nprovider. WILL THESE VACCINES GIVE ME OR MY CHILD COVID-19? No. These vaccines do not contain SARS-CoV-2 and cannot give you or your child COVID-19."}]}, {"title": "2d6b536b1740258da82768e96e2283af", "paragraphs": [{"qas": [{"question": "When you receive the first COVID-19 vaccine, you will get a vaccination card.", "id": "100000000000000000009478", "answers": [{"text": "Remember to bring the card when you return", "answer_start": 120}], "is_impossible": false}, {"question": "What do you need to bring with you when you return?", "id": "100000000000000000009479", "answers": [{"text": "vaccination card. Remember to bring the card", "answer_start": 102}], "is_impossible": false}, {"question": "What does the QR code provide to access the most recent Fact Sheets?", "id": "100000000000000000009480", "answers": [{"text": "scan", "answer_start": 319}], "is_impossible": false}, {"question": "What is the telephone number of the Moderna COVID-19 Vaccine website?", "id": "100000000000000000009481", "answers": [{"text": "Ask the vaccination provider \u2022 Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html \u2022 Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal- regulatory-and-policy-framework/emergency-use-authorization \u2022 Contact your state or local public health department", "answer_start": 426}], "is_impossible": false}, {"question": "Who can you contact to learn more?", "id": "100000000000000000009483", "answers": [{"text": "your state or local public health department", "answer_start": 675}], "is_impossible": false}, {"question": "What is the name of your state or local public health department?", "id": "100000000000000000009484", "answers": [{"text": "Contact", "answer_start": 667}], "is_impossible": false}, {"question": "Where will VACCINATION INFORMATION BE RECORDED?", "id": "100000000000000000009485", "answers": [{"text": "Contact your state or local public health department", "answer_start": 667}], "is_impossible": false}], "context": "KEEP THE VACCINATION CARD\nWhen you, or your child, receive the first COVID-19 vaccine, you will get a vaccination card. Remember to bring the card when you return. ADDITIONAL INFORMATION\nIf you have questions, visit the website or call the telephone number provided below. To access the most recent Fact Sheets, please scan the QR code provided below. Moderna COVID-19 Vaccine website Telephone number\nHOW CAN I LEARN MORE? \u2022 Ask the vaccination provider\n\u2022 Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html\n\u2022 Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-\nregulatory-and-policy-framework/emergency-use-authorization\n\u2022 Contact your state or local public health department\nWHERE WILL VACCINATION INFORMATION BE RECORDED?"}]}, {"title": "30eba48f28bc78e49d47165d6349e827", "paragraphs": [{"qas": [{"question": "What will ensure that you or your child receive the same vaccine when you return for the second dose?", "id": "100000000000000000009487", "answers": [{"text": "Immunization Information System", "answer_start": 117}], "is_impossible": false}, {"question": "What is the name of the primary series of vaccines?", "id": "100000000000000000009488", "answers": [{"text": "COVID-19", "answer_start": 636}], "is_impossible": false}, {"question": "What can the provider not charge you for?", "id": "100000000000000000009490", "answers": [{"text": "a vaccine dose", "answer_start": 514}], "is_impossible": false}, {"question": "What is the cost of a COVID-19 vaccination?", "id": "100000000000000000009491", "answers": [{"text": "out-of-pocket vaccine administration fee", "answer_start": 558}], "is_impossible": false}], "context": "The vaccination provider may include your or your child\u2019s vaccination information in your\nstate/local jurisdiction\u2019s Immunization Information System (IIS) or other designated system. This will ensure that you or your child receive the same vaccine when you return for the second\ndose of the primary series. For more information about IISs, visit:\nhttps://www.cdc.gov/vaccines/programs/iis/about.html. CAN I BE CHARGED AN ADMINISTRATION FEE FOR RECEIPT OF THESE\nNo. At this time, the provider cannot charge you for a vaccine dose and you cannot be charged\nan out-of-pocket vaccine administration fee or any other fee if only receiving a COVID-19\nvaccination."}]}, {"title": "2968b8acbb1f8b69ef9f5a226d7fbbef", "paragraphs": [{"qas": [{"question": "Who may seek reimbursement from a program or plan that covers COVID-19 vaccine administration fees for the vaccine recipient?", "id": "100000000000000000009492", "answers": [{"text": "vaccination providers", "answer_start": 9}], "is_impossible": false}, {"question": "What is the name of the CDC's Vaccination Program?", "id": "100000000000000000009494", "answers": [{"text": "COVID-19", "answer_start": 376}], "is_impossible": false}, {"question": "Who should be notified of any potential violations of the COVID-19 vaccination program requirements?", "id": "100000000000000000009495", "answers": [{"text": "Individuals becoming aware of any potential violations of the CDC COVID-19 Vaccination Program requirements are encouraged to report them to the Office of the Inspector General", "answer_start": 310}], "is_impossible": false}, {"question": "What does the Office of the Inspector General call?", "id": "100000000000000000009496", "answers": [{"text": "COVID-19 Vaccination Program requirements are encouraged to report them to the Office of the Inspector General, U.S. Department of Health and Human Services", "answer_start": 376}], "is_impossible": false}], "context": "However, vaccination providers may seek appropriate reimbursement from a\nprogram or plan that covers COVID-19 vaccine administration fees for the vaccine recipient\n(private insurance, Medicare, Medicaid, HRSA COVID-19 Uninsured Program for non-insured\nrecipients). WHERE CAN I REPORT CASES OF SUSPECTED FRAUD? Individuals becoming aware of any potential violations of the CDC COVID-19 Vaccination\nProgram requirements are encouraged to report them to the Office of the Inspector General, U.S.\nDepartment of Health and Human Services, at 1-800-HHS-TIPS or TIPS.HHS.GOV. WHAT IS THE COUNTERMEASURES INJURY COMPENSATION PROGRAM?"}]}, {"title": "bcaa0db1d290f93fe1bc8cea14ebd595", "paragraphs": [{"qas": [{"question": "How long must a claim be submitted to the CICP?", "id": "100000000000000000009498", "answers": [{"text": "within one (1) year", "answer_start": 307}], "is_impossible": false}, {"question": "How long must a vaccine be submitted to the CICP?", "id": "100000000000000000009499", "answers": [{"text": "within one (1) year", "answer_start": 307}], "is_impossible": false}, {"question": "How long does it take for the vaccine to be submitted?", "id": "100000000000000000009501", "answers": [{"text": "one (1) year", "answer_start": 314}], "is_impossible": false}, {"question": "What is an example of a public health emergency?", "id": "100000000000000000009503", "answers": [{"text": "COVID-19 pandemic", "answer_start": 652}], "is_impossible": false}], "context": "The Countermeasures Injury Compensation Program (CICP) is a federal program that may help\npay for costs of medical care and other specific expenses of certain people who have been\nseriously injured by certain medicines or vaccines, including these vaccines. Generally, a claim\nmust be submitted to the CICP within one (1) year from the date of receiving the vaccine. To\flearn more about this program, visit www.hrsa.gov/cicp/ or call 1-855-266-2427. WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)? An EUA is a mechanism to facilitate the availability and use of medical products, including\nvaccines, during public health emergencies, such as the current COVID-19 pandemic."}]}, {"title": "9154bdd3a0d02082c59db89b5884b56c", "paragraphs": [{"qas": [{"question": "What does HHS stand for?", "id": "100000000000000000009505", "answers": [{"text": "Health and Human Services", "answer_start": 38}], "is_impossible": false}, {"question": "What may FDA issue when certain criteria are met?", "id": "100000000000000000009506", "answers": [{"text": "an EUA", "answer_start": 329}], "is_impossible": false}, {"question": "What criteria includes that there are no adequate, approved, and available alternatives?", "id": "100000000000000000009507", "answers": [{"text": "certain criteria are met", "answer_start": 341}], "is_impossible": false}], "context": "An EUA\nis supported by a Secretary of Health and Human Services (HHS) declaration that circumstances\nexist to justify the emergency use of drugs and biological products during the COVID-19\npandemic. A product authorized for emergency use has not undergone the same type of review\nby FDA as an FDA approved product. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate,\napproved, and available alternatives."}]}, {"title": "f69648d2f519cc94fb252868449bf28a", "paragraphs": [{"qas": [{"question": "What do the benefits of the product outweigh the risks of?", "id": "100000000000000000009509", "answers": [{"text": "known and potential risks of the product", "answer_start": 253}], "is_impossible": false}, {"question": "What must be met to allow for the product to be used during the COVID-19 pandemic?", "id": "100000000000000000009510", "answers": [{"text": "the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria", "answer_start": 192}], "is_impossible": false}, {"question": "What is in effect for the duration of the EUA declaration justifying emergency use of the product?", "id": "100000000000000000009511", "answers": [{"text": "An EUA", "answer_start": 395}], "is_impossible": false}, {"question": "What happens to a product unless it is terminated or revoked?", "id": "100000000000000000009512", "answers": [{"text": "the product may no longer be used", "answer_start": 548}], "is_impossible": false}], "context": "In addition, the FDA decision is based on the totality of the\nscientific evidence available showing that the product may be effective to prevent COVID-19\nduring the COVID-19 pandemic and that the known and potential benefits of the product\noutweigh the known and potential risks of the product. All of these criteria must be met to allow\nfor the product to be used during the COVID-19 pandemic. An EUA is in effect for the duration of the COVID-19 EUA declaration justifying emergency\nuse of this product, unless terminated or revoked (after which the product may no longer be\nused)."}]}, {"title": "e4a380a16cce0938684035c3eecc80a0", "paragraphs": [{"qas": [{"question": "What is the name of Moderna US, Inc. Cambridge, MA 02139 2022 ModernaTX Inc. All rights reserved What was provided to vaccine recipient for electronic medical records/immunization information systems?", "id": "100000000000000000009514", "answers": [{"text": "Fact Sheet", "answer_start": 143}], "is_impossible": false}], "context": "Moderna US, Inc.\nCambridge, MA 02139\n\u00a92022 ModernaTX, Inc. All rights reserved. Patent(s): www.modernatx.com/patents\nScan to capture that this Fact Sheet was provided to vaccine\nrecipient for the electronic medical records/immunization\ninformation systems."}]}, {"title": "f9e09591c1ba83c3b8cd11ba70d7ab11", "paragraphs": [{"qas": [{"question": "What should booster doses be?", "id": "100000000000000000009518", "answers": [{"text": "older age group", "answer_start": 674}], "is_impossible": false}], "context": "Special Situations for COVID-19 Vaccination\nof Children and Adolescents\nAge Transitions and Interchangeability\nSpecial Situations for COVID-19 Vaccination\nof Children and Adolescents\nAge Transitions and Interchangeability\nModerna COVID-19 Vaccine for Children who Transition from a Younger to Older Age Group\nCDC recommends vaccine recipients receive the recommended age-appropriate vaccine product and dosage based on their age on\nthe day of vaccination. \u0083 If a person moves from a younger age group to an older age group during the primary series or between the primary series and receipt\nof the booster dose(s), they should receive the vaccine product and dosage for the older age group for all subsequent doses."}]}, {"title": "8ac027ffaaaefc622850485afdc8f0a5", "paragraphs": [{"qas": [{"question": "What is EUA?", "id": "100000000000000000009520", "answers": [{"text": "FDA emergency use authorization", "answer_start": 2}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000009521", "answers": [{"text": "FDA emergency use authorization", "answer_start": 2}], "is_impossible": false}], "context": "\u0083 FDA emergency use authorization (EUA) allows for different dosing for certain age transitions, which are not considered vaccine\nadministration errors and do not need to be reported to the Vaccine Adverse Event Reporting System (VAERS)."}]}, {"title": "2031b938ceb3792d6a3bb0a217a37d72", "paragraphs": [{"qas": [{"question": "What should children who turn from age 5 to age 6 years receive?", "id": "100000000000000000009522", "answers": [{"text": "0.25 mL (25 mcg) of the product authorized for years", "answer_start": 179}], "is_impossible": false}, {"question": "How much of the product authorized for years is recommended for children who started a primary series?", "id": "100000000000000000009523", "answers": [{"text": "0.25 mL", "answer_start": 180}], "is_impossible": false}, {"question": "What is the color of the cap/ magenta label border?", "id": "100000000000000000009524", "answers": [{"text": "dark blue", "answer_start": 234}], "is_impossible": false}, {"question": "How much of the product is authorized for children ages 6-11 years?", "id": "100000000000000000009525", "answers": [{"text": "0.50 mL", "answer_start": 271}], "is_impossible": false}], "context": "Children who turn from age 5 to age 6 years\nRecommended: Children who started a primary series and turned from age 5 to age 6 years before completion of the\nseries should receive:\n0.25 mL (25 mcg) of the\nproduct authorized for\nyears (dark blue cap/\nmagenta label border)\n0.50 mL (50 mcg) of\nthe product authorized\nfor children ages 6\u201311\nyears (dark blue cap/\npurple label border)\nChild turns 6\nAcceptable: : If the following dosing occurs, it is NOT considered an error and the primary series is considered complete."}]}, {"title": "455707b51b21bddd4f6c319d1ef326f", "paragraphs": [{"qas": [{"question": "What is the dose of COVID-19 Vaccination of Children and Adolescents Age Transitions?", "id": "100000000000000000009527", "answers": [{"text": "6\u201311 years (dark blue cap/purple label border) of the product authorized for children ages 12 years and older", "answer_start": 696}], "is_impossible": false}, {"question": "What color is the label on the COVID-19 product?", "id": "100000000000000000009528", "answers": [{"text": "dark blue", "answer_start": 101}], "is_impossible": false}, {"question": "What is recommended for children who started a primary series and turned from age 11 to age 12 years?", "id": "100000000000000000009530", "answers": [{"text": "of the product authorized for children ages 6\u201311 years (dark blue cap/purple label border) of the product authorized for children ages 12 years and older", "answer_start": 652}], "is_impossible": false}, {"question": "What color label is the product approved for children 12 years and older?", "id": "100000000000000000009532", "answers": [{"text": "red cap/light blue", "answer_start": 808}], "is_impossible": false}, {"question": "When dosing occurs, it is NOT considered an error and what is considered complete?", "id": "100000000000000000009533", "answers": [{"text": "the primary series", "answer_start": 934}], "is_impossible": false}], "context": "Either dose may be:\n\u0083 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years (dark blue cap/magenta label border), or\n\u0083 0.50 mL (50 mcg) of the product authorized for children ages 6\u201311 years (dark blue cap/purple label border)\nOR\nOR\fSpecial Situations for COVID-19 Vaccination\nof Children and Adolescents\nAge Transitions and Interchangeability\nModerna COVID-19 Vaccine for Children who Transition from a Younger to Older Age Group (continued)\nChildren who turn from age 11 years to 12 years\nRecommended: Children who started a primary series and turned from age 11 to age 12 years before completion of the\nseries should receive:\nof the product\nauthorized for\nchildren ages\n6\u201311 years (dark\nblue cap/purple\nlabel border)\nof the product\nauthorized for children\nages 12 years and\nolder (red cap/light\nblue label border)\nChild turns 12\nAcceptable: If the following dosing occurs, it is NOT considered an error and the primary series is considered complete."}]}, {"title": "897cb4133d77f207205ed72ada2a4a12", "paragraphs": [{"qas": [{"question": "What color is the label for COVID-19 Vaccination of Children and Adolescents?", "id": "100000000000000000009534", "answers": [{"text": "dark blue", "answer_start": 95}], "is_impossible": false}, {"question": "How many mcg of the product authorized for children ages 6-11 years is indicated?", "id": "100000000000000000009535", "answers": [{"text": "50", "answer_start": 31}], "is_impossible": false}, {"question": "What color label is indicated for children 12-17 years?", "id": "100000000000000000009536", "answers": [{"text": "red cap/light blue", "answer_start": 211}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine for Children who Transition from a Younger to Older Age Group?", "id": "100000000000000000009537", "answers": [{"text": "answer undefined", "answer_start": 211}], "is_impossible": false}, {"question": "What does CDC recommend that vaccine recipients receive?", "id": "100000000000000000009538", "answers": [{"text": "age-appropriate vaccine product and dosage", "answer_start": 514}], "is_impossible": false}], "context": "Either dose may be:\n\u0083 0.50 mL (50 mcg) of the product authorized for children ages 6\u201311 years (dark blue cap/purple label border),\nOR\n\u0083 0.50 mL (100 mcg) of the product authorized for children ages 12\u201317 years (red cap/light blue label border)\nOR OR\fSpecial Situations for COVID-19 Vaccination\nof Children and Adolescents\nAge Transitions and Interchangeability\nPfizer-BioNTech COVID-19 Vaccine for Children who Transition from a Younger to Older Age Group\nCDC recommends vaccine recipients receive the recommended age-appropriate vaccine product and dosage based on their age on\nthe day of vaccination."}]}, {"title": "3f6e10bf0165f4a3498b6b9ff5a767f3", "paragraphs": [{"qas": [{"question": "What is EUA?", "id": "100000000000000000009539", "answers": [{"text": "FDA emergency use authorization", "answer_start": 197}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000009540", "answers": [{"text": "FDA emergency use authorization", "answer_start": 197}], "is_impossible": false}, {"question": "What allows for different dosing for certain age transitions?", "id": "100000000000000000009541", "answers": [{"text": "FDA emergency use authorization", "answer_start": 197}], "is_impossible": false}, {"question": "What are not considered vaccine administration errors?", "id": "100000000000000000009542", "answers": [{"text": "age transitions", "answer_start": 275}], "is_impossible": false}], "context": "\u0083 If a person moves from a younger age group to an older age group during the primary series, they should receive the vaccine product\nand dosage for the older age group for all subsequent doses. \u0083 FDA emergency use authorization (EUA) allows for different dosing for certain age transitions, which are not considered vaccine\nadministration errors and do not need to be reported to the Vaccine Adverse Event Reporting System (VAERS)."}]}, {"title": "50725feea96b5a97a27d3424684b179", "paragraphs": [{"qas": [{"question": "What should children receive when they turn 5 of the product authorized for children ages 6 (maroon cap and label border)", "id": "100000000000000000009543", "answers": [{"text": "of the product authorized for children ages 6 (maroon cap and label border) Child turns 5 of the product authorized for children ages 5\u201311 years", "answer_start": 195}], "is_impossible": false}, {"question": "What is the color of the cap and label border?", "id": "100000000000000000009544", "answers": [{"text": "5\u201311 years", "answer_start": 330}], "is_impossible": false}, {"question": "How many doses should children receive between dose 2 and dose 3?", "id": "100000000000000000009546", "answers": [{"text": "6 (maroon cap and label border) Child turns 5 of the product authorized for children ages 5\u201311 years", "answer_start": 240}], "is_impossible": false}, {"question": "How many doses should a child receive in the primary series?", "id": "100000000000000000009547", "answers": [{"text": "of the product authorized for children ages 6 (maroon cap and label border) Child turns 5 of the product authorized for children ages 5\u201311 years", "answer_start": 195}], "is_impossible": false}, {"question": "What color cap and label border is used in the product authorized for children ages 6?", "id": "100000000000000000009548", "answers": [{"text": "maroon", "answer_start": 243}], "is_impossible": false}, {"question": "What is NOT considered an error and the primary series is considered complete?", "id": "100000000000000000009550", "answers": [{"text": "dosing", "answer_start": 866}], "is_impossible": false}], "context": "Children who turn from age 4 to age 5 years\nRecommended: Children who started a primary series and turned from age 4 to age 5 years between dose 1 and dose 2\nin the primary series should receive:\nof the product\nauthorized for\nchildren ages 6\n(maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren ages 5\u201311\nyears (orange cap\nand label border)\nof the product\nauthorized for\nchildren ages\n(orange cap and\nlabel border)\nRecommended: Children who started a primary series and turned from age 4 to age 5 years between dose 2 and dose 3\nin the primary series should receive:\nof the product\nauthorized for\nchildren ages 6\n(maroon cap and\nlabel border)\nof the product\nauthorized for\nchildren ages 6\n(maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren ages\n(orange cap and\nlabel border)\nAcceptable: If the following dosing occurs, it is NOT considered an error and the primary series is considered complete."}]}, {"title": "4a291b3fd683022c11afc012cfc898b8", "paragraphs": [{"qas": [{"question": "What is the color of the label border on the 2-dose primary series?", "id": "100000000000000000009552", "answers": [{"text": "orange", "answer_start": 118}], "is_impossible": false}], "context": "\u0083 A 2-dose primary series using the Pfizer-BioNTech COVID-19 Vaccine product authorized for children ages 5\u201311 years (orange\ncap and label border)\fSpecial Situations for COVID-19 Vaccination\nof Children and Adolescents\nAge Transitions and Interchangeability\nPfizer-BioNTech COVID-19 Vaccine for Children who Transition from a Younger to Older Age Group (Continuted)\nOR\n\u0083 A 3-dose primary series initiated with the Pfizer-BioNTech COVID-19 Vaccine product authorized for children ages 6 months\u20134\nyears (maroon cap and label border)."}]}, {"title": "dd442545f3faa0640b0a8dfd7f4dccdd", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine product for children ages 6 months to 4 years?", "id": "100000000000000000009554", "answers": [{"text": "doses 2 and 3", "answer_start": 8}], "is_impossible": false}, {"question": "What color cap and label border is included in the Ppfizer BioNTech Covid-19 vaccine product?", "id": "100000000000000000009555", "answers": [{"text": "maroon", "answer_start": 126}], "is_impossible": false}], "context": "Each of doses 2 and 3 may be with the Pfizer-BioNTech COVID-19 Vaccine product\nauthorized for children ages 6 months\u20134 years (maroon cap and label border), or the Pfizer-BioNTech COVID-19 Vaccine\nproduct authorized for children ages 5\u201311 years (orange cap and label border)."}]}, {"title": "c1bb9185ef8d696fceb4dee26eeae4c7", "paragraphs": [{"qas": [{"question": "How many weeks is recommended for children who turn from age 11 to 12 years?", "id": "100000000000000000009556", "answers": [{"text": "8", "answer_start": 3}], "is_impossible": false}, {"question": "What is the age range for orange cap and label border?", "id": "100000000000000000009559", "answers": [{"text": "5\u201311 years", "answer_start": 261}], "is_impossible": false}, {"question": "How many mL of the product is authorized for children ages 12-17 years?", "id": "100000000000000000009560", "answers": [{"text": "0.30", "answer_start": 317}], "is_impossible": false}, {"question": "What is NOT considered an error?", "id": "100000000000000000009561", "answers": [{"text": "If the following dosing", "answer_start": 430}], "is_impossible": false}], "context": "OR 8 weeks\nOR\nChildren who turn from age 11 years to 12 years\nRecommended: Children who started a primary series and turned from age 11 to age 12 years before completion of the\nseries should receive:\n0.20 mL (10 mcg) of the\nproduct authorized for\nchildren ages 5\u201311 years\n(orange cap and label border)\nChild turns 12\n0.30 mL (30 mcg) of the\nproduct authorized for\nchildren ages 12\u201317 years\n(gray cap and label border)\nAcceptable: If the following dosing occurs, it is NOT considered an error and the primary series is considered complete."}]}, {"title": "96d017061a2fe3cb903b28a94b31e50b", "paragraphs": [{"qas": [{"question": "What should you do if a different manufacturer is administered?", "id": "100000000000000000009567", "answers": [{"text": "follow the guidance below", "answer_start": 45}], "is_impossible": false}, {"question": "What should be done if the recommended interval between doses has been met?", "id": "100000000000000000009568", "answers": [{"text": "count both doses", "answer_start": 172}], "is_impossible": false}, {"question": "If ages 6 months through 4 years, complete the series following what schedule?", "id": "100000000000000000009569", "answers": [{"text": "Pfizer-BioNTech 3-dose schedule", "answer_start": 315}], "is_impossible": false}, {"question": "What is not recommended for repeating doses?", "id": "100000000000000000009570", "answers": [{"text": "\u25cb", "answer_start": 420}], "is_impossible": false}, {"question": "What is the age-appropriate vaccine from either manufacturer?", "id": "100000000000000000009572", "answers": [{"text": "Pfizer-BioNTech COVID-19", "answer_start": 137}], "is_impossible": false}, {"question": "How many doses of Pfizer-BioNTech and Moderna COVID-19 vaccines were given?", "id": "100000000000000000009573", "answers": [{"text": "1", "answer_start": 716}], "is_impossible": false}, {"question": "Which vaccine was given first?", "id": "100000000000000000009574", "answers": [{"text": "Pfizer-BioNTech COVID-19", "answer_start": 137}], "is_impossible": false}], "context": "If a different manufacturer is\nadministered, follow the guidance below:\n\u0083 If a dose of the age-appropriate product from BOTH\nModerna and Pfizer-BioNTech COVID-19 is given, count\nboth doses if the recommended interval between doses\nhas been met. \u25cb If ages 6 months through 4 years, complete the series\nfollowing the Pfizer-BioNTech 3-dose schedule using\nan age-appropriate vaccine from either manufacturer. See examples. \u25cb Repeating doses is not recommended. \u0083 This guidance applies to:\n\u25cb All eligible children, including those who are\nmoderately or severely immunocompromised. \u25cb Vaccines from both manufacturers, regardless which\nvaccine was given first. Examples:\nVaccination history: 1 dose of Pfizer-BioNTech and 1 dose of Moderna COVID-19 vaccines."}]}, {"title": "708ed1d71850b8980738dab0838eabb3", "paragraphs": [{"qas": [{"question": "Pfizer-BioNTech at least Moderna at least What is the name of the moderna primary series?", "id": "100000000000000000009575", "answers": [{"text": "Pfizer-BioNTech OR", "answer_start": 75}], "is_impossible": false}, {"question": "Moderna Primary series complete what?", "id": "100000000000000000009576", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 16}], "is_impossible": false}], "context": "Moderna\nat least\nPfizer-BioNTech\nPfizer-BioNTech\nat least\nModerna\nat least\nPfizer-BioNTech\nOR\nModerna\nPrimary\nseries\ncomplete"}]}, {"title": "94f74181056cf605b06ade1aaf400f95", "paragraphs": [{"qas": [{"question": "What does EUI stand for?", "id": "100000000000000000009578", "answers": [{"text": "Healthcare Providers", "answer_start": 37}], "is_impossible": false}, {"question": "When was the EUI issued?", "id": "100000000000000000009579", "answers": [{"text": "9/02/2022", "answer_start": 74}], "is_impossible": false}, {"question": "What is the name of the vaccine used by Pfizer-BioNTech?", "id": "100000000000000000009580", "answers": [{"text": "Comirnaty", "answer_start": 419}], "is_impossible": false}, {"question": "Who approved the use of the COVID-19 vaccine?", "id": "100000000000000000009581", "answers": [{"text": "Food and Drug Administration", "answer_start": 467}], "is_impossible": false}], "context": "Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nEmergency Use Instructions for Healthcare Providers:\nPfizer-BioNTech COVID-19 Vaccine for Primary and/or Additional Doses\nThe Centers for Disease Control and Prevention (CDC) is issuing Emergency Use Instructions (EUI) to provide\ninformation about the use of the COVID-19 vaccine by Pfizer-BioNTech (Comirnaty), which is approved\n(licensed) by the Food and Drug Administration (FDA) for the prevention of COVID-19 in individuals ages 16\nyears and older.1 The CDC-issued EUI provide information for the use of this vaccine that are beyond the FDA-\napproved labeling."}]}, {"title": "482a9db8c8c5ef28c0d9ef3e86635f62", "paragraphs": [{"qas": [{"question": "What is a higher risk group of people at higher risk of?", "id": "100000000000000000009585", "answers": [{"text": "mRNA COVID-19 vaccine-associated myocarditis", "answer_start": 305}], "is_impossible": false}, {"question": "Who issued the EUI?", "id": "100000000000000000009586", "answers": [{"text": "CDC", "answer_start": 4}], "is_impossible": false}], "context": "The CDC-issued EUI provide information on the following uses of the COVID-19 vaccine by\nPfizer-BioNTech for:\n\u2022 A longer interval of 3\u20138 weeks between the first and second primary dose of Pfizer-BioNTech COVID-\n19 vaccine for persons ages 12 years and older, particularly for individuals at higher risk of mRNA\nCOVID-19 vaccine-associated myocarditis."}]}, {"title": "7558e5154ff4611427faf0214f123e8b", "paragraphs": [{"qas": [{"question": "How long is it necessary to delay the second dose in people with asymptomatic SARS infection?", "id": "100000000000000000009588", "answers": [{"text": "3 months", "answer_start": 112}], "is_impossible": false}], "context": "\u2022 Delaying the second primary dose in persons ages 12 years and older who recently had SARS-CoV-2\ninfection, by 3 months from symptom onset or positive test (if infection was asymptomatic)\n\u2022 Primary dose(s), including for those with certain immunocompromising conditions or those with\nincomplete primary series, for persons ages 12 years and older who received primary or booster\nvaccination with certain non-FDA authorized or approved COVID-19 vaccines2. \u2022 An additional dose in persons ages 18 years and older with certain immunocompromising conditions\nwho received primary vaccination with the Janssen COVID-19 Vaccine."}]}, {"title": "ad7b7d6e103ccee6333fc673ca71169e", "paragraphs": [{"qas": [{"question": "What is the term for a hematopoietic cell transplant?", "id": "100000000000000000009593", "answers": [{"text": "HCT", "answer_start": 433}], "is_impossible": false}, {"question": "What is the name of the vaccine used by Moderna?", "id": "100000000000000000009596", "answers": [{"text": "COVID-19", "answer_start": 492}], "is_impossible": false}], "context": "\u2022 Revaccination of moderately or severely immunocompromised persons ages 12 years and older who\nreceived certain therapies (indicated below) and received primary dose(s) of COVID-19 vaccine prior to\nor during treatment. o\no\nReceived COVID-19 vaccine dose(s) during treatment with B-cell-depleting therapies over a\nlimited period\nReceived COVID-19 vaccine dose(s) prior to or during treatment involving hematopoietic cell\ntransplant (HCT) or chimeric antigen receptor (CAR)-T-cell therapy\nThe COVID-19 vaccine by Moderna under EUI also allow similar uses as an alternative mRNA COVID-19 vaccine\nto Pfizer-BioNTech, and the same or similar recommendations in the EUI also apply to the use of the COVID-19\nvaccine by Moderna under EUI."}]}, {"title": "4a49655f89c89c68a3932a894628f15c", "paragraphs": [{"qas": [{"question": "What is the Moderna EUI Fact Sheet for Healthcare Providers?", "id": "100000000000000000009597", "answers": [{"text": "CDC\u2019s Interim Clinical Considerations", "answer_start": 66}], "is_impossible": false}, {"question": "What is Pfizer-BioNTech allowed to use under the EUI?", "id": "100000000000000000009598", "answers": [{"text": "COVID-19 vaccine", "answer_start": 147}], "is_impossible": false}, {"question": "When was EUA Prescribing Information issued?", "id": "100000000000000000009601", "answers": [{"text": "2022", "answer_start": 404}], "is_impossible": false}, {"question": "What is the EUI for the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000009602", "answers": [{"text": "Full Emergency Use Authorization", "answer_start": 335}], "is_impossible": false}], "context": "See the Moderna EUI Fact Sheet for Healthcare Providers. Refer to CDC\u2019s Interim Clinical Considerations for specific recommendations on use of the COVID-19 vaccine by\nPfizer-BioNTech allowed under the EUI. For additional information about the COVID-19 vaccine by Pfizer-\nBioNTech COVID-19, refer to the Comirnaty package insert or the Full Emergency Use Authorization (EUA)\nPrescribing Information (FDA, 2022). What are EUI and why is CDC issuing EUI for the COVID-19 vaccine by Pfizer-BioNTech?"}]}, {"title": "c137d9f7e9fa18496c4c0cf7c00cf58b", "paragraphs": [{"qas": [{"question": "Who has legal authority to create, issue, and disseminate EUI before or during an emergency?", "id": "100000000000000000009604", "answers": [{"text": "The CDC Director", "answer_start": 389}], "is_impossible": false}, {"question": "What is the proprietary name for the product licensed under the Biologics License Application (BLA)?", "id": "100000000000000000009605", "answers": [{"text": "Comirnaty", "answer_start": 509}], "is_impossible": false}], "context": "In 2013, the Pandemic and All-Hazards Preparedness Reauthorization Act included a new provision that\nallowed for the issuance of EUI to permit CDC to inform healthcare providers and recipients about certain uses\nof FDA-approved or cleared medical products. Specifically, EUI inform healthcare providers and recipients\nabout such products\u2019 approved, licensed, or cleared conditions of use. The CDC Director has statutory (legal)\nauthority to create, issue, and disseminate EUI before or during an emergency. 1 Comirnaty is the proprietary name for the product licensed under the Biologics License Application (BLA)."}]}, {"title": "73873449ccfb8010db2f1338f2777a84", "paragraphs": [{"qas": [{"question": "How long has the Pfizer-BioNTech COVID-19 Vaccine been available?", "id": "100000000000000000009606", "answers": [{"text": "December 11, 2020", "answer_start": 62}], "is_impossible": false}, {"question": "What does EUA stand for?", "id": "100000000000000000009607", "answers": [{"text": "Emergency Use Authorization", "answer_start": 93}], "is_impossible": false}, {"question": "How long have the two approved formulations of Comirnaty been in use?", "id": "100000000000000000009608", "answers": [{"text": "\u226512 years", "answer_start": 251}], "is_impossible": false}, {"question": "What may the BLA-compliant vaccine bear the name?", "id": "100000000000000000009609", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine", "answer_start": 346}], "is_impossible": false}, {"question": "What is commonly referred to as the \"Pfizer vaccine?\"", "id": "100000000000000000009610", "answers": [{"text": "Comirnaty", "answer_start": 420}], "is_impossible": false}, {"question": "What do EUI refer to this vaccine as?", "id": "100000000000000000009611", "answers": [{"text": "COVID-19 vaccine by Pfizer-BioNTech", "answer_start": 560}], "is_impossible": false}], "context": "The Pfizer-BioNTech COVID-19 Vaccine has\nbeen available since December 11, 2020, pursuant to Emergency Use Authorization (EUA). The two approved formulations of Comirnaty and the two\nFDA-authorized formulations of Pfizer-BioNTech COVID-19 Vaccine for \u226512 years are the same formulations, and vials of the BLA-compliant vaccine may\nbear the name \u201cPfizer-BioNTech COVID-19 Vaccine.\u201d Because of these features, and because Comirnaty is commonly referred to as the \u201cPfizer vaccine\u201d\nor the \u201cPfizer-BioNTech COVID-19 Vaccine,\u201d these EUI refer to this vaccine as the COVID-19 vaccine by Pfizer-BioNTech."}]}, {"title": "2d97ad3b03cc7313f88c83ca2d6d4d62", "paragraphs": [{"qas": [{"question": "What is the original date of the Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000009612", "answers": [{"text": "9/02/2022", "answer_start": 74}], "is_impossible": false}, {"question": "Who issued the EUI to provide information about the use of the vaccine?", "id": "100000000000000000009615", "answers": [{"text": "CDC", "answer_start": 289}], "is_impossible": false}], "context": "Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nThe COVID-19 vaccine by Pfizer-BioNTech is approved by the FDA as a 2-dose primary series for active\nimmunization to prevent COVID-19 in persons ages 12 years and older. CDC is issuing these EUI to provide\ninformation about use of the COVID-19 vaccine by Pfizer-BioNTech for primary and/or additional doses that\nextend beyond its FDA-approved labeling as described further under \u201cWho can receive the COVID-19 vaccine\nby Pfizer-BioNTech\u201d and \u201cWhat are the doses and intervals of the COVID-19 vaccine by Pfizer-BioNTech for\nprimary and/or additional doses\u201d. What is COVID-19?"}]}, {"title": "57cb5e7615877ec0035c3b95f4b3b8d9", "paragraphs": [{"qas": [{"question": "What is the name of the new coronavirus that causes Coronavirus disease 2019?", "id": "100000000000000000009618", "answers": [{"text": "SARS-CoV-2", "answer_start": 94}], "is_impossible": false}, {"question": "When did Coronavirus Disease 2019 first appear?", "id": "100000000000000000009619", "answers": [{"text": "late 2019", "answer_start": 122}], "is_impossible": false}, {"question": "What is CoronaVirus disease 2019 primarily a respiratory illness that can affect other organs?", "id": "100000000000000000009620", "answers": [{"text": "infectious disease", "answer_start": 42}], "is_impossible": false}, {"question": "How many days after exposure to the virus can symptoms appear?", "id": "100000000000000000009621", "answers": [{"text": "2 to 14", "answer_start": 342}], "is_impossible": false}, {"question": "What are symptoms of the virus?", "id": "100000000000000000009622", "answers": [{"text": "fever or chills, cough, shortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea", "answer_start": 405}], "is_impossible": false}], "context": "Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the novel coronavirus, SARS-CoV-2,\nthat emerged in late 2019. It is predominantly a respiratory illness that can affect other organs. People with\nSARS-CoV-2 infection have reported a wide range of symptoms, ranging from no symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include fever or chills, cough,\nshortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat,\ncongestion or runny nose, nausea or vomiting, and diarrhea. Who can receive the COVID-19 vaccine by Pfizer-BioNTech?"}]}, {"title": "85b9b97ac2133e9f510413f14a0b8378", "paragraphs": [{"qas": [{"question": "Who can receive the COVID-19 vaccine under EUI?", "id": "100000000000000000009626", "answers": [{"text": "Persons ages 12 years and older", "answer_start": 264}], "is_impossible": false}, {"question": "What is the name of the vaccine that Moderna can also be used for similar uses?", "id": "100000000000000000009627", "answers": [{"text": "COVID-19", "answer_start": 91}], "is_impossible": false}, {"question": "What age group may receive a second dose of the COVID-19 vaccine?", "id": "100000000000000000009629", "answers": [{"text": "12 years and older", "answer_start": 277}], "is_impossible": false}, {"question": "How long after the first primary dose will the second primary dose last?", "id": "100000000000000000009630", "answers": [{"text": "3\u20138 weeks", "answer_start": 486}], "is_impossible": false}], "context": "The below describes who can receive the COVID-19 vaccine by Pfizer-BioNTech under EUI. The COVID-19\nvaccine by Moderna can also be used under EUI for similar uses as an alternative mRNA COVID-19 vaccine (see\nthe Moderna EUI Fact Sheet for Healthcare Providers). \u2022 Persons ages 12 years and older, particularly those at higher risk of mRNA COVID-19 vaccine-\nassociated myocarditis, may receive a second primary dose of the COVID-19 vaccine by Pfizer-\nBioNTech after a longer interval of 3\u20138 weeks following the first primary dose."}]}, {"title": "15781ef40602929e63c636ac4c38b852", "paragraphs": [{"qas": [{"question": "Who may receive the second primary dose after a deferral period of 3 months from symptom onset or positive test (if infection was asymptomatic)?", "id": "100000000000000000009631", "answers": [{"text": "Persons ages 12 years and older", "answer_start": 2}], "is_impossible": false}, {"question": "What is a primary dose of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000009633", "answers": [{"text": "Persons ages 12 years and older who received an incomplete primary series", "answer_start": 214}], "is_impossible": false}, {"question": "What is an incomplete primary series?", "id": "100000000000000000009634", "answers": [{"text": "only the first dose of 2-dose primary series", "answer_start": 295}], "is_impossible": false}], "context": "\u2022 Persons ages 12 years and older who recently had SARS-CoV-2 infection may receive the second\nprimary dose after a deferral period of 3 months from symptom onset or positive test (if infection was\nasymptomatic)\n\u2022 Persons ages 12 years and older who received an incomplete primary series (e.g., only the first dose of\n2-dose primary series) with certain non-FDA authorized or approved COVID-19 vaccines should receive\na primary dose of the COVID-19 vaccine by Pfizer-BioNTech."}]}, {"title": "a49f85231026a79d49353b81d2cc0b7c", "paragraphs": [{"qas": [{"question": "Who should receive an additional dose of the Janssen COVID-19 Vaccine?", "id": "100000000000000000009636", "answers": [{"text": "Ages 18 years and older", "answer_start": 273}], "is_impossible": false}, {"question": "What should age 12 years and older receive?", "id": "100000000000000000009637", "answers": [{"text": "an additional primary dose of the COVID-19 vaccine by Pfizer-BioNTech", "answer_start": 200}], "is_impossible": false}, {"question": "Who should be revaccinated with the CoviD-19 vaccine?", "id": "100000000000000000009638", "answers": [{"text": "Ages 12 years and older", "answer_start": 446}], "is_impossible": false}], "context": "\u2022 For certain moderately or severely immunocompromised persons:\no Ages 12 years and older who received primary vaccination with certain non-FDA authorized or\napproved COVID-19 vaccines should receive an additional primary dose of the COVID-19\nvaccine by Pfizer-BioNTech. o Ages 18 years and older who received primary vaccination with the Janssen COVID-19 Vaccine\nshould receive an additional dose with the COVID-19 vaccine by Pfizer-BioNTech. o Ages 12 years and older who received certain therapies (indicated below) and received\nprimary dose(s) of COVID-19 vaccine prior to or during treatment should be revaccinated with\nthe COVID-19 vaccine by Pfizer-BioNTech for any doses received before or during treatment."}]}, {"title": "b8b28edcea37661a72b742cde6c8bf5f", "paragraphs": [{"qas": [{"question": "What are the doses and intervals of the COVID-19 vaccine by Pfizer-BioNTech for primary and/or additional doses?", "id": "100000000000000000009640", "answers": [{"text": "30 \u03bcg in 0.3 mL", "answer_start": 390}], "is_impossible": false}, {"question": "What company makes the COVID-19 vaccine?", "id": "100000000000000000009641", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 269}], "is_impossible": false}, {"question": "What is the recommended interval for a second dose of the vaccine to persons 12 years and older?", "id": "100000000000000000009643", "answers": [{"text": "3\u20138 weeks", "answer_start": 494}], "is_impossible": false}, {"question": "How many weeks after the first dose is optimal for some people?", "id": "100000000000000000009644", "answers": [{"text": "3", "answer_start": 559}], "is_impossible": false}, {"question": "How long is the interval between doses?", "id": "100000000000000000009645", "answers": [{"text": "3 weeks", "answer_start": 559}], "is_impossible": false}], "context": "\u25aa Received COVID-19 vaccine dose(s) during treatment with B-cell-depleting therapies\nover a limited period\n\u25aa Received COVID-19 vaccine dose(s) prior to or during treatment involving HCT or CAR-\nT-cell therapy\nWhat are the doses and intervals of the COVID-19 vaccine by Pfizer-BioNTech for primary and/or additional\ndoses? \u2022 A second primary dose of the COVID-19 vaccine by Pfizer-BioNTech (30 \u03bcg in 0.3 mL) should be\nadministered intramuscularly to persons ages 12 years and older; this may be 3\u20138 weeks after the first\nprimary dose. The approved interval is 3 weeks after the first dose, but an 8-week interval may be\noptimal for some people."}]}, {"title": "37d1d5ee1c7f4472d27e0b52b6b4ca3d", "paragraphs": [{"qas": [{"question": "How long may a second dose of the COVID-19 vaccine be delayed?", "id": "100000000000000000009646", "answers": [{"text": "3 months", "answer_start": 103}], "is_impossible": false}, {"question": "What is the second dose?", "id": "100000000000000000009647", "answers": [{"text": "30 \u03bcg in 0.3 mL", "answer_start": 68}], "is_impossible": false}, {"question": "How long can a symptom onset of the SARS-CoV-2 infection last?", "id": "100000000000000000009648", "answers": [{"text": "3 months", "answer_start": 103}], "is_impossible": false}, {"question": "What should be administered intramuscularly to persons ages 12 years and older at least 28?", "id": "100000000000000000009650", "answers": [{"text": "Pfizer-BioNTech vaccine", "answer_start": 491}], "is_impossible": false}], "context": "\u2022 A second primary dose of the COVID-19 vaccine by Pfizer-BioNTech (30 \u03bcg in 0.3 mL) may be delayed\nby 3 months from symptom onset or positive test (if infection was asymptomatic) in persons ages 12\nyears and older who recently had SARS-CoV-2 infection\fPfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\n\u2022 A primary dose, including as an additional primary dose for those with certain immunocompromising\nconditions, of the Pfizer-BioNTech vaccine (30 \u03bcg in 0.3 mL) should be administered intramuscularly to\npersons ages 12 years and older at least 28 days after primary vaccination with certain non-FDA\nauthorized or approved COVID-19 vaccines."}]}, {"title": "10c9d6a7e94ac72e00530c348b88b913", "paragraphs": [{"qas": [{"question": "How many days after the first dose of a Janssen Covid-19 vaccine should a person receive a second dose?", "id": "100000000000000000009654", "answers": [{"text": "28", "answer_start": 398}], "is_impossible": false}, {"question": "What is the recommended duration of the additional dose of Janssen-BioNTech's vaccine?", "id": "100000000000000000009655", "answers": [{"text": "28 days", "answer_start": 211}], "is_impossible": false}, {"question": "Who is responsible for administering a dose of Pfizer's CoviD-19 vaccine in 0.3mL?", "id": "100000000000000000009656", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 50}], "is_impossible": false}, {"question": "How many days after the primary dose of the Janssen COVID-19 Vaccine is required for an additional dose of an mRNA vaccination?", "id": "100000000000000000009657", "answers": [{"text": "28", "answer_start": 398}], "is_impossible": false}], "context": "\u2022 An additional dose with the COVID-19 vaccine by Pfizer-BioNTech (30 \u03bcg in 0.3 mL) should be\nadministered intramuscularly for persons ages 12 years and older with certain immunocompromising\nconditions at least 28 days after a primary dose with the Janssen COVID-19 Vaccine (e.g., 1 primary\ndose of the Janssen COVID-19 Vaccine followed by an additional dose with an mRNA COVID-19 vaccine\nat least 28 days after the primary dose)."}]}, {"title": "e998503b0138aa6aa966553a43690442", "paragraphs": [{"qas": [{"question": "What should people who received 1 booster dose of the Janssen COVID-19 Vaccine receive at least once?", "id": "100000000000000000009658", "answers": [{"text": "an additional dose with the COVID-19 vaccine by Pfizer-BioNTech", "answer_start": 211}], "is_impossible": false}, {"question": "What is the recommended dose for people who have received both 1 primary dose and one booster dose?", "id": "100000000000000000009659", "answers": [{"text": "at least 2 months", "answer_start": 293}], "is_impossible": false}, {"question": "How much of a dose should people receive in addition to 1 primary and 2 booster doses of Janssen CoviD-19 vaccine?", "id": "100000000000000000009660", "answers": [{"text": "30 \u03bcg in 0.3 mL", "answer_start": 276}], "is_impossible": false}, {"question": "How long after the booster dose does it take for the vaccine to be vaccinated?", "id": "100000000000000000009662", "answers": [{"text": "2 months", "answer_start": 302}], "is_impossible": false}], "context": "People who received both 1 primary dose and 1 booster dose\nof the Janssen COVID-19 Vaccine or 1 primary dose of the Janssen COVID-19 Vaccine followed by 1\nbooster dose of an mRNA COVID-19 vaccine should receive an additional dose with the COVID-19\nvaccine by Pfizer-BioNTech (30 \u03bcg in 0.3 mL) at least 2 months after the booster dose. \u2022 Revaccination with the COVID-19 vaccine by Pfizer-BioNTech for any primary doses received before or\nduring treatment with certain therapies (indicated below)."}]}, {"title": "32f8edf620ffb1555e68f1d937a18867", "paragraphs": [{"qas": [{"question": "What are the latest dosing recommendations for COVID-19 vaccination?", "id": "100000000000000000009664", "answers": [{"text": "Table 3 COVID-19 vaccination schedule for moderately or severely immunocompromised people in CDC\u2019s Interim Clinical Considerations", "answer_start": 4}], "is_impossible": false}, {"question": "What are the dosing intervals based on when the benefits of vaccination outweigh the potential risks for the recipient?", "id": "100000000000000000009667", "answers": [{"text": "clinical judgment", "answer_start": 450}], "is_impossible": false}], "context": "See Table 3 COVID-19 vaccination schedule for moderately or severely immunocompromised people in CDC\u2019s\nInterim Clinical Considerations for the latest dosing recommendations. On a case-by-case basis, providers of\nmoderately or severely immunocompromised patients who are ages 12 years and older may administer the\nCOVID-19 vaccine by Pfizer-BioNTech outside of the FDA-authorized or FDA-approved labeling and CDC\nrecommended dosing intervals based on clinical judgment when the benefits of vaccination are deemed to\noutweigh the potential and unknown risks for the recipient. What are the formulations of the COVID-19 vaccine by Pfizer-BioNTech that these EUI apply to?"}]}, {"title": "3db49be8caf11f7ca91a76700495edb9", "paragraphs": [{"qas": [{"question": "What do the EUI apply to?", "id": "100000000000000000009668", "answers": [{"text": "FDA-approved formulations of the COVID-19 vaccine", "answer_start": 21}], "is_impossible": false}, {"question": "What are the two FDA-approved formulations of the COVID-19 vaccine distinguished by?", "id": "100000000000000000009669", "answers": [{"text": "purple and gray caps", "answer_start": 257}], "is_impossible": false}, {"question": "What are the purple and gray caps labeled as?", "id": "100000000000000000009671", "answers": [{"text": "Comirnaty or Pfizer- BioNTech COVID-19 Vaccine", "answer_start": 307}], "is_impossible": false}, {"question": "What is the tromethamine in the multidose vials with gray caps?", "id": "100000000000000000009672", "answers": [{"text": "Tris) buffer", "answer_start": 592}], "is_impossible": false}, {"question": "What does Tris stand for?", "id": "100000000000000000009674", "answers": [{"text": "tromethamine", "answer_start": 578}], "is_impossible": false}], "context": "The EUI apply to the FDA-approved formulations of the COVID-19 vaccine by Pfizer-BioNTech that may be used\nfor individuals 12 years of age and older. As of December 16, 2021, there are two FDA-approved formulations\nof this vaccine that are distinguished by purple and gray caps with vials labeled either as Comirnaty or Pfizer-\nBioNTech COVID-19 Vaccine. They are also FDA-authorized under EUA. The multiple dose vials with purple caps\ncontain phosphate buffered saline that must be diluted with normal saline prior to administration. The\nmultidose vials with gray caps contain tromethamine (Tris) buffer and do not require dilution for\nadministration."}]}, {"title": "ddfa33da99bb672ab01bc3527fd6c9cd", "paragraphs": [{"qas": [{"question": "How many g mRNA is contained in each dose of each vaccine?", "id": "100000000000000000009676", "answers": [{"text": "30 \u03bcg", "answer_start": 152}], "is_impossible": false}, {"question": "What does the FDA say can be used interchangeably?", "id": "100000000000000000009677", "answers": [{"text": "formulations of the vaccine", "answer_start": 193}], "is_impossible": false}, {"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)?", "id": "100000000000000000009678", "answers": [{"text": "Each formulation", "answer_start": 0}], "is_impossible": false}], "context": "Each formulation, when prepared according to its respective formulation-specific instructions\nfor administration, provide 0.3 mL doses (each containing 30 \u03bcg mRNA). FDA has explained that these\nformulations of the vaccine can be used interchangeably without presenting any safety or effectiveness\nconcerns, when prepared according to their respective formulation-specific instructions for use. The EUI do not apply to the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5),\nwhich is supplied in multiple dose vials with gray caps and labels with gray borders. What are the common side effects with the COVID-19 vaccine by Pfizer-BioNTech?"}]}, {"title": "db68698c7240eb0ee7636bdb0cf0518", "paragraphs": [{"qas": [{"question": "What is the name of the Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000009681", "answers": [{"text": "9/02/2022", "answer_start": 441}], "is_impossible": false}, {"question": "When was the original CDC-issued?", "id": "100000000000000000009682", "answers": [{"text": "11/17/2021", "answer_start": 474}], "is_impossible": false}, {"question": "What has been reported after administration of the vaccine outside of clinical trials?", "id": "100000000000000000009684", "answers": [{"text": "Severe allergic reactions", "answer_start": 571}], "is_impossible": false}, {"question": "What has happened to angioedema, syncope, myocarditis and pericarditus?", "id": "100000000000000000009685", "answers": [{"text": "Severe allergic reactions", "answer_start": 571}], "is_impossible": false}], "context": "Adverse reactions following administration of the vaccine that have been reported in clinical trials and/or post\nauthorization include injection site pain, fatigue, headache, muscle pain, chills, joint pain, fever, injection site\nswelling, injection site redness, nausea, malaise, lymphadenopathy, decreased appetite, rash, pain in\nextremity, diarrhea, and vomiting. Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nWhat are possible serious side effects with the COVID-19 vaccine by Pfizer-BioNTech? Severe allergic reactions, including anaphylaxis, and other hypersensitivity reactions (e.g., rash, pruritus,\nurticaria, angioedema), syncope, myocarditis and pericarditis have been reported following administration of\nthe vaccine outside of clinical trials."}]}, {"title": "c615a71979521ab975094dfb69b9494d", "paragraphs": [{"qas": [{"question": "What are two rare, serious adverse events that have been reported after receipt of mRNA COVID-19 vaccines?", "id": "100000000000000000009686", "answers": [{"text": "Myocarditis and/or pericarditis", "answer_start": 0}], "is_impossible": false}, {"question": "What is the highest risk currently observed in males ages 12-29 years?", "id": "100000000000000000009687", "answers": [{"text": "Myocarditis", "answer_start": 0}], "is_impossible": false}, {"question": "Who should not receive the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000009688", "answers": [{"text": "males", "answer_start": 174}], "is_impossible": false}], "context": "Myocarditis and/or pericarditis are rare, serious adverse events that have\nbeen reported after receipt of mRNA COVID-19 vaccines, with the highest risk currently observed in males ages\n12\u201329 years. Who should not receive the COVID-19 vaccine by Pfizer-BioNTech?"}]}, {"title": "9009d90b1ecfdf1984a417d326dae495", "paragraphs": [{"qas": [{"question": "What section of the Comirnaty package insert contains warnings and precautions?", "id": "100000000000000000009690", "answers": [{"text": "Contraindications, and", "answer_start": 194}], "is_impossible": false}, {"question": "What should be provided to persons receiving a primary or additional dose of the COVID-19 vaccine by Pfizer-BioNTech as described in the EUI?", "id": "100000000000000000009691", "answers": [{"text": "Provide the EUI Fact Sheet for Recipients and Caregivers", "answer_start": 639}], "is_impossible": false}, {"question": "What is the name of the vaccine by Pfizer-BioNTech described in the EUI?", "id": "100000000000000000009692", "answers": [{"text": "COVID-19", "answer_start": 22}], "is_impossible": false}, {"question": "What do recipients and caregivers need?", "id": "100000000000000000009693", "answers": [{"text": "EUI Fact Sheet", "answer_start": 651}], "is_impossible": false}], "context": "Do not administer the COVID-19 vaccine by Pfizer-BioNTech to persons with known history of a severe allergic\nreaction (e.g., anaphylaxis) to a previous dose or any component of the vaccine (see Contraindications, and\nWarnings and Precautions sections in the Comirnaty package insert or Full EUA Prescribing Information as well\nas CDC\u2019s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the\nUnited States for additional considerations). What information should be provided to persons receiving a primary or additional dose of the COVID-19\nvaccine by Pfizer-BioNTech as described in the EUI? \u2022 Provide the EUI Fact Sheet for Recipients and Caregivers."}]}, {"title": "1f99e7afb83fcfa11ef9b12f3c436033", "paragraphs": [{"qas": [{"question": "What does a CDC COVID-19 Vaccination Record Card contain?", "id": "100000000000000000009694", "answers": [{"text": "lot number and date of administration recorded for the primary, additional, or booster dose of the COVID-19 vaccine", "answer_start": 94}], "is_impossible": false}, {"question": "What is the lot number and date of administration for the primary, additional, or booster dose?", "id": "100000000000000000009695", "answers": [{"text": "COVID-19 Vaccination Record Card", "answer_start": 16}], "is_impossible": false}, {"question": "Who provides the v-safe information sheet to vaccine recipients?", "id": "100000000000000000009696", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 213}], "is_impossible": false}, {"question": "What does CDC monitor?", "id": "100000000000000000009699", "answers": [{"text": "safety of COVID-19 vaccines", "answer_start": 607}], "is_impossible": false}, {"question": "What is the name of the website that provides information on the safety of COVID-19 vaccines?", "id": "100000000000000000009700", "answers": [{"text": "www.cdc.gov/vsafe", "answer_start": 665}], "is_impossible": false}], "context": "\u2022 Provide a CDC COVID-19 Vaccination Record Card to the recipient or their caregiver with the lot number\nand date of administration recorded for the primary, additional, or booster dose of the COVID-19 vaccine\nby Pfizer-BioNTech. \u2022 Provide the v-safe information sheet to vaccine recipients/caregivers and encourage vaccine recipients\nto participate in v-safe. V-safe is a voluntary smartphone-based tool that uses text messaging and web\nsurveys to check in with people who have been vaccinated to identify potential side effects after COVID-\n19 vaccination. V-safe asks questions that help CDC monitor the safety of COVID-19 vaccines. For more\ninformation, visit: www.cdc.gov/vsafe."}]}, {"title": "4758bf5196e3e448560dd66ed09c2aee", "paragraphs": [{"qas": [{"question": "What is available supporting evidence for use of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000009701", "answers": [{"text": "additional primary doses", "answer_start": 97}], "is_impossible": false}, {"question": "What has not systematically evaluated the safety, immunogenicity, and efficacy of an additional dose of the Covid-19 vaccine?", "id": "100000000000000000009702", "answers": [{"text": "CDC", "answer_start": 210}], "is_impossible": false}], "context": "What is the available supporting evidence for use of the COVID-19 vaccine by Pfizer-BioNTech for additional\nprimary doses in people who received a primary vaccination with non-FDA authorized or approved COVID-\nCDC has not systematically evaluated the safety, immunogenicity, and efficacy of an additional dose of the\nCOVID-19 vaccine by Pfizer-BioNTech following receipt of primary vaccination with a non-FDA authorized or\napproved COVID-19 vaccine. Most evidence is with use of a booster dose after primary vaccination."}]}, {"title": "ce5bb8c15743957d23441d54dc48b9d", "paragraphs": [{"qas": [{"question": "What are IgG and neutralizing antibodies?", "id": "100000000000000000009707", "answers": [{"text": "binding", "answer_start": 326}], "is_impossible": false}, {"question": "When was the AstraZeneca COVID-19 vaccine used as a heterologous boost?", "id": "100000000000000000009708", "answers": [{"text": "after primary vaccination", "answer_start": 576}], "is_impossible": false}, {"question": "What type of antibodies were generally higher when an mRNA vaccine was used?", "id": "100000000000000000009709", "answers": [{"text": "neutralizing", "answer_start": 345}], "is_impossible": false}], "context": "Studies of\nCOVID-19 vaccine boosting in the United Kingdom have shown that a third dose of AstraZeneca, Moderna, or\nPfizer-BioNTech COVID-19 vaccines successfully boosted immune responses in people who had been primed\nwith two doses of Pfizer-BioNTech or AstraZeneca COVID-19 vaccines approximately 3 months earlier. Levels of\nbinding (IgG) and neutralizing antibodies, including against Delta variant, were generally higher when an mRNA\nvaccine was used as either a heterologous or homologous boost, or where the AstraZeneca COVID-19 vaccine\nwas used as a heterologous boost after primary vaccination with the Pfizer-BioNTech COVID-19 vaccine\n(Munro et al., 2021)."}]}, {"title": "f25960fcabb65f9531e8f1fa7dc71194", "paragraphs": [{"qas": [{"question": "What vaccine was used to boost those who received the COVID-19 vaccine?", "id": "100000000000000000009710", "answers": [{"text": "AstraZeneca", "answer_start": 286}], "is_impossible": false}, {"question": "What type of boosters had higher rates of local and systemic adverse reactions?", "id": "100000000000000000009711", "answers": [{"text": "heterologous than homologous boosters", "answer_start": 108}], "is_impossible": false}], "context": "Frequencies of local and systemic adverse reactions in the 7 days post booster\nvaccination were higher with heterologous than homologous boosters and in those aged under 70 years when\ncompared to older recipients. Frequencies of local and systemic adverse reactions were higher when the\nAstraZeneca COVID-19 vaccine was used to boost those who received primary vaccination with the Pfizer-\nBioNTech COVID-19 vaccine, when compared with the Pfizer-BioNTech COVID-19 vaccine after either primary\nvaccination (Munro et al., 2021)."}]}, {"title": "310e26583852456385abdfb4576fe745", "paragraphs": [{"qas": [{"question": "Pfizer-BioNTech has additional supporting evidence for use of what vaccine?", "id": "100000000000000000009713", "answers": [{"text": "COVID-19", "answer_start": 46}], "is_impossible": false}, {"question": "What did an unpublished small, randomized trial in Bahrain find?", "id": "100000000000000000009714", "answers": [{"text": "higher levels of IgG antibodies", "answer_start": 414}], "is_impossible": false}, {"question": "How many doses of the COVID-19 vaccine did a Bahraini study show?", "id": "100000000000000000009715", "answers": [{"text": "third", "answer_start": 293}], "is_impossible": false}, {"question": "What did a third dose of Pfizer-BioNTech COVID-19 vaccine result in higher levels of?", "id": "100000000000000000009716", "answers": [{"text": "IgG antibodies", "answer_start": 430}], "is_impossible": false}, {"question": "What is the spike-antigen of SARS-CoV-2?", "id": "100000000000000000009717", "answers": [{"text": "anti-S-IgG", "answer_start": 487}], "is_impossible": false}], "context": "Additional supporting evidence for use of the COVID-19 vaccine by Pfizer-BioNTech for additional primary or\nbooster doses in people who received a non-FDA authorized or approved COVID-19 primary vaccination series\nare as follows. An unpublished small, randomized trial in Bahrain found that a third dose of Pfizer-BioNTech\nCOVID-19 vaccine after a 2-dose Sinopharm BIBP COVID-19 vaccine primary series resulted in higher levels of\nIgG antibodies against the spike-antigen of SARS-CoV-2 (anti-S-IgG) compared to a 3-dose series of Sinopharm\fPfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nBIBP COVID-19 vaccine (SAGE, 2021)."}]}, {"title": "6fba4d3d2536053b8828f42d43e4307b", "paragraphs": [{"qas": [{"question": "How many doses of the Sinopharm BIBP COVID-19 vaccine did Lebanon HCWs receive?", "id": "100000000000000000009719", "answers": [{"text": "2", "answer_start": 102}], "is_impossible": false}, {"question": "What was the dose of the Pfizer-BioNTech Covid-19 vaccine?", "id": "100000000000000000009720", "answers": [{"text": "single booster dose", "answer_start": 165}], "is_impossible": false}, {"question": "How much higher were the anti-S-IgG titers in the pilot prospective cohort study?", "id": "100000000000000000009721", "answers": [{"text": "significantly higher", "answer_start": 225}], "is_impossible": false}, {"question": "What variant of the Delta variant was given by Patamatamkul in 2021)?", "id": "100000000000000000009724", "answers": [{"text": "Delta", "answer_start": 641}], "is_impossible": false}, {"question": "What was the local and systemic reactogenicity reported to be?", "id": "100000000000000000009726", "answers": [{"text": "mild to moderate", "answer_start": 730}], "is_impossible": false}], "context": "In a pilot prospective cohort study of healthcare workers (HCWs) from\nLebanon, 50 HCWs who received a 2-dose primary series of Sinopharm BIBP COVID-19 vaccine and a single\nbooster dose of Pfizer-BioNTech COVID-19 vaccine had significantly higher anti-S-IgG titers compared to 50\nhomologous vaccinees (2 primary series doses and 1 booster dose of Pfizer-BioNTech COVID-19 vaccine)\n(Moghnieh, 2021). A longitudinal study of 41 Thai HCWs who received a 2-dose primary series of Sinovac\n(CoronaVac) COVID-19 vaccine demonstrated booster antibody responses following either AstraZeneca or\nPfizer-BioNTech COVID-19 vaccines, including against the Delta variant (Patamatamkul, 2021). Local and\nsystemic reactogenicity was reported to be mild to moderate across studies."}]}, {"title": "9b10e49651098a5ce67c5574122341f5", "paragraphs": [{"qas": [{"question": "What does VE stand for?", "id": "100000000000000000009728", "answers": [{"text": "vaccine effectiveness", "answer_start": 159}], "is_impossible": false}, {"question": "WHO\u2019s Strategic Advisory Group of Experts has noted that data on vaccine effectiveness are limited on what?", "id": "100000000000000000009729", "answers": [{"text": "safety, immunogenicity, and effectiveness of heterologous versus homologous additional doses", "answer_start": 432}], "is_impossible": false}, {"question": "On Immunization has noted that data are limited on the safety, immunogenicity, and effectiveness of what?", "id": "100000000000000000009730", "answers": [{"text": "heterologous versus homologous additional doses", "answer_start": 477}], "is_impossible": false}, {"question": "Evidence suggests that use of a heterologous vaccine for an additional dose may be more immunogenic than a homologous series of vaccines?", "id": "100000000000000000009731", "answers": [{"text": "evolving", "answer_start": 525}], "is_impossible": false}], "context": "Finally, a study from Chile\nexamining heterologous boosting with AztraZeneca or Pfizer-BioNTech among Sinovac-CoronaVac primed\nindividuals demonstrated higher vaccine effectiveness (VE) against infection, symptomatic disease, and\nintensive care unit admission compared with homologous boosting (Araos, 2021). WHO\u2019s Strategic Advisory Group of Experts (SAGE) on Immunization has noted that although data are currently\nlimited on the safety, immunogenicity, and effectiveness of heterologous versus homologous additional doses,\nevolving evidence suggests that use of a heterologous vaccine for an additional dose may be more\nimmunogenic than a homologous series."}]}, {"title": "248f1023baae035ceb42643ad098ed24", "paragraphs": [{"qas": [{"question": "Who has advised countries to consider heterologous additional doses based on supply availability?", "id": "100000000000000000009732", "answers": [{"text": "WHO", "answer_start": 215}], "is_impossible": false}, {"question": "How many people have received the Sinopharm BIBP or Sinovac- CoronaVac COVID-19 vaccines?", "id": "100000000000000000009733", "answers": [{"text": "people aged 60 years and over", "answer_start": 89}], "is_impossible": false}, {"question": "How many countries are using boosters after non-FDA authorized or approved COVID-19 vaccines?", "id": "100000000000000000009734", "answers": [{"text": "More than 80", "answer_start": 338}], "is_impossible": false}], "context": "In its recommendations for an additional dose in certain\nimmunocompromised people and in people aged 60 years and over who received Sinopharm BIBP or Sinovac-\nCoronaVac COVID-19 vaccines as a 2-dose primary series, WHO has advised that countries can consider\nheterologous additional doses based on supply availability (WHO SAGE 2021a-c). More than 80 countries are using boosters after non-FDA authorized or approved COVID-19 vaccines."}]}, {"title": "f2164398ced4bffc0061a836aa49c0c1", "paragraphs": [{"qas": [{"question": "What are other contextual factors?", "id": "100000000000000000009738", "answers": [{"text": "epidemiology of COVID-19", "answer_start": 362}], "is_impossible": false}], "context": "Countries such as the United Kingdom (JCVI, 2021a-b), Canada (National Advisory Committee on Vaccination,\n2021), Germany, and France have recommended heterologous dosing, including with use of Pfizer-BioNTech\nCOVID-19 vaccine, for an additional primary series and/or booster dose based on their reviews of available\nimmunological and safety data, as well as the epidemiology of COVID-19 and other contextual factors."}]}, {"title": "3047dd55a820566d07dc1345d5f1f871", "paragraphs": [{"qas": [{"question": "What was the Phase 1/2 open- label clinical study conducted in the United States?", "id": "100000000000000000009740", "answers": [{"text": "NCT04889209", "answer_start": 230}], "is_impossible": false}], "context": "The heterologous booster dose of Pfizer-BioNTech COVID-19 vaccine in individuals who completed primary\nvaccination with Janssen COVID-19 Vaccine is supported by the immunogenicity data from a Phase 1/2 open-\nlabel clinical study (NCT04889209) by the National Institutes of Health conducted in the United States that\nevaluated heterologous booster regimens of FDA-authorized COVID-19 vaccines."}]}, {"title": "b9709e6c54bf79ae30eab7eb58eb3e41", "paragraphs": [{"qas": [{"question": "How many weeks prior to enrollment were adults vaccinated with a Moderna COVID-19 Vaccine 2-dose series?", "id": "100000000000000000009742", "answers": [{"text": "12", "answer_start": 232}], "is_impossible": false}, {"question": "How many vaccines were given to patients with SARS-CoV-2 infection?", "id": "100000000000000000009743", "answers": [{"text": "three", "answer_start": 371}], "is_impossible": false}], "context": "In this study, adults who had\ncompleted primary vaccination with a Moderna COVID-19 Vaccine 2-dose series (N=151), a Janssen COVID-19\nVaccine single-dose (N=156), or a Pfizer-BioNTech COVID-19 vaccine 2-dose series (N=151) at least 12 weeks\nprior to enrollment and who reported no history of SARS-CoV-2 infection were randomized 1:1:1 to receive a\nbooster dose of one of three vaccines: Moderna COVID-19 Vaccine, Janssen COVID-19 Vaccine, or Pfizer-\nBioNTech COVID-19 Vaccine."}]}, {"title": "ceae429603d9866b56931941c21ee52", "paragraphs": [{"qas": [{"question": "How was a booster response demonstrated regardless of which COVID-19 vaccine?", "id": "100000000000000000009746", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine was demonstrated regardless of which COVID-19 vaccine was used for primary vaccination", "answer_start": 289}], "is_impossible": false}, {"question": "What was demonstrated regardless of which COVID-19 vaccine was used for primary vaccination?", "id": "100000000000000000009747", "answers": [{"text": "A booster response", "answer_start": 263}], "is_impossible": false}, {"question": "What did not identify any new safety concerns?", "id": "100000000000000000009748", "answers": [{"text": "An overall review of adverse reactions reported following the Pfizer-BioNTech COVID-19 vaccine heterologous booster dose", "answer_start": 410}], "is_impossible": false}, {"question": "What was reported after the Pfizer-BioNTech COVID-19 vaccine primary vaccination or homologous booster dose?", "id": "100000000000000000009749", "answers": [{"text": "adverse reactions", "answer_start": 587}], "is_impossible": false}], "context": "Neutralizing antibody titers, as measured by a pseudovirus neutralization assay\nusing a lentivirus expressing the SARS-CoV-2 Spike protein with D614G mutation, were assessed prior to\nadministration of the booster dose (Day 1) and after the booster dose (Day 15). A booster response to the\nPfizer-BioNTech COVID-19 Vaccine was demonstrated regardless of which COVID-19 vaccine was used for\nprimary vaccination. An overall review of adverse reactions reported following the Pfizer-BioNTech COVID-19\nvaccine heterologous booster dose did not identify any new safety concerns as compared to adverse reactions\nreported following the Pfizer-BioNTech COVID-19 vaccine primary vaccination or homologous booster dose\n(FDA, 2022)."}]}, {"title": "fb9027aa70ec54b6142d154d0d3535d2", "paragraphs": [{"qas": [{"question": "Small studies in solid organ transplant recipients demonstrate immunogenicity of a 4th mRNA dose when administered 1\u20132 months after the 3rd dose?", "id": "100000000000000000009751", "answers": [{"text": "Toulouse, Strasbourg, and Baltimore demonstrate immunogenicity of a 4th mRNA dose when administered 1\u20132 months after the 3rd dose (Kamar et al., 2021", "answer_start": 204}], "is_impossible": false}, {"question": "How many months after the 3rd dose?", "id": "100000000000000000009752", "answers": [{"text": "1\u20132 months", "answer_start": 304}], "is_impossible": false}], "context": "Recent studies indicate that additional doses in people who are moderately or severely immunocompromised\nare safe and can increase antibody response. Small studies in solid organ transplant recipients in Toulouse,\nStrasbourg, and Baltimore demonstrate immunogenicity of a 4th mRNA dose when administered 1\u20132 months\nafter the 3rd dose (Kamar et al., 2021; Benotmane et al., preprint; Alejo et al., 2021)."}]}, {"title": "2b2064aaef7e4d88359433c011c2f680", "paragraphs": [{"qas": [{"question": "When did multiple studies demonstrate safety and immunogenicity of a booster dose in the general population?", "id": "100000000000000000009754", "answers": [{"text": "when administered at intervals as short as 3 months following a 2-dose primary", "answer_start": 153}], "is_impossible": false}, {"question": "How long did a 2-dose primary Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet last?", "id": "100000000000000000009755", "answers": [{"text": "9/02/2022", "answer_start": 306}], "is_impossible": false}, {"question": "When was the original CDC-issued 11/17/2021?", "id": "100000000000000000009756", "answers": [{"text": "9/02/2022", "answer_start": 306}], "is_impossible": false}, {"question": "When was the first booster dose issued?", "id": "100000000000000000009757", "answers": [{"text": "11/17/2021", "answer_start": 339}], "is_impossible": false}, {"question": "How long after primary vaccination have multiple countries implemented booster doses?", "id": "100000000000000000009758", "answers": [{"text": "at least 3 months", "answer_start": 463}], "is_impossible": false}, {"question": "What is the longest interval between the first and second dose?", "id": "100000000000000000009759", "answers": [{"text": "8 weeks", "answer_start": 641}], "is_impossible": false}, {"question": "How long is the interval between the first and second dose of the mRNA vaccine?", "id": "100000000000000000009760", "answers": [{"text": "8 weeks", "answer_start": 641}], "is_impossible": false}], "context": "Multiple studies,\nincluding COV-BOOST and the NIH mix-and-match study demonstrated safety and immunogenicity of a booster\ndose in the general population when administered at intervals as short as 3 months following a 2-dose primary\fPfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nseries (Munro et al., 2021; Atmar et al., preprint). Finally, multiple countries have implemented booster doses\nat least 3 months after primary vaccination in the general population (e.g., UK, Germany, Netherlands). What is the available supporting evidence for a longer/extended interval (8 weeks) between the first and\nsecond dose in the mRNA vaccine primary series schedule?"}]}, {"title": "51cb8fc3e12a6156cda1a32cbabd9e1f", "paragraphs": [{"qas": [{"question": "What may be greater and fewer risks with a longer dosing interval?", "id": "100000000000000000009762", "answers": [{"text": "greater benefits", "answer_start": 202}], "is_impossible": false}, {"question": "What may be limited by delaying the second dose beyond an interval of 8 weeks?", "id": "100000000000000000009763", "answers": [{"text": "the benefit", "answer_start": 271}], "is_impossible": false}, {"question": "Several studies provide evidence that indicates greater immunogenicity and VE following a longer interval between the first and second dose of what?", "id": "100000000000000000009764", "answers": [{"text": "mRNA primary series", "answer_start": 503}], "is_impossible": false}], "context": "New evidence suggests that an interval longer than 3 weeks between primary series doses may reduce the risk\nof myocarditis and result in greater immunogenicity and effectiveness, such that there may be greater benefits\nand fewer risks with this dosing interval; however, the benefit of delaying the second dose beyond an interval\nof 8 weeks may be limited. Several studies provide evidence that indicate greater immunogenicity and VE following a longer interval\nbetween the first and second dose of the mRNA primary series."}]}, {"title": "f7f9ac7286c425511a60ee2b51e79661", "paragraphs": [{"qas": [{"question": "What was higher after an extended dosing interval with mRNA vaccine compared to a standard 3-4 week interval?", "id": "100000000000000000009765", "answers": [{"text": "Neutralizing antibody titers", "answer_start": 2}], "is_impossible": false}, {"question": "How many observational cohort of SARS-CoV-2 infection nave health care workers in the United Kingdom received Pfizer-BioNTech COVID-19?", "id": "100000000000000000009766", "answers": [{"text": "334", "answer_start": 302}], "is_impossible": false}, {"question": "How long after their second dose did the workers receive the Covid-19 vaccine?", "id": "100000000000000000009768", "answers": [{"text": "4 weeks", "answer_start": 512}], "is_impossible": false}], "context": "\u2022 Neutralizing antibody titers were higher following an extended dosing (6-14 weeks) interval with\nmRNA vaccine, compared to a standard 3\u20134 week interval (Payne, 2021; Grunau, 2021; Amirthalingam,\n2021; Parry, 2022). \u2022 Among an observational cohort of SARS-CoV-2 infection na\u00efve health care workers (n=334) in the\nUnited Kingdom, persons who received Pfizer-BioNTech COVID-19 Vaccine following an extended\ndosing interval (6\u201314 week) had higher neutralizing antibody titers and antigen-specific B cell\nresponses 4 weeks after their second dose, compared to persons with a short interval (3\u20134 week)\n(Payne, 2021)."}]}, {"title": "e1eef6b02f556f1b59e0d383c48305c", "paragraphs": [{"qas": [{"question": "Who observed sustained B and T cell responses?", "id": "100000000000000000009769", "answers": [{"text": "Investigators", "answer_start": 2}], "is_impossible": false}, {"question": "What may promote efficient T cell expansion and long-term memory cell persistence?", "id": "100000000000000000009770", "answers": [{"text": "the longer interval between vaccine doses", "answer_start": 71}], "is_impossible": false}, {"question": "Who conducted a large test-negative design study?", "id": "100000000000000000009771", "answers": [{"text": "Skowronski", "answer_start": 465}], "is_impossible": false}, {"question": "What was significantly higher with a longer dosing interval?", "id": "100000000000000000009772", "answers": [{"text": "two-dose mRNA VE", "answer_start": 328}], "is_impossible": false}, {"question": "What did VE appear to plateau at the 7-8 week interval?", "id": "100000000000000000009773", "answers": [{"text": "mRNA", "answer_start": 337}], "is_impossible": false}], "context": "o Investigators observed sustained B and T cell responses, noting that the longer interval\nbetween vaccine doses may promote efficient T cell expansion and long-term memory cell\npersistence (Payne, 2021). \u2022 In a large test-negative design study to evaluate VE among adults aged \u226518 years in British Columbia\nand Quebec, Canada, two-dose mRNA VE against infection and hospitalization was significantly higher\nwith a longer dosing interval (7\u20138 weeks vs. 3\u20134 weeks) (Skowronski, 2021). VE appeared to plateau at\nthe 7\u20138 week interval."}]}, {"title": "4e304d951c30e20320ebc222fd17f390", "paragraphs": [{"qas": [{"question": "What did a test-negative case control study show about Pfizer-BioNTech VE?", "id": "100000000000000000009774", "answers": [{"text": "higher with longer (>6 weeks) intervals", "answer_start": 119}], "is_impossible": false}, {"question": "How long was the interval between the first and second dose of mRNA vaccines?", "id": "100000000000000000009775", "answers": [{"text": "(>6 weeks", "answer_start": 138}], "is_impossible": false}, {"question": "What may improve the safety of mRNA vaccines for young men?", "id": "100000000000000000009776", "answers": [{"text": "A longer interval between the first and second dose", "answer_start": 235}], "is_impossible": false}], "context": "\u2022 A test-negative case control study among adults aged 50\u201389 years in England demonstrated that\nPfizer-BioNTech VE was higher with longer (>6 weeks) intervals compared to short (3\u20134 weeks)\nintervals for all age groups (Amirthalingam). A longer interval between the first and second dose of mRNA vaccines may improve safety, especially for\nyoung men."}]}, {"title": "ab6728d3475fead7f353952daedcfe01", "paragraphs": [{"qas": [{"question": "What is the name of the vaccine that was used in the retrospective cohort?", "id": "100000000000000000009778", "answers": [{"text": "Moderna-Moderna", "answer_start": 629}], "is_impossible": false}, {"question": "How long did it take to get the vaccine?", "id": "100000000000000000009779", "answers": [{"text": "\u22658 weeks", "answer_start": 536}], "is_impossible": false}, {"question": "How many vaccine doses were given at extended intervals?", "id": "100000000000000000009780", "answers": [{"text": "\u22658 weeks", "answer_start": 536}], "is_impossible": false}, {"question": "What were the reported rates of myocarditis?", "id": "100000000000000000009781", "answers": [{"text": "greater", "answer_start": 260}], "is_impossible": false}, {"question": "How long did it take for people to receive their second vaccine?", "id": "100000000000000000009782", "answers": [{"text": "\u22658 weeks", "answer_start": 536}], "is_impossible": false}], "context": "\u2022 In an unpublished (preprint) retrospective population-based cohort using Canada\u2019s provincial vaccine\nregistry and passive vaccine safety surveillance between December 2020 and September 2021,\nreported rates of myocarditis/pericarditis among all persons were greater with shorter intervals (3\u20134\nweeks) between dose 1 and dose 2 compared to extended intervals (\u22658 weeks) for both Moderna\n(Buchan, preprint). \u2022 The lower reported rates of myocarditis/pericarditis among persons receiving their second vaccine\ndose at extended intervals (\u22658 weeks) was observed across schedules of mRNA vaccine primary series\n(i.e., Pfizer-Pfizer, Moderna-Moderna, Pfizer-Moderna) (Buchan, preprint)."}]}, {"title": "81a670f7bb709b367340a4d45aea9172", "paragraphs": [{"qas": [{"question": "What have countries recommended for extended mRNA vaccine primary series dosing?", "id": "100000000000000000009784", "answers": [{"text": "all persons or specific sub- groups, based on their reviews of available immunological, safety, and effectiveness data", "answer_start": 176}], "is_impossible": false}, {"question": "What is the evidence for delaying the second dose in people who recently had SARS-CoV-2 infection by 3 months from symptom onset or positive test if infection was asymptomatic?", "id": "100000000000000000009785", "answers": [{"text": "available supporting evidence", "answer_start": 407}], "is_impossible": false}], "context": "Countries such as Australia, Canada, Denmark, Finland, France, Germany, Norway, Taiwan, and the United\nKingdom have recommended extended mRNA vaccine primary series dosing for all persons or specific sub-\ngroups, based on their reviews of available immunological, safety, and effectiveness data, as well as the\nepidemiology of COVID-19, operational considerations, and other contextual factors. What is the available supporting evidence for delaying the second primary dose in people who recently had\nSARS-CoV-2 infection by 3 months from symptom onset or positive test (if infection was asymptomatic)?"}]}, {"title": "de9cc30caf2d50c29b4b8eabc0722b0", "paragraphs": [{"qas": [{"question": "What is the original date of the Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000009786", "answers": [{"text": "11/17/2021", "answer_start": 107}], "is_impossible": false}, {"question": "What does SARS-CoV-2 infection induce?", "id": "100000000000000000009787", "answers": [{"text": "a robust humoral and cellular immune response", "answer_start": 148}], "is_impossible": false}, {"question": "How long does a longer interval between infection and vaccination allow for the immune response to mature?", "id": "100000000000000000009788", "answers": [{"text": "3 or 6 months", "answer_start": 251}], "is_impossible": false}, {"question": "How long have studies observed decreased risk of subsequent infection?", "id": "100000000000000000009790", "answers": [{"text": "80-93%", "answer_start": 570}], "is_impossible": false}, {"question": "What may delay vaccination for 3 months?", "id": "100000000000000000009791", "answers": [{"text": "after infection", "answer_start": 651}], "is_impossible": false}, {"question": "Delaying vaccination for 3 months after infection may help to maximize protection with what?", "id": "100000000000000000009792", "answers": [{"text": "minimal risk to the individual", "answer_start": 714}], "is_impossible": false}], "context": "Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nSARS-CoV-2 infection induces a robust humoral and cellular immune response (CDC, 2021). Additionally, a\nlonger interval of at least 3 or 6 months between infection and vaccination may improve immune response by\nallowing time for the response to mature and avoiding interference from the vaccine (Abu-Raddad L, 2021;\nZhong, 2021). Multiple large-scale studies have observed decreased risk of subsequent infection with\nantigenically similar variants by 80-93% for months after infection (CDC, 2021). Delaying vaccination for 3\nmonths after infection may therefore help to maximize protection with minimal risk to the individual."}]}, {"title": "30d0f1095380baca5a840e4abcb019cd", "paragraphs": [{"qas": [{"question": "What are two factors that can impact level of protection?", "id": "100000000000000000009793", "answers": [{"text": "age and comorbidities", "answer_start": 189}], "is_impossible": false}, {"question": "What was the overall risk of reinfection during the Omicron wave?", "id": "100000000000000000009794", "answers": [{"text": "increased", "answer_start": 285}], "is_impossible": false}], "context": "However, robustness and duration of protection is variable (National Collaborating Center for Methods and\nTools, 2021). The circulating variant, as well as individual-level factors such as age and comorbidities, can\nimpact level of protection. For example, overall risk of reinfection increased during the Omicron wave, and\nprotection from infection or vaccination, was less robust than against previous variants (Pulliam et al., 2022). Additionally, some populations (e.g., older adults, immunocompromised) may have decreased levels of\nprotection following infection, necessitating an interval that balances the benefits and risks of delaying\nvaccination after infection at a population level."}]}, {"title": "229fbe93e83b4a69ef720f3fbe556e75", "paragraphs": [{"qas": [{"question": "Numerous immunologic studies and growing number of epidemiologic studies have shown that vaccinating previously infected individuals significantly enhances their immune response and effectively reduces the risk of subsequent infection.", "id": "100000000000000000009799", "answers": [{"text": "Vaccination continues to be recommended regardless of the option for delaying vaccination after infection. Numerous immunologic studies and a growing number of epidemiologic studies have shown that vaccinating previously infected individuals significantly enhances their immune response and effectively reduces the risk of subsequent infection, including in the setting of increased circulation of more infectious variants", "answer_start": 0}], "is_impossible": false}], "context": "Vaccination continues to be recommended regardless of the option for delaying vaccination after infection. Numerous immunologic studies and a growing number of epidemiologic studies have shown that vaccinating\npreviously infected individuals significantly enhances their immune response and effectively reduces the risk of\nsubsequent infection, including in the setting of increased circulation of more infectious variants (CDC, 2021). What is the available supporting evidence for revaccination of people who received COVID-19 vaccine during\nB-cell-depleting therapy administered over a limited period?"}]}, {"title": "392c85c918a8a109d1bc503de52e2c66", "paragraphs": [{"qas": [{"question": "What do studies of people on B-cell-depleting therapies indicate patients do not achieve adequate seroconversion if they were vaccinated during therapy?", "id": "100000000000000000009801", "answers": [{"text": "decreased odds ratio", "answer_start": 115}], "is_impossible": false}, {"question": "The timing of vaccination relative to therapy influences what?", "id": "100000000000000000009802", "answers": [{"text": "vaccine immunogenicity", "answer_start": 289}], "is_impossible": false}, {"question": "How long after therapy has improved seroconversion?", "id": "100000000000000000009803", "answers": [{"text": "6 months", "answer_start": 334}], "is_impossible": false}, {"question": "What is the option to be revaccinated for people who received vaccination during therapy?", "id": "100000000000000000009804", "answers": [{"text": "would allow the opportunity to develop a more sufficient immune response", "answer_start": 527}], "is_impossible": false}], "context": "Studies of people on B-cell-depleting therapies indicate patients do not achieve adequate seroconversion or\nhave a decreased odds ratio of seroconversion if they were vaccinated during therapy (Haggenberg, 2022a;\nHaggenberg, 2022b).The timing of vaccination relative to therapy influences vaccine immunogenicity;\nvaccination at least 6 months after therapy has demonstrated improved seroconversion (Kornek, 2022;\nSchietzel, 2022, Disanto, 2021). The option to be revaccinated for people who received vaccination during\ntherapy would allow the opportunity to develop a more sufficient immune response."}]}, {"title": "e260129c343aa2cc65e5798191feb021", "paragraphs": [{"qas": [{"question": "What did clinical studies of 2-dose primary series support benefit of?", "id": "100000000000000000009806", "answers": [{"text": "COVID-19 vaccine", "answer_start": 319}], "is_impossible": false}, {"question": "Pfizer-BioNTech's vaccine prevented severe what?", "id": "100000000000000000009807", "answers": [{"text": "COVID-19", "answer_start": 376}], "is_impossible": false}, {"question": "Pfizer-BioNTech's effectiveness in preventing severe COVID-19 was supported by what?", "id": "100000000000000000009808", "answers": [{"text": "FDA approval", "answer_start": 403}], "is_impossible": false}], "context": "Risk\u2010Benefit of the COVID-19 vaccine by Pfizer-BioNTech as Primary or Additional Vaccination for Individuals\nDescribed in the EUI\nThe duration of vaccine-induced protection from primary vaccination with COVID-19 vaccines is unknown. Efficacy data from clinical studies of 2-dose primary series supported benefit of the COVID-19 vaccine by\nPfizer-BioNTech in preventing severe COVID-19 and supported its FDA approval. Effectiveness of an additional\nprimary dose of the COVID-19 vaccine by Pfizer-BioNTech is inferred from immunogenicity data in\nimmunocompromised adults who received a single additional primary dose."}]}, {"title": "732cde5b104cd1feacc51fcf290a4f83", "paragraphs": [{"qas": [{"question": "What was the relative vaccine efficacy of the COVID-19 vaccine among people aged 16 years and older?", "id": "100000000000000000009810", "answers": [{"text": "95.3%", "answer_start": 64}], "is_impossible": false}, {"question": "What percentage of the confidence interval was 89.5%, 98.3%?", "id": "100000000000000000009811", "answers": [{"text": "95%", "answer_start": 71}], "is_impossible": false}, {"question": "When was the booster dose of the vaccine administered?", "id": "100000000000000000009812", "answers": [{"text": "between 10\u201312 months following completion of primary series) in the previous 2 months", "answer_start": 247}], "is_impossible": false}, {"question": "How long after completion of the primary series did people who received a booster dose receive the vaccine?", "id": "100000000000000000009813", "answers": [{"text": "10\u201312 months", "answer_start": 255}], "is_impossible": false}, {"question": "What were the rates of local or systemic adverse events in these trials similar or lower after a booster dose than after the second primary dose?", "id": "100000000000000000009814", "answers": [{"text": "lower", "answer_start": 468}], "is_impossible": false}], "context": "Clinical trials demonstrated that\nrelative vaccine efficacy was 95.3% (95% confidence interval: 89.5%, 98.3%) among persons aged 16 years and\nolder who received a booster dose of the COVID-19 vaccine by Pfizer-BioNTech (administered predominantly\nbetween 10\u201312 months following completion of primary series) in the previous 2 months, compared to those\nwho had only completed two primary doses. Rates of local or systemic adverse events in these trials were\nsimilar or lower after a booster dose than after the second primary dose (Perez, 2021; Gruber, 2021)."}]}, {"title": "7dfa5f08b44e2909bb97609ee84d57c8", "paragraphs": [{"qas": [{"question": "How many people received a booster dose of the COVID-19 vaccine by Pfizer-BioNTech at least 5 months after primary vaccination?", "id": "100000000000000000009815", "answers": [{"text": "over 4.1 million", "answer_start": 130}], "is_impossible": false}, {"question": "What did the Ministry of Health of Israel reveal about the safety of the vaccine?", "id": "100000000000000000009816", "answers": [{"text": "no new safety concerns", "answer_start": 307}], "is_impossible": false}, {"question": "What is limited by available data on the safety or efficacy of a Pfizer-BioNTech COVID-19 vaccine dose?", "id": "100000000000000000009818", "answers": [{"text": "after receipt of a non-FDA authorized or approved COVID-19 vaccine", "answer_start": 415}], "is_impossible": false}], "context": "Additionally, the real world data from the Ministry of Health of Israel that included over 6,300 individuals aged\n12\u201315 years and over 4.1 million individuals aged 16 years and older who received a booster dose of the\nCOVID-19 vaccine by Pfizer-BioNTech at least 5 months after primary vaccination revealed no new safety\nconcerns. Available data on the safety or efficacy of a Pfizer-BioNTech COVID-19 vaccine dose after receipt of a non-FDA\nauthorized or approved COVID-19 vaccine are limited."}]}, {"title": "e0f4a1aaae7784f3bbf7d3c04bf1f158", "paragraphs": [{"qas": [{"question": "What may be outweighed by the potential risks of an additional primary dose of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000009819", "answers": [{"text": "its likely benefit to enhance or restore protection by the primary vaccination", "answer_start": 202}], "is_impossible": false}, {"question": "What might have waned over time in people with immunocompromising conditions?", "id": "100000000000000000009820", "answers": [{"text": "primary vaccination", "answer_start": 261}], "is_impossible": false}, {"question": "What is being revised to no longer provide for certain booster dose uses of the COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000009821", "answers": [{"text": "EUI", "answer_start": 432}], "is_impossible": false}], "context": "However, based on available information, it appears\nreasonable to anticipate that known and potential risks of an additional primary dose of the COVID-19 vaccine\nby Pfizer-BioNTech may be outweighed by its likely benefit to enhance or restore protection by the primary\nvaccination, which might have waned over time, especially in people with immunocompromising conditions or\ntaking immunosuppressive medications. In addition, these EUI are being revised to no longer provide for certain booster dose uses of the COVID-19 vaccine by\nPfizer-BioNTech."}]}, {"title": "9e3bb3955bd7ea4b2a917abf901ef645", "paragraphs": [{"qas": [{"question": "What is the original name of the Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000009822", "answers": [{"text": "Omicron", "answer_start": 84}], "is_impossible": false}, {"question": "When was the original CDC-issued BA.4/BA.5) issued by the FDA?", "id": "100000000000000000009823", "answers": [{"text": "11/17/2021", "answer_start": 199}], "is_impossible": false}, {"question": "What does the FDA want to improve by approving the Moderna Covid-19 vaccine?", "id": "100000000000000000009824", "answers": [{"text": "protection conferred by COVID-19 booster doses against the currently circulating Omicron variant of SARS-CoV- 2, resulting in a more favorable benefit/risk balance", "answer_start": 335}], "is_impossible": false}], "context": "The FDA has authorized the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron\fPfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nBA.4/BA.5) and the Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) for the express purpose of\nimproving protection conferred by COVID-19 booster doses against the currently circulating Omicron variant of SARS-CoV-\n2, resulting in a more favorable benefit/risk balance as compared to the use of the COVID-19 vaccine by Pfizer-BioNTech."}]}, {"title": "48a53858060d221094ae9640b0b9813", "paragraphs": [{"qas": [{"question": "What is being revised to no longer provide for the use of the monovalent COVID-19 vaccine by Pfizer-BioNTech?", "id": "100000000000000000009828", "answers": [{"text": "EUI", "answer_start": 232}], "is_impossible": false}, {"question": "What does Pfizer-BioNTech use for certain booster dose uses?", "id": "100000000000000000009829", "answers": [{"text": "COVID-19 vaccine", "answer_start": 58}], "is_impossible": false}, {"question": "What are the only FDA-approved vaccines for which EUI provides for primary, additional, and/or booster doses?", "id": "100000000000000000009830", "answers": [{"text": "Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine", "answer_start": 518}], "is_impossible": false}, {"question": "What type of vaccines are EUI approved for?", "id": "100000000000000000009831", "answers": [{"text": "bivalent booster vaccines", "answer_start": 186}], "is_impossible": false}], "context": "Consequently, the benefit/risk balance for the use of the COVID-19 vaccine by Pfizer-BioNTech for booster dose use is\nexpected to be less favorable compared to the available alternative bivalent booster vaccines. Accordingly, these EUI are\nbeing revised to no longer provide for the use of the monovalent COVID-19 vaccine by Pfizer-BioNTech for certain booster\ndose uses. Refer to the CDC\u2019s Interim Clinical Considerations for Use of COVID-19 Vaccines for additional information. Available Alternatives\nCurrently, the Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine are the only FDA-approved\nvaccines for which EUI provide for primary, additional, and/or booster dose administration."}]}, {"title": "11f46290afdfb1708cb87e7a6270f266", "paragraphs": [{"qas": [{"question": "What is the acronym for Multisystem Inflammatory Syndrome?", "id": "100000000000000000009836", "answers": [{"text": "MIS", "answer_start": 426}], "is_impossible": false}, {"question": "What does MIS stand for?", "id": "100000000000000000009837", "answers": [{"text": "Multisystem Inflammatory Syndrome", "answer_start": 391}], "is_impossible": false}, {"question": "How do you report COVID-19?", "id": "100000000000000000009839", "answers": [{"text": "result in hospitalization or death", "answer_start": 484}], "is_impossible": false}, {"question": "What is the number for VAERS reporting?", "id": "100000000000000000009841", "answers": [{"text": "1-800-822-7967", "answer_start": 659}], "is_impossible": false}, {"question": "Who is the author of this article?", "id": "100000000000000000009842", "answers": [{"text": "Abu-Raddad L, Chemaitelly H, Ayoub HH", "answer_start": 686}], "is_impossible": false}], "context": "Reporting Adverse Event or Medication Errors\nThe vaccination provider is responsible for mandatory reporting of the following to the Vaccine Adverse Event\nReporting System (VAERS):\n\u2022 vaccine administration errors whether or not associated with an adverse event,\n\u2022 serious adverse events (irrespective of attribution to vaccination),\n\u2022 cases of myocarditis\n\u2022 cases of pericarditis\n\u2022 cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and\n\u2022 cases of COVID-19 that result in hospitalization or death. Complete and submit reports to VAERS online at https://vaers.hhs.gov/reportevent.html. For further assistance with reporting to VAERS call 1-800-822-7967. References\nAbu-Raddad L, Chemaitelly H, Ayoub HH, et al."}]}, {"title": "b1eb2ecd0d44b6ee8d823f47f2027fce", "paragraphs": [{"qas": [{"question": "What is the association of Prior SARS-CoV-2 Infection with Risk of Breakthrough Infection Following mRNA Vaccination in Qatar?", "id": "100000000000000000009843", "answers": [{"text": "JAMA. 2021;326(19):1930-1939", "answer_start": 115}], "is_impossible": false}, {"question": "When did Alejo J., et al. Antibody Response to a Fourth Dose of a Vaccine in Solid Organ Transplant Recipients: A Case Series?", "id": "100000000000000000009844", "answers": [{"text": "2021", "answer_start": 290}], "is_impossible": false}, {"question": "What is the date of the Covid-19 vaccine effectiveness assessment in Chile?", "id": "100000000000000000009845", "answers": [{"text": "25 October 2021", "answer_start": 494}], "is_impossible": false}, {"question": "Who is the author of the Heterologous SARS-CoV-2 Booster Vaccinations Preliminary Report?", "id": "100000000000000000009846", "answers": [{"text": "Atmar, R.L.,", "answer_start": 595}], "is_impossible": false}], "context": "Association of Prior SARS-CoV-2 Infection With Risk of\nBreakthrough Infection Following mRNA Vaccination in Qatar. JAMA. 2021;326(19):1930-1939. Alejo J., et al. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant\nRecipients: A Case Series. Transplantation 2021;105(21):e280-e281. Amirthalingam G, Bernal, JL, Andrews, NJ, et al. Serological responses and vaccine effectiveness for extended\nAraos R, Jara A. Covid-19 vaccine effectiveness assessment in Chile - 25 October 2021\n(https://cdn.who.int/media/docs/default-source/blue-print/chile_rafael-araos_who-vr-\nAtmar, R.L., et al. Heterologous SARS-CoV-2 Booster Vaccinations \u2013 Preliminary Report. medRxiv Preprint."}]}, {"title": "a306c65c390a15fbe5ea2ff9343cc889", "paragraphs": [{"qas": [{"question": "What does a fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improve in kidney transplant recipients?", "id": "100000000000000000009847", "answers": [{"text": "serum neutralization against the delta variant", "answer_start": 139}], "is_impossible": false}, {"question": "When was the original CDC-issued COVID-19 Vaccine EUI Healthcare Providers Fact Sheet issued?", "id": "100000000000000000009850", "answers": [{"text": "11/17/2021", "answer_start": 476}], "is_impossible": false}, {"question": "What is a science brief of SARS-CoV-2 infection-induced immunity?", "id": "100000000000000000009851", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet", "answer_start": 369}], "is_impossible": false}, {"question": "What does Anti-CD20 Infusion Timing Have to Do with Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis?", "id": "100000000000000000009852", "answers": [{"text": "Association of Disease-Modifying Treatment", "answer_start": 608}], "is_impossible": false}, {"question": "What is the JAMA Neurology 78(12):1529-1531?", "id": "100000000000000000009853", "answers": [{"text": "FDA", "answer_start": 804}], "is_impossible": false}], "context": "Benotmane, I., Bruel T., Planas, D., Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273\nSARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients. Buchan SA, et al. Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by\nvaccine product, schedule and interval. Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nCDC. Science Brief: SARS-CoV-2 infection-induced and vaccine-induced immunity. 2021. Disanto G, Sacco R, Bernasconi, E. Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing\nWith Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis. JAMA Neurology. 2021;78(12):1529-1531. FDA."}]}, {"title": "ff2913a9f0c74ded818075c55a96000b", "paragraphs": [{"qas": [{"question": "When was the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 vaccine Revised?", "id": "100000000000000000009855", "answers": [{"text": "January 3, 2022", "answer_start": 173}], "is_impossible": false}, {"question": "Who is the Advisory Committee on Immunization Practices meeting, September 22, 2021?", "id": "100000000000000000009856", "answers": [{"text": "Healthcare Providers", "answer_start": 15}], "is_impossible": false}, {"question": "What is a higher antibody response generated with a 6- to 7-week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Dosing Interval?", "id": "100000000000000000009857", "answers": [{"text": "Grunau B et al", "answer_start": 343}], "is_impossible": false}, {"question": "What is the name of the COVID-19 booster vaccine programme?", "id": "100000000000000000009859", "answers": [{"text": "Joint Committee on Vaccination and Immunisation", "answer_start": 549}], "is_impossible": false}, {"question": "What year is the programme for winter 2021 to 2022?", "id": "100000000000000000009860", "answers": [{"text": "COVID-19 booster vaccine programme for winter 2021 to 2022. London (United Kingdom): Department of Health & Social Care; programme-for-winter-2021-to-2022", "answer_start": 632}], "is_impossible": false}, {"question": "Where is the Department of Health & Social Care located?", "id": "100000000000000000009861", "answers": [{"text": "London (United Kingdom", "answer_start": 692}], "is_impossible": false}], "context": "Fact Sheet for Healthcare Providers Administering Vaccine. Emergency Use Authorization of the Pfizer-\nBioNTech COVID-19 Vaccine to Prevent Coronavirus Disease 2019, Revised January 3, 2022\nGruber, W. BNT162b2 [COMIRNATY\u00ae (COVID-19 Vaccine, mRNA)] Booster (Third) Dose. Advisory Committee\non Immunization Practices meeting, September 22, 2021:\nGrunau B et al. A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute\nRespiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval. Clin Infect Dis. 2021 Nov 30:\nJoint Committee on Vaccination and Immunisation (JCVI). JCVI statement regarding a COVID-19 booster\nvaccine programme for winter 2021 to 2022. London (United Kingdom): Department of Health & Social Care;\nprogramme-for-winter-2021-to-2022."}]}, {"title": "83b88f39b961c02251e906e991f0bcc2", "paragraphs": [{"qas": [{"question": "Where is London, United Kingdom located?", "id": "100000000000000000009864", "answers": [{"text": "London", "answer_start": 97}], "is_impossible": false}, {"question": "Infection Diseases 2021;4(11):e2136030.", "id": "100000000000000000009865", "answers": [{"text": "third primary dose vaccination", "answer_start": 65}], "is_impossible": false}, {"question": "What is sufficient antibody response in majority of immunocompromised hematology patients?", "id": "100000000000000000009866", "answers": [{"text": "Three-dose mRNA-1273 vaccination schedule", "answer_start": 532}], "is_impossible": false}, {"question": "What is the mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients?", "id": "100000000000000000009867", "answers": [{"text": "sufficient antibody response", "answer_start": 575}], "is_impossible": false}], "context": "Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London\n(United Kingdom): Department of Health & Social Care; 1 Sept 2021.\nimmunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-\nprimary-dose-vaccination. Kamar, N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA-based vaccine in\nrecipients of a solid organ transplant. Infection Diseases 2021;4(11):e2136030. Haggenburg S, Hofsink Q, Lissenberg-Witte BI, et al. Three-dose mRNA-1273 vaccination schedule: sufficient\nantibody response in majority of immunocompromised hematology patients. medRxiv. 2022a. Preprint. doi:\nHaggenburg S, Lissenberg-Witte B.I, van Binnendijk RS., et al. Quantitative analysis of mRNA-1273 COVID-19\nvaccination response in immunocompromised adult hematology patients. Blood Advances. 2022;6(5):1537-\n1546."}]}, {"title": "51833cc0c3c4989ea2e5bcd7aab5ef75", "paragraphs": [{"qas": [{"question": "What does SAGE stand for?", "id": "100000000000000000009870", "answers": [{"text": "Strategic Advisory Group of Experts on Immunization", "answer_start": 174}], "is_impossible": false}, {"question": "What is needed for older persons who have received 2 doses of inactivated COVID-19 vaccines?", "id": "100000000000000000009872", "answers": [{"text": "3rd dose", "answer_start": 325}], "is_impossible": false}], "context": "Kornek B, Leutmezer F, Rommer PS, et al. B Cell Depletion and SARS-CoV-2 Vaccine Responses in\nNeuroimmunologic Patients. Annals of Neurology. 2022;91:342-352. Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) \u2013 5 October 2021. Geneva: World\nHealth Organization; 2021. Kaslow DC. Policy question: Is a 3rd dose needed for older persons who have\nreceived 2 doses of inactivated COVID-19 vaccines? https://www.who.int/news-\nroom/events/detail/2021/10/04/default-calendar/sage_meeting_october_2021. Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nMoghnieh R, Mekdashi R, El-Hassan S, et al."}]}, {"title": "d794401a3fc771e3a0eaaad1d576157b", "paragraphs": [{"qas": [{"question": "How many doses of ChAdOx1 nCov-19 or BNT162b2 were given as a third dose of COVID-19?", "id": "100000000000000000009874", "answers": [{"text": "two", "answer_start": 340}], "is_impossible": false}, {"question": "What is the name of the booster used in the pilot prospective cohort study?", "id": "100000000000000000009875", "answers": [{"text": "BNT162b2", "answer_start": 37}], "is_impossible": false}, {"question": "What is the name of the study that was a blinded, multicentre, randomised, controlled, phase 2 trial?", "id": "100000000000000000009877", "answers": [{"text": "COV-BOOST", "answer_start": 392}], "is_impossible": false}, {"question": "When was the National Advisory Committee Statement: Guidance on booster COVID-19 vaccine doses in Canada published?", "id": "100000000000000000009878", "answers": [{"text": "3 Dec 2021", "answer_start": 651}], "is_impossible": false}, {"question": "What is the name of the public health agency of Canada?", "id": "100000000000000000009879", "answers": [{"text": "Public Health Agency of Canada", "answer_start": 619}], "is_impossible": false}, {"question": "When is the date of the Public Health Agency of Canada's announcement?", "id": "100000000000000000009880", "answers": [{"text": "3 Dec 2021", "answer_start": 651}], "is_impossible": false}, {"question": "Where is the National Collaborating Centre for Methods and Tools located?", "id": "100000000000000000009881", "answers": [{"text": "Canada", "answer_start": 611}], "is_impossible": false}], "context": "Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-\nCorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective\ncohort study from Lebanon. Vaccine 2021; 139:6713-9. Munro, Alasdair PS, et al. \"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet (2021). National Advisory Committee on Vaccination. An Advisory Committee Statement: Guidance on booster COVID-\n19 vaccine doses in Canada. Public Health Agency of Canada; 3 Dec 2021.\nhttps://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-\nvaccine-doses.pdf\nNational Collaborating Centre for Methods and Tools."}]}, {"title": "346d72b6d24d5844f07b2581f540b4ea", "paragraphs": [{"qas": [{"question": "What is the current effectiveness, immunogenicity, and safety of COVID-19 vaccines in persons who have had a prior, confirmed infection?", "id": "100000000000000000009882", "answers": [{"text": "Rapid Review Update 1: What is the ongoing effectiveness", "answer_start": 0}], "is_impossible": false}, {"question": "Hamilton (ON): McMaster University; 2021.", "id": "100000000000000000009883", "answers": [{"text": "COVID-19 vaccines", "answer_start": 88}], "is_impossible": false}, {"question": "Induction of robust neutralizing antibodies against the COVID-19 Delta variant with what?", "id": "100000000000000000009887", "answers": [{"text": "ChAdOx1 nCoV-19 or BNT162b2", "answer_start": 520}], "is_impossible": false}, {"question": "What does Longet S, Austin JA, et al. 2021. Immunogenicity of standard and extended dosing intervals of BNT162b2 vaccine?", "id": "100000000000000000009888", "answers": [{"text": "Payne RP", "answer_start": 695}], "is_impossible": false}], "context": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19 infection?. Hamilton (ON): McMaster University; 2021. Available from: https://www.nccmt.ca/covid-\n19/covid-19-rapid-evidence-service/36. Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPatamatamkul S, Thammawat S, Buranrat B. Induction of robust neutralizing antibodies against the COVID-19\nDelta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with\nCoronaVac. medRxiv 2021.09.25.21264099; doi: https://doi.org/10.1101/2021.09.25.21264099. Payne RP, Longet S, Austin JA, et al. 2021. Immunogenicity of standard and extended dosing intervals of\nBNT162b2 mRNA vaccine. Cell."}]}, {"title": "25e03ec93c6a95fbaeef50f37aa10b37", "paragraphs": [{"qas": [{"question": "What is the name of the Advisory Committee on Immunization Practices meeting held on November 19, 2021?", "id": "100000000000000000009889", "answers": [{"text": "Skowronski DM", "answer_start": 397}], "is_impossible": false}, {"question": "What is the date of the Committee on Immunization Practices meeting?", "id": "100000000000000000009891", "answers": [{"text": "November 19, 2021", "answer_start": 379}], "is_impossible": false}, {"question": "How many patients had cellular immune responses on SARS-CoV-2 vaccines?", "id": "100000000000000000009894", "answers": [{"text": "1342", "answer_start": 786}], "is_impossible": false}, {"question": "What is the name of the systematic review and meta-analysis of 1342 patients?", "id": "100000000000000000009895", "answers": [{"text": "Schietzel S, Anderegg M, Limacher A, et al. Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies", "answer_start": 602}], "is_impossible": false}], "context": "doi: 10.1016/j.cell.2021.10.011\nPulliam JRC, van Schalkwyk C, Govender N, et al. Increased risk of SARS-CoV-2 reinfection associated with\nemergence of the Omicron variant in South Africa. 2022. https://doi.org/10.1101/2021.11.11.21266068\nPerez, J. Efficacy and safety of BNT162b2 booster \u2013 C4591031 2 month interim analysis. Advisory Committee\non Immunization Practices meeting, November 19, 2021:\nSkowronski DM. 2021, MedRxiv preprint. Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules\nand extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada. Schietzel S, Anderegg M, Limacher A, et al. Humoral and cellular immune responses on SARS-CoV-2 vaccines in\npatients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients. Infections. 2022;8:e002036."}]}, {"title": "7ccd3381c7d6cd29393b5a82a2007f43", "paragraphs": [{"qas": [{"question": "What is the acronym for WHO Strategic Advisory Group of Experts on Immunization?", "id": "100000000000000000009896", "answers": [{"text": "SAGE", "answer_start": 90}], "is_impossible": false}, {"question": "When was the Interim recommendations for an extended primary series with an additional vaccine dose updated?", "id": "100000000000000000009897", "answers": [{"text": "26 October 2021", "answer_start": 247}], "is_impossible": false}, {"question": "Who issued the EUI Healthcare Providers Fact Sheet?", "id": "100000000000000000009898", "answers": [{"text": "Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC", "answer_start": 332}], "is_impossible": false}, {"question": "What is the name of the WHO Strategic Advisory Group of Experts on Immunization?", "id": "100000000000000000009899", "answers": [{"text": "SAGE", "answer_start": 90}], "is_impossible": false}, {"question": "Who developed the recommendations for use of CoronaVac?", "id": "100000000000000000009900", "answers": [{"text": "Sinovac Interim guidance", "answer_start": 608}], "is_impossible": false}], "context": "doi:10.1136/rmdopen-2021-002036. WHO Strategic Advisory Group of Experts on Immunization (SAGE). Interim recommendations for an extended\nprimary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised\npersons;.updated 26 October 2021. Geneva: World Health Organization; 2021.\nimmunocompromised-persons. Pfizer-BioNTech COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 9/02/2022; originally CDC-issued 11/17/2021;\nWHO Strategic Advisory Group of Experts on Immunization (SAGE). Interim recommendations for use of the\ninactivated COVID-19 vaccine, CoronaVac, developed by Sinovac Interim guidance; updated 21 October 2021. Geneva: World Health Organization; 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-\nvaccines-SAGE_recommendation-Sinovac-CoronaVac-2021.1. WHO Strategic Advisory Group of Experts on Immunization (SAGE)."}]}, {"title": "1c0e0011da19e1df35c1264ef6b3d4a", "paragraphs": [{"qas": [{"question": "When was the BIBP updated?", "id": "100000000000000000009903", "answers": [{"text": "28 October 2021", "answer_start": 141}], "is_impossible": false}], "context": "Interim recommendations for use of the\ninactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm; updated 28\nOctober 2021. Geneva: World Health Organization; 2021. https://www.who.int/publications/i/item/WHO-\n2019-nCoV-vaccines-SAGE-recommendation-BIBP. Zhong D, Xiao S, Debes AK, Egbert ER, Caturegli P, Colantuoni E, et al. Durability of Antibody Levels After\nVaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection. JAMA. 2021 Dec"}]}, {"title": "61e822520157c01d74041c865fb22880", "paragraphs": [{"qas": [{"question": "Who completed the prevaccination checklist for COVID-19 Vaccines Information for Healthcare Professionals?", "id": "100000000000000000009906", "answers": [{"text": "the recipient", "answer_start": 136}], "is_impossible": false}, {"question": "What can be given based on the answers to the questions?", "id": "100000000000000000009907", "answers": [{"text": "COVID-19 vaccine", "answer_start": 230}], "is_impossible": false}], "context": "Prevaccination Checklist\nfor COVID-19 Vaccines\nInformation for Healthcare Professionals\nUsing the prevaccination checklist completed by the recipient, review clinical guidance based on the answers to the questions to\ndetermine if COVID-19 vaccine can be given."}]}, {"title": "70842c2986687dedbf5271ecb000f086", "paragraphs": [{"qas": [{"question": "What are the Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States?", "id": "100000000000000000009908", "answers": [{"text": "Advisory Committee on Immunization Practices on Immunization General Best Practice Guidelines", "answer_start": 143}], "is_impossible": false}, {"question": "What is the Advisory Committee on Immunization Practices about Immunization General Best Practice Guidelines?", "id": "100000000000000000009909", "answers": [{"text": "Interim Clinical Considerations for Use of COVID-19 Vaccines", "answer_start": 26}], "is_impossible": false}, {"question": "What are people with a history of:  Allergy-related contraindication to a different type of?", "id": "100000000000000000009911", "answers": [{"text": "\u25cb Allergy-related contraindication to a different type of \u25cb Non-severe, immediate (onset within 4 hours) allergic reaction after a previous dose of COVID-19 vaccine", "answer_start": 521}], "is_impossible": false}], "context": "Use this guidance with:\n\u0083 Interim Clinical Considerations for Use of COVID-19 Vaccines\nCurrently Approved or Authorized in the United States\n\u0083 Advisory Committee on Immunization Practices on\nImmunization General Best Practice Guidelines\n\u0083 Interim COVID-19 Immunization Schedule for Ages 6 Months\nand Older\n\u0083 COVID-19 Vaccination Clinical & Professional Resources for\neach vaccine product\nConsider the following post-vaccination observation times to monitor for syncope and allergic reactions:\n\u0083 People with a history of:\n\u25cb Allergy-related contraindication to a different type of\n\u25cb Non-severe, immediate (onset within 4 hours) allergic\nreaction after a previous dose of COVID-19 vaccine."}]}, {"title": "deb30df7c7435a231388fadcd5bf5b25", "paragraphs": [{"qas": [{"question": "How should Healthcare professionals be competent in treating severe allergies?", "id": "100000000000000000009915", "answers": [{"text": "at the time of vaccine administration", "answer_start": 238}], "is_impossible": false}, {"question": "How can other routine vaccines be given?", "id": "100000000000000000009916", "answers": [{"text": "any time before or after COVID-19 vaccination", "answer_start": 573}], "is_impossible": false}, {"question": "How old is the person to be vaccinated?", "id": "100000000000000000009918", "answers": [{"text": "1", "answer_start": 730}], "is_impossible": false}], "context": "\u25cb Anaphylaxis after non-COVID-19 vaccines or injectable\ntherapies\n\u0083 All other people\nHealthcare professionals should be familiar with identifying severe\nallergic reactions, including anaphylaxis, and be competent in\ntreating these events at the time of vaccine administration. See\nManagement of Anaphylaxis at COVID-19 Vaccination Sites | CDC\nfor guidance. COVID-19 vaccines are administered by IM injection and can be\ngiven at the same clinical visit as other routinely administered\nvaccines using separate injection sites. Other routine vaccines\ncan also be administered any time before or after COVID-19\nvaccination. Orthopoxvirus vaccines (monkey pox) have additional\nconsiderations. See guidance section 8 Clinical Guidance. 1. How old is the person to be vaccinated?"}]}, {"title": "f501309a7dd5c4bddb03caa0a59dd4c9", "paragraphs": [{"qas": [{"question": "Which vaccine can be administered to persons 18 years of age and older?", "id": "100000000000000000009921", "answers": [{"text": "Janssen COVID-19", "answer_start": 154}], "is_impossible": false}, {"question": "Why can't people who receive the Novavax vaccine be given it?", "id": "100000000000000000009922", "answers": [{"text": "safety considerations", "answer_start": 272}], "is_impossible": false}, {"question": "Moderna Covid-19 vaccine can be given to people who are 6 months of age or older?", "id": "100000000000000000009924", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 474}], "is_impossible": false}, {"question": "Pfizer-BioNTech COVIV-19 vaccine is given to persons 6 months and older, what is the age range?", "id": "100000000000000000009925", "answers": [{"text": "6 months of age and older", "answer_start": 538}], "is_impossible": false}], "context": "Clinical considerations based on the age of the recipient include:\nCOVID-19 vaccines products (monovalent and bivalent)\nhave different age indications. \u0083 Janssen COVID-19 Vaccine can be administered to persons\n18 years of age and older in certain limited situations due to\nsafety considerations. \u0083 Novavax COVID-19 Vaccine can be administrated to persons 12\nyears of age and older. \u0083 Moderna COVID-19 Vaccine can be administered to persons\nages 6 months of age and older. \u0083 Pfizer-BioNTech COVID-19 vaccine can be administered to\npersons 6 months of age and older."}]}, {"title": "286accff807bfb81356061d881f249c4", "paragraphs": [{"qas": [{"question": "People receiving mRNA or Novavax COVID-19 vaccines should be made aware of the rare risk of what?", "id": "100000000000000000009927", "answers": [{"text": "myocarditis and/or pericarditis", "answer_start": 338}], "is_impossible": false}, {"question": "What is the rare risk of myocarditis?", "id": "100000000000000000009928", "answers": [{"text": "People receiving mRNA or Novavax COVID-19 vaccines, especially males ages 12\u201339 years, should be made aware of the rare risk of myocarditis and/or pericarditis", "answer_start": 210}], "is_impossible": false}, {"question": "What is reducing the risk of severe outcomes from COVID-19?", "id": "100000000000000000009929", "answers": [{"text": "COVID-19 vaccination", "answer_start": 434}], "is_impossible": false}, {"question": "Counseling should include the need to seek care if symptoms of what?", "id": "100000000000000000009930", "answers": [{"text": "myocarditis or pericarditis", "answer_start": 620}], "is_impossible": false}, {"question": "What are symptoms of myocarditis?", "id": "100000000000000000009931", "answers": [{"text": "chest pain, shortness of breath, or tachycardia", "answer_start": 656}], "is_impossible": false}, {"question": "What are some symptoms of pericarditus?", "id": "100000000000000000009932", "answers": [{"text": "chest pain, shortness of breath, or tachycardia", "answer_start": 656}], "is_impossible": false}], "context": "Use the manufacturers' fact sheets for healthcare professionals\nand CDC clinical materials for healthcare professionals and to\nidentify the correct product based on the vaccine composition\nand recipient's age. People receiving mRNA or Novavax COVID-19 vaccines,\nespecially males ages 12\u201339 years, should be made\naware of the rare risk of myocarditis and/or pericarditis\nfollowing receipt of these COVID-19 vaccines and the\nbenefit of COVID-19 vaccination in reducing the risk of\nsevere outcomes from COVID-19, including the possibility\nof cardiac sequelae. Counseling should include the need to\nseek care if symptoms of myocarditis or pericarditis, such as\nchest pain, shortness of breath, or tachycardia develop after\nvaccination, particularly in the week after vaccination."}]}, {"title": "1cfd94a2d8d36237c523cdf479a3dc2a", "paragraphs": [{"qas": [{"question": "How long is the interval between the doses of COVID-19 vaccines?", "id": "100000000000000000009934", "answers": [{"text": "8 weeks", "answer_start": 54}], "is_impossible": false}, {"question": "What might reduce the risk?", "id": "100000000000000000009935", "answers": [{"text": "Extending the interval between these vaccines dose to 8 weeks", "answer_start": 0}], "is_impossible": false}, {"question": "How old are adults ages 65 and older?", "id": "100000000000000000009936", "answers": [{"text": "65 years", "answer_start": 243}], "is_impossible": false}, {"question": "What is an increased concern about COVID-19 community levels or an individual's higher risk of severe disease?", "id": "100000000000000000009937", "answers": [{"text": "Additional recipient education materials", "answer_start": 397}], "is_impossible": false}], "context": "Extending\nthe interval between these vaccines dose to 8 weeks might\nreduce the risk. Note: There are some persons the extended interval should not\nbe considered including those who are:\n\u0083 Moderately or severely immunocompromised\n\u0083 Adults ages 65 years and older;\n\u0083 In situations in which there is increased concern about\nCOVID-19 community levels or an individual\u2019s higher risk of\nsevere disease. Additional recipient education materials\fPrevaccination Checklist\nfor COVID-19 Vaccines\nInformation for Healthcare Professionals\n2. Is the person to be vaccinated sick today? People with mild illnesses can be vaccinated. Do not\nwithhold vaccination if a person is taking antibiotics."}]}, {"title": "67535473e5701844797dce87de814966", "paragraphs": [{"qas": [{"question": "What is one way to delay vaccinating patients with moderate or severe illness?", "id": "100000000000000000009940", "answers": [{"text": "until the illness has improved", "answer_start": 174}], "is_impossible": false}, {"question": "What is another way to defer vaccination of people with current SARS-CoV-2 infection?", "id": "100000000000000000009941", "answers": [{"text": "Asymptomatic infection", "answer_start": 391}], "is_impossible": false}, {"question": "How long does it take to recover from acute illness and isolation has been discontinued?", "id": "100000000000000000009942", "answers": [{"text": "defer vaccination until recovery from the acute illness and isolation has been discontinued. \u0083 Asymptomatic infection: defer vaccination until isolation has been discontinued. This recommendation applies regardless of whether the SARS- CoV-2 infection occurred before the recipient received an initial dose or between doses. Viral or serological testing to assess for current or prior infection solely for the purpose of vaccine- decision making is not recommended. 3", "answer_start": 296}], "is_impossible": false}, {"question": "What is another term for asymptomatic infection?", "id": "100000000000000000009943", "answers": [{"text": "defer vaccination until isolation has been discontinued", "answer_start": 415}], "is_impossible": false}, {"question": "What is not recommended to assess for current or prior infection?", "id": "100000000000000000009946", "answers": [{"text": "Viral or serological testing", "answer_start": 621}], "is_impossible": false}, {"question": "What does serological testing not do?", "id": "100000000000000000009947", "answers": [{"text": "vaccine- decision making", "answer_start": 717}], "is_impossible": false}], "context": "While there is no evidence acute illness reduces vaccine\nefficacy or increases adverse reactions, as a precaution, delay\nvaccinating patients with moderate or severe illness until\nthe illness has improved. Defer vaccination of people with current SARS-CoV-2\ninfection. For those with\n\u0083 Symptoms: defer vaccination until recovery from the acute\nillness and isolation has been discontinued. \u0083 Asymptomatic infection: defer vaccination until isolation has\nbeen discontinued. This recommendation applies regardless of whether the SARS-\nCoV-2 infection occurred before the recipient received an initial\ndose or between doses. Viral or serological testing to assess\nfor current or prior infection solely for the purpose of vaccine-\ndecision making is not recommended. 3."}]}, {"title": "291051d94392816744da59dcdb9b889c", "paragraphs": [{"qas": [{"question": "Which vaccines are approved or authorized for primary series doses?", "id": "100000000000000000009950", "answers": [{"text": "monovalent vaccines", "answer_start": 252}], "is_impossible": false}, {"question": "What vaccine product should be used for all primary series doses?", "id": "100000000000000000009951", "answers": [{"text": "The same vaccine product should be used for all primary series doses. Moderna and Pfizer-BioNTech", "answer_start": 325}], "is_impossible": false}], "context": "Has the person to be vaccinated ever received a dose of COVID-19 vaccine? COVID-19 vaccination is recommended for everyone 6\nmonths of age and older. For the primary series, Moderna,\nNovavax, and Pfizer-BioNTech COVID-19 vaccines are\nrecommended; only monovalent vaccines are approved or\nauthorized for primary series doses. The same vaccine product\nshould be used for all primary series doses. Moderna and Pfizer-BioNTech are recommended for booster\ndoses. People ages 5 years and older are recommended to\nreceive 1 bivalent mRNA booster dose after completion\nof any monovalent primary series or previously received\nmonovalent booster dose(s). Use an age-appropratie\nproduct."}]}, {"title": "968df9af06dbc3e54c5222b38defe88f", "paragraphs": [{"qas": [{"question": "What is a good place to check medical records to determine previously administered doses of the vaccine?", "id": "100000000000000000009955", "answers": [{"text": "immunization information systems, and vaccination record cards", "answer_start": 218}], "is_impossible": false}, {"question": "If the vaccine product previously administered cannot be determined, is no longer available or contraindicated, what can be used?", "id": "100000000000000000009956", "answers": [{"text": "any age-appropriate COVID-19 vaccine product", "answer_start": 395}], "is_impossible": false}, {"question": "How many days after the first dose of the COVID-19 vaccine can any age-appropriate vaccine product be administered?", "id": "100000000000000000009957", "answers": [{"text": "28", "answer_start": 469}], "is_impossible": false}], "context": "Janssen COVID-19 Vaccine can be administered to persons 18\nyears of age and older in certain limited situations due to safety\nconsiderations. To determine previously administered COVID-19 doses, check\nmedical records, immunization information systems, and\nvaccination record cards. If the vaccine product previously\nadministered cannot be determined, is no longer available, or\ncontraindicated, any age-appropriate COVID-19 vaccine product\nmay be administered at least 28 days after the first dose."}]}, {"title": "41a92c2c8a23d11156e3c2c6bbc28fa6", "paragraphs": [{"qas": [{"question": "Who can use the Interim Immunization Schedule for Ages 6 Months and Older to schedule doses?", "id": "100000000000000000009958", "answers": [{"text": "Persons who received COVID-19 vaccine outside the United States", "answer_start": 84}], "is_impossible": false}, {"question": "What can be found in the link Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References and Previous Updates | CDC 4?", "id": "100000000000000000009959", "answers": [{"text": "Vaccination guidance", "answer_start": 148}], "is_impossible": false}, {"question": "People who take immunosuppressive medications or therapies are at increased risk?", "id": "100000000000000000009962", "answers": [{"text": "severe COVID-19 disease", "answer_start": 635}], "is_impossible": false}], "context": "Use the Interim Immunization Schedule for Ages 6 Months\nand Older to schedule doses\nPersons who received COVID-19 vaccine outside the United States\nVaccination guidance for people vaccinated outside of the United States can be found in the link Interim Clinical Considerations for\nUse of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\n4. Does the recipient have a health condition or undergoing treatment that makes them\nmoderately or severely immunocompromised? People with moderate or severe immunocompromising\nconditions or people who take immunosuppressive medications\nor therapies are at increased risk for severe COVID-19\ndisease."}]}, {"title": "9ac2762dfca951e4de15b2c8e34b6c8a", "paragraphs": [{"qas": [{"question": "Who can self-report if they are moderate or severe immunocompromised?", "id": "100000000000000000009964", "answers": [{"text": "People", "answer_start": 252}], "is_impossible": false}, {"question": "Why should vaccinators not deny vaccination to a person due to lack of documentation?", "id": "100000000000000000009965", "answers": [{"text": "immune status", "answer_start": 422}], "is_impossible": false}, {"question": "What can be administered to people with underlying medical conditions?", "id": "100000000000000000009966", "answers": [{"text": "COVID-19 vaccines", "answer_start": 0}], "is_impossible": false}, {"question": "Why would you deny COVID-19 vaccination to a person?", "id": "100000000000000000009967", "answers": [{"text": "lack of documentation of immune status", "answer_start": 397}], "is_impossible": false}, {"question": "How does the person to be vaccinated receive a hematopoietic cell transplant?", "id": "100000000000000000009969", "answers": [{"text": "since receiving COVID-19 vaccine", "answer_start": 713}], "is_impossible": false}], "context": "COVID-19 vaccines may be administered to people\nwith underlying medical conditions, such as HIV infection\nor other immunocompromising conditions, or who take\nimmunosuppressive medications or therapies, and who have no\ncontraindications to vaccination. People can self-report if they\nare moderately or severely immunocompromised. Vaccinators\nshould not deny COVID-19 vaccination to a person due to lack of\ndocumentation of immune status. Use the Interim Immunization Schedule for Ages 6 Months\nand Older to schedule doses\fPrevaccination Checklist\nfor COVID-19 Vaccines\nInformation for Healthcare Professionals\n5. Has the person to be vaccinated received a hematopoietic cell transplant (HCT) or CAR-T-cell\ntherapy since receiving COVID-19 vaccine?"}]}, {"title": "59ae6a893e156ccb59a1401b23706302", "paragraphs": [{"qas": [{"question": "Who should be revaccinated for any monovalent primary series and bivalent booster doses received before or during treatment at least 3 months after transplant or CAR-T cell therapy?", "id": "100000000000000000009970", "answers": [{"text": "HCT and CAR-T-cell recipients", "answer_start": 0}], "is_impossible": false}, {"question": "What should the patient receive after transplant or CAR-T-cell therapy?", "id": "100000000000000000009971", "answers": [{"text": "1 bivalent booster dose", "answer_start": 376}], "is_impossible": false}, {"question": "How many doses of COVID-19 Vaccines Currently Approved or Authorized in the United States?", "id": "100000000000000000009972", "answers": [{"text": "Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States 6", "answer_start": 497}], "is_impossible": false}], "context": "HCT and CAR-T-cell recipients who received doses of COVID-19 vaccine prior to or during HCT or CAR-T cell therapy, should be\nrevaccinated for any monovalent primary series and bivalent booster doses received before or during treatment at least 3 months (12\nweeks) after transplant or CAR-T-cell therapy. After revaccination with the primary series, the patient should receive 1 bivalent booster\ndose. There is no revaccination for monovalent booster doses. Additional information can be found at: Interim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Approved or Authorized in the United States\n6."}]}, {"title": "8059e6e339583db612c4b190a825fbcf", "paragraphs": [{"qas": [{"question": "What should providers try to determine if reactions reported after vaccination are consistent with immediate allergic reactions?", "id": "100000000000000000009974", "answers": [{"text": "When vaccine recipients report a history of an immediate allergic reaction", "answer_start": 68}], "is_impossible": false}, {"question": "What are not contraindications to receiving additional doses of a vaccine?", "id": "100000000000000000009976", "answers": [{"text": "vasovagal reaction or postvaccination side effects", "answer_start": 361}], "is_impossible": false}], "context": "Has the person to be vaccinated ever had an allergic reaction to:\n* When vaccine recipients report a history of an immediate allergic reaction, providers should attempt to determine whether reactions reported following\nvaccination are consistent with immediate allergic reactions versus other types of reactions commonly observed following vaccination, such as vasovagal reaction or\npostvaccination side effects (which are not contraindications to receiving additional doses of that vaccine). \u2020 People with a known allergy to polysorbate have a contraindication to both Novavax and Janssen COVID-19 vaccines and a precaution to mRNA COVID-19 vaccines."}]}, {"title": "29646875e22ccd7f337a54e18472755", "paragraphs": [{"qas": [{"question": "What is an allergy-related contraindication to one type of COVID-19 vaccine a precaution to the other types?", "id": "100000000000000000009978", "answers": [{"text": "A previous dose", "answer_start": 126}], "is_impossible": false}, {"question": "People with a severe allergic reaction* to a prior COVID-19 vaccine dose or a known allergic reaction?", "id": "100000000000000000009980", "answers": [{"text": "COVID-19 vaccine", "answer_start": 400}], "is_impossible": false}, {"question": "What is a contrainidcation to the same type of COVID-19 vaccine?", "id": "100000000000000000009981", "answers": [{"text": "People with a severe allergic reaction", "answer_start": 220}], "is_impossible": false}, {"question": "People who had an immediate (less than 4 hours) but non-severe allergic reaction to a previous dose of the vaccine have what?", "id": "100000000000000000009982", "answers": [{"text": "a precaution to receiving the same type of COVID-19 vaccine product", "answer_start": 572}], "is_impossible": false}, {"question": "What is an allergic reaction to a previous dose of COVID-19 vaccine?", "id": "100000000000000000009983", "answers": [{"text": "severe", "answer_start": 234}], "is_impossible": false}, {"question": "Have a precaution to receiving the same type of vaccine product?", "id": "100000000000000000009984", "answers": [{"text": "People who had an immediate (less than 4 hours), but non- severe allergic reaction to a previous dose of COVID-19 vaccine", "answer_start": 444}], "is_impossible": false}], "context": "In\nall other cases, an allergy-related contraindication to one type of COVID-19 vaccine is a precaution to the other types. \u0083 A previous dose OR a component of any COVID-19 vaccine\n\u0083 A previous dose of COVID-19 vaccine? People with a severe allergic reaction* to a previous COVID-19\nvaccine dose or a known (diagnosed) allergy to a component\nof the vaccine have a contrainidcation to the same type of\nCOVID-19 vaccine (mRNA, Novavax, Janssen). People who had an immediate (less than 4 hours), but non-\nsevere allergic reaction to a previous dose of COVID-19 vaccine,\nhave a precaution to receiving the same type of COVID-19\nvaccine product."}]}, {"title": "d948bcc6841190d382e8518d65c2cce5", "paragraphs": [{"qas": [{"question": "What should providers consider observing for 30 minutes after vaccination?", "id": "100000000000000000009986", "answers": [{"text": "COVID-19 vaccine product", "answer_start": 56}], "is_impossible": false}, {"question": "People with a contraindication to one type of COVID-19 vaccine should not receive what?", "id": "100000000000000000009987", "answers": [{"text": "any doses of that type of vaccine", "answer_start": 286}], "is_impossible": false}, {"question": "What are the potential characteristics of allergic reactions, vasovagal reactions, and vaccine side effects following?", "id": "100000000000000000009989", "answers": [{"text": "COVID-19 vaccine components", "answer_start": 378}], "is_impossible": false}, {"question": "What is important to determine if a person can receive additional doses of the vaccine?", "id": "100000000000000000009990", "answers": [{"text": "determining the etiology", "answer_start": 570}], "is_impossible": false}], "context": "Although they can receive the same product,\na different COVID-19 vaccine product can also be administered. Providers should consider observing these patients for 30\nminutes after vaccination\nPeople with a contraindication to one type of COVID-19 vaccine\n(e.g., mRNA) should not receive any doses of that type of vaccine\nand have a precaution to the other types of vaccine\u2020. For COVID-19 vaccine components see:\nPotential characteristics of allergic reactions, vasovagal reactions, and vaccine side effects following\nIn patients who experience post-vaccination symptoms, determining the etiology (including allergic reaction, vasovagal reaction, or\nvaccine side effects) is important to determine whether a person can receive additional doses of the vaccine."}]}, {"title": "be763c5ecacb827d3b1c0f4ab01ee07", "paragraphs": [{"qas": [{"question": "What can be found at Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination?", "id": "100000000000000000009991", "answers": [{"text": "Additional information", "answer_start": 0}], "is_impossible": false}, {"question": "Has the person to be vaccinated ever had anaphylactics after another vaccine or another injectable medication?", "id": "100000000000000000009992", "answers": [{"text": "A history of anaphylaxis", "answer_start": 287}], "is_impossible": false}, {"question": "What is anaphylaxis to any other vaccine or injectable therapy?", "id": "100000000000000000009993", "answers": [{"text": "A history of anaphylaxis to any other vaccine or injectable therapy (i.e., intramuscular, intravenous, or subcutaneous vaccines or therapies not related to a component of COVID-19 vaccines) is a precaution to COVID-19 vaccines", "answer_start": 287}], "is_impossible": false}, {"question": "What component elicited the allergic reaction?", "id": "100000000000000000009996", "answers": [{"text": "non-COVID-19 vaccine or therapy has multiple components, one or more of which is a component of a COVID-19 vaccine", "answer_start": 540}], "is_impossible": false}], "context": "Additional information\ncan be found at Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination. 7. Has the person to be vaccinated ever had anaphylaxis after another vaccine (other than\nCOVID-19 vaccine) or another injectable medication? A history of anaphylaxis to any other vaccine or injectable\ntherapy (i.e., intramuscular, intravenous, or subcutaneous\nvaccines or therapies not related to a component of COVID-19\nvaccines) is a precaution to COVID-19 vaccines. This also\napplies if the non-COVID-19 vaccine or therapy has multiple\ncomponents, one or more of which is a component of a\nCOVID-19 vaccine, and it is unknown which component\nelicited the allergic reaction."}]}, {"title": "1995c522f8dc0b0f5779aa8f069d85d4", "paragraphs": [{"qas": [{"question": "What can be given but counsel patients about unknown risks of developing a severe allergic reaction?", "id": "100000000000000000009997", "answers": [{"text": "Vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "Providers should consider observing patients for how long after vaccination?", "id": "100000000000000000009999", "answers": [{"text": "30 minutes", "answer_start": 316}], "is_impossible": false}, {"question": "What is a precaution to a subsequent dose of any COVID-19 vaccine?", "id": "100000000000000000010000", "answers": [{"text": "Development of myocarditis or pericarditis after a dose of an mRNA (Moderna, Pfizer-BioNTech) or Novavax COVID-19 vaccine", "answer_start": 527}], "is_impossible": false}, {"question": "What should be avoided after a dose of an mRNA?", "id": "100000000000000000010001", "answers": [{"text": "subsequent doses", "answer_start": 714}], "is_impossible": false}], "context": "Vaccine may be given, but\ncounsel patients about unknown risks of developing a severe\nallergic reaction and balance these risks against the benefits\nof vaccination. Deferral of vaccination and/or consultation\nwith an allergist-immunologist should be considered. Providers should consider observing these patients for\n30 minutes after vaccination. Prevaccination Checklist\nfor COVID-19 Vaccines\nInformation for Healthcare Professionals\n8. Clinical Considerations:\nResponse Consideration\nHistory of myocarditis\nor pericarditis\n\u0083 Development of myocarditis or pericarditis after a dose of an mRNA (Moderna, Pfizer-BioNTech)\nor Novavax COVID-19 vaccine is a precaution to a subsequent dose of any COVID-19 vaccine and\nsubsequent doses should generally be avoided."}]}, {"title": "44f82c0b3827ee7a8b4e6bd318f28b2b", "paragraphs": [{"qas": [{"question": "What should a person wait until after their episode has resolved to receive a COVID-19 vaccine?", "id": "100000000000000000010002", "answers": [{"text": "If after a risk assessment", "answer_start": 2}], "is_impossible": false}], "context": "\u0083 If after a risk assessment, the decision is made to receive a subsequent COVID-19 vaccine dose, the\nperson should wait until after their episode has resolved."}]}, {"title": "6b00aec36f2ebf1695b2350499035bfc", "paragraphs": [{"qas": [{"question": "What is considered unrelated to vaccination with Moderna, Novavax, or Pfizer-BioNTech?", "id": "100000000000000000010003", "answers": [{"text": "The myocarditis or pericarditis", "answer_start": 66}], "is_impossible": false}, {"question": "How long after the most recent dose of COVID-19 vaccine did the diagnosis of myocarditis occur?", "id": "100000000000000000010005", "answers": [{"text": "3 weeks", "answer_start": 299}], "is_impossible": false}, {"question": "What is the personal risk of severe acute COVID-19?", "id": "100000000000000000010006", "answers": [{"text": "age, underlying conditions", "answer_start": 402}], "is_impossible": false}, {"question": "What is ACIP\u2019s General Best Practice Guidelines for Immunization?", "id": "100000000000000000010007", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 577}], "is_impossible": false}, {"question": "For information on potential use of Janssen Vaccine, see Appendix A?", "id": "100000000000000000010008", "answers": [{"text": "General Best Practice Guidelines for Immunization", "answer_start": 489}], "is_impossible": false}, {"question": "What is a person who has a history of not related to mRNA?", "id": "100000000000000000010010", "answers": [{"text": "myocarditis or pericarditis", "answer_start": 668}], "is_impossible": false}], "context": "Considerations for subsequent COVID-19\nvaccination may include:\n\u25cb The myocarditis or pericarditis was considered unrelated to vaccination with Moderna, Novavax,\nor Pfizer-BioNTech (e.g., due to SARS-CoV-2 or other viruses), especially if the myocarditis or\npericarditis diagnosis occurred more than 3 weeks after the most recent dose of COVID-19 vaccine\n\u25cb Personal risk of severe acute COVID-19 (e.g., age, underlying conditions)\n\u25cb Timing of any immunomodulatory therapies;\nConsult ACIP\u2019s General Best Practice Guidelines for Immunization\n\u0083 For information on potential use of Janssen COVID-19 Vaccine in this situation, see Appendix A\n\u0083 Persons who have a history of myocarditis or pericarditis unrelated to mRNA (Moderna, Pfizer-Bio-\nNTech) or Novavax COVID-19 vaccination may receive any currently FDA-approved or -authorized\nCOVID-19 vaccine after the episode of myocarditis or pericarditis has resolved."}]}, {"title": "a8cf5b1fa28d7559da96e016ce3b4558", "paragraphs": [{"qas": [{"question": "What is a precaution to receipt of the COVID-19 vaccine?", "id": "100000000000000000010011", "answers": [{"text": "Persons with a history of multisystem inflammatory syndrome", "answer_start": 90}], "is_impossible": false}, {"question": "Who may request a consultation from healthcare providers and health departments?", "id": "100000000000000000010012", "answers": [{"text": "Clinical Immunization Safety Assessment Project", "answer_start": 414}], "is_impossible": false}, {"question": "Who may request a consultation from the Clinical Immunization Safety Assessment Project?", "id": "100000000000000000010013", "answers": [{"text": "Healthcare providers and health departments", "answer_start": 329}], "is_impossible": false}, {"question": "What is another name for HIT?", "id": "100000000000000000010017", "answers": [{"text": "heparin-induced thrombocytopenia", "answer_start": 560}], "is_impossible": false}], "context": "History of multisystem\ninflammatory\nsyndrome; either MIS-C\n(children) or MIS-A\n(adults)\n\u0083 Persons with a history of multisystem inflammatory syndrome; either MIS-C (children) or MIS-A\n(adults) is a precaution to receipt of COVID-19 vaccine. \u0083 Considerations when conducting a risk assessment for potential COVID-19 vaccination\n\u0083 Healthcare providers and health departments may also request a consultation from the Clinical\nImmunization Safety Assessment Project\nHistory of an immune-\nmediated syndrome\ncharacterized by\nthrombosis and\nthrombocytopenia,\nsuch as heparin-induced\nthrombocytopenia (HIT)\n\u0083 Janssen COVID-19 vaccine is not recommended for persons with a history of an episode of an\nimmune-mediated syndrome characterized by thrombosis and thrombocytopenia, such as\nspontaneous or classic HIT. \u0083 These persons should receive an mRNA (ie."}]}, {"title": "ec31e3cd35533d0904cccdce85fdea2f", "paragraphs": [{"qas": [{"question": "Moderna or Pfizer-BioNTech) or Novavax COVID-19 vaccine?", "id": "100000000000000000010018", "answers": [{"text": "History of thrombosis", "answer_start": 57}], "is_impossible": false}, {"question": "History of thrombosis with what syndrome?", "id": "100000000000000000010019", "answers": [{"text": "thrombocytopenia syndrome", "answer_start": 83}], "is_impossible": false}, {"question": "What is contraindicated for persons with a history of TTS?", "id": "100000000000000000010020", "answers": [{"text": "Janssen COVID-19 vaccine", "answer_start": 118}], "is_impossible": false}, {"question": "What are based on adenovirus vectors?", "id": "100000000000000000010021", "answers": [{"text": "Janssen COVID-19 vaccine is contraindicated for persons with a history of TTS following a dose of Janssen COVID-19 vaccine", "answer_start": 118}], "is_impossible": false}, {"question": "Who should receive a booster dose of bivalent mRNA vaccine?", "id": "100000000000000000010022", "answers": [{"text": "persons with a history of TTS following a dose of Janssen COVID-19 vaccine", "answer_start": 166}], "is_impossible": false}, {"question": "What is a precaution?", "id": "100000000000000000010023", "answers": [{"text": "A history of GBS", "answer_start": 606}], "is_impossible": false}, {"question": "What is a precaution for receipt of Janssen COVID-19 Vaccine?", "id": "100000000000000000010024", "answers": [{"text": "A history of GBS", "answer_start": 606}], "is_impossible": false}], "context": "Moderna or Pfizer-BioNTech) or Novavax COVID-19 vaccine. History of thrombosis\nwith\nthrombocytopenia\nsyndrome (TTS)\n\u0083 Janssen COVID-19 vaccine is contraindicated for persons with a history of TTS following a dose of\nJanssen COVID-19 vaccine (or other COVID-19 vaccines not currently authorized in the U.S. that are\nbased on adenovirus vectors, e.g., AstraZenca). \u0083 These persons should receive a booster dose of bivalent mRNA vaccine (Moderna, Pfizer-BioNTech). For\naddtional guidance see Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendix A\nHistory of Guillain-\nBarr\u00e9 Syndrome (GBS)\n\u0083 A history of GBS, either before or after COVID-19 vaccination, is a precaution for receipt of Janssen\nCOVID-19 Vaccine."}]}, {"title": "fe07e78d0869a30132e3af785347c2a8", "paragraphs": [{"qas": [{"question": "What is recommended for people who develop GBS within 6 weeks of Janssen COVID-19 vaccination?", "id": "100000000000000000010025", "answers": [{"text": "An mRNA or Novavax COVID-19 vaccine is recommended. \u0083 Persons who develop GBS within 6 weeks of Janssen COVID-19 vaccination should only receive an mRNA COVID-19 vaccine", "answer_start": 0}], "is_impossible": false}, {"question": "Who should only receive an mRNA Covid-19 vaccine?", "id": "100000000000000000010026", "answers": [{"text": "Persons who develop GBS within 6 weeks of Janssen COVID-19 vaccination", "answer_start": 54}], "is_impossible": false}, {"question": "What is recommended for everyone ages 6 months and older?", "id": "100000000000000000010027", "answers": [{"text": "COVID-19 vaccination", "answer_start": 339}], "is_impossible": false}, {"question": "People who recently had COVID-19 disease or SARS-CoV-2 infection may consider delaying their primary series or booster dose dose by 3 months from symptom onset?", "id": "100000000000000000010028", "answers": [{"text": "mRNA", "answer_start": 3}], "is_impossible": false}, {"question": "What is the term for asymptomatic infection?", "id": "100000000000000000010030", "answers": [{"text": "SARS-CoV-2", "answer_start": 468}], "is_impossible": false}], "context": "An mRNA or Novavax COVID-19 vaccine is recommended. \u0083 Persons who develop GBS within 6 weeks of Janssen COVID-19 vaccination should only receive an\nmRNA COVID-19 vaccine. Prevaccination Checklist\nfor COVID-19 Vaccines\nInformation for Healthcare Professionals\nResponse Consideration\nHistory of prior\nCOVID-19 disease in\nthe last 3 months\n\u0083 COVID-19 vaccination is recommended for everyone ages 6 months and older, regardless of a\nhistory of symptomatic or asymptomatic SARS-CoV-2 infection. People who recently had COVID-19\ndisease or SARS-CoV-2 infection (within the last 3 months) may consider delaying their primary\nseries or booster dose dose by 3 months from symptom onset or positive test (if infection\nwas asymptomatic)."}]}, {"title": "f019ebba426701a374d64aba854085eb", "paragraphs": [{"qas": [{"question": "What should be considered when determining whether to delay getting a booster dose after infection?", "id": "100000000000000000010031", "answers": [{"text": "Individual factors", "answer_start": 2}], "is_impossible": false}, {"question": "What is NOT RECOMMENDED for the purpose of vaccine decision-making?", "id": "100000000000000000010033", "answers": [{"text": "Viral testing", "answer_start": 238}], "is_impossible": false}, {"question": "Have you been vaccinated with monkeypox vaccine in the last 4 weeks?", "id": "100000000000000000010034", "answers": [{"text": "monkeypox vaccine", "answer_start": 427}], "is_impossible": false}], "context": "\u0083 Individual factors such as risk of severe disease, COVID-19 community level, or characteristics of the\npredominant SARS-CoV-2 strain should be considered when determining whether to delay getting\na booster dose after infection. \u0083 NOTE: Viral testing to assess for acute SARS-CoV-2 infection or serologic testing to assess\nfor prior infection is NOT RECOMMENDED for the purpose of vaccine decision-making. Been vaccinated with\nmonkeypox vaccine in\nthe last 4 weeks?"}]}, {"title": "f34f11a3763ac996010a776d52fb7aec", "paragraphs": [{"qas": [{"question": "What should not be delayed because of recent receipt of a Moderna, Novavax, or Pfizer-BioNTech COVID-19 vaccine?", "id": "100000000000000000010036", "answers": [{"text": "orthopoxvirus vaccination", "answer_start": 124}], "is_impossible": false}], "context": "\u0083 If an orthopoxvirus vaccine is recommended for prophylaxis in the setting of an orthopoxvirus (e.g.,\nmonkeypox) outbreak, orthopoxvirus vaccination should not be delayed because of recent receipt\nof a Moderna, Novavax, or Pfizer-BioNTech COVID-19 vaccine; no minimum interval between\nCOVID-19 vaccination with these vaccines and orthopoxvirus vaccination is necessary."}]}, {"title": "a7765d7d143b9265a9a13ee1a5487492", "paragraphs": [{"qas": [{"question": "How long after a JYNNEOS or ACAM2000 orthopoxvirus vaccination should people wait for a COVID-19 vaccine?", "id": "100000000000000000010037", "answers": [{"text": "4 weeks", "answer_start": 79}], "is_impossible": false}, {"question": "What is the risk for myocarditis after receiving a moderna, Novavax, or Pfizer-BioNTech COVID-19 vaccine and mRNA?", "id": "100000000000000000010038", "answers": [{"text": "unknown", "answer_start": 413}], "is_impossible": false}, {"question": "What is the name of the vaccine and mRNA?", "id": "100000000000000000010039", "answers": [{"text": "ACAM2000", "answer_start": 300}], "is_impossible": false}, {"question": "What is another name for Novavax COVID-19 vaccine?", "id": "100000000000000000010040", "answers": [{"text": "Moderna", "answer_start": 167}], "is_impossible": false}], "context": "\u0083 People, particularly adolescent or young adult males, might consider waiting 4 weeks after\northopoxvirus vaccination (either JYNNEOS or ACAM2000) before receiving a Moderna, Novavax,\nor Pfizer-BioNTech COVID-19 vaccine because of the observed risk for myocarditis and pericarditis\nafter receipt of ACAM2000 orthopoxvirus vaccine and mRNA (i.e., Moderna or Pfizer-BioNTech) and\nNovavax COVID-19 vaccines and the unknown risk for myocarditis and pericarditis after JYNNEOS."}]}, {"title": "7964c2b5259d91e70266a197c09b46f2", "paragraphs": [{"qas": [{"question": "What is the name of the summary document for Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized or Approved in the United States?", "id": "100000000000000000010041", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 215}], "is_impossible": false}, {"question": "Pfizer-BioNTech * Booster doses are only indicated for recipients 18 years and older in limited situations?", "id": "100000000000000000010042", "answers": [{"text": "https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html", "answer_start": 337}], "is_impossible": false}, {"question": "What is the name of the Vaccine vial cap color?", "id": "100000000000000000010043", "answers": [{"text": "Monovalent Gray Gray", "answer_start": 797}], "is_impossible": false}, {"question": "What are the doses of Monovalent Maroon Orange?", "id": "100000000000000000010045", "answers": [{"text": "3 \u00b5g 0.2 mL NA NA 5\u201311 years", "answer_start": 644}], "is_impossible": false}, {"question": "Where can you find a list of vaccines in limited situations?", "id": "100000000000000000010046", "answers": [{"text": "https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html", "answer_start": 337}], "is_impossible": false}, {"question": "NA 5-11 years Bivalent Orange Orange Yes NA NA 10 g 0.2 mL 12 years and older Monovalent Gray Gray No 30 %g 0.3mL NA NA 12 year and older What is the age indication for Vaccine composition?", "id": "100000000000000000010047", "answers": [{"text": "composition Vaccine vial cap color Label border color Dilution required Primary series Booster doses Dose Injection volume Dose Injection volume 6 months\u20135 years Monovalent Dark blue Magenta", "answer_start": 930}], "is_impossible": false}, {"question": "What is required Primary series Booster doses?", "id": "100000000000000000010048", "answers": [{"text": "Dilution", "answer_start": 507}], "is_impossible": false}, {"question": "What color is the vial cap color Label border color Dilution required Primary series Booster doses Dose Injection volume 6 months\u20135 years Monovalent Dark blue Magenta No 25 g 0.25 mL NA NA 6-11 years Bivalent Dark Blue Gray No NA NA 25", "id": "100000000000000000010049", "answers": [{"text": "Dilution required", "answer_start": 1481}], "is_impossible": false}, {"question": "What color is no NA NA 25 g 0.25 mL 12 years and older Monovalent Red Light blue No 100 ge 0.5 ml NA NA 12 years & older Bivalent Dark blue Gray No NA NA 50 gg 0.5mL Janssen Age indication Vaccine composition Label border color Dilution required Primary series Booster doses Dose Injection volume 18 years and younger", "id": "100000000000000000010050", "answers": [{"text": "Bivalent Dark blue Gray", "answer_start": 1217}], "is_impossible": false}, {"question": "What is the Dose Injection volume 18 years and older Monovalent Blue No Color No particles particles Novavax Age indication Vaccine composition What is a label border color Dilution required Primary series Booster doses?", "id": "100000000000000000010051", "answers": [{"text": "No particles particles", "answer_start": 1617}], "is_impossible": false}, {"question": "Why is Janssen COVID-19 Vaccine authorized?", "id": "100000000000000000010054", "answers": [{"text": "safety considerations", "answer_start": 2061}], "is_impossible": false}], "context": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nCOVID-19 vaccine products currently approved or authorized in the United States\nPfizer-BioNTech\n* Booster doses are only indicated for recipients 18 years and age and older in limited situations, see: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html\nAge indication Vaccine\ncomposition\nVaccine vial\ncap color\nLabel border\ncolor\nDilution\nrequired\nPrimary series Booster doses\nDose Injection volume Dose Injection volume\n6 months\u20134 years Monovalent Maroon Maroon Yes 3 \u00b5g 0.2 mL NA NA\n5\u201311 years Monovalent Orange Orange Yes 10 \u00b5g 0.2 mL NA NA\n5\u201311 years Bivalent Orange Orange Yes NA NA 10 \u00b5g 0.2 mL\n12 years and older Monovalent Gray Gray No 30 \u00b5g 0.3 mL NA NA\n12 years and older Bivalent Gray Gray No NA NA 30 \u00b5g 0.3 mL\nModerna\nAge indication Vaccine\ncomposition\nVaccine vial\ncap color\nLabel border\ncolor\nDilution\nrequired\nPrimary series Booster doses\nDose Injection volume Dose Injection volume\n6 months\u20135 years Monovalent Dark blue Magenta No 25 \u00b5g 0.25 mL NA NA\n6-11 years Monovalent Dark blue Purple No 50 \u00b5g 0.5 mL NA NA\n6-11 years Bivalent Dark blue Gray No NA NA 25 \u00b5g 0.25 mL\n12 years and older Monovalent Red Light blue No 100 \u00b5g 0.5 mL NA NA\n12 years and older Bivalent Dark blue Gray No NA NA 50 \u00b5g 0.5 mL\nJanssen\nAge indication Vaccine\ncomposition\nVaccine vial\ncap color\nLabel border\ncolor\nDilution\nrequired\nPrimary series Booster doses\nDose Injection volume Dose Injection volume\n18 years and older Monovalent Blue No Color No\nparticles\nparticles\nNovavax\nAge indication Vaccine\ncomposition\nVaccine vial\ncap color\nLabel border\ncolor\nDilution\nrequired\nPrimary series Booster doses*\nDose Injection volume Dose Injection volume\n12 years and older Monovalent Royal blue No Color No\n5 \u00b5g rS and 50 \u00b5g of\nMatrix-M\u2122 adjuvant\n5 \u00b5g rS and 50 \u00b5g of\nMatrix-M\u2122 adjuvant\nJanssen COVID-19 Vaccine is authorized for adults ages 18 years and older in certain limited situations due to safety considerations."}]}, {"title": "1091b69c6ab91be0d76cee88ca4e2b6d", "paragraphs": [{"qas": [{"question": "What is the Interim COVID-19 Immunization Schedule for Ages 6 Months or Older?", "id": "100000000000000000010056", "answers": [{"text": "https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19- Pre-vaccination counseling", "answer_start": 468}], "is_impossible": false}, {"question": "Who provides the vaccine-specific Fact Sheet for Recipients and Caregivers?", "id": "100000000000000000010057", "answers": [{"text": "Pfizer-BioNTech", "answer_start": 647}], "is_impossible": false}, {"question": "What is the CDC's Prevaccination Screening Form and Guidance document?", "id": "100000000000000000010059", "answers": [{"text": "Screen for contraindications and precautions", "answer_start": 854}], "is_impossible": false}], "context": "For guidance on respective record\nreview, scheduling and administration of Janssen vaccine see Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendix A\fSummary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nAll currently authorized or approved COVID-19 vaccines\nCOVID-19 vaccination schedule\n\u0083 See the Interim COVID-19 Immunization Schedule for Ages 6 Months or Older at https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-\nPre-vaccination counseling\nPrior to vaccination:\n\u0083 Provide the vaccine-specific Fact Sheet for Recipients and Caregivers Pfizer-BioNTech (https://www.fda.gov/media/144413/download), Moderna\n(https://www.fda.gov/media/144637/download), Janssen (https://www.fda.gov/media/146304/download), Novavax (www.novavaxcovidvaccine.com)\n\u0083 Screen for contraindications and precautions. CDC's Prevaccination Screening Form and Guidance document can be found at www.cdc.gov/\nvaccines/covid-19/info-by-product/index.html."}]}, {"title": "76666ccdc0cdac566ec8033bbf37ff4e", "paragraphs": [{"qas": [{"question": "What are expected reactions post-vaccination?", "id": "100000000000000000010061", "answers": [{"text": "pain and swelling at the injection site, fever, fatigue, headaches", "answer_start": 210}], "is_impossible": false}, {"question": "Who should be informed of the expected reactions after vaccination?", "id": "100000000000000000010062", "answers": [{"text": "parents, or guardians", "answer_start": 139}], "is_impossible": false}, {"question": "What is a benefit of COVID-19 vaccination in reducing the risk of severe outcomes?", "id": "100000000000000000010064", "answers": [{"text": "Inform mRNA and Novavax vaccine recipients especially males ages 12-39 years, of the rare risk of myocarditis and pericarditis", "answer_start": 281}], "is_impossible": false}, {"question": "Counseling should include the need to seek care if symptoms of what?", "id": "100000000000000000010065", "answers": [{"text": "myocarditis or pericarditis", "answer_start": 617}], "is_impossible": false}, {"question": "What should be sought if symptoms of myocarditis occur after vaccination?", "id": "100000000000000000010066", "answers": [{"text": "Counseling should also include the need to seek care", "answer_start": 549}], "is_impossible": false}], "context": "\u0083 Inform vaccine recipients mRNA or Novavax COVID-19 vaccines are recommended over Janssen COVID-19 Vaccine. \u0083 Counsel vaccine recipients, parents, or guardians about expected reactions post-vaccination (e.g., pain and swelling at the injection site, fever,\nfatigue, headaches). \u0083 Inform mRNA and Novavax vaccine recipients especially males ages 12-39 years, of the rare risk of myocarditis and pericarditis following receipt of\nthese COVID-19 vaccines and the benefit of COVID-19 vaccination in reducing the risk of severe outcomes from COVID-19.\u2020 Counseling should also\ninclude the need to seek care if symptoms of myocarditis or pericarditis occur after vaccination, particularly in the week following vaccination."}]}, {"title": "ff31505a533ea7ba1a4ed4a2b38d9bce", "paragraphs": [{"qas": [{"question": "What is TTS?", "id": "100000000000000000010068", "answers": [{"text": "thrombosis with thrombocytopenia syndrome", "answer_start": 253}], "is_impossible": false}, {"question": "What does TTS stand for?", "id": "100000000000000000010069", "answers": [{"text": "thrombocytopenia syndrome", "answer_start": 269}], "is_impossible": false}, {"question": "Who should seek immediate medical attention after receiving the Janssen vaccine?", "id": "100000000000000000010070", "answers": [{"text": "Inform vaccine recipients", "answer_start": 147}], "is_impossible": false}, {"question": "What should be used for all doses in the primary series?", "id": "100000000000000000010071", "answers": [{"text": "COVID-19 monovalent vaccine product", "answer_start": 604}], "is_impossible": false}, {"question": "What is the name of the Janssen vaccine?", "id": "100000000000000000010072", "answers": [{"text": "COVID-19", "answer_start": 208}], "is_impossible": false}], "context": "For\nmore information see: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#myocarditis-pericarditis. \u0083 Inform vaccine recipients interested in or receiving Janssen COVID-19 Vaccine of the risk and symptoms of thrombosis with thrombocytopenia\nsyndrome (TTS), as well as the need to seek immediate medical care should symptoms develop after receiving Janssen vaccine. For more\ninformation see: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us-appendix.html#appendix-a. Interchangeability of vaccines\n\u0083 In general, the same COVID-19 monovalent vaccine product (Pfizer-BioNTech, Moderna, Novavax) should be used for all doses in the primary series."}]}, {"title": "1464ea18b19ec3447a2eccbe26aada3c", "paragraphs": [{"qas": [{"question": "What can be used in situations where the previous product cannot be determined/not available or a person is unable to complete a series with the same COVID-19 vaccine due to a contraindication?", "id": "100000000000000000010073", "answers": [{"text": "any age-appropriate mRNA COVID-19 vaccine", "answer_start": 190}], "is_impossible": false}, {"question": "What is the minimum interval for booster vaccination?", "id": "100000000000000000010075", "answers": [{"text": "28 days", "answer_start": 281}], "is_impossible": false}, {"question": "Recommendations vary based on what?", "id": "100000000000000000010077", "answers": [{"text": "age and primary series product", "answer_start": 421}], "is_impossible": false}], "context": "In exceptional situations when the previous product cannot be determined/not available or if a person is unable to complete a series with the same\nCOVID-19 vaccine due to a contraindication any age-appropriate mRNA COVID-19 vaccine may be used (administer at a minimum interval of 28 days). \u0083 For booster vaccination, any homologous or heterologous age-appropriate mRNA vaccine can be used. Recommendations vary\nbased on age and primary series product. (https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us. html#timing-spacing-interchangeability).\u2021\nCoadministration with other vaccines\n\u0083 COVID-19 vaccines may be administered on the same day as other vaccines."}]}, {"title": "ae58523d9b02dfc6b40d6b63acbe49b0", "paragraphs": [{"qas": [{"question": "Where should you administer each injection?", "id": "100000000000000000010081", "answers": [{"text": "in a different injection site", "answer_start": 342}], "is_impossible": false}, {"question": "What is the name of the mRNA booster that is recommended for booster vaccination?", "id": "100000000000000000010082", "answers": [{"text": "homologous or heterologous", "answer_start": 649}], "is_impossible": false}], "context": "\u0083 Persons, particularly adolescent or young adult males, might consider waiting 4 weeks after orthopoxvirus (monkeypox) vaccination (either\nJYNNEOS or ACAM2000) before receiving a Moderna, Novavax, or Pfizer-BioNtech COVID-19 vaccine because of the observed risk for myocarditis\nand/or pericarditis after JYNNEOS. \u0083 Administer each injection in a different injection site. \u2020 See Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States at: www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#recommendations for detailed\nguidance. \u2021 For booster vaccination, homologous or heterologous mRNA booster is recommended."}]}, {"title": "5ce21d6cbc651c4aebf3b694b854fe74", "paragraphs": [{"qas": [{"question": "What is the name of the Summary Document for Interim Clinical Considerations for Use of COVID-19 Vaccines currently Authorized or Approved in the United States?", "id": "100000000000000000010083", "answers": [{"text": "MIS-A", "answer_start": 988}], "is_impossible": false}, {"question": "What is an example of a severe allergic reaction after a previous dose or to a component of the vaccine?", "id": "100000000000000000010084", "answers": [{"text": "anaphylaxis", "answer_start": 255}], "is_impossible": false}, {"question": "What is a known diagnosed allergy to a component of the COVID-19 vaccine?", "id": "100000000000000000010085", "answers": [{"text": "Severe allergic reaction", "answer_start": 223}], "is_impossible": false}, {"question": "What is anaphylaxis after receiving a Janssen Covid-19 Vaccine?", "id": "100000000000000000010086", "answers": [{"text": "Severe allergic reaction", "answer_start": 223}], "is_impossible": false}, {"question": "Who is based on adenovirus vectors?", "id": "100000000000000000010087", "answers": [{"text": "AstraZeneca", "answer_start": 626}], "is_impossible": false}, {"question": "What is the name of the vaccine based on adenovirus vectors?", "id": "100000000000000000010088", "answers": [{"text": "AstraZeneca", "answer_start": 626}], "is_impossible": false}, {"question": "What is a history of anaphylaxis after any other vaccine?", "id": "100000000000000000010089", "answers": [{"text": "Precautions", "answer_start": 640}], "is_impossible": false}, {"question": "What is the acronym for multisystem inflammatory syndrome in adults?", "id": "100000000000000000010090", "answers": [{"text": "MIS-A", "answer_start": 988}], "is_impossible": false}, {"question": "Moderate or severe acute illness, with or without fever?", "id": "100000000000000000010093", "answers": [{"text": "\u00b6", "answer_start": 1304}], "is_impossible": false}, {"question": "History of what after a dose of an mRNA or Novavax?", "id": "100000000000000000010094", "answers": [{"text": "myocarditis or pericarditis", "answer_start": 1377}], "is_impossible": false}, {"question": "What should be revaccinated for if received doses of COVID-19 vaccine prior to or during HCT or CAR-T cell therapy?", "id": "100000000000000000010096", "answers": [{"text": "any monovalent primary series", "answer_start": 1755}], "is_impossible": false}, {"question": "How long after a transplant or CAR-T-cell therapy are series and bivalent booster doses received?", "id": "100000000000000000010097", "answers": [{"text": "3 months", "answer_start": 1857}], "is_impossible": false}], "context": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nAll currently authorized or approved COVID-19 vaccines\nContraindications\nHistory of:\n\u0083 Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19 vaccine\n\u0083 A known diagnosed allergy to a component of the COVID-19 vaccine\n\u0083 For the Janssen COVID-19 Vaccine, TTS following receipt of a previous Janssen COVID-19 Vaccine (or other COVID-19 vaccines not currently\nauthorized or approved in the United States that are based on adenovirus vectors, e.g., AstraZeneca)\u00a7\nPrecautions\n\u0083 History of anaphylaxis after any other vaccine or injectable therapy (i.e., intramuscular, intravenous, or subcutaneous vaccines or therapies\n[excluding subcutaneous immunotherapy for allergies, i.e., \u201callergy shots\u201d])\n\u0083 History of multisystem inflammatory syndrome in children (MIS-C) or multisystem inflammatory syndrome in adults (MIS-A)\n\u0083 History of an immediate (within 4 hours of exposure) non-severe allergic reaction after a dose of one type of COVID-19 vaccine have a precaution\nto the same type of COVID-19 vaccine\n\u0083 Allergy-related contraindication to one type of COVID-19 vaccine have a precaution to the other types of COVID-19 vaccines.\u00b6\n\u0083 Moderate or severe acute illness, with or without fever\n\u0083 History of myocarditis or pericarditis after a dose of an mRNA or Novavax COVID-19 vaccine\n\u0083 For Janssen COVID-19 Vaccine, a history of Guillain-Barr\u00e9 syndrome**\nConsiderations for all FDA-authorized or -approved COVID-19 vaccines\nPersons receiving HCT and CAR-T-cell\ntherapy\n\u0083 If received doses of COVID-19 vaccine prior to or during HCT or CAR-T cell therapy, should be revaccinated for any monovalent primary series\nand bivalent booster doses received before or during treatment at least 3 months (12 weeks) after transplant or CAR-T-cell therapy."}]}, {"title": "104a33b1b73b00d78659703a30116200", "paragraphs": [{"qas": [{"question": "What is not available for monovalent booster doses?", "id": "100000000000000000010098", "answers": [{"text": "revaccination", "answer_start": 11}], "is_impossible": false}, {"question": "What is the Interim COVID-19 Immunization Schedule for Ages 6 Months or Older at https://www.cdc.gov/vaccines/covid-19/downloads/COPID-19- Persons receiving immunosuppressive therapies?", "id": "100000000000000000010099", "answers": [{"text": "revaccination for monovalent booster doses. Persons who are moderately or severely immunocompromised \u0083", "answer_start": 11}], "is_impossible": false}, {"question": "What vaccine is recommended for everyone ages 6 months and older?", "id": "100000000000000000010101", "answers": [{"text": "COVID-19", "answer_start": 522}], "is_impossible": false}, {"question": "What is the recommended age for COVID-19 vaccination?", "id": "100000000000000000010102", "answers": [{"text": "6 months and older", "answer_start": 576}], "is_impossible": false}, {"question": "How long does it take for someone to discontinue isolation?", "id": "100000000000000000010103", "answers": [{"text": "until person has recovered from acute illness", "answer_start": 693}], "is_impossible": false}], "context": "There is no\nrevaccination for monovalent booster doses. Persons who are moderately or\nseverely immunocompromised\n\u0083 See the Interim COVID-19 Immunization Schedule for Ages 6 Months or Older at https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-\nPersons receiving\nimmunosuppressive therapies\n\u0083 Whenever possible, COVID-19 vaccines should be administered at least 2 weeks before initiation or resumption of immunosuppressive therapies\n\u0083 Current infection\n\u0083 History of previous infection\n\u0083 Exposed to an infected person\nCOVID-19 vaccination is recommended for everyone ages 6 months and older, regardless of a history of symptomatic or asymptomatic SARS-CoV-2\ninfection. \u0083 Defer vaccination until person has recovered from acute illness and criteria have been met for them to discontinue isolation."}]}, {"title": "f6ad14a14517106f58240e713d54426a", "paragraphs": [{"qas": [{"question": "What is not recommended for the purpose of vaccine?", "id": "100000000000000000010105", "answers": [{"text": "Viral testing", "answer_start": 177}], "is_impossible": false}, {"question": "What is not recommended for the purpose of vaccine decision-making?", "id": "100000000000000000010106", "answers": [{"text": "Viral testing", "answer_start": 177}], "is_impossible": false}, {"question": "What is NOT recommended for post-exposure prophylaxis?", "id": "100000000000000000010107", "answers": [{"text": "COVID-19 vaccination", "answer_start": 480}], "is_impossible": false}, {"question": "People with a history of an episode of an immune-mediated syndrome, such as spontaneous or classic HIT, should not receive what?", "id": "100000000000000000010108", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 736}], "is_impossible": false}], "context": "\u0083 People who recently had SARS-CoV-2 infection may consider delaying their next COVID-19 dose by 3 months from symptom onset or positive test\n(if infection was asymptomatic). \u0083 Viral testing to assess for acute SARS-CoV-2 infection or serologic testing to assess for prior infection is not recommended for the purpose of\nvaccine decision-making. \u0083 Additional information at: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#infection\n\u0083 COVID-19 vaccination is not recommended for post-exposure prophylaxis. \u00a7 Additionally, people with a history of an episode of immune-mediated syndrome characterized by thrombosis and thrombocytopenia, such as spontaneous or classic HIT, should not receive Janssen COVID-19 Vaccine."}]}, {"title": "edb2f5df6449fffbade5e9c9313c16c5", "paragraphs": [{"qas": [{"question": "Who should not receive another dose of Janssen COVID-19 Vaccine?", "id": "100000000000000000010112", "answers": [{"text": "People who develop GBS", "answer_start": 196}], "is_impossible": false}, {"question": "What should these people receive for subsequent doses?", "id": "100000000000000000010113", "answers": [{"text": "mRNA COVID-19 vaccine", "answer_start": 386}], "is_impossible": false}], "context": "These people should receive an\nmRNA or Novavax COVID-19 vaccine booster dose. \u00b6 People with a known allergy to polysorbate have a contraindication to both Novavax ad Janssen COVID-19 vaccines. ** People who develop GBS within 6 weeks after receipt of Janssen COVID-19 Vaccine should not receive another dose of Janssen COVID-19 Vaccine. These people should receive a booster dose of an mRNA COVID-19 vaccine for subsequent doses."}]}, {"title": "a8ccce3717bbd7cd92f04cfc3f204abc", "paragraphs": [{"qas": [{"question": "How long after an SARS-CoV-2 infection can COVID-19 vaccines be given?", "id": "100000000000000000010114", "answers": [{"text": "at least 90 days", "answer_start": 374}], "is_impossible": false}, {"question": "How long does it take to recover from an MIS-C diagnosis?", "id": "100000000000000000010116", "answers": [{"text": "90 days", "answer_start": 383}], "is_impossible": false}, {"question": "What is the minimum time period for recovery?", "id": "100000000000000000010117", "answers": [{"text": "90 days", "answer_start": 383}], "is_impossible": false}, {"question": "How long after a diagnosis is it?", "id": "100000000000000000010118", "answers": [{"text": "90 days", "answer_start": 383}], "is_impossible": false}], "context": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nConsiderations for all FDA-authorized or -approved COVID-19 vaccines\nPersons with history of multisystem\ninflammatory syndrome (MIS-C and\nMIS-A) from SARS-CoV-2 infection\n\u0083 COVID-19 vaccines can be given; wait until clinical recovery and at least 90 days after an MIS-C or MIS-A diagnosis."}]}, {"title": "a29fa7591a0d90200fb0b5b1c7a5a9f3", "paragraphs": [{"qas": [{"question": "Who should have a conversation to discuss the benefits and risks of receiving a COVID-19 vaccine?", "id": "100000000000000000010119", "answers": [{"text": "the vaccine recipient, guardian, and clinical team or specialist", "answer_start": 194}], "is_impossible": false}, {"question": "What is an important factor when considering COVID-19 vaccination?", "id": "100000000000000000010121", "answers": [{"text": "Clinical recovery", "answer_start": 338}], "is_impossible": false}, {"question": "What can be given at any interval following receipt of passive antibody therapy?", "id": "100000000000000000010122", "answers": [{"text": "COVID-19 vaccination", "answer_start": 707}], "is_impossible": false}], "context": "\u0083 For persons who have had MIS-C or MIS-A from SARS-CoV-2 infection who have not yet received COVID-19 vaccine or who developed MIS-C or\nMIS-A after COVID-19 vaccination, a conversation between the vaccine recipient, guardian, and clinical team or specialist to discuss benefits and\nrisks of receiving a COVID-19 vaccine is encouraged. \u0083 Clinical recovery, including return to normal cardiac function, is an important factor when considering COVID-19 vaccination. Additional\ninformation at: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#covid19-vaccination-misc-misa\nPersons who received passive antibody\ntherapy (convalescent plasma/\nmonoclonal antibodies)\n\u0083 COVID-19 vaccination can be given at any interval following receipt of passive antibody therapy."}]}, {"title": "9d384193cc3b62a17bdc01e06449daf8", "paragraphs": [{"qas": [{"question": "Who should wait 2 weeks after COVID-19 vaccination before receiving tixagevimab?", "id": "100000000000000000010123", "answers": [{"text": "Persons", "answer_start": 2}], "is_impossible": false}, {"question": "Who should be vaccinated according to the recommended schedule?", "id": "100000000000000000010124", "answers": [{"text": "Persons who are pregnant", "answer_start": 138}], "is_impossible": false}, {"question": "What is a precaution to a subsequent dose of any COVID-19 vaccine?", "id": "100000000000000000010125", "answers": [{"text": "Development of myocarditis or pericarditis", "answer_start": 417}], "is_impossible": false}], "context": "\u0083 Persons should wait 2 weeks after COVID-19 vaccination before receiving tixagevimab/cilgavimab (EVUSHELD) for pre-exposure prophylaxis. Persons who are pregnant,\nbreastfeeding, trying to get pregnant,\nor might become pregnant in the future\n\u0083 Are recommended to be vaccinated according to the recommended schedule. Considerations for mRNA vaccines and Novavax\nPersons with a history of myocarditis\nor pericarditis\n\u0083 Development of myocarditis or pericarditis after a dose of an mRNA or Novavax COVID-19 vaccine is a precaution to a subsequent dose of any\nCOVID-19 vaccine."}]}, {"title": "202b8ff82c6e9903f8f42a28f145826a", "paragraphs": [{"qas": [{"question": "What is the name of the appendix that provides information on the use of Janssen's vaccine?", "id": "100000000000000000010128", "answers": [{"text": "Appendix A", "answer_start": 246}], "is_impossible": false}, {"question": "Who should wait until after their episode has resolved to get a second dose of the Janssen Vaccine?", "id": "100000000000000000010129", "answers": [{"text": "If after a risk assessment", "answer_start": 2}], "is_impossible": false}, {"question": "Who may receive any age-appropriate COVID-19 vaccine after the episode of myocarditis has resolved?", "id": "100000000000000000010131", "answers": [{"text": "Persons who have a history of myocarditis or pericarditis unrelated to mRNA or Novavax COVID-19 vaccination", "answer_start": 369}], "is_impossible": false}], "context": "\u0083 If after a risk assessment the decision is made to receive a subsequent COVID-19 vaccine dose, the person should wait until after their episode has\nresolved. \u0083 For information on potential use of Janssen COVID-19 Vaccine in this situation, see Appendix A at www.cdc.gov/vaccines/covid-19/clinical-\nconsiderations/interim-considerations-us-appendix. html#appendix-a\n\u0083 Persons who have a history of myocarditis or pericarditis unrelated to mRNA or Novavax COVID-19 vaccination may receive any age-appropriate\nCOVID-19 vaccine after the episode of myocarditis or pericarditis has resolved."}]}, {"title": "23a47d740ee78593077b8e9c3b95e0ba", "paragraphs": [{"qas": [{"question": "What is a precaution for receipt of the Janssen COVID-19 Vaccine?", "id": "100000000000000000010132", "answers": [{"text": "A history of GBS", "answer_start": 439}], "is_impossible": false}, {"question": "What is the name of the Guillain- Barr\u00e9 syndrome?", "id": "100000000000000000010133", "answers": [{"text": "GBS", "answer_start": 432}], "is_impossible": false}, {"question": "Who should receive a booster dose of an mRNA or Novavax vaccine for subsequent doses?", "id": "100000000000000000010135", "answers": [{"text": "Persons who develop GBS within 6 weeks of Janssen COVID-19 vaccination", "answer_start": 559}], "is_impossible": false}, {"question": "Who should receive a booster dose of an mRNA COVID-19 vaccine for subsequent doses?", "id": "100000000000000000010136", "answers": [{"text": "Persons who develop GBS within 6 weeks of Janssen COVID-19 vaccination", "answer_start": 559}], "is_impossible": false}], "context": "\u0083 For more information see: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#myocarditis-pericarditis\nConsiderations for Janssen COVID-19 Vaccine\nJanssen COVID-19 Vaccine is authorized for adults ages 18 years and older in certain limited situations due to safety considerations. For more information, see https://www.cdc.gov/vaccines/\nPersons with a history of Guillain-\nBarr\u00e9 syndrome (GBS)\n\u0083 A history of GBS is a precaution for receipt of Janssen COVID-19 Vaccine. An mRNA or Novavax vaccine is recommended..\n\u0083 Persons who develop GBS within 6 weeks of Janssen COVID-19 vaccination should only receive an mRNA COVID-19 vaccine for subsequent\ndoses. These people should receive a booster dose of an mRNA COVID-19 vaccine for subsequent doses."}]}, {"title": "56d3446bec7634f5248bbe1fde5464f3", "paragraphs": [{"qas": [{"question": "What is thrombocytopenia syndrome?", "id": "100000000000000000010137", "answers": [{"text": "TTS", "answer_start": 249}], "is_impossible": false}, {"question": "What is the name of the adenovirus vector-based COVID-19 vaccine?", "id": "100000000000000000010139", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 375}], "is_impossible": false}, {"question": "How long should a person receive a dose of an mRNA covid-19 vaccine as a booster dose?", "id": "100000000000000000010140", "answers": [{"text": "at least 2 months", "answer_start": 579}], "is_impossible": false}], "context": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nConsiderations for Janssen COVID-19 Vaccine\nPersons with a history of thrombosis\nwith thrombocytopenia syndrome\n(TTS)\n\u0083 It is contraindicated to administer Janssen COVID-19 Vaccine to persons with a history of TTS following receipt of the Janssen COVID-19 Vaccine or\nany other adenovirus vector-based COVID-19 vaccines (e.g., AstraZeneca\u2019s COVID-19 Vaccine). \u0083 These persons should receive a dose of an mRNA COVID-19 vaccine as a booster dose at least 2 months (8 weeks) following their dose of the\nJanssen COVID-19 Vaccine and after their clinical condition has stabilized."}]}, {"title": "38ea1d417afb05e16a38cf84012530cb", "paragraphs": [{"qas": [{"question": "Who should receive the mRNA or Novavax Covid-19 vaccine?", "id": "100000000000000000010143", "answers": [{"text": "Persons with a history of heparin- induced thrombocytopenia", "answer_start": 0}], "is_impossible": false}, {"question": "What is HIT?", "id": "100000000000000000010144", "answers": [{"text": "heparin- induced thrombocytopenia", "answer_start": 26}], "is_impossible": false}, {"question": "What is the name of the mRNA or Novavax COVID-19 vaccine?", "id": "100000000000000000010145", "answers": [{"text": "Janssen COVID-19 Vaccine", "answer_start": 215}], "is_impossible": false}, {"question": "What are the recommendations for people vaccinated outside of the US?", "id": "100000000000000000010146", "answers": [{"text": "depend on the number and type of vaccine(s) received for the primary series and booster doses, whether the primary series was completed, and whether a booster dose was received", "answer_start": 465}], "is_impossible": false}], "context": "Persons with a history of heparin-\ninduced thrombocytopenia (HIT)\n\u0083 Persons with a history of an episode of an immune-mediated syndrome characterized by TTS, such as a spontaneous or classic HIT, should not\nreceive Janssen COVID-19 Vaccine. \u0083 These persons should receive an mRNA or Novavax COVID-19 vaccine. General COVID-19 Vaccination Information\nPersons vaccinated outside the\nUnited States\n\u0083 The recommendations for people vaccinated outside the United States depend on the number and type of vaccine(s) received for the primary\nseries and booster doses, whether the primary series was completed, and whether a booster dose was received."}]}, {"title": "84171aee554ca1b8dea2756ce5a292df", "paragraphs": [{"qas": [{"question": "Why should providers consider observing vaccine recipients for 15 minutes after vaccination?", "id": "100000000000000000010148", "answers": [{"text": "the risk of syncope", "answer_start": 238}], "is_impossible": false}, {"question": "What is a risk of syncope?", "id": "100000000000000000010149", "answers": [{"text": "Vaccination providers, particularly when vaccinating adolescents, should consider observing vaccine recipients for 15 minutes", "answer_start": 83}], "is_impossible": false}], "context": "Current guidance can be found at:\nPost-vaccination observation periods\n15 minutes: Vaccination providers, particularly when vaccinating adolescents, should consider observing vaccine recipients for 15 minutes after\nvaccination because of the risk of syncope."}]}, {"title": "feefd4010c8db878038b3867b0739ecb", "paragraphs": [{"qas": [{"question": "What should vaccinators observe for 30 minutes after a vaccination?", "id": "100000000000000000010150", "answers": [{"text": "persons with the following medical histories", "answer_start": 60}], "is_impossible": false}, {"question": "What should providers monitor for after vaccination to monitor for allergic reactions?", "id": "100000000000000000010151", "answers": [{"text": "medical histories", "answer_start": 87}], "is_impossible": false}, {"question": "How long should a person have an allergic reaction after receiving a COVID-19 vaccine?", "id": "100000000000000000010152", "answers": [{"text": "30 minutes", "answer_start": 109}], "is_impossible": false}, {"question": "What is not recommended for vaccine decision-making or to assess immunity following vaccination?", "id": "100000000000000000010153", "answers": [{"text": "Antibody testing", "answer_start": 454}], "is_impossible": false}, {"question": "What should be reported to VAERS?", "id": "100000000000000000010154", "answers": [{"text": "Adverse events that occur following COVID-19 vaccination", "answer_start": 586}], "is_impossible": false}], "context": "30 minutes: Vaccination providers should consider observing persons with the following medical histories for 30 minutes after vaccination to\nmonitor for allergic reactions:\n\u0083 An allergy-related contraindication to a different type of COVID-19 vaccine\n\u0083 Non-severe, immediate (onset within 4 hours) allergic reaction after a previous dose of COVID-19 vaccine\n\u0083 Anaphylaxis after non-COVID-19 vaccines or injectable therapies\nSARS-CoV-2 antibody testing \u0083 Antibody testing is not recommended for vaccine decision-making or to assess immunity following vaccination. Reporting requirements\nAdverse events that occur following COVID-19 vaccination should be reported to VAERS (https://vaers.hhs.gov/)."}]}, {"title": "89ea205deddff8b58ad49f5babca9ee9", "paragraphs": [{"qas": [{"question": "What are providers of COVID-19 required to report?", "id": "100000000000000000010155", "answers": [{"text": "Vaccine administration errors \u0083 Serious adverse events", "answer_start": 45}], "is_impossible": false}, {"question": "What are some cases of Multisystem Inflammatory Syndrome?", "id": "100000000000000000010156", "answers": [{"text": "Cases of COVID-19 that result in hospitalization or death", "answer_start": 147}], "is_impossible": false}], "context": "COVID-19 providers are required to\nreport:\n\u0083 Vaccine administration errors\n\u0083 Serious adverse events\n\u0083 Cases of Multisystem Inflammatory Syndrome\n\u0083 Cases of COVID-19 that result in hospitalization or death"}]}]}